FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Cragan, J
   Ellington, S
   Delaney, A
   Smoots, A
   Song, Z
   Galang, R
   Rasmussen, SA
   Honein, MA
   Moore, CA
AF Cragan, J.
   Ellington, S.
   Delaney, A.
   Smoots, A.
   Song, Z.
   Galang, R.
   Rasmussen, S. A.
   Honein, M. A.
   Moore, C. A.
TI CONGENITAL ZIKA VIRUS INFECTION AND NEURAL TUBE DEFECTS
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Meeting Abstract
CT 39th Annual David W Smith Workshop on Malformations and Morphogenesis
CY AUG 24-29, 2018
CL Banff, CANADA
C1 [Cragan, J.; Ellington, S.; Delaney, A.; Smoots, A.; Song, Z.; Galang, R.; Rasmussen, S. A.; Honein, M. A.; Moore, C. A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR
PY 2019
VL 179
IS 4
BP 728
EP 729
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA HQ8LS
UT WOS:000462676800138
DA 2020-07-08
ER

PT J
AU Morazzani, EM
   Compton, JR
   Leary, DH
   Berry, AV
   Hu, X
   Marugan, JJ
   Glass, PJ
   Legler, PM
AF Morazzani, Elaine M.
   Compton, Jaimee R.
   Leary, Dagmar H.
   Berry, Angela V.
   Hu, Xin
   Marugan, Juan J.
   Glass, Pamela J.
   Legler, Patricia M.
TI Proteolytic cleavage of host proteins by the Group IV viral proteases of
   Venezuelan equine encephalitis virus and Zika virus
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE VEEV; Alphavirus; nsP2 protease; Protease inhibitors; Host protein
   substrates; Innate immune response; Evasion; Interferon antagonism;
   Host-pathogen interactions; Co-translational silencing;
   Post-translational silencing; Antiviral drug target; Zika virus;
   Microcephaly
ID FRIZZLED-RELATED PROTEIN-1; TATA-BINDING PROTEIN; POLYMERASE-II
   TRANSCRIPTION; TRIM FAMILY PROTEINS; NF-KAPPA-B; 3C PROTEASE;
   SINDBIS-VIRUS; NS2B-NS3 PROTEASE; ADAPTER PROTEIN; RIG-I
AB The alphaviral nonstructural protein 2 (nsP2) cysteine proteases (EC 3.4.22.-) are essential for the proteolytic processing of the nonstructural (ns) polyprotein and are validated drug targets. A common secondary role of these proteases is to antagonize the effects of interferon (IFN). After delineating the cleavage site motif of the Venezuelan equine encephalitis virus (VEEV) nsP2 cysteine protease, we searched the human genome to identify host protein substrates. Here we identify a new host substrate of the VEEV nsP2 protease, human TRIM14, a component of the mitochondria] antiviral-signaling protein (MAVS) signalosome. Short stretches of homologous host-pathogen protein sequences (SSHHPS) are present in the nonstructural polyprotein and TRIM14. A 25-residue cyan-yellow fluorescent protein TRIM14 substrate was cleaved in vitro by the VEEV nsP2 protease and the cleavage site was confirmed by tandem mass spectrometry. A TRIM14 cleavage product also was found in VEEV-infected cell lysates. At least ten other Group IV ( + )ssRNA viral proteases have been shown to cleave host proteins involved in generating the innate immune responses against viruses, suggesting that the integration of these short host protein sequences into the viral protease cleavage sites may represent an embedded mechanism of IFN antagonism. This interference mechanism shows several parallels with those of CRISPR/Cas9 and RNAi/RISC, but with a protease recognizing a protein sequence common to both the host and pathogen. The short host sequences embedded within the viral genome appear to be analogous to the short phage sequences found in a host's CRISPR spacer sequences. To test this algorithm, we applied it to another Group IV virus, Zika virus (ZIKV), and identified cleavage sites within human SFRP1 (secreted frizzled related protein 1), a retinal G, alpha subunit, NT5M, and Forkhead box protein G1 (FOXG1) in vitro. Proteolytic cleavage of these proteins suggests a possible link between the protease and the virus-induced phenotype of ZIKV. The algorithm may have value for selecting cell lines and animal models that recapitulate virus-induced phenotypes, predicting host-range and susceptibility, selecting oncolytic viruses, identifying biomarkers, and de-risking live virus vaccines. Inhibitors of the proteases that utilize this mechanism may both inhibit viral replication and alleviate suppression of the innate immune responses.
C1 [Morazzani, Elaine M.; Glass, Pamela J.] US Army Med Res Inst Infect Dis, Frederick, MD 21702 USA.
   [Berry, Angela V.] Hampton Univ, Sch Pharm, Hampton, VA 23668 USA.
   [Hu, Xin; Marugan, Juan J.] NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA.
   [Compton, Jaimee R.; Leary, Dagmar H.; Legler, Patricia M.] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.
RP Legler, PM (corresponding author), 4555 Overlook Ave SW, Washington, DC 20375 USA.
EM Patricia.legler@nrl.navy.mil
RI Glass, Pamela/AAN-5555-2020
OI Legler, Patricia/0000-0003-1196-1061
FU DTRA project [CB-SEED-SEED09-2-0061, CBCa114-CBM-05-2-0019]; Office of
   Naval Research (ONR) 6.1 base fundingOffice of Naval Research; NRL
   HBCU/MI summer internship program - ONR [N0017315RMV04]
FX This work was supported by DTRA project numbers CB-SEED-SEED09-2-0061
   and CBCa114-CBM-05-2-0019, Office of Naval Research (ONR) 6.1 base
   funding, and the NRL HBCU/MI summer internship program sponsored by the
   ONR (#N0017315RMV04).
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akhrymuk I, 2016, VIROLOGY, V487, P230, DOI 10.1016/j.virol.2015.09.023
   Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108
   Atasheva S, 2010, J VIROL, V84, P4158, DOI 10.1128/JVI.02554-09
   Augustine C, 2001, MECH DEVELOP, V109, P395, DOI 10.1016/S0925-4773(01)00533-0
   Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06
   Barral PM, 2009, VIROLOGY, V391, P171, DOI 10.1016/j.virol.2009.06.045
   Bellecave P, 2010, HEPATOLOGY, V51, P1127, DOI 10.1002/hep.23426
   Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105
   Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125
   Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Campos-Gomez J, 2016, VIROLOGY, V496, P77, DOI 10.1016/j.virol.2016.05.012
   Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894
   Chang JHT, 1999, HUM MOL GENET, V8, P575, DOI 10.1093/hmg/8.4.575
   Cheung J. F, 2011, STRUCTURE CHIKUNGUNY
   CLARK ME, 1993, MOL CELL BIOL, V13, P1232, DOI 10.1128/MCB.13.2.1232
   CLARK ME, 1991, EMBO J, V10, P2941, DOI 10.1002/j.1460-2075.1991.tb07844.x
   Compton JR, 2017, BIOCHEMISTRY-US, V56, P6221, DOI 10.1021/acs.biochem.7b00746
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Cruz AA, 2013, PROTEIN SCI, V22, P1, DOI 10.1002/pro.2185
   DAS S, 1993, J VIROL, V67, P3326, DOI 10.1128/JVI.67.6.3326-3331.1993
   Dastidar SG, 2012, J BIOL CHEM, V287, P14749, DOI 10.1074/jbc.M111.328336
   de Breyne S, 2008, VIROLOGY, V378, P118, DOI 10.1016/j.virol.2008.05.019
   DING MX, 1989, VIROLOGY, V171, P280, DOI 10.1016/0042-6822(89)90539-4
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Esteve P, 2011, NAT NEUROSCI, V14, P562, DOI 10.1038/nn.2794
   Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600
   FALK MM, 1990, J VIROL, V64, P748, DOI 10.1128/JVI.64.2.748-756.1990
   Fata CL, 2002, J VIROL, V76, P8632, DOI 10.1128/JVI.76.17.8632-8640.2002
   Foeger N, 2002, J BIOL CHEM, V277, P44300, DOI 10.1074/jbc.M208006200
   Fotaki V, 2013, DEV BIOL, V380, P299, DOI 10.1016/j.ydbio.2013.04.017
   Fros JJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060166
   Garmashova N, 2007, J VIROL, V81, P13552, DOI 10.1128/JVI.01576-07
   Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06
   Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Graham KL, 2004, J VIROL, V78, P6313, DOI 10.1128/JVI.78.12.6313-6321.2004
   GRIGERA PR, 1984, VIROLOGY, V136, P10, DOI 10.1016/0042-6822(84)90243-5
   Gropman AL, 2006, PEDIATR NEUROL, V34, P337, DOI 10.1016/j.pediatrneurol.2005.08.018
   HARDY WR, 1989, J VIROL, V63, P4653, DOI 10.1128/JVI.63.11.4653-4664.1989
   Hirose S, 2003, BIOCHEM BIOPH RES CO, V311, P351, DOI 10.1016/j.bbrc.2003.09.212
   Hiscott J, 2006, BIOCHEM PHARMACOL, V72, P1477, DOI 10.1016/j.bcp.2006.06.030
   Hollidge BS, 2011, VIRUSES-BASEL, V3, P629, DOI 10.3390/v3060629
   Hu GW, 2019, ONCOL RES, V27, P439, DOI 10.3727/096504018X15214994641786
   Hu X, 2016, BIOCHEMISTRY-US, V55, P3007, DOI 10.1021/acs.biochem.5b00992
   Ibrahim B, 2018, VIRUS RES, V251, P86, DOI 10.1016/j.virusres.2018.05.009
   Jacob FD, 2009, EUR J HUM GENET, V17, P1577, DOI 10.1038/ejhg.2009.95
   James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104
   Jia X, 2017, J IMMUNOL, V198, P4652, DOI 10.4049/jimmunol.1601322
   Kading RC, 2016, AM J TROP MED HYG, V95, P993, DOI 10.4269/ajtmh.16-0625
   Kiemer L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-72
   Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528
   Kundu P, 2005, J VIROL, V79, P9702, DOI 10.1128/JVI.79.15.9702-9713.2005
   Kuyumcu-Martinez M, 2004, J VIROL, V78, P8172, DOI 10.1128/JVI.78.15.8172-8182.2004
   Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004
   Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002
   Lee YS, 2012, EUR J IMMUNOL, V42, P2564, DOI 10.1002/eji.201242445
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102
   Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327
   Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05
   Lin W, 2001, FEBS LETT, V507, P1, DOI 10.1016/S0014-5793(01)02885-X
   Ma M, 2016, J PEDIATR-US, V178, P233, DOI 10.1016/j.jpeds.2016.08.032
   Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940
   Marcos S, 2015, J NEUROSCI, V35, P4729, DOI 10.1523/JNEUROSCI.3304-13.2015
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104
   Morazzani E. M, 2017, PROTEOLYTIC CLEAVAGE
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Munir M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc2
   Nenasheva VV, 2015, IMMUNOL RES, V62, P255, DOI 10.1007/s12026-015-8653-1
   Neznanov N, 2005, J BIOL CHEM, V280, P24153, DOI 10.1074/jbc.M502303200
   Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248
   Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413
   Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pratt DW, 2012, MOL SYNDROMOL, V3, P284, DOI 10.1159/000345845
   Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051
   Qu L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002169
   Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239
   Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105
   REAGAN REGINALD L., 1955, TRANS AMER MICROSC SOC, V74, P77, DOI 10.2307/3223847
   Romero-Brey I, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060160
   Ruge DR, 2011, ANAL BIOCHEM, V411, P200, DOI 10.1016/j.ab.2011.01.002
   Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274
   SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Shin G, 2012, P NATL ACAD SCI USA, V109, P16534, DOI 10.1073/pnas.1210418109
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Simmons JD, 2009, J VIROL, V83, P10571, DOI 10.1128/JVI.01041-09
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   STRAUSS EG, 1992, VIROLOGY, V191, P932, DOI 10.1016/0042-6822(92)90268-T
   Su X, 2016, ONCOTARGET, V7, P9939, DOI 10.18632/oncotarget.6941
   Sun D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16484-1
   SWAROOP A, 1991, NUCLEIC ACIDS RES, V19, P4725, DOI 10.1093/nar/19.17.4725
   Tan P, 2017, MOL CELL, V68, P293, DOI 10.1016/j.molcel.2017.09.035
   Trevant B, 2008, J CELL PHYSIOL, V217, P113, DOI 10.1002/jcp.21482
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Vezzali R, 2016, ONCOTARGET, V7, P37436, DOI 10.18632/oncotarget.9545
   Wang D, 2014, J VIROL, V88, P10252, DOI 10.1128/JVI.00869-14
   Wang D, 2012, J VIROL, V86, P9311, DOI 10.1128/JVI.00722-12
   Wang SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep32336
   Weidman MK, 2003, VIRUS RES, V95, P75, DOI 10.1016/S0168-1702(03)00164-3
   Xu GX, 2017, SCI REP-UK, V7, DOI 10.1038/srep42411
   Yalamanchili P, 1997, J VIROL, V71, P6881, DOI 10.1128/JVI.71.9.6881-6886.1997
   Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229
   Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zhang D, 2009, PROTEIN EXPRES PURIF, V64, P89, DOI 10.1016/j.pep.2008.10.013
   Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07
   Zhou Z, 2014, P NATL ACAD SCI USA, V111, pE245, DOI 10.1073/pnas.1316941111
NR 116
TC 3
Z9 3
U1 2
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD APR
PY 2019
VL 164
BP 106
EP 122
DI 10.1016/j.antiviral.2019.02.001
PG 17
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HR7AG
UT WOS:000463303700010
PM 30742841
OA Other Gold
DA 2020-07-08
ER

PT J
AU Pitts, J
   Hsia, CY
   Lian, WL
   Wang, JH
   Pfeil, MP
   Kwiatkowski, N
   Li, ZN
   Jang, J
   Gray, NS
   Yang, PL
AF Pitts, Jared
   Hsia, Chih-Yun
   Lian, Wenlong
   Wang, Jinhua
   Pfeil, Marc-Philipp
   Kwiatkowski, Nicholas
   Li, Zhengnian
   Jang, Jaebong
   Gray, Nathanael S.
   Yang, Priscilla L.
TI Identification of small molecule inhibitors targeting the Zika virus
   envelope protein
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID TETRAVALENT DENGUE VACCINE; INFECTION; IMMUNOGENICITY; EFFICACY;
   PHASE-1; DISEASE; SAFETY
AB The recent emergence of Zika virus, a mosquito-borne flavivirus, in the Americas has shed light on the severe neurological diseases associated with infection, notably congenital microcephaly in newborns and Guillain-Barre syndrome in adults. Despite the recent focus on Zika virus, there are currently no approved vaccines or antiviral therapies available to treat or prevent infection. In this study we established a competitive amplified luminescent proximity homogeneous assay (ALPHAscreen) to identify small molecule inhibitors targeting the envelope protein of Zika virus (Zika E). We utilized this assay to screen two libraries of nearly 27,000 compounds and identified seven novel inhibitors of Zika E. Characterization of these primary screening leads demonstrated that inhibition of Zika virus occurs at non-cytotoxic concentrations for all seven lead compounds. In addition, we found that all seven lead compounds have potent activity against the closely related dengue virus 2 but not vesicular stomatitis virus, an unrelated enveloped virus. Biochemical experiments indicate that these compounds act by preventing E-mediated membrane fusion. This work highlights a new method for the discovery and optimization of direct-acting antivirals targeting the E protein of Zika and other flaviviruses.
C1 [Pitts, Jared; Hsia, Chih-Yun; Lian, Wenlong; Pfeil, Marc-Philipp; Yang, Priscilla L.] Harvard Med Sch, Dept Microbiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
   [Pitts, Jared; Hsia, Chih-Yun; Lian, Wenlong; Pfeil, Marc-Philipp; Yang, Priscilla L.] Harvard Med Sch, Blavatnik Inst, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
   [Wang, Jinhua; Kwiatkowski, Nicholas; Li, Zhengnian; Jang, Jaebong; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, 360 Longwood Ave, Boston, MA 02215 USA.
   [Wang, Jinhua; Kwiatkowski, Nicholas; Li, Zhengnian; Jang, Jaebong; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 360 Longwood Ave, Boston, MA 02215 USA.
RP Yang, PL (corresponding author), Harvard Med Sch, Dept Microbiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Yang, PL (corresponding author), Harvard Med Sch, Blavatnik Inst, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM priscilla_yang@hms.harvard.edu
OI Yang, Priscilla/0000-0001-7456-2557; Li, Zhengnian/0000-0001-5851-8011
FU Blavatnik Biomedical Accelerator and National Institutes of Health
   [U19AI109740]
FX Special thanks to Jennifer Smith and the ICCB-Longwood Screening
   Facility staff for access to the screening compounds, instrumentation,
   and technical support. We would also like to thank the following
   colleagues for sharing reagents: Lee Gehrke for the DENV2 New Guinea C
   strain virus; Didier Musso and Nathalie Pardigon for ZIKV PF13-251013-18
   strain; Sean Whelan for VSV; Katya Heldwein for S2 cells; and Eva Harris
   for BHK-21 cells. The office of Congressman Michael Capuano is thanked
   for assistance in importing ZIKV. The work in this manuscript has been
   supported by the Blavatnik Biomedical Accelerator and National
   Institutes of Health award U19AI109740.
CR Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2016, J INFECT DIS, V214, P1793, DOI 10.1093/infdis/jiw340
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lian WL, 2018, ACS INFECT DIS, V4, P1395, DOI 10.1021/acsinfecdis.8b00127
   Lim SP, 2019, ANTIVIR RES, V163, P156, DOI 10.1016/j.antiviral.2018.12.016
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rawle RJ, 2018, ACS CENTRAL SCI, V4, P1503, DOI 10.1021/acscentsci.8b00494
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schmidt AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002627
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 28
TC 3
Z9 3
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD APR
PY 2019
VL 164
BP 147
EP 153
DI 10.1016/j.antiviral.2019.02.008
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HR7AG
UT WOS:000463303700014
PM 30771406
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Yang, X
   Qi, JX
   Peng, RC
   Dai, LP
   Gould, EA
   Gao, GF
   Tien, P
AF Yang, Xu
   Qi, Jianxun
   Peng, Ruchao
   Dai, Lianpan
   Gould, Ernest A.
   Gao, George F.
   Tien, Po
TI Molecular Basis of a Protective/Neutralizing Monoclonal Antibody
   Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and
   Louping Ill Virus
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE louping ill virus (LIV); crystal structure; envelope protein (E);
   monoclonal neutralizing/protective antibody; tick-borne encephalitis
   virus (TBEV); tick-borne flaviviruses (TBFVs)
ID WEST-NILE-VIRUS; ZIKA VIRUS; NEUTRALIZING ANTIBODIES; STRUCTURAL
   BIOLOGY; CRYSTAL-STRUCTURE; DOMAIN-III; SPECIFICITY; EVOLUTION;
   RESPONSES; DENGUE
AB Tick-borne encephalitis virus (TBEV) and louping ill virus (LIV) are members of the tick-borne flaviviruses (TBFVs) in the family Flaviviridae which cause encephalomeningitis and encephalitis in humans and other animals. Although vaccines against TBEV and LIV are available, infection rates are rising due to the low vaccination coverage. To date, no specific therapeutics have been licensed. Several neutralizing monoclonal antibodies (MAbs) show promising effectiveness in the control of TBFVs, but the underlying molecular mechanisms are yet to be characterized. Here, we determined the crystal structures of the LIV envelope (E) protein and report the comparative structural analysis of a TBFV broadly neutralizing murine MAb (MAb 4.2) in complex with either the LIV or TBEV E protein. The structures reveal that MAb 4.2 binds to the lateral ridge of domain III of the E protein (EDIII) of LIV or TBEV, an epitope also reported for other potently neutralizing MAbs against mosquito-borne flaviviruses (MBFVs), but adopts a unique binding orientation. Further structural analysis suggested that MAb 4.2 may neutralize flavivirus infection by preventing the structural rearrangement required for membrane fusion during virus entry. These findings extend our understanding of the vulnerability of TBFVs and other flaviviruses (including MBFVs) and provide an avenue for antibody-based TBFV antiviral development.
   IMPORTANCE Understanding the mechanism of antibody neutralization/protection against a virus is crucial for antiviral countermeasure development. Tick-borne encephalitis virus (TBEV) and louping ill virus (LIV) are tick-borne flaviviruses (TBFVs) in the family Flaviviridae. They cause encephalomeningitis and encephalitis in humans and other animals. Although vaccines for both viruses are available, infection rates are rising due to low vaccination coverage. In this study, we solved the crystal structures of the LIV envelope protein (E) and a broadly neutralizing/protective TBFV MAb, MAb 4.2, in complex with E from either TBEV or LIV. Key structural features shared by TBFV E proteins were analyzed. The structures of E-antibody complexes showed that MAb 4.2 targets the lateral ridge of both the TBEV and LIV E proteins, a vulnerable site in flaviviruses for other potent neutralizing MAbs. Thus, this site represents a promising target for TBFV antiviral development. Further, these structures provide important information for understanding TBFV antigenicity.
C1 [Yang, Xu; Qi, Jianxun; Peng, Ruchao; Gao, George F.; Tien, Po] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Yang, Xu] Univ Chinese Acad Sci, Sch Life Sci, Beijing, Peoples R China.
   [Dai, Lianpan; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.
   [Gould, Ernest A.] UVE, Marseille, France.
   [Gould, Ernest A.] Aix Marseille Univ, IRD, INSERM IHU Mediterranee Infect 190 1207, Marseille, France.
RP Gao, GF; Tien, P (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.
EM tienpo@im.ac.cn
FU Strategic Priority Research Program of the Chinese Academy of
   SciencesChinese Academy of Sciences [XDB29010200]; China National Grand
   S&T Special Project [2015ZX09102024]; External Cooperation Program of
   the Chinese Academy of SciencesChinese Academy of Sciences
   [153211KYSB20160001]; Youth Innovation Promotion Association of CAS
   [2015078]
FX We thank Zheng Fan of the Institute of Microbiology, Chinese Academy of
   Sciences, for support with SPR assays and Yan Chai, Chao Su, Dan Lu, Hao
   Song, and Yi Shi in our group, as well as the staff at the Shanghai
   Synchrotron Radiation Facility (beamline 19U), for help with data
   collection, experiments, and manuscript editing.; This study was
   supported by the Strategic Priority Research Program of the Chinese
   Academy of Sciences (XDB29010200), the China National Grand S&T Special
   Project (2015ZX09102024), and the External Cooperation Program of the
   Chinese Academy of Sciences (153211KYSB20160001). George F. Gao is a
   leading principal investigator of the National Natural Science
   Foundation of China Innovative Research Group (81621091). Lianpan Dai is
   supported by the Youth Innovation Promotion Association of CAS (grant
   no. 2015078).
CR Aad G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.161801
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brackney DE, 2016, CURR OPIN VIROL, V21, P67, DOI 10.1016/j.coviro.2016.08.005
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   Elsterova J, 2017, TICKS TICK-BORNE DIS, V8, P253, DOI 10.1016/j.ttbdis.2016.11.007
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fuzik T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02882-0
   GAO GF, 1994, J GEN VIROL, V75, P609, DOI 10.1099/0022-1317-75-3-609
   Gao GF, 1997, ACTA VIROL, V41, P259
   GAO GF, 1993, J GEN VIROL, V74, P109, DOI 10.1099/0022-1317-74-1-109
   GAO GF, 1993, VIRUS RES, V30, P129, DOI 10.1016/0168-1702(93)90002-5
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   JIANG W, 1994, VIROLOGY, V200, P21, DOI 10.1006/viro.1994.1158
   JIANG WR, 1993, J GEN VIROL, V74, P931, DOI 10.1099/0022-1317-74-5-931
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kiermayr S, 2009, J VIROL, V83, P8482, DOI 10.1128/JVI.00660-09
   Klitting R, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0053-x
   KLUGER G, 1995, LANCET, V346, P1502, DOI 10.1016/S0140-6736(95)92527-9
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   Li HT, 2005, J IMMUNOL, V174, P195, DOI 10.4049/jimmunol.174.1.195
   Liu KF, 2017, CELL RES, V27, P151, DOI 10.1038/cr.2016.102
   Lu XS, 2019, CELL REP, V26, P438, DOI 10.1016/j.celrep.2018.12.065
   Luca VC, 2013, J VIROL, V87, P818, DOI 10.1128/JVI.01950-12
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   McGuire K, 1998, J GEN VIROL, V79, P981, DOI 10.1099/0022-1317-79-5-981
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mukherjee M, 2006, PROTEIN SCI, V15, P1342, DOI 10.1110/ps.051844006
   Musyoki AM, 2016, P NATL ACAD SCI USA, V113, P13869, DOI 10.1073/pnas.1608406113
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Schr?dinger L., 2015, PYMOL MOL GRAPH SYST
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069
   Tsouchnikas G, 2015, J VIROL, V89, P7970, DOI 10.1128/JVI.00938-15
   Volk DE, 2006, VIROLOGY, V351, P188, DOI 10.1016/j.virol.2006.03.030
   Volk DE, 2009, VIROLOGY, V394, P12, DOI 10.1016/j.virol.2009.09.001
   Waldvogel K, 1996, EUR J PEDIATR, V155, P775, DOI 10.1007/BF02002905
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang XD, 2018, SCI CHINA LIFE SCI, V61, P1432, DOI 10.1007/s11427-018-9363-4
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   ZANOTTO PMD, 1995, VIROLOGY, V210, P152
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 63
TC 1
Z9 1
U1 1
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2019
VL 93
IS 8
AR e02132-18
DI 10.1128/JVI.02132-18
PG 18
WC Virology
SC Virology
GA HR5GQ
UT WOS:000463175300022
PM 30760569
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Zhang, NN
   Zhang, L
   Deng, YQ
   Feng, Y
   Ma, F
   Wang, Q
   Ye, Q
   Han, YY
   Sun, XM
   Zhang, FC
   Qi, XP
   Wang, GQ
   Dai, JJ
   Xia, XS
   Qin, CF
AF Zhang, Na-Na
   Zhang, Li
   Deng, Yong-Qiang
   Feng, Yue
   Ma, Feng
   Wang, Qi
   Ye, Qing
   Han, Yuanyuan
   Sun, Xiaomei
   Zhang, Fu-Chun
   Qi, Xiaopeng
   Wang, Guoqing
   Dai, Jiejie
   Xia, Xueshan
   Qin, Cheng-Feng
TI Zika Virus Infection in Tupaia belangeri Causes Dermatological
   Manifestations and Confers Protection against Secondary Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE animal model; pathogenesis; Zika virus
ID LEADS; CELLS; MODEL; MICE; TRANSMISSION; EMERGENCE; PSORIASIS;
   PREGNANCY; STRAIN; RHESUS
AB Animal models of Zika virus (ZIKV) infection have recently been established in mice, guinea pigs, and nonhuman primates. Tree shrews (Tupaia belangeri) are an emerging experimental animal in biomedical applications, but their susceptibility to ZIKV infection has not been explored. In the present study, we show that subcutaneous inoculation of ZIKV led to rapid viremia and viral secretion in saliva, as well as to typical dermatological manifestations characterized by massive diffuse skin rash on the trunk. Global transcriptomic sequencing of peripheral blood mononuclear cells isolated from ZIKV-infected animals revealed systematic gene expression changes related to the inflammatory response and dermatological manifestations. Importantly, ZIKV infection readily triggered the production of high-titer neutralizing antibodies, thus preventing secondary homologous infection in tree shrews. However, neonatal tree shrews succumbed to ZIKV challenge upon intracerebral infection. The tree shrew model described here recapitulates the most common dermatological manifestations observed in ZIKV-infected patients and may greatly facilitate the elucidation of ZIKV pathogenesis and the development of novel vaccines and therapeutics.
   IMPORTANCE The reemergence of Zika virus (ZIKV) has caused a global public health crisis since 2016, and there are currently no vaccines or antiviral drugs to prevent or treat ZIKV infection. However, considerable advances have been made in understanding the biology and pathogenesis of ZIKV infection. In particular, various animal models have been successfully established to mimic ZIKV infection and its associated neurological diseases and to evaluate potential countermeasures. However, the clinical symptoms in these mouse and nonhuman primate models are different from the common clinical manifestations seen in human ZIKV patients; in particular, dermatological manifestations are rarely recapitulated in these animal models. Here, we developed a new animal model of ZIKV infection in tree shrews, a rat-sized, primate-related mammal. In vitro and in vivo characterization of ZIKV infection in tree shrews established a direct link between ZIKV infection and the immune responses and dermatological manifestations. The tree shrew model described here, as well as other available animal models, provides a valuable platform to study ZIKV pathogenesis and to evaluate vaccines and therapeutics.
C1 [Zhang, Na-Na; Deng, Yong-Qiang; Ye, Qing; Qin, Cheng-Feng] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Zhang, Li; Feng, Yue; Wang, Qi; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Yunnan Prov Ctr Mol Med, Kunming, Yunnan, Peoples R China.
   [Deng, Yong-Qiang; Zhang, Fu-Chun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Ma, Feng] Chinese Acad Med Sci, Ctr Syst Med, Inst Basic Med Sci, Beijing, Peoples R China.
   [Ma, Feng] Peking Union Med Coll, Beijing, Peoples R China.
   [Han, Yuanyuan; Sun, Xiaomei; Dai, Jiejie] Chinese Acad Med Sci, Ctr Tree Shrew Germplasm Resources, Inst Med Biol, Kunming, Yunnan, Peoples R China.
   [Han, Yuanyuan; Sun, Xiaomei; Dai, Jiejie] Peking Union Med Coll, Kunming, Yunnan, Peoples R China.
   [Qi, Xiaopeng] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.
   [Wang, Guoqing] Jilin Univ, Sch Basic Med, Changchun, Jilin, Peoples R China.
   [Ma, Feng] Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China.
RP Qin, CF (corresponding author), Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Xia, XS (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Yunnan Prov Ctr Mol Med, Kunming, Yunnan, Peoples R China.
EM oliverxia2000@aliyun.com; qincf@bmi.ac.cn
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [U1702282, 81772176, 31770190, 31670883];
   National Key Research and Development Project of China [2016YFD0500304];
   National Science and Technology Major Project of China
   [2018ZX09711003-005-002]; Excellent Young Scientist Program [81522025];
   Innovative Research Group of the NSFC [81621005]; Newton Advanced
   Fellowship from the UK Academy of Medical Sciences [NAF003\1003]; Yunnan
   Innovative Team Project [2015HC030]; CAMS Initiative for Innovative
   Medicine [2016-I2M-1-005]; Yunnan Science and Technology Talent and
   Platform Program [2017HC019]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) (grants U1702282, 81772176, 31770190, and 31670883), the
   National Key Research and Development Project of China (grant
   2016YFD0500304), and the National Science and Technology Major Project
   of China (grant 2018ZX09711003-005-002). C.-F.Q. was supported by the
   Excellent Young Scientist Program (no. 81522025), the Innovative
   Research Group of the NSFC (no. 81621005), and a Newton Advanced
   Fellowship from the UK Academy of Medical Sciences (no. NAF003\1003).
   X.X. was supported by the Yunnan Innovative Team Project (2015HC030).
   F.M. was supported by the CAMS Initiative for Innovative Medicine (no.
   2016-I2M-1-005). J.D. was supported by the Yunnan Science and Technology
   Talent and Platform Program (2017HC019).
CR Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Cosano-Quero A, 2018, ACTAS DERMO-SIFILOGR, V109, pE13, DOI 10.1016/j.ad.2017.02.021
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dobson JS, 2019, CLIN EXP DERMATOL, V44, P4, DOI 10.1111/ced.13733
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416
   Feng Y, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.29053
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huang F, 2013, AIDS RES HUM RETROV, V29, P1177, DOI [10.1089/aid.2013.0112, 10.1089/AID.2013.0112]
   Kim T, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky083
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lawrence M, 2017, BIOINFORMATICS, V33, P3311, DOI 10.1093/bioinformatics/btx450
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li CH, 2017, CELL RES, V27, P241, DOI 10.1038/cr.2016.156
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li LH, 2016, J VIROL, V90, P790, DOI 10.1128/JVI.02258-15
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miller LJ, 2018, AM J TROP MED HYG, V98, P864, DOI 10.4269/ajtmh.17-0686
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tong YM, 2011, J VIROL, V85, P2793, DOI 10.1128/JVI.01818-10
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Wang Z, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0859-5
   Wilsmann-Theis D, 2016, J EUR ACAD DERMATOL, V30, P1165, DOI 10.1111/jdv.13269
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu L, 2016, P NATL ACAD SCI USA, V113, P10950, DOI 10.1073/pnas.1604939113
   Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049
   Yang ZF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-111
   Yao YG, 2017, ZOOL RES, V38, P118, DOI 10.24272/j.issn.2095-8137.2017.032
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004
NR 54
TC 3
Z9 3
U1 0
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2019
VL 93
IS 8
AR e01982-18
DI 10.1128/JVI.01982-18
PG 14
WC Virology
SC Virology
GA HR5GQ
UT WOS:000463175300015
PM 30728253
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kurscheidt, FA
   Mesquita, CSS
   Damke, GMZF
   Damke, E
   Carvalho, ARBD
   Suehiro, TT
   Teixeira, JJV
   da Silva, VRS
   Souza, RP
   Consolaro, MEL
AF Kurscheidt, Fabio A.
   Mesquita, Cristiane S. S.
   Damke, Gabrielle M. Z. F.
   Damke, Edilson
   Carvalho, Analine R. B. de A.
   Suehiro, Tamy T.
   Teixeira, Jorge J., V
   da Silva, Vania R. S.
   Souza, Raquel P.
   Consolaro, Marcia E. L.
TI Persistence and clinical relevance of Zika virus in the male genital
   tract
SO NATURE REVIEWS UROLOGY
LA English
DT Review
ID MALE SEXUAL TRANSMISSION; SERTOLI-CELLS; UNITED-STATES; BODY-FLUIDS;
   INFECTION; SEMEN; SPERM; RNA; PROLIFERATION; REPLICATION
AB Zika virus (ZIKV) is a re-emerging mosquito-transmitted flavivirus associated with congenital abnormalities in newborns and with Guillain-Barre syndrome in adults. The virus can also be sexually transmitted and can persist in the male genital tract. Studies evaluating the kinetics of ZIKV in seminal shedding of men who have been infected, as well as in animal and cellular models of infection, have shown that, in addition to the testis and epididymis, the prostate and seminal vesicles could also be involved in persistent ZIKV infection. Additionally, some studies have reported that men infected with ZIKV can present with genitourinary symptoms such as haematospermia, prostatitis, painful ejaculation, penile discharge, and oligospermia; however, little is known about the effect of ZIKV on fertility. Understanding the mechanisms that underlie persistent ZIKV infections in men is crucial to developing guidelines, effective vaccines, and therapies.
C1 [Kurscheidt, Fabio A.; Mesquita, Cristiane S. S.; Damke, Gabrielle M. Z. F.; Damke, Edilson; Carvalho, Analine R. B. de A.; Suehiro, Tamy T.; da Silva, Vania R. S.; Souza, Raquel P.; Consolaro, Marcia E. L.] Univ Estadual Maringa, Dept Clin Anal & Biomed, Lab Clin Cytol & Semen Anal, Maringa, Parana, Brazil.
   [Teixeira, Jorge J., V] Univ Estadual Maringa, Div Epidemiol, Dept Clin Anal & Biomed, Maringa, Parana, Brazil.
RP Consolaro, MEL (corresponding author), Univ Estadual Maringa, Dept Clin Anal & Biomed, Lab Clin Cytol & Semen Anal, Maringa, Parana, Brazil.
EM melconsolaro@gmail.com
RI Consolaro, Marcia Edilaine Lopes/I-4932-2014
OI Consolaro, Marcia Edilaine Lopes/0000-0001-9102-4865
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES),
   Brazilian GovernmentCAPES
FX This work was supported by grants from Coordenacao de Aperfeicoamento de
   Pessoal de Nivel superior (CAPES), Brazilian Government.
CR Amann RP, 2008, J ANDROL, V29, P469, DOI 10.2164/jandrol.107.004655
   American Society for Reproductive Medicine, 2018, GUID PROV CAR WOM ME
   Andrade MCR, 2004, MEM I OSWALDO CRUZ, V99, P581, DOI 10.1590/S0074-02762004000600009
   Antony JM, 2015, VACCINE, V33, P3073, DOI 10.1016/j.vaccine.2014.12.004
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Biava M, 2018, NEW MICROBIOL, V41, P30
   Breton S, 2015, GENOME, V58, P423, DOI 10.1139/gen-2015-0090
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, GUID UD LAB TEST ZIK
   Chakhtoura N, 2018, CURR OPIN OBSTET GYN, V30, P116, DOI 10.1097/GCO.0000000000000440
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Chui K, 2011, CELL TRANSPLANT, V20, P619, DOI 10.3727/096368910X536563
   COMHAIRE FH, 1989, J ANDROL, V10, P50
   Cordeiro CN, 2017, CURR OPIN OBSTET GYN, V29, P175, DOI 10.1097/GCO.0000000000000366
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Cruz TE, 2019, AM J TROP MED HYG, V100, P183, DOI 10.4269/ajtmh.18-0623
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Dym M, 1970, Biology Reprod., V3, P308
   DYM M, 1973, ANAT RECORD, V175, P639, DOI 10.1002/ar.1091750402
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Food and Drug Administration, 2016, DON SCREEN REC RED R
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huits R., 2016, B WORLD HEALTH ORGAN, V6, P1
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee WT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01591-17
   Lemke G, 2013, COLD SPRING HARB PER, V5, P1
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li R, 2017, RADIOL INFECT DIS, V4, P88, DOI [10.1016/j.jrid.2017.01.002, DOI 10.1016/J.JRID.2017.01.002]
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M., 2016, BMJ-BRIT MED J, V353, P1
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oliveira Souto I., 2016, ENFERM INFEC MICR CL, V36, P21
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Percivalle E, 2017, NEW MICROBIOL, V40, P197
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   ROBERT M, 1995, HUM REPROD, V10, P2192, DOI 10.1093/oxfordjournals.humrep.a136267
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594
   Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Spearman P, 2006, CURR PHARM DESIGN, V12, P1147, DOI 10.2174/138161206776055859
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stefanovic KB, 2009, AM FAM PHYSICIAN, V80, P1421
   Takashima S, 2015, STEM CELL REP, V4, P489, DOI 10.1016/j.stemcr.2015.01.010
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Washington CI, 2016, SEMIN REPROD MED, V34, P293, DOI 10.1055/s-0036-1592067
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2018, ZIK VIR ZIKV CLASS T
   World Health Organization, 2018, EM ZIK VIR SIT REP
   World Health Organization, 2010, WHO LAB MAN EX PROC
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 120
TC 12
Z9 12
U1 3
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4812
EI 1759-4820
J9 NAT REV UROL
JI Nat. Rev. Urol.
PD APR
PY 2019
VL 16
IS 4
BP 211
EP 230
DI 10.1038/s41585-019-0149-7
PG 20
WC Urology & Nephrology
SC Urology & Nephrology
GA HR3GL
UT WOS:000463024700007
PM 30696994
DA 2020-07-08
ER

PT J
AU Perez, F
   Llau, A
   Gutierrez, G
   Bezerra, H
   Coelho, G
   Ault, S
   Barbiratto, SB
   de Resende, MC
   Cerezo, L
   Kleber, GL
   Pacheco, O
   Perez, OL
   Picos, V
   Rojas, DP
   Siqueira, JB
   Suarez, MF
   Harris, E
   Castellanos, LG
   Espinal, C
   San Martin, JL
AF Perez, Freddy
   Llau, Anthony
   Gutierrez, Gamaliel
   Bezerra, Haroldo
   Coelho, Giovanini
   Ault, Steven
   Barbiratto, Sulamita Brandao
   de Resende, Marcelo Carballo
   Cerezo, Lizbeth
   Kleber, Giovanni Luz
   Pacheco, Oscar
   Lenin Perez, Octavio
   Picos, Victor
   Rojas, Diana P.
   Siqueira, Joao Bosco
   Fidel Suarez, Marco
   Harris, Eva
   Castellanos, Luis Gerardo
   Espinal, Carlos
   San Martin, Jose Luis
TI The decline of dengue in the Americas in 2017: discussion of multiple
   hypotheses
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE Dengue; decline; Americas; hypotheses
ID ANTIBODY-DEPENDENT ENHANCEMENT; ZIKA VIRUS; NEUTRALIZING ANTIBODIES;
   CONSENSUS METHODS; AEDES-AEGYPTI; INFECTION; TRANSMISSION; PROTECTION;
   ILLNESS; VECTOR
AB Objective Since the 1980s, dengue incidence has increased 30-fold. However, in 2017, there was a noticeable reduction in reported dengue incidence cases within the Americas, including severe and fatal cases. Understanding the mechanism underlying dengue's incidence and decline in the Americas is vital for public health planning. We aimed to provide plausible explanations for the decline in 2017. Methods An expert panel of representatives from scientific and academic institutions, Ministry of Health officials from Latin America and PAHO/WHO staff met in October 2017 to propose hypotheses. The meeting employed six moderated plenary discussions in which participants reviewed epidemiological evidence, suggested explanatory hypotheses, offered their expert opinions on each and developed a consensus. Results The expert group established that in 2017, there was a generalised decreased incidence, severity and number of deaths due to dengue in the Americas, accompanied by a reduction in reported cases of both Zika and chikungunya virus infections, with no change in distribution among age groups affected. This decline was determined to be unlikely due to changes in epidemiological surveillance systems, as similar designs of surveillance systems exist across the region. Although sudden surveillance disruption is possible at a country or regional level, it is unlikely to occur in all countries simultaneously. Retrospective modelling with epidemiological, immunological and entomological information is needed. Host or immunological factors may have influenced the decline in dengue cases at the population level through immunity; however, herd protection requires additional evidence. Uncertainty remains regarding the effect on the outcome of sequential infections of different dengue virus (DENV) types and Zika virus (ZIKV), and vice versa. Future studies were recommended that examine the epidemiological effect of prior DENV infection on Zika incidence and severity, the epidemiological effect of prior Zika virus infection on dengue incidence and severity, immune correlates based on new-generation ELISA assays, and impact of prior DENV/other arbovirus infection on ZIKV immune response in relation to number of infections and the duration of antibodies in relation to interval of protection. Follow-up studies should also investigate whether increased vector control intensification activities contributed to the decline in transmission of one or more of these arboviruses. Additionally, proposed studies should focus on the potential role of vector competence when simultaneously exposed to various arboviruses, and on entomological surveillance and its impact on circulating vector species, with a goal of applying specific measures that mitigate seasonal occurrence or outbreaks. Conclusions Multifactorial events may have accounted for the decline in dengue seen in 2017. Differing elements might explain the reduction in dengue including elements of immunity, increased vector control, and even vector and\or viruses changes or adaptations. Most of the results of this expert consensus group meeting are hypothetical and based on limited evidence. Further studies are needed.
C1 [Perez, Freddy] PAHO, Communicable Dis & Environm Determinants Hlth Dep, 525 23rd St NW, Washington, DC 20037 USA.
   [Llau, Anthony; Espinal, Carlos] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA.
   [Gutierrez, Gamaliel; Bezerra, Haroldo; Coelho, Giovanini; Castellanos, Luis Gerardo; San Martin, Jose Luis] PAHO, Neglected Trop & Vector Borne Dis, Washington, DC USA.
   [Ault, Steven] Univ Maryland, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.
   [Barbiratto, Sulamita Brandao] Minist Hlth, Natl Dengue Control Program, Brasilia, DF, Brazil.
   [de Resende, Marcelo Carballo] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Cerezo, Lizbeth] Minist Hlth Panama, Natl Epidemiol Dept, Panama City, Panama.
   [Kleber, Giovanni Luz] Univ Fed Rio Grande Norte Hosp, Dept Infectol, Natal, RN, Brazil.
   [Pacheco, Oscar] Minist Hlth, Publ Hlth Prevent & Surveillance, Bogota, Colombia.
   [Lenin Perez, Octavio] Minist Hlth, Dengue Program, Managua, Nicaragua.
   [Picos, Victor] Minist Hlth, Res Lab Dengue & Other Viral Dis, Maracay, Venezuela.
   [Rojas, Diana P.] Univ Florida, Dept Biostat, Gainesville, FL USA.
   [Siqueira, Joao Bosco] Univ Fed Goias, Goiania, Go, Brazil.
   [Fidel Suarez, Marco] Univ Mayor San Andres, La Paz, Bolivia.
   [Harris, Eva] Univ Calif Berkeley, Ctr Global Publ Hlth, Berkeley, CA 94720 USA.
RP Perez, F (corresponding author), PAHO, Communicable Dis & Environm Determinants Hlth Dep, 525 23rd St NW, Washington, DC 20037 USA.
EM perezf@paho.org
RI Perez, Freddy/AAN-3893-2020; Rojas, Diana Patricia/AAC-2469-2019
OI Rojas, Diana Patricia/0000-0003-0241-6416; Pacheco Garcia, Oscar
   Eduardo/0000-0001-5939-6407
CR Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cecilio AB, 2009, BRAZ J BIOL, V69, P123, DOI 10.1590/S1519-69842009000100015
   CHANDLER AC, 1945, AM J TROP MED, V25, P145
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Chung YK, 2002, TROP MED INT HEALTH, V7, P322, DOI 10.1046/j.1365-3156.2002.00873.x
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cross H, 2005, INT J LEPROSY, V73, P28, DOI 10.1489/1544-581X(2005)73[28:CMABBC]2.0.CO;2
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Gordon A, PRIOR DENGUE VIRUS I
   Gordon A, 2018, CLIN INFECT DIS, V67, P1760, DOI 10.1093/cid/ciy356
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hutchings Andrew, 2006, J Health Serv Res Policy, V11, P218, DOI 10.1258/135581906778476553
   Hutchings Andrew, 2006, J Health Serv Res Policy, V11, P172, DOI 10.1258/135581906777641659
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P437, DOI 10.1590/S0074-02762002000300031
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Ministerio de Salud de Peru, 2016, PLAN NAC PREP RESP F
   Ministry of Health of Brazil, 2018, SAL NAC COORD CONTR
   MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Murphy MK, 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.3310/hta2030
   PAHO Pan American Health Organization (PAHO), 2017, ZIK CUM CAS
   PAHO Pan American Health Organization (PAHO), 2017, CHIK DAT MAPS STAT
   Pan American Health Organization (PAHO), 2017, PLISA PLAT INF SAL A
   Pan American Health Organization (PAHO), 1995, DENG DENG HEM FEV AM
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Lopes TRR, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860043, 10.1590/s1678-9946201860043]
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Schneider J, 2001, TIME LINE DENGUE AM
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
NR 49
TC 12
Z9 12
U1 5
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD APR
PY 2019
VL 24
IS 4
BP 442
EP 453
DI 10.1111/tmi.13200
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HR3KV
UT WOS:000463036800007
PM 30624838
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Xie, XP
   Shi, PY
AF Xie, Xuping
   Shi, Pei-Yong
TI Anti-Zika virus RNAi in neural progenitor cells
SO CELL RESEARCH
LA English
DT Editorial Material
ID INTERFERENCE; IMMUNITY
AB Zika virus (ZIKV), a flavivirus that is primarily transmitted by mosquitoes, can cause devastating microcephaly and other congenital syndromes in infants born to infected pregnant women. In a recent paper in Cell Research, Xu et al. present data demonstrating that (i) ZIKV infection induces RNA interference (RNAi)-mediated antiviral defense in human neural progenitor cells and (ii) treatment with enoxacin, a broad-spectrum antibiotic with known RNAi-enhancing activity, prevents ZIKV infection and microcephalic defect in brain organoids.
C1 [Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019
CR Abell NS, 2017, J AM CHEM SOC, V139, P1400, DOI 10.1021/jacs.6b11751
   Cullen BR, 2017, IMMUNITY, V46, P970, DOI 10.1016/j.immuni.2017.05.004
   KOZAK RA, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9100297
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Xu YP, 2019, CELL RES, V29, P265, DOI 10.1038/s41422-019-0152-9
NR 10
TC 1
Z9 1
U1 0
U2 1
PU INST BIOCHEMISTRY & CELL BIOLOGY
PI SHANGHAI
PA SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD APR
PY 2019
VL 29
IS 4
BP 261
EP 262
DI 10.1038/s41422-019-0158-3
PG 2
WC Cell Biology
SC Cell Biology
GA HR1AW
UT WOS:000462861400002
PM 30874610
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Xu, YP
   Qiu, Y
   Zhang, BY
   Chen, GL
   Chen, Q
   Wang, M
   Mo, F
   Xu, JY
   Wu, J
   Zhang, RR
   Cheng, ML
   Zhang, NN
   Lyu, B
   Zhu, WL
   Wu, MH
   Ye, Q
   Zhang, D
   Man, JH
   Li, XF
   Cui, J
   Xu, ZH
   Hu, BY
   Zhou, X
   Qin, CF
AF Xu, Yan-Peng
   Qiu, Yang
   Zhang, Boya
   Chen, Guilai
   Chen, Qi
   Wang, Miao
   Mo, Fan
   Xu, Jiuyue
   Wu, Jin
   Zhang, Rong-Rong
   Cheng, Meng Li
   Zhang, Na-Na
   Lyu, Bao
   Zhu, Wen-Liang
   Wu, Meng-Hua
   Ye, Qin
   Zhang, Da
   Man, Jiang-Hong
   Li, Xiao-Feng
   Cui, Jie
   Xu, Zhiheng
   Hu, Baoyang
   Zhou, Xi
   Qin, Cheng-Feng
TI Zika virus infection induces RNAi-mediated antiviral immunity in human
   neural progenitors and brain organoids
SO CELL RESEARCH
LA English
DT Article
ID STEM-CELLS; CEREBRAL ORGANOIDS; INTERFERENCE; IDENTIFICATION;
   SUPPRESSION; INHIBITION; INDUCTION; EMERGENCE
AB The re-emergence of Zika virus (ZIKV) in the Western Hemisphere has resulted in global public health crisis since 2015. ZIKV preferentially infects and targets human neural progenitor cells (hNPCs) and causes fetal microcephaly upon maternal infection. hNPCs not only play critical roles during fetal brain development, but also persist in adult brain throughout life. Yet the mechanism of innate antiviral immunity in hNPCs remains largely unknown. Here, we show that ZIKV infection triggers the abundant production of virus-derived small interfering RNAs in hNPCs, but not in the more differentiated progenies or somatic cells. Ablation of key RNAi machinery components significantly enhances ZIKV replication in hNPCs. Furthermore, enoxacin, a broad-spectrum antibiotic that is known as an RNAi enhancer, exerts potent anti-ZIKV activity in hNPCs and other RNAi-competent cells. Strikingly, enoxacin treatment completely prevents ZIKV infection and circumvents ZIKV-induced microcephalic phenotypes in brain organoid models that recapitulate human fetal brain development. Our findings highlight the physiological importance of RNAi-mediated antiviral immunity during the early stage of human brain development, uncovering a novel strategy to combat human congenital viral infections through enhancing RNAi.
C1 [Xu, Yan-Peng; Chen, Qi; Zhang, Rong-Rong; Cheng, Meng Li; Zhang, Na-Na; Ye, Qin; Li, Xiao-Feng; Qin, Cheng-Feng] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Qiu, Yang; Wang, Miao; Xu, Jiuyue; Lyu, Bao; Cui, Jie; Zhou, Xi] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China.
   [Zhang, Boya; Chen, Guilai; Mo, Fan; Zhu, Wen-Liang; Wu, Meng-Hua; Zhang, Da; Hu, Baoyang] Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, Beijing 100101, Peoples R China.
   [Zhang, Boya; Chen, Guilai; Mo, Fan; Xu, Jiuyue; Zhu, Wen-Liang; Wu, Meng-Hua; Zhang, Da; Cui, Jie; Xu, Zhiheng; Hu, Baoyang; Zhou, Xi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Wu, Jin; Man, Jiang-Hong] Natl Ctr Biomed Anal, Inst Basic Med Sci, State Key Lab Prote, Beijing 100850, Peoples R China.
   [Zhang, Rong-Rong; Cheng, Meng Li; Qin, Cheng-Feng] Anhui Med Univ, Sch Basic Sci, Hefei 230032, Anhui, Peoples R China.
   [Lyu, Bao; Zhou, Xi] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.
   [Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Ctr Excellence Brain Sci & Intelligence Technol, Beijing 100101, Peoples R China.
RP Qin, CF (corresponding author), Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Zhou, X (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China.; Hu, BY (corresponding author), Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, Beijing 100101, Peoples R China.; Hu, BY; Zhou, X (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Qin, CF (corresponding author), Anhui Med Univ, Sch Basic Sci, Hefei 230032, Anhui, Peoples R China.; Zhou, X (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.
EM byhu@ioz.ac.cn; zhouxi@wh.iov.cn; qincf@bmi.ac.cn
RI Qiu, Yang/AAQ-4435-2020
OI Cui, Jie/0000-0001-8176-9951; Zhou, Xi/0000-0002-3846-5079; Wang,
   Miao/0000-0003-0470-2694
FU National Key Research and Development Project of China [2016YFD0500304];
   Research Program of CAS [XDA16020604]; Strategic Priority Research
   Program of CAS [XDPB0301]; National Science and Technology Major Project
   of China [2018ZX09711003, 2018ZX10101004, 2017ZX10304402]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81873964, 31770190, 31730108, 81661148054, 81661130162,
   81621005, 81522025, 31522004]; Newton Advanced Fellowship from the UK
   Academy of Medical Sciences; CAS Pioneer Hundred Talents Program
FX We thank Drs. B.R. Cullen (Duke University Medical Center), S. Bao
   (Cleveland Clinic), W. Li (CAS), and A. Zheng (CAS) for critical
   reagents, and A.D. Davidson (University of Bristol) for proofreading the
   manuscript. This work was supported by the National Key Research and
   Development Project of China (2016YFD0500304), the Research Program of
   CAS (XDA16020604), the Strategic Priority Research Program of CAS
   (XDPB0301), the National Science and Technology Major Project of China
   (2018ZX09711003, 2018ZX10101004 and 2017ZX10304402), the National
   Natural Science Foundation of China (81873964, 31770190, 31730108,
   81661148054, 81661130162, 81621005, 81522025 and 31522004). C.-F.Q. and
   X.Z. were supported by the Newton Advanced Fellowship from the UK
   Academy of Medical Sciences. J.C. was supported by funding from the CAS
   Pioneer Hundred Talents Program.
CR Abell NS, 2017, J AM CHEM SOC, V139, P1400, DOI 10.1021/jacs.6b11751
   Backes S, 2014, CELL REP, V8, P114, DOI 10.1016/j.celrep.2014.05.038
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Berkhout B, 2018, CURR OPIN VIROL, V32, P9, DOI 10.1016/j.coviro.2018.07.008
   Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14
   Bogerd HP, 2014, RNA, V20, P923, DOI 10.1261/rna.044545.114
   Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cullen BR, 2017, IMMUNITY, V46, P970, DOI 10.1016/j.immuni.2017.05.004
   Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding SW, 2018, CURR OPIN IMMUNOL, V54, P109, DOI 10.1016/j.coi.2018.06.010
   Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Girardi E, 2013, MBIO, V4, DOI 10.1128/mBio.00698-13
   Guo YL, 2017, IMMUNOL CELL BIOL, V95, P17, DOI 10.1038/icb.2016.70
   Guo ZX, 2019, NAT REV IMMUNOL, V19, P31, DOI 10.1038/s41577-018-0071-x
   Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004
   Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127
   Kennedy EM, 2015, P NATL ACAD SCI USA, V112, pE6945, DOI 10.1073/pnas.1513421112
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Li Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.250
   Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930
   Maillard PV, 2016, EMBO J, V35, P2505, DOI 10.15252/embj.201695086
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Orioli IM, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5018
   Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Samuel GH, 2018, TRENDS MICROBIOL, V26, P447, DOI 10.1016/j.tim.2017.12.005
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481
   Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai K, 2018, RNA, V24, P1172, DOI 10.1261/rna.066332.118
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang BY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0763-y
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang QZ, 2008, CELL RES, V18, P1077, DOI 10.1038/cr.2008.287
NR 66
TC 10
Z9 11
U1 15
U2 34
PU INST BIOCHEMISTRY & CELL BIOLOGY
PI SHANGHAI
PA SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD APR
PY 2019
VL 29
IS 4
BP 265
EP 273
DI 10.1038/s41422-019-0152-9
PG 9
WC Cell Biology
SC Cell Biology
GA HR1AW
UT WOS:000462861400004
PM 30814679
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Honein, MA
   Cetron, MS
   Meaney-Delman, D
AF Honein, Margaret A.
   Cetron, Martin S.
   Meaney-Delman, Dana
TI Endemic Zika virus transmission: implications for travellers
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Honein, Margaret A.; Meaney-Delman, Dana] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA.
   [Cetron, Martin S.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30341 USA.
RP Honein, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA.
EM mhonein@cdc.gov
CR Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   ORENSTEIN WA, 1984, JAMA-J AM MED ASSOC, V251, P1988, DOI 10.1001/jama.251.15.1988
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Sasmono RT, 2018, EMERG INFECT DIS, V24, P1740, DOI 10.3201/eid2409.180582
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Saxena SK, 2019, TRAVEL MED INFECT DI, V27, P121, DOI 10.1016/j.tmaid.2018.10.022
   US Centers for Disease Control and Prevention, 2018, ZIK TRAV INF
   World Health Organization, WHO STAT 1 M INT HLT
NR 11
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD APR
PY 2019
VL 19
IS 4
BP 349
EP 351
DI 10.1016/S1473-3099(18)30793-X
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA HQ7KQ
UT WOS:000462599400017
PM 30826191
OA Bronze
DA 2020-07-08
ER

PT J
AU Ruchusatsawat, K
   Wongjaroen, P
   Posanacharoen, A
   Rodriguez-Barraquer, I
   Sangkitporn, S
   Cummings, DAT
   Salje, H
AF Ruchusatsawat, Kriangsak
   Wongjaroen, Pattara
   Posanacharoen, Arisara
   Rodriguez-Barraquer, Isabel
   Sangkitporn, Somchai
   Cummings, Derek A. T.
   Salje, Henrik
TI Long-term circulation of Zika virus in Thailand: an observational study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID INFECTION; PHILIPPINES
AB Background Little is known about the historical and current risk of Zika virus infection in southeast Asia, where the mosquito vector is widespread and other arboviruses circulate endemically. Centralised Zika virus surveillance began in Thailand in January, 2016. We assessed the long-term circulation of Zika virus in Thailand.
   Methods In this observational study, we analysed data from individuals with suspected Zika virus infection who presented at hospitals throughout the country and had biological samples (serum, plasma, or urine) tested for confirmation with PCR at the National Institute of Health laboratories in Bangkok. We analysed the spatial and age distribution of cases, and constructed time-resolved phylogenetic trees using genomes from Thailand and elsewhere to estimate when Zika virus was first introduced.
   Findings Of the 3089 samples from 1717 symptomatic individuals tested between January, 2016, and December, 2017, 368 were confirmed to have Zika virus infection. Cases of Zika virus infection were reported throughout the year, and from 29 of the 76 Thai provinces. Individuals had 2.8 times (95% CI 2.3-3.6) the odds of testing positive for Zika virus infection if they came from the same district and were sick within the same year of a person with a confirmed infection relative to the odds of testing positive anywhere, consistent with focal transmission. The probability of cases being younger than 10 years was 0.99 times (0.72-1.30) the probability of being that age in the underlying population. This probability rose to 1.62 (1.33-1.92) among those aged 21-30 years and fell to 0.53 (0.40-0.66) for those older than 50 years. This age distribution is consistent with that observed in the Zika virus epidemic in Colombia. Phylogenetic reconstructions suggest persistent circulation within Thailand since at least 2002.
   Interpretation Our evidence shows that Zika virus has circulated at a low but sustained level for at least 16 years, suggesting that Zika virus can adapt to persistent endemic transmission. Health systems need to adapt to cope with regular occurrences of the severe complications associated with infection. Copyright (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Ruchusatsawat, Kriangsak; Wongjaroen, Pattara; Posanacharoen, Arisara; Sangkitporn, Somchai] Minist Publ Hlth, Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand.
   [Rodriguez-Barraquer, Isabel] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL USA.
   [Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Salje, Henrik] Inst Pasteur, Math Modelling Infect Dis Unit, CNRS, UMR2000, F-75015 Paris, France.
   [Cummings, Derek A. T.; Salje, Henrik] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
RP Salje, H (corresponding author), Inst Pasteur, Math Modelling Infect Dis Unit, CNRS, UMR2000, F-75015 Paris, France.
EM henrik.salje@pasteur.fr
FU National Science FoundationNational Science Foundation (NSF)
   [DEB-1642174]; National Institute of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01AI114703]; European Research CouncilEuropean Research Council (ERC)
   [804744]
FX HS, IR-B, and DATC were funded by National Science Foundation
   (DEB-1642174). DATC was also funded by the National Institute of Health
   (R01AI114703), and HS was also funded by the European Research Council
   (804744).
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Jewell NP, 2019, BIOSTATISTICS, V20, P332, DOI 10.1093/biostatistics/kxy005
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nitatpattana N, 2018, MICROBIOL RESOUR ANN, V6, DOI [10.1128/genomeA.00121-18, 10.1128/genomea.00121-18]
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
NR 27
TC 22
Z9 22
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD APR
PY 2019
VL 19
IS 4
BP 439
EP 446
DI 10.1016/S1473-3099(18)30718-7
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA HQ7KQ
UT WOS:000462599400039
PM 30826189
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Ruchusatsawat, K
   Wongjaroen, P
   Posanacharoen, A
AF Ruchusatsawat, K.
   Wongjaroen, P.
   Posanacharoen, A.
TI Long-term circulation of Zika virus in Thailand: an observational study
   (vol 19, pg 439, 2019)
SO LANCET INFECTIOUS DISEASES
LA English
DT Correction
CR Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD APR
PY 2019
VL 19
IS 4
BP E109
EP E109
DI 10.1016/S1473-3099(19)30100-8
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA HQ7KQ
UT WOS:000462599400002
OA Bronze
DA 2020-07-08
ER

PT J
AU Gutierrez-Bugallo, G
   Piedra, LA
   Rodriguez, M
   Bisset, JA
   Lourenco-de-Oliveira, R
   Weaver, SC
   Vasilakis, N
   Vega-Rua, A
AF Gutierrez-Bugallo, Gladys
   Augusto Piedra, Luis
   Rodriguez, Magdalena
   Bisset, Juan A.
   Lourenco-de-Oliveira, Ricardo
   Weaver, Scott C.
   Vasilakis, Nikos
   Vega-Rua, Anubis
TI Vector-borne transmission and evolution of Zika virus
SO NATURE ECOLOGY & EVOLUTION
LA English
DT Review
ID AEDES-AEGYPTI MOSQUITOS; DENGUE VIRUS; YELLOW-FEVER; VERTICAL
   TRANSMISSION; INFECTION; EMERGENCE; SUSCEPTIBILITY; EPIDEMIOLOGY;
   ENHANCEMENT; CIRCULATION
AB Zika virus (ZIKV), discovered in the Zika Forest of Uganda in 1947, is a mosquito-borne flavivirus related to yellow fever, dengue and West Nile viruses. From its discovery until 2007, only sporadic ZIKV cases were reported, with mild clinical manifestations in patients. Therefore, little attention was given to this virus before epidemics in the South Pacific and the Americas that began in 2013. Despite a growing number of ZIKV studies in the past three years, many aspects of the virus remain poorly characterized, particularly the spectrum of species involved in its transmission cycles. Here, we review the mosquito and vertebrate host species potentially involved in ZIKV vector-borne transmission worldwide. We also provide an evidence-supported analysis regarding the possibility of ZIKV spillback from an urban cycle to a zoonotic cycle outside Africa, and we review hypotheses regarding recent emergence and evolution of ZIKV. Finally, we identify critical remaining gaps in the current knowledge of ZIKV vector-borne transmission.
C1 [Gutierrez-Bugallo, Gladys; Augusto Piedra, Luis; Rodriguez, Magdalena; Bisset, Juan A.] Inst Trop Med Pedro Kourf, PAHO WHO Collaborating Ctr Dengue & Its Control, Ctr Res Diagnost & Reference, Dept Vector Control, Havana, Cuba.
   [Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Inst Oswaldo Cruz, FIOCRUZ, Rio De Janeiro, Brazil.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vega-Rua, Anubis] Inst Pasteur Guadeloupe, Lab Vector Control Res, Unit Transmiss Reservoir & Pathogen Divers, Les Abymes, Guadeloupe, France.
RP Vega-Rua, A (corresponding author), Inst Pasteur Guadeloupe, Lab Vector Control Res, Unit Transmiss Reservoir & Pathogen Divers, Les Abymes, Guadeloupe, France.
EM avega@pasteur.fr
OI Bisset Lazcano, Juan Andres/0000-0002-3447-4947; Gutierrez-Bugallo,
   Gladys/0000-0003-4415-7045; Vasilakis, Nikos/0000-0002-0708-3289
FU Special Programme for Research and Training in Tropical Diseases (TDR)
   from the World Health Organization [2017/713047-0]; European Union's
   Horizon 2020 Research and innovation programme under "ZIKALLIANCE"
   [734548]; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24 AI120942, U01 AI115577]; Programme
   Operationnel FEDER-Guadeloupe-Conseil Regional 2014-2020 [2015-FED-192]
FX This work has been notably supported by the Special Programme for
   Research and Training in Tropical Diseases (TDR) from the World Health
   Organization (Grant 2017/713047-0). The European Union's Horizon 2020
   Research and innovation programme under "ZIKALLIANCE" (Grant Agreement
   no. 734548) partially supported A.V.-R. and R.L.d.O. The Programme
   Operationnel FEDER-Guadeloupe-Conseil Regional 2014-2020 (Grant
   2015-FED-192) partially supported A.V.-R. NIH grants R24 AI120942 and
   U01 AI115577 provided a partial support for N.V. and S.C.W.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos SS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2543-4
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Day JF, 2001, ANNU REV ENTOMOL, V46, P111, DOI 10.1146/annurev.ento.46.1.111
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joob B, 2017, ASIAN PAC J TROP MED, V10, P199, DOI 10.1016/j.apjtm.2017.01.011
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Libraty DH, 2001, J VIROL, V75, P3501, DOI 10.1128/JVI.75.8.3501-3508.2001
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lourenco Jose, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Mutebi JP, 2018, EMERG INFECT DIS, V24, P808, DOI 10.3201/eid2404.171919
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pan American Health Organization, 2017, REG ZIK EP UPD AM AU
   Pereira-Silva JW, 2018, MEM I OSWALDO CRUZ, V113, P56, DOI 10.1590/0074-02760170329
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Ortiz MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15706-w
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   Rosenstierne MW, 2018, EMERG INFECT DIS, V24, P948, DOI 10.3201/eid2405.180153
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Rylands Anthony B., 2009, P23, DOI 10.1007/978-0-387-78705-3_2
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Song S, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.80
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06
   Vasilakis N, 2007, VIROLOGY, V358, P402, DOI 10.1016/j.virol.2006.08.049
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vasilakis N, 2010, J VIROL, V84, P3726, DOI 10.1128/JVI.02640-09
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   World Health Organisation, 2018, ZIK VIR ZIKV CLASS T, P1
   Yee DA, 2018, MED VET ENTOMOL, V32, P255, DOI 10.1111/mve.12289
   Yeh SC, 2018, DNA CELL BIOL, V37, P154, DOI 10.1089/dna.2017.4059
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 95
TC 14
Z9 14
U1 6
U2 27
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2397-334X
J9 NAT ECOL EVOL
JI Nat. Ecol. Evol.
PD APR
PY 2019
VL 3
IS 4
BP 561
EP 569
DI 10.1038/s41559-019-0836-z
PG 9
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA HQ6QC
UT WOS:000462542100017
PM 30886369
OA Green Published
DA 2020-07-08
ER

PT J
AU Anjusha, M
   Khushhali, P
   Ajay, P
AF Anjusha, Mune
   Khushhali, Pandey
   Ajay, Pandey
TI Analysis of synonymous codon usage bias of Dengue, Zika and Yellow fever
   virus and their vector - host adaptation
SO RESEARCH JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Codon usage; Zika virus; Dengue virus; Yellow fever virus; mutation;
   evolution
ID TRANSMISSION; GENOMES
AB Virus vector and host relationship is a unique biological interaction that involves virus entry, escapes mechanism and hosts immune system. The change in codon usage pattern of viruses is an evolutionary event that facilitates their survival, in addition to adapting their fitness to the external environment, especially their hosts. The current work is a study of codon usage patterns of Zika virus (ZIKV) strains, Dengue virus (DENV) serotype and Yellow fever virus (YFV). It also aims to study the codon usage pattern of their primary vector Aedes aegypti and host Homo sapiens.
   The study - based observed similarity is expressed in terms of choices of preferred codons in virus, vector and host. It is also observed that the codon usage bias of viruses is influenced by mutation pressure and natural selection. The adaptation of codon usage helps the virus to adapt to multiple host and vectors. The results suggest that viruses have a distinct, identifiable host and vector - specific codon usage pattern that is advantageous for efficient replication in host and transmission within vectors and hosts.
C1 [Anjusha, Mune; Khushhali, Pandey; Ajay, Pandey] Maulana Azad Natl Inst Technol, Ringgold Stand Inst, Biol Sci & Engn, Bhopal 462007, India.
RP Anjusha, M (corresponding author), Maulana Azad Natl Inst Technol, Ringgold Stand Inst, Biol Sci & Engn, Bhopal 462007, India.
EM anjumune@gmail.com
CR Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686
   Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109
   Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.47
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Kim WM, 2008, ADV EXP MED BIOL, V640, P325, DOI 10.1007/978-0-387-09789-3_22
   Krieg AM, 2003, SCAND J INFECT DIS, V35, P653, DOI 10.1080/00365540310015999
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Lu H, 2005, ACTA BIOCH BIOPH SIN, V37, P1, DOI 10.1093/abbs/37.1.1
   Ma JJ, 2013, J ANIM VET ADV, V12, P88
   Muktar Y., 2016, J TROPICAL DIS, V4, P223
   Mune A, 2017, BIOSCI BIOTECHNO RES, V10, P680, DOI 10.21786/bbrc/10.4/11
   Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4
   Severson DW, 2004, INSECT BIOCHEM MOLEC, V34, P715, DOI 10.1016/j.ibmb.2004.03.024
   SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   Stedman KM, 2013, J VIROL, V87, P1919, DOI 10.1128/JVI.02610-12
   Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308
   van Hemert F, 2016, J GEN VIROL, V97, P2608, DOI 10.1099/jgv.0.000579
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Velazquez-Salinas L., 2016, PLOS ONE, V25, P11
   Wang H., 2016, PLOS ONE, V12
   Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
NR 27
TC 0
Z9 0
U1 1
U2 3
PU RESEARCH JOURNAL BIOTECHNOLOGY
PI INDORE
PA SECTOR A-80, SCHEME NO 54, VIJAY NAGAR, A B ROAD, INDORE, 452 010 MP,
   INDIA
SN 2278-4535
J9 RES J BIOTECHNOL
JI Res. J. Biotechnol.
PD APR
PY 2019
VL 14
IS 4
BP 89
EP 110
PG 22
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA HQ6ZE
UT WOS:000462567700011
DA 2020-07-08
ER

PT J
AU Van den Bossche, D
   Michiels, J
   Cnops, L
   Foque, N
   Meersman, K
   Huits, R
   Arien, KK
   Van Esbroeck, M
AF Van den Bossche, Dorien
   Michiels, Johan
   Cnops, Lieselotte
   Foque, Nikki
   Meersman, Kathleen
   Huits, Ralph
   Arien, Kevin K.
   Van Esbroeck, Marjan
TI Challenges in diagnosing Zikaexperiences from a reference laboratory in
   a non-endemic setting
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Diagnosis; Serology; Challenges
ID ZIKA VIRUS-INFECTION; LINKED IMMUNOSORBENT ASSAYS; ANTIBODIES; DENGUE;
   SPECIFICITY; IGM; KINETICS
AB Diagnosing a patient with Zika infection is not always straightforward. Here, we aim to describe our data collected from December 2015 to December 2017 and discuss the implemented algorithm and diagnostic challenges we encountered. At the National Reference Center for Arboviruses at the Institute of Tropical Medicine, Antwerp, Belgium (ITM), a commercial Zika virus (ZIKV) enzyme-linked immunosorbent assay (ELISA) detecting immunoglobulin (Ig) M and IgG, a commercial ZIKV immunofluorescence assay (IFA) detecting IgM, and an in-house Zika virus neutralization test (VNT) were implemented. For molecular detection of ZIKV, an in-house and a commercial real-time RT-PCR were applied. An algorithm, adapted from the European Centre for Disease Control and Prevention (ECDC), was implemented. Between December 2015 and December 2017, we tested 6417 patients for ZIKV. Of those, according to ECDC criteria, 127 (2.0%) were classified as a confirmed Zika infection of which 39 by RT-PCR (0.6%), 15 (0.2%) as a probable Zika infection, 73 (1.1%) as undefined, and 65 (1.0%) as false positive reactions. Main challenges were the brief window for detection of IgM, cross-reactivity of antibodies with other flaviviruses and malaria, and low VNT titers in the acute phase. In RT-PCR negative samples, classification of ZIKV infection as recent or past proved difficult, when IgM was negative. The majority of patients could be classified according to ECDC criteria, though 1.1% of patients remained undefined and 1.0% were ELISA false positive reactions. Complementary IFA IgM was of added value to increase IgM detection rates. Improved serological assays and more longitudinal data on antibody kinetics are needed.
C1 [Van den Bossche, Dorien; Cnops, Lieselotte; Foque, Nikki; Meersman, Kathleen; Huits, Ralph; Van Esbroeck, Marjan] Natl Reference Ctr Arboviruses, Inst Trop Med, Dept Clin Sci, Kronenburgstr 43-3, Antwerp, Belgium.
   [Michiels, Johan; Arien, Kevin K.] Inst Trop Med, Dept Biomed Sci, Unit Virol, Antwerp, Belgium.
   [Arien, Kevin K.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.
RP Van den Bossche, D (corresponding author), Natl Reference Ctr Arboviruses, Inst Trop Med, Dept Clin Sci, Kronenburgstr 43-3, Antwerp, Belgium.
EM dvandenbossche@itg.be
RI Huits, Ralph/I-8361-2019
OI Huits, Ralph/0000-0001-8803-9468; Cnops, Lieselotte/0000-0003-0658-1291;
   Van Esbroeck, Marjan/0000-0002-7294-6319
FU Belgian Ministry of Social Affairs through a fund within the Health
   Insurance System; European Union's Horizon 2020 research and innovation
   program under ZikaPLAN grant [734584]
FX The National Reference Center of arboviruses (Institute of Tropical
   Medicine) is partially supported by the Belgian Ministry of Social
   Affairs through a fund within the Health Insurance System. The Institute
   of Tropical Medicine was partially funded by European Union's Horizon
   2020 research and innovation program under ZikaPLAN grant agreement no.
   734584.
CR [Anonymous], ANTW VRAG RISK MAN G
   Arien KK, 2018, LANCET GLOB HEALTH, V6, pE830, DOI 10.1016/S2214-109X(18)30295-X
   Arien KK, 2018, LANCET GLOB HEALTH, V6, pE494, DOI 10.1016/S2214-109X(18)30122-0
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Basile AJ, 2018, J VIROL METHODS, V260, P26, DOI 10.1016/j.jviromet.2018.06.018
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevetion-CDC, 2017, UPD GUID US LAB TEST
   Charrel RN, 2016, TRAVEL MED INFECT DI, V14, P11, DOI 10.1016/j.tmaid.2016.01.006
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, CURR ZIK VIR TRANSM
   European Centre for Disease Prevention and Control, INT CAS DEF SURV ZIK
   European Centre for Disease Prevention and Control (ECDC), 2016, INT GUID HEALTHC PRO
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Granger D, 2016, 32 CLIN VIR S FLOR U
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lustig Y, 2016, EURO SURVEILL, V21
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mogling R, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.36.30609
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   World Health Organization, 2016, LAB TEST ZIK VIR INF
NR 36
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD APR
PY 2019
VL 38
IS 4
BP 771
EP 778
DI 10.1007/s10096-019-03472-8
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HP6GE
UT WOS:000461781100021
PM 30680570
DA 2020-07-08
ER

PT J
AU Russo, RR
   dos Santos, NN
   Cintra, ACO
   Figueiredo, LTM
   Sampaio, SV
   Aquino, VH
AF Russo, Raquel Rinaldi
   dos Santos Junior, Nilton Nascimento
   Oliveira Cintra, Adelia Cristina
   Moraes Figueiredo, Luiz Tadeu
   Sampaio, Suely Vilela
   Aquino, Victor Hugo
TI Expression, purification and virucidal activity of two recombinant
   isoforms of phospholipase A(2) from Crotalus durissus terrificus venom
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID SNAKE-VENOM; FUNCTIONAL EXPRESSION; COLORIMETRIC ASSAY;
   ENZYMATIC-ACTIVITY; CROTOXIN ISOFORMS; ESCHERICHIA-COLI; PROLIFERATION;
   STABILITY; TOXICITY; SUBUNIT
AB The global emergence and re-emergence of arthropod-borne viruses (arboviruses) over the past four decades have become a public health crisis of international concern, especially in tropical and subtropical countries. A limited number of vaccines against arboviruses are available for use in humans; therefore, there is an urgent need to develop antiviral compounds. Snake venoms are rich sources of bioactive compounds with potential for antiviral prospection. The major component of Crotalus durissus terrificus venom is a heterodimeric complex called crotoxin, which is constituted by an inactive peptide (crotapotin) and a phospholipase A(2) (PLA(2)-CB). We showed previously the antiviral effect of PLA(2)-CB against dengue virus, yellow fever virus and other enveloped viruses. The aims of this study were to express two PLA(2)-CB isoforms in a prokaryotic system and to evaluate their virucidal effects. The sequences encoding the PLA(2)-CB isoforms were optimized and cloned into a plasmid vector (pG21a) for recombinant protein expression. The recombinant proteins were expressed in the E. coli BL21(DE3) strain as insoluble inclusion bodies; therefore, the purification was performed under denaturing conditions, using urea for protein solubilization. The solubilized proteins were applied to a nickel affinity chromatography matrix for binding. The immobilized recombinant proteins were subjected to an innovative protein refolding step, which consisted of the application of a decreasing linear gradient of urea and dithiothreitol (DTT) concentrations in combination with the detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate (CHAPS) as a protein stabilizer. The refolded recombinant proteins showed phospholipase activity and virucidal effects against chikungunya virus, dengue virus, yellow fever virus and Zika virus.
C1 [Russo, Raquel Rinaldi; Aquino, Victor Hugo] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Anal Toxicol & Food Sci, Lab Virol, Ribeirao Preto, SP, Brazil.
   [dos Santos Junior, Nilton Nascimento] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, Lab Neuroimmunoendocrinol, Ribeirao Preto, SP, Brazil.
   [Oliveira Cintra, Adelia Cristina; Sampaio, Suely Vilela] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Anal Toxicol & Food Sci, Lab Toxinol, Ribeirao Preto, SP, Brazil.
   [Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Ribeirao Preto Med Sch, Virol Res Ctr, Ribeirao Preto, SP, Brazil.
RP Aquino, VH (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Anal Toxicol & Food Sci, Lab Virol, Ribeirao Preto, SP, Brazil.
EM vhugo@fcfrp.usp.br
RI Vilela, Suely/D-7429-2012
OI Vilela, Suely/0000-0003-3274-180X; Aquino, Victor
   Hugo/0000-0003-1910-0776
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/02438-6]; National Council of
   Technological and Scientific Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [479512/2012-4];
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2012/12605-1]; CNPq-PQNational Council for Scientific and Technological
   Development (CNPq) [306471/2017-5]
FX This work was supported by the Sao Paulo Research Foundation (FAPESP),
   grant no. 2014/02438-6) and the National Council of Technological and
   Scientific Development (CNPq) (grant no. 479512/2012-4). RR was
   supported by a FAPESP scholarship (grant no. 2012/12605-1) and VHA holds
   a CNPq-PQ fellowship (grant no. 306471/2017-5).
CR Alibolandi M, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/631607
   Amaral JK, 2018, J RHEUMATOL, V45, P1491, DOI 10.3899/jrheum.171237
   Pereanez JA, 2012, J MOL GRAPH MODEL, V35, P36, DOI 10.1016/j.jmgm.2012.01.004
   BOUCHIER C, 1991, BIOCHIM BIOPHYS ACTA, V1088, P401, DOI 10.1016/0167-4781(91)90132-6
   BURLESON FG, 1992, VIROLOGY LAB MANUAL
   Chen YH, 2004, BIOCHEM J, V381, P25, DOI 10.1042/BJ20040125
   Chioato L, 2003, TOXICON, V42, P869, DOI 10.1016/j.toxicon.2003.11.027
   Chiou YL, 2008, TOXICON, V51, P270, DOI 10.1016/j.toxicon.2007.10.001
   Collins ND, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0566-9
   DEARAUJO AL, 1987, TOXICON, V25, P1181, DOI 10.1016/0041-0101(87)90136-X
   Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w
   Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2
   FAURE G, 1994, EUR J BIOCHEM, V223, P161, DOI 10.1111/j.1432-1033.1994.tb18978.x
   FAURE G, 1993, EUR J BIOCHEM, V214, P491, DOI 10.1111/j.1432-1033.1993.tb17946.x
   Faure G, 2011, J MOL BIOL, V412, P176, DOI 10.1016/j.jmb.2011.07.027
   Ferre H, 2005, PROTEIN SCI, V14, P2141, DOI 10.1110/ps.051396105
   Figueiredo LT, 2015, REV SOC BRAS MED TRO
   Figueiredo LT, 2016, REV SOC BRAS MED TRO
   Francischetti IMB, 2000, COMP BIOCHEM PHYS C, V127, P23, DOI 10.1016/S0742-8413(00)00129-8
   HENDON RA, 1971, P NATL ACAD SCI USA, V68, P1560, DOI 10.1073/pnas.68.7.1560
   HJELMELAND LM, 1980, P NATL ACAD SCI-BIOL, V77, P6368, DOI 10.1073/pnas.77.11.6368
   JAENICKE R, 1982, BIOPHYS STRUCT MECH, V8, P231, DOI 10.1007/BF00537204
   Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Muller VDM, 2012, TOXICON, V59, P507, DOI 10.1016/j.toxicon.2011.05.021
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Muller VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112351
   Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123
   Nunes DCO, 2013, PARASITOLOGY, V140, P844, DOI 10.1017/S0031182013000012
   Quach ND, 2014, BIOCHEM PHARMACOL, V90, P338, DOI 10.1016/j.bcp.2014.05.022
   Castillo JCQ, 2012, TOXINS, V4, P1500, DOI 10.3390/toxins4121500
   Reeks TA, 2015, CELL MOL LIFE SCI, V72, P1939, DOI 10.1007/s00018-015-1844-z
   Rodrigues RS, 2009, PROTEIN PEPTIDE LETT, V16, P894, DOI 10.2174/092986609788923266
   RUBSAMEN K, 1971, N-S ARCH PHARMAKOL, V270, P274
   Russo RR, 2014, J VIROL ANTIVIR RES, V3, P1
   Sakkas H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040175
   Samy RP, 2012, CURR MED CHEM, V19, P6150
   Seto M, 2008, PROTEIN EXPRES PURIF, V58, P194, DOI 10.1016/j.pep.2007.11.013
   Sharp Tyler M, 2017, Curr Epidemiol Rep, V4, P11, DOI 10.1007/s40471-017-0095-y
   Silveira LB, 2013, J PHARMACEUT BIOMED, V73, P35, DOI 10.1016/j.jpba.2012.04.008
   Slotta KH, 1938, BER DTSCH CHEM GES, V71, P1076, DOI 10.1002/cber.19380710527
   Smith Harold E., 2007, Journal of Structural and Functional Genomics, V8, P27, DOI 10.1007/s10969-007-9030-7
   STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Quartino PJY, 2012, BIOCHEM BIOPH RES CO, V427, P321, DOI 10.1016/j.bbrc.2012.09.051
NR 46
TC 4
Z9 4
U1 3
U2 15
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD APR
PY 2019
VL 164
IS 4
BP 1159
EP 1171
DI 10.1007/s00705-019-04172-6
PG 13
WC Virology
SC Virology
GA HP0ZD
UT WOS:000461394200019
PM 30809709
DA 2020-07-08
ER

PT J
AU Mamidi, R
   Miller, M
   Banerjee, T
   Romine, W
   Sheth, A
AF Mamidi, Ravali
   Miller, Michele
   Banerjee, Tanvi
   Romine, William
   Sheth, Amit
TI Identifying Key Topics Bearing Negative Sentiment on Twitter: Insights
   Concerning the 2015-2016 Zika Epidemic
SO JMIR PUBLIC HEALTH AND SURVEILLANCE
LA English
DT Article
DE social media; machine learning; natural language processing;
   epidemiology; Zika; infodemiology; infoveillance; twitter; sentiment
   analysis
ID SOCIAL MEDIA; VIRUS; ENHANCEMENT
AB Background: To understand the public sentiment regarding the Zika virus, social media can be leveraged to understand how positive, negative, and neutral sentiments are expressed in society. Specifically, understanding the characteristics of negative sentiment could help inform federal disease control agencies' efforts to disseminate relevant information to the public about Zika-related issues.
   Objective: The purpose of this study was to analyze the public sentiment concerning Zika using posts on Twitter and determine the qualitative characteristics of positive, negative, and neutral sentiments expressed.
   Methods: Machine learning techniques and algorithms were used to analyze the sentiment of tweets concerning Zika. A supervised machine learning classifier was built to classify tweets into 3 sentiment categories: positive, neutral, and negative. Tweets in each category were then examined using a topic-modeling approach to determine the main topics for each category, with focus on the negative category.
   Results: A total of 5303 tweets were manually annotated and used to train multiple classifiers. These performed moderately well (F1 score=0.48-0.68) with text-based feature extraction. All 48,734 tweets were then categorized into the sentiment categories. Overall, 10 topics for each sentiment category were identified using topic modeling, with a focus on the negative sentiment category.
   Conclusions: Our study demonstrates how sentiment expressed within discussions of epidemics on Twitter can be discovered. This allows public health officials to understand public sentiment regarding an epidemic and enables them to address specific elements of negative sentiment in real time. Our negative sentiment classifier was able to identify tweets concerning Zika with 3 broad themes: neural defects,Zika abnormalities, and reports and findings. These broad themes were based on domain expertise and from topics discussed in journals such as Morbidity and Mortality Weekly Report and Vaccine. As the majority of topics in the negative sentiment category concerned symptoms, officials should focus on spreading information about prevention and treatment research.
C1 [Mamidi, Ravali; Banerjee, Tanvi; Sheth, Amit] Wright State Univ, Comp Sci & Engn, Dayton, OH 45435 USA.
   [Miller, Michele; Romine, William] Wright State Univ, Dept Biol Sci, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.
   [Banerjee, Tanvi; Sheth, Amit] Wright State Univ, Comp Sci & Engn, Kno E Sis, Dayton, OH 45435 USA.
RP Miller, M (corresponding author), Wright State Univ, Dept Biol Sci, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.
EM millerme91@gmail.com
OI Sheth, Amit/0000-0002-0021-5293; Romine, William/0000-0002-0386-1688
CR [Anonymous], 2016, WALL STREET J
   [Anonymous], SCI DAILY
   Bamler R., 2017, P 34 INT C MACH LEAR, P380
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   BitBucket, ZIK SENT
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   British Broadcasting Corporation (BBC), ZIK VIR SCAR THOUGHT
   Brown P, 2016, COMPUT LINGUIST, V18, P467
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, MICR OTH BIRTH DEF
   Centers for Disease Control and Prevention, FIGHT BIT
   Centers for Disease Control and Prevention, PRENATAL CARE
   Centers for Disease Control and Prevention, CAR BAB CONG ZIK SYN
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Centers for Disease Control and Prevention (CDC), CONG ZIK SYNDR OTH B
   Chen L, 2012, EXTRACTING DIVERSE S
   Chibueze EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01991-y
   Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297
   Daniulaityte Raminta, 2016, JMIR Public Health Surveill, V2, pe162
   Devaux CA, 2015, INFECT GENET EVOL, V29, P26, DOI 10.1016/j.meegid.2014.10.028
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Forman G, 2010, ACM SIGKDD EXPLOR NE, V12, P49, DOI DOI 10.1145/1882471.1882479
   Ghenai A, 2017, CATCHING ZIKA FEVER
   Gimpel K, 2011, P 49 ANN M ASS COMP, V2
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Gonzalez-Ibanez R, 2011, 49 ANN M ASS COMP LI
   Househ M, 2016, HEALTH INFORM J, V22, P470, DOI 10.1177/1460458214568037
   International Business Machines, IBM J
   Ji X, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2013), P335, DOI 10.1109/ICHI.2013.47
   Lau JH, 2012, COLING, P1519
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mahyoub J, 2017, TOXICITY UPTAKE HALO
   Malet D, 2013, ANN C AUSTR POL STUD
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031
   Mikolov T, NEURAL INFORM PROCES
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Muppalla R, 2017, P ANN INT IEEE EMBS, P1194, DOI 10.1109/EMBC.2017.8037044
   Nakov P., 2016, P 10 INT WORKSH SEM, P1, DOI [DOI 10.18653/V1/S16-1001, 10.18653/v1/s16-1001]
   National Institute of Health, 2018, NIH BEG CLIN TRIAL L
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pollard WE, 2003, J HEALTH COMMUN, V8, P93, DOI 10.1080/10810730390224893
   Rare Technologies, GENS DEF PAR
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rong X., WORD2VEC PARAMETER L
   Schnirring L., LAB FINDINGS HINT DE
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Sheth A, 2017, 2017 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE (WI 2017), P1, DOI 10.1145/3106426.3109448
   Slovic P, 2007, AFFECT HEURISTIC
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Sun LH, WASHINGTON POST
   Tang JJ, 2014, TRANSPORT RES REC, P21, DOI 10.3141/2443-03
   Tepperman J, 2006, YEAH RIGHT SARCASM R
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
   Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0
   WHO, 2016, HIST ZIK VIR
   WHO, 2017, DENG SEV DENG
   Wijeratne S, 2016, WORD EMBEDDINGS ENHA
   Word2vec, 2013, GOOGL COD
NR 59
TC 1
Z9 1
U1 1
U2 1
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 2369-2960
J9 JMIR PUBLIC HLTH SUR
JI JMIR Public Health Surveill.
PD APR-JUN
PY 2019
VL 5
IS 2
BP 78
EP 96
AR UNSP e11036
DI 10.2196/11036
PG 19
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LE6EL
UT WOS:000526816400007
PM 31165711
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lizarazo, E
   Vincenti-Gonzalez, M
   Grillet, ME
   Bethencourt, S
   Diaz, O
   Ojeda, N
   Ochoa, H
   Rangel, MA
   Tami, A
AF Lizarazo, Erley
   Vincenti-Gonzalez, Maria
   Grillet, Maria E.
   Bethencourt, Sarah
   Diaz, Oscar
   Ojeda, Noheliz
   Ochoa, Haydee
   Rangel, Maria Auxiliadora
   Tami, Adriana
TI Spatial Dynamics of Chikungunya Virus, Venezuela, 2014
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID AEDES-AEGYPTI; DENGUE EPIDEMICS; TRANSMISSION; OUTBREAK; EVOLUTIONARY;
   INFECTION; SPREAD; ZIKA; ARBOVIRUSES; DISPERSAL
AB Since chikungunya virus emerged in the Caribbean region in late 2013, approximate to 45 countries have experienced chikungunya outbreaks. We described and quantified the spatial and temporal events after the introduction and propagation of chikungunya into an immunologically naive population from the urban north-central region of Venezuela during 2014. The epidemic curve (n = 810 cases) unraveled within 5 months with a basic reproductive number of 3.7 and a radial spread traveled distance of 9.4 km at a mean velocity of 82.9 m/day. The highest disease diffusion speed occurred during the first 90 days, and space and space-time modeling suggest the epidemic followed a particular geographic pathway with spatiotemporal aggregation. The directionality and heterogeneity of transmission during the first introduction of chikungunya indicated existence of areas of diffusion and elevated risk for disease and highlight the importance of epidemic preparedness. This information will help in managing future threats of new or reemerging arboviruses.
C1 [Lizarazo, Erley; Vincenti-Gonzalez, Maria; Tami, Adriana] Univ Groningen, Groningen, Netherlands.
   [Grillet, Maria E.] Univ Cent Venezuela, Caracas, Venezuela.
   [Bethencourt, Sarah; Tami, Adriana] Univ Carabobo, Valencia, Venezuela.
   [Diaz, Oscar; Ojeda, Noheliz; Ochoa, Haydee; Rangel, Maria Auxiliadora] Fdn Inst Carabobeno Salud, Carabobo, Venezuela.
RP Tami, A (corresponding author), Univ Med Ctr Groningen, Dept Med Microbiol, Hanzepl 1,HPC EB80, NL-9713 GZ Groningen, Netherlands.
EM a.tami@umcg.nl
RI Lizarazo, Erley/AAF-8338-2019; Vincenti-Gonzalez, Maria/Y-1087-2019
OI Lizarazo, Erley/0000-0003-2749-9780; Tami, Adriana/0000-0002-1918-9144
FU Fondo Nacional de Ciencia y Tecnologia e Innovacion (FONACIT)
   [201100129, 20130020]; Department of Medical Microbiology and Infection
   Prevention, University Medical Center Groningen (UMCG), University of
   Groningen, Groningen, the Netherlands; UMCG, University of Groningen,
   Groningen, the Netherlands; Netherlands Organization for Scientific
   Research, the NetherlandsNetherlands Organization for Scientific
   Research (NWO)Netherlands Government [040.11.590/2129]
FX This work was supported by the Fondo Nacional de Ciencia y Tecnologia e
   Innovacion (FONACIT), grant 201100129, 20130020; and by the Department
   of Medical Microbiology and Infection Prevention, University Medical
   Center Groningen (UMCG), University of Groningen, Groningen, the
   Netherlands. E.L. and M.V.-G. received the Abel Tasman Talent Program
   grant from the UMCG, University of Groningen, Groningen, the
   Netherlands. M.E.G. received a travel grant from the Netherlands
   Organization for Scientific Research (grant no. 040.11.590/2129), the
   Netherlands, 2017.
CR Agha SB, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005858
   Aldstadt J, 2007, STOCH ENV RES RISK A, V21, P487, DOI 10.1007/s00477-007-0132-3
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   BARRERA R, 1993, J AM MOSQUITO CONTR, V9, P189
   Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   Chowell G, 2013, MATH BIOSCI ENG, V10, P1455, DOI 10.3934/mbe.2013.10.1455
   Coelho FC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18455
   Dale M. R., 2014, SPATIAL ANAL GUIDE E
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Elsinga J, 2017, J INFECT DIS, V216, P573, DOI 10.1093/infdis/jix312
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Grillet ME, 2016, TRIBUNA INVESTIGADOR, V17, P42
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042
   KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25
   KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441
   Marimoutou C, 2015, CLIN MICROBIOL INFEC, V21, P688, DOI 10.1016/j.cmi.2015.02.024
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nishiura H, 2010, J R SOC INTERFACE, V7, P297, DOI 10.1098/rsif.2009.0153
   Oletta L JF, 2016, GAC MED CARACAS, V124, P122
   Pan American Health Organization, 2015, NUMB REP CAS CHIK FE
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Perkins TA, 2015, PLOS CURR, P7
   Pimentel R, 2014, REV PANAM SALUD PUBL, V36, P336
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rodhain Francois, 1997, P45
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Vincenti-Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005317
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   WATERMAN SH, 1985, AM J TROP MED HYG, V34, P625, DOI 10.4269/ajtmh.1985.34.625
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   = World Health Organization, 1995, GUID DENG SURV MOSQ, V8
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 48
TC 3
Z9 3
U1 1
U2 3
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2019
VL 25
IS 4
BP 672
EP 680
DI 10.3201/eid2504.172121
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HP3UZ
UT WOS:000461604500007
PM 30882314
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Evans, AB
   Winkler, CW
   Peterson, KE
AF Evans, Alyssa B.
   Winkler, Clayton W.
   Peterson, Karin E.
TI Differences in Neuropathogenesis of Encephalitic California Serogroup
   Viruses
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID JAMESTOWN-CANYON-VIRUS; LA-CROSSE VIRUS; TAHYNA VIRUS; ARBOVIRAL
   INFECTIONS; AEDES MOSQUITOS; UNITED-STATES; ZIKA VIRUS; ANTIBODIES;
   BUNYAVIRIDAE; ORTHOBUNYAVIRUS
AB The California serogroup of orthobunyaviruses comprises a group of mosquitoborne viruses, including La Crosse (LACV), snowshoe hare (SSHV), Tahyna (TAHV), Jamestown Canyon (JCV), and Inkoo (INKV) viruses, that cause neurologic disease in humans of differing ages with varying incidences. To determine how the pathogenesis of these viruses differs, we compared their ability to induce disease in mice and replicate and induce cell death in vitro. In mice, LACV, TAHV, and SSHV induced neurologic disease after intraperitoneal and intranasal inoculation, and JCV induced disease only after intranasal inoculation. INKV rarely induced disease, which correlated with less viral antigen in the brain than the other viruses. In vitro, all viruses replicated to high titers; however, LACV, SSHV, and TAHV induced high cell death, whereas JCV and INKV did not. Results demonstrated that CSG viruses differ in neuropathogenesis in vitro and in vivo, which correlates with the differences in pathogenesis reported in humans.
C1 [Evans, Alyssa B.; Winkler, Clayton W.; Peterson, Karin E.] NIAID, NIH, Hamilton, MT 59840 USA.
RP Peterson, KE (corresponding author), NIAID, NIH, Lab Persistent Viral Dis, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.
EM petersonka@niaid.nih.gov
RI Winkler, Clayton/F-8031-2018
OI Winkler, Clayton/0000-0002-4460-3378; Evans, Alyssa/0000-0002-3766-9272
FU National Institutes of Allergy and Infectious Diseases Division of
   Intramural Research, National Institutes of Health
FX This work was supported by the National Institutes of Allergy and
   Infectious Diseases Division of Intramural Research, National Institutes
   of Health.
CR Anderson JF, 2015, AM J TROP MED HYG, V92, P377, DOI 10.4269/ajtmh.14-0291
   Andreadis TG, 2008, VECTOR-BORNE ZOONOT, V8, P175, DOI 10.1089/vbz.2007.0169
   Artsob H, 1983, Prog Clin Biol Res, V123, P277
   Bennett RS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-135
   Bennett RS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-136
   Bennett RS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-25
   BERRY RL, 1977, MOSQ NEWS, V37, P494
   Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06
   BOROMISA RD, 1986, AM J TROP MED HYG, V35, P1285, DOI 10.4269/ajtmh.1986.35.1285
   Butchi NB, 2011, AM J PATHOL, V179, P783, DOI 10.1016/j.ajpath.2011.04.011
   CAMPBELL GL, 1989, AM J TROP MED HYG, V40, P428, DOI 10.4269/ajtmh.1989.40.428
   Centers for Disease Control and Prevention, 2018, E GEPGR DOSTR
   CLARK GG, 1986, J MED ENTOMOL, V23, P588, DOI 10.1093/jmedent/23.6.588
   Drebot M A, 2015, Can Commun Dis Rep, V41, P117
   ELDRIDGE BF, 1987, J WILDLIFE DIS, V23, P199, DOI 10.7589/0090-3558-23.2.199
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   Gaensbauer JT, 2014, PEDIATRICS, V134, pE642, DOI 10.1542/peds.2014-0498
   Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006145
   HEARD PB, 1990, J AM MOSQUITO CONTR, V6, P461
   Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7
   Hughes HR, 2017, VIROLOGY, V512, P201, DOI 10.1016/j.virol.2017.09.022
   ISSEL C J, 1973, Journal of Wildlife Diseases, V9, P245
   ISSEL CJ, 1972, AM J TROP MED HYG, V21, P985, DOI 10.4269/ajtmh.1972.21.985
   Jentes ES, 2010, AM J TROP MED HYG, V83, P388, DOI 10.4269/ajtmh.2010.09-0688
   Kilian P, 2010, VIRUS RES, V149, P119, DOI 10.1016/j.virusres.2010.01.005
   Kosoy O, 2016, VECTOR-BORNE ZOONOT, V16, P191, DOI 10.1089/vbz.2015.1865
   Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078
   KUNZ C, 1964, AM J TROP MED HYG, V13, P738, DOI 10.4269/ajtmh.1964.13.738
   Lau L, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx150
   MCFARLANE BL, 1981, CAN J MICROBIOL, V27, P1219, DOI 10.1139/m81-187
   MONATH TPC, 1970, AM J EPIDEMIOL, V92, P40, DOI 10.1093/oxfordjournals.aje.a121178
   PANTUWAT.S, 1972, AM J TROP MED HYG, V21, P476, DOI 10.4269/ajtmh.1972.21.476
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Pastula DM, 2015, AM J TROP MED HYG, V93, P384, DOI 10.4269/ajtmh.15-0196
   PINGER RR, 1975, AM J TROP MED HYG, V24, P1006, DOI 10.4269/ajtmh.1975.24.1006
   Putkuri N, 2007, CLIN VACCINE IMMUNOL, V14, P1555, DOI 10.1128/CVI.00288-07
   Putkuri N, 2016, EMERG INFECT DIS, V22, P810, DOI 10.3201/eid2205.151015
   Rhyan J, 2015, J WILDLIFE DIS, V51, P769, DOI 10.7589/2015-01-021
   Sonnleitner ST, 2014, VECTOR-BORNE ZOONOT, V14, P272, DOI 10.1089/vbz.2013.1360
   SRIHONGSE S, 1984, AM J TROP MED HYG, V33, P1218, DOI 10.4269/ajtmh.1984.33.1218
   Taylor KG, 2014, J VIROL, V88, P11070, DOI 10.1128/JVI.01866-14
   WALKER ED, 1993, J AM MOSQUITO CONTR, V9, P131
   Walters LL, 1999, AM J TROP MED HYG, V60, P806, DOI 10.4269/ajtmh.1999.60.806
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Winkler CW, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0836-3
   Winkler C, 2015, ACTA NEUROPATHOL, V130, P233, DOI 10.1007/s00401-015-1433-0
NR 46
TC 3
Z9 3
U1 0
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2019
VL 25
IS 4
BP 728
EP 738
DI 10.3201/eid2504.181016
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HP3UZ
UT WOS:000461604500013
PM 30882310
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hill, SC
   de Vasconcelos, JN
   Granja, BG
   Theze, J
   Jandondo, D
   Neto, Z
   Mirandela, M
   Sebastiao, CD
   Candido, ALM
   Clemente, C
   da Silva, SP
   de Oliveira, T
   Pybus, OG
   Faria, NR
   Afonso, JM
AF Hill, Sarah C.
   de Vasconcelos, Jocelyne Neto
   Granja, Bernardo Gutierrez
   Theze, Julien
   Jandondo, Domingos
   Neto, Zoraima
   Mirandela, Marinela
   Sebastiao, Cruz dos Santos
   Micolo Candido, Ana Lulsa
   Clemente, Carina
   da Silva, Sara Pereira
   de Oliveira, Tulio
   Pybus, Oliver G.
   Faria, Nuno R.
   Afonso, Joana Morals
TI Early Genomic Detection of Cosmopolitan Genotype of Dengue Virus
   Serotype 2, Angola, 2018
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID OUTBREAK; ZIKA
AB We used portable genome sequencing to investigate reported dengue virus transmission in Angola. Our results show that autochthonous transmission of dengue serotype 2 (cosmopolitan genotype) occurred in January 2018.
C1 [Hill, Sarah C.; Granja, Bernardo Gutierrez; Theze, Julien; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Oxford, England.
   [de Vasconcelos, Jocelyne Neto; Jandondo, Domingos; Neto, Zoraima; Mirandela, Marinela; Sebastiao, Cruz dos Santos; Micolo Candido, Ana Lulsa; Afonso, Joana Morals] Inst Nacl Invest Saude, Luanda, Angola.
   [Granja, Bernardo Gutierrez] Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, Quito, Ecuador.
   [Clemente, Carina; da Silva, Sara Pereira] Cligest, Luanda, Angola.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Durban, South Africa.
RP Afonso, JM (corresponding author), Inst Nacl Invest Saude, Luanda, Angola.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, Peter Medawar Bldg, Oxford OX1 3SY, England.
EM nuno.faria@zoo.ox.ac.uk; jinafonso.7@gmail.com
RI Pybus, Oliver g/B-2640-2012; Faria, Nuno Rodrigues/I-2975-2012
OI Pybus, Oliver g/0000-0002-8797-2667; Hill, Sarah/0000-0002-2995-2596;
   Faria, Nuno Rodrigues/0000-0001-8839-2798
FU Wellcome TrustWellcome Trust; Royal Society Sir Henry Dale Fellowship
   [204311/Z/16/Z]; Higher Education Funding Council for England's Global
   Challenges Research Fund [005073]; John Fell Research Fund [005166];
   Africa-Oxford Travel Grants [AfiOx-48, AfiOx-60]
FX This study was made possible by funding from the Wellcome Trust and
   Royal Society Sir Henry Dale Fellowship (grant no. 204311/Z/16/Z), the
   Higher Education Funding Council for England's Global Challenges
   Research Fund (grant no. 005073), and the John Fell Research Fund (grant
   no. 005166). Travel to Angola by S.C.H. and N.R.F. was supported by
   Africa-Oxford Travel Grants (grant nos. AfiOx-48 and AfiOx-60).
CR Abreu C, 2016, J CLIN VIROL, V79, P77, DOI 10.1016/j.jcv.2016.04.011
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Schwartz E., 2013, Eurosurveillance, V18, P20488
   Sharp TM, 2013, MMWR-MORBID MORTAL W, V62, P504
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
NR 12
TC 6
Z9 6
U1 2
U2 3
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2019
VL 25
IS 4
BP 784
EP 787
DI 10.3201/eid2504.180958
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HP3UZ
UT WOS:000461604500020
PM 30882320
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reyes, Y
   Bowman, NM
   Becker-Dreps, S
   Centeno, E
   Collins, MH
   Liou, GJA
   Bucardo, F
AF Reyes, Yaoska
   Bowman, Natalie M.
   Becker-Dreps, Sylvia
   Centeno, Edwing
   Collins, Matthew H.
   Liou, Guei-Jiun Alice
   Bucardo, Filemon
TI Prolonged Shedding of Zika Virus RNA in Vaginal Secretions, Nicaragua
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID TRANSMISSION
AB Zika virus, an arthropodborne flavivirus pathogen in humans, is unusual because it can be sexually transmitted and can be shed for prolonged periods in semen. We report viral shedding in vaginal secretions for up to 6 months, indicating the potential for sexual and vertical transmission by infected women.
C1 [Reyes, Yaoska; Centeno, Edwing; Bucardo, Filemon] Univ Nacl Autonoma Nicaragua, Leon, Nicaragua.
   [Bowman, Natalie M.; Becker-Dreps, Sylvia; Collins, Matthew H.; Liou, Guei-Jiun Alice] Univ N Carolina, Div Infect Dis, Sch Med, Chapel Hill, NC 27999 USA.
RP Bowman, NM (corresponding author), Univ N Carolina, Sch Med, CB 7030,Bioinformat Bldg,2nd Fl,130 Mason Farm Rd, Chapel Hill, NC 27999 USA.
EM nbowman@med.unc.edu
FU US National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21 AI129532]; University of North Carolina at Chapel Hill
FX This work was funded by US National Institute of Allergy and Infectious
   Diseases grant no. R21 AI129532 and an Emerging Challenges in Biomedical
   Research award from the University of North Carolina at Chapel Hill.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lozier MJ, 2018, CLIN INFECT DIS, V67, P624, DOI 10.1093/cid/ciy209
   Mcgee D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188645
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Paz-Bailey G, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJM0A1613108]
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
NR 15
TC 3
Z9 3
U1 0
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2019
VL 25
IS 4
BP 808
EP 810
DI 10.3201/eid2504.180977
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HP3UZ
UT WOS:000461604500026
PM 30882329
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Perng, GC
   Ho, TC
   Shih, HI
   Lee, CH
   Huang, PW
   Chung, CH
   Ko, NY
   Ko, WC
   Chien, YW
AF Perng, Guey Chuen
   Ho, Tzu-Chuan
   Shih, Hsin-, I
   Lee, Chia-Hua
   Huang, Pei-Wen
   Chung, Chih-Huan
   Ko, Nai-Ying
   Ko, Wen-Chien
   Chien, Yu-Wen
TI Seroprevalence of Zika and Dengue Virus Antibodies among Migrant
   Workers, Taiwan, 2017
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INFECTION
AB A serosurvey of 600 workers newly arrived in Taiwan from 4 Southeast Asia countries showed that 18 (3%) were positive for Zika virus IgM; 6 (1%) fulfilled the World Health Organization criteria for laboratory-confirmed recent Zika virus infection. The incidence of Zika virus infection in Southeast Asia might be underestimated.
C1 [Perng, Guey Chuen] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan, Taiwan.
   [Ho, Tzu-Chuan; Shih, Hsin-, I; Lee, Chia-Hua; Huang, Pei-Wen; Ko, Nai-Ying; Ko, Wen-Chien; Chien, Yu-Wen] Natl Cheng Kung Univ, Coll Med, Tainan, Taiwan.
   [Shih, Hsin-, I; Ko, Nai-Ying; Ko, Wen-Chien; Chien, Yu-Wen] Natl Cheng Kung Univ Hosp, Tainan, Taiwan.
   [Chung, Chih-Huan] Kuo Gen Hosp, Tainan, Taiwan.
RP Chien, YW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, 1 Univ Rd, Tainan 70101, Taiwan.
EM yuwenchien@mail.ncku.edu.tw
OI Ko, Nai-Ying/0000-0002-3007-2537
FU Taiwan National Health Research Institutes [NHRI-106A1-MRCO-0517171];
   Ministry of Health and WelfareMinistry of Health, Labour and Welfare,
   Japan [MOHW104-CDC-C-114-114901-H105002]; Taiwan Ministry of Science and
   Technology [MOST 106-2320-B-006-036, MOST-105-2321-B-006-024]; National
   Cheng Kung University Hospital [NCKUH-10702020]
FX This work was partially supported by the Taiwan National Health Research
   Institutes (grant no. NHRI-106A1-MRCO-0517171 to Y.-W.C.), Ministry of
   Health and Welfare (MOHW104-CDC-C-114-114901-H105002 to G.C.P.), Taiwan
   Ministry of Science and Technology (MOST 106-2320-B-006-036 to Y.-W.C.
   and MOST-105-2321-B-006-024 to G.C.P.), and National Cheng Kung
   University Hospital (NCKUH-10702020 to Y.-W.C.).
CR Chu DT, 2017, EUR J CLIN MICROBIOL, V36, P2041, DOI 10.1007/s10096-017-3030-8
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Khongwichit S, 2018, MICROBES INFECT, V20, P670, DOI 10.1016/j.micinf.2018.01.007
   Kuan MM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-182
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002581
   ten Bosch QA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006965
   Ward MJ, 2018, AM J TROP MED HYG, V99, P780, DOI 10.4269/ajtmh.18-0237
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
NR 15
TC 4
Z9 4
U1 1
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2019
VL 25
IS 4
BP 814
EP 816
DI 10.3201/eid2504.181449
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HP3UZ
UT WOS:000461604500028
PM 30882327
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mansuy, JM
   El Costa, H
   Gouilly, J
   Mengelle, C
   Pasquier, C
   Martin-Blondel, G
   Izopet, J
   Jabrane-Ferrat, N
AF Mansuy, Jean-Michel
   El Costa, Hicham
   Gouilly, Jordi
   Mengelle, Catherine
   Pasquier, Christophe
   Martin-Blondel, Guillaume
   Izopet, Jacques
   Jabrane-Ferrat, Nabila
TI Peripheral Plasma and Semen Cytokine Response to Zika Virus in Humans
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID INFECTION; SPERM
AB We assessed Zika virus RNA and select cytokine levels in semen, blood, and plasma samples from an infected patient in South America. Viral RNA was detected in semen >2 months after viremia clearance; cytokine profiles differed in semen and plasma. After viremia, Zika virus appears to become compartmentalized in the male reproductive tract.
C1 [Mansuy, Jean-Michel; El Costa, Hicham; Mengelle, Catherine; Pasquier, Christophe; Martin-Blondel, Guillaume; Izopet, Jacques] CHU Toulouse, Toulouse, France.
   [El Costa, Hicham; Gouilly, Jordi; Martin-Blondel, Guillaume; Izopet, Jacques; Jabrane-Ferrat, Nabila] Univ Toulouse III, INSERM, U1043, CNRS,UMR5282, Toulouse, France.
RP Mansuy, JM (corresponding author), Inst Federatif Biol, Lab Virol, 330 Ave Grande Bretagne, F-31059 Toulouse, France.
EM mansuy.jm@chu-toulouse.fr
RI Martin-Blondel, Guillaume/K-6762-2014; Jabrane-Ferrat,
   Nabila/K-1224-2014
OI Martin-Blondel, Guillaume/0000-0002-8363-7028; Jabrane-Ferrat,
   Nabila/0000-0003-4809-7836; EL COSTA, Hicham/0000-0001-8889-9759;
   PASQUIER, Christophe/0000-0001-9223-0150; IZOPET,
   JACQUES/0000-0002-8462-3234
CR Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Fraczek M, 2008, J ANDROL, V29, P85, DOI 10.2164/jandrol.107.003319
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Rametse CL, 2014, VIRAL IMMUNOL, V27, P200, DOI 10.1089/vim.2013.0136
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
NR 8
TC 2
Z9 2
U1 0
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2019
VL 25
IS 4
BP 823
EP 825
DI 10.3201/eid2504.171886
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HP3UZ
UT WOS:000461604500031
PM 30882325
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carvalho, FR
   Medeiros, T
   Vianna, RAD
   Douglass-Jaimes, G
   Nunes, PCG
   Quintans, MDS
   Souza, CF
   Cavalcanti, SMB
   dos Santos, FB
   de Oliveira, SA
   Cardoso, CAA
   Silva, AA
AF Carvalho, Fabiana Rabe
   Medeiros, Thalia
   de Oliveira Vianna, Renata Artimos
   Douglass-Jaimes, Guillermo
   Guerra Nunes, Priscila Conrado
   Salgado Quintans, Maria Dolores
   Souza, Cintia Fernandes
   Baeta Cavalcanti, Silvia Maria
   dos Santos, Flavia Barreto
   de Oliveira, Solange Artimos
   Araujo Cardoso, Claudete Aparecida
   Silva, Andrea Alice
TI Simultaneous circulation of arboviruses and other congenital infections
   in pregnant women in Rio de Janeiro, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Arboviruses; Vertical transmission of infectious disease; Pregnancy
ID CHIKUNGUNYA VIRUS-INFECTION; ANTIBODY KINETICS; EPIDEMIC; DENGUE
AB Background: Arboviruses (Zika, dengue and chikungunya) represent a major risk for pregnant women, especially because their vertical transmission can lead to neurological damage in newborns. Early diagnosis can be difficult due to similar clinical presentation with other congenital infections that are associated with congenital abnormalities.
   Objectives: To investigate the circulation of arboviruses and other pathogens responsible for congenital infections, reporting clinical aspects and geographic distribution of maternal rash in a metropolitan region of Rio de Janeiro (Brazil).
   Methods: Cross-sectional study with pregnant women presenting rash attended at the Exanthematic Diseases Unit (Niteroi, Rio de Janeiro) from 2015 to 2018. Diagnosis of arboviruses was performed by real-time PCR (RT-qPCR) and laboratorial screening for syphilis, toxoplasmosis, rubella, cytomegalovirus and HIV was assessed. Demographic data was used for georeferencing analysis.
   Findings: We included 121 pregnant women, of whom Zika virus was detected in 45 cases (37.2%), chikungunya in 33 (27.3%) and dengue in one (0.8%). Five patients presented syphilis, and we observed one case each of listeria, cytomegalovirus, and a syphilis-toxoplasmosis case. Similarity of clinical symptoms was observed in all groups; however, 84.8% of patients with chikungunya presented arthralgia. Following the decline of Zika cases, chikungunya infection was mostly observed during 2017-2018. Considering pregnant women infected with arboviruses and other infections, 41% resided in urban slums, mostly in Niteroi.
   Main conclusions: Simultaneous circulation of arboviruses and other agents responsible for congenital infections were observed; however, we did not identify co-infections between arboviruses. In this scenario, we emphasize the importance of adequate prenatal care to provide an accurate diagnosis of maternal rash.
C1 [Carvalho, Fabiana Rabe; Medeiros, Thalia; de Oliveira Vianna, Renata Artimos; Souza, Cintia Fernandes; Araujo Cardoso, Claudete Aparecida; Silva, Andrea Alice] Univ Fed Fluminense, Fac Med, Lab Multiusuario Apoio Pesquisa Nefrol & Ciencias, Niteroi, RJ, Brazil.
   [Douglass-Jaimes, Guillermo] Pomona Coll, Environm Anal Program, Claremont, CA 91711 USA.
   [Guerra Nunes, Priscila Conrado; dos Santos, Flavia Barreto] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Salgado Quintans, Maria Dolores; Araujo Cardoso, Claudete Aparecida] Univ Fed Fluminense, Fac Med, Dept Maternoinfantil, Niteroi, RJ, Brazil.
   [Baeta Cavalcanti, Silvia Maria] Univ Fed Fluminense, Inst Biomed, Dept Microbiol & Parasitol, Niteroi, RJ, Brazil.
   [de Oliveira, Solange Artimos] Univ Fed Fluminense, Fac Med, Dept Med Clin, Niteroi, RJ, Brazil.
   [Silva, Andrea Alice] Univ Fed Fluminense, Fac Med, Dept Patol, Niteroi, RJ, Brazil.
RP Silva, AA (corresponding author), Hosp Univ Antonio Pedro, Dept Patol, Lab Multiusuario Apoio Pesquisa Nefrol & Ciencias, Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
EM fabianarc@id.uff.br; thaliamedeiros@id.uff.br; renatavianna03@gmail.com;
   guillermo.douglass-jaimes@pomona.edu; pricgn@ioc.fiocruz.br;
   mdsquintans@id.uff.br; cinttiafs@yahoo.com.br;
   silviacavalcanti67@gmail.com; flaviab@ioc.fiocniz.br;
   sartimos@id.uff.br; claudetecardoso@id.uff.br; aasilva@id.uff.br
RI Medeiros, Thalia/F-4007-2018; Silva, Andrea Alice/J-6729-2012; amsalu,
   ribka/G-8780-2019
OI Medeiros, Thalia/0000-0002-5642-4027; Silva, Andrea
   Alice/0000-0001-5856-6128; Souza, Cintia/0000-0001-6068-5097; Santos,
   Flavia/0000-0002-1309-5366
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPESCAPES
   [D035.117.001/ D035.117.003/D014.216.001]; Pro-reitoria de Pos-graduacao
   Pesquisa e Inovacao from the Universidade Federal Fluminense
   (Proppi/UFF)
FX This work was supported by the Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior - CAPES (D035.117.001/ D035.117.003/D014.216.001) and
   by the Pro-reitoria de Pos-graduacao Pesquisa e Inovacao from the
   Universidade Federal Fluminense (Proppi/UFF).
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Brazil: Ministry of Health, 2018, EP B SYPH, V48
   Brazil: Ministry of Health, 2007, 1 SEM PART MAN FOR M
   Brazil: Ministry of Health, 2017, INT GUID SURV HLTH C
   Contopoulos-Ioannidis D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006510
   Dotters-Katz SK, 2015, OBSTET GYNECOL SURV, V70, P453, DOI 10.1097/OGX.0000000000000184
   Escobar M, 2017, EMERG INFECT DIS, V23, P1777, DOI 10.3201/eid2311.170480
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Ingall D., 2006, INFECT DIS FETUS NEW, P643
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   da Silva DAL, 2016, J FOOD PROTECT, V79, P628, DOI 10.4315/0362-028X.JFP-15-482
   Lovero K., 2017, SUPER SPECIAL MOMS G
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Oliveira RG, 2018, BMC INFECT DIS, V18, P1
   Paixao ES, 2018, EMERG INFECT DIS, V24, P1748, DOI 10.3201/eid2409.170361
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ramful D, 2014, J INFECT DIS, V209, P1726, DOI 10.1093/infdis/jit814
   Andaki ACR, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00105317, 10.1590/0102-311X00105317]
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Snyder RE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005287
   Domingues RMSM, 2012, CAD SAUDE PUBLICA, V28, P425, DOI 10.1590/S0102-311X2012000300003
   Van der Linden V., 2016, MMWR-MORBID MORTAL W, P1
   Watanaveeradej V, 2006, EMERG INFECT DIS, V12, P1770, DOI 10.3201/eid1211.051560
NR 29
TC 1
Z9 1
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD APR
PY 2019
VL 192
BP 49
EP 54
DI 10.1016/j.actatropica.2019.01.020
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HO9GE
UT WOS:000461268800006
PM 30685232
DA 2020-07-08
ER

PT J
AU Martin, E
   Medeiros, MCI
   Carbajal, E
   Valdez, E
   Juarez, JG
   Gracia-Luna, S
   Salazar, A
   Qualls, WA
   Hinojosa, S
   Borucki, MK
   Manley, HA
   Badillo-Vargas, IE
   Frank, M
   Hamer, GL
AF Martin, Estelle
   Medeiros, Matthew C. I.
   Carbajal, Ester
   Valdez, Edwin
   Juarez, Jose G.
   Gracia-Luna, Selene
   Salazar, Aaron
   Qualls, Whitney A.
   Hinojosa, Steven
   Borucki, Monica K.
   Manley, Heather A.
   Badillo-Vargas, Ismael E.
   Frank, Matthias
   Hamer, Gabriel L.
TI Surveillance of Aedes aegypti indoors and outdoors using Autocidal
   Gravid Ovitraps in South Texas during local transmission of Zika virus,
   2016 to 2018
SO ACTA TROPICA
LA English
DT Article
DE Aedes aegypti; Socioeconomic conditions; Temperature; Vector-borne
   diseases; United States; Relative abundance; Household
ID DIPTERA-CULICIDAE; YELLOW-FEVER; CHIKUNGUNYA-VIRUS; MEXICO BORDER;
   UNITED-STATES; DENGUE-FEVER; RISK-FACTORS; TEMPERATURE; ALBOPICTUS;
   HEALTH
AB The yellow fever mosquito, Aedes aegypti, has facilitated the re-emergence of dengue virus (DENV) and emergence of chikungunya virus (CHIKV) and Zika virus (ZIKV) in the Americas and the Caribbean. The recent transmission of these arboviruses in the continental United States has been limited, to date, to South Florida and South Texas despite Ae. aegypti occurring over a much larger geographical region within the country. The main goal of our study was to provide the first long term longitudinal study of Ae. aegypti and enhance the knowledge about the indoor and outdoor relative abundance of Ae. aegypti as a proxy for mosquito-human contact in South Texas, a region of the United States that is at high risk for mosquito-borne virus transmission. Here, the relative abundance of indoors and outdoors mosquitoes of households in eight different communities was described. Surveillance was done weekly from September 2016 to April 2018 using the CDC Autocidal Gravid Ovitraps in low- and middle-income communities. A total of 69 houses were included in this survey among which 36 were in the low-income communities (n = 11 for Donna, n = 15 for Progresso, n = 5 for Mesquite, n = 5 for Chapa) and 33 in middle-income communities (n = 9 for La Feria, n = 8 for Weslaco, n = 11 for McAllen, and n = 5 for Rio Rico). Overall, Ae. aegypti was the dominant species (59.2% of collections, n = 7255) followed by Culex spp. mosquitoes (27.3% of collections, n = 3350). Furthermore, we demonstrated for Ae. aegypti that 1) outdoor relative abundance was higher compared to indoor relative abundance, 2) low-income communities were as sociated with an increase in mosquito relative abundance indoors when compared to middle-income communities, 3) no difference was observed in the number of mosquitoes collected outdoors between low-income and middle-income communities, and 4) warmer months were positively correlated with outdoor relative abundance whereas no seasonality was observed in the relative abundance of mosquitoes indoors. Additionally, Ae. aegypti mosquitoes collected in South Texas were tested using a specific ZIKV/CHIKV multiplex real-time PCR assay, however, none of the mosquitoes tested positive. Our data highlights the occurrence of mosquitoes indoors in the continental United States and that adults are collected nearly every week of the calendar year. These mosquito data, obtained concurrently with local ZIKV transmission of 10 locally acquired cases in nearby communities, represent a baseline for future studies in the Lower Rio Grande Valley (LRGV) including vector control interventions relying on the oviposition behavior to reduce mosquito populations and pathogen transmission.
C1 [Martin, Estelle; Carbajal, Ester; Valdez, Edwin; Juarez, Jose G.; Gracia-Luna, Selene; Hamer, Gabriel L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Medeiros, Matthew C. I.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.
   [Salazar, Aaron] City McAllen, Hlth & Code Compliance Dept, Mcallen, TX USA.
   [Qualls, Whitney A.] Texas Dept State Hlth Serv, Zoonosis Control Branch, Austin, TX USA.
   [Hinojosa, Steven] Hidalgo Cty Hlth & Human Serv, Edinburg, TX USA.
   [Borucki, Monica K.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA USA.
   [Manley, Heather A.] Texas A&M Univ, Inst Infect Anim Dis, College Stn, TX USA.
   [Badillo-Vargas, Ismael E.] Texas A&M AgriLife Res, Dept Entomol, Weslaco, TX USA.
RP Martin, E (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
EM estellemartin@tamu.edu; ghamer@tamu.edu
OI Garcia-Luna, Selene M./0000-0001-8420-5078; Juarez Valdez,
   Jose/0000-0002-0583-478X
FU U.S. Department of Energy by Lawrence Livermore National
   LaboratoryUnited States Department of Energy (DOE) [DE-AC52-07NA27344];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5R21A1128953-02];
   Texas A&M AgriLife Research
FX We are grateful to the residents of the eight communities in the Lower
   Rio Grande Valley, TX, that granted us permission to trap mosquitoes
   using the AGO traps on their property. We also thank Lopamudra
   Chakraborty, Cierra Briggs, Helena Hopson, Catalina Osornia, Hugo
   Flores, Rosa Badillo and Courtney Avila for assistance in the field. We
   are grateful to Dr. Roberto Barrera and Dr. Aaron Brault for reviewing
   this manuscript. This work was performed, in part, under the auspices of
   the U.S. Department of Energy by Lawrence Livermore National Laboratory
   under Contract DE-AC52-07NA27344. Funding was also provided by National
   Institutes of Health 5R21A1128953-02 and Texas A&M AgriLife Research.
CR Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Arruda Pedrosa de Almeida Costa E., 2010, IMPACT SMALL VARIATI
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Brady OJ, 2014, MAPPING EPIDEMIOLOGY
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Carter DE, 1996, ENVIRON HEALTH PERSP, V104, P590, DOI 10.2307/3433077
   Champion SR, 2014, ENVIRON HEALTH INSIG, V8, P35, DOI 10.4137/EHI.S16004
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cilek JE, 2017, J AM MOSQUITO CONTR, V33, P103, DOI 10.2987/16-6628.1
   Degener CM, 2014, MEM I OSWALDO CRUZ, V109, P1030, DOI 10.1590/0074-0276140234
   Ernst KC, 2017, J MED ENTOMOL, V54, P204, DOI 10.1093/jme/tjw141
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940
   Grech MG, 2015, ACTA TROP, V146, P1, DOI 10.1016/j.actatropica.2015.02.010
   Gubler DJ, 1996, T ROY SOC TROP MED H, V90, P449, DOI 10.1016/S0035-9203(96)90286-2
   GUBLER DJ, 1994, AM J TROP MED HYG, V50, P50, DOI 10.4269/ajtmh.1994.50.50
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Gunning CE, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006378
   Hahn M. B., 2016, J MED ENTOMOL
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Hargrove WL, 2015, INT J ENV RES PUB HE, V12, P3864, DOI 10.3390/ijerph120403864
   Homedes N, 2003, AM J PUBLIC HEALTH, V93, P2016, DOI 10.2105/AJPH.93.12.2016
   Johnson T. L., 2017, J MED ENTOMOL
   Joy TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046946
   Kean J, 2015, INSECTS, V6, P236, DOI 10.3390/insects6010236
   LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Marinho RA, 2016, J VECTOR ECOL, V41, P1, DOI 10.1111/jvec.12187
   Monaghan Ai., 2016, PLOS CURR, V8
   PAHO, 2017, NUMB REP CAS CHIK FE
   PAHO, 2018, NUMB REP CAS DENG SE
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Roth A, 2014, EURO SURVEIL, V19
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   SALLAM MF, 2017, INT J ENV RES PUBLIC, V14
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   Sivagnaname N, 2012, INDIAN J MED RES, V136, P739
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   SOPER FL, 1965, AM J TROP MED HYG, V14, P887, DOI 10.4269/ajtmh.1965.14.887
   Spiegel JM, 2007, TROP MED INT HEALTH, V12, P503, DOI 10.1111/j.1365-3156.2007.01818.x
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Vitek CJ, 2014, J MED ENTOMOL, V51, P1019, DOI 10.1603/ME13005
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Zellweger RM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006051
NR 60
TC 5
Z9 5
U1 1
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD APR
PY 2019
VL 192
BP 129
EP 137
DI 10.1016/j.actatropica.2019.02.006
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HO9GE
UT WOS:000461268800017
PM 30763563
OA Other Gold
DA 2020-07-08
ER

PT J
AU Fernandes, KM
   Tome, HVV
   Miranda, FR
   Concalves, WG
   Pascini, TV
   Serrao, JE
   Martins, GF
AF Fernandes, Kenner Morais
   Ventura Tome, Hudson Vaner
   Miranda, Franciane Rosa
   Concalves, Wagner Gonzaga
   Pascini, Tales Vicari
   Serrao, Jose Eduardo
   Martins, Gustavo Ferreira
TI Aedes aegypti larvae treated with spinosad produce adults with damaged
   midgut and reduced fecundity
SO CHEMOSPHERE
LA English
DT Article
DE Apoptosis; Bioinsecticide; Metamorphosis; Mosquitoes; Insecticide
   toxicity
ID INSECTICIDE RESISTANCE; DIPTERA; MOSQUITOS; CULICIDAE
AB The mosquito Aedes aegypti is the main vector of Dengue, Chikungunya, Zika, and yellow fever viruses, which are responsible for high human morbidity and mortality. The fight against these pathogens is mainly based on the control of the insect vector with the use of insecticides. Among insecticides, spinosad bioinsecticide is efficient against A. aegypti larvae and may be an alternative for vector control. Here, we investigate the sublethal effects of spinosad during midgut metamorphosis of A. aegypti females and its cumulative effects on blood acquisition capacity and fecundity in adults. We studied the midgut because it is an important model organ directly related to blood acquisition and digestion. Treatment of larvae with spinosad induced oxidative stress, apoptosis, and damage to the midgut cells at all stages of development and in adults. There was a reduction in the number of proliferating cells and the number of enteroendocrine cells in treated individuals. In addition, damage caused by spinosad led to a reduction in oviposition and egg viability of A. aegypti females. Finally, the exposure of mosquito larvae to sublethal concentrations of spinosad interfered with the development of the midgut, arresting the blood digestion and reproduction of adult females with blood digestion and reproduction difficulties. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Fernandes, Kenner Morais; Miranda, Franciane Rosa; Concalves, Wagner Gonzaga; Pascini, Tales Vicari; Serrao, Jose Eduardo; Martins, Gustavo Ferreira] Univ Fed Vicosa, Dept Biol Geral, BR-36570900 Vicosa, MG, Brazil.
   [Fernandes, Kenner Morais] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil.
   [Ventura Tome, Hudson Vaner] EAG Labs, 13709 Progress Blvd,24 Suite S163, Alachua, FL 32615 USA.
RP Martins, GF (corresponding author), Univ Fed Vicosa, Dept Biol Geral, BR-36570900 Vicosa, MG, Brazil.
EM gmartins@ufv.br
RI Pascini, Tales/AAM-2655-2020; Martins, Gustavo Ferreira/AAL-7744-2020;
   Fernandes, Kenner Morais/Z-1667-2019
OI Martins, Gustavo Ferreira/0000-0003-0614-8551; Fernandes, Kenner
   Morais/0000-0003-0576-8185; Serrao, Jose Eduardo/0000-0002-0477-4252
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   BrasilCAPES [001]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), BrasilNational Council for Scientific and
   Technological Development (CNPq) [302389/2016-4]
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) - Finance Code 001 and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Finance
   Code 302389/2016-4, Brasil.
CR Abraham EG, 2004, INSECT BIOCHEM MOLEC, V34, P667, DOI 10.1016/j.ibmb.2004.03.019
   Amcheslavsky A, 2014, CELL REP, V9, P32, DOI 10.1016/j.celrep.2014.08.052
   Ameku T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005004
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Martinez JD, 2019, DERMATOL CLIN, V37, P95, DOI 10.1016/j.det.2018.07.008
   Darriet F, 2005, J AM MOSQUITO CONTR, V21, P495, DOI 10.2987/8756-971X(2006)21[495:SANLAI]2.0.CO;2
   El Sobky Mona M, 2016, J Egypt Soc Parasitol, V46, P81
   Fernandes KM, 2015, MED VET ENTOMOL, V29, P245, DOI 10.1111/mve.12122
   Fernandes KM, 2014, PARASITOL INT, V63, P506, DOI 10.1016/j.parint.2014.01.004
   Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005
   Godoy RSM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15836
   Gonzalez PV, 2016, PARASITOL RES, V115, P2185, DOI 10.1007/s00436-016-4960-2
   Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Hertlein MB, 2010, J AM MOSQUITO CONTR, V26, P67, DOI 10.2987/09-5936.1
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lopes MP, 2018, PEST MANAG SCI, V74, P1311, DOI 10.1002/ps.4815
   Marcombe S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3187-8
   Marina CF, 2018, PARASITOL RES, V117, P1941, DOI 10.1007/s00436-018-5891-x
   Nishiura JT, 2003, J MED ENTOMOL, V40, P498, DOI 10.1603/0022-2585-40.4.498
   Perez CM, 2007, J MED ENTOMOL, V44, P631, DOI 10.1603/0022-2585(2007)44[631:SANDIF]2.0.CO;2
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Ray K, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.5501
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P93, DOI 10.2987/8756-971X(2006)22[93:LEOTBS]2.0.CO;2
   Sugiharto VA, 2016, J MED ENTOMOL, V53, P1100, DOI 10.1093/jme/tjw066
   Tome HW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-195
   Vantaux A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1514-5
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   Yang MJ, 2017, CHEMOSPHERE, V169, P155, DOI 10.1016/j.chemosphere.2016.11.065
NR 33
TC 5
Z9 5
U1 1
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD APR
PY 2019
VL 221
BP 464
EP 470
DI 10.1016/j.chemosphere.2019.01.068
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA HO1ZH
UT WOS:000460710700051
PM 30654260
DA 2020-07-08
ER

PT J
AU Bagno, FF
   Figueiredo, MM
   Villarrea, J
   Pereira, GD
   Godoi, LC
   da Fonseca, FG
AF Bagno, Flavia Fonseca
   Figueiredo, Maria Marta
   Villarrea, Jannely
   Pereira, Glauco de Carvalho
   Godoi, Lara Carvalho
   da Fonseca, Flavio Guimaraes
TI Undetected Chikungunya virus co-infections in a Brazilian region
   presenting hyper-endemic circulation of Dengue and Zika
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Chikungunya; Arboviruses; Diagnosis; Dengue; Zika; Co-infection
AB Background: Chikungunya virus (CHIKV) causes a disease characterized by acute onset of fever accompanied by arthralgia. Clinical similarities and co-circulation of other arboviruses such as Dengue virus (DENV) and Zika virus (ZIKV), have complicated their differentiation, making their diagnoses a challenge for the health authorities. Misdiagnosis is a serious issue to the management of patients and development of public health measures.
   Objectives: We carried out further screening of CHIKV, DENV and ZIKV cases in Minas Gerais, Brazil, after diagnostics were already issued by a state laboratory and according to the Brazilian Ministry of Health (BMH) policy. Our aim was to look for possible co-infections or previous arboviruses' exposure.
   Study design: Sera from 193 patients with symptoms of arboviral infections were tested for DEV, ZKV and/or CHIKV by the State laboratory, according to clinical suspicion and following standard BMH guidelines. After an official diagnosis was issued for each patient, we retested samples applying a broader panel of ELISA-based serological tests.
   Results: We identified 13 patients with concurrent or consecutive infections (IgM positive for more than one arbovirus), including 11 individuals that were positive for CHIKV and other previously confirmed arbovirus infection.
   Discussion: Guidelines established in many arbovirus-endemic countries prioritizes the diagnosis of Zika and Dengue and no further analyzes are done when samples are positive for those viruses. As a result, possible cases of co-infections with chikungunya are neglected, which affects the epidemiological assessments of virus circulation, patient management, and the development of public health policies.
C1 [Bagno, Flavia Fonseca; da Fonseca, Flavio Guimaraes] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Bagno, Flavia Fonseca; Figueiredo, Maria Marta; Godoi, Lara Carvalho; da Fonseca, Flavio Guimaraes] Ctr Tecnol Vacinas, Belo Horizonte, MG, Brazil.
   [Villarrea, Jannely] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.
   [Pereira, Glauco de Carvalho] Fundacao Ezequiel Dias FUNED, Belo Horizonte, MG, Brazil.
   [Godoi, Lara Carvalho] Univ Fed Minas Gerais, Colegio Tecn, Belo Horizonte, MG, Brazil.
RP da Fonseca, FG (corresponding author), Univ Fed Minas Gerais, Av Pres Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
EM flavia.bagno@gmail.com; mariamartafigueiredo@gmail.com;
   jvillarreal@college.harvard.edu; glaicone@gmail.com;
   lcarvalhogodoi@gmail.com; fdafonseca@icb.ufmg.br
OI Bagno, Flavia/0000-0003-1578-6678
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
   [CBB-APQ-03081-17 (EDITAL 001/2017), CBB-APQ-04295-17 (EDITAL 007/2017)]
FX We thank Marcos Vinicius F. Silva and Talita Emile R. Adelino (Fundacao
   Ezequiel Dias, Brazil) for helping with the sera samples. We thank Edel
   F Barbosa-Stancioli and the Centro de Tecnologia em Vacinas' team
   (CTVacinas, Brazil) for discussions. This work was supported by FAPEMIG
   -grants #CBB-APQ-03081-17 (EDITAL 001/2017) and #CBB-APQ-04295-17
   (EDITAL 007/2017).
CR Brazil Ministry of Health, 2018, DENG CHIK ZIK VIR EP
   Brazil Ministry of Health, 2017, CHIK CLIN MAN PORT, P5
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Edwards T, 2016, EMERG INFECT DIS, V22, P2003, DOI 10.3201/eid2211.161017
   Hisamuddini M, 2018, EPIDEMIOL INFECT, V146, P1642, DOI [10.1017/S0950268818001590, 10.1017/s0950268818001590]
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Ministry of Health of Brazil, 2017, HLTH BRAZ 2015 2016
   Neto N., 2018, OPEN FORUM INFECT S1, V5, pS167, DOI [10.1093/ofid/ofy210.454, DOI 10.1093/OFID/OFY210.454]
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   Watanabe S, 2019, J INFECT DIS, V219, P223, DOI 10.1093/infdis/jiy482
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 17
TC 5
Z9 5
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD APR
PY 2019
VL 113
BP 27
EP 30
DI 10.1016/j.jcv.2019.02.006
PG 4
WC Virology
SC Virology
GA HP1ZM
UT WOS:000461467700006
PM 30836281
DA 2020-07-08
ER

PT J
AU Nelson, EJ
   Luetke, MC
   McKinney, C
   Omodior, O
AF Nelson, Erik J.
   Luetke, Maya C.
   McKinney, Conner
   Omodior, Oghenekaro
TI Knowledge of the Sexual Transmission of Zika Virus and Preventive
   Practices Against Zika Virus Among US Travelers
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Zika virus; Travelers; Sexually transmitted diseases; Knowledge;
   attitudes and perceptions
ID UNITED-STATES; PREGNANT-WOMEN; ATTITUDES; INFECTION; OUTBREAK; INTERNET;
   RISK; INFORMATION; AMERICA; IMPACT
AB Individuals are often at increased risk of acquiring infectious disease while traveling. We sought to understand knowledge, attitudes and practices (KAP) regarding Zika virus among travelers from the United States. A total of 1043 study participants were recruited from a probability-based internet panel. Participants self-reported their knowledge of Zika infection and modes of transmission, and identified actions they had taken to prevent Zika infection and transmission including actions to prevent unintentional pregnancy since becoming aware of the Zika virus. Logistic regression was used to model the odds of taking preventive actions against Zika infection with adjustment for potential confounding factors. Knowledge of the sexual transmissibility of Zika virus significantly increased the odds of taking a preventive action against Zika infection, especially condom use or sexual abstention. Participants reported preferences for receiving information about Zika from private doctors and from the Internet. Discrepancies between where travelers seek information about Zika and how they would like to receive information regarding Zika were also found. These findings suggest that improving targeted messaging through online media may increase awareness of the sexual transmissibility of Zika as well as improve health communications with U.S. travelers. Travelers who are unaware of potential disease risks are less likely to adopt personal protective measures to protect themselves and reduce disease spread. Thus, future work should focus on improving communication and providing education to adopt effective prevention strategies while traveling.
C1 [Nelson, Erik J.; Luetke, Maya C.; McKinney, Conner] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1025 E 7th St,Suite 111, Bloomington, IN 47405 USA.
   [Omodior, Oghenekaro] Indiana Univ, Sch Publ Hlth, Dept Recreat Pk & Tourism Studies, Bloomington, IN USA.
RP Nelson, EJ (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1025 E 7th St,Suite 111, Bloomington, IN 47405 USA.
EM eriknels@indiana.edu
RI Omodior, Oghenekaro/Y-5662-2018; Luetke, Maya/AAK-5915-2020; Nelson,
   Erik/R-7239-2019
OI Omodior, Oghenekaro/0000-0002-6918-1917; Nelson,
   Erik/0000-0003-1658-8294; Luetke, Maya/0000-0001-6793-245X
CR [Anonymous], 2017, VERSION JUNE 2017
   Berenson AB, 2018, AM J TROP MED HYG, V98, P178, DOI 10.4269/ajtmh.17-0595
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Bundorf MK, 2006, HEALTH SERV RES, V41, P819, DOI 10.1111/j.1475-6773.2006.00510.x
   Cabada MM, 2003, J TRAVEL MED, V10, P214, DOI 10.2310/7060.2003.40508
   Cantrell MA, 2007, J ADV NURS, V60, P544, DOI 10.1111/j.1365-2648.2007.04448.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2018, WORLD MAP AR RISK ZI
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hamer DH, 2004, J TRAVEL MED, V11, P23, DOI 10.2310/7060.2004.13577
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hays RD, 2015, BEHAV RES METHODS, V47, P685, DOI 10.3758/s13428-015-0617-9
   Heitzinger Kristen, 2018, Prev Med Rep, V10, P20, DOI 10.1016/j.pmedr.2018.01.002
   Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Katler Q, 2017, INFECT DIS OBSTET GY, V2017
   Lalani T, 2016, TRAVEL MED INFECT DI
   Lantz PM, 2016, MILBANK Q, V94, P51, DOI 10.1111/1468-0009.12181
   Leonhard Sonja Emily, 2018, Pract Neurol, V18, P271, DOI 10.1136/practneurol-2017-001789
   Lestelle C, 2015, MED MALADIES INFECT, V45, P222, DOI 10.1016/j.medmal.2015.04.007
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Moise IK, 2018, EMERG INFECT DIS, V24, P1379, DOI 10.3201/eid2407.171650
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plaster AN, 2018, J COMMUN HEALTH, V43, P647, DOI 10.1007/s10900-017-0463-z
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Quam MB, 2016, TRAVEL MED INFECT DI
   R Foundation for Statistical Computing, 2017, LANG ENV STAT COMP C
   Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68
   Roupa Zoe, 2012, Mater Sociomed, V24, P131, DOI 10.5455/msm.2012.24.131-134
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Rubsamen N, 2017, EMERG THEMES EPIDEMI, V14, DOI 10.1186/s12982-017-0058-2
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Squiers L, 2018, AM J TROP MED HYG, V98, P1837, DOI 10.4269/ajtmh.17-0898
   U.S. Census Bureau, 2017, AM COMM SURV ACS
   Van Herck K, 2004, J TRAVEL MED, V11, P3, DOI 10.2310/7060.2004.13609
   Weber R, 2003, J TRAVEL MED, V10, P219, DOI 10.2310/7060.2003.40574
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   Widmar Nicole J Olynk, 2017, Prev Med Rep, V6, P162, DOI 10.1016/j.pmedr.2017.02.023
   Wilder-Smith A, 2018, TRAVEL MED INFECT DI
   Wong ML, 2007, SEX TRANSM DIS, V34, P237, DOI 10.1097/01.olq.0000233644.66090.05
   World Health Organization, 2017, ZIK VIR ZIKV CLASS T
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Zhang J, 2016, J TRAVEL MED
NR 55
TC 3
Z9 3
U1 2
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD APR
PY 2019
VL 44
IS 2
BP 377
EP 386
DI 10.1007/s10900-018-0594-x
PG 10
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA HO5ED
UT WOS:000460944900021
PM 30478625
DA 2020-07-08
ER

PT J
AU Fraser, B
   Alves, L
AF Fraser, Barbara
   Alves, Lise
TI Living with the consequences of Zika virus disease
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD APR
PY 2019
VL 3
IS 4
BP 215
EP 216
DI 10.1016/S2352-4642(19)30066-5
PG 2
WC Pediatrics
SC Pediatrics
GA HO8KC
UT WOS:000461198100011
PM 30878113
OA Bronze
DA 2020-07-08
ER

PT J
AU Rademan, R
   Markotter, W
   Paweska, JT
   van Vuren, PJ
AF Rademan, Rochelle
   Markotter, Wanda
   Paweska, Janusz T.
   van Vuren, Petrus Jansen
TI Multiplex real-time RT-PCR for detection and distinction of Spondweni
   and Zika virus
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Arbovirus; Zika virus; Spondweni virus; Flavivirus; Flaviviridae;
   multiplex; Aedes
ID GUILLAIN-BARRE-SYNDROME; SOUTH-AFRICA; INFECTION; MOSQUITOS; OUTBREAK;
   ISOLATIONS; TONGALAND; EPIDEMIC; ISLAND; BRAZIL
AB Zika (ZIKV) and Spondweni viruses (SPOV) are closely related mosquito borne flaviviruses in the Spondweni serogroup. The co-circulation and similar disease presentation following ZIKV and SPOV infection necessitates the development of a diagnostic tool for their simultaneous detection and distinction. We developed a one-step multiplex real-time RT-PCR (ZIKSPOV) to detect and distinguish between SPOV and ZIKV by utilizing a single primer set combined with virus specific hydrolysis probes. The ZIKSPOV assay was compared to published virus specific real-time RT-PCR assays and the limit of detection was comparable. The SPOV reference strain AR94 was detectable to 0.001 TCID50 per PCR reaction, while African lineage ZIKV (MR 766) was detectable to 0.002 TCID50 per reaction and Asian lineage ZIKV (H/PF/2013) to 0.05 TCID50 per reaction. The ZIKSPOV assay did not detect other flaviviruses, indicative of its specificity for Spondweni serogroup. The ZIKSPOV assay is a useful addition to arbovirus diagnostic and surveillance tools in areas where ZIKV and SPOV are expected to co-circulate. Further evaluation is required to demonstrate the application of the assay for detection of ZIKV and SPOV in mosquito and human clinical samples.
C1 [Rademan, Rochelle; Markotter, Wanda; Paweska, Janusz T.; van Vuren, Petrus Jansen] Univ Pretoria, Dept Med Virol, Ctr Viral Zoonoses, Fac Hlth Sci, Pretoria, South Africa.
   [Paweska, Janusz T.; van Vuren, Petrus Jansen] Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.
RP van Vuren, PJ (corresponding author), Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.
EM petrusv@nicd.ac.za
OI Markotter, Wanda/0000-0002-7550-0080; Rademan,
   Rochelle/0000-0002-0518-3243
FU Centre for Emerging Zoonotic and Parasitic Diseases, National Institute
   of Communicable Diseases (NICD), a division of the National Health
   Laboratory Services; National Research Foundation by the NRF-DST South
   African Research Chair in Infectious Diseases of Animals (Zoonoses)
   [98339]; Poliomyelitis Research Foundation [18/40]
FX The study was funded by the Centre for Emerging Zoonotic and Parasitic
   Diseases, National Institute of Communicable Diseases (NICD), a division
   of the National Health Laboratory Services. Ms. Rochelle Rademan was
   supported by a grant-linked National Research Foundation bursary
   supplied by the NRF-DST South African Research Chair in Infectious
   Diseases of Animals (Zoonoses) (grant no. 98339). Further financial
   support was obtained from the Poliomyelitis Research Foundation (grant
   no. 18/40).
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK G.W.A., 1952, T R SOC TROP MED HYG, V46
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   DRAPER C C, 1965, West Afr Med J, V14, P16
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P103
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   McINTOSH B. M., 1961, S AFRICAN MED JOUR, V35, P647
   MCINTOSH BM, 1972, J MED ENTOMOL, V9, P155
   Mlalcar J., 2016, ENGL J MED, V374, P951
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   White SK, 2018, EMERG INFECT DIS, V24, P1765, DOI 10.3201/eid2409.171957
   WOLFE MS, 1982, LANCET, V2, P1306
   WORTH CB, 1961, AM J TROP MED HYG, V10, P583, DOI 10.4269/ajtmh.1961.10.583
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 32
TC 0
Z9 0
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD APR
PY 2019
VL 266
BP 72
EP 76
DI 10.1016/j.jviromet.2019.01.011
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA HO3VR
UT WOS:000460851500011
PM 30731153
DA 2020-07-08
ER

PT J
AU Kayingo, G
AF Kayingo, Gerald
TI Bacteria and Viruses The Bogeymen in the Intensive Care Unit
SO PHYSICIAN ASSISTANT CLINICS
LA English
DT Article
DE Bacteria; Viruses; Sepsis; Nosocomial infections; Pneumonia; Zika;
   Ebola; Immunocompromised
ID INFECTION
AB This article covers the frequently encountered bacteria and viruses in the ICU. It focuses on recognition, management, and prevention. Emerging and difficult-to-treat organisms are covered in detail.
C1 [Kayingo, Gerald] Univ Calif Davis, Phys Assistant Program, Betty Irene Moore Sch Nursing, 2450 48th St,2120, Sacramento, CA 95817 USA.
RP Kayingo, G (corresponding author), Univ Calif Davis, Phys Assistant Program, Betty Irene Moore Sch Nursing, 2450 48th St,2120, Sacramento, CA 95817 USA.
EM gkayingo@ucdavis.edu
CR Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588
   El-Kholy A, 2012, AM J INFECT CONTROL, V40, pE216, DOI 10.1016/j.ajic.2011.12.010
   Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459
   Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928
   Gaynes RP, 1996, PEDIATRICS, V98, P357
   Kanegaye JT, 2001, PEDIATRICS, V108, P1169
   Kollef MH, 2008, WASHINGTON MANUAL CR
   Levy MM, 2018, INTENS CARE MED, V44, P925, DOI 10.1007/s00134-018-5085-0
   Parrillo JE, 2013, CRITICAL CARE MED E
   Raoof S, 2008, ACP MANUAL CRITICAL
   SPIVACK D, 1987, AM REV RESPIR DIS, V136, P1007, DOI 10.1164/ajrccm/136.4.1007
   Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754
NR 12
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2405-7991
J9 PHYS ASSIST CLIN
JI Phys. Assist. Clin.
PD APR
PY 2019
VL 4
IS 2
BP 323
EP +
DI 10.1016/j.cpha.2018.11.003
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA HN8AM
UT WOS:000460415900006
PM 32289089
OA Green Published
DA 2020-07-08
ER

PT J
AU Agrelli, A
   de Moura, RR
   Crovella, S
   Brandao, LAC
AF Agrelli, Almerinda
   de Moura, Ronald Rodrigues
   Crovella, Sergio
   Cavalcanti Brandao, Lucas Andre
TI ZIKA virus entry mechanisms in human cells
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Review
DE ZIKV; C-type lectin receptors; Apoptotic mimicry; ZIKV protein prM; ZIKV
   protein E
ID HUMAN DENDRITIC CELLS; C-TYPE LECTINS; DENGUE-VIRUS; DC-SIGN; JAPANESE
   ENCEPHALITIS; INHIBITS ZIKA; PRODUCTIVE INFECTION; CEREBRAL ORGANOIDS;
   HEPARAN-SULFATE; LINKED GLYCANS
AB Zika virus (ZIKV) is an enveloped, mosquito-borne Flavivirus, which infects cells through clathrin-mediated endocytosis and fusion employing acidic endosomes. Cell entry is mostly mediated by the viral glycoprotein E, although incomplete particle maturation enables viral protein prM and anionic lipids present in the viral membrane to mediate this process. Incomplete proteolytic maturation results in a set of highly heterogeneous particles. These heterogeneous and dynamic infectious particles offer a variety of possible receptor interaction sites on their surfaces, thus contributing to the wide range of cells susceptible to ZIKV as well as to variation in tissue tropism. This review addresses recent advances in the understanding of ZIKV entry process into cells and put together fundamental questions about viral replication, maturation and host-cell interactions.
C1 [Agrelli, Almerinda; Crovella, Sergio; Cavalcanti Brandao, Lucas Andre] Fed Univ Pernambuco UFPE, LIKA, Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [de Moura, Ronald Rodrigues; Crovella, Sergio] Fed Univ Pernambuco UFPE, Dept Genet, Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Cavalcanti Brandao, Lucas Andre] Fed Univ Pernambuco UFPE, Dept Pathol, Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
RP Agrelli, A (corresponding author), Fed Univ Pernambuco UFPE, LIKA, Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM almerinda.agrelli@ufpe.br; ppgg@ufpe.br; sergio.crovella@ufpe.br;
   dpatologia@ufpe.br
RI Moura, Ronald/AAE-2318-2020
OI Moura, Ronald/0000-0002-9112-7167; Agrelli,
   Almerinda/0000-0002-9908-742X
FU National Council for the Improvement of Higher Education - Brazil
   (CAPES) [001]; National Council for Scientific and Technological
   Development Brazil (CNPq)National Council for Scientific and
   Technological Development (CNPq); Department of Science and Technology
   of the Ministry of Health - Brazil (Decit/SCTIE/MS)
FX This study was financed by the National Council for the Improvement of
   Higher Education - Brazil (CAPES) - Finance Code 001, National Council
   for Scientific and Technological Development Brazil (CNPq) and the
   Department of Science and Technology of the Ministry of Health - Brazil
   (Decit/SCTIE/MS).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Alen MMF, 2009, VIROLOGY, V387, P67, DOI 10.1016/j.virol.2009.01.043
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Barkhash AV, 2012, ANTIVIR RES, V93, P64, DOI 10.1016/j.antiviral.2011.10.017
   Beasley DWC, 2004, EMERG INFECT DIS, V10, P2221, DOI 10.3201/eid1012.040647
   Brazil Ministry of Health, 2018, MON INT ALT CRESC DE
   Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC E. C. for D. P. and C, 2015, RAP RISK ASS ZIK VIR
   Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0
   Hackett BA, 2018, P NATL ACAD SCI USA, V115, P4246, DOI 10.1073/pnas.1720032115
   Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Haslwanter D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006643
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Hoving JC, 2014, CELL MICROBIOL, V16, P185, DOI 10.1111/cmi.12249
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936
   Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017
   Khoo US, 2008, J MOL MED, V86, P861, DOI 10.1007/s00109-008-0350-2
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008
   Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mercer J, 2010, ANN NY ACAD SCI, V1209, P49, DOI 10.1111/j.1749-6632.2010.05772.x
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Schuler-Faccini L, 2015, WEEKLY MMWR, V65, P1
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shimojima M, 2014, ARCH VIROL, V159, P2023, DOI 10.1007/s00705-014-2042-2
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Su CM, 2001, VIROLOGY, V286, P206, DOI 10.1006/viro.2001.0986
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thepparit C, 2004, INTERVIROLOGY, V47, P78, DOI 10.1159/000077830
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000934
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yuan L., 2017, SCIENCE, V88, P11726, DOI [10.1128/JVI.01140-14, DOI 10.1128/JVI.01140-14]
   Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 109
TC 7
Z9 7
U1 3
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD APR
PY 2019
VL 69
BP 22
EP 29
DI 10.1016/j.meegid.2019.01.018
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA HN1FH
UT WOS:000459932000004
PM 30658214
DA 2020-07-08
ER

PT J
AU Yan, Y
   Zhang, XT
   Wang, G
   Cheng, X
   Yan, Y
   Fu, YJ
   Yang, XS
   Jiang, ZY
AF Yan, Yuqi
   Zhang, Xiao-tan
   Wang, Guang
   Cheng, Xin
   Yan, Yu
   Fu, Ying-jie
   Yang, Xuesong
   Jiang, Zhenyou
TI Zika virus induces abnormal cranial osteogenesis by negatively affecting
   cranial neural crest development
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE ZIKV; Microcephaly; Osteogenesis; Cranial neural crest cells; EMT;
   Apoptosis
ID FETAL-BRAIN ABNORMALITY; MICROCEPHALY TIP; INFECTION; CELLS; CHICK;
   INDUCTION; AUTOPHAGY; CULTURE; GROWTH; THREAT
AB Zika virus (ZIKV) infection during gestation is deemed to be coupled to birth defects through direct impairment of the nervous system during neurogenesis. However, in this study, our data showed that ZIKV infection dramatically suppressed cranial osteogenesis, shown by Safranin O/Fast Green and alizarin red staining, in chick embryos, which provides another possibility that craniofacial bone malformation caused by ZIKV may be a major cause of ZIKV-mediated birth defects. By immunofluorescent staining and electron microcopy, we confirmed ZIKV infection in chick embryo neural tubes and sites of neural crest. Next, in vivo (chick embryos) and in vitro [primary culture of neural crest cells (NCC)] ZIKV and HNK-1 double immunofluorescent staining demonstrated that ZIKV infection inhibited the production of migratory NCC. The reduction of both AP-2 alpha- and Pax7-positive NCC in HH10 chick embryos infected by ZIKV confirmed that abnormal development of cranial NCC also occurred in the migratory process. Whole mount in situ hybridization demonstrated that cadherin 6B expression was elevated and Slug, FoxD3, and BMP4/Msx1 expressions decreased in ZIKV-infected HH10 chick embryos, implying that epithelial-mesenchymal transition (EMT) of neural crest production was blocked by ZIKV infection. Moreover, in vivo and in vitro pHIS3 and Pax7 double immunofluorescent staining showed that NCC proliferation was repressed by ZIKV infection. C-caspase-3 and AP-2 alpha double immunofluorescent staining in HH10 chick embryos and western blotting showed that NCC apoptosis increased following ZIKV infection. Finally, electron microscopy showed multiple autophagosomes in ZIKV-infected embryos, and western blot and LC3B immunofluorescent staining demonstrated that autophagy-related genes were activated by ZIKV infection. Taken together, our data first showed that ZIKV infection during embryogenesis could interfere with cranial neural crest development, which in turn causes aberrant cranial osteogenesis. Our results provided new insights into brain malformations induced by ZIKV infection.
C1 [Yan, Yuqi; Zhang, Xiao-tan; Wang, Guang; Cheng, Xin; Yan, Yu; Fu, Ying-jie; Yang, Xuesong; Jiang, Zhenyou] Jinan Univ, Med Coll, Guangzhou 510632, Guangdong, Peoples R China.
   [Yang, Xuesong] Jinan Univ, Med Coll, Key Lab Regenerat Med, Minist Educ, Guangzhou 510632, Guangdong, Peoples R China.
   [Yan, Yuqi; Fu, Ying-jie; Jiang, Zhenyou] Jinan Univ, Inst Med Microbiol, Guangzhou 510632, Guangdong, Peoples R China.
RP Yang, XS; Jiang, ZY (corresponding author), Jinan Univ, Med Coll, Guangzhou 510632, Guangdong, Peoples R China.
EM yang_xuesong@126.com; tjzhy@jnu.edu.cn
RI Wang, Guang/AAC-4624-2019
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81473454, 31771331]; Science and Technology
   Planning Project of Guangdong Province [2017A050506029]; Natural Science
   Foundation of Guangdong, ChinaNational Natural Science Foundation of
   Guangdong Province [2015A030313331]; National science and technology
   major projects of China [2018ZX10715004-002]
FX This study was supported by National Natural Science Foundation of China
   (81473454 and 31771331), Science and Technology Planning Project of
   Guangdong Province (2017A050506029). This study also received assistance
   from Natural Science Foundation of Guangdong, China (2015A030313331),
   and from the National science and technology major projects of China
   (2018ZX10715004-002).
CR Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Besnard M, 2014, EURO SURVEILL, V19
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bronner ME, 2015, NATURE, V527, P311, DOI 10.1038/nature15645
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.3.CO;2-X
   Cofre F, 2016, REV CHIL INFECTOL, V33, P96, DOI 10.4067/S0716-10182016000100018
   Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Datar Savita P, 2011, Rev Diabet Stud, V8, P245, DOI 10.1900/RDS.2011.8.245
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   ERICKSON CA, 1989, DEV BIOL, V134, P112, DOI 10.1016/0012-1606(89)90082-1
   Etchevers H, 2011, NAT PROTOC, V6, P1568, DOI 10.1038/nprot.2011.398
   Fairchild CL, 2014, MECH DEVELOP, V132, P1, DOI 10.1016/j.mod.2014.02.004
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hall BK, 2008, J BIOSCIENCES, V33, P781, DOI 10.1007/s12038-008-0098-4
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Minarcik J C, 2003, Orthod Craniofac Res, V6, P210, DOI 10.1046/j.1601-6335.2003.00268.x
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Naber HPH, 2013, BIOCHEM BIOPH RES CO, V435, P58, DOI 10.1016/j.bbrc.2013.04.037
   NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pei F, 2015, J DENT RES, V94, P175, DOI 10.1177/0022034514553815
   PENCHASZADEH VB, 1982, AM J MED GENET, V11, P397, DOI 10.1002/ajmg.1320110404
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Sailer MHM, 2013, J CELL SCI, V126, P3533, DOI 10.1242/jcs.125757
   Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221
   Schneider RA, 1999, DEV BIOL, V208, P441, DOI 10.1006/dbio.1999.9213
   Scott-Drechsel DE, 2013, DIABETES, V62, P234, DOI 10.2337/db12-0161
   Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   Vergara MN, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-22
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Wang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18321
   Zhang ZY, 2003, MECH DEVELOP, V120, P1469, DOI 10.1016/j.mod.2003.09.002
NR 48
TC 3
Z9 3
U1 2
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD APR
PY 2019
VL 69
BP 176
EP 189
DI 10.1016/j.meegid.2019.01.023
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA HN1FH
UT WOS:000459932000019
PM 30665021
DA 2020-07-08
ER

PT J
AU Yadav, PD
   Malhotra, B
   Sapkal, G
   Nyayanit, DA
   Deshpande, G
   Gupta, N
   Padinjaremattathil, UT
   Sharma, H
   Sahay, RR
   Sharma, P
   Mourya, DT
AF Yadav, Pragya D.
   Malhotra, Bharati
   Sapkal, Gajanan
   Nyayanit, Dimpal A.
   Deshpande, Gururaj
   Gupta, Nivedita
   Padinjaremattathil, Ullas T.
   Sharma, Himanshu
   Sahay, Rima R.
   Sharma, Pratibha
   Mourya, Devendra T.
TI Zika virus outbreak in Rajasthan, India in 2018 was caused by a virus
   endemic to Asia
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Human; Next-generation sequencing (NGS); Serum; Flavivirus;
   India
AB Zika virus (ZIKV) infection in human has been reported from Gujarat and Tamil Nadu states during the year 2016 and 2017 respectively. In paucity of complete genome data of ZIKV, the analysis and prediction were not possible. Zika cases were reported in Jaipur city, Rajasthan, India during the period of 21st September 2018 to 29th October 2018. In order to understand the circulating ZIKV strain in Rajasthan state about ten human serum samples from the positive cases of Jaipur city, Rajasthan state considering the locality and clustering variations were sequenced using next-generation sequencing (NGS) platform. Complete genome phylogenetic analysis of Jaipur city sequences with known GenBank ZIKV sequences revealed that the outbreak in Jaipur city was being caused by ZIKV belonging to Asian lineage. Partial genome sequencing revealed the presence of a pre-outbreak strain of ZIKV in Gujarat and current outbreak strain of Asian lineage in Tamil Nadu. Further sequence analysis of the five ZIKV positive samples of Jaipur revealed that the S139N and A188V mutations, linked to enhanced neurovirulence and transmission in animal models, were not found in the current outbreak strain. Whether this strain can cause birth defects and cause large outbreaks is not currently known, but they should be treated as such until more is known. With the identification of ZIKV in Gujarat, Tamil Nadu, and recent outbreaks of ZIKV in Rajasthan and Madhya Pradesh states alarm for India to enhance surveillance in other states and monitor the mutation and evolutionary changes in circulating Zika strains.
C1 [Yadav, Pragya D.; Sapkal, Gajanan; Nyayanit, Dimpal A.; Deshpande, Gururaj; Padinjaremattathil, Ullas T.; Sahay, Rima R.; Mourya, Devendra T.] Indian Council Med Res, Natl Inst Virol, 20-A Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
   [Malhotra, Bharati; Sharma, Himanshu; Sharma, Pratibha] Sawai Man Singh Med Coll, Jaipur, Rajasthan, India.
   [Gupta, Nivedita] Indian Council Med Res, Post Box 4911, New Delhi 110029, India.
RP Mourya, DT (corresponding author), Indian Council Med Res, Natl Inst Virol, 20-A Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
EM dtmourya@gmail.com
FU Indian Council of Medical Research-National Institute of Virology, Pune,
   India; Centers for Disease Control and Prevention Global Health Security
   AgendaUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [6 NU2GGH001903-02-01]
FX Financial support was provided by intramural funding of the Indian
   Council of Medical Research-National Institute of Virology, Pune, India,
   and Centers for Disease Control and Prevention Global Health Security
   Agenda grant no. 6 NU2GGH001903-02-01. The idea and concept are of the
   authors and not of the funding agency.
CR [Anonymous], 2018, WEEKLY OUTBREAKS
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bhardwaj S, 2017, INDIAN J MED RES, V146, P572, DOI 10.4103/ijmr.IJMR_1160_17
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Jaeger A, 2018, BIORXIV, DOI [10.1101/387118, DOI 10.1101/387118]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sapkal GN, 2018, J INFECTION, V76, P314, DOI 10.1016/j.jinf.2017.09.020
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Yadav PD, 2018, J GEN VIROL, V99, P991, DOI 10.1099/jgv.0.001102
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 16
TC 9
Z9 9
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD APR
PY 2019
VL 69
BP 199
EP 202
DI 10.1016/j.meegid.2019.01.026
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA HN1FH
UT WOS:000459932000021
PM 30703541
DA 2020-07-08
ER

PT J
AU Ferreira, FL
   Hauck, MS
   Duarte, LP
   de Magalhaes, JC
   da Silva, LSM
   Pimenta, LPS
   Lopes, JCD
   Mercadante-Simoes, MO
   Vieira, SA
AF Ferreira, Fernanda L.
   Hauck, Marcela S.
   Duarte, Lucienir P.
   de Magalhaes, Jose C.
   da Silva, Louise S. M.
   Pimenta, Lucia P. S.
   Lopes, Julio C. D.
   Mercadante-Simoes, Maria O.
   Vieira Filho, Sidney A.
TI Zika Virus Activity of the Leaf and Branch Extracts of Tontelea
   micrantha and Its Hexane Extracts Phytochemical Study
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE Tontelea micrantha; Celastraceae; friedelan-1,3,21-trione; antiviral
   activity; Zika virus
ID C-13 NMR-SPECTRA; CELASTRACEAE; CONSTITUENTS; TRITERPENES; PLANTS;
   DERIVATIVES; FRIEDELANE; PROFILE; BARK; STEM
AB The new triterpene friedelan-1,3,21-trione, the known compounds friedelan-3-one, 3 beta-friedelinol, 3,4-seco-friedelan-3-oic acid, 28-hydroxy friedelan-3 -one, friedelan-3 -oxo-28-al, friedelan-3,21-dione, 30-hydroxyfriedelan-3-one, a mixture of 30-hydroxyfriedelan-3-one/21 alpha-hydroxyfriedelan-3-one, 21 beta-hydroxyfriedelan-3-one, gutta-percha, squalene, and a mixture of palmitic/stearic/oleic acids were isolated from the hexane extracts of leaves and branches of T. micrantha. Their chemical structures were established by Fourier transform infrared spectroscopy (FTIR), gas chromatography (GC), 1D/2D nuclear magnetic resonance (NMR) and comparison with the literature data. All compounds were described for T. micrantha and the genus Tontelea for the first time. The branch and leaf extracts displayed anti-Zika virus activity at the lowest tested concentration of 15.6 mu g mL(-1), mainly virucidal effect, and presented no cytotoxicity to Vero cells. Furthermore, the ethyl acetate and methanolic leaf extracts demonstrated the best activities at the concentration of 31.2 and 15.6 mu g mL(-1) at the viral adsorption and penetration stages, respectively. These results showed that these extracts may be promising candidates for the Zika virus treatment.
C1 [Ferreira, Fernanda L.; Duarte, Lucienir P.; da Silva, Louise S. M.; Pimenta, Lucia P. S.; Lopes, Julio C. D.] Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, BR-31270901 Belo Horizonte, MG, Brazil.
   [Hauck, Marcela S.; de Magalhaes, Jose C.] Univ Fed Sao Joao Del Rei, Dept Quim Biotecnol & Engn Bioproc, Campus Alto Paraopeba, BR-36420000 Ouro Branco, MG, Brazil.
   [Mercadante-Simoes, Maria O.] Univ Estadual Montes Claros, Dept Biol Geral, Ctr Ciencias Biol & Saude, BR-39401089 Montes Claros, MG, Brazil.
   [Vieira Filho, Sidney A.] Univ Fed Ouro Preto, Dept Farm, Escola Farm, Campus Morro Cruzeiro, BR-35400000 Ouro Preto, MG, Brazil.
RP Duarte, LP (corresponding author), Univ Fed Minas Gerais, Dept Quim, Inst Ciencias Exatas, BR-31270901 Belo Horizonte, MG, Brazil.
EM lucienir@ufmg.br
RI Pimenta, Lucia/P-7140-2014; Duarte, Lucienir Pains P/J-6307-2012; Lopes,
   Julio CD/M-3490-2014; Pimenta, Lucia/Y-6800-2019
OI Duarte, Lucienir Pains P/0000-0002-8885-6625; Pimenta,
   Lucia/0000-0001-8384-6877
FU Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)Minas Gerais
   State Research Foundation (FAPEMIG); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPQ)National Council for
   Scientific and Technological Development (CNPq)
FX The authors thank to Fundacao de Amparo a Pesquisa de Minas Gerais
   (FAPEMIG) for the financial support and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPQ) for the scholarships
   (F.L.F.). The authors also thank Salomao B. V. Rodrigues for revising
   the English language and critical manuscript reviews.
CR Araujo ARB, 2017, S AFR J BOT, V112, P112, DOI 10.1016/j.sajb.2017.05.009
   Barreto MB, 2013, QUIM NOVA, V36, P675, DOI 10.1590/S0100-40422013000500011
   Clarice C. V., 2014, J MED PLANTS RES, V8, P68
   COUPERUS PA, 1978, ORG MAGN RESONANCE, V11, P590, DOI 10.1002/mrc.1270111203
   Ferreira FL, 2017, REV BRAS FARMACOGN, V27, P471, DOI 10.1016/j.bjp.2016.12.006
   Figueiredo JN, 1998, J NAT PROD, V61, P718, DOI 10.1021/np9704157
   Gonzalez-Coloma A, 2011, PHYTOCHEM REV, V10, P245, DOI 10.1007/s11101-010-9187-8
   Kanyara JN, 2005, PHYTOTHER RES, V19, P287, DOI 10.1002/ptr.1536
   Kaweetripob W, 2013, PHYTOCHEMISTRY, V96, P404, DOI 10.1016/j.phytochem.2013.09.027
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kohn LK, 2012, PHARM BIOL, V50, P1269, DOI 10.3109/13880209.2012.673627
   Li YZ, 2010, FITOTERAPIA, V81, P586, DOI 10.1016/j.fitote.2010.02.005
   Magalhaes CG, 2011, REV BRAS FARMACOGN, V21, P415, DOI 10.1590/S0102-695X2011005000039
   MAHATO SB, 1994, PHYTOCHEMISTRY, V37, P1517, DOI 10.1016/S0031-9422(00)89569-2
   Mercadante-Simoes MO, 2016, PLANT SPEC BIOL, V31, P117, DOI 10.1111/1442-1984.12093
   Mercadante-Simoes MO, 2014, AN ACAD BRAS CIENC, V86, P1167, DOI 10.1590/0001-3765201420130105
   Niero R, 2011, CURR PHARM DESIGN, V17, P1851, DOI 10.2174/138161211796391029
   Nunez MJ, 2016, EUR J MED CHEM, V111, P95, DOI 10.1016/j.ejmech.2016.01.049
   PATRA A, 1981, ORG MAGN RESONANCE, V17, P166, DOI 10.1002/mrc.1270170304
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian KD, 2010, J MED CHEM, V53, P3133, DOI 10.1021/jm901782m
   Ramos DF, 2008, REV BRAS CIENC FARM, V44, P669, DOI 10.1590/S1516-93322008000400013
   Rodrigues VG, 2015, QUIM NOVA, V38, P237, DOI 10.5935/0100-4042.20150001
   Salazar GCM, 2000, MAGN RESON CHEM, V38, P977, DOI 10.1002/1097-458X(200011)38:11<977::AID-MRC757>3.0.CO;2-9
   Setzer WN, 2000, AUST J CHEM, V53, P809, DOI 10.1071/CH00066
   Silva FC, 2011, J BRAZIL CHEM SOC, V22, P943, DOI 10.1590/S0103-50532011000500018
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Veloso CC, 2017, REV BRAS FARMACOGN, V27, P533, DOI 10.1016/j.bjp.2017.02.006
   Vieira SA, 2001, MAGN RESON CHEM, V39, P746, DOI 10.1002/mrc.942
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Xiong JA, 2010, BIOORGAN MED CHEM, V18, P6451, DOI 10.1016/j.bmc.2010.06.092
   Yasuhara-Bell J, 2010, ANTIVIR RES, V86, P231, DOI 10.1016/j.antiviral.2010.03.009
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 0
Z9 0
U1 1
U2 11
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD APR
PY 2019
VL 30
IS 4
BP 793
EP 803
DI 10.21577/0103-5053.20180210
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA HN0GY
UT WOS:000459866300012
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nolasco, D
   Oliveira, J
AF Nolasco, Diogo
   Oliveira, Jonice
TI Subevents detection through topic modeling in social media posts
SO FUTURE GENERATION COMPUTER SYSTEMS-THE INTERNATIONAL JOURNAL OF ESCIENCE
LA English
DT Article
DE Topic labeling; Topic modeling; Subevent detection; Social networks;
   Unsupervised learning
AB Event detection has been a significant topic for a long time, since the onset development of pervasive systems. The ability to gather data from various sensors, in a diverse number of formats, is a challenge due to the continuous growth of data volume. Users of social media act as human sensors, providing data and information in real time about entities and events. Most of the research about event detection - using human or non-human sensors - concentrates only on identifying events. These models assume an event to be a single entity and ignoring that it can be composed of other new events over time. The detection of subevents enriches the understanding of the main event, contextualizing it and creating a powerful knowledge about the scenario. To capture the parts of an event and the information changing over time, we created a scalable and modular topic modeling based algorithm. It identifies subevents and creates labels to represent them more accurately. We evaluate the proposed sub-event detection approach using two large-scale Twitter corpus. The first one is related to Brazil's political protests scenario. The second analyzes the Zika Virus epidemic in the world. Our approach detected several subevents, most of them are related to real subevents. Due to the nature of social networks, with a minimum delay between an event occurrence and its dissemination, these results can open an opportunity for temporal tracking of emergence and outbreak scenarios. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Nolasco, Diogo] Univ Fed Rio de Janeiro, Programa Posgrad Informat, Rio De Janeiro, Brazil.
   [Oliveira, Jonice] Univ Fed Rio de Janeiro, Dept Ciencia Comp, Rio De Janeiro, Brazil.
RP Nolasco, D (corresponding author), Univ Fed Rio de Janeiro, Programa Posgrad Informat, Rio De Janeiro, Brazil.
EM diogo.sousa@ppgi.ufrj.br; jonice@dcc.ufrj.br
RI , Jano/AAG-9116-2019
OI , Jano/0000-0001-5080-1955; Oliveira, Jonice/0000-0002-2495-1463
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX We would like to thank CAPES, CNPq and FAPERJ for the support.
CR Arabie P., 1996, CLUST CLASSIF
   BBC, 2016, BBC
   Becker H., 2011, TRENDING TOPICS REAL
   Berkrot B., 2016, ZIKAS IMPACT CHILDRE
   Berry M.W., 2010, TEXT MINING APPL THE
   Blei D., 2009, TOPIC MODELS CLASSIF
   Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Boettcher A, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON GREEN COMPUTING AND COMMUNICATIONS, CONFERENCE ON INTERNET OF THINGS, AND CONFERENCE ON CYBER, PHYSICAL AND SOCIAL COMPUTING (GREENCOM 2012), P358, DOI 10.1109/GreenCom.2012.59
   Brasil P., 2016, RES REVEALS MORE 100
   CAN F, 1990, ACM T DATABASE SYST, V15, P483, DOI 10.1145/99935.99938
   Coelho H., 2016, FIOCRUZ DETECTS ZIKA
   da Saude P., 2016, EPIDEMIC SITUATION Z
   de Oliveira J. Valenti, 2007, ADV FUZZY CLUSTERING
   Dollinger A., 2016, DEVOURING 1000 MOSQU
   Felix M., 2017, GNAT CAN TRANSMIT ZI
   Fox V., 2003, IEEE PERVASIVE
   Haghighi A., 2011, P 49 ANN M ASS COMP, V1, P389
   Hughes A. L., 2009, TWITTER ADOPTION USE
   Lauand B., 2016, CONTEXTUALIZATION SO
   Lee R., 2010, P 2 ACM SIGSPATIAL I, P1, DOI DOI 10.1145/1867699.1867701
   McNeil D., 2016, ZIKA EMERGING EPIDEM
   McNeil D. G., 2016, SEX MAY SPREAD ZIKA
   Metzler Donald, 2012, P 2012 C N AM CHAPT, P646
   Monroy-Hernandez A., 2013, IS BRAZILIAN UPRISIN
   Nolasco D., 2016, UFRJ
   Nolasco D, 2016, P ANN HICSS, P358, DOI 10.1109/HICSS.2016.51
   O'Callaghan D., 2014, MACH LEARN KNOWL DIS
   Pagan M., 2016, ZIKA VIRUS COULD BE
   Phuvipadawat S, 2010, Proceedings of the 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology - Workshops (WI-IAT 2010), P120, DOI 10.1109/WI-IAT.2010.205
   Popescu A.-M., 2010, P 19 ACM INT C INF K, P1873, DOI DOI 10.1145/1871437.1871751
   Resk F., 2016, MENS ABANDON MOTHERS
   Sankaranarayanan Jagan, 2009, P 17 ACM SIGSPATIAL, P42, DOI DOI 10.1145/1653771.1653781
   Steyvers M., 2007, HDB LATENT SEMANT AN
   Takahashi B, 2015, COMPUT HUM BEHAV, V50, P392, DOI 10.1016/j.chb.2015.04.020
   W. H. Organization, 2016, WHO DIR FEN CUMM OUT
   Wang D, 2014, PROCEEDINGS OF THE 13TH INTERNATIONAL SYMPOSIUM ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN' 14), P35, DOI 10.1109/IPSN.2014.6846739
   Weng J, 2011, P 4 INT AAAI C WEBL, P401
   Wolisz A., 2014, P 13 INT S INF PROC
   Zhao S., 2011, HUMAN REAL TIME SENS, P9
NR 40
TC 4
Z9 4
U1 5
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-739X
EI 1872-7115
J9 FUTURE GENER COMP SY
JI Futur. Gener. Comp. Syst.
PD APR
PY 2019
VL 93
BP 290
EP 303
DI 10.1016/j.future.2018.09.008
PG 14
WC Computer Science, Theory & Methods
SC Computer Science
GA HM3IA
UT WOS:000459365800024
DA 2020-07-08
ER

PT J
AU Majolo, F
   Marinowic, DR
   Moura, AA
   Machado, DC
   da Costa, JC
AF Majolo, Fernanda
   Marinowic, Daniel Rodrigo
   Moura, Adriana Avila
   Machado, Denise Cantarelli
   da Costa, Jaderson Costa
TI Use of induced pluripotent stem cells (iPSCs) and cerebral organoids in
   modeling the congenital infection and neuropathogenesis induced by Zika
   virus
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Review
DE iPSCs; organoids; microcephaly; pregnancy; Zika virus
ID HUMAN BRAIN; NEURAL PROGENITORS; INDUCTION
AB Infection with Zika virus (ZIKV) was recently demonstrated to be associated with damage to the central nervous system, especially microcephaly and the Guillain-Barre syndrome. This finding had alarmed public health agencies and mobilized institutions around the world to search for more information about the virus, its effects, pathophysiological mechanisms, and potential immunizations and treatments. Given the increasing interest in using iPSCs and cerebral organoids to model the congenital infection and neuropathogenesis induced by ZIKV, the aim of this review was to present an up-to-date summary of the publications on the association of ZIKV with microcephaly, using iPSCs and organoids. According to our review, the number of studies has decreased concomitantly with a decrease in the number of cases. The presence of subclinical lesions at birth, which may eventually present cognitive or behavioral problems in the future, suggests that persistent research efforts on the virus should be undertaken by the global health community till the threat is completely wiped out.
C1 [Majolo, Fernanda; Marinowic, Daniel Rodrigo; Machado, Denise Cantarelli; da Costa, Jaderson Costa] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst Rio Grande do Sul BraIns, Neurosci Lab, Porto Alegre, RS, Brazil.
   [Moura, Adriana Avila] Univ Fed Alagoas, Dept Med, Maceio, Brazil.
RP Majolo, F (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Med & Hlth Sci, BR-90610000 Porto Alegre, RS, Brazil.
EM fernanda.majolo@acad.pucrs.br
RI Majolo, Fernanda/S-5732-2018
OI Majolo, Fernanda/0000-0002-7955-078X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)CAPES
FX This study did not receive any specific grant from funding agencies in
   the public, commercial, or not-for-profit sectors. The first and second
   authors are grateful for the Postdoctoral grant from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Capes).
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Chitti Sai V., 2016, VirusDisease, V27, P211, DOI 10.1007/s13337-016-0317-9
   CLEARY EG, 1983, INT REV CONNECT TISS, V10, P97
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Depoux A, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0087-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034
   Dragunow M, 2008, NAT REV DRUG DISCOV, V7, P659, DOI 10.1038/nrd2617
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Ichida JK, 2015, EMBO J, V34, P1456, DOI 10.15252/embj.201591267
   Janssen S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00021-18
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Parent JM, 2015, NAT NEUROSCI, V18, P360, DOI 10.1038/nn.3944
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Salick MR, 2017, JOVE-J VIS EXP, V127, P56404
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Woosley RL, 2007, CLIN PHARMACOL THER, V81, P129, DOI 10.1038/sj.clpt.6100014
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang R, 2013, ACTA PHARMACOL SIN, V34, P765, DOI 10.1038/aps.2013.21
NR 50
TC 2
Z9 2
U1 1
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2019
VL 91
IS 4
BP 525
EP 532
DI 10.1002/jmv.25345
PG 8
WC Virology
SC Virology
GA HL2YR
UT WOS:000458577200002
PM 30357854
OA Bronze
DA 2020-07-08
ER

PT J
AU Strugarek, M
   Bossin, H
   Dumont, Y
AF Strugarek, Martin
   Bossin, Herve
   Dumont, Yves
TI On the use of the sterile insect release technique to reduce or
   eliminate mosquito populations
SO APPLIED MATHEMATICAL MODELLING
LA English
DT Article
DE Vector control; Sterile insect technique; Monotone dynamical system;
   Basin of attraction; Numerical simulation; Aedes spp
ID CYTOPLASMIC INCOMPATIBILITY; AEDES-AEGYPTI; WOLBACHIA; INFECTION;
   DENGUE; BIOLOGY
AB Vector control is critical to limit the circulation of vector-borne diseases, like chikungunya, dengue or zika, which have become important issues around the world. Among them, the Sterile Insect Technique (SIT) and the Incompatible Insect Technique (IIT) have recently aroused a renewed interest. In this paper we derive and study a minimalistic mathematical model designed for Aedes mosquito population elimination by SIT/IIT. Contrary to most of the previous models, it is bistable in general, allowing simultaneously for elimination of the population and for its survival. We consider different types of releases (constant, periodic or impulsive) and show necessary conditions to reach elimination in each case. We also estimate both sufficient and minimal treatment times. Biological parameters are estimated from a case study of an Aedes polynesiensis population, for which extensive numerical investigations illustrate the analytical results. The applications of this work are two-fold: to help identifying some key parameters that may need further field investigations, and to help designing release protocols. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Strugarek, Martin] AgroParisTech, 16 Rue Claude Bernard, F-75231 Paris 05, France.
   [Strugarek, Martin] Sorbonne Univ, Univ Paris Diderot SPC, CNRS, Lab Jacques Louis Lions,INRIA, F-75005 Paris, France.
   [Bossin, Herve] Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Tahiti, French Polynesi, France.
   [Dumont, Yves] CIRAD, Umr AMAP, Pretoria, South Africa.
   [Dumont, Yves] Univ Montpellier, AMAP, CIRAD, CNRS,INRA,IRD, Montpellier, France.
   [Dumont, Yves] Univ Pretoria, Dept Math & Appl Math, Pretoria, South Africa.
RP Dumont, Y (corresponding author), CIRAD, Umr AMAP, Pretoria, South Africa.
EM yves.dumont@cirad.fr
RI Dumont, Yves/O-3801-2017
OI Dumont, Yves/0000-0003-4817-685X
FU French Ministry of Health [3800/TIS]; European Regional Development Fund
   (ERDF)European Union (EU) [2012-32122, GURDTI 2017-0583-0001899];
   DST/NRF SARChI Chair M3B2 grant [82770]; STIC AmSud "MOSTICAW Project"
   [99999.007551/2015-00]
FX This study was part of the Phase 2 SIT feasibility project against Aedes
   albopictus in Reunion Island, jointly funded by the French Ministry of
   Health (Convention 3800/TIS) and the European Regional Development Fund
   (ERDF) (Convention No. 2012-32122 and Convention No. GURDTI
   2017-0583-0001899). YD was (partially) supported by the DST/NRF SARChI
   Chair M3B2 grant 82770. YD and MS also acknowledge partial supports from
   the STIC AmSud "MOSTICAW Project", Process No. 99999.007551/2015-00.
CR Anguelov R, 2012, AIP CONF PROC, V1487, P212, DOI 10.1063/1.4758961
   Anguelov R, 2012, COMPUT MATH APPL, V64, P374, DOI 10.1016/j.camwa.2012.02.068
   Bainov D., 1993, IMPULSIVE DIFFERENTI, P66
   Bliman PA, 2018, J MATH BIOL, V76, P1269, DOI 10.1007/s00285-017-1174-x
   Bourtzis K., 2008, ADV EXPT MED BIOL, V627
   Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271
   Dufourd C., 2012, BIOMATH, P1
   Dufourd C, 2013, COMPUT MATH APPL, V66, P1695, DOI 10.1016/j.camwa.2013.03.024
   Dumont Y, 2016, MATH BIOSCI, V281, P9, DOI 10.1016/j.mbs.2016.08.011
   Dumont Y, 2012, J MATH BIOL, V65, P809, DOI 10.1007/s00285-011-0477-6
   DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032
   Dyck VA, 2006, STERILE INSECT TECHN
   Farkas JZ, 2017, J MATH BIOL, V75, P621, DOI 10.1007/s00285-017-1096-7
   Farkas JZ, 2010, B MATH BIOL, V72, P2067, DOI 10.1007/s11538-010-9528-1
   Fenton A, 2011, AM NAT, V178, P333, DOI 10.1086/661247
   Hapairai L. K. M., 2013, ACTA TROPICA, V132
   Hapairai L. K. M., 2013, THESIS
   Hapairai LK, 2013, J MED ENTOMOL, V50, P965, DOI 10.1603/ME12246
   Hertig M, 1924, J MED RES, V44, P329
   Huang M, 2017, J BIOL DYNAM, V11, P147, DOI 10.1080/17513758.2016.1254286
   Hughes H, 2013, B MATH BIOL, V75, P796, DOI 10.1007/s11538-013-9835-4
   JACHOWSKI LA, 1954, AM J HYG, V60, P186, DOI 10.1093/oxfordjournals.aje.a119712
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Li Jia, 2015, J Biol Dyn, V9, P1, DOI 10.1080/17513758.2014.977971
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Nadin G, 2018, J MATH BIOL, V76, P1489, DOI 10.1007/s00285-017-1181-y
   O'Connor L., 2012, PLOS NEGLECT TROP D, V6, P1, DOI DOI 10.1371/J0UMAL.PNTD.0001797
   Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Rasgon JL, 2003, GENETICS, V165, P2029
   Riviere F., 1988, THESIS
   Sallet G., 2015, ARIMA, V20, P145
   Schraiber JG, 2012, J THEOR BIOL, V297, P26, DOI 10.1016/j.jtbi.2011.12.006
   Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025
   Smith H.L., 1995, MONOTONE DYNAMICAL S
   Strugarek M, 2018, MATH BIOSCI ENG, V15, P961, DOI 10.3934/mbe.2018043
   Suzuki T., 1978, Japanese Journal of Sanitary Zoology, V29, P279
NR 37
TC 6
Z9 6
U1 4
U2 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0307-904X
EI 1872-8480
J9 APPL MATH MODEL
JI Appl. Math. Model.
PD APR
PY 2019
VL 68
BP 443
EP 470
DI 10.1016/j.apm.2018.11.026
PG 28
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications; Mechanics
SC Engineering; Mathematics; Mechanics
GA HK1MT
UT WOS:000457669700024
DA 2020-07-08
ER

PT J
AU Balcarcel, A
   Foguel, M
   Ledezma, C
   Calvo-Marzal, P
   Torres, KC
AF Balcarcel, Angelica
   Foguel, Marcos
   Ledezma, Carlos
   Calvo-Marzal, Percy
   Torres, Karin Chumbimuni
TI Differentiation between ZIKA lineages using electrochemical biosensors
   based on nucleic acid detection
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 257th National Meeting of the American-Chemical-Society (ACS)
CY MAR 31-APR 04, 2019
CL Orlando, FL
SP Amer Chem Soc
C1 [Balcarcel, Angelica; Foguel, Marcos; Ledezma, Carlos; Calvo-Marzal, Percy; Torres, Karin Chumbimuni] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA.
EM angie_balcarcel@knights.ucf.edu
RI Foguel, Marcos Vinicius/AAD-5767-2020
OI Foguel, Marcos Vinicius/0000-0001-9584-1029
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 31
PY 2019
VL 257
MA 208
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA IN7KL
UT WOS:000478860500410
DA 2020-07-08
ER

PT J
AU Braunschweig, A
   Palanichamy, K
   Garg, H
   Joshi, A
AF Braunschweig, Adam
   Palanichamy, Kalanidhi
   Garg, Himanshu
   Joshi, Anjali
TI Synthetic carbohydrate receptors with potent anti-Zika virus activity
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 257th National Meeting of the American-Chemical-Society (ACS)
CY MAR 31-APR 04, 2019
CL Orlando, FL
SP Amer Chem Soc
C1 [Braunschweig, Adam; Palanichamy, Kalanidhi] CUNY, Adv Sci Res Ctr, New York, NY 10021 USA.
   [Braunschweig, Adam] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA.
   [Garg, Himanshu; Joshi, Anjali] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, El Paso, TX USA.
EM adam.braunschweig@asrc.cuny.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 31
PY 2019
VL 257
MA 75
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA IN7KL
UT WOS:000478860501651
DA 2020-07-08
ER

PT J
AU Carraher, C
   Mosca, F
   Slawek, P
   Roner, M
   Miller, L
   Haky, J
   Campbell, A
AF Carraher, Charles
   Mosca, Francesca
   Slawek, Paul
   Roner, Michael
   Miller, Lindsey
   Haky, Jerome
   Campbell, Anthony
TI Synthesis of organotin polyesters from camphoric acid and their ability
   to inhibit the Zika virus
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 257th National Meeting of the American-Chemical-Society (ACS)
CY MAR 31-APR 04, 2019
CL Orlando, FL
SP Amer Chem Soc
C1 [Carraher, Charles; Mosca, Francesca; Slawek, Paul; Haky, Jerome; Campbell, Anthony] Florida Atlantic Univ, Dept Chem & Biochem, Parkland, FL USA.
   [Roner, Michael; Miller, Lindsey] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.
EM carraher@fau.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 31
PY 2019
VL 257
MA 377
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA IN7KQ
UT WOS:000478861205051
DA 2020-07-08
ER

PT J
AU Darji, S
   Banerjee, T
   Santra, S
AF Darji, Saloni
   Banerjee, Tuhina
   Santra, Santimukul
TI Development of functional magnetic relaxation nanosensors for the
   investigation of zika binding and fusion mechanism
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 257th National Meeting of the American-Chemical-Society (ACS)
CY MAR 31-APR 04, 2019
CL Orlando, FL
SP Amer Chem Soc
C1 [Darji, Saloni] Pittsburg State Univ, Chem, Pittsburg, KS 66762 USA.
   [Banerjee, Tuhina; Santra, Santimukul] Pittsburg State Univ, Dept Chem, Pittsburg, KS 66762 USA.
EM sdarji@gus.pittstate.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 31
PY 2019
VL 257
MA 226
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA IN7KL
UT WOS:000478860501145
DA 2020-07-08
ER

PT J
AU Foguel, M
   Lynch, C
   Reed, A
   Balcarcel, A
   Calvo-Marzal, P
   Gerasimova, Y
   Torres, KC
AF Foguel, Marcos
   Lynch, Charles
   Reed, Adam
   Balcarcel, Angelica
   Calvo-Marzal, Percy
   Gerasimova, Yulia
   Torres, Karin Chumbimuni
TI Rapid and selective detection of Zika virus circulating in the Americas
   using electrochemical RNA-sensor along with NASBA
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 257th National Meeting of the American-Chemical-Society (ACS)
CY MAR 31-APR 04, 2019
CL Orlando, FL
SP Amer Chem Soc
C1 [Foguel, Marcos; Lynch, Charles; Reed, Adam; Balcarcel, Angelica; Calvo-Marzal, Percy; Gerasimova, Yulia; Torres, Karin Chumbimuni] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA.
   [Lynch, Charles] Rose Hulman Inst Technol, Terre Haute, IN 47803 USA.
EM mvfoguel@yahoo.com.br
RI Foguel, Marcos Vinicius/AAD-5767-2020
OI Foguel, Marcos Vinicius/0000-0001-9584-1029
NR 0
TC 0
Z9 0
U1 2
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 31
PY 2019
VL 257
MA 311
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA IN7KL
UT WOS:000478860500513
DA 2020-07-08
ER

PT J
AU Santos, J
   Silveira, R
   Toma, S
   Araki, K
   Brolo, A
   Corio, P
AF Santos, Jonnatan
   Silveira, Raisa
   Toma, Sergio
   Araki, Koiti
   Brolo, Alexandre
   Corio, Paola
TI Superparamagnetic iron oxide nanoparticles allied to gold nanoparticles
   in the detection of Zika virus by surface-enhanced Raman spectroscopy
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 257th National Meeting of the American-Chemical-Society (ACS)
CY MAR 31-APR 04, 2019
CL Orlando, FL
SP Amer Chem Soc
C1 [Santos, Jonnatan; Silveira, Raisa; Toma, Sergio; Araki, Koiti; Corio, Paola] Univ Sao Paulo, Insitute Chem, Sao Paulo, SP, Brazil.
   [Brolo, Alexandre] Univ Victoria, Dept Chem, Victoria, BC, Canada.
EM jonnatan@iq.usp.br
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 31
PY 2019
VL 257
MA 185
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA IN7KL
UT WOS:000478860500388
DA 2020-07-08
ER

PT J
AU Hastings, AK
   Hastings, K
   Uraki, R
   Hwang, J
   Gaitsch, N
   Dhaliwal, K
   Williamson, E
   Fikrig, E
AF Hastings, Andrew K.
   Hastings, Katherine
   Uraki, Ryuta
   Hwang, Jesse
   Gaitsch, Nellie
   Dhaliwal, Khushwant
   Williamson, Eric
   Fikrig, Erol
TI Loss of the TAM Receptor Axl Ameliorates Severe Zika Virus Pathogenesis
   and Reduces Apoptosis in Microglia
SO ISCIENCE
LA English
DT Article
ID TYROSINE KINASES; INFECTION; CELLS; INHIBITION; INDUCTION; MECHANISM;
   TARGETS; BRAZIL; BRAIN
AB The TAM receptor, Axl, has been implicated as a candidate entry receptor for Zika virus (ZIKV) infection but has been shown as inessential for virus infection in mice. To probe the role of Axl in murine ZIKV infection, we developed a mouse model lacking the Axl receptor and the interferon alpha/beta receptor (Ifnar(-/-) Axl(-/-)), conferring susceptibility to ZIKV. This model validated that Axl is not required for murine ZIKV infection and that mice lacking Axl are resistant to ZIKV pathogenesis. This resistance correlates to lower pro-interleukin-1 beta production and less apoptosis in microglia of ZIKV-infected mice. This apoptosis occurs through both intrinsic (caspase 9) and extrinsic (caspase 8) manners, and is age dependent, as younger Axl-deficient mice are susceptible to ZIKV pathogenesis. These findings suggest that Axl plays an important role in pathogenesis in the brain during ZIKV infection and indicates a potential role for Axl inhibitors as therapeutics during viral infection.
C1 [Hastings, Andrew K.; Uraki, Ryuta; Hwang, Jesse; Gaitsch, Nellie; Dhaliwal, Khushwant; Williamson, Eric; Fikrig, Erol] Yale Univ, Dept Internal Med, Sect Infect Dis, Sch Med, New Haven, CT 06520 USA.
   [Hastings, Katherine] Yale Univ, Yale Canc Ctr, Sch Med, New Haven, CT 06520 USA.
   [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Fikrig, E (corresponding author), Yale Univ, Dept Internal Med, Sect Infect Dis, Sch Med, New Haven, CT 06520 USA.; Fikrig, E (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM erol.fikrig@yale.edu
OI Gaitsch, Hallie/0000-0002-6656-607X
FU HHMIHoward Hughes Medical Institute
FX We would like to acknowledge Akiko Iwasaki and Carla Rothlin, along with
   their respective laboratories, for providing mice, expert advice, and
   the use of equipment for these experiments. We would also like to
   acknowledge the animal care technicians whomaintained our mouse
   colonies. E. F. is an HHMI investigator, and funds from HHMI were used
   to perform these experiments.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bosurgi L, 2013, P NATL ACAD SCI USA, V110, P13091, DOI 10.1073/pnas.1302507110
   Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710
   Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428
   Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353
   Carrera Silva E.A., 2013, IMMUNITY, V39, P160
   CHATTOPADHYAY S., 2013, MBIO, V4
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630
   Galdiero M, 1999, INFECT IMMUN, V67, P1432, DOI 10.1128/IAI.67.3.1432-1438.1999
   Ganesh K, 2012, J IMMUNOL, V189, P2563, DOI 10.4049/jimmunol.1102762
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han J, 2016, AUTOPHAGY, V12, P2326, DOI 10.1080/15548627.2016.1235124
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9
   Huang LR, 2000, P NATL ACAD SCI USA, V97, P3406, DOI 10.1073/pnas.060026497
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miller L., 2010, ANAL GELS W BLOTS IM
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980
   Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, EUROSURVEILLANCE, V79, P20720
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450
   Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   World Health Organization, 2016, ZIK SIT REP
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Xiong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072772
   Yang YB, 2010, J MED VIROL, V82, P735, DOI 10.1002/jmv.21720
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 67
TC 3
Z9 3
U1 1
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2589-0042
J9 ISCIENCE
JI iScience
PD MAR 29
PY 2019
VL 13
BP 339
EP +
DI 10.1016/j.isci.2019.03.003
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HR0PA
UT WOS:000462829500028
PM 30884311
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gonzalez, MA
   Pavan, MG
   Fernandes, RS
   Busquets, N
   David, MR
   Lourenco-Oliveira, R
   Garcia-Perez, AL
   Maciel-de-Freitas, R
AF Gonzalez, Mikel A.
   Pavan, Marcio G.
   Fernandes, Rosilainy S.
   Busquets, Nuria
   David, Mariana R.
   Lourenco-Oliveira, Ricardo
   Garcia-Perez, Ana L.
   Maciel-de-Freitas, Rafael
TI Limited risk of Zika virus transmission by five Aedes albopictus
   populations from Spain
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes albopictus; Zika virus; Spanish populations; Vector competence;
   Viral copies; RT-qPCR; Plaque assay
ID INVASIVE MOSQUITOS; SKUSE DIPTERA; 1ST RECORD; AEGYPTI; ESTABLISHMENT;
   COMPETENCE; INFECTION; CULICIDAE; AMERICA; ECOLOGY
AB BackgroundAedes albopictus, the Asian tiger mosquito, is an exotic invasive species in Europe. It has substantial public health relevance due to its potential role in transmitting several human pathogens. Out of the European countries, Spain has one of the highest risk levels of autochthonous arbovirus transmission due to both the high density of Ae. albopictus and the extensive tourist influx from vector-endemic areas. This study aims to investigate the susceptibility of five Ae. albopictus populations from mainland Spain and the Balearic Islands to a Brazilian Zika virus (ZIKV) strain.MethodsThe F1 generation of each Ae. albopictus population was orally challenged with a ZIKV-infected blood meal (1.8x10(6)PFU/ml). At 7 and 14 days post-infection (dpi), mosquito bodies (thorax and abdomen) and heads were individually analysed through RT-qPCR to determine the infection rate (IR) and dissemination rate (DR), respectively. The saliva of infected mosquitoes was inoculated in Vero cells and the transmission rate was assessed by plaque assay or RT-qPCR on similar to 33 individuals per population.ResultsThe IR and DR ranged between 12-88%, and 0-60%, respectively, suggesting that ZIKV is capable of crossing the midgut barrier. Remarkably, no infectious viral particle was found in saliva samples, indicating a low ability of ZIKV to overcome the salivary gland barrier. A subsequent assay revealed that a second non-infective blood meal 48 h after ZIKV exposure did not influence Ae. albopictus vector competence.ConclusionsThe oral experimental ZIKV infections performed here indicate that Ae. albopictus from Spain become infected and disseminate the virus through the body but has a limited ability to transmit the Brazilian ZIKV strain through biting. Therefore, the results suggest a limited risk of autochthonous ZIKV transmission in Spain by Ae. albopictus.
C1 [Gonzalez, Mikel A.; Garcia-Perez, Ana L.] NEIKER Inst Vasco Invest & Desarrollo Agrario, Derio, Bizkaia, Spain.
   [Gonzalez, Mikel A.; Pavan, Marcio G.; Fernandes, Rosilainy S.; David, Mariana R.; Lourenco-Oliveira, Ricardo; Maciel-de-Freitas, Rafael] Fundacao Oswaldo Cruz IOC FIOCRUZ, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Busquets, Nuria] UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Bellaterra, Spain.
   [Lourenco-Oliveira, Ricardo; Maciel-de-Freitas, Rafael] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
RP Maciel-de-Freitas, R (corresponding author), Fundacao Oswaldo Cruz IOC FIOCRUZ, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
EM freitas@ioc.fiocruz.br
RI Busquets, Nuria/T-8431-2017
OI Garcia-Perez, Ana L./0000-0001-7404-1380; Maciel-de-Freitas,
   Rafael/0000-0002-2198-6492; Rocha David, Mariana/0000-0003-1241-3585
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/201.335/2016]; Basque GovernmentBasque
   Government; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [23038.007199/2012-17, 001]
FX Funding was supported by FAPERJ E-26/201.335/2016. MAG receives a 3-year
   postdoctoral fellowship funded by the Basque Government. Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Grant No.
   23038.007199/2012-17 and Finance Code 001).
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Alcibar RM, 2017, B ASOC ESP ENT, V41, P3
   Amuzu HE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0853-y
   Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x
   Armstrong PM, 2018, BIORXIV, DOI [10.1101/246306, DOI 10.1101/246306]
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Collantes F, 2016, ACTA TROP, V164, P64, DOI 10.1016/j.actatropica.2016.08.023
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   ECDC, 2018, AED ALB CURR KNOWN D
   ECDC. European Centre for Disease Prevetion and Control, 2018, ZIK TRANSM
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   European Centre for Disease Prevention and Control, 2018, NEW SETTL AED AEG RA
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex031
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Marano G, 2017, BLOOD TRANSFUS-ITALY, V15, P489, DOI 10.2450/2017.0215-17
   Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Petersen MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200766
   Ryckebusch F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112384
   Schaffner F, 2000, CR ACAD SCI III-VIE, V323, P373, DOI 10.1016/S0764-4469(00)00143-8
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Westbrook CJ, 2010, VECTOR-BORNE ZOONOT, V10, P241, DOI 10.1089/vbz.2009.0035
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 41
TC 7
Z9 7
U1 2
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 29
PY 2019
VL 12
AR 150
DI 10.1186/s13071-019-3359-1
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HS1CX
UT WOS:000463600700001
PM 30922370
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Huber, RG
   Lim, XN
   Ng, WC
   Sim, AYL
   Poh, HX
   Shen, Y
   Lim, SY
   Sundstrom, KB
   Sun, XY
   Aw, JG
   Too, HK
   Boey, PH
   Wilm, A
   Chawla, T
   Choy, MM
   Jiang, L
   de Sessions, PF
   Loh, XJ
   Alonso, S
   Hibberd, M
   Nagarajan, N
   Ooi, EE
   Bond, PJ
   Sessions, OM
   Wan, Y
AF Huber, Roland G.
   Lim, Xin Ni
   Ng, Wy Ching
   Sim, Adelene Y. L.
   Poh, Hui Xian
   Shen, Yang
   Lim, Su Ying
   Sundstrom, Karin B.
   Sun, Xuyang
   Aw, Jong Ghut
   Too, Horng Khit
   Boey, Peng Hee
   Wilm, Andreas
   Chawla, Tanu
   Choy, Milly M.
   Jiang, Lu
   de Sessions, Paola Florez
   Loh, Xian Jun
   Alonso, Sylvie
   Hibberd, Martin
   Nagarajan, Niranjan
   Ooi, Eng Eong
   Bond, Peter J.
   Sessions, October M.
   Wan, Yue
TI Structure mapping of dengue and Zika viruses reveals functional
   long-range interactions
SO NATURE COMMUNICATIONS
LA English
DT Article
ID RNA SECONDARY STRUCTURE; CODING REGION; IN-VIVO; SHAPE; ARCHITECTURE;
   TRANSLATION; ALIGNMENT
AB Dengue (DENV) and Zika (ZIKV) viruses are clinically important members of the Flaviviridae family with an 11 kb positive strand RNA genome that folds to enable virus function. Here, we perform structure and interaction mapping on four DENV and ZIKV strains inside virions and in infected cells. Comparative analysis of SHAPE reactivities across serotypes nominates potentially functional regions that are highly structured, conserved, and contain low synonymous mutation rates. Interaction mapping by SPLASH identifies many pair-wise interactions, 40% of which form alternative structures, suggesting extensive structural heterogeneity. Analysis of shared interactions between serotypes reveals a conserved macro-organization whereby interactions can be preserved at physical locations beyond sequence identities. We further observe that longer-range interactions are preferentially disrupted inside cells, and show the importance of new interactions in virus fitness. These findings deepen our understanding of Flavivirus genome organization and serve as a resource for designing therapeutics in targeting RNA viruses.
C1 [Huber, Roland G.; Sim, Adelene Y. L.; Bond, Peter J.] ASTAR, Bioinformat Inst, 30 Biopolis St 07-01, Singapore 138671, Singapore.
   [Lim, Xin Ni; Poh, Hui Xian; Lim, Su Ying; Aw, Jong Ghut; Wan, Yue] Genome Inst Singapore, Stem Cell & Regenerat Biol, Singapore 138672, Singapore.
   [Ng, Wy Ching; Sundstrom, Karin B.; Chawla, Tanu; Ooi, Eng Eong; Sessions, October M.] Duke NUS Grad Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
   [Shen, Yang; Wilm, Andreas; Nagarajan, Niranjan] Genome Inst Singapore, Computat Biol, Singapore 138672, Singapore.
   [Sun, Xuyang] Natl Neurosci Inst, Dept Neurol, 20 Coll Rd, Singapore 169856, Singapore.
   [Sun, Xuyang] Genome Inst Singapore, Stem Cell & Regenerat Biol, 60 Biopolis St, Singapore 138672, Singapore.
   [Too, Horng Khit; Boey, Peng Hee; Alonso, Sylvie; Ooi, Eng Eong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117545, Singapore.
   [Too, Horng Khit; Boey, Peng Hee; Alonso, Sylvie] Natl Univ Singapore, Life Sci Inst, Immunol Programme, Singapore 119077, Singapore.
   [Choy, Milly M.; Hibberd, Martin] Genome Inst Singapore, Infect Dis, Singapore 138672, Singapore.
   [Choy, Milly M.; Hibberd, Martin] London Sch Hyg & Trop Med, London WC1E 7HT, England.
   [Jiang, Lu; Loh, Xian Jun] ASTAR, Inst Mat Res & Engn IMRE, Singapore 138634, Singapore.
   [Jiang, Lu; Loh, Xian Jun] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117575, Singapore.
   [de Sessions, Paola Florez] Genome Inst Singapore, GERMS Platform, Singapore 138672, Singapore.
   [Ooi, Eng Eong; Sessions, October M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore.
   [Sessions, October M.] Natl Univ Singapore, Dept Pharm, Singapore 117559, Singapore.
   [Wan, Yue] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
   [Wan, Yue] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.
RP Bond, PJ (corresponding author), ASTAR, Bioinformat Inst, 30 Biopolis St 07-01, Singapore 138671, Singapore.; Wan, Y (corresponding author), Genome Inst Singapore, Stem Cell & Regenerat Biol, Singapore 138672, Singapore.; Sessions, OM (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.; Sessions, OM (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore.; Sessions, OM (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore 117559, Singapore.; Wan, Y (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.; Wan, Y (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.
EM peterjb@bii.a-star.edu.sg; october.sessions@duke-nus.edu.sg;
   wany@gis.a-star.edu.sg
OI Huber, Roland/0000-0001-5093-5988; Sun, Alfred
   Xuyang/0000-0002-7893-2006; Bond, Peter/0000-0003-2900-098X; Hibberd,
   Martin/0000-0001-8587-1849; Ooi, Eng Eong/0000-0002-0520-1544
FU A*STARAgency for Science Technology & Research (ASTAR); Society in
   Science-Branco Weiss Fellowship; Ministry of Education Singapore-MOE
   AcRF Tier 3 Grant [MOE2012-T3-1-008]; A*STAR Biomedical Research
   Council-Young Investigator Grant [BMRC YIG 1610651031]; National Medical
   Research Council (NMRC)National Medical Research Council, Singapore
   [NMRC/CSA/0060/2014, NMRC/CIRG/1462/2016]
FX We thank members of the Wan lab, Sessions lab, Ooi lab, Meng How Tan,
   Mariano Garcia-Blanco, and Ben Blencowe for discussions. Y.W. is
   supported by funding from A*STAR and Society in Science-Branco Weiss
   Fellowship. P.J.B. acknowledges support by funding from the Ministry of
   Education Singapore-MOE AcRF Tier 3 Grant Number MOE2012-T3-1-008.
   R.G.H. acknowledges support by funding from the A*STAR Biomedical
   Research Council-Young Investigator Grant BMRC YIG 1610651031. E.E.O. is
   supported by funding from the National Medical Research Council (NMRC)
   Senior Clinician-Scientist Award (NMRC/CSA/0060/2014) and Individual
   Research Grant (NMRC/CIRG/1462/2016).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Aw Jong Ghut Ashley, 2017, J Vis Exp, DOI 10.3791/55255
   Aw JGA, 2016, MOL CELL, V62, P603, DOI 10.1016/j.molcel.2016.04.028
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bidet K, 2018, ADV EXP MED BIOL, V1062, P45, DOI 10.1007/978-981-10-8727-1_4
   Burrill C. P., 2013, CURR PROTOC MICROBIO, V30
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Ivanyi-Nagy R, 2012, VIRUS RES, V167, P226, DOI 10.1016/j.virusres.2012.05.003
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Li P, 2018, CELL HOST MICROBE, V24, P875, DOI 10.1016/j.chom.2018.10.011
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Low JT, 2010, METHODS, V52, P150, DOI 10.1016/j.ymeth.2010.06.007
   Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101
   Mauger DM, 2015, P NATL ACAD SCI USA, V112, P3692, DOI 10.1073/pnas.1416266112
   Mustoe AM, 2018, CELL, V173, P181, DOI 10.1016/j.cell.2018.02.034
   Nicholson BL, 2014, NAT REV MICROBIOL, V12, P493, DOI 10.1038/nrmicro3288
   Pirakitikulr N, 2016, MOL CELL, V62, P111, DOI 10.1016/j.molcel.2016.01.024
   Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194
   Rivas E, 2017, NAT METHODS, V14, P45, DOI [10.1038/NMETH.4066, 10.1038/nmeth.4066]
   Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894
   Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/NMETH.3029, 10.1038/nmeth.3029]
   Smola MJ, 2016, P NATL ACAD SCI USA, V113, P10322, DOI 10.1073/pnas.1600008113
   Spitale RC, 2013, NAT CHEM BIOL, V9, P18, DOI [10.1038/NCHEMBIO.1131, 10.1038/nchembio.1131]
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237
   Ziv O, 2018, NAT METHODS, V15, P785, DOI 10.1038/s41592-018-0121-0
NR 38
TC 11
Z9 11
U1 2
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 29
PY 2019
VL 10
AR 1408
DI 10.1038/s41467-019-09391-8
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ9BP
UT WOS:000462721900007
PM 30926818
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gregorio, ER
   Medina, JRC
   Lomboy, MFTC
   Talaga, ADP
   Hernandez, PMR
   Kodama, M
   Kobayashi, J
AF Gregorio, Ernesto R., Jr.
   Medina, John Robert C.
   Lomboy, Marian Fe Theresa C.
   Talaga, Andre Dominic P.
   Hernandez, Paul Michael R.
   Kodama, Mitsuya
   Kobayashi, Jun
TI Knowledge, attitudes, and practices of public secondary school teachers
   on Zika Virus Disease: A basis for the development of evidence-based
   Zika educational materials for schools in the Philippines
SO PLOS ONE
LA English
DT Article
AB The Philippines is at risk in developing a Zika Virus (ZIKV) Disease Outbreak. One of the possible interventions is health education because students are potential health advocates and influencers to their communities through the knowledge transfers from their teachers. The competency of Filipino teachers on ZIKV Disease is yet to be described. This study aimed to assess the knowledge, attitudes, and practices of public secondary school teachers on ZIKV Disease. A modified version of the Knowledge, Attitudes, and Practices Survey Tool on Zika Virus Disease from the World Health Organization-Pan American Health Organization (WHO-PAHO) was used to assess the knowledge, attitudes, and practices of teachers of eight public secondary schools in five villages in Quezon City, Philippines. Out of the 609 respondents, 87.3% reported that their main source of information about ZIKV is tri-media, which includes television, print, and radio. Majority of the respondents mentioned that ZIKV is transmitted through a mosquito bite (80.3%). However, only half of the participants identified vector control as a preventive strategy. Moreover, only 54% admitted to have cleaned their water containers or water sources within the last week. Only a few identified mother-to-child (23%) and sexual intercourse (8%) as other means of transmission. Half (49.8%) of the respondents felt that it is possible to acquire ZIKV in their community, while 90% perceived that a private doctor (90%) or a public hospital (88%) can effectively treat the disease. Perceived stigma is high at 50%. This study showed there was good knowledge among teachers on vector transmission of ZIKV but poor knowledge on other aspects of the disease. Also, there was a low level of perceived susceptibility and severity ZIKV which can be explained by the absence of a personal encounter with a Zika patient and the low number of cases in the Philippines. Half of the respondents said that they cleaned the possible mosquito breeding sites within the last week, followed by those who cleaned their water source more than a week ago (19%). None of the socio-demographic characteristics is significantly associated with respondents' knowledge on Zika. Only income and location of residence were found to be significantly associated with attitudes towards Zika. These findings call for a comprehensive training program that includes development of teaching materials for public secondary school teachers on ZIKV Disease based from this study.
C1 [Gregorio, Ernesto R., Jr.; Medina, John Robert C.; Talaga, Andre Dominic P.; Kodama, Mitsuya; Kobayashi, Jun] Univ Philippines Manila, SEAMEO TROPMED Reg Ctr Publ Hlth Hosp Adm & Envir, Coll Publ Hlth, Dept Hlth Promot & Educ, Manila, Philippines.
   [Lomboy, Marian Fe Theresa C.; Hernandez, Paul Michael R.] Univ Philippines Manila, SEAMEO TROPMED Reg Ctr Publ Hlth Hosp Adm & Envir, Coll Publ Hlth, Dept Environm & Occupat Hlth, Manila, Philippines.
   [Gregorio, Ernesto R., Jr.; Medina, John Robert C.; Kodama, Mitsuya; Kobayashi, Jun] Univ Ryukyus, Grad Sch Hlth Sci, Dept Global Hlth, Nishihara, Okinawa, Japan.
   [Kobayashi, Jun] Univ Ryukyus, Japanese Consortium Global Sch Hlth Res, Nishihara, Okinawa, Japan.
RP Gregorio, ER (corresponding author), Univ Philippines Manila, SEAMEO TROPMED Reg Ctr Publ Hlth Hosp Adm & Envir, Coll Publ Hlth, Dept Hlth Promot & Educ, Manila, Philippines.; Gregorio, ER (corresponding author), Univ Ryukyus, Grad Sch Hlth Sci, Dept Global Hlth, Nishihara, Okinawa, Japan.
EM ergregorio@up.edu.ph
OI Gregorio, Ernesto Jr/0000-0003-1931-0458; Medina, John
   Robert/0000-0001-6647-5453; Hernandez, Paul Michael/0000-0003-0528-9766
FU Okinawa Prefecture of Japan
FX JK received a funding from the Okinawa Prefecture of Japan.
   http://www.infection.okinawa/.Okinawa Prefecture had no role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aidoo-Frimpong G, 2017, ANN GLOB HEALTH, V83, P59
   Alvarez LS, 2017, OPEN PUBLIC HLTH J, V10
   [Anonymous], 2017, ABS CBN NEWS    0203
   Arief M, 2017, JPPCM, V3, P81, DOI DOI 10.5530/jppcm.2017.2.20
   Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98
   Bonalos P, 2016, CNN PHILIPPINES 0817
   Bulario JS, 2018, 4 INT RES C HIGH ED, P891
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Casapulla SL, 2018, AIMS PUBLIC HEALTH, V5, P49, DOI 10.3934/publichealth.2018.1.49
   Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875
   Chaw LL, 2018, ASIAN PAC J TROP MED, V11, P638, DOI 10.4103/1995-7645.246340
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Department of Health, DIS SURV 2015 DENG M
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013
   Hattie J, 2003, BUILD TEACH QUAL WHA
   Heitzinger Kristen, 2018, Prev Med Rep, V10, P20, DOI 10.1016/j.pmedr.2018.01.002
   Huang Y, 2017, JMIR PUBLIC HLTH SUR, V3, DOI DOI 10.1186/S12889-017-4991-3
   Jayawardene WP, 2011, J SCHOOL HEALTH, V81, P566, DOI 10.1111/j.1746-1561.2011.00628.x
   Katler Quinton, 2017, Infect Dis Obstet Gynecol, V2017, P6350602, DOI 10.1155/2017/6350602
   Lohrmann C, 2000, J ADV NURS, V31, P696, DOI 10.1046/j.1365-2648.2000.01326.x
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Mwamwenda TS, MEDITERRANEAN J SOCI, V5, P500
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Philippine Statistics Authority, 2016, 2015 FULL YEAR OFF P
   Philippine Statistics Authority (PSA) and ICF, 2018, KEY FIND PHIL NAT DE
   Plaster AN, 2018, J COMMUNITY HLTH, P1
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Tun MMN, 2018, AM J TROP MED HYG, V98, P868, DOI 10.4269/ajtmh.17-0708
   Borges ALV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190024
   Whiteman A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6172-4
   World Health Organization, 2016, KNOWL ATT PRACT SURV
   World Health Organization [ WHO]/ PAHO, 2016, ZIK STRAT RESP PLAN
   World Health Organization [ WHO]/ PAHO, 2016, ZIK STRAT RESP PLAN
NR 36
TC 0
Z9 0
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2019
VL 14
IS 3
AR e0214515
DI 10.1371/journal.pone.0214515
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ7IR
UT WOS:000462594000079
PM 30921441
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tramonte, AR
   Christofferson, RC
AF Tramonte, A. Ryan
   Christofferson, Rebecca C.
TI Investigating the probability of establishment of Zika virus and
   detection through mosquito surveillance under different temperature
   conditions
SO PLOS ONE
LA English
DT Article
ID EXTRINSIC INCUBATION-TEMPERATURE; AEDES-AEGYPTI COMPETENCE;
   WEST-NILE-VIRUS; CHIKUNGUNYA VIRUS; VECTOR COMPETENCE; DENGUE INFECTION;
   UNITED-STATES; TRANSMISSION; TRAVELERS; OUTBREAK
AB Because of the increasing threat that Zika virus (ZIKV) poses to more sub-tropical area due to increased global travel, there is a need for better understanding of the effect(s) of temperature on the establishment potential of ZIKV within these subtropical, temperate, and/or seasonal Ae. aegypti populations. The first step to determining risk establishment of ZIKV in these regions is to assess ZIKV's ability to infect mosquitoes at less tropical temperatures, and thus be detected through common surveillance programs. To that end, the effect of two rearing temperatures (RT) and extrinsic incubation temperatures (EIT) on infection and dissemination rates was evaluated, as well as the interactions of such. Total, there were four combinations (RT24-EIT24, RT24-EIT28, RT28-EIT24, RT28-EIT28). Further, a stochastic SEIR framework was adapted to determine whether observed data could lead to differential success of establishment of ZIKV in naive mosquito populations. There was no consistent pattern in significant differences found across treatments for either infection or dissemination rates (p>0.05), where only a significant difference was found in infection rates between RT24-EIT24 (44%) and RT28-EIT24 (82.6%). Across all temperature conditions, the model predicted between a 76.4% and 95.4% chance of successful establishment of ZIKV in naive mosquito populations under model assumptions. We further show that excluding the maximum observed infection and dissemination rates likely overestimates the probability of local establishment of ZIKV. These results indicate that 1) there is no straightforward relationship between RT, EIT, and infection/dissemination rates, 2) in more temperate climates, ZIKV may still have the ability to establish in populations of Aedes aegypti, 3) despite an overall lack of significant differences in infection/dissemination rates, temperature may still alter the kinetics of ZIKV within the mosquito enough to affect the likelihood of infection establishment and detection within the context of mosquito surveillance programs, and 4) both the temporal and magnitude qualities of vector competence are necessary for parameterization of within-mosquito virus kinetics.
C1 [Tramonte, A. Ryan; Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
   [Christofferson, Rebecca C.] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA.
RP Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.; Christofferson, RC (corresponding author), Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA.
EM rcarri1@lsu.edu
FU NIH/NIGMSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM122077]
FX This work was supported by NIH/NIGMS grant R01GM122077. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alto BW, 2018, J MED ENTOMOL, V55, P217, DOI 10.1093/jme/tjx182
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Andreadis TG, 2001, EMERG INFECT DIS, V7, P670
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Buckner EA, 2016, J MED ENTOMOL, V53, P91, DOI 10.1093/jme/tjv145
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Chisenhall DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-252
   Christofferson RC, 2016, J INFECT DIS, V214, pS466, DOI 10.1093/infdis/jiw283
   Christofferson RC, 2016, ENVIRON HEALTH INSIG, V10, P119, DOI [10.4137/EHI.S38345, 10.4137/ehi.s38345]
   Christofferson RC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-282
   Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lindholm DA, 2017, AM J TROP MED HYG, V96, P903, DOI 10.4269/ajtmh.16-0635
   Lindsey NP, 2015, AM J TROP MED HYG, V92, P82, DOI 10.4269/ajtmh.14-0442
   Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martin E, 2019, ACTA TROP, V192, P129, DOI 10.1016/j.actatropica.2019.02.006
   Mbaika S, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0566-7
   Moore CG, 1993, DIS DOV B DIS NCFL P
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Muturi EJ, 2012, J VECTOR ECOL, V37, P154, DOI 10.1111/j.1948-7134.2012.00212.x
   Muturi EJ, 2011, VECTOR-BORNE ZOONOT, V11, P1157, DOI 10.1089/vbz.2010.0209
   Pires AM, 2008, REVSTAT-STAT J, V6, P165
   Prevention CfDCa, 2017, PREV DFDCA ADV PEOPL
   Prevention CfDCa, 2017, PREV CFDCA ZIK VIR P
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Roth A, 2014, EURO SURVEILL, V19
   SMITH GC, 1993, J MED ENTOMOL, V30, P257, DOI 10.1093/jmedent/30.1.257
   Teets Frank D, 2014, Virol Rep, V1-2, P2
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Toro C, 2017, AM J TROP MED HYG, V96, P701, DOI 10.4269/ajtmh.16-0335
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   White DJ, 2001, EMERG INFECT DIS, V7, P643
NR 50
TC 2
Z9 2
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 28
PY 2019
VL 14
IS 3
AR e0214306
DI 10.1371/journal.pone.0214306
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ7IR
UT WOS:000462594000052
PM 30921386
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bloom, DE
   Cadarette, D
AF Bloom, David E.
   Cadarette, Daniel
TI Infectious Disease Threats in the Twenty-First Century: Strengthening
   the Global Response
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE global health; global health systems; infectious disease; outbreak;
   epidemic; pandemic; antimicrobial resistance (AMR); pandemic
   preparedness and response
ID 1918 INFLUENZA; HEALTH; MORTALITY; DENGUE; VIRUS; CHALLENGES; LESSONS;
   EBOLA; RISK
AB The world has developed an elaborate global health system as a bulwark against known and unknown infectious disease threats. The system consists of various formal and informal networks of organizations that serve different stakeholders; have varying goals, modalities, resources, and accountability; operate at different regional levels (i.e., local, national, regional, or global); and cut across the public, private-for-profit, and private-not-for-profit sectors. The evolving global health system has done much to protect and promote human health. However, the world continues to be confronted by longstanding, emerging, and reemerging infectious disease threats. These threats differ widely in terms of severity and probability. They also have varying consequences for morbidity and mortality, as well as for a complex set of social and economic outcomes. To various degrees, they are also amenable to alternative responses, ranging from clean water provision to regulation to biomedical countermeasures. Whether the global health system as currently constituted can provide effective protection against a dynamic array of infectious disease threats has been called into question by recent outbreaks of Ebola, Zika, dengue, Middle East respiratory syndrome, severe acute respiratory syndrome, and influenza and by the looming threat of rising antimicrobial resistance. The concern ismagnified by rapid population growth in areas with weak health systems, urbanization, globalization, climate change, civil conflict, and the changing nature of pathogen transmission between human and animal populations. There is also potential for human-originated outbreaks emanating from laboratory accidents or intentional biological attacks. This paper discusses these issues, along with the need for a (possibly self-standing) multi-disciplinary Global Technical Council on Infectious Disease Threats to address emerging global challenges with regard to infectious disease and associated social and economic risks. This Council would strengthen the global health system by improving collaboration and coordination across organizations (e.g., the WHO, Gavi, CEPI, national centers for disease control, pharmaceutical manufacturers, etc.); filling in knowledge gaps with respect to (for example) infectious disease surveillance, research and development needs, financing models, supply chain logistics, and the social and economic impacts of potential threats; and making high-level, evidence-based recommendations for managing global risks associated with infectious disease.
C1 [Bloom, David E.; Cadarette, Daniel] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.
RP Bloom, DE (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.
EM dbloom@hsph.harvard.edu
FU Bill & Melinda Gates Foundation through the Value of Vaccination
   Research Network
FX The authors thank Steve Black, Olga Jonas, David Salisbury, and Robert
   Steinglass for offering valuable comments during the drafting of this
   article. The authors also thank Francesco Berlanda Scorza, Frank
   Baehner, and a third anonymous reviewer for their constructive feedback,
   and they thank Aldo Tagliabue for his support throughout the editorial
   process. DB and DC received general support for their work on this
   article from the Bill & Melinda Gates Foundation through the Value of
   Vaccination Research Network.
CR Adeyi OOB, 2017, DRUG RESISTANT INFEC, V2
   Alsan M, 2006, WORLD DEV, V34, P613, DOI 10.1016/j.worlddev.2005.09.006
   [Anonymous], 2018, COAL EP PREP INN TUR
   [Anonymous], 2018, 2018 ANN REV DIS PRI
   [Anonymous], 2018, ECONOMIST, V428, P75
   [Anonymous], 2017, MARBURG VIRUS DIS
   [Anonymous], 2006, BBC NEWS
   [Anonymous], 2017, PLAG OUTBR MAD EXT S
   Asiedu Elizabeth, 2015, J AFRICAN TRADE, V2, P1, DOI DOI 10.1016/J.J0AT2015.01.001
   Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x
   Barnighausen T, 2013, IMPACT DENGUE TOURIS
   Barnighausen T, 2013, SEMIN IMMUNOL, V25, P104, DOI 10.1016/j.smim.2013.04.010
   BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   Bergsten F., 2015, FINANC TIMES
   Bloom D. E., 2018, Finance & Development, V55, P46
   Bloom DE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaj2345
   Bonner R., 1994, NY TIMES
   Burns A, 2008, 47417 WORLD BANK
   Camacho A, 2018, LANCET GLOB HEALTH, V6, pE680, DOI 10.1016/S2214-109X(18)30230-4
   Carroll R, 2009, GUARD
   Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266
   Centers for Disease Control and Prevention, 2017, 2014 2016 EB OUTBR W
   Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P761
   Centers for Disease Control and Prevention, 2012, FREQ ASK QUEST SARS
   Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Division of High-Consequence Pathogens and Pathology (DHCPP), 2018, VAR CREUTZF JAK DIS
   Coalition for Epidemic Preparedness Innovations, 2019, PRIOR DIS
   Coalition for Epidemic Preparedness Innovations, 2016, PREL BUS PLAN 2017 2
   Coalition for Epidemic Preparedness Innovations, 2019, OUR PLATF TECHN
   Constenla D, 2015, PHARMACOECONOMICS, V33, P1107, DOI 10.1007/s40273-015-0294-7
   Coutts AP, 2014, NY TIMES
   Cressey D, 2014, NATURE, V514, P14, DOI 10.1038/514014a
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026
   Fan VY, 2018, B WORLD HEALTH ORGAN, V96, P129, DOI 10.2471/BLT.17.199588
   Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247
   Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]
   Fox Maggie, 2018, NBC NEWS
   Friedman ND, 2016, CLIN MICROBIOL INFEC, V22, P416, DOI 10.1016/j.cmi.2015.12.002
   Garrett L, 2015, FOREIGN AFF, V94, P80
   Gavi The Vaccine Alliance., 2016, EB VACC PURCH COMM G
   Glassman A, 2018, FINANCING OUTBREAK P
   Goel AK, 2015, WORLD J CLIN CASES, V3, P20, DOI 10.12998/wjcc.v3.i1.20
   Gouglas D, 2018, LANCET GLOB HEALTH, V6, pE1386, DOI 10.1016/S2214-109X(18)30346-2
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3
   Institute for Health Metrics and Evaluation, 2019, GBD RES TOOL
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   Jonas OB, 2013, PANDEMIC RISK
   Kupferschmidt K, 2017, SCIENCE, DOI [10.1126/science.aan7069, DOI 10.1126/SCIENCE.AAN7069]
   Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2
   Lipsitch M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001646
   Mavalankar D, 2009, QUANTIFYING IMPACT C
   McNeil Jr DG, 2014, NY TIMES        0515, pA1
   Monaco L, 2018, FOREIGN POLICY
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   National Academy of Medicine, 2016, NEGL DIM GLOB SEC FR
   Noyce RS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188453
   Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349
   Partlow J, 2016, WASHINGTON POST
   PATTERSON KD, 1991, B HIST MED, V65, P4
   Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587
   Post T, 1994, NEWSWEEK, V124, P40
   Ramzy A., 2018, NY TIMES
   Rappuoli R, 2018, SEARCH SUSTAIN UNPUB
   Rappuoli R, 2017, NATURE, V552, P165
   Reuters, 2018, REUTERS
   Review on Antimicrobial Resistance, 2014, ANTIMICROBIAL RESIST
   Riedel Stefan, 2004, Proc (Bayl Univ Med Cent), V17, P400
   Rudan I, 2015, LANCET, V385, P92, DOI 10.1016/S0140-6736(14)62006-7
   Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066
   Sevilla JP, 2018, P NATL ACAD SCI USA, V115, P12911, DOI 10.1073/pnas.1717161115
   Shane Scott, 2010, NY TIMES
   Stiglitz J, 2015, GUARD
   Tacconelli E, 2017, GLOBAL PRIORITY LIST
   Takahashi H, 2004, EMERG INFECT DIS, V10, P117, DOI 10.3201/eid1001.030238
   Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979
   The National Academies The U. S. Department of Homeland Security., 2004, BIOL ATT HUM PATH BI
   Thorpe KE, 2018, HEALTH AFFAIR, V37, P662, DOI 10.1377/hlthaff.2017.1153
   United Nations Department of Economic and Social Affairs, 2018, WORLD URB PROSP 2018
   United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP PROSP 2017
   United Nations General Assembly, 2016, PROT HUM FUT HLTH CR
   Wang HY, 2017, GLOB POLICY, V8, P113, DOI 10.1111/1758-5899.12396
   Weinraub B., 1974, NY TIMES, P3
   Welch Chris, 2009, CNN
   WHO, 2019, CHOLERA
   WHO, 2015, REP EB INT ASS PAN
   WHO, 2011, PAND INFL PREP FRAM
   *WHO, 2003, CUM NUMB REP PROB CA
   WHO, 2018, ZIK VIR
   WHO, 2018, WHO WORLD BANK GROUP
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   World Bank, 2018, WORLD DEV IND
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   World Health Organization, 2018, LIST BLUEPR PRIOR DI
   World Health Organization, 2017, MULT RES TUB MDR TB
   World Health Organization, 2018, NIP VIR
   World Health Organization, 2019, SARS SEV AC RESP SYN
   World Health Organization, 2018, RIFT VALL FEV
   World Health Organization, 2016, R D BLUEPR ACT PREV
   World Health Organization, 2019, GLOB HLTH OBS GHO DA
   World Health Organization, 2017, METH PRIOR SEV EM DI
   World Health Organization, 2017, LASS FEV
   World Health Organization, 2018, EB VIR DIS
   World Health Organization, 2013, CRIM CONG HAEM FEV
   Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400
NR 104
TC 20
Z9 20
U1 16
U2 28
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAR 28
PY 2019
VL 10
AR 549
DI 10.3389/fimmu.2019.00549
PG 12
WC Immunology
SC Immunology
GA HQ8PL
UT WOS:000462686800001
PM 30984169
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mustafa, YM
   Meuren, LM
   Coelho, SVA
   de Arruda, LB
AF Mustafa, Yasmin Mucuna
   Meuren, Lana Monteiro
   Antunes Coelho, Sharton Vinicius
   de Arruda, Luciana Barros
TI Pathways Exploited by Flaviviruses to Counteract the Blood-Brain Barrier
   and Invade the Central Nervous System
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE blood-brain barrier; flavivirus; Japanese encephalitis virus; West Nile
   virus; Zika virus; dengue virus; yellow fever virus; brain microvascular
   endothelial cells
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS;
   MICROVASCULAR ENDOTHELIAL-CELLS; ZIKA-VIRUS; DENGUE VIRUS; IN-VITRO;
   HUMAN ASTROCYTES; VIRAL-INFECTION; IFN-ALPHA/BETA
AB Human infection by different flaviviruses may cause severe neurologic syndromes, through pathogenic mechanisms that are still largely unknown. Japanese encephalitis virus (JEV), West Nile virus (WNV), Zika virus (ZIKV), yellow fever virus (YFV), dengue virus (DENV), and tick-borne encephalitis virus (TBEV) are believed to reach the central nervous system by a hematogenous route, upon crossing the blood-brain barrier. Although the disruption of BBB during flavivirus infection has been largely evidenced in experimental models, the relevance of BBB breakdown for virus entering the brain was not completely elucidated. In vitro models of BBB had demonstrated that these viruses replicated in brain microvascular endothelial cells (BMECs), which induced downregulation of tight junction proteins and increased the permeability of the barrier. Other reports demonstrated that infection of BMECs allowed the basolateral release of infectious particles, without a remarkable cytopathic effect, what might be sufficient for virus invasion. Virus replication and activation of other cells associated to the BBB, mostly astrocytes and microglia, were also reported to affect the endothelial barrier permeability. This event might occur simultaneously or after BMECs infection, being a secondary effect leading to BBB disruption. Importantly, activation of BMECs, astrocytes, and microglia by flaviviruses was associated to the expression and secretion of inflammatory mediators, which are believed to recruit leukocytes to the CNS. The leukocyte infiltrate could further mediate viral invasion through a Trojan horse mechanism and might contribute to BBB breakdown and to neurological alterations. This review discussed the previous studies regarding in vitro and in vivo models of JEV, WNV, ZIKV, YFV, DENV, and TBEV infection and addressed the pathways for BBB overcome and invasion of the CNS described for each virus infection, aiming to increment the knowledge and stimulate further discussion about the role of BBB in the neuropathogenesis of flavivirus infection.
C1 [Mustafa, Yasmin Mucuna; Meuren, Lana Monteiro; Antunes Coelho, Sharton Vinicius; de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio de Janeiro, Brazil.
RP de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio de Janeiro, Brazil.
EM arruda@micro.ufrj.br
RI Arruda, Luciana B/N-9086-2013
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; FINEPCiencia Tecnologia e Inovacao (FINEP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ)
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. This work
   was also supported by FINEP, CNPq, and FAPERJ. LM, and SC are the
   recipients of a CNPq fellowship. YM is the recipient of a CAPES
   fellowship.
CR Agrawal T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069465
   Al-Obaidi MMJ, 2017, VIRUS RES, V233, P17, DOI 10.1016/j.virusres.2017.02.012
   Alimonti JB, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0100-y
   Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575
   Araujo FMC, 2011, J VIROL METHODS, V177, P128, DOI 10.1016/j.jviromet.2011.07.003
   Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Vasconcelos BCB, 2016, NEUROPATHOLOGY, V36, P3, DOI 10.1111/neup.12229
   Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016
   BARRETT ADT, 1986, J GEN VIROL, V67, P631, DOI 10.1099/0022-1317-67-4-631
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   Bhatt RS, 2015, IMMUNOBIOLOGY, V220, P1170, DOI 10.1016/j.imbio.2015.06.002
   Bian PY, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0486-5
   Bily T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10745
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chang CY, 2015, GLIA, V63, P1915, DOI 10.1002/glia.22857
   CHATURVEDI UC, 1991, J GEN VIROL, V72, P859, DOI 10.1099/0022-1317-72-4-859
   Chen CJ, 2014, J VIROL, V88, P1150, DOI 10.1128/JVI.02738-13
   Chen S, 2012, PHYS REV SPEC TOP-PH, V8, DOI 10.1103/PhysRevSTPER.8.020113
   Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI 10.1016/j.virol.2012.09.038
   Vieira MADES, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170538
   Dai JF, 2008, J VIROL, V82, P4164, DOI 10.1128/JVI.02621-07
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dhole P, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0658-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Douam F, 2017, MBIO, V8, DOI [10.1128/mBio.00819-17, 10.1128/mbio.00819-17]
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FABRY Z, 1995, J IMMUNOL, V155, P325
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15
   Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165
   Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311
   Holzmann H, 2003, VACCINE, V21, pS36, DOI 10.1016/S0264-410X(02)00819-8
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Jain N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005329
   JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512
   JOHNSON RT, 1985, ANN NEUROL, V18, P567, DOI 10.1002/ana.410180510
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kellman EM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060329
   Lai CY, 2012, J NEUROCHEM, V123, P250, DOI 10.1111/j.1471-4159.2012.07889.x
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Li GH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00449
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Luethy LN, 2016, VIROLOGY, V487, P1, DOI 10.1016/j.virol.2015.09.019
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   MIMS CA, 1957, BRIT J EXP PATHOL, V38, P329
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Palus M, 2017, VIROLOGY, V507, P110, DOI 10.1016/j.virol.2017.04.012
   Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Patabendige A, 2018, MOL CELL NEUROSCI, V89, P60, DOI 10.1016/j.mcn.2018.04.002
   Paul AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04839-7
   Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   de Souza KPR, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-267
   Rochfort KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101815
   Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598
   Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0
   Ruzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020472
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Salimi H, 2016, NEUROTHERAPEUTICS, V13, P514, DOI 10.1007/s13311-016-0443-5
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Samy AM, 2018, ACTA TROP, V188, P108, DOI 10.1016/j.actatropica.2018.08.014
   Sarathy VV, 2015, J GEN VIROL, V96, P3035, DOI 10.1099/jgv.0.000246
   Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Siegenthaler JA, 2013, CURR OPIN NEUROBIOL, V23, P1057, DOI 10.1016/j.conb.2013.06.006
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Soe HJ, 2017, J GEN VIROL, V98, P2993, DOI 10.1099/jgv.0.000981
   Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898
   Sucheston LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030950
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Thounaojam MC, 2014, J NEUROCHEM, V129, P143, DOI 10.1111/jnc.12609
   Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786
   Velandia-Romero ML, 2012, J NEUROVIROL, V18, P374, DOI 10.1007/s13365-012-0117-y
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036
   Wan WB, 2014, INT J NEUROSCI, V124, P75, DOI 10.3109/00207454.2013.825258
   Wang K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01148
   Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08
   Wang SH, 2008, J IMMUNOL, V181, P2084, DOI 10.4049/jimmunol.181.3.2084
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Yamada M, 2009, J COMP PATHOL, V141, P156, DOI 10.1016/j.jcpa.2009.04.006
   Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012
NR 117
TC 10
Z9 11
U1 3
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAR 28
PY 2019
VL 10
AR 525
DI 10.3389/fmicb.2019.00525
PG 14
WC Microbiology
SC Microbiology
GA HQ8PU
UT WOS:000462687900001
PM 30984122
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Whitehead, SS
   Pierson, TC
AF Whitehead, Stephen S.
   Pierson, Theodore C.
TI Crosstalk between dengue and Zika
SO NATURE
LA English
DT Editorial Material
ID VIRUS
AB The factors that contributed to the explosive nature of the 2015 Zika outbreak in the Americas are not well understood. A new analysis explores the link between prior dengue virus exposure and Zika virus infection.
C1 [Whitehead, Stephen S.; Pierson, Theodore C.] NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Pierson, TC (corresponding author), NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM piersontc@niaid.nih.gov
RI Whitehead, Stephen/AAG-2787-2019
CR Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608
NR 11
TC 3
Z9 3
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 28
PY 2019
VL 567
IS 7749
BP 467
EP 468
DI 10.1038/d41586-019-00868-6
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ8EC
UT WOS:000462655800036
PM 30911157
OA Bronze
DA 2020-07-08
ER

PT J
AU Phumee, A
   Chompoosri, J
   Intayot, P
   Boonserm, R
   Boonyasuppayakorn, S
   Buathong, R
   Thavara, U
   Tawatsin, A
   Joyjinda, Y
   Wacharapluesadee, S
   Siriyasatien, P
AF Phumee, Atchara
   Chompoosri, Jakkrawarn
   Intayot, Proawpilart
   Boonserm, Rungfar
   Boonyasuppayakorn, Siwaporn
   Buathong, Rome
   Thavara, Usavadee
   Tawatsin, Apiwat
   Joyjinda, Yutthana
   Wacharapluesadee, Supaporn
   Siriyasatien, Padet
TI Vertical transmission of Zika virus in Culex quinquefasciatus Say and
   Aedes aegypti (L.) mosquitoes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BLOOD MEAL ANALYSIS; WEST-NILE-VIRUS; AE.-ALBOPICTUS; VECTOR;
   COMPETENCE; CULICIDAE; DIPTERA; PIPIENS; RNAI
AB Several mosquito species have been described as vectors for the Zika virus (ZIKV), such as those in the Aedes, Anopheles, Mansonia and Culex genera. Our previous survey studies were found the ZIKV RNA positive in both male, female and larvae of Culex quinquefasciatus Say and Aedes aegypti (L.) mosquitoes collected from active ZIKV infected patients' homes in Thailand. Therefore, the aims of this study were to investigate whether ZIKV could be vertically transmitted in Cx. quinquefasciatus, Ae. aegypti and Ae. albopictus. Laboratory and field colonies of these mosquito species were maintained and artificially fed with ZIKV in human blood. Fully engorged mosquitoes (F-0) were selected and reared for the vertical transmission study. The subsequent mosquito generations were fed with human blood without the virus. ZIKV in the mosquitoes was detected by hemi-nested RT-PCR and sequencing. C6/36 cells were used to isolate ZIKV from samples that tested positive by hemi-nested RT-PCR. Moreover, ZIKV was identified by immunocytochemical staining 7 days after infection in several organs of infected F-0 females, including the salivary glands, midguts, yoke granules and facet cells of the eye. The localization of the ZIKV antigen was identified by the presence of the specific antibody in the salivary glands, midguts, yoke granules and facet cells. ZIKV was detected in female and male Cx. quinquefasciatus until the F-6 and F-2 generations, respectively. The isolated virus showed cytopathic effects in C6/36 cells by 5 days postinfection. The results suggested that the vertical transmission of ZIKV occurs in Cx. quinquefasciatus in the laboratory. However, we were able to detect the presence of ZIKV in Ae. aegypti in only the F-1 generation in both male and female mosquitoes, and Ae. albopictus mosquitoes were not able to vertically transmit the virus at all. Data obtained from this study could be valuable for developing a better understanding of the role of Cx. quinquefasciatus as a potential vector for ZIKV transmission in Thailand and may be useful in creating more effective mosquito vector control strategies in the future.
C1 [Phumee, Atchara; Joyjinda, Yutthana; Wacharapluesadee, Supaporn] Chulalongkorn Univ, Neurosci Ctr Res & Dev, Thai Red Cross Emerging Infect Hlth Sci Ctr, Fac Med, Bangkok 10330, Thailand.
   [Phumee, Atchara; Joyjinda, Yutthana; Wacharapluesadee, Supaporn] Chulalongkorn Univ, WHO CC Res & Training Viral Zoonoses King Chulalo, Fac Med, Bangkok 10330, Thailand.
   [Phumee, Atchara; Boonserm, Rungfar; Siriyasatien, Padet] Chulalongkorn Univ, Fac Med, Dept Parasitol, Vector Biol & Vector Borne Dis Res Unit, Bangkok 10330, Thailand.
   [Chompoosri, Jakkrawarn; Thavara, Usavadee; Tawatsin, Apiwat] Natl Inst Hlth, Dept Med Sci, Nonthaburi 11000, Thailand.
   [Intayot, Proawpilart] Chulalongkorn Univ, Fac Med, Med Sci Program, Bangkok 10330, Thailand.
   [Boonyasuppayakorn, Siwaporn] Chulalongkorn Univ, Fac Med, Dept Microbiol, Appl Med Virol Res Unit, Bangkok 10330, Thailand.
   [Buathong, Rome] Minist Publ Hlth, Bur Epidemiol, Dept Dis Control, Nonthaburi 11000, Thailand.
RP Siriyasatien, P (corresponding author), Chulalongkorn Univ, Fac Med, Dept Parasitol, Vector Biol & Vector Borne Dis Res Unit, Bangkok 10330, Thailand.
EM padet.s@chula.ac.th
RI PHUMEE, ATCHARA/AAG-4881-2020
OI Siriyasatien, Padet/0000-0002-9248-1678; PHUMEE,
   ATCHARA/0000-0001-8243-7406; Boonyasuppayakorn,
   Siwaporn/0000-0002-3631-3573
FU National Science and Technology Development Agency (Thailand)
   [P-1650702]; Research Chair Grant; National Research Council of
   ThailandNational Research Council of Thailand (NRCT); Health Systems
   Research Institute [61-003]; Rachadapisek Sompote Fund [RA/MF 2/62];
   World Health Organization Thailand (WHO-Thailand); United States Agency
   for International Development (USAID) grantUnited States Agency for
   International Development (USAID)
FX This study was supported by National Science and Technology Development
   Agency (Thailand) (Grant No. P-1650702), the Research Chair Grant and
   National Research Council of Thailand, Health Systems Research Institute
   (Grant No. 61-003), Rachadapisek Sompote Fund (RA/MF 2/62), and the
   World Health Organization Thailand (WHO-Thailand), and the United States
   Agency for International Development (USAID) grant.
CR Alfonso-Parra C, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020049
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   BAQAR S, 1993, AM J TROP MED HYG, V48, P757, DOI 10.4269/ajtmh.1993.48.757
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Donald Claire L, 2012, Insects, V3, P511, DOI 10.3390/insects3020511
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Gokhale M. D., 2013, ISRN ENTOMOL, V2013, P1, DOI DOI 10.1155/2013/451592
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Khaklang S, 2014, J VECTOR ECOL, V39, P448, DOI 10.1111/jvec.12122
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lequime S, 2014, INFECT GENET EVOL, V28, P681, DOI 10.1016/j.meegid.2014.07.025
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mishra Nalini, 2018, International Journal of Mosquito Research, V5, P1
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nitatpattana Narong, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P875
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Phumee A, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010030
   Pothikasikorn J, 2010, J VECTOR ECOL, V35, P149, DOI 10.1111/j.1948-7134.2010.00041.x
   ProMed-mail, 2018, PRO MBDS ZIK VIR THA
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   ROSEN L, 1988, AM J TROP MED HYG, V39, P123, DOI 10.4269/ajtmh.1988.39.123
   ROSEN L, 1989, AM J TROP MED HYG, V40, P548, DOI 10.4269/ajtmh.1989.40.548
   Saldana MA, 2017, MEM I OSWALDO CRUZ, V112, P81, DOI 10.1590/0074-02760160373
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zinser M, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.20
NR 57
TC 5
Z9 5
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 27
PY 2019
VL 9
AR 5257
DI 10.1038/s41598-019-41727-8
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ5OP
UT WOS:000462462800023
PM 30918310
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU O'Donnell, KL
   Meberg, B
   Schiltz, J
   Nilles, ML
   Bradley, DS
AF O'Donnell, Kyle L.
   Meberg, Bernadette
   Schiltz, James
   Nilles, Matthew L.
   Bradley, David S.
TI Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika
   Virus Challenge without Inducing Antibody-Dependent Enhancement
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; IgY; Immunotherapy
ID DENGUE VIRUS; MANNOSE RECEPTOR; BRAZIL; INFECTIONS; PROTECTION; CELLS;
   NS1
AB The Zika virus (ZIKV) is a newly emerged pathogen in the Western hemisphere. It was declared a global health emergency by the World Health Organization in 2016. There have been 223,477 confirmed cases, including 3720 congenital syndrome cases since 2015. ZIKV infection symptoms range from asymptomatic to Gullain-Barre syndrome and extensive neuropathology in infected fetuses. Passive and active vaccines have been unsuccessful in the protection from or the treatment of flaviviral infections due to antibody-dependent enhancement (ADE). ADE causes an increased viral load due to an increased monocyte opsonization by non-neutralizing, low-avidity antibodies from a previous dengue virus (DENV) infection or from a previous exposure to ZIKV. We have previously demonstrated that polyclonal avian IgY generated against whole-killed DENV-2 ameliorates DENV infection in mice while not inducing ADE. This is likely due to the inability of the Fc portion of IgY to bind to mammalian Fc receptors. We have shown here that ZIKV oligoclonal IgY is able to neutralize the virus in vitro and in IFNAR(-/-) mice. The concentration of ZIKV-specific IgY yielding 50% neutralization (NT50) was 25 mu g/mL. The exposure of the ZIKV, prior to culture with ZIKV-specific IgY or 4G2 flavivirus-enveloped IgG, demonstrated that the ZIKV-specific IgY does not induce ADE. ZIKV IgY was protective in vivo when administered following a lethal ZIKV challenge in 3-week-old IFNAR(-/-) mice. We propose polyclonal ZIKV-specific IgY may provide a viable passive immunotherapy for a ZIKV infection without inducing ADE.
C1 [O'Donnell, Kyle L.; Meberg, Bernadette; Nilles, Matthew L.; Bradley, David S.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA.
   [Schiltz, James] Avianax LLC, Grand Forks, ND 58202 USA.
RP Bradley, DS (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA.
EM kyle.odonnell@und.edu; bernadette.meberg@und.edu;
   jschiltz@schiltzfoods.com; matthew.nilles@und.edu;
   david.s.bradley@und.edu
OI Nilles, Matthew/0000-0002-2235-8682
FU Center of Research Excellence for Avian Therapeutics for Infectious
   Diseases; Center for Biomedical Research Excellence for Host Pathogen
   Interactions [NIH NIGMS P20GM113123]
FX The funding for the research was obtained from the Center of Research
   Excellence for Avian Therapeutics for Infectious Diseases and the Center
   for Biomedical Research Excellence for Host Pathogen Interactions (NIH
   NIGMS P20GM113123).
CR Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brien M, 2017, PLACENTA, V55, P54, DOI 10.1016/j.placenta.2017.05.004
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chaichana P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092173
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Conroy PJ, 2014, J BIOL CHEM, V289, P15384, DOI 10.1074/jbc.M114.562470
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Fink AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005721
   Haese N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003803
   Hatta H, 1997, CARIES RES, V31, P268, DOI 10.1159/000262410
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kollberg H, 2003, PEDIATR PULM, V35, P433, DOI 10.1002/ppul.10290
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   LARSSON A, 1993, POULTRY SCI, V72, P1807, DOI 10.3382/ps.0721807
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Marinho CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102014
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MCCORMACK WT, 1989, GENE DEV, V3, P838, DOI 10.1101/gad.3.6.838
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   PARVARI R, 1990, P NATL ACAD SCI USA, V87, P3072, DOI 10.1073/pnas.87.8.3072
   REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9
   Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tirziu E., 2010, 2010 TIMISOARA IMMUN
   Torche AM, 2006, VET IMMUNOL IMMUNOP, V109, P209, DOI 10.1016/j.vetimm.2005.08.016
   Vega CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042788
   Wan SW, 2017, J IMMUNOL, V199, P2834, DOI 10.4049/jimmunol.1601523
   West AP, 2004, IMMUNITY, V20, P601, DOI 10.1016/S1074-7613(04)00113-X
   World Health Organisation, GUID PLAQ RED NEUTR
NR 42
TC 0
Z9 0
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR 26
PY 2019
VL 11
IS 3
AR 301
DI 10.3390/v11030301
PG 15
WC Virology
SC Virology
GA HT2LU
UT WOS:000464395000001
PM 30917523
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alfano, C
   Gladwyn-Ng, I
   Couderc, T
   Lecuit, M
   Nguyen, L
AF Alfano, Christian
   Gladwyn-Ng, Ivan
   Couderc, Therese
   Lecuit, Marc
   Nguyen, Laurent
TI The Unfolded Protein Response: A Key Player in Zika Virus-Associated
   Congenital Microcephaly
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Review
DE unfolded protein response; ER stress; cortical progenitors; cerebral
   cortex; microcephaly; Zika virus
ID ENDOPLASMIC-RETICULUM STRESS; GLIAL-CELLS; T-CELLS; ACTIVATION;
   CONTRIBUTES; DEATH; INFECTION; MICROGLIA; PROLIFERATION; INFLAMMATION
AB Zika virus (ZIKV) is a mosquito-borne virus that belongs to the Flaviviridae family, together with dengue, yellow fever, and West Nile viruses. In the wake of its emergence in the French Polynesia and in the Americas, ZIKV has been shown to cause congenital microcephaly. It is the first arbovirus which has been proven to be teratogenic and sexually transmissible. Confronted with this major public health challenge, the scientific and medical communities teamed up to precisely characterize the clinical features of congenital ZIKV syndrome and its underlying pathophysiological mechanisms. This review focuses on the critical impact of the unfolded protein response (UPR) on ZIKV-associated congenital microcephaly. ZIKV infection of cortical neuron progenitors leads to high endoplasmic reticulum (ER) stress. This results in both the stalling of indirect neurogenesis, and UPR-dependent neuronal apoptotic death, and leads to cortical microcephaly. In line with these results, the administration of molecules inhibiting UPR prevents ZIKV-induced cortical microcephaly. The discovery of the link between ZIKV infection and UPR activation has a broader relevance, since this pathway plays a crucial role in many distinct cellular processes and its induction by ZIKV may account for several reported ZIKV-associated defects.
C1 [Alfano, Christian; Gladwyn-Ng, Ivan; Nguyen, Laurent] Univ Liege, GIGA Stem Cells, Interdisciplinary Cluster Appl Genoprote GIGA R, Liege, Belgium.
   [Couderc, Therese; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France.
   [Couderc, Therese; Lecuit, Marc] INSERM, U1117, Biol Infect, Paris, France.
   [Lecuit, Marc] Paris Descartes Univ, Necker Enfants Malad Hosp, Div Infect Dis & Trop Med, Inst Imagine,Sorbonne Paris Cite, Paris, France.
RP Nguyen, L (corresponding author), Univ Liege, GIGA Stem Cells, Interdisciplinary Cluster Appl Genoprote GIGA R, Liege, Belgium.; Lecuit, M (corresponding author), Inst Pasteur, Biol Infect Unit, Paris, France.; Lecuit, M (corresponding author), INSERM, U1117, Biol Infect, Paris, France.; Lecuit, M (corresponding author), Paris Descartes Univ, Necker Enfants Malad Hosp, Div Infect Dis & Trop Med, Inst Imagine,Sorbonne Paris Cite, Paris, France.
EM marc.lecuit@pasteur.fr; lnguyen@uliege.be
RI Lecuit, Marc/M-4126-2019
OI Lecuit, Marc/0000-0002-4491-1063
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance [734548]; European Virus Archives goes Global (EVAg) project
   [653316]; Institut Pasteur; INSERMInstitut National de la Sante et de la
   Recherche Medicale (Inserm); LabEx IBEID; F.R.S.F. N.R.S.Fonds de la
   Recherche Scientifique - FNRS; Fonds Leon Fredericq; Fondation Medicale
   Reine Elisabeth; Fondation Simone et Pierre Clerdent; Belgian Science
   Policy (IAP-VII network) [P7/20]; ARCFondation ARC pour la Recherche sur
   le CancerAustralian Research Council [ARC11/16-01]; EUEuropean Union
   (EU) [734548]; ERANET Neuron STEM-MCD; NeuroTalk
FX This work was supported by the European Union's Horizon 2020 Research
   and Innovation Programme under ZIKAlliance Grant Agreement No 734548 (to
   LN and ML) and by the European Virus Archives goes Global (EVAg) project
   under grant agreement No 653316. ML was also funded by Institut Pasteur,
   INSERM, and LabEx IBEID. LN was funded by F.R.S.F. N.R.S., the Fonds
   Leon Fredericq, the Fondation Medicale Reine Elisabeth, the Fondation
   Simone et Pierre Clerdent, the Belgian Science Policy (IAP-VII network
   P7/20), the ARC (ARC11/16-01), the EU H2020 ZIKAlliance (#734548), the
   ERANET Neuron STEM-MCD, and NeuroTalk. LN and IG-N are, respectively
   senior research associate and postdoctoral fellows from F.R.S-F. N.R.S.
CR de Franca TLB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091990
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caswell RJ, 2018, INT J STD AIDS, V29, P1238, DOI 10.1177/0956462418779465
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diop F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206093
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dugas-Ford J, 2015, ANNU REV NEUROSCI, V38, P351, DOI 10.1146/annurev-neuro-071714-033911
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Galmiche A, 2017, CURR OPIN ONCOL, V29, P41, DOI 10.1097/CCO.0000000000000339
   Garcez PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31149-3
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Godin JD, 2016, TRENDS NEUROSCI, V39, P394, DOI 10.1016/j.tins.2016.04.002
   Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62
   Guadagno J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.59
   Gurumayum S, 2018, VIROLOGY, V514, P203, DOI 10.1016/j.virol.2017.11.007
   Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161
   Ta HM, 2016, J NEUROCHEM, V139, P1124, DOI 10.1111/jnc.13714
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   Hosoi T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03388
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433
   Kim S, 2015, J IMMUNOL, V194, P4498, DOI 10.4049/jimmunol.1401399
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kum DB, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0092-2
   Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005
   Laguesse S, 2015, CELL TISSUE RES, V359, P17, DOI 10.1007/s00441-014-1979-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee YJ, 2016, ARCH PHARM RES, V39, P705, DOI 10.1007/s12272-016-0736-6
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang YR, 2017, NEUROTOXICOLOGY, V63, P137, DOI 10.1016/j.neuro.2017.09.015
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Liu J, 2018, INT J BIOL SCI, V14, P1099, DOI 10.7150/ijbs.26400
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Lunardi S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1027473
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Peloggia A, 2018, INT J GYNECOL OBSTET, V143, P277, DOI 10.1002/ijgo.12663
   Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062
   Radford H, 2015, ACTA NEUROPATHOL, V130, P633, DOI 10.1007/s00401-015-1487-z
   Richardson RB, 2018, NAT MICROBIOL, V3, P1214, DOI 10.1038/s41564-018-0244-1
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Rothan HA, 2019, MOL NEUROBIOL, V56, P2551, DOI 10.1007/s12035-018-1263-x
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8
   Smith JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00422
   Smith JA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00222
   Sprenkle NT, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0183-y
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tuttle AH, 2018, NAT METHODS, V15, P994, DOI 10.1038/s41592-018-0224-7
   van der Linden H, 2018, NEW ENGL J MED, V379, P891, DOI 10.1056/NEJMc1716070
   van Weering HRJ, 2011, HIPPOCAMPUS, V21, P220, DOI 10.1002/hipo.20742
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038402
   Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373
   Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263
   Valdespino-Vazquez MY, 2019, CLIN INFECT DIS, V68, P903, DOI 10.1093/cid/ciy616
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203
   Zukor K, 2018, J NEUROVIROL, V24, P273, DOI 10.1007/s13365-017-0595-z
NR 96
TC 1
Z9 1
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD MAR 26
PY 2019
VL 13
AR 94
DI 10.3389/fncel.2019.00094
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA HQ8BM
UT WOS:000462648800001
PM 30971894
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Boyce, MR
   Katz, R
AF Boyce, Matthew R.
   Katz, Rebecca
TI Community Health Workers and Pandemic Preparedness: Current and
   Prospective Roles
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE community health worker; Ebola; health security; pandemic; preparedness;
   resilience; Zika
ID MOTIVATION; CARE
AB Despite the importance of community health workers (CHWs) to health systems in resource-constrained environments, relatively little has been written about their contributions to pandemic preparedness. In this perspective piece, we draw from the response to the 2014 Ebola and 2015 Zika epidemics to review examples whereby CHWs contributed to health security and pandemic preparedness. CHWs promoted pandemic preparedness prior to the epidemics by increasing the access to health services and products within communities, communicating health concepts in a culturally appropriate fashion, and reducing the burdens felt by formal healthcare systems. During the epidemics, CHWs promoted pandemic preparedness by acting as community-level educators and mobilizers, contributing to surveillance systems, and filling health service gaps. Acknowledging the success CHWs have had in these roles and in previous interventions, we propose that the cadre may be better engaged in pandemic preparedness in the future. Some practical strategies for achieving this include training and using CHWs to communicate One Health information to at-risk communities prior to outbreaks, pooling them into a reserve health corps to be used during public health emergencies, and formalizing agreements and strategies to promote the early engagement of CHWs in response actions. Recognizing that CHWs already play a role in pandemic preparedness, we feel that expanding the roles and responsibilities of CHWs represents a practical means of improving pandemic and community-level resilience.
C1 [Boyce, Matthew R.; Katz, Rebecca] Georgetown Univ, Ctr Global Hlth Sci & Secur, Washington, DC 20057 USA.
RP Boyce, MR (corresponding author), Georgetown Univ, Ctr Global Hlth Sci & Secur, Washington, DC 20057 USA.
EM mboyce93@gmail.com
OI Boyce, Matthew/0000-0002-6224-9755
CR A Ministry of Sharing (AMOS) Health and Hope, 2017, ANN REP JOURN HLTH A
   Alhassan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158541
   Campbell C, 2011, GLOB PUBLIC HEALTH, V6, P125, DOI 10.1080/17441690903334232
   Corless IB, 2018, NURS OUTLOOK, V66, P412, DOI 10.1016/j.outlook.2018.06.003
   Eaneff S, 2017, B WHO
   Gautier Lara, 2017, Glob Health Res Policy, V2, P35, DOI 10.1186/s41256-017-0055-6
   Johnson G, 2017, COMMUNITY HLTH WORKE
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658
   Kickbusch I, 2016, GLOB HEALTH PROMOT, V23, P75, DOI 10.1177/1757975915606833
   Lehmann U., 2007, COMMUNITY HLTH WORKE
   Lewin SA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub2
   Lohfeld L, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1455-7
   Miller NP, 2018, J GLOB HEALTH, V8, DOI [10.7189/jogh-08-020601, 10.7189/jogh.08.020601]
   Mpembeni RNM, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0035-1
   Muller MP, 2006, EUR J CLIN MICROBIOL, V25, P230, DOI 10.1007/s10096-006-0127-x
   Munster VJ, 2018, NEW ENGL J MED, V379, P1198, DOI 10.1056/NEJMp1807691
   Perry HB, 2016, B WORLD HEALTH ORGAN, V94, P551, DOI 10.2471/BLT.15.164020
   Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086
   Ruckstuhl L, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2005-7
   Scott V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3071-4
   Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950
   Strachan DL, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0020-8
   Tierney KJ, 2014, SOCIAL ROOTS RISK PR
   Topp SM, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0062-y
   Vandi M A, 2017, Public Health Action, V7, pS55, DOI 10.5588/pha.16.0082
   Wadge H., 2016, BRAZILS FAMILY HLTH
   World Health Organization, 2018, DIS OUTBREAK NEWS WE
   World Health Organization, 2015, STRENGTH PRIM HEALTH
   World Health Organization, 2009, INF CONTR MEAS HEALT
   World Health Organization, 2011, COMM CAS MAN INFL OU
NR 31
TC 1
Z9 1
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD MAR 26
PY 2019
VL 7
AR 62
DI 10.3389/fpubh.2019.00062
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HR2YV
UT WOS:000463004500001
PM 30972316
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kraemer, MUG
   Golding, N
   Bisanzio, D
   Bhatt, S
   Pigott, DM
   Ray, SE
   Brady, OJ
   Brownstein, JS
   Faria, NR
   Cummings, DAT
   Pybus, OG
   Smith, DL
   Tatem, AJ
   Hay, SI
   Reiner, RC
AF Kraemer, M. U. G.
   Golding, N.
   Bisanzio, D.
   Bhatt, S.
   Pigott, D. M.
   Ray, S. E.
   Brady, O. J.
   Brownstein, J. S.
   Faria, N. R.
   Cummings, D. A. T.
   Pybus, O. G.
   Smith, D. L.
   Tatem, A. J.
   Hay, S. I.
   Reiner, R. C., Jr.
TI Utilizing general human movement models to predict the spread of
   emerging infectious diseases in resource poor settings
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EBOLA-VIRUS DISEASE; ZOONOTIC NICHE; TIME-SERIES; ZIKA VIRUS;
   TRANSMISSION; LIBERIA; EPIDEMIC; DYNAMICS; OUTBREAK; MOBILITY
AB Human mobility is an important driver of geographic spread of infectious pathogens. Detailed information about human movements during outbreaks are, however, difficult to obtain and may not be available during future epidemics. The Ebola virus disease (EVD) outbreak in West Africa between 2014-16 demonstrated how quickly pathogens can spread to large urban centers following one cross-species transmission event. Here we describe a flexible transmission model to test the utility of generalised human movement models in estimating EVD cases and spatial spread over the course of the outbreak. A transmission model that includes a general model of human mobility significantly improves prediction of EVD's incidence compared to models without this component. Human movement plays an important role not only to ignite the epidemic in locations previously disease free, but over the course of the entire epidemic. We also demonstrate important differences between countries in population mixing and the improved prediction attributable to movement metrics. Given their relative rareness, locally derived mobility data are unlikely to exist in advance of future epidemics or pandemics. Our findings show that transmission patterns derived from general human movement models can improve forecasts of spatio-temporal transmission patterns in places where local mobility data is unavailable.
C1 [Kraemer, M. U. G.; Faria, N. R.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, M. U. G.; Brownstein, J. S.] Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, M. U. G.; Brownstein, J. S.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA 02115 USA.
   [Golding, N.] Univ Melbourne, Dept BioSci, Parkville, Vic, Australia.
   [Bisanzio, D.] RTI Int, Washington, DC USA.
   [Bisanzio, D.] Univ Nottingham, Sch Med, Epidemiol & Publ Hlth Div, Nottingham, England.
   [Bhatt, S.] Imperial Coll London, London, England.
   [Pigott, D. M.; Ray, S. E.; Smith, D. L.; Hay, S. I.; Reiner, R. C., Jr.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Brady, O. J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Cummings, D. A. T.] Univ Florida, Dept Biol, Gainesville, FL USA.
   [Cummings, D. A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Smith, D. L.] Sanaria Inst Global Hlth & Trop Med, Rockville, MD USA.
   [Tatem, A. J.] Univ Southampton, Dept Geog & Environm Sci, WorldPop, Southampton, Hants, England.
   [Tatem, A. J.] Flowminder Fdn, Stockholm, Sweden.
RP Kraemer, MUG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Kraemer, MUG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA 02115 USA.; Hay, SI; Reiner, RC (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
EM moritz.kraemer@zoo.ox.ac.uk; sihay@uw.edu; bcreiner@uw.edu
RI Hay, Simon I/F-8967-2015; Pybus, Oliver g/B-2640-2012; Smith,
   David/L-8850-2013; Faria, Nuno Rodrigues/I-2975-2012
OI Hay, Simon I/0000-0002-0611-7272; Pybus, Oliver g/0000-0002-8797-2667;
   Bhatt, Samir/0000-0002-0891-4611; Smith, David/0000-0003-4367-3849;
   Faria, Nuno Rodrigues/0000-0001-8839-2798; Golding,
   Nick/0000-0001-8916-5570; Ray, Sarah/0000-0002-5775-8344
FU Research for Health in Humanitarian Crises (R2HC) programme managed by
   ELRHA; Wellcome TrustWellcome Trust; Department of International
   Development (DFID); The Branco Weiss Fellowship -Society in Science;
   National Institute of Child Health and Human DevelopmentUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [T32HD040128]; National Library of Medicine of
   the National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Library of Medicine (NLM) [R01LM010812, R01LM011965]; Bill & Melinda
   Gates FoundationGates Foundation [OPP1119467, OPP1093011, OPP1106023,
   OPP1132415]; Discovery Early Career Researcher Award from the Australian
   Research CouncilAustralian Research Council [DE180100635]; NIH/National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U10AI089674]; Wellcome Trust Sustaining Health [10688/Z/15/Z]; RAPIDD
   programme of the Science & Technology Directorate, Department of
   Homeland Security; Fogarty International Center (FIC)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC); National Institutes of
   Health (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; US NIH MIDAS programUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U54-GM088491]; Sir Henry Wellcome Fellowship - Wellcome
   TrustWellcome Trust [206471/Z/17/Z]; Oxford Martin School
FX MUGK is funded by the Research for Health in Humanitarian Crises (R2HC)
   programme managed by ELRHA (to SIH). The R2HC programme is funded
   equally by the Wellcome Trust and the Department of International
   Development (DFID). MUGK is also supported by The Branco Weiss
   Fellowship -Society in Science, administered by the ETH Zurich and
   acknowledges funding from a Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128) and the National
   Library of Medicine of the National Institutes of Health (R01LM010812,
   R01LM011965). NG, DB and DMP received funding from the Bill & Melinda
   Gates Foundation (#OPP10937011, #OPP1068048). NG was supported by a
   Discovery Early Career Researcher Award from the Australian Research
   Council (DE180100635). DLS and AJT are funded by the NIH/National
   Institute of Allergy and Infectious Diseases (#U10AI089674), and the
   Bill & Melinda Gates Foundation (AJT #OPP1106427, #1032350, DLS
   #OPP1110495). AJT is also supported by a Wellcome Trust Sustaining
   Health Grant (#10688/Z/15/Z). SIH is funded by a Senior Research
   Fellowship from the Wellcome Trust (#095066), and grants from the Bill &
   Melinda Gates Foundation (#OPP1119467, #OPP1093011, #OPP1106023 and
   #OPP1132415). DLS, AJT, SIH and RCR also acknowledge funding support
   from the RAPIDD programme of the Science & Technology Directorate,
   Department of Homeland Security, and the Fogarty International Center
   (FIC), National Institutes of Health (NIH). D.A.T.C. was supported by US
   NIH MIDAS program (U54-GM088491). OJB was funded by a Sir Henry Wellcome
   Fellowship funded by the Wellcome Trust (grant number 206471/Z/17/Z).
   This research received funding from the Oxford Martin School. Funding:
   Wellcome Trust.
CR Ajelli M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0678-3
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Backer JA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005210
   Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106
   Bharti N, 2011, SCIENCE, V334, P1424, DOI 10.1126/science.1210554
   Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Currie J, 2016, SCIENCE, V351, P815, DOI 10.1126/science.aad8521
   D'Silva JP, 2017, J THEOR BIOL, V428, P65, DOI 10.1016/j.jtbi.2017.05.034
   de Montjoye Y.-A., 2014, ARXIV14074885V2
   Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111
   Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062
   du Plessis L, 2015, TRENDS MICROBIOL, V23, P383, DOI 10.1016/j.tim.2015.04.007
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Fang LQ, 2016, P NATL ACAD SCI USA, V113, P4488, DOI 10.1073/pnas.1518587113
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Farrar JJ, 2014, NEW ENGL J MED, V371, P1545, DOI 10.1056/NEJMe1411471
   Faye O, 2015, LANCET INFECT DIS, V15, P320, DOI 10.1016/S1473-3099(14)71075-8
   Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108
   Finger F, 2016, P NATL ACAD SCI USA, V113, P6421, DOI 10.1073/pnas.1522305113
   Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guarani V, 2016, ELIFE, V5, DOI 10.7554/eLife.17163
   Halloran ME, 2014, SCIENCE, V346, P433, DOI 10.1126/science.346.6208.433-a
   Hastie T.J., 1990, GEN ADDITIVE MODELS
   Jongejans E, 2015, THEOR ECOL-NETH, V8, P207, DOI 10.1007/s12080-014-0245-5
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer M. U. G, 2015, MOVEMENT FUNCTIONS A
   Kraemer MUG, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0144-x
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kramer AM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160294
   Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lessler J., 2014, PLOS CURR OUTBREAKS, V2
   Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6
   Mylne A, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.42
   Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047
   Nocedal J., 1999, NUMERICAL OPTIMIZATI, DOI [10.5194/bgd-11-12733-2014, DOI 10.5194/BGD-11-12733-2014]
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Poletto, 2014, EUROSURVEILLANCE, V19, P8
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Rambaut A., PHYLOGEOGRAPHY 2014
   Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268
   Reiner RC, 2012, P NATL ACAD SCI USA, V109, P2033, DOI 10.1073/pnas.1108438109
   Rivers C, 2014, NATURE, V515, P493, DOI 10.1038/515492a
   Ruktanonchai NW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1315-5
   Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069
   Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856
   Sorichetta A, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.66
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716
   Uchida H., 2008, AGGLOMERATION INDEX
   Valdez LD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12172
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181
   Wesolowski A., 2014, PLOS CURR OUTBREAKS, V29
   Wesolowski A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02064-4
   Wesolowski A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004267
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
   WHO, 2016, EB SIT REP
   Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x
   Yang W, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0536
NR 75
TC 4
Z9 4
U1 3
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 26
PY 2019
VL 9
AR 5151
DI 10.1038/s41598-019-41192-3
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ3GN
UT WOS:000462298600038
PM 30914669
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Goodman, AG
   Rasmussen, AL
AF Goodman, Alan G.
   Rasmussen, Angela L.
TI Editorial: Host-Pathogen Interactions During Arboviral Infections
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Editorial Material
DE West Nile virus; dengue virus; chikungunya virus; tick-borne
   encephalitis virus; Japanese encephalitis virus; Zika virus; systems
   biology; immunity
ID WEST-NILE-VIRUS
C1 [Goodman, Alan G.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.
   [Goodman, Alan G.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
   [Rasmussen, Angela L.] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
RP Goodman, AG (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.; Goodman, AG (corresponding author), Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.; Rasmussen, AL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
EM alan.goodman@wsu.edu; alr2105@cumc.columbia.edu
RI Goodman, Alan/AAQ-1108-2020
OI Goodman, Alan/0000-0001-6394-332X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI128103, U19AI109761]; Washington
   State University's College of Veterinary Medicine
FX Research in the Goodman Lab is supported by NIH grant R21AI128103 and
   funds from Washington State University's College of Veterinary Medicine.
   AR is supported by NIH grant U19AI109761.
CR ArboNET, 2018, FIN ANN MAPS DAT 199
   Chen CC, 2013, INT J ENV RES PUB HE, V10, P3052, DOI 10.3390/ijerph10073052
   Driskell RR, 2014, EXP DERMATOL, V23, P629, DOI 10.1111/exd.12450
   Hanley KA, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P351, DOI 10.1016/B978-0-12-374153-0.00016-3
   Jindal H, 2014, HUM VACC IMMUNOTHER, V10, P2245, DOI 10.4161/hv.28953
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lindsey NP, 2014, MMWR-MORBID MORTAL W, V63, P521
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Tham HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01040
NR 9
TC 2
Z9 2
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD MAR 26
PY 2019
VL 9
AR 77
DI 10.3389/fcimb.2019.00077
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HQ6RO
UT WOS:000462545900002
PM 30972308
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sher, AA
   Glover, KKM
   Coombs, KM
AF Sher, Affan A.
   Glover, Kathleen K. M.
   Coombs, Kevin M.
TI Zika Virus Infection Disrupts Astrocytic Proteins Involved in Synapse
   Control and Axon Guidance
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE RNA virus infection; proteomics; aptamers; SOMAScan; astrocytic
   dysregulation; virus-host interaction
ID GLIOMA-CELLS; HUMAN BRAIN; GROWTH; MIGRATION; INVASION; RECEPTOR;
   KINASE; STAT3; EIF5A; PHOSPHORYLATION
AB The first human Zika virus (ZIKV) outbreak was reported in Micronesia in 2007, followed by one in Brazil in 2015. Recent studies have reported cases in Europe, Oceania and Latin America. In 2016, ZIKV transmission was also reported in the US and the World Health Organization declared it a Public Health Emergency of International Concern. Because various neurological conditions are associated with ZIKV, such as microcephaly, Guillain-Barre syndrome, and other disorders of both the central and peripheral nervous systems, including encephalopathy, (meningo) encephalitis and myelitis, and because of the lack of reliable patient diagnosis, numerous ongoing studies seek to understand molecular mechanisms underlying ZIKV pathogenesis. Astrocytes are one of the most abundant cells in the CNS. They control axonal guidance, synaptic signaling, neurotransmitter trafficking and maintenance of neurons, and are targeted by ZIKV. In this study, we used a newly developed multiplexed aptamer-based technique (SOMAScan) to examine > 1300 human astrocyte cell proteins. We identified almost 300 astrocyte proteins significantly dysregulated by ZIKV infection that span diverse functions and signaling pathways, including protein translation, synaptic control, cell migration and differentiation.
C1 [Sher, Affan A.; Glover, Kathleen K. M.; Coombs, Kevin M.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.
   [Sher, Affan A.; Glover, Kathleen K. M.; Coombs, Kevin M.] Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada.
   [Coombs, Kevin M.] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada.
RP Coombs, KM (corresponding author), Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.; Coombs, KM (corresponding author), Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada.; Coombs, KM (corresponding author), Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada.
EM kevin.coombs@umanitoba.ca
FU Children's Hospital Research Institute of Manitoba; University of
   Manitoba
FX This research was supported by an operating grant from the Children's
   Hospital Research Institute of Manitoba, which was not involved in data
   generation or interpretation. The authors would like to thank members of
   their laboratory group for helpful suggestions, and Gao Ang and Victor
   Spicer for technical support. KG was the recipient of a Graduate
   Enhancement Training Studentship from the University of Manitoba.
CR Ahmad F., 2018, VIROL IMMUNOL J, V2
   Allen NJ, 2013, CURR OPIN NEUROBIOL, V23, P1027, DOI 10.1016/j.conb.2013.06.004
   Angers-Loustau A, 2004, MOL CANCER RES, V2, P595
   Ashpole NM, 2013, J BIOL CHEM, V288, P14599, DOI 10.1074/jbc.M113.466235
   Ashpole NM, 2012, J BIOL CHEM, V287, P8495, DOI 10.1074/jbc.M111.323915
   Ayanlaja AA, 2018, SEMIN CANCER BIOL, V53, P212, DOI 10.1016/j.semcancer.2018.07.005
   Baert JL, 2007, ONCOGENE, V26, P415, DOI 10.1038/sj.onc.1209801
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Becerra-Calixto A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00088
   Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012
   Caine EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07993-2
   Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043
   Chaboub LS, 2013, SEMIN PEDIATR NEUROL, V20, P230, DOI 10.1016/j.spen.2013.10.003
   Chawla A, 2014, BIOPHYS J, V106, p104A, DOI 10.1016/j.bpj.2013.11.646
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Choi BR, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.147
   Coombs KM, 2011, EXPERT REV PROTEOMIC, V8, P659, DOI [10.1586/EPR.11.55, 10.1586/epr.11.55]
   Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10
   Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Glover K. K. M., 2019, PROTEOMICS, V19, DOI [10.1002/pmic01800309, DOI 10.1002/PMIC01800309]
   Glover K. K. M., 2017, J MOL BIOCH, V6, P26
   Gonzalez-Perez Oscar, 2012, J Stem Cells, V7, P181, DOI jsc.2012.7.3.181
   Gu JJ, 2016, AM J TRANSL RES, V8, P3780
   Hagemann C, 2012, WORLD J CLIN ONCOL, V3, P67, DOI 10.5306/wjco.v3.i5.67
   Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8
   Haviernik J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040184
   Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200
   Hong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086851
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Hwang M, 2018, J VIROL, V92, DOI 10.1128/JVI.01901-17
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jacobsen CT, 2003, DEV NEUROSCI-BASEL, V25, P207, DOI 10.1159/000072269
   Jiang XL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02923
   Kamat P. K., 2014, THER TARGETS NEUROL, V1
   Kim J, 2015, J NEUROCHEM, V134, P927, DOI 10.1111/jnc.13178
   Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495
   KOZAK RA, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9100297
   Kuiper JWP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005030
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Landstrom M, 2000, CURR BIOL, V10, P535, DOI 10.1016/S0960-9822(00)00470-X
   Leonhard Sonja Emily, 2018, Pract Neurol, V18, P271, DOI 10.1136/practneurol-2017-001789
   Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031
   Liu B, 2007, J NEUROSCI RES, V85, P3523, DOI 10.1002/jnr.21364
   Long Fan, 2004, In Silico Biology, V4, P395
   Lupberger J, 2013, HEPATOLOGY, V58, P1225, DOI [10.1002/hep.26404, 10.1002/hep.26443]
   Mandell JW, 1999, NEUROREPORT, V10, P3567, DOI 10.1097/00001756-199911260-00019
   Marquina-Sanchez B, 2017, J STEROID BIOCHEM, V172, P198, DOI 10.1016/j.jsbmb.2016.10.001
   Mazars A, 2001, J BIOL CHEM, V276, P36797, DOI 10.1074/jbc.M101672200
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349
   Ohtaki N, 2007, J VIROL, V81, P5940, DOI 10.1128/JVI.02137-06
   Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425
   Olsen ME, 2017, DNA CELL BIOL, V36, P198, DOI 10.1089/dna.2016.3611
   Park J, 2013, BRAIN RES, V1533, P37, DOI 10.1016/j.brainres.2013.08.028
   Pelechano V, 2017, NUCLEIC ACIDS RES, V45, P7326, DOI 10.1093/nar/gkx479
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3339/fnhum.2016.00566
   Renault-Mihara F, 2017, J CELL BIOL, V216, P2533, DOI 10.1083/jcb.201610102
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005
   Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Farias KJS, 2013, SCI WORLD J, DOI 10.1155/2013/282734
   Smirnova OA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041219
   SOMAScan, 2017, SSM002 SOMASCAN
   Sooryanarain H, 2017, J VIROL, V91, DOI 10.1128/JVI.00621-17
   Steen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010811
   Suarez AAR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006839
   Takashima S, 2015, STEM CELL REP, V4, P489, DOI 10.1016/j.stemcr.2015.01.010
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Terni B, 2017, BRAIN RES BULL, V129, P74, DOI 10.1016/j.brainresbull.2016.08.017
   Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294
   Vester D, 2009, PROTEOMICS, V9, P3316, DOI 10.1002/pmic.200800893
   Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988
   Wang LZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01357-4
   Wang SB, 2017, J VIROL, V91, DOI [10.1128/jvi.01055-17, 10.1128/JVI.01055-17]
   Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128
   Wang Z, 2002, ACTA PHARMACOL SIN, V23, P974
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4
   Wu DM, 2018, J CELL MOL MED, V22, P4963, DOI 10.1111/jcmm.13760
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Yang SY, 2014, J STEROID BIOCHEM, V143, P460, DOI 10.1016/j.jsbmb.2014.07.001
   Yang SY, 2009, P NATL ACAD SCI USA, V106, P14820, DOI 10.1073/pnas.0902377106
   Yang Y, 2018, ONCOL LETT, V15, P4523, DOI 10.3892/ol.2018.7819
   Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zamora AP, 2016, VIROLOGY, V495, P18, DOI 10.1016/j.virol.2016.04.021
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
   Zheng K, 2014, REV MED VIROL, V24, P274, DOI 10.1002/rmv.1796
NR 100
TC 5
Z9 5
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAR 26
PY 2019
VL 10
AR 596
DI 10.3389/fmicb.2019.00596
PG 20
WC Microbiology
SC Microbiology
GA HQ6HH
UT WOS:000462513500002
PM 30984137
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tsai, JJ
   Liu, WL
   Lin, PC
   Huang, BY
   Tsai, CY
   Chou, PH
   Lee, FC
   Ping, CF
   Lee, PYA
   Liu, LT
   Chen, CH
AF Tsai, Jih-Jin
   Liu, Wei-Liang
   Lin, Ping-Chang
   Huang, Bo-Yi
   Tsai, Ching-Yi
   Chou, Pin-Hsing
   Lee, Fu-Chun
   Ping, Chia-Fong
   Lee, Pei-Yu Alison
   Liu, Li-Teh
   Chen, Chun-Hong
TI An RT-PCR panel for rapid serotyping of dengue virus serotypes 1 to 4 in
   human serum and mosquito on a field-deployable PCR system
SO PLOS ONE
LA English
DT Article
ID INSULATED ISOTHERMAL PCR; OF-NEED DIAGNOSIS; AEDES-AEGYPTI;
   CLINICAL-MANIFESTATIONS; ASSAY; INFECTION; EPIDEMIOLOGY; TAIWAN; FEVER;
   RNA
AB Background
   Dengue fever, a mosquito-borne disease, is caused by dengue virus (DENV) which includes four major serotypes (DENV-1, -2, -3, and -4). Some serotypes cause more severe diseases than the other; severe dengue is associated with secondary infections by a different serotype. Timely serotyping can provide early warning of dengue epidemics to improve management of patients and outbreaks. A mobile insulated isothermal PCR (iiPCR) system is available to allow molecular detection of pathogens near points of need.
   Methodology/Principle findings
   In this study, side-by-side comparison with the CDC DENV-1-4 Real Time RT-PCR (qRTPCR) was performed to evaluate the performance of four singleplex DENV-1-4 serotyping reverse transcription-iiPCR (RT-iiPCR) reagents for DENV subtyping on the mobile PCR system. The four RT-iiPCRs did not react with Zika virus and chikungunya virus; tests with serial dilutions of the four DENV serotypes made in human serum showed they had detection endpoints comparable to those of the reference method, indicating great analytical sensitivity and specificity. Clinical performance of the RT-iiPCR reagents was evaluated by testing 40 serum samples each (around 20 target serotype-positive and 20 DENV-negative); all four reagents had high agreement (97.5-100%) with the reference qRT-PCR. Moreover, testing of mosquitoes separately infected experimentally with each serotype showed that the four reagents detected specifically their target DENV serotypes in mosquito.
   Conclusions/Significance
   With analytical and clinical performance comparable to the reference qRT-PCR assay, the four index RT-iiPCR reagents on the field-deployable PCR system can serve as a useful tool for DENV detection near points of needs.
C1 [Tsai, Jih-Jin; Lin, Ping-Chang; Huang, Bo-Yi; Tsai, Ching-Yi; Liu, Li-Teh] Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin; Lin, Ping-Chang; Huang, Bo-Yi; Tsai, Ching-Yi] Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.
   [Liu, Wei-Liang; Chen, Chun-Hong] Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Zhunan, Taiwan.
   [Chou, Pin-Hsing; Lee, Fu-Chun; Ping, Chia-Fong; Lee, Pei-Yu Alison] GeneReach Biotechnol, Taichung, Taiwan.
   [Liu, Li-Teh] Chung Hwa Univ Med Technol, Coll Med Technol, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.
   [Chen, Chun-Hong] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.
RP Tsai, JJ (corresponding author), Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan.; Tsai, JJ (corresponding author), Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan.; Tsai, JJ (corresponding author), Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan.; Tsai, JJ (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.; Chen, CH (corresponding author), Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Zhunan, Taiwan.; Chen, CH (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.
EM jijits@cc.kmu.edu.tw; chunhong@nhri.org.tw
OI TSAI, JIH-JIN/0000-0003-2226-8916; CHEN, CHUN-HONG/0000-0002-3028-5508
FU Ministry of Health and Welfare, Taiwan [MOHW108-TDU-B-212-133006,
   M08L6030]; NHRI (National Health Research Institutes, Taiwan)National
   Health Research Institutes - Taiwan [NHRI-108A1-MRCO-0419191]
FX This study was supported partly by the Ministry of Health and Welfare,
   Taiwan (https://www.mohw.gov.tw/mp-2.html) (MOHW108-TDU-B-212-133006,
   and M08L6030 to JJT), and in part by NHRI (National Health Research
   Institutes, Taiwan)(grant no. NHRI-108A1-MRCO-0419191,
   http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do, to JJT). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. GeneReach
   Biotechnology provided support in the form of salaries for authors
   P.-H.C., F.-C.L., C.-F.P. and P.-Y.A.L., but did not have any additional
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Alm E, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1226-z
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Anwar A, 2009, J MOL DIAGN, V11, P537, DOI 10.2353/jmoldx.2009.080164
   Balasuriya UBR, 2017, J VIROL METHODS, V241, P58, DOI 10.1016/j.jviromet.2016.12.010
   Balasuriya UBR, 2014, J VIROL METHODS, V207, P66, DOI 10.1016/j.jviromet.2014.06.016
   Bangs MJ, 2007, J MED ENTOMOL, V44, P163, DOI 10.1603/0022-2585(2007)44[163:PODVRI]2.0.CO;2
   Carossino M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2852-4
   Chan KS, 2009, J MICROBIOL IMMUNOL, V42, P471
   Chang HFG, 2012, BIOTECHNOL J, V7, P662, DOI 10.1002/biot.201100453
   Chang K, 2017, AM J TROP MED HYG, V97, P361, DOI 10.4269/ajtmh.16-1018
   Chen HX, 2015, J MOL DIAGN, V17, P722, DOI 10.1016/j.jmoldx.2015.06.008
   Chua KH, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1183-z
   Cooke KL, 2018, J VET INTERN MED, V32, P232, DOI 10.1111/jvim.15033
   Cucunawangsih Lugito NPH, 2017, VIROLOGY RES TREATME, V8
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Gaikwad Seema, 2017, J Lab Physicians, V9, P177, DOI 10.4103/0974-2727.208265
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Go YY, 2017, J MOL DIAGN, V19, P817, DOI 10.1016/j.jmoldx.2017.06.007
   Go YY, 2016, J CLIN MICROBIOL, V54, P1528, DOI 10.1128/JCM.00225-16
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Huang JH, 2007, AM J TROP MED HYG, V77, P903, DOI 10.4269/ajtmh.2007.77.903
   Lau SM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2091-y
   Lauterbach SE, 2018, VECTOR-BORNE ZOONOT, DOI [10.1089/vbz.2018, DOI 10.1089/VBZ.2018]
   Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191
   Ocwieja KE, 2014, AM J TROP MED HYG, V91, P225, DOI 10.4269/ajtmh.13-0523
   Pang J, 2017, J CLIN MICROBIOL
   Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005
   Parkash O, 2015, VIRUSES-BASEL, V7, P5410, DOI 10.3390/v7102877
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461
   Tsai JJ, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01865-17, 10.1128/JCM.01865-17]
   Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278
   Tsai YL, 2012, J VIROL METHODS, V181, P134, DOI 10.1016/j.jviromet.2012.01.017
   van Panhuis WG, 2010, J INFECT DIS, V202, P1002, DOI 10.1086/656141
   Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13
   Wang WK, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00203-18
   Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
NR 44
TC 0
Z9 0
U1 2
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 25
PY 2019
VL 14
IS 3
AR e0214328
DI 10.1371/journal.pone.0214328
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ1KV
UT WOS:000462157600055
PM 30908535
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yang, SNY
   Atkinson, SC
   Fraser, JE
   Wang, CX
   Maher, B
   Roman, N
   Forwood, JK
   Wagstaff, KM
   Borg, NA
   Jans, DA
AF Yang, Sundy N. Y.
   Atkinson, Sarah C.
   Fraser, Johanna E.
   Wang, Chunxiao
   Maher, Belinda
   Roman, Noelia
   Forwood, Jade K.
   Wagstaff, Kylie M.
   Borg, Natalie A.
   Jans, David A.
TI Novel Flavivirus Antiviral That Targets the Host Nuclear Transport
   Importin alpha/beta 1 Heterodimer
SO CELLS
LA English
DT Article
DE flavivirus; nuclear transport inhibitors; importins; viral infection;
   dengue virus
ID NONSTRUCTURAL PROTEIN 5; DENGUE VIRUS; INTERLEUKIN-8 INDUCTION;
   CRYSTAL-STRUCTURE; CAPSID PROTEIN; INHIBITOR; LOCALIZATION; PROTECTION;
   EXPORT; BETA
AB Dengue virus (DENV) threatens almost 70% of the world's population, with no effective vaccine or therapeutic currently available. A key contributor to infection is nuclear localisation in the infected cell of DENV nonstructural protein 5 (NS5) through the action of the host importin (IMP) alpha/beta 1 proteins. Here, we used a range of microscopic, virological and biochemical/biophysical approaches to show for the first time that the small molecule GW5074 has anti-DENV action through its novel ability to inhibit NS5-IMP alpha/beta 1 interaction in vitro as well as NS5 nuclear localisation in infected cells. Strikingly, GW5074 not only inhibits IMP alpha binding to IMP beta 1, but can dissociate preformed IMP alpha/beta 1 heterodimer, through targeting the IMP alpha armadillo (ARM) repeat domain to impact IMP alpha thermal stability and alpha-helicity, as shown using analytical ultracentrifugation, thermostability analysis and circular dichroism measurements. Importantly, GW5074 has strong antiviral activity at low mu M concentrations against not only DENV-2, but also zika virus and West Nile virus. This work highlights DENV NS5 nuclear targeting as a viable target for anti-flaviviral therapeutics.
C1 [Yang, Sundy N. Y.; Fraser, Johanna E.; Wang, Chunxiao; Maher, Belinda; Wagstaff, Kylie M.; Jans, David A.] Monash Univ, Monash Biomed Discovery Inst, Nucl Signaling Lab, Clayton, Vic 3800, Australia.
   [Yang, Sundy N. Y.; Atkinson, Sarah C.; Fraser, Johanna E.; Wang, Chunxiao; Maher, Belinda; Wagstaff, Kylie M.; Borg, Natalie A.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.
   [Atkinson, Sarah C.; Borg, Natalie A.] Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia.
   [Roman, Noelia; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2650, Australia.
   [Fraser, Johanna E.] Monash Univ, Inst Vector Borne Dis, World Mosquito Program, Clayton, Vic 3800, Australia.
   [Maher, Belinda] Monash Univ, Sch Clin Sci, Blood Canc Therapeut Lab, Clayton, Vic 3800, Australia.
RP Jans, DA (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Nucl Signaling Lab, Clayton, Vic 3800, Australia.; Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.
EM sundy.yang@monash.edu; sarah.atkinson@monash.edu;
   johanna.fraser@eliminatedengue.com; chunxiao.wang@monash.edu;
   belinda.maher@monash.edu; nroman@csu.edu.au; jforwood@csu.edu.au;
   kylie.wagstaff@monash.edu; natalie.borg@monash.edu;
   David.Jans@monash.edu
RI ; Fraser, Johanna/I-2938-2014
OI Wagstaff, Kylie/0000-0003-4791-1410; Jans, David/0000-0001-5115-4745;
   Fraser, Johanna/0000-0002-8020-2985
FU National Health and Medical Research Council AustraliaNational Health
   and Medical Research Council of Australia [APP1002486/APP1103050,
   APP1043511, APP1117470, APP1072267]; Australian Research
   CouncilAustralian Research Council [110100223]
FX This research was funded by the National Health and Medical Research
   Council Australia (Senior Principal Research Fellowship
   APP1002486/APP1103050; Project grant APP1043511; Development grant
   APP1117470; Early Career Fellowship APP1072267); and Australian Research
   Council (Future Fellowship #110100223).
CR Alvarez-Garcia D, 2014, J MED CHEM, V57, P8530, DOI 10.1021/jm5010418
   Atkinson SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18742-8
   Audsley MD, 2016, J GEN VIROL, V97, P2463, DOI 10.1099/jgv.0.000575
   Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108
   Caly L, 2012, ANTIVIR RES, V95, P202, DOI 10.1016/j.antiviral.2012.06.008
   Coudeville L, 2016, VACCINE, V34, P6426, DOI 10.1016/j.vaccine.2016.08.050
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019
   Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Jans DA, 2019, CURR OPIN CELL BIOL, V58, P50, DOI 10.1016/j.ceb.2019.01.001
   Jans DA, 2018, ADV EXP MED BIOL, V1062, P199, DOI 10.1007/978-981-10-8727-1_15
   Johnston T, 2016, FUTURE MED CHEM, V8, P1941, DOI 10.4155/fmc-2016-0104
   Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625
   LAUE TM, 1992, ANAL ULTRACENTRIFUGA, P90, DOI DOI 10.1007/S00249-009-0425-1
   Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031
   Lopez-Denman AJ, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12848
   Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v
   Medin CL, 2006, J INFECT DIS, V193, P1070, DOI 10.1086/502630
   Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   MUNOZ V, 1995, PROTEIN SCI, V4, P1577, DOI 10.1002/pro.5560040816
   Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   Siltz LAF, 2014, J VIROL, V88, P11091, DOI 10.1128/JVI.01877-14
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wagstaff KM, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12953
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wagstaff KM, 2011, J BIOMOL SCREEN, V16, P192, DOI 10.1177/1087057110390360
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Zachariae U, 2008, STRUCTURE, V16, P906, DOI 10.1016/j.str.2008.03.007
NR 39
TC 5
Z9 5
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAR 24
PY 2019
VL 8
IS 3
AR 281
DI 10.3390/cells8030281
PG 15
WC Cell Biology
SC Cell Biology
GA HS9TX
UT WOS:000464210700001
PM 30909636
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Beare, S
   Simpson, E
   Gray, K
   Andjelic, D
AF Beare, Skye
   Simpson, Emma
   Gray, Kate
   Andjelic, Denitza
TI Rapid Integration of Zika Virus Prevention Within Sexual and
   Reproductive Health Services and Beyond: Programmatic Lessons From Latin
   America and the Caribbean
SO GLOBAL HEALTH-SCIENCE AND PRACTICE
LA English
DT Article
AB The emergence of the Zika virus (ZIKV) in Latin America and the Caribbean during the 2015-2016 outbreak has required local health systems to adapt, suddenly and continuously. This field action report explores the outbreak's sexual and reproductive health (SRH) complexities and the experience of the International Planned Parenthood Federation (IPPF) and 4 of its member associations as part of the United States Agency for International Development's rapid response in the region. It outlines approaches and actions that IPPF and its member associations undertook over 3 broad programmatic phases-developing ZIKV protocols and training personnel; delivering ZIKV-integrated services and information; and providing screening, care, and support for children and families affected by congenital Zika syndrome (CZS)-as the project worked to integrate ZIKV prevention, screening, and response within SRH service delivery models. It also describes the challenges and lessons learned in implementing a ZIKV response program in the region and recommendations from a service delivery perspective that can be useful in informing the responses to future rapid onset epidemics with SRH relevance. Challenges identified include adapting to a rapidly evolving evidence base during the early stages of the epidemic; traditional and restrictive regional social norms around gender, sex, and sexuality; the lack of focus on sexual transmission in national ZIKV public health messaging; and a lack of services, government support, and referral pathways for supporting children and families affected by CZS. Some of the key recommendations include finding ways to share rapidly evolving clinical updates conveniently and frequently, such as through digital technologies and platforms; partnering with multidisciplinary organizations, such as disability rights and services organizations, that can fill gaps in needed services; and leveraging the need for urgent action as a catalyst of change around more inclusive and gender-transformative social norms and services.
C1 [Beare, Skye; Andjelic, Denitza] Int Planned Parenthood Federat Western Hemisphere, New York, NY 10038 USA.
   [Simpson, Emma; Gray, Kate] Int Planned Parenthood Federat, London, England.
RP Beare, S (corresponding author), Int Planned Parenthood Federat Western Hemisphere, New York, NY 10038 USA.
EM sbeare@ippfwhr.org
FU United States Agency for International Development as part of the wider
   Support for International Family Planning Organizations 2 - Sustainable
   Networks Project (SIFPO2) Project
FX The SIFPO2 Zika Prevention Project was funded by the United States
   Agency for International Development as part of the wider Support for
   International Family Planning Organizations 2 - Sustainable Networks
   Project (SIFPO2) Project.
CR Ahmed Azam, 2016, NY TIMES
   [Anonymous], 2014, NEW STUD FINDS 40 PR
   Collucci C, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6157
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Osamor PE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005127
   Pan American Health Organization (PAHO); World Health Organization (WHO), 2017, ZIK EP REP EL SALV
   Pan American Health Organization (PAHO); World Health Organization (WHO), 2017, ZIK EP REP HOND
   Pan American Health Organization (PAHO); World Health Organization (WHO), 2017, ZIK EP REP DOM REP
   Pan American Health Organization (PAHO); World Health Organization (WHO), 2017, ZIK EP REP GUAT
NR 11
TC 3
Z9 3
U1 1
U2 3
PU US AGENCY INT DEVELOPMENT-USAID
PI BALTIMORE
PA US AGENCY INT DEVELOPMENT-USAID, BALTIMORE, MD 00000 USA
SN 2169-575X
J9 GLOB HEALTH-SCI PRAC
JI Glob. Health
PD MAR 22
PY 2019
VL 7
IS 1
BP 116
EP 127
DI 10.9745/GHSP-D-18-00356
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HU0WX
UT WOS:000464994000011
PM 30926740
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ocampo, CB
   Mina, NJ
   Echavarria, MI
   Acuna, M
   Caballero, A
   Navarro, A
   Aguirre, A
   Criollo, IS
   Forero, F
   Azuero, O
   Alexander, ND
AF Ocampo, Clara B.
   Mina, Neila J.
   Echavarria, Maria I.
   Acuna, Miguel
   Caballero, Alexi
   Navarro, Andres
   Aguirre, Andres
   Criollo, Ingrid S.
   Forero, Francia
   Azuero, Oscar
   Alexander, Neal D.
TI VECTOS: An Integrated System for Monitoring Risk Factors Associated With
   Urban Arbovirus Transmission
SO GLOBAL HEALTH-SCIENCE AND PRACTICE
LA English
DT Article
ID DENGUE SURVEILLANCE; AEDES-AEGYPTI; ASIA-PACIFIC; PREVENTION;
   INFORMATION; FEVER; AREA
AB In Colombia, as in many Latin American countries, decision making and development of effective strategies for vector control of urban diseases such as dengue, Zika, and chikungunya is challenging for local health authorities. The heterogeneity of transmission in urban areas requires an efficient risk-based allocation of resources to control measures. With the objective of strengthening the capacity of local surveillance systems to identify variables that favor urban arboviral transmission, a multidisciplinary research team collaborated with the local Secretary of Health officials of 3 municipalities in Colombia (Giron, Yopal, and Buga), in the design of an integrated information system called VECTOS from 2015 to 2018. Information and communication technologies were used to develop 2 mobile applications to capture entomological and social information, as well as a web-based system for the collection, geo-referencing, and integrated information analysis using free geospatial software. This system facilitates the capture and analysis of epidemiological information from the Colombian national surveillance system (SIVIGILA), periodic entomological surveys-mosquito larvae and pupae in premises and peridomestic breeding sites-and surveys of knowledge, attitudes, and practices (KAP) in a spatial and temporal context at the neighborhood level. The data collected in VECTOS are mapped and visualized in graphical reports. The system enables real-time monitoring of weekly epidemiological indicators, entomological indices, and social surveys. Additionally, the system enables risk stratification of neighborhoods, using selected epidemiological, entomological, demographic, and environmental variables. This article describes the VECTOS system and the lessons learned during its development and use. The joint analysis of epidemiological and entomological data within a geographic information system in VECTOS gives better insight to the routinely collected data and identifies the heterogeneity of risk factors between neighborhoods. We expect the system to continue to strengthen vector control programs in evidence-based decision making and in the design and enhanced follow-up of vector control strategies.
C1 [Ocampo, Clara B.; Mina, Neila J.; Echavarria, Maria I.; Alexander, Neal D.] Ctr Int Entrenamiento & Invest Med CIDEIM, Santiago De Cali, Colombia.
   [Ocampo, Clara B.] Red AEDES, Bucaramanga, Colombia.
   [Ocampo, Clara B.; Echavarria, Maria I.; Navarro, Andres; Aguirre, Andres; Alexander, Neal D.] Univ ICESI, Santiago De Cali, Colombia.
   [Acuna, Miguel; Caballero, Alexi] CIC, Piedecuesta Santander, Colombia.
   [Criollo, Ingrid S.] Municipal Secretariat Hlth Yopal, Yopal, Colombia.
   [Forero, Francia] Municipal Secretariat Hlth Giron, Giron, Colombia.
   [Azuero, Oscar] Municipal Secretariat Hlth Buga, Buga, Colombia.
RP Ocampo, CB (corresponding author), Ctr Int Entrenamiento & Invest Med CIDEIM, Santiago De Cali, Colombia.; Ocampo, CB (corresponding author), Red AEDES, Bucaramanga, Colombia.; Ocampo, CB (corresponding author), Univ ICESI, Santiago De Cali, Colombia.
EM claraocampo@cideim.org.co
FU program "Desarrollo investigacion aplicada para contribuir a un modelo
   efectivo y sostenible de intervencion del dengue en Santander, Casanare
   y Valle del Cauca" (Development of applied research to contribute to an
   effective and sustainable model of dengue [009]; ColcienciasDepartamento
   Administrativo de Ciencia, Tecnologia e Innovacion Colciencias
   [567-2013]; US NIH International Fogarty Center Global Infectious
   Disease Research Training Program [D43 TW006589]
FX This project was financed through the program "Desarrollo investigacion
   aplicada para contribuir a un modelo efectivo y sostenible de
   intervencion del dengue en Santander, Casanare y Valle del Cauca"
   (Development of applied research to contribute to an effective and
   sustainable model of dengue intervention in Santander, Casanare and
   Valle del Cauca), financed by "Sistema General de Regalias (SGR), Fondo
   de Ciencia, Tecnologia e Innovacion (CTeI) aprobado por el Organo
   Colegiado de Administracion y Decision (OCAD), mediante el Acuerdo 009
   de 2013." Additional support for the Doctoral training of Neila Julieth
   Mina was received by the Colciencias Fellowship 567-2013 and US NIH
   International Fogarty Center Global Infectious Disease Research Training
   Program, Award Number D43 TW006589.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9
   Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847
   Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   Hernandez-Avila JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070231
   FOCKS DA, 2003, REV ENTOMOLOGICAL SA
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Kienberger S, 2013, GEOSPATIAL HEALTH, V8, P313, DOI 10.4081/gh.2013.76
   Krystosik AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181208
   Cavalcante KRLJ, 2017, EPIDEMIOL SERV SAUDE, V26, P617, DOI 10.5123/S1679-49742017000300018
   Lwin MO, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4657
   Lwin May Oo, 2017, JMIR Public Health Surveill, V3, pe65, DOI 10.2196/publichealth.7376
   Ministerio de la Proteccion Social de Colombia (MPS) Instituto Nacional de Salud Organizacion Panamericana de la Salud, 2012, GEST VIG ENT CONTR T
   Ocampo CB, 2014, ACTA TROP, V132, P15, DOI 10.1016/j.actatropica.2013.12.019
   Organizacion Panamericana de la Salud (OPS)/ Organizacion Mundial de la Salud (OMS), 2017, ZIK ACT EP 25 MAYO 2
   Padilla JC, 2012, DENGUE COLOMBIA EPID
   Porcasi X, 2012, GEOSPATIAL HEALTH, V6, pS31
   Regis L, 2009, AN ACAD BRAS CIENC, V81, P655, DOI 10.1590/S0001-37652009000400004
   Restrepo BN, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/120496
   Reyes-Castro PA, 2017, ACTA TROP, V167, P174, DOI 10.1016/j.actatropica.2017.01.001
   Spiegel Jerry, 2005, EcoHealth, V2, P273, DOI 10.1007/s10393-005-8388-x
   Tambo E, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0148-3
   Vanlerberghe V, 2017, REV PANAM SALUD PUBL, V41, DOI 10.26633/RPSP.2017.16
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   World Health Organization (WHO), 2017, OP GUID EARL WARN RE
NR 30
TC 0
Z9 0
U1 1
U2 3
PU US AGENCY INT DEVELOPMENT-USAID
PI BALTIMORE
PA US AGENCY INT DEVELOPMENT-USAID, BALTIMORE, MD 00000 USA
SN 2169-575X
J9 GLOB HEALTH-SCI PRAC
JI Glob. Health
PD MAR 22
PY 2019
VL 7
IS 1
BP 128
EP 137
DI 10.9745/GHSP-D-18-00300
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HU0WX
UT WOS:000464994000012
PM 30926741
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Lima, GP
   Rozenbaum, D
   Pimentel, C
   Frota, ACC
   Vivacqua, D
   Machado, ES
   Sztajnbok, F
   Abreu, T
   Soares, RA
   Hofer, CB
AF Lima, Giulia P.
   Rozenbaum, Daniel
   Pimentel, Clarisse
   Cisne Frota, Ana Cristina
   Vivacqua, Daniela
   Machado, Elizabeth S.
   Sztajnbok, Fernanda
   Abreu, Thalita
   Soares, Raquel A.
   Hofer, Cristina B.
TI Factors associated with the development of Congenital Zika Syndrome: a
   case-control study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Congenital Zika Syndrome; Rio de Janeiro; Case-control; Gestational age
ID VIRUS-INFECTION; PREGNANCY; INFANTS
AB BackgroundWe aim to investigate possible maternal- and pregnancy-related factors associated with the development of Congenital Zika Syndrome (CZS) in children of mothers with probable gestational infection.MethodsThis case-control study, we recruited mother-infant pairs between May 2015 and October 2017 in a pediatric infectious disease clinic in Rio de Janeiro. Inclusion criteria required either that the mother reported Zika infection symptoms during pregnancy or that the infant presented with clinical or imaging features of the CZS. Exclusion criteria included detection of an alternative cause for the patient's presentation or negative polymerase chain reaction assays for Zika in all specimens tested within 12days from the beginning of maternal symptoms. Infants with CZS (CDC definition) were selected as cases and infants without CZS, but with probable maternal Zika virus infection during pregnancy, were selected as controls. Maternal and pregnancy-related informations were collected and their relationship to the presence of congenital anomalies due to CZS was assessed by Fisher exact or Mann-Whitney test.ResultsOut of the 42 included neonates, 24 (57.1%) were diagnosed with CZS (cases). The mean maternal age at the birth was 21years old. The early occurrence of maternal symptoms during pregnancy was the only variable associated with CZS (odds ratio=0.87, 95% CI: 0.78-0.97).Case's mothers presented symptoms until the 25th week of gestational age (GA), while control's mothers presented until 36th weeks of GA. Income; illicit drug, alcohol, or tobacco use during pregnancy; other infections during pregnancy (including previous dengue infection) were not associated with CZS.ConclusionsOur study corroborates the hypothesis that Zika virus infection earlier in pregnancy is a risk factor to the occurrence of congenital anomalies in their fetuses.
C1 [Lima, Giulia P.; Rozenbaum, Daniel; Pimentel, Clarisse; Cisne Frota, Ana Cristina; Vivacqua, Daniela; Machado, Elizabeth S.; Sztajnbok, Fernanda; Abreu, Thalita; Soares, Raquel A.; Hofer, Cristina B.] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Ilha Fundao, R Bruno Lobo 50, Rio De Janeiro, Brazil.
RP Hofer, CB (corresponding author), Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Ilha Fundao, R Bruno Lobo 50, Rio De Janeiro, Brazil.
EM giulia.p.lima@gmail.com; cbhofer@hucff.ufrj.br
RI Frota, Ana Cristina/L-3644-2018
OI Frota, Ana Cristina/0000-0002-2825-4374; hofer,
   cristina/0000-0001-8633-0913
FU Faperj (Chamada de Arboviroses, rede 6, sub-rede A, CBH); CNPQ (PQ-2)
FX Faperj (Chamada de Arboviroses, rede 6, sub-rede A, CBH), CNPQ (PQ-2,
   for CBH). The funding body did not have any participation in the design
   of the study and collection, analysis, and interpretation of data, and
   in writing the manuscript.
CR Bhadelia N, 2016, EVID BASED MED, V0, P1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Pan American Health Organization, 2017, ZIK CUM CAS
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Santa Rita Ticiane Henriques, 2017, BMC Res Notes, V10, P457, DOI 10.1186/s13104-017-2796-1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   United Nations Development Programme, 2017, SOC IMP ASS ZIK VIR
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   World Health Organization, 2016, ZIK SIT REP
NR 17
TC 2
Z9 2
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 22
PY 2019
VL 19
AR 277
DI 10.1186/s12879-019-3908-4
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA HQ2GD
UT WOS:000462217400001
PM 30902046
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, CW
   Hor, CHH
   Kwek, SS
   Tee, HK
   Sam, IC
   Goh, ELK
   Ooi, EE
   Chan, YF
   Wang, LF
AF Tan, Chee Wah
   Hor, Catherine Hong Huan
   Kwek, Swee Sen
   Tee, Han Kang
   Sam, I-Ching
   Goh, Eyleen L. K.
   Ooi, Eng Eong
   Chan, Yoke Fun
   Wang, Lin-Fa
TI Cell surface alpha 2,3-linked sialic acid facilitates Zika virus
   internalization
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Zika virus; flavivirus; sialic acid; neural progenitor cells;
   internalization
ID ENVELOPE PROTEIN; HEPARAN-SULFATE; C6/36 CELLS; INFECTION; DENGUE;
   BINDING; AXL; IDENTIFICATION; RECEPTORS; EFFICIENCY
AB The emergence of neurotropic Zika virus (ZIKV) raised a public health emergency of global concern. ZIKV can cross the placental barrier and infect foetal brains, resulting in microcephaly, but the pathogenesis of ZIKV is poorly understood. With recent findings reporting AXL as a type I interferon antagonist rather than an entry receptor, the exact entry mechanism remains unresolved. Here we report that cell surface sialic acid plays an important role in ZIKV infection. Removal of cell surface sialic acid by neuraminidase significantly abolished ZIKV infection in Vero cells and human induced-pluripotent stem cells-derived neural progenitor cells. Furthermore, knockout of the sialic acid biosynthesis gene encoding UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase resulted in significantly less ZIKV infection of both African and Asian lineages. Huh7 cells deficient in alpha 2,3-linked sialic acid through knockout of ST3 beta-galactoside-alpha 2,3-sialyltransferase 4 had significantly reduced ZIKV infection. Removal of membrane-bound, un-internalized virus with pronase treatment revealed the role of sialic acid in ZIKV internalization but not attachment. Sialyllactose inhibition studies showed that there is no direct interaction between sialic acid and ZIKV, implying that sialic acid could be mediating ZIKV-receptor complex internalization. Identification of alpha 2,3-linked sialic acid as an important host factor for ZIKV internalization provides new insight into ZIKV infection and pathogenesis.
C1 [Tan, Chee Wah; Kwek, Swee Sen; Ooi, Eng Eong; Wang, Lin-Fa] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
   [Hor, Catherine Hong Huan; Goh, Eyleen L. K.] Duke NUS Med Sch, Neurosci Acad Clin Programme, Singapore, Singapore.
   [Tee, Han Kang; Sam, I-Ching; Chan, Yoke Fun] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.
RP Wang, LF (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
EM linfa.wang@duke-nus.edu.sg
RI Sam, Jamal I-Ching/B-8688-2010; Chan, Yoke Fun/B-5351-2010
OI Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke
   Fun/0000-0001-7089-0510; Ooi, Eng Eong/0000-0002-0520-1544; Wang,
   Lin-Fa/0000-0003-2752-0535; Goh, Eyleen/0000-0002-8244-6959
FU National Medical Research Council (NMRC)National Medical Research
   Council, Singapore [ZRRF16006]; Ministry of Education, Singapore
   (MOE)Ministry of Education, Singapore [MOE2015-T2-1-022]
FX This work is supported in part by the National Medical Research Council
   (NMRC) [grant ZRRF16006 (LFW)] and Ministry of Education, Singapore
   (MOE) [grant MOE2015-T2-1-022 (Eyleen Goh)].
CR Alexander DA, 2002, J VIROL, V76, P11265, DOI 10.1128/JVI.76.22.11265-11272.2002
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chu JJH, 2005, VIROLOGY, V339, P249, DOI 10.1016/j.virol.2005.05.026
   Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickey DD, 2011, J VIROL, V85, P9023, DOI 10.1128/JVI.05154-11
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Effertz K, 1999, J BIOL CHEM, V274, P28771, DOI 10.1074/jbc.274.40.28771
   Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099
   Gan ES, 2017, EMBO J, V36, P1348, DOI 10.15252/embj.201695642
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kubota M, 2016, P NATL ACAD SCI USA, V113, P11579, DOI 10.1073/pnas.1608383113
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114
   Liu H, 2004, J MED VIROL, V72, P618, DOI 10.1002/jmv.20025
   Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9865
   Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023
   Marianneau P, 1996, J GEN VIROL, V77, P2547, DOI 10.1099/0022-1317-77-10-2547
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Merfeld E, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.273
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Munoz MD, 1998, FEMS MICROBIOL LETT, V168, P251
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nokhbeh MR, 2005, J VIROL, V79, P7087, DOI 10.1128/JVI.79.11.7087-7094.2005
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pham ND, 2017, J BIOL CHEM, V292, P9637, DOI 10.1074/jbc.M116.764597
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   SalasBenito JS, 1997, J VIROL, V71, P7246, DOI 10.1128/JVI.71.10.7246-7252.1997
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199
   Stehle T, 2014, J VIROL, V88, P7696, DOI 10.1128/JVI.03683-13
   Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346
   Stuart-Harris CH, 1939, LANCET, V1, P497
   Su CTE, 2015, JOVE-J VIS EXP, DOI 10.3791/52408
   Su PY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-162
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585
   Viswanathan K, 2015, METHODS MOL BIOL, V1321, P171, DOI 10.1007/978-1-4939-2760-9_12
   Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wasik BR, 2016, TRENDS MICROBIOL, V24, P991, DOI 10.1016/j.tim.2016.07.005
   WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Winter C, 2006, J GEN VIROL, V87, P1209, DOI 10.1099/vir.0.81651-0
   Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141
NR 59
TC 2
Z9 2
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAR 22
PY 2019
VL 8
IS 1
BP 426
EP 437
DI 10.1080/22221751.2019.1590130
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HQ2EW
UT WOS:000462213900003
PM 30898036
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Du, SY
   Liu, Y
   Liu, JY
   Zhao, J
   Champagne, C
   Tong, LQ
   Zhang, RL
   Zhang, FC
   Qin, CF
   Ma, P
   Chen, CH
   Liang, GD
   Liu, QY
   Shi, PY
   Cazelles, B
   Wang, PH
   Tian, HY
   Cheng, G
AF Du, Senyan
   Liu, Yang
   Liu, Jianying
   Zhao, Jie
   Champagne, Clara
   Tong, Liangqin
   Zhang, Renli
   Zhang, Fuchun
   Qin, Cheng-Feng
   Ma, Ping
   Chen, Chun-Hong
   Liang, Guodong
   Liu, Qiyong
   Shi, Pei-Yong
   Cazelles, Bernard
   Wang, Penghua
   Tian, Huaiyu
   Cheng, Gong
TI Aedes mosquitoes acquire and transmit Zika virus by breeding in
   contaminated aquatic environments
SO NATURE COMMUNICATIONS
LA English
DT Article
ID WEST-NILE-VIRUS; AEGYPTI; INFECTION; URINE
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that predominantly circulates between humans and Aedes mosquitoes. Clinical studies have shown that Zika viruria in patients persists for an extended period, and results in infectious virions being excreted. Here, we demonstrate that Aedes mosquitoes are permissive to ZIKV infection when breeding in urine or sewage containing low concentrations of ZIKV. Mosquito larvae and pupae, including from field Aedes aegypti can acquire ZIKV from contaminated aquatic systems, resulting in ZIKV infection of adult females. Adult mosquitoes can transmit infectious virions to susceptible type I/II interferon receptor-deficient (ifnagr-/-) C57BL/6 (AG6) mice. Furthermore, ZIKV viruria from infected AG6 mice can causes mosquito infection during the aquatic life stages. Our studies suggest that infectious urine could be a natural ZIKV source, which is potentially transmissible to mosquitoes when breeding in an aquatic environment.
C1 [Du, Senyan; Liu, Yang; Liu, Jianying; Zhao, Jie; Tong, Liangqin; Cheng, Gong] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Sch Med, Beijing 100084, Peoples R China.
   [Du, Senyan; Cheng, Gong] Tsinghua Univ, Sch Med, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.
   [Du, Senyan; Zhang, Renli; Cheng, Gong] Shenzhen Ctr Dis Control & Prevent, Inst Pathogen Organisms, Shenzhen 518055, Guangdong, Peoples R China.
   [Liu, Yang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Champagne, Clara; Cazelles, Bernard] CNRS, ENS, UMR 8197, IBENS, F-75005 Paris, France.
   [Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Eighth Peoples Hosp, Inst Infect Dis, Guangzhou 510060, Guangdong, Peoples R China.
   [Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Ma, Ping] Tsinghua Univ Hosp, Dept Clin Lab, Beijing 100084, Peoples R China.
   [Chen, Chun-Hong] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli 35053, Taiwan.
   [Liang, Guodong] Natl Inst Viral Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, CDC, Beijing 102206, Peoples R China.
   [Liu, Qiyong] Natl Inst Communicable Dis Control & Prevent, CDC, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Cazelles, Bernard] Sorbone Univ, IRD, Int Ctr Math & Computat Modeling Complex Syst UMM, F-93143 Bondy, France.
   [Wang, Penghua] Univ Connecticut, Hlth Ctr, Sch Med, Dept Immunol, Farmington, CT 06030 USA.
   [Tian, Huaiyu] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China.
RP Cheng, G (corresponding author), Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Sch Med, Beijing 100084, Peoples R China.; Cheng, G (corresponding author), Tsinghua Univ, Sch Med, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.; Cheng, G (corresponding author), Shenzhen Ctr Dis Control & Prevent, Inst Pathogen Organisms, Shenzhen 518055, Guangdong, Peoples R China.; Tian, HY (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China.
EM tianhuaiyu@gmail.com; gongcheng@mail.tsinghua.edu.cn
RI Cazelles, Bernard/B-1572-2013; wang, Penghua/AAL-4011-2020
OI Cazelles, Bernard/0000-0002-7972-361X; Qin,
   Cheng-Feng/0000-0002-0632-2807; CHEN, CHUN-HONG/0000-0002-3028-5508
FU National Key Research and Development Plan of China
   [2018ZX09711003-004-003, 2018YFA0507202, 2016YFD0500400,
   2017ZX10305501-003]; Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [31825001, 81730063, 81571975, 81673234];
   Municipal Healthcare Joint-Innovation Major Project of Guangzhou
   [201704020229]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01AI132526]; Academy of Medical SciencesAcademy of Medical Sciences
   (AMS); Newton Fund; Shenzhen San-Ming Project for prevention and
   research on vector-borne diseases [SZSM201611064]
FX This work was funded by grants from the National Key Research and
   Development Plan of China (2018ZX09711003-004-003, 2018YFA0507202,
   2016YFD0500400, 2017ZX10305501-003), the Natural Science Foundation of
   China (31825001, 81730063, 81571975, 81673234), the Shenzhen San-Ming
   Project for prevention and research on vector-borne diseases
   (SZSM201611064), and the Municipal Healthcare Joint-Innovation Major
   Project of Guangzhou (201704020229). P.W. is supported by a National
   Institutes of Health award R01AI132526. We thank that Professor Scott
   Weaver from the UTMB provided critical suggestions for the manuscript.
   G.C. is a Newton Advanced Fellow awarded by the Academy of Medical
   Sciences and the Newton Fund. We also thank the core facilities of the
   Center for Life Sciences and Center of Biomedical Analysis for technical
   assistance (Tsinghua University).
CR Alvares CA, 2013, THEOR APPL CLIMATOL, V113, P407, DOI 10.1007/s00704-012-0796-6
   Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Burke R, 2010, MED VET ENTOMOL, V24, P117, DOI 10.1111/j.1365-2915.2010.00864.x
   CDC, 2018 CAS COUNTS US
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Oliveira MI, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860015, 10.1590/S1678-9946201860015]
   de Sousa RS, 2016, SAUDE SOC-SAO PAULO, V25, P1095, DOI [10.1590/s0104-12902016157497, 10.1590/S0104-12902016157497]
   Dom Nazri Che, 2016, International Journal of Mosquito Research, V3, P25
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Giatti LL, 2004, REV SAUDE PUBL, V38, P571, DOI [10.1590/S0034-89102004000400014, 10.1590/s0034-89102004000400014]
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hashimoto T, 2017, EMERG INFECT DIS, V23, P1222, DOI 10.3201/eid2307.170519
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Ren ST, 2014, UROLITHIASIS, V42, P409, DOI 10.1007/s00240-014-0689-5
   Robey IF, 2013, BIOMED RES INT, DOI 10.1155/2013/485196
   Robey IF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-235
   Rose C, 2015, CRIT REV ENV SCI TEC, V45, P1827, DOI 10.1080/10643389.2014.1000761
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Smartt CT, 2017, MEM I OSWALDO CRUZ, V112, P829, DOI 10.1590/0074-02760170182
   Soares Gil Luiz Herman, 2015, Revista Pan-Amazonica de Saude, V6, P73
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294, DOI 10.3201/eid1108.0238
   Utomo S. W, 2016, ASIAN J APPL SCI, V2, P481
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wang Feng-tian, 2009, Chinese Journal of Virology, V25, P83
   WHO, 2017, ZIKA CUM CAS
   World Health Organization, ZIK VIR INF IND
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhu YB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01244-6
NR 53
TC 3
Z9 3
U1 4
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 22
PY 2019
VL 10
AR 1324
DI 10.1038/s41467-019-09256-0
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HP9EI
UT WOS:000461995000001
PM 30902991
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI Zika warnings eased around the world as growing immunity brings lower
   risk
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Centers for Disease Control and Prevention, 2019, ZIK TRAV INF
   Public Health England National Travel Health Network and Centre, 2019, ZIK VIR CLIN TRAV GU
NR 2
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 21
PY 2019
VL 364
AR l1341
DI 10.1136/bmj.l1341
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA HQ8AQ
UT WOS:000462646500013
PM 30898769
DA 2020-07-08
ER

PT J
AU Toppenberg-Pejcic, D
   Noyes, J
   Allen, T
   Alexander, N
   Vanderford, M
   Gamhewage, G
AF Toppenberg-Pejcic, Deborah
   Noyes, Jane
   Allen, Tomas
   Alexander, Nyka
   Vanderford, Marsha
   Gamhewage, Gaya
TI Emergency Risk Communication: Lessons Learned from a Rapid Review of
   Recent Gray Literature on Ebola, Zika, and Yellow Fever
SO HEALTH COMMUNICATION
LA English
DT Review
DE Emergency risk communication; LMIC; review; social media; community
   engagement; gray literature
AB A rapid review of gray literature from 2015 to 2016 was conducted to identify the lessons learned for emergency risk communication from recent outbreaks of Ebola, Zika, and yellow fever. Gray literature databases and key websites were searched and requests for documents were posted to expert networks. A total of 83 documents met inclusion criteria, 68 of which are cited in this report. This article focuses on the 3 questions, out of 12 posed by World Health Organization as part of a Guideline development process, dealing most directly with communicating risk during health emergencies: community engagement, trust building, and social media. Documents were evaluated for credibility using an Authority, Accuracy, Coverage, Objectivity, Date, Significance (AACODS) checklist? and if the document contained a study, a method-specific tool was applied. A rapid content analysis of included sources was undertaken with relevant text either extracted verbatim or summarized and mapped against the questions. A database subset was created for each question and citations were assigned to the subset(s) for which they contained relevant information. Multiple designations per document were common. Database subsets were used to synthesize the results into a coherent narrative. The gray literature strongly underlines the central importance of local communities. A one-size-fits-all approach does not work. For maximum effectiveness, local communities need to be involved with and own emergency risk communication processes, preferably well before an emergency occurs. Social media can open new avenues for communication, but is not a general panacea and should not be viewed as a replacement for traditional modes of communication. In general, the gray literature indicates movement toward greater recognition of emergency risk communication as a vitally important element of public health.
C1 [Toppenberg-Pejcic, Deborah; Noyes, Jane] WHO, Geneva, Switzerland.
   [Noyes, Jane] Bangor Univ, Sch Social Sci, Bangor, Gwynedd, Wales.
   [Allen, Tomas] WHO, Strategy Policy & Informat Dept, Geneva, Switzerland.
   [Alexander, Nyka] WHO, Hlth Emergencies Programme, Geneva, Switzerland.
   [Vanderford, Marsha] WHO, Dept Commun, Geneva, Switzerland.
   [Gamhewage, Gaya] WHO, Hazard Management Dept, Geneva, Switzerland.
RP Toppenberg-Pejcic, D (corresponding author), WHO, Geneva, Switzerland.
EM datoppenberg@gmail.com
OI Toppenberg-Pejcic, Deborah/0000-0001-7032-9950
FU World Health OrganizationWorld Health Organization [001]
CR Abramson D., 2016, US PUBLICS PERCEPTIO
   ACAPS, 2015, EB OUTBR LIB COMM CH
   ACF International, 2015, COMM LED EB MAN ER C
   Adams V., 2016, OCB EBOLA REV SUMMAR
   Allie M.-P., 2016, OCB EBOLA REV 1
   Anoko J. N., COMMUNICATION REBELL
   Assessment Capacities Project (ACAPS), 2015, EB OUTBR SIERR LEON
   Balde A, 2016, ELEMENTS CULTURE HAV
   Bastide L., 2015, GENERATING EVI UNPUB
   Bristol N., 2016, BOLSTERING PUBLIC HL
   Davis T., 2016, EBOLA BARRIER ANAL C
   De Roeck D., 2016, GUIDANCE NOTE USE OR
   DuBois M, 2015, EBOLA RESPONSE W AFR
   Eckert K. S., 2016, EVIDENCE SYNTHESES S
   Francia M, 2015, SOCIAL MOBILIZERS EM
   Gautier L., 2016, ANAL COMMUNITY LED I
   Gautier L., 2016, ANAL COMMUNITY UNPUB
   Gautier L., PREPARING EBOLA VIRU
   Gautier L., PREPARING EBOL UNPUB
   Global Communities Partners for Good, STOPP EB ITS TRACKS
   Health Communication Capacity Collaborative, 2016, HC3 LANDSC SUMM REP
   Hird T., 2016, LESSONS EBOLA AFFECT
   Independent Monitoring Board of the Global Polio Eradication Initiative, 2015, NOW IS TIM PEAK PERF
   Institute of Development Studies (IDS), AFR APPG INQ COMM LE
   International Federation of Red Cross and Red Crescent Societies (IFRC), 2015, EB DIGN RESP DIGN RE
   International Rescue Committee (IRC), 2016, MONTS EB PREV RESP C
   International Rescue Committee (IRC), 2016, EV IRC SUPP RE UNPUB
   International Rescue Committee (IRC), 2016, MONTS EB PREV UNPUB
   Jones T., 2016, ADDRESSING BARRIERS
   Kamai-Yanni M., 2015, NEVER BUILDING RESIL
   Korkoyah D. T., 2015, EBOLA IMPACT REVEALE
   Liberia Ministry of Health, 2015, NAT KNOWL ATT PRACT
   McKay J., 2015, EBOLA RESPONSE PROVI
   Medecins Sans Frontieres, 2016, MSF SUPP RES EB
   Miller L., 2016, EBOLA LESSONS READER
   Modarres N., 2015, COMMUNITY PERSPECTIV
   Novak J., 2016, EVIDENCE SYNTHESES S
   Oosterhoff P., COMMUNITY BASED EBOL
   Oosterhoff P., 2015, EBOLA CRISIS APPEAL
   Oxfam International, 2015, EB IS STILL HER LIB
   Oxfam International, 2015, EB IS STILL HER VOIC
   Oxfam International, 2015, PRIOR COMM ENG STREN
   Peremans M., 2016, OCB EBOLA REV 4
   Quinn M, 2016, GOVERNANCE HLTH POST
   Richards P, 2015, VILLAGE RESPONSES EB
   Richards P, 2015, WHAT CAUSES EBOLA VI
   Richards P., 2015, EBOLA INFECT SPREADS
   Rubyan-Ling D., 2015, BRIEFING PAPER DIASP
   Savoia E., 2015, RICE RISK COMMUNICAT
   Schoch-Spana M, 2016, STEWARD MED COUNTERM
   Schoch-Spana M., 2016, STEWARD MED COUNTER
   Sopory P., 2017, EVIDENCE SYNTHESES S
   Stalcup M., 2016, BRAZILS MEDIA ECOLOG
   Sugg C., 2016, COMING AGE COMMUNICA
   Sustersic L., 2015, SOCIAL MOBILIZATION
   Sustersic L., 2015, SOCIAL MOBILIZ UNPUB
   Turner M. M., 2016, EBOLA RISK COMMUNICA
   United Kingdom House of Commons International Development Committee, 2016, EB RESP PUBL HLTH EM
   United Nations Children's Fund (UNICEF), 2015, HOT SPOT BUST COMM F
   United Nations Children's Fund (UNICEF), 2015, EB BATTL ZER WORK RE
   United Nations General Assembly, 2016, PROT HUM FUT HLTH CR
   United Nations General Assembly, 2016, PROT HUM FUT HLTH CR
   United Nations Global Ebola Response, 2015, MAK DIFF GLOB EB RES
   United Nations Global Ebola Response, 2015, EB OUTBR UPD OV NEED
   United States Environmental Protection Agency (EPA), 2015, COMM ENG CAS AN METH
   United States Environmental Protection Agency (EPA), 2015, COMM ENG CAS AN METH
   University of Chicago National Research Center & The March of Dimes, 2016, ZIK VIR GAPS AM KNOW
   University of Minnesota, 2015, REC ACC DEV EB VACC
   University of Minnesota, 2015, REC ACC DEV EB VACC
   University of Minnesota, 2015, REC ACCL DEV EB VACC
   WHO, 2015, ON YEAR EB EP DEADL
   WHO, 2015, REP EB INT ASS PAN
   Wilkinson S., 2016, USING MEDIA COMMUNIC
   World Health Organization, 2015, WHO STRAT RESP PLAN
   World Health Organization, 2015, WHO EM REF WORKSH RE
   World Health Organization, 2015, EB INT ASS PAN REP S
   World Health Organization, 2015, ACC PROGR HIV TUB MA
   World Health Organization, 2015, EB VIR DIS PREP TAK
   World Vision, 2016, STILL SURV EB EM REC
   Y Care International, 2016, SIERR LEON YMCA EB O
NR 80
TC 9
Z9 9
U1 7
U2 12
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1041-0236
EI 1532-7027
J9 HEALTH COMMUN
JI Health Commun.
PD MAR 21
PY 2019
VL 34
IS 4
BP 437
EP 455
DI 10.1080/10410236.2017.1405488
PG 19
WC Communication; Health Policy & Services
SC Communication; Health Care Sciences & Services
GA HP2FG
UT WOS:000461483100008
PM 29558199
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Sherman, KE
   Rouster, SD
   Kong, LX
   Aliota, MT
   Blackard, JT
   Dean, GE
AF Sherman, Kenneth E.
   Rouster, Susan D.
   Kong, Ling X.
   Aliota, Matthew T.
   Blackard, Jason T.
   Dean, Gary E.
TI Zika virus replication and cytopathic effects in liver cells
SO PLOS ONE
LA English
DT Article
ID TRANSMISSION; PROPAGATION; STATES
AB Zika virus (ZIKV) has emerged globally as an important pathogen, since it has been recognized as a cause of microcephaly and other neurologic processes and sequalae in newborns. The virus shares homology with Hepaciviruses and therefore may be a cause of hepatitis. We sought to characterize ZIKV replication in hepatocyte-derived cell lines. Huh7.5 and HepG2 cells were infected with ZIKV and replication potential was evaluated by multiple methods including plaque assay, qRT-PCR, negative-strand ZIKV RNA production, and ZIKV NS1 protein production. Growth curves in cells and supernatant were compared to replicative capacity in Vero cells. Overall, viral replication in both hepatocyte lines approximated that observed in the Vero cells. Cell cytopathology was observed after 3 days of infection and apoptosis markers increased. Transmission electron microscopy revealed evidence of viral capsids in cells and negative staining revealed ZIKV particles in the supernatant. Conclusions: Hepatocyte-derived cell lines are permissive for ZIKV replication and produce an overt cytopathic effect consistent with development of an acute viral hepatitis. Further evaluation of replication and injury is warranted.
C1 [Sherman, Kenneth E.; Rouster, Susan D.; Kong, Ling X.; Blackard, Jason T.] Univ Cincinnati, Coll Med, Internal Med, Cincinnati, OH 45221 USA.
   [Aliota, Matthew T.] Univ Wisconsin, Madison, WI USA.
   [Dean, Gary E.] Univ Cincinnati, Coll Med, Mol Genet, Cincinnati, OH USA.
   [Aliota, Matthew T.] Univ Minnesota Twin Cities, Dept Vet & Biomed Sci, Minneapolis, MN USA.
RP Sherman, KE (corresponding author), Univ Cincinnati, Coll Med, Internal Med, Cincinnati, OH 45221 USA.
EM Kenneth.Sherman@uc.edu
OI Aliota, Matthew/0000-0002-6902-9149
FU University of Cincinnati College of Medicine; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R21AI131454, R01AI132563, R56AI132563]
FX This study was supported by a Distinguished Senior Investigator award
   from the University of Cincinnati College of Medicine to KES; and NIH
   funding grants R21AI131454, R01AI132563, R56AI132563 to MTA. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FRANCIS TI, 1972, B WORLD HEALTH ORGAN, V46, P659
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanford RE, 1998, METHODS MOL MED, P2543, DOI [10.1056/NEJMoa0805715, DOI 10.1056/NEJMOA0805715]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Sherman KE, 2018, JAIDS-J ACQ IMM DEF, V78, pE35, DOI 10.1097/QAI.0000000000001718
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003
   Weger- Lucarelli J., 2017, J VIROLOGY, V91
   WU Y, 2017, SCI REPORTS, V7
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
NR 18
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 20
PY 2019
VL 14
IS 3
AR e0214016
DI 10.1371/journal.pone.0214016
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HP6AW
UT WOS:000461765900064
PM 30893357
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ferreira, RO
   Garcez, PP
AF Ferreira, Raiane O.
   Garcez, Patricia P.
TI Dissecting the Toxic Effects of Zika Virus Proteins on Neural Progenitor
   Cells
SO NEURON
LA English
DT Editorial Material
ID STEM-CELLS; NEUROGENESIS
AB The mechanisms by which Zika virus (ZIKV) disrupts neurogenesis and causes microcephaly are poorly understood. In this issue of Neuron, Li et al. (2019) demonstrate that ZIKV protease NS2B-NS3 heterodimers cleave Septin-2 and lead to cytokinesis defects.
C1 [Ferreira, Raiane O.; Garcez, Patricia P.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
RP Garcez, PP (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
EM ppgarcez@icb.ufrj.br
RI Garcez, Patricia/F-8026-2012
OI Garcez, Patricia/0000-0002-9107-1335
CR Bhagat R, 2018, CELL DEATH DIFFER, V25, P1837, DOI 10.1038/s41418-018-0163-y
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Jiang X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01067
   Lee I, 2018, VIRUSES, V10, DOI 10.3390/v10050233
   Li HD, 2019, NEURON, V101, P1089, DOI 10.1016/j.neuron.2019.01.010
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 10
TC 2
Z9 2
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD MAR 20
PY 2019
VL 101
IS 6
BP 989
EP 991
DI 10.1016/j.neuron.2019.03.009
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA HP7WO
UT WOS:000461901500001
PM 30897362
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, HD
   Saucedo-Cuevas, L
   Yuan, L
   Ross, D
   Johansen, A
   Sands, D
   Stanley, V
   Guemez-Gamboa, A
   Gregor, A
   Evans, T
   Chen, SB
   Tan, L
   Molina, H
   Sheets, N
   Shiryaev, SA
   Terskikh, AV
   Gladfelter, AS
   Shresta, S
   Xu, ZH
   Gleeson, JG
AF Li, Hongda
   Saucedo-Cuevas, Laura
   Yuan, Ling
   Ross, Danica
   Johansen, Anide
   Sands, Daniel
   Stanley, Valentina
   Guemez-Gamboa, Alicia
   Gregor, Anne
   Evans, Todd
   Chen, Shuibing
   Tan, Lei
   Molina, Henrik
   Sheets, Nicholas
   Shiryaev, Sergey A.
   Terskikh, Alexey, V
   Gladfelter, Amy S.
   Shresta, Sujan
   Xu, Zhiheng
   Gleeson, Joseph G.
TI Zika Virus Protease Cleavage of Host Protein Septin-2 Mediates Mitotic
   Defects in Neural Progenitors
SO NEURON
LA English
DT Article
ID CITRON KINASE; STEM-CELLS; NS2B-NS3 PROTEASE; CYTOKINESIS; BRAIN;
   ORGANIZATION; FLAVIVIRUS; INFECTION; MITOSIS; NEUROGENESIS
AB Zika virus (ZIKV) targets neural progenitor cells in the brain, attenuates cell proliferation, and leads to cell death. Here, we describe a role for the ZIKV protease NS2B-NS3 heterodimer in mediating neurotoxicity through cleavage of a host protein required for neurogenesis. Similar to ZIKV infection, NS2B-NS3 expression led to cytokinesis defects and cell death in a protease activity-dependent fashion. Among binding partners, NS2B-NS3 cleaved Septin-2, a cytoskeletal factor involved in cytokinesis. Cleavage of Septin-2 occurred at residue 306 and forced expression of a non-cleavable Septin-2 restored cytokinesis, suggesting a direct mechanism of ZIKV-induced neural toxicity.
C1 [Li, Hongda; Saucedo-Cuevas, Laura; Johansen, Anide; Guemez-Gamboa, Alicia; Gregor, Anne; Gleeson, Joseph G.] Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA.
   [Li, Hongda; Saucedo-Cuevas, Laura; Ross, Danica; Johansen, Anide; Sands, Daniel; Stanley, Valentina; Guemez-Gamboa, Alicia; Gregor, Anne; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, Dept Neurosci, La Jolla, CA 92093 USA.
   [Yuan, Ling; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.
   [Evans, Todd; Chen, Shuibing; Tan, Lei] Weill Cornell Med, Dept Surg, New York, NY 10065 USA.
   [Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA.
   [Sheets, Nicholas; Shresta, Sujan] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.
   [Shiryaev, Sergey A.; Terskikh, Alexey, V] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.
   [Gladfelter, Amy S.] Univ North Carolina Chapel Hill, Dept Biol, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.
RP Gleeson, JG (corresponding author), Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA.; Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, Dept Neurosci, La Jolla, CA 92093 USA.
EM jogleeson@ucsd.edu
RI Terskikh, Alexey/U-8407-2019
OI Sands, Daniel/0000-0001-6880-7036; Guemez-Gamboa,
   Alicia/0000-0001-6890-4661; tan, lei/0000-0002-8473-4911
FU Druckenmiller Fellowship from the New York Stem Cell Foundation;
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 NS106387]
FX We thank Alex Strongin from Sanford-Burnham-Prebys Discovery Institute
   for the ZIKV NS2B3 clone; Guo-li Ming and Hongjun Song from University
   of Pennsylvania for NS2B and NS3 clones; Amy Gladfelter from UNC for
   Septin clones; the Rockefeller University Bio-imaging Resource Center;
   Kevin Cannon at The University of North Carolina at Chapel Hill; Oswald
   Quehenberger, Aaron Armando, and Milda Simonaitis at the UCSD Lipidomics
   Core; and Alysson Muotri, Alexey Terskikh, Charles Rice, Margaret
   MacDonald, and Edward Holmes for discussions. H.L. is supported by a
   Druckenmiller Fellowship from the New York Stem Cell Foundation. The
   work was supported by NIH grant R01 NS106387 to J.G.G., A.V.T., and S.S.
   J.G.G. is an Investigator with the Howard Hughes Medical Institute. The
   Sohn Conference Foundation and the Leona M. and Harry B. Helmsley
   Charitable Trust are acknowledged for mass spectrometry instrumentation.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Beites CL, 1999, NAT NEUROSCI, V2, P434
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bianchi FT, 2017, CELL REP, V18, P1674, DOI 10.1016/j.celrep.2017.01.054
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Carleton M, 2006, MOL CELL BIOL, V26, P3853, DOI 10.1128/MCB.26.10.3853-3863.2006
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Avino PP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015834
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DeMay BS, 2011, J CELL BIOL, V193, P1065, DOI 10.1083/jcb.201012143
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   El Amine N, 2013, J CELL BIOL, V203, P487, DOI 10.1083/jcb.201305053
   Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031
   Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ghouzzi Vincent El, 2017, Cell Death Dis, V8, pe2567, DOI 10.1038/cddis.2016.446
   Hayashi MT, 2013, ONCOGENE, V32, P4593, DOI 10.1038/onc.2012.615
   Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005
   Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0
   Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HD, 2016, AM J HUM GENET, V99, P501, DOI 10.1016/j.ajhg.2016.07.004
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   LoTurco JJ, 2003, CEREB CORTEX, V13, P588, DOI 10.1093/cercor/13.6.588
   Madaule P, 1998, NATURE, V394, P491
   Marques ID, 2012, CELL BIOCHEM BIOPHYS, V62, P317, DOI 10.1007/s12013-011-9307-0
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Meseroll RA, 2013, EUKARYOT CELL, V12, P182, DOI 10.1128/EC.00251-12
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Moawia A, 2017, ANN NEUROL, V82, P562, DOI 10.1002/ana.25044
   Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shindo A, 2014, SCIENCE, V343, P649, DOI 10.1126/science.1243126
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Volpe JJ, 2018, VOLPES NEUROLOGY NEW
   Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407
   WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042
   YAMSHCHIKOV VF, 1995, J VIROL, V69, P1995, DOI 10.1128/JVI.69.4.1995-2003.1995
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhou H, 2006, PROTEINS, V65, P692, DOI 10.1002/prot.21129
   Zuo ZL, 2009, J VIROL, V83, P1060, DOI 10.1128/JVI.01325-08
NR 66
TC 8
Z9 8
U1 1
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD MAR 20
PY 2019
VL 101
IS 6
BP 1089
EP +
DI 10.1016/j.neuron.2019.01.010
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA HP7WO
UT WOS:000461901500012
PM 30713029
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Bhargava, S
   Patel, T
   Gaikwad, R
   Patil, UK
   Gayen, S
AF Bhargava, Sonam
   Patel, Tarun
   Gaikwad, Ruchi
   Patil, Umesh Kumar
   Gayen, Shovanlal
TI Identification of structural requirements and prediction of inhibitory
   activity of natural flavonoids against Zika virus through molecular
   docking and Monte Carlo based QSAR Simulation
SO NATURAL PRODUCT RESEARCH
LA English
DT Article
DE Zika virus; NS2B-NS3 protease; flavonoids; Monte Carlo QSAR; docking
ID NS2B-NS3 PROTEASE; DENGUE; SMILES
AB There has been growing interest in the research of flavonoids due to their potential antiviral activities. Recently, some natural flavonoids have shown potential inhibitory activity against zika virus NS3-NS2B protease. In order to accelerate the drug discovery efforts using flavonoids, a Monte Carlo simulation-based QSAR method has been applied to find out the structural requirements for the inhibitory activity. The best QSAR model was obtained using SMILES descriptors and HSG descriptors with (EC)-E-1 connectivity with the following statistical parameters: R-2 = 0.9569 and Q(2) = 0.9050 for the test set. The best model was further utilised for the prediction of inhibitory activity of some other natural flavonoids. Four flavonoids (amentoflavone, fisetin, isorhamnetin and theaflavin-3-gallate) have shown higher predicted inhibitory activity and further validated by performing docking analysis. This study may help in understanding and performing natural flavonoids-based drug discovery against zika virus.
   [GRAPHICS]
   .
C1 [Bhargava, Sonam; Patel, Tarun; Gaikwad, Ruchi; Patil, Umesh Kumar; Gayen, Shovanlal] Dr Hari Singh Gour Vishwavidyalaya, Dept Pharmaceut Sci, Lab Drug Design & Discovery, Sagar, India.
RP Gayen, S (corresponding author), Dr Hari Singh Gour Vishwavidyalaya, Dept Pharmaceut Sci, Lab Drug Design & Discovery, Sagar, India.
EM shovanlal.gayen@gmail.com
OI Patel, Tarun/0000-0002-9842-1609
CR Ahmed B, 2017, NAT PROD RES, V26, P1, DOI [10.1080/14786419.2017.1320786, DOI 10.1080/14786419.2017.1320786]
   Amin S. A., 2017, J BIOMOL STRUCT DYN
   Amin SA, 2016, BIOORG MED CHEM LETT, V26, P5712, DOI 10.1016/j.bmcl.2016.10.058
   Amin SA, 2016, CAN J CHEM, V94, P637, DOI 10.1139/cjc-2016-0050
   Bhargava S, 2017, SAR QSAR ENV RES
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1
   Jasamai M, 2015, NAT PROD RES, V29, P1055, DOI 10.1080/14786419.2014.971317
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ojha PK, 2011, CHEMOMETR INTELL LAB, V109, P146, DOI 10.1016/j.chemolab.2011.08.007
   Ojha PK, 2011, CHEMOMETR INTELL LAB, V107, P194, DOI 10.1016/j.chemolab.2011.03.011
   Qin CF, 2014, SCI CHINA LIFE SCI, V57, P1230, DOI 10.1007/s11427-014-4783-2
   Roy PP, 2009, CHEM BIOL DRUG DES, V73, P442, DOI 10.1111/j.1747-0285.2009.00791.x
   Sosa AM, 2016, NAT PROD RES, V12, P1
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Toropov AA, 2005, INDIAN J CHEM A, V44, P1545
   Toropova AP, 2011, CENT EUR J CHEM, V9, P846, DOI 10.2478/s11532-011-0064-0
   Ul Qamar MT, 2014, BIOINFORMATION, V10, P460, DOI 10.6026/97320630010460
   Veselinovic J, 2014, ACTA FAC MEDICAE NAI, V31, P95, DOI 10.2478/afmnai-2014-0011
   Worachartcheewan A, 2015, MOL DIVERS, V19, P955, DOI 10.1007/s11030-015-9614-2
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
NR 23
TC 7
Z9 7
U1 1
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
PD MAR 19
PY 2019
VL 33
IS 6
BP 851
EP 857
DI 10.1080/14786419.2017.1413574
PG 7
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA HW3PV
UT WOS:000466606100013
PM 29241370
DA 2020-07-08
ER

PT J
AU Rajiah, K
   Maharajan, MK
   Yin, PY
   Yee, YW
   Lin, WW
   Kean, CH
AF Rajiah, Kingston
   Maharajan, Mari Kannan
   Yin, Pua Yin
   Yee, Yap Wei
   Lin, Wong Wan
   Kean, Chew Hui
TI Zika Outbreak Emergency Preparedness and Response of Malaysian Private
   Healthcare Professionals: Are They Ready?
SO MICROORGANISMS
LA English
DT Article
DE Zika; Malaysia; health care providers; epidemic
ID VIRUS-INFECTION; WORKERS KNOWLEDGE; TRANSMISSION; ATTITUDES; SINGAPORE;
   STUDENTS; CITIES; REGION; WOMEN
AB Zika virus has been declared as a public health emergency of international concern. The Center for Disease Control and Prevention has issued guidelines reminding healthcare workers about the importance of taking steps to prevent the spread of Zika virus, how to test and isolate patients suspected of carrying the Zika virus, and how to protect themselves from infection. Therefore, it is of utmost importance for healthcare professionals to be fully aware of Zika virus preparedness, and response measures should an outbreak occur in Malaysia in order to quickly and efficiently contain the outbreak, ensure the safety of individual or healthcare personnel safety, as well as to prevent further spreading of the disease. This research aims to show how prepared Malaysian healthcare professionals are against Zika virus and how well can they respond during an outbreak. In total, 504 healthcare professionals (128 general practitioners, 215 community pharmacists, 161 nurses) from private health clinics were the target population of the four states of Malaysia where Zika cases suspected. The sample size of each category was calculated by using a formula for estimating the population proportion. An additional 10% of the calculated sample size was added to compensate the non-response rate. The Center For Disease Control and Prevention and World Health Organisation provided a checklist to assess how prepared healthcare professionals are for an Zika outbreak. This checklist was modified to a questionnaire in order to assess health care professionals' preparedness and response to the Zika outbreak. Community pharmacists are still lacking in their preparedness and perceived response to the Zika outbreak compared to the general practitioners in the private sector. Hence community pharmacists should attend training given by the Ministry of Health Malaysia as a continuing education, which may help them to respond during a Zika outbreak.
C1 [Rajiah, Kingston; Maharajan, Mari Kannan] Int Med Univ, Sch Pharm, Dept Pharm Practice, Kuala Lumpur 57000, Malaysia.
   [Yin, Pua Yin; Yee, Yap Wei; Lin, Wong Wan; Kean, Chew Hui] Int Med Univ, Sch Pharm, Dept Pharm, Kuala Lumpur 57000, Malaysia.
RP Rajiah, K (corresponding author), Int Med Univ, Sch Pharm, Dept Pharm Practice, Kuala Lumpur 57000, Malaysia.
EM kingrajiah@gmail.com; MariKannan@imu.edu.my; yinyin1311@gmail.com;
   vinny.yap@gmail.com; ww11094@gmail.com; huikeanchew@gmail.com
RI Maharajan, MariKannan/F-6660-2017; Rajiah, Kingston/G-6681-2014
OI Maharajan, MariKannan/0000-0001-6812-0533; Rajiah,
   Kingston/0000-0002-7875-2902
FU Institute for Research, Development and Innovation [BP I-01-14 (23)
   2017]
FX This research was funded by Institute for Research, Development and
   Innovation, grant number BP I-01-14 (23) 2017"and "The APC was funded by
   BP I-01-14 (23) 2017".
CR Alemayehu M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0229-7
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Centers for Disease Control and Prevention, ZIK VIR HEALTHC PROF
   Centers for Disease Control and Prevention, ZIK TRAV INF
   Centers for Disease Control and Prevention, ZIK VIR HEALTHC PROV
   de Jong W, 2018, CRIT REV MICROBIOL, V44, P487, DOI [10.1080/1040841X.2018.1438986, 10.1080/1040841x.2018.1438986]
   Department of Health and Environmental Control, PREP PLANN RESP CHEC
   Dhimal M, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0426-3
   European Centre for Disease Prevention and Control, OUTBR REP ZIK VIR DI
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Harapan H, 2019, CLIN EPIDEMIOL GLOB, V7, P542, DOI 10.1016/j.cegh.2018.12.006
   Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Koh D, 2005, MED CARE, V43, P676, DOI 10.1097/01.mlr.0000167181.36730.cc
   KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Ministry of Health Malaysia, MIN HLTH GUID ZIK VI
   Ministry of Health Malaysia, GUID CONT PROF DEV P
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   Siraj Amir S, 2017, BMJ Glob Health, V2, pe000309, DOI 10.1136/bmjgh-2017-000309
   Teng Y, 2017, J INFECTION, V74, P484, DOI 10.1016/j.jinf.2017.01.015
   United Nations International Children's Emergency Fund, ZIK GLOB RESP
   WHO, ZIK VIR COMPL 2016 P
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   Wong LP, 2017, VACCINE, V35, P5912, DOI 10.1016/j.vaccine.2017.08.074
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organization, ZIK VIR REG PREP
   Yung C. F, 2017, PLOS CURR, V9, DOI [10.2471/BLT.16.183426, DOI 10.2471/BLT.16.183426]
NR 34
TC 2
Z9 2
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD MAR 19
PY 2019
VL 7
IS 3
AR 87
DI 10.3390/microorganisms7030087
PG 11
WC Microbiology
SC Microbiology
GA HS8VR
UT WOS:000464147700003
PM 30893885
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Iannolo, G
   Sciuto, MR
   Cuscino, N
   Pallini, R
   Douradinha, B
   Vitiani, LR
   De Maria, R
   Conaldi, PG
AF Iannolo, Gioacchin
   Sciuto, Maria Rita
   Cuscino, Nicola
   Pallini, Roberto
   Douradinha, Bruno
   Vitiani, Lucia Ricci
   De Maria, Ruggero
   Conaldi, Pier Giulio
TI Zika virus infection induces MiR34c expression in glioblastoma stem
   cells: new perspectives for brain tumor treatments
SO CELL DEATH & DISEASE
LA English
DT Article
ID MOUSE NUMB; SURVIVAL
AB Zika virus (ZIKV) is a flavivirus with a marked effect on fetal nervous system development. ZIKV treatment has recently been found to also have a benefit against glioblastoma, a highly aggressive brain tumor with a poor prognosis. The reported data do not completely explain the mechanism beyond this effect. Nevertheless, in the majority of the cases no adverse effect has been found in healthy adult humans. In this study, we characterized the ZIKV infection mechanism on glioblastoma stem cells, which are considered responsible for the tumor progression and resistance to conventional therapies. Moreover, we explain why the action of this virus is directed to the stem cells in the nervous system counterpart. Our results confirm the effectiveness of ZIKV treatment against glioblastoma, indicating novel molecular targets that can be introduced for more powerful therapies.
C1 [Iannolo, Gioacchin; Cuscino, Nicola; Conaldi, Pier Giulio] IRCCS ISMETT Mediterranean Inst Transplantat & Ad, Dept Res, Palermo, Italy.
   [Sciuto, Maria Rita; Vitiani, Lucia Ricci] Ist Super Sanita, Dept Oncol & Mol Med, Rome, Italy.
   [Pallini, Roberto] Univ Cattolica Sacro Cuore, Ist Neurochirurg, Rome, Italy.
   [Pallini, Roberto; De Maria, Ruggero] Fdn Policlin Univ A Gemelli IRCCS, Palermo, Italy.
   [Douradinha, Bruno] Ri MED Fdn IRCCS ISMETT, Regenerat Med & Immunol Unit, Palermo, Italy.
   [De Maria, Ruggero] Univ Cattolica Sacro Cuore, Ist Patol Gen, Rome, Italy.
RP Iannolo, G (corresponding author), IRCCS ISMETT Mediterranean Inst Transplantat & Ad, Dept Res, Palermo, Italy.
EM iannolo@yahoo.com
RI De Maria, Ruggero/S-6385-2019; PALLINI, Roberto/AAA-3747-2019; Conaldi,
   Pier Giulio/AAC-1573-2019; Sciuto, Maria Rita/Z-2167-2019; Pallini,
   Roberto/AAA-3760-2019
OI De Maria, Ruggero/0000-0003-2255-0583; PALLINI,
   Roberto/0000-0002-4611-8827; iannolo, gioacchin/0000-0002-7710-4735;
   Conaldi, Pier Giulio/0000-0003-1994-8005; SCIUTO, Maria
   Rita/0000-0002-3673-3623
FU IRCCS-ISMETT
FX We thank Dr. Giovanni Rezza (ISS Italian National Institute of Health)
   for providing the ZIKV. For technical help we thank C. Carcione. Numb
   Tween was a gift from Elisa Santolini, whom we all remember. The study
   was funded by IRCCS-ISMETT.
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247
   Bu PC, 2016, CELL STEM CELL, V18, P189, DOI 10.1016/j.stem.2016.01.006
   Cosco D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17579
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haas TL, 2017, CELL STEM CELL, V21, P35, DOI 10.1016/j.stem.2017.04.009
   Hai L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0119-z
   Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100
   Iannolo G, 2008, CRIT REV ONCOL HEMAT, V66, P42, DOI 10.1016/j.critrevonc.2007.09.004
   Iannolo G, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0400-9
   Iannolo G, 2016, CELL TRANSPLANT, V25, P353, DOI 10.3727/096368915X688245
   Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4
   Landre V, 2016, ONCOTARGET, V7, P11785, DOI 10.18632/oncotarget.7600
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Marziali G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21557
   Niklison-Chirou MV, 2016, MOL NEUROBIOL, V53, P4509, DOI 10.1007/s12035-015-9381-1
   Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644
   Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Seely BL, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-15
   Singh SK, 2003, CANCER RES, V63, P5821
   Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403
   Yamazaki H, 2012, EXP THER MED, V3, P793, DOI 10.3892/etm.2012.497
   Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X
NR 33
TC 3
Z9 3
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD MAR 19
PY 2019
VL 10
AR 263
DI 10.1038/s41419-019-1499-z
PG 10
WC Cell Biology
SC Cell Biology
GA HQ4XM
UT WOS:000462414600001
PM 30890698
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, L
   Wang, RK
   Wang, L
   Ben, HJ
   Yu, L
   Gao, F
   Shi, XL
   Yin, CB
   Zhang, FC
   Xiang, Y
   Zhang, LQ
AF Wang, Lin
   Wang, Ruoke
   Wang, Lei
   Ben, Haijing
   Yu, Lei
   Gao, Fei
   Shi, Xuanling
   Yin, Chibiao
   Zhang, Fuchun
   Xiang, Ye
   Zhang, Linqi
TI Structural Basis for Neutralization and Protection by a Zika
   Virus-Specific Human Antibody
SO CELL REPORTS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; WEST-NILE-VIRUS; DENGUE VIRUS;
   MOLECULAR-MECHANISMS; ENVELOPE PROTEIN; MOSQUITO; POTENT; VISUALIZATION;
   EPIDEMIOLOGY; GLYCOPROTEIN
AB We previously reported a human monoclonal antibody, ZK2B10, capable of protection against Zika virus (ZIKV) infection and microcephaly in developing mouse embryos. Here, we report the structural features and mechanism of action of ZK2B10. The crystal structure at a resolution of 2.32 angstrom revealed that the epitope is located on the lateral ridge of DIII of the envelope glycoprotein. Cryo-EM structure with mature ZIKV showed that the antibody binds to Dills around the icosahedral 2-fold, 3-fold, and 5-fold axes, a distinct feature compared to those reported for DIII-specific antibodies. The binding of ZK2B10 to ZIKV has no detectable effect on viral attachment to target cells or on conformational changes of the E glycoprotein in the acidic environment, suggesting that ZK2B10 functions at steps between the formation of the fusion intermediate and membrane fusion. These results provide structural and mechanistic insights into how ZK2B10 mediates protection against ZIKV infection.
C1 [Wang, Lin; Wang, Lei; Xiang, Ye] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol, Dept Basic Med Sci,Sch Med,Ctr Global Hlth & Infe, Beijing 100084, Peoples R China.
   [Wang, Ruoke; Ben, Haijing; Gao, Fei; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol,Comprehens AI, Dept Basic Med Sci,Sch Med,Ctr Global Hlth & Infe, Beijing 100084, Peoples R China.
   [Yu, Lei; Yin, Chibiao; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
RP Xiang, Y (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol, Dept Basic Med Sci,Sch Med,Ctr Global Hlth & Infe, Beijing 100084, Peoples R China.; Zhang, LQ (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol,Comprehens AI, Dept Basic Med Sci,Sch Med,Ctr Global Hlth & Infe, Beijing 100084, Peoples R China.
EM yxiang@mail.tsinghua.edu.cn; zhanglinqi@tsinghua.edu.cn
FU National Natural Science FoundationNational Natural Science Foundation
   of China [81530065, 31430037, 81590762]; Grand Challenge China
   [81661128042]; National Science and Technology Major Projects
   [2018ZX10731101-002, 2017ZX10201101-001-003]; Ministry of Science and
   Technology of ChinaMinistry of Science and Technology, China
   [2014CB542500-03]; National Science and Technology Major Project
   [2017ZX10305501-003]; Special Program of Guangdong Provincial Department
   of Science and Technology [2016A020248001]; Guangzhou Health Care and
   Cooperation Innovation Major grant [20174020229]
FX We are grateful to the ZIKV-convalescent patient for donating the blood
   samples from which mAbs were isolated. We thank Drs. Jian Wang, Wenxin
   Hong, and Lingzhai Zhao for providing the patient with treatment and
   care. This work was supported by National Natural Science Foundation
   awards 81530065, 31430037, and 81590762, and in part by Grand Challenge
   China (81661128042), National Science and Technology Major Projects
   (2018ZX10731101-002 and 2017ZX10201101-001-003), and the Ministry of
   Science and Technology of China (2014CB542500-03). The project was also
   supported by the National Science and Technology Major Project
   (2017ZX10305501-003), the Special Program of Guangdong Provincial
   Department of Science and Technology (2016A020248001), and the Guangzhou
   Health Care and Cooperation Innovation Major grant (20174020229).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Avelino-Silva VI, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30843-1
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beckham JD, 2017, J NEUROVIROL, V23, P339, DOI 10.1007/s13365-017-0528-x
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389
   Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Goddard J, 2016, AM J MED, V129, P1149, DOI 10.1016/j.amjmed.2016.07.021
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Gubler D., 2007, FIELDS VIROLOGY
   Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Jiang SB, 2019, CELL MOL IMMUNOL, V16, P96, DOI 10.1038/s41423-018-0043-x
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   Kong WL, 2018, MICROB PATHOGENESIS, V114, P476, DOI 10.1016/j.micpath.2017.12.031
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ozkurt Z, 2017, EURASIAN J MED, V49, P142, DOI 10.5152/eurasianjmed.2017.17147
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perez S., 2016, EUROSURVEILLANCE, V21
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pierson TC, 2012, STRUCTURE, V20, P200, DOI 10.1016/j.str.2012.01.014
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Qiu XD, 2018, NAT MICROBIOL, V3, P287, DOI 10.1038/s41564-017-0099-x
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008
   Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Williams J. A., 2017, J VIROL
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 104
TC 6
Z9 6
U1 1
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD MAR 19
PY 2019
VL 26
IS 12
BP 3360
EP +
DI 10.1016/j.celrep.2019.02.062
PG 14
WC Cell Biology
SC Cell Biology
GA HP4MC
UT WOS:000461649100017
PM 30893607
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Brown, JA
   Singh, G
   Acklin, JA
   Lee, S
   Duehr, JE
   Chokola, AN
   Frere, JJ
   Hoffman, KW
   Foster, GA
   Krysztof, D
   Cadagan, R
   Jacobs, AR
   Stramer, SL
   Krammer, F
   Garcia-Sastre, A
   Lim, JK
AF Brown, Julia A.
   Singh, Gursewak
   Acklin, Joshua A.
   Lee, Silviana
   Duehr, James E.
   Chokola, Anupa N.
   Frere, Justin J.
   Hoffman, Kevin W.
   Foster, Gregory A.
   Krysztof, David
   Cadagan, Richard
   Jacobs, Adam R.
   Stramer, Susan L.
   Krammer, Florian
   Garcia-Sastre, Adolfo
   Lim, Jean K.
TI Dengue Virus Immunity Increases Zika Virus-Induced Damage during
   Pregnancy
SO IMMUNITY
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; HUMAN PLACENTAL TROPHOBLASTS;
   CROSS-REACTIVITY; BIRTH-DEFECTS; INFECTION; DISEASE; PATHOGENESIS;
   PROTECTION; CELLS; EMERGENCE
AB Zika virus (ZIKV) has recently been associated with birth defects and pregnancy loss after maternal infection. Because dengue virus (DENV) and ZIKV co-circulate, understanding the role of antibody-dependent enhancement in the context of pregnancy is critical. Here, we showed that the presence of DENV-specific antibodies in ZIKV-infected pregnant mice significantly increased placental damage, fetal growth restriction, and fetal resorption. This was associated with enhanced viral replication in the placenta that coincided with an increased frequency of infected trophoblasts. ZIKV-infected human placental tissues also showed increased replication in the presence of DENV antibodies, which was reversed by FcyR blocking antibodies. Furthermore, ZIKV-mediated fetal pathogenesis was enhanced in mice in the presence of a DENV-reactive monoclonal antibody, but not in the presence of the LALA variant, indicating a dependence on FcyR engagement. Our data suggest a possible mechanism for the recent increase in severe pregnancy outcomes after ZIKV infection in DENV-endemic areas.
C1 [Brown, Julia A.; Singh, Gursewak; Acklin, Joshua A.; Lee, Silviana; Duehr, James E.; Chokola, Anupa N.; Frere, Justin J.; Hoffman, Kevin W.; Cadagan, Richard; Krammer, Florian; Garcia-Sastre, Adolfo; Lim, Jean K.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Brown, Julia A.; Acklin, Joshua A.; Lee, Silviana; Duehr, James E.; Chokola, Anupa N.; Hoffman, Kevin W.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.
   [Cadagan, Richard; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Foster, Gregory A.; Krysztof, David; Stramer, Susan L.] Amer Red Cross, Gaithersburg, MD USA.
   [Jacobs, Adam R.] Icahn Sch Med Mt Sinai, Dept Obstet & Gynecol, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA.
RP Lim, JK (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
EM jean.lim@mssm.edu
RI amsalu, ribka/G-8780-2019; Krammer, Florian/H-3237-2019
OI Krammer, Florian/0000-0003-4121-776X; Chokola,
   Anupa/0000-0003-4225-7640; Frere, Justin/0000-0002-7514-8873; Duehr,
   James/0000-0003-2077-6685
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI130299, R21AI129486, R21AI139593,
   R21AI127955, U19AI118610]; NIAID training grant [T32AI007647]; NIH, as
   part of the WRCEVA program: Dengue Virus Type 4 [PR 06-65-740,
   NR-49757]; NIH, as part of the WRCEVA program: Dengue Virus Type 1
   [BC89/94, NR-3787]
FX We thank Drs. Matthew J. Evan and Marion Sourisseau for providing the
   RNA standards for ZIKV quantification, Dr. Christian Schindler for
   providing the original Stat2<SUP>-/-</SUP> mice, and Dr. Domenico
   Tortorella for providing the NS3 antibody. We also thank David Sachs for
   assistance with R and Justin Taft for assistance with CellProfiler
   software. We are grateful to Drs. Dusan Bogunovic and Christopher J.
   Obara for invaluable evaluation of our manuscript. We thank Dr. Michael
   Donovan, Olha Fedoryshyn, Anastasiya Dzhun, and Josefa Lopez from the
   Biorepository and Pathology CoRE at the Mount Sinai Health System.
   Microscopy and image analysis were performed at the Microscopy CoRE at
   the Icahn School of Medicine at Mount Sinai. This work was supported by
   NIAID grants R21AI130299, R21AI129486, R21AI139593, and R21AI127955;
   NIAID training grant T32AI007647; and a supplement to NIAID grant
   U19AI118610. The following reagents were obtained through BEI Resources,
   NIAID, and NIH, as part of the WRCEVA program: Dengue Virus Type 4, PR
   06-65-740, NR-49757; Dengue Virus Type 1, BC89/94, NR-3787. Zika virus
   strain PRVABC59 was obtained through ATCC (VR-1843).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Aguado LC, 2015, CELL HOST MICROBE, V18, P714, DOI 10.1016/j.chom.2015.11.003
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Gil-Sanchez Alfonso, 2011, Frontiers in Genetics, V2, P57, DOI 10.3389/fgene.2011.00057
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lozano NA, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12972
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simister NE, 1998, VACCINE, V16, P1451, DOI 10.1016/S0264-410X(98)00107-8
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Tomashek KM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005025
   van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031
   Woods L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00308-x
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yougbare I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00269-1
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
   Zumla A, 2014, NEW ENGL J MED, V371, P1076, DOI 10.1056/NEJMc1408436
NR 65
TC 22
Z9 23
U1 3
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD MAR 19
PY 2019
VL 50
IS 3
BP 751
EP +
DI 10.1016/j.immuni.2019.01.005
PG 17
WC Immunology
SC Immunology
GA HP4QH
UT WOS:000461660500023
PM 30737148
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Martin-Acebes, MA
   Saiz, JC
AF Martin-Acebes, Miguel A.
   Saiz, Juan-Carlos
TI The Scientific Response to Zika Virus
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Editorial Material
DE Zika virus; epidemics; scientific literature; antiviral; vaccines
ID BIBLIOMETRIC ANALYSIS; DENGUE
AB Zika virus (ZIKV) is a mosquito-borne pathogen that became renowned in 2015 in Brazil mainly due to its association with microcephaly in newborns. Although most infections in adults are asymptomatic or cause mild illnesses, in a reduced number of cases, ZIKV can also produce severe complications that include neurological disorders (Guillain-Barre syndrome), ocular lesions, or reproductive alterations. From 2015 the efforts of a significant part of the scientific community were placed on ZIKV research, which has resulted in an unpredicted escalation of the knowledge of the biology and pathology of this virus. The rapid response of the scientific community against ZIKV highlights its enormous potential to counter attack a viral threat within a short time period. It is expected that this huge collaborative effort will produce affordable and effective prophylactic and therapeutic tools against ZIKV. Nevertheless, there are still other arboviral threats different from ZIKV that should not be forgotten.
C1 [Martin-Acebes, Miguel A.; Saiz, Juan-Carlos] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
RP Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
EM martin.mangel@inia.es; jcsaiz@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; Saiz,
   Juan-Carlos/0000-0001-8269-5544
CR Albuquerque PC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005132
   Azevedo RSS, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120496
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   de Melo M.C., 2017, INT J CURR RES, V9, P13
   Delwiche Frances A., 2018, Science & Technology Libraries, V37, P113, DOI 10.1080/0194262X.2018.1431589
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Herrada CA, 2018, J MED DEVICES, V12, DOI 10.1115/1.4041086
   Kaner J, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0194-4
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Nazerai L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010029
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Salam AP, 2017, ANN INTERN MED, V166, P725, DOI [10.7326/M16-2530, 10.7326/m16-2530]
   Sutarjono B, 2019, J INFECT DIS, V219, P734, DOI 10.1093/infdis/jiy572
   Valiant WG, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy151
   Valiant WG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0132-z
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
NR 28
TC 2
Z9 2
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD MAR 15
PY 2019
VL 8
IS 3
AR 369
DI 10.3390/jcm8030369
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA HT2ZZ
UT WOS:000464434400006
PM 30884762
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Degner, EC
   Ahmed-Braimah, YH
   Borziak, K
   Wolfner, MF
   Harrington, LC
   Dorus, S
AF Degner, Ethan C.
   Ahmed-Braimah, Yasir H.
   Borziak, Kirill
   Wolfner, Mariana F.
   Harrington, Laura C.
   Dorus, Steve
TI Proteins, Transcripts, and Genetic Architecture of Seminal Fluid and
   Sperm in the Mosquito Aedes aegypti
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID MALE ACCESSORY-GLAND; HOMOMORPHIC SEX-CHROMOSOMES; DENGUE VECTOR
   MOSQUITO; EXPRESSION ANALYSIS; ANOPHELES-GAMBIAE; FEMALE MONOGAMY;
   LARGE-SCALE; RNA-SEQ; DROSOPHILA; PEPTIDE
AB The yellow fever mosquito, Aedes aegypti, transmits several viruses causative of serious diseases, including dengue, Zika, and chikungunya. Some proposed efforts to control this vector involve manipulating reproduction to suppress wild populations or to replace them with disease-resistant mosquitoes. The design of such strategies requires an intimate knowledge of reproductive processes, yet our basic understanding of reproductive genetics in this vector remains largely incomplete. To accelerate future investigations, we have comprehensively catalogued sperm and seminal fluid proteins (SFPs) transferred to females in the ejaculate using tandem mass spectrometry. By excluding female-derived proteins using an isotopic labeling approach, we identified 870 sperm proteins and 280 SFPs. Functional composition analysis revealed parallels with known aspects of sperm biology and SFP function in other insects. To corroborate our proteome characterization, we also generated transcriptomes for testes and the male accessory glands-the primary contributors to Ae. aegypti sperm and seminal fluid, respectively. Differential gene expression of accessory glands from virgin and mated males suggests that transcripts encoding proteins involved in protein translation are upregulated post-mating. Several SFP transcripts were also modulated after mating, but >90% remained unchanged. Finally, a significant enrichment of SFPs was observed on chromosome 1, which harbors the male sex determining locus in this species. Our study provides a comprehensive proteomic and transcriptomic characterization of ejaculate production and composition and thus provides a foundation for future investigations of Ae. aegypti reproductive biology, from functional analysis of individual proteins to broader examination of reproductive processes.
C1 [Degner, Ethan C.; Harrington, Laura C.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.
   [Ahmed-Braimah, Yasir H.; Wolfner, Mariana F.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.
   [Borziak, Kirill; Dorus, Steve] Syracuse Univ, Ctr Reprod Evolut, Syracuse, NY 13244 USA.
RP Harrington, LC (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.; Wolfner, MF (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.; Dorus, S (corresponding author), Syracuse Univ, Ctr Reprod Evolut, Syracuse, NY 13244 USA.
EM mfw5@cornell.edu; lch27@cornell.edu; sdorus@syr.edu
OI Wolfner, Mariana/0000-0003-2701-9505; Borziak,
   Kirill/0000-0001-8126-9690; Ahmed-Braimah, Yasir/0000-0002-5805-5894
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI095491]; Cornell Graduate School
   fellowship; Cornell Entomology Department Griswold grant;
   NIH/NICHDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01HD059060,
   R21HD088910]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1S10OD010693-01,
   1S10OD017992-01]; NSFNational Science Foundation (NSF)
   [OAC1541396/ACI-1541396]
FX This study was supported by NIH/NIAID grant R01AI095491 to MFW and LCH,
   NIH/NICHD grant R21HD088910 to S.D. and MFW, a Cornell Graduate School
   fellowship to ECD, and a Cornell Entomology Department Griswold grant to
   ECD and LCH. YHAB was supported by NIH/NICHD grant R01HD059060 to MFW
   and Andrew G. Clark. RNA-seq data and mass spectrometry data were made
   possible by NIH grants 1S10OD010693-01 and 1S10OD017992-01,
   respectively. Proteomics computing was supported by NSF grant
   OAC1541396/ACI-1541396 to Eric Sedore of the Syracuse University
   Information Technology Services. Mosquito images in Graphical Abstract
   used with permission, (c) 2016 David Felix Duneau.
CR ADLAKHA V, 1975, J INSECT PHYSIOL, V21, P1453, DOI 10.1016/0022-1910(75)90207-3
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Alfonso-Parra C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004451
   Alfonso-Parra C, 2014, J INSECT PHYSIOL, V70, P117, DOI 10.1016/j.jinsphys.2014.07.004
   Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823
   Avila FW, 2010, GENETICS, V186, P595, DOI 10.1534/genetics.110.119735
   Baer B, 2012, J PROTEOMICS, V75, P5646, DOI 10.1016/j.jprot.2012.08.002
   Baer B, 2009, PROTEOMICS, V9, P2085, DOI 10.1002/pmic.200800708
   BAO SN, 1993, J SUBMICR CYTOL PATH, V25, P213
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Beckmann JF, 2013, INSECT BIOCHEM MOLEC, V43, P867, DOI 10.1016/j.ibmb.2013.07.002
   Bednarova A, 2013, COMP BIOCHEM PHYS C, V158, P142, DOI 10.1016/j.cbpc.2013.07.002
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boes KE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002946
   Bonilla ML, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2327-1
   Bono JM, 2011, P NATL ACAD SCI USA, V108, P7878, DOI 10.1073/pnas.1100388108
   Borras E., 2017, PROTEOMICS, V17
   Borziak K, 2016, SCI REP-UK, V6, DOI 10.1038/srep35864
   Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717
   Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7
   CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Clements A.N., 1992, BIOL MOSQUITOES DEV
   Conine CC, 2018, DEV CELL, V46, P470, DOI 10.1016/j.devcel.2018.06.024
   Corrigan L, 2014, J CELL BIOL, V206, P671, DOI 10.1083/jcb.201401072
   Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092
   DAPPLES C C, 1974, International Journal of Insect Morphology and Embryology, V3, P279, DOI 10.1016/0020-7322(74)90023-3
   Degner EC, 2016, MOL REPROD DEV, V83, P897, DOI 10.1002/mrd.22653
   Degner EC, 2016, AM J TROP MED HYG, V94, P780, DOI 10.4269/ajtmh.15-0893
   Deutsch EW, 2015, PROTEOM CLIN APPL, V9, P745, DOI 10.1002/prca.201400164
   Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915
   Dorus S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-177
   Duvall LB, 2017, CURR BIOL, V27, P3734, DOI 10.1016/j.cub.2017.10.074
   Ellison C., 2018, BIORXIV
   Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439
   Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178
   Fischer BE, 2012, P ROY SOC B-BIOL SCI, V279, P2636, DOI 10.1098/rspb.2012.0153
   Fontaine A, 2017, GENOME BIOL EVOL, V9, P2322, DOI 10.1093/gbe/evx171
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   FUCHS MS, 1968, LIFE SCI PT 1 PHYSI, V7, P835, DOI 10.1016/0024-3205(68)90114-8
   FUCHS MS, 1969, J INSECT PHYSIOL, V15, P701, DOI 10.1016/0022-1910(69)90265-0
   GWADZ RW, 1971, BIOL BULL, V140, P201, DOI 10.2307/1540069
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hammond AM, 2017, PATHOG GLOB HEALTH, V111, P412, DOI 10.1080/20477724.2018.1438880
   Hatala AJ, 2018, J MED ENTOMOL, V55, P1051, DOI 10.1093/jme/tjy040
   Helinski MEH, 2012, J INSECT PHYSIOL, V58, P1307, DOI 10.1016/j.jinsphys.2012.07.003
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Joshi N. A., 2011, SICKLE SLIDING WINDO
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1
   KLOWDEN MJ, 1991, J INSECT PHYSIOL, V37, P721, DOI 10.1016/0022-1910(91)90105-9
   Konuma T, 2012, ENDOCRINOLOGY, V153, P3111, DOI 10.1210/en.2011-1533
   LaFlamme BA, 2013, MOL REPROD DEV, V80, P80, DOI 10.1002/mrd.22130
   Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675
   Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Leiblich A, 2012, P NATL ACAD SCI USA, V109, P19292, DOI 10.1073/pnas.1214517109
   LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003
   Lindholm AK, 2016, TRENDS ECOL EVOL, V31, P315, DOI 10.1016/j.tree.2016.02.001
   Macias VM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091006
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   Miller D, 2006, Gynecol Obstet Fertil, V34, P840, DOI 10.1016/j.gyobfe.2006.07.013
   Miyata H, 2012, CYTOSKELETON, V69, P207, DOI 10.1002/cm.21012
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Morley Alexander A, 2014, Biomol Detect Quantif, V1, P1
   Naccarati C, 2012, PEPTIDES, V34, P150, DOI 10.1016/j.peptides.2011.10.027
   Nagaoka S, 2012, INSECT BIOCHEM MOLEC, V42, P571, DOI 10.1016/j.ibmb.2012.04.004
   Ndiaye M, 1997, TISSUE CELL, V29, P675, DOI 10.1016/S0040-8166(97)80043-2
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6
   Peng J, 2005, CURR BIOL, V15, P207, DOI 10.1016/j.cub.2005.01.034
   Perotti ME, 2001, MOL REPROD DEV, V60, P248, DOI 10.1002/mrd.1085
   Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pilch B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r40
   Pitts RJ, 2014, P NATL ACAD SCI USA, V111, P2566, DOI 10.1073/pnas.1322923111
   Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2
   Predel R, 2010, J PROTEOME RES, V9, P2006, DOI 10.1021/pr901187p
   RAMALINGAM S, 1983, INT J INSECT MORPHOL, V12, P87, DOI 10.1016/0020-7322(83)90002-8
   Reidenbach KR, 2012, GENOME BIOL EVOL, V4, P1202, DOI 10.1093/gbe/evs095
   Rhea JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000967
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rognes T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-221
   Sepil I., 2018, MOL CELLULAR PROTEOM
   Sharma U, 2018, DEV CELL, V46, P481, DOI 10.1016/j.devcel.2018.06.023
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Shi QM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2213-6
   Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690
   Sirot L. K., 2014, COLD SPRING HARB PER, V7
   Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007
   Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989
   Stephens K, 2018, MOL REPROD DEV, V85, P440, DOI 10.1002/mrd.22980
   Sutton ER, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3280-3
   Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733
   Thaler CD, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109488
   Toups MA, 2010, GENETICS, V186, P763, DOI 10.1534/genetics.110.118794
   Vicoso B, 2013, P NATL ACAD SCI USA, V110, P6453, DOI 10.1073/pnas.1217027110
   Villarreal SM, 2018, J INSECT PHYSIOL, V108, P1, DOI 10.1016/j.jinsphys.2018.05.001
   Visconti PE, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.104109
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002
   Werner M, 2008, BIOL REV, V83, P191, DOI 10.1111/j.1469-185X.2008.00039.x
   Whittington E, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4293-2
   Whittington E, 2015, INSECT BIOCHEM MOLEC, V62, P183, DOI 10.1016/j.ibmb.2015.02.011
   Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524
   Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zareie R, 2013, J PROTEOME RES, V12, P5180, DOI 10.1021/pr4004773
NR 115
TC 7
Z9 7
U1 2
U2 16
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD MAR 15
PY 2019
VL 18
IS 3
SU 1
BP S6
EP S22
DI 10.1074/mcp.RA118.001067
PG 17
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA HQ5YK
UT WOS:000462488500005
PM 30552291
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kallel, H
   Matheus, S
   Mayence, C
   Houcke, S
   Mathien, C
   Lavergne, A
   Hommel, D
AF Kallel, Hatem
   Matheus, Severine
   Mayence, Claire
   Houcke, Stephanie
   Mathien, Cyrille
   Lavergne, Anne
   Hommel, Didier
TI Capillary leak-syndrome triggered by Maripa virus in French Guiana: case
   report and implication for pathogenesis
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Hantavirus; Maripa; Pulmonary syndrome; Capillary leak-syndrome
ID HANTAVIRUS PULMONARY SYNDROME; INFECTION; DENGUE; SHOCK; ZIKA
AB BackgroundWe report hereby a severe case of Hantavirus Pulmonary Syndrome (HPS) induced by Maripa virus in French Guiana and describe the mechanism of severity of the human disease.Case presentationA 47-year- old patient started presenting a prodromic period with fever, dyspnea, cough and head ache. This clinical presentation was followed by a rapid respiratory, hemodynamic and renal failure leading to admission in the ICU. Biological exams revealed an increased haematocrit level with a paradoxical low protein level. Echocardiographic and hemodynamic monitoring showed a normal left ventricular function with low filling pressures, an elevated extravascular lung water index and pulmonary vascular permeability index. These findings were compatible with a capillary leak-syndrome (CLS).ConclusionsThe severity of HPS caused by the virus Maripa in French Guiana can be explained by the tropism of hantavirus for the microvascular endothelial cell leading to a CLS.
C1 [Kallel, Hatem; Mayence, Claire; Houcke, Stephanie; Mathien, Cyrille; Hommel, Didier] Ctr Hosp Andree Rosemon Cayenne, Serv Reanimat Polyvalente, Ave Flamboyants 6006, Cayenne 97306, BP, French Guiana.
   [Matheus, Severine] Inst Pasteur, Ctr Natl Reference Hantavirus, Lab Associe, Cayenne, French Guiana.
   [Lavergne, Anne] Inst Pasteur, Lab Interact Virus Hotes, Cayenne, French Guiana.
RP Kallel, H (corresponding author), Ctr Hosp Andree Rosemon Cayenne, Serv Reanimat Polyvalente, Ave Flamboyants 6006, Cayenne 97306, BP, French Guiana.
EM kallelhat@yahoo.fr
CR Antonen J, 2013, SCAND J INFECT DIS, V45, P494, DOI 10.3109/00365548.2012.755268
   Borges AA, 2008, CURR OPIN INFECT DIS, V21, P293, DOI 10.1097/QCO.0b013e3282f88b6f
   CLARKSON B, 1960, AM J MED, V29, P193, DOI 10.1016/0002-9343(60)90018-8
   Hayasaka D, 2007, VIRUS RES, V123, P120, DOI 10.1016/j.virusres.2006.08.006
   Laine O, 2015, INFECT DIS-NOR, V47, P107, DOI 10.3109/00365548.2014.969304
   MacNeil A, 2011, VIRUS RES, V162, P138, DOI 10.1016/j.virusres.2011.09.017
   Matheus S, 2018, EMERG INFECT DIS, V24, P1734, DOI 10.3201/eid2409.180223
   Matheus S, 2017, EMERG INFECT DIS, V23, P1722, DOI 10.3201/eid2310.170842
   Matheus S, 2010, EMERG INFECT DIS, V16, P739, DOI 10.3201/eid1604.090831
   Meltzer E, 2012, AM J TROP MED HYG, V86, P536, DOI 10.4269/ajtmh.2012.10-0670
   Outinen TK, 2016, INFECT DIS-NOR, V48, P682, DOI 10.1080/23744235.2016.1192719
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Taylor SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003470
   Terajima M, 2007, IMMUNOL LETT, V113, P117, DOI 10.1016/j.imlet.2007.08.003
NR 15
TC 1
Z9 1
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 15
PY 2019
VL 19
AR 260
DI 10.1186/s12879-019-3887-5
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA HP0RE
UT WOS:000461372700003
PM 30876401
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Glynn-Robinson, A
   Sloan-Gardner, T
   Trungove, M
   Corvisy, R
   Bright, A
   Katsoulis, C
   Albarricin, R
   Knope, K
   Burroughs, A
   Bareja, C
   Cairns, A
   Pennington, K
   Roche, P
   Vette, K
AF Glynn-Robinson, Anna
   Sloan-Gardner, Tim
   Trungove, Mark
   Corvisy, Rachael
   Bright, Amy
   Katsoulis, Carolyn
   Albarricin, Rizsa
   Knope, Katrina
   Burroughs, Amy
   Bareja, Christina
   Cairns, Allison
   Pennington, Kate
   Roche, Paul
   Vette, Kaitlyn
CA NNDSS Annual Report Working Grp
TI Australia's notifiable disease status, 2015: Annual report of the
   National Notifiable Diseases Surveillance System
SO COMMUNICABLE DISEASES INTELLIGENCE
LA English
DT Article
ID GENITAL CHLAMYDIA-TRACHOMATIS; ACELLULAR PERTUSSIS-VACCINE; MALE SEXUAL
   TRANSMISSION; ZIKA VIRUS; JAPANESE ENCEPHALITIS; MEASLES ELIMINATION;
   CONGENITAL-RUBELLA; NORTH QUEENSLAND; BAT LYSSAVIRUS; MUMPS OUTBREAK
AB In 2015, 67 diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 320,480 notifications of communicable diseases to the National Notifiable Diseases Surveillance System, an increase of 16% on the number of notifications in 2014. In 2015, the most frequently notified diseases were vaccine preventable diseases (147,569 notifications, 46% of total notifications), sexually transmissible infections (95,468 notifications, 30% of total notifications), and gastrointestinal diseases (45,326 notifications, 14% of total notifications). There were 17,337 notifications of bloodborne diseases; 12,253 notifications of vectorborne diseases; 1,815 notifications of other bacterial infections; 710 notifications of zoonoses and 2 notifications of quarantinable diseases.
CR Ali H, 2012, SEX TRANSM INFECT, V88, P552, DOI 10.1136/sextrans-2011-050423
   Allworth A., 1996, Communicable Diseases Intelligence, V20, P504
   Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089
   Animal Health Australia, 2013, AN HLTH AUSTR 2012
   [Anonymous], 2017, WHO REC SURV STAND P
   [Anonymous], 2015, AUSTR CHILDHOOD IMMU
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Atkinson WWS, 2011, EPIDEMIOLOGY PREVENT
   Australasian Society for HIV Medicine, 2014, HIV VIR HEP STIS GUI
   Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine, 2016, AUSTR STI MAN GUID U
   Australian Bureau of Statistics, 2015, AUSTR DEM STAT
   Australian Bureau of Statistics, 2011, CENS POP HOUS CHAR A
   Australian Bureau of Statistics, 2011, 12690 SACC
   Australian Government Department of Health, 2014, 4 NAT AB TORR STRAIT
   Australian Government Department of Health, 2014, 3 NAT SEX TRANSM INF
   Australian Government  Department Of Health, 2014, TUB NOT AUSTR ANN RE
   Australian Government Department of Health and Ageing, 2004, GUID SMALLP OUTBR PR
   Australian insititute of Health and Welfare, 2014, NAT DRUG STRAT HOUS
   Australian Institute of Health and Welfare, 2008, NAT HLTH DAT DICT 13
   Australian Institute of Health and Welfare, 2005, AG STAND RAT ID DEF
   Australian Institute of Health and Welfare, 2015, HLTH AUSTR PRIS 2015
   Australian Technical Advisory Group on Immunisation, 2013, AUSTR IMM HDB
   Australian Technical Advisory Group on Immunisation (ATAGI) National Health and Medical Research Council, 2013, AUSTR IMM HDB
   Bangor-Jones R D, 2009, MED J AUSTRALIA, V191, P4
   Bareja C, 2014, COMMUN DIS INTELL, V38, pE36
   Barr I, 2016, EUROSURVEILLANCE, V21
   Bat Health Focus Group, 2016, ABLV BAT STATS AUSTR
   Beard FH, 2015, COMMUN DIS INTELL, V39, pE329
   Beeckman DSA, 2009, CLIN MICROBIOL INFEC, V15, P11, DOI 10.1111/j.1469-0691.2008.02669.x
   Bell M, 1997, Commun Dis Intell, V21, P29
   Bell R, 2010, COMMUN DIS INTELL, V34, P396
   Bennett J.E., 2014, PRINCIPLES PRACTICE
   Bowden FJ, 2005, SEX TRANSM INFECT, V81, P365, DOI 10.1136/sti.2004.013227
   Burckhardt F, 2006, SEX TRANSM INFECT, V82, P24, DOI 10.1136/sti.2004.011882
   Butler T, 2015, NATL PRISON ENTRANTS
   Calisher CH, 2012, TRAVEL MED INFECT DI, V10, P69, DOI 10.1016/j.tmaid.2012.01.003
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375
   Centre for Disease Control Northern Territory, 2015, NO TERRITORY DIS CON, V22, P1
   Chandran A, 2008, VACCINES
   Chen MY, 2007, INT J STD AIDS, V18, P239, DOI 10.1258/095646207780658854
   Chen MY, 2005, AUST NZ J PUBL HEAL, V29, P249, DOI 10.1111/j.1467-842X.2005.tb00763.x
   Cohen C, 2007, EMERG INFECT DIS, V13, P12
   Communicable Diseases Branch, 2010, N S W Public Health Bull, V21, P103, DOI 10.1071/NB10025
   Communicable Diseases Branch, 2015, NSW ZOON ANN SURV RE
   Communicable Diseases Network Australia, 2009, MEN DIS INV SURV CAS
   Communicable Diseases Network Australia, 2013, SER NAT GUID PERT
   Communicable Diseases Network Australia, 2013, SER NAT GUID RAB VIR
   Communicable Diseases Network Australia, 2015, SYPH INF PRIM SEC EA
   Communicable Diseases Network Australia, 2016, AUSTR NAT NOT DIS CA
   Communicable Diseases Network Australia, 2015, NAT NOT DIS SURV SYS
   Corvisy R, 2013, COMMUN DIS INTELL, V37, pE313
   Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888
   Cumpston JHL., 1989, HLTH DIS AUSTR
   Curran M, 1997, Commun Dis Intell, V21, P281
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dayan GH, 2008, NEW ENGL J MED, V358, P1580, DOI 10.1056/NEJMoa0706589
   de Jong B, 2010, EUROSURVEILLANCE, V15, P2
   De Serres G, 2000, AM J EPIDEMIOL, V151, P1039, DOI 10.1093/oxfordjournals.aje.a010145
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deeks SL, 2011, CAN MED ASSOC J, V183, P1014, DOI 10.1503/cmaj.101371
   Demicheli V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub3
   Department of Health Australian Government, 2016, AUSTR IMM HDB
   Deschuyffeleer TPG, 2012, ANN OCCUP HYG, V56, P340, DOI 10.1093/annhyg/mer102
   Donnan EJ, 2012, CLIN INFECT DIS, V54, P775, DOI 10.1093/cid/cir949
   Donovan B, 2015, SEX HEALTH, V12, P48, DOI 10.1071/SH14179
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eales KM, 2010, AM J TROP MED HYG, V83, P876, DOI 10.4269/ajtmh.2010.10-0237
   Ehreth J, 2003, VACCINE, V21, P596, DOI 10.1016/S0264-410X(02)00623-0
   Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002
   Fenner F, 1988, SMALLPOX ITS ERADICA
   Fitzsimmons G, 2012, COMMUN DIS INTELL, V36, pE213
   Forssman B, 2007, MED J AUSTRALIA, V187, P345, DOI 10.5694/j.1326-5377.2007.tb01278.x
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Francis JR, 2014, PEDIATRICS, V133, pE1063, DOI 10.1542/peds.2013-1782
   Fraser GC, 1996, EMERG INFECT DIS, V2, P327, DOI 10.3201/eid0204.960408
   Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094
   Gidding H F, 2001, Commun Dis Intell Q Rep, V25, P133
   Gidding HF, 2016, J EPIDEMIOL GLOB HEA, V6, P197, DOI 10.1016/j.jegh.2015.12.004
   Gidding HF, 2007, VACCINE, V25, P8637, DOI 10.1016/j.vaccine.2007.07.046
   Gidding HF, 2007, VACCINE, V25, P3574, DOI 10.1016/j.vaccine.2007.01.090
   Gidding HF, 2009, VACCINE, V27, P2037, DOI 10.1016/j.vaccine.2009.02.007
   Global Polio Eradication Initiative, 2017, WILD POL VIR LIST 20
   Graham S, 2012, MED J AUSTRALIA, V197, P642, DOI 10.5694/mja12.10163
   GRATTANSMITH PJ, 1992, MED J AUSTRALIA, V156, P651, DOI 10.5694/j.1326-5377.1992.tb121465.x
   Gray TJ, 2012, COMMUN DIS INTELL, V36, P107
   Gupta RK, 2005, BMJ-BRIT MED J, V330, P1132, DOI 10.1136/bmj.330.7500.1132
   Guzman M G, 1987, Bull Pan Am Health Organ, V21, P270
   Hammerschlag MR, 1998, SEX TRANSM INFECT, V74, P167, DOI 10.1136/sti.74.3.167
   Hanna JN, 1999, MED J AUSTRALIA, V170, P533, DOI 10.5694/j.1326-5377.1999.tb127878.x
   Hanna JN, 2000, MED J AUSTRALIA, V172, P597, DOI 10.5694/j.1326-5377.2000.tb124126.x
   Hanna JN, 2004, MED J AUSTRALIA, V180, P24, DOI 10.5694/j.1326-5377.2004.tb05769.x
   Harrington S, 2009, CHRISTMAS ISLAND COC
   Heyman D, 2015, CONTROL COMMUNICABLE
   Heywood AE, 2009, B WORLD HEALTH ORGAN, V87, P64, DOI 10.2471/BLT.07.046375
   Hocking J, 2003, AUST NZ J PUBL HEAL, V27, P405, DOI 10.1111/j.1467-842X.2003.tb00417.x
   Hooper PT, 1997, B I PASTEUR, V95, P209, DOI 10.1016/S0020-2452(97)83529-5
   Jackson J, 2012, EMERG INFECT DIS, V18, P1484, DOI 10.3201/eid1809.111856
   Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Khandaker G, 2014, VACCINE, V32, P6746, DOI 10.1016/j.vaccine.2014.10.021
   Klug GM, 2014, COMMUN DIS INTELL, V38, pE348
   Knope K, 2013, COMMUN DIS INTELL Q, V37, pE1
   Knope K, 2016, COMMUN DIS INTELL, V40
   Knope K, 2013, COMMUN DIS INTELL Q, V37, pE55
   Kolbe A, 2006, MED J AUSTRALIA, V185, P281, DOI 10.5694/j.1326-5377.2006.tb00562.x
   Lahra M, 2015, COMM DIS INTELL, V40
   Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Li J, 2002, COMMUN DIS INTELL, V26, P462
   Lin Ming, 2001, N S W Public Health Bull, V12, P172, DOI 10.1071/NB01058
   Lindsay MDA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004114
   Lowbridge Chris P, 2012, N S W Public Health Bull, V23, P31, DOI 10.1071/NB11037
   Luca Simona, 2013, Maedica (Buchar), V8, P53
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   MacLachlan JH, 2013, AUST NZ J PUBL HEAL, V37, P416, DOI 10.1111/1753-6405.12049
   Martin N, 2016, COMM DIS INTELL, V40
   Mauskopf Josephine, 2013, J Med Econ, V16, P264, DOI 10.3111/13696998.2012.752376
   McCarthy M., 2016, BMJ, V352
   MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981
   McLean H, 2012, MANUAL SURVEILLANCE
   Miller M, 2005, COMMUN DIS INTELL, V29, P1
   Ministerio da Saude, 2015, CONF ZIK VIR BRAS
   Munoz Flor M, 2006, Semin Pediatr Infect Dis, V17, P14, DOI 10.1053/j.spid.2005.11.005
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naidu L, 2013, COMMUN DIS INTELL, V37, pS1
   National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, 2012, HEP B VACC AUSTR NCI
   National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, HEP B VACC AUSTR INF
   National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, 2014, SIGN EV HEP B VACC P
   National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, 2009, HAEM INFL TYP B HIB
   National HBV Testing Policy Expert Reference Committee, 2015, NAT HEP B TEST POL 2
   National HCV Testing Policy Expert Reference Committee, 2012, NAT HEP C TEST POL 2
   National Health and Medical Research Council (NHMRC), 2013, AUSTR IMM HDB
   National Tuberculosis Advisory Committee, 2013, COMMUN DIS INTELL, V37, pE65
   O'Connor BA, 2007, EPIDEMIOL INFECT, V135, P34, DOI 10.1017/S095026880600656X
   O'Leary FM, 2004, MED J AUSTRALIA, V180, P29, DOI 10.5694/j.1326-5377.2004.tb05770.x
   Pacific Public Health Surveillance Network, 2015, PAC SYNDR SURV REP 1
   Pacific Public Health Surveillance Network, 2015, EM MEMB PACNET
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Parida MM, 2008, FUTURE VIROL, V3, P179, DOI 10.2217/17460794.3.2.179
   Plotkin SA, 2008, MUMPS VACCINE
   Pravinkumar SJ, 2010, EUROSURVEILLANCE, V15, P4
   Prestage G, 2008, SEX HEALTH, V5, P97, DOI 10.1071/SH07080
   Preziosi MP, 2003, CLIN INFECT DIS, V37, P772, DOI 10.1086/377270
   Public Health England, 2013, IMMUNISATION INFECT, P394
   Punpanich W, 2012, INT J INFECT DIS, V16, pE714, DOI 10.1016/j.ijid.2012.05.1025
   Queensland Department of Agriculture, 2013, AN HLTH DIS
   Queensland Health, QUEENSL DENG MAN PLA
   Quinn H, 2010, 12 NAT IMM C AD S AU
   Quinn HE, 2007, VACCINE, V25, P1304, DOI 10.1016/j.vaccine.2006.09.084
   Quinn HE, 2014, PEDIATRICS, V133, pE513, DOI 10.1542/peds.2013-3181
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Razali K, 2007, DRUG ALCOHOL DEPEN, V91, P228, DOI 10.1016/j.drugalcdep.2007.05.026
   Roberts-Witteveen A, 2014, SEX HEALTH, V11, P324, DOI 10.1071/SH13205
   Rota MC, 2013, EURO SURVEILL, V18
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1
   SCHLENKER TL, 1992, JAMA-J AM MED ASSOC, V267, P823, DOI 10.1001/jama.267.6.823
   Sheridan SL, 2014, MED J AUSTRALIA, V200, P334, DOI 10.5694/mja13.11069
   Song N, 2012, VACCINE, V30, P4073, DOI 10.1016/j.vaccine.2012.04.025
   Stephens N, 2010, AUST NZ J PUBL HEAL, V34, P120, DOI 10.1111/j.1753-6405.2010.00494.x
   Strebel PM, 2008, VACCINES
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   The Australian Department of Health, 2015, POL AUSTR NAT ENT RE
   The Kirby Institute, 2014, HIV VIR HEP SEX TRAN, P2052
   The Kirby Institute, 2015, HIV VIR HEP SEX TRAN, P2052
   Tonga Ministry of Health, 2015, EM PACNET MEMB
   University of Adelaide, 2015, 26 U AD
   van den Beld MJ, DIFFERENTIATION SHIG, P1435
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Veitch M., 2013, COMM DIS CONTR C 201
   Victoria Department of Health, 2009, BLUE BOOK GUID CONTR
   Ward JS, 2011, MED J AUSTRALIA, V194, P525, DOI 10.5694/j.1326-5377.2011.tb03089.x
   Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41
   Western Pacific Regional Office, 2012, RUB CONG RUB SYNDR
   Westphal D, 2017, COMM DIS CONTR C INF, P7
   Westphal D, 2016, PUBL HLTH ASS AUSTR
   Whelan J, 2010, EUROSURVEILLANCE, V15, P11
   Whelan P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001619
   Whiley H, 2011, EMERG INFECT DIS, V17, P579, DOI 10.3201/eid1704.100446
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   World Health Organisation (WHO), 2013, CUM NUMB CONF HUM CA
   World Health Organization, 2014, DIS FACT SHEETS
   World Health Organization, 2004, REP WHO FAO OIE JOIN
   World Health Organization, 2016, 1 M INT HLTH REG 200
   World Health Organization, WORLD MAL REP 2015
   World Health Organization, 2014, 4 W PAC COUNTR AR AR
   World Health Organization Western Pacific Regional Office, 2016, POL B WEEK 1 5 JAN 2
   World Health Organization (WHO), 2016, DENG SEV DENG
   World Health Organization. Zoonoses, 1959, TECHNICAL REPORT SER, V169
   World Health Organization-WHO, 2003, HUM LEPT GUID DIAGN
   Zoonoses Fielding J., 2007, VICTORIAN INFECT DIS, V10, P47
   2015, COMMUN DIS INTELL, V39, pE387
   1999, MORTAL MORB WKLY REP, V48, P243
NR 196
TC 3
Z9 3
U1 1
U2 4
PU AUSTRALIAN GOVERNMENT, DEPT HEALTH & AGEING
PI CANBERRA
PA OFFICE HEALTH PROTECTION SURVEILLANCE BRANCH, GPO BOX 9848, CANBERRA,
   ACT 2601, AUSTRALIA
SN 0725-3141
EI 1445-4866
J9 COMMUN DIS INTELL
JI Commun. Dis. Intell.
PD MAR 15
PY 2019
VL 43
DI 10.33321/cdi.2019.43.6
PG 186
WC Infectious Diseases
SC Infectious Diseases
GA HP2OS
UT WOS:000461515900001
PM 30879283
OA Bronze
DA 2020-07-08
ER

PT J
AU Rosa-Fernandes, L
   Cugola, FR
   Russo, FB
   Kawahara, R
   Freire, CCD
   Leite, PEC
   Stern, ACB
   Angeli, CB
   de Oliveira, DBL
   Melo, SR
   Zanotto, PMD
   Durigon, EL
   Larsen, MR
   Beltrao-Braga, PCB
   Palmisano, G
AF Rosa-Fernandes, Livia
   Cugola, Fernanda Rodrigues
   Russo, Fabiele Baldino
   Kawahara, Rebeca
   de Melo Freire, Caio Cesar
   Correa Leite, Paulo Emlio
   Bassi Stern, Ana Carolina
   Angeli, Claudia Blanes
   Leal de Oliveira, Danielle Bruna
   Melo, Stella Rezende
   de Andrade Zanotto, Paolo Marinho
   Durigon, Edison Luiz
   Larsen, Martin Rossel
   Baleeiro Beltrao-Braga, Patricia Cristina
   Palmisano, Giuseppe
TI Zika Virus Impairs Neurogenesis and Synaptogenesis Pathways in Human
   Neural Stem Cells and Neurons
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Article
DE Zika virus; microcephaly; congenital Zika syndrome; neurogenesis;
   synaptogenesis
ID TISSUE GROWTH-FACTOR; MICROTUBULE-ASSOCIATED PROTEIN; SEXUAL
   TRANSMISSION; DIFFERENTIATION; DOUBLECORTIN; BETA; ENRICHMENT;
   TGF-BETA-1; MOLECULES; CORTEX
AB Growing evidences have associated Zika virus (ZIKV) infection with congenital malformations, including microcephaly. Nonetheless, signaling mechanisms that promote the disease outcome are far from being understood, affecting the development of suitable therapeutics. In this study, we applied shotgun mass spectrometry (MS)based proteomics combined with cell biology approaches to characterize altered molecular pathways on human neuroprogenitor cells (NPC) and neurons derived from induced pluripotent stem cells infected by ZIKV-BR strain, obtained from the 2015 Brazilian outbreak. Furthermore, ZIKV-BR infected NPCs showed unique alteration of pathways involved in neurological diseases, cell death, survival and embryonic development compared to ZIKV-AF, showing a human adaptation of the Brazilian viral strain. Besides, infected neurons differentiated from NPC presented an impairment of neurogenesis and synaptogenesis processes. Taken together, these data explain that CNS developmental arrest observed in Congenital Zika Syndrome is beyond neuronal cell death.
C1 [Rosa-Fernandes, Livia; Larsen, Martin Rossel] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.
   [Cugola, Fernanda Rodrigues; Russo, Fabiele Baldino; Leal de Oliveira, Danielle Bruna; Melo, Stella Rezende; de Andrade Zanotto, Paolo Marinho; Durigon, Edison Luiz; Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Kawahara, Rebeca; Bassi Stern, Ana Carolina; Angeli, Claudia Blanes; Palmisano, Giuseppe] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.
   [de Melo Freire, Caio Cesar] Univ Fed Sao Carlos, Dept Genet & Evolut, Sao Carlos, SP, Brazil.
   [Correa Leite, Paulo Emlio] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil.
RP Larsen, MR (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.; Palmisano, G (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil.
EM mrl@bmb.sdu.dk; patriciacbbbraga@usp.br; palmisano.gp@usp.com
RI Beltrao-Braga, Patricia C B/D-6450-2013; Palmisano,
   Giuseppe/N-3602-2013; de A. Zanotto, Paolo M./B-9286-2019; Oliveira,
   Danielle BL/H-8030-2015; Leite, Paulo Emilio C/N-3443-2013;
   Rosa-Fernandes, Livia/AAH-3734-2019
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Palmisano,
   Giuseppe/0000-0003-1336-6151; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; Oliveira, Danielle BL/0000-0002-3452-1336;
   Leite, Paulo Emilio C/0000-0002-1783-1228; Rosa-Fernandes,
   Livia/0000-0003-1612-1950; Oliveira, Danielle/0000-0002-0534-0886
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [202077/2015-2, 441105/2016-5, 441878/2014-8]; FAPESPFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/02866-0, 2011/20683-0,
   2013/08844-3, 2016/02978-6, 2018/16748-8, 2014/06863-3]; NGO "The Tooth
   Fairy Project"; Ministero della SaluteMinistry of Health, Italy
   [172/GR-2011-02350301]; VILLUM Center for Bioanalytical Sciences at the
   University of Southern Denmark; CAPESCAPES
FX LR-F was supported by CNPq (202077/2015-2). RK was supported by FAPESP
   (2015/02866-0). PZ was supported by CNPq (441105/2016-5). PB-B was
   supported by FAPESP (2011/20683-0, 2013/08844-3, 2016/02978-6, and
   2018/16748-8), the NGO "The Tooth Fairy Project" and CAPES for Ph.D.
   fellowship. GP was supported by FAPESP (2014/06863-3), CNPq
   (441878/2014-8) and Ricerca Finalizzata (Convenzione
   n.172/GR-2011-02350301) from the Ministero della Salute. This work was
   also supported by the VILLUM Center for Bioanalytical Sciences at the
   University of Southern Denmark.
CR Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Benitez MJ, 2014, BBA-MOL CELL RES, V1843, P245, DOI 10.1016/j.bbamcr.2013.11.013
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9
   Burkarth N, 2007, MOL CELL NEUROSCI, V36, P59, DOI 10.1016/j.mcn.2007.06.001
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cheng YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30314
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3
   Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5
   Jiang X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01067
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248
   Lambi AG, 2012, DEV DYNAM, V241, P1944, DOI 10.1002/dvdy.23888
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee M, 2017, DEV BIOL, V424, P62, DOI 10.1016/j.ydbio.2017.02.010
   Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Miller MW, 2003, J COMP NEUROL, V460, P410, DOI 10.1002/cne.10658
   Mishima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090004
   Palmisano G, 2012, MOL CELL PROTEOMICS, V11, P1191, DOI 10.1074/mcp.M112.017509
   Palmisano G, 2010, NAT PROTOC, V5, P1974, DOI 10.1038/nprot.2010.167
   Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012
   Quinn DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42920
   Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057
   ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167
   Rodriguez-Martinez G, 2012, CNS NEUROL DISORD-DR, V11, P844, DOI 10.2174/1871527311201070844
   Russo FB, 2018, BIOL PSYCHIAT, V83, P569, DOI 10.1016/j.biopsych.2017.09.021
   Russo FB, 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI 10.1016/j.bbrc.2017.01.074
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Sanchez-San Martin C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32400-7
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tarr J., 2015, FASEB J S, V29, P63, DOI [10.3390/jdb6030018, DOI 10.3390/JDB6030018]
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Trimbuch T, 2016, NAT REV NEUROSCI, V17, P118, DOI 10.1038/nrn.2015.16
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27
   Williams KL, 2006, J NEUROSCI RES, V84, P716, DOI 10.1002/jnr.20983
   Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 55
TC 3
Z9 3
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD MAR 15
PY 2019
VL 13
AR 64
DI 10.3389/fncel.2019.00064
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA HP6HT
UT WOS:000461785600001
PM 30949028
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Valdespino-Vazquez, MY
   Sevilla-Reyes, EE
   Lira, R
   Yocupicio-Monroy, M
   Piten-Isidro, E
   Boukadida, C
   Hernandez-Pando, R
   Soriano-Jimenez, JD
   Herrera-Salazar, A
   Figueroa-Damian, R
   Reyes-Teran, G
   Zamora-Escudero, R
   Cardona-Perez, JA
   Maldonado-Rodriguez, A
   Moreno-Verduzco, ER
   Torres-Flores, JM
AF Yolotzin Valdespino-Vazquez, Maria
   Sevilla-Reyes, Edgar E.
   Lira, Rosalia
   Yocupicio-Monroy, Martha
   Piten-Isidro, Elvira
   Boukadida, Celia
   Hernandez-Pando, Rogelio
   David Soriano-Jimenez, Juan
   Herrera-Salazar, Alma
   Figueroa-Damian, Ricardo
   Reyes-Teran, Gustavo
   Zamora-Escudero, Rodrigo
   Arturo Cardona-Perez, Jorge
   Maldonado-Rodriguez, Angelica
   Romelia Moreno-Verduzco, Elsa
   Miguel Torres-Flores, Jesus
TI Congenital Zika Syndrome and Extra-Central Nervous System Detection of
   Zika Virus in a Pre-term Newborn in Mexico
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; congenital Zika syndrome; co-infection; dissemination
ID WEST-NILE-VIRUS; YELLOW-FEVER; INFECTION; REPLICATION; BRAZIL; BRAIN;
   TRANSMISSION; PATHOLOGY; DISEASE; CELLS
AB Background During pregnancy, the Zika virus (ZIKV) replicates in the placenta and central nervous system (CNS) of infected fetuses; nevertheless, the ability of ZIKV to replicate in other fetal tissues has not been extensively characterized.
   Methods We researched whether dissemination of congenitally-acquired ZIKV outside the CNS exists by searching for the accumulation of the viral envelope protein, ZIKV ribonucleic acid (RNA), and infectious viral particles in different organs of a deceased newborn with Congenital Zika Syndrome. A real-time qualitative polymerase chain reaction (qPCR) was used to detect ZIKV RNA in the brain, thymus, lungs, kidneys, adrenal glands, spleen, liver, and small intestine. The same tissues were analyzed by indirect immunofluorescence and immunoperoxidase assays using the monoclonal antibody 4G2 to detect ZIKV envelope antigens. Isolation of infectious ZIKV in a cell culture was carried out using brain and kidney samples.
   Results A postmortem, virological analysis of multiple organs, such as the kidneys (epithelial cells in the renal tubules), lungs (bronchial epithelia), thymus (epithelial cells inside the Hassall's corpuscles), and brain (neurons, ependymal cells, and macrophages) revealed the presence of ZIKV RNA and envelope antigens. Other tissues of the deceased newborn tested positive by qPCR for Epstein-Barr virus and human herpesvirus 6, including the brain cortex (Epstein-Barr) and the thymus, kidneys, and adrenal glands (human herpesvirus 6). The kidneys were identified as a significant niche for viral replication, given that infectious particles were successfully isolated from renal tissues.
   Conclusions Our findings demonstrate the ability of congenitally-acquired ZIKV to produce disseminated infections and the viral tropism towards epithelial cells.
   This is a detailed study that demonstrates the ability of congenitally-acquired Zika virus to disseminate outside a fetal central nervous system. Moreover, viral replication in the kidneys of the deceased newborn is also demonstrated by viral isolation and electron microscopy.
C1 [Yolotzin Valdespino-Vazquez, Maria; David Soriano-Jimenez, Juan] Inst Nacl Perinatol, Dept Anat Patol, Mexico City, DF, Mexico.
   [Sevilla-Reyes, Edgar E.; Piten-Isidro, Elvira; Boukadida, Celia; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.
   [Lira, Rosalia; Maldonado-Rodriguez, Angelica] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Unidad Med Alta Especialidad Hosp Pediat, Unidad Invest Med Enfermedades Infecciosa & Paras, Mexico City, DF, Mexico.
   [Yocupicio-Monroy, Martha] Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, Mexico City, DF, Mexico.
   [Hernandez-Pando, Rogelio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Patol, Secc Patol Expt, Mexico City, DF, Mexico.
   [Herrera-Salazar, Alma; Figueroa-Damian, Ricardo] Inst Nacl Perinatol, Dept Infectol & Inmunol, Mexico City, DF, Mexico.
   [Zamora-Escudero, Rodrigo] Inst Nacl Perinatol, Direcc Med, Mexico City, DF, Mexico.
   [Arturo Cardona-Perez, Jorge] Inst Nacl Perinatol, Direcc Gen, Mexico City, DF, Mexico.
   [Miguel Torres-Flores, Jesus] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Lab Virol, Carpio & Plan Ayala S-N, Mexico City 11340, DF, Mexico.
   [Romelia Moreno-Verduzco, Elsa] Inst Nacl Perinatol, Subdirecc Serv Auxiliares Diagnost, Mexico City, DF, Mexico.
RP Torres-Flores, JM (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Lab Virol, Carpio & Plan Ayala S-N, Mexico City 11340, DF, Mexico.
EM chu_torrey@hotmail.com
RI Flores, Jesus Miguel Torres/AAE-2860-2020
OI Lira, Rosalia/0000-0002-6812-9471; Torres Flores,
   Jesus/0000-0002-2194-521X; Yocupicio-Monroy, Martha/0000-0001-7885-5656
FU CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [183448,
   233977]
FX This work was supported by grants from CONACyT (grant numbers 183448 and
   233977).
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Adams O, 1998, J INFECT DIS, V178, P544, DOI 10.1086/517470
   Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3
   deFreitas RB, 1997, T ROY SOC TROP MED H, V91, P538, DOI 10.1016/S0035-9203(97)90016-X
   Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   GOLDBERG GN, 1981, JAMA-J AM MED ASSOC, V246, P1579, DOI 10.1001/jama.246.14.1579
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Saxena V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002275
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163
   Wiley CA, 2017, NEUROPATHOLOGY, V37, P393, DOI 10.1111/neup.12385
NR 42
TC 4
Z9 4
U1 1
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 15
PY 2019
VL 68
IS 6
BP 903
EP 912
DI 10.1093/cid/ciy616
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HO7OL
UT WOS:000461136900004
PM 30188990
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ball, JD
   Elbadry, MA
   Telisma, T
   White, SK
   Chavannes, S
   Anilis, MG
   Prosperi, M
   Cummings, DAT
   Lednicky, JA
   Morris, JG
   de Rochars, MB
AF Ball, Jacob D.
   Elbadry, Maha A.
   Telisma, Taina
   White, Sarah K.
   Chavannes, Sonese
   Anilis, Marie Gina
   Prosperi, Mattia
   Cummings, Derek A. T.
   Lednicky, John A.
   Morris, J. Glenn, Jr.
   de Rochars, Madsen Beau
TI Clinical and Epidemiologic Patterns of Chikungunya Virus Infection and
   Coincident Arboviral Disease in a School Cohort in Haiti, 2014-2015
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE arbovirus; Haiti; chikungunya virus
ID DENGUE; OUTBREAK; ILLNESS; BLOOD; CHILD
AB Background Beginning in December 2013, an epidemic of chikungunya virus (CHIKV) infection spread across the Caribbean and into virtually all countries in the Western hemisphere, with >2.4 million cases reported through the end of 2017.
   Methods We monitored a cohort of school children in rural Haiti from May 2014, through February 2015, for occurrence of acute undifferentiated febrile illness, with clinical and laboratory data available for 252 illness episodes.
   Results Our findings document passage of the major CHIKV epidemic between May and July 2014, with 82 laboratory-confirmed cases. Subsequent peaks of febrile illness were found to incorporate smaller outbreaks of dengue virus serotypes 1 and 4 and Zika virus, with identification of additional infections with Mayaro virus, enterovirus D68, and coronavirus NL63. CHIKV and dengue virus serotype 1 infections were more common in older children, with a complaint of arthralgia serving as a significant predictor for infection with CHIKV (odds ratio, 16.2; 95% confidence interval, 8.0-34.4; positive predictive value, 66%; negative predictive value, 80%).
   Conclusions Viral/arboviral infections were characterized by a pattern of recurrent outbreaks and case clusters, with the CHIKV epidemic representing just one of several arboviral agents moving through the population. Although clinical presentations of these agents are similar, arthralgias are highly suggestive of CHIKV infection.
   Data were obtained for 252 Haitian children with acute febrile illness from May 2014 through February 2015. Findings document passage of the major 2014 Chikungunya virus epidemic (82 laboratory-confirmed cases), as well as ongoing outbreaks/cases of Dengue, Zika, and Mayaro.
C1 [Ball, Jacob D.; Elbadry, Maha A.; White, Sarah K.; Prosperi, Mattia; Cummings, Derek A. T.; Lednicky, John A.; Morris, J. Glenn, Jr.; de Rochars, Madsen Beau] Univ Florida, Emerging Pathogens Inst, 2055 Mowry Rd,POB 100009, Gainesville, FL 32610 USA.
   [Ball, Jacob D.; Prosperi, Mattia] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA.
   [Ball, Jacob D.; Prosperi, Mattia] Univ Florida, Coll Med, Gainesville, FL USA.
   [Elbadry, Maha A.; White, Sarah K.; Lednicky, John A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA.
   [Telisma, Taina; Chavannes, Sonese; Anilis, Marie Gina] Christianville Fdn, Christianville Sch Clin, Gressier, Haiti.
   [Cummings, Derek A. T.] Univ Florida, Coll Liberal Arts & Sci, Dept Biol, Gainesville, FL USA.
   [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA.
   [de Rochars, Madsen Beau] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA.
RP Morris, JG (corresponding author), Univ Florida, Emerging Pathogens Inst, 2055 Mowry Rd,POB 100009, Gainesville, FL 32610 USA.
EM jgmorris@epi.ufl.edu
RI Elbadry, Maha Adel/AAH-4444-2020; Lednicky, John A/C-5678-2012
OI Elbadry, Maha Adel/0000-0002-6089-4523; 
FU US Department of Health and Human Services [R01 AI126357-01S1, U01
   GM110721-01]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
FX This work was supported by the US Department of Health and Human
   Services (grants R01 AI126357-01S1 to J.G.M. and Models of Infectious
   Disease Agent Study U01 GM110721-01 to D.A.T.C.) and the National
   Institutes of Health (grants to D.A.T.C.).
CR Alva-Urcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187897
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cassadou S, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.13.20752
   Danis-Lozano R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186923
   De Rochars VEMB, 2015, AM J TROP MED HYG, V92, P752, DOI 10.4269/ajtmh.14-0059
   De Rochars VMB, 2017, AM J TROP MED HYG, V96, P144, DOI [10.4269/ajtmh.16-0685, 10.4269/ajtmh.16-0585]
   Elbadry MA, 2017, GENOME ANNOUNC, V5
   Elbadry M, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00331-17, 10.1128/genomea.00331-17]
   ElBadry M, 2016, PEDIATR INFECT DIS J, V35, P1048, DOI 10.1097/INF.0000000000001283
   Galan-Huerta KA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050248
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hyndman R. J., 2016, FORECAST FORECASTING
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Moreira J, 2018, CLIN MICROBIOL INFEC, V24, P827, DOI 10.1016/j.cmi.2018.05.001
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sasmono RT, 2017, AM J TROP MED HYG, V97, P1393, DOI 10.4269/ajtmh.16-0935
   Sharp TM, 2016, J INFECT DIS, V214, pS475, DOI 10.1093/infdis/jiw245
   Tomashek KM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005859
   White S, 2014, PLOS NEGLECT TROP D, V12
   White SK, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00148-17, 10.1128/genomea.00148-17]
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 32
TC 4
Z9 4
U1 2
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 15
PY 2019
VL 68
IS 6
BP 919
EP 926
DI 10.1093/cid/ciy582
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HO7OL
UT WOS:000461136900006
PM 30184178
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Hu, LC
   Tang, MX
   Wu, ZD
   Xi, ZY
   Yu, JS
AF Hu, Linchao
   Tang, Moxun
   Wu, Zhongdao
   Xi, Zhiyong
   Yu, Jianshe
TI The threshold infection level for Wolbachia invasion in random
   environments
SO JOURNAL OF DIFFERENTIAL EQUATIONS
LA English
DT Article
DE Population dynamics; Wolbachia; Threshold infection level; Stochastic
   dynamics
ID AEDES-AEGYPTI; CYTOPLASMIC INCOMPATIBILITY; DYNAMICS; POPULATION;
   SPREAD; MODELS; TEMPERATURE
AB Dengue fever and Zika are mosquito-borne diseases threatening human health. A novel strategy for mosquito-borne disease control uses the bacterium Wolbachia to block virus transmission. It requires releasing Wolbachia infected mosquitoes to exceed a threshold level. Since an accurate forecast for temperature and rainfall, the major environmental conditions regulating the mosquito dynamics, is often not available over a long time period, it is important to explore how the threshold releasing level changes in random environments. In this work, we estimate the threshold level in a stochastic system of differential equations where the reproduction rates of mosquitoes change randomly. We prove that the threshold level is, surprisingly, defined by a deterministic curve that does not fluctuate with environmental conditions. The major difficulty in the proof is to construct various auxiliary curves to limit the dynamic behaviors of the whole family of innumerable solutions satisfying a given initial condition. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Hu, Linchao; Wu, Zhongdao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510080, Guangdong, Peoples R China.
   [Tang, Moxun] Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
   [Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.
   [Yu, Jianshe] Guangzhou Univ, Ctr Appl Math, Guangzhou 510006, Guangdong, Peoples R China.
RP Tang, MX (corresponding author), Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
EM tang@math.msu.edu
FU National Research and Development Plan of China [2016YFC1200500];
   Scientific and Technological Leading Talents of Guangzhou Development
   District [2016-2414]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [11631005]
FX We thank Profs. Odo Diekmann, Glenn Webb, and Michael Turelli for their
   valuable suggestions. This work was supported by National Research and
   Development Plan of China (2016YFC1200500), Scientific and Technological
   Leading Talents of Guangzhou Development District (2016-2414), National
   Natural Science Foundation of China (11631005).
CR Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Calisher CH, 2005, EMERG INFECT DIS, V11, P738
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012
   Cheng Q, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004417
   Dang NH, 2014, J DIFFER EQUATIONS, V257, P2078, DOI 10.1016/j.jde.2014.05.029
   Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876
   Farkas JZ, 2010, B MATH BIOL, V72, P2067, DOI 10.1007/s11538-010-9528-1
   FINE PEM, 1978, J INVERTEBR PATHOL, V31, P10, DOI 10.1016/0022-2011(78)90102-7
   Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121
   Hu LC, 2015, THEOR POPUL BIOL, V106, P32, DOI 10.1016/j.tpb.2015.09.003
   Huang MG, 2015, SCI CHINA MATH, V58, P77, DOI 10.1007/s11425-014-4934-8
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LAVEN H, 1956, NATURE, V177, P141, DOI 10.1038/177141a0
   Ndiaye PI, 2006, J THEOR BIOL, V243, P222, DOI 10.1016/j.jtbi.2006.06.005
   Nguyen HD, 2011, J DIFFER EQUATIONS, V250, P386, DOI 10.1016/j.jde.2010.08.023
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Wiwatanaratanabutr S, 2006, MED VET ENTOMOL, V20, P300, DOI 10.1111/j.1365-2915.2006.00640.x
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zhang XH, 2015, MATH BIOSCI, V269, P164, DOI 10.1016/j.mbs.2015.09.004
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
NR 25
TC 8
Z9 8
U1 4
U2 36
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-0396
EI 1090-2732
J9 J DIFFER EQUATIONS
JI J. Differ. Equ.
PD MAR 15
PY 2019
VL 266
IS 7
BP 4377
EP 4393
DI 10.1016/j.jde.2018.09.035
PG 17
WC Mathematics
SC Mathematics
GA HI4PP
UT WOS:000456433000019
DA 2020-07-08
ER

PT J
AU Martinez-Sobrido, L
   Almazan, F
AF Martinez-Sobrido, Luis
   Almazan, Fernando
TI New Advances on Zika Virus Research
SO VIRUSES-BASEL
LA English
DT Editorial Material
C1 [Martinez-Sobrido, Luis] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
   [Almazan, Fernando] Campus Univ Autonoma Madrid, CSIC, CNB, Dept Mol & Cell Biol, 3 Darwin St, Madrid 28049, Spain.
RP Martinez-Sobrido, L (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
EM Luis_Martinez@URMC.Rochester.edu; falmazan@cnb.csic.es
RI ; Almazan, Fernando/K-8781-2015
OI Martinez-Sobrido, Luis/0000-0001-7084-0804; Almazan,
   Fernando/0000-0002-5752-8469
CR Alves MP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110593
   Amaro F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020179
   AVILAPEREZ G, 2018, VIRUSES-BASEL, V10, DOI DOI 10.3390/V10110597
   Azouz F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020162
   Barnard TR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120728
   Bhadra S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120714
   De Ory F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070379
   El Kalamouni C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010002
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Goodfellow FT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100550
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020157
   Mantke OD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090491
   Marquez-Jurado S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100547
   Mlera L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010042
   Munster M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070368
   Oliveira DBL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110615
   Rayner JO, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050229
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Setoh YX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100541
   Simon D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120698
   Singh S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100530
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Taylor CT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050253
   Thurmond S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120712
   Viedma MDM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110649
   Willard KA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010020
   Yun SI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080422
   Zhang LD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110634
   Zhang LZ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120700
   Zhao LM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090470
NR 32
TC 1
Z9 1
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR 14
PY 2019
VL 11
IS 3
AR 258
DI 10.3390/v11030258
PG 4
WC Virology
SC Virology
GA HT2KT
UT WOS:000464392300005
PM 30875715
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Winter, C
   Kosch, R
   Ludlow, M
   Osterhaus, ADME
   Jung, K
AF Winter, Christine
   Kosch, Robin
   Ludlow, Martin
   Osterhaus, Albert D. M. E.
   Jung, Klaus
TI Network meta-analysis correlates with analysis of merged independent
   transcriptome expression data
SO BMC BIOINFORMATICS
LA English
DT Article
DE Fold change; Gene expression; Meta-analysis; Network meta-analysis;
   Research synthesis
ID GENE-EXPRESSION; CELL-DEATH; MICROARRAY ANALYSIS; LYMPHOTOXIN-BETA;
   MESSENGER-RNA; ZIKA VIRUS; CXCR3; INFECTION; PROTEIN; ENCEPHALITIS
AB BackgroundUsing meta-analysis, high-dimensional transcriptome expression data from public repositories can be merged to make group comparisons that have not been considered in the original studies. Merging of high-dimensional expression data can, however, implicate batch effects that are sometimes difficult to be removed. Removing batch effects becomes even more difficult when expression data was taken using different technologies in the individual studies (e.g. merging of microarray and RNA-seq data). Network meta-analysis has so far not been considered to make indirect comparisons in transcriptome expression data, when data merging appears to yield biased results.ResultsWe demonstrate in a simulation study that the results from analyzing merged data sets and the results from network meta-analysis are highly correlated in simple study networks. In the case that an edge in the network is supported by multiple independent studies, network meta-analysis produces fold changes that are closer to the simulated ones than those obtained from analyzing merged data sets. Finally, we also demonstrate the practicability of network meta-analysis on a real-world data example from neuroinfection research.ConclusionsNetwork meta-analysis is a useful means to make new inferences when combining multiple independent studies of molecular, high-throughput expression data. This method is especially advantageous when batch effects between studies are hard to get removed.
C1 [Winter, Christine; Kosch, Robin; Jung, Klaus] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Bunteweg 1-P, D-30559 Hannover, Germany.
   [Ludlow, Martin; Osterhaus, Albert D. M. E.] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses, Bunteweg 17p, D-30559 Hannover, Germany.
RP Jung, K (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Bunteweg 1-P, D-30559 Hannover, Germany.
EM christine.winter1@tiho-hannover.de; klaus.jung@tiho-hannover.de
OI Jung, Klaus/0000-0001-9955-748X
FU Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the
   Ministry of Science and Culture of Lower Saxony
FX This work was supported by the Niedersachsen-Research Network on
   Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of
   Lower Saxony. The funding body was not involved in the design of the
   study and collection, analysis, and interpretation of data and in
   writing the manuscript.
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A
   Chen HL, 2010, J NEUROSCI RES, V88, P3508, DOI 10.1002/jnr.22506
   Dalmau J, 1999, BRAIN, V122, P27, DOI 10.1093/brain/122.1.27
   Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ejeskar K, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-161
   Fawaz NA, 2012, EUR J HAEMATOL, V88, P350, DOI 10.1111/j.1600-0609.2011.01739.x
   Grinde B, 2007, VIRUS RES, V123, P86, DOI 10.1016/j.virusres.2006.08.005
   Hornung R, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0870-z
   Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855
   Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Kazmirchuk T, 2017, COMPUT BIOL CHEM, V71, P180, DOI 10.1016/j.compbiolchem.2017.10.011
   Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057
   Kong P, 2018, NEUROSCI LETT, V662, P51, DOI 10.1016/j.neulet.2017.09.051
   Kosch R, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4914-4
   Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037
   Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z
   Lipinski MJ, 2016, EUR HEART J, V37, P536, DOI 10.1093/eurheartj/ehv563
   Liu MT, 2000, J IMMUNOL, V165, P2327, DOI 10.4049/jimmunol.165.5.2327
   Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963
   Logotheti M, 2013, SCI WORLD J, DOI 10.1155/2013/685917
   Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201
   Lundberg P, 2007, INVEST OPHTH VIS SCI, V48, P4162, DOI 10.1167/iovs.07-0261
   Munoz-Erazo L, 2012, MOL VIS, V18, P730
   Naughton BJ, 2015, J ALZHEIMERS DIS, V43, P93, DOI 10.3233/JAD-140606
   Nazar M, 2012, ENDOCRINOLOGY, V153, P6114, DOI 10.1210/en.2012-1567
   Nygaard V, 2016, BIOSTATISTICS, V17, P29, DOI 10.1093/biostatistics/kxv027
   Plow EF, 2004, TRENDS CARDIOVAS MED, V14, P180, DOI 10.1016/j.tcm.2004.04.001
   Poorebrahim M, 2017, ARCH VIROL, V162, P1299, DOI 10.1007/s00705-017-3242-3
   Rau A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-91
   Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101
   Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058
   Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI [10.1093/nar/gkp967, 10.1093/nar/gkq1184]
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   SCHMECHEL DE, 1980, BRAIN RES, V190, P195, DOI 10.1016/0006-8993(80)91169-5
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Sobieraj DM, 2015, THROMB RES, V135, P888, DOI 10.1016/j.thromres.2015.02.032
   Sudmant PH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0853-4
   Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086
   Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265
   VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460
   Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719
   Wu S, 2013, ASIAN PAC J CANCER P, V14, P6347, DOI 10.7314/APJCP.2013.14.11.6347
   Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287
   Zhang B, 2008, J IMMUNOL, V180, P2641, DOI 10.4049/jimmunol.180.4.2641
   Zhang B, 2010, J NEUROIMMUNOL, V224, P28, DOI 10.1016/j.jneuroim.2010.05.003
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang L, 2015, GENET MOL RES, V14, P7218, DOI 10.4238/2015.June.29.15
   Zimmermann J, 2017, J NEUROVIROL, V23, P394, DOI 10.1007/s13365-016-0508-6
NR 54
TC 1
Z9 1
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD MAR 14
PY 2019
VL 20
AR 144
DI 10.1186/s12859-019-2705-9
PG 10
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA HP0BK
UT WOS:000461329800003
PM 30876387
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Silva, SJR
   Paiva, MHS
   Guedes, DRD
   Krokovsky, L
   de Melo, FL
   da Silva, MAL
   da Silva, A
   Ayres, CFJ
   Pena, L
AF Ribeiro da Silva, Severino Jefferson
   Santos Paiva, Marcelo Henrique
   Duarte Guedes, Duschinka Ribeiro
   Krokovsky, Larissa
   de Melo, Fabio Lopes
   Lopes da Silva, Maria Almerice
   da Silva, Adakicia
   Junqueira Ayres, Constancia Flavia
   Pena, Lindomarj
TI Development and Validation of Reverse Transcription Loop-Mediated
   Isothermal Amplification (RT-LAMP) for Rapid Detection of ZIKV in
   Mosquito Samples from Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AEDES-AEGYPTI; VIRUS; EPIDEMIC; TRANSMISSION
AB The rapid spread of Zika virus (ZIKV) represents a global public health problem, especially in areas that harbor several mosquito species responsible for virus transmission, such as Brazil. In these areas, improvement in mosquito control needs to be a top priority, but mosquito viral surveillance occurs inefficiently in ZIKV-endemic countries. Quantitative reverse transcription PCR (qRT-PCR) is the gold standard for molecular diagnostic of ZIKV in both human and mosquito samples. However, the technique presents high cost and limitations for Point-of-care (POC) diagnostics, which hampers its application for a large number of samples in entomological surveillance programs. Here, we developed and validated a one-step reverse transcription LAMP (RT-LAMP) platform for detection of ZIKV in mosquito samples. The RT-LAMP assay was highly specific for ZIKV and up to 10,000 times more sensitive than qRT-PCR. Assay validation was performed using 60 samples from Aedes aegypti and Culex quinquefasciatus mosquitoes collected in Pernambuco State, Brazil, which is at the epicenter of the Zika epidemic. The RT-LAMP had a sensitivity of 100%, specificity of 91.18%, and overall accuracy of 95.24%. Thus, our POC diagnostics is a powerful and inexpensive tool to monitor ZIKV in mosquito populations and will allow developing countries to establish better control strategies for this devastating pathogen.
C1 [Ribeiro da Silva, Severino Jefferson; da Silva, Adakicia; Pena, Lindomarj] Fundacao Oswaldo Cruz, FIOCRUZ, Dept Virol, Recife, PE, Brazil.
   [Santos Paiva, Marcelo Henrique] Fed Univ Pernambuco UFPE, Agreste Acad Ctr, Caruaru, PE, Brazil.
   [Santos Paiva, Marcelo Henrique; Duarte Guedes, Duschinka Ribeiro; Krokovsky, Larissa; Junqueira Ayres, Constancia Flavia] Fundacao Oswaldo Cruz, FIOCRUZ, Dept Entomol, Recife, PE, Brazil.
   [de Melo, Fabio Lopes; Lopes da Silva, Maria Almerice] Fundacao Oswaldo Cruz, FIOCRUZ, Dept Parasitol, Recife, PE, Brazil.
RP Pena, L (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, Dept Virol, Recife, PE, Brazil.
EM lindomar.pena@cpqam.fiocruz.br
RI de Melo, Fabio Lopes/AAD-6319-2020; Ayres, Constancia/AAQ-3448-2020
FU Foundation for Science and Technology of Pernambuco (FACEPE)
   [APQ-0154-2.12/16]; IDRC
FX This work was supported by the Foundation for Science and Technology of
   Pernambuco (FACEPE - APQ-0154-2.12/16). S.S. is supported by a Masters
   Scholarship sponsored by IDRC. The funder had no role in study design,
   sample collection and analyses of results, decision to publish, or
   preparation of the manuscript. We are grateful to Ana Paula de Araujo
   and Monica Crespo for their assistance with Probit analysis.
CR Adams ER, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00386-18
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Beckmann JF, 2012, J MED ENTOMOL, V49, P1103, DOI 10.1603/ME12049
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Carossino M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2852-4
   Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandes JN, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0496
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Kaarj K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30797-9
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lamb LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22102-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Marli T, 2016, J INFECT DIS, DOI [10.1093/infdis/jiw477, DOI 10.1093/INFDIS/JIW477]
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nemoto M, 2010, J VET MED SCI, V72, P823, DOI 10.1292/jvms.09-0446
   Noden BH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192331
   Oloniniyi OK, 2017, J VIROL METHODS, V246, P8, DOI 10.1016/j.jviromet.2017.03.011
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   Paiva MHS, 2017, GENET MOL BIOL, V40, P597, DOI [10.1590/1678-4685-GMB-2016-0312, 10.1590/1678-4685-gmb-2016-0312]
   Schwab SR, 2018, EPIDEMICS-NETH, V23, P55, DOI 10.1016/j.epidem.2017.12.004
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tanner Nathan A, 2014, Curr Protoc Mol Biol, V105, DOI 10.1002/0471142727.mb1514s105
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zhao JT, 2019, VIRUS GENES, V55, P43, DOI 10.1007/s11262-018-1612-x
NR 57
TC 6
Z9 6
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 14
PY 2019
VL 9
AR 4494
DI 10.1038/s41598-019-40960-5
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HO7TI
UT WOS:000461151800078
PM 30872672
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, P
   Yu, X
   Wang, PH
   Cheng, G
AF Wu, Pa
   Yu, Xi
   Wang, Penghua
   Cheng, Gong
TI Arbovirus lifecycle in mosquito: acquisition, propagation and
   transmission
SO EXPERT REVIEWS IN MOLECULAR MEDICINE
LA English
DT Review
DE Arboviruses; mosquitoes; transmission
ID RNA INTERFERENCE RNAI; ZIKA VIRUS-INFECTION; JAK-STAT PATHWAY;
   DENGUE-VIRUS; AEDES-AEGYPTI; DEFENSE STRATEGIES; SINDBIS VIRUS; PROTEIN;
   RECEPTOR; INSECT
AB Mosquitoes are haematophagous vectors for hundreds of pathogenic viruses that are aetiological agents of human diseases. In nature, mosquito-borne viruses maintain a lifecycle between mosquitoes and vertebrate animals. Viruses are acquired by a naive mosquito from an infected host by blood meals and then propagate extensively in the mosquito's tissues. This mosquito then becomes a virus reservoir and is competent to transmit the viruses to a naive vertebrate host through the next blood meal. To survive in and efficiently cycle between two distinct host environments, mosquito-borne viruses have evolved delicate and smart strategies to comprehensively exploit host and vector factors. Here, we provide an update on recent studies of the mechanisms of virus survival in, acquisition and transmission by mosquitoes.
C1 [Wu, Pa; Yu, Xi; Cheng, Gong] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.
   [Wu, Pa; Yu, Xi; Cheng, Gong] Shenzhen Ctr Dis Control & Prevent, SZCDC SUSTech Joint Key Lab Trop Dis, Shenzhen 518055, Guangdong, Peoples R China.
   [Wang, Penghua] Univ Connecticut, Ctr Hlth, Sch Med, Dept Immunol, Farmington, CT 06030 USA.
RP Cheng, G (corresponding author), Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Cheng, G (corresponding author), Shenzhen Ctr Dis Control & Prevent, SZCDC SUSTech Joint Key Lab Trop Dis, Shenzhen 518055, Guangdong, Peoples R China.
EM gongcheng@mail.tsinghua.edu.cn
RI wang, Penghua/AAL-4011-2020
FU National Key Research and Development Plan of China [2016ZX10004001-008,
   2016YFC1201000, 2016YFD0500400]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81730063, 81571975,
   31825001]; Shenzhen San-Ming Project for prevention and research on
   vector-borne diseases [SZSM201611064]
FX This study was supported by grants from the National Key Research and
   Development Plan of China (2016ZX10004001-008, 2016YFC1201000 and
   2016YFD0500400), the National Natural Science Foundation of China
   (81730063, 81571975 and 31825001), and the Shenzhen San-Ming Project for
   prevention and research on vector-borne diseases (SZSM201611064).
CR Anglero-Rodriguez YI, 2017, ELIFE, V6, DOI 10.7554/eLife.28844
   Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4
   Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Gao GF, 2018, CELL, V172, P1157, DOI 10.1016/j.cell.2018.02.025
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Iranpour M, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2015.19
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Mathur K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38065
   Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   PAHO, 2017, ZIK CAS CONG SYNDR A
   Parikh GR, 2009, J GEN VIROL, V90, P292, DOI 10.1099/vir.0.005116-0
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977
   Rose PP, 2011, CELL HOST MICROBE, V10, P97, DOI 10.1016/j.chom.2011.06.009
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Sakoonwatanyoo P, 2006, INTERVIROLOGY, V49, P161, DOI 10.1159/000089377
   Salas-Benito J, 2007, AM J TROP MED HYG, V77, P283, DOI 10.4269/ajtmh.2007.77.283
   Samuel GH, 2018, TRENDS MICROBIOL, V26, P447, DOI 10.1016/j.tim.2017.12.005
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Saraiva RG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006443
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704
   Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565
   Shokal U, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00759
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Tassetto M, 2017, CELL, V169, P314, DOI 10.1016/j.cell.2017.03.033
   Wagar ZL, 2017, INSECT MOL BIOL, V26, P734, DOI 10.1111/imb.12334
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xiao XP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004848
   Xiao XP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004027
   Zhu YB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01244-6
NR 71
TC 2
Z9 2
U1 8
U2 22
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1462-3994
J9 EXPERT REV MOL MED
JI Expert Rev. Mol. Med.
PD MAR 13
PY 2019
VL 21
AR e1
DI 10.1017/erm.2018.6
PG 6
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA HO6WF
UT WOS:000461073200001
PM 30862324
DA 2020-07-08
ER

PT J
AU Hemachudha, P
   Wacharapluesadee, S
   Buathong, R
   Petcharat, S
   Bunprakob, S
   Ruchiseesarod, C
   Roeksomtawin, P
   Hemachudha, T
AF Hemachudha, Pasin
   Wacharapluesadee, Supaporn
   Buathong, Rome
   Petcharat, Sininat
   Bunprakob, Saowalak
   Ruchiseesarod, Chanida
   Roeksomtawin, Pankeaw
   Hemachudha, Thiravat
TI Lack of Transmission of Zika Virus Infection to Breastfed Infant
SO CLINICAL MEDICINE INSIGHTS-CASE REPORTS
LA English
DT Article
DE Zika virus; breastfeeding; transmission
AB Zika virus (ZIKV) continues to affect certain parts of the World. Here we report a case that supports breastfeeding regardless of mother ZIKV status by providing clinical and virological studies.
C1 [Hemachudha, Pasin; Wacharapluesadee, Supaporn; Petcharat, Sininat; Bunprakob, Saowalak; Ruchiseesarod, Chanida; Hemachudha, Thiravat] Chulalongkorn Univ, Thai Red Cross Emerging Infect Dis Hlth Sci Ctr, World Hlth Org, Chulalongkorn Hosp,Fac Med,Collaborating Ctr Res, Phyathai Rd, Bangkok 10330, Thailand.
   [Buathong, Rome] Minist Publ Hlth, Dept Dis Control, Bur Epidemiol, Nonthaburi, Thailand.
   [Roeksomtawin, Pankeaw] Thai Red Cross Soc, Relief & Publ Hlth Bur, Bangkok, Thailand.
RP Hemachudha, P (corresponding author), Chulalongkorn Univ, Thai Red Cross Emerging Infect Dis Hlth Sci Ctr, World Hlth Org, Chulalongkorn Hosp,Fac Med,Collaborating Ctr Res, Phyathai Rd, Bangkok 10330, Thailand.
EM pasin.hemachudha@gmail.com
FU Cluster and Programme Management Office (CPMO) [P-15-50535]; National
   Science and Technology Development Agency, Thailand (NSTDA);
   Ratchadaphiseksomphot Fund of Faculty of Medicine, Chulalongkorn
   University, Thailand; World Health Organization Thailand (WHO-Thailand);
   United States Agency for International Development (USAID)United States
   Agency for International Development (USAID);  [P-13-01091]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by a research grant from the Research Chair Grant
   (P-13-01091); Cluster and Programme Management Office (CPMO)
   (P-15-50535); the National Science and Technology Development Agency,
   Thailand (NSTDA), the Ratchadaphiseksomphot Fund of Faculty of Medicine,
   Chulalongkorn University, Thailand; the World Health Organization
   Thailand (WHO-Thailand); and the United States Agency for International
   Development (USAID).
CR Besnard M, 2013, EV PERINATAL TRANSMI
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   WHO, EP AL NEUR SYNDR MAL
   World Health Organisation, INF FEED AR ZIK VIR
NR 11
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1179-5476
J9 CLIN MED INSIGHT-CAS
JI Clin. Med. Insights-Case Rep.
PD MAR 12
PY 2019
VL 12
AR UNSP 1179547619835179
DI 10.1177/1179547619835179
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA HQ2JP
UT WOS:000462227300001
PM 30886528
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dopico, E
   Del-Rei, RP
   Espinoza, B
   Ubillos, I
   Zanchin, NIT
   Sulleiro, E
   Moure, Z
   Celedon, PAF
   Souza, WV
   da Silva, ED
   Gomes, YM
   Santos, FLN
AF Dopico, Eva
   Del-Rei, Rodrigo Pimenta
   Espinoza, Bertha
   Ubillos, Itziar
   Tonin Zanchin, Nilson Ivo
   Sulleiro, Elena
   Moure, Zaira
   Fiorani Celedon, Paola Alejandra
   Souza, Wayner Vieira
   da Silva, Edimilson Domingos
   Gomes, Yara Miranda
   Neves Santos, Fred Luciano
TI Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas
   disease diagnosis in immigrants living in a non-endemic setting
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Chagas disease; Trypanosoma cruzi; Chimeric antigens; Immunoassay;
   Accuracy
ID SERODIAGNOSIS; CONSENSUS; ANTIGENS; PEPTIDE
AB BackgroundChronic Chagas Disease (CD) diagnosis is based on serological methods employing crude, semipurified or recombinant antigens, which may result in low sensitivity or cross-reactivity. To reduce these restrictions, we developed a strategy involving use of molecules containing repetitive fragments of Trypanosoma cruzi conserved proteins. Diagnostic performance of IBMP-8.1 and IBMP-8.4 chimeric antigens (Molecular Biology Institute of Parana - IBMP in Portuguese acronym) was assessed to diagnose T. cruzi-infected and non-infected immigrants living in Barcelona (Spain), a non-endemic setting for Chagas disease.MethodsReactivity of IBMP-8.1 and IBMP-8.4 was assessed using an in-house automated ELISA with 347 positive and 331 negative individuals to Chagas disease. Antigenic cross-reactivity was measured with sera samples from pregnant women with Toxoplasma gondii (n=98) and Zika virus (n=75) antibodies.ResultsThe area under the curve values was 1 and 0.99 for the IBMP-8.1 and IBMP-8.4 proteins, respectively, demonstrating excellent diagnostic accuracy. The reactivity index was higher for IBMP-8.1 than IBMP-8.4 in positive samples and no significant difference in reactivity index was observed in negative samples. Sensitivity ranged from 99.4% for IBMP-8.1 to 99.1% for IBMP-8.4 and was not statistically different. Specificity for IBMP-8.1 reached 100 and 99.7% for IBMP-8.4, both nearly 100% accurate. No antigenic cross-reactivity was observed and reactivity index was similar to that for negative Chagas disease individuals.ConclusionsOur results showed an outstanding performance of IBMP-8.1 and IBMP-8.4 chimeric antigens by ELISA and suggest both chimeric antigens could also be used for Chagas disease diagnosis in immigrants living in non-endemic settings.
C1 [Dopico, Eva; Ubillos, Itziar] Catalan Inst Hlth, Lab Clin Terr Metropolitana Sud, Barcelona, Catalonia, Spain.
   [Del-Rei, Rodrigo Pimenta] Fac Technol & Sci Bahia, Salvador, BA, Brazil.
   [Espinoza, Bertha] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico.
   [Tonin Zanchin, Nilson Ivo] Fundacao Oswaldo Cruz, Carlos Chagas Inst, Curitiba, Parana, Brazil.
   [Sulleiro, Elena; Moure, Zaira] Vall dHebron Univ Hosp, Microbiol Dept, PROSICS, Barcelona, Catalonia, Spain.
   [Fiorani Celedon, Paola Alejandra] Mol Biol Inst Parana, Curitiba, Parana, Brazil.
   [Souza, Wayner Vieira; Gomes, Yara Miranda] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [da Silva, Edimilson Domingos] Fundacao Oswaldo Cruz, Immunobiol Technol Inst, Rio De Janeiro, Brazil.
   [Neves Santos, Fred Luciano] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
RP Santos, FLN (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
EM fred.santos@bahia.fiocruz.br
RI Zanchin, Nilson Ivo Tonin/AAB-4907-2019; Souza, Wayner V/H-3798-2013;
   SANTOS, Fred/S-2954-2019
OI Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694; SANTOS,
   Fred/0000-0002-3944-0818; Sulleiro, Elena/0000-0002-9783-6060
FU Goncalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz/BA)
FX This research project was funded by a Goncalo Moniz Institute, Oswaldo
   Cruz Foundation (Fiocruz/BA). The funder was not involved in the design
   of the study, in the collection, analysis and interpretation of the
   data, or in writing the manuscript.
CR Abras A, 2017, PARASITOL INT, V66, P83, DOI 10.1016/j.parint.2016.12.003
   Angheben A, 2015, BLOOD TRANSFUS-ITALY, V13, P540, DOI 10.2450/2015.0040-15
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   Brito VD, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00961-18
   Camussone C, 2009, CLIN VACCINE IMMUNOL, V16, P899, DOI 10.1128/CVI.00005-09
   Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799
   Eurostat, TOT NUMB LONG TERM I
   Hernandez P, 2010, CLIN VACCINE IMMUNOL, V17, P1598, DOI 10.1128/CVI.00489-08
   Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498
   Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723
   Instituto Nacional de Estadistica, POBL RES FECH SEX ED
   Leeflang MMG, 2019, CLIN MICROBIOL INFEC, V25, P54, DOI 10.1016/j.cmi.2018.06.011
   Martin DL, 2014, AM J TROP MED HYG, V90, P1074, DOI 10.4269/ajtmh.13-0391
   Mucci J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005972
   Santos FLN, 2018, AM J TROP MED HYG, V99, P1174, DOI 10.4269/ajtmh.17-0727
   Santos FLN, 2017, J CLIN MICROBIOL, V55, P2934, DOI 10.1128/JCM.00851-17
   Santos FLN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005433
   Santos FLN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161100
   Pane S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3118-5
   Arandes AS, 2009, ACTA TROP, V112, P228, DOI 10.1016/j.actatropica.2009.07.014
   Strasen J, 2014, CLIN RES CARDIOL, V103, P1, DOI 10.1007/s00392-013-0613-y
   TIBAYRENC M, 1991, PARASITOL TODAY, V7, P228, DOI 10.1016/0169-4758(91)90234-F
   Umezawa ES, 2003, TRANSFUSION, V43, P91, DOI 10.1046/j.1537-2995.2003.00279.x
   Umezawa ES, 1999, J CLIN MICROBIOL, V37, P1554, DOI 10.1128/JCM.37.5.1554-1560.1999
   Verani JR, 2009, AM J TROP MED HYG, V80, P410
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021
   Zingales B, 2018, ACTA TROP, V184, P38, DOI 10.1016/j.actatropica.2017.09.017
   Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009
NR 29
TC 2
Z9 2
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 12
PY 2019
VL 19
AR 251
DI 10.1186/s12879-019-3872-z
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA HP0QX
UT WOS:000461371800002
PM 30871504
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carta, KG
   Britto, IJM
   Meza, Y
   Morr, I
   Marques, J
   Flores, VF
   Allison, T
   Lopez-Jimenez, F
   Terzic, C
   Mendoza, I
AF Carta, Karina Gonzalez
   Britto, Ivan J. Mendoza
   Meza, Yolimar
   Morr, Igor
   Marques, Juan
   Flores, Vicente Finizola
   Allison, Thomas
   Lopez-Jimenez, Francisco
   Terzic, Carmen
   Mendoza, Ivan
TI SEX AND GENDER DIFFERENCES IN ZIKA MYOCARDITIS
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Meeting Abstract
CT 68th Annual Scientific Session and Expo of the
   American-College-of-Cardiology (ACC)
CY MAR 16-18, 2019
CL New Orleans, LA
SP Amer Coll Cardiol
C1 Mayo Clin, Rochester, MN USA.
   Univ Cent Venezuela, Inst Cardiol Trop, Caracas, Venezuela.
NR 0
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD MAR 12
PY 2019
VL 73
IS 9
SU 1
MA 1144-525
BP 719
EP 719
DI 10.1016/S0735-1097(19)31327-0
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HO0BU
UT WOS:000460565900719
OA Bronze
DA 2020-07-08
ER

PT J
AU Kalogeropoulou, A
   Lygerou, Z
   Taraviras, S
AF Kalogeropoulou, Argyro
   Lygerou, Zoi
   Taraviras, Stavros
TI Cortical Development and Brain Malformations: Insights From the
   Differential Regulation of Early Events of DNA Replication
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE DNA replication; origins licensing; cortex development; neural stem
   cells; microcephaly
ID ORIGIN RECOGNITION COMPLEX; NEURAL STEM-CELLS; DORMANT ORIGINS;
   VENTRICULAR ZONE; PROGENITOR CELLS; MUTATIONS; CYCLE; GENOME;
   MECHANISMS; DIVERSITY
AB During the development of the cortex distinct populations of Neural Stem Cells (NSCs) are defined by differences in their cell cycle duration, self-renewal capacity and transcriptional profile. A key difference across the distinct populations of NSCs is the length of G1 phase, where the licensing of the DNA replication origins takes place by the assembly of a pre-replicative complex. Licensing of DNA replication is a process that is adapted accordingly to the cell cycle length of NSCs to secure the timed duplication of the genome. Moreover, DNA replication should be efficiently coordinated with ongoing transcription for the prevention of conflicts that would impede the progression of both processes, compromising the normal course of development. In the present review we discuss how the differential regulation of the licensing and initiation of DNA replication in different cortical NSCs populations is integrated with the properties of these stem cells populations. Moreover, we examine the implication of the initial steps of DNA replication in the pathogenetic mechanisms of neurodevelopmental defects and Zika virus-related microcephaly, highlighting the significance of the differential regulation of DNA replication during brain development.
C1 [Kalogeropoulou, Argyro; Taraviras, Stavros] Univ Patras, Med Sch, Dept Physiol, Patras, Greece.
   [Lygerou, Zoi] Univ Patras, Dept Gen Biol, Med Sch, Patras, Greece.
RP Taraviras, S (corresponding author), Univ Patras, Med Sch, Dept Physiol, Patras, Greece.
EM taraviras@med.upatras.gr
RI Taraviras, Stavros/AAJ-4690-2020
OI Taraviras, Stavros/0000-0002-7455-647X
FU ARISTEIA II; Foundation Sante; GEMCCTR
FX This work was supported by ARISTEIA II, GEMCCTR "Self-renewal and
   differentiation decisions in neural stem cells: Geminin, cell cycle
   control and transcriptional regulation" and the Foundation Sante.
CR Agirman G, 2017, FEBS LETT, V591, P3978, DOI 10.1002/1873-3468.12924
   Albert M, 2017, EMBO J, V36, P2642, DOI 10.15252/embj.201796764
   Alver RC, 2014, DNA REPAIR, V19, P182, DOI 10.1016/j.dnarep.2014.03.012
   Arai Y, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00384
   Azzarelli R, 2015, WIRES DEV BIOL, V4, P197, DOI 10.1002/wdev.174
   Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108
   Bertipaglia C, 2018, SEMIN CELL DEV BIOL, V82, P57, DOI 10.1016/j.semcdb.2017.11.033
   Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775
   Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776
   Borrell V, 2014, NEUROSCI RES, V86, P14, DOI 10.1016/j.neures.2014.04.004
   Burrage LC, 2015, AM J HUM GENET, V97, P904, DOI 10.1016/j.ajhg.2015.11.006
   Caillat Christophe, 2012, Subcell Biochem, V62, P71, DOI 10.1007/978-94-007-4572-8_5
   Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005
   de Munnik SA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0322-x
   Delmolino LM, 2001, J BIOL CHEM, V276, P26947, DOI 10.1074/jbc.M101870200
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dwyer ND, 2016, J NEUROSCI, V36, P11394, DOI 10.1523/JNEUROSCI.2359-16.2016
   Ernst C, 2016, TRENDS NEUROSCI, V39, P290, DOI 10.1016/j.tins.2016.03.001
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Fenwick AL, 2016, AM J HUM GENET, V99, P125, DOI 10.1016/j.ajhg.2016.05.019
   Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002
   Fujii-Yamamoto H, 2005, J BIOL CHEM, V280, P12976, DOI 10.1074/jbc.M412224200
   Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88
   Ge XQ, 2015, STEM CELL REP, V5, P185, DOI 10.1016/j.stemcr.2015.06.002
   German J, 2007, HUM MUTAT, V28, P743, DOI 10.1002/humu.20501
   Goodship J, 2000, AM J HUM GENET, V67, P498, DOI 10.1086/303023
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Govindan S, 2017, FEBS LETT, V591, P3960, DOI 10.1002/1873-3468.12846
   Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024
   Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777
   Guo RB, 2007, NUCLEIC ACIDS RES, V35, P6297, DOI 10.1093/nar/gkm536
   Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109
   Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245
   Hua BL, 2017, GENETICS, V207, P29, DOI 10.1534/genetics.115.186627
   Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105
   Jackson AP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a013060
   Khetarpal P, 2016, MOL GENET GENOMICS, V291, P1, DOI 10.1007/s00438-015-1110-y
   Li CJ, 2002, MOL CELL BIOL, V22, P105, DOI 10.1128/MCB.22.1.105-116.2002
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200
   Lim L, 2018, NEURON, V100, P294, DOI 10.1016/j.neuron.2018.10.009
   Lin YL, 2012, CURR GENOMICS, V13, P65, DOI 10.2174/138920212799034767
   Matson JP, 2017, ELIFE, V6, DOI 10.7554/eLife.30473
   Matsuzaki F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015719
   Mazouzi A, 2014, EXP CELL RES, V329, P85, DOI 10.1016/j.yexcr.2014.09.030
   Miyata T, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00473
   Mokrani-Benhelli H, 2013, HUM MUTAT, V34, P374, DOI 10.1002/humu.22245
   Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002
   Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002
   Nordman J, 2012, DEVELOPMENT, V139, P455, DOI 10.1242/dev.061838
   Ogi T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002945
   Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200
   Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483
   Rash BG, 2013, J NEUROSCI, V33, P10802, DOI 10.1523/JNEUROSCI.3621-12.2013
   Reynolds JJ, 2017, NAT GENET, V49, P537, DOI 10.1038/ng.3790
   Rivera-Mulia JC, 2016, MOL CELL, V62, P756, DOI 10.1016/j.molcel.2016.05.007
   Rivera-Mulia JC, 2015, GENOME RES, V25, P1091, DOI 10.1101/gr.187989.114
   Sahara S, 2009, NEURON, V63, P48, DOI 10.1016/j.neuron.2009.06.006
   Shima N, 2017, DNA REPAIR, V56, P166, DOI 10.1016/j.dnarep.2017.06.019
   Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930
   Stancik EK, 2010, J NEUROSCI, V30, P7028, DOI 10.1523/JNEUROSCI.6131-09.2010
   Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113
   Symeonidou IE, 2012, FEBS LETT, V586, P2803, DOI 10.1016/j.febslet.2012.07.042
   TAKAHASHI T, 1995, J NEUROSCI, V15, P6046
   Takebayashi S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040110
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801
   Uzquiano A, 2018, J NEUROCHEM, V146, P500, DOI 10.1111/jnc.14338
   Vetro A, 2017, EUR J HUM GENET, V25, P646, DOI 10.1038/ejhg.2017.5
   White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   2012, EUR J HUM GENET, V20, P598, DOI DOI 10.1038/EJHG.2011.269
   2014, SEMIN CELL DEV BIOL, V30, P174, DOI DOI 10.1016/J.SEMCDB.2014.03.013
   2002, J NEUROSCI OFF J SOC, V22, P6610, DOI DOI 10.1523/JNEUROSCI.22-15-06610
NR 78
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD MAR 11
PY 2019
VL 7
AR UNSP 29
DI 10.3389/fcell.2019.00029
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA HX2CM
UT WOS:000467199400002
PM 30915332
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lopez, SBG
   Guimaraes-Ribeiro, V
   Rodriguez, JVG
   Dorand, FAPS
   Salles, TS
   Sa-Guimaraes, TE
   Alvarenga, ESL
   Melo, ACA
   Almeida, RV
   Moreira, MF
AF Lopez, Sheila Barbara G.
   Guimaraes-Ribeiro, Victor
   Rodriguez, Joao Victor G.
   Dorand, Fernando A. P. S.
   Salles, Tiago S.
   Sa-Guimaraes, Thayane E.
   Alvarenga, Evelyn S. L.
   Melo, Ana Claudia A.
   Almeida, Rodrigo, V
   Moreira, Monica F.
TI RNAi-based bioinsecticide for Aedes mosquito control
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CHITIN SYNTHASE GENES; DOUBLE-STRANDED-RNA; RED FLOUR BEETLE; DSRNA;
   INTERFERENCE; RESISTANCE; EXPRESSION; SEQUENCE; DELIVERY; INSECTS
AB Zika virus infection and dengue and chikungunya fevers are emerging viral diseases that have become public health threats. Their aetiologic agents are transmitted by the bite of genus Aedes mosquitoes. Without effective therapies or vaccines, vector control is the main strategy for preventing the spread of these diseases. Increased insecticide resistance calls for biorational actions focused on control of the target vector population. The chitin required for larval survival structures is a good target for biorational control. Chitin synthases A and B (CHS) are enzymes in the chitin synthesis pathway. Double-stranded RNA (dsRNA)-mediated gene silencing (RNAi) achieves specific knockdown of target proteins. Our goal in this work, a new proposed RNAi-based bioinsecticide, was developed as a potential strategy for mosquito population control. DsRNA molecules that target five different regions in the CHSA and B transcript sequences were produced in vitro and in vivo through expression in E. coli HT115 and tested by direct addition to larval breeding water. Mature and immature larvae treated with dsRNA targeting CHS catalytic sites showed significantly decreased viability associated with a reduction in CHS transcript levels. The few larval and adult survivors displayed an altered morphology and chitin content. In association with diflubenzuron, this bioinsecticide exhibited insecticidal adjuvant properties.
C1 [Lopez, Sheila Barbara G.; Guimaraes-Ribeiro, Victor; Rodriguez, Joao Victor G.; Dorand, Fernando A. P. S.; Salles, Tiago S.; Sa-Guimaraes, Thayane E.; Alvarenga, Evelyn S. L.; Melo, Ana Claudia A.; Almeida, Rodrigo, V; Moreira, Monica F.] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [Melo, Ana Claudia A.; Moreira, Monica F.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil.
RP Moreira, MF (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, BR-21941909 Rio De Janeiro, RJ, Brazil.; Moreira, MF (corresponding author), Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil.
EM monica@iq.ufrj.br
RI Moreira, Monica F./J-4507-2016; Almeida, Rodrigo V/I-4362-2013; Almeida,
   Rodrigo/AAE-3019-2019; Melo, Ana C. A./V-6533-2019; Melo, Ana C
   A/Y-9734-2019
OI Moreira, Monica F./0000-0002-3720-415X; Almeida, Rodrigo
   V/0000-0002-0164-6044; Almeida, Rodrigo/0000-0002-0164-6044; Melo, Ana C
   A/0000-0003-0686-7089; Salles, Tiago/0000-0002-5822-1426
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Instituto Nacional de Ciencia e Tecnologia em
   Entomologia Molecular (INCT-EM/CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E_18/2015, 221797]
FX The authors Lopez S.B.G., Salles T.S., Sa-Guimaraes T.E.,
   Guimaraes-Ribeiro, V. and Alvarenga E.S.L. received graduate fellowships
   from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES). This study was supported financially by the Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional
   de Ciencia e Tecnologia em Entomologia Molecular (INCT-EM/CNPq),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and
   the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio
   de Janeiro (FAPERJ)-Edital: E_18/2015 pedido: 221797.
CR ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509
   Arakane Y, 2004, INSECT BIOCHEM MOLEC, V34, P291, DOI 10.1016/j.ibmb.2003.11.004
   Arakane Y, 2008, INSECT BIOCHEM MOLEC, V38, P959, DOI 10.1016/j.ibmb.2008.07.006
   Attasart P, 2013, VIRUS RES, V171, P252, DOI 10.1016/j.virusres.2012.11.012
   Bashir H, 2016, BIOTECHNOL APPL BIOC, V63, P708, DOI 10.1002/bab.1426
   Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881
   Dalla Bona AC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1634-y
   Despres L, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0716
   Doucet D, 2012, ADV INSECT PHYSIOL, V43, P437, DOI 10.1016/B978-0-12-391500-9.00006-1
   Douris V, 2016, P NATL ACAD SCI USA, V113, P14692, DOI 10.1073/pnas.1618258113
   Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052
   Franco TA, 2016, INSECT BIOCHEM MOLEC, V69, P82, DOI 10.1016/j.ibmb.2015.02.012
   Galdeano DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171847
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Henriques BS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603140
   Hogenkamp DG, 2005, INSECT BIOCHEM MOLEC, V35, P529, DOI 10.1016/j.ibmb.2005.01.016
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004
   Ibrahim GH, 2000, INSECT BIOCHEM MOLEC, V30, P1213, DOI 10.1016/S0965-1748(00)00100-4
   INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P
   Joga MR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00553
   Kamola PJ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004656
   Lee EJ, 2006, ANAL BIOCHEM, V357, P299, DOI 10.1016/j.ab.2006.06.011
   Lin YH, 2017, PEST MANAG SCI, V73, P960, DOI 10.1002/ps.4407
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez-Martinez G, 2012, J MED ENTOMOL, V49, P215, DOI 10.1603/ME11122
   Luo Y, 2013, INSECT MOL BIOL, V22, P574, DOI 10.1111/imb.12046
   MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3
   McEwan DL, 2012, MOL CELL, V47, P746, DOI 10.1016/j.molcel.2012.07.014
   Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709
   Ministerio da Saude, 2017, B EP SECR VIG SAUD, V48
   Moreira MF, 2007, INSECT BIOCHEM MOLEC, V37, P1249, DOI 10.1016/j.ibmb.2007.07.017
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Mysore K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2112-5
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Paris M, 2011, PEST MANAG SCI, V67, P122, DOI 10.1002/ps.2046
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Pillai AB, 2017, INSECT MOL BIOL, V26, P127, DOI 10.1111/imb.12282
   Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82
   Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8
   Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100
   Shukla JN, 2016, RNA BIOL, V13, P656, DOI 10.1080/15476286.2016.1191728
   Singh AD, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6901
   Slatko BE, 2014, MOL BIOCHEM PARASIT, V195, P88, DOI 10.1016/j.molbiopara.2014.07.004
   Souza-Ferreira PS, 2014, INSECT BIOCHEM MOLEC, V51, P101, DOI 10.1016/j.ibmb.2013.12.004
   Tellam RL, 2000, EUR J BIOCHEM, V267, P6025, DOI 10.1046/j.1432-1327.2000.01679.x
   Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006
   Tetreau G, 2012, APPL ENVIRON MICROB, V78, P8362, DOI 10.1128/AEM.02088-12
   Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579
   Vicente E., 2003, Ciencia e Tecnologia de Alimentos, V23, P370, DOI 10.1590/S0101-20612003000300013
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x
   Zanatta FB, 2007, J PERIODONTOL, V78, P2127, DOI 10.1902/jop.2007.070090
   Zhang H, 2015, ENTOMOL EXP APPL, V155, P218, DOI 10.1111/eea.12300
   Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x
   Zhang X, 2015, JOVE-J VIS EXP, DOI 10.3791/52523
   Zimoch L, 2002, CELL TISSUE RES, V308, P287, DOI 10.1007/s00441-002-0546-7
NR 63
TC 5
Z9 6
U1 1
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 11
PY 2019
VL 9
AR 4038
DI 10.1038/s41598-019-39666-5
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HO2NH
UT WOS:000460751300021
PM 30858430
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yue, C
   Teitz, S
   Miyabashi, T
   Boller, K
   Lewis-Ximenez, LL
   Baylis, SA
   Blumel, J
AF Yue, Constanze
   Teitz, Sebastian
   Miyabashi, Tomoyuki
   Boller, Klaus
   Lewis-Ximenez, Lia Laura
   Baylis, Sally A.
   Bluemel, Johannes
TI Inactivation and Removal of Chikungunya Virus and Mayaro Virus from
   Plasma-derived Medicinal Products
SO VIRUSES-BASEL
LA English
DT Article
DE alphaviruses; inactivation; heat treatment; S; D treatment;
   plasma-derived medicinal products; chikungunya virus; Mayaro virus;
   virus retentive filtration; nanofiltration
ID WEST-NILE-VIRUS; ZIKA VIRUS; SOLVENT/DETERGENT TREATMENT; HEAT
   INACTIVATION; VACCINIA VIRUS; TREATED PLASMA; EPIDEMIC; THERMOSTABILITY;
   NANOFILTRATION; PASTEURIZATION
AB Background: Chikungunya virus (CHIKV) and Mayaro virus (MAYV) are closely related members of the Semliki Forest complex within the genus alphavirus and are transmitted by arthropods, causing acute febrile illness in humans. CHIKV has spread to almost all continents, whereas autochthonous MAYV infections have been reported in South America and in the Caribbean. Nevertheless, there was concern about potential spread of MAYV to other regions similar to CHIKV in the past. The risk for transmission of emerging viruses by blood transfusion and the safety of plasma-derived medicinal products (PDMPs) are constant concerns. The manufacturing processes of PDMPs include procedures to inactivate/remove viruses. Methods: In this study, we investigated the reduction of MAYV and CHIKV by heat inactivation in various matrices, solvent/detergent treatment and nanofiltration. Results: Unexpectedly, MAYV was significantly more resistant to heat and solvent/detergent treatment compared to CHIKV. However, being similar in size, both MAYV and CHIKV were removed below the detection limit by 35 nm virus filters. Conclusions: The inactivation profiles of different alphavirus members vary considerably, even within the Semliki Forest Complex. However, robust dedicated viral inactivation/removal procedures commonly used in the plasma product industry are effective in inactivating or removing MAYV and CHIKV.
C1 [Yue, Constanze; Boller, Klaus; Baylis, Sally A.; Bluemel, Johannes] Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
   [Teitz, Sebastian; Miyabashi, Tomoyuki] Asahi Kasei, D-51105 Cologne, Germany.
   [Lewis-Ximenez, Lia Laura] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, RJ, Brazil.
RP Yue, C (corresponding author), Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
EM Constanze.Yue@pei.de; s.teitz@akbio.eu;
   miyabayashi.tb@om.asahi-kasei.co.jp; Klaus.Boller@pei.de;
   lialewis.fiocruz@gmail.com; Sally.Baylis@pei.de; Johannes.Bluemel@pei.de
CR Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Burnouf T, 2005, CURR NANOSCI, V1, P189, DOI 10.2174/157341305774642894
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   Cardone F, 2012, TRANSFUSION, V52, P953, DOI 10.1111/j.1537-2995.2011.03425.x
   Cella E, 2018, ASIAN PAC J TROP MED, V11, P194, DOI 10.4103/1995-7645.228433
   Centers for Diease Control and Prevention, 2018, GEOGR DISTR CHIK VIR
   Dichtelmuller HO, 2009, TRANSFUSION, V49, P1931, DOI 10.1111/j.1537-2995.2009.02222.x
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Espindola OM, 2006, J VIROL METHODS, V134, P171, DOI 10.1016/j.jviromet.2006.01.001
   Fang Y, 2009, AM J TROP MED HYG, V80, P862, DOI 10.4269/ajtmh.2009.80.862
   Farcet MR, 2017, TRANSFUSION, V57, P797, DOI 10.1111/trf.13953
   HARRISON SC, 1971, J MOL BIOL, V60, P523, DOI 10.1016/0022-2836(71)90186-0
   Hassing RJ, 2010, EUROSURVEILLANCE, V15, P22
   Henss L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010082
   HOROWITZ B, 1992, BLOOD, V79, P826
   Huang YJS, 2015, VECTOR-BORNE ZOONOT, V15, P674, DOI 10.1089/vbz.2015.1795
   Huangfu CJ, 2017, BIOLOGICALS, V46, P139, DOI 10.1016/j.biologicals.2017.01.009
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   KNEVELMAN A, 1994, VOX SANG, V66, P89, DOI 10.1111/j.1423-0410.1994.tb00288.x
   Kre<ss> J.A., 2017, COLLABORATIVE STUDY
   Leydold SM, 2012, TRANSFUSION, V52, P2122, DOI 10.1111/j.1537-2995.2012.03565.x
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095
   Park SL, 2016, J VIROL METHODS, V234, P152, DOI 10.1016/j.jviromet.2016.04.004
   Pisani G, 2016, TRANSFUS MED HEMOTH, V43, P158, DOI 10.1159/000446219
   Rabenau HF, 2016, BUNDESGESUNDHEITSBLA, V59, P540, DOI 10.1007/s00103-016-2325-8
   Remington KM, 2004, VOX SANG, V87, P10, DOI 10.1111/j.1423-0410.2004.00530.x
   Rezvan H, 2006, MED J ISLAM REPUB IR, V20, P86
   Roberts P, 2000, BIOLOGICALS, V28, P29, DOI 10.1006/biol.1999.0236
   Roberts P, 2002, BIOLOGICALS, V30, P255, DOI 10.1006/biol.2002.0340
   Roberts P, 1999, BIOLOGICALS, V27, P263, DOI 10.1006/biol.1999.0178
   Ruppach H, 2014, BIOPROCESS J, V12, P24, DOI [10.12665/J124.Ruppach, DOI 10.12665/J124.RUPPACH]
   Seitz H, 2002, BIOLOGICALS, V30, P197, DOI 10.1006/biol.2002.0328
   Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   UEMURA Y, 1994, VOX SANG, V67, P246, DOI 10.1111/j.1423-0410.1994.tb01246.x
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81
NR 46
TC 0
Z9 0
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR 7
PY 2019
VL 11
IS 3
AR 234
DI 10.3390/v11030234
PG 13
WC Virology
SC Virology
GA HT2RD
UT WOS:000464409200005
PM 30866548
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Harapan, H
   Mudatsir, M
   Yufika, A
   Nawawi, Y
   Wahyuniati, N
   Anwar, S
   Yusri, F
   Haryanti, N
   Wijayanti, NP
   Rizal, R
   Fitriani, D
   Maulida, NF
   Syahriza, M
   Ikram, I
   Fandoko, TP
   Syahadah, M
   Asrizal, FW
   Aletta, A
   Jamil, KF
   Rajamoorthy, Y
   Hadisoemarto, PF
   Wagner, AL
   Groneberg, DA
   Kuch, U
   Sasmono, RT
   Muller, R
   Imrie, A
AF Harapan, Harapan
   Mudatsir, Mudatsir
   Yufika, Amanda
   Nawawi, Yusuf
   Wahyuniati, Nur
   Anwar, Samsul
   Yusri, Fitria
   Haryanti, Novi
   Wijayanti, Nanda Putri
   Rizal, Rizal
   Fitriani, Devi
   Maulida, Nurul Fadhliati
   Syahriza, Muhammad
   Ikram, Ikram
   Fandoko, Try Purwo
   Syahadah, Muniati
   Asrizal, Febrivan Wahyu
   Aletta, Alma
   Jamil, Kurnia Fitri
   Rajamoorthy, Yogambigai
   Hadisoemarto, Panji Fortuna
   Wagner, Abram Luther
   Groneberg, David Alexander
   Kuch, Ulrich
   Sasmono, R. Tedjo
   Mueller, Ruth
   Imrie, Allison
TI Community acceptance and willingness-to-pay for a hypothetical Zika
   vaccine: A cross-sectional study in Indonesia
SO VACCINE
LA English
DT Article
DE Zika virus; Zika vaccine; Zika vaccination; Acceptance;
   Willingness-to-pay
ID DENGUE VACCINE; VIRUS-INFECTION; PARENT ATTITUDES; DETERMINANTS;
   TRANSMISSION; KNOWLEDGE; OUTBREAK
AB Background: Understanding people's perceptions of the economic benefits of a potential Zika vaccine (ZV) is critical to accelerating its introduction into either public sector programs or private market. The aim of this study was to assess the acceptance and willingness-to-pay (WTP) for a hypothetical ZV and the associated explanatory variables in Indonesia.
   Methods: We conducted a health facility-based cross-sectional study in Aceh and West Sumatra province from 1 February to 13 June 2018. Patients who visited outpatient departments, have had children or were expecting their first child, were approached and interviewed to collect information on acceptance, WTP, demographic and socio-economic variables and attitudes towards childhood vaccines. Associations of explanatory variables influencing acceptance and WTP were assessed using logistic regression and linear regression analysis, respectively.
   Results: In total, 956 respondents were included in the final analysis of acceptance, of whom 338 (353%) expressed their WTP. We found that 757 (79.1%) of the respondents were likely to be vaccinated and to recommend their partner to be vaccinated. Higher educational attainment, having a job, having heard about Zika and a good attitude towards childhood vaccination were associated with ZV acceptance in the univariate analyses. In the multivariate analysis, attitude towards childhood vaccination was the strongest predictor for ZV vaccination. We found the geometric mean and median of WTP was US$ 13.1 (95% CI: 11.37-15.09) and US$ 7.0 (95% CI: 4.47-10.98), respectively. In the final model, having heard about Zika, having a job, and higher income were associated with a higher WTP.
   Conclusion: Although the acceptance rate of the ZV is relatively high in Indonesia, less than 40% of respondents are willing to pay, underscoring the need for a low-cost, high-quality vaccine and public sector subsidies for Zika vaccinations in the country. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Harapan, Harapan; Mudatsir, Mudatsir; Wahyuniati, Nur; Ikram, Ikram; Jamil, Kurnia Fitri] Univ Syiah Kuala, Sch Med, Med Res Unit, Banda Aceh, Aceh, Indonesia.
   [Harapan, Harapan; Mudatsir, Mudatsir] Univ Syiah Kuala, Sch Med, Trop Dis Ctr, Banda Aceh, Aceh, Indonesia.
   [Harapan, Harapan; Mudatsir, Mudatsir] Univ Syiah Kuala, Sch Med, Dept Microbiol, Banda Aceh, Aceh, Indonesia.
   [Harapan, Harapan; Imrie, Allison] Univ Western Australia, Sch Biomed Sci, Nedlands, WA, Australia.
   [Yufika, Amanda; Nawawi, Yusuf; Aletta, Alma] Univ Syiah Kuala, Sch Med, Dept Family Med, Banda Aceh, Aceh, Indonesia.
   [Anwar, Samsul] Univ Syiah Kuala, Fac Math & Nat Sci, Dept Stat, Banda Aceh, Aceh, Indonesia.
   [Yusri, Fitria] Malikussaleh Univ, Sch Med, Lhokseumawe, Aceh, Indonesia.
   [Haryanti, Novi] Community Hlth Ctr Meurah Mulia, North Aceh, Aceh, Indonesia.
   [Wijayanti, Nanda Putri] Community Hlth Ctr Tapaktuan, South Aceh, Aceh, Indonesia.
   [Rizal, Rizal] Bunda Hosp, Lhokseumawe, Aceh, Indonesia.
   [Fitriani, Devi] Community Hlth Ctr Teunom, Aceh Jaya, Aceh, Indonesia.
   [Maulida, Nurul Fadhliati] Meuraxa Hosp, Banda Aceh, Aceh, Indonesia.
   [Syahriza, Muhammad] Univ Syiah Kuala, Sch Med, Dept Publ Hlth & Community Med, Banda Aceh, Aceh, Indonesia.
   [Fandoko, Try Purwo] Community Hlth Ctr Gunung, Padang Panjang, West Sumatra, Indonesia.
   [Syahadah, Muniati] Community Hlth Ctr Lima Kaum, Tanah Datar, West Sumatra, Indonesia.
   [Asrizal, Febrivan Wahyu] Community Hlth Ctr Tanjung Paku, Solok, West Sumatra, Indonesia.
   [Jamil, Kurnia Fitri] Univ Syiah Kuala, Sch Med, Dept Internal Med, Banda Aceh, Aceh, Indonesia.
   [Rajamoorthy, Yogambigai] Univ Tunku Abdul Rahman, Dept Econ, Selangor, Malaysia.
   [Hadisoemarto, Panji Fortuna] Univ Padjadjaran, Fac Med, Grad Program Publ Hlth, Bandung, Indonesia.
   [Wagner, Abram Luther] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Groneberg, David Alexander; Kuch, Ulrich; Mueller, Ruth] Goethe Univ, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.
   [Sasmono, R. Tedjo] Eijkman Inst Mol Biol, Jakarta, Indonesia.
   [Mueller, Ruth] Inst Trop Med, Unit Med Entomol, Antwerp, Belgium.
RP Harapan, H (corresponding author), Univ Syiah Kuala, Sch Med, Med Res Unit, Jl T Tanoeh Abe, Darussalam 23111, Banda Aceh, Indonesia.
EM harapan@unsyiah.ac.id
RI Sasmono, Tedjo/H-5680-2016; Imrie, Allison/AAH-2421-2019; Wagner,
   Abram/X-6379-2019; Harapan, Harapan/I-8741-2016; Mudatsir,
   Mudatsir/Q-4999-2017; Muller, Ruth/D-2551-2009
OI Sasmono, Tedjo/0000-0003-0986-2590; Wagner, Abram/0000-0003-4691-7802;
   Harapan, Harapan/0000-0001-7630-8413; Mudatsir,
   Mudatsir/0000-0002-5643-9384; Muller, Ruth/0000-0003-3909-3876; Yufika,
   Amanda/0000-0001-8408-9396; /0000-0001-8726-0793
FU Department of Foreign Affairs and Trade; University of Western
   Australia; NHMRC Centre of Research Excellence in Emerging Infectious
   Diseases (CREID)National Health and Medical Research Council of
   Australia; Federal Ministry of Education and ResearchFederal Ministry of
   Education & Research (BMBF) [01KI1717]
FX We would like to thank to the participants of this study. HH is a
   recipient of an Australia Awards Scholarship (AAS) from the Department
   of Foreign Affairs and Trade, Scholarship for International Research
   Fees (SIRF) from The University of Western Australia and NHMRC Centre of
   Research Excellence in Emerging Infectious Diseases (CREID) Scholarship.
   RM, UK and DAG were supported by the Federal Ministry of Education and
   Research under the program "Nationales Forschungsnetz Zoonotische
   Infektionskrankheiten" (01KI1717). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahmed A, 2018, J INFECT PUBLIC HEAL, V11, P153, DOI 10.1016/j.jiph.2017.09.007
   Ajzen I., 1992, J CONSUM PSYCHOL, V1, P297, DOI DOI 10.1016/S1057-7408(08)80057-5
   Azizi FSM, 2017, VACCINE, V35, P2955, DOI 10.1016/j.vaccine.2017.04.010
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Birhane MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004486
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Dhimal M, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0426-3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O., 2016, ZIKA VIRUS IS SET SP, V355, pi5577
   Feng Changyong, 2014, Shanghai Arch Psychiatry, V26, P105, DOI 10.3969/j.issn.1002-0829.2014.02.009
   Fugenschuh A, 2016, OPTIMAL CONTROL INTE
   GLEJSER H, 1969, J AM STAT ASSOC, V64, P316, DOI 10.2307/2283741
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hadisoemarto PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002427
   Hansla A, 2008, ENERG POLICY, V36, P768, DOI 10.1016/j.enpol.2007.10.027
   Harapan H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110648
   Harapan H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3006-z
   Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013
   Harapan H, 2017, SE ASIAN J TROP MED, V48, P297
   Harapan H, 2017, HUM VACC IMMUNOTHER, V13, P786, DOI 10.1080/21645515.2016.1259045
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Harapan H, 2017, ACTA TROP, V166, P249, DOI 10.1016/j.actatropica.2016.11.035
   Harapan H, 2016, ASIAN PAC J TROP MED, V9, P1092, DOI 10.1016/j.apjtm.2016.07.036
   Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lee JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003810
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Noah Norman, 2008, Epidemiol Infect, V136, P865, DOI 10.1017/S0950268808000733
   O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Opel DJ, 2013, JAMA PEDIATR, V167, P1065, DOI 10.1001/jamapediatrics.2013.2483
   Opel DJ, 2011, VACCINE, V29, P6598, DOI 10.1016/j.vaccine.2011.06.115
   Opel DJ, 2011, HUM VACCINES, V7, P419, DOI 10.4161/hv.7.4.14120
   Ophir Y, 2018, J PUBLIC HEALTH-UK, P1
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Palanca-Tan R, 2008, VACCINE, V26, P914, DOI 10.1016/j.vaccine.2007.12.011
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Rajamoorthy Y, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6375-8
   Sasmono RT, 2018, EMERG INFECT DIS, V24, P1740, DOI 10.3201/eid2409.180582
   Sauerborn R, 2005, SCAND J PUBLIC HEALT, V33, P146, DOI 10.1080/14034940510005743
   Shoukat A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1091-x
   Slunge D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143875
   Vielot NA, 2018, AM J TROP MED HYG, V98, P1848, DOI 10.4269/ajtmh.17-0907
   WHO, 2017, ZIK SIT REP
   WHO. UN International children's Emergency Fund, 2017, WHO UNICEF ZIK VIR Z
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong LP, 2017, VACCINE, V35, P5912, DOI 10.1016/j.vaccine.2017.08.074
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yang J., 2012, INTERPRETING COEFFIC
   Yap BW, 2011, J STAT COMPUT SIM, V81, P2141, DOI 10.1080/00949655.2010.520163
   Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018
NR 57
TC 7
Z9 7
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAR 7
PY 2019
VL 37
IS 11
BP 1398
EP 1406
DI 10.1016/j.vaccine.2019.01.062
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HP1DK
UT WOS:000461405400004
PM 30739794
DA 2020-07-08
ER

PT J
AU Byers, NM
   Fleshman, AC
   Perera, R
   Molins, CR
AF Byers, Nathaniel M.
   Fleshman, Amy C.
   Perera, Rushika
   Molins, Claudia R.
TI Metabolomic Insights into Human Arboviral Infections: Dengue,
   Chikungunya, and Zika Viruses
SO VIRUSES-BASEL
LA English
DT Review
DE arbovirus; metabolomics; metabolism; alphavirus; flavivirus; lipid
ID CHROMATOGRAPHY-MASS SPECTROMETRY; SAMPLE PREPARATION; FATTY-ACIDS;
   NORMALIZATION METHODS; GAS-CHROMATOGRAPHY; ARACHIDONIC-ACID;
   INBORN-ERRORS; HUMAN-BLOOD; LARGE-SCALE; FEVER
AB The global burden of arboviral diseases and the limited success in controlling them calls for innovative methods to understand arbovirus infections. Metabolomics has been applied to detect alterations in host physiology during infection. This approach relies on mass spectrometry or nuclear magnetic resonance spectroscopy to evaluate how perturbations in biological systems alter metabolic pathways, allowing for differentiation of closely related conditions. Because viruses heavily depend on host resources and pathways, they present unique challenges for characterizing metabolic changes. Here, we review the literature on metabolomics of arboviruses and focus on the interpretation of identified molecular features. Metabolomics has revealed biomarkers that differentiate disease states and outcomes, and has shown similarities in metabolic alterations caused by different viruses (e.g., lipid metabolism). Researchers investigating such metabolomic alterations aim to better understand host-virus dynamics, identify diagnostically useful molecular features, discern perturbed pathways for therapeutics, and guide further biochemical research. This review focuses on lessons derived from metabolomics studies on samples from arbovirus-infected humans.
C1 [Byers, Nathaniel M.; Fleshman, Amy C.; Molins, Claudia R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
   [Perera, Rushika] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
RP Molins, CR (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
EM ngv8@cdc.gov; muj3@cdc.gov; Rushika.Perera@colostate.edu;
   CMolins@cdc.gov
OI Fleshman, Amy/0000-0003-0807-228X
FU U.S. Department of EnergyUnited States Department of Energy (DOE);
   Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX N.M.B. was funded by appointment to the Research Participation Program
   at the Centers for Disease Control and Prevention (CDC), administered by
   the Oak Ridge Institute for Science and Education through an interagency
   agreement between the U.S. Department of Energy and the Centers for
   Disease Control and Prevention.
CR Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003
   Amberg A, 2017, METHODS MOL BIOL, V1641, P229, DOI 10.1007/978-1-4939-7172-5_13
   [Anonymous], 2008, NEWB SCREEN LAB B
   Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001
   Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bingol Kerem, 2018, High Throughput, V7, DOI 10.3390/ht7020009
   Birungi G, 2010, J PROTEOME RES, V9, P6523, DOI 10.1021/pr100727m
   Bothwell JHF, 2011, BIOL REV, V86, P493, DOI 10.1111/j.1469-185X.2010.00157.x
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Bradbury KE, 2011, NUTRIENTS, V3, P152, DOI 10.3390/nu3010152
   Brennan L, 2014, PROG NUCL MAG RES SP, V83, P42, DOI 10.1016/j.pnmrs.2014.09.001
   BROOKS JB, 1983, J CHROMATOGR, V276, P279, DOI 10.1016/S0378-4347(00)85094-X
   Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S
   Cajka T, 2016, ANAL CHEM, V88, P524, DOI 10.1021/acs.analchem.5b04491
   Calder PC, 2002, EUR J CLIN NUTR, V56, pS14, DOI 10.1038/sj.ejcn.1601478
   Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935
   Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794
   Chang HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01208-2
   Chaturvedi UC, 2009, FEMS IMMUNOL MED MIC, V56, P9, DOI 10.1111/j.1574-695X.2009.00544.x
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Cui L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006217
   Cui L, 2017, J VIROL, V91, DOI [10.1128/jvi.00386-17, 10.1128/JVI.00386-17]
   Cui L, 2017, J PROTEOME RES, V16, P2614, DOI 10.1021/acs.jproteome.7b00173
   Cui L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004607
   Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373
   Dahal UP, 2011, DRUG METAB DISPOS, V39, P2355, DOI 10.1124/dmd.111.040865
   Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012
   De Livera AM, 2012, ANAL CHEM, V84, P10768, DOI 10.1021/ac302748b
   Dunn WB, 2012, BIOANALYSIS, V4, P2249, DOI [10.4155/BIO.12.204, 10.4155/bio.12.204]
   Ejigu BA, 2013, OMICS, V17, P473, DOI 10.1089/omi.2013.0010
   El-Bacha T, 2016, J VIROL, V90, P7429, DOI 10.1128/JVI.00187-16
   Emwas Abdul-Hamid M, 2015, Methods Mol Biol, V1277, P161, DOI 10.1007/978-1-4939-2377-9_13
   Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324
   Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200
   Fang ML, 2015, ANAL CHEM, V87, P10935, DOI 10.1021/acs.analchem.5b03003
   Ficicioglu C, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001842
   Findlay JS, 2015, J GEN VIROL, V96, P2693, DOI 10.1099/jgv.0.000226
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gonzalez-Dominguez R, 2017, BIOANALYSIS, V9, P131, DOI 10.4155/bio-2016-0202
   Gorrochategui E, 2016, TRAC-TREND ANAL CHEM, V82, P425, DOI 10.1016/j.trac.2016.07.004
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Gowda GAN, 2017, ANAL CHEM, V89, P4620, DOI 10.1021/acs.analchem.7b00171
   Gowda GAN, 2013, CURR METABOL, V1, P227, DOI 10.2174/2213235X113019990005
   GUDBJORNSSON B, 1991, ANN RHEUM DIS, V50, P669, DOI 10.1136/ard.50.10.669
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647
   Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777
   Huang F, 2005, AM J PHYSIOL-LUNG C, V289, pL176, DOI 10.1152/ajplung.00003.2005
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   IUPAC, COMPENDIUM CHEM TERM
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Katajamaa M, 2007, J CHROMATOGR A, V1158, P318, DOI 10.1016/j.chroma.2007.04.021
   Kema IP, 2000, J CHROMATOGR B, V747, P33, DOI 10.1016/S0378-4347(00)00341-8
   Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297
   Khedr A, 2016, J CHROMATOGR B, V1009, P44, DOI 10.1016/j.jchromb.2015.12.011
   Khedr A, 2015, J SEP SCI, V38, P316, DOI 10.1002/jssc.201400749
   Kirwan JA, 2013, ANAL BIOANAL CHEM, V405, P5147, DOI 10.1007/s00216-013-6856-7
   Kirwan JA, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.12
   Kitteringham NR, 2009, J CHROMATOGR B, V877, P1229, DOI 10.1016/j.jchromb.2008.11.013
   Knipe D.M., 2013, FIELDS VIROLOGY
   Kohl SM, 2012, METABOLOMICS, V8, pS146, DOI 10.1007/s11306-011-0350-z
   Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8
   Lehninger A.L., 2008, LEHNINGER PRINCIPLES
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123
   Liebscher S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007029
   Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Mak CM, 2013, CRIT REV CL LAB SCI, V50, P142, DOI 10.3109/10408363.2013.847896
   Manchester M, 2017, ADV VIRUS RES, V98, P57, DOI 10.1016/bs.aivir.2017.02.001
   Marco-Ramell A, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-017-2006-0
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   MCLAFFERTY FW, 1981, SCIENCE, V214, P280, DOI 10.1126/science.7280693
   McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02373
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Misra BB, 2016, ELECTROPHORESIS, V37, P86, DOI 10.1002/elps.201500417
   Mushtaq MY, 2014, PHYTOCHEM ANALYSIS, V25, P291, DOI 10.1002/pca.2505
   Nevalainen TJ, 1997, J INFECTION, V35, P251, DOI 10.1016/S0163-4453(97)92966-2
   Nico D, 2018, FRONT MED-LAUSANNE, V5, DOI [10.3389/fmed.2018.00025, 10.3389/fmed2018.00025]
   Noto A, 2014, J MATERN-FETAL NEO M, V27, P53, DOI 10.3109/14767058.2014.955963
   Melo CFOR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30385-x
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Pasquali M, 2006, AM J MED GENET C, V142C, P64, DOI 10.1002/ajmg.c.30086
   Patejko M, 2017, J CHROMATOGR B, V1043, P150, DOI 10.1016/j.jchromb.2016.09.029
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Perera R, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P45
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pompeia C, 2003, CELL BIOCHEM FUNCT, V21, P97, DOI 10.1002/cbf.1012
   Ren S, 2015, METABOLOMICS, V11, P1492, DOI 10.1007/s11306-015-0823-6
   Riekeberg Eli, 2017, F1000Res, V6, P1148, DOI 10.12688/f1000research.11495.1
   Roberts Lee D, 2012, Curr Protoc Mol Biol, VChapter 30, DOI 10.1002/0471142727.mb3002s98
   Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125
   Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038
   Shahfiza N, 2017, ACTA BIOCHIM POL, V64, P215, DOI 10.18388/abp.2015_1224
   Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200
   Shrinet J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36833
   Singh L, 2017, WORLD J CLIN CASES, V5, P303, DOI 10.12998/wjcc.v5.i7.303
   Smith AM, 2019, BIOL PSYCHIAT, V85, P345, DOI 10.1016/j.biopsych.2018.08.016
   Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39
   Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106
   Spicer R, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1242-7
   Sridharan A, 2013, J VIROL, V87, P11648, DOI 10.1128/JVI.01156-13
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534
   Sysi-Aho M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-93
   Tallima H, 2018, J ADV RES, V11, P33, DOI 10.1016/j.jare.2017.11.004
   Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y
   Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042
   TOLLINGER CD, 1979, CLIN CHEM, V25, P1787
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   van Oort PMP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020449
   Villamor E, 2018, BRIT J NUTR, V120, P787, DOI 10.1017/S0007114518002039
   Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013
   Voge NV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004449
   Wang KZ, 2016, INT J BIOL SCI, V12, P872, DOI 10.7150/ijbs.15641
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weber RJM, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-016-1147-x
   (WHO). World Health Organization, 2009, DENG GUID DIAGN TREA, P147
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   World Health Organization, 1997, DENG HAEM FEV DIAGN, pviii
   World Health Organization Regional Office for South East Asia, 2011, COMPR GUID PREV CONT, pxiv
   Wu YM, 2016, J CHROMATOGR A, V1430, P80, DOI 10.1016/j.chroma.2015.12.007
   Xia J, 2011, CURR PROTOC BIOINFOR, V14, P1, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]
   Xiao JF, 2012, TRAC-TREND ANAL CHEM, V32, P1, DOI 10.1016/j.trac.2011.08.009
   Yi LZ, 2016, ANAL CHIM ACTA, V914, P17, DOI 10.1016/j.aca.2016.02.001
   Zhang S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100521
NR 139
TC 3
Z9 3
U1 1
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR 6
PY 2019
VL 11
IS 3
AR 225
DI 10.3390/v11030225
PG 30
WC Virology
SC Virology
GA HT2QW
UT WOS:000464408500003
PM 30845653
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Phumee, A
   Buathong, R
   Boonserm, R
   Intayot, P
   Aungsananta, N
   Jittmittraphap, A
   Joyjinda, Y
   Wacharapluesadee, S
   Siriyasatien, P
AF Phumee, Atchara
   Buathong, Rome
   Boonserm, Rungfar
   Intayot, Proawpilart
   Aungsananta, Nucharat
   Jittmittraphap, Akanitt
   Joyjinda, Yutthana
   Wacharapluesadee, Supaporn
   Siriyasatien, Padet
TI Molecular Epidemiology and Genetic Diversity of Zika Virus from
   Field-Caught Mosquitoes in Various Regions of Thailand
SO PATHOGENS
LA English
DT Article
DE Zika virus; mosquitoes; molecular epidemiology; genetic diversity;
   Thailand
ID PHYLOGENY; NS5
AB Zika virus (ZIKV) infection is an emerging and re-emerging arbovirus disease that is transmitted to humans through the bite of infected mosquitoes. ZIKV infections were first described in Thailand in 1954 from the sera of indigenous residents and several travelers returning from Thailand in 2014. However, reported cases in Thailand have been increasing since 2015 and 2016, and epidemiological information about the vectors of ZIKV is unclear. We investigated the molecular epidemiology and genetic diversity of ZIKV from mosquitoes collected from different geographic regions experiencing ZIKV outbreaks in Thailand. Polymerase chain reaction was used to amplify the non-structural protein (NS5) gene of ZIKV, which was then sequenced. A total of 1026 mosquito samples (626 females, 367 males, and 33 larvae) were collected from active ZIKV patients' houses. ZIKV was detected in 79 samples (7.7%), including Aedes aegypti (2.24% female, 1.27% male, and 0.19% larvae), Culex quinquefasciatus (1.85% female, 1.66% male, and 0.29% larvae), and Armigeres subalbatus (0.1% female and 0.1% male), whereas no ZIKV was detected in Aedes albopictus. Phylogenetic analysis of the 79 positive samples were classified into two clades: Those closely related to a previous report in Thailand, and those related to ZIKV found in the Americas. This is the first report of the detection of ZIKV in Ae. aegypti, Cx. quinquefasciatus, and Ar. subalbatus mosquitoes, and genetic variations of ZIKV in the mosquitoes collected from several geographic regions of Thailand were examined. Detection of ZIKV in male and larval mosquitoes suggests that vertical transmission of ZIKV occurred in these mosquito species. This study provides a more in-depth understanding of the patterns and epidemiologic data of ZIKV in Thailand; the data could be used for future development of more effective prevention and control strategies of ZIKV in Thailand.
C1 [Phumee, Atchara; Joyjinda, Yutthana; Wacharapluesadee, Supaporn] Chulalongkorn Univ, Thai Red Cross Emerging Infect Dis Hlth Sci Ctr, Collaborating Ctr Res & Training Viral Zoonoses, WHO,Chulalongkorn Hosp,Fac Med, Bangkok 10330, Thailand.
   [Phumee, Atchara; Boonserm, Rungfar; Siriyasatien, Padet] Chulalongkorn Univ, Vector Biol & Vector Borne Dis Res Unit, Dept Parasitol, Fac Med, Bangkok 10330, Thailand.
   [Buathong, Rome] Minist Publ Hlth, Bur Epidemiol, Dept Dis Control, Nonthaburi 11000, Thailand.
   [Intayot, Proawpilart] Chulalongkorn Univ, Med Sci Program, Fac Med, Bangkok 10330, Thailand.
   [Aungsananta, Nucharat] Bangkok Metropolitan Adm, Dept Hlth, Publ Hlth Ctr 22 Wat Pak Bor, Bangkok 10250, Thailand.
   [Jittmittraphap, Akanitt] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok 10400, Thailand.
RP Siriyasatien, P (corresponding author), Chulalongkorn Univ, Vector Biol & Vector Borne Dis Res Unit, Dept Parasitol, Fac Med, Bangkok 10330, Thailand.
EM amphumee@gmail.com; romebua@hotmail.com; sky_rung123@hotmail.com;
   khunproaw@gmail.com; thephonee@gmail.com; akanitt@hotmail.com;
   yutthana.jjd@gmail.com; spwa@hotmail.com; padet.s@chula.ac.th
RI PHUMEE, ATCHARA/AAG-4881-2020
OI Siriyasatien, Padet/0000-0002-9248-1678; PHUMEE,
   ATCHARA/0000-0001-8243-7406
FU National Science and Technology Development Agency (Thailand)
   [P-16-50702]; Research Chair Grant; National Research Council of
   ThailandNational Research Council of Thailand (NRCT); Health Systems
   Research Institute [61-003]; Rachadapisaek Sompote Fund [RA/MF 11/61];
   World Health Organization (WHO)World Health Organization; United States
   Agency for International Development (USAID) grantUnited States Agency
   for International Development (USAID)
FX This study was supported by National Science and Technology Development
   Agency (Thailand) (Grant No. P-16-50702), the Research Chair Grant and
   National Research Council of Thailand, Health Systems Research Institute
   (Grant No. 61-003), Rachadapisaek Sompote Fund (Grant No. RA/MF 11/61),
   and the World Health Organization (WHO) and the United States Agency for
   International Development (USAID) grant.
CR Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   ProMed mail, PRO MBDS ZIK VIR THA
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Shinohara K., ZIKA VIRUS JAPAN EX
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tawatsin A, 2018, THAI J VET MED, V48, P551
   Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organization (WHO), EM SIT REP ZIK VIR M
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 46
TC 4
Z9 4
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-0817
J9 PATHOGENS
JI Pathogens
PD MAR 6
PY 2019
VL 8
IS 1
AR 30
DI 10.3390/pathogens8010030
PG 11
WC Microbiology
SC Microbiology
GA HS9WE
UT WOS:000464216600002
PM 30845707
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cardozo, LE
   Russo, PST
   Gomes-Correia, B
   Araujo-Pereira, M
   Sepulveda-Hermosilla, G
   Maracaja-Coutinho, V
   Nakaya, HI
AF Cardozo, Lucas E.
   Russo, Pedro S. T.
   Gomes-Correia, Bruno
   Araujo-Pereira, Mariana
   Sepulveda-Hermosilla, Gonzalo
   Maracaja-Coutinho, Vinicius
   Nakaya, Helder, I
TI webCEMiTool: Co-expression Modular Analysis Made Easy
SO FRONTIERS IN GENETICS
LA English
DT Article
DE co-expression analysis; systems biology; transcriptomics; web tool; data
   integration
AB Co-expression analysis has been widely used to elucidate the functional architecture of genes under different biological processes. Such analysis, however, requires substantial knowledge about programming languages and/or bioinformatics skills. We present webCEMiTool,(1) a unique online tool that performs comprehensive modular analyses in a fully automated manner. The webCEMiTool not only identifies co-expression gene modules but also performs several functional analyses on them. In addition, webCEMiTool integrates transcriptomic data with interactome information (i.e., protein-protein interactions) and identifies potential hubs on each network. The tool generates user-friendly html reports that allow users to search for specific genes in each module, as well as check if a module contains genes overrepresented in specific pathways or altered in a specific sample phenotype. We used webCEMiTool to perform a modular analysis of single-cell RNA-seq data of human cells infected with either Zika virus or dengue virus.
C1 [Cardozo, Lucas E.; Russo, Pedro S. T.; Araujo-Pereira, Mariana; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Gomes-Correia, Bruno; Maracaja-Coutinho, Vinicius] Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Santiago, Chile.
   [Sepulveda-Hermosilla, Gonzalo] Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago, Chile.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
EM hnakaya@usp.br
RI Nakaya, Helder/AAF-1738-2020; Maracaja-Coutinho, Vinicius/R-5256-2019
OI Nakaya, Helder/0000-0001-5297-9108; Maracaja-Coutinho,
   Vinicius/0000-0002-8873-9381
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2012/19278-6, 2013/08216-2, 2017/05762-7, 2018/10748-6]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [313662/2017-7]; FONDECYT-CONICYTComision Nacional de Investigacion
   Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [11161020];
   PAI-CONICYT [PAI79170021]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES)CAPES [001]
FX This work was supported by grants from FAPESP (2012/19278-6,
   2013/08216-2, 2017/05762-7, 2018/10748-6); CNPq (313662/2017-7);
   FONDECYT-CONICYT (11161020); and PAI-CONICYT (PAI79170021). This study
   was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Beins E, 2016, GLIA, V64, P1007, DOI 10.1002/glia.22979
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Desai AP, 2017, PEERJ, V5, DOI 10.7717/peerj.3678
   Janova H, 2016, GLIA, V64, P635, DOI 10.1002/glia.22955
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Sharma Ankush, 2017, Front Immunol, V8, P918, DOI 10.3389/fimmu.2017.00918
   Tzfadia O, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01194
   Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110
   Wang J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004892
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
   Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128
NR 12
TC 1
Z9 1
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAR 6
PY 2019
VL 10
AR 146
DI 10.3389/fgene.2019.00146
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA HO4DL
UT WOS:000460872200001
PM 30894872
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kikuti, M
   Cruz, JS
   Rodrigues, MS
   Tavares, AS
   Paploski, IAD
   Silva, MMO
   Santana, PM
   Tauro, LB
   Silva, GAOF
   Campos, GS
   Araujo, JMG
   Kitron, U
   Reis, MG
   Ribeiro, GS
AF Kikuti, Mariana
   Cruz, Jaqueline S.
   Rodrigues, Moreno S.
   Tavares, Aline S.
   Paploski, Igor A. D.
   Silva, Monaise M. O.
   Santana, Perla M.
   Tauro, Laura B.
   Silva, Greice A. O. F.
   Campos, Gubio S.
   Araujo, Josello M. G.
   Kitron, Uriel
   Reis, Mitermayer G.
   Ribeiro, Guilherme S.
TI Accuracy of the SD BIOLINE Dengue Duo for rapid point-of-care diagnosis
   of dengue
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS; NS1 ANTIGEN; TEST KIT; EPIDEMIC; INFECTIONS; SAMPLES; IGM
AB Background
   Rapid diagnosis tests (RDTs) are easy to carry out, provide fast results, and could potentially guide medical treatment decisions. We investigated the performance of a commercially available RDT, which simultaneously detects the non-structural 1 (NS1) dengue virus (DENV) antigen, and IgM and IgG DENV antibodies, using representative serum samples from individuals in a dengue endemic area in Salvador, Brazil.
   Methodology/Principal findings
   We evaluated the accuracy of the SD BIOLINE Dengue Duo RDT (Abbott, Santa Clara, USA; former Alere Inc, Waltham, USA) in a random collection of sera. Samples included acute-phase sera from 246 laboratory-confirmed dengue cases and 108 non-dengue febrile patients enrolled in a surveillance study for dengue detection, 73 healthy controls living in the same surveillance community, and 73 blood donors. RDT accuracy was blindly assessed based on the combined results for the NS1 and the IgM test components. The RDT sensitivity was 46.8% (38.6% for the NS1 component and 13.8% for the IgM component). Sensitivity was greater for samples obtained from patients with secondary DENV infections (49.8%) compared to primary infections (31.1%) (P:0.02) and was also influenced by the result in the confirmatory dengue diagnostic test, ranging from 39.7% for samples of cases confirmed by IgM-ELISA seroconversion between paired samples to 90.4% for samples of cases confirmed by a positive NS1-ELISA. The RDT specificity was 94.4% for nondengue febrile patients, 87.7% for the community healthy controls, and 95.9% for the blood donors.
   Conclusions/Significance
   The SD BIOLINE Dengue Duo RDT showed good specificities, but low sensitivity, suggesting that it may be more useful to rule in than to rule out a dengue diagnosis in dengue endemic regions.
C1 [Kikuti, Mariana; Cruz, Jaqueline S.; Rodrigues, Moreno S.; Tavares, Aline S.; Silva, Monaise M. O.; Santana, Perla M.; Silva, Greice A. O. F.; Reis, Mitermayer G.; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Kikuti, Mariana; Paploski, Igor A. D.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Paploski, Igor A. D.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.
   [Tauro, Laura B.] Consejo Nacl Invest Cient & Tecn, Inst Nacl Med Trop, Puerto Iguazu, Misiones, Argentina.
   [Campos, Gubio S.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Araujo, Josello M. G.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Natal, RN, Brazil.
   [Kitron, Uriel] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Reis, Mitermayer G.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Reis, Mitermayer G.; Ribeiro, Guilherme S.] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Kikuti, Mariana/G-2313-2017; Reis, Mitermayer/AAO-9742-2020; Araujo,
   Joselio M G/B-5502-2013; Ribeiro, Guilherme/B-6624-2008; Paploski, Igor
   AD/D-7015-2014
OI Kikuti, Mariana/0000-0001-8119-7236; Reis,
   Mitermayer/0000-0002-3051-9060; Araujo, Joselio M G/0000-0003-3548-2786;
   Ribeiro, Guilherme/0000-0002-6798-2059; Paploski, Igor
   AD/0000-0002-3689-2042; Rodrigues, Moreno/0000-0002-1594-2311
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [550160/2010-8, 400830/2013-2, 440891/2016-7]; Bahia Foundation
   for Research Support [PNX0010/2011, PPP0055/2011, JCB0020/2013,
   PET0026/2013, APP0044/2016, PET0022/2016]; Coordination for the
   Improvement of Higher Education Personnel, Brazilian Ministry of
   Education [440891/2016-7, 001]; Federal University of Bahia; Oswaldo
   Cruz Foundation
FX This study was supported by the Brazilian National Council for
   Scientific and Technological Development (grant 550160/2010-8 to MGR,
   grants 400830/2013-2 and 440891/2016-7 to GSR; and scholarships to IADP,
   MSR, LBT, UK, MGR, and GSR); the Bahia Foundation for Research Support
   (grant PNX0010/2011 to MGR, grants PPP0055/2011, JCB0020/2013,
   PET0026/2013, APP0044/2016, PET0022/2016 to GSR, and scholarship to MMOS
   and GAOFS); the Coordination for the Improvement of Higher Education
   Personnel, Brazilian Ministry of Education (grant 440891/2016-7, finance
   code 001 to GSR, and scholarship to MK), the Federal University of
   Bahia; and the Oswaldo Cruz Foundation (scholarship to MMOS, JSC and
   AST). The funding sources had no role in study design; in the
   collection, analysis and interpretation of data; in the writing of the
   paper; and in the decision to submit the article for publication.
CR Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   [Anonymous], 2015, STAT STAT SOFTW REL
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030
   Carter MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003424
   Castaneda DM, 2016, VIROLOGY, V497, P136, DOI 10.1016/j.virol.2016.07.014
   Paploski IAD, 2018, ANN INTERN MED, V168, P301, DOI 10.7326/M17-1949
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Kao C, 2005, LAB DIAGNOSIS DENGUE, P5, DOI [10.1186/1743-422X-7-361, DOI 10.1186/1743-422X-7-361]
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lertjuthaporn S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200564
   Marques RE, 2018, IMMUNOLOGY, V155, P477, DOI 10.1111/imm.12988
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Piedrahita LD, 2016, AM J TROP MED HYG, V95, P315, DOI 10.4269/ajtmh.15-0492
   Prado PS, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170433
   Sanchez-Vargas LA, 2014, DIAGN MICR INFEC DIS, V78, P368, DOI 10.1016/j.diagmicrobio.2013.12.019
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Simonnet C, 2017, EUR J CLIN MICROBIOL, V36, P2441, DOI 10.1007/s10096-017-3083-8
   Teixeira Maria da Glória, 2005, Cad. Saúde Pública, V21, P1307, DOI 10.1590/S0102-311X2005000500002
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Vickers IE, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0164-9
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 33
TC 3
Z9 3
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 6
PY 2019
VL 14
IS 3
AR e0213301
DI 10.1371/journal.pone.0213301
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HN7LX
UT WOS:000460372100077
PM 30840708
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hansen, S
   Hotop, SK
   Faye, O
   Ndiaye, O
   Bohlken-Fascher, S
   Pessoa, R
   Hufert, F
   Stahl-Hennig, C
   Frank, R
   Czerny, CP
   Schmidt-Chanasit, J
   Sanabani, SS
   Sall, AA
   Niedrig, M
   Bronstrup, M
   Fritz, HJ
   Abd El Wahed, A
AF Hansen, Soeren
   Hotop, Sven-Kevin
   Faye, Oumar
   Ndiaye, Oumar
   Boehlken-Fascher, Susanne
   Pessoa, Rodrigo
   Hufert, Frank
   Stahl-Hennig, Christiane
   Frank, Ronald
   Czerny, Claus-Peter
   Schmidt-Chanasit, Jonas
   Sanabani, Sabri S.
   Sall, Amadou A.
   Niedrig, Matthias
   Broenstrup, Mark
   Fritz, Hans-Joachim
   Abd El Wahed, Ahmed
TI Diagnosing Zika virus infection against a background of other
   flaviviruses: Studies in high resolution serological analysis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME
AB Zika virus (ZIKV) is a mosquito-borne flavivirus. Homologous proteins of different flaviviruses display high degrees of sequence identity, especially within subgroups. This leads to extensive immunological cross-reactivity and corresponding problems for developing a ZIKV-specific serological assay. In this study, peptide microarrays were employed to identify individual ZIKV antibody targets with promise in differential diagnosis. A total of 1643 overlapping oligopeptides were synthesized and printed onto glass slides. Together, they encompass the full amino acid sequences of ZIKV proteomes of African, Brazilian, USA, and French Polynesian origins. The resulting ZIKV scanning microarray chips were used to screen three pools of sera from recent Zika outbreaks in Senegal and Cape Verde, in Brazil, and from overseas travelers returning to the EU. Together with a mixed pool of well characterized, archived sera of patients suffering from infections by dengue, yellow fever, tick-borne encephalitis, and West Nile viruses, a total of 42 sera went into the study. Sixty-eight antibody target regions were identified. Most of which were hitherto unknown. Alignments and sequence comparisons revealed 13 of which could be classified as bona fide ZIKV-specific. These identified antibody target regions constitute a founding set of analytical tools for serological discrimination of ZIKV from other flaviviruses.
C1 [Hansen, Soeren; Boehlken-Fascher, Susanne; Czerny, Claus-Peter; Abd El Wahed, Ahmed] Univ Goettingen, Div Microbiol & Anim Hyg, D-37075 Gottingen, Germany.
   [Hotop, Sven-Kevin; Broenstrup, Mark] Helmholtz Zentrum Infekt Forsch, Dept Chem Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany.
   [Hotop, Sven-Kevin; Broenstrup, Mark] DZIF, Braunschweig, Germany.
   [Faye, Oumar; Ndiaye, Oumar; Sall, Amadou A.] Inst Pasteur, Dakar, Senegal.
   [Pessoa, Rodrigo; Sanabani, Sabri S.] Univ Sao Paulo, Trop Med Inst Sao Paulo, Dept Dermatol, Lab Dermatol & Immunodeficiencies,LIM 56, Sao Paulo, Brazil.
   [Hufert, Frank] Brandenburg Med Sch Fontane, Inst Microbiol & Virol, Senftenberg, Germany.
   [Stahl-Hennig, Christiane] Deutsch Primatenzentrum GmbH, Leibniz Inst Primatenforsch, Unit Infect Models, Gottingen, Germany.
   [Frank, Ronald] AIMS Sci Prod GmbH, Berlin, Germany.
   [Schmidt-Chanasit, Jonas] WHO, Collaborating Ctr Arbovirus & Hemorrhag Fever Ref, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
   [Niedrig, Matthias] Robert Koch Inst, Nordufer 20, D-13353 Berlin, Germany.
   [Fritz, Hans-Joachim] Akad Wissensch Gottingen, Theaterstr 7, D-37073 Gottingen, Germany.
RP Abd El Wahed, A (corresponding author), Univ Goettingen, Div Microbiol & Anim Hyg, D-37075 Gottingen, Germany.
EM abdelwahed@gwdg.de
RI Faye, Oumar/T-7168-2019; Sanabani, Sabri Saeed/F-5600-2012
OI Sanabani, Sabri Saeed/0000-0002-8876-8262
CR Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dikmans A, 2006, QSAR COMB SCI, V25, P1069, DOI 10.1002/qsar.200640130
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Homan J., 2016, BIORXIV, DOI [10.1101/044834, DOI 10.1101/044834]
   Hotop SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086857
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kaida K, 2009, GLYCOBIOLOGY, V19, P676, DOI 10.1093/glycob/cwp027
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 32
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 6
PY 2019
VL 9
AR 3648
DI 10.1038/s41598-019-40224-2
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HN7SH
UT WOS:000460391500031
PM 30842564
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saisuk, W
   Srisawat, C
   Yoksan, S
   Dharakul, T
AF Saisuk, W.
   Srisawat, C.
   Yoksan, S.
   Dharakul, T.
TI Hybridization Cascade Plus Strand-Displacement Isothermal Amplification
   of RNA Target with Secondary Structure Motifs and Its Application for
   Detecting Dengue and Zika Viruses
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; EXPONENTIAL AMPLIFICATION; COLORIMETRIC
   DETECTION; SENSITIVE DETECTION; DNA AMPLIFICATION; MOLECULAR-BEACON;
   SPECIFICITY; MICRORNA; KINETICS; SURFACE
AB Biological RNA generally comprises secondary structure motifs which cause a problem for target RNA detection by isothermal amplification methods. The complexity of the secondary structures makes RNA targets inaccessible for probe hybridization, resulting in decreased sensitivity and selectivity. This is particularly important because the hybridization step of the isothermal amplification method requires a limited temperature range. A strand-displacement strategy can enhance the hybridization efficiency between the probe and target RNA with secondary structure motifs. A short, single stranded segment within the secondary structure can be used as a toehold for initiating strand displacement. The strategy has been used to establish a highly sensitive isothermal amplification by a combination of a hairpin probe hybridization and strand displacement amplification. The hairpin probe is placed on the single-stranded segment of the target RNA's secondary structure to initiate strand displacement. The probe's hybridization cascade provides a template for exponential amplification in two directions by strand-displacement amplification, designated hybridization cascade plus strand-displacement isothermal amplification (HyCaSD). The method requires no reverse transcription step. HyCaSD showed an excellent sensitivity with the limit of detection in the femtomolar (fM) range for synthetic targets as well as viral RNAs. Discrimination between DENV/ZIKV and JEV/CHIKV was successfully demonstrated using real viruses. Therefore, HyCaSD is a promising platform that can be further developed for diagnostic applications.
C1 [Saisuk, W.] Mahidol Univ, Siriraj Hosp, Fac Med, Grad Program Immunol, Bangkok 10700, Thailand.
   [Saisuk, W.; Dharakul, T.] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand.
   [Srisawat, C.] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand.
   [Yoksan, S.] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom 73170, Thailand.
RP Dharakul, T (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand.
EM tararaj.dha@mahidol.ac.th
OI Saisuk, Wachira/0000-0002-6020-0018; Dharakul,
   Tararaj/0000-0002-5602-0778
FU Siriraj Graduate Scholarship, Faculty of Medicine Siriraj Hospital
FX W.S. was supported by a Siriraj Graduate Scholarship, Faculty of
   Medicine Siriraj Hospital.
CR Alnimr A, 2012, INT J MYCOBACT, V1, P170, DOI 10.1016/j.ijmyco.2012.09.001
   Armitage BA, 2003, DRUG DISCOV TODAY, V8, P222, DOI 10.1016/S1359-6446(03)02611-4
   Bonnet G, 1999, P NATL ACAD SCI USA, V96, P6171, DOI 10.1073/pnas.96.11.6171
   Chen CL, 2007, NUCLEIC ACIDS RES, V35, P2875, DOI 10.1093/nar/gkm177
   Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101
   Gao Y, 2006, NUCLEIC ACIDS RES, V34, P3370, DOI 10.1093/nar/gkl422
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Iglesias NG, 2011, RNA BIOL, V8, P249, DOI 10.4161/rna.8.2.14992
   Khodakov DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08721
   Khodakov DA, 2013, J AM CHEM SOC, V135, P5612, DOI 10.1021/ja310991r
   Koos B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8294
   Lahoud G, 2008, NUCLEIC ACIDS RES, V36, P3409, DOI 10.1093/nar/gkn209
   Lane S, 2004, BIOSENS BIOELECTRON, V20, P728, DOI 10.1016/j.bios.2004.04.014
   Li F, 2016, ANALYST, V141, P4417, DOI 10.1039/c6an00898d
   Li W, 2016, TALANTA, V148, P116, DOI 10.1016/j.talanta.2015.10.078
   Li YB, 2017, TALANTA, V164, P196, DOI 10.1016/j.talanta.2016.11.047
   LIMA WF, 1992, BIOCHEMISTRY-US, V31, P12055, DOI 10.1021/bi00163a013
   Liu W, 2017, SCI REP-UK, V7, DOI 10.1038/srep40125
   Liu WT, 2007, APPL ENVIRON MICROB, V73, P73, DOI 10.1128/AEM.01468-06
   Machinek RRF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6324
   Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307
   Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681
   Najioullah F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-164
   Nguyen C, 2011, CHEM-EUR J, V17, P13052, DOI 10.1002/chem.201101987
   Ravan H, 2016, BIOSENS BIOELECTRON, V80, P67, DOI 10.1016/j.bios.2016.01.047
   Shen ZF, 2018, ANAL CHEM, V90, P3335, DOI 10.1021/acs.analchem.7b04895
   Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429
   Suleman E, 2016, J VET DIAGN INVEST, V28, P536, DOI 10.1177/1040638716659864
   Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528
   Tsai HP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005036
   Tsourkas A, 2003, NUCLEIC ACIDS RES, V31, P1319, DOI 10.1093/nar/gkg212
   Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100
   Vet JAM, 1999, P NATL ACAD SCI USA, V96, P6394, DOI 10.1073/pnas.96.11.6394
   WALKER GT, 1993, PCR METH APPL, V3, P1
   WALKER GT, 1992, NUCLEIC ACIDS RES, V20, P1691, DOI 10.1093/nar/20.7.1691
   WALKER GT, 1992, P NATL ACAD SCI USA, V89, P392, DOI 10.1073/pnas.89.1.392
   WALKER GT, 1994, NUCLEIC ACIDS RES, V22, P2670, DOI 10.1093/nar/22.13.2670
   Wang MH, 2018, BIOSENS BIOELECTRON, V107, P34, DOI 10.1016/j.bios.2018.02.015
   Wu D, 2017, ANAL CHIM ACTA, V957, P55, DOI 10.1016/j.aca.2016.12.023
   Xu H, 2017, TALANTA, V164, P511, DOI 10.1016/j.talanta.2016.12.017
   Xu H, 2017, BIOSENS BIOELECTRON, V90, P314, DOI 10.1016/j.bios.2016.12.003
   Xu JG, 2015, BIOSENS BIOELECTRON, V73, P19, DOI 10.1016/j.bios.2015.05.045
   Xu YJ, 2016, ANAL CHIM ACTA, V936, P229, DOI 10.1016/j.aca.2016.07.007
   Ying LM, 2001, CHEM PHYS LETT, V334, P145, DOI 10.1016/S0009-2614(00)01425-1
   Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596
   Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/nchem.1246, 10.1038/NCHEM.1246]
   Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957
   Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s
   Zhang Y, 2012, ANAL CHEM, V84, P224, DOI 10.1021/ac202405q
   Zhu J, 2014, BIOSENS BIOELECTRON, V59, P276, DOI 10.1016/j.bios.2014.03.051
NR 50
TC 3
Z9 3
U1 11
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD MAR 5
PY 2019
VL 91
IS 5
BP 3286
EP 3293
DI 10.1021/acs.analchem.8b03736
PG 8
WC Chemistry, Analytical
SC Chemistry
GA HO1YS
UT WOS:000460709200018
PM 30742406
DA 2020-07-08
ER

PT J
AU Reveillaud, J
   Bordenstein, SR
   Cruaud, C
   Shaiber, A
   Esen, OC
   Weill, M
   Makoundou, P
   Lolans, K
   Watson, AR
   Rakotoarivony, I
   Bordenstein, SR
   Eren, AM
AF Reveillaud, Julie
   Bordenstein, Sarah R.
   Cruaud, Corinne
   Shaiber, Alon
   Esen, Ozcan C.
   Weill, Mylene
   Makoundou, Patrick
   Lolans, Karen
   Watson, Andrea R.
   Rakotoarivony, Ignace
   Bordenstein, Seth R.
   Eren, A. Murat
TI The Wolbachia mobilome in Culex pipiens includes a putative plasmid
SO NATURE COMMUNICATIONS
LA English
DT Article
ID GENOME SEQUENCE; DNA; STRAIN; INFECTION; BACTERIA; VISUALIZATION;
   ENDOSYMBIONT; EVOLUTION; ALIGNMENT; DATABASE
AB Wolbachia is a genus of obligate intracellular bacteria found in nematodes and arthropods worldwide, including insect vectors that transmit dengue, West Nile, and Zika viruses. Wolbachia's unique ability to alter host reproductive behavior through its temperate bacteriophage WO has enabled the development of new vector control strategies. However, our understanding of Wolbachia's mobilome beyond its bacteriophages is incomplete. Here, we reconstruct near-complete Wolbachia genomes from individual ovary metagenomes of four wild Culex pipiens mosquitoes captured in France. In addition to viral genes missing from the Wolbachia reference genome, we identify a putative plasmid (pWCP), consisting of a 9.23-kbp circular element with 14 genes. We validate its presence in additional Culex pipiens mosquitoes using PCR, long-read sequencing, and screening of existing metagenomes. The discovery of this previously unrecognized extrachromosomal element opens additional possibilities for genetic manipulation of Wolbachia.
C1 [Reveillaud, Julie; Rakotoarivony, Ignace] Univ Montpellier, ASTRE, INRA, CIRAD, F-34398 Montpellier, France.
   [Bordenstein, Sarah R.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Cruaud, Corinne] Commissariat Energie Atom & Energies Alternat CEA, Inst Biol Francois Jacob, F-91057 Evry, France.
   [Shaiber, Alon; Eren, A. Murat] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA.
   [Shaiber, Alon; Esen, Ozcan C.; Lolans, Karen; Watson, Andrea R.; Eren, A. Murat] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Weill, Mylene; Makoundou, Patrick] Univ Montpellier, ISEM, CNRS, UMR,IRD,EPHE, F-34095 Montpellier, France.
   [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Bordenstein, Seth R.] Vanderbilt Univ, Vanderbilt Inst Infect Immunol & Inflammat, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Eren, A. Murat] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA.
RP Reveillaud, J (corresponding author), Univ Montpellier, ASTRE, INRA, CIRAD, F-34398 Montpellier, France.; Eren, AM (corresponding author), Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA.; Eren, AM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Eren, AM (corresponding author), Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA.
EM reveillaud.j@gmail.com; a.murat.eren@gmail.com
RI Eren, A. Murat/Q-5497-2019
OI Eren, A. Murat/0000-0001-9013-4827; Lolans, Karen/0000-0003-1903-756X;
   Watson, Andrea/0000-0003-0128-6795
FU National Institute for Agronomical Research (INRA) Young Researcher
   grant (2017); National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI132581, R21AI133522]; National Science FoundationNational Science
   Foundation (NSF) [1456778]; Vanderbilt Microbiome Initiative; INRA
   Metaprogram (Microbial Ecology and Metagenomics) MEM from INRA;
   University of ChicagoUniversity of Chicago; Keck FoundationW.M. Keck
   Foundation; Gastrointestinal Research Foundation grant
FX We thank Albane Marie, Gregory Lambert, and Jean-Baptiste Panchau from
   EID (Entente Interdepartementale de Demoustication) for field Culex
   pipiens samples; Maria del Mar Fernandez de Marco from Animals Plant
   Health Agency for antibiotic-treated Culex pipiens individuals; Evan
   Kiefl, Richard Fox, and Frederick Gavory for their help with
   computational matters; Phoebe Rice, Sean Crosson, and Marie-Agnes Petit
   for their insights into plasmid biology; Nick Loman, Lois Maignien,
   Manon Bonneau, and Emmanuelle Jousselin for their insights into
   sequencing. This research was funded by the National Institute for
   Agronomical Research (INRA) Young Researcher grant (2017) to J.R. and
   National Institutes of Health awards R01 AI132581 and R21AI133522,
   National Science Foundation award 1456778, and Vanderbilt Microbiome
   Initiative funding to Seth R Bordenstein. The INRA Metaprogram
   (Microbial Ecology and Metagenomics) MEM from INRA provided a USA
   mobility grant to J.R., and A.M.E. was funded by the University of
   Chicago start-up funds and the Keck Foundation. K.L. was supported by a
   Gastrointestinal Research Foundation grant. The funders had no role in
   study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR Alberti A, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.93
   Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/nmeth.3103, 10.1038/NMETH.3103]
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Andrews ES, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003075
   Atyame C. M., 2011, PLOS NEGLECT TROP D, V5, P20
   Atyame CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087336
   Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bonneau M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02749-w
   Bordenstein SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13155
   Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Burkhardt NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029511
   Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110
   Cerveau N, 2011, GENOME BIOL EVOL, V3, P1175, DOI 10.1093/gbe/evr096
   Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12
   Chafee ME, 2010, MOL BIOL EVOL, V27, P501, DOI 10.1093/molbev/msp275
   Conner WR, 2017, ECOL EVOL, V7, P9391, DOI 10.1002/ece3.3449
   COREN JS, 1995, J MOL BIOL, V249, P176, DOI 10.1006/jmbi.1995.0287
   Delmont TO, 2018, NAT MICROBIOL, V3, P804, DOI 10.1038/s41564-018-0176-9
   Delmont TO, 2018, PEERJ, V6, DOI 10.7717/peerj.4320
   Delmont TO, 2016, PEERJ, V4, DOI 10.7717/peerj.1839
   Duron O, 2006, MOL ECOL, V15, P3061, DOI 10.1111/j.1365-294X.2006.02996.x
   El Karkouri K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147492
   Eren AM, 2015, PEERJ, V3, DOI 10.7717/peerj.1319
   Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643
   Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Funkhouser-Jones LJ, 2018, CURR BIOL, V28, P1692, DOI 10.1016/j.cub.2018.04.010
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Harms A, 2018, MOL CELL, V70, P768, DOI 10.1016/j.molcel.2018.01.003
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Ishmael N, 2009, MICROBIOL-SGM, V155, P2211, DOI 10.1099/mic.0.027581-0
   Iturbe-Ormaetxe I, 2011, J MICROBIOL METH, V84, P134, DOI 10.1016/j.mimet.2010.10.019
   Jeffries Claire L, 2016, Curr Trop Med Rep, V3, P20
   Joubert D. A., 2017, PLOS NEGLECT TROP D, V11, P1
   Kent BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024984
   Kent BN, 2011, GENOME BIOL EVOL, V3, P209, DOI 10.1093/gbe/evr007
   Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133
   Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106
   Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480
   Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333
   Konieczny I, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0026-2014
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leffers G, 1996, J MOL BIOL, V258, P839, DOI 10.1006/jmbi.1996.0291
   LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922
   Lo N, 2002, MOL BIOL EVOL, V19, P341, DOI 10.1093/oxfordjournals.molbev.a004087
   Mains J. W., 2016, SCI REP, V6, P1
   Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248
   Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160
   Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174
   Petridis M, 2011, MOL ECOL RESOUR, V11, P753, DOI 10.1111/j.1755-0998.2011.02991.x
   Pritchard L, 2016, ANAL METHODS-UK, V8, P12, DOI [10.1039/C5AY02550H, 10.1039/c5ay02550h]
   Riegler M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S12
   Salzberg SL, 2009, J BACTERIOL, V191, P1725, DOI 10.1128/JB.01731-08
   Sanogo YO, 2006, INSECT BIOCHEM MOLEC, V36, P80, DOI 10.1016/j.ibmb.2005.11.001
   Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]
   Serbus LR, 2007, PLOS PATHOG, V3, P1930, DOI 10.1371/journal.ppat.0030190
   Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908
   Shen XD, 2012, ARCH VIROL, V157, P2133, DOI 10.1007/s00705-012-1409-5
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Shropshire JD, 2018, P NATL ACAD SCI USA, V115, P4987, DOI 10.1073/pnas.1800650115
   Singhal K, 2018, MOL GENET GENOMICS, V293, P525, DOI 10.1007/s00438-017-1402-5
   Siozios S, 2013, MICROBIOL RESOUR ANN, V1, DOI 10.1128/genomeA.00032-13
   Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71
   Sun LV, 2001, J BACTERIOL, V183, P2219, DOI 10.1128/JB.183.7.2219-2225.2001
   Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33
   Taylor MJ, 2018, MICROBIOL-SGM, V164, P1345, DOI 10.1099/mic.0.000724
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139
   Wintersinger JA, 2015, BIOINFORMATICS, V31, P1305, DOI 10.1093/bioinformatics/btu808
   Wood DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034715
   Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169
   WRIGHT JD, 1978, J ULTRA MOL STRUCT R, V63, P79, DOI 10.1016/S0022-5320(78)80046-X
   Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007
NR 85
TC 4
Z9 4
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 5
PY 2019
VL 10
AR 1051
DI 10.1038/s41467-019-08973-w
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HN7VZ
UT WOS:000460402300010
PM 30837458
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Silveira, PR
   de Oliveira, MM
   Alves, SG
AF Silveira, Priscila R.
   de Oliveira, Marcelo M.
   Alves, Sidiney G.
TI Local vs. Long-Range Infection in Unidimensional Epidemics
SO FRONTIERS IN PHYSICS
LA English
DT Article
DE contact process; Levy-flights; absorbing state; non-equilibrium phase
   transitions; critical phenomena
ID PHASE-TRANSITIONS; SEXUAL TRANSMISSION; ZIKA; MODELS
AB We study the effects of local and distance interactions in the unidimensional contact process (CP). In the model, each site of a lattice is occupied by an individual, which can be healthy or infected. As in the standard CP, each infected individual spreads the disease to one of its first-neighbors with rate., and with unitary rate, it becomes healthy. However, in our model, an infected individual can transmit the disease to an individual at a distance l apart. This step mimics a vector-mediated transmission. We observe the host-host interactions do not alter the critical exponents significantly in comparison to a process with only Levy-type interactions. Our results confirm, numerically, early field-theoretic predictions.
C1 [Silveira, Priscila R.; de Oliveira, Marcelo M.; Alves, Sidiney G.] Univ Fed Sao Joao del Rei, Dept Fis & Matemat, Sao Joao Del Rei, Brazil.
RP de Oliveira, MM (corresponding author), Univ Fed Sao Joao del Rei, Dept Fis & Matemat, Sao Joao Del Rei, Brazil.
EM mmdeoliveira@ufsj.edu.br
RI de Oliveira, Marcelo M./D-7586-2011; Alves, Sidiney/H-9501-2016
OI de Oliveira, Marcelo M./0000-0002-8940-1972; Alves,
   Sidiney/0000-0001-7666-0361
FU Brazilian agency CNPqNational Council for Scientific and Technological
   Development (CNPq); Brazilian agency FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG)
FX This work was partially supported by Brazilian agencies CNPq and
   FAPEMIG.
CR Botari T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.037101
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Corte L, 2008, NAT PHYS, V4, P420, DOI 10.1038/nphys891
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Oliveira MM, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052138
   de Oliveira MM, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062126
   de Oliveira MM, 2006, BRAZ J PHYS, V36, P685, DOI 10.1590/S0103-97332006000500020
   de Oliveira MM, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011121
   de Oliveira MM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016129
   Durrett R, 1999, SIAM REV, V41, P677, DOI 10.1137/S0036144599354707
   Fiore CE, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041103
   Fiore CE, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042101
   Ginelli F, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026121
   Ginelli F, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/08/P08008
   GRASSBERGER P, 1982, Z PHYS B CON MAT, V47, P365, DOI 10.1007/BF01313803
   GRASSBERGER P, 1986, FRACTALS PHYS
   HARRIS TE, 1974, ANN PROBAB, V2, P969, DOI 10.1214/aop/1176996493
   Henkel M, 2008, THEOR MATH PHYS SER, P1
   Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152
   Hinrichsen H, 1999, EUR PHYS J B, V7, P635, DOI 10.1007/s100510050656
   Hinrichsen H, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07006
   JANICKI A, 1995, MATH COMPUT SIMULAT, V39, P9, DOI 10.1016/0378-4754(95)00132-H
   Janssen HK, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061117
   Janssen HK, 1999, EUR PHYS J B, V7, P137, DOI 10.1007/s100510050596
   JANSSEN HK, 1981, Z PHYS B CON MAT, V42, P151, DOI 10.1007/BF01319549
   Juhasz R, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032815
   Klafter J., 2011, 1 STEPS RANDOM WALKS
   MARRO J, 1999, NONEQUILIBRIUM PHASE
   MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283
   Montroll E. W., 1979, FLUCTUATION PHENOMEN
   Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678
   Odor G, 2004, REV MOD PHYS, V76, P663, DOI 10.1103/RevModPhys.76.663
   Odor G, 2007, UNIVERSALITY NONEQUI
   Okuma S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.012503
   Parshani R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.258701
   Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Pedro TB, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032131
   Solano CMD, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.042123
   Takeuchi KA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.234503
   TANG LH, 1992, PHYS REV A, V45, pR8309, DOI 10.1103/PhysRevA.45.R8309
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   ZIFF RM, 1986, PHYS REV LETT, V56, P2553, DOI 10.1103/PhysRevLett.56.2553
NR 43
TC 0
Z9 0
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-424X
J9 FRONT PHYS-LAUSANNE
JI Front. Physics
PD MAR 4
PY 2019
VL 7
AR 17
DI 10.3389/fphy.2019.00017
PG 6
WC Physics, Multidisciplinary
SC Physics
GA HN7EP
UT WOS:000460352000001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Guerra-Reyes, L
   Iguiniz-Romero, RA
AF Guerra-Reyes, Lucia
   Iguiniz-Romero, Ruth A.
TI Performing purity: reproductive decision-making and implications for a
   community under threat of zika in iquitos, Peru
SO CULTURE HEALTH & SEXUALITY
LA English
DT Article
DE Reproduction; decision-making; sexual risk; Zika; Peru
ID HEALTH; GENDER; SEX; MACHISMO; LIMA
AB The long-term management and prevention of Zika virus requires understanding of reproductive and sexual health behaviours, including mechanisms of partnered decision-making. In this article, we report on a qualitative study conducted before the arrival of Zika in Iquitos, Peru. We assessed existing patterns of reproductive decision-making among partnered men and women in a community under threat of Zika and discuss how these may impact Zika prevention in the long-term. We used a rapid qualitative assessment methodology, including in-depth semi-structured interviews with partnered women (28) and men (21). Deeply unequal gender role expectations limit discussion of reproductive decisions until after a first child is born. Women needed to perform a domestic 'of-the-house' role to be considered suitable partners, leading them to hide their knowledge of sexual and reproductive health. Condoms symbolise risk and are unused with partners in committed relationships. A shared perception that men must take care of female partner's sexual health, translates into male sexual and reproductive preferences overcoming female desires. Existing decision-making patterns lead to an increased risk of Zika exposure. Long-term response should expand Zika virus information and preventive messages to men and young people, in addition to engaging with broader societal challenges to gender inequity.
C1 [Guerra-Reyes, Lucia] Indiana Univ, Sch Publ Hlth, Bloomington, IN 47405 USA.
   [Iguiniz-Romero, Ruth A.] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Lima, Peru.
RP Guerra-Reyes, L (corresponding author), Indiana Univ, Sch Publ Hlth, Bloomington, IN 47405 USA.
EM luguerra@indiana.edu
OI Iguiniz Romero, Ruth/0000-0002-9973-4981
FU NSF-RAPID Division of Behavioral, and Cognitive Sciences- Cultural
   Anthropology Grant [1642729]
FX This study was funded by an NSF-RAPID Division of Behavioral, and
   Cognitive Sciences- Cultural Anthropology Grant #1642729.
CR Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Alvarez FN, 2016, HEALTH POLICY PLANN, V31, P114, DOI 10.1093/heapol/czv013
   Aspilcueta-Gho Daniel, 2013, Rev. perú. med. exp. salud publica, V30, P480
   Beebe J., 2014, RAPID QUALITATIVE IN
   Boesten J., 2016, CONVERSATION
   BUTLER J, 1988, THEATRE J, V40, P519, DOI 10.2307/3207893
   Chirinos Jesús L., 2006, Cad. Saúde Pública, V22, P79, DOI 10.1590/S0102-311X2006000100009
   Cianelli R, 2008, CULT HEALTH SEX, V10, P297, DOI 10.1080/13691050701861439
   De la Cruz-Penaran D, 2003, SALUD PUBLICA MEXICO, V45, P461
   Dreweke J., 2016, GUTTMACHER POLICY RE, V19, P23
   Gutmann M. C., 2011, REPROD GLOBALIZATION, P53, DOI 10.1215/9780822393948
   Harrington EK, 2016, CULT HEALTH SEX, V18, P453, DOI 10.1080/13691058.2015.1091507
   Instituto Nacional de Estadistica e Informatica (INEI), 2015, EST POBL PER 2015
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Kinsler Janni J, 2014, Open AIDS J, V8, P17, DOI 10.2174/1874613601408010017
   Maternowska C, 2010, CULT HEALTH SEX, V12, P29, DOI 10.1080/13691050903108688
   Noland CM, 2006, SEX ROLES, V55, P283, DOI 10.1007/s11199-006-9083-2
   Palomino N, 2011, GLOB PUBLIC HEALTH, V6, pS73, DOI 10.1080/17441692.2011.590813
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quevedo-Gomez MC, 2012, CULT HEALTH SEX, V14, P223, DOI 10.1080/13691058.2011.629682
   Quiroz Diaz N. A., 2009, REV SALUD SEXUALIDAD, V1
   Ramos M., 2002, SEXUAL PHYS VIOLENCE
   Ramos Padilla Miguel, 2006, Rev. perú. med. exp. salud publica, V23, P201
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82
   Sternberg P, 2004, HEALTH PROMOT INT, V19, P389, DOI 10.1093/heapro/dah312
NR 26
TC 4
Z9 4
U1 0
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1369-1058
EI 1464-5351
J9 CULT HEALTH SEX
JI Cult. Health Sex
PD MAR 4
PY 2019
VL 21
IS 3
BP 309
EP 322
DI 10.1080/13691058.2018.1469790
PG 14
WC Family Studies; Social Sciences, Biomedical
SC Family Studies; Biomedical Social Sciences
GA HL4JF
UT WOS:000458682900005
PM 29889609
DA 2020-07-08
ER

PT J
AU Cohnstaedt, LW
   Alfonso-Parra, C
AF Cohnstaedt, Lee W.
   Alfonso-Parra, Catalina
TI 2018 HIGHLIGHTS OF MOSQUITO AND VECTOR BIOLOGY AND CONTROL IN LATIN
   AMERICA
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes; Anopheles; Culex; Dengue; Mosquito control; Insecticide
   resistance; Phlobotomine; Sand flies
AB The 28th Annual Latin American Symposium presented by the American Mosquito Control Association (AMCA) was held as part of the 84th Annual Meeting of the AMCA held in Kansas City, MO, in February 2018. The Latin American Symposium promotes the participation of vector control specialists, public health workers, and academic members from Latin America and the sharing of scientific data between continents. Generally, presentations are in Spanish with simultaneous translation into English. The majority of presentation slides are in English to facilitate communication among all meeting attendees. This publication includes summaries of 14 oral presentations by participants from Colombia, Mexico, and the United States of America. Topics addressed in the 3 sessions of the symposium included: larval habitats, insecticide resistance, new Aedes mosquito traps, blood meal analysis and fitness outcomes, vertical transmission of dengue, and transstadial composition of midgut microbiota. Control techniques discussed included sterile insect technique (SIT) with radiation, SIT by Wolbachia, thermal fogging, ultra-low volume pesticide applications, indoor residual spraying, Bacillus thuringiensis israelensis de Barjac (Bti), and Spinosad larval treatments. Presentations were also given on species composition and diversity of phlebotomine sand flies. Presentations were related to the vector species belonging to the mosquito genera, Anopheles, Aedes, and Culex as well as phlebotomine sand flies involved in the transmission of the causal agents of malaria, arboviruses (dengue, chikungunya, Zika), and leishmaniasis.
C1 [Cohnstaedt, Lee W.] USDA, Arthropod Borne Anim Dis Res Unit, Ctr Grain & Anim Hlth Res, 1515 Coll Ave, Manhattan, KS 66502 USA.
   [Alfonso-Parra, Catalina] Univ Antioquia, Max Planck Tandem Grp Mosquito Reprod Biol, Medellin, Colombia.
RP Alfonso-Parra, C (corresponding author), Univ Antioquia, Max Planck Tandem Grp Mosquito Reprod Biol, Medellin, Colombia.
EM catalfonso@gmail.com
FU Clarke Mosquito Control
FX Financial support for the 28th Annual Symposium was provided by Clarke
   Mosquito Control. Funds from this sponsor provided support for the
   Annual Meeting of the Latin American Student Competition. The continuing
   support by the AMCA for this symposium is also acknowledged. Enthusiasm
   and interest for this symposium among Spanish-and non-Spanish-speaking
   participants continues to be high and it will continue to be a part of
   the future annual meetings.
CR Clark GG, 2007, J AM MOSQUITO CONTR, V23, P449, DOI 10.2987/5684.1
   Clark Gary G, 2004, J Am Mosq Control Assoc, V20, P376
   Clark GG, 2006, J AM MOSQUITO CONTR, V22, P732, DOI 10.2987/8756-971X(2006)22[732:MVCABI]2.0.CO;2
   Clark GG, 2014, J AM MOSQUITO CONTR, V30, P204, DOI 10.2987/14-6418.1
   Clark GG, 2013, J AM MOSQUITO CONTR, V29, P251, DOI 10.2987/13-6356.1
   Clark GG, 2012, J AM MOSQUITO CONTR, V28, P102, DOI 10.2987/12-6253.1
   Clark GG, 2011, J AM MOSQUITO CONTR, V27, P280, DOI 10.2987/11-6147.1
   Clark GG, 2010, J AM MOSQUITO CONTR, V26, P306, DOI 10.2987/10-6033.1
   Clark GG, 2009, J AM MOSQUITO CONTR, V25, P486, DOI 10.2987/09-5929.1
   Clark GG, 2008, J AM MOSQUITO CONTR, V24, P571, DOI 10.2987/08-5810.1
   Clark GG, 2005, J AM MOSQUITO CONTR, V21, P412, DOI 10.2987/8756-971X(2006)21[412:MVCABI]2.0.CO;2
   Clark GG, 2002, J AM MOSQUITO CONTR, V18, P138
   Clark GG, 2001, J AM MOSQUITO CONTR, V17, P166
   Clark GG, 1997, J AM MOSQUITO CONTR, V13, P113
   CLARK GG, 1993, J AM MOSQUITO CONTR, V9, P441
   CLARK GG, 1995, J AM MOSQUITO CONTR, V11, P343
   CLARK GG, 1991, J AM MOSQUITO CONTR, V7, P633
   Clark GG, 1999, J AM MOSQUITO CONTR, V15, P407
   Clark GG, 1998, J AM MOSQUITO CONTR, V14, P219
   Clark GG, 1996, J AM MOSQUITO CONTR, V12, P460
   CLARK GG, 1992, J AM MOSQUITO CONTR, V8, P305
   Clark GG, 2000, J AM MOSQUITO CONTR, V16, P295
   Cohnstaedt LW, 2017, J AM MOSQUITO CONTR, V33, P215, DOI 10.2987/17-6653.1
   Cohnstaedt LW, 2016, J AM MOSQUITO CONTR, V32, P315, DOI 10.2987/16-6605.1
   Cohnstaedt LW, 2015, J AM MOSQUITO CONTR, V31, P286, DOI 10.2987/moco-31-03-286-296.1
NR 25
TC 0
Z9 0
U1 0
U2 1
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD MAR
PY 2019
VL 35
IS 1
BP 40
EP 46
DI 10.2987/18-6769.1
PG 7
WC Entomology
SC Entomology
GA IJ1VJ
UT WOS:000475686700005
PM 31442178
OA Bronze
DA 2020-07-08
ER

PT J
AU Rund, SSC
   Moise, IK
   Beier, JC
   Martinez, ME
AF Rund, Samuel S. C.
   Moise, Imelda K.
   Beier, John C.
   Martinez, Micaela Elvira
TI RESCUING TROVES OF HIDDEN ECOLOGICAL DATA TO TACKLE EMERGING
   MOSQUITO-BORNE DISEASES
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Arbovirus; Big Data; open data; surveillance; Zika
ID STEGOMYIA-ALBOPICTUS; AEGYPTI
AB Despite the major impact of mosquitoes on human health, knowledge gaps exist regarding their natural population dynamics. Even the most basic information-such as spatiotemporal abundance-is mostly unavailable. In the USA, municipalities have created agencies for mosquito control and monitoring, yet no national open-access repository for mosquito surveillance data exists. Vectors, and the pathogens they transmit, know no jurisdictions. We identify >1,000 mosquito control agencies and identify those which make their population abundance surveillance data publicly available. We directly survey Floridian mosquito districts to estimate, from one state alone, the potential amount of hidden data. We generate a large, standardized data set from publicly available online data and demonstrate that spatiotemporal population abundance can be reconstructed and analyzed across data generators. We propose that the ensemble of US mosquito control agencies can, and should, be used to develop a national-and potentially international-open-access repository of mosquito surveillance data, generating the data capital needed to gain a mechanistic understanding of vector population dynamics, and identify existing digital infrastructure that could be leveraged for digitizing and collating extant and future surveillance data for such a repository.
C1 [Rund, Samuel S. C.] Univ Notre Dame, Dept Biol Sci, VectorBase, 329 Galvin Life Ctr, Notre Dame, IN 46556 USA.
   [Rund, Samuel S. C.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Moise, Imelda K.] Univ Miami, Coll Arts & Sci, Dept Geog & Reg Studies, 1300 Campo Sano Dr, Coral Gables, FL 33124 USA.
   [Moise, Imelda K.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Martinez, Micaela Elvira] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, 722 West 168th St, New York, NY 10032 USA.
RP Rund, SSC (corresponding author), Univ Notre Dame, Dept Biol Sci, VectorBase, 329 Galvin Life Ctr, Notre Dame, IN 46556 USA.; Rund, SSC (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3FL, Midlothian, Scotland.
RI Moise, Imelda K/AAL-7226-2020; Rund, Samuel SC/AAH-5724-2019; Martinez,
   Micaela/J-3721-2013
OI Moise, Imelda K/0000-0003-0222-780X; Rund, Samuel
   SC/0000-0002-1701-7787; Martinez, Micaela/0000-0002-9248-9450
FU NIH Directors Early Independence AwardUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA; Office of the
   Director, National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [DP5OD023l00]; Royal SocietyRoyal Society of London [NF140517]; National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health, Department of Health and Human ServicesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [HHSN272201400029C]; Centers for Disease Control and PreventionUnited
   States Department of Health & Human ServicesCenters for Disease Control
   & Prevention - USA [U01CK000510]; US National Science Foundation
   Postdoctoral Fellowship in Biology [1523757]
FX This work was possible due to the efforts of the 148 mosquito control
   agencies who collected mosquito population abundance data and made their
   data available online. We thank all the Florida Mosquito Control agency
   representatives who participated in the survey. We also thank research
   students Nathan Nixon and Ben Weise for their assistance in locating and
   digitizing data and Paul Hickner, Luke McNally, Cynthia Lord, and Frank
   Collins for their helpful comments. Micaela Martinez was funded by a US
   National Science Foundation Postdoctoral Fellowship in Biology, Award
   Number 1523757, and is currently funded by the NIH Directors Early
   Independence Award. Research reported in this publication was supported
   by the Office of the Director, National Institutes of Health, under
   Award Number DP5OD023l00. Samuel S.C. Rund was funded by the Royal
   Society (NF140517) and the National Institute of Allergy and Infectious
   Diseases, National Institutes of Health, Department of Health and Human
   Services, under Contract Number HHSN272201400029C. Imelda K. Moise and
   John C. Beier were supported by Cooperative Agreement Number
   U01CK000510, funded by the Centers for Disease Control and Prevention.
   The contents are solely the responsibility of the authors and do not
   necessarily represent the official views of the Centers for Disease
   Control and Prevention or the Department of Health and Human Services.
CR Acheson ES, 2015, VECTOR-BORNE ZOONOT, V15, P173, DOI 10.1089/vbz.2014.1742
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   CDC, 2013, W NIL VIR US GUID SU
   Chaskopoulou A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1736-6
   Costello MJ, 2013, TRENDS ECOL EVOL, V28, P454, DOI 10.1016/j.tree.2013.05.002
   Evans SR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002432
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   NACCHO [National Association of County and City Health Officials], 2016, MOSQ SURV CONTR ASS
   NPIC [National Pesticide Information Center], 2018, STAT CONT MOSQ VECT
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Roche DG, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001779
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Rund SSC, 2018, BIORXIV, DOI [10.1101/429142, DOI 10.1101/429142]
   Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079
   Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715
   World Health Organization, 2014, GLOB BRIEF VECT BORN
NR 17
TC 3
Z9 3
U1 0
U2 0
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD MAR
PY 2019
VL 35
IS 1
BP 75
EP 83
DI 10.2987/18-6781.1
PG 9
WC Entomology
SC Entomology
GA IJ1VJ
UT WOS:000475686700012
PM 31442186
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Gilsdorf, JR
   Spearman, P
   Englund, JA
   Tan, TQ
   Bryant, KA
AF Gilsdorf, Janet R.
   Spearman, Paul
   Englund, Janet A.
   Tan, Tina Q.
   Bryant, Kristina A.
TI Pediatric Infectious Diseases Meets the Future
SO JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY
LA English
DT Editorial Material
DE compensation; job market; pediatric infectious diseases; pediatric
   subspecialist; workforce
ID PRACTICE PATTERNS; WORKFORCE; SECTION
AB Pediatric infectious diseases physicians are dedicated to the diagnosis, prevention, and management of infections in children. As such, we play large, and important, roles in the clinical care of children from birth to late adolescence and in infection prevention, antimicrobial stewardship, research pertaining to infections, public health, international and global health, and advocacy for children's health. Furthermore, we are critical to the education of future physicians (in general), pediatricians, and infectious diseases doctors. In addition to diagnosing and treating bacterial, fungal, viral, and parasitic infections known through the ages, we have been at the forefront of meeting today's new infectious threats to children's health, which include the following: antibiotic-resistant organisms; hospital-acquired infections; global outbreaks such as Ebola, Zika, human immunodeficiency virus-acquired immune deficiency syndrome, and new strains of influenza; infections in immunocompromised children; vaccine-preventable infections; the inefficient use of medical resources; and the high cost of medical care.
C1 [Gilsdorf, Janet R.] Univ Michigan, Dept Pediat, Med Sch, Ann Arbor, MI 48109 USA.
   [Spearman, Paul] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA.
   [Englund, Janet A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Tan, Tina Q.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Bryant, Kristina A.] Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40292 USA.
RP Gilsdorf, JR (corresponding author), D5101 Med Profess,Bldg SPC 5718, Ann Arbor, MI 48109 USA.
EM gilsdorf@umich.edu
CR American Board of Pediatrics, 2016, PED PHYS WORKF DAT B
   Association of American Medical Colleges, MED STUD ED DEBT COS
   Bell JR, 2016, JAMA OTOLARYNGOL, V142, P823, DOI 10.1001/jamaoto.2016.1163
   Bonura EM, 2016, CLIN INFECT DIS, V63, P155, DOI 10.1093/cid/ciw263
   Bridgemohan C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2164
   Gilbert DL, 2017, PEDIATR NEUROL, V66, P89, DOI 10.1016/j.pediatrneurol.2016.08.018
   Hosseinzadeh P, 2017, J PEDIATR ORTHOPED, V37, pE19, DOI 10.1097/BPO.0000000000000665
   Joint Commission on Hospital Accreditation, 2016, Jt Comm Perspect, V36, P3
   McQuillen DP, 2008, CLIN INFECT DIS, V47, P1051, DOI 10.1086/592067
   National Residency Match Program, 2017, MATCH RES STAT PED S
   Primack WA, 2015, AM J KIDNEY DIS, V66, P33, DOI 10.1053/j.ajkd.2015.03.022
   Radabaugh CL, 2015, PEDIATR CRIT CARE ME, V16, pE308, DOI 10.1097/PCC.0000000000000480
   Rochlin JM, 2011, PEDIATRICS, V127, P254, DOI 10.1542/peds.2010-1285
   Ross RD, 2017, J AM COLL CARDIOL, V69, P1347, DOI 10.1016/j.jacc.2016.09.921
   Salsberg E, 2016, ANAL NRMP SMS MATCH
   Schmitt S, 2014, CLIN INFECT DIS, V58, P22, DOI 10.1093/cid/cit610
   Shapiro E, 2017, J PEDIATR UROL, V13, P68, DOI 10.1016/j.jpurol.2016.09.002
   Yeh SH, 2019, J PEDIAT INF DIS SOC, V8, P29, DOI 10.1093/jpids/pix094
   Youngclaus J, PHYS ED DEBT COST AT
NR 19
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2048-7193
EI 2048-7207
J9 J PEDIAT INF DIS SOC
JI J. Pediatr. Infect. Dis. Soc.
PD MAR
PY 2019
VL 8
IS 1
BP 9
EP 12
DI 10.1093/jpids/piy042
PG 4
WC Infectious Diseases; Pediatrics
SC Infectious Diseases; Pediatrics
GA IF1AI
UT WOS:000472809100001
PM 29788443
DA 2020-07-08
ER

PT J
AU Perez-Cabezas, V
   Ruiz-Molinero, C
   Nunez-Moraleda, B
   Jimenez-Rejano, JJ
   Chillon-Martinez, R
   Moral-Munoz, JA
AF Perez-Cabezas, Veronica
   Ruiz-Molinero, Carmen
   Nunez-Moraleda, Bernardo
   Jesus Jimenez-Rejano, Jose
   Chillon-Martinez, Raquel
   Moral-Munoz, Jose A.
TI Guillain-Barre syndrome and Zika infection: identifying leading
   producers, countries relative specialization and collaboration
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Review
DE Zika virus; Guillain-Barre syndrome; bibliometrics; scientometrics
ID NILE VIRUS-INFECTION; DENGUE VIRUS; TRANSMISSION; EPIDEMIOLOGY;
   EMERGENCE; OUTBREAK; HISTORY; MODEL; INDEX
AB Zika virus (Zikv) infection implies a significant public health issue due to the different syndromes associated. It is related to several central nervous system problems, such as microcephaly and Guillain-Barre Syndrome. In this way, the first document about the relation of Guillain-Barre Syndrome and Zika indexed in Web of Science was published in 2014. Therefore, the primary goal of the present study is to analyze the leading scientific producers, the relative specialization of the countries and the collaboration network in the research area. A total of 384 manuscripts were identified. Two manuscripts were published in 2014 and 2015; the remaining documents are distributed during 2016 (136), 2017 (186) and 2018 (59) (until April). In conclusion, Zikv and Guillain-Barre Syndrome research has experienced a significant increase in the last years. This may be related to the topic is an important issue of public health concern in the countries affected by Zikv outbreaks. In that sense, Brazil, India and Colombia make a great effort, considering their economic and social resources, in research. However, this study implies a preliminary overview of the research on this topic, a more extended period is needed to define the lines of research and collaboration between countries and authors.
C1 [Perez-Cabezas, Veronica; Ruiz-Molinero, Carmen; Moral-Munoz, Jose A.] Univ Cadiz, Dept Nursing & Physiotherapy, Cadiz 11009, Spain.
   [Nunez-Moraleda, Bernardo] Univ Cadiz, Dept Comp Sci & Engn, Cadiz 11009, Spain.
   [Jesus Jimenez-Rejano, Jose; Chillon-Martinez, Raquel] Univ Seville, Dept Physiotherapy, E-41009 Seville, Spain.
   [Moral-Munoz, Jose A.] Univ Cadiz, Inst Res & Innovat Biomed Sci Prov Cadiz INiBICA, Cadiz 11009, Spain.
RP Ruiz-Molinero, C (corresponding author), Univ Cadiz, Dept Nursing & Physiotherapy, Cadiz 11009, Spain.
EM cermen.ruizmolinero@uca.es
RI Moral-Munoz, Jose A./A-5893-2014; Perez-Cabezas, Veronica/AAB-4137-2020
OI Moral-Munoz, Jose A./0000-0002-6465-982X; 
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhardwaj S, 2017, INDIAN J MED RES, V146, P572, DOI 10.4103/ijmr.IJMR_1160_17
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x
   Dehdarirad T, 2019, FEMS MICROBIOL LETT, V366, DOI [10.1093/fem-sle/fnz004, DOI 10.1093/FEM-SLE/FNZ004]
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gutierrez-Salcedo M, 2018, APPL INTELL, V48, P1275, DOI 10.1007/s10489-017-1105-y
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hodge DR, 2011, J SOC WORK EDUC, V47, P579, DOI 10.5175/JSWE.2011.201000024
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kelly S, 2013, MMWR-MORBID MORTAL W, V62, P622
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Moore Melinda, 2017, Rand Health Q, V6, P5
   Moral-Munoz JA, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny230
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Perez-Cabezas V, 2018, SCIENTOMETRICS, V116, P555, DOI 10.1007/s11192-018-2712-z
   Perianes-Rodriguez A, 2016, J INFORMETR, V10, P1178, DOI 10.1016/j.joi.2016.10.006
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sangam SL, 2018, SCIENTOMETRICS, V115, P351, DOI 10.1007/s11192-018-2668-z
   Seipel MMO, 2003, J SOC WORK EDUC, V39, P79
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   The World Bank, 2017, GDP CURR US WORLD BA
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Eck NJ, 2010, J AM SOC INF SCI TEC, V61, P2405, DOI 10.1002/asi.21421
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   van Eck NJ, 2014, VISUALIZING BIBLIOME, P285, DOI [10.1007/978-3-319-10377-8_13, DOI 10.1007/978-3-319-10377-8_13, 10.1007/978-3-319-10377-8_13(InEng.)]
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zyoud SH, 2015, HUM EXP TOXICOL, V34, P12, DOI 10.1177/0960327114531993
NR 46
TC 1
Z9 1
U1 5
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0378-1097
EI 1574-6968
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD MAR
PY 2019
VL 366
IS 5
AR fnz035
DI 10.1093/femsle/fnz035
PG 8
WC Microbiology
SC Microbiology
GA IA7UR
UT WOS:000469763400002
PM 30759205
DA 2020-07-08
ER

PT J
AU de Souza, LM
   Inada, NM
   Venturini, FP
   Carmona-Vargas, CC
   Pratavieira, S
   de Oliveira, KT
   Kurachi, C
   Bagnato, VS
AF de Souza, Larissa Marila
   Inada, Natalia Mayumi
   Venturini, Francine Perri
   Carmona-Vargas, Christian C.
   Pratavieira, Sebastiao
   de Oliveira, Kleber Thiago
   Kurachi, Cristina
   Bagnato, Vanderlei Salvador
TI Photolarvicidal effect of curcuminoids from Curcuma longa Linn. against
   Aedes aegypti larvae
SO JOURNAL OF ASIA-PACIFIC ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Curcuma longa; Curcuminoids; Daylight; PDI effect;
   Photolarvicidal activity; Photosensitizer
ID PHOTODYNAMIC INACTIVATION; CHLOROPHYLL DERIVATIVES; INSECTICIDES;
   VECTOR; MODEL
AB In this study we evaluated the photolarvicidal activity of different curcuminoids forms: Natural Turmeric (NT), Synthetic Curcumin (SC) and Synthetic curcumin formulated with sucrose (SCS) against Aedes aegypti larvae which is the major vector of dengue, chikungunya and Zika viruses. Two strategies for curcuminoids delivery were chosen for the experiments: (i) larvae exposed to aqueous solutions of curcuminoids in the concentration range of 5-25 mg/L (w/v) and (ii) larvae exposed to two different types of curcuminoids carriers (pet food). Phototoxic effects of the curcuminoids were evaluated by counting the dead larvae after sunlight exposure, at irradiance range of 30-60 mW/cm(2). The characteristic photobleaching time for each curcuminoids in solution was also determined in order to infer the safety of these molecules in the natural environment. Curcuminoids solutions showed high photolarvicidal activity after 30 min of sunlight irradiation, with LC50 values of 20.0, 11.6 and 2.2 mg/L for NT, SC and SCS, respectively. The curcuminoids carriers, despite showing high mortality (about 90%), presented photodynamic activity only after 8 h of sunlight irradiation. The curcuminoids remained in the aqueous solution for up to 3 h; subsequently, the maximum absorption peak of these pigments was completely modified. The characteristic photobleaching time for each sample was 6, 32 and 60 min for NT, SC and SCS. These original and relevant results show that the combination of curcuminoids pigments with sunlight establishes an extremely effective alternative for Ae. aegypti larvae control, ensuring high environmental safety due to the low persistence of these molecules in the presence of light.
C1 [de Souza, Larissa Marila] Univ Fed Sao Carlos, PPG Biotec, BR-13565905 Sao Carlos, SP, Brazil.
   [de Souza, Larissa Marila; Inada, Natalia Mayumi; Venturini, Francine Perri; Pratavieira, Sebastiao; Kurachi, Cristina; Bagnato, Vanderlei Salvador] Univ Sao Paulo, Sao Carlos Inst Phys, POB 369, BR-13560970 Sao Carlos, SP, Brazil.
   [Carmona-Vargas, Christian C.; de Oliveira, Kleber Thiago] Univ Fed Sao Carlos, Dept Chem, BR-13565905 Sao Carlos, SP, Brazil.
RP de Souza, LM (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, POB 369, BR-13560970 Sao Carlos, SP, Brazil.
EM larissamarila@hotmail.com
RI Pratavieira, Sebastiao/F-1029-2014; /AAP-3629-2020
OI Pratavieira, Sebastiao/0000-0002-5012-8470; de Souza, Larissa
   Marila/0000-0001-7884-2011; Carmona-Vargas, Christian
   C./0000-0002-8981-9957
FU National Council for Scientific and Technological Development -
   CNPQNational Council for Scientific and Technological Development (CNPq)
   [44058520163]; Ministry of Health (Brazil); Sao Paulo Research
   Foundation - FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2009/54035-4, 2013/07276-1, 2018/00106-7]; Coordination for
   the Improvement of Higher Education Personnel - CAPESCAPES
FX We appreciate financial support from National Council for Scientific and
   Technological Development - CNPQ (Grant No.: 44058520163), Ministry of
   Health (Brazil), Sao Paulo Research Foundation -FAPESP (Grants Nos.:
   2009/54035-4 (Confocal Microscope), 2013/07276-1 (Optics and Photonics
   Research Center - CePOF), 2018/00106-7 (KTO), Coordination for the
   Improvement of Higher Education Personnel - CAPES.
CR Ali A, 2015, J MED ENTOMOL, V52, P979, DOI 10.1093/jme/tjv072
   Allison RR, 2008, PHOTODIAGN PHOTODYN, V5, P19, DOI 10.1016/j.pdpdt.2008.02.001
   Almeida L. P., 2006, THESIS
   Alves E, 2015, J PHOTOCH PHOTOBIO C, V22, P34, DOI 10.1016/j.jphotochemrev.2014.09.003
   Anstrom DM, 2012, J MED ENTOMOL, V49, P350, DOI 10.1603/ME11117
   Awad H. H., 2008, Journal of Agriculture and Social Sciences, V4, P85
   Azizullah A, 2015, ENVIRON IMPACT ASSES, V50, P156, DOI 10.1016/j.eiar.2014.09.011
   Azizullah A, 2014, PARASITOL RES, V113, P4321, DOI 10.1007/s00436-014-4175-3
   Ben Amor T, 2000, INSECT BIOCHEM MOLEC, V30, P915, DOI 10.1016/S0965-1748(00)00072-2
   CALLAHAM MF, 1977, ENVIRON ENTOMOL, V6, P669, DOI 10.1093/ee/6.5.669
   Carmona-Vargas CC, 2017, REACT CHEM ENG, V2, P366, DOI 10.1039/c6re00207b
   CASIDA JE, 1980, ENVIRON HEALTH PERSP, V34, P189, DOI 10.2307/3428960
   Chaton PF, 2002, ECOTOX ENVIRON SAFE, V52, P8, DOI 10.1006/eesa.2002.2166
   Coat S, 2011, ENVIRON POLLUT, V159, P1692, DOI 10.1016/j.envpol.2011.02.036
   De Souza L. M., 2017, J LIFE SCI, V11, P74
   Dovigo LN, 2013, MED MYCOL, V51, P243, DOI 10.3109/13693786.2012.714081
   El-Sharaby A., 1978, B SOC ENTOMOL EGYPT, V62, P269
   El-Tayeb TA, 2013, AFR ENTOMOL, V21, P15, DOI 10.4001/003.021.0108
   Fabris C, 2012, ACTA TROP, V123, P239, DOI 10.1016/j.actatropica.2012.05.011
   FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032
   Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin
   Jiang YD, 2014, INT J ENDOCRINOL, DOI 10.1155/2014/983016
   Karunaratne V, 2005, CURR SCI INDIA, V89, P170
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lucantoni L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001434
   Martins M. C., 1992, B BRAZ SOC FOOD SCI, V26, P56
   Peret-Almeida L, 2005, FOOD RES INT, V38, P1039, DOI 10.1016/j.foodres.2005.02.021
   Richter P. R., 2014, FRONT ENV SCI, V18, P1
   ROBINSON JR, 1983, RESIDUE REV, V88, P69
   Roth GN, 1998, J NAT PROD, V61, P542, DOI 10.1021/np970459f
   Sagnou M, 2012, ACTA TROP, V123, P190, DOI 10.1016/j.actatropica.2012.05.006
   SCHILDMACHER H., 1950, BIOL ZENTRALBL, V69, P468
   Silva A., 2017, THESIS
   Silva A. P., 2015, 15 INT PHOT ASS WORL, V12
   Smijs TGM, 2007, J ANTIMICROB CHEMOTH, V59, P433, DOI 10.1093/jac/dkl490
   Soria-Lozano P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0524-3
   Souza C. R. A., 1993, THESIS
   Venturini F. P., 2017, 16 INT PHOT ASS WORL
   Wohllebe S, 2009, PARASITOL RES, V104, P593, DOI 10.1007/s00436-008-1235-6
   Wu JY, 2007, BIOL PHARM BULL, V30, P1336, DOI 10.1248/bpb.30.1336
   1998, PHOTOCHEM PHOTOBIOL, V67, P206
   2012, PHOTOCHEM PHOTOBIOL, V11, P294, DOI DOI 10.1039/C1PP05154G
   2010, PHOTOCHEM PHOTOBIOL, V86, P639, DOI DOI 10.1111/J.1751-1097.2009.00704.X
   2015, LASER MED SCI, V30, P1867, DOI DOI 10.1007/S10103-014-1696-Z
   2017, PHOTOMED LASER SURG, V35, P105, DOI DOI 10.1089/PHO.2016.4114
   1978, ENV ENTOMOL, V7, P205
NR 46
TC 3
Z9 3
U1 3
U2 5
PU KOREAN SOC APPLIED ENTOMOLOGY
PI SUWON
PA NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA,
   249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA
SN 1226-8615
EI 1876-7990
J9 J ASIA-PAC ENTOMOL
JI J. Asia-Pac. Entomol.
PD MAR
PY 2019
VL 22
IS 1
BP 151
EP 158
DI 10.1016/j.aspen.2018.12.016
PG 8
WC Entomology
SC Entomology
GA HX1XS
UT WOS:000467187000022
DA 2020-07-08
ER

PT J
AU Muzumdar, S
   Rothe, MJ
   Grant-Kels, JM
AF Muzumdar, Sonal
   Rothe, Marti Jill
   Grant-Kels, Jane M.
TI The rash with maculopapules and fever in adults
SO CLINICS IN DERMATOLOGY
LA English
DT Article
ID ZIKA VIRUS; UPDATE
AB There is a broad differential diagnosis for the presentation of fever and maculopapular rash in an adult. Although some causative conditions are benign, others are medical emergencies that require prompt diagnosis. We describe various conditions that result in a fever and maculopapular rash in adults. These include infectious processes (meningococcemia, infectious mononucleosis, West Nile virus, zika virus, rubella, primary human immunodeficiency virus, parvovirus B19, ebolavirus), tick-borne illnesses (Rocky Mountain spotted fever, ehrlichiosis), and hypersensitivity reactions (exanthematous drug reactions). We also provide an algorithm to aid in the diagnosis of the patient with fever and maculopapular rash. Such conditions that can occur in adults but are seen predominantly in children are discussed in the article "Rash with maculopapules and fever in children" of this issue. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Muzumdar, Sonal; Rothe, Marti Jill; Grant-Kels, Jane M.] Univ CT Hlth Ctr, Dermatol Dept, Farmington, CT 06030 USA.
RP Grant-Kels, JM (corresponding author), Univ CT Hlth Ctr, Dermatol Dept, Farmington, CT 06030 USA.
EM grant@uchc.edu
CR Aronson M, 2018, UPTODATE
   Bircher A, 2018, UPTODATE
   Chirch L, 2015, CLIN INFECT DIS, P139
   Chovel-Sella A, 2013, PEDIATRICS, V131, pE1424, DOI 10.1542/peds.2012-1575
   Cohen J., 2015, HARRISONS PRINCIPLES, P1186
   Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gurtler L, 2016, TRANSFUS MED HEMOTH, V43, P203, DOI 10.1159/000445852
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johri Sharat, 2005, Med J Armed Forces India, V61, P369, DOI 10.1016/S0377-1237(05)80071-1
   Kassutto S, 2004, CLIN INFECT DIS, V38, P1452, DOI 10.1086/420745
   Khambaty MM, 2010, EMERG MED CLIN N AM, V28, P355, DOI 10.1016/j.emc.2010.01.001
   Koyfman A, 2011, AFR J EMERG MED, V1, P174, DOI 10.1016/j.afjem.2011.07.007
   Kuhn J, 2015, HARRISONS PRINCIPLES, P1304
   Lopez F, 2018, UPTODATE
   Martinez MJ, 2015, INFECT DIS THER, V4, P365, DOI 10.1007/s40121-015-0079-5
   Peterson L., 2018, UPTODATE
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006
   Salinas LJ, 2010, AM J MED SCI, V340, P194, DOI 10.1097/MAJ.0b013e3181e93817
   Scaparrotta A, 2015, ARCH MED SCI, V11, P908, DOI 10.5114/aoms.2015.53315
   Servey JT, 2007, AM FAM PHYSICIAN, V75, P373
   Shinkai K, 2015, HARRISONS PRINCIPLES, P377
   Stern RS, 2012, NEW ENGL J MED, V366, P2492, DOI 10.1056/NEJMcp1104080
   US Department of Health and Human Services, GUID US ANT AG AD AD
   Vouloumanou EK, 2012, CURR OPIN HEMATOL, V19, P14, DOI 10.1097/MOH.0b013e32834daa08
   World Health Organization, ON MONTH MARK EB OUT
   2005, CLIN DERMATOL, V23, P148, DOI DOI 10.1016/J.CLINDERMATOL.2004.06.019
NR 28
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0738-081X
EI 1879-1131
J9 CLIN DERMATOL
JI Clin. Dermatol.
PD MAR-APR
PY 2019
VL 37
IS 2
BP 109
EP 118
DI 10.1016/j.clindermatol.2018.12.004
PG 10
WC Dermatology
SC Dermatology
GA HV8QB
UT WOS:000466246000004
PM 30981291
DA 2020-07-08
ER

PT J
AU Bharucha, T
   Sengvilaipaseuth, O
   Seephonelee, M
   Vongsouvath, M
   Vongsouvath, M
   Rattanavong, S
   Piorkowski, G
   Lecuit, M
   Gorman, C
   Pommier, JD
   Garson, JA
   Newton, PN
   de Lamballerie, X
   Dubot-Peres, A
AF Bharucha, Tehmina
   Sengvilaipaseuth, Onanong
   Seephonelee, Malee
   Vongsouvath, Malavanh
   Vongsouvath, Manivanh
   Rattanavong, Sayaphet
   Piorkowski, Geraldine
   Lecuit, Marc
   Gorman, Christopher
   Pommier, Jean-David
   Garson, Jeremy A.
   Newton, Paul N.
   de Lamballerie, Xavier
   Dubot-Peres, Audrey
TI Viral RNA Degradation Makes Urine a Challenging Specimen for Detection
   of Japanese Encephalitis Virus in Patients With Suspected CNS Infection
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE diagnosis; flavivirus; Japanese encephalitis virus; RNA; RT-qPCR
ID WEST NILE VIRUS; ZIKA VIRUS; SAMPLES; IGM
AB Background. Japanese encephalitis virus (JEV) is a leading cause of central nervous system (CNS) infections in Asia and results in significant morbidity and mortality. JEV RNA is rarely detected in serum or cerebrospinal fluid (CSF), and diagnosis of JEV infection is usually based on serological tests that are frequently difficult to interpret. Unlike serum or CSF, urine is relatively easy to obtain, but, to date, there has been minimal work on the feasibility of testing urine for JEV RNA.
   Methods. We investigated the use of lysis buffer and a Microsep device to optimize urine storage for detection of JEV RNA by reverse transcription real-time polymerase chain reaction (RT-qPCR). The best of the studied methods was then evaluated in consecutive patients admitted to the hospital with suspected CNS infections in Laos.
   Results. We demonstrated degradation of JEV RNA in urine after even short storage periods at 4 degrees C or-80 degrees C. Although there was no advantage in using a Microsep concentration device alone, immediate addition of lysis buffer to fresh urine improved the detection of JEV RNA at the limit of detection.
   Conclusions. In 2 studies of 41 patients with acute encephalitis syndrome, 11 (27%) were positive for JEV IgM in CSF and/or serum, and 2 (4.9%) were JEV RT-qPCR positive from throat swabs. JEV RNA was not detected in any of these patients' urine samples. However, lysis buffer was only used during a prospective study, that is, for only 17/41 (41%) patient urine samples. Our findings suggest a need for larger studies testing urine for JEV RNA, with urine collected at different times from symptom onset, and using lysis buffer, which stabilizes RNA, for storage.
C1 [Bharucha, Tehmina; Sengvilaipaseuth, Onanong; Seephonelee, Malee; Vongsouvath, Malavanh; Vongsouvath, Manivanh; Rattanavong, Sayaphet; Newton, Paul N.; Dubot-Peres, Audrey] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Microbiol Lab, Viangchan, Laos.
   [Bharucha, Tehmina; Garson, Jeremy A.] UCL, Div Infect & Immun, London, England.
   [Newton, Paul N.; Dubot-Peres, Audrey] Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Piorkowski, Geraldine; de Lamballerie, Xavier; Dubot-Peres, Audrey] Aix Marseille Univ, Inserm 1207, IRD 190, IHU Mediterranee Infect,UVE, Marseille, France.
   [Lecuit, Marc] Inst Pasteur, INSERM, U1117, Biol Infect Unit, Paris, France.
   [Lecuit, Marc] Paris Descartes Univ, Necker Enfants Malad Univ Hosp, Div Infect Dis & Trop Med, Paris, France.
   [Gorman, Christopher; Pommier, Jean-David] Inst Pasteur Int Network, Inst Pasteur Cambodge, Phnom Penh, Cambodia.
   [Garson, Jeremy A.] NHS Blood & Transplant, Transfus Microbiol, London, England.
RP Bharucha, T (corresponding author), Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Microbiol Lab, Viangchan, Laos.
EM t.bharucha@doctors.org.uk
RI Garson, Jeremy A/C-5357-2008; Lecuit, Marc/J-4073-2013; Lecuit,
   Marc/M-4126-2019
OI Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063;
   Pommier, Jean-David/0000-0001-9154-7607; Newton,
   Paul/0000-0002-4608-6431; Garson, Jeremy/0000-0003-0553-0126
FU European Union (EuropeAid, INNOVATE ) [315-047]; Total Foundation;
   Horizon 2020 research and the innovation program EVAg [653316]; Wellcome
   Trust of Great BritainWellcome Trust; Institute of Research for
   Development, Aix-Marseille University
FX The research has been implemented in collaboration with the ComAcross
   project (www.onehealthsea.org/comacross) thanks to the financial support
   of the European Union (EuropeAid, INNOVATE contract 315-047). It was
   also supported by Total Foundation, Horizon 2020 research and the
   innovation program EVAg under grant agreement No. 653316, the Institute
   of Research for Development, Aix-Marseille University, and the Wellcome
   Trust of Great Britain.
CR Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Aubry F, 2013, MICROBIOL RESOUR ANN, V1, DOI 10.1128/genomeA.00157-12
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Bharucha T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26333-4
   Bharucha T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194412
   Brassard J, 2005, J VIROL METHODS, V123, P163, DOI 10.1016/j.jviromet.2004.09.018
   Caldwell JP, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0635-8
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Dubot-Peres A, 2015, LANCET INFECT DIS, V15, P1376, DOI 10.1016/S1473-3099(15)00405-3
   Gorchakov R, 2019, AM J TROP MED HYG, V100, P427, DOI 10.4269/ajtmh.18-0755
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heffelfinger JD, 2017, MMWR-MORBID MORTAL W, V66, P579, DOI 10.15585/mmwr.mm6622a3
   Huang GKL, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx203
   Johnson BW, 2016, AM J TROP MED HYG, V94, P820, DOI 10.4269/ajtmh.15-0631
   Khalakdina A, 2010, INT J INFECT DIS, V14, pE79, DOI 10.1016/j.ijid.2009.11.020
   Lu T, 2019, J MED VIROL, V91, P115, DOI 10.1002/jmv.25280
   Mai NTH, 2017, OPEN FORUM INFECT DI, V4, pXXX
   Mortimer PP, 2015, REV MED VIROL, V25, P203, DOI 10.1002/rmv.1840
   MORTIMER PP, 1991, REV MED VIROL, V1, P73
   Nagy A, 2016, ARCH VIROL, V161, P1797, DOI 10.1007/s00705-016-2844-5
   Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Robinson JS, 2010, AM J TROP MED HYG, V83, P1146, DOI 10.4269/ajtmh.2010.10-0212
   Simon-Loriere E, 2017, NEW ENGL J MED, V376, P1483, DOI 10.1056/NEJMc1701600
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30
   WHOROft Western, 2014, 4 HANDS ON TRAIN WOR
   Zhao H, 2013, CLIN INFECT DIS, V57, P157, DOI 10.1093/cid/cit169
NR 28
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD MAR
PY 2019
VL 6
IS 3
AR UNSP ofz048
DI 10.1093/ofid/ofz048
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HU5OD
UT WOS:000465327200020
PM 30882014
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Myers, TR
   McCarthy, NL
   Panagiotakopoulos, L
   Omer, SB
AF Myers, Tanya R.
   McCarthy, Natalie L.
   Panagiotakopoulos, Lakshmi
   Omer, Saad B.
TI Estimation of the Incidence of Guillain-Barre Syndrome During Pregnancy
   in the United States
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE Guillain-Barre syndrome; pregnancy; Vaccine Safety Datalink
ID VACCINE SAFETY
AB Guillain-Barre syndrome (GBS) is an adverse event of interest after vaccination, yet few data are available for background rates during pregnancy. We confirmed 2 cases of incident GBS and estimated an incidence of 2.8 confirmed GBS cases per million person-years (95% confidence interval, 0.5-9.3), indicating rare occurrence. Our findings will help inform safety assessments of Zika vaccines in pregnant populations.
C1 [Myers, Tanya R.; McCarthy, Natalie L.; Panagiotakopoulos, Lakshmi] Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Omer, Saad B.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.
   [Omer, Saad B.] Emory Univ, Dept Global Hlth, Atlanta, GA 30322 USA.
   [Omer, Saad B.] Emory Vaccine Ctr, Atlanta, GA USA.
RP Myers, TR (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, 1600 Clifton Rd NE,MS V18-4, Atlanta, GA 30329 USA.
EM vje9@cdc.gov
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA;
   National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI074492]
FX This work was supported by the Centers for Disease Control and
   Prevention. Dr. Myers was supported by the National Institute of Allergy
   and Infectious Diseases (Award Number T32AI074492).
CR Baxter R, 2012, CLIN INFECT DIS, V54, P800, DOI 10.1093/cid/cir960
   Cheng Q, 1998, EPIDEMIOLOGY, V9, P601
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Klein NP, 2010, VACCINE, V28, P1062, DOI 10.1016/j.vaccine.2009.10.115
   McNeil MM, 2014, VACCINE, V32, P5390, DOI 10.1016/j.vaccine.2014.07.073
   Naleway AL, 2013, VACCINE, V31, P2898, DOI 10.1016/j.vaccine.2013.03.069
   Rothman KJ, 1979, NATL I HLTH PUBLICAT, V79-1649
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Shui IM, 2012, NEUROEPIDEMIOLOGY, V39, P109, DOI 10.1159/000339248
NR 10
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD MAR
PY 2019
VL 6
IS 3
AR UNSP ofz071
DI 10.1093/ofid/ofz071
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HU5OD
UT WOS:000465327200037
PM 31312665
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Echavarria-Consuegra, L
   Smit, JM
   Reggiori, F
AF Echavarria-Consuegra, Liliana
   Smit, Jolanda M.
   Reggiori, Fulvio
TI Role of autophagy during the replication and pathogenesis of common
   mosquito-borne flavi- and alphaviruses
SO OPEN BIOLOGY
LA English
DT Review
DE autophagy; arboviruses; flaviviruses; alphaviruses; dengue virus; West
   Nile virus
ID VIRUS-INDUCED AUTOPHAGY; DENGUE-VIRUS; WEST-NILE; GENE-EXPRESSION; ATG
   PROTEINS; ULK1 COMPLEX; ER STRESS; CHIKUNGUNYA; FLAVIVIRUSES; RNA
AB Arboviruses that are transmitted to humans by mosquitoes represent one of the most important causes of febrile illness worldwide. In recent decades, we have witnessed a dramatic re-emergence of several mosquito-borne arboviruses, including dengue virus (DENV), West Nile virus (WNV), chikungunya virus (CHIKV) and Zika virus (ZIKV). DENV is currently the most common mosquito-borne arbovirus, with an estimated 390 million infections worldwide annually. Despite a global effort, no specific therapeutic strategies are available to combat the diseases caused by these viruses. Multiple cellular pathways modulate the outcome of infection by either promoting or hampering viral replication and/or pathogenesis, and autophagy appears to be one of them. Autophagy is a degradative pathway generally induced to counteract viral infection. Viruses, however, have evolved strategies to subvert this pathway and to hijack autophagy components for their own benefit. In this review, we will focus on the role of autophagy in mosquito-borne arboviruses with emphasis on DENV, CHIKV, WNV and ZIKV, due to their epidemiological importance and high disease burden.
C1 [Echavarria-Consuegra, Liliana; Smit, Jolanda M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, Groningen, Netherlands.
   [Reggiori, Fulvio] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands.
RP Smit, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Prevent, Groningen, Netherlands.; Reggiori, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands.
EM jolanda.smit@umcg.nl; f.m.reggiori@umcg.nl
RI Reggiori, Fulvio/U-8327-2019
OI Reggiori, Fulvio/0000-0003-2652-2686
FU ZonMW VICI [016.130.606]; ZonMW TOP [91217002]; Marie Sklodowska-Curie
   Cofund [713660]; Marie Sklodowska Curie ETN [765912]; Sklodowska-Curie
   Cofund [713660]; Erasmus Mundus EURICA mobility programme; Graduate
   School of Medical Sciences PhD scholarship (University Medical Center
   Groningen); ALW Open Programme [ALWOP.310]
FX F.R. is supported by ZonMW VICI (016.130.606), ZonMW TOP (91217002), ALW
   Open Programme (ALWOP.310) and Marie Sklodowska-Curie Cofund (713660)
   and Marie Sklodowska Curie ETN (765912) grants. J.M.S. is also supported
   by a Sklodowska-Curie Cofund (713660). L.E.-C. is supported by Erasmus
   Mundus EURICA mobility programme and Graduate School of Medical Sciences
   PhD scholarship (University Medical Center Groningen).
CR Abernathy E, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006926
   Abounit Kadija, 2012, World J Biol Chem, V3, P1, DOI 10.4331/wjbc.v3.i1.1
   Abraham R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075854
   Acharya D, 2016, METHODS MOL BIOL, V1435, P249, DOI 10.1007/978-1-4939-3670-0_19
   Acosta EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044835
   Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Ahola T., 2016, CHIKUNGUNYA VIRUS AD, P75, DOI [10.1007/978-3-319-42958-8_6, DOI 10.1007/978-3-319-42958-8]
   Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Beatman E, 2012, VIROLOGY, V433, P262, DOI 10.1016/j.virol.2012.08.016
   Beckham J David, 2015, Continuum (Minneap Minn), V21, P1599, DOI 10.1212/CON.0000000000000240
   Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556
   Bestebroer J, 2013, TRAFFIC, V14, P1029, DOI 10.1111/tra.12091
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carroll B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02746-z
   Centers for Disease Control and Prevention (CDC), 2017, SYMPT DIAGN TREATM W
   Charbonnier LM, 2012, METHODS MOL BIOL, V821, P435, DOI 10.1007/978-1-61779-430-8_28
   Chen HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004828
   Chen ST, 2017, ALGORITHMS, V10, DOI 10.3390/a10040131
   Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158
   Cieehomska IA, 2007, AUTOPHAGY, V3, P586
   Comesana M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193480
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284
   Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040
   Dupont N, 2017, INT REV CEL MOL BIO, V328, P1, DOI 10.1016/bs.ircmb.2016.08.001
   DYER O, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5759
   Fang YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110655
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150
   Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ge L, 2017, EMBO REP, V18, P1586, DOI 10.15252/embr.201744559
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heckmann BL, 2017, J MOL BIOL, V429, P3561, DOI 10.1016/j.jmb.2017.08.012
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hidari Kazuya I P J, 2011, Trop Med Health, V39, P37, DOI 10.2149/tmh.2011-S03
   Hoornweg TE, 2016, J VIROL, V90, P4745, DOI 10.1128/JVI.03184-15
   Horne KM, 2014, VIRUSES-BASEL, V6, P4373, DOI 10.3390/v6114373
   Huang JQ, 2014, MOL CELL BIOCHEM, V397, P157, DOI 10.1007/s11010-014-2183-3
   Huang XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22303
   Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018
   Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114
   Jackson WT, 2015, VIROLOGY, V479, P450, DOI 10.1016/j.virol.2015.03.042
   JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996
   Judith D, 2016, CHIKUNGUNYA VIRUS AD, P149
   Judith D, 2013, EMBO REP, V14, P534, DOI 10.1038/embor.2013.51
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Khongwichit S, 2016, MICROB PATHOGENESIS, V101, P104, DOI 10.1016/j.micpath.2016.11.009
   Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Kobayashi S, 2014, VIRUS RES, V191, P83, DOI 10.1016/j.virusres.2014.07.016
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021
   Korkhov VM, 2009, J CELL BIOCHEM, V107, P86, DOI 10.1002/jcb.22103
   Koyama-Honda I, 2013, AUTOPHAGY, V9, P1491, DOI 10.4161/auto.25529
   Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Kruppa AJ, 2016, TRAFFIC, V17, P878, DOI 10.1111/tra.12410
   Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012
   Kuma A, 2010, SEMIN CELL DEV BIOL, V21, P683, DOI 10.1016/j.semcdb.2010.03.002
   Law BK, 2005, CRIT REV ONCOL HEMAT, V56, P47, DOI 10.1016/j.critrevonc.2004.09.009
   Lee YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18909-3
   Lee YR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-65
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin MG, 2016, CURR OPIN CELL BIOL, V39, P61, DOI 10.1016/j.ceb.2016.02.010
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu Z, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.183
   Ljungberg K, 2016, CHIKUNGUNYA VIRUS, P45, DOI DOI 10.1007/978-3-319-42958-8_4
   Margariti A, 2013, J BIOL CHEM, V288, P859, DOI 10.1074/jbc.M112.412783
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Matsui T, 2018, J CELL BIOL, V217, P2633, DOI 10.1083/jcb.201712058
   Mauthe M, 2016, AUTOPHAGY, V12, P2502, DOI 10.1080/15548627.2016.1236878
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Mendes A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030138
   Mercer TJ, 2018, J BIOL CHEM, V293, P5386, DOI 10.1074/jbc.R117.810366
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Metz SW, 2016, CHIKUNGUNYA VIRUS AD, P63, DOI DOI 10.1007/978-3-319-42958-8_5
   Gutierrez-Robledo LM, 2017, GAC MED MEX, V153, P190
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   Nakamura S, 2017, J CELL SCI, V130, P1209, DOI 10.1242/jcs.196352
   Nakatogawa H, 2015, AUTOPHAGY, V11, P2377, DOI 10.1080/15548627.2015.1106665
   Nakatogawa H, 2013, ESSAYS BIOCHEM, V55, P39, DOI [10.1042/bse0550039, 10.1042/BSE0550039]
   Nhan NT, 2001, CLIN INFECT DIS, V32, P204, DOI 10.1086/318479
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Oh Ji Eun, 2013, Immune Netw, V13, P1, DOI 10.4110/in.2013.13.1.1
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
   Panyasrivanit M, 2011, VIROLOGY, V418, P74, DOI 10.1016/j.virol.2011.07.010
   Panyasrivanit M, 2009, AUTOPHAGY, V5, P434, DOI 10.4161/auto.5.3.7925
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Proikas-Cezanne T, 2015, J CELL SCI, V128, P207, DOI 10.1242/jcs.146258
   Pu JY, 2017, ARCH VIROL, V162, P3645, DOI 10.1007/s00705-017-3516-9
   Reggiori F, 2017, J MOL BIOL, V429, P486, DOI 10.1016/j.jmb.2017.01.002
   Rocha RF, 2018, BIOL CHEM, V399, P203, DOI 10.1515/hsz-2017-0236
   Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014
   Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249
   Sanz MA, 2005, PROTEIN REV, V1, P233
   Schmaljohn AL, 1996, MORPHOLOGIE BIOL PHY, P1
   Scholte FEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071047
   Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002
   Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866
   Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226
   SINGH I, 1992, J VIROL, V66, P7049, DOI 10.1128/JVI.66.12.7049-7058.1992
   Snyder JE, 2013, J VIROL, V87, P8511, DOI 10.1128/JVI.00449-13
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stevens AJ, 2009, J MED CHEM, V52, P7911, DOI 10.1021/jm900652e
   Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tharmarajah Kothila, 2017, F1000Res, V6, P2114, DOI 10.12688/f1000research.12461.1
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Troupin A, 2016, METHODS MOL BIOL, V1435, P15, DOI 10.1007/978-1-4939-3670-0_2
   Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018
   Utt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151616
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Verlhac P, 2015, CELL HOST MICROBE, V17, P515, DOI 10.1016/j.chom.2015.02.008
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020
   White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941
   Wong KZ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060294
   Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048
   Wu SY, 2013, J INFECTION, V67, P329, DOI 10.1016/j.jinf.2013.05.003
   Wu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32243
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Yang KC, 2018, BIOCHEM SOC T, V46, P97, DOI 10.1042/BST20170102
   Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865
   Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021
   Zhang JS, 2018, CELL HOST MICROBE, V23, P819, DOI 10.1016/j.chom.2018.05.005
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
   2009, CELL HOST MICROBE, V5, P365, DOI DOI 10.1016/J.CHOM.2009.03.007
   2003, J BIOL CHEM, V278, P3671, DOI DOI 10.1074/JBC.M208247200
   2011, J BIOL CHEM, V286, P2214, DOI DOI 10.1074/JBC.M110.192500
   2008, VIROLOGY, V374, P240, DOI DOI 10.1016/J.VIROL.2008.02.016
   2018, BIOCHEM PHARMACOL, V154, P54, DOI DOI 10.1016/J.BCP.2018.04.008
   2015, AUTOPHAGY, V11, P861, DOI DOI 10.1080/15548627.2015.1037062
   2007, EXP GERONTOL, V42, P120, DOI DOI 10.1016/J.EXGER.2006.05.019
   2010, CELL MOL LIFE SCI, V67, P2773, DOI DOI 10.1007/S00018-010-0357-Z
   2012, J VIROL, V86, P1072, DOI DOI 10.1128/JVI.01667-12
   2012, J VIROL, V86, P5674, DOI DOI 10.1128/JVI.06581-11
   2012, J VIROL, V86, P1360, DOI DOI 10.1128/JVI.01805-12
   2014, MOL CELL, V55, P238, DOI DOI 10.1016/J.MOLCEL.2014.05.021
   2003, J BIOL CHEM, V278, P2438, DOI DOI 10.1074/JBC.M301717200
   1992, J BIOL CHEM, V267, P1639
NR 171
TC 5
Z9 6
U1 1
U2 1
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2046-2441
J9 OPEN BIOL
JI Open Biol
PD MAR
PY 2019
VL 9
IS 3
AR 190009
DI 10.1098/rsob.190009
PG 20
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HU6WJ
UT WOS:000465422200007
PM 30862253
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carvalho, TGC
   dos Santos, IM
   Bedor, CNG
   de Alencar, EB
AF Carvalho, Thiego G. C.
   dos Santos, Ieda M.
   Bedor, Cheila N. G.
   de Alencar Filho, Edilson B.
TI Principal Component Analysis (PCA) and Construction of a SIMCA
   Classification Model to Monoterpenes and Analogs with Larvicidal
   Activity in Aedes aegypti
SO REVISTA VIRTUAL DE QUIMICA
LA English
DT Article
DE Monoterpenes; Aedes aegypti; arboviruses; larvicidal activity; CCV-based
   algorithm; SIMCA
AB The arboviruses Dengue, Zika and Chicungunya are global public health problems that can be mainly transmitted by the bit of the Aedes aegypti mosquitoes. The prevention of these diseases involves the insect control, by chemical, physical or biological methods, considering both larval and adult stages. Natural products have been studied as more secure and effective chemical alternatives, through the use of extracts, fractions, and isolated compounds. Based on the previous paper of Santos and coworkers, which related the larvicidal activity of monoterpenes and analogs against Aedes aegypti, this work presents an unusual variable selection procedure, based on Clustering Coefficients of Variation (CCV) method, aiming to generate a classification model by SIMCA, capable of helping in the search of compounds with greater larvicidal potential.
C1 [Carvalho, Thiego G. C.; dos Santos, Ieda M.; Bedor, Cheila N. G.; de Alencar Filho, Edilson B.] Univ Fed Vale Sao Francisco, Lab Modelagem Mol Aplicada Farm LAMMAF, Colegiado Farm, BR-56304205 Petrolina, PE, Brazil.
RP de Alencar, EB (corresponding author), Univ Fed Vale Sao Francisco, Lab Modelagem Mol Aplicada Farm LAMMAF, Colegiado Farm, BR-56304205 Petrolina, PE, Brazil.
EM edilson.beserra@univasf.edu.br
RI Bedor, Cheila N G/B-3829-2018
OI Bedor, Cheila N G/0000-0002-1614-7539
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FACEPE; UNIVASF
FX The authors thank to CNPq, CAPES, FACEPE and UNIVASF for the financial
   support and scholarships as well as the CENAPAD-UFC for the
   computational facilities. The activity of access to the genetic
   patrimony was registered in SisGen with code #A079750.
CR [Anonymous], 2017, DRAG SOFTW MOL DESCR, P382
   [Anonymous], 2015, ACD CHEMSKETCH VERS
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   da Silva GNS, 2016, PEST MANAG SCI, V72, P1883, DOI 10.1002/ps.4221
   Zara ALDA, 2016, EPIDEMIOL SERV SAUDE, V25, P391, DOI 10.5123/S1679-49742016000200017
   Dennington R., 2016, GAUSSVIEW VERSION 6
   dos Santos IM, 2018, STRUCT CHEM, V29, P1287, DOI 10.1007/s11224-018-1110-8
   Fong S, 2014, 2014 NINTH INTERNATIONAL CONFERENCE ON DIGITAL INFORMATION MANAGEMENT (ICDIM), P205, DOI 10.1109/ICDIM.2014.6991429
   Frisch M.J., 2016, GAUSSIAN 09W REVISIO
   Roy K., 2015, QUANTITATIVE STRUCTU
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   2016, MED CHEM RES, V25, P2171, DOI DOI 10.1007/S00044-016-1650-7
NR 17
TC 0
Z9 0
U1 0
U2 0
PU BRAZILIAN CHEMICAL SOC
PI NITEROI
PA SECRETERIA REGIONAL RIO DO JANEIRO, UNIV FED FLUMINENSE, NITEROI, RJ
   24020-141, BRAZIL
SN 1984-6835
J9 REV VIRTUAL QUIM
JI Rev. Virtual Quim.
PD MAR-APR
PY 2019
VL 11
IS 2
BP 411
EP 424
DI 10.21577/1984-6835.20190031
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA HU8OH
UT WOS:000465548200005
OA Bronze
DA 2020-07-08
ER

PT J
AU Bailey, MJ
   Broecker, F
   Duehr, J
   Arumemi, F
   Krammer, F
   Palese, P
   Tan, GS
AF Bailey, Mark J.
   Broecker, Felix
   Duehr, James
   Arumemi, Fortuna
   Krammer, Florian
   Palese, Peter
   Tan, Gene S.
TI Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika
   Virus
SO MBIO
LA English
DT Article
DE Fc-mediated responses; NS1; Zika virus; antibody-dependent enhancement
   of disease; flavivirus; nonneutralizing antibodies; vaccine
ID DENGUE VIRUS; YELLOW-FEVER; STRUCTURAL BASIS; DNA VACCINE; NS1;
   IMMUNOGENICITY; ENCEPHALITIS; IMMUNIZATION; SPECIFICITY; ENHANCEMENT
AB Zika virus is a mosquito-borne flavivirus which can cause severe disease in humans, including microcephaly and other congenital malformations in newborns and Guillain-Barre syndrome in adults. There are currently no approved prophylactics or therapeutics for Zika virus; the development of a safe and effective vaccine is an urgent priority. Preclinical studies suggest that the envelope glycoprotein can elicit potently neutralizing antibodies. However, such antibodies are implicated in the phenomenon of antibody-dependent enhancement of disease. We have previously shown that monoclonal antibodies targeting the Zika virus nonstructural NS1 protein are protective without inducing antibody-dependent enhancement of disease. Here, we investigated whether the NS1 protein itself is a viable vaccine target. Wild-type mice were vaccinated with an NS1-expressing DNA plasmid followed by two adjuvanted protein boosters, which elicited high antibody titers. Passive transfer of the immune sera was able to significantly protect STAT2 knockout mice against lethal challenge by Zika virus. In addition, long-lasting NS1-specific IgG responses were detected in serum samples from patients in either the acute or the convalescent phase of Zika virus infection. These NS1-specific antibodies were able to functionally engage Fc gamma receptors. In contrast, envelope-specific antibodies did not activate Fc-mediated effector functions on infected cells. Our data suggest that the Zika virus NS1 protein, which is expressed on infected cells, is critical for Fc-dependent cell-mediated immunity. The present study demonstrates that the Zika virus NS1 protein is highly immunogenic and can elicit protective antibodies, underscoring its potential for an effective Zika virus vaccine.
   IMPORTANCE Zika virus is a global public health threat that causes microcephaly and congenital malformations in newborns and Guillain-Barre syndrome in adults. Currently, no vaccines or treatments are available. While antibodies targeting the envelope glycoprotein can neutralize virus, they carry the risk of antibody-dependent enhancement of disease (ADE). In contrast, antibodies generated against the NS1 protein can be protective without eliciting ADE. The present study demonstrates the effectiveness of an NS1-based vaccine in eliciting high titers of protective antibodies against Zika virus disease in a mouse model. Sera generated by this vaccine can elicit Fc-mediated effector functions against Zika virus-infected cells. Lastly, we provide human data suggesting that the antibody response against the Zika virus NS1 protein is long-lasting and functionally active. Overall, our work will inform the development of a safe and effective Zika virus vaccine.
C1 [Bailey, Mark J.; Broecker, Felix; Duehr, James; Krammer, Florian; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Bailey, Mark J.; Duehr, James] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.
   [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.
   [Arumemi, Fortuna; Tan, Gene S.] J Craig Venter Inst, Infect Dis, La Jolla, CA 92037 USA.
   [Tan, Gene S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
RP Tan, GS (corresponding author), J Craig Venter Inst, Infect Dis, La Jolla, CA 92037 USA.; Tan, GS (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
EM gtan@jcvi.org
RI Broecker, Felix/AAC-5609-2019; Krammer, Florian/H-3237-2019
OI Krammer, Florian/0000-0003-4121-776X; Duehr, James/0000-0003-2077-6685;
   Bailey, Mark/0000-0003-3874-5334
FU MSTP training grant [NIH T32 GM007280]; Leopoldina German Academy of
   Sciences; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI129477]; J. Craig Venter
   Institute
FX M.J.B. is supported by an MSTP training grant (NIH T32 GM007280). F.B.
   acknowledges financial support by the Leopoldina German Academy of
   Sciences through a postdoctoral fellowship. Zika virus vaccine research
   in the Krammer laboratory is supported by NIH grant R21AI129477. G.S.T.
   is supported with startup funding from the J. Craig Venter Institute.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Chuang YC, 2014, J VIROL, V88, P13759, DOI 10.1128/JVI.02166-14
   Chuang YC, 2011, J IMMUNOL, V187, P6483, DOI 10.4049/jimmunol.1102218
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duehr J, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00011-18, 10.1128/mspheredirect.00011-18]
   Dugast AS, 2011, VIROLOGY, V415, P160, DOI 10.1016/j.virol.2011.03.012
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Gao XJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3173-y
   Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Hajra A, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12607
   He WQ, 2016, P NATL ACAD SCI USA, V113, P11931, DOI 10.1073/pnas.1609316113
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Li AZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05276-4
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu XL, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0072-6
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sanofi Pasteur, 2018, FOC ON DENG
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vargas-Inchaustegui DA, 2013, CURR HIV RES, V11, P407, DOI 10.2174/1570162X113116660063
   Wan SW, 2017, J IMMUNOL, V199, P2834, DOI 10.4049/jimmunol.1601523
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Watts Alexander G, 2018, J Travel Med, V25, DOI 10.1093/jtm/tay132
   Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 60
TC 5
Z9 5
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2019
VL 10
IS 2
AR e02861-18
DI 10.1128/mBio.02861-18
PG 16
WC Microbiology
SC Microbiology
GA HU2CB
UT WOS:000465077600009
PM 30940710
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, Q
   Wu, J
   Ye, Q
   Ma, F
   Zhu, Q
   Wu, Y
   Shan, C
   Xie, XP
   Li, DP
   Zhan, XY
   Li, CF
   Li, XF
   Qin, XL
   Zhao, TY
   Wu, HT
   Shi, PY
   Man, JH
   Qin, CF
AF Chen, Qi
   Wu, Jin
   Ye, Qing
   Ma, Feng
   Zhu, Qian
   Wu, Yan
   Shan, Chao
   Xie, Xuping
   Li, Dapei
   Zhan, Xiaoyan
   Li, Chunfeng
   Li, Xiao-Feng
   Qin, Xiaoling
   Zhao, Tongyan
   Wu, Haitao
   Shi, Pei-Yong
   Man, Jianghong
   Qin, Cheng-Feng
TI Treatment of Human Glioblastoma with a Live Attenuated Zika Virus
   Vaccine Candidate (vol 9, e01683-18, 2018)
SO MBIO
LA English
DT Correction
C1 [Chen, Qi; Ye, Qing; Li, Chunfeng; Li, Xiao-Feng; Qin, Xiaoling; Zhao, Tongyan; Qin, Cheng-Feng] Acad Mil Med Sci, State Key Lab Pathogen & Biosecur, Inst Microbiol & Epidemiol, Beijing, Peoples R China.
   [Wu, Jin; Zhan, Xiaoyan; Man, Jianghong] Natl Ctr Biomed Anal, State Key Lab Prote, Beijing, Peoples R China.
   [Ye, Qing] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Ma, Feng; Li, Dapei; Li, Chunfeng] Chinese Acad Med Sci, Ctr Syst Med, Inst Basic Med Sci, Beijing, Peoples R China.
   [Ma, Feng; Li, Dapei; Li, Chunfeng] Peking Union Med Coll, Beijing, Peoples R China.
   [Ma, Feng; Li, Dapei; Li, Chunfeng] Suzhou Inst Syst Med, Suzhou, Peoples R China.
   [Zhu, Qian; Wu, Yan; Wu, Haitao] Beijing Inst Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China.
   [Shan, Chao; Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Wu, Jin] Acad Mil Med Sci, Tianjin Key Lab Risk Assessment & Control Technol, Inst Environm Med, Tianjin, Peoples R China.
RP Qin, CF (corresponding author), Acad Mil Med Sci, State Key Lab Pathogen & Biosecur, Inst Microbiol & Epidemiol, Beijing, Peoples R China.; Man, JH (corresponding author), Natl Ctr Biomed Anal, State Key Lab Prote, Beijing, Peoples R China.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu; jhman@ncba.ac.cn; qincf@bmi.ac.cn
RI Xie, Xuping/AAD-7406-2019
OI Shan, Chao/0000-0002-3953-3782
CR Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
NR 1
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2019
VL 10
IS 2
AR e00433-19
DI 10.1128/mBio.00433-19
PG 1
WC Microbiology
SC Microbiology
GA HU2CB
UT WOS:000465077600016
PM 30940705
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Song, YT
   Mugavero, J
   Stauft, CB
   Wimmer, E
AF Song, Yutong
   Mugavero, JoAnn
   Stauft, Charles B.
   Wimmer, Eckard
TI Dengue and Zika Virus 5 ' Untranslated Regions Harbor Internal Ribosomal
   Entry Site Functions
SO MBIO
LA English
DT Article
DE Zika virus; cap-dependent translation; cap-independent translation;
   dengue virus; internal ribosome entry site; IRES
ID POLIOVIRUS RNA; MESSENGER-RNA; IN-VITRO; TRANSLATION EFFICIENCY;
   INITIATION SITES; IRES; EXPRESSION; INFECTION; SEQUENCE; ELEMENTS
AB The Flavivirus genus of the Flaviviridae family encompasses numerous enveloped plus-strand RNA viruses. Dengue virus (DENV), a flavivirus, is the leading cause of serious arthropod-borne disease globally. The genomes of DENV, like the genomes of yellow fever virus (YFV), West Nile fever virus (WNV), or Zika virus (ZIKV), control their translation by a 5'-terminal capping group. Three other genera of Flaviviridae are remarkable because their viruses use internal ribosomal entry sites (IRESs) to control translation, and they are not arthropod transmitted. In 2006, E. Harris' group published work suggesting that DENV RNA does not stringently need a cap for translation. They proposed that instead DENV translation is controlled by an interplay between 5' and 3' termini. Here we present evidence that the DENV or ZIKV 5' untranslated regions (5'-UTRs) alone have IRES competence. This conclusion is based, first, on the observation that uncapped monocistronic mRNAs 5' terminated with the DENV or ZIKV 5'-UTRs can efficiently direct translation of a reporter gene in BHK and C6/36 cells and second, that either 5'-UTR placed between two reporter genes can efficiently induce expression of the downstream gene in BHK cells but not in C6/36 cells. These experiments followed observations that uncapped DENV/ZIKV genomic transcripts, 5' terminated with pppAN... or GpppAN..., can initiate infections of mammalian (BHK) or mosquito (C6/36) cells. IRES competence of the 5' UTRs of DENV/ZIKV raises many open questions regarding the biology and control, as well as the evolution, of insect-borne flaviviruses.
   IMPORTANCE Members of the genus Flavivirus of Flaviviridae are important human pathogens of great concern because they cause serious diseases, sometimes death, in human populations living in tropical, subtropical (dengue virus [ DENV], Zika virus [ ZIKV], and yellow fever virus), or moderate climates (West Nile virus). Flaviviruses are known to control their translation by a cap-dependent mechanism. We have observed, however, that the uncapped genomes of DENV or ZIKV can initiate infection of mammalian and insect cells. We provide evidence that the short 5' untranslated region (5'-UTR) of DENV or ZIKV genomes can fulfill the function of an internal ribosomal entry site (IRES). This strategy frees these organisms from the cap-dependent mechanism of gene expression at an as yet unknown stage of proliferation. The data raise new questions about the biology and evolution of flaviviruses, possibly leading to new controls of flavivirus disease.
C1 [Song, Yutong; Mugavero, JoAnn; Stauft, Charles B.; Wimmer, Eckard] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.
   [Stauft, Charles B.; Wimmer, Eckard] Codagenix Inc, Farmingdale, NY 11735 USA.
RP Song, YT; Wimmer, E (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.; Wimmer, E (corresponding author), Codagenix Inc, Farmingdale, NY 11735 USA.
EM yutong.song@stonybrook.edu; eckard.wimmer@stonybrook.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [RO1AI110792,
   1R21AI126048]
FX This work was supported in parts by grants from the National Institutes
   of Health RO1AI110792 (E.W.) and 1R21AI126048 (Y.S.).
CR Amin MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202767
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   BROWN BA, 1979, VIROLOGY, V97, P396, DOI 10.1016/0042-6822(79)90350-7
   Carter JR, 2008, J GEN VIROL, V89, P3150, DOI 10.1099/vir.0.2008/003921-0
   Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536
   Chappell SA, 2004, P NATL ACAD SCI USA, V101, P9590, DOI 10.1073/pnas.0308759101
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   DORNER AJ, 1984, J VIROL, V50, P507, DOI 10.1128/JVI.50.2.507-514.1984
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Edgil D, 2003, VIROLOGY, V317, P275, DOI 10.1016/j.virol.2003.08.012
   Finkelstein Y, 1999, J BIOTECHNOL, V75, P33, DOI 10.1016/S0168-1656(99)00131-5
   GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417
   Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   MOLLA A, 1992, NATURE, V356, P255, DOI 10.1038/356255a0
   Nagarajan VK, 2013, BBA-GENE REGUL MECH, V1829, P590, DOI 10.1016/j.bbagrm.2013.03.005
   PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   PILIPENKO EV, 1992, CELL, V68, P119, DOI 10.1016/0092-8674(92)90211-T
   PILIPENKO EV, 1994, J MOL BIOL, V241, P398, DOI 10.1006/jmbi.1994.1516
   Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3
   Randall G, 2003, P NATL ACAD SCI USA, V100, P235, DOI 10.1073/pnas.0235524100
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   RICE C M, 1989, New Biologist, V1, P285
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112
   Shen SH, 2014, REV CELL BIOL MOL ME, P589
   SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0
   Song YT, 2012, J VIROL, V86, P1999, DOI 10.1128/JVI.05871-11
   Stauft CB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198303
   Svitkin YV, 2001, RNA, V7, P1743
   Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016
   Terenin IM, 2013, NUCLEIC ACIDS RES, V41, P1807, DOI 10.1093/nar/gks1282
   Trotman JB, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1504
   VANDERWERF S, 1986, P NATL ACAD SCI USA, V83, P2330
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Weingarten-Gabbay S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4939
   Wellensiek BP, 2013, NAT METHODS, V10, P747, DOI 10.1038/nmeth.2522
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000
   WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033
NR 46
TC 6
Z9 6
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2019
VL 10
IS 2
AR e00459-19
DI 10.1128/mBio.00459-19
PG 16
WC Microbiology
SC Microbiology
GA HU2CB
UT WOS:000465077600084
PM 30967466
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Castanha, PMS
   Souza, WV
   Braga, C
   de Araujo, TVB
   Ximenes, RAA
   Albuquerque, MDPM
   Montarroyos, UR
   Miranda, DB
   Cordeiro, MT
   Dhalia, R
   Marques, ETA
   Rodrigues, LC
   Martelli, CMT
   de Brito, CAA
   Batista, JDL
   Bezerra, LCA
   Rocha, MAW
   Carvalho, MDCG
   Silva, PFS
   Pastich, F
   Valongueiro, S
   Melo, AP
   Montarroyos, U
   Ramos, RCF
   Brandao, SP
AF Castanha, Priscila M. S.
   Souza, Wayner V.
   Braga, Cynthia
   Barreto de Araujo, Thalia Velho
   Ximenes, Ricardo A. A.
   Albuquerque, Maria de Fatima P. M.
   Montarroyos, Ulisses R.
   Miranda-Filho, Democrito B.
   Cordeiro, Marli T.
   Dhalia, Rafael
   Marques, Ernesto T. A., Jr.
   Rodrigues, Laura C.
   Martelli, Celina M. T.
   Antunes de Brito, Carlos Alexandre
   Lyra Batista, Joanna d'Arc
   Albuquerque Bezerra, Luciana Caroline
   Wanderley Rocha, Maria Angela
   Costa Gomes Carvalho, Maria Durce
   Sobral Silva, Paula Fabiana
   Pastich, Fabiana
   Valongueiro, Sandra
   Melo, Ana Paula
   Montarroyos, Ulisses
   Ferreira Ramos, Regina Coeli
   Brandao Filho, Sinval Pinto
CA Microcephaly Epidemic Res Grp
TI Perinatal analyses of Zika- and dengue virus-specific neutralizing
   antibodies: A microcephaly case-control study in an area of high dengue
   endemicity in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LOAD
AB Laboratory confirmation of Zika virus (ZIKV) infection during pregnancy is challenging due to cross-reactivity with dengue virus (DENV) and limited knowledge about the kinetics of anti-Zika antibody responses during pregnancy. We described ZIKV and DENV serological markers and the maternal-fetal transfer of antibodies among mothers and neonates after the ZIKV microcephaly outbreak in Northeast Brazil (2016). We included 89 microcephaly cases and 173 neonate controls at time of birth and their mothers. Microcephaly cases were defined as newborns with a particular head circumference (2 SD below the mean). Two controls without microcephaly were matched by the expected date of delivery and area of residence. We tested maternal serum for recent (ZIKV genome, IgM and IgG3 anti-NS1) and previous (ZIKV and DENV neutralizing antibodies [NAbs]) markers of infection. Multiple markers of recent or previous ZIKV and DENV infection in mothers were analyzed using principal component analysis (PCA). At delivery, 5.6% of microcephaly case mothers and 1.7% of control mothers were positive for ZIKV IgM. Positivity for ZIKV IgG3 anti-NS1 was 8.0% for case mothers and 3.5% for control mothers. ZIKV NAbs was slightly higher among mothers of cases (69.6%) than that of mothers of controls (57.2%; p = 0.054). DENV exposure was detected in 85.8% of all mothers. PCA discriminated two distinct components related to recent or previous ZIKV infection and DENV exposure. ZIKV NAbs were higher in newborns than in their corresponding mothers (p<0.001). We detected a high frequency of ZIKV exposure among mothers after the first wave of the ZIKV outbreak in Northeast Brazil. However, we found low sensitivity of the serological markers to recent infection (IgM and IgG3 anti-NS1) in perinatal samples of mothers of microcephaly cases. Since the neutralization test cannot precisely determine the time of infection, testing for ZIKV immune status should be performed as early as possible and throughout pregnancy to monitor acute Zika infection in endemic areas.
C1 [Castanha, Priscila M. S.; Souza, Wayner V.; Braga, Cynthia; Barreto de Araujo, Thalia Velho; Albuquerque, Maria de Fatima P. M.; Cordeiro, Marli T.; Dhalia, Rafael; Marques, Ernesto T. A., Jr.; Martelli, Celina M. T.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Castanha, Priscila M. S.; Ximenes, Ricardo A. A.; Montarroyos, Ulisses R.; Miranda-Filho, Democrito B.] Univ Pernambuco, Sch Med Sci, Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho; Ximenes, Ricardo A. A.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Martelli, CMT (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
EM turchicm@gmail.com
RI Marques, Ernesto T. A/L-4967-2013; Dhalia, Rafael/AAD-5432-2020;
   Montarroyos, Ulisses/AAJ-7527-2020; Souza, Wayner V/H-3798-2013; Braga,
   Maria Cynthia/A-8204-2013; CASTANHA, PRISCILA/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; CASTANHA, PRISCILA/0000-0002-1220-5308;
   Turchi Martelli, Celina Maria/0000-0002-2491-0688
FU Brazilian Ministry of Health, Pan American Health Organization,
   Enhancing Research Activity in Epidemic Situations; National Advisory
   Board of Scientific and Technological Development (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq])National Council for
   Scientific and Technological Development (CNPq) [306708/2014-0,
   308818/2013-0, 308590/2013-9, 308491/2013-0, 304174/2014-9,
   306222/2013-2]; European Union's Horizon 2020 research and innovation
   programme under Zika-PLAN [734584]; CuraZika
FX This study was funded by the Brazilian Ministry of Health, Pan American
   Health Organization, Enhancing Research Activity in Epidemic Situations.
   Some of the investigators received partial support from the National
   Advisory Board of Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq]; scholarship
   306708/2014-0 to CMTM, 308818/2013-0 to RAAX, 308590/2013-9 to DBM-F,
   308491/2013-0 to MFPMA, 304174/2014-9 to CB, and 306222/2013-2 to WVS).
   LCR is partly funded by the European Union's Horizon 2020 research and
   innovation programme under Zika-PLAN (grant agreement no. 734584). The
   study also received parcial support from CuraZika to ETAM. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brazilian Minister of Health, 2017, MONITORAMENTO DOS CA
   Brazilian Minister of Health, 2017, 57 BRAZ MIN HLTH
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pan American Health Organization, 2019, EP UPD YELL FEV 25 J
   Pan American Health Organization, 2018, EP REP BRAZ
   Pan American Health Organization, 2018, REG ZIK EP UPD AM
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Simmons G, 2018, CLIN INFECT DIS, V66, P1181, DOI 10.1093/cid/cix972
   SMFM Consult Series #39, 2016, J INFECT DIS, V214, pB9
   World Health Organization, 2018, ZIK VIR SIT REP
   World Health Organization, 2018, ZIK VIR FACT SHEET
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 46
TC 6
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007246
DI 10.1371/journal.pntd.0007246
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300043
PM 30856223
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dinnon, KH
   Gallichotte, EN
   Fritch, EJ
   Menachery, VD
   Baric, RS
AF Dinnon, Kenneth H., III
   Gallichotte, Emily N.
   Fritch, Ethan J.
   Menachery, Vineet D.
   Baric, Ralph S.
TI Shortening of Zika virus CD-loop reduces neurovirulence while preserving
   antigenicity
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ENVELOPE PROTEIN; MOUSE MODEL; GLYCOSYLATION; INFECTION; OUTBREAK;
   VACCINE; CELLS
AB Zika virus (ZIKV) is a mosquito-borne positive sense RNA virus. Recently, ZIKV emerged into the Western hemisphere as a human health threat, with severe disease associated with developmental and neurological complications. The structural envelope protein of ZIKV and other neurotropic flaviviruses contains an extended CD-loop relative to non-neurotropic flaviviruses, and has been shown to augment ZIKV stability and pathogenesis. Here we show that shortening the CD-loop in ZIKV attenuates the virus in mice, by reducing the ability to invade and replicate in the central nervous system. The CD-loop mutation was genetically stable following infection in mice, though secondary site mutations arise adjacent to the CD-loop. Importantly, while shortening of the CD-loop attenuates the virus, the CD-loop mutant maintains antigenicity in immunocompetent mice, eliciting an antibody response that similarly neutralizes both the mutant and wildtype ZIKV. These findings suggest that the extended CD-loop in ZIKV is a determinant of neurotropism and may be a target in live-attenuated vaccine design, for not only ZIKV, but for other neurotropic flaviviruses.
C1 [Dinnon, Kenneth H., III; Gallichotte, Emily N.; Fritch, Ethan J.; Menachery, Vineet D.; Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Menachery, Vineet D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.
RP Baric, RS (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.; Baric, RS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.
EM rbaric@email.unc.edu
OI Baric, Ralph/0000-0001-6827-8701; Menachery, Vineet/0000-0001-8803-7606;
   Dinnon, Kenneth/0000-0002-8942-1551
FU National Institutes of Allergy and Infectious Diseases (NIH NIAID) [U19
   AI107810, P01 AI106695];  [T32 AI007419]
FX This research was funded by U19 AI107810 and P01 AI106695 programs from
   National Institutes of Allergy and Infectious Diseases (NIH NIAID).
   Training grant funding T32 AI007419 supported KD and EG. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR [Anonymous], 2017, MBIO, V8, pS98
   [Anonymous], 2016, J TRAVEL MED, V23, pNP1
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Borawake K, 2011, INDIAN J CRIT CARE M, V15, P190, DOI 10.4103/0972-5229.84896
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Collins ND, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0566-9
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Gallichotte EN, 2017, J INFECT DIS, V216, P1196, DOI 10.1093/infdis/jix473
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   Johnson B.W., 2016, NEUROTROPIC VIRAL IN, V1, P229
   Khromava AY, 2005, VACCINE, V23, P3256, DOI 10.1016/j.vaccine.2005.01.089
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li J, 2006, J GEN VIROL, V87, P613, DOI 10.1099/vir.0.81320-0
   Luplertlop N, 2017, J VECTOR DIS, V54, P207, DOI 10.4103/0972-9062.217611
   Madi Deepak, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS70, DOI 10.12980/APJTB.4.2014C1006
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Xie X, 2017, MBIO, V8, P1
NR 38
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007212
DI 10.1371/journal.pntd.0007212
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300029
PM 30845254
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Naveca, FG
   Claro, I
   Giovanetti, M
   de Jesus, JG
   Xavier, J
   Iani, FCD
   do Nascimento, VA
   de Souza, VC
   Silveira, PP
   Lourenco, J
   Santillana, M
   Kraemer, MUG
   Quick, J
   Hill, SC
   Theze, J
   Carvalho, RDD
   Azevedo, V
   Salles, FCD
   Nunes, MRT
   Lemos, PD
   Candido, DD
   Pereira, GD
   Oliveira, MAA
   Meneses, CAR
   Maito, RM
   Cunha, CRS
   Campos, DPD
   Castilho, MD
   Siqueira, TCD
   Terra, TM
   de Albuquerque, CFC
   da Cruz, LN
   de Abreu, AL
   Martins, DV
   Simoes, DSDV
   de Aguiar, RS
   Luz, SLB
   Loman, N
   Pybus, OG
   Sabino, EC
   Okumoto, O
   Alcantara, LCJ
   Faria, NR
AF Naveca, Felipe Gomes
   Claro, Ingra
   Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   de Melo Iani, Felipe Campos
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Silveira, Paola Paz
   Lourenco, Jose
   Santillana, Mauricio
   Kraemer, Moritz U. G.
   Quick, Josh
   Hill, Sarah C.
   Theze, Julien
   de Oliveira Carvalho, Rodrigo Dias
   Azevedo, Vasco
   da Silva Salles, Flavia Cristina
   Teixeira Nunes, Marcio Roberto
   Lemos, Poliana da Silva
   Candido, Darlan da Silva
   Pereira, Glauco de Carvalho
   Assuncao Oliveira, Marluce Aparecida
   Ribeiro Meneses, Catia Alexandra
   Maito, Rodrigo Melo
   Santa Brigida Cunha, Claudeth Rocha
   de Sousa Campos, Daniela Palha
   Castilho, Marcia da Costa
   da Silva Siqueira, Thalita Caroline
   Terra, Tiza Matos
   Campelo de Albuquerque, Carlos F.
   da Cruz, Laura Nogueira
   de Abreu, Andre Luis
   Martins, Divino Valerio
   de Moraes Vanlume Simoes, Daniele Silva
   de Aguiar, Renato Santana
   Bessa Luz, Sergio Luiz
   Loman, Nicholas
   Pybus, Oliver G.
   Sabino, Ester C.
   Okumoto, Osnei
   Junior Alcantara, Luiz Carlos
   Faria, Nuno Rodrigues
TI Genomic, epidemiological and digital surveillance of Chikungunya virus
   in the Brazilian Amazon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MAYARO VIRUS; POPULATION-DYNAMICS; MATO-GROSSO; ZIKA VIRUS; OUTBREAK;
   INFERENCE; EMERGENCE; OROPOUCHE; DISEASE; ILLNESS
AB Background Since its first detection in the Caribbean in late 2013, chikungunya virus (CHIKV) has affected 51 countries in the Americas. The CHIKV epidemic in the Americas was caused by the CHIKV-Asian genotype. In August 2014, local transmission of the CHIKV-Asian genotype was detected in the Brazilian Amazon region. However, a distinct lineage, the CHIKV-East-Central-South-America (ECSA)-genotype, was detected nearly simultaneously in Feira de Santana, Bahia state, northeast Brazil. The genomic diversity and the dynamics of CHIKV in the Brazilian Amazon region remains poorly understood despite its importance to better understand the epidemiological spread and public health impact of CHIKV in the country.
   Methodology/Principal findings We report a large CHIKV outbreak (5,928 notified cases between August 2014 and August 2018) in Boa vista municipality, capital city of Roraima's state, located in the Brazilian Amazon region. We generated 20 novel CHIKV-ECSA genomes from the Brazilian Amazon region using MinION portable genome sequencing. Phylogenetic analyses revealed that despite an early introduction of the Asian genotype in 2015 in Roraima, the large CHIKV outbreak in 2017 in Boa Vista was caused by an ECSA-lineage most likely introduced from northeastern Brazil. Epidemiological analyses suggest a basic reproductive number of R-0 of 1.66, which translates in an estimated 39 (95% CI: 36 to 45) % of Roraima's population infected with CHIKV-ECSA. Finally, we find a strong association between Google search activity and the local laboratory-confirmed CHIKV cases in Roraima.
   Conclusions/Significance This study highlights the potential of combining traditional surveillance with portable genome sequencing technologies and digital epidemiology to inform public health surveillance in the Amazon region. Our data reveal a large CHIKV-ECSA outbreak in Boa Vista, limited potential for future CHIKV outbreaks, and indicate a replacement of the Asian genotype by the ECSA genotype in the Amazon region.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; de Souza, Victor Costa; Bessa Luz, Sergio Luiz] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; de Melo Iani, Felipe Campos; de Oliveira Carvalho, Rodrigo Dias; Azevedo, Vasco; Pereira, Glauco de Carvalho; Assuncao Oliveira, Marluce Aparecida; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [de Jesus, Jaqueline Goes; Xavier, Joilson] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [de Melo Iani, Felipe Campos] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Silveira, Paola Paz; de Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Lourenco, Jose; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
   [Santillana, Mauricio] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   [Santillana, Mauricio] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Quick, Josh; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Teixeira Nunes, Marcio Roberto; Lemos, Poliana da Silva] Brazilian Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Ribeiro Meneses, Catia Alexandra; Maito, Rodrigo Melo; Santa Brigida Cunha, Claudeth Rocha] Lab Cent Saude Publ, Boa Vista, Roraima, Brazil.
   [de Sousa Campos, Daniela Palha; da Silva Siqueira, Thalita Caroline] Secretaria Municipal Saude Boa Vista, Superintendencia Vigilancia Saude, Roraima, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tiza Matos] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [da Cruz, Laura Nogueira; de Abreu, Andre Luis; Martins, Divino Valerio; de Moraes Vanlume Simoes, Daniele Silva; Okumoto, Osnei] MS, SVS, Brasilia, DF, Brazil.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
EM luiz.alcantara@ioc.fiocruz.br; nuno.faria@zoo.ox.ac.uk
RI Aguiar, Renato S/G-3542-2015; Giovanetti, Marta/AAK-7408-2020; Sabino,
   Ester Cerdeira/F-7750-2010; Azevedo, Vasco A/B-1556-2019; Loman,
   Nicholas/Z-1573-2019; Pybus, Oliver g/B-2640-2012; Faria, Nuno
   Rodrigues/I-2975-2012
OI Aguiar, Renato S/0000-0001-5180-3717; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Pybus, Oliver g/0000-0002-8797-2667;
   Lourenco, Jose/0000-0002-9318-2581; Iani, Felipe/0000-0002-3629-8529;
   Luz, Sergio Luiz Bessa/0000-0001-5887-7372; Faria, Nuno
   Rodrigues/0000-0001-8839-2798; Hill, Sarah/0000-0002-2995-2596; da Silva
   Sales, Flavia Cristina/0000-0002-9048-0030; Souza, Victor Costa
   de/0000-0002-3869-1519; Nascimento, Valdinete/0000-0002-7786-4718;
   Alcantara, Luiz/0000-0002-6769-9931; Carvalho,
   Rodrigo/0000-0003-0216-7173; Xavier, Joilson/0000-0003-3916-2018
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [440685/2016-8, 440856/2016-7]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES [88887.130716/2016-00,
   88881.130825/2016-00, 88887.130823/2016-00]; EU's Horizon 2020 Programme
   through ZIKAlliance [PRES-005-FEX-17-4-2-33]; Royal SocietyRoyal Society
   of London; Wellcome Trust Sir Henry Dale Fellowship [204311/Z/16/Z];
   John Fell Research Fund [005166]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN]; National Institute of General Medical Sciences of
   the NIH (USA) [R01GM130668]; internal GCRF grant [005073]
FX The ZIBRA-2 project is funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant 440685/2016-8) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (grant
   88887.130716/2016-00). FGN is funded by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br, grant
   440856/2016-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (http://www.capes.gov.br, grants 88881.130825/2016-00 and
   88887.130823/2016-00). L.C.J.A. is supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant PRES-005-FEX-17-4-2-33). N.R.F. is
   funded by a Royal Society and Wellcome Trust Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN). MS was partially supported by the
   National Institute of General Medical Sciences of the NIH (USA) under
   award number R01GM130668. The funders had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR [Anonymous], 2015, PUBMED, V7, pe141
   [Anonymous], 2017, EMERGING INFECTIOUS, V23, ps6
   [Anonymous], 2015, PUBMED, V31, P43
   [Anonymous], 2016, PLOS CURRENTS OUTBRE, V39, pS1, DOI 10.2337/dc16-S001
   [Anonymous], 2015, PUBMED, V4, pA1
   [Anonymous], 2010, EURO SURVEILLANCE, V15, pe1936
   [Anonymous], 2016, PUBMED, V44, pD7
   [Anonymous], 2016, EVOLUTION, V2, pA49
   [Anonymous], 2016, PUBMED, V21, piii
   de Brito CAA, 2017, MEM I OSWALDO CRUZ, V112, P650, DOI 10.1590/0074-02760170124
   Aragao CF, 2018, ACTA TROP, V186, P1, DOI 10.1016/j.actatropica.2018.06.022
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrillo FB, 2019, J VIROL, V93, DOI 10.1128/JVI.01622-18
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   da Silva NM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300003, 10.5123/s1679-49742018000300003]
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860019, 10.1590/s1678-9946201860019]
   Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Freitas Andre Ricardo Ribas, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.14608e586cd321d8d5088652d7a0d884
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Lourenco Jose, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Figueiredo LTM, 2017, REV SOC BRAS MED TRO, V50, P583, DOI 10.1590/0037-8682-0397-2017
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Obolski U, 2018, MVSE R PACKAGE ESTIM, DOI [10.1101/360701, DOI 10.1101/360701]
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Organization PAWH, 2017, NUMB REP CAS CHIK FE
   Pauvolid-Correa A, 2015, MEM I OSWALDO CRUZ, V110, P125, DOI 10.1590/0074-02760140383
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Receveur M. C., 2010, EUROSURVEILLANCE, V15, P18
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Souza TM, 2017, PLOS CURRENTS, V9, DOI [10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727, DOI 10.1371/CURRENTS.OUTBREAKS.4200119978D62CCAA454599CD27357]
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Team RC, 2014, R LANG ENV COMP
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   VASCONCELOS PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 79
TC 8
Z9 8
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007065
DI 10.1371/journal.pntd.0007065
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300007
PM 30845267
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ryan, SJ
   Carlson, CJ
   Mordecai, EA
   Johnson, LR
AF Ryan, Sadie J.
   Carlson, Colin J.
   Mordecai, Erin A.
   Johnson, Leah R.
TI Global expansion and redistribution of Aedes-borne virus transmission
   risk with climate change
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE-FEVER; CHIKUNGUNYA VIRUS; ZIKA VIRUS; DISEASE; VECTOR;
   TEMPERATURE; POPULATION; AEGYPTI; MODELS; IMPACT
AB Forecasting the impacts of climate change on Aedes-borne virusesespecially dengue, chikungunya, and Zikais a key component of public health preparedness. We apply an empirically parameterized model of viral transmission by the vectors Aedes aegypti and Ae. albopictus, as a function of temperature, to predict cumulative monthly global transmission risk in current climates, and compare them with projected risk in 2050 and 2080 based on general circulation models (GCMs). Our results show that if mosquito range shifts track optimal temperature ranges for transmission (21.3-34.0 degrees C for Ae. aegypti; 19.9-29.4 degrees C for Ae. albopictus), we can expect poleward shifts in Aedes-borne virus distributions. However, the differing thermal niches of the two vectors produce different patterns of shifts under climate change. More severe climate change scenarios produce larger population exposures to transmission by Ae. aegypti, but not by Ae. albopictus in the most extreme cases. Climate-driven risk of transmission from both mosquitoes will increase substantially, even in the short term, for most of Europe. In contrast, significant reductions in climate suitability are expected for Ae. albopictus, most noticeably in southeast Asia and west Africa. Within the next century, nearly a billion people are threatened with new exposure to virus transmission by both Aedes spp. in the worst-case scenario. As major net losses in year-round transmission risk are predicted for Ae. albopictus, we project a global shift towards more seasonal risk across regions. Many other complicating factors (like mosquito range limits and viral evolution) exist, but overall our results indicate that while climate change will lead to increased net and new exposures to Aedes-borne viruses, the most extreme increases in Ae. albopictus transmission are predicted to occur at intermediate climate change scenarios.
C1 [Ryan, Sadie J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.
   [Carlson, Colin J.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA.
   [Carlson, Colin J.] Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD USA.
   [Mordecai, Erin A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA.
   [Johnson, Leah R.] Virginia Polytech & State Univ, Dept Stat, Blacksburg, VA USA.
RP Ryan, SJ (corresponding author), Univ Florida, Dept Geog, Gainesville, FL 32611 USA.; Ryan, SJ (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.; Ryan, SJ (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.
EM sjryan@ufl.edu
OI Ryan, Sadie/0000-0002-4308-6321; Johnson, Leah/0000-0002-9922-579X
FU National Science FoundationNational Science Foundation (NSF)
   [DEB-1518681, NSF DEB-1641145, DEB-1640780]; CDCCentre National de la
   Recherche Scientifique (CNRS)United States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
   [1U01CK000510-01]; Centers for Disease Control and PreventionUnited
   States Department of Health & Human ServicesCenters for Disease Control
   & Prevention - USA; Stanford Woods Institute for the Environment;
   Stanford Center for Innovation in Global Health
FX This work was funded by the National Science Foundation (DEB-1518681 to
   SJR, LRJ, EAM, NSF DEB-1641145 to SJR, and DEB-1640780 to EAM), and CDC
   grant 1U01CK000510-01: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: the Gateway Program, to SJR. This publication was
   supported by the Cooperative Agreement Number above from the Centers for
   Disease Control and Prevention. Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the Centers for Disease Control and Prevention.
   Support was also provided by the Stanford Woods Institute for the
   Environment
   (https://woods.stanford.edu/research/environmental-venture-projects),
   and the Stanford Center for Innovation in Global Health
   (http://globalhealth.stanford.edu/research/seed-grants.html).The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Acharya BK, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020187
   [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875
   [Anonymous], 2017, GLOB HEALTH, V2, pe115
   [Anonymous], 2015, PLOS CURR, V7, pe141
   [Anonymous], 2016, EURO SURVEILL BULL E, V21, piii
   Astrom C, 2012, ECOHEALTH, V9, P448, DOI 10.1007/s10393-012-0808-0
   Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Butterworth MK, 2017, ENVIRON HEALTH PERSP, V125, P579, DOI 10.1289/EHP218
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Carlson CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22989-0
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   CIESIN (Center for International Earth Science Information Network-Columbia University), 2016, GRIDD POP WORLD VERS
   Colon-Gonzalez FJ, 2018, P NATL ACAD SCI USA, V115, P6243, DOI 10.1073/pnas.1718945115
   Equihua M, 2017, ACTA TROP, V166, P316, DOI 10.1016/j.actatropica.2016.11.014
   Escobar LE, 2016, SCI REP, P6, DOI [10. 1038/s41598-016-0015-2, DOI 10.1038/S41598-016-0015-2]
   Evans MV, 2018, TRENDS PARASITOL
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Flage R, 2015, RELIAB ENG SYST SAFE, V144, P61, DOI 10.1016/j.ress.2015.07.008
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Getz WM, 2018, ECOL LETT, V21, P153, DOI 10.1111/ele.12893
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2010, VECTOR BIOLOGY, ECOLOGY AND CONTROL, P39, DOI 10.1007/978-90-481-2458-9_4
   Hagel K, 2017, PALGR COMMUN, V3, DOI 10.1057/palcomms.2017.27
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hoberg EP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0553
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Ibelings BW, 2011, FRESHWATER BIOL, V56, P754, DOI 10.1111/j.1365-2427.2010.02565.x
   Johnson LR, 2015, ECOLOGY, V96, P203, DOI 10.1890/13-1964.1
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2
   Lowe R, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002613
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Moran AE, 2012, GLOB HEART, V7, P315, DOI 10.1016/j.gheart.2012.10.004
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322
   Musso D, 2018, LANCET INFECT DIS
   Ng V, 2017, ENV HLTH PERSPECT, P125
   O'Neill BC, 2018, CLIMATIC CHANGE, V146, P287, DOI 10.1007/s10584-017-2009-x
   Olival KJ, 2017, ECOHEALTH, V14, P1, DOI 10.1007/s10393-017-1220-6
   Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petchey OL, 2015, ECOL LETT, V18, P597, DOI 10.1111/ele.12443
   Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6
   Riou J, 2017, EPIDEMICS
   Ross N., FASTERIZE HIGH PERFO
   Ryan SJ, 2015, VECTOR-BORNE ZOONOT, V15, P718, DOI 10.1089/vbz.2015.1822
   Ryan SJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00094.1
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Shocket MS, 2018, ELIFE, V7, DOI 10.7554/eLife.37762
   Sissoko D, 2010, TROP MED INT HEALTH, V15, P600, DOI 10.1111/j.1365-3156.2010.02485.x
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Tjaden NB, 2017, TRENDS PARASITOL
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V201018344
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 82
TC 34
Z9 34
U1 17
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007213
DI 10.1371/journal.pntd.0007213
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300030
PM 30921321
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ogasawara, N
   Misaki, M
   Adachi, S
AF Ogasawara, Nao
   Misaki, Masafumi
   Adachi, Satoshi
TI Method for the determination of residual formaldehyde in an inactivated
   Zika vaccine formulated with aluminum hydroxide gel
SO BIOLOGICALS
LA English
DT Article
ID MINERAL-WATER
AB A simple method for the determination of low levels of residual formaldehyde in an inactivated Zika vaccine formulated with aluminum hydroxide gel was developed for the assessment of drug product quality. Formaldehyde was reacted with 2,4-dinitrophenylhydrazine (DNPH) and the derivatized product was detected by HPLC with an UV detector at 360 nm. The derivatization reaction could be carried out in a 2-mL HPLC vial and the sample was analyzed directly. The method was fully validated according to the International Conference on Harmonization Q2 guidelines. Aluminum hydroxide gel up to 1.0 mg/mL (aluminum concentration) did not interfere with the determination of formaldehyde in drug product. Formaldehyde concentrations of 0.05 mu g/mL (quantitation limit) to 1.00 mu g/mL in the Zika vaccine could be precisely determined. Hence, this method proved to be suitable for quality control of the Zika vaccine.
C1 [Ogasawara, Nao; Misaki, Masafumi; Adachi, Satoshi] Takeda Pharmaceut Co Ltd, Global Vaccine Business Unit, Prod Operat, Japan CMC, 4720 Takeda, Yamaguchi 7438502, Japan.
RP Ogasawara, N (corresponding author), Takeda Pharmaceut Co Ltd, Global Vaccine Business Unit, Prod Operat, Japan CMC, 4720 Takeda, Yamaguchi 7438502, Japan.
EM nao.ogasawara@takeda.com
FU Federal funds from the Department of Health and Human Services; Office
   of the Assistant Secretary for Preparedness and Response; Biomedical
   Advanced Research and Development Authority [HHSO100201600015C]
FX Zika vaccine project has been funded with Federal funds from the
   Department of Health and Human Services; Office of the Assistant
   Secretary for Preparedness and Response; Biomedical Advanced Research
   and Development Authority, under Contract No. HHSO100201600015C.
CR COHEN HP, 1993, J LIQ CHROMATOGR, V16, P1667, DOI 10.1080/10826079308021680
   Dabrowska A, 2003, FOOD ADDIT CONTAM A, V20, P1170, DOI 10.1080/02652030310001620441
   Gudlavalleti SK, 2015, J PHARMACEUT BIOMED, V107, P432, DOI 10.1016/j.jpba.2015.01.034
   ICH (International conference on harmonisation), 2005, HARM TRIP GUID Q2 VA
   Kobayashi N., 2016, Journal of Japan Society on Water Environment, V39, P211, DOI 10.2965/jswe.39.211
   Ministry of Health Labor and Welfare JAPAN, OFF QUAL CONTR METH
   Mutsuga M, 2006, FOOD ADDIT CONTAM A, V23, P212, DOI 10.1080/02652030500398361
   Uchiyama S, 2011, J CHROMATOGR B, V879, P1282, DOI 10.1016/j.jchromb.2010.09.028
   Vogel M, 2000, FRESEN J ANAL CHEM, V366, P781, DOI 10.1007/s002160051572
NR 9
TC 0
Z9 0
U1 0
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1045-1056
EI 1095-8320
J9 BIOLOGICALS
JI Biologicals
PD MAR
PY 2019
VL 58
BP 73
EP 75
DI 10.1016/j.biologicals.2018.12.001
PG 3
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
GA HR7DL
UT WOS:000463312000011
PM 30660437
DA 2020-07-08
ER

PT J
AU Cruz-Pacheco, G
   Esteva, L
   Ferreira, CP
AF Cruz-Pacheco, Gustavo
   Esteva, Lourdes
   Ferreira, Claudia Pio
TI A MATHEMATICAL ANALYSIS OF ZIKA VIRUS EPIDEMIC IN RIO DE JANEIRO AS A
   VECTOR-BORNE AND SEXUALLY TRANSMITTED DISEASE
SO JOURNAL OF BIOLOGICAL SYSTEMS
LA English
DT Article
DE Basic Reproductive Number; Sensitivity Analysis; Ordinary Differential
   Equations
ID BASIC REPRODUCTION NUMBER; SENSITIVITY-ANALYSIS; TRANSMISSION; DYNAMICS;
   MATRICES; WOMEN
AB In this work we formulate a mathematical model to assess the importance of sexual transmission during the Zika virus outbreak that occurred in Rio de Janeiro, Brazil, in 2015. To this end, we deduce from the model an analytical expression of the basic reproduction number of Zika, R-0, in terms of the vectorial and sexual transmissions, and we use the estimations given in Ref. 1 [Villela DAM, Bastos LS, de Carvalho LM, Cruz OG, Gomes MFC, Durovni B, Lemos MC, Saraceni V, Coelho FC, Codeco CT, Zika in Rio de Janeiro: Assessment of basic reproduction number and comparison with dengue outbreaks, Epidemiol Infect 145(8): 1649-1657, 2017] for the R-0 values of Zika virus and dengue virus epidemics in Rio de Janeiro to evaluate the contribution of sexual transmission of Zika virus. According to the obtained results, sexual transmission (pure plus mediated by vector transmission) contributes from 23% to 46% for the R-0 increment. Also, an asymmetric sexual transmission between men and women can explain the fact that the incidence of Zika virus in women was 60% higher than in man during the 2015 epidemics. We also carry out a sensitivity analysis using R-0 as the output parameter. The results of this analysis have shown that the transmission rate between human and mosquito populations, the mosquito mortality rate, and the human infectious period are the parameters that contribute more to the R-0 variation, highlighting the importance of vector control to halt disease transmission.
C1 [Cruz-Pacheco, Gustavo] UNAM, IIMAS, Ciudad Univ, Ciudad De Mexico 04510, Mexico.
   [Esteva, Lourdes] UNAM, Fac Ciencias, Ciudad Univ, Ciudad De Mexico 04510, Mexico.
   [Ferreira, Claudia Pio] Sao Paulo State Univ UNESP, Inst Biosci, Dept Biostat, BR-18618689 Botucatu, SP, Brazil.
RP Ferreira, CP (corresponding author), Sao Paulo State Univ UNESP, Inst Biosci, Dept Biostat, BR-18618689 Botucatu, SP, Brazil.
EM cruz@mym.iimas.unam.mx; lesteva@ciencias.unam.mx; claudia.pio@unesp.br
RI ferreira, claudia P/C-8016-2012
OI ferreira, claudia P/0000-0002-9404-6098
FU PAPIIT-UNAMPrograma de Apoyo a Proyectos de Investigacion e Innovacion
   Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IN113716];
   Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [16/23738-3]
FX Lourdes Esteva acknowledges the support of Projects IN113716
   PAPIIT-UNAM. Claudia Pio Ferreira expresses her thanks to the Grant
   16/23738-3 from Sao Paulo Research Foundation (FAPESP). We also want to
   thank the two anonymous referees for their careful reading that helped
   us to improve the manuscript.
CR Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Allard A, 2017, P NATL ACAD SCI USA, V114, P8969, DOI 10.1073/pnas.1703073114
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Burchell AN, 2011, J INFECT DIS, V204, P1723, DOI 10.1093/infdis/jir644
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Diekmann O., 2000, WILEY SERIES MATH CO
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Esteva-Peralta L, 2002, MATH COMPUT MODEL, V36, P491, DOI 10.1016/S0895-7177(02)00178-4
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Gubler DJ, 1986, ARBOVIRUS EPIDEMIOLO, VII, P213
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   HOOPER RR, 1978, AM J EPIDEMIOL, V108, P136, DOI 10.1093/oxfordjournals.aje.a112597
   Hyun Mo Yang, 2015, Applied Mathematics and Computation, V265, P103, DOI 10.1016/j.amc.2015.04.112
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization (PAHO), 2018, TIM EM ZIK VIR AM
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pereira-Silva JW, 2018, MEM I OSWALDO CRUZ, V113, P56, DOI 10.1590/0074-02760170329
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d
   Saltelli A, 2004, SENSITIVITY ANAL PRA
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Villela DAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123794
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   World Health Organization (WHO), 2016, WORD KEY MESS ZIK VI
   Yang HM, 2014, BIOSYSTEMS, V126, P52, DOI 10.1016/j.biosystems.2014.10.002
NR 42
TC 2
Z9 2
U1 0
U2 3
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-3390
EI 1793-6470
J9 J BIOL SYST
JI J. Biol. Syst.
PD MAR
PY 2019
VL 27
IS 1
BP 83
EP 105
DI 10.1142/S0218339019500050
PG 23
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA HS3FU
UT WOS:000463749100005
DA 2020-07-08
ER

PT J
AU Deng, SQ
   Huang, Q
   Wei, HX
   Zhou, LJ
   Yao, LJ
   Li, DL
   Wu, SZ
   Chen, JT
   Peng, HJ
AF Deng, Shengqun
   Huang, Qiang
   Wei, Haixia
   Zhou, Lijuan
   Yao, Lijie
   Li, Dongliang
   Wu, Shuizhen
   Chen, Jiating
   Peng, Hongjuan
TI Beauveria bassiana infection reduces the vectorial capacity of Aedes
   albopictus for the Zika virus
SO JOURNAL OF PEST SCIENCE
LA English
DT Article
DE Beauveria bassiana; Aedes albopictus; Zika virus; Vectorial capacity;
   Vector competence; Mosquito control
ID METARHIZIUM-ANISOPLIAE; DIPTERA-CULICIDAE; AE.-ALBOPICTUS; AEGYPTI;
   OUTBREAK; HISTORY; COMPETENCE; VIRULENCE; FECUNDITY; PROSPECTS
AB Zika virus (ZIKV), a mosquito-borne flavivirus, poses a serious threat to public health worldwide, and Aedes albopictus is one of its vectors. To evaluate the potential of the entomopathogenic fungus Beauveria bassiana for ZIKV vector control, we compared the vectorial capacity of Ae. albopictus females blood-fed with ZIKV with or without exposure to Beauveria bassiana. We found that fungal infection significantly decreased the amount of ZIKV by 3.6-, 12.3- and 7.8-fold in mosquito midguts, heads and salivary glands, respectively. Similarly, fungal infection also reduced the rates of ZIKV dissemination, potential transmission and potential population transmission for mosquitoes by 26.8%, 38.4% and 35.2%, respectively. On the other hand, the median survival time and fecundity of fungus-infected mosquitoes were reduced by 84.2% and 39.8% in comparison with those of the non-fungus-infected mosquitoes. The first gonotrophic cycle length was increased by 15.3% because of fungal infection. This study revealed that B. bassiana infection significantly reduced the vectorial capacity of A. albopictus for ZIKV, which suggested that B. bassiana could be broadly and efficiently used in the field for the control of Zika vectors.
C1 [Deng, Shengqun; Huang, Qiang; Wei, Haixia; Zhou, Lijuan; Yao, Lijie; Li, Dongliang; Wu, Shuizhen; Chen, Jiating; Peng, Hongjuan] Southern Med Univ, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.
RP Peng, HJ (corresponding author), Southern Med Univ, Dept Pathogen Biol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.
EM floriapeng@hotmail.com
FU National Key R&D Program of China [2017YFD0500400]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [81772217, 20180907, 81572012]; Guangdong Provincial Natural Science
   Foundation Project [2016A030311025, 2017A030313694]; Science and
   Technology Planning Project of Guangdong Province [2018A050506038];
   Guangzhou health and medical collaborative innovation major special
   project [201604020011]
FX We thank Dr. Changwen Ke for kindly providing Zika virus strain Z16006
   to conduct this study. This research was supported by National Key R&D
   Program of China (2017YFD0500400), National Natural Science Foundation
   of China (81772217, 20180907, 81572012), Guangdong Provincial Natural
   Science Foundation Project (2016A030311025, 2017A030313694), Science and
   Technology Planning Project of Guangdong Province (2018A050506038) and
   Guangzhou health and medical collaborative innovation major special
   project (201604020011) to HJP.
CR Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Baronti C, 2014, GENOME ANNOUNC
   Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bukhari T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-23
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2018, WORLD MAP AR RISK ZI
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   CLARK TB, 1968, J INVERTEBR PATHOL, V11, P1, DOI 10.1016/0022-2011(68)90047-5
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   de Paula AR, 2008, BIOCONTROL SCI TECHN, V18, P1017, DOI 10.1080/09583150802509199
   Deng SQ, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0422-1
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Padilla-Guerrero IE, 2011, MICROBIOL-SGM, V157, P199, DOI 10.1099/mic.0.042697-0
   Fang WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043069
   Farenhorst M, 2008, AM J TROP MED HYG, V78, P910, DOI 10.4269/ajtmh.2008.78.910
   Farenhorst M, 2011, J MED ENTOMOL, V48, P305, DOI 10.1603/ME10134
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Garza-Hernandez JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002013
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guzzetta G, 2016, EURO SURVEILL
   Hurd H, 2001, TRENDS PARASITOL, V17, P363, DOI 10.1016/S1471-4922(01)01927-4
   Hurd H, 2009, ADV PARASIT, V68, P85, DOI 10.1016/S0065-308X(08)00604-0
   Jaronski ST, 2010, BIOCONTROL, V55, P159, DOI 10.1007/s10526-009-9248-3
   Kamareddine L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-22
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Knols BGJ, 2010, FUTURE MICROBIOL, V5, P339, DOI 10.2217/FMB.10.11
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leta S, 2017, INT J INFECT DIS
   Li YJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2581-y
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lord JC, 2005, J INVERTEBR PATHOL, V89, P19, DOI 10.1016/j.jip.2005.04.006
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pal S, 2007, J BIOL CHEM, V282, P8969, DOI 10.1074/jbc.M605927200
   Paula AR, 2013, LETT APPL MICROBIOL, V57, P157, DOI 10.1111/lam.12090
   Paula AR, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-256
   Pedrini N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00024
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rath A, 2017, PEST MANAG SCI INDIA
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Toopaang W, 2017, FUNGAL BIOL-UK, V121, P664, DOI 10.1016/j.funbio.2017.04.007
   Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wei G, 2017, P NATL ACAD SCI USA, V114, P5994, DOI 10.1073/pnas.1703546114
   Zhang MC, 2010, AM J TROP MED HYG, V83, P700, DOI 10.4269/ajtmh.2010.10-0193
NR 52
TC 4
Z9 5
U1 3
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1612-4758
EI 1612-4766
J9 J PEST SCI
JI J. Pest Sci.
PD MAR
PY 2019
VL 92
IS 2
BP 781
EP 789
DI 10.1007/s10340-019-01081-0
PG 9
WC Entomology
SC Entomology
GA HR4VY
UT WOS:000463146700035
DA 2020-07-08
ER

PT J
AU Pavela, R
   Pavoni, L
   Bonacucina, G
   Cespi, M
   Kavallieratos, NG
   Cappellacci, L
   Petrelli, R
   Maggi, F
   Benelli, G
AF Pavela, Roman
   Pavoni, Lucia
   Bonacucina, Giulia
   Cespi, Marco
   Kavallieratos, Nickolas G.
   Cappellacci, Loredana
   Petrelli, Riccardo
   Maggi, Filippo
   Benelli, Giovanni
TI Rationale for developing novel mosquito larvicides based on
   isofuranodiene microemulsions
SO JOURNAL OF PEST SCIENCE
LA English
DT Article
DE Culex quinquefasciatus; Eco-friendly pesticides; Essential oil;
   Filariasis; Non-target organisms; Smyrnium olusatrum; Sublethal
   toxicity; Zika virus vector
ID SMYRNIUM-OLUSATRUM L.; APIACEAE ESSENTIAL OILS; CULEX-QUINQUEFASCIATUS
   SAY; INSECTICIDE RESISTANCE; SECONDARY METABOLITES;
   TITHONIA-DIVERSIFOLIA; BIOLOGICAL-ACTIVITY; TOXICITY; AEDES;
   NANOEMULSION
AB Isofuranodiene is a bioactive furanosesquiterpene occurring as the major volatile compound in the essential oil from Smyrnium olusatrum (Apiaceae). It has a notable potentiality to be used as a botanical insecticide. However, its low solubility together with susceptibility to oxidation and thermal degradation limits its application on a wide scale. To face these challenges, isofuranodiene was encapsulated in stable microemulsions (MEs) at two concentrations (ME 750: 0.75%, ME 375: 0.375%). We assessed the larvicidal activity in the short term and after several days of exposure of pure isofuranodiene and its MEs against the filariasis vector Culex quinquefasciatus. The impact of ME-based larvicide at sublethal concentrations on adult emergence was evaluated. Finally, to shed light on potential ecotoxicology risks for nontarget invertebrates, MEs were tested on the aquatic microcrustacean Daphnia magna and on the earthworm Eisenia fetida. Pure isofuranodiene and S. olusatrum leaf essential oil, used as controls, showed their potential as mosquito larvicidal agents (LC50 of 29.2 and 18.6LL(-1), respectively). Isofuranodiene formulated in ME 750 was effective against C. quinquefasciatus larvae, leading to significant larval mortality over time and a marked decrease in adult emergence. Both isofuranodiene MEs showed little impact on the nontarget aquatic microcrustacean Daphnia magna (ME 750 and ME 375: mortality <19% after 48h of exposure at 32mL L-1 and 20mL L-1, respectively) as well as on earthworms (ME 750 and ME 375: no mortality and mortality <7% after 14days of exposure to 1000mgkg(-1), respectively), outlining their potential employ in vector control operations.
C1 [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106 6, Czech Republic.
   [Pavela, Roman] Czech Univ Life Sci Prague, Dept Plant Protect, Kamycka 129, Prague 16500 6, Czech Republic.
   [Pavoni, Lucia; Bonacucina, Giulia; Cespi, Marco; Cappellacci, Loredana; Petrelli, Riccardo; Maggi, Filippo] Univ Camerino, Sch Pharm, I-62032 Camerino, Italy.
   [Kavallieratos, Nickolas G.] Agr Univ Athens, Dept Crop Sci, Lab Agr Zool & Entomol, 75 Iera Odos Str, Athens, Greece.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM giovanni.benelli@unipi.it
RI Pavela, Roman/Q-8647-2016; Kavallieratos, Nickolas G./AAH-4066-2019
OI Kavallieratos, Nickolas/0000-0001-5851-5013; Pavela,
   Roman/0000-0001-7866-4278; Kavallieratos, Nickolas/0000-0003-4342-1289
FU Ministry of Agriculture of the Czech RepublicMinistry of Agriculture,
   Czech Republic [MZE-RO0418]
FX Roman Pavela would like to thank the Ministry of Agriculture of the
   Czech Republic for its financial support concerning botanical pesticides
   and basic substances research (Project MZE-RO0418).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Afshar FH, 2017, IND CROP PROD, V98, P46, DOI 10.1016/j.indcrop.2017.01.004
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   ARNASON JT, 1985, J NAT PROD, V48, P581, DOI 10.1021/np50040a010
   BALDOVINI N, 1959, PHYTOCHEM ANALYSIS, V12, P58, DOI DOI 10.1002/1099-1565(200101/02)12:1
   Barata C, 2006, AQUAT TOXICOL, V78, P1, DOI 10.1016/j.aquatox.2006.01.013
   Barata C, 2004, AQUAT TOXICOL, V66, P125, DOI 10.1016/j.aquatox.2003.07.004
   Benelli G, 2018, J PEST SCI
   Benelli G, 2018, SAUDI J BIOL SCI
   Benelli G, 2018, IND CROP PROD, V122, P308, DOI 10.1016/j.indcrop.2018.05.032
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, IND CROP PROD, V112, P668, DOI 10.1016/j.indcrop.2017.12.062
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J PEST SCI, V90, P693, DOI 10.1007/s10340-016-0829-5
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Brinkkemper O, 2015, VEG HIST ARCHAEOBOT, V24, P249, DOI 10.1007/s00334-014-0471-1
   Brunetti A, 2019, PHYTOMEDICINE, V52, P51, DOI 10.1016/j.phymed.2018.09.220
   CARTE B, 1986, J ORG CHEM, V51, P3528, DOI 10.1021/jo00368a025
   Cespi M, 2017, FLAVOUR FRAG J, V32, P159, DOI 10.1002/ffj.3367
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P465, DOI 10.1016/j.biortech.2007.11.060
   Date AA, 2008, INT J PHARMACEUT, V355, P19, DOI 10.1016/j.ijpharm.2008.01.004
   Dekebo A, 2002, FITOTERAPIA, V73, P48, DOI 10.1016/S0367-326X(01)00367-7
   Duarte JL, 2015, REV BRAS FARMACOGN, V25, P189, DOI [10.1016/j.bjp.2015.02.2010, 10.1016/j.bjp.2015.02.010]
   Fabbri J, 2018, ACTA TROP, V187, P5, DOI 10.1016/j.actatropica.2018.07.013
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Garcia G, 2017, J ESSENT OIL RES, V29, P214, DOI 10.1080/10412905.2016.1251982
   Ghosh V, 2013, ASIAN J CHEM, V25, pS321
   Giordano G, 2017, P NATL ACAD SCI USA, V114, P3451, DOI 10.1073/pnas.1614655114
   GRODE SH, 1984, J NAT PROD, V47, P76, DOI 10.1021/np50031a009
   Guillet G, 2000, PHOTOCHEM PHOTOBIOL, V71, P111, DOI 10.1562/0031-8655(2000)071&lt;0111:SIPSIM&gt;2.0.CO;2
   Hashem AS, 2018, ENVIRON SCI POLLUT R, V25, P18802, DOI 10.1007/s11356-018-2068-1
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1
   Hernando MD, 2003, WATER RES, V37, P4091, DOI 10.1016/S0043-1354(03)00348-8
   Isman MB, 2015, PEST MANAG SCI, V71, P1587, DOI 10.1002/ps.4088
   Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005
   Isman MB, 2011, PHYTOCHEM REV, V10, P197, DOI 10.1007/s11101-010-9170-4
   Jankowska M, 2018, MOLECULES, V23, DOI 10.3390/molecules23010034
   KAWABATA J, 1981, AGR BIOL CHEM TOKYO, V45, P1447, DOI 10.1080/00021369.1981.10864706
   Li WP, 2016, NAT PROD RES, V30, P1162, DOI 10.1080/14786419.2015.1041139
   Li ZH, 2010, MOLECULES, V15, P8933, DOI 10.3390/molecules15128933
   Maggi F, 2017, FITOTERAPIA, V117, P52, DOI 10.1016/j.fitote.2016.12.009
   Maggi F, 2015, FLAVOUR FRAG J, V30, P139, DOI 10.1002/ffj.3221
   Maggi F, 2012, FOOD CHEM, V135, P2852, DOI 10.1016/j.foodchem.2012.07.027
   McPhail KL, 2001, J NAT PROD, V64, P1183, DOI 10.1021/np010085x
   Mollo E, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00092
   Mustafa AM, 2016, FOOD CHEM, V192, P782, DOI 10.1016/j.foodchem.2015.07.079
   Nuchuchua O, 2009, AAPS PHARMSCITECH, V10, P1234, DOI 10.1208/s12249-009-9323-1
   Orsomando G, 2016, IND CROP PROD, V85, P181, DOI 10.1016/j.indcrop.2016.03.003
   Pavela R, 2019, IND CROP PROD, V129, P631, DOI 10.1016/j.indcrop.2018.11.073
   Pavela R, 2018, ENVIRON SCI POLLUT R, V25, P10904, DOI 10.1007/s11356-018-1398-3
   Pavela R, 2017, IND CROP PROD, V109, P603, DOI 10.1016/j.indcrop.2017.09.013
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Petrelli R, 2017, PARASITOL INT, V66, P146, DOI 10.1016/j.parint.2017.01.001
   Quassinti L, 2014, FITOTERAPIA, V97, P133, DOI 10.1016/j.fitote.2014.06.004
   Quassinti L, 2013, FOOD CHEM, V138, P808, DOI 10.1016/j.foodchem.2012.11.075
   Randall RE, 2003, J ECOL, V91, P325, DOI 10.1046/j.1365-2745.2003.00761.x
   Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781
   Sakulku U, 2009, INT J PHARMACEUT, V372, P105, DOI 10.1016/j.ijpharm.2008.12.029
   Setzer WN, 2008, J MOL MODEL, V14, P335, DOI 10.1007/s00894-008-0274-3
   Song SL, 2009, COLLOID SURFACE A, V350, P57, DOI 10.1016/j.colsurfa.2009.08.034
   Sugumar S, 2014, B ENTOMOL RES, V104, P393, DOI 10.1017/S0007485313000710
   Sut S, 2018, FITOTERAPIA, V124, P145, DOI 10.1016/j.fitote.2017.11.002
   Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023
   Talegaonkar Sushama, 2008, Recent Pat Drug Deliv Formul, V2, P238
   US EPA, 2012, EST PROGR INT SUIT M
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Vasantha-Srinivasan P, 2018, ENVIRON SCI POLLUT R, V25, P10371, DOI 10.1007/s11356-017-9236-6
   Venditti A, 2014, CHEM BIODIVERS, V11, P245, DOI 10.1002/cbdv.201300253
   WHO, 1996, CTDWHOPESIC961
NR 79
TC 19
Z9 19
U1 9
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1612-4758
EI 1612-4766
J9 J PEST SCI
JI J. Pest Sci.
PD MAR
PY 2019
VL 92
IS 2
BP 909
EP 921
DI 10.1007/s10340-018-01076-3
PG 13
WC Entomology
SC Entomology
GA HR4VY
UT WOS:000463146700045
DA 2020-07-08
ER

PT J
AU Brady, OJ
   Osgood-Zimmerman, A
   Kassebaum, NJ
   Ray, SE
   de Araujo, VEM
   da Nobrega, AA
   Frutuoso, LCV
   Lecca, RCR
   Stevens, A
   de Oliveira, BZ
   de Lima, JM
   Bogoch, II
   Mayaud, P
   Jaenisch, T
   Mokdad, AH
   Murray, CJL
   Hay, SI
   Reiner, RC
   Marinho, F
AF Brady, Oliver J.
   Osgood-Zimmerman, Aaron
   Kassebaum, Nicholas J.
   Ray, Sarah E.
   de Araujo, Valdelaine E. M.
   da Nobrega, Aglaer A.
   Frutuoso, Livia C. V.
   Lecca, Roberto C. R.
   Stevens, Antony
   de Oliveira, Bruno Zoca
   de Lima, Jose M., Jr.
   Bogoch, Isaac I.
   Mayaud, Philippe
   Jaenisch, Thomas
   Mokdad, Ali H.
   Murray, Christopher J. L.
   Hay, Simon I.
   Reiner, Robert C.
   Marinho, Fatima
TI The association between Zika virus infection and microcephaly in Brazil
   2015-2017: An observational analysis of over 4 million births
SO PLOS MEDICINE
LA English
DT Article
ID DEFECTS; PREVALENCE; TRANSMISSION; PREGNANCY; WOMEN
AB Background In 2015, high rates of microcephaly were reported in Northeast Brazil following the first South American Zika virus (ZIKV) outbreak. Reported microcephaly rates in other Zika-affected areas were significantly lower, suggesting alternate causes or the involvement of arboviral cofactors in exacerbating microcephaly rates.
   Methods and findings We merged data from multiple national reporting databases in Brazil to estimate exposure to 9 known or hypothesized causes of microcephaly for every pregnancy nationwide since the beginning of the ZIKV outbreak; this generated between 3.6 and 5.4 million cases (depending on analysis) over the time period 1 January 2015-23 May 2017. The association between ZIKV and microcephaly was statistically tested against models with alternative causes or with effect modifiers. We found no evidence for alternative non-ZIKV causes of the 2015-2017 microcephaly outbreak, nor that concurrent exposure to arbovirus infection or vaccination modified risk. We estimate an absolute risk of microcephaly of 40.8 (95% CI 34.2-49.3) per 10,000 births and a relative risk of 16.8 (95% CI 3.2-369.1) given ZIKV infection in the first or second trimester of pregnancy; however, because ZIKV infection rates were highly variable, most pregnant women in Brazil during the ZIKV outbreak will have been subject to lower risk levels. Statistically significant associations of ZIKV with other birth defects were also detected, but at lower relative risks than that of microcephaly (relative risk < 1.5). Our analysis was limited by missing data prior to the establishment of nationwide ZIKV surveillance, and its findings may be affected by unmeasured confounding causes of microcephaly not available in routinely collected surveillance data.
   Conclusions This study strengthens the evidence that congenital ZIKV infection, particularly in the first 2 trimesters of pregnancy, is associated with microcephaly and less frequently with other birth defects. The finding of no alternative causes for geographic differences in microcephaly rate leads us to hypothesize that the Northeast region was disproportionately affected by this Zika outbreak, with 94% of an estimated 8.5 million total cases occurring in this region, suggesting a need for seroprevalence surveys to determine the underlying reason.
C1 [Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Osgood-Zimmerman, Aaron; Kassebaum, Nicholas J.; Ray, Sarah E.; Mokdad, Ali H.; Hay, Simon I.; Reiner, Robert C.; Marinho, Fatima] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Kassebaum, Nicholas J.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.
   [de Araujo, Valdelaine E. M.; da Nobrega, Aglaer A.; Frutuoso, Livia C. V.; Lecca, Roberto C. R.; Stevens, Antony; de Oliveira, Bruno Zoca; de Lima, Jose M., Jr.; Marinho, Fatima] Minist Hlth Brazil, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Bogoch, Isaac I.] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada.
   [Mayaud, Philippe] London Sch Hyg & Trop Med, Dept Clin Res, London, England.
   [Jaenisch, Thomas] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
RP Brady, OJ (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.; Marinho, F (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.; Marinho, F (corresponding author), Minist Hlth Brazil, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
EM oliver.brady@lshtm.ac.uk; mfmsouza@gmail.com
RI Hay, Simon I/F-8967-2015
OI Hay, Simon I/0000-0002-0611-7272; Ray, Sarah/0000-0002-5775-8344; Vinhal
   Frutuoso, Livia Carla/0000-0001-7926-1075
FU European UnionEuropean Union (EU) [734548]; Sir Henry Wellcome
   Fellowship - Wellcome TrustWellcome Trust [206471/Z/17/Z]; Bill and
   Melinda Gates FoundationGates Foundation [OP1183567, OPP1132415,
   OPP1093011, OPP1159934, OPP1176062]
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme under ZIKAlliance Grant Agreement no.
   734548. OJB was funded by a Sir Henry Wellcome Fellowship funded by the
   Wellcome Trust (206471/Z/17/Z) and a grant from the Bill and Melinda
   Gates Foundation (OP1183567). SIH is funded by grants from the Bill &
   Melinda Gates Foundation (OPP1132415, OPP1093011, OPP1159934 and
   OPP1176062). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2017, VIDOMOSTI VERKHOVNOY, V1, P2
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Benites BD, 2019, AM J TROP MED HYG, V100, P174, DOI 10.4269/ajtmh.17-0843
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Franca GVA, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/s1679-49742018000200014
   Green RF, 2010, ANN EPIDEMIOL, V20, P241, DOI 10.1016/j.annepidem.2009.10.009
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047
   Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Instituto Brasileiro de Geografia e Estatistica, 2018, 2010 POP CENS
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Lary JM, 2001, TERATOLOGY, V64, P237, DOI 10.1002/tera.1070
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   R Core Team, 2017, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Yang J, 2008, AM J EPIDEMIOL, V167, P145, DOI 10.1093/aje/kwm283
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 47
TC 14
Z9 14
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD MAR
PY 2019
VL 16
IS 3
AR e1002755
DI 10.1371/journal.pmed.1002755
PG 21
WC Medicine, General & Internal
SC General & Internal Medicine
GA HR2VQ
UT WOS:000462996000002
PM 30835728
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tang, T
   Weng, TJ
   Jia, HX
   Luo, SD
   Xu, Y
   Li, LH
   Zhang, PP
AF Tang, Tan
   Weng, Tujun
   Jia, Hongxing
   Luo, Sida
   Xu, Ye
   Li, Liuhe
   Zhang, Peipei
TI Harnessing the layer-by-layer assembly technique to design biomaterials
   vaccines for immune modulation in translational applications
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID TOLL-LIKE RECEPTORS; COATED GOLD NANOPARTICLES; IN-VIVO; LYMPH-NODE;
   T-CELLS; POLYELECTROLYTE MULTILAYERS; MICRONEEDLE ARRAYS; DENDRITIC
   CELLS; CONTROLLED DELIVERY; POLYPLEX DELIVERY
AB The existence of challenging diseases such as cancers, HIV and Zika requires developing new vaccines that can generate tunable and robust immune responses against the diseases. Biomaterials-based techniques have been broadly explored for designing vaccines that can produce controllable and potent immunity. Among the existing biomaterials-based strategies, the layer-by-layer (LbL) assembly technique is remarkably attractive in vaccine design due to its unique features such as programmed and versatile cargo loading, cargo protection, co-delivery, juxtaposing of immune signals, etc. In this work, we reviewed the existing LbL-based vaccine design techniques for translational applications. Specifically, we discussed nanovaccines constructed by coating polyelectrolyte multilayers (PEMs) on nanoparticles, microcapsule vaccines assembled from PEMs, polyplex/complex vaccines condensed from charged materials and microneedle vaccines deposited with PEMs, highlighting the employment of these techniques to promote immunity against diseases ranging from cancers to infectious and autoimmune diseases (i.e., HIV, influenza, multiple sclerosis, etc.). Additionally, the review specifically emphasized using LbL-based vaccine technologies for tuning the cellular and molecular pathways, demonstrating the unique advantages presented by these vaccination strategies. These studies showed the versatility and potency of using LbL-based techniques for designing the next generation of biomaterials vaccines for translational purposes.
C1 [Tang, Tan; Jia, Hongxing; Luo, Sida; Xu, Ye; Li, Liuhe; Zhang, Peipei] Beihang Univ, Sch Mech Engn & Automat, Dept Mat Proc & Controlling, Beijing, Peoples R China.
   [Weng, Tujun] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Orthopaed, Beijing, Peoples R China.
RP Zhang, PP (corresponding author), Beihang Univ, Sch Mech Engn & Automat, Dept Mat Proc & Controlling, Beijing, Peoples R China.
EM pzhang@buaa.edu.cn
RI Xu, Ye/E-7963-2011
OI Xu, Ye/0000-0003-4322-244X; Luo, Sida/0000-0002-5673-6100
FU BUAA start-up funding [ZG216S18B2]
FX This work is supported by BUAA start-up funding (#ZG216S18B2).
CR Adams JL, 2015, NAT REV DRUG DISCOV, V14, P603, DOI 10.1038/nrd4596
   Aguado BA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam8645
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Andorko JI, 2016, CELL MOL BIOENG, V9, P418, DOI 10.1007/s12195-016-0455-6
   Andorko JI, 2015, AAPS J, V17, P323, DOI 10.1208/s12248-014-9708-2
   Anselmo AC, 2015, J CONTROL RELEASE, V199, P29, DOI 10.1016/j.jconrel.2014.11.027
   Ariga K, 2006, J NANOSCI NANOTECHNO, V6, P2278, DOI 10.1166/jnn.2006.503
   Asghar W, 2015, MATER TODAY, V18, P539, DOI 10.1016/j.mattod.2015.05.002
   Badylak SF, 2016, SCIENCE, V352, P298, DOI 10.1126/science.aaf7587
   Bishop CJ, 2015, ACTA BIOMATER, V11, P393, DOI 10.1016/j.actbio.2014.09.020
   Bookstaver ML, 2018, TRENDS IMMUNOL, V39, P135, DOI 10.1016/j.it.2017.10.002
   Borges J, 2014, CHEM REV, V114, P8883, DOI 10.1021/cr400531v
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Bourgeois-Daigneault MC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao1641
   Brandenberg N, 2016, ADV MATER, V28, P7450, DOI 10.1002/adma.201601099
   Cao FQ, 2018, BIOMATER SCI-UK, V6, P473, DOI 10.1039/c7bm01082f
   Chakrabarti KR, 2016, ONCOTARGET, V7, P10486, DOI 10.18632/oncotarget.7251
   Chen Y, 2013, ADV MATER, V25, P3144, DOI 10.1002/adma.201205292
   Chen YJ, 2018, BIOMATER SCI-UK, V6, P1120, DOI 10.1039/c8bm00017d
   Cheung AS, 2018, NAT BIOTECHNOL, V36, P160, DOI 10.1038/nbt.4047
   Cheung AS, 2015, NANO TODAY, V10, P511, DOI 10.1016/j.nantod.2015.06.007
   Chew SA, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201600766
   Chiu YC, 2015, ACS BIOMATER SCI ENG, V1, P1200, DOI 10.1021/acsbiomaterials.5b00375
   Dai ZF, 2001, ADV MATER, V13, P1339, DOI 10.1002/1521-4095(200109)13:17<1339::AID-ADMA1339>3.0.CO;2-Q
   Dawson E, 2017, ACS BIOMATER SCI ENG, V3, P169, DOI 10.1021/acsbiomaterials.6b00384
   De Geest BG, 2012, ACS NANO, V6, P2136, DOI 10.1021/nn205099c
   De Koker S, 2016, ANGEW CHEM INT EDIT, V55, P1334, DOI 10.1002/anie.201508626
   De Koker S, 2010, J IMMUNOL, V184, P203, DOI 10.4049/jimmunol.0803591
   De Koker S, 2009, ANGEW CHEM INT EDIT, V48, P8485, DOI 10.1002/anie.200903769
   Demoulins T, 2016, NANOMED-NANOTECHNOL, V12, P711, DOI 10.1016/j.nano.2015.11.001
   Demoulinsa T, 2017, J CONTROL RELEASE, V266, P256, DOI 10.1016/j.jconrel.2017.09.018
   DeMuth PC, 2014, ADV HEALTHC MATER, V3, P47, DOI 10.1002/adhm.201300139
   DeMuth PC, 2013, NAT MATER, V12, P367, DOI [10.1038/NMAT3550, 10.1038/nmat3550]
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   DeMuth PC, 2010, ADV MATER, V22, P4851, DOI 10.1002/adma.201001525
   Dierendonck M, 2012, J CONTROL RELEASE, V161, P592, DOI 10.1016/j.jconrel.2012.03.001
   Dodet B, 2014, VACCINE, V32, P1624, DOI 10.1016/j.vaccine.2013.08.032
   Donnelly R, 2015, DRUG DELIV TRANSL RE, V5, P311, DOI 10.1007/s13346-015-0250-2
   Dreaden EC, 2015, CLIN CANCER RES, V21, P4410, DOI 10.1158/1078-0432.CCR-15-0013
   Estrada LPH, 2015, BIOMATER SCI-UK, V3, P787, DOI 10.1039/c5bm00052a
   Gallovic MD, 2016, BIOMATER SCI-UK, V4, P483, DOI 10.1039/c5bm00451a
   Gambuzza M, 2011, J NEUROIMMUNOL, V239, P1, DOI 10.1016/j.jneuroim.2011.08.010
   Gammon JM, 2016, ONCOTARGET, V7, P15421, DOI 10.18632/oncotarget.7304
   Gammon JM, 2015, J CONTROL RELEASE, V210, P169, DOI 10.1016/j.jconrel.2015.05.277
   Gao Y, 2011, ACS NANO, V5, P9788, DOI 10.1021/nn2033105
   Gentile P, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/42/422001
   Gerber A, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-32
   Ghosh R, 2013, BIOMATERIALS, V34, P807, DOI 10.1016/j.biomaterials.2012.10.023
   Gooshe M, 2014, EXPERT REV CLIN IMMU, V10, P1277, DOI 10.1586/1744666X.2014.953061
   Gosselin EA, 2018, NAT MATER, V17, P484, DOI 10.1038/s41563-018-0077-6
   Green JJ, 2016, NATURE, V540, P386, DOI 10.1038/nature21005
   Hainline KM, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700930
   He YP, 2018, ACS NANO, V12, P10272, DOI 10.1021/acsnano.8b05373
   Hess KL, 2017, BIOMATERIALS, V118, P51, DOI 10.1016/j.biomaterials.2016.11.052
   Hotaling NA, 2014, BIOMATER SCI-UK, V2, P1426, DOI 10.1039/c4bm00138a
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/NNANO.2013.254, 10.1038/nnano.2013.254]
   Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007
   Duong HTT, 2018, J CONTROL RELEASE, V269, P225, DOI 10.1016/j.jconrel.2017.11.025
   Indermun S, 2014, J CONTROL RELEASE, V185, P130, DOI 10.1016/j.jconrel.2014.04.052
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Jewell CM, 2006, BIOMACROMOLECULES, V7, P2483, DOI 10.1021/bm0604808
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Johnston APR, 2012, ACS NANO, V6, P6667, DOI 10.1021/nn3010476
   Kakwere H, 2018, BIOMATER SCI-UK, V6, P2850, DOI 10.1039/c8bm00891d
   Kato N, 2005, J PHYS CHEM B, V109, P19604, DOI 10.1021/jp052748f
   Kelly SH, 2017, ADV DRUG DELIVER REV, V114, P3, DOI 10.1016/j.addr.2017.04.009
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005
   Kirkland B, 2013, LAB CHIP, V13, P3367, DOI 10.1039/c3lc50562f
   Lankalapalli S, 2009, INDIAN J PHARM SCI, V71, P481, DOI 10.4103/0250-474X.58165
   Lee Y, 2011, J CONTROL RELEASE, V155, P3, DOI 10.1016/j.jconrel.2010.09.009
   Leone M, 2017, PHARM RES-DORDR, V34, P2223, DOI 10.1007/s11095-017-2223-2
   Lerouge S, 2018, CYTOTHERAPY, V20, pS106
   Li AW, 2018, NAT MATER, V17, P528, DOI 10.1038/s41563-018-0028-2
   Lin J, 2018, ACS APPL MATER INTER, V10, P6124, DOI 10.1021/acsami.7b16235
   Lin J, 2014, J POLYM RES, V21, DOI 10.1007/s10965-014-0435-2
   Liu YR, 2013, LAB CHIP, V13, P1316, DOI 10.1039/c2lc40364a
   Lizotte PH, 2016, NAT NANOTECHNOL, V11, P295, DOI [10.1038/NNANO.2015.292, 10.1038/nnano.2015.292]
   Luo M, 2017, J CONTROL RELEASE, V263, P200, DOI 10.1016/j.jconrel.2017.03.033
   Luo RC, 2012, SMALL, V8, P2585, DOI 10.1002/smll.201200398
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lv SX, 2018, J AM CHEM SOC, V140, P1235, DOI 10.1021/jacs.7b12776
   Lynn GM, 2015, NAT BIOTECHNOL, V33, P1201, DOI 10.1038/nbt.3371
   Madhusudana SN, 2014, EXPERT REV VACCINES, V13, P641, DOI 10.1586/14760584.2014.901893
   Mann JFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067412
   Mayya KS, 2003, ADV FUNCT MATER, V13, P183, DOI 10.1002/adfm.200390028
   Meka VS, 2017, DRUG DISCOV TODAY, V22, P1697, DOI 10.1016/j.drudis.2017.06.008
   Miranda-Hernandez S, 2013, AM J CLIN EXP IMMUNO, V2, P75
   Morton SW, 2013, BIOMATERIALS, V34, P5328, DOI 10.1016/j.biomaterials.2013.03.059
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Muddineti OS, 2015, INT J PHARMACEUT, V484, P252, DOI 10.1016/j.ijpharm.2015.02.038
   Nagaich U, 2017, J ADV PHARM TECHNOL, V8, P1, DOI 10.4103/2231-4040.197330
   Ory EC, 2017, ONCOTARGET, V8, P111567, DOI 10.18632/oncotarget.22874
   Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991
   Oyston P, 2012, J MED MICROBIOL, V61, P889, DOI 10.1099/jmm.0.039180-0
   Park J, 2015, J BIOMED MATER RES A, V103, P170, DOI 10.1002/jbm.a.35150
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pei P, 2018, BIOMATER SCI-UK, V6, P1414, DOI 10.1039/c8bm00005k
   Persano S, 2017, BIOMATERIALS, V125, P81, DOI 10.1016/j.biomaterials.2017.02.019
   Podda G, 2013, J NEUROIMMUNE PHARM, V8, P791, DOI 10.1007/s11481-013-9483-3
   Polak R, 2015, ADV HEALTHC MATER, V4, P2832, DOI 10.1002/adhm.201500604
   Poon Z, 2011, NANO LETT, V11, P2096, DOI 10.1021/nl200636r
   Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18
   Qiao CM, 2017, BIOMATER SCI-UK, V5, P1603, DOI 10.1039/c7bm00244k
   Quinn HL, 2014, EXPERT OPIN DRUG DEL, V11, P1769, DOI 10.1517/17425247.2014.938635
   Ramasamy T, 2014, ACTA BIOMATER, V10, P5116, DOI 10.1016/j.actbio.2014.08.021
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Richardson JJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2491
   Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118
   Sadtler K, 2019, BIOMATERIALS, V192, P405, DOI 10.1016/j.biomaterials.2018.11.002
   Sadtler K, 2017, TISSUE ENG PT A, V23, P1044, DOI [10.1089/ten.tea.2016.0304, 10.1089/ten.TEA.2016.0304]
   Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272
   Sahdev P, 2014, PHARM RES-DORDR, V31, P2563, DOI 10.1007/s11095-014-1419-y
   Samson A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7577
   Schmid D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01830-8
   Schneider G, 2004, NANO LETT, V4, P1833, DOI 10.1021/nl0490826
   Senut MC, 2016, SMALL, V12, P631, DOI 10.1002/smll.201502346
   Sexton A, 2009, ACS NANO, V3, P3391, DOI 10.1021/nn900715g
   Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381
   Shu SJ, 2010, BIOMATERIALS, V31, P6039, DOI 10.1016/j.biomaterials.2010.04.016
   Shu SJ, 2010, ACTA BIOMATER, V6, P210, DOI 10.1016/j.actbio.2009.06.020
   Skwarczynski M, 2014, NANOMEDICINE-UK, V9, P2657, DOI [10.2217/NNM.14.187, 10.2217/nnm.14.187]
   Smith TT, 2017, J CLIN INVEST, V127, P2176, DOI 10.1172/JCI87624
   Stephan MT, 2010, J IMMUNOTHER, V33, P866
   Sukhorukov GB, 2005, SMALL, V1, P194, DOI 10.1002/smll.200400075
   Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763
   Tang L, 2018, NAT BIOTECHNOL, V36, P707, DOI 10.1038/nbt.4181
   Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003
   Tirrell M, 2018, ACS CENTRAL SCI, V4, P532, DOI 10.1021/acscentsci.8b00284
   Tostanoski LH, 2019, BIOMATER SCI-UK, V7, P798, DOI 10.1039/c8bm01572d
   Tostanoski LH, 2017, ADV DRUG DELIVER REV, V114, P60, DOI 10.1016/j.addr.2017.03.005
   Tostanoski LH, 2016, ACS NANO, V10, P9334, DOI 10.1021/acsnano.6b04001
   Tsai SJ, 2018, NANO RES, V11, P5642, DOI 10.1007/s12274-018-2181-y
   Wang C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3682
   Wang CM, 2015, J MATER CHEM B, V3, P7372, DOI 10.1039/c5tb00766f
   Wang Q, 2017, BIOMATER SCI-UK, V5, P1407, DOI 10.1039/c7bm00254h
   Wang T, 2016, METHODS MOL BIOL, V1404, P651, DOI 10.1007/978-1-4939-3389-1_42
   Wang ZB, 2014, LANGMUIR, V30, P13483, DOI 10.1021/la503393j
   Wang ZB, 2013, ANALYST, V138, P7303, DOI 10.1039/c3an01604h
   Wang ZB, 2012, SOFT MATTER, V8, P7630, DOI 10.1039/c2sm25835h
   Wohl BM, 2012, J CONTROL RELEASE, V158, P2, DOI 10.1016/j.jconrel.2011.08.035
   Xia JF, 2015, ACS APPL MATER INTER, V7, P6293, DOI 10.1021/acsami.5b00613
   Xiao FX, 2016, CHEM SOC REV, V45, P3088, DOI 10.1039/c5cs00781j
   Yang MY, 2018, RSC ADV, V8, P13612, DOI 10.1039/c8ra00013a
   Yang YJ, 2010, ACTA BIOMATER, V6, P3092, DOI 10.1016/j.actbio.2010.02.042
   Yin Q, 2018, BIOMATER SCI-UK, V6, P1189, DOI 10.1039/c8bm00149a
   Zeng Q, 2017, BIOMATER SCI-UK, V6, P115, DOI 10.1039/c7bm00520b
   Zeng Q, 2017, ACS BIOMATER SCI ENG, V3, P195, DOI 10.1021/acsbiomaterials.6b00414
   Zhang PP, 2018, MATERIALS, V11, DOI 10.3390/ma11040623
   Zhang PP, 2017, BIOTECHNOL BIOENG, V114, P423, DOI 10.1002/bit.26083
   Zhang PP, 2015, ACS NANO, V9, P6465, DOI 10.1021/acsnano.5b02153
   Zhang PP, 2015, ACS APPL MATER INTER, V7, P4518, DOI 10.1021/am506866a
   Zhang PP, 2014, NANOSCALE, V6, P10095, DOI 10.1039/c4nr01564a
   Zhang PP, 2014, NANOSCALE, V6, P8762, DOI 10.1039/c4nr01851f
   Zhang PP, 2013, ADV HEALTHC MATER, V2, P540, DOI 10.1002/adhm.201200200
   Zhang PP, 2011, SMALL, V7, P2998, DOI 10.1002/smll.201101238
   Zhao Y, 2018, BIOMACROMOLECULES, V19, P3594, DOI 10.1021/acs.biomac.8b01080
   Zheng ZQ, 2017, J MATER CHEM B, V5, P7014, DOI 10.1039/c7tb01546a
   Zhu HF, 2018, NAT PRODUCT BIOPROSP, V8, P297, DOI 10.1007/s13659-018-0177-7
NR 160
TC 3
Z9 3
U1 9
U2 63
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PD MAR 1
PY 2019
VL 7
IS 3
BP 715
EP 732
DI 10.1039/c8bm01219a
PG 18
WC Materials Science, Biomaterials
SC Materials Science
GA HR5ZL
UT WOS:000463226900002
PM 30762040
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI RE: Seroprevalence of Zika virus among asymptomatic pregnant mothers and
   their newborns in the Najran region of southwest Saudi Arabia
SO ANNALS OF SAUDI MEDICINE
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok 10150, Thailand.
   [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Surin, Thailand.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok 10150, Thailand.
EM sorayasri@out-look.co.th
CR Alayed MS, 2018, ANN SAUDI MED, V38, P408, DOI 10.5144/0256-4947.2018.408
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 0
PU K FAISAL SPEC HOSP RES CENTRE
PI RIYADH
PA PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA
SN 0256-4947
EI 1319-9226
J9 ANN SAUDI MED
JI Ann. Saudi Med.
PD MAR-APR
PY 2019
VL 39
IS 2
BP 124
EP 124
DI 10.5144/0256-4947.2019.124
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA HR7KZ
UT WOS:000463334200010
PM 30955021
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nelson, MI
   Lloyd-Smith, JO
   Simonsen, L
   Rambaut, A
   Holmes, EC
   Chowell, G
   Miller, MA
   Spiro, DJ
   Grenfell, B
   Viboud, C
AF Nelson, Martha, I
   Lloyd-Smith, James O.
   Simonsen, Lone
   Rambaut, Andrew
   Holmes, Edward C.
   Chowell, Gerardo
   Miller, Mark A.
   Spiro, David J.
   Grenfell, Bryan
   Viboud, Cecile
TI Fogarty International Center collaborative networks in infectious
   disease modeling: Lessons learnt in research and capacity building
SO EPIDEMICS
LA English
DT Review
DE Infectious diseases; Transmission models; Computational models; Pathogen
   evolution; Capacity building; Emerging disease threats; Influenza;
   Control; Policy
ID INFLUENZA SEASONALITY; BIG DATA; GLOBAL MIGRATION; 6 CHALLENGES;
   MERS-COV; VACCINATION; DYNAMICS; VIRUS; TRANSMISSION; IMPACT
AB Due to a combination of ecological, political, and demographic factors, the emergence of novel pathogens has been increasingly observed in animals and humans in recent decades. Enhancing global capacity to study and interpret infectious disease surveillance data, and to develop data-driven computational models to guide policy, represents one of the most cost-effective, and yet overlooked, ways to prepare for the next pandemic. Epidemiological and behavioral data from recent pandemics and historic scourges have provided rich opportunities for validation of computational models, while new sequencing technologies and the 'big data' revolution present new tools for studying the epidemiology of outbreaks in real time. For the past two decades, the Division of International Epidemiology and Population Studies (DIEPS) of the NIH Fogarty International Center has spearheaded two synergistic programs to better understand and devise control strategies for global infectious disease threats. The Multinational Influenza Seasonal Mortality Study (MISMS) has strengthened global capacity to study the epidemiology and evolutionary dynamics of influenza viruses in 80 countries by organizing international research activities and training workshops. The Research and Policy in Infectious Disease Dynamics (RAPIDD) program and its precursor activities has established a network of global experts in infectious disease modeling operating at the research-policy interface, with collaborators in 78 countries. These activities have provided evidence-based recommendations for disease control, including during large-scale outbreaks of pandemic influenza, Ebola and Zika virus. Together, these programs have coordinated international collaborative networks to advance the study of emerging disease threats and the field of computational epidemic modeling. A global community of researchers and policy-makers have used the tools and trainings developed by these programs to interpret infectious disease patterns in their countries, understand modeling concepts, and inform control policies. Here we reflect on the scientific achievements and lessons learnt from these programs (h-index = 106 for RAPIDD and 79 for MISMS), including the identification of outstanding researchers and fellows; funding flexibility for timely research workshops and working groups (particularly relative to more traditional investigator-based grant programs); emphasis on group activities such as large-scale modeling reviews, model comparisons, forecasting challenges and special journal issues; strong quality control with a light touch on outputs; and prominence of training, data-sharing, and joint publications.
C1 [Nelson, Martha, I; Lloyd-Smith, James O.; Rambaut, Andrew; Chowell, Gerardo; Miller, Mark A.; Spiro, David J.; Grenfell, Bryan; Viboud, Cecile] NIH, Fogarty Int Ctr, Div Int Epidemiol & Populat Studies, Bldg 10, Bethesda, MD 20892 USA.
   [Lloyd-Smith, James O.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA.
   [Simonsen, Lone] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark.
   [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Charles Perkins Ctr, Sch Life & Environm Sci, Sydney, NSW, Australia.
   [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
   [Chowell, Gerardo] Georgia State Univ, Dept Populat Hlth Sci, Sch Publ Hlth, Atlanta, GA 30303 USA.
   [Grenfell, Bryan] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.
RP Viboud, C (corresponding author), NIH, Fogarty Int Ctr, Div Int Epidemiol & Populat Studies, Bldg 10, Bethesda, MD 20892 USA.
EM viboudc@mail.nih.gov
RI Rambaut, Andrew/B-2481-2009; Simonsen, Lone/K-4531-2014; Holmes,
   Edward/Y-2789-2019
OI Rambaut, Andrew/0000-0003-4337-3707; Simonsen, Lone/0000-0003-1535-8526;
   Holmes, Edward/0000-0001-9596-3552; Rambaut FRSE, Professor
   Andrew/0000-0002-1278-598X
FU Department of Homeland SecurityUnited States Department of Homeland
   Security (DHS); HHS Pandemic Threat Unit; FICUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC); Office of Global Affairs
FX We acknowledge support from the Department of Homeland Security and FIC
   for the RAPIDD program, and the HHS Pandemic Threat Unit, Office of
   Global Affairs and FIC for the MISMS program. We are grateful to Felix
   Wu, Amherst College, for performing a thorough bibliometric analysis of
   the RAPIDD and MISMS publications and generating maps of co-authors. We
   are thankful to Kate Skoczdopole for continued administrative support of
   the RAPIDD and MISMS programs.
CR Adler AJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-232
   Agua-Agum J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002170
   Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012
   Alonso WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17214
   Alonso WJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-982
   Alonso WJ, 2015, INFLUENZA OTHER RESP, V9, P101, DOI 10.1111/irv.12308
   Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065
   Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P3173, DOI 10.1073/pnas.1113342109
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Ayora-Talavera G, 2017, VACCINE, V35, P4738, DOI 10.1016/j.vaccine.2017.07.020
   Bansal S, 2016, J INFECT DIS, V214, pS375, DOI 10.1093/infdis/jiw400
   Becker A., 2016, TSIR IMPLEMENTATION
   Bharti N, 2011, SCIENCE, V334, P1424, DOI 10.1126/science.1210554
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biek R, 2015, TRENDS ECOL EVOL, V30, P306, DOI 10.1016/j.tree.2015.03.009
   Bloom-Feshbach K., 2012, PLOS ONE
   Bloom-Feshbach K, 2011, J INFECT DIS, V204, P1157, DOI 10.1093/infdis/jir510
   Blumberg S, 2013, EPIDEMICS-NETH, V5, P131, DOI 10.1016/j.epidem.2013.05.002
   Blumberg S, 2014, AM J EPIDEMIOL, V179, P1375, DOI 10.1093/aje/kwu068
   Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buhnerkempe M. G., 2015, ELIFE, P4
   Buhnerkempe MG, 2015, EPIDEMICS-NETH, V10, P26, DOI 10.1016/j.epidem.2014.10.001
   Camacho Anton, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.406ae55e83ec0b5193e30856b9235ed2
   Charu V, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005382
   Chowell G, 2014, EPIDEMICS-NETH, V9, P40, DOI 10.1016/j.epidem.2014.09.011
   Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069
   Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436
   Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164
   Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023
   Chretien J. P., 2015, ELIFE, P4
   Day T, 2006, P ROY SOC B-BIOL SCI, V273, P2945, DOI 10.1098/rspb.2006.3638
   de Mello WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005095
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864
   Frost SDW, 2015, EPIDEMICS-NETH, V10, P88, DOI 10.1016/j.epidem.2014.09.001
   Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09
   Gog JR, 2015, EPIDEMICS-NETH, V10, P45, DOI 10.1016/j.epidem.2014.09.009
   Gog JR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003635
   Gostic K. M., 2015, ELIFE, P4
   Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322
   Green HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079360
   He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300
   Holmes EC, 2011, J VIROL, V85, P6923, DOI 10.1128/JVI.00438-11
   Hughes J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003081
   Huijben S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003578
   Katz JM, 2004, IMMUNOL RES, V29, P113, DOI 10.1385/IR:29:1-3:113
   Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343
   Kennedy DA, 2016, EVOL APPL, V9, P344, DOI 10.1111/eva.12342
   Kerr PJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002950
   King A. A., 2018, SIMULATION BASED INF
   Klepac P, 2015, EPIDEMICS-NETH, V10, P97, DOI 10.1016/j.epidem.2014.12.001
   Kouyos RD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0566
   Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167
   Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112
   Kucharski AJ, 2015, EMERG INFECT DIS, V21, P852, DOI 10.3201/eid2105.141137
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Lemey Philippe, 2009, PLoS Curr, V1, pRRN1031, DOI 10.1371/currents.RRN1031
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lessler J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002802
   Lipsitch M, 2016, ELIFE, V5, DOI 10.7554/eLife.18491
   Lloyd-Smith JO, 2015, EPIDEMICS-NETH, V10, pIII, DOI 10.1016/j.epidem.2015.02.001
   Lloyd-Smith JO, 2015, EPIDEMICS-NETH, V10, P35, DOI 10.1016/j.epidem.2014.09.002
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Merler S., 2017, EPIDEMICS
   Metcalf CJE, 2015, EPIDEMICS-NETH, V10, P93, DOI 10.1016/j.epidem.2014.08.008
   Metcalf CJE, 2015, EPIDEMICS-NETH, V10, P40, DOI 10.1016/j.epidem.2014.12.003
   Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716
   Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906
   Morris DH, 2017, TRENDS MICROBIOL
   Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012
   Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131
   Nelson MI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7696
   Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077
   Nelson MI, 2009, VIROLOGY, V388, P270, DOI 10.1016/j.virol.2009.03.026
   Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133
   Office of Science Ta. P., 2016, EP PRED FED EFF OPP
   Park M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0333
   Pepin KM, 2017, ECOL LETT, V20, P275, DOI 10.1111/ele.12732
   Pepin KM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-592
   Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440
   Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642
   Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945
   Rasmussen DA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003570
   Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198
   Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108
   Reiner R. C., 2015, ELIFE, P4
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107
   Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052
   Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137
   Russell CA, 2014, ELIFE, V3, DOI 10.7554/eLife.03883
   Shaman Jeffrey, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.3408774290b1a0f2dd7cae877c8b8ff6
   Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837
   Shrestha S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15314
   Shrestha S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005982
   Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265
   Simonsen L., 2011, VACCINE S2, V29, P1
   Simonsen L., 2003, INT C SERIES, V1265
   Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103
   Simonsen L, 2016, J INFECT DIS, V214, pS380, DOI 10.1093/infdis/jiw376
   Simonsen L, 2009, VACCINE, V27, P6300, DOI 10.1016/j.vaccine.2009.07.008
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Subramanian R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005204
   Takahashi S, 2015, SCIENCE, V347, P1240, DOI 10.1126/science.aaa3438
   Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383
   Viboud C., 2017, EPIDEMICS
   Viboud C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0199
   Weinberger DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001776
   Weinberger DM, 2014, EUR RESPIR J, V43, P833, DOI 10.1183/09031936.00056813
   Weinberger DM, 2012, J INFECT DIS, V205, P458, DOI 10.1093/infdis/jir749
   Wesolowski A., 2016, J INFECT DIS
   Wesolowski A, 2016, J INFECT DIS, V214, pS414, DOI 10.1093/infdis/jiw273
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
   WHO, 2017, YELL FEV BRAZ UPD
   WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992
   Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149
   Woolhouse MEJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0191
   World Bank and Ecohealth Alliance, 2018, ON HLTH OP FRAM
   Worobey M, 2014, NATURE, V508, P254, DOI 10.1038/nature13016
   Yang W, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005201
   Yang W, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0536
   Yang W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004383
   Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552
NR 133
TC 1
Z9 1
U1 2
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD MAR
PY 2019
VL 26
BP 116
EP 127
DI 10.1016/j.epidem.2018.10.004
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA HR5LD
UT WOS:000463187400012
PM 30446431
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Josefina, RV
   Carlos, RLJ
   Alejandra, CM
   Cristina, JSR
   Patricia, GMK
   Karina, AP
AF Vazquez Josefina, Reynoso
   Jesus Carlos, Ruvalcaba Ledezma
   Miranda Alejandra, Chavarria
   Reyna Cristina, Jimenez Sanchez
   Karla Patricia, Guzman Meneses
   Perez Karina, Alamilla
TI Zika; A Threat to Making Important Decisions on Maternal and Perinatal
   Health
SO JOURNAL OF PURE AND APPLIED MICROBIOLOGY
LA English
DT Review
DE Zika; Association; Microcephaly; Asymptomatic
ID VIRUS
AB The Zika virus disease represents a great challenge for the medical-scientific community not only because of the association that exists with microcephaly and other congenital anomalies, but also because of the presence of confirmed cases of congenital syndrome associated with Zika in asymptomatic pregnant women, It is very important to carry out a timely detection and diagnosis to evaluate the probability of having an anomaly, the quality of life that the baby will have or the probability of the legal interruption of pregnancy.
C1 [Vazquez Josefina, Reynoso] Univ State Hidalgo, Inst Hlth Sci Autonomous, Dept Pharm, Pachuca, Mexico.
   [Vazquez Josefina, Reynoso] Univ State Hidalgo, Inst Hlth Sci Autonomous, Publ Hlth ICSa UAEH, Pachuca, Mexico.
   [Jesus Carlos, Ruvalcaba Ledezma] ICSa UAEH, Dept Med, Publ Hlth, Pachuca, Mexico.
   [Miranda Alejandra, Chavarria] Inst Elise Freinet, Dept Publ Hlth, Pachuca, Mexico.
   [Miranda Alejandra, Chavarria] SSH Hlth Serv Hidalgo, Pachuca, Mexico.
   [Reyna Cristina, Jimenez Sanchez] ICSa UAEH, Dept Nursing, Pachuca, Mexico.
   [Karla Patricia, Guzman Meneses; Perez Karina, Alamilla] Uaeh, Pharm, Pachuca, Mexico.
RP Carlos, RLJ (corresponding author), ICSa UAEH, Dept Med, Publ Hlth, Pachuca, Mexico.
EM dcspjcarlos@gmail.com
CR Olortegui RA, 2017, REV PERU GINECOL OBS, V63, P71
   [Anonymous], 2018, SINAVE DGE SS SISTEM
   Cao B, 2018, FUTURE MICROBIOL, V13, P137, DOI 10.2217/fmb-2017-0213
   Cdc. gov, 2018, DAT MICR DEF NAC NCB
   Ceped. org, 2003, SIT LEG AB ENT REP M
   Direccion General de Epidemiologia, 2016, LIN EST VIG EP DIAGN
   Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508
   OMS/ OPS, 2016, CONS PROV AT MUJ GES
   Pacheco E., 2015, REV HOSP CLIN U CHIL, V26, P277
   Rodriguez R. G., 2016, REV CUBANA MED GEN I, V35
   Vanlandingham DL, 2016, J MED ENTOMOL, V53, P1024, DOI 10.1093/jme/tjw025
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 0
Z9 0
U1 0
U2 1
PU DR M N KHAN
PI BHOPAL
PA 54, NEAR POST OFFICE, THANA ST, BHOPAL, SHAHJAHANABAD 462 001, INDIA
SN 0973-7510
EI 2581-690X
J9 J PURE APPL MICROBIO
JI J. Pure Appl. Microbiol.
PD MAR
PY 2019
VL 13
IS 1
BP 45
EP 49
DI 10.22207/JPAM.13.1.04
PG 5
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA HR3GI
UT WOS:000463024400004
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rajarethinam, J
   Ong, J
   Lim, SH
   Tay, YH
   Bounliphone, W
   Chong, CS
   Yap, G
   Ng, LC
AF Rajarethinam, Jayanthi
   Ong, Janet
   Lim, Shi-Hui
   Tay, Yu-Heng
   Bounliphone, Wacha
   Chong, Chee-Seng
   Yap, Grace
   Ng, Lee-Ching
TI Using Human Movement Data to Identify Potential Areas of Zika
   Transmission: Case Study of the Largest Zika Cluster in Singapore
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE zika; human movement; mobile phone data; disease transmission; risk
ID HUMAN MOBILITY; VIRUS; OUTBREAK; IMPACT
AB Singapore experienced its first Zika virus (ZIKV) cluster in August 2016. To understand the implication of human movement on disease spread, a retrospective study was conducted using aggregated and anonymized mobile phone data to examine movement from the cluster to identify areas of possible transmission. An origin-destination model was developed based on the movement of three groups of individuals: (i) construction workers, (ii) residents and (iii) visitors out of the cluster locality to other parts of the island. The odds ratio of ZIKV cases in a hexagon visited by an individual from the cluster, independent of the group of individuals, is 3.20 (95% CI: 2.65-3.87, p-value < 0.05), reflecting a higher count of ZIKV cases when there is a movement into a hexagon from the cluster locality. A comparison of independent ROC curves tested the statistical significance of the difference between the areas under the curves of the three groups of individuals. Visitors (difference in AUC = 0.119) and residents (difference in AUC = 0.124) have a significantly larger difference in area under the curve compared to the construction workers (p-value < 0.05). This study supports the proof of concept of using mobile phone data to approximate population movement, thus identifying areas at risk of disease transmission.
C1 [Rajarethinam, Jayanthi; Ong, Janet; Bounliphone, Wacha; Chong, Chee-Seng; Ng, Lee-Ching] Natl Environm Agcy, Environm Hlth Inst, 11 Biopolis Way,06-05-08, Singapore 138667, Singapore.
   [Lim, Shi-Hui; Tay, Yu-Heng] Starhub Ltd, 67 Ubi Ave 1,05-01 StarHub Green, Singapore 408942, Singapore.
   [Yap, Grace] Natl Environm Agcy, Environm Publ Hlth Operat, 40 Scotts Rd,13-00 Environm Bldg, Singapore 228231, Singapore.
   [Ng, Lee-Ching] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
RP Ng, LC (corresponding author), Natl Environm Agcy, Environm Hlth Inst, 11 Biopolis Way,06-05-08, Singapore 138667, Singapore.; Ng, LC (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
EM jayanthi_rajarethinam@nea.gov.sg; janet_ong@nea.gov.sg;
   shihui713@gmail.com; tayyh89@gmail.com; wacha.bounliphone@gmail.com;
   chong_chee_seng@nea.gov.sg; grace_yap@nea.gov.sg;
   ng_lee_ching@nea.gov.sg
FU NEA, Singapore
FX The study was funded by NEA, Singapore.
CR [Anonymous], 2019, CONSTRUCTION SECTOR
   [Anonymous], 2018, CITY POPULATION SING
   Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923
   Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chow A, 2017, EMERG INFECT DIS, V23, P677, DOI 10.3201/eid2304.161716
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Department of Singapore Statistics, 2018, POP POP STRUCT
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541
   Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   Liang SH, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3311-6
   Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Ong J, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-018-3281-y
   Ong J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006587
   Ruktanonchai NW, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004846
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Wesolowski A, 2016, J INFECT DIS, V214, pS414, DOI 10.1093/infdis/jiw273
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 30
TC 1
Z9 1
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAR 1
PY 2019
VL 16
IS 5
AR 808
DI 10.3390/ijerph16050808
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA HQ8HD
UT WOS:000462664200133
PM 30841598
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gratton, R
   Agrelli, A
   Tricarico, PM
   Brandao, L
   Crovella, S
AF Gratton, Rossella
   Agrelli, Almerinda
   Tricarico, Paola Maura
   Brandao, Lucas
   Crovella, Sergio
TI Autophagy in Zika Virus Infection: A Possible Therapeutic Target to
   Counteract Viral Replication
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE Zika virus; autophagy; Akt-mTOR; innate immunity; therapeutic targets
ID HUMAN DENDRITIC CELLS; WEST NILE VIRUS; DENGUE-VIRUS; DC-SIGN;
   PHOSPHATIDYLSERINE RECEPTORS; PRODUCTIVE INFECTION; INHIBITION; INNATE;
   FLAVIVIRUS; PROTEIN
AB Zika virus (ZIKV) still constitutes a public health concern, however, no vaccines or therapies are currently approved for treatment. A fundamental process involved in ZIKV infection is autophagy, a cellular catabolic pathway delivering cytoplasmic cargo to the lysosome for degradationconsidered as a primordial form of innate immunity against invading microorganisms. ZIKV is thought to inhibit the Akt-mTOR signaling pathway, which causes aberrant activation of autophagy promoting viral replication and propagation. It is therefore appealing to study the role of autophagic molecular effectors during viral infection to identify potential targets for anti-ZIKV therapeutic intervention.
C1 [Gratton, Rossella; Tricarico, Paola Maura; Crovella, Sergio] IRCCS Burlo Garofolo, Dept Adv Diagnost, Via Istria 65-1, I-34137 Trieste, Italy.
   [Agrelli, Almerinda] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami, Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Brandao, Lucas] Univ Fed Pernambuco, Dept Pathol, Ave Prof Moraes Rego,1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Crovella, Sergio] Univ Trieste, Dept Med Surg & Hlth Sci, Str Fiume 447, I-34149 Trieste, Italy.
RP Gratton, R (corresponding author), IRCCS Burlo Garofolo, Dept Adv Diagnost, Via Istria 65-1, I-34137 Trieste, Italy.
EM rossella.gratton@gmail.com; almerindaapimentel@gmail.com;
   tricaricopa@gmail.com; dpatologia@ufpe.br;
   sergio.crovella@burlo.trieste.it
RI tricarico, paola/AAB-8972-2019
OI tricarico, paola/0000-0002-1954-4126; Agrelli,
   Almerinda/0000-0002-9908-742X
FU National Council for the Improvement of Higher Education, Brazil (CAPES)
   [001]; National Council for Scientific and Technological Development,
   Brazil (CNPq)National Council for Scientific and Technological
   Development (CNPq); Department of Science and Technology of the Ministry
   of Health, Brazil (Decit/SCTIE/MS); IRCCS Burlo Garofolo grant "Ricerca
   Corrente" [RC09/17]
FX This research was funded by the National Council for the Improvement of
   Higher Education, Brazil (CAPES), Finance Code 001; the National Council
   for Scientific and Technological Development, Brazil (CNPq); the
   Department of Science and Technology of the Ministry of Health, Brazil
   (Decit/SCTIE/MS); and by the IRCCS Burlo Garofolo grant "Ricerca
   Corrente" RC09/17.
CR Abernathy E, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006926
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Ahmad L, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00155
   Amaya C, 2015, FEBS LETT, V589, P3343, DOI 10.1016/j.febslet.2015.09.021
   Arroyo DS, 2014, INT IMMUNOPHARMACOL, V18, P55, DOI 10.1016/j.intimp.2013.11.001
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Beatman E, 2012, VIROLOGY, V433, P262, DOI 10.1016/j.virol.2012.08.016
   Bento CF, 2013, J CELL SCI, V126, P1059, DOI 10.1242/jcs.123075
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Blazquez AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002509
   Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x
   BRASIL, 2018, B EPIDEMIOLOGICO, V49, P1, DOI DOI 10.1111/are.13485
   BYRD TF, 1991, J CLIN INVEST, V88, P351, DOI 10.1172/JCI115301
   Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Chiramel Abhilash I, 2013, Cells, V2, P83, DOI 10.3390/cells2010083
   Martinez JD, 2019, DERMATOL CLIN, V37, P95, DOI 10.1016/j.det.2018.07.008
   De Mei C, 2015, ONCOGENE, V34, P2597, DOI 10.1038/onc.2014.203
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031
   Esteves E, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1734151
   Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168
   Ferreira DF, 2000, J MED MICROBIOL, V49, P313, DOI 10.1099/0022-1317-49-4-313
   Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x
   Gannage M, 2010, SEMIN IMMUNOPATHOL, V32, P373, DOI 10.1007/s00281-010-0227-7
   Gimenez-Xavier P, 2008, INT J MOL MED, V22, P781, DOI 10.3892/ijmm_00000085
   Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0
   Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104
   Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002
   Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540
   Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936
   Ke PY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123940
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Legssyer R, 2003, J INORG BIOCHEM, V94, P36, DOI 10.1016/S0162-0134(02)00633-5
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053
   LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Martin-Acebes MA, 2015, AUTOPHAGY, V11, P861, DOI 10.1080/15548627.2015.1037062
   Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957
   McAfee Q, 2012, P NATL ACAD SCI USA, V109, P8253, DOI 10.1073/pnas.1118193109
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000
   Mukherjee S., 2016, COMMUNIT ACQUIR INFE, V3, P31, DOI [10.4103/2225-6482.184908, DOI 10.4103/2225-6482.184908]
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2018, CLIN MICROBIOL INFEC, V24, P566, DOI 10.1016/j.cmi.2018.03.007
   Nabar NR, 2018, IMMUNOLOGY, VI, P75
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181
   Ojha CR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02340
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petherick KJ, 2015, J BIOL CHEM, V290, P28726, DOI [10.1074/jbc.A114.627778, 10.1074/jbc.C114.627778]
   Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011
   PRIETO A, 2011, J COMP NEUROL, V425, P295, DOI DOI 10.1002/1096-9861(20000918)425:2
   Randall G, 2018, TRENDS MICROBIOL, V26, P640, DOI 10.1016/j.tim.2018.05.010
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Richetta C, 2013, CELL MICROBIOL, V15, P368, DOI 10.1111/cmi.12043
   Rossi M, 2009, J CELL SCI, V122, P3330, DOI 10.1242/jcs.048181
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Shoji-Kawata S, 2009, BBA-MOL CELL RES, V1793, P1478, DOI 10.1016/j.bbamcr.2009.02.008
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Solitro AR, 2016, FUTURE MED CHEM, V8, P73, DOI 10.4155/fmc.15.166
   Su EW, 2008, CYTOKINE, V44, P9, DOI 10.1016/j.cyto.2008.06.013
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thompson JM, 2008, ADV DRUG DELIVER REV, V60, P786, DOI 10.1016/j.addr.2007.11.003
   TSAI WP, 1990, AIDS RES HUM RETROV, V6, P481, DOI 10.1089/aid.1990.6.481
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Vinod V, 2014, PHARMACOL RES, V82, P1, DOI 10.1016/j.phrs.2014.03.005
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 116
TC 5
Z9 5
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR 1
PY 2019
VL 20
IS 5
AR 1048
DI 10.3390/ijms20051048
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HQ6QE
UT WOS:000462542300047
PM 30823365
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, JK
   Shin, OS
AF Lee, Jae Kyung
   Shin, Ok Sarah
TI Advances in Zika Virus-Host Cell Interaction: Current Knowledge and
   Future Perspectives
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE Zika virus; cellular targets; innate immune evasion; cell death
ID WEST-NILE-VIRUS; DENGUE VIRUS; VIRAL-INFECTION; PLACENTAL PATHOLOGY;
   SEXUAL TRANSMISSION; SERUM-LEVELS; PROTEIN; BLOOD; BRAIN; PREGNANCY
AB Emerging mosquito-transmitted RNA viruses, such as Zika virus (ZIKV) and Chikungunya represent human pathogens of an immense global health problem. In particular, ZIKV has emerged explosively since 2007 to cause a series of epidemics in the South Pacific and most recently in the Americas. Although typical ZIKV infections are asymptomatic, ZIKV infection during pregnancy is increasingly associated with microcephaly and other fetal developmental abnormalities. In the last few years, genomic and molecular investigations have established a remarkable progress on the pathogenic mechanisms of ZIKV infection using in vitro and in vivo models. Here, we highlight recent advances in ZIKV-host cell interaction studies, including cellular targets of ZIKV, ZIKV-mediated cell death mechanisms, host cell restriction factors that limit ZIKV replication, and immune evasion mechanisms utilized by ZIKV. Understanding of the mechanisms of ZIKV-host interaction at the cellular level will contribute crucial insights into the development of ZIKV therapeutics and vaccines.
C1 [Lee, Jae Kyung; Shin, Ok Sarah] Korea Univ, Guro Hosp, Coll Med, Dept Biomed Sci, Seoul 08308, South Korea.
RP Shin, OS (corresponding author), Korea Univ, Guro Hosp, Coll Med, Dept Biomed Sci, Seoul 08308, South Korea.
EM jae.lee0321@gmail.com; oshin@korea.ac.kr
FU Basic Science Research Program of the National Research Foundation of
   Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2016R1C1B2006493]; Korea University Research Grant
FX This research was supported by the Basic Science Research Program of the
   National Research Foundation of Korea (NRF) and was funded by the
   Ministry of Science, ICT & Future Planning (NRF-2016R1C1B2006493) and
   Korea University Research Grant.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Akpovwa H, 2016, CELL BIOCHEM FUNCT, V34, P191, DOI 10.1002/cbf.3182
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   ALVARADOSOCARRA.J, 2018, DIS, V23, P14, DOI DOI 10.1016/j.tmaid.2018.02.002
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Batista MN, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010049
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095
   Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Cui L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004607
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Depoux A, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0087-6
   Durbin A.P., 2016, VACCINE DEV ZIKA VIR, P299
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Fourie T, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy261
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Gnecco JS, 2017, CURR PHARM DESIGN, V23, P6115, DOI 10.2174/1381612823666170825142649
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee J, 2016, J MATERN-FETAL NEO M, V29, P707, DOI 10.3109/14767058.2015.1020293
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu J, 2018, INT J BIOL SCI, V14, P1099, DOI 10.7150/ijbs.26400
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Feitosa RNM, 2016, VIRAL IMMUNOL, V29, P379, DOI 10.1089/vim.2016.0026
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Palma-Ocampo HK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0383-4
   Pan American Health Organization (PAHO), 2018, ZIK CAS CONG SYNDR A
   Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6
   Peloggia A, 2018, INT J GYNECOL OBSTET, V143, P277, DOI 10.1002/ijgo.12663
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Salam AP, 2018, LANCET INFECT DIS, V18, P144, DOI 10.1016/S1473-3099(18)30020-3
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Singh S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100530
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yockey LJ, 2018, IMMUNITY, V49, P397, DOI 10.1016/j.immuni.2018.07.017
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang H, 2017, CAN J INFECT DIS MED, V2017, DOI 10.1155/2017/1671607
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
NR 120
TC 8
Z9 8
U1 4
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR 1
PY 2019
VL 20
IS 5
AR 1101
DI 10.3390/ijms20051101
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HQ6QE
UT WOS:000462542300100
PM 30836648
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sutarjono, B
AF Sutarjono, Bayu
TI Can We Better Understand How Zika Leads to Microcephaly? A Systematic
   Review of the Effects of the Zika Virus on Human Brain Organoids
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Zika; organoid; microcephaly; neural progenitor cells
ID NEURAL PROGENITORS; CEREBRAL ORGANOIDS; GLIAL-CELLS; INFECTION;
   EXPOSURE; OUTCOMES; GROWTH; CORTEX; AXL
AB Background The innovative human brain organoid model represents a unique opportunity to better understand the genesis of congenital brain abnormalities, particularly microcephaly, caused by Zika virus (ZIKV) infection during early pregnancy.
   Methods A systematic review was conducted to investigate how ZIKV leads to microcephaly in a novel experimental model that mimics early brain development. Studies were gathered by searching MEDLINE/Pubmed, LILACS, and LiSSa for reports on effects of ZIKV infection on human brain organoids. From 146 identified papers, 13 articles were selected for review.
   Results This review found that ZIKV of African, Latin American, and Asian lineages caused productive replication after 72 hours, preferentially infected neural progenitor cells over mature neurons, reduced both cell populations, and caused premature differentiation. Limited data involving only African and Latin American lineages showed a reduction in populations of proliferating cells and intermediate cells, and overall decreased viability. Furthermore, all 3 lineages caused heightened apoptosis and reduced organoid size.
   Conclusions This review concludes that, in organoids, ZIKV causes productive replication, infects neural progenitor cells over mature neurons, decreases both populations, causes premature differentiation, induces apoptosis, and reduces size.
   This systematic review reveals that ZIKV causes productive replication, infects neural progenitor cells over mature neurons, decreases both populations, causes premature differentiation, induces apoptosis, and reduces organoid size. Limited data show reductions in proliferating cells, intermediate cells, and overall viability.
C1 [Sutarjono, Bayu] Saba Univ, Sch Med, 27 Jackson Rd, Devens, MA 01434 USA.
RP Sutarjono, B (corresponding author), Saba Univ, Sch Med, 27 Jackson Rd, Devens, MA 01434 USA.
EM b.sutarjono@saba.edu
FU Saba University School of Medicine
FX This work was supported by Saba University School of Medicine.
CR Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 46
TC 6
Z9 6
U1 3
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 1
PY 2019
VL 219
IS 5
BP 734
EP 745
DI 10.1093/infdis/jiy572
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HQ7KM
UT WOS:000462599000008
PM 30256965
DA 2020-07-08
ER

PT J
AU Falade, B
AF Falade, Bankole
TI Leveraging media informatics for the surveillance and understanding of
   disease outbreaks
SO SOUTH AFRICAN JOURNAL OF SCIENCE
LA English
DT Article
DE Zika; syndromic surveillance; knowledge crisis; risk perception; public
   understanding of science
ID ZIKA VIRUS; REPRESENTATIONS; PERCEPTION; COVERAGE; RISK
AB Syndromic disease surveillance mechanisms can be enhanced by incorporating mass media informatics for disease discourse and aberration detection and social psychology for understanding risk perceptions and the drivers of uptake and resistance. Using computerised text analysis, the coverage of the outbreak of Zika virus in Brazil in 2017/2018 in four newspapers - O Estado, O Globo, the Times of London and the New York Times - was examined and patterns were compared with Google Trends. Quantitative indicators showed waves of attention to Zika peaked in the same period but local newspapers, O Estado and O Globo, indicated lower levels of anxiety in the run up to the Olympics when compared with foreign media. The unusual surge in attention to dengue in early 2015 was an early indication to sound the alarm for extensive clinical investigations. This, together with the flagging of Zika by O Globo almost a year before the global alarm, indicates the suitability of this method for surveillance and detection of aberrations. Media attention waves are also significantly associated with Google Trends, indicating empirical equivalence. Qualitative indicators show the extra motivation over Google, World Wide Web or Twitter searches by highlighting public perceptions. Findings show the absence of a stable body of scientific knowledge at the outbreak and an ensuing crisis of understanding. Local concerns were about the economic crisis, religious beliefs, poverty and crime - all inhibitors to containment - while the global alarm was amplified by risk to tourists and athletes, and political disputes mixed with religious beliefs.
   Significance:
   This study contributes to research on the use of longitudinal media data as surrogate sources for syndromic disease surveillance.
   Mass media informatics provide empirical equivalence to Google Trends.
   Clinical and non-clinical factors contributed to public anxiety over disease epidemics.
   Lack of clinical knowledge at the onset of the crisis contributed to anxiety among scientists and the public.
C1 [Falade, Bankole] Stellenbosch Univ, CREST, South African Res Chair Sci Commun, Stellenbosch, South Africa.
RP Falade, B (corresponding author), Stellenbosch Univ, CREST, South African Res Chair Sci Commun, Stellenbosch, South Africa.
EM bankolefalade@gmail.com
OI /0000-0003-1985-2273
FU National Research Foundation of South AfricaNational Research Foundation
   - South Africa [93097]; MACAS Project, Economic and Social Research
   Council, UK [ES/K005820/1]
FX National Research Foundation of South Africa (grant no. 93097); MACAS
   Project, Economic and Social Research Council, UK (grant ES/K005820/1)
CR Ahmed AN, 2018, NEURAL COMPUT APPL, V29, P889, DOI 10.1007/s00521-016-2496-0
   Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9
   Aslam AA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3532
   Bauer M, 2014, ATOMS BYTES GENES PU
   Bauer MW, 2007, PUBLIC UNDERST SCI, V16, P79, DOI 10.1177/0963662506071287
   Belluck P, 2016, NY TIMES, P16
   Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740
   Boswell J, 2016, SUNDAY TIMES, P2
   Bowater D, 2016, DAILY TELEGRAPH, P7
   Centers for Disease Control and Prevention, PRINC EP PUBL HLTH P
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cohen B, 1963, PRESS FOREIGN POLICY
   Doniz D, 2016, NY TIMES, P25
   Einsiedel EF, 2000, UNDERSTANDING PUBLIC, P144
   Falade B. A., 2017, S AFR J SCI, V113, P8, DOI DOI 10.17159/SAJS.2017/20160359
   Falade B, 2015, PAP SOC REPRESENT, V24
   Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544
   GERBNER G, 1969, AV COMMUN REV, V17, P137
   Giardullo P, 2018, MOSQUITO MANAGEMENT, P84
   Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166
   Groseclose SL, 2017, ANNU REV PUBL HEALTH, V38, P57, DOI 10.1146/annurev-publhealth-031816-044348
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Henning Kelly J, 2004, MMWR Suppl, V53, P5
   Herszenhorn D, 2016, NY TIMES, P15
   Hider J, 2016, THE TIMES OF LONDON, P34
   Hirst P, 2016, THE TIMES OF LONDON, P76
   Jacobs A, 2016, NY TIMES, P6
   Jacobs A, 2016, NY TIMES, P1
   Joffe H, 2002, SOC SCI MED, V54, P955, DOI 10.1016/S0277-9536(01)00068-5
   Jovchelovitch S, 2007, KNOWLEDGE CONTEXT RE
   Jovchelovitch S, 2015, CAMBRIDGE HANDBOOK OF SOCIAL REPRESENTATIONS, P163
   Kington T, 2016, NY TIMES, P5
   Maccur J, 2016, NY TIMES, P7
   MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990
   McNeil D, 2016, NY TIMES, P3
   McNeil D, 2015, NY TIMES, P6
   McQuail Denis, 1977, MASS COMMUNICATION S, P70
   Mockovici S., 1984, SOCIAL REPRESENTATIO, P3
   Moscovici S, 2008, PSYCHANALYSE SON IMA
   Muller O, 2016, EUR J INFORM SYST, V25, P289, DOI 10.1057/ejis.2016.2
   Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583
   Pan American Health Organization/World Health Organization, 2016, TIM EM ZIK VIR AM
   Park RE, 1940, AM J SOCIOL, V45, P669, DOI 10.1086/218445
   Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143
   Petersen J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015831
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   Romeo S, 2016, NY TIMES, P1
   Romero SA, 2016, NY TIMES, P4
   Santillana M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004513
   Senior J, 2016, NY TIMES, P1
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x
   SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507
   Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Sreeharsha V, 2016, NY TIMES, P10
   Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759
   Vora S., 2016, NY TIMES
   Washer P, 2006, SOC SCI MED, V63, P2141, DOI 10.1016/j.socscimed.2006.05.018
   Whipple T., 2016, THE TIMES OF LONDON, P1
   World Health Organization, THE HIST OF ZIK
   Wynne B., 1982, RATIONALITY RITUAL W
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   ZIMAN J, 1991, SCI TECHNOL HUM VAL, V16, P99, DOI 10.1177/016224399101600106
NR 65
TC 0
Z9 0
U1 5
U2 11
PU ACAD SCIENCE SOUTH AFRICA A S S AF
PI LYNWOOD RIDGE
PA PO BOX 72135, LYNWOOD RIDGE 0040, SOUTH AFRICA
SN 0038-2353
EI 1996-7489
J9 S AFR J SCI
JI S. Afr. J. Sci.
PD MAR-APR
PY 2019
VL 115
IS 3-4
BP 75
EP 83
AR 5290
DI 10.17159/sajs.2019/5290
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HQ8JO
UT WOS:000462671100018
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Johari, NA
   Toh, SY
   Voon, K
   Lim, PKC
AF Johari, N. A.
   Toh, S. Y.
   Voon, K.
   Lim, P. K. C.
TI Detection of Zika virus RNA in Aedes aegypti and Aedes albopictus larvae
   in Klang Valley, Peninsular Malaysia
SO TROPICAL BIOMEDICINE
LA English
DT Article
ID DENGUE; MOSQUITOS; OUTBREAK
AB We report the presence of Zika virus RNA in naturally infected field captured Aedes aegypti and Ae. albopictus mosquito larvae in Malaysia from May 2016 to April 2017. Zika virus RNA was detected (n = 30) in the larvae of both Aedes mosquito species. Phylogenetic analysis of the NS5 partial sequence of all positive samples shows that the circulating Zika virus in the field collected larvae are of the Asian lineage.
C1 [Johari, N. A.; Toh, S. Y.; Voon, K.; Lim, P. K. C.] Int Med Univ, 126,Jalan Jalil Perkasa 19, Kuala Lumpur 57000, Malaysia.
RP Johari, NA (corresponding author), Int Med Univ, 126,Jalan Jalil Perkasa 19, Kuala Lumpur 57000, Malaysia.
EM nuraliajohari@imu.edu.my
RI Johari, Nur Alia Binti/M-4536-2015; Voon, Kenny/AAF-8611-2019
OI Johari, Nur Alia Binti/0000-0003-4874-3164; 
FU International Medical University (IMU) internal research grant [IMU
   334/2015]
FX We thank the community at residential areas in Selangor and Kuala Lumpur
   for their support and assistance during field collections for the study.
   We also thank Professor Datuk Dr Lokman Hakim Bin Sulaiman for reviewing
   this manuscript and for his helpful comments. Funding: This work was
   supported by the International Medical University (IMU) internal
   research grant (Project ID: IMU 334/2015).
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bernama, 2016, ZIK 2 VIR STRAINS ID
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, SURV CONTR AED AEG A
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faiz M, 2017, TROP BIOMED, V34, P118
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mohd-Zaki AH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003159
   Rozilawati H, 2015, TROP BIOMED, V32, P49
   Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2015, EP AL NEUR SYNDR CON
NR 16
TC 1
Z9 1
U1 0
U2 3
PU MALAYSIAN SOC PARASITOLOGY TROPICAL MEDICINE
PI KUALA LUMPUR
PA C/O INST MEDICAL REEARCH, JALAN PAHANG, KUALA LUMPUR, 50588, MALAYSIA
SN 0127-5720
J9 TROP BIOMED
JI Trop. Biomed.
PD MAR
PY 2019
VL 36
IS 1
BP 310
EP 314
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HR1WT
UT WOS:000462927500032
DA 2020-07-08
ER

PT J
AU Favoretto, SR
   Araujo, DB
   Duarte, NFH
   Oliveira, DBL
   da Crus, NG
   Mesquita, F
   Leal, F
   Machado, RRG
   Gaio, F
   Oliveira, WF
   Zanotto, PMA
   Durigon, EL
AF Favoretto, Silvana R.
   Araujo, Danielle B.
   Duarte, Nayle F. H.
   Oliveira, Danielle B. L.
   da Crus, Nathalia G.
   Mesquita, Flavio
   Leal, Fabyano
   Machado, Rafael R. G.
   Gaio, Fernanda
   Oliveira, Walber F.
   Zanotto, Paolo M. A.
   Durigon, Edison L.
TI Zika Virus in Peridomestic Neotropical Primates, Northeast Brazil
SO ECOHEALTH
LA English
DT Article
DE Antibodies; Brazil; Neotropical primates; qRT-PCR; Zika virus
ID DENGUE VIRUS
AB Zika virus (ZIKV) is a mosquito-borne viral disease associated with fetal microcephaly and other central nervous system (CNS) symptomatology. It was first identified in a Rhesus macaque in Uganda in 1947 and later in humans (Zika fever). In 2015, ZIKV was notified in Northeast Brazil where it was associated with CNS alterations and with rapid epidemic spread. Considering that ZIKV infects Old World monkeys, the aim of this study was to follow its potential in neotropical primates. Here, we show the detection of ZIKV in marmosets and capuchin monkeys captured in Ceara state, Northeast Brazil. Nine (9/132) samples were positive by quantitative RT-PCR assay. Neutralizing antibodies in primates for ZIKV were also detected by PRNT. The ZIKV-positive samples were obtained from peridomestic animals captured in proximity to humans in areas with reports of ZIKV-associated microcephaly cases during the epidemic period. These results reiterate the molecular evidence of ZIKV infection in neotropical primates, and the temporal detection suggests that detection in primates occurred during the epidemic period in humans. However, a continuous surveillance is necessary to exclude the possibility of virus circulation and transmission in wild environments.
C1 [Favoretto, Silvana R.; Araujo, Danielle B.] Pasteur Inst Sao Paulo, Ave Paulista 393, BR-01311000 Sao Paulo, SP, Brazil.
   [Favoretto, Silvana R.; Araujo, Danielle B.; Oliveira, Danielle B. L.; da Crus, Nathalia G.; Mesquita, Flavio; Leal, Fabyano; Machado, Rafael R. G.; Zanotto, Paolo M. A.; Durigon, Edison L.] Univ Sao Paulo, Inst Biomed Sci, Lab Clin & Mol Virol, Ave Prof Lineu Prestes 1374,Room 225, BR-05508900 Sao Paulo, SP, Brazil.
   [Duarte, Nayle F. H.] Hlth Dept Ceara State NUVET SESA, Ctr Vector Borne Dis, Rua Tabajaras 268, BR-60060510 Fortaleza, Ceara, Brazil.
   [Gaio, Fernanda; Oliveira, Walber F.] Brazilian Inst Environm & Renewable Nat Resources, Wild Anim Screening Ctr CETAS, Rua Wilson Pereira 351, BR-60843150 Fortaleza, Ceara, Brazil.
RP Araujo, DB (corresponding author), Pasteur Inst Sao Paulo, Ave Paulista 393, BR-01311000 Sao Paulo, SP, Brazil.; Araujo, DB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Lab Clin & Mol Virol, Ave Prof Lineu Prestes 1374,Room 225, BR-05508900 Sao Paulo, SP, Brazil.
EM daniellebastos@usp.br
RI Araujo, Danielle B/M-9540-2013; de A. Zanotto, Paolo M./B-9286-2019;
   Oliveira, Danielle BL/H-8030-2015
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Oliveira, Danielle
   BL/0000-0002-3452-1336; Rahal Guaragna Machado,
   Rafael/0000-0001-6974-5092; Mesquita, Flavio/0000-0002-4200-7943;
   Oliveira, Danielle/0000-0002-0534-0886
FU Sao Paulo Research Foundation-FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/16333-1]; Coordination for the
   Improvement of Higher Level, or Education, Personnel-CAPESCAPES;
   National Council for Scientific and Technological
   Development-CNPqNational Council for Scientific and Technological
   Development (CNPq); Sao Paulo Research Foundation-FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX This study was funded by Sao Paulo Research Foundation-FAPESP (Grant
   2014/16333-1). Authors Araujo, Danielle and Machado, Rafael have
   received research grants from the Coordination for the Improvement of
   Higher Level, or Education, Personnel-CAPES. Author da Crus, Nathalia
   has received research grant from the National Council for Scientific and
   Technological Development-CNPq. Author Mesquita, Flavio has received
   research grant from the Sao Paulo Research Foundation-FAPESP.
CR Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   [Anonymous], 2007, WHO GUID PLAQ RED NE
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brazil Ministry of Health, 2014, SURV GUID EP NONH PR
   Brazil Ministry of Health, 2016, B EPIDEMIOLOGICO, V47
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Ceara State Health Department, 2017, EP REP MICR CNS MALF
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   de Oliveira EF, 2018, TRANSBOUND EMERG DIS, V65, P1094, DOI 10.1111/tbed.12829
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Faye O, 2015, PLOS NEGLECT TROP D, V15, P492, DOI [10.1186/s12879-015-1231-2, DOI 10.1186/S12879-015-1231-2]
   Ferreira MS, 2014, IMMUNOL LETT, V158, P126, DOI 10.1016/j.imlet.2013.12.008
   Forthofer RN, 2007, BIOSTATISTICS GUIDE, P269, DOI [10.1016/B978-0-12-369492-8.50015-7, DOI 10.1016/B978-0-12-369492-8.50015-7]
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   NIH-National Institutes of Health National Institute of allergy and Infectious Diseases, LID STAT WEB TOOLSPL
   Omatsu T, 2011, J GEN VIROL, V41, DOI [10. 1099/vir. 0. 060384-0, DOI 10.1099/VIR.0.060384-0]
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rylands A. B., 2015, SAPAJUS LIBIDINOSUS, DOI [10.2305/IUCN.UK.2015-1.RLTS.T136346A70613080.en, DOI 10.2305/IUCN.UK.2015-1.RLTS.T136346A70613080.EN]
   Rylands AB, 2008, CALLITHRIX JACCHUS I, DOI DOI 10.2305/IUCN.UK.2008
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Thompson SJ, 2017, ECOHEALTH, V14, P821, DOI 10.1007/s10393-017-1277-2
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Verona CES, 2006, TRATADO ANIMAIS SELV, P358
   WHO, 2017, ZIK FACT SHEET
   WHO-World Health Organization, 2017, HIST ZIK VIR DIG TIM
NR 36
TC 7
Z9 7
U1 2
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1612-9202
EI 1612-9210
J9 ECOHEALTH
JI EcoHealth
PD MAR
PY 2019
VL 16
IS 1
BP 61
EP 69
DI 10.1007/s10393-019-01394-7
PG 9
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA HQ1FQ
UT WOS:000462144000004
PM 30690661
DA 2020-07-08
ER

PT J
AU Simkins, J
   Coro, A
   Morris, M
   Camargo, JF
   Anjan, S
   Vianna, R
   Selvaggi, G
   Beduschi, T
   Tekin, A
   Morsi, M
   Abbo, L
AF Simkins, Jacques
   Coro, Ana
   Morris, Michele
   Camargo, Jose Fernando
   Anjan, Shweta
   Vianna, Rodrigo
   Selvaggi, Gennaro
   Beduschi, Thiago
   Tekin, Akin
   Morsi, Mahmoud
   Abbo, Lilian
TI Solid organ transplantation from Zika IgM positive donors: Not always a
   true positive
SO CLINICAL TRANSPLANTATION
LA English
DT Letter
ID VIRUS
C1 [Simkins, Jacques; Coro, Ana; Morris, Michele; Camargo, Jose Fernando; Anjan, Shweta; Abbo, Lilian] Univ Miami, Miller Sch Med, Dept Med Infect Dis, Miami, FL 33136 USA.
   [Vianna, Rodrigo; Selvaggi, Gennaro; Beduschi, Thiago; Tekin, Akin; Morsi, Mahmoud] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.
RP Simkins, J (corresponding author), Univ Miami, Miller Sch Med, Dept Med Infect Dis, Miami, FL 33136 USA.
EM jsimkins@med.miami.edu
RI Morsi, Mahmoud/AAP-4675-2020
OI Morsi, Mahmoud/0000-0001-7236-6966
CR Centers for Disease Control and Prevention, ZIK VIR DIS US 2015
   Hall V, 2018, MMWR-MORBID MORTAL W, V67, P265, DOI 10.15585/mmwr.mm6709a1
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Simkins J, 2018, AM J TRANSPLANT, V18, P731, DOI 10.1111/ajt.14582
   United Network for Organ Sharing (UNOS), GUID ORG DON TRANSPL
NR 8
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0902-0063
EI 1399-0012
J9 CLIN TRANSPLANT
JI Clin. Transplant.
PD MAR
PY 2019
VL 33
IS 3
AR e13492
DI 10.1111/ctr.13492
PG 2
WC Surgery; Transplantation
SC Surgery; Transplantation
GA HP7SB
UT WOS:000461888100018
PM 30786060
DA 2020-07-08
ER

PT J
AU Li, PC
   Jang, J
   Hsia, CY
   Groomes, PV
   Lian, W
   de Wispelaere, M
   Pitts, JD
   Wang, J
   Kwiatkowski, N
   Gray, NS
   Yang, PL
AF Li, Pi-Chun
   Jang, Jaebong
   Hsia, Chih-Yun
   Groomes, Patrice V.
   Lian, Wenlong
   de Wispelaere, Melissanne
   Pitts, Jared D.
   Wang, Jinhua
   Kwiatkowski, Nicholas
   Gray, Nathanael S.
   Yang, Priscilla L.
TI Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum
   Activity and Antiviral Efficacy in Vivo
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE flavivirus; antiviral; envelope protein inhibitor; viral entry
   inhibitor; fusion inhibitor; dengue virus
ID DENGUE VIRUS-INFECTION; ANTIBODY-DEPENDENT ENHANCEMENT; ENVELOPE
   PROTEIN; ENCEPHALITIS-VIRUS; ZIKA VIRUS; CROSS-REACTIVITY; ENTRY;
   GLYCOPROTEIN; DISEASE; IDENTIFICATION
AB Vaccines and antivirals to combat dengue, Zika, and other flavivirus pathogens present a major, unmet medical need. Vaccine development has been severely challenged by the antigenic diversity of these viruses and the propensity of non-neutralizing, cross-reactive antibodies to facilitate cellular infection and increase disease severity. As an alternative, direct-acting antivirals targeting the flavivirus envelope protein, E, have the potential to act via an analogous mode of action without the risk of antibody-dependent enhancement of infection and disease. We previously discovered that structurally diverse small molecule inhibitors of the dengue virus E protein exhibit varying levels of antiviral activity against other flaviviruses in cell culture. Here, we demonstrate that the broad-spectrum activity of several cyanohydrazones against dengue, Zika, and Japanese encephalitis viruses is due to specific inhibition of E-mediated membrane fusion during viral entry and provide proof of concept for pharmacological inhibition of E as an antiviral strategy in vivo.
C1 [Hsia, Chih-Yun; Groomes, Patrice V.; Lian, Wenlong; de Wispelaere, Melissanne; Pitts, Jared D.; Yang, Priscilla L.] Harvard Med Sch, Blavatnik Inst, Dept Microbiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
   [Li, Pi-Chun; Jang, Jaebong; Wang, Jinhua; Kwiatkowski, Nicholas; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 360 Longwood Ave, Boston, MA 02215 USA.
   [Li, Pi-Chun; Jang, Jaebong; Wang, Jinhua; Kwiatkowski, Nicholas; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, 360 Longwood Ave, Boston, MA 02215 USA.
RP Yang, PL (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Microbiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM priscilla_yang@hms.harvard.edu
RI de Wispelaere, Melissanne/S-3117-2019
OI de Wispelaere, Melissanne/0000-0002-0682-3054; Groomes,
   Patrice/0000-0001-5944-2493
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R56AI095499, R01AI095499,
   U19AI109740]; Blavatnik Biomedical Accelerator at Harvard University
FX Stephen C. Harrison and Ian Walker are thanked for technical assistance
   in expression of recombinant DENV E proteins. We thank the following
   colleagues for sharing reagents: Didier Musso and Nathalie Pardigon for
   Zika PF13-251013-18; John Aaskov for the hybridoma cell line producing
   Mab 6F3.1; Lee Gehrke for DENV2 New Guinea C virus; Aravinda de Silva
   for other DENV strains; Sean Whelan for VSV-eGFP reporter virus; Eva
   Harris for BHK-21 cells; Stephen C. Harrison for the synthetic DENV2 sE
   gene and insect cell lines. Kelly Arnett and the Center for
   Macromolecular Interactions and Jennifer Smith and the ICCB-Longwood
   Screening Facility provided access to instruments and technical support.
   We thank Brian Shoichet for help with the PAINS assays utilizing MDH.
   Isabella Zafra is thanked for performing antiviral assays in a
   preliminary phase of this work. This work was supported by NIH awards
   R56AI095499, R01AI095499, and U19AI109740 and an award from the
   Blavatnik Biomedical Accelerator at Harvard University.
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   CECILIA D, 1991, VIROLOGY, V181, P70, DOI 10.1016/0042-6822(91)90471-M
   Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Gaudin Y., 2002, FUSION BIOL MEMBRANE, V34, P379
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Halstead SB, 2016, J INFECT DIS, V214, P1793, DOI 10.1093/infdis/jiw340
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   HASEGAWA H, 1992, VIROLOGY, V191, P158, DOI 10.1016/0042-6822(92)90177-Q
   Hurrelbrink RJ, 2001, J VIROL, V75, P7692, DOI 10.1128/JVI.75.16.7692-7702.2001
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Lian WL, 2018, ACS INFECT DIS, V4, P1395, DOI 10.1021/acsinfecdis.8b00127
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Monath TP, 2002, J VIROL, V76, P1932, DOI 10.1128/JVI.76.4.1932-1943.2002
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710
   Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schmidt AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002627
   Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Stein DA, 2011, J VIROL, V85, P10154, DOI 10.1128/JVI.05298-11
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 52
TC 2
Z9 2
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD MAR
PY 2019
VL 5
IS 3
BP 460
EP 472
DI 10.1021/acsinfecdis.8b00322
PG 25
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA HO7ME
UT WOS:000461130800014
PM 30608640
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Abinaya, M
   Vaseehara, B
   Rekha, R
   Shanthini, S
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Al-Anbr, MN
AF Abinaya, Muthukumar
   Vaseehara, Baskaralingam
   Rekha, Ravichandran
   Shanthini, Sivakumar
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Al-Anbr, Mohammed N.
TI Microbial exopolymer-capped selenium nanowires - Towards new
   antibacterial, antibiofilm and arbovirus vector larvicides?
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Dengue; Lymphatic filariasis; Microbial pathogens; Nanobiotechnology;
   Nanoparticles, Zika virus
ID ONE-DIMENSIONAL NANOSTRUCTURES; ZINC-OXIDE NANOPARTICLES; SILVER
   NANOPARTICLES; AEDES-AEGYPTI; ANTIOXIDANT ACTIVITIES;
   STAPHYLOCOCCUS-AUREUS; CHEMICAL-COMPOSITION; ZNO NANOPARTICLES; MOSQUITO
   VECTORS; BORNE COMPOUNDS
AB Arboviral diseases and microbial pathogens resistant to commercially available drugs are on the rise. Herein, a facile microbial-based approach was developed to synthesize selenium nanowires (Se NWs) using microbial exopolymer (MEP) extracted from the Bacillus licheniformis (probiotic bacteria). MEP-Se NWs were characterized using UV-Visible, XRD, FTIR, HR-TEM, FE-SEM and EDX. An UV-Visible peak was detected at 330 nm while XRD spectrum data pointed out the crystalline nature of MEP-Se NWs. FTIR spectrum revealed functional groups with strong absorption peaks in the range 3898.52-477.97 cm(-1). FE-SEM and HR-TEM revealed that the obtained structures were nanowires of 10-30 nm diameter. Se presence was confirmed by EDX analysis. MEP-Se NWs at 100 mu g/ml highly suppressed the growth of both Gram ((-)) and Gram ((+)) bacteria. Further, microscopic analysis evidenced that 75 mu g/ml MEP-Se NWs suppressed biofilm formation. Hemolytic assays showed that MEP-Se NWs were moderately cytotoxic. In addition, LC50 values lower than 10 mu g/ml were estimated testing MEP-Se NWs on both Aedes aegypti and Culex quinquefasciatus 3rd instar larvae. Morphological and histological techniques were used to elucidate on the damages triggered in mosquito tissues, with special reference to midgut, post-exposure to MEP-Se NWs. Therefore, based on our findings, MEP-Se NWs can be considered for entomological and biomedical applications, with special reference to the management of biofilm forming microbial pathogens and arbovirus mosquito vectors.
C1 [Abinaya, Muthukumar; Vaseehara, Baskaralingam; Rekha, Ravichandran] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Block,6th Floor, Karaikkudi 630004, Tamil Nadu, India.
   [Shanthini, Sivakumar] Fdn Innovat Res Sci & Technol, Ctr Anim Sci Res & Extens Serv, NGO Colony Rd, Nagercoil 629002, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Govt Coll Women, Dept Zool, Kumbakonam 612001, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.; Al-Anbr, Mohammed N.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia.
RP Vaseehara, B (corresponding author), Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Block,6th Floor, Karaikkudi 630004, Tamil Nadu, India.; Alharbi, NS (corresponding author), King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia.
EM vaseeharanb@gmail.com; nalharbi1@ksu.edu.sa
RI /L-2836-2013; GOVINDARAJAN, MARIMUTHU/A-8070-2019; Alharbi, Naiyf
   S/B-9402-2019; Khaled, Jamal/D-8188-2017
OI /0000-0001-7018-5379; GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931;
   Muthukumar, Abinaya/0000-0002-9635-4852
FU RUSA-Phase 2.0 grant, Policy (TNMulti-Gen), Dept. of Edn. Govt of India
   [F.24-51/2014-U]; DST-INSPIRE fellowship, New Delhi, India [IF160623];
   Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [RG-1438-074]
FX The authors gratefully acknowledge the financial support of RUSA-Phase
   2.0 grant sanctioned No. F.24-51/2014-U, Policy (TNMulti-Gen), Dept. of
   Edn. Govt of India. M.A. thanks the support of DST-INSPIRE fellowship
   [IF160623], New Delhi, India. The authors extend their appreciation to
   the Deanship of Scientific Research at King Saud University for funding
   this work through research group No. RG-1438-074. The authors thank the
   Deanship of Scientific Research and RSSU at King Saud University for
   their technical support.
CR Abinaya M, 2018, ENVIRON SCI POLLUT R, V25, P18604, DOI 10.1007/s11356-018-2002-6
   Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   Beheshti N, 2013, J TRACE ELEM MED BIO, V27, P203, DOI 10.1016/j.jtemb.2012.11.002
   Benelli G, 2019, SAUDI J BIOL SCI, V26, P921, DOI 10.1016/j.sjbs.2018.06.007
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhattacharya D, 2005, CRIT REV BIOTECHNOL, V25, P199, DOI 10.1080/07388550500361994
   Brown K M, 2001, Public Health Nutr, V4, P593
   Chen H, 2010, MATER RES BULL, V45, P699, DOI 10.1016/j.materresbull.2010.02.016
   Chen JY, 2007, LANGMUIR, V23, P4120, DOI 10.1021/la063193y
   Chen WW, 2015, CARBOHYD POLYM, V132, P574, DOI 10.1016/j.carbpol.2015.06.064
   Das D, 2013, COLLOID SURFACE B, V111, P556, DOI 10.1016/j.colsurfb.2013.06.041
   Dhanjal S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-52
   Dharumadurai Dhanasekaran, 2013, Asian Pacific Journal of Tropical Disease, V3, P174
   Di JW, 2004, ELECTROANAL, V16, P644, DOI 10.1002/elan.200302855
   Divya M, 2018, J PHOTOCH PHOTOBIO B, V178, P211, DOI 10.1016/j.jphotobiol.2017.11.008
   Dwivedi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057404
   Elshikh M, 2016, BIOTECHNOL LETT, V38, P1015, DOI 10.1007/s10529-016-2079-2
   Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275
   Forootanfar H, 2014, J TRACE ELEM MED BIO, V28, P75, DOI 10.1016/j.jtemb.2013.07.005
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2011, PARASITOL RES, V109, P93, DOI 10.1007/s00436-010-2224-0
   Hariharan H, 2012, CHALCOGENIDE LETT, V9, P509
   Hong WY, 2014, BIOMATERIALS, V35, P9573, DOI 10.1016/j.biomaterials.2014.08.027
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006
   Jayaprakash V, 2011, BEST PRACT RES CL GA, V25, P507, DOI 10.1016/j.bpg.2011.09.006
   Khater H. F., 2018, INTRO CHAPTER GLOBAL, DOI [10.5772/intechopen.82331, DOI 10.5772/INTECHOPEN.82331]
   Kieliszek M, 2019, BIOL TRACE ELEM RES, V187, P328, DOI 10.1007/s12011-018-1390-2
   Klonowska A, 2005, APPL ENVIRON MICROB, V71, P5607, DOI 10.1128/AEM.71.9.5607-5609.2005
   Lai FR, 2010, CARBOHYD POLYM, V81, P323, DOI 10.1016/j.carbpol.2010.02.011
   Lampis S., 2012, ENVIRON ENG MANAG J, V11, P3
   Le Costaouec T, 2012, CARBOHYD POLYM, V90, P49, DOI 10.1016/j.carbpol.2012.04.059
   Leivers S, 2011, CARBOHYD RES, V346, P2710, DOI 10.1016/j.carres.2011.09.010
   Li SK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/40/405101
   Li YQ, 2014, ANGEW CHEM INT EDIT, V53, P5837, DOI 10.1002/anie.201310135
   Liu L., 2018, NAT COMMUN, V444, P1
   Liu XL, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.43
   Lu QY, 2006, CHEM MATER, V18, P159, DOI 10.1021/cm051082z
   Ma YR, 2005, LANGMUIR, V21, P6161, DOI 10.1021/la050801l
   Masek A, 2017, FOOD CHEM, V215, P501, DOI 10.1016/j.foodchem.2016.07.183
   Messarah M, 2012, EXP TOXICOL PATHOL, V64, P167, DOI 10.1016/j.etp.2010.08.002
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001
   Pavela R, 2018, ENVIRON SCI POLLUT R, V25, P10493, DOI 10.1007/s11356-017-0267-9
   Pavela R, 2017, J PEST SCI, V90, P683, DOI [10.1007/s10340-016-0828-6, 10.1007/s10340-016-0763-6]
   PEREZ C, 1990, Acta Biologiae et Medicinae Experimentalis, V15, P113
   Rajendran D, 2013, RES J BIOTECHNOL, V8, P1
   Ramya S, 2015, J TRACE ELEM MED BIO, V32, P30, DOI 10.1016/j.jtemb.2015.05.005
   Rekha R, 2019, J TRACE ELEM MED BIO, V51, P191, DOI 10.1016/j.jtemb.2018.10.017
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006
   Senthilkumaran C. K., 2007, ISRN NANOTECHNOL, V18, DOI [10.1088/0957-4484/18/40/405101, DOI 10.1088/0957-4484/18/40/405101]
   Shah CP, 2010, MATER RES BULL, V45, P1213, DOI 10.1016/j.materresbull.2010.05.013
   Shakibaie M, 2015, J TRACE ELEM MED BIO, V29, P235, DOI 10.1016/j.jtemb.2014.07.020
   Shakibaie M, 2013, PHARM BIOL, V51, P58, DOI 10.3109/13880209.2012.710241
   Shakibaie M, 2010, BIOTECHNOL APPL BIOC, V56, P7, DOI 10.1042/BA20100042
   Shen QA, 2010, ANAEROBE, V16, P380, DOI 10.1016/j.anaerobe.2010.06.006
   Shoeibi S, 2017, J TRACE ELEM MED BIO, V39, P135, DOI 10.1016/j.jtemb.2016.09.003
   Sowndarya P, 2017, ARTIF CELL NANOMED B, V45, P1490, DOI 10.1080/21691401.2016.1252383
   Srivastava N, 2013, POWDER TECHNOL, V244, P26, DOI 10.1016/j.powtec.2013.03.050
   Stiefel P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0376-x
   Sundararajan B, 2017, J TRACE ELEM MED BIO, V43, P187, DOI 10.1016/j.jtemb.2017.03.008
   Tam K, 2010, BIOSCI BIOTECH BIOCH, V74, P696, DOI 10.1271/bbb.90454
   Torres SK, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1236-3
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Turlo J, 2010, FOOD CHEM TOXICOL, V48, P1085, DOI 10.1016/j.fct.2010.01.030
   Velusamy P, 2015, IND CROP PROD, V66, P103, DOI 10.1016/j.indcrop.2014.12.042
   Vijayakumar S, 2015, SPECTROCHIM ACTA A, V137, P886, DOI 10.1016/j.saa.2014.08.064
   Wadhwani SA, 2016, APPL MICROBIOL BIOT, V100, P2555, DOI 10.1007/s00253-016-7300-7
   Wang HL, 2007, FREE RADICAL BIO MED, V42, P1524, DOI 10.1016/j.freeradbiomed.2007.02.013
   Wang YP, 2008, INT J BIOL MACROMOL, V43, P283, DOI 10.1016/j.ijbiomac.2008.06.011
   Wang ZL, 2008, J NANOSCI NANOTECHNO, V8, P27, DOI 10.1166/jnn.2008.N08
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087
   Xiong SL, 2006, CRYST GROWTH DES, V6, P1711, DOI 10.1021/cg060005t
   Yang F, 2012, INT J NANOMED, V7, P835, DOI 10.2147/IJN.S28278
   Yazdi MH, 2012, BIOL TRACE ELEM RES, V149, P22, DOI 10.1007/s12011-012-9402-0
   Ye SH, 2016, CARBOHYD POLYM, V142, P230, DOI 10.1016/j.carbpol.2016.01.058
   Ye SH, 2012, CARBOHYD POLYM, V87, P764, DOI 10.1016/j.carbpol.2011.08.057
   Yu K. X., 2015, ASIAN PAC J TROP DIS, V8
   Zhang JS, 2001, BIOFACTORS, V15, P27, DOI 10.1002/biof.5520150103
   Zhang WJ, 2011, COLLOID SURFACE B, V88, P196, DOI 10.1016/j.colsurfb.2011.06.031
   Zimmerman MT, 2015, J INORG BIOCHEM, V145, P30, DOI 10.1016/j.jinorgbio.2014.12.020
NR 91
TC 2
Z9 2
U1 2
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD MAR
PY 2019
VL 192
BP 55
EP 67
DI 10.1016/j.jphotobiol.2019.01.009
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA HO7LW
UT WOS:000461129700009
PM 30685584
DA 2020-07-08
ER

PT J
AU Estofolete, CF
   Terzian, ACB
   Colombo, TE
   Guimaraes, GD
   Ferraz, HC
   da Silva, RA
   Greque, GV
   Nogueira, ML
AF Estofolete, Cassia F.
   Terzian, Ana C. B.
   Colombo, Tatiana E.
   Guimaraes, Georgia de Freitas
   Ferraz Junior, Helio C.
   da Silva, Rafael A.
   Greque, Gilmar V.
   Nogueira, Mauricio L.
TI Co-infection between Zika and different Dengue serotypes during DENV
   outbreak in Brazil
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Arbovirus; Arbovi ruses; Co-infection; Dengue; Zika
ID MEDIUM-SIZED CITY; CLINICAL PRESENTATION; SEXUAL TRANSMISSION; VIRUS;
   CHIKUNGUNYA; INFECTION; PATIENT; STATE
AB Background: The recent introduction of new arboviruses in the Americas, as Zika virus (ZIKV) and Chikungunya virus (CHIKV), increased the risk of outbreaks and arboviral co-infections. Herein, we report twelve cases of co-infection of ZIKV and different DENV serotypes in a city located in the northwest region of Sao Paulo State, Brazil, which is hyper-endemic to Dengue.
   Methods: Between January and November 2016, 1254 suspected cases of arboviral infection were available by our surveillance program in Sao Jose do Rio Preto. All suspected patients were examined and, when they were arboviral disease-suspectd, had sera separated and viral RNA analyzed by PCR/qPCR assays to determine the diagnosis of DENV 1-4, ZIKV, or CHIKV in the same samples. After the molecular results, twelve patients with ZIKV-DENV coinfection were identified and their clinical and laboratory characteristics were described.
   Results: The mean between symptoms onset and collected sample of 3 days. DENV-1 was identified in seven co-infected patients and DEN2 in other five. Two patients presented alarm signs of Dengue and no one was hospitalized.
   Conclusions: The constant presence of co-circulating arboviruses increases the chance of co-infection and demonstrates the importance of the differential diagnosis, especially during periods of arboviral outbreaks. The impact of this co-infection is known individual and collectively. (C) 2018 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Estofolete, Cassia F.; Terzian, Ana C. B.; Guimaraes, Georgia de Freitas; Ferraz Junior, Helio C.; da Silva, Rafael A.; Nogueira, Mauricio L.] Sao Jose Do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Colombo, Tatiana E.] Univ Paulista, Campus Sao Jose Rio Preto, Sao Paulo, SP, Brazil.
   [Greque, Gilmar V.] Sao Jose Do Rio Preto Reg Sch Med Fdn FUNFARME, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Sao Jose Do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM cassiafestolete@gmail.com; anacarolinaterzian@gmail.com;
   taty_ec@hotmail.com; gfggeorgia@gmail.com; hcfjunior@gmail.com;
   rafa_m112@hotmail.com; greque@terra.com.br; mnogueira@famerp.br
RI Estofolete, Cassia/N-6673-2019; Ferraz, Helen/AAF-1060-2019; Nogueira,
   Mauricio L/B-7599-2012
OI Estofolete, Cassia/0000-0001-7324-1591; Nogueira, Mauricio
   L/0000-0003-1102-2419
FU Sao Paulo State Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3, 2015/12295-0];
   FAPESP Zika Network
FX This work is supported by the Sao Paulo State Research Foundation
   (FAPESP) [grant No. 2013/21719-3 for MLN and the 2015/12295-0 fellowship
   for ACBT]. This work was supported by the FAPESP Zika Network.
CR Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535
   [Anonymous], 2016, PROC SER AD VIG FEBR
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   BRASIL, 2016, DENG DIAGN MAN CLIN, P58
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   Chiaravalloti-Neto F, 1996, EPIDEMIOLOGIA DENGUE
   Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   Dhanoa A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1731-8
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI [10.1590/S0034-89102005000300016, 10.1590/s0034-89102005000300016]
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Vasconcelos P. F., 2005, TRATADO INFECTOLOGIA, P289
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 28
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAR-APR
PY 2019
VL 12
IS 2
BP 178
EP 181
DI 10.1016/j.jiph.2018.09.007
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HO2IV
UT WOS:000460738500005
PM 30301701
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Re: The Complex Interpretation and Management of Zika Virus Test Results
SO JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE
LA English
DT Letter
ID DIAGNOSIS
C1 [Yasri, Sora] KMT Primary Care Ctr, Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Dept Biol Sci, Pune, Maharashtra, India.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Med Ctr, Bangkok, Thailand.
CR Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lin KW, 2018, J AM BOARD FAM MED, V31, P924, DOI 10.3122/jabfm.2018.06.180061
   Mantke OD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090491
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 5
TC 0
Z9 0
U1 0
U2 0
PU AMER BOARD FAMILY MEDICINE
PI LEXINGTON
PA 2228 YOUNG DR, LEXINGTON, KY 40505 USA
SN 1557-2625
EI 1558-7118
J9 J AM BOARD FAM MED
JI J. Am. Board Fam. Med.
PD MAR-APR
PY 2019
VL 32
IS 2
BP 280
EP 281
DI 10.3122/jabfm.2019.02.180340
PG 3
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA HO1LG
UT WOS:000460666700022
PM 30850467
OA Bronze
DA 2020-07-08
ER

PT J
AU Lin, KW
   Kraemer, JD
   Piltch-Loeb, R
   Stoto, MA
AF Lin, Kenneth W.
   Kraemer, John D.
   Piltch-Loeb, Rachael
   Stoto, Michael A.
TI Response: Re: The Complex Interpretation and Management of Zika Virus
   Test Results
SO JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE
LA English
DT Letter
C1 [Lin, Kenneth W.] Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20057 USA.
   [Kraemer, John D.; Stoto, Michael A.] Georgetown Univ, Dept Hlth Syst Adm, Washington, DC 20057 USA.
   [Piltch-Loeb, Rachael] NYU, Coll Global Publ Hlth, New York, NY 10003 USA.
RP Lin, KW (corresponding author), Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20057 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER BOARD FAMILY MEDICINE
PI LEXINGTON
PA 2228 YOUNG DR, LEXINGTON, KY 40505 USA
SN 1557-2625
EI 1558-7118
J9 J AM BOARD FAM MED
JI J. Am. Board Fam. Med.
PD MAR-APR
PY 2019
VL 32
IS 2
BP 281
EP 281
DI 10.3122/jabfm.2019.02.180348
PG 1
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA HO1LG
UT WOS:000460666700023
OA Bronze
DA 2020-07-08
ER

PT J
AU Satyal, P
   Hieu, HV
   Chuong, NTH
   Hung, NH
   Sinh, LH
   The, PV
   Tai, TA
   Hien, VT
   Setzer, WN
AF Satyal, Prabodh
   Ho Viet Hieu
   Nguyen Thi Hong Chuong
   Nguyen Huy Hung
   Le Hoang Sinh
   Pham Van The
   Thieu Anh Tai
   Vu Thi Hien
   Setzer, William N.
TI Chemical composition, Aedes mosquito larvicidal activity, and repellent
   activity against Triatoma rubrofasciata of Severinia monophylla leaf
   essential oil
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Dengue fever; Trypanosomiasis; Sabinene; -Caryophyllene; Vector control;
   Vietnam
ID INSECTICIDE RESISTANCE; INHIBITORY-ACTIVITY; AMERICAN COCKROACH;
   CHAGAS-DISEASE; DENGUE; ACETYLCHOLINESTERASE; TOXICITY; L.;
   CONSTITUENTS; ATALANTIA
AB Aedes aegypti and Ae. albopictus are key vectors in the spread of arboviruses such as dengue, chikungunya, yellow fever, and Zika. Triatoma rubrofasciata is an assassin bug whose populations and association with humans have dramatically increased and may represent a serious health concern. Control of insect vectors is a logical course of action to prevent the spread of these insect-borne infections. This work presents the leaf essential oil composition, mosquito larvicidal activities, and insect-repellent activity of Severinia monophylla. The essential oil of S. monophylla from Vietnam was obtained by hydrodistillation and analyzed by gas chromatography and mass spectrometry. The major components were sabinene, -caryophyllene, bicyclogermacrene, germacrene D, (E)-nerolidol, globulol, and linalool. The leaf essential oil showed remarkable larvicidal activity against Ae. aegypti with LC50 (48h) of 7.1g/mL and Ae. albopictus with LC50 (48h) of 36g/mL. The essential oil also showed repellent activity on T. rubrofasciata at a concentration of 0.5%.
C1 [Satyal, Prabodh; Setzer, William N.] Aromat Plant Res Ctr, 230 N 1200 E,Suite 102, Lehi, UT 84043 USA.
   [Ho Viet Hieu] Duy Tan Univ, Parasitol & Entomol Unit, Dept Med, 03 Quang Trung, Da Nang, Vietnam.
   [Nguyen Thi Hong Chuong; Nguyen Huy Hung; Le Hoang Sinh] Duy Tan Univ, Ctr Adv Chem, Inst Res & Dev, 03 Quang Trung, Da Nang, Vietnam.
   [Pham Van The] Thu Dau Mot Univ, Ctr Sci Res & Practice, Phu Hoa Ward, 06 Tran Van On St, Thu Dau Mot City, Binh Duong Prov, Vietnam.
   [Thieu Anh Tai] Duy Tan Univ, Dept Pharm, 03 Quang Trung, Da Nang, Vietnam.
   [Vu Thi Hien] Ho Chi Minh City Univ Nat Resources & Environm, Fac Hydrometerol, Ho Chi Minh City, Vietnam.
   [Setzer, William N.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
RP Setzer, WN (corresponding author), Aromat Plant Res Ctr, 230 N 1200 E,Suite 102, Lehi, UT 84043 USA.; Hung, NH (corresponding author), Duy Tan Univ, Ctr Adv Chem, Inst Res & Dev, 03 Quang Trung, Da Nang, Vietnam.; Setzer, WN (corresponding author), Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
EM huyhung2602@gmail.com; wsetzer@chemistry.uah.edu
RI , Van The Pham/S-6239-2019; Satyal, Prabodh/AAA-4627-2020
OI , Van The Pham/0000-0002-1223-0175; Setzer, William
   N./0000-0002-3639-0528
FU Duy Tan University; doTERRA International
FX The authors are grateful to Duy Tan University for financial support of
   this research project. P.S. and W.N.S. participated in this work as part
   of the activities of the Aromatic Plant Research Center (APRC,
   https://aromaticplant.org/); we are grateful to doTERRA International
   (https://www.doterra.com/US/en) for the financial support of the APRC.
CR Abou-Taleb HK, 2016, NAT PROD RES, V30, P710, DOI 10.1080/14786419.2015.1038999
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Airy-Shaw HK, 1939, B MISC INF ROYAL BOT, V1939, P290
   Arun KD, 2015, INT J MOSQ RES A, V2, P25
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Baskar K, 2018, PHYSIOL MOL PLANT P, V101, P197, DOI 10.1016/j.pmpp.2017.03.002
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10515, DOI 10.1007/s11356-017-0635-5
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2012, B INSECTOL, V65, P177
   Bonesi M, 2010, J ENZYM INHIB MED CH, V25, P622, DOI 10.3109/14756360903389856
   Brummitt RK, 1998, TAXON, V47, P411, DOI 10.2307/1223771
   Casida John E., 2000, Agricultural Chemistry and Biotechnology, V43, P185
   Cheng SS, 2013, IND CROP PROD, V47, P310, DOI 10.1016/j.indcrop.2013.03.016
   Claver M. A., 2015, INT J RES STUD BIOSC, V3, P130
   DAMBOLENA JS, 2016, PSYCHE-CAMBRIDGE, V2016, DOI DOI 10.1155/2016/4595823
   Das AK, 2013, J ENVIRON BIOL, V34, P569
   Dekker T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-183
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Do TL, 2004, MED PLANTS DRUGS VIE
   Dohi S, 2009, J AGR FOOD CHEM, V57, P4313, DOI 10.1021/jf804013j
   Duc T, 2008, J SCI TECHNOL U DA N, V6, P71
   Dujardin JP, 2015, MEM I OSWALDO CRUZ, V110, P319, DOI 10.1590/0074-02760140446
   Quyen DL, 2018, AM J TROP MED HYG, V98, P402, DOI 10.4269/ajtmh.17-0630
   Enan E, 2001, COMP BIOCHEM PHYS C, V130, P325, DOI 10.1016/S1532-0456(01)00255-1
   Enan EE, 2005, ARCH INSECT BIOCHEM, V59, P161, DOI 10.1002/arch.20076
   Ferrero AA, 2006, FITOTERAPIA, V77, P381, DOI 10.1016/j.fitote.2006.03.004
   Ffrench-Constant RH, 2016, J NEUROGENET, V30, P163, DOI 10.1080/01677063.2016.1229781
   Finney D., 2009, PROBIT ANAL
   Giatropoulos A, 2013, PARASITOL RES, V112, P1113, DOI 10.1007/s00436-012-3239-5
   Gomez A, 2011, MEM I OSWALDO CRUZ, V106, P993, DOI 10.1590/S0074-02762011000800015
   Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Gross AD, 2013, ACS SYM SER, V1141, P97
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hijaz F, 2016, PLANT SIGNAL BEHAV, V11, P1
   Jankowska M, 2018, MOLECULES, V23, DOI 10.3390/molecules23010034
   Kamrin M.A, 1997, PESTICIDE PROFILES T
   Kang JS, 2013, PESTIC BIOCHEM PHYS, V105, P50, DOI 10.1016/j.pestbp.2012.11.007
   Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56
   Koutsaviti K, 2015, PARASITOL RES, V114, P583, DOI 10.1007/s00436-014-4220-2
   Lanteigne M, 2015, ARCH ENVIRON CON TOX, V68, P354, DOI 10.1007/s00244-014-0086-7
   Lardeux F, 2010, TROP MED INT HEALTH, V15, P1037, DOI 10.1111/j.1365-3156.2010.02573.x
   Laurent D, 1997, PHYTOTHER RES, V11, P285, DOI 10.1002/(SICI)1099-1573(199706)11:4<285::AID-PTR95>3.0.CO;2-T
   Leal-Cardoso JH, 2010, EUR J PHARMACOL, V645, P86, DOI 10.1016/j.ejphar.2010.07.014
   Lima B, 2011, CHEM BIODIVERS, V8, P924, DOI 10.1002/cbdv.201000230
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lopez MD, 2010, IND CROP PROD, V31, P284, DOI 10.1016/j.indcrop.2009.11.005
   Lopez SB, 2011, J AGR FOOD CHEM, V59, P5286, DOI 10.1021/jf104966b
   Masetti A, 2016, B INSECTOL, V69, P307
   Menichini F, 2009, FITOTERAPIA, V80, P297, DOI 10.1016/j.fitote.2009.03.008
   Mougabure-Cueto G, 2015, ACTA TROP, V149, P70, DOI 10.1016/j.actatropica.2015.05.014
   Nair K. Narayanan, 1995, Taxon, V44, P429, DOI 10.2307/1223423
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Narusuye K, 2005, J NEURAL TRANSM, V112, P193, DOI 10.1007/s00702-004-0187-y
   Nattudurai G, 2017, ENVIRON SCI POLLUT R, V24, P1619, DOI 10.1007/s11356-016-7857-9
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   Nour S. A., 2018, Journal of Pharmacognosy and Phytotherapy, V10, P56, DOI 10.5897/jpp2018.0488
   Ochocka JR, 2002, PHARM BIOL, V40, P395, DOI 10.1076/phbi.40.5.395.8452
   Olmedo R, 2015, Agriscientia, V32, P113
   Park IK, 2003, J STORED PROD RES, V39, P375, DOI 10.1016/S0022-474X(02)00030-9
   Patterson JS, 2001, MED VET ENTOMOL, V15, P443, DOI 10.1046/j.0269-283x.2001.00333.x
   Pavela R, 2018, ENVIRON SCI POLLUT R, V25, P10493, DOI 10.1007/s11356-017-0267-9
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pham HH, 2002, CAY CO VIETNAM AN IL
   Pino JA, 2006, J ESSENT OIL RES, V18, P24, DOI 10.1080/10412905.2006.9699376
   Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008
   Satyal P., 2015, THESIS
   Satyal P, 2013, NAT PROD COMMUN, V8, P1777
   Scalerandi E, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01579
   Scora R. W., 1994, Journal of Essential Oil Research, V6, P363
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1002/etc.5620190726, 10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2]
   Sugita N, 2018, APPL ENTOMOL ZOOL, V53, P519, DOI 10.1007/s13355-018-0583-7
   Tak JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42432
   Tanaka T, 1931, MEDED S RIJKS HERB L, V69, P4
   Thirugnanasampandan R, 2017, PHARM RES, V7, pS52
   Tong F, 2012, PEST MANAG SCI, V68, P1122, DOI 10.1002/ps.3280
   Tropicos, 2018, MISS BOT GARD
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wheeler GS, 2003, J CHEM ECOL, V29, P188
   WUNDERLIN RP, 1998, GUIDE VASCULAR PLANT
   Yeom HJ, 2015, J AGR FOOD CHEM, V63, P2241, DOI 10.1021/jf505927n
   Zarrad K, 2015, IND CROP PROD, V76, P121, DOI 10.1016/j.indcrop.2015.06.039
NR 89
TC 4
Z9 4
U1 5
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD MAR
PY 2019
VL 118
IS 3
BP 733
EP 742
DI 10.1007/s00436-019-06212-1
PG 10
WC Parasitology
SC Parasitology
GA HN8VJ
UT WOS:000460474600002
PM 30671730
DA 2020-07-08
ER

PT J
AU Suman, DS
AF Suman, Devi Shankar
TI Evaluation of enhanced oviposition attractant formulations against Aedes
   and Culex vector mosquitoes in urban and semi-urban areas
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Oviposition attractant; Ovitraps; Mosquito surveillance; Container
   mosquito; Arboviruses; Vector-borne diseases
ID ALBOPICTUS DIPTERA-CULICIDAE; EGG SURFACE-MORPHOLOGY; BG-SENTINEL TRAPS;
   LETHAL OVITRAP; RESPONSES; AEGYPTI; MORPHOMETRICS; AUSTRALIA; EFFICACY;
   NUISANCE
AB Surveillance is not only an important tool to assess the population dynamics of vector mosquitoes, but it can also be used to control vector-borne diseases. Mosquito vectors that belong to several genera such as Anopheles, Aedes, and Culex play a crucial role in the transmission of malaria, dengue, chikungunya, Zika, and elephantiasis diseases worldwide. We tested the efficacy of two commercial-grade oviposition attractant formulations that were developed for the container-inhabiting Aedes aegypti, Aedes albopictus, and Culex quinquefasciatus mosquitoes present in urban or semi-urban environments. These attractants can lure gravid females. Field trials were conducted in residential yards during a post-rainy season in September and October. Our data showed considerable efficacy for both attractants. Aedes-attractant collected 1.6-fold more larvae (101.2 +/- 10.5 larvae/trap) than the control, and Culex-attractant collected 1.27-fold more larvae (151.2 +/- 12.5 larvae/trap) than the control, resulting in 0.8 and 0.7 oviposition attraction indices (OAIs), respectively. Regression analysis indicated that the Aedes-attractant was more stable than the Culex-attractant. Location and time did not alter the efficacy of these attractants. Our experiment suggests that these attractants can be used for the development of species-specific gravid traps to detect, estimate, and control the mosquito population in urban and semi-urban areas.
C1 [Suman, Devi Shankar] Zool Survey India, Kolkata 700053, WB, India.
RP Suman, DS (corresponding author), Zool Survey India, Kolkata 700053, WB, India.
EM dssuman37@gmail.com
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Arunachalam N., 1999, Tropical Biomedicine, V16, P25
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Bellini R, 1996, J AM MOSQUITO CONTR, V12, P632
   BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153
   Abramides GC, 2011, T ROY SOC TROP MED H, V105, P281, DOI 10.1016/j.trstmh.2011.01.003
   Clements AN, 1992, BIOL MOSQUITOES DEV, P222
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Day JF, 2016, INSECTS, V7, DOI 10.3390/insects7040065
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Degener CM, 2015, MEM I OSWALDO CRUZ, V110, P517, DOI 10.1590/0074-02760140374
   Englbrecht C, 2015, J AM MOSQUITO CONTR, V31, P16, DOI 10.2987/14-6444.1
   Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gaugler R, 2017, COLLAPSIBLE STACKABL
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Jackson MJ, 2012, J AM MOSQUITO CONTR, V28, P292, DOI 10.2987/12-6241R.1
   Johnson BJ, 2017, J MED ENTOMOL, V54, P340, DOI 10.1093/jme/tjw166
   Kampen H, 2017, PARASITOL RES, V116, P3253, DOI 10.1007/s00436-017-5619-3
   KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111
   Organization WH, 2014, GLOB BRIEF VECT BORN
   Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x
   Ponnusamy L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1068-y
   Ponnusamy L, 2010, J CHEM ECOL, V36, P709, DOI 10.1007/s10886-010-9806-2
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Ritchie SA, 2009, MED VET ENTOMOL, V23, P295, DOI 10.1111/j.1365-2915.2009.00833.x
   Seenivasagan T, 2010, J MED ENTOMOL, V47, P329, DOI 10.1603/ME09130
   Sharma KR, 2008, PARASITOL RES, V103, P1065, DOI 10.1007/s00436-008-1094-1
   Sharma KR, 2009, PARASITOL RES, V104, P281, DOI 10.1007/s00436-008-1189-8
   Silver JB., 2007, MOSQUITO ECOLOGY FIE
   Sirivanakarn S., 1976, Contributions Am ent Inst, V12, P1
   Suman DS, 2008, PARASITOL RES, V104, P173, DOI 10.1007/s00436-008-1162-6
   Suman DS, 2009, J VECTOR ECOL, V34, P191, DOI [10.1111/j.1948-7134.2009.00026.x, 10.3376/038.034.0204]
   Suman DS, 2013, ACTA TROP, V128, P103, DOI 10.1016/j.actatropica.2013.06.025
   Suman DS, 2011, ARTHROPOD STRUCT DEV, V40, P479, DOI 10.1016/j.asd.2011.04.003
   Trexler JD, 1998, J MED ENTOMOL, V35, P967, DOI 10.1093/jmedent/35.6.967
   Unlu I, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2034-7
   Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 42
TC 1
Z9 1
U1 2
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD MAR
PY 2019
VL 118
IS 3
BP 743
EP 750
DI 10.1007/s00436-019-06228-7
PG 8
WC Parasitology
SC Parasitology
GA HN8VJ
UT WOS:000460474600003
PM 30719534
DA 2020-07-08
ER

PT J
AU Kumar, K
   Arshad, SS
   Toung, OP
   Abba, Y
   Selvarajah, GT
   Abu, J
   Yasmin, AR
   Ong, BL
   Bande, F
AF Kumar, Kiven
   Arshad, Siti Suri
   Toung, Ooi Peck
   Abba, Yusuf
   Selvarajah, Gayathri Thevi
   Abu, Jalila
   Yasmin, A. R.
   Ong, Bee Lee
   Bande, Faruku
TI The distribution of important sero-complexes of flaviviruses in Malaysia
SO TROPICAL ANIMAL HEALTH AND PRODUCTION
LA English
DT Review
DE Arthropod; Flavivirus; Human; Animal; Sero-complex
ID JAPANESE ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; DENGUE VIRUS; ZIKA VIRUS;
   CRYSTAL-STRUCTURE; TEMBUSU VIRUS; ENVELOPE GLYCOPROTEIN; ARBOVIRUS
   INFECTIONS; LANGAT VIRUS; KUNJIN VIRUS
AB Flaviviruses (FVs) are arthropod-borne viruses of medical and veterinary importance. Numerous species of FVs have been isolated from various host; mainly humans, animals, ticks, and mosquitoes. Certain FVs are extremely host-specific; at the same time, some FVs can infect an extensive range of species. Based on published literatures, 11 species of FVs have been detected from diverse host species in Malaysia. In humans, dengue virus and Japanese encephalitis virus have been reported since 1901 and 1942. In animals, the Batu Cave virus, Sitiawan virus, Carey Island, Tembusu virus, Duck Tembusu virus, and Japanese encephalitis viruses were isolated from various species. In mosquitoes, Japanese encephalitis virus and Kunjin virus were isolated from Culex spp., while Zika virus and Jugra virus were isolated from Aedes spp. In ticks, the Langat virus was isolated from Ixodes spp. One of the major challenges in the diagnosis of FVs is the presence of sero-complexes as a result of cross-reactivity with one or more FV species. Subsequently, the distribution of specific FVs among humans and animals in a specific population is problematic to assess and often require comprehensive and thorough analyses. Molecular assays such as quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and digital droplet RT-PCR (ddRT-PCR) have been used for the differentiation of flavivirus infections to increase the accuracy of epidemiological data for disease surveillance, monitoring, and control. In situations where sero-complexes are common in FVs, even sensitive assays such as qRT-pCR can produce false positive results. In this write up, an overview of the various FV sero-complexes reported in Malaysia to date and the challenges faced in diagnosis of FV infections are presented.
C1 [Kumar, Kiven; Arshad, Siti Suri; Abba, Yusuf; Bande, Faruku] Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang 43400, Selangor, Malaysia.
   [Toung, Ooi Peck; Selvarajah, Gayathri Thevi; Abu, Jalila] Univ Putra Malaysia, Fac Vet Med, Dept Vet Clin Studies, Serdang 43400, Selangor, Malaysia.
   [Yasmin, A. R.] Univ Putra Malaysia, Fac Vet Med, Dept Vet Lab Diagnost, Serdang 43400, Selangor, Malaysia.
   [Ong, Bee Lee] Univ Malaysia Kelantan, Fac Med City Campus, Dept Vet Clin Studies, Fac Vet, Locked Bag 36, Kota Baharu 16100, Kelantan, Malaysia.
RP Kumar, K; Arshad, SS (corresponding author), Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang 43400, Selangor, Malaysia.
EM kivenkumar@yahoo.com; suri@upm.edu.my
RI Abba, Yusuf/M-6836-2019; Abba, Yusuf/E-3154-2016; Bande,
   Faruku/D-4677-2011
OI Abba, Yusuf/0000-0001-7888-9004; Abba, Yusuf/0000-0001-7888-9004;
   Selvarajah, Gayathri Thevi/0000-0001-7240-9882; Bande,
   Faruku/0000-0003-1526-4028
FU Graduate Putra Initiative, Putra Grant [9492700]; Fundamental Research
   Grant Scheme from Universiti Putra Malaysia [FRGS-5535001]; Ministry of
   Higher Education MalaysiaMinistry of Education, Malaysia
FX The authors would like to acknowledge financial assistance from Graduate
   Putra Initiative, Putra Grant (9492700) and Fundamental Research Grant
   Scheme (FRGS-5535001) from Universiti Putra Malaysia and Ministry of
   Higher Education Malaysia, respectively.
CR Aldred J, 1990, COMMUN DIS INTEL, V22, P9
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   BANCROFT WH, 1976, AM J TROP MED HYG, V25, P500, DOI 10.4269/ajtmh.1976.25.500
   Banet-Noach C, 2003, AVIAN PATHOL, V32, P489, DOI 10.1080/0307945031000154080
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bharucha T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26333-4
   Blitvich BJ, 2008, ANIM HLTH RES REV MA, V19, P1
   BOWEN ETW, 1970, ANN TROP MED PARASIT, V64, P263, DOI 10.1080/00034983.1970.11686690
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   CRUICKSHANK EK, 1951, T ROY SOC TROP MED H, V45, P113, DOI 10.1016/S0035-9203(51)90624-4
   Dejnirattisai W, 2016, NATURE IMMUNOLOGY, V17, P1
   Dhimal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129869
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins S., 2016, F1000RESEARCH, V5, P1
   Fuzik T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02882-0
   Gamino V, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-39
   Gao XY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0270-z
   Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1
   Hall RA, 2001, ANN NY ACAD SCI, V951, P153
   HAMMON WM, 1956, P SOC EXP BIOL MED, V91, P521
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hirota J, 2010, J VET MED SCI, V72, P369, DOI 10.1292/jvms.09-0311
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hobson-Peters J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/379738
   Homonnay ZG, 2014, AVIAN PATHOL, V43, P552, DOI 10.1080/03079457.2014.973832
   Joubert J, 2018, NEUROEPIDEMIOLOGY IN TROPICAL HEALTH, P87, DOI 10.1016/B978-0-12-804607-4.00008-3
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   King A.M.Q., 2012, VIRUS TAXONOMY CLASS
   Kono Y, 2000, AM J TROP MED HYG, V63, P94, DOI 10.4269/ajtmh.2000.63.94
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar K, 2018, ACTA TROP, V185, P219, DOI 10.1016/j.actatropica.2018.05.017
   Kumar K, 2018, TROP ANIM HEALTH PRO, V50, P741, DOI 10.1007/s11250-017-1490-6
   LEAKE CJ, 1986, T ROY SOC TROP MED H, V80, P831, DOI 10.1016/0035-9203(86)90397-4
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   LEWIS L, 1947, ARCH NEURO PSYCHIATR, V57, P430, DOI 10.1001/archneurpsyc.1947.02300270048004
   Li J, 2016, CROSS PROTECTION IND, V2015, P1
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li XS, 2015, J CLIN MICROBIOL, V53, P2734, DOI 10.1128/JCM.00770-15
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lin J, 2015, AVIAN DIS, V59, P244, DOI 10.1637/10960-101514-Reg
   Liu PP, 2013, SCI CHINA LIFE SCI, V56, P701, DOI 10.1007/s11427-013-4515-z
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Lyons AC, 2018, VECTOR-BORNE ZOONOT, V18, P469, DOI 10.1089/vbz.2018.2283
   MacDONALD W. W., 1965, J MED ENTOMOL, V1, P335, DOI 10.1093/jmedent/1.4.335
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Mackenzie JS, 2007, PERSP MED V, V16, P201, DOI 10.1016/S0168-7069(06)16010-3
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marchette NJ, 1994, HDB ZOONOSES, P275
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Mohd-Zaki A., 2014, PLOS NEGLECT TROP D, V8, P1
   MONATH TP, 1996, FIELDS VIROLOGY, P961
   Mudin RN, 2015, INT MED J MALAYS, V14, P5
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Nath B, 2017, MICROB PATHOGENESIS, V111, P187, DOI 10.1016/j.micpath.2017.08.046
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   NOWAK T, 1987, VIROLOGY, V156, P127, DOI 10.1016/0042-6822(87)90443-0
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   O'Guinn ML, 2013, AM J TROP MED HYG, V89, P1023, DOI 10.4269/ajtmh.13-0160
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pang EL, 2016, ASIAN PAC J TROP MED, V9, P386, DOI 10.1016/j.apjtm.2016.03.004
   Parija S.C., 2012, TXB MICROBIOLOGY IMM
   Paterson P. Y., 1952, AM J TROP MED HYG, V66, P320
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Payne S, 2017, VIRUSES: FROM UNDERSTANDING TO INVESTIGATION, P1
   Platt GS, 1973, ANN TROP MED PARASIT, V69, P65
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Prakash S, 2017, VIROLOGY MYCOLOGY, V6, P27
   PRICE WH, 1967, AM J EPIDEMIOL, V86, P11, DOI 10.1093/oxfordjournals.aje.a120716
   Prikhod'ko GG, 2001, VIROLOGY, V286, P328, DOI 10.1006/viro.2001.0980
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Rumyantsev AA, 2006, J VIROL, V80, P1427, DOI 10.1128/JVI.80.3.1427-1439.2006
   Schweitzer BK, 2009, LABMEDICINE, V40, P493, DOI 10.1309/LM5YWS85NJPCWESW
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Skae FMT, 1902, BRIT MED J, V1902, P1581, DOI 10.1136/bmj.2.2185.1581-a
   SMITH C E G, 1956, J Hyg (Lond), V54, P569
   SMITH CEG, 1956, NATURE, V178, P581, DOI 10.1038/178581a0
   SMITH CEG, 1974, T ROY SOC TROP MED H, V68, P96, DOI 10.1016/0035-9203(74)90182-5
   Smith D. R., 2012, FLAVIVIRUS COMPENDIU
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106
   Sudeep AB, 2013, INDIAN J MED RES, V138, P257
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Tesh RB, 2002, EMERG INFECT DIS, V8, P245, DOI 10.3201/eid0803.010238
   Thongyuan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180013
   Upadhyay KR, 2013, JAPANESE ENCEPHALITI, P1
   Upadhyay RK, 2013, BIOMED RES INT, DOI 10.1155/2013/591290
   Vinomarlini G, 2011, SE ASIAN J TROP MED, V42, P94
   VYTHILINGAM I, 1994, J AM MOSQUITO CONTR, V10, P228
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   WHITEHEAD RH, 1968, T ROY SOC TROP MED H, V62, P439, DOI 10.1016/0035-9203(68)90096-5
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong SC, 2008, TROP MED INT HEALTH, V13, P52, DOI 10.1111/j.1365-3156.2007.01967.x
   Wu XL, 2017, J VIROL METHODS, V248, P166, DOI 10.1016/j.jviromet.2017.06.015
   Young P.R., 2013, MANSONS TROPICAL DIS, P129
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
NR 114
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0049-4747
EI 1573-7438
J9 TROP ANIM HEALTH PRO
JI Trop. Anim. Health Prod.
PD MAR
PY 2019
VL 51
IS 3
BP 495
EP 506
DI 10.1007/s11250-018-01786-x
PG 12
WC Agriculture, Dairy & Animal Science; Veterinary Sciences
SC Agriculture; Veterinary Sciences
GA HN8ZJ
UT WOS:000460487100001
PM 30604332
DA 2020-07-08
ER

PT J
AU Bovbjerg, ML
AF Bovbjerg, Marit L.
TI Current Resources for Evidence-Based Practice, March 2019
SO JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING
LA English
DT Article
ID ZIKA VIRUS-INFECTION; CESAREAN-SECTION; PRETERM BIRTH; HEALTH; WOMEN;
   DISPARITIES; INFANTS; BRAZIL; DONT
C1 [Bovbjerg, Marit L.] Oregon State Univ, Coll Publ Hlth & Human Sci, Milam Hall 103, Corvallis, OR 97331 USA.
RP Bovbjerg, ML (corresponding author), Oregon State Univ, Coll Publ Hlth & Human Sci, Milam Hall 103, Corvallis, OR 97331 USA.
EM marit.bovbjerg@oregonstate.edu
CR Alfirevic Z, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008991.pub3
   American College of Nurse-Midwives, 2016, ACNM POS STAT EL PRI
   American College of Obstetricians and Gynecologists & Society for Maternal-Fetal Medicine, 2014, OBST CAR CONS NUMB 1
   [Anonymous], 2019, OBSTET GYNECOL, V133, pE73, DOI 10.1097/AOG.0000000000003006
   [Anonymous], 1985, LANCET, V2, P436
   Belluz J., 2016, VOX             0122
   Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759
   Betran AP, 2018, LANCET, V392, P1358, DOI 10.1016/S0140-6736(18)31927-5
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7
   Bohren MA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub6
   Burcher P, 2016, BIRTH-ISS PERINAT C, V43, P346, DOI 10.1111/birt.12240
   Byron K, 2017, J MED ETHICS, V43, P334, DOI 10.1136/medethics-2016-103862
   Centers for Disease Control and Prevention, 2018, PREN CAR
   Centers for Disease Control and Prevention, 2018, PREGN WOM ZIK
   Curtin Sally C, 2015, Natl Vital Stat Rep, V64, P1
   Dodd JM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012024.pub2
   Duncan LG, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1319-3
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hosseini VM, 2018, WOMEN BIRTH, V31, P254, DOI 10.1016/j.wombi.2017.10.007
   Lawn JE, 2016, BEST PRACT RES CL OB, V36, P169, DOI 10.1016/j.bpobgyn.2016.07.004
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1
   Mazzoni A, 2011, BJOG-INT J OBSTET GY, V118, P391, DOI 10.1111/j.1471-0528.2010.02793.x
   McKinnon B, 2016, CAN MED ASSOC J, V188, pE19, DOI 10.1503/cmaj.150464
   Medley N, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012505.pub2
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   National Partnership for Women and Families, WHAT AR SOM FACT DRI
   Ota E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000230.pub5
   Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816
   Sandall J, 2018, LANCET, V392, P1349, DOI 10.1016/S0140-6736(18)31930-5
   Sandall J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub4
   Sangkomkamhang US, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006178.pub3
   Schroeder E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2292
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sheen K, 2018, J CLIN NURS, V27, P2523, DOI 10.1111/jocn.14219
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   WHO, 2018, ZIK VIR
   Wijma K, 1998, J PSYCHOSOM OBST GYN, V19, P84, DOI 10.3109/01674829809048501
   Wiklund I, 2018, LANCET, V392, P1288, DOI 10.1016/S0140-6736(18)32325-0
   World Health Organization, 2015, WHO STAT CAES SECT R
   Yoshida S, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010508
NR 43
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0884-2175
EI 1552-6909
J9 JOGNN-J OBST GYN NEO
JI JOGNN
PD MAR
PY 2019
VL 48
IS 2
BP 230
EP 248
DI 10.1016/j.jogn.2019.01.007
PG 19
WC Nursing; Obstetrics & Gynecology
SC Nursing; Obstetrics & Gynecology
GA HO1DV
UT WOS:000460646500015
PM 30735623
DA 2020-07-08
ER

PT J
AU Aponte, A
   Penilla, RP
   Rodriguez, AD
   Ocampo, CB
AF Aponte, Angelica
   Patricia Penilla, R.
   Rodriguez, Americo D.
   Ocampo, Clara B.
TI Mechanisms of pyrethroid resistance in Aedes (Stegomyia) aegypti from
   Colombia
SO ACTA TROPICA
LA English
DT Article
DE Aedes aegypti; Pyrethroids; Resistance; Insecticides; Glutathion
   S-transferases; kdr mutations
ID SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; CROSS-RESISTANCE; F1534C
   MUTATION; VECTOR; MOSQUITOS; VIRUS; DDT
AB In Colombia Aedes (Stegomyia) aegypti is the main vector of urban arboviruses such as dengue, chikungunya and Zika. This urban mosquito has a well-established capacity to develop insecticide resistance to different types of insecticides (pyrethroids, organochlorides, organophosphates), using multiple resistance mechanisms. An understanding of ongoing resistance mechanisms is critical to determining the activities of vector control programs.
   In order to identify the biochemical and molecular mechanisms associated with pyrethroid resistance in Colombia, three laboratory-selected strains resistant to DDT, Propoxur and lambdacyhalothrin, and 7 field collected strains were evaluated. CDC bioassays were performed to measure the susceptibility status to pyrethroid type I (permethrin) and II (deltamethrin and lambdacyhalothrin), and potential cross-resistance to different types of insecticides; organochlorine (DDT), carbamates (propoxur) and organophosphates (malathion). The enzymatic activity of esterases, glutathione S-transferases (GST) and P-450 monooxygenases were biochemically determined. Frequencies of kdr mutations Val1016Ile and Phe1534cys were determined through real-time PCR. The Rockefeller strain of Aedes (Stegomyia) aegypti was used as the susceptible control.
   The laboratory-selected strains "propoxur" and "lambdacyhalothrin" and one field population (Medellin (BF) F-2 were resistant to all evaluated pyrethroids. Six of the seven field populations as well as the laboratory-selected "DDT" strain were resistant to permethrin. All the evaluated strains were resistant to DDT. Cross-resistance between lambdacyhalothrin and propoxur was observed in the laboratory-selected strains; however, all field-collected strains were susceptible to propoxur and no evidence of malathion resistance was found. The main biochemical mechanism for resistance observed in the field-collected strains was related to the enzyme GST. Further, the frequencies of kdr mutations alleles associated with insecticide resistance were high and ranged from 0.02 to 0.72 for Ile1016 and from 0.44 to 0.99 for Cys1534. Strains with high frequencies of both kdr mutations were resistant to both type I and II pyrethroids. These results suggest that Ae. aegypti from Colombia have developed multiple resistance mechanisms associated with pyrethroid resistance; therefore a resistance management strategy against these field populations of Ae. Aegypti, incorporating these findings is strongly recommended.
C1 [Aponte, Angelica; Ocampo, Clara B.] CIDEIM, Carrera 125 19-225, Cali, Colombia.
   [Patricia Penilla, R.; Rodriguez, Americo D.] Inst Nacl Salud Publ Mexico, Ctr Reg Invest Salud Publ, Ave 4 Norte 19 Calle Poniente, Chiapas 307000, Tapachula, Mexico.
   [Ocampo, Clara B.] Univ ICESI, Calle 18 122-135, Cali, Colombia.
RP Ocampo, CB (corresponding author), CIDEIM, Carrera 125 19-225, Cali, Colombia.
EM aaponte017@gmail.com; penilla@insp.mx; americo@insp.mx;
   claraocampo@cideim.org.co
OI Penilla, R. Patricia/0000-0002-0780-1527
FU COLCIENCIASDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias [567-2012]; Banco de la Reptiblica de Colombia
   [3787-2016]; program "Desarrollo investigacion aplicada para contribuir
   a un modelo efectivo y sostenible de intervention del dengue en
   Santander, Casanare y Valle del Cauca" (Development of applied research
   to contribute to an effective and sustainable model of dengue [009];
   Fogarty International Center of the National Institutes of Health under
   AwaBanco de la Reptiblica de Colombia [3787-2016, D43TW006589]
FX The first author obtained a PhD scholarship [No 567-2012] from
   COLCIENCIAS during 2013-2017. This project was supported partially
   supported by Banco de la Reptiblica de Colombia. [Project No 3787-2016]
   and financed through the program "Desarrollo investigacion aplicada para
   contribuir a un modelo efectivo y sostenible de intervention del dengue
   en Santander, Casanare y Valle del Cauca" (Development of applied
   research to contribute to an effective and sustainable model of dengue
   intervention in Santander, Casanare and Valle del Cauca), financed by
   "Sistema General de Regalias (SGR), Fondo de Ciencia, Tecnologia e
   Innovacion (CTeI) aprobado por el Organo Colegiado de Administration y
   Decision (OCAD), mediante el Acuerdo 009 de 2013". Research reported in
   this publication was supported by the Fogarty International Center of
   the National Institutes of Health under AwaBanco de la Reptiblica de
   Colombia. [Project No 3787-2016] rd Number [D43TW006589]. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5
   Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Bento J., 2018, LEVELS RESISTANCE PY
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonner MR, 2010, CANCER CAUSE CONTROL, V21, P871, DOI 10.1007/s10552-010-9514-9
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brogdon William G, 2010, INSTRUCCIONES EVALUA, P1
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Atencia MC, 2016, BIOMEDICA, V36, P432, DOI 10.7705/biomedica.v36i3.2834
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x
   Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081
   Francis S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179673
   Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Granada Y, 2018, INSECTS, V9, DOI 10.3390/insects9010023
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   [Instituto Nacional de Salud Instituto Nacional de Salud. Informe epidemiologico], 2014, I NAC SAL, V27
   Karunamoorthi K, 2013, HEALTH SCOPE, V2, DOI 10.17795/jhealthscope-9840
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018
   Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005
   Maestre-Serrano R, 2012, WORLDS LARGEST SCI T, DOI [10.5772/31243, DOI 10.5772/31243]
   Maestre-Serrano R, 2014, PESTIC BIOCHEM PHYS, V116, P63, DOI 10.1016/j.pestbp.2014.09.014
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Ocampo CB, 2011, ACTA TROP, V118, P37, DOI 10.1016/j.actatropica.2011.01.007
   Padilla J.C., 2012, DENGUE EN COLOMBIA
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Ranson H., 2008, TROPIKA, P1
   Roldan S., 2013, BIOMEDICA, V33
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-rodriguez K., 2018, PARALLEL EVOLUTION V, P1, DOI [10.1038/s41598-018-25222-0, DOI 10.1038/S41598-018-25222-0]
   Santacoloma L, 2012, BIOMEDICA, V32, P333, DOI [10.7705/biomedica.v32i3.680, 10.1590/S0120-41572012000300004]
   Varon LS, 2010, REV PANAM SALUD PUBL, V27, P66, DOI 10.1590/S1020-49892010000100010
   Sritharan J, 2017, CANCER EPIDEMIOL, V48, P96, DOI 10.1016/j.canep.2017.04.006
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   *WHO, 2005, GUID LAB FIELD TEST, P1
   WHO, 2005, SAF PYR PUBL HLTH US
   WHO, 2006, PEST APPL THEIR APPL, V1, P125, DOI [10.1111/j.1439-0310.2006.01165.x, DOI 10.1111/J.1439-0310.2006.01165.X]
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 47
TC 2
Z9 2
U1 3
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAR
PY 2019
VL 191
BP 146
EP 154
DI 10.1016/j.actatropica.2018.12.021
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HN9CG
UT WOS:000460495200019
PM 30552882
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Suesdek, L
AF Suesdek, Lincoln
TI Microevolution of medically important mosquitoes - A review
SO ACTA TROPICA
LA English
DT Review
DE Culicidae; Vector-borne diseases; Evolution; Adaptation; Evolvability
ID QUINQUEFASCIATUS DIPTERA-CULICIDAE; AEDES-AEGYPTI POPULATIONS;
   GEOGRAPHIC GENETIC-VARIATION; ANOPHELES-DIRUS MOSQUITOS; CULEX-PIPIENS
   COMPLEX; INSECTICIDE RESISTANCE; WING GEOMETRY; MOLECULAR SYSTEMATICS;
   EVOLUTIONARY HISTORY; ZIKA VIRUS
AB This review intends to discuss central issues regarding the microevolution of mosquito (Culicidae) vectors of several pathogens and how this process impacts vector biology, disease transmission, and vector control attempts. On the microevolutionary context, it comparatively discusses the current knowledge on the population genetics of representatives of the genera Aedes, Anopheles and Culex, and comments on insecticide resistance of culicids. It also discusses other biological aspects of culicids that are not usually addressed in microevolutionary studies, such as vectorial competence, endosymbiosis, and wing morphology. One conclusion is that mosquitoes are highly genetically variable, adaptable, fast evolving, and have versatile vectorial competence. Unveiling microevolutionary patterns is fundamental for the design and maintenance of all control programs. Sampling methods for assessing microevolution must be standardized and must follow meaningful guidelines, such as those of "landscape genetics". A good understanding of microevolution requires more than a collection of case studies on population genetics and resistance. Future research could deal not only with the microevolution sense stricto, but also with evolutionarily meaningful issues, such as inheritable characters, epigenetics, physiological cost-free plasticity, vector immunity, symbiosis, pathogen-mosquito co-evolution and environmental variables. A genotyping panel for seeking adaptive phenotypes as part of the standardization of population genetics methods is proposed. The investigative paradigm should not only be retrospective but also prospective, despite the un-predictability of evolution. If we integrate all suggestions to tackle mosquito evolution, a global revolution to counter vector-borne diseases can be provoked.
C1 [Suesdek, Lincoln] Inst Butantan, Av Vital Brazil 1500, BR-05503900 Sao Paulo, SP, Brazil.
   [Suesdek, Lincoln] Univ Sao Paulo, Inst Med Trop, Av Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
RP Suesdek, L (corresponding author), Inst Butantan, Av Vital Brazil 1500, BR-05503900 Sao Paulo, SP, Brazil.
EM lincoln.suesdek@butantan.gov.br
RI Suesdek, Lincoln/C-7943-2013
OI Suesdek, Lincoln/0000-0001-6829-738X
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2006/02622-5, 2014/27172-9,
   2016/50008-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [23038.005.274/2011-24]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [311805/2014-0]
FX Grants were received from Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo #2006/02622-5, #2014/27172-9 and #2016/50008-6, from Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior, 23038.005.274/2011-24
   and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   #311805/2014-0.
CR Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Angella AF, 2007, MEM I OSWALDO CRUZ, V102, P953, DOI 10.1590/S0074-02762007000800010
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Ashfaq M, 2014, PLOS ONE, V9
   Athrey G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003097
   Ayres CFJ, 2004, J AM MOSQUITO CONTR, V20, P350
   Barillas-Mury C, 2005, CELL MICROBIOL, V7, P1539, DOI 10.1111/j.1462-5822.2005.00615.x
   Becker N, 2012, J AM MOSQUITO CONTR, V28, P53, DOI 10.2987/8756-971X-28.4s.53
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543
   BOSIO CF, 1992, J MED ENTOMOL, V29, P985, DOI 10.1093/jmedent/29.6.985
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Brochero H, 2010, AM J TROP MED HYG, V83, P585, DOI 10.4269/ajtmh.2010.09-0482
   Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brugman VA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020389
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Campos M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2014-y
   Campos M, 2012, ECOL EVOL, V2, P2794, DOI 10.1002/ece3.392
   Campos SS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2543-4
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Carballar-Lejarazu R, 2017, PATHOG GLOB HEALTH, V111, P424, DOI 10.1080/20477724.2018.1427192
   Carvalho G. C, 2017, PARASIT VECTORS, V10
   Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Chen L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002030
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Ciota AT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-305
   Coetzee M, 2013, ANNU REV ENTOMOL, V58, P393, DOI 10.1146/annurev-ento-120811-153628
   Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001
   Cornel A, 2012, J AM MOSQUITO CONTR, V28, P113, DOI 10.2987/8756-971X-28.4s.113
   Costantini C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P209
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deitz KC, 2012, MOL ECOL, V21, P4498, DOI 10.1111/j.1365-294X.2012.05724.x
   Donnelly MJ, 2016, TRENDS PARASITOL, V32, P197, DOI 10.1016/j.pt.2015.12.001
   Dujardin JP, 2008, INFECT GENET EVOL, V8, P875, DOI 10.1016/j.meegid.2008.07.011
   Dujardin Jean-Pierre Al, 2010, BMC Res Notes, V3, P266, DOI 10.1186/1756-0500-3-266
   Dumas E, 2016, INSECT MOL BIOL, V25, P800, DOI 10.1111/imb.12264
   Failloux AB, 1999, ANN SOC ENTOMOL FR, V35, P1
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Ferreira-de-Lima VH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2643-9
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Fonseca DM, 2009, INFECT GENET EVOL, V9, P1197, DOI 10.1016/j.meegid.2009.06.023
   Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247
   Fonseca DM, 2006, AM J TROP MED HYG, V74, P284, DOI 10.4269/ajtmh.2006.74.284
   Fraser JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006751
   Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x
   Gimnig JE, 1999, J MED ENTOMOL, V36, P23, DOI 10.1093/jmedent/36.1.23
   Gloria-Soria A, 2016, MED VET ENTOMOL, V30, P235, DOI 10.1111/mve.12153
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gomez-Diaz E, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00277
   Gorrochotegui-Escalante N, 2000, AM J TROP MED HYG, V62, P200, DOI 10.4269/ajtmh.2000.62.200
   Gorrochotegui-Escalante N, 2002, AM J TROP MED HYG, V66, P213, DOI 10.4269/ajtmh.2002.66.213
   Guidez A, 2017, AM J TROP MED HYG, V95, P443
   Hansen MHH, 2003, OIKOS, V102, P309, DOI 10.1034/j.1600-0706.2003.12537.x
   Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hendry AP, 2001, GENETICA, V112, P1, DOI 10.1023/A:1013368628607
   Humeres SG, 1998, MEM I OSWALDO CRUZ, V93, P57, DOI 10.1590/S0074-02761998000100011
   Ingham VA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07615-x
   Juneja P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004765
   Karthika P, 2018, ACTA TROP, V183, P84, DOI 10.1016/j.actatropica.2018.04.006
   Kayondo JK, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-59
   Kent RJ, 2007, J MED ENTOMOL, V44, P50, DOI 10.1603/0022-2585(2007)44[50:GDBCPF]2.0.CO;2
   King JG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03981-8
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   KUNO E, 1991, ANNU REV ENTOMOL, V36, P285, DOI 10.1146/annurev.en.36.010191.001441
   Leftwich PT, 2016, EVOL APPL, V9, P212, DOI 10.1111/eva.12280
   Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003
   Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004
   Lohmus M, 2012, INFECT ECOL EPIDEMIO, V2
   Lorenz C, 2017, INFECT GENET EVOL, V54, P205, DOI 10.1016/j.meegid.2017.06.029
   Lorenz C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0581-8
   Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851
   Low VL, 2014, MED VET ENTOMOL, V28, P157, DOI 10.1111/mve.12022
   Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9
   Manguin S, 2008, INFECT GENET EVOL, V8, P489, DOI 10.1016/j.meegid.2007.11.004
   Markianos K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145308
   Matthews SD, 2007, MED VET ENTOMOL, V21, P358, DOI 10.1111/j.1365-2915.2007.00703.x
   MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0
   Mayr E, 1942, SYSTEMATICS ORIGIN S
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Miles A, 2017, NATURE, V552, P96, DOI 10.1038/nature24995
   Mirabello L, 2008, MED VET ENTOMOL, V22, P109, DOI 10.1111/j.1365-2915.2008.00731.x
   Morais SA, 2012, REV INST MED TROP SP, V54, P325, DOI 10.1590/S0036-46652012000600007
   Moreno M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-137
   Motoki MT, 2012, INFECT GENET EVOL, V12, P1246, DOI 10.1016/j.meegid.2012.04.002
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Murugan K, 2016, PARASITOL RES, V115, P107, DOI 10.1007/s00436-015-4726-2
   Nayar JK, 2003, J MED ENTOMOL, V40, P882, DOI 10.1603/0022-2585-40.6.882
   Nayar JK, 2002, J MED ENTOMOL, V39, P854, DOI 10.1603/0022-2585-39.6.854
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Nkya TE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0480-z
   Offit K, 2011, HUM GENET, V130, P3, DOI 10.1007/s00439-011-1028-3
   Oshaghi MA, 2007, ACTA TROP, V101, P241, DOI 10.1016/j.actatropica.2007.02.006
   Osorio HC, 2014, MED VET ENTOMOL, V28, P103, DOI 10.1111/mve.12020
   Petersen V, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0740-6
   Pfeiler E, 2013, SCI WORLD J, DOI 10.1155/2013/724609
   Pierson JC, 2018, EVOL APPL, V11, P1162, DOI 10.1111/eva.12636
   Pinto J, 2002, MOL ECOL, V11, P2183, DOI 10.1046/j.1365-294X.2002.01587.x
   Poolprasert P, 2008, J VECTOR ECOL, V33, P158, DOI 10.3376/1081-1710(2008)33[158:GSAGFO]2.0.CO;2
   Popovici J, 2010, MEM I O CRUZ, V105
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Powell JR, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P101
   Rasgon JL, 2006, P R SOC B, V273, P1603, DOI 10.1098/rspb.2006.3493
   Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713
   Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042
   RIDLEY M, 2004, EVOLUTION
   Saarman NP, 2017, EVOL APPL, V10, P1031, DOI 10.1111/eva.12508
   Sarma DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-76
   Scarpassa VM, 2011, AM J TROP MED HYG, V85, P857, DOI 10.4269/ajtmh.2011.11-0150
   Shaikevich EV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1333-8
   Sharma AK, 2010, ACTA TROP, V116, P89, DOI 10.1016/j.actatropica.2010.06.003
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Simonato M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1429-1
   Sinka ME, 2011, PARASIT VECTORS, V4
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Srivastava H, 2010, INFECT GENET EVOL, V10, P620, DOI 10.1016/j.meegid.2010.04.002
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   TAUIL PL, 1985, CAD SAUDE PUBLICA, V1, P71
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x
   Trerotola M, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0041-3
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   Vadivalagan C, 2017, ACTA TROP, V169, P43, DOI 10.1016/j.actatropica.2017.01.020
   Vadivalagan C, 2016, PARASITOL RES, V115, P1149, DOI 10.1007/s00436-015-4847-7
   Venkatesan M, 2010, MOL ECOL, V19, P1573, DOI 10.1111/j.1365-294X.2010.04577.x
   Vidal PO, 2012, MEM I OSWALDO CRUZ, V107, P1030, DOI 10.1590/S0074-02762012000800011
   Vidal PO, 2012, INFECT GENET EVOL, V12, P591, DOI 10.1016/j.meegid.2011.11.013
   Vilcinskas A, 2017, ADV INSECT PHYSIOL, V53, P145, DOI 10.1016/bs.aiip.2017.05.001
   Walton C, 2001, MOL ECOL, V10, P569, DOI 10.1046/j.1365-294x.2001.01201.x
   Walton C, 2000, MOL BIOL EVOL, V17, P962, DOI 10.1093/oxfordjournals.molbev.a026377
   Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140
   Werblow A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102158
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wilke A. B. B, 2016, PLOS ONE, V11, P1
NR 142
TC 1
Z9 1
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAR
PY 2019
VL 191
BP 162
EP 171
DI 10.1016/j.actatropica.2018.12.013
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HN9CG
UT WOS:000460495200021
PM 30529448
DA 2020-07-08
ER

PT J
AU Gregory, N
   Ewers, RM
   Chung, AYC
   Cator, LJ
AF Gregory, Nichar
   Ewers, Robert M.
   Chung, Arthur Y. C.
   Cator, Lauren J.
TI El Nino drought and tropical forest conversion synergistically determine
   mosquito development rate
SO ENVIRONMENTAL RESEARCH LETTERS
LA English
DT Article
DE El Nino; drought; Aedes albopictus; tropical forest; oil palm;
   mosquitoes
ID AEDES-ALBOPICTUS DIPTERA; SENSU-STRICTO DIPTERA; OIL PALM; HOST-SEEKING;
   TEMPERATURE-FLUCTUATIONS; MALARIA TRANSMISSION; AEGYPTI DIPTERA; ADULT
   SIZE; MICROCLIMATE; CULICIDAE
AB Extreme warming events can profoundly alter the transmission dynamics of mosquito-borne diseases by affecting mosquito life-history traits (e.g. survival, growth and reproduction). At local scales, temperatures are determined largely by vegetation structure and can be dramatically altered by drivers of land-use change (e.g. forest conversion). Disturbance activities can also hinder the buffering capacity of natural habitats, making them more susceptible to seasonal climate variation and extreme weather events (e.g. droughts). In experiments spanning three years, we investigated the interactive effects of tropical forest conversion and climate on fine-scale temperature, and the consequences for mosquito larval development. This study was conducted in the northern Malaysian Bornean state of Sabah using local Aedes albopictus mosquitoes; important vectors of dengue, chikungunya and Zika viruses. We demonstrate that variation in temperatures due to forest conversion dramatically increases development rates in Ae. albopictus mosquitoes. However, this effect was mediated by an El Nino Southern Oscillation (ENSO) drought event. In normal years, mean temperatures did not differ between land-use types, however mosquitoes reared in oil palm plantations typically emerged 2-3 days faster than in logged forests. During an ENSO drought, mean temperatures did differ between land-use types, but surprisingly this did not result in different mosquito development rates. Driving this idiosyncratic response may be the differences in daily temperature fluctuations between the land-use types that either push mosquito larvae towards optimal development, or over the thermal optimum, thereby reducing fitness. This work highlights the importance of considering the synergistic effects of land-use and seasonal climate variations for predicting the thermal response of a key mosquito life-history trait driving disease transmission dynamics.
C1 [Gregory, Nichar; Ewers, Robert M.; Cator, Lauren J.] Imperial Coll London, Dept Life Sci, Silwood Pk,Buckhurst Rd, Ascot SL5 7PY, Berks, England.
   [Chung, Arthur Y. C.] Forest Res Ctr, Forestry Dept, POB 1407, Sandakan 90715, Sabah, Malaysia.
RP Gregory, N (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk,Buckhurst Rd, Ascot SL5 7PY, Berks, England.
EM n.gregory15@imperial.ac.uk
OI Gregory, Nichar/0000-0002-0872-9950
FU Imperial College London Grantham Institute for Climate Change Research
   Science and Solutions for a Changing Planet doctoral training program
   (SSCP DTP); Sime Darby Foundation
FX This study was supported by an Imperial College London Grantham
   Institute for Climate Change Research Science and Solutions for a
   Changing Planet doctoral training program (SSCP DTP) studentship awarded
   to NG, and Sime Darby Foundation funding to the SAFE Project. Permission
   to conduct research was provided by the Sabah Biodiversity Council,
   Yayasan Sabah, Maliau Basin Management Committee, and the Southeast Asia
   Rainforest Research Partnership (SEARRP). Logistical support was
   provided by the SAFE project coordinator, Ryan Gray, and the fieldwork
   support by the SAFE project field staff. Two anonymous reviewers
   provided helpful comments on a previous version of the manuscript.
CR Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548
   Angilletta MJ Jr, 2009, THERMAL ADAPTATION T, DOI [10.1093/icb/icq003, DOI 10.1093/ICB/ICQ003]
   Araujo MD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-261
   Aussenac G, 2000, ANN FOR SCI, V57, P287
   Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Chaves LF, 2012, PARASITOLOGY, V139, P14, DOI 10.1017/S0031182011001685
   Conn JE, 2002, AM J TROP MED HYG, V66, P18, DOI 10.4269/ajtmh.2002.66.18
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Ewers RM, 2011, PHILOS T R SOC B, V366, P3292, DOI 10.1098/rstb.2011.0049
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243
   Fornace K, 2016, INFECT DIS
   Frey SJK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501392
   GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0
   Hardwick SR, 2015, AGR FOREST METEOROL, V201, P187, DOI 10.1016/j.agrformet.2014.11.010
   Hashizume M, 2009, P NATL ACAD SCI USA, V106, P1857, DOI 10.1073/pnas.0806544106
   HUEY RB, 1979, AM ZOOL, V19, P357
   HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Kovacs B, 2017, AGR FOREST METEOROL, V234, P11, DOI 10.1016/j.agrformet.2016.11.268
   L'Heureux ML, 2017, B AM METEOROL SOC, V98, P1363, DOI 10.1175/BAMS-D-16-0009.1
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Luskin MS, 2011, BASIC APPL ECOL, V12, P540, DOI 10.1016/j.baae.2011.06.004
   LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775
   Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502
   Meijide A, 2018, AGR FOREST METEOROL, V252, P208, DOI 10.1016/j.agrformet.2018.01.013
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   NASCI RS, 1994, J MED ENTOMOL, V31, P123, DOI 10.1093/jmedent/31.1.123
   Null J., 2016, NINO NINA YEARS INTE
   Paaijmans KP, 2011, BIOL LETT, V8
   Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107
   Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106
   PARKER AH, 1952, B ENTOMOL RES, V43, P221, DOI 10.1017/S0007485300030698
   Perez-Diaz JL, 2012, J COLLOID INTERF SCI, V381, P180, DOI 10.1016/j.jcis.2012.05.034
   Pfeifer M, 2016, REMOTE SENS ENVIRON, V176, P84, DOI 10.1016/j.rse.2016.01.014
   R Core Team, 2014, R LANG ENV STAT COMP
   Renaud V, 2011, THEOR APPL CLIMATOL, V105, P119, DOI 10.1007/s00704-010-0361-0
   Riutta T, 2018, GLOBAL CHANGE BIOL, V24, P2913, DOI 10.1111/gcb.14068
   Sabajo CR, 2017, BIOGEOSCIENCES, V14, P4619, DOI 10.5194/bg-14-4619-2017
   Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415
   Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639
   Vincenti-Gonzalez MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24003-z
   Walsh RPD, 1999, PHILOS T R SOC B, V354, P1869, DOI 10.1098/rstb.1999.0528
   Walsh RPD, 1996, J TROP ECOL, V12, P385, DOI 10.1017/S0266467400009585
   Zirbel Kylie, 2018, Royal Society Open Science, V5, P180539, DOI 10.1098/rsos.180539
NR 52
TC 1
Z9 1
U1 2
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-9326
J9 ENVIRON RES LETT
JI Environ. Res. Lett.
PD MAR
PY 2019
VL 14
IS 3
AR 035003
DI 10.1088/1748-9326/ab0036
PG 8
WC Environmental Sciences; Meteorology & Atmospheric Sciences
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences
GA HN9RA
UT WOS:000460535400002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Zimler, RA
   Alto, BW
AF Zimler, Rebecca A.
   Alto, Barry W.
TI Florida Aedes aegypti (Diptera: Culicidae) and Aedes albopictus Vector
   Competency for Zika Virus
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE infection; transmission potential; Florida Zika vectors
ID MOSQUITOS; OUTBREAK
AB Zika virus (ZIKV) first spread into Brazil in 2013 and is now present throughout the Americas. In 2016, Florida witnessed the beginnings of local ZIKV transmission. No reports of local transmission have been reported for 2018; however, travel related cases continue to be reported. Recurrence of local transmission in the United States is a major public health risk in Florida where vectors Aedes aegypti (Diptera: Culicidae, Linnaeus) and Aedes albopictus (Diptera: Culicidae, Skuse) are abundant and there is a high potential for virus reintroduction. A dose-response study was used to evaluate susceptibility and transmission potential of Florida Ae. aegypti and Ae. albopictus to ZIKV originating from Puerto Rico. Mosquitoes were orally exposed to one of three doses of ZIKV. Higher doses of infected blood resulted in overall greater infection rates in both mosquito species. Ae. aegypti and Ae. albopictus were susceptible to infection with ZIKV and revealed a significant species by dose interaction. At low doses, Ae. aegypti was significantly less susceptible to infection with ZIKV than Ae. albopictus (6.7% and 44.4%, respectively). In contrast, at high doses, Ae. aegypti was significantly more susceptible to infection than Ae. albopictus (75.8% and 53.8%, respectively). No significant differences were observed between Ae. aegypti and Ae. albopictus in disseminated infection (0-75%) and saliva infection (0-52.4%). These observations suggest greater susceptibility to infection for Ae. albopictus at lower doses likely encountered by viremic humans. However, low disseminated infection and saliva infection for Ae. albopictus, combined with catholic feeding behavior, are likely to limit transmission potential relative to Ae. aegypti.
C1 [Zimler, Rebecca A.; Alto, Barry W.] Univ Florida, IFAS, Florida Med Entomol Lab, Dept Entomol & Nematol, 200 9th St SE, Vero Beach, FL 32962 USA.
RP Alto, BW (corresponding author), Univ Florida, IFAS, Florida Med Entomol Lab, Dept Entomol & Nematol, 200 9th St SE, Vero Beach, FL 32962 USA.
EM bwalto@ufl.edu
FU Florida Department of Agriculture and Consumer Services [024378];
   Florida Department of Health [7ZK15]
FX We thank L. P. Lounibos, M. C. Carrasquilla, S. Deleveaux, and T. Swan
   for the collection and establishment of the mosquito colonies used in
   this research, S. Bellamy, B. Eastmond, S. Ortiz, and K. Wiggins for
   assistance with the experiment, and J. Colee for assistance with
   statistical analysis. ZIKV (strain PRVABC59) was kindly provided by the
   Centers of Disease Control. This research was supported by grants from
   the Florida Department of Agriculture and Consumer Services (contract
   024378) and the Florida Department of Health (contract 7ZK15).
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2018, ZIK VIR
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Di Luca M, 2016, EUROSURVEILLANCE, V5, P1
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Florida Department of Health (FDOH), 2018, CHIK FEV CHIK
   Florida Department of Health (FDOH), 2018, ZIK FREE FLOR
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   PAHO, 2015, EP AL INCR MICR NE B
   Pan American Health Organization (PAHO), 2016, EP UPD NEUR SYNDR CO
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Teets Frank D, 2014, Virol Rep, V1-2, P2
   Vazeille M, 2003, AM J TROP MED HYG, V68, P203, DOI 10.4269/ajtmh.2003.68.203
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 32
TC 3
Z9 3
U1 2
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2019
VL 56
IS 2
BP 341
EP 346
DI 10.1093/jme/tjy231
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HO0WY
UT WOS:000460627600007
PM 30668772
OA Bronze
DA 2020-07-08
ER

PT J
AU Reed, EMX
   Byrd, BD
   Richards, SL
   Eckardt, M
   Williams, C
   Reiskind, MH
AF Reed, Emily M. X.
   Byrd, Brian D.
   Richards, Stephanie L.
   Eckardt, Megan
   Williams, Carl
   Reiskind, Michael H.
TI A Statewide Survey of Container Aedes Mosquitoes (Diptera: Culicidae) in
   North Carolina, 2016: A Multiagency Surveillance Response to Zika Using
   Ovitraps
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes albopictus; Aedes triseriatus; Aedes japonicus; distribution
ID ALLIED TAXA DIPTERA; STEGOMYIA ALBOPICTUS; HABITAT SEGREGATION;
   MORPHOLOGICAL DATA; UNITED-STATES; VIRUS; AEGYPTI; CLASSIFICATION;
   CHIKUNGUNYA; PHYLOGENY
AB Native and invasive container-inhabiting Aedes mosquitoes (Diptera: Culicidae) play important roles in the transmission of endemic and traveler-introduced arboviruses in the United States. In response to the emergence of Zika virus into the Americas, we surveyed the distribution of container Aedes spp. of public health importance within North Carolina during 2016 using ovitraps. A seasonal survey was conducted in 18 counties from the mountains to the coast to identify species incriminated in the transmission of chikungunya, dengue, La Crosse, yellow fever, and Zika viruses. Multiple local, state, and federal agencies participated in the study and submitted more than 3,600 ovistrips. Aedes albopictus (Skuse) (81.4%, n = 54,458) was the most common and widespread species found in this survey, followed by Aedes triseriatus (Say) (10.7%, n = 7,169) and Aedes japonicus (Theobald) (7.9%, n = 5,262). We did not find Aedes aegypti and rarely found Aedes hendersoni (Cockerell). We assessed broad-scale climatic and other factors and determined that longitude, elevation, rainfall, and temperature had significant effects on explaining the variation in presence, abundance, and phenology of container Aedes in North Carolina. However, much of the variation in these outcomes was not explained at this coarse scale and may benefit from finer-scale analyses. These efforts represent the largest ovitrap survey ever conducted in the state.
C1 [Reed, Emily M. X.; Reiskind, Michael H.] North Carolina State Univ, Dept Entomol & Plant Pathol, 100 Derieux Pl, Raleigh, NC 27695 USA.
   [Byrd, Brian D.; Eckardt, Megan] Western Carolina Univ, Environm Hlth Sci Program, Vectorborne Infect Dis Lab, 3971 Little Savannah Rd,CHHS 416, Cullowhee, NC 28723 USA.
   [Richards, Stephanie L.] East Carolina Univ, Environm Hlth Sci Program, Dept Hlth Educ & Promot, 3403 Carol Belk Bldg,300 Curry Court, Greenville, NC 27858 USA.
   [Williams, Carl] North Carolina Div Publ Hlth, Communicable Dis Branch, 1902 Mail Serv Ctr, Raleigh, NC 27699 USA.
RP Reiskind, MH (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, 100 Derieux Pl, Raleigh, NC 27695 USA.
EM mhreiski@ncsu.edu
RI Reiskind, Michael Hay/I-5614-2012
OI Reiskind, Michael/0000-0001-7307-9416
FU NC DHHS subcontract [DHHS 33894, NCDHHS AA908]
FX We wish to thank the participating agencies and their dedicated
   personnel. Anastasia Figurskey (NCSU), Avian White (ECU), and Joe Davis
   (WCU) processed ovistrips in the university laboratories. Jesse Bell
   (NOAA National Centers for Environmental Information, Asheville, NC)
   provided climate data. We thank three anonymous reviewers who spent
   considerable time improving this manuscript. This work was supported by
   an NC DHHS subcontract to ECU, NCSU, and WCU (DHHS 33894) and through
   NCDHHS AA908 assistance to local Health Departments (Larry Michael, NC
   DHHS Environmental Health Section). We dedicate this manuscript to Dr.
   Bruce Harrison whose longstanding service to the citizens of NC and
   persistent efforts documenting the presence of native and invasive
   mosquitoes within the state remain greatly appreciated.
CR Barton K, 2018, MU MLN MULTIMODEL IN
   Cohnstaedt LW, 2016, AM BIOL TEACH, V78, P317, DOI 10.1525/abt.2016.78.4.317
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Del Rosario KL, 2014, J ENVIRON HEALTH, V76, P8
   Gaensbauer JT, 2014, PEDIATRICS, V134, pE642, DOI 10.1542/peds.2014-0498
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler D.J., 1997, DENGUE DENGUE HEMORR
   Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006145
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Harris MC, 2015, EMERG INFECT DIS, V21, P646, DOI 10.3201/eid2104.140734
   Harrison B. A, 2016, MOSQUITOES MID ATLAN, V2016-01
   Hopperstad KA, 2016, J MED ENTOMOL, V53, P836, DOI 10.1093/jme/tjw050
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Reeves WK, 2004, ZOOTAXA, P1
   Reinert JF, 2008, ZOOL J LINN SOC-LOND, V153, P29, DOI 10.1111/j.1096-3642.2008.00382.x
   Reinert JF, 2006, ZOOL J LINN SOC-LOND, V148, P1, DOI 10.1111/j.1096-3642.2006.00254.x
   Reiskind MH, 2017, MED VET ENTOMOL, V31, P44, DOI 10.1111/mve.12193
   Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Silver J.B., 2008, MOSQUITO ECOLOGY FIE
   Szumlas DE, 1996, J MED ENTOMOL, V33, P598, DOI 10.1093/jmedent/33.4.598
   Vanlandingham DL, 2016, J MED ENTOMOL, V53, P1024, DOI 10.1093/jme/tjw025
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Westby KM, 2015, J AM MOSQUITO CONTR, V31, P233, DOI 10.2987/moco-31-03-233-241.1
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
NR 30
TC 1
Z9 1
U1 2
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2019
VL 56
IS 2
BP 483
EP 490
DI 10.1093/jme/tjy190
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HO0WY
UT WOS:000460627600024
PM 30380070
DA 2020-07-08
ER

PT J
AU Koosha, M
   Vatandoost, H
   Karimian, F
   Choubdar, N
   Abai, MR
   Oshaghi, MA
AF Koosha, Mona
   Vatandoost, Hassan
   Karimian, Fateh
   Choubdar, Nayyereh
   Abai, Mohammad Reza
   Oshaghi, Mohammad Ali
TI Effect of Serratia AS1 (Enterobacteriaceae: Enterobacteriales) on the
   Fitness of Culex pipiens (Diptera: Culicidae) for Paratransgenic and
   RNAi Approaches
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Culex pipiens; Serratia AS1; fitness; RNAi; paratransgenesis
ID WEST NILE VIRUS; ANOPHELES-STEPHENSI; PLASMODIUM-FALCIPARUM; AEDES
   TRISERIATUS; RESISTANCE; MOSQUITOS; BACTERIA; INTERFERENCE; COMPLEX;
   FIELD
AB The mosquito Culex pipiens is the primary vector of Rift Valley fever, West Nile, encephalitis, and Zika viruses, and periodic lymphatic filariasis. Developing insecticide resistance in mosquitoes demands the development of new approaches to fight these diseases. Paratransgenesis and RNAi approaches by using engineered bacteria have been shown to reduce mosquito vector competence. Serratia-AS1 is a bacterium found in mosquitoes and was genetically modified for expression of antimalaria effector molecules that repress development of malaria parasites in mosquitoes. The aim of this study was to determine how a genetically marked Serratia strain expressing the mCherry fluorescent protein (mCherry-Serratia) affects the colonization potential, life span, blood feeding behavior, fecundity, and fertility of Cx. pipiens. mCherry-Serratia bacteria disseminated into larvae, pupae, and newly emerged adults and dramatically increased in numbers following a blood meal. The bacterium was transmitted to progeny, showing that it can extend horizontally, transstadially, and vertically through the mosquito population. The presence of mCherry-Serratia did not affect blood feeding behavior, survival rate, fecundity, and fertility of Culex mosquitoes. This is the first study to evaluate the effects of an engineered bacteria on the fitness of Cx. pipiens. Although challenges remain, such as producing engineered bacteria to secrete anti-pathogens associated with Cx. pipiens, introducing such bacteria into mosquito populations, our findings of minimal fitness cost caused by Serratia-AS1 bode well for the development of paratransgenesis and RNAi approaches.
C1 [Koosha, Mona; Vatandoost, Hassan; Karimian, Fateh; Choubdar, Nayyereh; Abai, Mohammad Reza; Oshaghi, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran.
RP Oshaghi, MA (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Entomol & Vector Control, Tehran, Iran.
EM moshaghi@tums.ac.ir
FU Tehran University of Medical Sciences, IranTehran University of Medical
   Sciences [30353, 37653]
FX We thank Marcelo Jacobs-Lorena Professor of Molecular Microbiology and
   Immunology Deputy-Director, at Johns Hopkins Bloomberg School of Public
   Health for his immense help with editing and critical reading of the
   manuscript. This study was supported by the Tehran University of Medical
   Sciences, Iran Grant numbers 30353 and 37653. We thank Ms. Salimi
   (Department of Medical Parasitology, SPH, and TUMS) for helping in
   fluorescent microscopy and Naser Ghasemi (Department of Medical
   Entomology and Vector Control, SPH, TUMS) for rearing mosquitoes.
CR Amraoui F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036757
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   CHAMBERLAIN R, 1961, ANNU REV ENTOMOL, V6, P371, DOI 10.1146/annurev.en.06.010161.002103
   Chandler LJ, 1998, J MED ENTOMOL, V35, P567, DOI 10.1093/jmedent/35.4.567
   Chavshin AR, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0635-6
   Chavshin AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-419
   Chavshin AR, 2013, SYMBIOSIS, V60, P17, DOI 10.1007/s13199-013-0231-5
   Chavshin AR, 2012, ACTA TROP, V121, P129, DOI 10.1016/j.actatropica.2011.10.015
   Clements A.N., 1992, BIOL MOSQUITOES, V1, DOI [10.1016/0169-4758(93)90183-G, DOI 10.1016/0169-4758(93)90183-G]
   Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002
   Dehghan H, 2017, J ARTHROPOD-BORNE DI, V11, P515
   DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219
   Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Fu SH, 2017, SCI CHINA LIFE SCI, V60, P1364, DOI 10.1007/s11427-017-9196-8
   Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371
   Gu JB, 2010, AM J TROP MED HYG, V83, P614, DOI 10.4269/ajtmh.2010.10-0074
   Gu JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021329
   Gusmao DS, 2007, MEM I OSWALDO CRUZ, V102, P919, DOI 10.1590/S0074-02762007000800005
   Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10
   Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052
   Hurwitz I, 2011, INT J BIOL SCI, V7, P1334, DOI 10.7150/ijbs.7.1334
   Hurwitz I, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-82
   Iori A., 1990, Parassitologia, V32, P151
   Karami M, 2016, J ARTHROPOD-BORNE DI, V10, P349
   Koosha M, 2017, EXP PARASITOL, V181, P102, DOI 10.1016/j.exppara.2017.08.003
   Krida G, 2011, Bull Soc Pathol Exot, V104, P250, DOI 10.1007/s13149-010-0122-4
   Limoee M, 2007, PESTIC BIOCHEM PHYS, V87, P138, DOI 10.1016/j.pestbp.2006.07.003
   Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008
   MAGAYUKA SA, 1972, B WORLD HEALTH ORGAN, V46, P801
   Maleki-Ravasan N, 2014, J ARTHROPOD-BORNE DI, V8, P69
   MITCHELL CJ, 1980, ARTHROPOD VECTORS, P313
   Nasci RS, 2001, EMERG INFECT DIS, V7, P742
   Nicholson GM, 2007, TOXICON, V49, P413, DOI 10.1016/j.toxicon.2006.11.028
   Olson KE, 2002, INSECT BIOCHEM MOLEC, V32, P1333, DOI 10.1016/S0965-1748(02)00096-6
   Paoletti MG, 2000, J AGR ENVIRON ETHIC, V12, P279, DOI 10.1023/A:1009571131089
   Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214
   PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076
   Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96
   REINERT J. F., 2009, EUROPEAN MOSQUITO B, V27, P68
   Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3
   Salim-Abadi Y, 2016, J ARTHROPOD-BORNE DI, V10, P483
   Sanchez-Vargas I, 2004, VIRUS RES, V102, P65, DOI 10.1016/j.virusres.2004.01.017
   Shaikevich EV, 2010, COMP CYTOGENET, V4, P161, DOI 10.3897/compcytogen.v4i2.45
   Shaikevich EV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1333-8
   Sharma P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-235
   SUBRA R, 1981, INSECT SCI APPL, V1, P319, DOI 10.1017/S1742758400000618
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   Vinogradova E. B., 2000, CULEX PIPIENS PIPIEN
   Vogels CBF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1677-0
   Wang SB, 2017, SCIENCE, V357, P1399, DOI 10.1126/science.aan5478
   Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109
   Woodring J, 1998, AM J TROP MED HYG, V58, P587, DOI 10.4269/ajtmh.1998.58.587
   Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x
   Zamore PD, 2001, NAT STRUCT BIOL, V8, P746, DOI 10.1038/nsb0901-746
   Zink SD, 2015, VIRUSES-BASEL, V7, P5619, DOI 10.3390/v7102886
NR 59
TC 1
Z9 1
U1 3
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2019
VL 56
IS 2
BP 553
EP 559
DI 10.1093/jme/tjy183
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HO0WY
UT WOS:000460627600034
PM 30388221
DA 2020-07-08
ER

PT J
AU Liu, H
   Dixon, D
   Bibbs, CS
   Xue, RD
AF Liu, Hui
   Dixon, Daniel
   Bibbs, Christopher S.
   Xue, Rui-De
TI Autocidal Gravid Ovitrap Incorporation with Attractants for Control of
   Gravid and Host-Seeking Aedes aegypti (Diptera: Culicidae)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; mosquito control; autocidal gravid ovitrap; attractant
AB Aedes aegypti Linnaeus (Diptera: Culicidae) is a primary vector of multiple arboviruses including Zika, dengue, chikungunya, and yellow fever. After incorporating BG lure or BG lure + octenol, the CDC's Autocidal Gravid Ovitrap (AGO) was more effective at collecting and controlling host-seeking female Ae. aegypti than gravid female mosquitoes. The addition of octenol to the AGO did not increase the number of female mosquitoes captured by the AGO, compared with the AGO alone. The AGO baited with the BG lure captured a significant number of host-seeking female Ae. aegypti. This finding indicates that the combination of AGO with BG lure could enable the trap to control female Ae. aegypti mosquitoes representing either host-seeking or gravid physiological states.
C1 [Liu, Hui] Jiangsu Prov Dis Control & Prevent, Nanjing 210009, Peoples R China.
   [Liu, Hui; Dixon, Daniel; Bibbs, Christopher S.; Xue, Rui-De] Anastasia Mosquito Control Dist, 120 EOC Dr, St Augustine, FL 32092 USA.
RP Xue, RD (corresponding author), Anastasia Mosquito Control Dist, 120 EOC Dr, St Augustine, FL 32092 USA.
EM xueamcd@gmail.com
FU SpringStar, Inc.; SBIR grant from the National Institute of Health
   [2R44AI115782-02]
FX Gratitude is extended to Dena Autry, Dillon Streuber, and Courtney
   Cunningham for assisting during the course of study. Research reported
   in this publication was supported by SpringStar, Inc., as a sub-award
   from an SBIR grant from the National Institute of Health under grant
   number 2R44AI115782-02. All AGO trap materials were supplied by
   SpringStar, Inc.
CR Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Kline D. L., 2006, TECHNICAL B FLORID M, V7, P2
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Morgan S, 2018, J VECTOR ECOL, V43, P1
   Steib BM, 2001, CHEM SENSES, V26, P523, DOI 10.1093/chemse/26.5.523
   TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311
NR 9
TC 2
Z9 2
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2019
VL 56
IS 2
BP 576
EP 578
DI 10.1093/jme/tjy207
PG 3
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HO0WY
UT WOS:000460627600038
PM 30462293
OA Green Published
DA 2020-07-08
ER

PT J
AU Alves-Leon, SV
   Lima, MD
   Nunes, PCG
   Chimelli, LMC
   Rabelo, K
   Nogueira, RMR
   de Bruycker-Nogueira, F
   de Azeredo, EL
   Bahia, PR
   Lopes, FCR
   de Souza, JPBM
   Fontes-Dantas, FL
   Paes, MV
   Lemos, ERS
   Santos, FB
AF Alves-Leon, Soniza Vieira
   Lima, Monique da Rocha
   Guerra Nunes, Priscila Conrado
   Cardao Chimelli, Leila Maria
   Rabelo, Kissila
   Ribeiro Nogueira, Rita Maria
   de Bruycker-Nogueira, Fernanda
   de Azeredo, Elzinandes Leal
   Bahia, Paulo Roberto
   Rueda Lopes, Fernanda Cristina
   Barreto Marcondes de Souza, Jorge P.
   Fontes-Dantas, Fabricia Lima
   Paes, Marciano Viana
   Lemos, Elba R. S.
   Santos, Flavia Barreto
TI Zika virus found in brain tissue of a multiple sclerosis patient
   undergoing an acute disseminated encephalomyelitis-like episode
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Article
DE Multiple sclerosis; Zika virus; acute disseminated encephalomyelitis;
   differential diagnosis; immunotherapy
AB Background: A range of different neurological manifestations has been reported in fetuses and adults after Zika virus (ZIKV) infection.
   Objective: We describe a detection of the ZIKV in the brain tissue from a multiple sclerosis (MS) patient with acute disseminated encephalomyelitis (ADEM)-like event in Rio de Janeiro, Brazil.
   Methods: Biological samples collected during the hospitalization were tested by serology and molecular diagnostic for various infectious agents. Histopathological analysis was performed using the anti-flavivirus group 4G2 monoclonal antibody, anti-ZIKV non-structural 1 (NS1) monoclonal antibody, and anti-CD4, CD8, and CD11b antibodies.
   Results: Anti-ZIKV IgM and IgG antibodies were positive in the serum and urine. A brain biopsy showed ZIKV protein in brain cells and T CD8 infiltration in brain tissue.
   Conclusion: Our data describe the coexistence of a recent central nervous system (CNS) ZIKV infection accompanied by a severe ADEM-like syndrome outcome in a patient with clinical history of MS. A de novo immune response concomitant with ZIKV infection might be involved in the mechanism of the ADEM-like syndrome and response to immunotherapy. The present report reinforces the importance of providing the differential diagnosis of acute episodes of MS exacerbation in an environment prone to ZIKV expression.
C1 [Alves-Leon, Soniza Vieira; Bahia, Paulo Roberto; Rueda Lopes, Fernanda Cristina] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, SNC, Ctr Referencia & Pesquisa Esclerose Multipla & Ou, Rio De Janeiro, Brazil.
   [Alves-Leon, Soniza Vieira; Barreto Marcondes de Souza, Jorge P.; Fontes-Dantas, Fabricia Lima] Univ Fed Estado Rio de Janeiro UNIRIO, Programa Posgrad Neurol, Rio De Janeiro, Brazil.
   [Lima, Monique da Rocha; Guerra Nunes, Priscila Conrado; de Bruycker-Nogueira, Fernanda; de Azeredo, Elzinandes Leal; Santos, Flavia Barreto] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Cardao Chimelli, Leila Maria] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Rabelo, Kissila] Univ Estado Rio de Janeiro UNIRIO, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Paes, Marciano Viana] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Lemos, Elba R. S.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Hantaviroses & Rickettsioses, Rio De Janeiro, Brazil.
RP Alves-Leon, SV (corresponding author), Neurol Dept, Rua Mariz & Barros 775, BR-20270901 Rio De Janeiro, RJ, Brazil.
EM sonizavleon@globo.com
RI Leon, Soniza V Alves/J-7786-2012; Fontes, Fabricia Lima/K-1998-2015;
   Fontes-Dantas, Fabricia Lima/Y-1330-2019
OI Fontes, Fabricia Lima/0000-0002-5201-0927; Fontes-Dantas, Fabricia
   Lima/0000-0002-5201-0927; Rabelo, Kissila/0000-0001-7579-7788; Santos,
   Flavia/0000-0002-1309-5366; Paes, Marciano/0000-0002-2266-2801
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES; Department of Science and Technology (DECIT)Department of
   Science & Technology (India) [14/2016]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: Brazilian
   National Council for Scientific and Technological Development (CNPq),
   Coordination for the Improvement of Higher Education Personnel (CAPES),
   and Department of Science and Technology (DECIT No. 14/2016).
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Das Sarma J, 2014, J NEUROVIROL, V20, P122, DOI 10.1007/s13365-013-0188-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lassmann H, 2010, BRAIN, V133, P317, DOI 10.1093/brain/awp342
   McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
NR 10
TC 2
Z9 2
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD MAR
PY 2019
VL 25
IS 3
BP 427
EP 430
DI 10.1177/1352458518781992
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HO1ST
UT WOS:000460691800018
PM 30226115
DA 2020-07-08
ER

PT J
AU Benjamin, LA
AF Benjamin, Laura A.
TI A tale of two demyelinating diseases and Zika virus
SO MULTIPLE SCLEROSIS JOURNAL
LA English
DT Article
C1 [Benjamin, Laura A.] Univ Liverpool, Inst Infect & Global Hlth, Brain Infect Grp, Ronald Ross Bldg,8 West Derby St, Liverpool L69 7BE, Merseyside, England.
   [Benjamin, Laura A.] UCL, Inst Neurol, London, England.
RP Benjamin, LA (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Brain Infect Grp, Ronald Ross Bldg,8 West Derby St, Liverpool L69 7BE, Merseyside, England.
EM l.benjamin@nhs.net
OI Benjamin, Laura/0000-0002-9685-1664
CR Alves-Leon SV, 2019, MULT SCLER J, V25, P427, DOI 10.1177/1352458518781992
   Leonhard Sonja Emily, 2018, Pract Neurol, V18, P271, DOI 10.1136/practneurol-2017-001789
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Tenembaum S, 2007, NEUROLOGY, V68, pS23, DOI 10.1212/01.wnl.0000259404.51352.7f
   Willyard C, 2017, NAT MED, V23, P899
NR 5
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1352-4585
EI 1477-0970
J9 MULT SCLER J
JI Mult. Scler. J.
PD MAR
PY 2019
VL 25
IS 3
BP 430
EP 431
DI 10.1177/1352458518799584
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HO1ST
UT WOS:000460691800019
PM 30226108
DA 2020-07-08
ER

PT J
AU McCullough, J
   Alter, HJ
   Ness, PM
AF McCullough, Jeffrey
   Alter, Harvey J.
   Ness, Paul M.
TI Interpretation of pathogen load in relationship to infectivity and
   pathogen reduction efficacy
SO TRANSFUSION
LA English
DT Review
ID HEPATITIS-B-VIRUS; WEST-NILE-VIRUS; MEDIATED AMPLIFICATION ASSAY;
   POLYMERASE-CHAIN-REACTION; TRANSFUSION-TRANSMITTED MALARIA;
   BLOOD-DONORS; ZIKA VIRUS; VIRAL LOAD; C VIRUS; CYTOMEGALOVIRUS DNA
C1 [McCullough, Jeffrey] Univ Minnesota, Minneapolis, MN USA.
   [Alter, Harvey J.] NIH, Dept Transfus Med, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Ness, Paul M.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA.
   [Ness, Paul M.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA.
RP McCullough, J (corresponding author), Univ Minnesota, 7400 Shannon Dr, Edina, MN 55439 USA.
EM mccul001@umn.edu
CR Allain JP, 2016, LANCET, V387, P1753, DOI 10.1016/S0140-6736(16)00581-X
   Allain JP, 2013, TRANSFUSION, V53, P1405, DOI 10.1111/trf.12096
   Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249
   Aprahamian H, 2016, STAT MED, V35, P5283, DOI 10.1002/sim.7066
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Biswas R, 2003, TRANSFUSION, V43, P788, DOI 10.1046/j.1537-2995.2003.00424.x
   Bloch EM, 2013, TRANSFUSION, V53, P2299, DOI 10.1111/trf.12098
   Bouchardeau F, 2006, TRANSFUSION, V46, P2047, DOI 10.1111/j.1537-2995.2006.01031.x
   Bremer CM, 2009, TRANSFUSION, V49, P1621, DOI 10.1111/j.1537-2995.2009.02188.x
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Busch MP, 1996, J INFECT DIS, V174, P26, DOI 10.1093/infdis/174.1.26
   Busch MP, 2000, VOX SANG, V78, P253
   Busch MP, 2005, TRANSFUSION, V45, P254, DOI 10.1111/j.1537-2995.2004.04215.x
   Busch MP, 2003, TRANSFUSION, V43, P1173, DOI 10.1046/j.1537-2995.2003.00524.x
   Candotti D, 2008, J HEPATOL, V49, P537, DOI 10.1016/j.jhep.2008.04.017
   Cardo LJ, 2007, TRANSFUS APHER SCI, V37, P131, DOI 10.1016/j.transci.2007.07.002
   Chursi S, 2014, AM J TROP MED HYG, V90, P410, DOI 10.4269/ajtmh.12-0681
   Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651
   Committee for Proprietary Medicinal Products, 1996, NOT GUID VIR VAL STU
   Coste J, 2003, TRANSFUSION, V43, P116, DOI 10.1046/j.1537-2995.2003.00328.x
   de Haan TR, 2007, FETAL DIAGN THER, V22, P55, DOI 10.1159/000095845
   DONEGAN E, 1990, TRANSFUSION, V30, P851, DOI 10.1046/j.1537-2995.1990.30991048798.x
   El Chaar M, 2013, TRANSFUSION, V53, P3174, DOI 10.1111/trf.12235
   Ekiaby M, 2015, TRANSFUSION, V55, P1186, DOI 10.1111/trf.13061
   Epstein JS, 2003, TRANSFUSION, V43, P1347, DOI 10.1046/j.1537-2995.2003.00584.x
   Faddy HM, 2016, VOX SANG, V111, P235, DOI 10.1111/vox.12414
   Fearon MA, 2017, TRANSFUSION, V57, P1420, DOI 10.1111/trf.14089
   Feldmann H, 2018, NEW ENGL J MED, V378, P1440, DOI 10.1056/NEJMe1803212
   Ferreira MC, 2006, TRANSFUSION, V46, P156, DOI 10.1111/j.1537-2995.2006.00688.x
   Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005
   FRATANTONI JC, 1990, TRANSFUSION, V30, P480, DOI 10.1046/j.1537-2995.1990.30690333474.x
   Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x
   Gonzalez R, 2010, TRANSFUSION, V50, P221, DOI 10.1111/j.1537-2995.2009.02343.x
   Goodrich RP, 2010, TRANSFUSION, V50, P1827, DOI 10.1111/j.1537-2995.2010.02635.x
   Gowland P, 2004, TRANSFUSION, V44, P1555, DOI 10.1111/j.1537-2995.2004.04071.x
   Grabarczyk P, 2015, TRANSFUSION, V55, P2246, DOI 10.1111/trf.13193
   Grabarczyk P, 2013, TRANSFUSION, V53, P2512, DOI 10.1111/trf.12190
   Greenlee DJ, 2002, TRANSFUSION, V42, P403, DOI 10.1046/j.1525-1438.2002.00020.x
   Harritshoj LH, 2016, TRANSFUSION, V56, P2225, DOI 10.1111/trf.13700
   HART H, 1993, TRANSFUSION, V33, P838, DOI 10.1046/j.1537-2995.1993.331094054622.x
   Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5
   Hsia CC, 2006, TRANSFUSION, V46, P1829, DOI 10.1111/j.1537-2995.2006.00974.x
   Juhl D, 2015, VOX SANG, V109, P305, DOI 10.1111/vox.12295
   Juhl D, 2014, VOX SANG, V107, P226, DOI 10.1111/vox.12162
   Juhl D, 2014, TRANSFUS MED HEMOTH, V41, P52, DOI 10.1159/000357650
   Keil SD, 2015, TRANSFUSION, V55, P858, DOI 10.1111/trf.12945
   Keil SD, 2013, TRANSFUSION, V53, P2278, DOI 10.1111/trf.12079
   Kirchhoff LV, 2006, TRANSFUSION, V46, P298, DOI 10.1111/j.1537-2995.2006.00715.x
   KIRCHHOFF LV, 1993, NEW ENGL J MED, V329, P639, DOI 10.1056/NEJM199308263290909
   Kleinman SH, 2005, TRANSFUSION, V45, P1247, DOI 10.1111/j.1537-2995.2005.00198.x
   Kleinman SH, 2003, TRANSFUSION, V43, P696, DOI 10.1046/j.1537-2995.2003.00391.x
   Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x
   Kuhns MC, 2004, TRANSFUSION, V44, P1332, DOI 10.1111/j.1537-2995.2004.04055.x
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lai L, 2012, TRANSFUSION, V52, P447, DOI 10.1111/j.1537-2995.2011.03289.x
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Leiby DA, 2005, TRANSFUSION, V45, P1804, DOI 10.1111/j.1537-2995.2005.00609.x
   Lindblom A, 2005, CLIN INFECT DIS, V41, P1201, DOI 10.1086/444503
   Matsumoto C, 2001, TRANSFUSION, V41, P878, DOI 10.1046/j.1537-2995.2001.41070878.x
   McCullough J, 2016, TRANSFUSION MED
   McKenzie FE, 2002, J PARASITOL, V88, P521, DOI 10.1645/0022-3395(2002)088[0521:PVBSD]2.0.CO;2
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mohammed H, 2008, TRANSFUSION, V48, P1348, DOI 10.1111/j.1537-2995.2008.01771.x
   Moritz ED, 2017, TRANSFUSION, V57, P1781, DOI 10.1111/trf.14103
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Nagaharu K, 2017, TRANSFUSION, V57, P1414, DOI 10.1111/trf.14088
   Negrette OS, 2005, PEDIATRICS, V115, pE668, DOI 10.1542/peds.2004-1732
   Normann A, 2004, J MED VIROL, V72, P10, DOI 10.1002/jmv.10532
   Nubling CM, 2002, TRANSFUSION, V42, P1037, DOI 10.1046/j.1537-2995.2002.00166.x
   Operskalski EA, 2003, TRANSFUSION, V43, P1433, DOI 10.1046/j.1537-2995.2003.00475.x
   Owusu-Ofori A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1289-3
   Prince AM, 2001, TRANSFUSION, V41, P329, DOI 10.1046/j.1537-2995.2001.41030329.x
   Ren FR, 2011, TRANSFUSION, V51, P2588, DOI 10.1111/j.1537-2995.2011.03215.x
   Rios M, 2008, J INFECT DIS, V198, P1300, DOI 10.1086/592277
   Roback JD, 2005, TRANSFUSION, V45, P1722, DOI 10.1111/j.1537-2995.2005.00596.x
   Roback JD, 2003, TRANSFUSION, V43, P314, DOI 10.1046/j.1537-2995.2003.00312.x
   Saldanha J, 1999, VOX SANG, V76, P149, DOI 10.1046/j.1423-0410.1999.7630149.x
   Salles NA, 2013, TRANSFUSION, V53, P2593, DOI 10.1111/trf.12316
   Satake M, 2007, TRANSFUSION, V47, P1197, DOI 10.1111/j.1537-2995.2007.01276.x
   Sauleda S, 2015, TRANSFUSION, V55, P972, DOI 10.1111/trf.12929
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Slavov SN, 2016, INDIAN J HEMATOL BLO, V32, pS323, DOI 10.1007/s12288-015-0607-1
   Stolz M, 2014, TRANSFUSION, V54, P2961, DOI 10.1111/trf.12694
   Stone M, 2017, TRANSFUSION A, V4A, P57
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Stramer SL, 2011, TRANSFUSION, V51, P2012, DOI 10.1111/j.1537-2995.2011.03140.x
   Tabuchi A, 2008, J MED VIROL, V80, P2064, DOI 10.1002/jmv.21320
   Tonnetti L, 2010, TRANSFUSION, V50, P1019, DOI 10.1111/j.1537-2995.2009.02538.x
   Vanlandingham DL, 2013, TRANSFUSION, V53, P284, DOI 10.1111/j.1537-2995.2012.03717.x
   Vermeulen M, 2013, TRANSFUSION, V53, P2384, DOI 10.1111/trf.12117
   Wang JT, 2002, TRANSFUSION, V42, P1592, DOI 10.1046/j.1537-2995.2002.00274.x
   Weusten JJAM, 2002, TRANSFUSION, V42, P537, DOI 10.1046/j.1537-2995.2002.00099.x
   Weusten J, 2017, TRANSFUSION, V57, P841, DOI 10.1111/trf.14050
   Weusten J, 2011, TRANSFUSION, V51, P203, DOI 10.1111/j.1537-2995.2010.02804.x
   Yoshikawa A, 2007, TRANSFUSION, V47, P1162, DOI 10.1111/j.1537-2995.2007.01234.x
   Yotsuyanagi H, 2001, TRANSFUSION, V41, P1093, DOI 10.1046/j.1537-2995.2001.41091093.x
   Zanetti AR, 2007, TRANSFUSION, V47, P1328, DOI 10.1111/j.1537-2995.2007.01298.x
   Zhu TF, 2003, J VIROL, V77, P6108, DOI 10.1128/JVI.77.11.6108-6116.2003
   Ziemann M, 2007, TRANSFUSION, V47, P1972, DOI 10.1111/j.1537-2995.2007.01420.x
   Ziemann M, 2017, TRANSFUSION, V57, P1691, DOI 10.1111/trf.14105
   Ziemann M, 2013, TRANSFUSION, V53, P2183, DOI 10.1111/trf.12199
NR 103
TC 7
Z9 7
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2019
VL 59
IS 3
BP 1132
EP 1146
DI 10.1111/trf.15103
PG 15
WC Hematology
SC Hematology
GA HN8UL
UT WOS:000460471900031
PM 30592305
OA Bronze
DA 2020-07-08
ER

PT J
AU Squiers, L
   Lynch, M
   Dolina, S
   Ray, S
   Kelly, B
   Herrington, J
   Turner, M
   Chawla, D
   Becker-Dreps, S
   Stamm, L
   McCormack, L
AF Squiers, L.
   Lynch, M.
   Dolina, S.
   Ray, S.
   Kelly, B.
   Herrington, J.
   Turner, M.
   Chawla, D.
   Becker-Dreps, S.
   Stamm, L.
   McCormack, L.
TI Zika and travel in the news: a content analysis of US news stories
   during the outbreak in 2016-2017
SO PUBLIC HEALTH
LA English
DT Article
DE Zika; Travel; Content analysis; US media
AB Objectives: This study aimed to understand what information the US media communicated about Zika virus (ZIKV) and travel in 2016 and 2017.
   Study design: We conducted a content analysis of news coverage about ZIKV and travel from April 5, 2016 to March 31, 2017.
   Methods: We obtained a stratified, random sample of English language, US print newspaper and television news coverage about ZIKV and travel. We developed a coding scheme to assess key messages in the news, including how ZIKV is transmitted, the symptoms and outcomes of ZIKV infection, and recommended prevention behaviors.
   Results: Almost all news stories mentioned mosquito-borne transmission (96.8%) and just over half mentioned sexual transmission (55.3%). News stories were more likely to talk about ZIKV outcomes (78.8%) than ZIKV symptoms (40.6%). However, outcomes affecting babies were mentioned more frequently than outcomes affecting adults. Recommendations included a wide array of protective behaviors, such as delaying or avoiding travel (77.6%) and using mosquito repellent (41.0%). However, few studies (10.9%) mentioned barriers to practicing ZIKV prevention behaviors.
   Conclusions: Public health organizations and professionals can use these findings to help improve communication about future outbreaks of mosquito-borne illnesses. We also recommend conducting real-time monitoring of news media and frequent content analysis of news stories to ensure coverage provides the information the public needs. (C) 2019 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
C1 [Squiers, L.; Lynch, M.; Dolina, S.; Ray, S.; Kelly, B.; McCormack, L.] RTI Int, POB 12194, Res Triangle Pk, NC USA.
   [Herrington, J.; Turner, M.; Chawla, D.; Becker-Dreps, S.; Stamm, L.] Univ N Carolina, Gillings Sch Global Publ Hlth, 135 Dauer Dr, Chapel Hill, NC 27515 USA.
   [Becker-Dreps, S.] Univ N Carolina, Sch Med, 321 S Columbia St, Chapel Hill, NC 27515 USA.
RP Squiers, L (corresponding author), RTI Int, 6110 Execut Blvd,Suite 902, Rockville, MD 20852 USA.
EM lsquiers@rti.org; mlynch@rti.org; sdolina@rti.org; sray@rti.org;
   bkelly@rti.org; jimhsph@email.unc.edu; malwolfe@email.unc.edu;
   chawlad@live.unc.edu; sb@email.unc.edu; lstamm@email.unc.edu;
   lmac@rti.org
CR Centers for Disease Control and Prevention, 2017, 2016 CAS COUNTS US
   Coleman R, 2006, J MASS COMMUN Q, V83, P313, DOI 10.1177/107769900608300206
   Maron DF, 2016, SCI AM, V314, P84, DOI 10.1038/scientificamerican0416-84
   McCombs ME, 1972, PUBLIC OPIN QUART, P36
   Ophir Y, 2020, HEALTH COMMUN, V35, P35, DOI 10.1080/10410236.2018.1536958
   Sell TK, 2018, RISK ANAL, V38, P2514, DOI 10.1111/risa.12961
   Squiers L, 2018, AM J TROP MED HYG, V98, P1837, DOI 10.4269/ajtmh.17-0898
   Travel Agent, 2016, AM TRAV LARG UNF ZIK
   Widmar Nicole J Olynk, 2017, Prev Med Rep, V6, P162, DOI 10.1016/j.pmedr.2017.02.023
NR 9
TC 1
Z9 1
U1 1
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0033-3506
EI 1476-5616
J9 PUBLIC HEALTH
JI Public Health
PD MAR
PY 2019
VL 168
BP 164
EP 167
DI 10.1016/j.puhe.2018.12.009
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HN4GZ
UT WOS:000460143700024
PM 30772009
DA 2020-07-08
ER

PT J
AU Rackow, A
   Ehmen, C
   von Possel, R
   Medialdea-Carrera, R
   Brown, D
   de Filippis, AMB
   de Sequeira, PC
   Nogueira, RMR
   Halili, B
   Jakupi, X
   Berisha, L
   Ahmeti, S
   Sherifi, K
   Schmidt-Chanasit, J
   Schmitz, H
   Mika, A
   Emmerich, P
   Deschermeier, C
AF Rackow, Anne
   Ehmen, Christa
   von Possel, Ronald
   Medialdea-Carrera, Raquel
   Brown, David
   de Filippis, Ana Maria Bispo
   de Sequeira, Patricia Carvalho
   Nogueira, Rita Maria Ribeiro
   Halili, Barie
   Jakupi, Xhevat
   Berisha, Lindita
   Ahmeti, Salih
   Sherifi, Kurtesh
   Schmidt-Chanasit, Jonas
   Schmitz, Herbert
   Mika, Angela
   Emmerich, Petra
   Deschermeier, Christina
TI Immunoglobulin-like Domain of HsFc mu R as a Capture Molecule for
   Detection of Crimean-Congo Hemorrhagic Fever Virus-and Zika
   Virus-Specific IgM Antibodies
SO CLINICAL CHEMISTRY
LA English
DT Article
ID LINKED IMMUNOSORBENT ASSAYS
AB BACKGROUND: The cellular surface molecule HsTOSO/FAIM3/HsFc mu R has been identified as an IgM-specific Fc receptor expressed on lymphocytes. Here, we show that its extracellular immunoglobulin-like domain (HsFc mu R-Igl) specifically binds to IgM/antigen immune complexes (ICs) and exploit this property for the development of novel detection systems for IgM antibodies directed against Crimean-Congo hemorrhagic fever virus (CCHFV) and Zika virus (ZIKV).
   METHODS: His-tagged HsFc mu R-Igl was expressed in Escherichia coli and purified by affinity chromatography, oxidative refolding, and size-exclusion chromatography. Specific binding of HsFc mu R-Igl to IgM/antigen ICs was confirmed, and 2 prototypic ELISAs for the detection of anti-CCHFV and anti-ZIKV IgM antibodies were developed. Thereby, patient sera and virus-specific recombinant antigens directly labeled with horseradish peroxidase (HRP) were coincubated on HsFc mu R-Igl-coated ELISA plates. Bound ICs were quantified by measuring turnover of a chromogenic HRP substrate.
   RESULTS: Assay validation was performed using paired serum samples from 15 Kosovar patients with a PCR-confirmed CCHFV infection and 28 Brazilian patients with a PCR-confirmed ZIKV infection, along with a panel of a priori CCHFV/ZIKV-IgM-negative serum samples. Both ELISAs were highly reproducible. Sensitivity and specificity were comparable with or even exceeded in-house gold standard testing and commercial kits. Furthermore, latex beads coated with HsFc mu R-Igl aggregated upon coincubation with an IgM-positive serum and HRP-labeled antigen but not with either component alone, revealing a potential for use of HsFc mu R-Igl as a capture molecule in aggregation-based rapid tests.
   CONCLUSIONS: Recombinant HsFc mu R-Igl is a versatile capture molecule for IgM/antigen ICs of human and animal origin and can be applied for the development of both plate-and bead-based serological tests. (c) 2018 American Association for Clinical Chemistry
C1 [Rackow, Anne; Ehmen, Christa; Mika, Angela; Deschermeier, Christina] Bernhard Nocht Inst Trop Med, Diagnost Dev Lab, Hamburg, Germany.
   [von Possel, Ronald; Schmidt-Chanasit, Jonas; Schmitz, Herbert; Emmerich, Petra] Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany.
   [Medialdea-Carrera, Raquel] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Brown, David; de Filippis, Ana Maria Bispo; de Sequeira, Patricia Carvalho; Nogueira, Rita Maria Ribeiro] Fiocruz MS, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Halili, Barie; Berisha, Lindita] Univ Clin Ctr Kosovo, Infect Dis Clin, Pristhina, Kosovo.
   [Jakupi, Xhevat] Natl Inst Publ Hlth Kosova, Dept Microbiol, Pristhina, Kosovo.
   [Ahmeti, Salih] Univ Prishtina Hasan Prishtina, Med Fac, Prishtina, Kosovo.
   [Ahmeti, Salih] Univ Clin Ctr Kosovo, Infect Dis Clin, Prishtina, Kosovo.
   [Sherifi, Kurtesh] Univ Pristhina Hasan Prishtina, Fac Agr & Vet Med, Pristhina, Kosovo.
   [Emmerich, Petra] Univ Rostock, Dept Trop Med & Infect Dis, Ctr Internal Med 2, Rostock, Germany.
RP Deschermeier, C (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
EM descherm@bnitm.de
OI Medialdea-Carrera, Raquel/0000-0002-0371-5138
FU Vereinigung der Freunde des Tro-peninstituts Hamburg eV; EXIST
   Forschungstransfer [03EFFHH016]; EFRE
   [BWF/H/52228/2012/13.10.10-1/3.4,6]; German Federal Foreign Office
   [ZMV-162513AA0277]
FX A. Rackow, Vereinigung der Freunde des Tro-peninstituts Hamburg eV; C.
   Ehmen, EXIST Forschungstransfer 03EFFHH016 and EFRE
   BWF/H/52228/2012/13.10.10-1/3.4,6 to institution; A. Mika, EFRE
   (BWF/H/52228/2012/13.10.10-1/3.4,6) for 2012-2015 to institution; P.
   Emmerich, German Federal Foreign Office, ZMV-162513AA0277 to
   institution; C. Deschermeier, EXIST Forschungstransfer 03EFFHH016 and
   EFRE BWF/H/52228/2012/13.10.10-1/3.4,6 to institution.
CR Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006
   Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12
   COHEN IR, 1967, J IMMUNOL, V98, P143
   Emmerich P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006366
   Emmerich P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002580
   Emmerich P, 2010, J CLIN VIROL, V48, P294, DOI 10.1016/j.jcv.2010.05.002
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Freire MCLC, 2017, ACS OMEGA, V2, P3913, DOI 10.1021/acsomega.7b00608
   Gabriel M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006361
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Huzly D, 2016, EURO SURVEILL, V21
   Kubagawa H, 2009, J EXP MED, V206, P2779, DOI 10.1084/jem.20091107
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Meersman K, 2016, EURO SURVEILL, V21
   Mertens M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003519
   MEURMAN OH, 1978, J CLIN PATHOL, V31, P483, DOI 10.1136/jcp.31.5.483
   Olschlager S, 2011, J CLIN VIROL, V50, P90, DOI 10.1016/j.jcv.2010.09.018
   Pecani A, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1173-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Samudzi RR, 2012, J VIROL METHODS, V179, P70, DOI 10.1016/j.jviromet.2011.09.023
   Sas MA, 2018, ANTIVIR RES, V151, P24, DOI 10.1016/j.antiviral.2018.01.006
   Schmitz H, 2011, MED MICROBIOL IMMUN, V200, P233, DOI 10.1007/s00430-011-0195-0
   Shima H, 2010, INT IMMUNOL, V22, P149, DOI 10.1093/intimm/dxp121
   Simard JF, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5841
   Steinhagen K, 2016, EURO SURVEILL, V21
   WHO, 2015, WORKSH PRIOR PATH
   Xu X, 2016, PLOS CURR, V8
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
NR 31
TC 1
Z9 1
U1 1
U2 4
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD MAR
PY 2019
VL 65
IS 3
BP 451
EP 461
DI 10.1373/clinchem.2018.294819
PG 11
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA HN1OV
UT WOS:000459957500014
PM 30709812
OA Bronze
DA 2020-07-08
ER

PT J
AU Zammarchi, L
   Colao, MG
   Mantella, A
   Capobianco, T
   Mazzarelli, G
   Ciccone, N
   Kiros, ST
   Mantengoli, E
   Rossolini, GM
   Bartoloni, A
AF Zammarchi, Lorenzo
   Colao, Maria Grazia
   Mantella, Antonia
   Capobianco, Teresa
   Mazzarelli, Gianna
   Ciccone, Nunziata
   Kiros, Seble Tekle
   Mantengoli, Elisabetta
   Rossolini, Gian Maria
   Bartoloni, Alessandro
TI Evaluation of a new rapid fluorescence immunoassay for the diagnosis of
   dengue and Zika virus infection
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Dengue; Zika; Serology; Rapid; Fluorescence
AB Background: Dengue (DENV) and Zika virus (ZIKV) are important mosquito-transmitted viruses.
   Objectives: To investigate the performance of Standard F, Fluorescence Immunoassay (FIA, SD Biosensor Inc., Suwon, South Korea) providing results in 15 min to detect DENV IgG, IgM and NS1Ag, and ZIKV IgG, IgM, and Ag.
   Study design: A well-characterized panel of patient samples (11 acute DENV, 11 acute ZIKV, 10 past DENV, 10 past ZIKV infection, 36 with other conditions) were tested with the FIA test.
   Results: In acute DENV infection, the combination of FIA-NS1Ag and/or IgM positivity showed a sensitivity of 100%. In past DENV, FIA-IgG test showed a sensitivity of 70%. Specificity of FIA-DENV NS1Ag, IgG, and IgM was 87.5%, 83.5%, and 91.7%, respectively. The sensitivity of FIA-ZIKV IgM and FIA-ZIKV Ag, in confirmed acute infection, was 72.7% and 9.1%, respectively. FIA-ZIKV Ag did not improve the sensitivity in detecting acute ZIKV infection, being positive only in one IgM positive sample. In past ZIKV infection (32-183 days after symptom onset), FIA-ZIKV IgG and IgM showed a sensitivity of 40% and 80% respectively, generating an overall 90% sensitivity. Specificity of FIA-ZIKV Ag, IgM, and IgG was 92.6%, 100%, and 97%, respectively.
   Conclusion: FIA test, a rapid and easy to perform assay, showed high sensitivity to detect acute DENV infection, but lower in acute ZIKV infection. In past ZIKV infections, the best performance of FIA test is obtained by combining detection of IgG and IgM.
C1 [Zammarchi, Lorenzo; Mantella, Antonia; Kiros, Seble Tekle; Mantengoli, Elisabetta; Rossolini, Gian Maria; Bartoloni, Alessandro] Univ Florence, Dept Expt & Clin Med, Florence, Italy.
   [Zammarchi, Lorenzo; Bartoloni, Alessandro] Careggi Univ & Hosp, Infect & Trop Dis Unit, Florence, Italy.
   [Zammarchi, Lorenzo; Mantella, Antonia; Bartoloni, Alessandro] Careggi Univ Hosp, Referral Ctr Trop Dis Tuscany, Infect & Trop Dis Unit, Florence, Italy.
   [Colao, Maria Grazia; Capobianco, Teresa; Mazzarelli, Gianna; Ciccone, Nunziata; Rossolini, Gian Maria] Careggi Univ & Hosp, Clin Microbiol & Virol Unit, Florence, Italy.
RP Bartoloni, A (corresponding author), Largo Brambilla 3, I-50134 Florence, Italy.
EM alessandro.bartoloni@unifi.it
OI ZAMMARCHI, Lorenzo/0000-0003-0892-8404
CR Castro Marcia C, 2017, Lancet Infect Dis, V17, pe70, DOI 10.1016/S1473-3099(16)30545-X
   Fortuna C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2320-1
   Magurano F, 2015, VECTOR-BORNE ZOONOT, V15, P258, DOI 10.1089/vbz.2014.1724
   Ministerodella Salute, 2018, PIANO NAZIONALE SORV
   Rodriguez-Manzano J, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0633-x
   S. D. Biosensor, 2018, SD BIOS PROD CAT
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   WHO, 2018, REV SAGE REC US DENG
   Zammarchi L, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.056
NR 11
TC 1
Z9 1
U1 2
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD MAR
PY 2019
VL 112
BP 34
EP 39
DI 10.1016/j.jcv.2019.01.011
PG 6
WC Virology
SC Virology
GA HN4BF
UT WOS:000460128500006
PM 30738366
DA 2020-07-08
ER

PT J
AU Fischer, C
   Drosten, C
   Drexler, JF
AF Fischer, Carlo
   Drosten, Christian
   Drexler, Jan Felix
TI The difficulties in obtaining reliable Zika virus diagnostics
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID EXTERNAL QUALITY ASSESSMENT
C1 [Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Charite Univ Med Berlin, D-10117 Berlin, Germany.
   [Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Free Univ Berlin, D-10117 Berlin, Germany.
   [Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Humboldt Univ, D-10117 Berlin, Germany.
   [Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, D-10117 Berlin, Germany.
   [Drosten, Christian; Drexler, Jan Felix] German Ctr Infect Res, Berlin, Germany.
RP Drexler, JF (corresponding author), Charite Univ Med Berlin, D-10117 Berlin, Germany.; Drexler, JF (corresponding author), Free Univ Berlin, D-10117 Berlin, Germany.; Drexler, JF (corresponding author), Humboldt Univ, D-10117 Berlin, Germany.; Drexler, JF (corresponding author), Berlin Inst Hlth, Inst Virol, D-10117 Berlin, Germany.; Drexler, JF (corresponding author), German Ctr Infect Res, Berlin, Germany.
EM felix.drexler@charite.de
OI Drexler, Jan Felix/0000-0002-3509-0232; Fischer,
   Carlo/0000-0001-9163-2406
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Collucci C, 2018, 73 LAB ERRAM DIAGNOS
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Koopmans M, 2019, LANCET INFECT DIS, V19, pE59, DOI 10.1016/S1473-3099(18)30497-3
NR 5
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2019
VL 19
IS 3
BP 240
EP 241
DI 10.1016/S1473-3099(19)30049-0
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA HN1AM
UT WOS:000459919500023
PM 30833056
OA Bronze
DA 2020-07-08
ER

PT J
AU Gao, HX
   Lin, YX
   He, JF
   Zhou, SL
   Liang, MJ
   Huang, CB
   Li, XB
   Liu, C
   Zhang, P
AF Gao, Huixin
   Lin, Yuxia
   He, Junfang
   Zhou, Shili
   Liang, Mujiao
   Huang, Changbai
   Li, Xiaobo
   Liu, Chao
   Zhang, Ping
TI Role of heparan sulfate in the Zika virus entry, replication, and cell
   death
SO VIROLOGY
LA English
DT Article
DE Heparan sulfate; Zika virus; Replication; Cell death
ID DENGUE VIRUS; ENVELOPE PROTEIN; BINDING; INTERFERON; INFECTION; TYPE-2;
   GLYCOSAMINOGLYCAN; PROTEOGLYCANS; GLYCOPROTEIN; ATTACHMENT
AB Zika virus (ZIKV) is an emerging arbovirus and its infection associates with neurologic diseases. Whether heparan sulfate (HS), an attachment factor for many viruses, plays a role in the ZIKV infection remains controversial. Our study generated several HS biosynthesis-deficient cell clones by disrupting SLC35B2, B3GAT3, or B4GALT7 gene using the CRISPR/Cas9 system. The HS deficiency did not affect the viral attachment and internalization of ZIKV, but reduced the attachment of Dengue virus (DENY) 2. The early RNA and protein levels of ZIKV and DENV2 were impaired in the HS deficient cells, while the viral yields were not accordingly reduced. Our data further showed that HS promoted the cell death induced by virus infection, and inhibition of cell death significantly increased the viral replication of ZIKV and DENV2. Collectively, our study described an unexpected role of HS in the viral attachment, replication and cell death induced by ZIKV.
C1 [Gao, Huixin; Lin, Yuxia; He, Junfang; Zhou, Shili; Liang, Mujiao; Huang, Changbai; Li, Xiaobo; Liu, Chao; Zhang, Ping] Sun Yat Sen Univ, Dept Immunol, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.
   [Gao, Huixin; Lin, Yuxia; He, Junfang; Zhou, Shili; Liang, Mujiao; Huang, Changbai; Li, Xiaobo; Liu, Chao; Zhang, Ping] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510080, Guangdong, Peoples R China.
RP Liu, C; Zhang, P (corresponding author), Sun Yat Sen Univ, Dept Immunol, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China.
EM liuchao9@mail.sysu.edu.cn; zhangp36@mail.sysu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81371794]; Guangdong Science and Technology
   Department [2017A050501012, 2018A050506029]; Natural Science Foundation
   of Guangdong ProvinceNational Natural Science Foundation of Guangdong
   Province [2017A030313504]; Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities
   [17ykjc01]
FX This work was supported by National Natural Science Foundation of China
   [grant number 81371794], Guangdong Science and Technology Department
   [grant number 2017A050501012, 2018A050506029], Natural Science
   Foundation of Guangdong Province [grant number 2017A030313504], and
   Fundamental Research Funds for the Central Universities [grant number
   17ykjc01].
CR BALKWILL F, 1978, NATURE, V274, P798, DOI 10.1038/274798a0
   Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998
   Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040
   Chen HL, 2010, BIOPOLYMERS, V94, P331, DOI 10.1002/bip.21371
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000
   Ferguson MC, 2015, J VIROL, V89, P7536, DOI 10.1128/JVI.03645-14
   Fry EE, 1999, EMBO J, V18, P543, DOI 10.1093/emboj/18.3.543
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Goodfellow IG, 2001, J VIROL, V75, P4918, DOI 10.1128/JVI.75.10.4918-4921.2001
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000
   Lortat-Jacob H, 2006, BIOCHEM SOC T, V34, P461, DOI 10.1042/BST0340461
   Maslow JN, 2017, HUM VACC IMMUNOTHER, V13, P2918, DOI 10.1080/21645515.2017.1358325
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Murakami S, 2017, J VIROL, V91, DOI 10.1128/JVI.00503-17
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Okamoto T, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090243
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Salas A, 2000, GUT, V47, P88, DOI 10.1136/gut.47.1.88
   Sasaki M, 2018, J INFECT DIS, V217, P1740, DOI 10.1093/infdis/jiy081
   Shafee N, 2003, J GEN VIROL, V84, P2191, DOI 10.1099/vir.0.19022-0
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Silva LA, 2014, J VIROL, V88, P2385, DOI 10.1128/JVI.03116-13
   Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12
   Tanaka A, 2017, J VIROL, V91, DOI [10.1128/JVI.00432-17, 10.1128/jvi.00432-17]
   Vicenzi E, 2018, BIOCHEM SOC T, V46, P609, DOI [10.1042/BST20170399, 10.1042/bst20170399]
   YURA Y, 1992, J INVEST DERMATOL, V98, P494, DOI 10.1111/1523-1747.ep12499867
   Zhang XY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.55
NR 40
TC 4
Z9 5
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD MAR
PY 2019
VL 529
BP 91
EP 100
DI 10.1016/j.virol.2019.01.019
PG 10
WC Virology
SC Virology
GA HN5AW
UT WOS:000460195900011
PM 30684694
OA Bronze
DA 2020-07-08
ER

PT J
AU Francese, R
   Civra, A
   Ritta, M
   Donalisio, M
   Argenziano, M
   Cavalli, R
   Mougharbel, AS
   Kortz, U
   Lembo, D
AF Francese, Rachele
   Civra, Andrea
   Ritta, Massimo
   Donalisio, Manuela
   Argenziano, Monica
   Cavalli, Roberta
   Mougharbel, Ali S.
   Kortz, Ulrich
   Lembo, David
TI Anti-zika virus activity of polyoxometalates
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Antivirals; Polyoxometalates; Entry inhibitor; Flavivirus
ID HEXATUNGSTOTELLURATE(VI); TRANSMISSION; INHIBITION
AB Zika virus (ZIKV) is an emerging infectious viral pathogen associated with severe fetal cerebral anomalies and the paralytic Guillain-Barre syndrome in adults. It was the cause of a recent global health crisis following its entrance into a naive population in the Americas. Nowadays, no vaccine or specific antiviral against ZIKV is available. In this study, we identified three polyoxometalates (POMs), the Anderson-Evans type [TeW6O24](6-) (TeW6), and the Keggin-type [TiW11CoO40](8-)_(TiW11Co), and [Ti2PW10O40](7-) (Ti2PW10), that inhibit ZIKV infection with EC(50)s in the low micromolar range. Ti2PW10, the POM with the greatest selectivity index (SI), was selected and the step of ZIKV replicative cycle putatively inhibited was investigated by specific antiviral assays. We demonstrated that Ti2PW10 targets the entry process of ZIKV infection and it is able to significantly reduce ZIKV progeny production. These results suggest that the polyanion Ti2PW10 could be a good starting point to develop an effective therapeutic to treat ZIKV infection.
C1 [Francese, Rachele; Civra, Andrea; Ritta, Massimo; Donalisio, Manuela; Lembo, David] Univ Turin, S Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Lab Mol Virol & Antiviral Res, Turin, Italy.
   [Argenziano, Monica; Cavalli, Roberta] Univ Turin, Dept Drug Sci & Technol, Innovat Pharmaceut & Cosmet Technol & Nanotechnol, Turin, Italy.
   [Mougharbel, Ali S.; Kortz, Ulrich] Jacobs Univ, Dept Life Sci & Chem, Campus Ring 1, D-28759 Bremen, Germany.
RP Lembo, D (corresponding author), Univ Turin, S Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Lab Mol Virol & Antiviral Res, Turin, Italy.; Kortz, U (corresponding author), Jacobs Univ, Dept Life Sci & Chem, Campus Ring 1, D-28759 Bremen, Germany.
EM u.kortz@jacobs-university.de; david.lembo@unito.it
FU University of Turin [RILO 2018]
FX This work was financially supported by the University of Turin [Grant
   number RILO 2018].
CR Barnard DL, 1997, ANTIVIR RES, V34, P27, DOI 10.1016/S0166-3542(96)01019-4
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen YG, 1997, SYN REACT INORG MET, V27, P239, DOI 10.1080/00945719708000149
   Colovic MB, 2017, TOXICOL APPL PHARM, V333, P68, DOI 10.1016/j.taap.2017.08.010
   DOMAILLE PJ, 1983, INORG CHEM, V22, P818, DOI 10.1021/ic00147a023
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hasenknopf B, 2005, FRONT BIOSCI-LANDMRK, V10, P275, DOI 10.2741/1527
   Ilyas Z, 2014, METALLOMICS, V6, P1521, DOI 10.1039/c4mt00106k
   Iqbal J, 2013, MED CHEM RES, V22, P1224, DOI 10.1007/s00044-012-0125-8
   Ly HGT, 2015, ANGEW CHEM INT EDIT, V54, P7391, DOI 10.1002/anie.201502006
   Mauracher SG, 2014, ACTA CRYSTALLOGR D, V70, P2301, DOI 10.1107/S1399004714013777
   MCCARTHY M, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I3048
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pope M.T., 2012, ENCY INORGANIC BIOIN, DOI [10.1002/ 9781119951438. eibc0185. pub2., DOI 10.1002/9781119951438.EIBC0185.PUB2, 10.1002/9781119951438.eibc0185.pub2]
   Pope M. T, 1983, HETEROPOLY ISOPOLY O
   POPE MT, 1991, ANGEW CHEM INT EDIT, V30, P34, DOI 10.1002/anie.199100341
   Qi Y, 2013, ANTIVIR RES, V100, P392, DOI 10.1016/j.antiviral.2013.08.025
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rhule JT, 1998, CHEM REV, V98, P327, DOI 10.1021/cr960396q
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sarafianos SG, 1996, BIOCHEM J, V319, P619, DOI 10.1042/bj3190619
   SCHMIDT KJ, 1986, ACTA CRYSTALLOGR C, V42, P1115, DOI 10.1107/S0108270186093204
   Selman M, 2018, MOL THER, V26, P56, DOI 10.1016/j.ymthe.2017.10.014
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shigeta S, 2003, ANTIVIR RES, V58, P265, DOI 10.1016/S0166-3542(03)00009-3
   Shigeta S, 2006, BIOMED PHARMACOTHER, V60, P211, DOI 10.1016/j.biopha.2006.03.009
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Wang J, 2014, ACS APPL MATER INTER, V6, P9785, DOI 10.1021/am502193f
   Yang P, 2016, BIOCHEMISTRY-US, V55, P2841, DOI 10.1021/acs.biochem.6b00354
NR 37
TC 5
Z9 5
U1 9
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2019
VL 163
BP 29
EP 33
DI 10.1016/j.antiviral.2019.01.005
PG 5
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HM9ZL
UT WOS:000459843400004
PM 30653996
DA 2020-07-08
ER

PT J
AU Zhou, WS
   Woodson, M
   Sherman, MB
   Neelakanta, G
   Sultana, H
AF Zhou, Wenshuo
   Woodson, Michael
   Sherman, Michael B.
   Neelakanta, Girish
   Sultana, Hameeda
TI Exosomes mediate Zika virus transmission through SMPD3 neutral
   Sphingomyelinase in cortical neurons
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Exosomes; ZIKA virus; transmission; cryo-EM; neutral Sphingomyelinase;
   GW4869; cortical neurons
ID CELL-DERIVED EXOSOMES; EXTRACELLULAR VESICLES; C VIRUS; PATHOGENESIS;
   BIOGENESIS; CONTRIBUTES; DYNAMICS; PROTEIN; BRAIN
AB The harmful effects of ZIKA virus (ZIKV) infection are reflected by severe neurological manifestations such as microcephaly in neonates and other complications associated with Guillain-Barre syndrome in adults. The transmission dynamics of ZIKV in or between neurons, or within the developing brains of the foetuses are not fully understood. Using primary cultures of murine cortical neurons, we show that ZIKV uses exosomes as mediators of viral transmission between neurons. Cryo-electron microscopy showed heterogeneous population of neuronal exosomes with a size range of 30-200nm. Increased production of exosomes from neuronal cells was noted upon ZIKV infection. Neuronal exosomes contained both ZIKV viral RNA and protein(s) that were highly infectious to naive cells. RNaseA and neutralizing antibodies treatment studies suggest the presence of viral RNA/proteins inside exosomes. Exosomes derived from time- and dose-dependent incubations showed increasing viral loads suggesting higher packaging and delivery of ZIKV RNA and proteins. Furthermore, we noted that ZIKV induced both activity and gene expression of neutral Sphingomyelinase (nSMase)-2/SMPD3, an important molecule that regulates production and release of exosomes. Silencing of SMPD3 in neurons resulted in reduced viral burden and transmission through exosomes. Treatment with SMPD3 specific inhibitor GW4869, significantly reduced ZIKV loads in both cortical neurons and in exosomes derived from these neuronal cells. Taken together, our results suggest that ZIKV modulates SMPD3 activity in cortical neurons for its infection and transmission through exosomes perhaps leading to severe neuronal death that may result in neurological manifestations such as microcephaly in the developing embryonic brains.
C1 [Zhou, Wenshuo; Neelakanta, Girish; Sultana, Hameeda] Old Dominion Univ, Dept Biol Sci, Ctr Mol Med, Norfolk, VA 23529 USA.
   [Woodson, Michael; Sherman, Michael B.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Sherman, Michael B.] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Sultana, Hameeda] Univ Virginia, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.
RP Sultana, H (corresponding author), Old Dominion Univ, Dept Biol Sci, Ctr Mol Med, Norfolk, VA 23529 USA.; Sultana, H (corresponding author), Univ Virginia, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.
EM hsultana@odu.edu
RI zhou, wenshuo/AAJ-5212-2020
FU Old Dominion University
FX This work was supported by independent Startup funds from Old Dominion
   University to HS.
CR Anderson MR, 2016, NEUROTHERAPEUTICS, V13, P535, DOI 10.1007/s13311-016-0450-6
   Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29
   Bukong TN, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004424
   Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145
   Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025
   Cosset FL, 2014, J HEPATOL, V60, P674, DOI 10.1016/j.jhep.2013.10.015
   Couzin J, 2005, SCIENCE, V308, P1862, DOI 10.1126/science.308.5730.1862
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Di Maio V, 2008, BRAIN RES, V1225, P26, DOI 10.1016/j.brainres.2008.06.016
   Dinkins MB, 2016, J NEUROSCI, V36, P8653, DOI 10.1523/JNEUROSCI.1429-16.2016
   Dutta S, 2018, BBA-GEN SUBJECTS, V1862, P40, DOI 10.1016/j.bbagen.2017.10.004
   Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003
   Frenkel LD, 2018, EUR J CLIN MICROBIOL, V37, P209, DOI 10.1007/s10096-017-3111-8
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Haslwanter D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006643
   Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2
   Janas AM, 2016, BBA-BIOMEMBRANES, V1858, P1139, DOI 10.1016/j.bbamem.2016.02.011
   Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001
   Kanninen Katja, 2016, Duodecim, V132, P1957
   Kanninen KM, 2016, BBA-MOL BASIS DIS, V1862, P403, DOI 10.1016/j.bbadis.2015.09.020
   Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005
   Khavandgar Z, 2011, J CELL BIOL, V194, P277, DOI 10.1083/jcb.201102051
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lang JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165926
   Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647
   Liu ZQ, 2014, BIOCHEM BIOPH RES CO, V455, P218, DOI 10.1016/j.bbrc.2014.10.146
   Longatti A, 2015, VIRUSES-BASEL, V7, P6707, DOI 10.3390/v7122967
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005
   Madison MN, 2015, VIRUSES-BASEL, V7, P4093, DOI 10.3390/v7072810
   Malm T, 2016, NEUROCHEM INT, V97, P193, DOI 10.1016/j.neuint.2016.04.011
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Menck K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1378056
   Ming GL, 2017, CELL STEM CELL, V20, P749, DOI 10.1016/j.stem.2017.05.010
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Russo FB, 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI 10.1016/j.bbrc.2017.01.074
   Schey KL, 2015, METHODS, V87, P75, DOI 10.1016/j.ymeth.2015.03.018
   SCHOEPP RJ, 1984, J CLIN MICROBIOL, V20, P1017, DOI 10.1128/JCM.20.5.1017-1019.1984
   Sherman MB, 2006, J VIROL, V80, P10395, DOI 10.1128/JVI.01137-06
   Sherman MB, 2009, VIROLOGY, V387, P11, DOI 10.1016/j.virol.2009.02.038
   Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102
   Stoffel W, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.385
   Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x
   Sultana H, 2012, J IMMUNOL, V189, P3150, DOI 10.4049/jimmunol.1201140
   Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002
   Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309
   Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855
   Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30
   Vora A, 2018, P NATL ACAD SCI USA, V115, pE6604, DOI 10.1073/pnas.1720125115
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103
   Xu CR, 2014, EMBO J, V33, P2157, DOI 10.15252/embj.201488671
   Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou WS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006764
   Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339
NR 72
TC 5
Z9 5
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAR 1
PY 2019
VL 8
IS 1
BP 307
EP 326
DI 10.1080/22221751.2019.1578188
PG 20
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HN1TA
UT WOS:000459968700001
PM 30866785
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chao, DY
   Whitney, MT
   Davis, BS
   Medina, FA
   Munoz, JL
   Chang, GJJ
AF Chao, Day-Yu
   Whitney, Matthew T.
   Davis, Brent S.
   Medina, Freddy A.
   Munoz, Jorge L.
   Chang, Gwong-Jen J.
TI Comprehensive Evaluation of Differential Serodiagnosis between Zika and
   Dengue Viral Infections
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE dengue virus; ELISA; Zika virus; differential diagnosis
ID LINKED IMMUNOSORBENT ASSAYS; VIRUS-LIKE PARTICLES; NEUTRALIZING
   ANTIBODIES; MEMBRANE ASSOCIATION; ENCEPHALITIS-VIRUS; INTERIM GUIDANCE;
   IMMUNOGLOBULIN-M; IGM ANTIBODY; WEST-NILE; DIAGNOSIS
AB Diagnostic testing for Zika virus (ZIKV) or dengue virus (DENV) infection can be accomplished by a nucleic acid detection method; however, a negative result does not exclude infection due to the low virus titer during infection depending on the timing of sample collection. Therefore, a ZIKV- or DENV-specific serological assay is essential for the accurate diagnosis of patients and to mitigate potential severe health outcomes. A retrospective study design with dual approaches of collecting human serum samples for testing was developed. All serum samples were extensively evaluated by using both noninfectious wild-type (wt) virus-like particles (VLP5) and soluble nonstructural protein 1 (NS1) in the standard immunoglobulin M (IgM) antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA). Both ZIKV-derived wt-VLP- and NS1-MAC-ELISAs were found to have similar sensitivities for detecting anti-premembrane/envelope and NS1 antibodies from ZIKV-infected patient sera, although lower cross-reactivity to DENV2/3-NS1 was observed. Furthermore, group cross-reactive (GR)-antibody-ablated homologous fusion peptide-mutated (FP)-VLPs consistently showed higher positive-to-negative values than homologous wt-VLPs. Therefore, we used DENV-2/3 and ZIKV FP-VLPs to develop a novel, serological algorithm for differentiating ZIKV from DENV infection. Overall, the sensitivity and specificity of the FP-VLP-MAC-ELISA and the NS1-MAC-ELISA were each higher than 80%, with no statistical significance. The accuracy can reach up to 95% with the combination of FP-VLP and NS1 assays. In comparison to current guidelines using neutralization tests to measure ZIKV antibody, this approach can facilitate laboratory screening for ZIKV infection, especially in regions where DENV infection is endemic and capacity for neutralization testing does not exist.
C1 [Chao, Day-Yu] Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung, Taiwan.
   [Whitney, Matthew T.; Davis, Brent S.; Chang, Gwong-Jen J.] US Dept HHS, Publ Hlth Serv, Div Vector Borne Dis, Ctr Dis Control & Prevent, Ft Collins, CO 80524 USA.
   [Medina, Freddy A.; Munoz, Jorge L.] US Dept HHS, Publ Hlth Serv, Div Vector Borne Dis, Ctr Dis Control & Prevent, San Juan, PR USA.
RP Chao, DY (corresponding author), Natl Chung Hsing Univ, Coll Vet Med, Grad Inst Microbiol & Publ Hlth, Taichung, Taiwan.; Chang, GJJ (corresponding author), US Dept HHS, Publ Hlth Serv, Div Vector Borne Dis, Ctr Dis Control & Prevent, Ft Collins, CO 80524 USA.
EM dychao@nchu.edu.tw; gxc7@cdc.gov
OI day-yu, chao/0000-0001-7139-026X
FU MOST overseas short-term fellowship from the CDC; CDC Intramural
   Research Fund; Office of Infectious Disease, Bureau for Global Health,
   U.S. Agency for International DevelopmentUnited States Agency for
   International Development (USAID); CDCCentre National de la Recherche
   Scientifique (CNRS)United States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
FX D.-Y.C. was supported by a MOST overseas short-term fellowship from the
   CDC to conduct this study. Portions of this publication were supported
   by the CDC Intramural Research Fund and the Office of Infectious
   Disease, Bureau for Global Health, U.S. Agency for International
   Development, under the terms of an Interagency Agreement with CDC. The
   funding sources of this study had no role in the study design, data
   collection, data analysis, data interpretation, or writing of the
   report.
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5527
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Chao DY, 2015, J CLIN MICROBIOL, V53, P557, DOI 10.1128/JCM.02735-14
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Crill WD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00334
   Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Galula JU, 2016, J CLIN MICROBIOL, V54, P412, DOI 10.1128/JCM.02469-15
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Holmes DA, 2005, J CLIN MICROBIOL, V43, P3227, DOI 10.1128/JCM.43.7.3227-3236.2005
   Hughes HR, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-115
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Mishra N, 2018, MBIO, V9, DOI 10.1128/mBio.00095-18
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Roberson JA, 2007, J CLIN MICROBIOL, V45, P3167, DOI 10.1128/JCM.01143-07
   Rockstroh A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.87
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Singh RK, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02677
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00992-18, 10.1128/jcm.00992-18]
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 41
TC 3
Z9 3
U1 1
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAR
PY 2019
VL 57
IS 3
AR UNSP e01506-18
DI 10.1128/JCM.01506-18
PG 14
WC Microbiology
SC Microbiology
GA HM9JU
UT WOS:000459801000014
PM 30541932
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Granger, D
   Theel, ES
AF Granger, Dane
   Theel, Elitza S.
TI Evaluation of a Rapid lmmunochromatographic Assay and Two Enzyme-Linked
   Immunosorbent Assays for Detection of IgM-Class Antibodies to Zika Virus
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE IgM antibodies; immunochromatographic assay; MAC-ELISA; Zika virus
AB There are currently five serologic assays available for detection of anti-Zika virus (ZIKV) IgM-class antibodies with U.S. Food and Drug Administration emergency use authorization. Among these are the Chembio DPP Zika IgM system (DPP Zika ICA; Chembio, Medford, NY), a rapid immunochromatographic assay (ICA), and the InBios ZIKV Detect 2.0 IgM antibody capture enzyme-linked immunosorbent assay (ZIKV 2.0 MAC-ELISA; InBios international, Inc., Seattle, WA), which has replaced the original InBios ZIKV Detect MAC-ELISA. We evaluated performance of these three serologic assays using 72 specimens characterized by plaque reduction neutralization testing (PRNT) for the presence or absence of neutralizing antibodies (NAbs) to ZIKV, dengue virus (DENV), and West Nile virus (WNV). The InBios ZIKV 2.0 MAC-ELISA was "presumptive Zika positive" in all 15 PRNT-confirmed ZIKV samples, while the Chembio DPP Zika ICA was nonreactive in three (20%) and the InBios ZIKV MAC-ELISA was negative in four (27%). The Chembio DPP Zika ICA and InBios ZIKV 2.0 MAC-ELISA showed >95% specificity in 22 ZIKV/DENV-seronegative specimens and in 13 samples positive for NAbs to non-ZIKV flaviviruses. Comparatively, the InBios ZIKV MAC-ELISA was "presumptive" or "possible Zika positive" in 8 of 12 WNV or DENV PRNT-positive samples and in 12 of 22 PRNT-seronegative sera. Our findings suggest that replacement of the InBios ZIKV MAC-ELISA with the InBios ZIKV 2.0 MAC-ELISA will lead to fewer samples requiring PRNT, minimizing unnecessary anxiety among patients ultimately determined to be seronegative for ZIKV and DENV by PRNT and alleviating some of the testing burden on laboratories performing PRNT.
C1 [Granger, Dane; Theel, Elitza S.] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA.
RP Theel, ES (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA.
EM theel.elitza@mayo.edu
CR Centers for Disease Control and Prevention, 2018, ZIK CAS US
   Centers for Disease Control and Prevention, 2018, ZIK VIR TEST GUID
   Centers for Disease Control and Prevetion-CDC, 2017, UPD GUID US LAB TEST
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   InBios International Inc, 2018, ZIKV DET 2 0 IGM CAP
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Rajapakse NS, 2018, EMERG INFECT DIS, V24, P1422, DOI 10.3201/eid2408.180057
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sloan A, 2018, DIAGN MICR INFEC DIS, V90, P264, DOI 10.1016/j.diagmicrobio.2017.11.018
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00992-18, 10.1128/jcm.00992-18]
NR 18
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAR
PY 2019
VL 57
IS 3
AR UNSP e01413-18
DI 10.1128/JCM.01413-18
PG 9
WC Microbiology
SC Microbiology
GA HM9JU
UT WOS:000459801000008
PM 30541936
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Nelson, CS
   Cruz, DV
   Su, M
   Xie, GH
   Vandergrift, N
   Pass, RF
   Forman, M
   Diener-West, M
   Koelle, K
   Arav-Boger, R
   Permar, SR
AF Nelson, Cody S.
   Cruz, Diana Vera
   Su, Melody
   Xie, Guanhua
   Vandergrift, Nathan
   Pass, Robert F.
   Forman, Michael
   Diener-West, Marie
   Koelle, Katia
   Arav-Boger, Ravit
   Permar, Sallie R.
TI Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by
   Seronegative Glycoprotein B Vaccinees
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE DNA sequencing; glycoprotein B; human cytomegalovirus; vaccine
ID GENE FLOW; DIVERSITY; DNA; POPULATIONS; INFECTIONS; GENOTYPES; FIXATION;
   NUMBER; GP116
AB Human cytomegalovirus (HCMV) is the most common congenital infection worldwide and a frequent cause of hearing loss and debilitating neurologic disease in newborn infants. Thus, a vaccine to prevent HCMV-associated congenital disease is a public health priority. One potential strategy is vaccination of women of child bearing age to prevent maternal HCMV acquisition during pregnancy. The glycoprotein B (gB) plus MF59 adjuvant subunit vaccine is the most efficacious tested clinically to date, demonstrating 50% protection against primary HCMV infection in a phase 2 clinical trial. Yet, the impact of gB/MF59-elicited immune responses on the population of viruses acquired by trial participants has not been assessed. In this analysis, we employed quantitative PCR as well as multiple sequencing methodologies to interrogate the magnitude and genetic composition of HCMV populations infecting gB/MF59 vaccinees and placebo recipients. We identified several differences between the viral dynamics in acutely infected vaccinees and placebo recipients. First, viral load was reduced in the saliva of gB vaccinees, though not in whole blood, vaginal fluid, or urine. Additionally, we observed possible anatomic compartmentalization of gB variants in the majority of vaccinees compared to only a single placebo recipient. Finally, we observed reduced acquisition of genetically related gB1, gB2, and gB4 genotype " supergroup" HCMV variants among vaccine recipients, suggesting that the gB1 genotype vaccine construct may have elicited partial protection against HCMV viruses with antigenically similar gB sequences. These findings suggest that gB immunization had a measurable impact on viral intrahost population dynamics and support future analysis of a larger cohort.
   IMPORTANCE Though not a household name like Zika virus, human cytomegalovirus (HCMV) causes permanent neurologic disability in one newborn child every hour in the United States, which is more than that for Down syndrome, fetal alcohol syndrome, and neural tube defects combined. There are currently no established effective measures to prevent viral transmission to the infant following HCMV infection of a pregnant mother. However, the glycoprotein B (gB)/MF59 vaccine, which aims to prevent pregnant women from acquiring HCMV, is the most successful HCMV vaccine tested clinically to date. Here, we used viral DNA isolated from patients enrolled in a gB vaccine trial who acquired HCMV and identified several impacts that this vaccine had on the size, distribution, and composition of the in vivo viral population. These results have increased our understanding of why the gB/MF59 vaccine was partially efficacious, and such investigations will inform future rational design of a vaccine to prevent congenital HCMV.
C1 [Nelson, Cody S.; Su, Melody; Xie, Guanhua; Vandergrift, Nathan; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27708 USA.
   [Cruz, Diana Vera] Duke Univ, Dept Computat Biol & Bioinformat, Durham, NC USA.
   [Pass, Robert F.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA.
   [Forman, Michael] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA.
   [Diener-West, Marie] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA.
   [Koelle, Katia] Emory Univ, Dept Biol, Atlanta, GA 30322 USA.
   [Arav-Boger, Ravit] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA.
RP Permar, SR (corresponding author), Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27708 USA.; Arav-Boger, R (corresponding author), Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA.
EM boger@jgmi.edu; sallie.permar@dm.duke.edu
OI Nelson, Cody/0000-0002-1046-455X; Pass, Robert/0000-0003-2029-0247; Vera
   Cruz, Diana/0000-0002-8754-7724
FU University of Alabama at Birmingham from NIH/NIAID [P01AI043681,
   U01AI063565]; Sanofi Pasteur; NIH/NICHD Director's New Innovator grant
   [DP2HD075699]; NIH/NIAID R21 grant [R21AI136556]; NIH/NIAID R08 grant
   [R08AI074907]; NIH/NICHD F30 grant [F30HD089577]
FX The gB/MF59 vaccine clinical trial was supported by grants to the
   University of Alabama at Birmingham from NIH/NIAID (P01AI043681 and
   U01AI063565) and by Sanofi Pasteur. This work was supported by an
   NIH/NICHD Director's New Innovator grant to S.R.P (DP2HD075699), an
   NIH/NIAID R21 grant to S.R.P. (R21AI136556), an NIH/NIAID R08 grant to
   R.A.-B. (R08AI074907), and an NIH/NICHD F30 grant to C.S.N
   (F30HD089577).
CR Baraniak I, 2018, P NATL ACAD SCI USA, V115, P6273, DOI 10.1073/pnas.1800224115
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bernstein DI, 2016, VACCINE, V34, P313, DOI 10.1016/j.vaccine.2015.11.056
   Bradley AJ, 2008, J MED VIROL, V80, P1615, DOI 10.1002/jmv.21241
   CHOU SW, 1992, VIROLOGY, V188, P388, DOI 10.1016/0042-6822(92)90771-G
   Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496
   Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71
   Dal Monte P, 2001, J HUMAN VIROL, V4, P26
   Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0
   Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Ehlinger EP, 2011, J INFECT DIS, V204, P1672, DOI 10.1093/infdis/jir632
   Forman MS, 2017, J INFECT DIS, V215, P1523, DOI 10.1093/infdis/jix188
   Griffiths PD, 2011, LANCET, V377, P1256, DOI 10.1016/S0140-6736(11)60136-0
   Hassan-Walker AF, 2004, J MED VIROL, V74, P573, DOI 10.1002/jmv.20210
   Hathaway NJ, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gkx1201
   Huang E S, 1980, Ann N Y Acad Sci, V354, P332, DOI 10.1111/j.1749-6632.1980.tb27976.x
   Hudson RR, 2000, GENETICS, V155, P2011
   HUDSON RR, 1992, GENETICS, V132, P583
   KIMURA M, 1969, GENETICS, V61, P763
   KIMURA M, 1962, GENETICS, V47, P713
   Klein M, 1999, J VIROL, V73, P878, DOI 10.1128/JVI.73.2.878-886.1999
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   MEYER H, 1992, J GEN VIROL, V73, P2375, DOI 10.1099/0022-1317-73-9-2375
   Murthy S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015949
   Nelson CW, 2015, INFECT GENET EVOL, V30, P1, DOI 10.1016/j.meegid.2014.11.026
   Nelson CS, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0074-4
   Nelson CS, 2018, P NATL ACAD SCI USA, V115, P6267, DOI 10.1073/pnas.1800177115
   Nelson CS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94002
   Nelson CS, 1995, GENETIC SIGNATURES H, DOI [10.1101/432922, DOI 10.1101/432922]
   Novak Z, 2008, J CLIN MICROBIOL, V46, P882, DOI 10.1128/JCM.01079-07
   O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10
   Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749
   Peek R, 1998, INVEST OPHTH VIS SCI, V39, P1183
   Potzsch S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002172
   Ramanan P, 2013, INFECT CHEMOTHER, V45, P260, DOI 10.3947/ic.2013.45.3.260
   Renzette N, 2015, P NATL ACAD SCI USA, V112, pE4120, DOI 10.1073/pnas.1501880112
   Renzette N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003735
   Renzette N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001344
   SLATKIN M, 1989, GENETICS, V123, P603
   Sowmya P, 2009, J MED VIROL, V81, P861, DOI 10.1002/jmv.21459
   Stratton KR, 2000, VACCINES 21 CENTURY
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tanaka Y, 2002, BONE MARROW TRANSPL, V30, P315, DOI 10.1038/sj.bmt.1703661
   Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00
   URBAN M, 1992, J VIROL, V66, P1303, DOI 10.1128/JVI.66.3.1303-1311.1992
   Wang D, 2011, VACCINE, V29, P9075, DOI 10.1016/j.vaccine.2011.09.056
   Wang JB, 1996, J INFECT DIS, V174, P387, DOI 10.1093/infdis/174.2.387
   Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001
   Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
NR 52
TC 3
Z9 3
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2019
VL 93
IS 5
AR e01695-18
DI 10.1128/JVI.01695-18
PG 17
WC Virology
SC Virology
GA HL8VZ
UT WOS:000459022000018
PM 30518646
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Eyer, L
   Fojtikova, M
   Nencka, R
   Rudolf, I
   Hubalek, Z
   Ruzek, D
AF Eyer, Ludek
   Fojtikova, Martina
   Nencka, Radim
   Rudolf, Ivo
   Hubalek, Zdenek
   Ruzek, Daniel
TI Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2
   '-C-Methyladenosine Prevents Death in a Mouse Model of West Nile Virus
   Infection
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE West Nile virus; antiviral agents; flavivirus; nucleoside analogs
ID ADENOSINE NUCLEOSIDE INHIBITOR; HEPATITIS-C; TICK-BORNE; DENGUE VIRUS;
   URIDINE PHOSPHORYLASE; ANTIVIRAL ACTIVITY; ZIKA VIRUS; NEW-YORK;
   REPLICATION; ENCEPHALITIS
AB West Nile virus (WNV) is a medically important emerging arbovirus causing serious neuroinfections in humans and against which no approved antiviral therapy is currently available. In this study, we demonstrate that 2'-C-methyl- or 4'-azido-modified nucleosides are highly effective inhibitors of WNV replication, showing nanomolar or low micromolar anti-WNV activity and negligible cytotoxicity in cell culture. One representative of C2'-methylated nucleosides, 7-deaza-2'-C-methyladenosine, significantly protected WNV-infected mice from disease progression and mortality. Twice daily treatment at 25 mg/kg starting at the time of infection resulted in 100% survival of the mice. This compound was highly effective, even if the treatment was initiated 3 days postinfection, at the time of a peak of viremia, which resulted in a 90% survival rate. However, the antiviral effect of 7-deaza-2'-C-methyladenosine was absent or negligible when the treatment was started 8 days postinfection (i.e., at the time of extensive brain infection). The 4'-azido moiety appears to be another important determinant for highly efficient inhibition of WNV replication in vitro. However, the strong anti-WNV effect of 4'-azidocytidine and 4'-azido-aracytidine was cell type dependent and observed predominantly in porcine kidney stable (PS) cells. The effect was much less pronounced in Vero cells. Our results indicate that 2'-C-methylated or 4'-azidated nucleosides merit further investigation as potential therapeutic agents for treating WNV infections as well as infections caused by other medically important flaviviruses.
C1 [Eyer, Ludek; Fojtikova, Martina; Ruzek, Daniel] Vet Res Inst, Dept Virol, Brno, Czech Republic.
   [Eyer, Ludek; Ruzek, Daniel] Czech Acad Sci, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic.
   [Nencka, Radim] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic.
   [Rudolf, Ivo; Hubalek, Zdenek] Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic.
   [Rudolf, Ivo; Hubalek, Zdenek] Masaryk Univ, Dept Expt Biol, Brno, Czech Republic.
RP Ruzek, D (corresponding author), Vet Res Inst, Dept Virol, Brno, Czech Republic.; Ruzek, D (corresponding author), Czech Acad Sci, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic.
EM ruzekd@paru.cas.cz
RI Ruzek, Daniel/G-9275-2014; Hubalek, Zdenek/AAF-8071-2019; Rudolf,
   Ivo/G-1112-2014; Hubalek, Zdenek/G-1111-2014; Eyer, Ludek/U-4883-2018
OI Ruzek, Daniel/0000-0003-4655-2380; Rudolf, Ivo/0000-0001-6602-2905;
   Hubalek, Zdenek/0000-0003-4732-0987; Eyer, Ludek/0000-0001-7761-0702
FU Czech Science FoundationGrant Agency of the Czech Republic [16-20054S]
FX This study was supported by a grant from the Czech Science Foundation
   (grant 16-20054S). The funder had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030
   Baier A., 2011, FLAVIVIRUS ENCEPHALI, P89
   Balestri F, 2007, NEUROCHEM INT, V51, P517, DOI 10.1016/j.neuint.2007.06.007
   Beasley DWC, 2004, ARCH VIROL, P35
   Benhamou Y, 2003, NEW ENGL J MED, V348, P177, DOI 10.1056/NEJM200301093480218
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P3255, DOI 10.1128/AAC.00397-10
   Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10
   Chowers MY, 2001, EMERG INFECT DIS, V7, P675
   Dauphin G, 2004, COMP IMMUNOL MICROB, V27, P343, DOI 10.1016/j.cimid.2004.03.009
   De Clercq E, 2005, NAT REV DRUG DISCOV, V4, P928, DOI 10.1038/nrd1877
   De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3
   De Clercq E, 2004, NAT REV MICROBIOL, V2, P704, DOI 10.1038/nrmicro975
   De Clercq E, 2008, EXPERT OPIN EMERG DR, V13, P393, DOI [10.1517/14728214.13.3.393 , 10.1517/14728214.13.3.393]
   De Clercq E, 2011, ANNU REV PHARMACOL, V51, P1, DOI 10.1146/annurev-pharmtox-010510-100228
   Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   Eldrup AB, 2004, J MED CHEM, V47, P2283, DOI 10.1021/jm030424e
   Eyer Ludek, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618761299
   Eyer L, 2017, J VIROL, V91, DOI 10.1128/JVI.01028-17
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Flint M, 2014, ANTIMICROB AGENTS CH, V58, P3206, DOI 10.1128/AAC.02393-14
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Huang YS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0169228, 10.1371/journal.pone.0]
   Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415
   Julander JG, 2010, ANTIVIR RES, V86, P261, DOI 10.1016/j.antiviral.2010.03.004
   Khromykh AA, 1999, J VIROL, V73, P10272, DOI 10.1128/JVI.73.12.10272-10280.1999
   Klumpp K, 2006, J BIOL CHEM, V281, P3793, DOI 10.1074/jbc.M510195200
   Klumpp K, 2008, J BIOL CHEM, V283, P2167, DOI 10.1074/jbc.M708929200
   Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006
   KOZUCH O, 1975, ACTA VIROL, V19, P498
   Kumar M, 2014, VIRUSES-BASEL, V6, P2328, DOI 10.3390/v6062328
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Lashkov AA, 2016, CRYSTALLOGR REP+, V61, P826, DOI 10.1134/S1063774516050138
   Lee JC, 2015, ANTIVIR RES, V116, P1, DOI 10.1016/j.antiviral.2015.01.002
   Lefebvre DJ, 2014, TRANSBOUND EMERG DIS, V61, pE89, DOI 10.1111/tbed.12069
   Lim SM, 2011, VIRUSES-BASEL, V3, P811, DOI 10.3390/v3060811
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Mateo R, 2015, MBIO, V6, DOI 10.1128/mBio.01960-15
   MELNICK JL, 1951, P SOC EXP BIOL MED, V77, P661, DOI 10.3181/00379727-77-18884
   Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Ray AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009
   Rocha-Pereira J, 2012, BIOCHEM BIOPH RES CO, V427, P796, DOI 10.1016/j.bbrc.2012.10.003
   Rocha-Pereira J, 2013, J VIROL, V87, P11798, DOI 10.1128/JVI.02064-13
   Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0
   Rudolf I, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.31.20867
   Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06
   Schul W, 2010, ANTIVIR RES, V86, pA24, DOI 10.1016/j.antiviral.2010.02.347
   Smith DB, 2009, J MED CHEM, V52, P219, DOI 10.1021/jm800981y
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j
   Stedman C, 2014, THER ADV GASTROENTER, V7, P131, DOI 10.1177/1756283X13515825
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 64
TC 4
Z9 4
U1 1
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD MAR
PY 2019
VL 63
IS 3
AR e02093-18
DI 10.1128/AAC.02093-18
PG 14
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA HM7TV
UT WOS:000459683500026
PM 30642926
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Diteepeng, T
   Khongwichit, S
   Paemanee, A
   Roytrakul, S
   Smith, DR
AF Diteepeng, Thamonwan
   Khongwichit, Sarawut
   Paemanee, Atchara
   Roytrakul, Sittiruk
   Smith, Duncan R.
TI Proteomic analysis of monkey kidney LLC-MK2 cells infected with a Thai
   strain Zika virus
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID DENGUE VIRUS; RNA; EPIDEMIC; PROTEIN; URINE
AB Zika virus (ZIKV) has been endemic in Southeast Asian countries for several years, but the presence of the virus has not been associated with significant outbreaks of infection unlike other countries around the world where the Asian lineage ZIKV was introduced recently. However, few studies have been undertaken using the endemic virus. The Thai isolate was shown to have a similar tissue tropism to an African isolate of ZIKV, albeit that the Thai isolate infected cells at a lower level as compared to the African isolate. To further understand the pathogenesis of the Thai isolate, a 2D-gel proteomic analysis was undertaken of ZIKV infected LLC-MK2 cells. Seven proteins (superoxide dismutase [Mn], peroxiredoxin 2, ATP synthase subunit alpha, annexin A5 and annexin A1, carnitine o-palmitoyltransferase 2 and cytoskeleton-associated protein 2) were identified as differentially regulated. Of four proteins selected for validation, three (superoxide dismutase [Mn], peroxiredoxin 2, ATP synthase subunit alpha, and annexin A1) were shown to be differentially regulated at both the transcriptional and translational levels. The proteins identified were primarily involved in energy production both directly, and indirectly through mediation of autophagy, as well as in the response to oxidative stress, possibly occurring as a consequence of increased energy production. This study provides further new information on the pathogenesis of ZIKV.
C1 [Diteepeng, Thamonwan; Khongwichit, Sarawut; Paemanee, Atchara; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Mol Pathol Lab, Salaya Campus,25-25 Phuttamonton Sai 4, Salaya 73170, Nakhon Pathom, Thailand.
   [Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Thailand Sci Pk,Phahonyothin Rd, Khlong Luang 12120, Pathum Thani, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Mol Pathol Lab, Salaya Campus,25-25 Phuttamonton Sai 4, Salaya 73170, Nakhon Pathom, Thailand.
EM duncan.smi@mahidol.ac.th
RI Smith, Duncan R/C-6891-2011
OI Smith, Duncan R/0000-0002-6592-9852; Roytrakul,
   Sittiruk/0000-0003-3696-8390; Paemanee, Atchara/0000-0001-9206-3153;
   Diteepeng, Thamonwan/0000-0003-2832-2565
FU Thailand Research FundThailand Research Fund (TRF) [BRG6080006];
   Development and Promotion of Science and Technology (DPST) talents
   project
FX This work was supported by the Thailand Research Fund (BRG6080006). TD
   was supported by a scholarship from the Development and Promotion of
   Science and Technology (DPST) talents project.
CR Acosta-Ampudia Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00116
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Arora S, 2016, CELL DEATH DIFFER, V23, P1243, DOI 10.1038/cdd.2016.19
   Babiychuk EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023706
   Barbier V, 2017, VIROLOGY, V500, P149, DOI 10.1016/j.virol.2016.10.022
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Coyaud E, 2018, MOL CELL PROTEOM
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Ghislat G, 2012, J CELL SCI, V125, P92, DOI 10.1242/jcs.086728
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Hiramoto H, 2015, ACTA MED OKAYAMA, V69, P71
   Holley AK, 2011, INT J MOL SCI, V12, P7114, DOI 10.3390/ijms12107114
   Jiang X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01067
   Jitobaom K, 2016, SCI REP-UK, V6, DOI 10.1038/srep35753
   Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006
   Khongwichit S, 2018, MICROBES INFECT, V56, P6
   Kuehnl A, 2016, BIOL CHEM, V397, P949, DOI 10.1515/hsz-2016-0183
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leecharoenkiat A, 2011, BLOOD CELL MOL DIS, V47, P143, DOI 10.1016/j.bcmd.2011.06.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Montoya M, 2018, J INFECT DIS
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nitatpattana N, 2018, MICROBIOL RESOUR ANN, V6, DOI [10.1128/genomeA.00121-18, 10.1128/genomea.00121-18]
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Peng H, 2018, VIRUSES
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Qiu GH, 2015, CYTOTECHNOLOGY, V67, P1, DOI 10.1007/s10616-014-9761-9
   Rufer AC, 2009, CELL MOL LIFE SCI, V66, P2489, DOI 10.1007/s00018-009-0035-1
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   SUN J, 1993, FEBS LETT, V329, P79, DOI 10.1016/0014-5793(93)80198-4
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD MAR
PY 2019
VL 164
IS 3
BP 725
EP 737
DI 10.1007/s00705-018-04137-1
PG 13
WC Virology
SC Virology
GA HM5RR
UT WOS:000459533400008
PM 30612200
DA 2020-07-08
ER

PT J
AU Gurung, S
   Reuter, D
   Maxted, M
   Singleton, K
   Hyatt, K
   Martin, A
   Dubaut, J
   Preno, A
   Papin, J
   Myers, D
AF Gurung, Sunam
   Reuter, Darlene
   Maxted, Marta
   Singleton, Krista
   Hyatt, Kim
   Martin, Ashley
   Dubaut, Jamie
   Preno, Alisha
   Papin, James
   Myers, Dean
TI Pregnancy Outcome following Zika Virus (ZIKV) Infection during the 3rd
   Trimester in the Olive Baboon (Papio Anubis): Evidence Does Not Support
   a Protective Role for Type III Interferons.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 66th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 12-16, 2019
CL Paris, FRANCE
SP Soc Reproduct Investigat
C1 [Gurung, Sunam; Reuter, Darlene; Maxted, Marta; Singleton, Krista; Hyatt, Kim; Martin, Ashley; Dubaut, Jamie; Preno, Alisha; Papin, James; Myers, Dean] Univ Oklahoma HSC, Oklahoma City, OK USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2019
VL 26
SU 1
MA O-006
BP 65A
EP 66A
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA HM6TL
UT WOS:000459610400007
DA 2020-07-08
ER

PT J
AU Nadeau, HC
   Maxted, M
   Gurung, S
   Reuter, D
   Singleton, K
   Martin, A
   Dubaut, J
   Preno, A
   Hyatt, K
   Papin, J
   Myers, D
AF Nadeau, Hugh C.
   Maxted, Marta
   Gurung, Sunam
   Reuter, Darlene
   Singleton, Krista
   Martin, Ashley
   Dubaut, Jamie
   Preno, Alisha
   Hyatt, Kim
   Papin, James
   Myers, Dean
TI Maternal Zika Virus (ZIKV) Infection Following Vaginal Inoculation with
   ZIKV Infected Semen in the Pregnant Olive Baboon.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 66th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 12-16, 2019
CL Paris, FRANCE
SP Soc Reproduct Investigat
C1 [Nadeau, Hugh C.; Maxted, Marta; Gurung, Sunam; Reuter, Darlene; Singleton, Krista; Martin, Ashley; Dubaut, Jamie; Preno, Alisha; Hyatt, Kim; Papin, James; Myers, Dean] Univ Oklahoma HSC, Oklahoma City, OK USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2019
VL 26
SU 1
MA O-092
BP 95A
EP 95A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA HM6TL
UT WOS:000459610400093
DA 2020-07-08
ER

PT J
AU Guzeloglu-Kayisli, O
   Guo, XF
   Semerci, N
   Ozmen, A
   Larsen, K
   Sabah, A
   Schatz, F
   Kayisli, UA
   Lockwood, CJ
AF Guzeloglu-Kayisli, Ozlem
   Guo, Xiaofang
   Semerci, Nihan
   Ozmen, Asli
   Larsen, Kellie
   Sabah, Aayat
   Schatz, Frederick
   Kayisli, Umit A.
   Lockwood, Charles J.
TI Tizoxanide Exerts Anti-Viral Effects by Inhibiting ZIKA Virus
   Replication in Infected-Human Endometrial Stromal Cells (HESCs), First
   Trimester (FTDCs) and Term Decidual Cells (TDCs): Implications in
   Preventing ZIKV Infection.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 66th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 12-16, 2019
CL Paris, FRANCE
SP Soc Reproduct Investigat
C1 [Guzeloglu-Kayisli, Ozlem; Guo, Xiaofang; Semerci, Nihan; Ozmen, Asli; Larsen, Kellie; Sabah, Aayat; Schatz, Frederick; Kayisli, Umit A.; Lockwood, Charles J.] Univ S Florida, Tampa, FL USA.
RI Ozmen, Asli/AAS-5359-2020
OI Ozmen, Asli/0000-0002-2024-6249
FU Florida Department of Health [7ZK23]
FX Supported by Florida Department of Health (#7ZK23).
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2019
VL 26
SU 1
MA O-103
BP 98A
EP 99A
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA HM6TL
UT WOS:000459610400104
DA 2020-07-08
ER

PT J
AU Gurung, S
   Reuter, D
   Martin, A
   Dubaut, J
   Preno, A
   Papin, J
   Myers, D
AF Gurung, Sunam
   Reuter, Darlene
   Martin, Ashley
   Dubaut, Jamie
   Preno, Alisha
   Papin, James
   Myers, Dean
TI Fetal Cortical Inflammation Following Zika Virus (ZIKV) Infection during
   the 3rd Trimester in the Olive Baboon (Papio Anubis)
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 66th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 12-16, 2019
CL Paris, FRANCE
SP Soc Reproduct Investigat
C1 [Gurung, Sunam; Reuter, Darlene; Martin, Ashley; Dubaut, Jamie; Preno, Alisha; Papin, James; Myers, Dean] Univ Oklahoma HSC, Oklahoma City, OK USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2019
VL 26
SU 1
MA F-120
BP 250A
EP 250A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA HM6TL
UT WOS:000459610400551
DA 2020-07-08
ER

PT J
AU Block, L
   Aliota, M
   Wang, X
   Friedrich, T
   Mean, K
   Schotzko, M
   Wenzel, A
   Wipez, G
   Golos, T
   Schmidt, JK
AF Block, L.
   Aliota, M.
   Wang, X.
   Friedrich, T.
   Mean, K.
   Schotzko, M.
   Wenzel, A.
   Wipez, G.
   Golos, T.
   Schmidt, J. Kropp
TI Seasonality and Zika Virus (ZIKV) Impact In Vitro Implantation in a
   Rhesus Macaque Model.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 66th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 12-16, 2019
CL Paris, FRANCE
SP Soc Reproduct Investigat
C1 [Block, L.; Aliota, M.; Wang, X.; Friedrich, T.; Mean, K.; Schotzko, M.; Wenzel, A.; Wipez, G.; Golos, T.; Schmidt, J. Kropp] Univ Wisconsin, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2019
VL 26
SU 1
MA F-230
BP 286A
EP 286A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA HM6TL
UT WOS:000459610400659
DA 2020-07-08
ER

PT J
AU Guo, XF
   Kayisli, UA
   Semerci, N
   Ozmen, A
   Larsen, K
   Urmi, SA
   Huang, J
   Schatz, F
   Lockwood, C
   Guzeloglu-Kayisli, O
AF Guo, Xiaofang
   Kayisli, Umit A.
   Semerci, Nihan
   Ozmen, Asli
   Larsen, Kellie
   Urmi, Shaheda Akter
   Huang, Joseph
   Schatz, Frederick
   Lockwood, Charles
   Guzeloglu-Kayisli, Ozlem
TI Human Decidual Cells are Highly Permissive to ZIKA Virus Infection in a
   Trimester-Dependent Manner.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 66th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 12-16, 2019
CL Paris, FRANCE
SP Soc Reproduct Investigat
C1 [Guo, Xiaofang; Kayisli, Umit A.; Semerci, Nihan; Ozmen, Asli; Larsen, Kellie; Urmi, Shaheda Akter; Huang, Joseph; Schatz, Frederick; Lockwood, Charles; Guzeloglu-Kayisli, Ozlem] Univ S Florida, Morsani Coll Med, Tampa, FL USA.
RI Ozmen, Asli/AAS-5359-2020
OI Ozmen, Asli/0000-0002-2024-6249
FU Florida Department of Health [7ZK23]
FX Supported by the Florida Department of Health (#7ZK23).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2019
VL 26
SU 1
MA F-263
BP 297A
EP 297A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA HM6TL
UT WOS:000459610400692
DA 2020-07-08
ER

PT J
AU Andrade, CBV
   Coelho, SVA
   Gomes, HR
   Bloise, FF
   Matthews, SG
   Bloise, E
   Arruda, LB
   Ortiga-Carvalho, TM
AF Andrade, Cherley B. V.
   Coelho, Sharton V. A.
   Gomes, Hanailly R.
   Bloise, Flavia F.
   Matthews, Stephen G.
   Bloise, Enrrico
   Arruda, Luciana B.
   Ortiga-Carvalho, Tania M.
TI Compromised of Placental ABC Transporters in an Immunocompetent Model of
   Zika Virus Congenital Infection.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 66th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 12-16, 2019
CL Paris, FRANCE
SP Soc Reproduct Investigat
C1 [Andrade, Cherley B. V.; Coelho, Sharton V. A.; Gomes, Hanailly R.; Bloise, Flavia F.; Arruda, Luciana B.; Ortiga-Carvalho, Tania M.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Matthews, Stephen G.] Univ Toronto, Toronto, ON, Canada.
   [Bloise, Enrrico] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2019
VL 26
SU 1
MA S-166
BP 354A
EP 354A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA HM6TL
UT WOS:000459610400862
DA 2020-07-08
ER

PT J
AU Chughtai, AA
AF Chughtai, Aisha A.
TI The Aftermath and Effects of Zika Virus on Human Growth and Development
SO AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY
LA English
DT Meeting Abstract
CT 88th Annual Meeting of the
   American-Association-of-Physical-Anthropologists (AAPA)
CY MAR 27-30, 2019
CL Cleveland, OH
SP Amer Assoc Phys Anthropologists
C1 [Chughtai, Aisha A.] Univ Penn, Anthropol, Philadelphia, PA 19104 USA.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-9483
EI 1096-8644
J9 AM J PHYS ANTHROPOL
JI Am. J. Phys. Anthropol.
PD MAR
PY 2019
VL 168
SU 68
BP 42
EP 42
PG 1
WC Anthropology; Evolutionary Biology
SC Anthropology; Evolutionary Biology
GA HL0UM
UT WOS:000458409600161
DA 2020-07-08
ER

PT J
AU Singh, J
   Aballay, A
AF Singh, Jogender
   Aballay, Alejandro
TI Similar Neural Pathways Control Foraging in Mosquitoes and Worms
SO MBIO
LA English
DT Article
DE A. aegypti; C. elegans; NPR-1; aversion behavior; bacterial
   colonization; feeding; neuropeptide Y
ID CARBON-DIOXIDE AVOIDANCE; HOST-SEEKING BEHAVIOR; AEDES-AEGYPTI; OXYGEN
AB Female Aedes aegypti mosquitoes bite human hosts to obtain a blood meal and, in the process, act as vectors for many disease-causing viruses, including the dengue, chikungunya, yellow fever, and Zika viruses. After a complete meal, the female mosquitoes lose attraction to their hosts for several days. New research shows that pharmacological activation of neuropeptide Y-like receptor (NPYLR) signaling elicits host aversion in female mosquitoes. This behavior of mosquitoes shows remarkable similarities to a bacterial-aversion behavior of the nematode Caenorhabditis elegans. Feeding on pathogenic bacteria causes bloating of the gut in C. elegans that leads to activation of NPYLR signaling and bacterial aversion. Several studies suggest that this newly discovered mechanism underlying foraging may be conserved across a large number of species. A better understanding of the regulation of NPYLR signaling pathways could provide molecular targets for the control of eating behaviors in different animals, including human-disease vectors.
C1 [Singh, Jogender; Aballay, Alejandro] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.
RP Aballay, A (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.
EM aballay@ohsu.edu
OI Singh, Jogender/0000-0002-7947-0405
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM0709077, AI117911]
FX The work in the Aballay laboratory is supported by grants from the
   National Institutes of Health (GM0709077 and AI117911).
CR Brandt JP, 2015, CURR BIOL, V25, P2228, DOI 10.1016/j.cub.2015.07.037
   Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105
   Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100
   BROWN MR, 1994, J INSECT PHYSIOL, V40, P399, DOI 10.1016/0022-1910(94)90158-9
   Carrillo MA, 2013, J NEUROSCI, V33, P9675, DOI 10.1523/JNEUROSCI.4541-12.2013
   Duvall LB, 2019, CELL, V176, P687, DOI 10.1016/j.cell.2018.12.004
   Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105
   Hallem EA, 2011, CURR BIOL, V21, P377, DOI 10.1016/j.cub.2011.01.048
   KLOWDEN MJ, 1981, J INSECT PHYSIOL, V27, P799, DOI 10.1016/0022-1910(81)90071-8
   KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P583, DOI 10.1016/0022-1910(79)90073-8
   Liesch J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002486
   McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044
   Reddy KC, 2011, P NATL ACAD SCI USA, V108, P12887, DOI 10.1073/pnas.1108265108
   Scott K, 2011, NEURON, V69, P194, DOI 10.1016/j.neuron.2010.12.018
   Singh J, 2019, DEV CELL, V49, P89, DOI 10.1016/j.devcel.2019.02.001
   Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d
NR 18
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2019
VL 10
IS 2
AR e00656-19
DI 10.1128/mBio.00656-19
PG 4
WC Microbiology
SC Microbiology
GA LB8WD
UT WOS:000524910300016
PM 31040241
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jo, S
   Kim, Y
   Choi, JS
AF Jo, Sungho
   Kim, Youngji
   Choi, Jeong Sil
TI Influencing factors on preventive health behaviours for Zika virus in
   pregnant women and their partners
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE attitudes; gender; health motivation; knowledge; Zika virus
ID ATTITUDES; KNOWLEDGE
AB Aims and objectives To identify Zika virus-related knowledge, attitudes to Zika virus and health motivations of pregnant women, women preparing for pregnancy and their partners, and to identify factors that influence preventive health behaviours for Zika virus infection. Background Prevention of Zika virus infection is becoming a major worldwide public health effort. The high-risk group for Zika virus infection comprises women who are pregnant or preparing for pregnancy. Few studies have addressed preventive health behaviours for Zika virus infection by gender. Design This study was a descriptive cross-sectional survey. Methods Participants (112 males and 147 females) were selected by convenience sampling from three obstetric clinics located in South Korea. Women and their partners who visited obstetric clinics during pregnancy or preparing for pregnancy were included as subjects. Results Factors associated with preventive health behaviours for Zika virus were checking infection status of Zika virus on destinations when planning a trip and attitudes to Zika virus in males and age, educational level, intention to travel to Zika virus endemic countries, attitudes to Zika virus and health motivation in females. Conclusions Factors that influence preventive health behaviours for Zika virus were different by gender. However, attitudes to Zika virus were influential to both genders. Gender differences should be considered in development of health policies to improve preventive health behaviours for Zika virus. Younger and less educated women are to be targeted, and health management programmes should be developed to promote health motivation. Relevance to clinical practice Pregnant women, women preparing for pregnancy and their partners need education and public health promotion to improve self-management during travel to places where Zika virus is endemic. Health policies and health management programmes considering age and educational background should be developed to promote health motivation in women of childbearing age.
C1 [Jo, Sungho] Dankook Univ, Coll Med, Cheonan, South Korea.
   [Kim, Youngji; Choi, Jeong Sil] Gachon Univ, Coll Nursing, Incheon, South Korea.
RP Choi, JS (corresponding author), Gachon Univ, Coll Nursing, Incheon, South Korea.
EM jschoi408@empas.com
OI choi, jeongsil/0000-0002-9316-0171
FU Gachon University research fund [GCU-2017-0174]
FX Gachon University research fund, Grant/Award Number: GCU-2017-0174
CR AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   CHAMPION VL, 1993, NURS RES, V42, P139
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fraiz LD, 2018, VACCINE, V36, P165, DOI 10.1016/j.vaccine.2017.11.021
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Huang Yu, 2017, JMIR Public Health Surveill, V3, pe81, DOI 10.2196/publichealth.7663
   Korea Centers for Disease Control and Prevention, 2016, ZIK VIR PREV GUID KO
   Lee EH, 2002, CANCER NURS, V25, P391, DOI 10.1097/00002820-200210000-00010
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RIPPETOE PA, 1987, J PERS SOC PSYCHOL, V52, P596, DOI 10.1037/0022-3514.52.3.596
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Sim K. Y., 2018, KOREAN J EMERGENCY M, V22, P21, DOI [10.14408/kjems.2018.22.1.021, DOI 10.14408/KJEMS.2018.22.1.021]
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Zika Virus Preparedness and Response Task Force, 2017, PUBL HLTH WEEKL REP, P260
NR 22
TC 0
Z9 0
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD MAR
PY 2019
VL 28
IS 5-6
BP 894
EP 901
DI 10.1111/jocn.14698
PG 8
WC Nursing
SC Nursing
GA HL0CM
UT WOS:000458362400017
PM 30367529
OA Bronze
DA 2020-07-08
ER

PT J
AU Liu, ZY
   Shi, WF
   Qin, CF
AF Liu, Zhong-Yu
   Shi, Wei-Feng
   Qin, Cheng-Feng
TI The evolution of Zika virus from Asia to the Americas
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID RNA-RNA INTERACTIONS; DENGUE VIRUS; NEURAL PROGENITORS; CHIKUNGUNYA
   VIRUS; CRYSTAL-STRUCTURE; NS2B-NS3 PROTEASE; STRUCTURAL BASIS; SINGLE
   MUTATION; SOUTH-PACIFIC; I INTERFERON
AB Zika virus (ZIKV) was once considered an obscure member of the large and diverse family of mosquito-borne flaviviruses, and human infections with ZIKV were thought to be sporadic, with mild and self-limiting symptoms. The large-scale ZIKV epidemics in the Americas and the unexpected uncovering of a link to congenital birth defects escalated ZIKV infections to the status of a global public health emergency. Recent studies that combined reverse genetics with modelling in multiple systems have provided evidence that ZIKV has acquired additional amino acid substitutions at the same time as congenital Zika syndrome and other birth defects were detected. In this Progress article, we summarize the evolution of ZIKV during its spread from Asia to the Americas and discuss potential links to pathogenesis.
C1 [Liu, Zhong-Yu; Qin, Cheng-Feng] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Liu, Zhong-Yu; Qin, Cheng-Feng] Guangzhou Med Univ, Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Liu, Zhong-Yu] Sun Yat Sen Univ, Sch Med Shenzhen, Guangzhou, Guangdong, Peoples R China.
   [Shi, Wei-Feng] Taishan Med Coll, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An, Shandong, Peoples R China.
RP Qin, CF (corresponding author), Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Qin, CF (corresponding author), Guangzhou Med Univ, Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.; Shi, WF (corresponding author), Taishan Med Coll, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An, Shandong, Peoples R China.
EM shiwf@ioz.ac.cn; qincf@bmi.ac.cn
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU National Key Research and Development Project of China [2016YFD0500304,
   2018ZX09711003, 2017FYC1200800, 2017ZX10104001-006]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [31770190, U1702282, 81661148054, 81621005, 81522025]; Newton Advanced
   Fellowship from the UK Academy of Medical Sciences; Taishan Scholar
   programme of Shandong province [ts201511056]
FX The authors thank E. C. Holmes (University of Sydney) for insightful
   discussion, X. Wang (Chinese Academy of Science) for assistance with
   figure preparation of virion models and M. J. Carr (University College
   Dublin) for proofreading the manuscript before submission. The authors
   apologize to all colleagues whose work they could not cite owing to
   space limitations. Research in the authors' laboratory was financially
   supported by the National Key Research and Development Project of China
   (No. 2016YFD0500304, 2018ZX09711003, 2017FYC1200800 and
   2017ZX10104001-006), the National Natural Science Foundation of China
   (Nos. 31770190, U1702282, 81661148054, 81621005 and 81522025), the
   Newton Advanced Fellowship from the UK Academy of Medical Sciences to
   C.-F.Q. and the Taishan Scholar programme of Shandong province
   (ts201511056) to W.-F.S.
CR Akiyama B. M., SCIENCE, V354
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Bukrejewska M, 2017, ACTA CRYSTALLOGR D, V73, P767, DOI 10.1107/S2059798317010737
   Cao-Lormeau V. M., LANCET, V387
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Delatorre E, 2017, MEM I OSWALDO CRUZ, V112, P793, DOI 10.1590/0074-02760170299
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Eisen JA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000224
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friedrich S, 2018, J VIROL, V92, DOI 10.1128/JVI.01647-17
   Funk A., J VIROL, V84
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gillespie L. K., J VIROL, V84
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gu SH, 2017, VIRUS GENES, V53, P918, DOI 10.1007/s11262-017-1500-9
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Ikejezie J., 2015, ZIKA VIRUS TRANSMISS
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang Q., CELL STEM CELL, V19, P663
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nicholson BL, 2014, NAT REV MICROBIOL, V12, P493, DOI 10.1038/nrmicro3288
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Priya R, 2013, INFECT GENET EVOL, V20, P396, DOI 10.1016/j.meegid.2013.09.030
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Schnettler E., J VIROL, V86
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shi WF, 2017, SCI CHINA LIFE SCI, V60, P1317, DOI 10.1007/s11427-017-9211-0
   Silva P. A., J VIROL, V84
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   St John AL, 2013, NAT REV MICROBIOL, V11, P420, DOI 10.1038/nrmicro3030
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organization, 2017, ZIKA SITUATION REPOR
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Z., SCIENCE, V354
   Zhao FF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28890-0
NR 127
TC 19
Z9 19
U1 14
U2 38
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD MAR
PY 2019
VL 17
IS 3
BP 131
EP 139
DI 10.1038/s41579-018-0134-9
PG 9
WC Microbiology
SC Microbiology
GA HL2CL
UT WOS:000458510700005
PM 30617340
DA 2020-07-08
ER

PT J
AU Espinal, MA
   Andrus, JK
   Jauregui, B
   Waterman, SH
   Morens, DM
   Santos, JI
   Horstick, O
   Francis, LA
   Olson, D
AF Espinal, Marcos A.
   Andrus, Jon K.
   Jauregui, Barbara
   Waterman, Stephen Hull
   Morens, David Michael
   Ignacio Santos, Jose
   Horstick, Olaf
   Francis, Lorraine Ayana
   Olson, Daniel
TI Emerging and Reemerging Aedes-Transmitted Arbovirus Infections in the
   Region of the Americas: Implications for Health Policy
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID TETRAVALENT DENGUE VACCINE; ZIKA VIRUS-INFECTION; NUTRITIONAL
   INTERVENTIONS; WATER-QUALITY; EPIDEMIOLOGY; SANITATION; EFFICACY;
   DISEASE; FEVER
AB The increasing geographical spread and disease incidence of arboviral infections are among the greatest public health concerns in the Americas. The region has observed an increasing trend in dengue incidence in the last decades, evolving from low to hyperendemicity. Yellow fever incidence has also intensified in this period, expanding from sylvatic-restricted activity to urban outbreaks. Chikungunya started spreading pandemically in 2005 at an unprecedented pace, reaching the Americas in 2013. The following year, Zika also emerged in the region with an explosive outbreak, carrying devastating congenital abnormalities and neurologic disorders and becoming one of the greatest global health crises in years.
   The inadequate arbovirus surveillance in the region and the lack of serologic tests to differentiate among viruses poses substantial challenges. The evidence for vector control interventions remains weak. Clinical management remains the mainstay of arboviral disease control. Currently, only yellow fever and dengue vaccines are licensed in the Americas, with several candidate vaccines in clinical trials.
   The Global Arbovirus Group of Experts provides in this article an overview of progress, challenges, and recommendations on arboviral prevention and control for countries of the Americas.
C1 [Espinal, Marcos A.] WHO, Communicable Dis & Environm Determinants Hlth, Pan Amer Hlth Org, Washington, DC USA.
   [Andrus, Jon K.; Jauregui, Barbara] George Washington Univ, Dept Global Hlth, Milken Inst Publ Hlth, Washington, DC USA.
   [Andrus, Jon K.] Univ Colorado, Div Vaccines & Immunizat, Ctr Global Hlth, Boulder, CO 80309 USA.
   [Waterman, Stephen Hull] Natl Ctr Emerging & Zoonot Dis, Dengue Branch, Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [Morens, David Michael] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Ignacio Santos, Jose] Univ Nacl Autonoma Mexico, Med Sch, Expt Med Res Unit, Mexico City, DF, Mexico.
   [Horstick, Olaf] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Baden Wuerttemb, Germany.
   [Francis, Lorraine Ayana] Caribbean Publ Hlth Agcy, Communicable Dis & Emergency Response, Port Of Spain, Trinidad Tobago.
   [Olson, Daniel] Univ Colorado, Pediat Infect Dis Dept, Sch Med, Aurora, CO USA.
   [Olson, Daniel] Colorado Sch Publ Hlth, Epidemiol Dept, Aurora, CO USA.
RP Andrus, JK (corresponding author), 2811 Battery Pl, Washington, DC 20016 USA.
EM andrus@gwu.edu
FU World Health OrganizationWorld Health Organization [001]
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Andrus JK, 2012, YELLOW FEVER HLTH DI, P391
   [Anonymous], 2016, DENG GUID PAT CAR RE
   [Anonymous], 2009, 9789241547871 WHO
   Arredondo-Garcia JL, 2018, CLIN MICROBIOL INFEC, V24, P755, DOI 10.1016/j.cmi.2018.01.018
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Casey RM, 2018, N ENGL J MED
   Centers for Disease Control and Prevention, 2017, DENG LAB GUID DIAGN
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Espinal M., 2017, PAN AM J PUBLIC HLTH, V41, P1
   Etienne C, 2017, AM J TROP MED HYG, V97, P16, DOI 10.4269/ajtmh.17-0207
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feinberg MB, 2017, SCIENCE, V358, P865, DOI 10.1126/science.aaq0215
   Gordon A, 2018, CLIN INFECT DIS, V67, P1760, DOI 10.1093/cid/ciy356
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hamrick PN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005897
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Horstick O, 2018, LANCET INFECT DIS, V18, pE147, DOI 10.1016/S1473-3099(17)30422-X
   Horstick O, 2017, SE ASIAN J TROP MED, V48, P181
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Null C, 2018, LANCET GLOB HEALTH, V6, pE316, DOI 10.1016/S2214-109X(18)30005-6
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pan American Health Organization, 2014, 24 M TECHN ADV GROUP
   Pan American Health Organization, 2011, NUMB REP CAS DENG SE
   Pan American Health Organization, PLISA HLTH INF PLATF
   Pan American Health Organization, 2017, NUMB REP CAS DENG SE
   Pan American Health Organization, ARB DIAGN LAB NETW A
   Pan American Health Organization, 2016, 1 AD HOC M TECHN ADV
   Pang EL, 2017, ASIAN PAC J TROP MED, V10, P209, DOI 10.1016/j.apjtm.2017.03.003
   Pilger D., 2010, TROPIKA, V1, P1
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Powers AM, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00104-16
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Srikiatkhachorn A, 2016, EXPERT REV VACCINES, V15, P455, DOI 10.1586/14760584.2016.1116949
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Tofail F, 2018, LANCET CHILD ADOLESC, V2, P255, DOI 10.1016/S2352-4642(18)30031-2
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   WHO, 2016, TECHN HDB DENG SURV
   World Health Organization, 2018, YELLOW FEVER AM, V93, P329
NR 57
TC 8
Z9 8
U1 2
U2 7
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD MAR
PY 2019
VL 109
IS 3
BP 387
EP 392
DI 10.2105/AJPH.2018.304849
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HK4BH
UT WOS:000457864000029
PM 30676796
OA Green Published
DA 2020-07-08
ER

PT J
AU Pavela, R
   Benelli, G
   Pavoni, L
   Bonacucina, G
   Cespi, M
   Cianfaglione, K
   Bajalan, I
   Morshedloo, MR
   Lupidi, G
   Romano, D
   Canale, A
   Maggi, F
AF Pavela, Roman
   Benelli, Giovanni
   Pavoni, Lucia
   Bonacucina, Giulia
   Cespi, Marco
   Cianfaglione, Kevin
   Bajalan, Iman
   Morshedloo, Mohammad Reza
   Lupidi, Giulio
   Romano, Donato
   Canale, Angelo
   Maggi, Filippo
TI Microemulsions for delivery of Apiaceae essential oils-Towards highly
   effective and eco-friendly mosquito larvicides?
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article
DE Pimpinella anisum; Trachyspermum ammi; Crithmum maritimum; Culex
   quinquefasciatus; Daphnia magna; Eisenia fetida; Sub-Lethal effects
ID CULEX-QUINQUEFASCIATUS SAY; PIMPINELLA-ANISUM L.; INSECTICIDE
   RESISTANCE; REPELLENT ACTIVITY; ACUTE TOXICITY; ZIKA VIRUS;
   NANOEMULSION; PLANTS; OFFICINALIS; CHALLENGES
AB The development of effective and eco-friendly pesticides to manage mosquito vector larvae is a timely and crucial challenge nowadays. Insecticide resistance is on the rise, therefore plant-borne insecticides with multiple mode of action may represent promising candidates to control insect vectors. In the present work, we encapsulated selected essential oils (EOs) from Pimpinella anisum, Trachyspennum cutuni and Crithnuan maritimum into highly stable microemulsions (MEs) with the aim to develop effective and eco-friendly larvicidal formulations. MEs made with both single EOs and their mixtures were tested against 3rd instar larvae of Culex quinquefasciams, assessing acute and chronic toxicity, emergence of adults, and their impact on non-target invertebrates, i.e., Daphnia magna, Tubifex tubifex and Eisenia fetida. All MEs were able to exert toxicity against mosquito larvae, with LC50 values in the ranges 1.45-4.01 ml L-1, along with high larval mortality and low percentage of hatched adults following short-term exposure to sublethal concentrations. Low or no mortality was observed on D. magna and E. fetida. Taken together, these results give new insights for the exploitation of plant borne EOs as active ingredients of novel and reliable larvicidal products.
C1 [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106, Czech Republic.
   [Pavela, Roman] Czech Univ Life Sci Prague, Dept Plant Protect, Kamycka 129, Prague 16500, Suchdol, Czech Republic.
   [Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Pavoni, Lucia; Bonacucina, Giulia; Cespi, Marco; Lupidi, Giulio; Maggi, Filippo] Univ Camerino, Sch Pharm, I-62032 Camerino, Italy.
   [Cianfaglione, Kevin] Univ Bretagne Occidentale, EA Geoarchitecture 2219, UFR Sci & Tech, F-29200 Brest, France.
   [Cianfaglione, Kevin] Univ Camerino, Sch Biosci & Vet Med, I-62032 Camerino, Italy.
   [Bajalan, Iman] Islamic Azad Univ, Borujerd Branch, Young Researchers & Elite Club, Borujerd, Iran.
   [Morshedloo, Mohammad Reza] Univ Maragheh, Dept Hort Sci, Fac Agr, Maragheh, Iran.
   [Romano, Donato] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM giovanni.benelli@unipi.it
RI Cianfaglione, Kevin/AAL-8874-2020; Pavela, Roman/Q-8647-2016
OI Pavela, Roman/0000-0001-7866-4278; Romano, Donato/0000-0003-4975-3495
FU Ministry of Agriculture of the Czech RepublicMinistry of Agriculture,
   Czech Republic [MZE-RO0418]; University of Camerino (FAR, Fondo di
   Ateneo per la Ricerca)
FX R. Pavela is grateful to the Ministry of Agriculture of the Czech
   Republic for its financial support concerning plant-borne pesticide and
   basic substances research (Project MZE-RO0418). F. Maggi thanks the
   University of Camerino (FAR, Fondo di Ateneo per la Ricerca 2014/2015)
   for financial support. Mr. Sergio Corradetti is kindly acknowledged for
   furnishing the anise sample.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Afshar FH, 2017, IND CROP PROD, V98, P46, DOI 10.1016/j.indcrop.2017.01.004
   [Anonymous], 2005, EUROPEAN PHARMACOPOE, V2
   Bairwa Ranjan, 2012, Pharmacogn Rev, V6, P56, DOI 10.4103/0973-7847.95871
   Benelli G, 2019, SAUDI J BIOL SCI, V26, P921, DOI 10.1016/j.sjbs.2018.06.007
   Benelli G, 2018, IND CROP PROD, V122, P308, DOI 10.1016/j.indcrop.2018.05.032
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, IND CROP PROD, V112, P668, DOI 10.1016/j.indcrop.2017.12.062
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2013, PARASITOL RES, V112, P1155, DOI 10.1007/s00436-012-3246-6
   Bettinetti R, 2005, WATER AIR SOIL POLL, V162, P385, DOI 10.1007/s11270-005-7419-0
   Bharati M, 2018, ACTA TROP, V187, P78, DOI 10.1016/j.actatropica.2018.07.004
   Bilia A. R., 2014, EVID COMPLEMENT ALTE, V2014
   Bonacucina G, 2009, J PHARM SCI-US, V98, P1, DOI 10.1002/jps.21423
   Bremness L., 2004, ERBE DORLING KINDERS
   Buckingham SC, 2015, J INFECTION, V71, pS88, DOI 10.1016/j.jinf.2015.04.009
   Carrio E, 2012, J ETHNOPHARMACOL, V141, P1021, DOI 10.1016/j.jep.2012.03.049
   Castilhos RV, 2018, NEOTROP ENTOMOL, V47, P311, DOI 10.1007/s13744-017-0547-6
   CBI, 2009, NAT INGR COSM EU MAR
   CBI, 2009, NAT COL FLAV THICK M
   Cespi M, 2017, FLAVOUR FRAG J, V32, P159, DOI 10.1002/ffj.3367
   Cornara L, 2009, J ETHNOPHARMACOL, V125, P16, DOI 10.1016/j.jep.2009.06.021
   Date AA, 2008, INT J PHARMACEUT, V355, P19, DOI 10.1016/j.ijpharm.2008.01.004
   Du ZP, 2016, ACS SUSTAIN CHEM ENG, V4, P983, DOI 10.1021/acssuschemeng.5b01058
   Duarte JL, 2015, REV BRAS FARMACOGN, V25, P189, DOI [10.1016/j.bjp.2015.02.2010, 10.1016/j.bjp.2015.02.010]
   Fernandes JN, 2018, TRENDS PARASITOL, V34, P359, DOI 10.1016/j.pt.2018.01.005
   FFNSC2, 2012, MASS SPECTR DAT
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Fotakis EA, 2017, ACTA TROP, V174, P29, DOI 10.1016/j.actatropica.2017.06.005
   Ghosh V, 2013, ASIAN J CHEM, V25, pS321
   Giatropoulos A, 2013, PARASITOL RES, V112, P1113, DOI 10.1007/s00436-012-3239-5
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Gupta S, 2008, J PHARM SCI-US, V97, P22, DOI 10.1002/jps.21177
   Hashem AS, 2018, ENVIRON SCI POLLUT R, V25, P18802, DOI 10.1007/s11356-018-2068-1
   Iannarelli R, 2018, IND CROP PROD, V114, P81, DOI 10.1016/j.indcrop.2018.01.076
   Iannarelli R, 2017, IND CROP PROD, V104, P99, DOI 10.1016/j.indcrop.2017.04.028
   Isman MB, 2006, ADV PHYTOMED, V3, P29
   Isman MB, 2015, PEST MANAG SCI, V71, P1587, DOI 10.1002/ps.4088
   Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005
   Jambulingam P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1768-y
   Jumaa M, 2002, EUR J PHARM BIOPHARM, V54, P207, DOI 10.1016/S0939-6411(02)00057-7
   Kamte SLN, 2018, ECOTOX ENVIRON SAFE, V156, P154, DOI 10.1016/j.ecoenv.2018.03.032
   Lawrence MJ, 2012, ADV DRUG DELIVER REV, V64, P175, DOI 10.1016/j.addr.2012.09.018
   Lopez V, 2018, PARASITOL RES, V117, P861, DOI 10.1007/s00436-018-5764-3
   Lubbe A, 2011, IND CROP PROD, V34, P785, DOI 10.1016/j.indcrop.2011.01.019
   Majekodunmi S. O., 2015, AM J BIOMED ENG, V5, P67, DOI [DOI 10.5923/J.AJBE.201, DOI 10.5923/J.AJBE.20150502.03]
   Mastrantonio V, 2017, ACTA TROP, V171, P37, DOI 10.1016/j.actatropica.2017.03.012
   McClements DJ, 2007, CRIT REV FOOD SCI, V47, P611, DOI 10.1080/10408390701289292
   McClements DJ, 2012, SOFT MATTER, V8, P1719, DOI 10.1039/c2sm06903b
   Miresmailli S, 2014, TRENDS PLANT SCI, V19, P29, DOI 10.1016/j.tplants.2013.10.002
   Morshedloo MR, 2017, PLANT PHYSIOL BIOCH, V111, P119, DOI 10.1016/j.plaphy.2016.11.023
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   NIST 17, 2017, MASS SPECTR LIB NIST
   Nuchuchua O, 2009, AAPS PHARMSCITECH, V10, P1234, DOI 10.1208/s12249-009-9323-1
   Pavela R, 2007, J ESSENT OIL BEAR PL, V10, P346, DOI 10.1080/0972060X.2007.10643566
   Pavela R, 2018, ENVIRON SCI POLLUT R, V25, P10904, DOI 10.1007/s11356-018-1398-3
   Pavela R, 2018, CHEM BIODIVERS, V15, DOI 10.1002/cbdv.201700382
   Pavela R, 2017, IND CROP PROD, V109, P603, DOI 10.1016/j.indcrop.2017.09.013
   Pavela R, 2017, J PEST SCI, V90, P683, DOI [10.1007/s10340-016-0828-6, 10.1007/s10340-016-0763-6]
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2014, J ASIA-PAC ENTOMOL, V17, P287, DOI 10.1016/j.aspen.2014.02.001
   Pavela R, 2012, J ESSENT OIL BEAR PL, V15, P144, DOI 10.1080/0972060X.2012.10644030
   Pavela R, 2009, PARASITOL RES, V105, P1365, DOI 10.1007/s00436-009-1571-1
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   Quassinti L, 2014, FITOTERAPIA, V97, P133, DOI 10.1016/j.fitote.2014.06.004
   Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008
   Ribeiro AV, 2018, CROP PROT, V110, P207, DOI 10.1016/j.cropro.2017.08.014
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Sakulku U, 2009, INT J PHARMACEUT, V372, P105, DOI 10.1016/j.ijpharm.2008.12.029
   Savo V, 2011, J ETHNOPHARMACOL, V135, P376, DOI 10.1016/j.jep.2011.03.027
   Shrinivas P. K., 2008, MARKET RES DATA ESSE
   Song SL, 2009, COLLOID SURFACE A, V350, P57, DOI 10.1016/j.colsurfa.2009.08.034
   Sugumar S, 2014, B ENTOMOL RES, V104, P393, DOI 10.1017/S0007485313000710
   Tabari MA, 2017, VET PARASITOL, V245, P86, DOI 10.1016/j.vetpar.2017.08.012
   Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023
   Vadivalagan C, 2017, ACTA TROP, V169, P43, DOI 10.1016/j.actatropica.2017.01.020
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Vitali LA, 2016, ARAB J CHEM, V9, P775, DOI 10.1016/j.arabjc.2015.06.002
   WHO, 1996, CTDWHOPESIC961
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 91
TC 31
Z9 30
U1 8
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-6690
EI 1872-633X
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD MAR
PY 2019
VL 129
BP 631
EP 640
DI 10.1016/j.indcrop.2018.11.073
PG 10
WC Agricultural Engineering; Agronomy
SC Agriculture
GA HJ9FM
UT WOS:000457504200068
DA 2020-07-08
ER

PT J
AU Barrera, R
   Amador, M
   Acevedo, V
   Beltran, M
   Munoz, JL
AF Barrera, R.
   Amador, M.
   Acevedo, V.
   Beltran, M.
   Munoz, J. L.
TI A comparison of mosquito densities, weather and infection rates of Aedes
   aegypti during the first epidemics of Chikungunya (2014) and Zika (2016)
   in areas with and without vector control in Puerto Rico
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Chikungunya; dengue; mosquito control; Zika
ID VIRUS CIRCULATION; VIRAL-RNA; DENGUE; DIPTERA; SURVEILLANCE;
   TRANSMISSION; TRAP; HISTORY
AB In Puerto Rico, the first records of the transmission of Chikungunya (CHIKV) and Zika (ZIKV) viruses were confirmed in May 2014 and December 2015, respectively. Transmission of CHIKV peaked in September 2014, whereas that of ZIKV peaked in August 2016. The emergence of these mosquito-transmitted arboviruses in the context of a lack of human population immunity allowed observations of whether the outbreaks were associated with Aedes aegypti (Diptera: Culicidae) densities and weather. Mosquito density was monitored weekly in four communities using sentinel autocidal gravid ovitraps (AGO traps) during 2016 in order to provide data to be compared with the findings of a previous study carried out during the 2014 CHIKV epidemic. Findings in two communities protected against Ae. aegypti using mass AGO trapping (three traps per house in most houses) were compared with those in two nearby communities without vector control. Mosquito pools were collected to detect viral RNA of ZIKV, CHIKV and dengue virus. In areas without vector control, mosquito densities and rates of ZIKV detection in 2016 were significantly higher, similarly to those observed for CHIKV in 2014. The density of Ae. aegypti in treated sites was less than two females/trap/week, which is similar to the putative adult female threshold for CHIKV transmission. No significant differences in mosquito density or infection rates with ZIKV and CHIKV at the same sites between years were observed. Although 2016 was significantly wetter, mosquito densities were similar.
C1 [Barrera, R.; Amador, M.; Acevedo, V.] Ctr Dis Control & Prevent, Entomol & Ecol Team, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Beltran, M.; Munoz, J. L.] Ctr Dis Control & Prevent, Mol Diagnost Lab, Dengue Branch, San Juan, PR USA.
RP Barrera, R (corresponding author), Ctr Dis Control & Prevent, Entomol & Ecol Team, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
EM rbarrera@cdc.gov
FU US Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX The authors thank the residents of Arboleda, La Margarita, Playa and
   Villodas and their field personnel Orlando Gonzalez, Luis Rivera, Luis
   Perez, Eduado Perez, Jeyson Diaz, Jose Maysonet, Damian Suren, Luis
   Alvarado, John Acevedo, Ali Figueroa, Heric Leon and Luis Ramirez. The
   authors also thank Joanelis Medina, Jose Perez and Jesus Vazquez for
   testing mosquito pools, and Stephen Waterman, Ryan Hemme and Gilberto
   Felix for helpful discussions and support. This investigation was fully
   funded by the US Centers for Disease Control and Prevention.
CR Acevedo V, 2016, J AM MOSQUITO CONTR, V32, P254, DOI 10.2987/15-6525.1
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Arguello DF, 2015, AM J TROP MED HYG, V92, P486, DOI 10.4269/ajtmh.14-0231
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Bangs MJ, 2001, J MED ENTOMOL, V38, P720, DOI 10.1603/0022-2585-38.5.720
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   Barrera R., 2010, BIOMEDICA, V21, P179
   Barrera R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2596-4
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2016, BIOMEDICA, V36, P454, DOI 10.7705/biomedica.v36i3.2892
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biggerstaff B, 2016, POOLEDINRATE VERSION
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Brown A.W.A, 1977, WORLD GEOGRAPHY HUMA, P271
   Burkhalter KL, 2017, EMERG INFECT DIS, V23, P680, DOI 10.3201/eid2304.161772
   Centers for Disease Control and Prevention, 2018, SURV CONTR AED AEG A
   Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043
   Paploski IAD, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1705-0
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   Dzul-Manzanilla F, 2015, J AM MOSQUITO CONTR, V31, P275, DOI 10.2987/moco-31-03-275-277.1
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   FOCKS DA, 2003, REV ENTOMOLOGICAL SA
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   He DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00253-1
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Jones RC, 2011, J AM MOSQUITO CONTR, V27, P315, DOI 10.2987/10-6098.1
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lega J, 2017, J MED ENTOMOL, V54, P1375, DOI 10.1093/jme/tjx077
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Mavale M, 2012, AM J TROP MED HYG, V86, P178, DOI 10.4269/ajtmh.2012.11-0236
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Pilger D, 2011, TROP MED INT HEALTH, V16, P1143, DOI 10.1111/j.1365-3156.2011.02818.x
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Sang RC, 2008, AM J TROP MED HYG, V78, P77
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sharp TM, 2016, J INFECT DIS, V214, pS475, DOI 10.1093/infdis/jiw245
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 60
TC 6
Z9 6
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD MAR
PY 2019
VL 33
IS 1
BP 68
EP 77
DI 10.1111/mve.12338
PG 10
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HK2KO
UT WOS:000457739700006
PM 30225842
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Coleman, B
   Coarsey, C
   Kabir, MA
   Asghar, W
AF Coleman, Benjamin
   Coarsey, Chad
   Kabir, Md Alamgir
   Asghar, Waseem
TI Point-of-care colorimetric analysis through smartphone video
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Smartphone; Point of care; Biosensor; Zika detection; Cell phone
ID EMERGING TECHNOLOGIES; PLATFORM; READER; ELISA; GOLD
AB Point-of-care (POC) tests often rely on smartphone image methods for colorimetric analysis, but the results of such methods are frequently difficult to reproduce or standardize. The problem is aggravated by unpredictable image capture conditions, which pose a significant challenge when low limits of detection (LOD) are needed. Application-specific smartphone attachments are often used to standardize imaging conditions, but there has recently been an interest in equipment-free POC colorimetric analysis. Improved output metrics and preprocessing methods have been developed, but equipment-free imaging often has a high LOD and is inappropriate for quantitative tasks. Additional work is necessary to replace external smartphone attachments with algorithms. Towards this end, we have developed a video processing method that synthesizes many images into a single output metric. We use image features to select the best inputs from a large set of video frames and demonstrate that the resulting output values have a stronger correlation with laboratory methods and a lower standard error. The developed algorithm only requires 20 s of video and can easily be integrated with existing processing methods. We apply our algorithm to the NS1-based sandwich ELISA for Zika detection and show that the LOD is two times lower when our video-based method is used.
C1 [Coleman, Benjamin; Coarsey, Chad; Kabir, Md Alamgir; Asghar, Waseem] Coll Engn & Comp Sci, Asghar Lab, Micro & Nanotechnol Med, Boca Raton, FL 33431 USA.
   [Coleman, Benjamin; Coarsey, Chad; Kabir, Md Alamgir; Asghar, Waseem] Florida Atlantic Univ, Dept Comp & Elect Engn & Comp Sci, Boca Raton, FL 33431 USA.
   [Asghar, Waseem] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.
RP Asghar, W (corresponding author), Coll Engn & Comp Sci, Asghar Lab, Micro & Nanotechnol Med, Boca Raton, FL 33431 USA.
EM wasghar@fau.edu
RI Kabir, Alamgir/M-4273-2019
OI Kabir, Alamgir/0000-0002-1659-3125
FU Florida Department of Health (FDOH) [7ZK10]; FAU Faculty Mentoring
   Award; Humanity in Science Award; College of Engineering and Computer
   Science, Florida Atlantic University, Boca Raton, FL; Institute for
   Sensing and Embedded Networking Systems Engineering (I-SENSE) Research
   Initiative Award;  [NIHR15AI127214]
FX We acknowledge research support from Florida Department of Health (FDOH)
   7ZK10, NIHR15AI127214, Institute for Sensing and Embedded Networking
   Systems Engineering (I-SENSE) Research Initiative Award, FAU Faculty
   Mentoring Award, Humanity in Science Award, and a start-up research
   support from College of Engineering and Computer Science, Florida
   Atlantic University, Boca Raton, FL.
CR Berg B, 2015, ACS NANO, V9, P7857, DOI 10.1021/acsnano.5b03203
   BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9
   Chen GH, 2014, ANAL CHEM, V86, P6843, DOI 10.1021/ac5008688
   Kim SC, 2017, SENSOR ACTUAT B-CHEM, V239, P52, DOI 10.1016/j.snb.2016.07.159
   McCracken KE, 2016, ANAL METHODS-UK, V8, P6591, DOI 10.1039/c6ay01575a
   McGeough CM, 2013, IEEE T BIOMED CIRC S, V7, P655, DOI 10.1109/TBCAS.2012.2234122
   McGonigle AJS, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010223
   Mudanyali O, 2012, LAB CHIP, V12, P2678, DOI [10.1039/c21c40235a, 10.1039/c2lc40235a]
   Murdock RC, 2013, ANAL CHEM, V85, P11634, DOI 10.1021/ac403040a
   Ogirala T, 2017, MED BIOL ENG COMPUT, V55, P1735, DOI 10.1007/s11517-016-1605-7
   Oncescu V, 2013, LAB CHIP, V13, P3232, DOI 10.1039/c3lc50431j
   Pollock NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003981
   Roda A, 2016, TRAC-TREND ANAL CHEM, V79, P317, DOI 10.1016/j.trac.2015.10.019
   Salles MO, 2014, ANAL METHODS-UK, V6, P2047, DOI 10.1039/c3ay41727a
   Shafiee H, 2015, ANNU REV MED, V66, P387, DOI 10.1146/annurev-med-092112-143017
   Shen L, 2012, LAB CHIP, V12, P4240, DOI [10.1039/c2lc40741, 10.1039/c2lc40741h]
   Sumriddetchkajorn S, 2014, SENSOR ACTUAT B-CHEM, V191, P561, DOI 10.1016/j.snb.2013.10.024
   Sumriddetchkajorn S, 2013, SENSOR ACTUAT B-CHEM, V182, P592, DOI 10.1016/j.snb.2013.03.080
   Vashist SK, 2015, TRENDS BIOTECHNOL, V33, P692, DOI 10.1016/j.tibtech.2015.09.001
   Vashist SK, 2015, BIOSENS BIOELECTRON, V67, P248, DOI 10.1016/j.bios.2014.08.027
   Veigas B, 2012, LAB CHIP, V12, P4802, DOI 10.1039/c2lc40739f
   Wang SQ, 2011, LAB CHIP, V11, P3411, DOI 10.1039/c1lc20479c
   Wei QS, 2014, ACS NANO, V8, P1121, DOI 10.1021/nn406571t
   Yetisen AK, 2014, SENSOR ACTUAT B-CHEM, V196, P156, DOI 10.1016/j.snb.2014.01.077
   Zhu HY, 2013, LAB CHIP, V13, P1282, DOI 10.1039/c3lc41408f
   Zhu HY, 2011, LAB CHIP, V11, P315, DOI 10.1039/c01c00358a
NR 26
TC 7
Z9 7
U1 3
U2 42
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD MAR 1
PY 2019
VL 282
BP 225
EP 231
DI 10.1016/j.snb.2018.11.036
PG 7
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA HG6KJ
UT WOS:000455090000028
PM 30828133
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Reed, AJ
   Connelly, RP
   Williams, A
   Tran, M
   Shim, BS
   Choe, H
   Gerasimova, YV
AF Reed, Adam J.
   Connelly, Ryan P.
   Williams, Allison
   Tran, Maithi
   Shim, Byoung-Shik
   Choe, Hyeryun
   Gerasimova, Yulia, V
TI Label-free pathogen detection by a deoxyribozyme cascade with visual
   signal readout
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Pathogen detection; Isothermal amplification; Deoxyribozyme cascade;
   G-quadruplex peroxidase; Colorimetric test; NASBA
ID SEQUENCE-BASED AMPLIFICATION; NUCLEIC-ACID DETECTION; HEPATITIS-A VIRUS;
   16S RIBOSOMAL-RNA; ZIKA VIRUS; BINARY DEOXYRIBOZYME;
   MOLECULAR-DETECTION; BASIC KIT; DNA; NASBA
AB A colorimetric nucleic acid based test for label-free pathogen detection has been developed and used for the detection of the Zika virus. The test relies on nucleic acid sequence-based amplification (NASBA) of a viral RNA followed by interrogation of the amplicon by a cascade of deoxyribozymes constituting a visual split deoxyribozyme (vsDz) probe. The probe consists of a split phosphodiesterase deoxyribozyme, which forms its catalytic core upon binding to a specific amplicon fragment. The catalytically active complex recognizes and cleaves an inhibited peroxidase-like deoxyribozyme (PDz), thereby activating it. Active PDz catalyzes hydrogen peroxide-mediated oxidation of a colorless substrate into a colored product, thereby generating a visible signal. Viral RNA (10(6) copies/mL or higher) triggers intense color within 2 h. The test selectively differentiates between Zika and closely related dengue and West Nile viruses. The reported technology combines isothermal amplification and visual detection and therefore represents a basis for the future development of a cost-efficient and instrument-free method for point-of-care nucleic acid analysis.
C1 [Reed, Adam J.; Connelly, Ryan P.; Williams, Allison; Tran, Maithi; Gerasimova, Yulia, V] Univ Cent Florida, Chem Dept, Orlando, FL 32816 USA.
   [Shim, Byoung-Shik; Choe, Hyeryun] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.
RP Gerasimova, YV (corresponding author), Univ Cent Florida, Chem Dept, Orlando, FL 32816 USA.
EM yulia.gerasimova@ucf.edu
OI Gerasimova, Yulia/0000-0001-8804-9770
FU Florida Department of Health, Biomedical Research Program [7ZK33];
   National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21AI123876, R01AI110692]
FX This work was supported by the Florida Department of Health, Biomedical
   Research Program (grant 7ZK33), National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health (grants
   R21AI123876 and R01AI110692).
CR Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Batule BS, 2018, J AGR FOOD CHEM, V66, P3003, DOI 10.1021/acs.jafc.7b05289
   Boulet GAV, 2010, J CLIN MICROBIOL, V48, P2524, DOI 10.1128/JCM.00173-10
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Deiman B, 2002, MOL BIOTECHNOL, V20, P163, DOI 10.1385/MB:20:2:163
   Dey S., 2017, MOL2NET, V3, DOI [10.3390/mol2net-03-04966, DOI 10.3390/MOL2NET-03-04966]
   Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Gerasimova YV, 2015, RNA, V21, P1834, DOI 10.1261/rna.052613.115
   Gerasimova YV, 2013, CHEMBIOCHEM, V14, P2087, DOI 10.1002/cbic.201300471
   Gerasimova YV, 2013, ANGEW CHEM INT EDIT, V52, P10586, DOI 10.1002/anie.201303919
   Gerasimova YV, 2010, CHEMBIOCHEM, V11, P811, DOI 10.1002/cbic.201000006
   Gerasimova YV, 2010, CHEM BIOL, V17, P104, DOI 10.1016/j.chembiol.2010.02.003
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Greene SR, 2003, J VIROL METHODS, V108, P123, DOI 10.1016/S0166-0934(02)00286-0
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   James AS, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0985-8
   Jean J, 2001, APPL ENVIRON MICROB, V67, P5593, DOI 10.1128/AEM.67.12.5593-5600.2001
   Jean J, 2002, J VIROL METHODS, V105, P123, DOI 10.1016/S0166-0934(02)00096-4
   Jiang X, 2018, ANGEW CHEM INT EDIT, V57, P17211, DOI 10.1002/anie.201809993
   Kaarj K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30797-9
   Kolpashchikov DM, 2007, CHEMBIOCHEM, V8, P2039, DOI 10.1002/cbic.200700384
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Li XF, 2014, BIOMED RES INT, DOI 10.1155/2014/423181
   Loens K, 2003, J CLIN MICROBIOL, V41, P4448, DOI 10.1128/JCM.41.9.4448-4450.2003
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Lu XL, 2017, SCI REP-UK, V7, DOI 10.1038/srep44211
   Lunel F, 1999, HEPATOLOGY, V29, P528, DOI 10.1002/hep.510290237
   Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841
   Lobato IM, 2018, TRAC-TREND ANAL CHEM, V98, P19, DOI 10.1016/j.trac.2017.10.015
   Mahony JB, 2001, J CLIN MICROBIOL, V39, P1429, DOI 10.1128/JCM.39.4.1429-1435.2001
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mokany E, 2010, J AM CHEM SOC, V132, P1051, DOI 10.1021/ja9076777
   Mollasalehi H, 2013, BIOSENS BIOELECTRON, V47, P231, DOI 10.1016/j.bios.2013.03.012
   Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oh SJ, 2016, BIOSENS BIOELECTRON, V75, P293, DOI 10.1016/j.bios.2015.08.052
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pavlov V, 2004, ANAL CHEM, V76, P2152, DOI 10.1021/ac035219l
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pohlmann C, 2014, ANALYST, V139, P1063, DOI 10.1039/c3an02059b
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roy S, 2017, ACS SENSORS, V2, P1713, DOI 10.1021/acssensors.7b00671
   Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Vashist S. K., 2018, HDB IMMUNOASSAY TECH, P97
   Verma MS, 2015, BIOTECHNOL ADV, V33, P666, DOI 10.1016/j.biotechadv.2015.03.003
   Vina-Rodriguez A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4248756
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Yoo SM, 2016, TRENDS BIOTECHNOL, V34, P7, DOI 10.1016/j.tibtech.2015.09.012
NR 52
TC 3
Z9 3
U1 6
U2 39
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD MAR 1
PY 2019
VL 282
BP 945
EP 951
DI 10.1016/j.snb.2018.11.147
PG 7
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA HG6KJ
UT WOS:000455090000113
PM 31462856
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Srivastav, AK
   Yang, JY
   Luo, XF
   Ghosh, M
AF Srivastav, Akhil Kumar
   Yang, Junyuan
   Luo, XiaoFeng
   Ghosh, Mini
TI Spread of Zika virus disease on complex network-A mathematical study
SO MATHEMATICS AND COMPUTERS IN SIMULATION
LA English
DT Article
DE Zika model; Reproduction number; Parameter estimation; Optimal control
ID TRANSMISSION; OUTBREAK
AB Zika virus epidemic poses a major threat to public health globally. Initially, this disease was limited to Africa but now it is spreading throughout the World. It is well known that zika virus is transmitted to human by the bites of Aedes mosquitoes. Recently, there are reported cases of sexual transmission and transmission due to blood transfusion in many countries e.g., Argentina, France, New Zealand, USA etc. In this paper a mathematical model of Zika virus on complex network is formulated and analyzed keeping in mind both mosquito-borne and sexual transmission of this disease. The existence and global stability of disease-free equilibrium are discussed in detail. The basic reproduction number R0 of the model is computed and it is found that for R-0 < 1, the disease-free equilibrium of the model is globally asymptotically stable under some condition. In addition to this the final size relation of the proposed model is also computed. The key parameters of the model are computed using curve fitting to the real data by least-square method. Sensitivity analysis and numerical simulation are also performed for our proposed model. Finally, this model is extended to optimal control problem, to find the suitable cost-effective and time-dependent control strategies to reduce the number of infectives in a desired interval of time. (C) 2018 International Association for Mathematics and Computers in Simulation (IMACS). Published by Elsevier B.V. All rights reserved.
C1 [Srivastav, Akhil Kumar; Ghosh, Mini] Vellore Inst Technol, Sch Adv Sci, Div Math, Madras, Tamil Nadu, India.
   [Yang, Junyuan; Luo, XiaoFeng] Shanxi Univ, Complex Syst Res Ctr, Taiyuan, Shanxi, Peoples R China.
RP Ghosh, M (corresponding author), Vellore Inst Technol, Sch Adv Sci, Div Math, Madras, Tamil Nadu, India.
EM minighosh@vit.ac.in
RI Yang, Junyuan/AAH-5092-2019; Ghosh, Mini/K-5459-2017
OI Ghosh, Mini/0000-0001-9652-2409
CR Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   [Anonymous], 2016, WHO 1 M INT HLTH REG
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bonyah E., 2016, Asian Pacific Journal of Tropical Disease, V6, P673, DOI 10.1016/S2222-1808(16)61108-8
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Castillo-Chavez C, 2002, IMA VOL MATH APPL, V125, P229
   Centers for Disease Control and Prevention (CDC), 2016, CDC EMERGENCY OPERAT
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   Moreno Victor M., 2016, INFECT DIS MODELL, Vxxx, P1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization (PAHO), ZIK VIR INF
   Pontryagin L. S., 1962, MATH THEORY OPTIMAL
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapshak P., 2015, Global virology I - identifying and investigating viral diseases, P477
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
NR 28
TC 0
Z9 0
U1 1
U2 122
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4754
EI 1872-7166
J9 MATH COMPUT SIMULAT
JI Math. Comput. Simul.
PD MAR
PY 2019
VL 157
BP 15
EP 38
DI 10.1016/j.matcom.2018.09.014
PG 24
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA HA6SN
UT WOS:000450410200002
DA 2020-07-08
ER

PT J
AU Sousa, GC
   Queiroz, CM
   Sousa, P
   Lima, P
   da Silva, AAM
   Pires, N
   Barros, AK
AF Sousa, Gean Carlos
   Queiroz, Claudio M.
   Sousa, Patricia
   Lima, Priscila
   Moura da Silva, Antonio Augusto
   Pires, Nilviane
   Barros, Allan Kardec
TI Identification of Hypsarrhythmia in Children with Microcephaly Infected
   by Zika Virus
SO ENTROPY
LA English
DT Article
DE hypsarrhythmia; electroencephalographic; epileptic; identification;
   index
ID INFANTILE; ELECTROENCEPHALOGRAM; SPASMS
AB Hypsarrhythmia is an electroencephalographic pattern specific to some epileptic syndromes that affect children under one year of age. The identification of this pattern, in some cases, causes disagreements between experts, which is worrisome since an inaccurate diagnosis can bring complications to the infant. Despite the difficulties in visually identifying hypsarrhythmia, options of computerized assistance are scarce. Aiming to collaborate with the recognition of this electropathological pattern, we propose in this paper a mathematical index that can help electroencephalography experts to identify hypsarrhythmia. We performed hypothesis tests that indicated significant differences in the groups under analysis, where the p-values were found to be extremely small.
C1 [Sousa, Gean Carlos; Lima, Priscila; Barros, Allan Kardec] Fed Univ Maranhao UFMA, Dept Elect Engn, BR-65080805 Sao Luis, MA, Brazil.
   [Queiroz, Claudio M.] Univ Fed Rio Grande do Norte, Brain Inst, BR-59078970 Natal, RN, Brazil.
   [Sousa, Patricia] Univ Fed Maranhao, Univ Hosp, Dept Med, BR-65080805 Sao Luis, MA, Brazil.
   [Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Dept Publ Hlth, BR-65080805 Sao Luis, MA, Brazil.
   [Pires, Nilviane] Fed Univ Maranhao UFMA, Ctr Biol Sci & Hlth, Program Biotechnol, BR-65080805 Sao Luis, MA, Brazil.
RP Sousa, GC (corresponding author), Fed Univ Maranhao UFMA, Dept Elect Engn, BR-65080805 Sao Luis, MA, Brazil.
EM gean.pib@gmail.com; clausqueiroz@neuro.ufrn.br;
   cdneuropatricia@gmail.com; priscilalima_rocha@hotmail.com;
   aamouradasilva@gmail.com; nilvipires@gmail.com; akduailibe@gmail.com
RI Silva, Antonio A M/B-5410-2009; Queiroz, Claudio M/O-9549-2015
OI Silva, Antonio A M/0000-0003-4968-5138; Queiroz, Claudio
   M/0000-0001-5573-7702; Barros, Allan Kardec/0000-0002-1654-0955; Sousa,
   Nilviane/0000-0003-0702-6783
CR Altunel A, 2015, EPILEPSY RES, V111, P54, DOI 10.1016/j.eplepsyres.2015.01.005
   CASPERS H, 1983, Q REV BIOL, V58, P301
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   De Marchi LR, 2015, EPILEPTIC DISORD, V17, P188, DOI 10.1684/epd.2015.0738
   Gabor D., 1946, Journal of the Institution of Electrical Engineers. III. Radio and Communication Engineering, V93, P429
   Gibbs F.A., 1952, ATLAS ELECTROENCEFAL
   Gupta V, 2017, PATTERN RECOGN LETT, V94, P180, DOI 10.1016/j.patrec.2017.03.017
   Han J, 2009, Journal of Physics: Conference Series, V147, DOI 10.1088/1742-6596/147/1/012041
   Hussain SA, 2015, EPILEPSIA, V56, P77, DOI 10.1111/epi.12861
   IVES JR, 1977, ELECTROEN CLIN NEURO, V43, P880, DOI 10.1016/0013-4694(77)90011-6
   Kanda Paulo Afonso Medeiros, 2018, Neurodiagn J, V58, P11, DOI 10.1080/21646821.2018.1428461
   MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297
   Millichap John J, 2015, Pediatr Neurol Briefs, V29, P64, DOI 10.15844/pedneurbriefs-29-8-7
   Morettin P.A., 2014, ONDAS ONDALETAS ANAL
   Mytinger JR, 2018, J CLIN NEUROPHYSIOL, V35, P151, DOI 10.1097/WNP.0000000000000449
   Mytinger JR, 2015, EPILEPSY RES, V116, P93, DOI 10.1016/j.eplepsyres.2015.07.008
   Rodger James A., 2015, Informatics in Medicine Unlocked, V1, P17, DOI 10.1016/j.imu.2016.01.002
   Sharma A, 2016, J VIB CONTROL, V22, P176, DOI 10.1177/1077546314528021
   Smith RJ, 2017, BRAIN TOPOGR, V30, P810, DOI 10.1007/s10548-017-0588-5
   Stephane M., 2009, WAVELET TOUR SIGNAL, P263
   Torreao JRA, 2017, INT J MOD PHYS C, V28, DOI 10.1142/S0129183117500012
   Traitruengsakul S, 2017, MED BIOL ENG COMPUT, V55, P1659, DOI 10.1007/s11517-017-1616-z
   Traitruengsakul S, 2015, IEEE ENG MED BIO, P6194, DOI 10.1109/EMBC.2015.7319807
   YANG J, 1992, J OPT SOC AM A, V9, P334, DOI 10.1364/JOSAA.9.000334
NR 24
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1099-4300
J9 ENTROPY-SWITZ
JI Entropy
PD FEB 28
PY 2019
VL 21
IS 3
AR 232
DI 10.3390/e21030232
PG 8
WC Physics, Multidisciplinary
SC Physics
GA HT2LR
UT WOS:000464394700002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fleming, AM
   Nguyen, NLB
   Burrows, CJ
AF Fleming, Aaron M.
   Nguyen, Ngoc L. B.
   Burrows, Cynthia J.
TI Colocalization of m(6)A and G-Quadruplex-Forming Sequences in Viral RNA
   (HIV, Zika, Hepatitis B, and SV40) Suggests Topological Control of
   Adenosine N-6-Methylation
SO ACS CENTRAL SCIENCE
LA English
DT Article
ID SINGLE-NUCLEOTIDE-RESOLUTION; LONG TERMINAL REPEAT; MESSENGER-RNA;
   TELOMERIC DNA; CRYSTAL-STRUCTURE; PROMOTER; PROTEIN; METHYLATION;
   REVEALS; BINDING
AB This Outlook calls attention to two seemingly disparate and emerging fields regarding viral genomics that may be correlated in a way previously overlooked. First, we describe identification of conserved potential G-quadruplex-forming sequences (PQSs) in viral genomes relevant to human health. Studies have demonstrated that PQSs are highly conserved and can fold to G-quadruplexes (G4s) to regulate viral processes. Key examples include G4s as a countermeasure to the hosts immune system or G4-guided regulation of replication or transcription. Second, emerging data are discussed concerning the epitranscriptomic modification N-6-methyladenosine (m(6)A) in viral RNA installed by host proteins in a consensus sequence favoring 5'-GG(m(6)A)C-3'. The proposed pathways by which m6A is written, read, and erased in viral RNA genomes and the impact this has on viral replication are described. The structural reason why certain sites are selected for modification while others are not is still mysterious. Finally, we discuss our new observations regarding these previous sequencing data that identify m(6)A installation within the loops of two-tetrad PQSs in the RNA genomes of the Zika, HIV, hepatitis B, and SV40 viruses. We hypothesize that conserved viral PQSs can provide a framework (sequence and/or structural) for m(6)A installation. We also discuss literature sources suggesting that PQSs as sites of RNA modification could be a general phenomenon. We anticipate our observations will provide ample opportunities for exciting discoveries regarding the interplay between G4 structures and epitranscriptomic modifications of RNA.
C1 [Fleming, Aaron M.; Nguyen, Ngoc L. B.; Burrows, Cynthia J.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.
RP Fleming, AM; Burrows, CJ (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.
EM afleming@chem.utah.edu; burrows@chem.utah.edu
OI Burrows, Cynthia/0000-0001-7253-8529
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 GM093099]
FX This work was supported by a grant from the NIH (R01 GM093099).
CR Abou Assi H, 2018, NUCLEIC ACIDS RES, V46, P8038, DOI 10.1093/nar/gky735
   Aik W, 2014, NUCLEIC ACIDS RES, V42, P4741, DOI 10.1093/nar/gku085
   Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281
   Amrane S, 2014, J AM CHEM SOC, V136, P5249, DOI 10.1021/ja501500c
   Artusi S, 2016, NUCLEIC ACIDS RES, V44, P10343, DOI 10.1093/nar/gkw968
   Asamitsu S, 2019, CHEM-EUR J, V25, P417, DOI 10.1002/chem.201802691
   Aschenbrenner J, 2018, ANGEW CHEM INT EDIT, V57, P417, DOI 10.1002/anie.201710209
   Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006
   Bian WX, 2019, NUCLEIC ACIDS RES, V47, P56, DOI 10.1093/nar/gky1177
   Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]
   Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/nchem.1548, 10.1038/NCHEM.1548]
   Biswas B, 2018, ACS INFECT DIS, V4, P744, DOI 10.1021/acsinfecdis.7b00279
   Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296
   BOKAR JA, 1994, J BIOL CHEM, V269, P17697
   Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733
   Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068
   Butovskaya E, 2018, J AM CHEM SOC, V140, P13654, DOI 10.1021/jacs.8b05332
   Cammas A, 2017, NUCLEIC ACIDS RES, V45, P1584, DOI 10.1093/nar/gkw1280
   CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879
   Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861
   Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295
   Charley PA, 2018, J BIOL CHEM, V293, P285, DOI [10.1074/jbc.m117.805796, 10.1074/jbc.M117.805796]
   Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9
   Cho H, 2018, NAT PLANTS, V4, P376, DOI 10.1038/s41477-018-0157-2
   Chu JM, 2018, ACS CHEM BIOL, V13, P3243, DOI 10.1021/acschembio.7b00906
   Dai DJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0129-x
   De Nicola B, 2016, NUCLEIC ACIDS RES, V44, P6442, DOI 10.1093/nar/gkw432
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804
   Fleming AM, 2017, P NATL ACAD SCI USA, V114, P2604, DOI 10.1073/pnas.1619809114
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gokhale NS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006188
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gray RD, 2008, NUCLEIC ACIDS RES, V36, P4191, DOI 10.1093/nar/gkn379
   Grozhik AV, 2018, NAT CHEM BIOL, V14, P215, DOI [10.1038/NCHEMBIO.2546, 10.1038/nchembio.2546]
   Guilbaud G, 2017, NAT CHEM, V9, P1110, DOI [10.1038/NCHEM.2828, 10.1038/nchem.2828]
   Guo JU, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5371
   Guo SD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17629-y
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921
   Harris LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004562
   Hartstock K, 2019, CHEM-EUR J, V25, P3455, DOI 10.1002/chem.201804043
   HASHIMOTO S, 1976, J VIROL, V20, P425, DOI 10.1128/JVI.20.2.425-435.1976
   Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112
   HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0
   Herdy B, 2018, NUCLEIC ACIDS RES, V46, P11592, DOI 10.1093/nar/gky861
   Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995
   Holder IT, 2014, CHEM BIOL, V21, P1511, DOI 10.1016/j.chembiol.2014.09.014
   Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609
   Imam H, 2018, P NATL ACAD SCI USA, V115, P8829, DOI 10.1073/pnas.1808319115
   Jaubert C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26582-3
   Joachimi A, 2009, BIOORGAN MED CHEM, V17, P6811, DOI 10.1016/j.bmc.2009.08.043
   Ke S., 2015, GENE DEV, V29, P2053
   Kennedy EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02263-16
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   Kota S, 2015, APPL MICROBIOL BIOT, V99, P9761, DOI 10.1007/s00253-015-6808-6
   Kretschmer J, 2018, RNA, V24, P1339, DOI 10.1261/rna.064238.117
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   Lavezzo E, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006675
   Li GD, 2016, MICROBIOL MOL BIOL R, V80, P679, DOI 10.1128/MMBR.00065-15
   Liao SH, 2018, GENOM PROTEOM BIOINF, V16, P99, DOI 10.1016/j.gpb.2018.04.002
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]
   Lista MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16043
   Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432
   Liu NA, 2017, NUCLEIC ACIDS RES, V45, P6051, DOI 10.1093/nar/gkx141
   Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234
   Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113
   Lu WX, 2018, J BIOL CHEM, V293, P12992, DOI 10.1074/jbc.RA118.004215
   Lyonnais S, 2002, NUCLEIC ACIDS RES, V30, P5276, DOI 10.1093/nar/gkf644
   Lyons SM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01278-w
   Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468
   Manners O, 2019, BBA-GENE REGUL MECH, V1862, P370, DOI 10.1016/j.bbagrm.2018.10.015
   Mao SQ, 2018, NAT STRUCT MOL BIOL, V25, P951, DOI 10.1038/s41594-018-0131-8
   Marchand V, 2018, ANGEW CHEM INT EDIT, V57, P16785, DOI 10.1002/anie.201810946
   Marusic M, 2017, BBA-GEN SUBJECTS, V1861, P1229, DOI 10.1016/j.bbagen.2016.11.007
   Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022
   Metifiot M, 2014, NUCLEIC ACIDS RES, V42, P12352, DOI 10.1093/nar/gku999
   Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Molinie B, 2016, NAT METHODS, V13, P692, DOI 10.1038/nmeth.3898
   MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855
   Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/NCHEMBIO.1479, 10.1038/nchembio.1479]
   Nachtergaele S, 2018, ANNU REV GENET, V52, P349, DOI 10.1146/annurev-genet-120417-031522
   Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137
   Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711
   Perrone R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02291-1
   Perrone R, 2014, J ANTIMICROB CHEMOTH, V69, P3248, DOI 10.1093/jac/dku280
   Perrone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073121
   Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r
   Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692
   Piekna-Przybylska D, 2013, J BIOL CHEM, V288, P24140, DOI 10.1074/jbc.M113.477265
   Plyler J, 2009, CELL BIOCHEM BIOPHYS, V53, P43, DOI 10.1007/s12013-008-9038-z
   Prioleau MN, 2017, ADV EXP MED BIOL, V1042, P273, DOI 10.1007/978-981-10-6955-0_13
   Qiao Q, 2017, MOL CELL, V67, P361, DOI 10.1016/j.molcel.2017.06.034
   Rachwal PA, 2007, FEBS LETT, V581, P1657, DOI 10.1016/j.febslet.2007.03.040
   Rajendran A, 2013, J AM CHEM SOC, V135, P18575, DOI 10.1021/ja409085j
   Riquelme-Barrios S, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2018.00576
   Rouleau S, 2017, RNA, V23, P1172, DOI 10.1261/rna.060962.117
   Rouleau SG, 2018, RNA BIOL, V15, P198, DOI 10.1080/15476286.2017.1405211
   Ruggiero E, 2018, NUCLEIC ACIDS RES, V46, P3270, DOI 10.1093/nar/gky187
   Saranathan N, 2019, TRENDS MICROBIOL, V27, P148, DOI 10.1016/j.tim.2018.08.011
   Scalabrin M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45244
   Sendinc E., 2018, BIORXIV
   Shen W, 2009, J BIOL CHEM, V284, P33883, DOI 10.1074/jbc.M109.055368
   Smargiasso N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-362
   Tan B, 2018, J VIROL, V92, DOI 10.1128/JVI.00696-18
   Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   Topalis D, 2013, ANTIVIR RES, V97, P122, DOI 10.1016/j.antiviral.2012.11.007
   Tosoni E, 2015, NUCLEIC ACIDS RES, V43, P8884, DOI 10.1093/nar/gkv897
   Tsai K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006919
   Tuesuwan B., 2008, BIOCHEMISTRY-US, V47, P1909
   Wang SR, 2016, CELL CHEM BIOL, V23, P1113, DOI 10.1016/j.chembiol.2016.07.019
   Wang SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501535
   Wei DG, 2012, NUCLEIC ACIDS RES, V40, P4691, DOI 10.1093/nar/gks023
   WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7
   Wongsurawat T., 2018, BIORXIV
   Yang SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07224-8
   Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8
   Zhang DH, 2010, BIOCHEMISTRY-US, V49, P4554, DOI 10.1021/bi1002822
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
   Zhu J, 2018, ACS CHEM BIOL, V13, P2577, DOI 10.1021/acschembio.8b00522
NR 127
TC 2
Z9 2
U1 6
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2374-7943
EI 2374-7951
J9 ACS CENTRAL SCI
JI ACS Central Sci.
PD FEB 27
PY 2019
VL 5
IS 2
BP 218
EP 228
DI 10.1021/acscentsci.8b00963
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA HN6OP
UT WOS:000460305900005
PM 30834310
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, SY
   Koetzner, CA
   Payne, AF
   Nierode, GJ
   Yu, YL
   Wang, RF
   Barr, E
   Dordick, JS
   Kramer, LD
   Zhang, FM
   Linhardt, RJ
AF Kim, So Young
   Koetzner, Cheri A.
   Payne, Anne F.
   Nierode, Grego J.
   Yu, Yanlei
   Wang, Rufeng
   Barr, Evan
   Dordick, Jonathan S.
   Kramer, Laura D.
   Zhang, Fuming
   Linhardt, Robert J.
TI Glycosaminoglycan Compositional Analysis of Relevant Tissues in Zika
   Virus Pathogenesis and in Vitro Evaluation of Heparin as an Antiviral
   against Zika Virus Infection
SO BIOCHEMISTRY
LA English
DT Article
ID ENVELOPE PROTEIN; SULFATE; OLIGOSACCHARIDES; PROTEOGLYCANS; BINDING
AB Zika virus (ZIKV) is an enveloped RNA virus from the flavivirus family that can cause fetal neural abnormalities in pregnant women. Previously, we established that ZIKV-EP (envelope protein) binds to human placental chondroitin sulfate (CS), suggesting that CS may be a potential host cell surface receptor in ZIKV pathogenesis. In this study, we further characterized the GAG disaccharide composition of other biological tissues (i.e., mosquitoes, fetal brain cells, and eye tissues) in ZIKV pathogenesis to investigate the role of tissue specific GAGs. Heparan sulfate (HS) was the major GAG, and levels of HS-6-sulfo, HS 0S (unsulfated HS), and CS 4S disaccharides were the main differences in the GAG composition of Aedes aegypti and Aedes albopictus mosquitoes. In human fetal neural progenitor and differentiated cells, HS 0S and CS 4S were the main disaccharides. A change in disaccharide composition levels was observed between undifferentiated and differentiated cells. In different regions of the bovine eyes, CS was the major GAG, and the amounts of hyaluronic acid or keratan sulfate varied depending on the region of the eye. Next, we examined heparin (HP) of various structures to investigate their potential in vitro antiviral activity against ZIKV and Dengue virus (DENY) infection in Vero cells. All compounds effectively inhibited DENY replication; however, they surprisingly promoted ZIKV replication. HP of longer chain lengths more strongly promoted activity in ZIKV replication. This study further expands our understanding of role of GAGs in ZIKV pathogenesis and carbohydrate based antivirals against flaviviral infection.
C1 [Kim, So Young; Yu, Yanlei; Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Biochem & Biophys Grad Program, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Koetzner, Cheri A.; Payne, Anne F.; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Slingerlands, NY 12159 USA.
   [Nierode, Grego J.; Wang, Rufeng; Dordick, Jonathan S.; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Barr, Evan; Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol Sci, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA.
RP Zhang, FM; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
EM zhangf2@rpi.edu; linhar@rpi.edu
RI Yu, Yanlei/AAQ-4432-2020; amsalu, ribka/G-8780-2019
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [DK111958, CA231074,
   HL125371, NS088496]
FX This research was funded by National Institutes of Health Grants
   DK111958, CA231074, HL125371, and NS088496.
CR Acharya D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004139
   Anez G, 2009, J VIROL, V83, P10384, DOI 10.1128/JVI.01083-09
   Armistead JS, 2011, BIOCHEM J, V438, P475, DOI 10.1042/BJ20110694
   Belser JA, 2013, MICROBIOL MOL BIOL R, V77, P144, DOI 10.1128/MMBR.00058-12
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Inatani M, 2002, PROG RETIN EYE RES, V21, P429, DOI 10.1016/S1350-9462(02)00009-5
   Islam T, 2002, CARBOHYD RES, V337, P2239, DOI 10.1016/S0008-6215(02)00229-X
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Kamhi E, 2013, BIOL REV, V88, P928, DOI 10.1111/brv.12034
   Kauffman E, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2542
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x
   LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026
   LINHARDT RJ, 1988, J BIOL CHEM, V263, P13090
   Magnus Mariana Munari, 2018, Hematol., Transfus. Cell Ther., V40, P250, DOI 10.1016/j.htct.2018.01.011
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Park PJ, 2013, EXP EYE RES, V110, P1, DOI 10.1016/j.exer.2013.01.015
   Peng YF, 2018, GLYCOCONJUGATE J, V35, P119, DOI 10.1007/s10719-017-9808-1
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rowlands D, 2015, MOLECULES, V20, P3527, DOI 10.3390/molecules20033527
   Sinnis P, 2007, J BIOL CHEM, V282, P25376, DOI 10.1074/jbc.M704698200
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sridhar MS, 2018, INDIAN J OPHTHALMOL, V66, P190, DOI 10.4103/ijo.IJO_646_17
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Talarico LB, 2011, J GEN VIROL, V92, P1332, DOI 10.1099/vir.0.028522-0
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teweldemedhin M, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0612-2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang HS, 2017, GLYCOCONJUGATE J, V34, P643, DOI 10.1007/s10719-017-9786-3
   Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547
NR 39
TC 3
Z9 3
U1 5
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 26
PY 2019
VL 58
IS 8
BP 1155
EP 1166
DI 10.1021/acs.biochem.8b01267
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HN5CD
UT WOS:000460199700017
PM 30698412
DA 2020-07-08
ER

PT J
AU Paskey, AC
   Frey, KG
   Schroth, G
   Gross, S
   Hamilton, T
   Bishop-Lilly, KA
AF Paskey, Adrian C.
   Frey, Kenneth G.
   Schroth, Gary
   Gross, Stephen
   Hamilton, Theron
   Bishop-Lilly, Kimberly A.
TI Enrichment post-library preparation enhances the sensitivity of
   high-throughput sequencing-based detection and characterization of
   viruses from complex samples
SO BMC GENOMICS
LA English
DT Article
DE Genome enrichment; Virus detection; High-throughput sequencing; Virome
   profiling; Virome capture sequencing; Viral enrichment; Sequencing-based
   detection; Next generation sequencing; Hybridization-based target
   enrichment
ID FULL-GENOME AMPLIFICATION; ZIKA; IDENTIFICATION; EPIDEMIC; ASSAYS
AB BackgroundSequencing-based detection and characterization of viruses in complex samples can suffer from lack of sensitivity due to a variety of factors including, but not limited to, low titer, small genome size, and contribution of host or environmental nucleic acids. Hybridization-based target enrichment is one potential method for increasing the sensitivity of viral detection via high-throughput sequencing.ResultsThis study expands upon two previously developed panels of virus enrichment probes (for filoviruses and for respiratory viruses) to include other viruses of biodefense and/or biosurveillance concern to the U.S. Department of Defense and various international public health agencies. The newly expanded and combined panel is tested using carefully constructed synthetic metagenomic samples that contain clinically relevant amounts of viral genetic material. Target enrichment results in a dramatic increase in sensitivity for virus detection as compared to shotgun sequencing, yielding full, deeply covered viral genomes from materials with Ct values suggesting that amplicon sequencing would be likely to fail. Increased pooling to improve cost- and time-effectiveness does not negatively affect the ability to obtain full-length viral genomes, even in the case of co-infections, although as expected, it does decrease depth of coverage.ConclusionsHybridization-based target enrichment is an effective solution to obtain full-length viral genomes for samples from which virus detection would fail via unbiased, shotgun sequencing or even via amplicon sequencing. As the development and testing of probe sets for viral target enrichment expands and continues, the application of this technique, in conjunction with deeper pooling strategies, could make high-throughput sequencing more economical for routine use in biosurveillance, biodefense and outbreak investigations.
C1 [Paskey, Adrian C.; Frey, Kenneth G.; Hamilton, Theron; Bishop-Lilly, Kimberly A.] Naval Med Res Ctr Frederick, Biol Def Res Directorate, Genom & Bioinformat Dept, Frederick, MD 21702 USA.
   [Paskey, Adrian C.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Paskey, Adrian C.] Leidos, Reston, VA 20190 USA.
   [Schroth, Gary; Gross, Stephen] Illumina Inc, San Diego, CA 92122 USA.
RP Bishop-Lilly, KA (corresponding author), Naval Med Res Ctr Frederick, Biol Def Res Directorate, Genom & Bioinformat Dept, Frederick, MD 21702 USA.
EM Kimberly.a.bishop-lilly.civ@mail.mil
OI Gross, Stephen/0000-0003-0711-787X; Paskey, Adrian/0000-0003-4575-3092
FU U.S. Navy, Office of Naval Research, In-House Laboratory Independent
   Research (ILIR) Program; WUN [A1417]
FX LThis work was funded by U.S. Navy, Office of Naval Research, In-House
   Laboratory Independent Research (ILIR) Program and WUN A1417. The
   funding bodies had no role in the design of this study nor in the
   collection, analysis, or interpretation of data, nor in the writing of
   this manuscript.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   [Anonymous], 2014, COLD SPRING HARBOR P
   Blackley DJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600378
   Brown JR, 2016, J CLIN MICROBIOL, V54, P2530, DOI 10.1128/JCM.01052-16
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cruz CD, 2016, J VIROL METHODS, V235, P158, DOI 10.1016/j.jviromet.2016.06.001
   Cummings MJ, 2018, CLIN INFECT DIS
   Dehority WN, 2017, J MED VIROL, V89, P926, DOI 10.1002/jmv.24706
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Frey KG, 2015, METHOD MICROBIOL, V42, P525, DOI 10.1016/bs.mim.2015.06.004
   Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96
   Kaneko H, 2009, J GEN VIROL, V90, P1471, DOI 10.1099/vir.0.009225-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leguia M, 2017, J VIROL METHODS, V248, P77, DOI 10.1016/j.jviromet.2017.06.005
   Li PE, 2017, NUCLEIC ACIDS RES, V45, P67, DOI 10.1093/nar/gkw1027
   Luke T, 2018, J INFECT DIS
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Metsky HC, 2018, CAPTURING DIVERSE MI
   Metsky HC, 2017, NATURE
   O'Flaherty BM, 2018, GENOME RES, V28, P869, DOI 10.1101/gr.226316.117
   Oba M, 2018, BIOCHEM BIOPH RES CO, V495, P1871, DOI 10.1016/j.bbrc.2017.12.017
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Samorodnitsky E, 2015, HUM MUTAT, V36, P903, DOI 10.1002/humu.22825
   Silva MR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005712
   Sozhamannan S, 2015, VIRUSES-BASEL, V7, P3130, DOI 10.3390/v7062763
   Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   van Duijl-Richter MKS, 2015, J GEN VIROL, V96, P2122, DOI 10.1099/vir.0.000144
   Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Yang Y, 2018, METHODS MOL BIOL, V1838, P125, DOI 10.1007/978-1-4939-8682-8_10
NR 35
TC 2
Z9 2
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD FEB 26
PY 2019
VL 20
AR 155
DI 10.1186/s12864-019-5543-2
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA HN0HB
UT WOS:000459866700003
PM 30808306
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Overbosch, FW
   Elfrink, F
   Schinkel, J
   Sonder, GJB
AF Overbosch, Femke W.
   Elfrink, Floor
   Schinkel, Janke
   Sonder, Gerard J. B.
TI No chikungunya virus infections among Dutch long-term travellers to
   (sub)tropical countries: a prospective study 2008-2011
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Chikungunya; Travellers; Prospective
ID DISEASES; FEVER
AB BackgroundChikungunya is an arthropod-borne viral disease now identified in over 60 countries in Asia, Africa, Europe, and the Americas. Chikungunya virus (CHIKV) has spread in the last 15years to many countries, causing large local outbreaks. CHIKV infection can be clinically misdiagnosed in areas where dengue and/or Zika infections occur. Prospective studies are necessary to calculate the true incidence rate of CHIKV infection in travellers. The aim of this study was to obtain the attack and incidence rates of CHIKV infection among long-term travellers and identify associated risk factors.MethodsA previously collected prospective cohort of Dutch long-term travellers (12-52weeks) to subtropical and tropical countries was tested. From December 2008 to September 2011, participants were recruited at the travel clinic of the Public Health Service Amsterdam. A weekly diary was kept during travel in which participants recorded their itinerary, symptoms, and physician visits. On return, their pre- and post-travel blood samples were tested for the presence of IgG antibodies to CHIKV antigen. Seroconversions were confirmed by an in-house CHIKV neutralisation test.ResultsThe median age of 603 participants was 25years (interquartile range [IQR]: 23-29); 35.7% were male; median travel duration was 20weeks (IQR: 15-25), and purpose of travel was predominantly tourism (62%).The presence of anti-CHIKV IgG in the pre-travel sample, suggestive of previous CHIKV infection, was found for 3/603 participants (0.5%); all three had been previously travelling in either Africa or Asia. In one traveler who visited Latin America, a seroconversion was found (0.2%) but the CHIKV neutralisation test was negative, making the incidence rate 0.ConclusionNo chikungunya virus infections were found in this 2008-2011 prospective cohort of long-term travellers. We recommend the research be repeated, particularly as the sample size of our cohort might have been too small. Also, extensive spread of chikungunya virus has likely increased incidence rates among travellers since 2013.
C1 [Overbosch, Femke W.; Elfrink, Floor; Sonder, Gerard J. B.] Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands.
   [Overbosch, Femke W.; Elfrink, Floor; Sonder, Gerard J. B.] Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands.
   [Schinkel, Janke] Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, Amsterdam, Netherlands.
   [Sonder, Gerard J. B.] Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, Amsterdam, Netherlands.
RP Overbosch, FW (corresponding author), Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands.; Overbosch, FW (corresponding author), Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands.
EM foverbosch@ggd.amsterdam.nl
FU Netherlands Organization for Health Research and Development
   (ZonMW)Netherlands Organization for Health Research and Development
   [12501 0001]; Public Health Service Amsterdam, the
   NetherlandsNetherlands Government
FX This study was conducted within the Amsterdam Academic Collaborative
   Center on Public Health: a collaboration between the Public Health
   Service of Amsterdam and the Academic Medical Center of the University
   of Amsterdam, the Netherlands. The Amsterdam Academic Collaborative
   Center on Public Health is financially supported by the Netherlands
   Organization for Health Research and Development (ZonMW; grant number
   12501 0001). The study was funded by the Public Health Service
   Amsterdam, the Netherlands.
CR Bottieau E, 2009, EURO SURVEILL, V14
   Fernandez-Garcia MD, 2016, EURO SURVEILL, V21
   Gautret P, 2012, EURO SURVEILL, V17
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lim PL, 2009, J TRAVEL MED, V16, P289, DOI 10.1111/j.1708-8305.2009.00313.x
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Nicoletti L, 2008, EMERG INFECT DIS, V14, P177, DOI 10.3201/eid1401.070618
   Overbosch FW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192193
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Receveur M, 2010, EUROSURVEILLANCE, V15, P8, DOI [10.2807/ese.15.08.19494-en, DOI 10.2807/ESE.15.08.19494-EN]
   Reusken CBEM, 2013, J TRAVEL MED, V20, P44, DOI 10.1111/j.1708-8305.2012.00670.x
   Rianthavorn P, 2010, INT J INFECT DIS, V14, pE161, DOI 10.1016/j.ijid.2010.01.001
   Savini H, 2013, EMERG INFECT DIS, V19, P1297, DOI 10.3201/eid1908.121739
   Tanay A, 2008, J TRAVEL MED, V15, P382, DOI 10.1111/j.1708-8305.2008.00244.x
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Yoshikawa Minako Jen, 2013, Trop Med Health, V41, P67, DOI 10.2149/tmh.2011-05
NR 16
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 26
PY 2019
VL 19
AR 196
DI 10.1186/s12879-019-3819-4
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA HN0HH
UT WOS:000459867400003
PM 30808283
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Andrade, P
   Gimblet-Ochieng, C
   Modirian, F
   Collins, M
   Cardenas, M
   Katzelnick, LC
   Montoya, M
   Michlmayr, D
   Kuan, G
   Balmaseda, A
   Coloma, J
   de Silva, AM
   Harris, E
AF Andrade, Paulina
   Gimblet-Ochieng, Ciara
   Modirian, Faraz
   Collins, Matthew
   Cardenas, Maritza
   Katzelnick, Leah C.
   Montoya, Magelda
   Michlmayr, Daniela
   Kuan, Guillermina
   Balmaseda, Angel
   Coloma, Josefina
   de Silva, Aravinda M.
   Harris, Eva
TI Impact of pre-existing dengue immunity on human antibody and memory B
   cell responses to Zika
SO NATURE COMMUNICATIONS
LA English
DT Article
ID YELLOW-FEVER VIRUS; DEPENDENT ENHANCEMENT; CROSS-REACTIVITY;
   NEUTRALIZING ANTIBODIES; MULTICOLOR FLUOROSPOT; DISEASE SEVERITY;
   INFECTION; REPLICATION; CHIKUNGUNYA; VACCINATION
AB Little is known about enduring memory B cell (MBC) responses to Zika virus (ZIKV) and their relationship with circulating antibodies. Here we comprehensively assess MBC frequency and specificity alongside serum binding and neutralizing antibody responses to ZIKV similar to 2 weeks and similar to 8 months postinfection in 31 pediatric subjects with 0, 1 or >1 prior infections with the related dengue virus (DENV). ZIKV infection elicits a robust type-specific MBC response, and the majority of late convalescent anti-ZIKV serum neutralizing activity is attributable to ZIKV-specific antibodies. The number of prior DENV infections does not influence type-specific or cross-reactive MBC responses, although ZIKV has the highest cross-reactivity with DENV3. DENV cross-reactive MBCs expanded by ZIKV infection decline in number and proportion by late convalescence. Finally, ZIKV induces greater cross-reactivity in the MBC pool than in serum antibodies. Our data suggest immunity to DENV only modestly shapes breadth and magnitude of enduring ZIKV antibody responses.
C1 [Andrade, Paulina; Modirian, Faraz; Cardenas, Maritza; Katzelnick, Leah C.; Montoya, Magelda; Michlmayr, Daniela; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Andrade, Paulina] Univ San Francisco Quito, Colegio Ciencias Biol & Ambientales, EC-170157 Quito, Ecuador.
   [Gimblet-Ochieng, Ciara; Collins, Matthew; de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua 12014, Nicaragua.
   [Kuan, Guillermina; Balmaseda, Angel] Sustainable Sci Inst, Managua 14007, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Lab Nacl Virol, Ctr Nacl Diagnost & Referencia, Managua 16064, Nicaragua.
   [Collins, Matthew] Emory Univ, Sch Med, Div Infect Dis, Hope Clin,Emory Vaccine Ctr,Dept Med, Decatur, GA 30030 USA.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
FU National Institute of Allergy and Infectious Diseases (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P01AI106695, U19AI118610, R01AI099631]; Pediatric Dengue Vaccine
   Initiative grant VE-1 from the Bill and Melinda Gates Foundation; FIRST
   grant from the Bill and Melinda Gates Foundation; Instituto Carlos Slim
   de la Salud
FX We would like to thank our study team at the Centro de Salud Socrates
   Flores Vivas and the Laboratorio Nacional de Virologia at the Centro
   Nacional de Diagnostico y Referencia, Ministry of Health, as well as the
   Sustainable Sciences Institute, in Nicaragua for their high-quality work
   and dedication. We are also grateful to the study participants and their
   families. This work was supported by grants P01AI106695 (EH),
   U19AI118610 (EH), and R01AI099631 (AB) from the National Institute of
   Allergy and Infectious Diseases (NIH). The Pediatric Dengue Cohort Study
   was also supported by the Pediatric Dengue Vaccine Initiative grant VE-1
   (E.H.) from the Bill and Melinda Gates Foundation and by the FIRST grant
   (E.H. and J.C.) from the Bill and Melinda Gates Foundation and the
   Instituto Carlos Slim de la Salud.
CR Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54
   Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092
   Andrade P, 2018, METHODS MOL BIOL, V1808, P151, DOI 10.1007/978-1-4939-8567-8_13
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burger-Calderon R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006518
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2017, TRIOPL REAL TIM RT P, P1
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   de Alwis R., 2012, P NATL ACAD SCI USA, P1, DOI [10.1073/pnas.1200566109/-/DCSupplemental/pnas.201200566SI.pdf, DOI 10.1073/PNAS.1200566109/-/DCSUPPLEMENTAL/PNAS.201200566SI.PDF]
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350
   Grifoni A., 2017, J VIROL, V91, P601
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hadjilaou A, 2015, J IMMUNOL, V195, P3490, DOI 10.4049/jimmunol.1500918
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Katzelnick LC, 2018, P NATL ACAD SCI USA, V115, P10762, DOI 10.1073/pnas.1809253115
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   Mattia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027252
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Montoya M., 2018, J INFECT DIS, V496, P504
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Niedrig M, 1999, TROP MED INT HEALTH, V4, P867, DOI 10.1046/j.1365-3156.1999.00496.x
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Simon-Loriere E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5088
   Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14
   Smith SA, 2013, J INFECT DIS, V207, P1898, DOI 10.1093/infdis/jit119
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996
   World Health Organization, 1997, DENG HAEM FEV DIAGN, P1
   World Health Organization, 2018, ZIK EP UPD
   World-Health-Organization, 2009, DENG GUID DIAGN TREA, V1
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568
NR 68
TC 5
Z9 5
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 26
PY 2019
VL 10
AR 938
DI 10.1038/s41467-019-08845-3
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM8BY
UT WOS:000459704600002
PM 30808875
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Buchman, A
   Gamez, S
   Li, M
   Antoshechkin, I
   Li, HH
   Wang, HW
   Chen, CH
   Klein, MJ
   Duchemin, JB
   Paradkar, PN
   Akbari, OS
AF Buchman, Anna
   Gamez, Stephanie
   Li, Ming
   Antoshechkin, Igor
   Li, Hsing-Han
   Wang, Hsin-Wei
   Chen, Chun-Hong
   Klein, Melissa J.
   Duchemin, Jean-Bernard
   Paradkar, Prasad N.
   Akbari, Omar S.
TI Engineered resistance to Zika virus in transgenic Aedes aegypti
   expressing a polycistronic cluster of synthetic small RNAs
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE ZIKA; resistance; Aedes; aegypti; mosquito
ID GENE DRIVE; ARTIFICIAL MICRORNAS; MOSQUITO; WOLBACHIA; VECTOR;
   POPULATION; DISEASE; REPLICATION; SUPPRESSION; INHIBITION
AB Recent Zika virus (ZIKV) outbreaks have highlighted the necessity for development of novel vector control strategies to combat arboviral transmission, including genetic versions of the sterile insect technique, artificial infection with Wolbachia to reduce population size and/or vectoring competency, and gene drive-based methods. Here, we describe the development of mosquitoes synthetically engineered to impede vector competence to ZIKV. We demonstrate that a polycistronic cluster of engineered synthetic small RNAs targeting ZIKV is expressed and fully processed in Aedes aegypti, ensuring the formation of mature synthetic small RNAs in the midgut where ZIKV resides in the early stages of infection. Critically, we demonstrate that engineered Ae. aegypti mosquitoes harboring the anti-ZIKV transgene have significantly reduced viral infection, dissemination, and transmission rates of ZIKV. Taken together, these compelling results provide a promising path forward for development of effective genetic-based ZIKV control strategies, which could potentially be extended to curtail other arboviruses.
C1 [Buchman, Anna; Gamez, Stephanie; Li, Ming; Akbari, Omar S.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.
   [Antoshechkin, Igor] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Li, Hsing-Han] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.
   [Li, Hsing-Han; Wang, Hsin-Wei; Chen, Chun-Hong] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Township 350, Miaoli County, Taiwan.
   [Chen, Chun-Hong] Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Zhunan Township 350, Miaoli County, Taiwan.
   [Klein, Melissa J.; Duchemin, Jean-Bernard; Paradkar, Prasad N.] Australian Anim Hlth Lab, CSIRO Hlth & Biosecur, Geelong, Vic 3220, Australia.
   [Akbari, Omar S.] Univ Calif San Diego, Tata Inst Genet & Soc, La Jolla, CA 92093 USA.
   [Duchemin, Jean-Bernard] Inst Pasteur, Mosquitoes & Emerging Arboviruses, F-97306 Cayenne, French Guiana.
RP Akbari, OS (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.; Paradkar, PN (corresponding author), Australian Anim Hlth Lab, CSIRO Hlth & Biosecur, Geelong, Vic 3220, Australia.; Akbari, OS (corresponding author), Univ Calif San Diego, Tata Inst Genet & Soc, La Jolla, CA 92093 USA.
EM prasad.paradkar@csiro.au; oakbari@ucsd.edu
RI Duchemin, Jean-Bernard/AAE-8077-2020
OI Duchemin, Jean-Bernard/0000-0001-5044-4855; Gamez,
   Stephanie/0000-0003-0665-0066; CHEN, CHUN-HONG/0000-0002-3028-5508
FU NIH-K22 Career Transition Award [5K22AI113060]; NIH
   Exploratory/Developmental Research Grant AwardUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [1R21AI123937]; CSIROCommonwealth Scientific & Industrial Research
   Organisation (CSIRO)
FX We thank Prof. Robert Tesh and Dr. Nikos Vasilakis (University of Texas
   Medical Branch) for providing the ZIKV FSS13025 and PRVABC59 strains and
   Lee Trinidad for preparing viral stocks. We thank Christian Bowman for
   helping with the inverse PCR assay. We also thank Prof. Scott O'Neill
   (Institute of Vector-Borne Diseases, Monash University) and the World
   Mosquito Program for providing Wolbachia-infected mosquito eggs.
   Finally, we thank Dr. Guann-Yi Yu (National Tsing Hua University) for
   providing the Stat<SUP>-/-</SUP> mice used in this study. This work was
   supported, in part, by an NIH-K22 Career Transition Award
   (5K22AI113060), an NIH Exploratory/Developmental Research Grant Award
   (1R21AI123937 to O.S.A.), and CSIRO internal funding (to P.N.P.).
CR Akbari OS, 2014, ACS SYNTH BIOL, V3, P915, DOI 10.1021/sb300079h
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Amuzu HE, 2018, ECOL EVOL, V8, P5441, DOI 10.1002/ece3.4066
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595
   Chitti Sai V., 2016, VirusDisease, V27, P211, DOI 10.1007/s13337-016-0317-9
   CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Doyle M, 2016, 2016 INT C ENT, DOI [10.1603/ICE.2016.108064, DOI 10.1603/ICE.2016.108064]
   Franz AWE, 2011, INSECT MOL BIOL, V20, P587, DOI 10.1111/j.1365-2583.2011.01089.x
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kandul NP, 2018, BIORXIV, DOI [10.1101/377721, DOI 10.1101/377721]
   King JG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03981-8
   Kuo YP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006417
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Marris E, 2017, NATURE, V548, P17, DOI 10.1038/548017a
   Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x
   Matthews BJ, 2017, IMPROVED AEDES AEGYP, DOI [10.1101/240747, DOI 10.1101/240747]
   Meijer HA, 2014, BIOCHEM SOC T, V42, P1135, DOI 10.1042/BST20140142
   Mishra P, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060163
   Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895
   National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A
   Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255
   Pollack A, 2016, NY TIMES, pA1
   Saha A, 2016, ANTIVIR RES, V134, P42, DOI 10.1016/j.antiviral.2016.08.019
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870
   Waltz E., 2017, NATURE NEWS, DOI [10.1038/nature.2017.22959, DOI 10.1038/NATURE.2017.22959, 10.1038/nature.2017.22959.]
   World Health Organization, 2017, ZIK VIR COMPL QUEST
   Xie PW, 2013, NUCLEIC ACID THER, V23, P244, DOI 10.1089/nat.2012.0405
   Yen PS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0011-5
NR 48
TC 14
Z9 14
U1 5
U2 24
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 26
PY 2019
VL 116
IS 9
BP 3656
EP 3661
DI 10.1073/pnas.1810771116
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM7YA
UT WOS:000459694400051
PM 30723148
OA Green Published, Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Bennett, KP
   Brown, EM
   De los Santos, H
   Poegel, M
   Kiehl, TR
   Patton, EW
   Norris, S
   Temple, S
   Erickson, J
   McGuinness, DL
   Boles, NC
AF Bennett, Kristin P.
   Brown, Elisabeth M.
   De los Santos, Hannah
   Poegel, Matthew
   Kiehl, Thomas R.
   Patton, Evan W.
   Norris, Spencer
   Temple, Sally
   Erickson, John
   McGuinness, Deborah L.
   Boles, Nathan C.
TI Identifying Windows of Susceptibility by Temporal Gene Analysis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ZIKA VIRUS-INFECTION; EXPRESSION DATA; AUTISM; EXPOSURE; SCHIZOPHRENIA;
   BRAIN; FETAL; MECHANISMS; DISORDERS; PREGNANCY
AB Increased understanding of developmental disorders of the brain has shown that genetic mutations, environmental toxins and biological insults typically act during developmental windows of susceptibility. Identifying these vulnerable periods is a necessary and vital step for safeguarding women and their fetuses against disease causing agents during pregnancy and for developing timely interventions and treatments for neurodevelopmental disorders. We analyzed developmental time-course gene expression data derived from human pluripotent stem cells, with disease association, pathway, and protein interaction databases to identify windows of disease susceptibility during development and the time periods for productive interventions. The results are displayed as interactive Susceptibility Windows Ontological Transcriptome (SWOT) Clocks illustrating disease susceptibility over developmental time. Using this method, we determine the likely windows of susceptibility for multiple neurological disorders using known disease associated genes and genes derived from RNA-sequencing studies including autism spectrum disorder, schizophrenia, and Zika virus induced microcephaly. SWOT clocks provide a valuable tool for integrating data from multiple databases in a developmental context with data generated from next-generation sequencing to help identify windows of susceptibility.
C1 [Bennett, Kristin P.; Brown, Elisabeth M.; De los Santos, Hannah; Poegel, Matthew; Boles, Nathan C.] Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA.
   [Bennett, Kristin P.; Erickson, John; McGuinness, Deborah L.] Rensselaer Polytech Inst, Inst Data Applicat & Explorat, Troy, NY 12180 USA.
   [Bennett, Kristin P.; Patton, Evan W.; Norris, Spencer; McGuinness, Deborah L.] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA.
   [Kiehl, Thomas R.; Temple, Sally; Boles, Nathan C.] Neural Stem Cell Inst, Rensselaer, NY 12144 USA.
   [McGuinness, Deborah L.] Rensselaer Polytech Inst, Dept Cognit Sci, Troy, NY 12180 USA.
RP Bennett, KP; Boles, NC (corresponding author), Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA.; Bennett, KP (corresponding author), Rensselaer Polytech Inst, Inst Data Applicat & Explorat, Troy, NY 12180 USA.; Bennett, KP (corresponding author), Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA.; Boles, NC (corresponding author), Neural Stem Cell Inst, Rensselaer, NY 12144 USA.
EM bennek@rpi.edu; nathanboles@neuralsci.org
OI McGuinness, Deborah/0000-0001-7037-4567
FU NINDSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R35NS097277]; Regenerative Research
   Foundation; NIEHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS)
   [0255-0236-4609/1U2CES026555-01, NIH 0255-0236-4609/3U2CES026555-01S1,
   R41ES026224]; NSFNational Science Foundation (NSF) [1331023]
FX This work was supported by grants from NINDS (R35NS097277), the
   Regenerative Research Foundation, NIEHS (0255-0236-4609/1U2CES026555-01,
   NIH 0255-0236-4609/3U2CES026555-01S1, R41ES026224) and NSF (1331023).
CR Ackerman S., 1992, DISCOVERING BRAIN
   Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104
   Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101
   Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205
   [Anonymous], 2003, Y FCMC TOOLBOX V 1 0
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025
   Beaudet AL, 2007, NAT MED, V13, P534, DOI 10.1038/nm0507-534
   Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061
   Brites D, 2015, SEMIN FETAL NEONAT M, V20, P14, DOI 10.1016/j.siny.2014.12.002
   Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024
   Bruin JE, 2007, J ENDOCRINOL, V194, P171, DOI 10.1677/JOE-07-0050
   Budday S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00257
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chao HR, 2011, PEDIATR RES, V70, P596, DOI 10.1203/PDR.0b013e3182320b9b
   Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638
   Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101
   De Felice A, 2015, TOXICS, V3, P89, DOI 10.3390/toxics3010089
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fang WQ, 2014, CELL REP, V9, P1635, DOI 10.1016/j.celrep.2014.11.003
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   Foss-Feig JH, 2017, BIOL PSYCHIAT, V81, P848, DOI 10.1016/j.biopsych.2017.03.005
   Haugen AC, 2015, J DEV ORIG HLTH DIS, V6, P55, DOI 10.1017/S2040174414000580
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang Grace T, 2013, Pac Symp Biocomput, P212
   Kakar N, 2012, EUR J MED GENET, V55, P727, DOI 10.1016/j.ejmg.2012.08.010
   Kalkbrenner AE, 2015, EPIDEMIOLOGY, V26, P30, DOI 10.1097/EDE.0000000000000173
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Landrigan P. J., 2010, CURR OPIN PEDIAT
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   Lebo T., 2013, PROVO PROV ONTOLOGY
   Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064143
   Liu XM, 2017, J MED GENET, V54, P511, DOI 10.1136/jmedgenet-2016-104487
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McGuinness D. L., 2015, SMATDATA
   MILLER MW, 1986, SCIENCE, V233, P1308, DOI 10.1126/science.3749878
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436
   Mwansisya TE, 2017, SCHIZOPHR RES, V189, P9, DOI 10.1016/j.schres.2017.02.026
   Nevison CD, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-73
   O'Hare A, 2009, ARCH DIS CHILDHOOD-E, V94, P161, DOI 10.1136/adc.2008.150490
   Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612
   Patton E. W., 2015, P SEMSTATS
   Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020
   Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338
   Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7
   Rovida C, 2014, ATLA-ALTERN LAB ANIM, V42, P97, DOI 10.1177/026119291404200203
   Sapir T, 2012, HUM MOL GENET, V21, P1681, DOI 10.1093/hmg/ddr603
   Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Stansfield KH, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.147
   Szczepanski S, 2016, HUM GENET, V135, P157, DOI 10.1007/s00439-015-1619-5
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Tennessen JM, 2014, G3-GENES GENOM GENET, V4, P839, DOI 10.1534/g3.114.010652
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
   van de Leemput J, 2014, NEURON, V83, P51, DOI 10.1016/j.neuron.2014.05.013
   Varghese M, 2017, ACTA NEUROPATHOL, V134, P537, DOI 10.1007/s00401-017-1736-4
   Volpe JJ, 2008, NEUROLOGY NEWBORN
   Warren JL, 2016, STAT MED, V35, P2786, DOI 10.1002/sim.6891
   Williams A, 2017, DATA BRIEF, V15, P933, DOI 10.1016/j.dib.2017.10.060
   Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020
   World Health Organization, 2016, SIT REP
   Wu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036351
   Ye BS, 2017, ENVIRON POLLUT, V227, P234, DOI 10.1016/j.envpol.2017.04.039
   Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14
   Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684
NR 73
TC 1
Z9 1
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 26
PY 2019
VL 9
AR 2740
DI 10.1038/s41598-019-39318-8
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM7ZT
UT WOS:000459698900001
PM 30809014
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Souza, TML
   Vieira, YR
   Delatorre, E
   Barbosa-Lima, G
   Luiz, RLF
   Vizzoni, A
   Jain, K
   Miranda, MM
   Bhuva, N
   Gogarten, JF
   Ng, J
   Thakkar, R
   Calheiros, AS
   Monteiro, APT
   Bozza, PT
   Bozza, FA
   Tschoeke, DA
   Leomil, L
   de Mendonca, MCL
   Rodrigues, CDD
   Torres, MC
   de Filippis, AMB
   Nogueira, RMR
   Thompson, FL
   Lemos, C
   Durovni, B
   Cerbino-Neto, J
   Morel, CM
   Lipkin, WI
   Mishra, N
AF Souza, Thiago Moreno L.
   Vieira, Yasmine Rangel
   Delatorre, Edson
   Barbosa-Lima, Giselle
   Faria Luiz, Raul Leal
   Vizzoni, Alexandre
   Jain, Komal
   Miranda, Milene Mesquita
   Bhuva, Nishit
   Gogarten, Jan F.
   Ng, James
   Thakkar, Riddhi
   Calheiros, Andrea Surrage
   Teixeira Monteiro, Ana Paula
   Bozza, Patricia T.
   Bozza, Fernando A.
   Tschoeke, Diogo A.
   Leomil, Luciana
   Lima de Mendonca, Marcos Cesar
   dos Santos Rodrigues, Cintia Damasceno
   Torres, Maria C.
   Bispo de Filippis, Ana Maria
   Ribeiro Nogueira, Rita Maria
   Thompson, Fabiano L.
   Lemos, Cristina
   Durovni, Betina
   Cerbino-Neto, Jose
   Morel, Carlos M.
   Lipkin, W. Ian
   Mishra, Nischay
TI Emergence of the East-Central-South-African genotype of Chikungunya
   virus in Brazil and the city of Rio de Janeiro may have occurred years
   before surveillance detection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ZIKA VIRUS; PHYLOGENETIC ANALYSES; POPULATION-DYNAMICS; MODEL;
   TRANSMISSION; INFERENCE; ACCURACY
AB Brazil, which is hyperendemic for dengue virus DENV), has had recent Zika ZIKV) and CHIKV) Chikungunya virus outbreaks. Since March 2016, CHIKV is the arbovirus infection most frequently diagnosed in Rio de Janeiro. In the analysis of 1835 syndromic patients, screened by real time RT-PCR, 56.4% of the cases were attributed to CHIKV, 29.6% to ZIKV, and 14.1% to DENV-4. Sequence analyses of CHIKV from sixteen samples revealed that the East-Central-South-African ECSA) genotype of CHIKV has been circulating in Brazil since 2013 [95% bayesian credible interval BCI): 03/2012-10/2013], almost a year before it was detected by arbovirus surveillance program. Brazilian cases are related to Central African Republic sequences from 1980's. To the best of our knowledge, given the available sequence published here and elsewhere, the ECSA genotype was likely introduced to Rio de Janeiro early on 2014 02/2014; BCI: 07/2013-08/2014) through a single event, after primary circulation in the Bahia state at the Northestern Brazil in the previous year. The observation that the ECSA genotype of CHIKV was circulating undetected underscores the need for improvements in molecular methods for viral surveillance.
C1 [Souza, Thiago Moreno L.; Vieira, Yasmine Rangel; Barbosa-Lima, Giselle; Faria Luiz, Raul Leal; Vizzoni, Alexandre; Bozza, Fernando A.; Cerbino-Neto, Jose] Fundacao Oswaldo Cruz Fiocruz, INI, Rio De Janeiro, RJ, Brazil.
   [Jain, Komal; Bhuva, Nishit; Gogarten, Jan F.; Ng, James; Thakkar, Riddhi; Lipkin, W. Ian; Mishra, Nischay] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
   [Delatorre, Edson] Fiocruz MS, IOC, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.
   [Miranda, Milene Mesquita] Fiocruz MS, IOC, Lab Virus Resp & Sarampo, Rio De Janeiro, RJ, Brazil.
   [Souza, Thiago Moreno L.; Calheiros, Andrea Surrage; Teixeira Monteiro, Ana Paula; Bozza, Patricia T.] Fiocruz MS, IOC, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [Bozza, Fernando A.] DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio De Janeiro UFRJ, Inst Biol, Rio De Janeiro, RJ, Brazil.
   [Lima de Mendonca, Marcos Cesar; dos Santos Rodrigues, Cintia Damasceno; Torres, Maria C.; Bispo de Filippis, Ana Maria; Ribeiro Nogueira, Rita Maria] Fiocruz MS, IOC, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Thompson, Fabiano L.] Univ Fed Rio de Janeiro, SAGE COPPE, Rio de Janeiro, RJ, Brazil.
   [Lemos, Cristina; Durovni, Betina] Secretaria Municipal Saude, Rio De Janeiro, RJ, Brazil.
   [Souza, Thiago Moreno L.; Morel, Carlos M.] Fiocruz MS, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Dis Neglected Pop, INCT IDPN, Rio De Janeiro, RJ, Brazil.
   [Gogarten, Jan F.] Robert Koch Inst, Epidemiol Highly Pathogen Microorganisms, Berlin, Germany.
   [Gogarten, Jan F.] Free Univ Berlin, Inst Microbiol & Epizoot, Berlin, Germany.
RP Lipkin, WI (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.
EM wil2001@cumc.columbia.edu
RI Leomil, Luciana/O-4860-2019; Tschoeke, Diogo A/F-9913-2019; Delatorre,
   Edson/J-8330-2015; Vizzoni, Alexandre/W-8718-2019; Neto, Jose
   Cerbino/P-3713-2018; Morel, Carlos/Q-9657-2019; Monteiro, Ana Paula
   T/L-9540-2013
OI Tschoeke, Diogo A/0000-0001-8134-4259; Delatorre,
   Edson/0000-0002-5746-0820; Vizzoni, Alexandre/0000-0003-0004-5084; Neto,
   Jose Cerbino/0000-0001-9254-917X; Morel, Carlos/0000-0003-2752-0009;
   Bozza, Fernando Augusto/0000-0003-4878-0256; Bozza,
   Patricia/0000-0001-8349-9529; Souza, Thiago/0000-0003-2212-3899
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior - Brasil (CAPES)CAPES; National Council for Scientific and
   Technological Development (CNPq), Ministry of Science, Technology,
   Information and Communications [465313/2014-0]; Ministry of
   Education/CAPESCAPES [465313/2014-0]; Research Foundation of the State
   of Rio de Janeiro/FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [465313/2014-0]; Oswaldo
   Cruz Foundation/FIOCRUZ; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U19 AI109761]; DAADDeutscher Akademischer Austausch Dienst
   (DAAD); German Federal Ministry of Education and Research (BMBF)Federal
   Ministry of Education & Research (BMBF); People Programme (Marie Curie
   Actions) of the European Union's Seventh Framework Programme
   (FP7/2007-2013) under REAEuropean Union (EU) [605728]
FX We appreciate the contribution from Rio de Janeiro's city surveillance
   SMS-RJ. This study was financed in part by the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance
   Code 001. YRV and ED are funded by fellowships from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES). Funding
   was also provided by National Council for Scientific and Technological
   Development (CNPq), Ministry of Science, Technology, Information and
   Communications (No. 465313/2014-0); Ministry of Education/CAPES (No.
   465313/2014-0); Research Foundation of the State of Rio de
   Janeiro/FAPERJ (No. 465313/2014-0) and Oswaldo Cruz Foundation/FIOCRUZ.
   The study was also supported by the National Institutes of Health (U19
   AI109761) to N.M., W.I.L., K.J., R.T., J.N., N.B. at the Center for
   Infection and Immunity at Columbia University, New York; and J.F.G. is a
   fellow working at CII who was supported by the DAAD with funds from the
   German Federal Ministry of Education and Research (BMBF) and the People
   Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme (FP7/2007-2013) under REA grant agreement no 605728
   (P.R.I.M.E. - Postdoctoral Researchers International Mobility
   Experience). Funders had no role in the experiment design or
   interpretation.
CR [Anonymous], 1969, B EP SECR VIG SAUD
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI 10.1093/nar/gkt1030
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rathore Mobeen H, 2017, Adv Pediatr, V64, P27, DOI 10.1016/j.yapd.2017.04.002
   Sacramento C. Q., 2016, BIORXIV, V2016, DOI [10.1101/061671, DOI 10.1101/061671]
   Souza Thiara Manuele Alves, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   US Food and Drug Administration, 2017, CII ARBOVIROPLEX RRT
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   World Health Organization, 2004, LAB BIOS MAN 3 ED
NR 33
TC 9
Z9 9
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 26
PY 2019
VL 9
AR 2760
DI 10.1038/s41598-019-39406-9
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM7ZT
UT WOS:000459698900021
PM 30809003
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wongsurawat, T
   Jenjaroenpun, P
   Taylor, MK
   Lee, J
   Tolardo, AL
   Parvathareddy, J
   Kandel, S
   Wadley, TD
   Kaewnapan, B
   Athipanyasilp, N
   Skidmore, A
   Chung, D
   Chaimayo, C
   Whitt, M
   Kantakamalakul, W
   Sutthent, R
   Horthongkham, N
   Ussery, DW
   Jonsson, CB
   Nookaew, I
AF Wongsurawat, Thidathip
   Jenjaroenpun, Piroon
   Taylor, Mariah K.
   Lee, Jasper
   Tolardo, Aline Lavado
   Parvathareddy, Jyothi
   Kandel, Sangam
   Wadley, Taylor D.
   Kaewnapan, Bualan
   Athipanyasilp, Niracha
   Skidmore, Andrew
   Chung, Donghoon
   Chaimayo, Chutikarn
   Whitt, Michael
   Kantakamalakul, Wannee
   Sutthent, Ruengpung
   Horthongkham, Navin
   Ussery, David W.
   Jonsson, Colleen B.
   Nookaew, Intawat
TI Rapid Sequencing of Multiple RNA Viruses in Their Native Form
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE native RNA; genome; subgenomic mRNA; single-stranded RNA; virus;
   nanopore sequencing; rapid detection; MinION
ID ZIKA VIRUS; GENOMICS
AB Long-read nanopore sequencing by a MinION device offers the unique possibility to directly sequence native RNA. We combined an enzymatic poly-A tailing reaction with the native RNA sequencing to (i) sequence complex population of single stranded (ss)RNA viruses in parallel, (ii) detect genome, subgenomic mRNA/mRNA simultaneously, (iii) detect a complex transcriptomic architecture without the need for assembly, (iv) enable real-time detection. Using this protocol, positive-ssRNA, negative-ssRNA, with/without a poly(A)-tail, segmented/non-segmented genomes were mixed and sequenced in parallel. Mapping of the generated sequences on the reference genomes showed 100% length recovery with up to 97% identity. This work provides a proof of principle and the validity of this strategy, opening up a wide range of applications to study RNA viruses.
C1 [Wongsurawat, Thidathip; Jenjaroenpun, Piroon; Kandel, Sangam; Wadley, Taylor D.; Ussery, David W.; Nookaew, Intawat] Univ Arkansas Med Sci, Dept Biomed Informat, Coll Med, Little Rock, AR 72205 USA.
   [Taylor, Mariah K.; Lee, Jasper; Whitt, Michael; Jonsson, Colleen B.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.
   [Tolardo, Aline Lavado] Univ Sao Paulo, Virol Res Ctr, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Parvathareddy, Jyothi] Univ Tennessee, Ctr Hlth Sci, Reg Biocontainment Lab, Memphis, TN 38163 USA.
   [Kandel, Sangam] Univ Arkansas, Dept Bioinformat, Little Rock, AR 72204 USA.
   [Kaewnapan, Bualan; Athipanyasilp, Niracha; Chaimayo, Chutikarn; Kantakamalakul, Wannee; Sutthent, Ruengpung; Horthongkham, Navin] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.
   [Skidmore, Andrew; Chung, Donghoon] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.
   [Ussery, David W.; Nookaew, Intawat] Univ Arkansas Med Sci, Dept Physiol & Biophys, Coll Med, Little Rock, AR 72205 USA.
RP Nookaew, I (corresponding author), Univ Arkansas Med Sci, Dept Biomed Informat, Coll Med, Little Rock, AR 72205 USA.; Nookaew, I (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Coll Med, Little Rock, AR 72205 USA.
EM inookaew@uams.edu
RI Jonsson, Colleen/X-2360-2019
FU Helen Adams & Arkansas Research Alliance Endowed Chair; National
   Institute of General Medical Sciences of the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P20GM125503, R01AI103053]
FX This work was funded in part by the Helen Adams & Arkansas Research
   Alliance Endowed Chair, the National Institute of General Medical
   Sciences of the National Institutes of Health award no. P20GM125503
   andNational Institutes of Health award no R01AI103053.
CR Carrasco-Hernandez R, 2017, ILAR J, V58, P343, DOI 10.1093/ilar/ilx026
   Dapprich J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2836-6
   DeFilippis V, 2003, TRENDS BIOTECHNOL, V21, P452, DOI 10.1016/S0167-7799(03)00207-5
   Eckert SE, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000087
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Garalde DR, 2018, NAT METHODS, V15, P201, DOI [10.1038/NMETH.4577, 10.1038/nmeth.4577]
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Jenjaroenpun P, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky014
   Karamitros Timokratis, 2018, Methods Mol Biol, V1712, P43, DOI 10.1007/978-1-4939-7514-3_4
   Keller MW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32615-8
   Kilianski A, 2016, EMERG INFECT DIS, V22, P1448, DOI 10.3201/eid2208.160270
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Marston DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-444
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Vaser R, 2017, GENOME RES, V27, P737, DOI 10.1101/gr.214270.116
   Wongsurawat T, 2018, DECODING EPITRANSCRI, DOI [10.1101/487819, DOI 10.1101/487819]
   Woolhouse MEJ, 2016, EMERG INFECT DIS, V22, P2037, DOI 10.3201/eid2212.160123
NR 20
TC 4
Z9 4
U1 3
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 25
PY 2019
VL 10
AR 260
DI 10.3389/fmicb.2019.00260
PG 8
WC Microbiology
SC Microbiology
GA HM6MU
UT WOS:000459591500001
PM 30858830
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McDougall, WM
   Perreira, JM
   Hung, HF
   Vertii, A
   Xiaofei, E
   Zimmerman, W
   Kowalik, TF
   Doxsey, S
   Brass, AL
AF McDougall, William M.
   Perreira, Jill M.
   Hung, Hui-Fang
   Vertii, Anastassiia
   Xiaofei, E.
   Zimmerman, Wendy
   Kowalik, Timothy F.
   Doxsey, Stephen
   Brass, Abraham L.
TI Viral Infection or IFN-alpha Alters Mitotic Spindle Orientation by
   Modulating Pericentrin Levels
SO ISCIENCE
LA English
DT Article
ID CELLS; LOCALIZATION; INDUCTION; DIVISION; DWARFISM
AB Congenital microcephaly occurs in utero during Zika virus (ZIKV) infection. The single-gene disorder, Majewski osteodysplastic primordial dwarfism type II (MOPDII), also leads to microcephaly and is concomitant with a decrease in the centrosomal protein, pericentrin (PCNT). This protein is a known contributor of mitotic spindle misorientation and ultimately, microcephaly. Similar to MOPDII, either viral infection or interferon (IFN)-alpha exposure reduced PCNT levels at the mitotic spindle poles. We unexpectedly found that infection of cells with any one of a diverse set of viruses, such as ZIKV, dengue virus, cytomegalovirus, influenza A virus, or hepatitis B virus, or treatment of cells with the anti-viral cytokine, IFN-alpha, produced mitotic spindle misorientation. These findings demonstrate a related mechanism for the development of microcephaly in viral infection, the host's antiviral IFN response, and primordial dwarfism.
C1 [McDougall, William M.; Perreira, Jill M.; Xiaofei, E.; Kowalik, Timothy F.; Brass, Abraham L.] Univ Massachusetts, Med Sch, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA.
   [Hung, Hui-Fang] NINDS, Cell Biol Sect, Neurogenet Branch, NIH, Bethesda, MD 20814 USA.
   [Vertii, Anastassiia] Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.
   [Zimmerman, Wendy; Doxsey, Stephen] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA.
   [Brass, Abraham L.] Univ Massachusetts, Med Sch, Dept Med, Gastroenterol Div, Worcester, MA 01605 USA.
   [Brass, Abraham L.] Peak Gastroenterol Associates, Colorado Springs, CO 80907 USA.
RP Brass, AL (corresponding author), Univ Massachusetts, Med Sch, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA.; Doxsey, S (corresponding author), Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA.; Brass, AL (corresponding author), Univ Massachusetts, Med Sch, Dept Med, Gastroenterol Div, Worcester, MA 01605 USA.; Brass, AL (corresponding author), Peak Gastroenterol Associates, Colorado Springs, CO 80907 USA.
EM stephen.doxsey@umassmed.edu; abraham.brass@umassmed.edu
FU Investigators in the Pathogenesis of Infectious Disease grant from the
   Burroughs Wellcome Fund; Bill and Melinda Gates FoundationGates
   Foundation; Gilead Sciences Inc.Gilead Sciences
FX This work was funded by an Investigators in the Pathogenesis of
   Infectious Disease grant from the Burroughs Wellcome Fund to A.L.B.
   A.L.B. is grateful to the Bill and Melinda Gates Foundation and to
   Gilead Sciences Inc. for their support.
CR Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Chen CT, 2014, CURR BIOL, V24, P2327, DOI 10.1016/j.cub.2014.08.029
   Delaval B, 2008, SCIENCE, V319, P732, DOI 10.1126/science.1154513
   Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114
   DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gomez-Lopez S, 2014, CELL MOL LIFE SCI, V71, P575, DOI 10.1007/s00018-013-1386-1
   Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203
   Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976
   Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935
   Hung HF, 2016, CURR BIOL, V26, P1248, DOI 10.1016/j.cub.2016.04.033
   Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7
   Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940
   Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715
   Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paredes A. M., 2012, CURRENT PROTOCOLS MI, P14
   Prosser SL, 2017, NAT REV MOL CELL BIO, V18, P187, DOI 10.1038/nrm.2016.162
   Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Vertii A, 2018, CYTOSKELETON, V75, P87, DOI 10.1002/cm.21434
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
NR 25
TC 1
Z9 1
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2589-0042
J9 ISCIENCE
JI iScience
PD FEB 22
PY 2019
VL 12
BP 270
EP +
DI 10.1016/j.isci.2019.01.025
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HO0ON
UT WOS:000460603200022
PM 30716700
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kandel, Y
   Vulcan, J
   Rodriguez, SD
   Moore, E
   Chung, HN
   Mitra, S
   Cordova, JJ
   Martinez, KJL
   Moon, AS
   Kulkarni, A
   Ettestad, P
   Melman, S
   Xu, JN
   Buenemann, M
   Hanley, KA
   Hansen, IA
AF Kandel, Yashoda
   Vulcan, Julia
   Rodriguez, Stacy D.
   Moore, Emily
   Chung, Hae-Na
   Mitra, Soumi
   Cordova, Joel J.
   Martinez, Kalli J. L.
   Moon, Alex S.
   Kulkarni, Aditi
   Ettestad, Paul
   Melman, Sandra
   Xu, Jiannong
   Buenemann, Michaela
   Hanley, Kathryn A.
   Hansen, Immo A.
TI Widespread insecticide resistance in Aedes aegypti L. from New Mexico,
   USA
SO PLOS ONE
LA English
DT Article
ID SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; ZIKA VIRUS; PYRETHROID
   INSECTICIDES; POINT MUTATIONS; DIPTERA; CHLORPYRIFOS; MOSQUITOS; F1534C;
   DDT
AB Background
   Aedes aegypti mosquitoes are vectors of a variety of emerging viral pathogens, including yellow fever, dengue, chikungunya, and Zika virus. This species has established endemic populations in all cities across southern New Mexico sampled to date. Presently, control of Aedes-borne viruses relies on deployment of insecticides to suppress mosquito populations, but the evolution of insecticide resistance threatens the success of vector control programs. While insecticide resistance is quite common in Ae. aegypti field populations across much of the U.S., the resistance status of this species in populations from New Mexico has not previously been assessed.
   Results
   First, we collected information on pesticide use in cities in southern New Mexico and found that the most commonly used active ingredients were pyrethroids. The use of insecticides with the same mode-of-action over multiple years is likely to promote the evolution of resistance. To determine if there was evidence of resistance in some cities in southern New Mexico, we collected Ae. aegypti from the same cities and established laboratory strains to assess resistance to pyrethroid insecticides and, for a subset of populations, to organophosphate insecticides. F2 or F4 generation mosquitoes were assessed for insecticide resistance using bottle test bioassays. The majority of the populations from New Mexico that we analyzed were resistant to the pyrethroids permethrin and deltamethrin. A notable exception to this trend were mosquitoes from Alamogordo, a city that did not report using pyrethroid insecticides for vector control. We screened individuals from each population for known knock down resistance (kdr) mutations via PCR and found a strong association between the presences of the F1534C kdr mutation in the para gene of Ae. aegypti (homologue to F1534C in Musca domestica L.) and pyrethroid resistance.
   Conclusion
   High-level pyrethroid resistance is common in Ae. aegypti from New Mexico and geographic variation in such resistance is likely associated with variation in usage of pyrethroids for vector control. Resistance monitoring and management is recommended in light of the potential for arbovirus outbreaks in this state. Also, alternative approaches to mosquito control that do not involve insecticides should be explored.
C1 [Kandel, Yashoda; Vulcan, Julia; Rodriguez, Stacy D.; Moore, Emily; Chung, Hae-Na; Mitra, Soumi; Cordova, Joel J.; Martinez, Kalli J. L.; Moon, Alex S.; Kulkarni, Aditi; Xu, Jiannong; Hanley, Kathryn A.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Ettestad, Paul; Melman, Sandra] New Mexico Dept Hlth, Santa Fe, NM USA.
   [Buenemann, Michaela] New Mexico State Univ, Dept Geog, Las Cruces, NM 88003 USA.
RP Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
EM immoh@nmsu.edu
RI Xu, Jiannong/N-1583-2019
OI Xu, Jiannong/0000-0001-7332-4370
FU New Mexico Department of Health [17/665.0300.20615]; Regents of New
   Mexico State University, MOA [17/665.0300.20615]; Epidemiology and
   Laboratory Capacity for Infectious Diseases (ELC) continuation grant
   from the Centers of Disease Control and Prevention (CDC) [CK14-1401]
FX This research was funded under a Memorandum of Agreement between the New
   Mexico Department of Health and the Regents of New Mexico State
   University, MOA#: 17/665.0300.20615. Funding was procured by an
   Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)
   continuation grant (section M1, under CK14-1401) from the Centers of
   Disease Control and Prevention (CDC) awarded to the New Mexico
   Department of Health.
CR Alout H, 2016, HEREDITY, V116, P224, DOI 10.1038/hdy.2015.92
   Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Brogdon W, 2010, GUIDELINES EVALUATIN
   Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410
   Carrerwe Y, 2018, J MED ENTOMOLOGY
   Center SE, 2004, CIT GUID PEST US REG
   Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001
   Clements A.N, 1992, BIOL MOSQUITOES
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Chaves LF, 2015, B INSECTOL, V68, P61
   Grossman MK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0022
   Grossman MK, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2865-x
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z
   HEMINGWAY J, 1989, B ENTOMOL RES, V79, P123, DOI 10.1017/S0007485300018630
   Hendrichs J, 2009, ENCY INSECTS, P953
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332
   Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lopez B, 2014, J MED ENTOMOL, V51, P644, DOI 10.1603/ME13185
   Lopez-Monroy B, 2018, PEST MANAGEMENT SCI
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Macoris MD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006390
   Marquardt W. C, 2004, BIOL DIS VECTORS
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Pasteur N, 1999, J MED ENTOMOL, V36, P794, DOI 10.1093/jmedent/36.6.794
   Pittendrigh B, 1997, MOL GEN GENET, V256, P602, DOI 10.1007/s004380050608
   Plernsub S, 2013, TROP BIOMED, V30, P621
   Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2018, SCI REPORTS
   Silver JB., 2007, MOSQUITO ECOLOGY FIE
   Smith LB, 2018, PEST MANAG SCI, V74, P737, DOI 10.1002/ps.4771
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P536
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24
   Vasconcelos PFC, 2018, EMERGENCE CHIKUNGUNY, P215
   Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1
   Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009
   WILLIAMSON MS, 1993, MOL GEN GENET, V240, P17, DOI 10.1007/BF00276878
   Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204
   World Health Organization, 2016, TEST PROC INREMO
   Wu Y, 2001, Afr J Med Med Sci, V30 Suppl, P52
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 68
TC 6
Z9 6
U1 2
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2019
VL 14
IS 2
AR e0212693
DI 10.1371/journal.pone.0212693
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM8DR
UT WOS:000459709100117
PM 30794644
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Carvajal, A
   Medina, J
   Anderson, M
   Nieves, VJ
   Ramirez, M
   Vasquez, C
   Petrie, W
   Cardenas, G
   Beier, JC
AF Wilke, Andre B. B.
   Carvajal, Augusto
   Medina, Johana
   Anderson, Melissa
   Nieves, Veronica J.
   Ramirez, Monica
   Vasquez, Chalmers
   Petrie, William
   Cardenas, Gabriel
   Beier, John C.
TI Assessment of the effectiveness of BG-Sentinel traps baited with CO2 and
   BG-Lure for the surveillance of vector mosquitoes in Miami-Dade County,
   Florida
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS; AEDES-AEGYPTI; DIPTERA-CULICIDAE; TRANSMISSION; DENGUE;
   EFFICACY
AB Vector-borne diseases are an increasing issue to public health, endangering billions of people worldwide. Controlling vector mosquitoes is widely accepted as the most effective way to prevent vector-borne disease outbreaks. Mosquito surveillance is critical for the development of control strategies under the integrated vector management framework. We hypothesize that the effectiveness and reliability of using BG-Sentinel traps for the surveillance strongly depend on the bait used to attract mosquitoes. The objective of this study was to compare the effectiveness of BG-Sentinel traps baited with CO2 and BG-Lure. A total of 72 traps were deployed for 48 hours once a week for four weeks. For the initial 24-hour period, the traps were baited with CO2, and then for an additional 24 hours using the BG-Lure. Collected mosquitoes were analyzed using the Generalized Estimating Equation for repeated measures analysis. Biodiversity was assessed by the Shannon and Simpson indices and by individual rarefaction curves and SHE profiles. A total of 5,154 mosquitoes were collected, from which 3,514 by traps baited with CO2 and 1,640 mosquitoes by traps baited with BG-Lure. Aedes aegypti and Culex quinquefasciatus were the most abundant and dominant species. Results from the Generalized Estimating Equation models indicated that more than twice as many mosquitoes were attracted CO2 than to the BG-Lure. The comparison of attractiveness of CO2 and BG-Lure to Ae. aegypti and Cx. quinquefasciatus was non-significant, suggesting that both species were equally attracted by the baits. The individual rarefaction curves for Ae. aegypti and Cx. quinquefasciatus imply that traps baited with BG-Lure underestimated mosquito species richness compared to those baited with CO2. BG-Lure were less effective in attracting mosquitoes with low abundances and failed to collect Cx. coronator and Cx. nigripalpus, which were consistently collected by traps baited with CO2. According to our results, CO2 significantly (P< 0.05) attracted more mosquitoes (2.67 adjusted odds ratios) than the BG-Lure when adjusted for time and species, being more effective in assessing the relative abundance of vector mosquitoes and yielding more trustworthy results. Traps baited with CO2 collected not only more specimens, but also more species in a more consistent pattern.
C1 [Wilke, Andre B. B.; Cardenas, Gabriel; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Carvajal, Augusto; Medina, Johana; Anderson, Melissa; Nieves, Veronica J.; Ramirez, Monica; Vasquez, Chalmers; Petrie, William] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
RP Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
EM axb1737@med.miami.edu
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU CDC: Southeastern Regional Center of Excellence in Vector-Borne
   Diseases: The Gateway Program [1U01CK000510-01]
FX This research was supported by CDC (https://www.cdc.gov/) grant
   1U01CK000510-01: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: The Gateway Program. CDC had no role in the
   design of the study and collection, analysis, and interpretation of data
   and in writing the manuscript. JCB is the recipient of the grant.
CR Alto BW, 2014, VECTOR-BORNE ZOONOT, V14, P606, DOI 10.1089/vbz.2013.1501
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Buzas MA, 1998, J FORAMIN RES, V28, P233
   Cardoso JD, 2011, J VECTOR ECOL, V36, P175, DOI 10.1111/j.1948-7134.2011.00155.x
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darsie RF Jr, 2000, TECH B FLORIDA MOSQ, V1
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   de Azara TMF, 2013, MEM I OSWALDO CRUZ, V108, P229, DOI 10.1590/0074-0276108022013016
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Li YJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1724-x
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   Ludwig GV, 2002, AM J TROP MED HYG, V67, P67, DOI 10.4269/ajtmh.2002.67.67
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Mcnamara TS, 2014, MICROBIOL SPECTR, V1, P1
   Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155
   Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328
   Paixao ES, 2018, EMERG INFECT DIS, V24, P1748, DOI 10.3201/eid2409.170361
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Pombi M, 2014, PARASITE VECTOR, V7, P1, DOI [10.1186/1756-3305-7-1, DOI 10.1186/1756-3305-7-1]
   Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   Roiz D, 2016, J MED ENTOMOL, V53, P460, DOI 10.1093/jme/tjv184
   Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863
   Stoddard PK, 2018, ACTA TROP, V187, P108, DOI 10.1016/j.actatropica.2018.07.031
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2
   Watts J, 2000, WORLD HLTH, V78, P8
   WHO, 2013, OUTLOOKS PEST MANAG, V24, P142, DOI 10.1564/v24_jun_14
   WHO/UNICEF, 2017, EP UPD YELL FEV, P1
   Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Zannoli S, 2018, CHIKUNGUNYA ZIKA VIR, P193, DOI [10.1016/B978-0-12-811865-8.00006-4, DOI 10.1016/B978-0-12-811865-8.00006-4]
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zinser M, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.20
NR 51
TC 6
Z9 6
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2019
VL 14
IS 2
AR e0212688
DI 10.1371/journal.pone.0212688
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM8DR
UT WOS:000459709100115
PM 30794670
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kustin, T
   Ling, G
   Sharabi, S
   Ram, D
   Friedman, N
   Zuckerman, N
   Bucris, ED
   Glatman-Freedman, A
   Stern, A
   Mandelboim, M
AF Kustin, Talia
   Ling, Guy
   Sharabi, Sivan
   Ram, Daniela
   Friedman, Nehemya
   Zuckerman, Neta
   Bucris, Efrat Dahan
   Glatman-Freedman, Aharona
   Stern, Adi
   Mandelboim, Michal
TI A method to identify respiratory virus infections in clinical samples
   using next-generation sequencing
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PEDIATRIC-PATIENTS; RAPID DETECTION; MULTIPLEX PCR; C VIRUS; ASSAY;
   IDENTIFICATION; QUANTITATION; GENOMES; ZIKA; DNA
AB Respiratory virus infections are very common. Such infections impose an enormous economic burden and occasionally lead to death. Furthermore, every few decades, respiratory virus pandemics emerge, putting the entire world population at risk. Thus, there is an urgent need to quickly and precisely identify the infecting agent in a clinical setting. However, in many patients with influenza-like symptoms (ILS) the identity of the underlying pathogen remains unknown. In addition, it takes time and effort to individually identify the virus responsible for the ILS. Here, we present a new next-generation sequencing (NGS)-based method that enables rapid and robust identification of pathogens in a pool of clinical samples without the need for specific primers. The method is aimed at rapidly uncovering a potentially common pathogen affecting many samples with an unidentified source of disease.
C1 [Kustin, Talia; Ling, Guy; Stern, Adi] Tel Aviv Univ, Sch Mol Cell Biol & Biotechnol, George S Wise Fac Life Sci, Tel Aviv, Israel.
   [Sharabi, Sivan; Ram, Daniela; Friedman, Nehemya; Zuckerman, Neta; Bucris, Efrat Dahan; Mandelboim, Michal] Cha Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel.
   [Sharabi, Sivan; Friedman, Nehemya; Glatman-Freedman, Aharona; Mandelboim, Michal] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel.
   [Glatman-Freedman, Aharona] Israel Minist Hlth, Israel Ctr Dis Control, Tel Hashomer, Israel.
RP Stern, A (corresponding author), Tel Aviv Univ, Sch Mol Cell Biol & Biotechnol, George S Wise Fac Life Sci, Tel Aviv, Israel.; Mandelboim, M (corresponding author), Cha Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel.; Mandelboim, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel.
EM sternadi@post.tau.ac.il; michalman@sheba.health.gov.il
FU Edmond J. Safra Center for Bioinformatics at Tel-Aviv University
FX This study was supported in part by a fellowship from the Edmond J.
   Safra Center for Bioinformatics at Tel-Aviv University [to T.K. and
   G.L.].
CR Aguilar JC, 2000, J CLIN MICROBIOL, V38, P1191, DOI 10.1128/JCM.38.3.1191-1195.2000
   Alarcon B, 2006, J APPL MICROBIOL, V100, P352, DOI 10.1111/j.1365-2672.2005.02768.x
   Bibby K, 2011, LETT APPL MICROBIOL, V52, P386, DOI 10.1111/j.1472-765X.2011.03014.x
   Bronze MS, 2002, AM J MED SCI, V323, P316, DOI 10.1097/00000441-200206000-00004
   Echevarria JE, 1998, J CLIN MICROBIOL, V36, P1388
   Fernandez M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00871
   Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011
   Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11
   Gerna G, 2007, J CLIN VIROL, V38, P244, DOI 10.1016/j.jcv.2006.12.008
   Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382
   Hindiyeh M, 2000, J CLIN VIROL, V17, P119, DOI 10.1016/S1386-6532(00)00081-0
   Hindiyeh M, 2010, J CLIN MICROBIOL, V48, P1884, DOI 10.1128/JCM.02540-09
   Hindiyeh MY, 2008, J CLIN MICROBIOL, V46, P334, DOI 10.1128/JCM.01618-07
   Hino S, 2002, REV MED VIROL, V12, P151, DOI 10.1002/rmv.351
   Hsiao KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149901
   Hu AZ, 2005, J VIROL METHODS, V130, P145, DOI 10.1016/j.jviromet.2005.06.014
   Hu AZ, 2003, J CLIN MICROBIOL, V41, P149, DOI 10.1128/JCM.41.1.149-154.2003
   Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07
   Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292
   Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219
   Pabbaraju K, 2013, INFLUENZA OTHER RESP, V7, P954, DOI 10.1111/irv.12099
   Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785
   Peng YH, 2002, ARCH VIROL, V147, P21, DOI 10.1007/s705-002-8301-7
   Pifferi M, 2006, PEDIATR INFECT DIS J, V25, P804, DOI 10.1097/01.inf.0000232723.58355.f4
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Regev L, 2006, J CLIN MICROBIOL, V44, P1484, DOI 10.1128/JCM.44.4.1484-1489.2006
   Ross AGP, 2015, INT J INFECT DIS, V38, P89, DOI 10.1016/j.ijid.2015.07.016
   Singh AK, 2014, INDIAN J MED MICROBI, V32, P13, DOI 10.4103/0255-0857.124288
   Stralin K, 2005, APMIS, V113, P99, DOI 10.1111/j.1600-0463.2005.apm1130203.x
   Tokita H, 2002, J MED VIROL, V67, P501, DOI 10.1002/jmv.10129
   Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212
   Verstrepen WA, 2001, J CLIN MICROBIOL, V39, P4093, DOI 10.1128/JCM.39.11.4093-4096.2001
   Welfare W, 2016, BRIT J HOSP MED, V77, P704, DOI 10.12968/hmed.2016.77.12.704
   Wong K, 2012, ENVIRON INT, V45, P151, DOI 10.1016/j.envint.2012.02.009
   YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P3768, DOI 10.1128/AEM.61.10.3768-3768.1995
   YOSHINAGA T, 1969, ENDOKRINOLOGIE, V54, P410
   Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 40
TC 4
Z9 4
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 22
PY 2019
VL 9
AR 2606
DI 10.1038/s41598-018-37483-w
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM3UI
UT WOS:000459399400075
PM 30796243
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tong, C
   Javelle, E
   Grard, G
   Dia, A
   Lacrosse, C
   Fourie, T
   Gravier, P
   Watier-Grillot, S
   Lancelot, R
   Letourneur, F
   Comby, F
   Grau, M
   Cassou, L
   Meynard, JB
   Briolant, S
   Leparc-Goffart, I
   De Santi, VP
AF Tong, Christelle
   Javelle, Emilie
   Grard, Gilda
   Dia, Aissata
   Lacrosse, Constance
   Fourie, Toscane
   Gravier, Patrick
   Watier-Grillot, Stephanie
   Lancelot, Renaud
   Letourneur, Franck
   Comby, Frederic
   Grau, Martin
   Cassou, Lionel
   Meynard, Jean-Baptiste
   Briolant, Sebastien
   Leparc-Goffart, Isabelle
   De Santi, Vincent Pommier
TI Tracking Rift Valley fever: From Mali to Europe and other countries,
   2016
SO EUROSURVEILLANCE
LA English
DT Article
ID WHOLE-BLOOD; ZIKA VIRUS; VECTOR; DIPTERA; RNA
AB On 16 September 2016, the World Health Organization confirmed a Rift Valley fever (RVF) outbreak in Niger. Epidemiological surveillance was reinforced among the French Armed Forces deployed in Niger and bordering countries: Chad, Mali and Burkina Faso. On 26 October, a probable case of RVF was reported in a service member sampled in Mali 3 weeks earlier. At the time the result was reported, the patient was on vacation on Martinique. An epidemiological investigation was conducted to confirm this case and identify other cases. Finally, the case was not confirmed, but three suspected cases of RVF were confirmed using serological and molecular testing. RVF viral RNA was detectable in whole blood for 57 and 67 days after onset of symptoms for two cases, although it was absent from plasma and serum. At the time of diagnosis, these cases had already returned from Mali to Europe. The infectivity of other arboviruses in whole blood has already been highlighted. That RVF virus has been detected in whole blood that long after the onset of symptoms (67 days) raises the question of its potential prolonged infectivity. Because of exposure to tropical infectious diseases during deployment, military populations could import emerging pathogens to Europe.
C1 [Tong, Christelle; Dia, Aissata; Lacrosse, Constance; Watier-Grillot, Stephanie; Meynard, Jean-Baptiste; De Santi, Vincent Pommier] French Armed Forces Ctr Epidemiol & Publ Hlth CES, Marseille, France.
   [Javelle, Emilie] Laveran Mil Teaching Hosp, Marseille, France.
   [Grard, Gilda; Fourie, Toscane; Gravier, Patrick; Leparc-Goffart, Isabelle] French Armed Forces Biomed Res Inst IRBA, Natl Reference Ctr Arboviruses, Marseille, France.
   [Grard, Gilda; Fourie, Toscane; Gravier, Patrick; Leparc-Goffart, Isabelle] Aix Marseille Univ, UVE, Inserm 1207, IHU Mediterranee Infect,IRD 190, Marseille, France.
   [Lancelot, Renaud] CIRAD, Anim Hlth Terr Risks & Ecosyst Unit ASTRE, Montpellier, France.
   [Lancelot, Renaud] Univ Montpellier, CIRAD, INRA, UMR ASTRE, Montpellier, France.
   [Letourneur, Franck] French Mil Hlth Serv, Med Unit 7, Lyon, France.
   [Comby, Frederic] French Mil Hlth Serv, Med Unit 10, Laudun, France.
   [Grau, Martin] French Mil Hlth Serv, Med Unit 18, Frejus, France.
   [Cassou, Lionel] French Mil Hlth Serv, Med Unit 11, Toulouse, France.
   [Briolant, Sebastien] French Armed Forces Biomed Res Inst IRBA, Marseille, France.
   [Briolant, Sebastien; De Santi, Vincent Pommier] Aix Marseille Univ, AP HM, IHU Mediterranee Infect, UMR VITROME,IRD,SSA,VITROME, Marseille, France.
RP De Santi, VP (corresponding author), French Armed Forces Ctr Epidemiol & Publ Hlth CES, Marseille, France.; De Santi, VP (corresponding author), Aix Marseille Univ, AP HM, IHU Mediterranee Infect, UMR VITROME,IRD,SSA,VITROME, Marseille, France.
EM v.pommierdesanti@gmail.com
RI de Santi, Vincent Pommier/S-6203-2018
OI de Santi, Vincent Pommier/0000-0001-9971-1133
CR Al-Hazmi M, 2003, CLIN INFECT DIS, V36, P245, DOI 10.1086/345671
   Bird BH, 2007, J CLIN MICROBIOL, V45, P3506, DOI 10.1128/JCM.00936-07
   Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883
   Brustolin M, 2017, MED VET ENTOMOL, V31, P365, DOI 10.1111/mve.12254
   Chevalier V, 2010, EUROSURVEILLANCE, V15, P18
   Chevalier V, 2005, EMERG INFECT DIS, V11, P1693, DOI DOI 10.3201/EID1111.050193
   CURASSON G., 1934, BULL SOC PATH EXOTIQUE, V27, P599
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS OUTBR R
   Food and Agriculture Organization of the United Nations (FAO), 2017, RIFT VALL FEV NIG RI
   Golnar AJ, 2018, TRANSBOUND EMERG DIS, V65, P85, DOI 10.1111/tbed.12608
   Golnar AJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003163
   Grolla A, 2012, J CLIN VIROL, V54, P313, DOI 10.1016/j.jcv.2012.04.022
   Haneche F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.18.30222
   Hassan OA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001229
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434
   Lord CC, 2006, J MED ENTOMOL, V43, P623, DOI 10.1603/0022-2585(2006)43[623:RBHVAV]2.0.CO;2
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020
   MCINTOSH BM, 1980, S AFR MED J, V58, P803
   MEEGAN JM, 1979, VET REC, V105, P124, DOI 10.1136/vr.105.6.124
   Meegan JM, 1981, CONTRIB EPIDEMIOL BI, V3, P114
   Michel R, 2014, TRAVEL MED INFECT DI, V12, P330, DOI 10.1016/j.tmaid.2014.07.001
   Mondet B, 2005, J VECTOR ECOL, V30, P102
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nicholas DE, 2014, TROP MED INT HEALTH, V19, P1420, DOI 10.1111/tmi.12385
   Njenga MK, 2009, J CLIN MICROBIOL, V47, P1166, DOI 10.1128/JCM.01905-08
   Peyrefitte CN, 2005, EMERG INFECT DIS, V11, P757, DOI 10.3201/eid1105.040959
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   RIOU O, 1989, B SOC PATHOL EXOT, V82, P605
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Subudhi S, 2018, AM J TROP MED HYG, V98, P872, DOI 10.4269/ajtmh.17-0841
   United Nations Multidimensional Integrated Stabilization Mission, MINUSMAS PERS
   World Health Organization, 2017, WEEKL B OUTBR OTH EM
   World Health Organization Regional Office for Africa (WHO/Africa), 2017, NIAM REV APR ACT EP
   World Health Organization (WHO), 2016, RIFT VALL FEV NIG DI
   World Organisation for Animal Health (OIE), 2016, OIE TERR MAN 2016
NR 38
TC 2
Z9 2
U1 2
U2 5
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 21
PY 2019
VL 24
IS 8
BP 26
EP 34
DI 10.2807/1560-7917.ES.2019.24.8.1800213
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA HM2YQ
UT WOS:000459337900004
PM 30808441
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gallivan, M
   Oppenheim, B
   Madhav, NK
AF Gallivan, Mark
   Oppenheim, Ben
   Madhav, Nita K.
TI Using social media to estimate Zika's impact on tourism: #babymoon,
   2014-2017
SO PLOS ONE
LA English
DT Article
ID VIRUS; TRANSMISSION; EPIDEMIOLOGY; KNOWLEDGE; WOMEN
AB Zika virus infection during pregnancy can cause microcephaly and other birth defects. We hypothesized that the Latin America Zika epidemic resulted in pregnant women and their partners adopting behavioral changes to limit risk, leading them to forego travel to Zika-affected locations. We evaluated this hypothesis by studying travelers' intent and behavior through Twitter data related to babymoon: a holiday taken by parents-to-be before their baby is born. We found the odds of mentioning representative Zika-affected locations in #babymoon tweets dropped significantly (Odds ratio: 0.29, 95% CI: 0.20-0.40) after the Zika-microcephaly association became well-known. This result was further corroborated through a content analysis of #babymoon tweets mentioning Zika-affected locations, which identified if the Twitter user was physically present in the Zika-affected locations. Conversely, we found a small but statistically insignificant increase in the odds of mentioning Zika-free locations from #babymoon tweets (Odds Ratio: 1.11, 95% CI: 0.97-1.27) after the Zika-microcephaly association became well-known.
C1 [Gallivan, Mark; Oppenheim, Ben; Madhav, Nita K.] Metabiota Inc, San Francisco, CA 94104 USA.
RP Gallivan, M (corresponding author), Metabiota Inc, San Francisco, CA 94104 USA.
EM mgallivan@metabiota.com
RI Madhav, Nita K/J-1343-2018
CR Cervellin G, 2017, J EPIDEMIOL GLOB HEA, V7, P185, DOI 10.1016/j.jegh.2017.06.001
   comScore, 2015, COMSCORE REL JUL 201
   Curry CL, 2018, J OBSTET GYNAECOL RE, V44, P503, DOI 10.1111/jog.13533
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Google, 2018, BABYM GOOGL TRENDS
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583
   Pan American Health Organization; World Health Organization, 2018, ZIK CAS CONG SYNDR A
   R CT, 2017, R LANG ENV STAT COMP
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616
   Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001
   Tataryn J, 2018, Can Commun Dis Rep, V44, P18, DOI 10.14745/ccdr.v44i01a05
   U. S. Department of Commerce International Trade Administration National Travel and Tourism Office (NTTO), 2017, MONTHL DEP INT DEST
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   WHO, WHO MICR BRAZ
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 0
Z9 0
U1 3
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 21
PY 2019
VL 14
IS 2
AR e0212507
DI 10.1371/journal.pone.0212507
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM2WC
UT WOS:000459330800032
PM 30789944
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kikuchi, N
   Reed, A
   Gerasimova, YV
   Kolpashchikov, DM
AF Kikuchi, Nanami
   Reed, Adam
   Gerasimova, Yulia V.
   Kolpashchikov, Dmitry M.
TI Split Dapoxyl Aptamer for Sequence-Selective Analysis of Nucleic Acid
   Sequence Based Amplification Amplicons
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID FLUORESCENT MOLECULAR PROBES; SPINACH APTAMER; VIRUS-RNA; DNA; BEACONS;
   TECHNOLOGIES; FLUOROPHORE; DIAGNOSIS; ASSAY; GENE
AB Hybridization probes have been used for the detection of single nucleotide variations (SNV) in DNA and RNA sequences in the mix-and-read formats. Among the most conventional are Taqman probes, which require expensive quantitative polymerase chain reaction (qPCR) instruments with melting capabilities. More affordable isothermal amplification format requires hybridization probes that can selectively detect SNVs isothermally. Here we designed a split DNA aptamer (SDA) hybridization probe based on a recently reported DNA sequence that binds a dapoxyl dye and increases its fluorescence (Kato, T.; Shimada, I.; Kimura, R.; Hyuga, M., Light-up fluorophore-DNA aptamer pair for label-free turn-on aptamer sensors. Chem. Commun. 2016,.52, 4041-4044). SDA uses two DNA strands that have low affinity to the dapoxyl dye unless hybridized to abutting positions at a specific analyte and form a dye-binding site, which is accompanied by up to a 120-fold increase in fluorescence. SDA differentiates SNV in the inhA gene of Mycobacterium tuberculosis at ambient temperatures and detects a conserved region of the Zika virus after isothermal nucleic acid sequence based amplification (NASBA) reaction. The approach reported here can be used for detection of isothermal amplification products in the mix-and-read format as an alternative to qPCR.
C1 [Kikuchi, Nanami; Reed, Adam; Gerasimova, Yulia V.; Kolpashchikov, Dmitry M.] Univ Cent Florida, Chem Dept, 4111 Libra Dr, Orlando, FL 32816 USA.
   [Kolpashchikov, Dmitry M.] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.
RP Gerasimova, YV; Kolpashchikov, DM (corresponding author), Univ Cent Florida, Chem Dept, 4111 Libra Dr, Orlando, FL 32816 USA.; Kolpashchikov, DM (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.
EM Yulia.Gerasimova@ucf.edu; dmitry.kolpashchikov@ucf.edu
RI Kolpashchikov, Dmitry/AAO-2777-2020; Kolpashchuikov, Dmitry
   M./AAE-2085-2019
OI Gerasimova, Yulia/0000-0001-8804-9770
FU Florida Department of Health, Biomedical Research Program [7ZK33];
   NSFNational Science Foundation (NSF) [CBET 1706802, R21AI123876]
FX We thank Dr. Hyeryun Choe from the Department of Immunology and
   Microbiology, Scripps Research Institute, for providing Zika virus RNA.
   This work was supported by the Florida Department of Health, Biomedical
   Research Program (Grant 7ZK33) to Y.V.G. Funding from NSF Grants CBET
   1706802 and R21AI123876 that support studies for D.M.K. and Y.V.G.,
   respectively, are greatly appreciated.
CR Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a
   Bengtson HN, 2014, CHEMBIOCHEM, V15, P228, DOI 10.1002/cbic.201300657
   Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141
   Callison SA, 2006, J VIROL METHODS, V138, P60, DOI 10.1016/j.jviromet.2006.07.018
   Compton, 1991, J NATURE, V350, P91
   Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]
   Diwu Z, 1997, PHOTOCHEM PHOTOBIOL, V66, P424, DOI 10.1111/j.1751-1097.1997.tb03168.x
   Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135
   Juskowiak B, 2011, ANAL BIOANAL CHEM, V399, P3157, DOI 10.1007/s00216-010-4304-5
   Juul S, 2015, NANOSCALE, V7, P8332, DOI 10.1039/c5nr01705j
   Kato T, 2016, CHEM COMMUN, V52, P4041, DOI 10.1039/c5cc08816j
   KIEVITS T, 1991, J VIROL METHODS, V35, P273, DOI 10.1016/0166-0934(91)90069-C
   Kikuchi N, 2017, CHEM COMMUN, V53, P4977, DOI 10.1039/c7cc01540b
   Kikuchi N, 2016, CHEMBIOCHEM, V17, P1589, DOI 10.1002/cbic.201600323
   Kolpashchikov D.M., 2012, SCIENTIFICA, V2012, P17
   Kolpashchikov DM, 2005, J AM CHEM SOC, V127, P12442, DOI 10.1021/ja0529788
   Kolpashchikov DM, 2010, CHEM REV, V110, P4709, DOI 10.1021/cr900323b
   Lake A, 2010, ANGEW CHEM INT EDIT, V49, P4459, DOI 10.1002/anie.200907135
   Ma YL, 2018, ANAL CHEM, V90, P6532, DOI 10.1021/acs.analchem.8b00058
   Mader A, 2010, ANAL BIOANAL CHEM, V397, P3533, DOI 10.1007/s00216-010-3892-4
   Marras SAE, 2006, CLIN CHIM ACTA, V363, P48, DOI 10.1016/j.cccn.2005.04.037
   Moody A, 2000, J VIROL METHODS, V85, P55, DOI 10.1016/S0166-0934(99)00156-1
   Morris T, 1996, J CLIN MICROBIOL, V34, P2933, DOI 10.1128/JCM.34.12.2933-2936.1996
   Nguyen C, 2011, CHEM-EUR J, V17, P13052, DOI 10.1002/chem.201101987
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   Orlando C, 1998, CLIN CHEM LAB MED, V36, P255, DOI 10.1515/CCLM.1998.045
   Pafida M., 2008, REV MED VIROL, V18, P407
   Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413
   Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306
   Reinholt SJ, 2014, ANAL CHEM, V86, P849, DOI 10.1021/ac403417z
   Sando S, 2007, CHEMBIOCHEM, V8, P1795, DOI 10.1002/cbic.200700325
   Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083
   Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13
   Suzuki Y, 2015, BIOSENSORS-BASEL, V5, P337, DOI 10.3390/bios5020337
   Tan XH, 2014, ANAL CHEM, V86, P10864, DOI 10.1021/ac502986g
   Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303
   Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236
   Xiao Y, 2004, J AM CHEM SOC, V126, P7430, DOI 10.1021/ja031875r
   ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0
   Zhao XY, 2012, ANAL CHEM, V84, P8541, DOI 10.1021/ac3020609
NR 40
TC 7
Z9 7
U1 11
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD FEB 19
PY 2019
VL 91
IS 4
BP 2667
EP 2671
DI 10.1021/acs.analchem.8b03964
PG 5
WC Chemistry, Analytical
SC Chemistry
GA HM7FE
UT WOS:000459642400017
PM 30680988
DA 2020-07-08
ER

PT J
AU Richter, M
   Boldescu, V
   Graf, D
   Streicher, F
   Dimoglo, A
   Bartenschlager, R
   Klein, CD
AF Richter, Michael
   Boldescu, Veaceslav
   Graf, Dominik
   Streicher, Felix
   Dimoglo, Anatoli
   Bartenschlager, Ralf
   Klein, Christian D.
TI Synthesis, Biological Evaluation, and Molecular Docking of
   Combretastatin and Colchicine Derivatives and their hCE1-Activated
   Prodrugs as Antiviral Agents
SO CHEMMEDCHEM
LA English
DT Article
DE antiviral agents; colchicine; combretastatin; dengue; prodrugs; tubulin
   ligands; Zika
ID DENGUE-VIRUS; MOSQUITO CELLS; BINDING-SITE; TUBULIN; INHIBITORS;
   COMPLEX; CYTOTOXICITY; MACROPHAGES; INFECTION; INSIGHT
AB Recent studies indicate that tubulin can be a host factor for vector-borne flaviviruses like dengue (DENV) and Zika (ZIKV), and inhibitors of tubulin polymerization such as colchicine have been demonstrated to decrease virus replication. However, toxicity limits the application of these compounds. Herein we report prodrugs based on combretastatin and colchicine derivatives that contain an ester cleavage site for human carboxylesterase, a highly abundant enzyme in monocytes and hepatocytes targeted by DENV. Relative to their parent compounds, the cytotoxicity of these prodrugs was reduced by several orders of magnitude. All synthesized prodrugs containing a leucine ester were hydrolyzed by the esterase in vitro. In contrast to previous reports, the phenylglycine esters were not cleaved by human carboxylesterase. The antiviral activity of combretastatin, colchicine, and selected prodrugs against DENV and ZIKV in cell culture was observed at low micromolar and sub-micromolar concentrations. In addition, docking studies were performed to understand the binding mode of the studied compounds to tubulin.
C1 [Richter, Michael; Boldescu, Veaceslav; Graf, Dominik; Streicher, Felix; Klein, Christian D.] Heidelberg Univ, Inst Pharm & Mol Biotechnol, INF 364, D-69120 Heidelberg, Germany.
   [Dimoglo, Anatoli] Duzce Univ, Fac Engn, Duzce, Turkey.
   [Bartenschlager, Ralf] Heidelberg Univ, Mol Virol, Dept Infect Dis, INF 344, D-69120 Heidelberg, Germany.
   [Bartenschlager, Ralf] German Ctr Infect Res, Heidelberg Partner Site, Heidelberg, Germany.
   [Boldescu, Veaceslav] Moldova Acad Sci, Lab Organ Synth & Biopharmaceut, Inst Chem, Acad Str 3, MD-2028 Kishinev, Moldova.
RP Klein, CD (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, INF 364, D-69120 Heidelberg, Germany.
EM c.klein@uni-heidelberg.de
RI ; Bartenschlager, Ralf/L-2582-2015
OI Klein, Christian/0000-0003-3522-9182; Streicher,
   Felix/0000-0002-8375-2958; Richter, Michael/0000-0002-8227-0543;
   Bartenschlager, Ralf/0000-0001-5601-9307
FU Alexander vonHumboldt FoundationAlexander von Humboldt Foundation
FX V.B. is grateful for generous funding under the Georg Forster Research
   Fellowship received from the Alexander vonHumboldt Foundation. The
   authors acknowledge the technical assistance of Stephanie Kallis for the
   ZIKV antiviral assay, Natascha Stefan for the help in cell culture, and
   Heiko Rudy for the mass spectrometry data. M.R. thanks Torben
   LangHeinrich for his assistance in the synthesis of compound 9 a.
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Ahmed RI, 2017, J ENZYM INHIB MED CH, V32, P176, DOI 10.1080/14756366.2016.1244532
   Aly OM, 2014, ARCH PHARM, V347, P658, DOI 10.1002/ardp.201400096
   Baguley BC, 1997, ONCOL RES, V9, P55
   Baytas SN, 2014, BIOORGAN MED CHEM, V22, P3096, DOI 10.1016/j.bmc.2014.04.027
   Bencharit S, 2006, J MOL BIOL, V363, P201, DOI 10.1016/j.jmb.2006.08.025
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Boldescu V, 2013, CHEM J MOLD, V8, P21, DOI 10.19261/cjm.2013.08(2).02
   Charlton M. H., 2014, US Pat., Patent No. [US20140010762A1, 20140010762]
   Chee HY, 2004, BIOCHEM BIOPH RES CO, V320, P11, DOI 10.1016/j.bbrc.2004.05.124
   Chen W, 2008, ARCH VIROL, V153, P1777, DOI 10.1007/s00705-008-0183-x
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Da CX, 2013, J MED CHEM, V56, P7382, DOI 10.1021/jm400954h
   Esbolaev E. O., 1989, CHEM NAT COMPD, V25, P80
   Farce A, 2004, J ENZYM INHIB MED CH, V19, P541, DOI 10.1080/14756360612331280545
   Foo K. Y, 2015, BIOMED RES INT, V2015, P1
   Fournier-Dit-Chabert J, 2012, BIOORG MED CHEM LETT, V22, P7693, DOI 10.1016/j.bmcl.2012.09.104
   Fukami T, 2015, EUR J PHARM SCI, V78, P47, DOI 10.1016/j.ejps.2015.07.006
   Garazd YL, 2015, CHEM NAT COMPD+, V51, P1138, DOI 10.1007/s10600-015-1510-6
   Gaspari R, 2017, CHEM-US, V2, P102, DOI 10.1016/j.chempr.2016.12.005
   Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3
   Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412
   Huczynski A, 2015, EUR J MED CHEM, V90, P296, DOI 10.1016/j.ejmech.2014.11.037
   Jaroch K, 2016, PHARMACOL REP, V68, P1266, DOI 10.1016/j.pharep.2016.08.007
   Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162
   Kumbhar BV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156048
   Laizure SC, 2013, PHARMACOTHERAPY, V33, P210, DOI 10.1002/phar.1194
   Li DD, 2015, CHEM BIOL DRUG DES, V86, P731, DOI 10.1111/cbdd.12545
   Liang C, 2017, TETRAHEDRON LETT, V58, P2325, DOI 10.1016/j.tetlet.2017.04.047
   MACRAE WD, 1989, PLANTA MED, P531, DOI 10.1055/s-2006-962087
   Malysheva YB, 2012, BIOORGAN MED CHEM, V20, P4271, DOI 10.1016/j.bmc.2012.05.072
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Massarotti A, 2012, CHEMMEDCHEM, V7, P33, DOI 10.1002/cmdc.201100361
   Medarde M, 2004, J ENZYM INHIB MED CH, V19, P521, DOI 10.1080/14756360412331280473
   Mikstacka R, 2013, CELL MOL BIOL LETT, V18, P368, DOI 10.2478/s11658-013-0094-z
   Mphahlele MJ, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020059
   Needham LA, 2011, J PHARMACOL EXP THER, V339, P132, DOI 10.1124/jpet.111.183640
   Niu MM, 2014, ACTA PHARMACOL SIN, V35, P967, DOI 10.1038/aps.2014.34
   Paingankar MS, 2010, ARCH VIROL, V155, P1453, DOI 10.1007/s00705-010-0728-7
   Prota AE, 2014, J MOL BIOL, V426, P1848, DOI 10.1016/j.jmb.2014.02.005
   Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393
   ROSNER M, 1981, J MED CHEM, V24, P257
   SATAKE M, 1982, J GEN VIROL, V58, P339, DOI 10.1099/0022-1317-58-2-339
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   TANGWAI DF, 1993, BIOCHEMISTRY-US, V32, P6470, DOI 10.1021/bi00076a022
   Thayan R, 2009, SE ASIAN J TROP MED, V40, P56
   Tron GC, 2006, J MED CHEM, V49, P3033, DOI 10.1021/jm0512903
   VANDECANDELAERE A, 1994, BIOCHEMISTRY-US, V33, P2792, DOI 10.1021/bi00176a007
   Wang YX, 2016, FEBS J, V283, P102, DOI 10.1111/febs.13555
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WOODS JA, 1995, BRIT J CANCER, V71, P705, DOI 10.1038/bjc.1995.138
   Yadava U, 2017, RSC ADV, V7, P15917, DOI 10.1039/c7ra00370f
   Yasobu N, 2011, ACS MED CHEM LETT, V2, P348, DOI 10.1021/ml100287y
   Zayed MF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061731
NR 57
TC 3
Z9 3
U1 2
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1860-7179
EI 1860-7187
J9 CHEMMEDCHEM
JI ChemMedChem
PD FEB 19
PY 2019
VL 14
IS 4
BP 469
EP 483
DI 10.1002/cmdc.201800641
PG 15
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HL7PJ
UT WOS:000458933200005
PM 30605241
OA Bronze
DA 2020-07-08
ER

PT J
AU Sampieri, CL
   Montero, H
AF Luz Sampieri, Clara
   Montero, Hilda
TI Breastfeeding in the time of Zika: a systematic literature review
SO PEERJ
LA English
DT Review
DE Human-milk; Zika; Transmission; Nursing mother; Human lactation
ID VIRUS-INFECTION; FRENCH-POLYNESIA; TRANSMISSION; DIPTERA; HISTORY
AB Background. The disease Zika is considered as emergent. The infection can be acquired through different routes: a bite from the Aedes mosquito, sexual contact, from mother to child during pregnancy and by blood transfusion. The possibility of Zika transmission through human lactation has been considered. Zika is a disease of great concern for public health because it has been associated with neonatal and postnatal microcephaly, among other birth defects.
   Objectives. To review published evidence of the probable transmission of Zika through human lactation.
   Data sources. Electronic databases: Cochrane Central Register of Controlled Trials, EBSCO, Gale, Science Direct, Scopus, US National Library of Medicine (PubMed) and Web of Science. World Health Organization and Centers for Disease Control and Prevention web pages.
   Study eligibility criteria. To be eligible, studies of any design had to provide primary data of human breast milk as a potential fluid for the transmission of Zika, or primary or secondary follow-up data of infants with at least one previous published study that complied with the first criterion of eligibility.
   Participants. Studies about women with suspected, probable or confirmed Zika during pregnancy, or the postnatal period and beyond. Studies about infants who breastfeed directly from the breast or where fed with the expressed breast milk of the suspected, probable or confirmed women with Zika.
   Results. This study only chose data from research papers; no patients were taken directly by the authors. A total of 1,146 were screened and nine studies were included in the qualitative synthesis, from which a total of 10 cases were identified, with documented follow-up in three of these cases. Through the timing of maternal Zika infection, five cases were classified as prenatal (time before delivery), one as immediate postnatal (period from 0 to 4 days after birth); no cases were classified as medium postnatal (period from 5 days to 8 weeks after birth); two were classified as long postnatal (period from 8 weeks to 6 months after birth) and two as beyond six months after birth.
   Conclusion. Human milk may be considered as a potentially infectious fluid, but we found no currently documented studies of the long-term complications in infants up to 32 months of age, with suspected, probable or confirmed Zika through human lactation, or evidence with respect to the human pathophysiology of the infection acquired through human lactation. In the light of the studies reviewed here, the World Health Organization recommendation of June 29th 2016, remains valid: "the benefits of breastfeeding for the infant and mother outweigh any potential risk of Zika virus transmission through breast milk.''
C1 [Luz Sampieri, Clara; Montero, Hilda] Univ Veracruzana, Inst Salud Publ, Xalapa, Veracruz, Mexico.
RP Sampieri, CL (corresponding author), Univ Veracruzana, Inst Salud Publ, Xalapa, Veracruz, Mexico.
EM csampieri@uv.mx
FU Instituto de Salud Publica, Universidad Veracruzana (POA 2018);
   Direccion General de Desarrollo Academico e Innovacion Educativa,
   Universidad Veracruzana (POA 2019)
FX This work was supported by Instituto de Salud Publica, Universidad
   Veracruzana (POA 2018) and Direccion General de Desarrollo Academico e
   Innovacion Educativa, Universidad Veracruzana (POA 2019). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Besnard M, 2014, EURO SURVEILL, V19
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Blohm GM, 2017, GENOME ANNOUNCEMENTS, V5
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Centers for Disease Control and Prevention, 2018, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention, 2018, KEY MESS ZIK VIR DIS
   Centers for Disease Control and Prevention, 2018, ZIK VIR PREV TRANSM
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Chow-Shaffer E, 2000, J MED ENTOMOL, V37, P492, DOI 10.1603/0022-2585-37.4.492
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Desclaux A, 2018, NEW ENGL J MED, V378, P1458, DOI 10.1056/NEJMc1710453
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Giovanetti M, 2018, CLIN MICROBIOL INFEC, V24, P1111, DOI 10.1016/j.cmi.2018.06.008
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017
   Hagmann SHF, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0584-7
   Hassiotou F, 2015, ADV NUTR, V6, P267, DOI 10.3945/an.114.007377
   Hassiotou F, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.1
   Johnson PI, 2016, ENVIRON INT, V92-93, P716, DOI 10.1016/j.envint.2016.03.009
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Labbok MH, 2012, BREASTFEED MED, V7, P397, DOI 10.1089/bfm.2012.9975
   Lactation Education Accreditation and Approval Review Committee (LEAARC), 2018, LEAARC HOM
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Marinho RA, 2016, J VECTOR ECOL, V41, P1, DOI 10.1111/jvec.12187
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Tsai PJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2606-6
   United States Lactation Consultant Association (USLCA), 2018, FIND IBCLC
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, INF FEED AR ZIK VIR
NR 49
TC 1
Z9 1
U1 0
U2 3
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD FEB 19
PY 2019
VL 7
AR e6452
DI 10.7717/peerj.6452
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HL9WG
UT WOS:000459092700011
PM 30809448
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moriyama, M
   Ichinohe, T
AF Moriyama, Miyu
   Ichinohe, Takeshi
TI High ambient temperature dampens adaptive immune responses to influenza
   A virus infection
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE global warming; vector-borne diseases; immunity to viral infection;
   autophagy; inflammasomes
ID PATTERN-RECOGNITION RECEPTORS; COMMON COLD VIRUS; RIG-I; INFLAMMASOME
   ACTIVATION; ANTIVIRAL RESPONSES; INNATE IMMUNITY; RNA; DEFENSE;
   AUTOPHAGY
AB Although climate change may expand the geographical distribution of several vector-borne diseases, the effects of environmental temperature in host defense to viral infection in vivo are unknown. Here, we demonstrate that exposure of mice to the high ambient temperature of 36 degrees C impaired adaptive immune responses against infection with viral pathogens, influenza, Zika, and severe fever with thrombocytopenia syndrome phlebovirus. Following influenza virus infection, the high heat-exposed mice failed to stimulate inflammasome-dependent cytokine secretion and respiratory dendritic cell migration to lymph nodes. Although commensal microbiota composition remained intact, the high heat-exposed mice decreased their food intake and increased autophagy in lung tissue. Induction of autophagy in room temperature-exposed mice severely impaired virus-specific CD8 T cells and antibody responses following respiratory influenza virus infection. In addition, we found that administration of glucose or dietary short-chain fatty acids restored influenza virus-specific adaptive immune responses in high heat-exposed mice. These findings uncover an unexpected mechanism by which ambient temperature and nutritional status control virus-specific adaptive immune responses.
C1 [Moriyama, Miyu; Ichinohe, Takeshi] Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Int Res Ctr Infect Dis,Div Viral Infect,Minato Ku, Tokyo 1088639, Japan.
RP Ichinohe, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Int Res Ctr Infect Dis,Div Viral Infect,Minato Ku, Tokyo 1088639, Japan.
EM ichinohe@ims.u-tokyo.ac.jp
OI Moriyama, Miyu/0000-0003-0310-9047; Ichinohe,
   Takeshi/0000-0002-6376-2841
FU Japan Society for the Promotion of ScienceMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [25713018, 16H05193]; Japan Agency for Medical
   Research and DevelopmentJapan Agency for Medical Research and
   Development (AMED)
FX We thank A. Iwasaki (Yale University) for helpful discussions and
   comments on the manuscript, Y. Kawaoka (University of Wisconsin and The
   University of Tokyo) for providing the plasmids for reverse genetics,
   and T. Taniguchi (The University of Tokyo) for OT-I mice. This work was
   supported by the Japan Society for the Promotion of Science
   Grants-in-Aid for Scientific Research (25713018, 16H05193) and the
   Research Program on Emerging and Re-emerging Infectious Diseases, of the
   Japan Agency for Medical Research and Development. M.M. is a research
   fellow of the Japan Society for the Promotion of Science.
CR Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011
   Bajwa G, 2016, J IMMUNOL, V196, P2004, DOI 10.4049/jimmunol.1501557
   Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363
   Boonarkart C, 2017, ARCH VIROL, V162, P2231, DOI 10.1007/s00705-017-3334-0
   Chen M, 2014, NAT MED, V20, P507, DOI 10.1038/nm.3521
   Cheng M, 2014, CANCER RES, V74, P4030, DOI 10.1158/0008-5472.CAN-13-2462
   Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004
   Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616
   Feng SY, 2018, J MOL BIOL, V430, P3068, DOI 10.1016/j.jmb.2018.07.002
   Foxman EF, 2016, P NATL ACAD SCI USA, V113, P8496, DOI 10.1073/pnas.1601942113
   Foxman EF, 2015, P NATL ACAD SCI USA, V112, P827, DOI 10.1073/pnas.1411030112
   Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911
   Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505
   Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861
   Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006
   Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151
   Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Pang IK, 2013, NAT IMMUNOL, V14, P246, DOI 10.1038/ni.2514
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Ravussin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085876
   Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020
   Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336
   Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054
   Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022
   Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8
   Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007
   Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026
   Weber M, 2013, CELL HOST MICROBE, V13, P336, DOI 10.1016/j.chom.2013.01.012
   Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057
NR 37
TC 6
Z9 6
U1 1
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 19
PY 2019
VL 116
IS 8
BP 3118
EP 3125
DI 10.1073/pnas.1815029116
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HL9PH
UT WOS:000459074400052
PM 30718396
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Khairallah, M
   Mahendradas, P
   Curi, A
   Khochtali, S
   Cunningham, ET
AF Khairallah, Moncef
   Mahendradas, Padmamalini
   Curi, Andre
   Khochtali, Sana
   Cunningham, Emmett T., Jr.
TI Emerging Viral Infections Causing Anterior Uveitis
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Review
DE Arbovirus infection; anterior; uveitis; viral ocular infection; viruses
ID RIFT-VALLEY FEVER; VIRUS TYPE-I; INTRAOCULAR ANTIBODY-PRODUCTION; ZIKA
   VIRUS; CHIKUNGUNYA VIRUS; OCULAR MANIFESTATIONS; HUMAN-HERPESVIRUS;
   DENGUE-FEVER; CHORIORETINAL LESIONS; PARVOVIRUS B19
AB Purpose: To review the systemic and ocular manifestations of specific emergent viral infectious diseases relevant to the ophthalmologist with particular emphasis on anterior uveitis Methods: Review of literature. Results: Arboviral diseases are among the most important emergent and resurgent human infections, occurring mostly in tropical and subtropical zones, but appearing in virtually all regions of the world as a result of climate change, travel, and globalization. Arboviral infections are transmitted to humans by the bite of hematophagous arthropods, mainly mosquitoes. Systemic disease may range from asymptomatic to life-threatening. A wide variety of ocular manifestations, including uveitis, has been reported in association with these emerging viral diseases. Numerous viruses other than arboviruses also have been recently recognized as a potential cause of uveitis. Conclusions: Proper clinical diagnosis of any emerging infectious disease is based on epidemiological data, history, systemic symptoms and signs, and the pattern of ocular involvement. The diagnosis is usually confirmed by detection of virus-specific DNA or antivirus antibodies in serum.
C1 [Khairallah, Moncef; Khochtali, Sana] Univ Monastir, Fac Med, Fattouma Bourguiba Univ Hosp, Dept Ophthalmol, Monastir, Tunisia.
   [Mahendradas, Padmamalini] Narayana Nethralaya, Dept Uveitis & Ocular Immunol, Bangalore, Karnataka, India.
   [Curi, Andre] Fundacao Oswaldo Cruz, Natl Inst Infect Dis, Res Lab Infect Dis, Rio De Janeiro, Brazil.
   [Cunningham, Emmett T., Jr.] Calif Pacific Med Ctr, Dept Ophthalmol, San Francisco, CA USA.
   [Cunningham, Emmett T., Jr.] Stanford Univ, Sch Med, Dept Ophthalmol, Stanford, CA 94305 USA.
   [Cunningham, Emmett T., Jr.] UCSF Sch Med, Francis I Proctor Fdn, San Francisco, CA USA.
RP Khairallah, M (corresponding author), Univ Monastir, Fac Med, Fattouma Bourguiba Univ Hosp, Dept Ophthalmol, Monastir, Tunisia.
EM moncef.khairallah@yahoo.fr
CR Al-Hazmi A, 2005, OPHTHALMOLOGY, V112, P313, DOI 10.1016/j.ophtha.2004.09.018
   Al-Hazmi M, 2003, CLIN INFECT DIS, V36, P245, DOI 10.1086/345671
   Anninger WV, 2003, AM J OPHTHALMOL, V136, P1183, DOI 10.1016/S0002-9394(03)00738-4
   Babu K, 2012, INDIAN J OPHTHALMOL, V60, P73, DOI 10.4103/0301-4738.90495
   Bacsal KE, 2007, ARCH OPHTHALMOL-CHIC, V125, P501, DOI 10.1001/archopht.125.4.501
   Bains HS, 2003, ARCH OPHTHALMOL-CHIC, V121, P205, DOI 10.1001/archopht.121.2.205
   CALISHER CH, 1980, INTERVIROLOGY, V14, P229, DOI 10.1159/000149190
   Cesarman E, 1997, SEMIN DIAGN PATHOL, V14, P54
   Chan CK, 2006, OPHTHALMOLOGY, V113, P1539, DOI 10.1016/j.ophtha.2006.04.021
   Chanana B, 2007, EYE, V21, P1020, DOI 10.1038/sj.eye.6702863
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879
   Chee S-P, 2009, UVEITIS TEXT IMAGING, P699
   Cohen JI, 2010, J MED VIROL, V82, P996, DOI 10.1002/jmv.21751
   Connors Daniel B, 2015, Int Ophthalmol Clin, V55, P103, DOI 10.1097/IIO.0000000000000068
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   de Groot-Mijnes JDF, 2015, OPHTHALMOLOGY, V122, P1270, DOI 10.1016/j.ophtha.2015.01.006
   de Groot-Mijnes JDF, 2010, AM J OPHTHALMOL, V150, P628, DOI 10.1016/j.ajo.2010.05.015
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DEBOER JH, 1993, BRIT J OPHTHALMOL, V77, P829, DOI 10.1136/bjo.77.12.829
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dunn JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.DMIH2-0006-2015
   Elwan MS, 1997, ANN SAUDI MED, V17, P377, DOI 10.5144/0256-4947.1997.377
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   FRENKEL N, 1990, P NATL ACAD SCI USA, V87, P748, DOI 10.1073/pnas.87.2.748
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garg S, 2005, SURV OPHTHALMOL, V50, P3, DOI 10.1016/j.survophthal.2004.10.001
   GESSAIN A, 1985, LANCET, V2, P407
   Goldhardt R, 2016, OCUL IMMUNOL INFLAMM, V24, P610, DOI 10.3109/09273948.2015.1125513
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gyure KA, 2009, J NEUROPATH EXP NEUR, V68, P1053, DOI 10.1097/NEN.0b013e3181b88114
   Halstead S B, 1990, Southeast Asian J Trop Med Public Health, V21, P636
   Heinz C, 2005, GRAEF ARCH CLIN EXP, V243, P999, DOI 10.1007/s00417-005-1178-x
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Hershberger VS, 2003, OPHTHALMOLOGY, V110, P1732, DOI 10.1016/S0161-6420(03)00720-6
   Ikeda Eiko, 1998, Nippon Ganka Gakkai Zasshi, V102, P327
   Inoue T, 2011, ARCH OPHTHALMOL-CHIC, V129, P1629, DOI 10.1001/archophthalmol.2011.346
   Kaiser PK, 2003, AM J OPHTHALMOL, V136, P928, DOI 10.1016/S0002-9394(03)00866-3
   Kamoi K, 2012, CURR OPIN OPHTHALMOL, V23, P557, DOI 10.1097/ICU.0b013e328358b9ec
   Kapoor HK, 2006, CAN J OPHTHALMOL, V41, P741, DOI 10.1139/I06-069
   Khairallah M, 2007, EYE, V21, P952, DOI 10.1038/sj.eye.6702355
   Khairallah M, 2006, OPHTHAL SURG LAS IM, V37, P240, DOI 10.3928/15428877-20060501-11
   Khairallah M, 2004, OPHTHALMOLOGY, V111, P2065, DOI 10.1016/j.ophtha.2004.03.032
   Khairallah M, 2013, CURR OPIN OPHTHALMOL, V24, P574, DOI 10.1097/ICU.0b013e3283654e09
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kuchtey RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P1648, DOI 10.1001/archopht.121.11.1648
   Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002
   Lee JH, 2017, SURV OPHTHALMOL, V62, P404, DOI 10.1016/j.survophthal.2016.12.008
   LEVY JA, 1995, LANCET, V346, P786, DOI 10.1016/S0140-6736(95)91611-3
   Lim WK, 2004, OPHTHALMOLOGY, V111, P2057, DOI 10.1016/j.ophtha.2004.03.038
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Mahendradas P, 2010, INDIAN J OPHTHALMOL, V58, P545, DOI 10.4103/0301-4738.71707
   Maini R, 1999, BRIT J OPHTHALMOL, V83, P1403, DOI 10.1136/bjo.83.12.1403
   Matsuo T, 2002, OCUL IMMUNOL INFLAMM, V10, P197, DOI 10.1076/ocii.10.3.197.15602
   Meegan JM, 1981, CONTRIB EPIDEMIOL BI, V3, P114
   Mehta Salil, 2005, J Assoc Physicians India, V53, P656
   Merle H, 2002, AM J OPHTHALMOL, V134, P190, DOI 10.1016/S0002-9394(02)01521-0
   Merle H, 2001, AM J OPHTHALMOL, V131, P305, DOI 10.1016/S0002-9394(00)00645-0
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Mittal A, 2007, OPHTHALMOLOGY, V114, P1798, DOI 10.1016/j.ophtha.2007.03.045
   MOCHIZUKI M, 1992, LANCET, V339, P1110, DOI 10.1016/0140-6736(92)90699-4
   MOCHIZUKI M, 1992, J INFECT DIS, V166, P943, DOI 10.1093/infdis/166.4.943
   MOCHIZUKI M, 1992, AM J OPHTHALMOL, V114, P123, DOI 10.1016/S0002-9394(14)73974-1
   Myers JP, 2005, ARCH OPHTHALMOL-CHIC, V123, P1754, DOI 10.1001/archopht.123.12.1754
   Nah G, 2007, AVIAT SPACE ENVIR MD, V78, P1064, DOI 10.3357/ASEM.2138.2007
   Nahdi I, 2013, J MED VIROL, V85, P2079, DOI 10.1002/jmv.23708
   Nakano S, 2017, INVEST OPHTH VIS SCI, V58, P1553, DOI 10.1167/iovs.16-20556
   Nakao K, 2018, BRIT J OPHTHALMOL, V102, P373, DOI 10.1136/bjophthalmol-2017-310658
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Norwood PF, 2015, REV SCI TECH OIE, V34, P479, DOI 10.20506/rst.34.2.2373
   Nukui Y, 2006, EMERG INFECT DIS, V12, P343, DOI 10.3201/eid1202.050733
   OHBA N, 1989, JPN J OPHTHALMOL, V33, P1
   OSAME M, 1986, LANCET, V1, P1031
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Poetker SKW, 2011, J CLIN VIROL, V51, P54, DOI 10.1016/j.jcv.2011.02.004
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Ramakrishnan Reshma, 2016, Oman J Ophthalmol, V9, P160
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Ribera A, 2012, Med Trop (Mars), V72 Spec No, P83
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rogo LD, 2014, ACTA VIROL, V58, P199, DOI 10.4149/av_2014_03_199
   Rose N, 2011, INT J INFECT DIS, V15, pE147, DOI 10.1016/j.ijid.2010.10.004
   SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520
   SCHIRMER EC, 1991, P NATL ACAD SCI USA, V88, P5922, DOI 10.1073/pnas.88.13.5922
   SCHRIRE L, 1951, S Afr Med J, V25, P926
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seth Rajeev K, 2007, Semin Ophthalmol, V22, P81, DOI 10.1080/08820530701418375
   Shaikh S, 2004, BRIT J OPHTHALMOL, V88, P1599, DOI 10.1136/bjo.2004.049460
   Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008
   Singh SS, 2008, EPIDEMIOL INFECT, V136, P1277, DOI 10.1017/S0950268807009739
   Su DHW, 2007, OPHTHALMOLOGY, V114, P1743, DOI 10.1016/j.ophtha.2007.03.054
   Sugita S, 2012, INVEST OPHTH VIS SCI, V53, P4692, DOI 10.1167/iovs.12-10095
   Takahashi T, 2000, OCUL IMMUNOL INFLAMM, V8, P235, DOI 10.1076/ocii.8.4.235.6454
   The Eye Institute Dengue related Ophthalmic Complications Workgroup, 2006, EMERG INFECT DIS
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Van Gelder RN, 2010, AM J OPHTHALMOL, V150, P595, DOI 10.1016/j.ajo.2010.08.020
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Visser N, 2009, BRIT J OPHTHALMOL, V93, P841, DOI 10.1136/bjo.2008.150607
   Wadia R. S., 2007, Annals of the Indian Academy of Neurology, V10, P198
   *WHO, 1997, DENG HEM FEV DIAGN T
   Yadav HM, 2017, J OPHTHALMIC INFLAMM, V7, DOI 10.1186/s12348-017-0132-5
   YAMAGUCHI K, 1994, BRIT J OPHTHALMOL, V78, P163, DOI 10.1136/bjo.78.3.163
   YOSHIMURA K, 1993, AM J OPHTHALMOL, V116, P156, DOI 10.1016/S0002-9394(14)71279-6
   Zerr Danielle M, 2006, Herpes, V13, P20
NR 112
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PD FEB 17
PY 2019
VL 27
IS 2
BP 219
EP 228
DI 10.1080/09273948.2018.1562080
PG 10
WC Ophthalmology
SC Ophthalmology
GA HY0WS
UT WOS:000467835100007
PM 30794475
DA 2020-07-08
ER

PT J
AU Davidson, RB
   McCullagh, M
AF Davidson, Russell B.
   McCullagh, Martin
TI Theoretical Modeling of the RNA-Enhanced NTPase Activity of Dengue and
   Zika NS3 Helicases
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 63rd Annual Meeting of the Biophysical-Society
CY MAR 02-06, 2019
CL Baltimore, MD
SP Biophys Soc
C1 [Davidson, Russell B.; McCullagh, Martin] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB 15
PY 2019
VL 116
IS 3
SU 1
MA 2146-Pos
BP 434A
EP 435A
PG 2
WC Biophysics
SC Biophysics
GA HO2XG
UT WOS:000460779802181
DA 2020-07-08
ER

PT J
AU Nutho, B
   Mulholland, A
   Rungrotmongkol, T
AF Nutho, Bodee
   Mulholland, Adrian
   Rungrotmongkol, Thanyada
TI QM/MM Study on Cleavage Mechanism Catalyzed by Zika Virus NS2B/NS3
   Serine Protease
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 63rd Annual Meeting of the Biophysical-Society
CY MAR 02-06, 2019
CL Baltimore, MD
SP Biophys Soc
C1 [Nutho, Bodee] Chulalongkorn Univ, Program Biotechnol, Bangkok, Thailand.
   [Mulholland, Adrian] Univ Bristol, Sch Chem, Bristol, Avon, England.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Biochem, Bangkok, Thailand.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB 15
PY 2019
VL 116
IS 3
SU 1
MA 2771-Pos
BP 559A
EP 559A
DI 10.1016/j.bpj.2018.11.3005
PG 1
WC Biophysics
SC Biophysics
GA HO2XG
UT WOS:000460779802806
OA Bronze
DA 2020-07-08
ER

PT J
AU Masutani, B
   Morishita, S
AF Masutani, Bansho
   Morishita, Shinichi
TI A framework and an algorithm to detect low-abundance DNA by a handy
   sequencer and a palm-sized computer
SO BIOINFORMATICS
LA English
DT Article
ID REAL-TIME; GENOME; VIRUS; IDENTIFICATION; PATHOGENS; ZIKA
AB Motivation: Detection of DNA at low abundance with respect to the entire sample is an important problem in areas such as epidemiology and field research, as these samples are highly contaminated with non-target DNA. To solve this problem, many methods have been developed to date, but all require additional time-consuming and costly procedures. Meanwhile, the MinION sequencer developed by Oxford Nanopore Technology (ONT) is considered a powerful tool for tackling this problem, as it allows selective sequencing of target DNA. The main technology employed involves rejection of an undesirable read from a specific pore by inverting the voltage of that pore, which is referred to as 'Read Until'. Despite its usefulness, several issues remain to be solved in real situations. First, limited computational resources are available in field research and epidemiological applications. In addition, a high-speed online classification algorithm is required to make a prompt decision. Lastly, the lack of a theoretical approach for modeling of selective sequencing makes it difficult to analyze and justify a given algorithm.
   Results: In this paper, we introduced a statistical model of selective sequencing, proposed an efficient constant-time classifier for any background DNA profile, and validated its optimal precision. To confirm the feasibility of the proposed method in practice, for a pre-recorded mock sample, we demonstrate that the method can selectively sequence a 100 kb region, consisting of 0.1% of the entire read pool, and achieve approximately 500-fold amplification. Furthermore, the algorithm is shown to process 26 queries per second with a $500 palm-sized next unit of computing box using an Intel (R) Core (TM) i7 CPU without extended computer resources such as a GPU or high-performance computing. Next, we prepared a mixed DNA pool composed of Saccharomyces cerevisiae and lambda phage, in which any 200 kb region of S.cerevisiae consists of 0.1% of the whole sample. From this sample, a 30-230 kb region of S.cerevisiae chromosome 1 was amplified approximately 30-fold. In addition, this method allowed on-the-fly changing of the amplified region according to the uncovered characteristics of a given DNA sample.
C1 [Masutani, Bansho; Morishita, Shinichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba 2778583, Japan.
RP Masutani, B; Morishita, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Chiba 2778583, Japan.
EM ban-m@g.ecc.u-tokyo.ac.jp; moris@edu.k.u-tokyo.ac.jp
FU Core Research for Evolutional Science and Technology (CREST) programCore
   Research for Evolutional Science and Technology (CREST) [JPMJCR13W3];
   Japan Science and Technology Agency (JST)Japan Science & Technology
   Agency (JST); Japan Agency for Medical Research and Development
   (AMED)Japan Agency for Medical Research and Development (AMED)
FX This work was supported in part by the Core Research for Evolutional
   Science and Technology (CREST) program [JPMJCR13W3] from the Japan
   Science and Technology Agency (JST) to S.M. and the Advanced Genome
   Research and Bioinformatics Study to Facilitate Medical Innovation from
   the Japan Agency for Medical Research and Development (AMED) to S.M.
CR Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bagnall A, 2017, DATA MIN KNOWL DISC, V31, P606, DOI 10.1007/s10618-016-0483-9
   Cesa-Bianchi N., 2006, PREDICTION LEARNING
   Dau H. A, 2017, JUDICIOUS SETTING DY
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FLOYD RW, 1975, COMMUN ACM, V18, P173, DOI 10.1145/360680.360694
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Hagberg EE, 2016, J VIROL METHODS, V234, P43, DOI 10.1016/j.jviromet.2016.03.010
   Johnson Sarah S, 2017, J Biomol Tech, V28, P2, DOI 10.7171/jbt.17-2801-009
   Kav AB, 2013, J MICROBIOL METH, V95, P272, DOI 10.1016/j.mimet.2013.09.008
   Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105
   Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700
   Li H, 2018, BIOINFORMATICS, V1, P7
   Lipton Zachary C, 2014, Mach Learn Knowl Discov Databases, V8725, P225, DOI 10.1007/978-3-662-44851-9_15
   Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/NMETH.3930, 10.1038/nmeth.3930]
   Luo C., 2017, P MACHINE LEARNING R, P38
   Margos G, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3804-5
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   McIntyre ABR, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.35
   Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079
   Cao MD, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0137-2
   Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110
   Motahari A., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, P2741, DOI 10.1109/ISIT.2012.6284020
   Nan Y., 2012, P 29 INT C MACH LEAR, P289
   Organick L, 2018, NAT BIOTECHNOL, V36, P242, DOI 10.1038/nbt.4079
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rakthanmanon Thanawin, 2012, KDD, V2012, P262, DOI 10.1145/2339530.2339576
   Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002
   Roberts M, 2004, BIOINFORMATICS, V20, P3363, DOI 10.1093/bioinformatics/bth408
   SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055
   Salvadora S, 2007, INTELL DATA ANAL, V11, P561, DOI 10.3233/IDA-2007-11508
   Stano M, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw162
   Thomas C. M, 2008, ENCY LIFE SCI, V3, P189
   Trevors JT, 1996, ANTON LEEUW INT J G, V69, P293, DOI 10.1007/BF00399618
   Vintsyuk T. K., 1968, Cybernetics, V4, P52
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
NR 39
TC 3
Z9 3
U1 2
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD FEB 15
PY 2019
VL 35
IS 4
BP 584
EP 592
DI 10.1093/bioinformatics/bty663
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA HM2RI
UT WOS:000459316300007
PM 30776078
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Concurrent Guillain-Barre syndrome, transverse myelitis and encephalitis
   post-Zika and multiple arboviral immunity
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Joob B, 2018, ARQ NEURO-PSIQUIAT, V76, P63, DOI 10.1590/0004-282X20170173
   Mancera-Paez O, 2018, J NEUROL SCI, V395, P47, DOI 10.1016/j.jns.2018.09.028
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
NR 3
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD FEB 15
PY 2019
VL 397
BP 183
EP 183
DI 10.1016/j.jns.2018.10.031
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HL4RT
UT WOS:000458711500044
PM 30401491
DA 2020-07-08
ER

PT J
AU Woon, YL
   Lim, MF
   Abd Rashid, TRT
   Thayan, R
   Chidambaram, SK
   Rahim, SSSA
   Mudin, RN
   Sivasampu, S
AF Woon, Yuan Liang
   Lim, Mei Fong
   Abd Rashid, Tg Rogayah Tg
   Thayan, Ravindran
   Chidambaram, Suresh Kumar
   Rahim, Syed Sharizman Syed Abdul
   Mudin, Rose Nani
   Sivasampu, Sheamini
TI Zika virus infection in Malaysia: an epidemiological, clinical and
   virological analysis
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Malaysia; Epidemiology
ID PHYLOGENETIC ANALYSIS; CROSS-REACTIVITY; TRANSMISSION; OUTBREAK;
   WORLDWIDE; MOSQUITOS; SPREAD; ASSAY
AB Background: A major outbreak of the Zika virus (ZIKV) has been reported in Brazil in 2015. Since then, it spread further to other countries in the Americas and resulted in declaration of the Public Health Emergency of International Concern (PHEIC) by World Health Organization. In 2016, Singapore reported its first minor ZIKV epidemic. Malaysia shares similar ecological environment as Brazil and Singapore which may also favor ZIKV transmission. However, no ZIKV outbreak has been reported in Malaysia to date. This study aimed to discuss all confirmed ZIKV cases captured under Malaysia ZIKV surveillance system after declaration of the PHEIC; and explore why Malaysia did not suffer a similar ZIKV outbreak as the other two countries.
   Methods: This was an observational study reviewing all confirmed ZIKV cases detected in Malaysia through the ZIKV clinical surveillance and Flavivirus laboratory surveillance between June 2015 and December 2017. All basic demographic characteristics, co-morbidities, clinical, laboratory and outcome data of the confirmed ZIKV cases were collected from the source documents.
   Results: Only eight out of 4043 cases tested positive for ZIKV infection during that period. The median age of infected patients was 48.6 years and majority was Chinese. Two of the subjects were pregnant. The median interval between the onset of disease and the first detection of ZIKV Ribonucleic Acid (RNA) in body fluid was 3 days. Six cases had ZIKV RNA detected in both serum and urine samples. Phylogenetic analysis suggests that isolates from the 7 cases of ZIKV infection came from two clusters, both of which were local circulating strains.
   Conclusion: Despite similar ecological background characteristics, Malaysia was not as affected by the recent ZIKV outbreak compared to Brazil and Singapore. This could be related to pre-existing immunity against ZIKV in this population, which developed after the first introduction of the ZIKV in Malaysia decades ago. A serosurvey to determine the seroprevalence of ZIKV in Malaysia was carried out in 2017. The differences in circulating ZIKV strains could be another reason as to why Malaysia seemed to be protected from an outbreak.
C1 [Woon, Yuan Liang] Minist Hlth Malaysia, Natl Clin Res Ctr, Natl Inst Hlth, Clin Epidemiol Unit, Level 2,Block B4,Jalan Setia Murni U13-52, Shah Alam 40170, Selangor Darul, Malaysia.
   [Lim, Mei Fong; Sivasampu, Sheamini] Minist Hlth Malaysia, Natl Clin Res Ctr, Natl Inst Hlth, Healthcare Stat Unit, Level 4,Block B4,Jalan Setia Murni U13-52, Shah Alam 40170, Selangor Darul, Malaysia.
   [Abd Rashid, Tg Rogayah Tg; Thayan, Ravindran] Inst Med Res, Infect Dis Res Ctr, Virol Unit, Jalan Pahang, Kuala Lumpur 50588, Malaysia.
   [Chidambaram, Suresh Kumar] Hosp Sungai Buloh, Dept Gen Med, Jalan Hosp, Sungai Buloh 47000, Selangor Darul, Malaysia.
   [Rahim, Syed Sharizman Syed Abdul; Mudin, Rose Nani] Minist Hlth Malaysia, Dis Control Div, Sect Vector Borne Dis, Putrajaya 62590, Malaysia.
RP Woon, YL (corresponding author), Minist Hlth Malaysia, Natl Clin Res Ctr, Natl Inst Hlth, Clin Epidemiol Unit, Level 2,Block B4,Jalan Setia Murni U13-52, Shah Alam 40170, Selangor Darul, Malaysia.
EM ylwoon.crc@gmail.com
RI RAHIM, SYED SHARIZMAN SYED ABDUL/AAI-2643-2019; RAHIM, SYED SHARIZMAN
   SYED ABDUL/AAL-9658-2020; Liang, Woon Yuan/M-3551-2019
OI RAHIM, SYED SHARIZMAN SYED ABDUL/0000-0002-9090-2563; RAHIM, SYED
   SHARIZMAN SYED ABDUL/0000-0002-9090-2563; Liang, Woon
   Yuan/0000-0003-4834-9175
CR Abdullah NH, 2015, IMPLEMENTATION FLAVI
   [Anonymous], 2016, EPIDEMIOLOGICAL UPDA
   Arief M, 2017, JPPCM, V3, P81, DOI DOI 10.5530/jppcm.2017.2.20
   Aziz S, 2014, J VECTOR DIS, V51, P91
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Buathong R, 2018, ZIKA VIRUS INFECT TH
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins Sean, 2016, F1000Res, V5, P275
   FAQ, DO I NOT NEED PAT IN
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Fisher D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0737-9
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Judice CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22159-2
   Kochakarn T, 2016, ASIAN PAC J TROP MED, V9, P1026, DOI 10.1016/j.apjtm.2016.10.002
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Malaysia. M, 2017, PRESS STATEMENT SITU
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maurer-Stroh S., 2016, EURO SURVEILL, V21
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   [MOH Malaysia Malaysia MoH], 2016, UPD ZIK AL ADM DIR M
   MOH Singapore, 2013, COMM DIS SURV SING 2
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ng DHL, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3211-9
   Ng LC, 2016, EPIDEMIOL NEWS B, V42, P11
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wan-Norafikah O, 2012, SAINS MALAYS, V41, P1309
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong LP, 2017, J COMMUN HEALTH, V42, P854, DOI 10.1007/s10900-017-0326-7
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
NR 61
TC 6
Z9 6
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 13
PY 2019
VL 19
AR 152
DI 10.1186/s12879-019-3786-9
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA HL3LN
UT WOS:000458616900007
PM 30760239
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Anyamba, A
   Chretien, JP
   Britch, SC
   Soebiyanto, RP
   Small, JL
   Jepsen, R
   Forshey, BM
   Sanchez, JL
   Smith, RD
   Harris, R
   Tucker, CJ
   Karesh, WB
   Linthicum, KJ
AF Anyamba, Assaf
   Chretien, Jean-Paul
   Britch, Seth C.
   Soebiyanto, Radina P.
   Small, Jennifer L.
   Jepsen, Rikke
   Forshey, Brett M.
   Sanchez, Jose L.
   Smith, Ryan D.
   Harris, Ryan
   Tucker, Compton J.
   Karesh, William B.
   Linthicum, Kenneth J.
TI Global Disease Outbreaks Associated with the 2015-2016 El Nino Event
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CLIMATE VARIABILITY; UNITED-STATES; HEMORRHAGIC-FEVER; RENAL SYNDROME;
   DENGUE-FEVER; HUMAN PLAGUE; SOUTHERN-OSCILLATION; PRECIPITATION;
   CHOLERA; TRANSMISSION
AB Interannual climate variability patterns associated with the El Nino-Southern Oscillation phenomenon result in climate and environmental anomaly conditions in specific regions worldwide that directly favor outbreaks and/or amplification of variety of diseases of public health concern including chikungunya, hantavirus, Rift Valley fever, cholera, plague, and Zika. We analyzed patterns of some disease outbreaks during the strong 2015-2016 El Nino event in relation to climate anomalies derived from satellite measurements. Disease outbreaks in multiple El Nino-connected regions worldwide (including Southeast Asia, Tanzania, western US, and Brazil) followed shifts in rainfall, temperature, and vegetation in which both drought and flooding occurred in excess (14-81% precipitation departures from normal). These shifts favored ecological conditions appropriate for pathogens and their vectors to emerge and propagate clusters of diseases activity in these regions. Our analysis indicates that intensity of disease activity in some ENSO-teleconnected regions were approximately 2.5-28% higher during years with El Nino events than those without. Plague in Colorado and New Mexico as well as cholera in Tanzania were significantly associated with above normal rainfall (p < 0.05); while dengue in Brazil and southeast Asia were significantly associated with above normal land surface temperature (p < 0.05). Routine and ongoing global satellite monitoring of key climate variable anomalies calibrated to specific regions could identify regions at risk for emergence and propagation of disease vectors. Such information can provide sufficient lead-time for outbreak prevention and potentially reduce the burden and spread of ecologically coupled diseases.
C1 [Anyamba, Assaf; Soebiyanto, Radina P.] Univ Space Res Assoc, Columbia, MD 21046 USA.
   [Anyamba, Assaf; Soebiyanto, Radina P.; Small, Jennifer L.; Jepsen, Rikke; Tucker, Compton J.] NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD 20771 USA.
   [Chretien, Jean-Paul; Forshey, Brett M.; Sanchez, Jose L.] Armed Forces Hlth Surveillance Branch, Dept Def, Silver Spring, MD USA.
   [Britch, Seth C.; Linthicum, Kenneth J.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA.
   [Small, Jennifer L.; Jepsen, Rikke] Sci Syst & Applicat Inc, Lanham, MD USA.
   [Smith, Ryan D.; Harris, Ryan] US Air Force, Weather Squadron DoD Climate Serv 14, Asheville, NC USA.
   [Karesh, William B.] EcoHlth Alliance, New York, NY USA.
   [Chretien, Jean-Paul] Natl Ctr Med Intelligence, Ft Detrick, MD USA.
   [Jepsen, Rikke] Interstate Commiss Potomac River Basin, Rockville, MD USA.
RP Anyamba, A (corresponding author), Univ Space Res Assoc, Columbia, MD 21046 USA.; Anyamba, A (corresponding author), NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD 20771 USA.
EM assaf.anyamba@nasa.gov
OI Karesh, William/0000-0001-6042-2860
FU Department of Defense Health Agency-Armed Forces Health Surveillance
   Branch (AFHSB) Global Emerging Infections Surveillance and Response
   System (GEIS) [P2253_16_NS]; NOAANational Oceanic Atmospheric Admin
   (NOAA) - USA; NSFNational Science Foundation (NSF); NASANational
   Aeronautics & Space Administration (NASA); DOEUnited States Department
   of Energy (DOE)
FX This research was supported by funding from the Department of Defense
   Health Agency-Armed Forces Health Surveillance Branch (AFHSB) Global
   Emerging Infections Surveillance and Response System (GEIS) under
   Project #P2253_16_NS. Precipitation anomaly forecast products were
   generated by the North American Multi-Model Ensemble project and made
   available to this effort by United States Air Force, 14th Weather
   Squadron-Department of Defense Climate Services. The North American
   Multi-Model Ensemble project is supported by NOAA, NSF, NASA, and DOE.
   Credit also goes to the NCEP, IRI, and NCAR personnel in creating,
   updating, and maintaining the North American Multi-Model Ensemble
   archive. We also acknowledge the NOAA Climate Prediction Center and
   NASA/GSFC/Earth Science Data and Information System (ESDIS) which
   produce the climate and satellite derived data used in this study and to
   ProMED (http://www.promedmail.org/) for providing a platform for disease
   outbreak reporting. The views expressed in this article are those of the
   authors and do not reflect the official policy or position of the
   Department of Defense or of the U.S. Government.
CR Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2
   Africa  East, 2015, NON TRADITIONAL REF
   Anyamba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092538
   Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465
   Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289
   Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106
   Ari TB, 2010, AM J TROP MED HYG, V83, P624, DOI 10.4269/ajtmh.2010.09-0775
   Armed Forces Health Surveillance Branch, INT BIOS SUMM
   Azad S, 2014, J VECTOR DIS, V51, P165
   Becker E, 2016, CLIMATE WATCH M 0114
   Becker E, 2016, SCI AM, V315, P68, DOI 10.1038/scientificamerican1016-68
   Ben Ari T, 2008, BIOL LETTERS, V4, P737, DOI 10.1098/rsbl.2008.0363
   Bi P, 2003, JAMA-J AM MED ASSOC, V289, P176, DOI 10.1001/jama.289.2.176-d
   Bouma MJ, 2016, TROP MED INT HEALTH, V21, P1481, DOI 10.1111/tmi.12776
   Brunkard J. M, SALUD PUBLICA MEX, V50, P227
   Cai WJ, 2015, NAT CLIM CHANGE, V5, P849, DOI [10.1038/nclimate2743, 10.1038/NCLIMATE2743]
   Carver S, 2015, BIOSCIENCE, V65, P651, DOI 10.1093/biosci/biv047
   Cash BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107223
   Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106
   CDC, 2018, PLAGUE
   CDC, 2017, HANT DIS
   Chen MY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009132
   Chretien J. P., 2015, PLOS CURRENTS OUTBRE, V7, P2014
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Delgado-Petrocelli L, 2012, GEOSPATIAL HEALTH, V6, pS51
   Dhiman RC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1779-y
   Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X
   Enscore RE, 2002, AM J TROP MED HYG, V66, P186, DOI 10.4269/ajtmh.2002.66.186
   Epstein PR, 1999, SCIENCE, V285, P347, DOI 10.1126/science.285.5426.347
   Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079
   Field RD, 2009, NAT GEOSCI, V2, P185, DOI 10.1038/NGEO443
   Gagnon AS, 2001, CLIM RES, V19, P35, DOI 10.3354/cr019035
   Gao HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043686
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Guterres A, 2018, ONE HEALTH-AMSTERDAM, V5, P27, DOI 10.1016/j.onehlt.2017.12.002
   Hales S, 1996, LANCET, V348, P1664, DOI 10.1016/S0140-6736(05)65737-6
   Hanf M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-100
   Hashizume M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060001
   Hashizume M, 2011, ENVIRON HEALTH PERSP, V119, P239, DOI 10.1289/ehp.1002302
   Hjelle B, 2000, J INFECT DIS, V181, P1569, DOI 10.1086/315467
   Hu WB, 2010, OCCUP ENVIRON MED, V67, P307, DOI 10.1136/oem.2008.044966
   Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x
   International Society for Infectious Diseases, PROGR MON EM DIS PRO
   Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Kelly-Hope LA, 2004, VECTOR-BORNE ZOONOT, V4, P210, DOI 10.1089/vbz.2004.4.210
   Kirtman BP, 2014, B AM METEOROL SOC, V95, P585, DOI 10.1175/BAMS-D-12-00050.1
   Koplitz SN, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094023
   Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8
   Kreppel KS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003155
   Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Loh EH, 2015, VECTOR-BORNE ZOONOT, V15, P432, DOI 10.1089/vbz.2013.1563
   Love TB, 2004, C APPL CLIM
   Lyon B, 2005, J CLIMATE, V18, P5095, DOI 10.1175/JCLI3598.1
   Machalaba C, 2015, ANN GLOB HEALTH, V81, P445, DOI 10.1016/j.aogh.2015.08.002
   Mantilla G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-6
   MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205
   Mason SJ, 2001, B AM METEOROL SOC, V82, P619, DOI 10.1175/1520-0477(2001)082<0619:PPAAWE>2.3.CO;2
   McIntyre KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06948-9
   McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588
   Mitchell K. E., 2005, 19 INT C HYDR SAN DI, V1, P2, DOI DOI 10.1002/2014WR015442
   Moore SM, 2017, P NATL ACAD SCI USA, V114, P4436, DOI 10.1073/pnas.1617218114
   NASA, 2018, GLOB PREC CLIM PROJ
   NCEP/EMC Mesoscale Modeling Branch, NAT STAG 4 QPE MOS N
   NICHOLLS N, 1986, AUST J EXP BIOL MED, V64, P587, DOI 10.1038/icb.1986.62
   Nkoko DB, 2011, EMERG INFECT DIS, V17, P2026, DOI 10.3201/eid1711.110170
   NOAA, 2018, CLIM PRED CTR CPC UN
   NOAA, 2017, NON TRADITIONAL REF
   Novella NS, 2016, J APPL METEOROL CLIM, V55, P2575, DOI 10.1175/JAMC-D-16-0111.1
   O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6
   PAHO, HLTH INF PLATF AM DE
   Pan American Health Organization (PAHO), PAHO WHO DAT
   Parmenter RR, 1999, AM J TROP MED HYG, V61, P814, DOI 10.4269/ajtmh.1999.61.814
   Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pedati C, 2015, MMWR-MORBID MORTAL W, V64, DOI 10.15585/mmwr.mm6447a4
   Pollitzer R, 1954, NON TRADITIONAL REF, P689
   R Core Team, 2017, R LANG ENV STAT COMP
   Randall CJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05763-6
   REISEN WK, 1993, J MED ENTOMOL, V30, P151, DOI 10.1093/jmedent/30.1.151
   Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2
   Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999
   ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2
   Sehgal R, 1997, LANCET, V349, P729, DOI 10.1016/S0140-6736(05)60169-9
   Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547
   Stapp P, 2004, FRONT ECOL ENVIRON, V2, P235, DOI 10.1890/1540-9295(2004)002[0235:POEIPD]2.0.CO;2
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Tipayamongkholgul M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-422
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   USDA Center for Medical Agricultural and Veterinary Entomology, 2018, RIFT VALL FEV MON
   Vincenti-Gonzalez MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24003-z
   WHO, 2018, WEEKL EP REC WER
   World Health Organization and Centers for Disease Control and Prevention, 1999, LAB METH DIAGN EP DY
   World Health Organization (WHO), 2016, DIS OUTBREAK NE 0208
   World Health Organization (WHO), 2018, DIS OUTBREAK NE 0208
   Xiao H, 2013, EPIDEMIOL INFECT, V141, P1867, DOI 10.1017/S0950268812002555
   Xiao H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002260
   Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504
   Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100
   Zubair L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-140
NR 102
TC 8
Z9 8
U1 4
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 13
PY 2019
VL 9
AR 1930
DI 10.1038/s41598-018-38034-z
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HL2XE
UT WOS:000458571900003
PM 30760757
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hill, ME
   Yildiz, M
   Hardy, JA
AF Hill, Maureen E.
   Yildiz, Muslum
   Hardy, Jeanne A.
TI Cysteine Disulfide Traps Reveal Distinct Conformational Ensembles in
   Dengue Virus NS2B-NS3 Protease
SO BIOCHEMISTRY
LA English
DT Article
ID ZIKA VIRUS; CRYSTAL-STRUCTURE; NS3 PROTEASE; BINDING MODE; INHIBITION;
   PROTEINS; COFACTOR; COMPLEX; TYPE-2; ACTIVATION
AB The dengue virus protease (NS2B-NS3pro) plays a critical role in the dengue viral life cycle, making it an attractive drug target for dengue-related pathologies, including 4: dengue hemorrhagic fever. A number of studies indicate that NS2B-NS3pro undergoes a transition between two widely different conformational states: an "open" (inactive) conformation and a "closed" (active) conformation. For the past several years, the equilibrium between these states and the resting conformation of NS2B-NS3pro have been debated, although a strong consensus is emerging. To investigate the importance of such conformational states, we developed versions of NS2B-NS3pro that allow us to trap the enzyme in various distinct conformations. Our data from these variants suggest that the enzymatic activity appears to be dependent on the movement of NS2B and may rely on the flexibility of the protease core. Locking the enzyme into the "closed" conformation dramatically increased activity, strongly suggesting that the "closed" conformation is the active conformation. The observed resting state of the enzyme depends largely on the construct used to express the NS2B-NS3pro complex. In an "unlinked" construct, in which the NS2B and NS3 regions exist as independent, co-expressed polypeptides, the enzyme rests predominantly in a "closed", active conformation. In contrast, in a "linked" construct, in which NS2B and NS3 are attached by a nine-amino acid linker, NS2B-NS3pro adopts a more relaxed, alternative conformation. Nevertheless, even the unlinked construct samples both the "closed" and other alternative conformations. Given our findings, and the more realistic resemblance of NS2B-NS3pro to the native enzyme, these data strongly suggest that studies should focus on the "unlinked" constructs moving forward. Additionally, the results from these studies provide a more detailed understanding of the various poses of the dengue virus NS2B-NS3 protease and should help guide future drug discovery efforts aimed at this enzyme.
C1 [Hill, Maureen E.; Yildiz, Muslum; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, 374 LGRT,710 North Pleasant St, Amherst, MA 01003 USA.
   [Yildiz, Muslum] Gebze Tech Univ, Dept Mol Biol & Genet, TR-41400 Istanbul, Turkey.
RP Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, 374 LGRT,710 North Pleasant St, Amherst, MA 01003 USA.
EM hardy@chem.umass.edu
FU National Science FoundationNational Science Foundation (NSF) [CBET
   1511367]
FX This work was supported by National Science Foundation Grant CBET
   1511367 to J.A.H.
CR Aguiar M, 2016, LANCET INFECT DIS, V16, P882, DOI 10.1016/S1473-3099(16)30168-2
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   CAHOUR A, 1992, J VIROL, V66, P1535, DOI 10.1128/JVI.66.3.1535-1542.1992
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chen WN, 2016, J AM CHEM SOC, V138, P4539, DOI 10.1021/jacs.6b00416
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hill ME, 2018, ACS CHEM BIOL, V13, P2398, DOI 10.1021/acschembio.8b00508
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li H, 2014, FEBS LETT, V588, P2794, DOI 10.1016/j.febslet.2014.05.063
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pikkemaat MG, 2002, PROTEIN ENG, V15, P185, DOI 10.1093/protein/15.3.185
   Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136
   SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067
   Woestenenk E, 2017, PROTEIN EXPRES PURIF, V140, P16, DOI 10.1016/j.pep.2017.07.002
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200
   Yu HR, 2014, BIOTECHNOL ADV, V32, P308, DOI 10.1016/j.biotechadv.2013.10.012
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 43
TC 4
Z9 4
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 12
PY 2019
VL 58
IS 6
BP 776
EP 787
DI 10.1021/acs.biochem.8b00978
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HL7RF
UT WOS:000458938000037
PM 30472839
DA 2020-07-08
ER

PT J
AU Pischedda, E
   Scolari, F
   Valerio, F
   Carballar-Lejarazu, R
   Catapano, PL
   Waterhouse, RM
   Bonizzoni, M
AF Pischedda, Elisa
   Scolari, Francesca
   Valerio, Federica
   Carballar-Lejarazu, Rebeca
   Catapano, Paolo Luigi
   Waterhouse, Robert M.
   Bonizzoni, Mariangela
TI Insights Into an Unexplored Component of the Mosquito Repeatome:
   Distribution and Variability of Viral Sequences Integrated Into the
   Genome of the Arboviral Vector Aedes albopictus
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mosquitoes; viral integrations; immunity; piRNA pathway; domestication;
   repeatome
ID ASIAN TIGER MOSQUITO; PIRNA PATHWAY; RNA VIRUSES; TRANSPOSABLE ELEMENTS;
   FLAMENCO LOCUS; EVOLUTION; POPULATIONS; GENERATION; DIVERSITY; ALIGNMENT
AB The Asian tiger mosquito Aedes albopictus is an invasive mosquito and a competent vector for public-health relevant arboviruses such as Chikungunya (Alphavirus), Dengue and Zika (Flavivirus) viruses. Unexpectedly, the sequencing of the genome of this mosquito revealed an unusually high number of integrated sequences with similarities to non-retroviral RNA viruses of the Flavivirus and Rhabdovirus genera. These Non-retroviral Integrated RNA Virus Sequences (NIRVS) are enriched in piRNA clusters and coding sequences and have been proposed to constitute novel mosquito immune factors. However, given the abundance of NIRVS and their variable viral origin, their relative biological roles remain unexplored. Here we used an analytical approach that intersects computational, evolutionary and molecular methods to study the genomic landscape of mosquito NIRVS. We demonstrate that NIRVS are differentially distributed across mosquito genomes, with a core set of seemingly the oldest integrations with similarity to Rhabdoviruses. Additionally, we compare the polymorphisms of NIRVS with respect to that of fast and slow-evolving genes within the Ae. albopictus genome. Overall, NIRVS appear to be less polymorphic than slow-evolving genes, with differences depending on whether they occur in intergenic regions or in piRNA clusters. Finally, two NIRVS that map within the coding sequences of genes annotated as Rhabdovirus RNA-dependent RNA polymerase and the nucleocapsid-encoding gene, respectively, are highly polymorphic and are expressed, suggesting exaptation possibly to enhance the mosquito's antiviral responses. These results greatly advance our understanding of the complexity of the mosquito repeatome and the biology of viral integrations in mosquito genomes.
C1 [Pischedda, Elisa; Scolari, Francesca; Valerio, Federica; Catapano, Paolo Luigi; Bonizzoni, Mariangela] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
   [Carballar-Lejarazu, Rebeca] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.
   [Waterhouse, Robert M.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.
   [Waterhouse, Robert M.] Swiss Inst Bioinformat, Lausanne, Switzerland.
RP Bonizzoni, M (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.
EM m.bonizzoni@unipv.it
RI Waterhouse, Robert M/A-1858-2010; Scolari, Francesca/L-9233-2015
OI Waterhouse, Robert M/0000-0003-4199-9052; Carballar Lejarazu,
   Rebeca/0000-0002-9338-8774; Scolari, Francesca/0000-0003-3085-9038;
   Pischedda, Elisa/0000-0003-0976-9193
FU European Research Council Consolidator Grant (ERC-CoG) under the
   European Union's Horizon 2020 Program [ERC-CoG 682394]; Italian Ministry
   of Education, University and Research FARE-MIUR project [R1623HZAH5];
   Italian Ministry of Education, University and Research (MIUR):
   Dipartimenti di Eccellenza Program (2018-2022) Department of Biology and
   Biotechnology "L. Spallanzani," University of PaviaMinistry of
   Education, Universities and Research (MIUR); Swiss National Science
   Foundation grantSwiss National Science Foundation (SNSF) [PP00P3_170664]
FX This research was funded by a European Research Council Consolidator
   Grant (ERC-CoG) under the European Union's Horizon 2020 Program (Grant
   Number ERC-CoG 682394) to MB, by the Italian Ministry of Education,
   University and Research FARE-MIUR project R1623HZAH5 to MB, by the
   Italian Ministry of Education, University and Research (MIUR):
   Dipartimenti di Eccellenza Program (2018-2022) Department of Biology and
   Biotechnology "L. Spallanzani," University of Pavia, and by the Swiss
   National Science Foundation grant PP00P3_170664 to RW.
CR Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606
   Asif-Laidin A, 2017, DNA RES, V24, P459, DOI 10.1093/dnares/dsx017
   BARUFFI L, 1995, HEREDITY, V74, P425, DOI 10.1038/hdy.1995.60
   Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030
   Bernhardt SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044198
   Boston M., 2015, R STUDIO
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Bubner B, 2004, PLANT CELL REP, V23, P263, DOI 10.1007/s00299-004-0859-y
   Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chirn GW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005652
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   de Farias ST, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00125
   de Lamballerie X, 2002, J GEN VIROL, V83, P2443, DOI 10.1099/0022-1317-83-10-2443
   Dietzgen RG, 2017, VIRUS RES, V227, P158, DOI 10.1016/j.virusres.2016.10.010
   Djadid ND, 2006, ACTA TROP, V97, P65, DOI 10.1016/j.actatropica.2005.08.003
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Forster M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11534
   Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226
   Frank JA, 2017, CURR OPIN VIROL, V25, P81, DOI 10.1016/j.coviro.2017.07.021
   Gainetdinov I, 2017, RNA, V23, P1614, DOI 10.1261/rna.060939.117
   GARRISON E, 2012, GENOMICS, V1207, P3907, DOI DOI 10.1101/1207.3907
   Geoghegan JL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006215
   Gilbert C, 2018, CURR OPIN GENET DEV, V49, P15, DOI 10.1016/j.gde.2018.02.007
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Goubert C, 2017, MOL ECOL, V26, P3968, DOI 10.1111/mec.14184
   Guida V, 2016, GENETICS, V204, P631, DOI 10.1534/genetics.116.187922
   Guzzardo PM, 2013, CURR OPIN GENET DEV, V23, P44, DOI 10.1016/j.gde.2012.12.003
   Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388
   Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19
   Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002
   Horie M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25873
   Huang XW, 2017, TRENDS GENET, V33, P882, DOI 10.1016/j.tig.2017.09.002
   Joly-Lopez Z, 2018, CURR OPIN GENET DEV, V49, P34, DOI 10.1016/j.gde.2018.02.011
   JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109
   Kobayashi Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005785
   Koonin EV, 2015, VIROLOGY, V479, P2, DOI 10.1016/j.virol.2015.02.039
   Kotsakiozi P, 2017, ECOL EVOL, V7, P10143, DOI 10.1002/ece3.3514
   Kryukov K, 2019, VIRUS RES, V262, P30, DOI 10.1016/j.virusres.2018.02.002
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227
   Lammers Fritjof, 2017, Genome Biol Evol, V9, P2862, DOI 10.1093/gbe/evx170
   Langella O., 1999, POPULATION 1 2 31
   Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067
   Liu PW, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1815-8
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Maumus F, 2016, CURR OPIN PLANT BIOL, V30, P41, DOI 10.1016/j.pbi.2016.01.003
   Maumus F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094101
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Nag DK, 2017, J GEN VIROL, V98, P2731, DOI 10.1099/jgv.0.000945
   Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091
   Olson KE, 2017, CURR OPIN INSECT SCI, V22, P45, DOI 10.1016/j.cois.2017.05.010
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Petit M, 2016, P NATL ACAD SCI USA, V113, pE4218, DOI 10.1073/pnas.1607952113
   Pfaffl M. W., 2006, REAL TIME PCR, P63
   Pinzon N, 2018, PREPRINT, DOI [10.1101/339820, DOI 10.1101/339820]
   Reynolds JA, 2012, J INSECT PHYSIOL, V58, P966, DOI 10.1016/j.jinsphys.2012.04.013
   Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036
   Rozen S, 2000, Methods Mol Biol, V132, P365
   RStudio Team, 2015, RSTUDIO INT DEV R
   Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109
   Toth KF, 2016, ADV EXP MED BIOL, V886, P51, DOI 10.1007/978-94-017-7417-8_4
   Wang YH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040213
   Wang-Sattler R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001249
   Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Yamada KD, 2016, BIOINFORMATICS, V32, P3246, DOI 10.1093/bioinformatics/btw412
   Yuan JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S6
   Zanni V, 2013, P NATL ACAD SCI USA, V110, P19842, DOI 10.1073/pnas.1313677110
   Zdobnov EM, 2017, NUCLEIC ACIDS RES, V45, pD744, DOI 10.1093/nar/gkw1119
   Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004
NR 76
TC 3
Z9 3
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD FEB 12
PY 2019
VL 10
AR 93
DI 10.3389/fgene.2019.00093
PG 15
WC Genetics & Heredity
SC Genetics & Heredity
GA HL3GR
UT WOS:000458601400001
PM 30809249
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kumar, S
   Barouch-Bentov, R
   Xiao, F
   Schor, S
   Pu, SY
   Biquand, E
   Lu, A
   Lindenbach, BD
   Jacob, Y
   Demeret, C
   Einav, S
AF Kumar, Sathish
   Barouch-Bentov, Rina
   Xiao, Fei
   Schor, Stanford
   Pu, Szuyuan
   Biquand, Elise
   Lu, Albert
   Lindenbach, Brett D.
   Jacob, Yves
   Demeret, Caroline
   Einav, Shirit
TI MARCH8 Ubiquitinates the Hepatitis C Virus Nonstructural 2 Protein and
   Mediates Viral Envelopment
SO CELL REPORTS
LA English
DT Article
ID DENGUE VIRUS; IN-VIVO; LIGASES; REPLICATION; DEGRADATION; RELEASE; P7
AB The mechanisms that regulate envelopment of HCV and other viruses that bud intracellularly and/or lack late-domain motifs are largely unknown. We reported that K63 polyubiquitination of the HCV nonstructural (NS) 2 protein mediates HRS (ESCRT-0 component) binding and envelopment. Nevertheless, the ubiquitin signaling that governs NS2 ubiquitination remained unknown. Here, we map the NS2 interactome with the ubiquitin proteasome system (UPS) via mammalian cell-based screens. NS2 interacts with E3 ligases, deubiquitinases, and ligase regulators, some of which are candidate proviral or antiviral factors. MARCH8, a RING-finger E3 ligase, catalyzes K63-linked NS2 polyubiquitination in vitro and in HCV-infected cells. MARCH8 is required for infection with HCV, dengue, and Zika viruses and specifically mediates HCV envelopment. Our data reveal regulation of HCV envelopment via ubiquitin signaling and both a viral protein substrate and a ubiquitin K63-linkage of the understudied MARCH8, with potential implications for cell biology, virology, and host-targeted antiviral design.
C1 [Kumar, Sathish; Barouch-Bentov, Rina; Xiao, Fei; Schor, Stanford; Pu, Szuyuan; Einav, Shirit] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Kumar, Sathish; Barouch-Bentov, Rina; Xiao, Fei; Schor, Stanford; Pu, Szuyuan; Einav, Shirit] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
   [Biquand, Elise; Jacob, Yves; Demeret, Caroline] CNRS, Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN GMVR, Paris, France.
   [Biquand, Elise; Jacob, Yves; Demeret, Caroline] Univ Paris Diderot, Paris, France.
   [Lu, Albert] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.
   [Lindenbach, Brett D.] Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA.
RP Einav, S (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.; Einav, S (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
EM seinav@stanford.edu
RI LU, ALBERT/AAB-6134-2019
OI LU, ALBERT/0000-0002-7507-3330; Jacob, Yves/0000-0001-9125-2374;
   Biquand, Elise/0000-0001-9387-2550
FU Stanford Bio-X Interdisciplinary Initiative Program Award [RSG-14-11 0-0
   1 -MPC]; American Cancer SocietyAmerican Cancer Society
   [1U19AI10966201]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID)
FX This work was supported by grants from Stanford Bio-X Interdisciplinary
   Initiative Program Award, grant RSG-14-11 0-0 1 -MPC from the American
   Cancer Society, and grant 1U19AI10966201 from the National Institute of
   Allergy and Infectious Diseases to S.E. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Barouch-Bentov R, 2016, MBIO, V7, DOI 10.1128/mBio.01456-16
   Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005
   Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Biquand E, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00330-17
   Cai H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27778
   Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773
   Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822
   Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109
   Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014
   Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07
   Citrin R, 2016, EXPERT REV HEMATOL, V9, P873, DOI 10.1080/17474086.2016.1216311
   Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466
   de la Fuente C, 2013, J VIROL, V87, P4130, DOI 10.1128/JVI.03174-12
   Dentzer TG, 2009, J VIROL, V83, P12702, DOI 10.1128/JVI.01184-09
   Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056
   Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874
   Gao TS, 2013, NUCLEIC ACIDS RES, V41, pD445, DOI 10.1093/nar/gks1103
   Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06
   Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355
   Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200
   Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051
   Hutchins AP, 2013, MOL BIOL EVOL, V30, P1172, DOI 10.1093/molbev/mst022
   Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233
   Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07
   Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017
   Lee TL, 2008, BIOCHEM BIOPH RES CO, V375, P326, DOI 10.1016/j.bbrc.2008.07.164
   Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975
   Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155
   Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026
   Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200
   Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07
   Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845
   Poirson J, 2017, FEBS J, V284, P3171, DOI 10.1111/febs.14193
   Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278
   Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005
   Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527
   Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2
   Roy N, 2017, J CELL SCI, V130, P1596, DOI 10.1242/jcs.195412
   Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604
   Samji T, 2014, INT SCH RES NOTICES, V2014
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/nmeth.1888, 10.1038/NMETH.1888]
   Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103
   Sun Y, 2003, CANCER BIOL THER, V2, P623
   Tada T, 2015, NAT MED, V21, P1502, DOI 10.1038/nm.3956
   Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07
   van de Kooij B, 2013, J BIOL CHEM, V288, P6617, DOI 10.1074/jbc.M112.448209
   Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012
   Xiao F, 2018, MBIO, V9, DOI 10.1128/mBio.02233-17
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
   Zoulim F, 2015, GUT, V64, P1824, DOI 10.1136/gutjnl-2015-310421
NR 57
TC 3
Z9 3
U1 1
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 12
PY 2019
VL 26
IS 7
BP 1800
EP +
DI 10.1016/j.celrep.2019.01.075
PG 20
WC Cell Biology
SC Cell Biology
GA HL0SF
UT WOS:000458403600012
PM 30759391
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Grajales-Muniz, C
   Borja-Aburto, VH
   Cabrera-Gaytan, DA
   Rojas-Mendoza, T
   Arriaga-Nieto, L
   Vallejos-Paras, A
AF Grajales-Muniz, Concepcion
   Hugo Borja-Aburto, Victor
   Alejandro Cabrera-Gaytan, David
   Rojas-Mendoza, Teresita
   Arriaga-Nieto, Lumumba
   Vallejos-Paras, Alfonso
TI Zika virus: Epidemiological surveillance of the Mexican Institute of
   Social Security
SO PLOS ONE
LA English
DT Article
ID DENGUE VIRUS; INFECTION; ANTIBODIES
AB Introduction
   At the end of 2015, the first cases of Zika were identified in southern Mexico. During 2016, Zika spread as an outbreak to a large part of the country's coastal zones.
   Methodology
   The Zika epidemiological surveillance system records cases with clinical symptoms of Zika virus disease (ZVD) and those confirmed by means of a reverse polymerase chain reaction (RT-PCR) assay. This report includes the suspected and confirmed cases from 2016. Incidence rates were estimated by region and in pregnant women based on the proportion of confirmed cases.
   Results
   In total, 43,725 suspected cases of ZVD were reported. The overall incidence of suspected cases of ZVD was 82.0 per 100,000 individuals and 25.3 per 100,000 Zika cases. There were 4,168 pregnant women with suspected symptoms of ZVD, of which infection was confirmed in 1,082 (26%). The estimated incidence rate of ZVD for pregnant women nationwide was 186.1 positive Zika cases per 100,000 pregnant women.
   Conclusions
   The incidence of Zika in Mexico is higher than that reported previously in the National System of Epidemiological Surveillance. Positive cases of Zika must be estimated and reported.
C1 [Grajales-Muniz, Concepcion; Alejandro Cabrera-Gaytan, David; Rojas-Mendoza, Teresita; Arriaga-Nieto, Lumumba; Vallejos-Paras, Alfonso] IMSS, Div Epidemiol Surveillance Communicable Dis, Mexico City, DF, Mexico.
   [Hugo Borja-Aburto, Victor] IMSS, Unit Primary Hlth Care, Mexico City, DF, Mexico.
RP Vallejos-Paras, A (corresponding author), IMSS, Div Epidemiol Surveillance Communicable Dis, Mexico City, DF, Mexico.
EM alfonso.vallejos@imss.gob.mx
RI amsalu, ribka/G-8780-2019; ARRIAGA, LUMUMBA/B-7697-2019
OI ARRIAGA, LUMUMBA/0000-0003-0243-768X; Vallejos Paras,
   Alfonso/0000-0003-0972-8295; Rojas Mendoza, Teresita/0000-0002-6658-1739
FU CONACyT (Mexico's National Science and Research Council); Technical
   Committee and Fund Management International Cooperation in Science and
   Technology CONACYT (FONCICYT) [274386]
FX This work was supported by CONACyT (Mexico's National Science and
   Research Council). Through the Technical Committee and Fund Management
   International Cooperation in Science and Technology CONACYT (FONCICYT)
   number 274386 to VHBA. This work is part of "The Global Alliance to
   Control and Prevent the Zika Virus". The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Comision Nacional de Agua Mexico, REUM TEMP PRES MENS
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hernandez-Avila JE, 2018, B WORLD HEALTH ORGAN, V96, P306, DOI 10.2471/BLT.17.201004
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gutierrez JP, 2012, ENCUESTA NACL SALUD
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Haque U, 2016, ACTA TROP, V162, P5, DOI 10.1016/j.actatropica.2016.06.010
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Pan American Health Organization, ZIK CAS CONG SYNDR A
   Pan American Health Organization, 2017, ZIK CAS CONG SYNDR A
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Peterson A Townsend, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.a832cf06c4bf89fb2e15cb29d374f9de
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Secretaria de Salud, 2015, CAS CONF INF VIR ZIK
   Secretaria de Salud, MAN PROC EST VIG EP
   Secretaria de Salud, SEMANA EPIDEMIOLOGIC
   Secretaria de Salud Direccion General de Epidemiologia, DESGL CAS SINDR CONG
   Secretaria de Salud Direccion General de Epidemiologia, CAS CONF SINDR GUILL
   Secretaria de Salud. Direccion General de Epidemiologia, 2016, MAN PROC EST VIG EP
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   World Health Organization, FACT SHEETS ZIK VIR
NR 39
TC 0
Z9 0
U1 2
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 11
PY 2019
VL 14
IS 2
AR e0212114
DI 10.1371/journal.pone.0212114
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HL0OI
UT WOS:000458393400050
PM 30742671
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ojha, CR
   Rodriguez, M
   Karuppan, MKM
   Lapierre, J
   Kashanchi, F
   El-Hage, N
AF Ojha, Chet Raj
   Rodriguez, Myosotys
   Karuppan, Mohan Kumar Muthu
   Lapierre, Jessica
   Kashanchi, Fatah
   El-Hage, Nazira
TI Toll-like receptor 3 regulates Zika virus infection and associated host
   inflammatory response in primary human astrocytes
SO PLOS ONE
LA English
DT Article
ID NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; DENGUE VIRUS; AUTOPHAGY; AXL;
   PATHOGENESIS; ACTIVATION; DEFENSE; DISEASE; BRAZIL
AB The connection between Zika virus (ZIKV) and neurodevelopmental defects is widely recognized, although the mechanisms underlying the infectivity and pathology in primary human glial cells are poorly understood. Here we show that three isolated strains of ZIKV, an African strain MR766 (Uganda) and two closely related Asian strains R103451 (Honduras) and PRVABC59 (Puerto Rico) productively infect primary human astrocytes, although Asian strains showed a higher infectivity rate and increased cell death when compared to the African strain. Inhibition of AXL receptor significantly attenuated viral entry of MR766 and PRVABC59 and to a lesser extend R103451, suggesting an important role of TAM receptors in ZIKV cell entry, irrespective of lineage. Infection by PRVABC59 elicited the highest release of inflammatory molecules, with a 8-fold increase in the release of RANTES, 10-fold increase in secretion of IP-10 secretion and a 12-fold increase in IFN-beta secretion when compared to un-infected human astrocytes. Minor changes in the release of several growth factors, endoplasmic reticulum (ER)-stress response factors and the transcription factor, NF-kappa B were detected with the Asian strains, while significant increases in FOXO6, MAPK10 and JNK were detected with the African strain. Activation of the autophagy pathway was evident with increased expression of the autophagy related proteins Beclin1, LC3B and p62/SQSTM1 with all three strains of ZIKV. Pharmacological inhibition of the autophagy pathway and genetic inhibition of the Beclin1 showed minimal effects on ZIKV replication. The expression of toll-like receptor 3 (TLR3) was significantly increased with all three strains of ZIKV; pharmacological and genetic inhibition of TLR3 caused a decrease in viral titers and in viral-induced inflammatory response in infected astrocytes. We conclude that TLR3 plays a vital role in both ZIKV replication and viral-induced inflammatory responses, irrespective of the strains, while the autophagy protein Beclin1 influences host inflammatory responses.
C1 [Ojha, Chet Raj; Rodriguez, Myosotys; Karuppan, Mohan Kumar Muthu; Lapierre, Jessica; El-Hage, Nazira] Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.
   [Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA.
RP El-Hage, N (corresponding author), Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.
EM nelhage@fiu.edu
OI Ojha, Chet Raj/0000-0002-6816-8892
FU Florida Department of Health [7ZK09, R01 DA036154]
FX Dr. Nazira El-Hage received funding from the Florida Department of
   Health award number 7ZK09 and R01 DA036154 grant.
   (http://www.floridahealth.gov/) The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agbulos Darrell S, 2016, Curr Protoc Microbiol, V43, DOI 10.1002/cpmc.19
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40
   Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035
   Blackburn D, 2009, GLIA, V57, P1251, DOI 10.1002/glia.20848
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Boasso A, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/580968
   Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300
   Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10
   Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Chiramel Abhilash I, 2013, Cells, V2, P83, DOI 10.3390/cells2010083
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31
   DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437
   DEVER SM, 2015, MICROBIOL, V6, P1, DOI DOI 10.3389/FMICB.2015.00001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong XY, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-173
   El-Hage N, 2015, J VIROL, V89, P1024, DOI 10.1128/JVI.02022-14
   FAYE O, 2014, PLOS NEGLECT TROP D, V8, P5624
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fukunaga K, 2009, ADV EXP MED BIOL, V665, P130
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu WJ, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0031-z
   Liu Y, 2016, J MED VIROL, V88, P1596, DOI 10.1002/jmv.24504
   Marinelli C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0458-6
   Marziale M, 2017, P TEX A M MED STUD G
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Naveca FG, 2017, BIORXIV, DOI [10.1101/185041, DOI 10.1101/185041]
   Neidhart S, 2001, FEBS LETT, V508, P259, DOI 10.1016/S0014-5793(01)03090-3
   Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893
   RODRIGUEZ M, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9080201
   Rodriguez M, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080201
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Sreekanth GP, 2018, CELL SIGNAL, V48, P64, DOI 10.1016/j.cellsig.2018.05.002
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   VanMarle G, 2007, W NILE VIRUS INDUCED, DOI [10.1128/JVI.02422-06, DOI 10.1128/JVI.02422-06]
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Willy JA, 2015, MOL BIOL CELL, V26, P2190, DOI 10.1091/mbc.E15-01-0036
   Ferreira RAX, 2015, ACTA TROP, V149, P138, DOI 10.1016/j.actatropica.2015.04.023
   Xu J, 2017, J IMMUNOLOGY S, V198
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 74
TC 3
Z9 3
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 8
PY 2019
VL 14
IS 2
AR e0208543
DI 10.1371/journal.pone.0208543
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK7PK
UT WOS:000458181200007
PM 30735502
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodriguez-Barraquer, I
   Costa, F
   Nascimento, EJM
   Nery, N
   Castanha, PMS
   Sacramento, GA
   Cruz, J
   Carvalho, M
   De Olivera, D
   Hagan, JE
   Adhikarla, H
   Wunder, EA
   Coelho, DF
   Azar, SR
   Rossi, SL
   Vasilakis, N
   Weaver, SC
   Ribeiro, GS
   Balmaseda, A
   Harris, E
   Nogueira, ML
   Reis, MG
   Marques, ETA
   Cummings, DAT
   Ko, AI
AF Rodriguez-Barraquer, Isabel
   Costa, Federico
   Nascimento, Eduardo J. M.
   Nery Junior, Nivison
   Castanha, Priscila M. S.
   Sacramento, Gielson Almeida
   Cruz, Jaqueline
   Carvalho, Mayara
   De Olivera, Daiana
   Hagan, Jose E.
   Adhikarla, Haritha
   Wunder, Elsio A., Jr.
   Coelho, Danilo F.
   Azar, Sasha R.
   Rossi, Shannan L.
   Vasilakis, Nikos
   Weaver, Scott C.
   Ribeiro, Guilherme S.
   Balmaseda, Angel
   Harris, Eva
   Nogueira, Mauricio L.
   Reis, Mitermayer G.
   Marques, Ernesto T. A.
   Cummings, Derek A. T.
   Ko, Albert I.
TI Impact of preexisting dengue immunity on Zika virus emergence in a
   dengue endemic region
SO SCIENCE
LA English
DT Article
ID INFECTION; ANTIBODY; ENHANCEMENT; OUTBREAK; SALVADOR
AB The clinical outcomes associated with Zika virus (ZIKV) in the Americas have been well documented, but other aspects of the pandemic, such as attack rates and risk factors, are poorly understood. We prospectively followed a cohort of 1453 urban residents in Salvador, Brazil, and, using an assay that measured immunoglobulin G3 (IgG3) responses against ZIKV NS1 antigen, we estimated that 73% of individuals were infected during the 2015 outbreak. Attack rates were spatially heterogeneous, varying by a factor of 3 within a community spanning 0.17 square kilometers. Preexisting high antibody titers to dengue virus were associated with reduced risk of ZIKV infection and symptoms. The landscape of ZIKV immunity that now exists may affect the risk for future transmission.
C1 [Rodriguez-Barraquer, Isabel] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Costa, Federico; Nery Junior, Nivison; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, Federico; Nery Junior, Nivison; Sacramento, Gielson Almeida; Cruz, Jaqueline; Carvalho, Mayara; De Olivera, Daiana; Hagan, Jose E.; Wunder, Elsio A., Jr.; Ribeiro, Guilherme S.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Hagan, Jose E.; Adhikarla, Haritha; Wunder, Elsio A., Jr.; Reis, Mitermayer G.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Castanha, Priscila M. S.; Coelho, Danilo F.; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz MS, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [Coelho, Danilo F.] Univ Fed Pernambuco, Dept Fundamental Chem, BR-50740540 Recife, PE, Brazil.
   [Azar, Sasha R.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Ribeiro, Guilherme S.; Reis, Mitermayer G.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Balmaseda, Angel] Sustainable Sci Inst, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Sao Paulo, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA.
   [Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA.
   [Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
RP Ko, AI (corresponding author), Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.; Ko, AI (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Cummings, DAT (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.; Cummings, DAT (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
EM datc@ufl.edu; albert.ko@yale.edu
RI Wunder, Elsio Augusto/C-2733-2013; Costa, Federico/G-1838-2015; Marques,
   Ernesto T. A/L-4967-2013; Reis, Mitermayer/AAO-9742-2020; Coelho, Danilo
   Fernandes/AAC-9206-2020; Nogueira, Mauricio L/B-7599-2012; Ribeiro,
   Guilherme/B-6624-2008; Ko, Albert Icksang/P-2343-2015; CASTANHA,
   PRISCILA/G-1785-2012
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Costa,
   Federico/0000-0001-6951-2336; Marques, Ernesto T. A/0000-0003-3826-9358;
   Reis, Mitermayer/0000-0002-3051-9060; Coelho, Danilo
   Fernandes/0000-0002-1111-0825; Nogueira, Mauricio L/0000-0003-1102-2419;
   Ribeiro, Guilherme/0000-0002-6798-2059; Ko, Albert
   Icksang/0000-0001-9023-2339; CASTANHA, PRISCILA/0000-0002-1220-5308;
   Rocha Nery Junior, Nivison Ruy/0000-0002-8164-0602; Hagan,
   Jose/0000-0002-1837-6319; CRUZ, JAQUELINE/0000-0003-4128-1008
FU Yale School of Public Health; Oswaldo Cruz Foundation, Brazilian
   Ministry of Health; Brazilian National Council for Scientific and
   Technological DevelopmentNational Council for Scientific and
   Technological Development (CNPq) [400830/2013-2, 440891/2016-7];
   Brazilian National Council for Scientific and Technological Development
   (INCT-Dengue); Coordination for the Improvement of Higher Education
   Personnel, Brazilian Ministry of Education [440891/2016-7]; Research
   Support Foundation for the State of Bahia [FAPESB PET0026/2013,
   APP0044/2016, 10206/2015, PET0022/2016]; Research Support Foundation for
   the State of Sao Paulo [FAPESP 2013/21719-3, 2016/15021-1]; CuraZika
   Foundation; Wellcome TrustWellcome Trust [102330/Z/13/Z]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 AI121207, R01 TW009504, R01 AI052473, U01
   AI088752, R25 TW009338, R01 NS064905, R24 AI120942, U01 AI115577, R01
   AI099631, U54 AI065359, P01 AI106695, U19 AI118610, U54 GM088491, R01
   AI114703]; McLaughlin Fellowship Fund
FX Supported by grants from the Yale School of Public Health; Oswaldo Cruz
   Foundation, Brazilian Ministry of Health; Brazilian National Council for
   Scientific and Technological Development (400830/2013-2, 440891/2016-7,
   and INCT-Dengue); Coordination for the Improvement of Higher Education
   Personnel, Brazilian Ministry of Education [440891/2016-7, National
   Postdoctoral Program (PNPD)]; Research Support Foundation for the State
   of Bahia (FAPESB PET0026/2013, APP0044/2016, 10206/2015, and
   PET0022/2016); Research Support Foundation for the State of Sao Paulo
   (FAPESP 2013/21719-3 and 2016/15021-1); CuraZika Foundation
   (curazika.pitt.edu); Wellcome Trust (102330/Z/13/Z); and NIH grants R01
   AI121207, R01 TW009504, R01 AI052473, U01 AI088752, R25 TW009338, R01
   NS064905, R24 AI120942, U01 AI115577, R01 AI099631, U54 AI065359, P01
   AI106695, U19 AI118610, R01 AI114703, and U54 GM088491. S.R.A. was
   funded in part by the McLaughlin Fellowship Fund.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   ANDERSON R M, 1991
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Brazilian Institute of Geography and Statistics, EST POP 2017 CIT BAH
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   R Core Team, 2016, R LANG ENV STAT COMP
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Salvador Secretary of Health, 2018, SIT EP DENG CHIK ZIK
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
NR 43
TC 48
Z9 48
U1 2
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD FEB 8
PY 2019
VL 363
IS 6427
BP 607
EP +
DI 10.1126/science.aav6618
PG 36
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK6SM
UT WOS:000458114200043
PM 30733412
OA Bronze
DA 2020-07-08
ER

PT J
AU Hu, LC
   Huang, MG
   Tang, MX
   Yu, JS
   Zheng, B
AF Hu, Linchao
   Huang, Mugen
   Tang, Moxun
   Yu, Jianshe
   Zheng, Bo
TI Wolbachia spread dynamics in multi-regimes of environmental conditions
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Cytoplasmic incompatibility; Population replacement; Stochastic
   dynamics; Alarm period
ID AEDES-AEGYPTI; DENGUE VIRUS; TEMPERATURE; POPULATION; ALBOPICTUS;
   INFECTION; MOSQUITOS; SURVIVAL; DENSITY; MODELS
AB Mosquito-borne diseases such as dengue fever and Zika kill more than 700,000 people each year in the world. A novel strategy to control these diseases employs the bacterium Wolbachia whose infection in mosquitoes blocks virus replication. The prerequisite for this measure is to release Wolbachia infected mosquitoes to replace wild population. Due to the fluctuation of environmental conditions for mosquito growth, we develop and analyze a model of differential equations with parameters randomly changing over multiple environmental regimes. By comparing the dynamics between the stochastic system and constructed auxiliary systems, combined with other techniques, we provide sharp estimates on the threshold releasing level for Wolbachia fixation. We define the alarm period of disease transmission to measure the risk of mosquito-borne diseases. Our numerical simulations suggest that more frequent inter-regime transitions help reduce the alarm period, and the disease transmission is more sensitive to the average climatic conditions than the number of sub-regimes over a given time period. Further numerical examples also indicate that the reduction in the waiting time to suppress 95% of wild population is more evident when the releasing amount is increased up to a double of the wild population. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Hu, Linchao] Minist Educ, Key Lab Trop Dis Control, Beijing, Peoples R China.
   [Hu, Linchao] Sun Yat Sen Univ, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou 510080, Guangdong, Peoples R China.
   [Huang, Mugen] Guangdong Univ Finance & Econ, Sch Stat & Math, Guangzhou 510320, Guangdong, Peoples R China.
   [Tang, Moxun] Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
   [Yu, Jianshe; Zheng, Bo] Guangzhou Univ, Ctr Appl Math, Guangzhou 510006, Guangdong, Peoples R China.
   [Yu, Jianshe; Zheng, Bo] Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
RP Yu, JS (corresponding author), Guangzhou Univ, Ctr Appl Math, Guangzhou 510006, Guangdong, Peoples R China.; Yu, JS (corresponding author), Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Guangdong, Peoples R China.
EM linchaohu@outlook.com; jsyu@gzhu.edu.cn
FU National Research and Development Plan of China [2016YFC1200500];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11631005]; Science and Technology Planning Project
   of Guangzhou [201704020226]; Natural Science Foundation of Guangdong
   ProvinceNational Natural Science Foundation of Guangdong Province
   [2017A030310597]; Department of Education of Guangdong ProvinceNational
   Natural Science Foundation of Guangdong Province [2007KTSCX148]
FX This work was supported by National Research and Development Plan of
   China (2016YFC1200500), National Natural Science Foundation of China
   (11631005), the Science and Technology Planning Project of Guangzhou
   (201704020226), Natural Science Foundation of Guangdong Province
   (2017A030310597) and Department of Education of Guangdong Province
   (2007KTSCX148).
CR Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Calisher CH, 2005, EMERG INFECT DIS, V11, P738
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012
   Cheng Q, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004417
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   Deng Hui, 2017, Zhonghua Weisheng Shachong Yaoxie, V23, P48
   Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876
   Duan Heng-lu, 2017, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V28, P205
   [段金花 DUAN Jin-hua], 2009, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V20, P51
   Farkas JZ, 2010, B MATH BIOL, V72, P2067, DOI 10.1007/s11538-010-9528-1
   FINE PEM, 1978, J INVERTEBR PATHOL, V31, P10, DOI 10.1016/0022-2011(78)90102-7
   Fischer S, 2011, J VECTOR ECOL, V36, P94, DOI 10.1111/j.1948-7134.2011.00145.x
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121
   Hu L, 2018, J DIFFER EQUATIONS, DOI [10.1016/j.jde.2018.09, DOI 10.1016/J.JDE.2018.09]
   Hu LC, 2015, THEOR POPUL BIOL, V106, P32, DOI 10.1016/j.tpb.2015.09.003
   Huang MG, 2015, SCI CHINA MATH, V58, P77, DOI 10.1007/s11425-014-4934-8
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LAVEN H, 1956, NATURE, V177, P141, DOI 10.1038/177141a0
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Troncoso A, 2016, ASIAN PAC J TROP BIO, V6, P520, DOI 10.1016/j.apjtb.2016.04.004
   Van Z., 2010, J TROP MED, V10, P606
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weeks AR, 2002, TRENDS ECOL EVOL, V17, P257, DOI 10.1016/S0169-5347(02)02480-1
   Wiwatanaratanabutr S, 2006, MED VET ENTOMOL, V20, P300, DOI 10.1111/j.1365-2915.2006.00640.x
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Ye YXH, 2016, EVOLUTION, V70, P2459, DOI 10.1111/evo.13039
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zhang XH, 2015, MATH BIOSCI, V269, P164, DOI 10.1016/j.mbs.2015.09.004
   Zheng B, 2018, J BIOL DYNAM, V12, P596, DOI 10.1080/17513758.2018.1499969
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
NR 39
TC 3
Z9 3
U1 3
U2 20
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD FEB 7
PY 2019
VL 462
BP 247
EP 258
DI 10.1016/j.jtbi.2018.11.009
PG 12
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA HH8HN
UT WOS:000455972600020
PM 30448462
DA 2020-07-08
ER

PT J
AU Reichert, W
   Ejercito, J
   Guda, T
   Dong, XJ
   Wu, QL
   Ray, A
   Simon, JE
AF Reichert, William
   Ejercito, Jadrian
   Guda, Tom
   Dong, Xujun
   Wu, Qingli
   Ray, Anandasankar
   Simon, James E.
TI Repellency Assessment of Nepeta cataria Essential Oils and Isolated
   Nepetalactones on Aedes aegypti
SO SCIENTIFIC REPORTS
LA English
DT Article
ID N,N-DIETHYL-M-TOLUAMIDE DEET; PERSONAL PROTECTION; GLOBAL DISTRIBUTION;
   CATNIP OIL; MOSQUITO; PLANTS; ANOPHELES; EDUCATION; DIPTERA; HEALTH
AB There is an increased need for improved and affordable insect repellents to reduce transmission of rapidly spreading diseases with high mortality rates. Natural products are often used when DEET cannot be afforded or accessed and when consumers choose not to use a synthetic repellent. The essential oils from two newly bred Nepeta cataria (catnip) plants representing two different chemotypes and their respective isolated nepetalactone isomers were evaluated as mosquito repellents against Aedes aegypti mosquitoes that transmit the Zika and Dengue virus in a one choice landing rate inhibition assay. A dose response curve was generated for each treatment and a time course analysis of repellency was performed over 24 hours with a N. cataria essential oil sample. The results indicate that all essential oil samples and their respective purified nepetalactone isomers were able to achieve greater than 95% repellency. Between two and four hours, the ability to repel more than 95% of the mosquitoes diminished. At the lowest concentrations tested, the nepetalactones and crude essential oil samples were more effective than DEET at reducing the number of mosquito landings.
C1 [Reichert, William; Dong, Xujun; Wu, Qingli; Simon, James E.] Rutgers State Univ, Dept Plant Biol, New Use Agr & Nat Plant Prod Program, New Brunswick, NJ 08901 USA.
   [Ejercito, Jadrian; Guda, Tom; Ray, Anandasankar] Univ Calif Riverside, Dept Mol Cell & Syst Biol, Riverside, CA 92521 USA.
   [Dong, Xujun] Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China.
   [Wu, Qingli; Simon, James E.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Med Chem, Piscataway, NJ 08854 USA.
RP Simon, JE (corresponding author), Rutgers State Univ, Dept Plant Biol, New Use Agr & Nat Plant Prod Program, New Brunswick, NJ 08901 USA.; Simon, JE (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Med Chem, Piscataway, NJ 08854 USA.
EM jimsimon@rutgers.edu
OI Ray, Anandasankar/0000-0003-4133-2581
FU New Use Agriculture and Natural Plant Products Program; New Jersey
   Agricultural Experiment Station Hatch Project [NJ12158]
FX The authors would like to thank the New Use Agriculture and Natural
   Plant Products Program and the New Jersey Agricultural Experiment
   Station Hatch Project NJ12158 which provided funding for this work. We
   also thank Ed Dager, Mark Peacos and Harna Patel for their assistance in
   the field and greenhouse production of the catnip samples. The authors
   would also like to thank Chris Bainter at FLIR (R) Systems for his
   assistance in the project. We also thank Eric and Clancy Goodkind, as
   this project would not have been possible without their hospitality.
   Finally, we would like to thank Walter and Barbara Reichert for their
   continual support.
CR Abagli A. Z., 2011, Open Entomology Journal, V5, P45, DOI 10.2174/1874407901105010045
   Abd-Ella A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126406
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358
   Bernier UR, 2005, J MED ENTOMOL, V42, P306, DOI 10.1603/0022-2585(2005)042[0306:COCASR]2.0.CO;2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharya A. K., 1997, Journal of Essential Oil Research, V9, P361
   Birkett MA, 2011, PHYTOCHEMISTRY, V72, P109, DOI 10.1016/j.phytochem.2010.09.016
   Calafat AM, 2016, ENVIRON INT, V92-93, P398, DOI 10.1016/j.envint.2016.04.021
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   Carroll SP, 2006, J AM MOSQUITO CONTR, V22, P507, DOI 10.2987/8756-971X(2006)22[507:PARBMR]2.0.CO;2
   Chalchat J. C., 1997, Journal of Essential Oil Research, V9, P527
   Chauhan KR, 2005, J MED ENTOMOL, V42, P643, DOI 10.1603/0022-2585(2005)042[0643:FDEOCO]2.0.CO;2
   Chen-Hussey V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-173
   Clements A.N., 2012, BIOL MOSQUITOES, V3
   Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47
   Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121
   Gertler S. I., 1946, U.S. Patent, Patent No. [2,408,389, 2408389]
   Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Javidnia K, 2011, CHEM NAT COMPD+, V47, P843, DOI 10.1007/s10600-011-0080-5
   Kilic O, 2013, ASIAN J CHEM, V25, P8181, DOI 10.14233/ajchem.2013.15531
   Kitchen LW, 2009, J VECTOR ECOL, V34, P50, DOI [10.1111/j.1948-7134.2009.00007.x, 10.3376/038.034.0107]
   Klun JA, 2001, J MED ENTOMOL, V38, P809, DOI 10.1603/0022-2585-38.6.809
   Laska M, 2001, BEHAV NEUROSCI, V115, P632, DOI 10.1037/0735-7044.115.3.632
   Legeay S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28546
   Liblikas I, 2005, J NAT PROD, V68, P886, DOI 10.1021/np049647d
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285
   Misic D, 2015, PHYTOCHEM ANALYSIS, V26, P72, DOI 10.1002/pca.2538
   Morales MR, 1997, HORTSCIENCE, V32, P148, DOI 10.21273/HORTSCI.32.1.148
   Muller GC, 2008, J AM MOSQUITO CONTR, V24, P150, DOI 10.2987/8756-971X(2008)24[150:IPAMAS]2.0.CO;2
   OBICO JJA, 2014, PHILIPP SCI LETT, V7, P179
   Odalo JO, 2005, ACTA TROP, V95, P210, DOI 10.1016/j.actatropica.2005.06.007
   Peterson C. J., 2001, RECENT DEV INVERTEBR, V1090, P59
   Pickett JA, 2008, P NATL ACAD SCI USA, V105, P13195, DOI 10.1073/pnas.0807167105
   Pooter H. L. de, 1988, Flavour and Fragrance Journal, V3, P155, DOI 10.1002/ffj.2730030404
   Qiu H, 1997, Pharm Dev Technol, V2, P33, DOI 10.3109/10837459709022607
   Rana V. S., 2016, Journal of Herbs, Spices & Medicinal Plants, V22, P289
   Rasband W. S., 2016, IMAGE J VERSION 1 50
   Reichert W, 2016, HORTSCIENCE, V51, P588, DOI 10.21273/HORTSCI.51.5.588
   Schultz G, 2004, ENVIRON ENTOMOL, V33, P1562, DOI 10.1603/0046-225X-33.6.1562
   Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511
   Sharma S, 2013, PHARMACOPHORE, V4, P134
   SHARMA VP, 1994, J MED ENTOMOL, V31, P505, DOI 10.1093/jmedent/31.3.505
   Simonnet X., 2004, PLANTA MED, V79
   Swale D. R., 2012, CHARACTERIZATION INS
   Tawatsin A, 2001, J VECTOR ECOL, V26, P76
   Ulama D., 2016, IBISWORLD IND REPORT, P1
   van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785
   WALLER GR, 1969, SCIENCE, V164, P1281, DOI 10.1126/science.164.3885.1281
   WHO, 1996, CTDWHOPESIC961
   WHO, 2017, MAL FACT SHEET
   WHO, 2016, ZIK VIR MICR GUILL B, P1
   Willcox ML, 2004, BMJ-BRIT MED J, V329, P1156, DOI 10.1136/bmj.329.7475.1156
   World Health Organization, 2017, YELL FEV FACT SHEET
   World Health Organization, 2017, DENG SEV DENG FACT S
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
   Yasuoka J, 2006, AM J TROP MED HYG, V74, P1034, DOI 10.4269/ajtmh.2006.74.1034
   Zhu JJ, 2009, MED VET ENTOMOL, V23, P209, DOI 10.1111/j.1365-2915.2009.00809.x
NR 60
TC 4
Z9 5
U1 3
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 6
PY 2019
VL 9
AR 1524
DI 10.1038/s41598-018-36814-1
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK4CS
UT WOS:000457868400070
PM 30728370
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Russell, WA
   Stramer, SL
   Busch, MP
   Custer, B
AF Russell, W. Alton
   Stramer, Susan L.
   Busch, Michael P.
   Custer, Brian
TI Screening the Blood Supply for Zika Virus in the 50 US States and Puerto
   Rico A Cost-Effectiveness Analysis
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; BABESIA-MICROTI; TRANSFUSION; TRANSMISSION;
   INFECTION; DONATIONS; OUTBREAK; SURVIVAL; RISK
AB Background: In 2016, universal individual donation nucleic acid testing (ID-NAT) of donated blood for Zika virus began in U.S. states and territories.
   Objective: To assess the cost-effectiveness of universal ID-NAT in the first year of screening compared with alternatives for the 50 states and separately for Puerto Rico.
   Design: Microsimulation that captured Zika-related harms to transfusion recipients, sexual partners, and their infants.
   Data Sources: National testing results compiled by AABB and costs, utilities, and outcome probabilities estimated from the literature.
   Target Population: Transfusion recipients.
   Time Horizon: Lifetime.
   Perspective: Societal.
   Intervention: Universal ID-NAT, universal mini-pool NAT (MP-NAT), and ID-NAT exclusively for components transfused to women of childbearing age. Seasonally targeted strategies in Puerto Rico and geographically targeted strategies in the 50 states were also considered.
   Outcome Measures: Costs, quality-adjusted life-years (QALYs), and outcomes.
   Results of Base-Case Analysis: In Puerto Rico, MP-NAT exclusively during high mosquito season was cost-effective at $81 123 per QALY (95% CI, -$49 138 to $978 242 per QALY). No screening policy was cost-effective in the 50 states. Universal ID-NAT cost $341 million per QALY (CI, $125 million to $2.90 billion per QALY) compared with no screening in the 50 states.
   Results of Sensitivity Analysis: In Puerto Rico, MP-NAT only during the season of high mosquito activity was most cost-effective in 64% of probabilistic sensitivity analysis iterations. In the 50 states, no intervention was cost-effective in 99.99% of iterations. Cost-effectiveness was highly dependent on the rate of assumed infectious donations.
   Limitation: Data were limited on the component-specific transmissibility of Zika and long-term sequelae of infection.
   Conclusion: Screening was cost-effective only in the high mosquito season in Puerto Rico, and no evaluated screening policy was cost-effective in the 50 states. During periods with lower rates of Zika-infectious donations, the cost-effectiveness of screening will be even less favorable.
C1 [Russell, W. Alton] Stanford Univ, Stanford, CA 94305 USA.
   [Stramer, Susan L.] Amer Red Cross, Gaithersburg, MD USA.
   [Busch, Michael P.; Custer, Brian] Vitalant Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
   [Busch, Michael P.; Custer, Brian] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Russell, W. Alton] Stanford Univ, Huang Engn Ctr, Management Sci & Engn, 475 Via Ortega, Stanford, CA 94305 USA.
   [Stramer, Susan L.] Amer Red Cross, Sci Affairs, 9315 Gaither Rd, Gaithersburg, MD 20877 USA.
RP Russell, WA (corresponding author), Stanford Univ, Huang Engn Ctr, Management Sci & Engn, 475 Via Ortega, Stanford, CA 94305 USA.
EM altonr@stanford.edu
OI Russell, W Alton/0000-0003-1780-4470
FU Vitalant Research Institute
FX Mr. Russell was funded as an intern and contractor by Vitalant Research
   Institute. No external funding was received.
CR Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4
   Anez G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004445
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bell CF, 2003, CLIN THER, V25, P2464, DOI 10.1016/S0149-2918(03)80288-6
   Besnard M, 2014, EURO SURVEILL, V19
   Bish EK, 2015, TRANSFUSION, V55, P2256, DOI 10.1111/trf.13136
   Bureau of Transportation Statistics, 1995, 1995 AM TRAV SURV PR
   Busch MP, 2017, 2017 US FOOD DRUG AD
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2017, COM ZIK VIR DIS CAS
   Centers for Disease Control and Prevention, 2018, ZIK VIR 2018 CAS COU
   Centers for Disease Control and Prevention, 2016, ZIK VIR 2016 CAS COU
   Curtin S., 2015, 2010 PREGNANCY RATES
   Custer B, 2005, ANN INTERN MED, V143, P486, DOI 10.7326/0003-4819-143-7-200510040-00007
   Custer B, 2017, Vox Sang, V112, P526, DOI 10.1111/vox.12538
   Custer B, 2010, TRANSFUSION, V50, P2461, DOI 10.1111/j.1537-2995.2010.02704.x
   Custer B, 2009, TRANSFUS MED REV, V23, P1, DOI 10.1016/j.tmrv.2008.09.001
   De Vivo M, 2011, TOPICS SPINAL CORD I, V16, P1, DOI DOI 10.1310/SCI1604-1
   Department of Health and Human Services; U. S. Food and Drug Administration, 2017, 116 M BLOOD PROD ADV
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellingson KD, 2017, TRANSFUSION, V57, P1588, DOI 10.1111/trf.14165
   Ellingson KD, 2017, TRANSFUSION, V57, P1625, DOI 10.1111/trf.14164
   Forsberg A, 2005, CLIN REHABIL, V19, P900, DOI 10.1191/0269215505cr918oa
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Goodell AJ, 2014, TRANSFUSION, V54, P2245, DOI 10.1111/trf.12805
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x
   Hollmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060477
   Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x
   Jalal H, 2013, MED DECIS MAKING, V33, P880, DOI 10.1177/0272989X13492014
   Kamper-Jorgensen M, 2008, TRANSFUSION, V48, P2577, DOI 10.1111/j.1537-2995.2008.01881.x
   Kleinman S, 2004, TRANSFUSION, V44, P386, DOI 10.1111/j.1537-2995.2003.00660.x
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marshall DA, 2004, VOX SANG, V86, P28, DOI 10.1111/j.0042-9007.2004.00379.x
   Matos D, 2016, TRANSFUSION, V56, P215, DOI 10.1111/trf.13288
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murphy MSQ, 2017, TRANSFUSION, V57, P811, DOI 10.1111/trf.14001
   Musso D., 2014, EURO SURVEILL, V19
   O'Brien SF, 2016, TRANSFUSION, V56, DOI [10.1111/trf.13807, DOI 10.1111/TRF.13807]
   Oehler E, 2014, EURO SURVEILL, V19
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Simon MS, 2014, TRANSFUSION, V54, P889, DOI 10.1111/trf.12492
   Stramer SL, 2017, 2017 AM ASS BLOOD BA
   U.S. Food and Drug Administration, 2016, REV REC RED RISK ZIK
   U.S. Food and Drug Administration, 2018, REV REC RED RISK ZIK
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
NR 59
TC 8
Z9 8
U1 0
U2 0
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD FEB 5
PY 2019
VL 170
IS 3
BP 164
EP +
DI 10.7326/M18-2238
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA HK2IZ
UT WOS:000457735100004
PM 30615781
DA 2020-07-08
ER

PT J
AU Salazar, V
   Jagger, BW
   Mongkolsapaya, J
   Burgomaster, KE
   Dejnirattisai, W
   Winkler, ES
   Fernandez, E
   Nelson, CA
   Fremont, DH
   Pierson, TC
   Crowe, JE
   Screaton, GR
   Diamond, MS
AF Salazar, Vanessa
   Jagger, Brett W.
   Mongkolsapaya, Juthathip
   Burgomaster, Katherine E.
   Dejnirattisai, Wanwisa
   Winkler, Emma S.
   Fernandez, Estefania
   Nelson, Christopher A.
   Fremont, Daved H.
   Pierson, Theodore C.
   Crowe, James E., Jr.
   Screaton, Gavin R.
   Diamond, Michael S.
TI Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect
   against Spondweni Virus Infection and Pathogenesis in Mice
SO CELL REPORTS
LA English
DT Article
ID NEUTRALIZING HUMAN-ANTIBODIES; MOUSE MODEL; MEDIATED PROTECTION;
   CHIKUNGUNYA VIRUS; STRUCTURAL BASIS; ENHANCEMENT; VIREMIA; DETERMINANTS;
   RECOGNITION; EPIDEMIC
AB Spondweni virus (SPOV) is the flavivirus that is most closely related to Zika virus (ZIKV). Although SPOV causes sporadic human infections in Africa, recently it was found in Culex mosquitoes in Haiti. To investigate the pathogenic spectrum of SPOV, we developed infection models in mice. Although two SPOV strains failed to cause disease in immunocompetent mice, each accumulated in the brain, spleen, eye, testis, and kidney when type I interferon signaling was blocked and unexpectedly caused infection, immune cell infiltration, and swelling in the ankle. In pregnant mice, SPOV replicated in the placenta and fetus but did not cause placental insufficiency or microcephaly. We identified human antibodies from ZIKV or DENV immune subjects that neutralized SPOV infection and protected against lethal challenge. Our experiments describe similarities and differences in clinical syndromes between SPOV and ZIKV and suggest that their serological relatedness has implications for antibody therapeutics and flavivirus vaccine development.
C1 [Salazar, Vanessa; Jagger, Brett W.; Winkler, Emma S.; Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA.
   [Mongkolsapaya, Juthathip; Dejnirattisai, Wanwisa; Screaton, Gavin R.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England.
   [Mongkolsapaya, Juthathip] Mahidol Univ, Off Res & Dev, Dengue Hemorrhag Fever Res Unit, Siriraj Hosp,Fac Med, Bangkok 10700, Thailand.
   [Winkler, Emma S.; Fernandez, Estefania; Nelson, Christopher A.; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.
   [Burgomaster, Katherine E.; Pierson, Theodore C.] NIAID, Lab Viral Dis, NIH, Bethesda, MD 20892 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat, Med Ctr, Nashville, TN 37232 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Pathol Microbiol & Immunol, Nashville, TN 37232 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.
   [Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019; Crowe, James E./B-5549-2009; amsalu,
   ribka/G-8780-2019
OI Diamond, Michael/0000-0002-8791-3165; Crowe, James
   E./0000-0002-0049-1079; Screaton, Gavin/0000-0002-3549-4309; Salazar,
   Vanessa/0000-0002-1947-6039
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI127828, R01
   HD091218, T32 AI007163, T32 AI007172, HHSN272201200026C]; NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID); Wellcome TrustWellcome Trust; National Institute for
   Health Research Biomedical Research Centre funding scheme UK; MRC-NEWTON
   UK
FX This work was supported by grants from the NIH (R01 AI073755, R01
   AI127828, and R01 HD091218 to M.S.D.; R01 AI127828 to M.S.D. and J.E.C.;
   T32 AI007163 to E.F.; T32 AI007172 to B.W.J.; and HHSN272201200026C
   [CSGID] to D.H.F.), the intramural research program of NIAID (T.C.P.),
   Wellcome Trust to G.R.S., MRC-NEWTON UK to J.M., and The National
   Institute for Health Research Biomedical Research Centre funding scheme
   UK. We thank Bin Cao and Indira Mysorekar for tissue processing and
   Julie Fox for advice on statistical analysis.
CR Aliota MT, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006964
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   DRAPER C C, 1965, West Afr Med J, V14, P16
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fox JM, 2016, J IMMUNOL, V197, P4210, DOI 10.4049/jimmunol.1601426
   Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P103
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   White SK, 2018, EMERG INFECT DIS, V24, P1765, DOI 10.3201/eid2409.171957
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 52
TC 2
Z9 2
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 5
PY 2019
VL 26
IS 6
BP 1585
EP +
DI 10.1016/j.celrep.2019.01.052
PG 17
WC Cell Biology
SC Cell Biology
GA HK2AI
UT WOS:000457709200018
PM 30726740
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Puerta-Guardo, H
   Glasner, DR
   Espinosa, DA
   Biering, SB
   Patana, M
   Ratnasiri, K
   Wang, CL
   Beatty, PR
   Harris, E
AF Puerta-Guardo, Henry
   Glasner, Dustin R.
   Espinosa, Diego A.
   Biering, Scott B.
   Patana, Mark
   Ratnasiri, Kalani
   Wang, Chunling
   Beatty, P. Robert
   Harris, Eva
TI Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction
   Reflecting Disease Tropism
SO CELL REPORTS
LA English
DT Article
ID WEST-NILE-VIRUS; NONSTRUCTURAL PROTEIN NS1; DENGUE VIRUS; PLASMA
   LEAKAGE; INFECTION; GLYCOCALYX; PATHOGENESIS; ENHANCEMENT; ASSOCIATION;
   DISRUPTION
AB Flaviviruses cause systemic or neurotropic-encephalitic pathology in humans. The flavivirus nonstructural protein 1 (NS1) is a secreted glycoprotein involved in viral replication, immune evasion, and vascular leakage during dengue virus infection. However, the contribution of secreted NS1 from related flaviviruses to viral pathogenesis remains unknown. Here, we demonstrate that NS1 from dengue, Zika, West Nile, Japanese encephalitis, and yellow fever viruses selectively binds to and alters permeability of human endothelial cells from lung, dermis, umbilical vein, brain, and liver in vitro and causes tissue-specific vascular leakage in mice, reflecting the pathophysiology of each flavivirus. Mechanistically, each flavivirus NS1 leads to differential disruption of endothelial glycocalyx components, resulting in endothelial hyperpermeability. Our findings reveal the capacity of a secreted viral protein to modulate endothelial barrier function in a tissue-specific manner both in vitro and in vivo, potentially influencing virus dissemination and pathogenesis and providing targets for antiviral therapies and vaccine development.
C1 [Puerta-Guardo, Henry; Glasner, Dustin R.; Espinosa, Diego A.; Biering, Scott B.; Patana, Mark; Ratnasiri, Kalani; Wang, Chunling; Beatty, P. Robert; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
OI Glasner, Dustin/0000-0001-9821-6683; Espinosa, Diego
   A./0000-0002-4364-5031; Ratnasiri, Kalani/0000-0001-5953-0004; Biering,
   Scott/0000-0003-1991-629X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI24493]
FX We thank Carmel Malvar for her help with expression and purification of
   the recombinant NS1 protein DENV<SUP>WNV101-135</SUP> and Jeffrey Shu
   for his assistance with western blots. We thank Aravinda M. de Silva at
   the University of North Carolina, Chapel Hill for his kind donation of
   the baculovirus system used to produce the recombinant E protein from
   DENV2. We also thank B. Lamason, A. Azliyati, and Ana Rodriguez for
   facilitating transfer of HMEC-1, HPMEC-ST1.6R, and HBMECs, respectively.
   This work was supported by NIH grant R01 AI24493 (E.H.). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200
   Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Chen HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004828
   Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006
   Chung KM, 2008, J MED VIROL, V80, P547, DOI 10.1002/jmv.21091
   Connolly-Andersen AM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu027
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Diamond MS, 2004, NAT MED, V10, P1294, DOI 10.1038/nm1204-1294
   Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Hertz T, 2017, J IMMUNOL, V198, P4025, DOI 10.4049/jimmunol.1700029
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar R, 2008, J NEUROL SCI, V269, P41, DOI 10.1016/j.jns.2007.12.018
   Lai YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07308-3
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Puerta-Guardo H, 2013, J VIROL, V87, P7486, DOI 10.1128/JVI.00085-13
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   Ribeiro CF, 2017, INT J INFECT DIS, V55, P109, DOI 10.1016/j.ijid.2017.01.002
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Soni Brijesh K, 2017, Indian J Radiol Imaging, V27, P125, DOI 10.4103/ijri.IJRI_322_16
   Spindler KR, 2012, TRENDS MICROBIOL, V20, P282, DOI 10.1016/j.tim.2012.03.009
   Suwarto S, 2017, J INFECT DIS, V215, P992, DOI 10.1093/infdis/jix041
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang THC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46191
   Trung DT, 2010, CURR TOP MICROBIOL, V338, P57, DOI 10.1007/978-3-642-02215-9_5
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xu X, 2016, PLOS CURR, V8
NR 49
TC 32
Z9 33
U1 3
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 5
PY 2019
VL 26
IS 6
BP 1598
EP +
DI 10.1016/j.celrep.2019.01.036
PG 24
WC Cell Biology
SC Cell Biology
GA HK2AI
UT WOS:000457709200019
PM 30726741
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Vannice, KS
   Cassetti, MC
   Eisinger, RW
   Hombach, J
   Knezevic, I
   Marston, HD
   Wilder-Smith, A
   Cavaleri, M
   Krause, PR
AF Vannice, Kirsten S.
   Cassetti, M. Cristina
   Eisinger, Robert W.
   Hombach, Joachim
   Knezevic, Ivana
   Marston, Hilary D.
   Wilder-Smith, Annelies
   Cavaleri, Marco
   Krause, Philip R.
TI Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH
   meeting report on approaches to development and licensure of Zika
   vaccine candidates
SO VACCINE
LA English
DT Article
DE Zika vaccine; Vaccine licensure; Immunogenicity; Human challenge trials
ID VIRUS; PROTECTION; EFFICACY; IMMUNITY; TRIALS; DENGUE; ASIA
AB Since its peak in early 2016, the incidence of Zika virus (ZIKV) cases has declined to such low levels that Phase 3 field efficacy trials may be infeasible. While great progress was made to rapidly advance several vaccine candidates into Phase 1 and 2 clinical trials, in the absence of sustained viral transmission it may be difficult to evaluate the effectiveness of ZIKV vaccine candidates by conducting traditional clinical disease endpoint efficacy studies. However, ZIKV is still circulating at low levels in some areas and is likely to re-emerge in naive populations or in sites of prior epidemics once population immunity wanes. Therefore, the public health need for a ZIKV vaccine remains. To facilitate continued ZIKV vaccine development efforts, the World Health Organization's Initiative for Vaccine Research and the National Institutes of Health's National Institute of Allergy and Infectious Diseases co-hosted a meeting of experts in March 2018 to identify strategies to demonstrate vaccine effectiveness in view of waning ZIKV disease incidence. This paper outlines points for consideration for developers, regulators, and other stakeholders working towards a licensed ZIKV vaccine. These deliberations may also be applicable to development of vaccines for other emerging infections where the size, unpredictability, and ephemeral nature of outbreaks makes clinical disease endpoint efficacy trials to demonstrate vaccine effectiveness infeasible. (C) 2019 Published by Elsevier Ltd.
C1 [Vannice, Kirsten S.; Hombach, Joachim; Wilder-Smith, Annelies] WHO, Dept Immunizat Vaccines & Biol, Geneva, Switzerland.
   [Cassetti, M. Cristina; Eisinger, Robert W.; Marston, Hilary D.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Knezevic, Ivana] WHO, Dept Essential Med & Hlth Prod, Geneva, Switzerland.
   [Cavaleri, Marco] European Med Agcy, London, England.
   [Krause, Philip R.] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.
RP Vannice, KS (corresponding author), WHO, Dept Immunizat Vaccines & Biol, Geneva, Switzerland.
EM kirsten.vannice@gmail.com
OI Knezevic, Ivana/0000-0002-6441-7601; Krause, Philip/0000-0002-1045-7536
FU World Health OrganizationWorld Health Organization [001]
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   [Anonymous], BLOOD PROD REL BIOL
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027
   Darton TC, 2015, LANCET INFECT DIS, V15, P840, DOI 10.1016/S1473-3099(15)00068-7
   Durbin AP, 2017, J INFECT DIS, V216, pS971, DOI 10.1093/infdis/jix491
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Food and Drug Administration, 2016, SUMM BAS REG ACT VAX
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gruber MF, 2017, J INFECT DIS, V216, pS964, DOI 10.1093/infdis/jix433
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Marshall V, 2011, PEDIATRICS, V127, pS23, DOI 10.1542/peds.2010-1722E
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Moodie Z, 2018, J INFECT DIS, V217, P742, DOI 10.1093/infdis/jix609
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Shah SK, ETHICAL CONSIDERATIO
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   WHO, 2018, ZIK VACC DEV TECHN R
   WHO Expert Committee on Biological Standardization, 2017, TECH REP SER, V1004
   WHO Expert Committee on Biological Standardization, 2017, TECHNICAL REPORT SER, V1004
   WHOc, 2018, LIST BLUEPR PRIOR DI
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   World Health Organization, ZIK VIR DIS
   World Health Organization, EFF TRIALS ZIKV VACC
   World Health Organization, IND PART DAT MET ZIK
   World Health Organization, 2018, MAIN OUTC M WHO EXP
   World Health Organization, WHO GLOB CONS RES RE
NR 42
TC 14
Z9 14
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD FEB 4
PY 2019
VL 37
IS 6
BP 863
EP 868
DI 10.1016/j.vaccine.2018.12.040
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA HK9WH
UT WOS:000458343100014
PM 30639461
OA Green Published, Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Hu, BX
   Huo, YX
   Yang, LP
   Chen, GJ
   Luo, MH
   Yang, JL
   Zhou, JM
AF Hu, Benxia
   Huo, Yongxia
   Yang, Liping
   Chen, Guijun
   Luo, Minhua
   Yang, Jinlong
   Zhou, Jumin
TI ZIKV infection effects changes in gene splicing, isoform composition and
   lncRNA expression in human neural progenitor cells (vol 14, 217, 2017)
SO VIROLOGY JOURNAL
LA English
DT Correction
AB In the original publication of this article [1], two grants from National Science Foundation of China and Yunnan Provincial Government (U1602226) and by National Science Foundation of China (2016YFC1200404) were omitted in the Funding' section. The correct Funding' section is below.
C1 [Hu, Benxia; Huo, Yongxia; Yang, Liping; Chen, Guijun; Zhou, Jumin] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Key Lab Bioact Peptides Yunnan Prov, Kunming 650223, Yunnan, Peoples R China.
   [Hu, Benxia] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650204, Yunnan, Peoples R China.
   [Luo, Minhua] Wuhan Inst Virol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Virol, Wuhan 430071, Peoples R China.
   [Yang, Jinlong] BGI Shenzhen, BGI Yunnan, Kunming 650000, Yunnan, Peoples R China.
   [Yang, Jinlong] Yunnan Univ, Coll Life Sci, Kunming 650091, Yunnan, Peoples R China.
RP Zhou, JM (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Key Lab Bioact Peptides Yunnan Prov, Kunming 650223, Yunnan, Peoples R China.
EM zhoujm@mail.kiz.ac.cn
FU Ministry of Science and Technology of the People's Republic of
   ChinaMinistry of Science and Technology, China [2016YFA0100900]; Chinese
   Academy of SciencesChinese Academy of Sciences [KSCXZ-EW-BR-6]; Kunming
   Institute of Zoology, Chinese Academy of SciencesChinese Academy of
   Sciences [Y102421081]; Yunnan Provincial Government [2013FA051,
   2011HA005]; National Science Foundation of ChinaNational Natural Science
   Foundation of China [NSFC 81471966, NSFC 81672040, 2016YFC1200404];
   National Science Foundation of China and Yunnan Provincial Government
   [U1602226]
FX This work was supported by the Ministry of Science and Technology of the
   People's Republic of China (2016YFA0100900), by a grant from Chinese
   Academy of Sciences (KSCXZ-EW-BR-6) and a startup fund from Kunming
   Institute of Zoology, Chinese Academy of Sciences (Y102421081), by
   grants from Yunnan Provincial Government (2013FA051; 2011HA005) and by
   National Science Foundation of China (NSFC 81471966, NSFC 81672040,
   2016YFC1200404) and a joint grant from National Science Foundation of
   China and Yunnan Provincial Government (U1602226) to JZ.
CR Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
NR 1
TC 1
Z9 1
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD FEB 4
PY 2019
VL 16
AR 17
DI 10.1186/s12985-019-1122-z
PG 1
WC Virology
SC Virology
GA HK3HC
UT WOS:000457803200002
PM 30717754
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, L
   Shen, ZL
   Feng, Y
   Li, DQ
   Zhang, NN
   Deng, YQ
   Qi, XP
   Sun, XM
   Dai, JJ
   Yang, CG
   Yang, ZF
   Qin, CF
   Xia, XS
AF Zhang, Li
   Shen, Zhi-Li
   Feng, Yue
   Li, Dao-Qun
   Zhang, Na-Na
   Deng, Yong-Qiang
   Qi, Xiao-Peng
   Sun, Xiao-Mei
   Dai, Jie-Jie
   Yang, Chun-Guang
   Yang, Zi-Feng
   Qin, Cheng-Feng
   Xia, Xue-Shan
TI Infectivity of Zika virus on primary cells support tree shrew as animal
   model
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Zika virus; tree shrew; primary cells; tropism; infectivity
ID HUMAN ENDOTHELIAL-CELLS; SEXUAL TRANSMISSION; EFFICIENT INFECTION;
   TUPAIA-BELANGERI; HEPATITIS-C; MOUSE MODEL; IN-VITRO; LEADS
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that caused the public health emergency. Recently, we have proved a novel small animal tree shrew was susceptive to ZIKV infection and presented the most common rash symptoms as ZIKV patients. Here we further cultured the primary cells from different tissues of this animal to determine the tissue tropism of ZIKV infection in vitro. The results showed that the primary cells from tree shrew kidney, lung, liver, skin and aorta were permissive to ZIKV infection and could support viral replication by the detection of viral specific RNA intra- and extra-cells. In comparing, the skin fibroblast and vascular endothelial cells were highly permissive to ZIKV infection with high releasing of active virus particles in supernatants proved by its infectivity in established neonatal mouse model. The expressions of ZIKV envelop and nonstructural protein-1, and the effects and strong immune response of primary tree shrew cells were also detected followed by ZIKV infection. These findings provide powerful in vitro cell-level evidence to support tree shrew as animal model of ZIKV infection and may help to explain the rash manifestations in vivo.
C1 [Zhang, Li] Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Yunnan, Peoples R China.
   [Zhang, Li; Shen, Zhi-Li; Feng, Yue; Li, Dao-Qun; Xia, Xue-Shan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Yunnan Prov Ctr Mol Med, Kunming 650500, Yunnan, Peoples R China.
   [Zhang, Na-Na; Deng, Yong-Qiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Qi, Xiao-Peng] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.
   [Sun, Xiao-Mei; Dai, Jie-Jie] Chinese Acad Med Sci, Ctr Tree Shrew Germplasm Resources, Inst Med Biol, Kunming, Yunnan, Peoples R China.
   [Sun, Xiao-Mei; Dai, Jie-Jie] Peking Union Med Coll, Kunming, Yunnan, Peoples R China.
   [Yang, Chun-Guang; Yang, Zi-Feng] Guagnzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.
RP Xia, XS (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Yunnan Prov Ctr Mol Med, Kunming 650500, Yunnan, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM qincf@bmi.ac.cn; oliverxia2000@aliyun.com
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [U1702282, 81471937]; Yunnan provincial
   Innovative Team Project [2015HC030]; Excellent Young Scientist Program
   [81522025]; Innovative Research Group of the NSFC [81621005]; Newton
   Advanced Fellowship from the UK Academy of Medical Sciences
   [NAF003\1003]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) under grant No. U1702282 and No. 81471937; the Yunnan
   provincial Innovative Team Project under grant No. 2015HC030; the
   Excellent Young Scientist Program under grant No. 81522025; the
   Innovative Research Group of the NSFC under grant No. 81621005 and the
   Newton Advanced Fellowship from the UK Academy of Medical Sciences under
   grant No. NAF003\1003.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dewi BE, 2004, J VIROL METHODS, V121, P171, DOI 10.1016/j.jviromet.2004.06.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416
   Feng Y, 2017, J GEN VIROL, V98, P2069, DOI 10.1099/jgv.0.000869
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Kock J, 2001, J VIROL, V75, P5084, DOI 10.1128/JVI.75.11.5084-5089.2001
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee I, 2018, VIRUSES, V10, DOI 10.3390/v10050233
   LIL LIZ, 2016, J VIROL, V90, P790
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   LIXF, 2016, EBIOMEDICINE, V12, P170
   MAW LIS, 2017, CELL, V542, P168
   MAW LIS, 2016, CELL, V1510, P1511
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molina-Sanchez P, 2015, METHODS MOL BIOL, V1339, P111, DOI 10.1007/978-1-4939-2929-0_7
   Morrison TE, 2017, J VIROL, V91
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Seluanov A, 2010, J VISUAL EXP, DOI 10.3791/2033
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tsukiyama-Kohara K, 2014, EXP ANIM TOKYO, V63, P367, DOI 10.1538/expanim.14-0007
   Vervaeke P, 2015, REV MED VIROL, V25, P50, DOI 10.1002/rmv.1818
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Xu XP, 2007, J GEN VIROL, V88, P2504, DOI 10.1099/vir.0.82878-0
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099859
   Yu W, 2016, BMC INFECT DIS, V16, P80
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang NN, 2018, J VIROL MANUSCRIPTS
   CELL, P1511
NR 48
TC 6
Z9 6
U1 0
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD FEB 4
PY 2019
VL 8
IS 1
BP 232
EP 241
DI 10.1080/22221751.2018.1559707
PG 10
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HJ9TI
UT WOS:000457541600001
PM 30866776
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Azar, SR
   Diaz-Gonzalez, EE
   Danis-Lonzano, R
   Fernandez-Salas, I
   Weaver, SC
AF Azar, Sasha R.
   Diaz-Gonzalez, Esteban E.
   Danis-Lonzano, Rogelio
   Fernandez-Salas, Ildefonso
   Weaver, Scott C.
TI Naturally infected Aedes aegypti collected during a Zika virus outbreak
   have viral titres consistent with transmission
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
C1 [Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Diaz-Gonzalez, Esteban E.; Fernandez-Salas, Ildefonso] UANL FCB Monterrey, San Nicolas De Los Garza, Mexico.
   [Danis-Lonzano, Rogelio] Inst Nacl Salud Publ CRISP, Tapachula, Mexico.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
OI Diaz Gonzalez, Esteban Eduardo/0000-0001-6124-3282
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942]; McLaughlin Fellowship
   Fund (SRA)
FX This research was funded in part by NIH grant R24AI120942 (SCW) and the
   McLaughlin Fellowship Fund (SRA).
CR Ayres C, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.86
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Dick G.W.A., 1952, T R SOC TROP MED HYG, V46, P12, DOI [10.1016/0035-9203(52)90042-4, DOI 10.1016/0035-9203(52)90042-4]
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Karna AK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080434
   Kuo YP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006417
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 13
TC 5
Z9 5
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD FEB 4
PY 2019
VL 8
IS 1
BP 242
EP 244
DI 10.1080/22221751.2018.1561157
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HJ9TI
UT WOS:000457541600002
PM 30866777
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aspahan, MC
   Leonhard, SE
   Gomez, RS
   Rocha, ED
   Vilela, MRD
   Alvarenga, PPM
   Marinho, PES
   Kroon, EG
   Meira, F
AF Aspahan, Maira Cardoso
   Leonhard, Sonja Emily
   Gomez, Rodrigo Santiago
   Rocha, Eder da Silva
   da Silva Vilela, Michelle Ramos
   Martins Alvarenga, Pedro Paulo
   Silva Marinho, Paula Eillanny
   Kroon, Erna Geessien
   Meira, Fidel
TI Neuromyelitis optica spectrum disorder associated with Zika virus
   infection
SO NEUROLOGY-CLINICAL PRACTICE
LA English
DT Editorial Material
C1 [Aspahan, Maira Cardoso; Gomez, Rodrigo Santiago; Rocha, Eder da Silva; da Silva Vilela, Michelle Ramos; Meira, Fidel] Madre Teresa Hosp, Dept Neurol, Belo Horizonte, MG, Brazil.
   [Leonhard, Sonja Emily] Erasmus Univ, Med Sch, Dept Neurol, Rotterdam, Netherlands.
   [Martins Alvarenga, Pedro Paulo; Silva Marinho, Paula Eillanny; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Belo Horizonte, MG, Brazil.
RP Aspahan, MC (corresponding author), Madre Teresa Hosp, Dept Neurol, Belo Horizonte, MG, Brazil.
EM maiaspahan@gmail.com
OI Leonhard, Sonja/0000-0003-4832-6926
FU European Union's Horizon 2020 research and innovation programme through
   ZikaPLAN project [734584]; Fundacao de Amparoa Pesquisa do Estado de
   Minas GeraisMinas Gerais State Research Foundation (FAPEMIG); Fundacao
   CAPESCAPES; FAPEMIGMinas Gerais State Research Foundation (FAPEMIG);
   CNpqNational Council for Scientific and Technological Development
   (CNPq); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq)
FX M.C. Aspahan reports no disclosures. S.E. Leonhard reports participation
   on the European Union's Horizon 2020 research and innovation programme
   through ZikaPLAN project under grant agreement no. 734584. R.S. Gomez,
   E. da Silva Rocha, and M. Ramos da Silva Vilela report no disclosures.
   P.P. Martins Alvarenga receives research support from Fundacao de
   Amparoa Pesquisa do Estado de Minas Gerais. P. E. Silva Marinho receives
   research support from Fundacao CAPES, FAPEMIG, and CNpq. E.G. Kroon
   serves as an Associate Editor for Virology Journal and for Frontiers in
   Microbiology and receives research support from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Fundacao CAPES, and FAPEMIG.
   F. Meira reports no disclosures. Full disclosure form information
   provided by the authors is available with the full text of this article
   at Neurology.org/cp.
CR Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Sellner J, 2010, J AUTOIMMUN, V34, P371, DOI 10.1016/j.jaut.2009.09.013
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
NR 7
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2163-0402
EI 2163-0933
J9 NEUROL-CLIN PRACT
JI Neurol.-Clin. Pract.
PD FEB
PY 2019
VL 9
IS 1
BP E1
EP E3
DI 10.1212/CPJ.0000000000000546
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA IF5HL
UT WOS:000473111800001
PM 30859012
OA Green Published
DA 2020-07-08
ER

PT J
AU Carlin, AF
   Shresta, S
AF Carlin, Aaron F.
   Shresta, Sujan
TI Genome-wide approaches to unravelling host-virus interactions in Dengue
   and Zika infections
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID CELL IDENTITY; TRANSCRIPTIONAL ENHANCERS; FUNCTIONAL IMPLICATIONS;
   NEURAL PROGENITORS; SUPER-ENHANCERS; PROTEIN; BRAIN; REPLICATION;
   SELECTION; RISK
AB Genomics approaches are increasingly utilized to probe host viral interactions and identify mechanisms of viral pathogenesis and host-subversion. Here we review recent studies that utilize Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 screens, transcriptomics and epigenomics to gain insight into Dengue and Zika virus infections in humans. We discuss the benefits and limitations of recently utilized techniques that separate virally infected cells from neighboring uninfected cells to identify the mechanisms by which these viruses regulate host responses. We conclude by discussing how these approaches can best advance our understanding of Dengue and Zika virus pathogenesis in humans.
C1 [Carlin, Aaron F.; Shresta, Sujan] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
   [Shresta, Sujan] La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
RP Carlin, AF; Shresta, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.; Shresta, S (corresponding author), La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
EM acarlin@ucsd.edu; sujan@lji.org
FU NIAID/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI116813, R21 AI140063, R21 AI127988];
   Kyowa Kirin Pharmaceutical Research [1KL2TR001444]; Career Award for
   Medical Scientists from the Burroughs Wellcome FundBurroughs Wellcome
   Fund
FX This research was supported by NIAID/NIH grants R01 AI116813, R21
   AI140063, R21 AI127988 and Interactive Fund grant from Kyowa Kirin
   Pharmaceutical Research to SS, and KL2 Scholars: 1KL2TR001444 and a
   Career Award for Medical Scientists from the Burroughs Wellcome Fund to
   AFC.
CR Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787
   BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X
   Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92
   Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bowen JR, 2016, VIRUS RES, V218, P2, DOI 10.1016/j.virusres.2016.01.005
   Caires-Junior LC, 2018, NAT COMMUN, V9
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carlin AF, 2018, P NATL ACAD SCI USA, V115, pE9172, DOI 10.1073/pnas.1807690115
   Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8
   Cologna R, 2003, J VIROL, V77, P3929, DOI 10.1128/JVI.77.7.3929-3938.2003
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]
   Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536
   Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835
   Fields B. N., 2007, FIELDS VIROLOGY
   Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095
   Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gebre M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020055
   Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970
   Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222
   Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gross AM, 2016, MOL CELL, V62, P157, DOI 10.1016/j.molcel.2016.03.019
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hammerschmidt W, EPSTEIN BARR VIRUS, V1
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015
   Heaton BE, 2017, CELL REP, V20, P1503, DOI 10.1016/j.celrep.2017.07.060
   Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966
   Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829
   Heinz S, 2018, CELL, V174, P1522, DOI 10.1016/j.cell.2018.07.047
   Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949
   Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106
   Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053
   Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021
   Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petitt M, 2017, CURR OPIN VIROL, V27, P48, DOI 10.1016/j.coviro.2017.11.008
   Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Romanoski CE, 2015, TRENDS IMMUNOL, V36, P507, DOI 10.1016/j.it.2015.07.006
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x
   Vedham V, 2015, METHODS MOL BIOL, V1238, P333, DOI 10.1007/978-1-4939-1804-1_18
   Venegas M, 2012, ANN HEPATOL, V11, P827, DOI 10.1016/S1665-2681(19)31407-3
   Vreede FT, 2010, VIRULENCE, V1, P436, DOI 10.4161/viru.1.5.12967
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   WENGLER G, 1978, VIROLOGY, V89, P423, DOI 10.1016/0042-6822(78)90185-X
   Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035
   Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.2
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
   Zanini FRM, 2018, BIORXIV
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166
   2011, NATURE, V470, P264, DOI DOI 10.1038/NATURE09753
   2017, CELL REP, V20, P1503, DOI DOI 10.1016/J.CELREP.2017.07.060
NR 114
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD FEB
PY 2019
VL 34
BP 29
EP 38
DI 10.1016/j.coviro.2018.11.010
PG 10
WC Virology
SC Virology
GA HX6JK
UT WOS:000467509700006
PM 30576956
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Huang, YJS
   Higgs, S
   Vanlandingham, DL
AF Huang, Yan-Jang S.
   Higgs, Stephen
   Vanlandingham, Dana L.
TI Emergence and re-emergence of mosquito-borne arboviruses
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS; DENGUE;
   CHIKUNGUNYA; VACCINE; EUROPE; STATES
AB Arthropod-borne viruses (arboviruses) are ecologically distinct from many other pathogens because of the involvement of arthropod vectors and animal reservoirs. Several mosquito-borne arboviruses have emerged in various geographic regions during the past few decades. Since the beginning of the 21st century, the emergence of two mosquito-borne arboviruses, chikungunya and Zika, has taken place globally. Millions of infections have not only changed the epidemiology of previously obscure viruses, but also put the world's public health capability to the test. Newly recognized pathogenic mechanisms and modes of transmission demand the development of new strategies for disease control and treatment. The advancement of vaccine candidates in various phases of clinical trials and the evaluation of vector control strategies in the field provide the promise of new solutions for endemic or emerging diseases. In this review, the emergence of six medically important mosquito-borne arboviruses and new tools for disease control will be discussed.
C1 [Huang, Yan-Jang S.; Higgs, Stephen; Vanlandingham, Dana L.] Kansas State Univ, Dept Diagnost Med Pathobiol, Coll Vet Med, Manhattan, KS 66506 USA.
   [Huang, Yan-Jang S.; Higgs, Stephen; Vanlandingham, Dana L.] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
RP Higgs, S (corresponding author), Kansas State Univ, Dept Diagnost Med Pathobiol, Coll Vet Med, Manhattan, KS 66506 USA.; Higgs, S (corresponding author), Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
EM shiggs@k-state.edu
FU State of Kansas National Bio and Agro-defense Facility Transition Fund
FX This research received funding from the State of Kansas National Bio and
   Agro-defense Facility Transition Fund.
CR Ahuka-Mundeke S, 2018, NEW ENGL J MED, P1
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   Chippaux JP, 2018, J VENOM ANIM TOXINS, V24, DOI 10.1186/s40409-018-0162-y
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405
   Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022
   de Wispelaere M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005294
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Halstead SB, 2018, CHIKUNGUNYA ZIKA VIR, P69
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Heffelfinger JD, 2017, MMWR-MORBID MORTAL W, V66, P579, DOI 10.15585/mmwr.mm6622a3
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Kobayashi D, 2018, AM J TROP MED HYG, V98, P1460, DOI 10.4269/ajtmh.17-0954
   Li WF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004806
   Lyons AC, 2018, VECTOR-BORNE ZOONOT, V18, P469, DOI 10.1089/vbz.2018.2283
   Malla S, 2008, EMERG INFECT DIS, V14, P1669, DOI 10.3201/eid1410.080432
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Nemeth N, 2012, AM J TROP MED HYG, V87, P760, DOI 10.4269/ajtmh.2012.12-0141
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pandey Basu Dev, 2004, Nepal Med Coll J, V6, P157
   Park SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26208-8
   Reed W, 1902, J HYG-CAMBRIDGE, V2, P101, DOI 10.1017/S0022172400001856
   Reiter P, 2010, EUROSURVEILLANCE, V15, P4
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Ricklin ME, 2016, VET RES, V47, DOI 10.1186/s13567-016-0319-z
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Schuh AJ, 2014, J VIROL, V88, P4522, DOI 10.1128/JVI.02686-13
   Seki Naomi, 2015, Nihon Koshu Eisei Zasshi, V62, P238, DOI 10.11236/jph.62.5_238
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Succo T, 2016, EURO SURVEILL, V21
   Sunwoo JS, 2016, EMERG INFECT DIS, V22, P1841, DOI 10.3201/eid2210.160288
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Valiant WG, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy151
   Van der Stuyft P, 1999, LANCET, V353, P1558, DOI 10.1016/S0140-6736(99)03291-2
   Wouthuyzen-Bakker M, 2017, EURO SURVEILL, V22
   Yang L, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.57
   2011, J VIROL, V85, P2964, DOI DOI 10.1128/JVI.01963-10
   2011, EMERG INFECT DIS, V17, P880, DOI DOI 10.3201/EID1705.101939
   2017, EMERG INFECT DIS, V23, P1883, DOI DOI 10.3201/EID2311.161443
   2017, CURR CLIN MICROBIOL, V4, P208, DOI DOI 10.1007/S40588-017-0076-4
NR 51
TC 11
Z9 11
U1 3
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD FEB
PY 2019
VL 34
BP 104
EP 109
DI 10.1016/j.coviro.2019.01.001
PG 6
WC Virology
SC Virology
GA HX6JK
UT WOS:000467509700015
PM 30743191
DA 2020-07-08
ER

PT J
AU Wilson, N
AF Wilson, Niki
TI New World Zika Exchange
SO NATURAL HISTORY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURAL HISTORY MAGAZINE
PI NEW YORK
PA 36 WEST 25TH STREET, FIFTH FLOOR, NEW YORK, NY 10010 USA
SN 0028-0712
J9 NAT HIST
JI Nat. Hist.
PD FEB
PY 2019
VL 127
IS 2
BP 7
EP 7
PG 1
WC Biodiversity Conservation; Ecology
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA HI3ML
UT WOS:000456354200004
DA 2020-07-08
ER

PT J
AU Palermo, PM
   De la Mora-Covarrubias, A
   Jimenez-Vega, F
   Watts, DM
AF Palermo, Pedro M.
   De la Mora-Covarrubias, Antonio
   Jimenez-Vega, Florinda
   Watts, Douglas M.
TI Serological Evidence of Dengue and West Nile Virus Human Infection in
   Juarez City, Mexico
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Dengue; West Nile; antibodies; Ciudad Juarez
ID UNITED-STATES; VECTOR-BORNE; TEXAS; FEVER; TRANSMISSION; BORDER; RISK;
   SURVEILLANCE; CIRCULATION; ALBOPICTUS
AB Arboviruses are significant causes of human and animal diseases, globally. In the Rio Grande Valley of the United States-Mexico border region, endemic transmission of Dengue (DENV), Zika (ZIKV), and West Nile (WNV) viruses have been documented as a cause of human disease. Otherwise, very little is known about the distribution of arboviruses and their possible cause of human disease in other areas of the United States-Mexico border region. Therefore, a pilot serosurvey was conducted to determine if there was evidence of DENV and WNV infection among a human cohort in Anapra, Ciudad Juarez, Mexico. Baseline blood samples were obtained from 78 participants during May-June, 2015 and from 60 of the same participants again during November-December, 2015, and all the samples were tested for DENV and WNV indirect immunoglobulin G antibodies by an enzyme-linked immunosorbent assay and plaque reduction neutralization test (PRNT). The results showed that 14.1% (n = 11) of the 78 participants had neutralizing antibody to DENV and 5.13% (n = 4) had WNV-neutralizing antibody. Among 48 of 60 participants who were negative for DENV and WNV antibody during the baseline survey, 10.4% (n = 5) had acquired antibody to DENV (n = 4) and WNV (n = 1) by the second survey during November-December, 2015. These data support the local transmission of DENV and WNV in the Anapra, Ciudad Juarez community and therefore warrant further epidemiological studies to better understand the dynamics of transmission of these viruses in this United States-Mexico border city.
C1 [Palermo, Pedro M.; Watts, Douglas M.] Univ Texas El Paso, Dept Biol Sci, 500 West Univ Ave Vet Serv, El Paso, TX 79968 USA.
   [Palermo, Pedro M.; Watts, Douglas M.] Univ Texas El Paso, Border Biomed Res Ctr, 500 West Univ Ave Vet Serv, El Paso, TX 79968 USA.
   [De la Mora-Covarrubias, Antonio; Jimenez-Vega, Florinda] Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Juarez City, Mexico.
RP Palermo, PM (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 West Univ Ave Vet Serv, El Paso, TX 79968 USA.; Palermo, PM (corresponding author), Univ Texas El Paso, Border Biomed Res Ctr, 500 West Univ Ave Vet Serv, El Paso, TX 79968 USA.
EM ppalermo@utep.edu
CR Abell A, 2007, MMWR-MORBID MORTAL W, V56, P822
   [Anonymous], 2016, ARBONET CDC NATL SUR
   ANSARI MZ, 1993, J CLIN LAB ANAL, V7, P230, DOI 10.1002/jcla.1860070408
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blitvich BJ, 2003, EMERG INFECT DIS, V9, P853
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Cardenas VM, 2011, ANN EPIDEMIOL, V21, P922, DOI 10.1016/j.annepidem.2011.08.001
   Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1
   Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P841
   Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P57
   Centers for Disease Control (CDC), 1987, MMWR-MORBID MORTAL W, V36, P579
   Champion SR, 2014, ENVIRON HEALTH INSIG, V8, P35, DOI 10.4137/EHI.S16004
   de la Mora-Covarrubias A., 2008, Universidad y Ciencias, V24, P101
   De la Mora-Covarrubias A, 2011, CIENC FRONT REV CIEN, V9, P55
   De la Mora-Covarrubias A, 2007, REV SALUD PUBLICA NU, V8, P3
   de la Mora-Covarrubias A, 2010, SALUD PUBLICA MEXICO, V52, P127, DOI 10.1590/s0036-36342010000200004
   Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004
   Directorate General of Epidemiology (DGE) Secretariat of Health of Mexico, 2017, EP PROSP DENG 2017
   Directorate General of Epidemiology (DGE) Secretariat of Health of Mexico, 2016, EP PROSP DENG 2016
   Elizondo-Quiroga D, 2005, EMERG INFECT DIS, V11, P1449, DOI 10.3201/eid1109.050121
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Estrada-Franco JG, 2003, EMERG INFECT DIS, V9, P1604, DOI 10.3201/eid0912.030564
   Fernandez-Salas I, 2003, VECTOR-BORNE ZOONOT, V3, P209, DOI 10.1089/153036603322662192
   Rodriguez MDG, 2010, VECTOR-BORNE ZOONOT, V10, P151, DOI 10.1089/vbz.2008.0203
   Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HAFKIN B, 1982, AM J TROP MED HYG, V31, P1222, DOI 10.4269/ajtmh.1982.31.1222
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000256
   Hotta Susumu, 1998, Medical Entomology and Zoology, V49, P267
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   Jones JM, 2016, MMWR-MORBID MORTAL W, V65, P495, DOI 10.15585/mmwr.mm6519a3
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MALISON MD, 1983, JAMA-J AM MED ASSOC, V249, P496, DOI 10.1001/jama.249.4.496
   Mann BR, 2013, VIROLOGY, V436, P75, DOI 10.1016/j.virol.2012.10.023
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   National Institute of Statistic and Geography (INEGI), 2014, 2 CENS POP HOUS RES
   National Institute of Statistic and Geography (INEGI), 2015, STAT GEOGR ANN REP C
   Pew Hispanic Center, 2015, STAT PORTR HISP US
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Rios-Ibarra C, 2010, EMERG INFECT DIS, V16, P741, DOI 10.3201/eid1604.091614
   RODRIGUEZFIGUEROA L, 1995, AM J TROP MED HYG, V52, P496, DOI 10.4269/ajtmh.1995.52.496
   Ruiz Hernández Iván Elías, 2015, Invest. Geog, V0, P88, DOI 10.14350/rig.41793
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Texas Department of State Health Services, 2016 ARB ACT REP WEE
   Thomas DL, 2016, EMERG INFECT DIS, V22, P1002, DOI 10.3201/eid2206.152000
   Vitek CJ, 2014, J MED ENTOMOL, V51, P1019, DOI 10.1603/ME13005
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
NR 58
TC 0
Z9 0
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD FEB 1
PY 2019
VL 19
IS 2
BP 134
EP 141
DI 10.1089/vbz.2018.2302
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HR7ZT
UT WOS:000463374600009
PM 30160620
DA 2020-07-08
ER

PT J
AU Brito-Sierra, CA
   Kaur, J
   Hill, CA
AF Brito-Sierra, Carlos A.
   Kaur, Jasleen
   Hill, Catherine A.
TI Protocols for Testing the Toxicity of Novel Insecticidal Chemistries to
   Mosquitoes
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Biology; Issue 144; Mosquito; Aedes aegypti; Anopheles gambiae; Culex
   quinquefasciatus; larvicide; adulticide; endectocide; bioassay;
   toxicity; LC50
ID AEDES-AEGYPTI; RESISTANCE
AB New classes of insecticides with novel modes of action are needed to control insecticide resistant populations of mosquitoes that transmit diseases such as Zika, dengue and malaria. Assays for rapid, high-throughput analyses of unformulated novel chemistries against mosquito larvae and adults are presented. We describe protocols for single point-dose and dose response assays to evaluate the toxicity of small molecule chemistries to the Aedes aegypti vector of Zika, dengue and yellow fever, the malaria vector, Anopheles gambiae and the northern house mosquito, Culex quinquefasciatus, on contact and via ingestion. As an example, we evaluated the toxicity of amitriptyline, a small molecule antagonist of G protein-coupled receptors, via larval, adult topical and adult blood-feeding assay. The protocols provide a starting point to investigate insecticide potential. Results are discussed in the context of additional experiments to explore product applications and mechanisms for delivery.
C1 [Brito-Sierra, Carlos A.; Kaur, Jasleen; Hill, Catherine A.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.
   [Hill, Catherine A.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
RP Hill, CA (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.; Hill, CA (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
EM hillca@purdue.edu
OI Brito-Sierra, Carlos A/0000-0002-9616-6149
CR Ahmed MAI, 2012, J MED ENTOMOL, V49, P1405, DOI 10.1603/ME12030
   Ahmed MAI, 2015, PESTIC BIOCHEM PHYS, V120, P51, DOI 10.1016/j.pestbp.2015.01.014
   Aizoun N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-147
   [Anonymous], 2018, LIVERPOOL INSECT TES
   Bhatt S, 2015, ELIFE, V4, DOI 10.7554/eLife.09672
   Centers for Disease Control, 2011, GUID EV INS RES VECT
   Chaccour CJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-153
   Chen C. D., 2006, DENGUE B, V30
   Conley JM, 2015, J PHARMACOL EXP THER, V352, P53, DOI 10.1124/jpet.114.219717
   FONSECA IDALYD, 2005, Rev. Colomb. Entomol., V31, P107
   Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081
   Foy BD, 2011, TRENDS PARASITOL, V27, P423, DOI 10.1016/j.pt.2011.05.007
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003
   Hill CA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1477-6
   Hill CA, 2013, PESTIC BIOCHEM PHYS, V106, P141, DOI 10.1016/j.pestbp.2013.02.008
   Huang QC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14142
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Meyer JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001478
   Nuss A. B., 2015, PLOS NEGLECT TROP D, V9, P1
   Olson DM, 2000, PHYSIOL ENTOMOL, V25, P17, DOI 10.1046/j.1365-3032.2000.00155.x
   Owusu HF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0971-6
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Ranson H., 2010, TRENDS PARASITOL, P1
   Savignac R., 1981, SIMPLE CHARACTER REC
   SHIDRAWI GR, 1990, B WORLD HEALTH ORGAN, V68, P403
   Sylla M., 2013, MALARIAWORLD J, V4
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   *WHO, 1981, INSTR DET SUSC RES M
   WHO, 2013, TEST PROC INREMO
   WHO, 1996, REP WHO INF CONS EV
   World Health Organization, 2009, GLOB HLTH RISKS MORT, P2
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   World Health Organization, 2013, REP SECR NEGL TROP D
   Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6
NR 35
TC 0
Z9 0
U1 0
U2 0
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD FEB
PY 2019
IS 144
AR e57768
DI 10.3791/57768
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HR1PE
UT WOS:000462905000006
PM 30829331
DA 2020-07-08
ER

PT J
AU de La Vega, MA
   Piret, J
   Griffin, BD
   Rheaume, C
   Venable, MC
   Carbonneau, J
   Couture, C
   Almeida, RD
   Tremblay, RR
   Magalhes, KG
   Park, YK
   Roberts, CC
   Maslow, JN
   Sardesai, NY
   Kim, JJ
   Muthumani, K
   Weiner, DB
   Kobinger, GP
   Boivin, G
AF de La Vega, Marc-Antoine
   Piret, Jocelyne
   Griffin, Bryan D.
   Rheaume, Chantal
   Venable, Marie-Christine
   Carbonneau, Julie
   Couture, Christian
   Almeida, Raquel das Neves
   Tremblay, Roland R.
   Magalhaes, Kelly G.
   Park, Young K.
   Roberts, Christine C.
   Maslow, Joel N.
   Sardesai, Niranjan Y.
   Kim, J. Joseph
   Muthumani, Kar
   Weiner, David B.
   Kobinger, Gary P.
   Boivin, Guy
TI Zika-Induced Male Infertility in Mice Is Potentially Reversible and
   Preventable by Deoxyribonucleic Acid Immunization
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE animal model; DNA vaccine; infertility; sublethal; Zika virus
ID VIRUS SEXUAL TRANSMISSION; MOUSE MODEL; INFECTION; IMMUNITY; SEMEN;
   LEADS
AB Background. Zika virus (ZIKV) infection has been associated with prolonged viral excretion in human semen and causes testicular atrophy and infertility in 10-week-old immunodeficient mice.
   Male IFNAR(/) mice, knockout for type I interferon receptor, were immunized with GLS-5700, a deoxyribonucleic acid-based vaccine, before a subcutaneous ZIKV challenge with 6 10(5) plaque-forming units at 13 weeks of age. On day 28 postinfection, testes and epididymides were collected in some mice for histological and functional analyses, whereas others were mated with naive female wild-type C57BL/6J.
   Although all mice challenged with ZIKV developed viremia, most of them were asymptomatic, showed no weight loss, and survived infection. On day 28 postinfection, none of the unvaccinated, infected mice (9 of 9) exhibited abnormal spermatozoa counts or motility. However, 33% (3 of 9) and 36% (4 of 11) of mated males from this group were infertile, from 2 independent studies. Contrarily, males from the noninfected and the vaccinated, infected groups were all fertile. On days 75 and 207 postinfection, partial recovery of fertility was observed in 66% (2 of 3) of the previously infertile males.
   This study reports the effects of ZIKV infection on male fertility in a sublethal, immunodeficient mouse model and the efficacy of GLS-5700 vaccination in preventing male infertility.Male IFNAR(/) mice infected with ZIKV at an older age were shown to be infertile without overt signs of disease. This outcome was prevented by immunization with a DNA vaccine. A partial recovery of fertility was observed later after infection.
C1 [de La Vega, Marc-Antoine; Kobinger, Gary P.; Boivin, Guy] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada.
   [de La Vega, Marc-Antoine; Piret, Jocelyne; Rheaume, Chantal; Venable, Marie-Christine; Carbonneau, Julie; Kobinger, Gary P.; Boivin, Guy] Univ Laval, CHU Quebec, Ctr Rech Infectiol, Quebec City, PQ, Canada.
   [Griffin, Bryan D.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada.
   [Griffin, Bryan D.; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.
   [Couture, Christian] Inst Univ Cardiol & Pneumol Quebec, Dept Anatomopathol, Quebec City, PQ, Canada.
   [Couture, Christian] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ, Canada.
   [Almeida, Raquel das Neves; Magalhaes, Kelly G.] Univ Brasilia, Lab Immunol & Inflammat, Brasilia, DF, Brazil.
   [Tremblay, Roland R.] Univ Laval, CHU Quebec, Ctr Rech, Unite Rech Reprod Sante Mere & Enfant, Quebec City, PQ, Canada.
   [Park, Young K.; Roberts, Christine C.; Maslow, Joel N.] GeneOne Life Sci Inc, Seoul, South Korea.
   [Maslow, Joel N.] Morristown Med Ctr, Dept Med, Morristown, NJ USA.
   [Sardesai, Niranjan Y.; Kim, J. Joseph] Inovio Pharmaceut Inc, Plymouth Meeting, PA USA.
   [Muthumani, Kar; Weiner, David B.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Kobinger, Gary P.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Boivin, G (corresponding author), Univ Laval, CHU Quebec, Res Ctr Infect Dis, 2705 Boul Laurier,Room R-709, Quebec City, PQ G1V 4G2, Canada.
EM guy.boivin@crchudequebec.ulaval.ca
RI Muthumani, Kar/AAQ-4939-2020; Magalhaes, Kelly Grace/L-6081-2019
OI Muthumani, Kar/0000-0002-6807-2065; Magalhaes, Kelly
   Grace/0000-0002-7435-5272; Roberts, Christine/0000-0003-4359-7946; de La
   Vega, Marc-Antoine/0000-0002-5969-9990
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [148361]; Canada Research Chair in Emerging and
   Re-Emerging Pathogens (Tier 1) [2016-23]
FX This work was funded in part by a Foundation Grant from the Canadian
   Institutes of Health Research (grant no. 148361; to G. B.) and in part
   by the Canada Research Chair in Emerging and Re-Emerging Pathogens (Tier
   1) (2016-23) program awarded to G. P. K.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Cooper TG, 2005, HUM REPROD, V20, P9, DOI 10.1093/humrep/deh555
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jin JM, 2014, GENE, V551, P15, DOI 10.1016/j.gene.2014.08.048
   Khakshooy A, 2016, BIOINFORMATION, V12, P28, DOI 10.6026/97320630012028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Venturi G, 2016, EUROSURVEILLANCE, V21, P1
   World Health Organization, EP AL ZIK VIR INF
   World Health Organization, 2010, EX PROC HUM SEM
   World Health Organization, 2018, WHO VACC PIP TRACK Z
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 37
TC 2
Z9 2
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD FEB 1
PY 2019
VL 219
IS 3
BP 365
EP 374
DI 10.1093/infdis/jiy336
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HQ7KH
UT WOS:000462598400005
PM 30053014
OA Green Published
DA 2020-07-08
ER

PT J
AU Potokar, M
   Jorgacevski, J
   Zorec, R
AF Potokar, Maja
   Jorgacevski, Jernej
   Zorec, Robert
TI Astrocytes in Flavivirus Infections
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE astrocytes; flavivirus; neuroinfections; TBEV; ZIKV; WNV; JEV;
   encephalitis
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; TICK-BORNE ENCEPHALITIS;
   BRAIN-BARRIER PERMEABILITY; RADIAL GLIAL-CELLS; ZIKA VIRUS;
   NONPATHOGENIC STRAINS; SUBVENTRICULAR ZONE; ENDOTHELIAL-CELLS; VESICLE
   MOBILITY
AB Virus infections of the central nervous system (CNS) can manifest in various forms of inflammation, including that of the brain (encephalitis) and spinal cord (myelitis), all of which may have long-lasting deleterious consequences. Although the knowledge of how different viruses affect neural cells is increasing, understanding of the mechanisms by which cells respond to neurotropic viruses remains fragmented. Several virus types have the ability to infect neural tissue, and astrocytes, an abundant and heterogeneous neuroglial cell type and a key element providing CNS homeostasis, are one of the first CNS cell types to get infected. Astrocytes are morphologically closely aligned with neuronal synapses, blood vessels, and ventricle cavities, and thereby have the capacity to functionally interact with neurons and endothelial cells. In this review, we focus on the responses of astrocytes to infection by neurotropic flaviviruses, including tick-borne encephalitis virus (TBEV), Zika virus (ZIKV), West Nile virus (WNV), and Japanese encephalitis virus (JEV), which have all been confirmed to infect astrocytes and cause multiple CNS defects. Understanding these mechanisms may help design new strategies to better contain and mitigate virus- and astrocyte-dependent neuroinflammation.
C1 [Potokar, Maja; Jorgacevski, Jernej; Zorec, Robert] Univ Ljubljana, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Fac Med, Zaloska 4, Ljubljana 1000, Slovenia.
   [Potokar, Maja; Jorgacevski, Jernej; Zorec, Robert] Celica BIOMED, Tehnol Pk 24, Ljubljana 1000, Slovenia.
RP Potokar, M; Zorec, R (corresponding author), Univ Ljubljana, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Fac Med, Zaloska 4, Ljubljana 1000, Slovenia.; Potokar, M; Zorec, R (corresponding author), Celica BIOMED, Tehnol Pk 24, Ljubljana 1000, Slovenia.
EM maja.potokar@mf.uni-lj.si; jernej.jorgacevski@mf.uni-lj.si;
   robert.zorec@mf.uni-lj.si
RI JORGACEVSKI, JERNEJ/AAH-5425-2019
OI JORGACEVSKI, JERNEJ/0000-0003-3550-2011
FU Research Agency of Slovenia [P3 0310, J3 6790, J3 7605, J3 9266]
FX This work was supported by the Research Agency of Slovenia, grant
   numbers P3 0310, J3 6790, J3 7605, and J3 9266.
CR Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Alimonti JB, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0100-y
   Alvarez-Maubecin V, 2000, J NEUROSCI, V20, P4091
   Ariff IM, 2013, J NEUROIMMUNE PHARM, V8, P664, DOI 10.1007/s11481-013-9455-7
   Bardina SV, 2012, IMMUNOL RES, V54, P121, DOI 10.1007/s12026-012-8333-3
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372
   Bhowmick S, 2007, NEUROSCI LETT, V414, P45, DOI 10.1016/j.neulet.2006.11.070
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carmignoto G, 2010, BRAIN RES REV, V63, P138, DOI 10.1016/j.brainresrev.2009.11.007
   Chang CY, 2015, GLIA, V63, P1915, DOI 10.1002/glia.22857
   Charles-Orszag A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06948-x
   Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982
   Chen CJ, 2011, NEUROCHEM INT, V58, P234, DOI 10.1016/j.neuint.2010.12.009
   Chen CJ, 2010, J GEN VIROL, V91, P1028, DOI 10.1099/vir.0.013565-0
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Clarke P, 2014, J VIROL, V88, P1080, DOI 10.1128/JVI.02944-13
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205
   Depoux A, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0087-6
   Dienel GA, 2019, PHYSIOL REV, V99, P949, DOI 10.1152/physrev.00062.2017
   Dimcheff DE, 2004, J BIOL CHEM, V279, P33782, DOI 10.1074/jbc.M403304200
   Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691
   Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y
   Garmendia AE, 2001, MICROBES INFECT, V3, P223, DOI 10.1016/S1286-4579(01)01374-0
   Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746
   German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008
   Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528
   Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heinz FX, 2003, ADV VIRUS RES, V59, P63, DOI 10.1016/S0065-3527(03)59003-0
   Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2
   Hussmann KL, 2014, J GEN VIROL, V95, P1991, DOI 10.1099/vir.0.065474-0
   Hussmann KL, 2014, J GEN VIROL, V95, P862, DOI 10.1099/vir.0.060558-0
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Johnson RT, 2003, J NEUROVIROL, V9, P140, DOI [10.1080/713831480, 10.1080/13550280390194091]
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077427
   Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Knap N, 2012, VECTOR-BORNE ZOONOT, V12, P236, DOI 10.1089/vbz.2011.0728
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P54, DOI 10.1016/j.chom.2012.10.021
   Kreft M, 2013, CELL MOL LIFE SCI, V70, P1483, DOI 10.1007/s00018-012-1219-7
   Kuivanen S, 2017, J GEN VIROL, V98, P1744, DOI 10.1099/jgv.0.000857
   Kumar M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-80
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Lindqvist R, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1119-3
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mishra MK, 2008, CELL BIOL INT, V32, P1506, DOI 10.1016/j.cellbi.2008.08.020
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Myint KSA, 1999, AM J TROP MED HYG, V60, P338, DOI 10.4269/ajtmh.1999.60.338
   Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0
   Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912
   Osso LA, 2015, CELL, V163, P1574, DOI 10.1016/j.cell.2015.12.001
   Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0
   Palus M, 2014, J INFECTION, V68, P165, DOI 10.1016/j.jinf.2013.09.028
   Palus M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-77
   Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x
   Parpura V, 2010, NEUROCHEM INT, V57, P451, DOI 10.1016/j.neuint.2010.02.007
   Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008
   Patabendige A, 2018, MOL CELL NEUROSCI, V89, P60, DOI 10.1016/j.mcn.2018.04.002
   Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666
   Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x
   Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219
   Potokar M, 2013, INT J MOL SCI, V14, P11238, DOI 10.3390/ijms140611238
   Potokar M, 2011, HISTOL HISTOPATHOL, V26, P277, DOI 10.14670/HH-26.277
   Prebil Mateja, 2011, Archives of Physiology and Biochemistry, V117, P64, DOI 10.3109/13813455.2010.539616
   Quick ED, 2014, J VIROL, V88, P13005, DOI 10.1128/JVI.01994-14
   Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739
   Ravanini P, 2012, EUROSURVEILLANCE, V17, P2
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ruzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020472
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Stenovec M, 2011, ACTA PHYSIOL, V203, P457, DOI 10.1111/j.1748-1716.2011.02337.x
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Thrane AS, 2014, TRENDS NEUROSCI, V37, P620, DOI 10.1016/j.tins.2014.08.010
   Tonteri E, 2011, EMERG INFECT DIS, V17, P72, DOI 10.3201/eid1701.100051
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06
   Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036
   von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040
   Wang K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01148
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yao Y, 2014, CELL MOL LIFE SCI, V71, P683, DOI 10.1007/s00018-013-1459-1
   Yu C, 2013, VIRUS RES, V178, P471, DOI 10.1016/j.virusres.2013.10.012
   Yun SI, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030068
   Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714
   Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
   Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980
   Zorec R, 2019, NEUROSCI LETT, V689, P56, DOI 10.1016/j.neulet.2018.08.003
NR 127
TC 9
Z9 9
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB 1
PY 2019
VL 20
IS 3
AR 691
DI 10.3390/ijms20030691
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HQ4WR
UT WOS:000462412500235
PM 30736273
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Seferovic, MD
   Turley, M
   Valentine, GC
   Rac, M
   Castro, ECC
   Major, AM
   Sanchez, B
   Eppes, C
   Sanz-Cortes, M
   Dunn, J
   Kautz, TF
   Versalovic, J
   Muldrew, KL
   Stout, T
   Belfort, MA
   Demmler-Harrison, G
   Aagaard, KM
AF Seferovic, Maxim D.
   Turley, Michelle
   Valentine, Gregory C.
   Rac, Martha
   Castro, Eumenia C. C.
   Major, Angela M.
   Sanchez, Brianna
   Eppes, Catherine
   Sanz-Cortes, Magdalena
   Dunn, James
   Kautz, Tiffany F.
   Versalovic, James
   Muldrew, Kenneth L.
   Stout, Timothy
   Belfort, Michael A.
   Demmler-Harrison, Gail
   Aagaard, Kjersti M.
TI Clinical Importance of Placental Testing among Suspected Cases of
   Congenital Zika Syndrome
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE arbovirus; Zika virus; congenital Zika syndrome; placental Zika
   infection; microcephaly; congenital brain malformations; molecular
   virology; viral pathogenicity; placental testing
ID VIRUS-INFECTION; JANUARY; STATES; TROPHOBLASTS; OUTCOMES; BRAZIL; BRAIN
AB Contemporaneous Zika virus (ZIKV) strains can cause congenital Zika syndrome (CZS). Current ZIKV clinical laboratory testing strategies are limited and include IgM serology (which may wane 12 weeks after initial exposure) and nucleic acid testing (NAT) of maternal serum, urine, and placenta for (+) strand ZIKV RNA (which is often transient). The objectives of this study were to determine if use of additional molecular tools, such as quantitative PCR and microscopy, would add to the diagnostic value of current standard placental ZIKV testing in cases with maternal endemic exposure and indeterminate testing. ZIKV RNA was quantified from dissected sections of placental villi, chorioamnion sections, and full cross-sections of umbilical cord in all cases examined. Quantitation with high-resolution automated electrophoresis determined relative amounts of precisely verified ZIKV (74-nt amplicons). In order to localize and visualize stable and actively replicating placental ZIKV in situ, labeling of flaviviridae glycoprotein, RNA ISH against both (+) and (-) ZIKV-specific ssRNA strands, and independent histologic examination for significant pathologic changes were employed. We demonstrate that the use of these molecular tools added to the diagnostic value of placental ZIKV testing among suspected cases of congenital Zika syndrome with poorly ascribed maternal endemic exposure.
C1 [Seferovic, Maxim D.; Turley, Michelle; Valentine, Gregory C.; Rac, Martha; Sanchez, Brianna; Eppes, Catherine; Sanz-Cortes, Magdalena; Kautz, Tiffany F.; Belfort, Michael A.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet, Div Maternal Fetal Med, Houston, TX 77030 USA.
   [Seferovic, Maxim D.; Turley, Michelle; Valentine, Gregory C.; Rac, Martha; Sanchez, Brianna; Eppes, Catherine; Sanz-Cortes, Magdalena; Kautz, Tiffany F.; Belfort, Michael A.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.
   [Valentine, Gregory C.] Baylor Coll Med, Sect Neonatol, Pediat, Houston, TX 77030 USA.
   [Castro, Eumenia C. C.; Major, Angela M.; Dunn, James; Versalovic, James; Muldrew, Kenneth L.] Baylor Coll Med, Pathol & Immunol, Houston, TX 77030 USA.
   [Versalovic, James] Baylor Coll Med, Microbiol & Mol Virol, Houston, TX 77030 USA.
   [Stout, Timothy] Baylor Coll Med, Ophthalmol, Houston, TX 77030 USA.
   [Demmler-Harrison, Gail] Baylor Coll Med, Pediat, Infect Dis Sect, Houston, TX 77030 USA.
   [Demmler-Harrison, Gail] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Aagaard, Kjersti M.] Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA.
RP Aagaard, KM (corresponding author), Baylor Coll Med, Dept Obstet, Div Maternal Fetal Med, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Dept Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA.
EM maxim.seferovic@bcm.edu; michelle.turley@bcm.edu; gvalenti@bcm.edu;
   martha.rac@bcm.edu; ecastro@bcm.edu; amajor@bcm.edu;
   brianna.sanchez@bcm.edu; catherine.eppes@bcm.edu;
   magdalena.sanzcortes@bcm.edu; jjdunn@texaschildrens.org;
   tiffany.kautz@bcm.edu; jamesv@bcm.edu; kenneth.muldrew@bcm.edu;
   tim.stout@bcm.edu; belfort@bcm.edu; gdemmler@bcm.edu; aagaardt@bcm.edu
OI Valentine, Gregory/0000-0002-3055-2987
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01-HD091731]
FX This research was funded, in part, by the National Institutes of Health
   grant number R01-HD091731 to KMA. The APC was not funded by external
   grants.
CR Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Adibi JJ, 2016, CELL HOST MICROBE, V20, P9, DOI 10.1016/j.chom.2016.06.013
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gavegnano Christina, 2017, Pathog Immun, V2, P199, DOI 10.20411/pai.v2i2.190
   Hall NB, 2017, MMWR-MORBID MORTAL W, V66, P835, DOI 10.15585/mmwr.mm6631a5
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 39
TC 1
Z9 1
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB 1
PY 2019
VL 20
IS 3
AR 712
DI 10.3390/ijms20030712
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HQ4WR
UT WOS:000462412500256
PM 30736425
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, LM
   Alto, BW
   Shin, DY
AF Zhao, Liming
   Alto, Barry W.
   Shin, Dongyoung
TI Transcriptional Profile of Aedes aegypti Leucine-Rich Repeat Proteins in
   Response to Zika and Chikungunya Viruses
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Aedes aegypti; Leucine-Rich Repeat Proteins; Zika virus; chikungunya
   virus; immune responses; gene expression
ID DIPTERA-CULICIDAE; ANOPHELES-GAMBIAE; MOSQUITO; INFECTION; TRANSMISSION;
   COMPLEMENT; EXPRESSION; GENE; RECOGNITION; ACTIVATION
AB Aedes aegypti (L.) is the primary vector of chikungunya, dengue, yellow fever, and Zika viruses. The leucine-rich repeats (LRR)-containing domain is evolutionarily conserved in many proteins associated with innate immunity in invertebrates and vertebrates, as well as plants. We focused on the AaeLRIM1 and AaeAPL1 gene expressions in response to Zika virus (ZIKV) and chikungunya virus (CHIKV) infection using a time course study, as well as the developmental expressions in the eggs, larvae, pupae, and adults. RNA-seq analysis data provided 60 leucine-rich repeat related transcriptions in Ae. aegypti in response to Zika virus (Accession number: GSE118858, accessed on: August 22, 2018, GEO DataSets). RNA-seq analysis data showed that AaeLRIM1 (AAEL012086-RA) and AaeAPL1 (AAEL009520-RA) were significantly upregulated 2.5 and 3-fold during infection by ZIKV 7-days post infection (dpi) of an Ae. aegypti Key West strain compared to an Orlando strain. The qPCR data showed that LRR-containing proteins related genes, AaeLRIM1 and AaeAPL1, and five paralogues were expressed 100-fold lower than other nuclear genes, such as defensin, during all developmental stages examined. Together, these data provide insights into the transcription profiles of LRR proteins of Ae. aegypti during its development and in response to infection with emergent arboviruses.
C1 [Zhao, Liming; Alto, Barry W.; Shin, Dongyoung] Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
RP Zhao, LM (corresponding author), Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
EM lmzhao@ufl.edu; bwalto@ufl.edu; dshin@ufl.edu
FU Florida Department of Agriculture and Consumer Services [025364, 024246,
   023557, 020190, 021090, 020180, 021803, 022399]
FX This research was funded by the Florida Department of Agriculture and
   Consumer Services: Contract Numbers 025364, 024246, 023557, 020190 and
   021090 to Jorge Rey and Contract Number 020180 to Walter Tabachnick,
   Contract Numbers 021803 and 022399 to Liming Zhao and Barry Alto.
CR Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253
   Bartholomay LC, 2004, INFECT IMMUN, V72, P4114, DOI 10.1128/IAI.72.7.4114-4126.2004
   Bartholomay LC, 2018, ANNU REV ENTOMOL, V63, P145, DOI 10.1146/annurev-ento-010715-023530
   Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4
   Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Dong SZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3775-6
   Dong SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24729
   Estep AS, 2017, J MED ENTOMOL, V54, P1643, DOI 10.1093/jme/tjx143
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005
   Gasque P, 2016, J INFECT DIS, V214, pS446, DOI 10.1093/infdis/jiw362
   Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070
   HOUK EJ, 1981, ACTA TROP, V38, P163
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kantor AM, 2017, INSECT MOL BIOL, V26, P113, DOI 10.1111/imb.12275
   Kumar A, 2018, INSECTS, V9, DOI 10.3390/insects9030095
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kwon H, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2308-0
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246
   Ng A, 2011, AUTOPHAGY, V7, P1082, DOI 10.4161/auto.7.9.16464
   Osta MA, 2004, J EXP BIOL, V207, P2551, DOI 10.1242/jeb.01066
   Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789
   Passarelli AL, 2011, VIROLOGY, V411, P383, DOI 10.1016/j.virol.2011.01.009
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824
   Portereiko MF, 2006, PLANT PHYSIOL, V141, P957, DOI 10.1104/pp.106.079319
   Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400
   Powers AM, 2016, J INFECT DIS, V214, pS449, DOI 10.1093/infdis/jiw382
   Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672
   Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Scheiner S.M., 1993, DESIGN ANAL ECOLOGIC, P94
   Shrinet J, 2017, BIOCHEM BIOPH RES CO, V492, P617, DOI 10.1016/j.bbrc.2017.01.162
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Smith RC, 2016, TRENDS PARASITOL, V32, P979, DOI 10.1016/j.pt.2016.08.012
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Upton LM, 2015, J INNATE IMMUN, V7, P74, DOI 10.1159/000365331
   Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531
   Williams MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118817
   Yao JQ, 2011, BIOINFORMATION, V7, P44
   Zhao LM, 2008, J MED ENTOMOL, V45, P401, DOI 10.1603/0022-2585(2008)45[401:CCGAPE]2.0.CO;2
   Zhao LM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090470
   Zhao LM, 2018, J MED ENTOMOL, V55, P78, DOI 10.1093/jme/tjx174
   Zhao LM, 2017, J MED ENTOMOL, V54, P878, DOI 10.1093/jme/tjw244
NR 53
TC 1
Z9 1
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB 1
PY 2019
VL 20
IS 3
AR 615
DI 10.3390/ijms20030615
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HQ4WR
UT WOS:000462412500159
PM 30708982
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Carvalho, GHF
   de Andrade, MA
   de Araujo, CN
   Santos, ML
   de Castro, NA
   Charneau, S
   Monnerat, R
   de Santana, JM
   Bastos, IMD
AF Ferreira de Carvalho, George Harrison
   de Andrade, Milene Aparecida
   de Araujo, Carla Nunes
   Santos, Maria Lucilia
   de Castro, Natalia Alves
   Charneau, Sebastien
   Monnerat, Rose
   de Santana, Jaime Martins
   Dourado Bastos, Izabela Marques
TI Larvicidal and pupicidal activities of eco-friendly phenolic lipid
   products from Anacardium occidentale nutshell against arbovirus vectors
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Aedes aegypti; Culex quinquefasciatus; Insecticidal activity; Cashew nut
   shell liquid (CNSL); Field experiment; Cardol; Cardanol; Anacardic acid
ID NUT SHELL LIQUID; AEDES-AEGYPTI; ZIKA VIRUS; BOTANICAL INSECTICIDES;
   ESSENTIAL OILS; MOSQUITO; CHALLENGES; DISEASE
AB Aedes aegypti and Culex quinquefasciatus are vectors of diseases that constitute public health problems. The discovery of products capable of inhibiting their development which are less harmful to the environment would have a huge impact on vector control. Here, natural cashew nut shell liquid (CNSL), technical CNSL, anacardic acid, cardanol, and cardol were isolated from Anacardium occidentale and evaluated for larvicidal and pupicidal activity against Ae. aegypti and Cx. quinquefasciatus under laboratory and field conditions. The activities of phenol, resorcinol, salicylic acid, and pentadecane, commercial chemicals similar in structure to nut shell derivatives, were also evaluated. All of the fractions extracted from A. occidentale oil exerted larvicidal effects against both mosquito species (LC50 5.4-22.6mg/L), and two of the aforementioned were effective against pupae (LC50 90.8-109.7mg/L). Of all the fractions tested, cardol demonstrated the strongest larvicidal and pupicidal effects and presented the most prolonged residual activity against the larvae and pupae of Ae. aegypti and Cx. quinquefasciatus under field conditions. This study suggests that A. occidentale nut shell derivatives are sustainable and promising candidates for the development of novel insecticides to overcome the problem of harmful chemical insecticides.
C1 [Ferreira de Carvalho, George Harrison; de Andrade, Milene Aparecida; de Araujo, Carla Nunes; de Castro, Natalia Alves; de Santana, Jaime Martins; Dourado Bastos, Izabela Marques] Univ Brasilia, Pathogen Host Interface Lab, Dept Cell Biol, Brasilia, DF, Brazil.
   [Santos, Maria Lucilia] Univ Brasilia, Inst Chem, Brasilia, DF, Brazil.
   [Charneau, Sebastien] Univ Brasilia, Lab Prot Chem & Biochem, Dept Cell Biol, Brasilia, DF, Brazil.
   [Monnerat, Rose] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil.
RP de Santana, JM; Bastos, IMD (corresponding author), Univ Brasilia, Pathogen Host Interface Lab, Dept Cell Biol, Brasilia, DF, Brazil.
EM jsantana@unb.br; dourado@unb.br
RI Charneau, Sebastien/AAD-1145-2019; Santos, Maria Lucilia
   dos/AAS-3257-2020
OI Charneau, Sebastien/0000-0002-9364-7289; Santos, Maria Lucilia
   dos/0000-0002-0884-4211; Bastos, Izabela/0000-0002-2785-4255; NUNES DE
   ARAUJO, CARLA/0000-0002-1788-9745
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [923/18 CAPES-COFECUB]; Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [INCT-MCTI/CNPq/CAPES/FAPs 16/2014]; Fundacao de
   Amparo a Pesquisa do Distrito Federal (FAP-DF) [0913.000.417/2016,
   0193.001803/2017]; Empresa Brasileira de Pesquisa Agropecuaria (Embrapa)
FX This work was supported by grants and fellowships awarded by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES,
   grant 923/18 CAPES-COFECUB), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, INCT-MCTI/CNPq/CAPES/FAPs 16/2014),
   Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF, grants
   0913.000.417/2016 and 0193.001803/2017), and the Empresa Brasileira de
   Pesquisa Agropecuaria (Embrapa).
CR Arruda Walquíria, 2003, Rev. Soc. Bras. Med. Trop., V36, P17, DOI 10.1590/S0037-86822003000100004
   Attina TM, 2016, LANCET DIABETES ENDO, V4, P996, DOI 10.1016/S2213-8587(16)30275-3
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Bhattacharya Sajal, 2016, Journal of Entomology and Zoology Studies, V4, P73
   BRAGA I. A., 2007, REV EPIDEMIOLOGIA SA, V16, P179, DOI DOI 10.5123/S1679-49742007000400006
   Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos J, 2001, REV SAUDE PUBL, V35, P232, DOI 10.1590/S0034-89102001000300003
   Carbone P, 2006, REPROD TOXICOL, V22, P8, DOI 10.1016/j.reprotox.2006.01.006
   Carvalho Maria do Socorro Laurentino de, 2004, Rev. Saúde Pública, V38, P623, DOI 10.1590/S0034-89102004000500002
   CONSOLI R A G B, 1988, Memorias do Instituto Oswaldo Cruz, V83, P87, DOI 10.1590/S0074-02761988000100012
   Oliveira MSC, 2011, ACTA TROP, V117, P165, DOI 10.1016/j.actatropica.2010.08.003
   da Rocha E M, 2000, Rev Soc Bras Med Trop, V33, P545, DOI 10.1590/S0037-86822000000600005
   dos Santos ML, 1999, J BRAZIL CHEM SOC, V10, P13, DOI 10.1590/S0103-50531999000100003
   Finney D.T., 1971, PROBIT ANAL
   Forattini O P, 1978, Rev Saude Publica, V12, P297, DOI 10.1590/S0034-89101978000300005
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guissoni A.C.P., 2013, Rev. bras. plantas med., V15, P363, DOI 10.1590/S1516-05722013000300008
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Isman MB, 2017, IND CROP PROD, V110, P10, DOI 10.1016/j.indcrop.2017.07.012
   Thi KLP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2422-z
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kristensen F, 1997, EPIDEMIOLOGY, V8, P537, DOI 10.1097/00001648-199709000-00011
   Kubo I, 2003, J AGR FOOD CHEM, V51, P7624, DOI 10.1021/jf034674f
   Pham LD, 2017, CLINICOECONOMIC OUTC, V9, P1, DOI 10.2147/CEOR.S124023
   Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020
   Mazzetto SE, 2009, QUIM NOVA, V32, P732, DOI 10.1590/S0100-40422009000300017
   Mnif W, 2011, INT J ENV RES PUB HE, V8, P2265, DOI 10.3390/ijerph8062265
   Mutheneni SR, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.57
   Nagabhushana KS, 2002, J ENZYM INHIB MED CH, V17, P255, DOI 10.1080/1475636021000006243
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Patil SV, 2010, TROP BIOMED, V27, P360
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Silva Heloísa Helena Garcia da, 2004, Rev. Soc. Bras. Med. Trop., V37, P396, DOI 10.1590/S0037-86822004000500005
   Silva HHG, 1999, REV SOC BRAS MED TRO, V32, P349, DOI DOI 10.1590/S0037-86821999000400003
   Silva I, 2003, NEOTROP ENTOMOL, V32, P1992
   Stasiuk M, 2010, CELL MOL LIFE SCI, V67, P841, DOI 10.1007/s00018-009-0193-1
   THRONE JE, 1995, J ECON ENTOMOL, V88, P1513, DOI 10.1093/jee/88.5.1513
   Torres RC, 2015, PARASITOL RES, V114, P3699, DOI 10.1007/s00436-015-4598-5
   Trevisan MTS, 2006, FOOD CHEM TOXICOL, V44, P188, DOI 10.1016/j.fct.2005.06.012
   Vivekanandhan P, 2018, PHYSIOL MOL PLANT P, V101, P156, DOI 10.1016/j.pmpp.2017.05.005
   Vivekanandhan P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020388
   Wu YY, 2011, J PHARMACOL EXP THER, V339, P403, DOI 10.1124/jpet.111.181891
   Xiu YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099361
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 48
TC 3
Z9 3
U1 0
U2 11
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD FEB
PY 2019
VL 26
IS 6
BP 5514
EP 5523
DI 10.1007/s11356-018-3905-y
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA HO3OA
UT WOS:000460831600024
PM 30610586
DA 2020-07-08
ER

PT J
AU Sobkowicz, P
AF Sobkowicz, Pawel
TI Social Simulation Models at the Ethical Crossroads
SO SCIENCE AND ENGINEERING ETHICS
LA English
DT Article
DE Agent based models; Opinion dynamics; Attitude change; Big Data;
   Research ethics
ID SZNAJD MODEL; ZIKA VIRUS; DUAL-USE; PHASE-TRANSITIONS; OPINION
   FORMATION; HUMAN-BEHAVIOR; RESPONSIBILITY; MANIPULATION; IMPACT;
   PERSISTENCE
AB Computational models of group opinion dynamics are one of the most active fields of sociophysics. In recent years, advances in model complexity and, in particular, the possibility to connect these models with detailed data describing individual behaviors, preferences and activities, have opened the way for the simulations to describe quantitatively selected, real world social systems. The simulations could be then used to study what-if' scenarios for opinion change campaigns, political, ideological or commercial. The possibility of the practical application of the attitude change models necessitates that the research community working in the field should consider more seriously the moral aspects of their efforts, in particular the potential for their use for unintended goals. The paper discusses these issues, and offers a suggestion for a new research direction: using the attitude models to increase the awareness and detection of social manipulation cases. Such research would offer a scientific challenge and meet the ethical criteria.
C1 [Sobkowicz, Pawel] KEN 94-140, PL-02777 Warsaw, Poland.
RP Sobkowicz, P (corresponding author), KEN 94-140, PL-02777 Warsaw, Poland.
EM pawelsobko@gmail.com
RI Sobkowicz, Pawel/G-5276-2010
OI Sobkowicz, Pawel/0000-0002-7275-7235
CR Aach J, 2017, ELIFE, V6, DOI 10.7554/eLife.20674
   Alvarez R, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0042-4
   Athey S, 2017, SCIENCE, V355, P483, DOI 10.1126/science.aal4321
   Ball P, 2002, PHYSICA A, V314, P1, DOI 10.1016/S0378-4371(02)01042-7
   BenNaim E, 1996, PHYS REV E, V53, P3078, DOI 10.1103/PhysRevE.53.3078
   Bernardes AT, 2001, INT J MOD PHYS C, V12, P159, DOI 10.1142/S0129183101001584
   Borge-Holthoefer J, 2013, J STAT PHYS, V151, P383, DOI 10.1007/s10955-012-0595-6
   Boyd D., 2011, DECADE INTERNET TIME, V21
   Castellano C, 2003, EUROPHYS LETT, V63, P153, DOI 10.1209/epl/i2003-00490-0
   COX JT, 1986, ANN PROBAB, V14, P347, DOI 10.1214/aop/1176992521
   Das S, 2016, ACM T WEB, V10, DOI 10.1145/3001937
   DEFFEUANT G., 2002, JOURNAL OF ARTIFICIA, V5, P4
   Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078
   Dellarocas C, 2006, MANAGE SCI, V52, P1577, DOI 10.1287/mnsc.1060.0567
   DellaVigna S, 2007, Q J ECON, V122, P1187, DOI 10.1162/qjec.122.3.1187
   Duggins P, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3316
   Ehni HJ, 2008, ARCH IMMUNOL THER EX, V56, P147, DOI 10.1007/s00005-008-0020-7
   Epstein R, 2015, P NATL ACAD SCI USA, V112, pE4512, DOI 10.1073/pnas.1419828112
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fleischmann K. R., 2006, P AM SOC INFORM SCI, V43, P1, DOI DOI 10.1002/MEET.14504301254
   Fleischmann KR, 2017, BRIDGE, V41, P45
   Forelle M., 2015, ARXIV150707109
   Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701
   Galam S, 2012, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-1-4614-2032-3
   Galam S, 2002, PHYSICA A, V314, P256, DOI 10.1016/S0378-4371(02)01178-0
   Galam S, 2016, ARXIV160903933
   Gorwa R, 2017, 20172 U OXF
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5
   Holyst JA, 2001, ANN REV COMP PHYS, V9, P253
   Horbulin W. P., 2009, TECHNICAL REPORT
   Hosni H., 2017, PHILOS TECHNOL, DOI [10.1007/s13347-017-0265-3, DOI 10.1007/S13347-017-0265-3]
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Kacperski K, 2000, PHYSICA A, V287, P631, DOI 10.1016/S0378-4371(00)00398-8
   Kacperski K, 1999, PHYSICA A, V269, P511, DOI 10.1016/S0378-4371(99)00174-0
   KELMAN HC, 1965, J SOC ISSUES, V21, P31, DOI 10.1111/j.1540-4560.1965.tb00494.x
   Kijowski DJ, 2013, SCI ENG ETHICS, V19, P63, DOI 10.1007/s11948-011-9291-1
   Kleijnen JPC, 2001, EUR J OPER RES, V130, P223, DOI 10.1016/S0377-2217(00)00024-2
   Koepsell D, 2010, SCI ENG ETHICS, V16, P119, DOI 10.1007/s11948-009-9158-x
   Le Menestrel M, 2004, EUR J OPER RES, V153, P477, DOI 10.1016/S0377-2217(03)00168-1
   Lekka-Kowalik A, 2010, SCI ENG ETHICS, V16, P33, DOI 10.1007/s11948-009-9128-3
   de Lima TFM, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090920
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mihaylov T., 2015, P 19 C COMP NAT LANG, P310
   Mihaylov Todor, 2015, P INT C REC ADV NAT, P443
   Miller S, 2007, SCI ENG ETHICS, V13, P523, DOI 10.1007/s11948-007-9043-4
   Moran KR, 2016, J INFECT DIS, V214, pS404, DOI 10.1093/infdis/jiw375
   NOWAK A, 1990, PSYCHOL REV, V97, P362, DOI 10.1037/0033-295X.97.3.362
   Nowak Andrzej, 1996, MODELLING SIMULATION, P249, DOI DOI 10.1007/978-94-015-8686-3_14
   O'Neil C, 2016, WEAPONS MATH DESTRUC
   Palmer E, 2017, ETIKK PRAKSIS, V11, P89, DOI 10.5324/eip.v11i1.1978
   Pariser E., 2011, FILTER BUBBLE WHAT I
   Pasquale F, 2015, BLACK BOK SOC SECRET
   Pena-Lopez I, 2014, J SPAN CULT STUD, V15, P189, DOI 10.1080/14636204.2014.931678
   Pruyt E, 2007, 25 INT C SYST DYN SO
   Sabatelli L, 2003, INT J MOD PHYS C, V14, P1223, DOI 10.1142/S0129183103005352
   Sabatelli L, 2004, PHYSICA A, V334, P274, DOI 10.1016/j.physa.2003.10.062
   Selgelid MJ, 2009, B WORLD HEALTH ORGAN, V87, P720, DOI 10.2471/BLT.08.051383
   Slanina F, 2003, EUR PHYS J B, V35, P279, DOI 10.1140/epjb/e2003-00278-0
   Sobkowicz P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155098
   Sobkowicz P, 2010, INT J MOD PHYS C, V21, P839, DOI 10.1142/S0129183110015518
   Sobkowicz P, 2009, JASSS-J ARTIF SOC S, V12
   Stauffer D, 2002, EUR PHYS J B, V30, P587, DOI 10.1140/epjb/e2002-00418-0
   Stauffer D, 2002, COMPUT PHYS COMMUN, V146, P93, DOI 10.1016/S0010-4655(02)00439-3
   Stauffer D, 2001, J ARTIFICIAL SOC SOC, V5
   Sunstein C. R., 2016, J MARKETING BEHAV, V1, P213, DOI DOI 10.1561/107.00000014
   Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936
   Tufekci Zeynep, 2014, First Monday, V19, P152, DOI 10.5210/fm.v19i7.4901
   Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-37
   Verelst F, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0820
   Weisbuch G, 2004, EUR PHYS J B, V38, P339, DOI 10.1140/epjb/e2004-00126-9
   Weisbuch G., 2003, HETEROGENOUS AGENTS, P225
   Wragg T, 2006, MODELLING EFFECTS IN
   Zhang MX, 2016, JASSS-J ARTIF SOC S, V19, DOI 10.18564/jasss.3148
NR 74
TC 1
Z9 1
U1 1
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1353-3452
EI 1471-5546
J9 SCI ENG ETHICS
JI Sci. Eng. Ethics
PD FEB
PY 2019
VL 25
IS 1
BP 143
EP 157
DI 10.1007/s11948-017-9993-0
PG 15
WC Ethics; Engineering, Multidisciplinary; History & Philosophy Of Science;
   Multidisciplinary Sciences; Philosophy
SC Social Sciences - Other Topics; Engineering; History & Philosophy of
   Science; Science & Technology - Other Topics; Philosophy
GA HO9UH
UT WOS:000461310400009
PM 29129010
DA 2020-07-08
ER

PT J
AU Hu, T
   Li, J
   Carr, MJ
   Duchene, S
   Shi, WF
AF Hu, Tao
   Li, Juan
   Carr, Michael J.
   Duchene, Sebastian
   Shi, Weifeng
TI The Asian Lineage of Zika Virus: Transmission and Evolution in Asia and
   the Americas
SO VIROLOGICA SINICA
LA English
DT Review
DE Zika virus (ZIKV); Asian lineage; Transmission; Evolution; R-e
ID SOUTH-PACIFIC; PHYLOGENETIC ANALYSIS; FRENCH-POLYNESIA; EPIDEMIOLOGY;
   INFECTION; SPREAD; OUTBREAK; HISTORY; ISLAND
AB Since first isolation in 1947 from the Zika forest in Uganda, Zika virus (ZIKV) has been principally known as a benign agent associated with sporadic human infections in a restricted number of African countries. However, during 2015-2016, an Asian lineage of ZIKV caused an unprecedentedly large outbreak in the Americas and sizeable numbers of exported cases across the globe. In this review, we critically appraise the recent advances in molecular epidemiological studies of ZIKV performed to date, and we highlight the pivotal role played by genomic surveillance in elucidating the origins, dissemination and evolution of the Asian lineage of ZIKV in Asia and in the Americas.
C1 [Hu, Tao; Li, Juan; Shi, Weifeng] Taishan Med Coll, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An 271000, Shandong, Peoples R China.
   [Carr, Michael J.] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo, Hokkaido 0010020, Japan.
   [Carr, Michael J.] Univ Coll Dublin, Sch Med, Natl Virus Reference Lab, Dublin 4, Ireland.
   [Duchene, Sebastian] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Parkville, Vic 3020, Australia.
RP Shi, WF (corresponding author), Taishan Med Coll, Key Lab Etiol & Epidemiol Emerging Infect Dis Uni, Tai An 271000, Shandong, Peoples R China.
EM shiwf@ioz.ac.cn
OI Duchene, Sebastian/0000-0002-2863-0907; Carr,
   Michael/0000-0003-0011-6209
FU National Key Science and Technology Projects of China
   [2017ZX10104001-006]; National Science and Technology Major Project
   [2018ZX10101004-002]; Taishan Scholars program of Shandong Province
   [ts201511056]
FX This study was supported by the National Key Science and Technology
   Projects of China (2017ZX10104001-006) and the National Science and
   Technology Major Project (2018ZX10101004-002). W.S. was supported by the
   Taishan Scholars program of Shandong Province (ts201511056).
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Delatorre E, 2018, EMERG INFECT DIS, V24, P2119, DOI 10.3201/eid2411.180586
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Kenney AD, 2017, ANNU REV GENET, V51, P241, DOI 10.1146/annurev-genet-120116-023425
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZY, 2019, NAT REV MICROBIOL
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Rossi SL, 2018, TRENDS MICROBIOL, V26, P877, DOI 10.1016/j.tim.2018.05.007
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Siraj Amir S, 2017, BMJ Glob Health, V2, pe000309, DOI 10.1136/bmjgh-2017-000309
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Worobey M, 2017, NATURE, V546, P355, DOI 10.1038/nature22495
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 52
TC 4
Z9 4
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD FEB
PY 2019
VL 34
IS 1
BP 1
EP 8
DI 10.1007/s12250-018-0078-2
PG 8
WC Virology
SC Virology
GA HP0NF
UT WOS:000461362100001
PM 30684211
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, Y
   Gao, W
   Li, J
   Wu, WH
   Jiu, YM
AF Zhang, Yue
   Gao, Wei
   Li, Jian
   Wu, Weihua
   Jiu, Yaming
TI The Role of Host Cytoskeleton in Flavivirus Infection
SO VIROLOGICA SINICA
LA English
DT Review
DE Flavivirus; Host cytoskeleton; Actin filaments; Intermediate filaments;
   Microtubules
ID JAPANESE ENCEPHALITIS-VIRUS; DENGUE-VIRUS; WEST-NILE; ACTIN
   CYTOSKELETON; ENTRY REQUIRES; MOSQUITO CELLS; PROTEIN; REPLICATION;
   VIMENTIN; PATHWAY
AB The family of flaviviruses is one of the most medically important groups of emerging arthropod-borne viruses. Host cell cytoskeletons have been reported to have close contact with flaviviruses during virus entry, intracellular transport, replication, and egress process, although many detailed mechanisms are still unclear. This article provides a brief overview of the function of the most prominent flaviviruses-induced or -hijacked cytoskeletal structures including actin, microtubules and intermediate filaments, mainly focus on infection by dengue virus, Zika virus and West Nile virus. We suggest that virus interaction with host cytoskeleton to be an interesting area of future research.
C1 [Zhang, Yue; Gao, Wei; Li, Jian; Wu, Weihua; Jiu, Yaming] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
   [Zhang, Yue; Gao, Wei; Jiu, Yaming] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Jiu, YM (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.; Jiu, YM (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
EM ymjiu@ips.ac.cn
FU CAS Key Laboratory of Molecular Virology and Immunology, Institut
   Pasteur of Shanghai, Chinese Academy of Sciences [KLMVI-OP-201904];
   starting Grant of Institut Pasteur of Shanghai, Chinese Academy of
   Sciences [1185170000]
FX We thank Xia Jin (Institut Pasteur of Shanghai, Chinese Academy of
   Science) for discussions and critical reading of the manuscript. This
   work was supported by Collaborative Research Grant (KLMVI-OP-201904) of
   CAS Key Laboratory of Molecular Virology and Immunology, Institut
   Pasteur of Shanghai, Chinese Academy of Sciences, and the starting Grant
   of Institut Pasteur of Shanghai (1185170000), Chinese Academy of
   Sciences.
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Al-Obaidi MMJ, 2018, ACTA VIROL, V62, P16, DOI 10.4149/av_2018_102
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Ayala-Nunez NV, 2016, SCI REP-UK, V6, DOI 10.1038/srep28768
   Barreto-Vieira DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184397
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bily T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10745
   Blazquez AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002509
   Brault JB, 2011, VIROLOGY, V417, P369, DOI 10.1016/j.virol.2011.06.022
   Chee HY, 2004, BIOCHEM BIOPH RES CO, V320, P11, DOI 10.1016/j.bbrc.2004.05.124
   Chen W, 2008, ARCH VIROL, V153, P1777, DOI 10.1007/s00705-008-0183-x
   Chiou CT, 2003, J GEN VIROL, V84, P2795, DOI 10.1099/vir.0.19201-0
   Chu JJH, 2006, VIROLOGY, V349, P463, DOI 10.1016/j.virol.2006.01.022
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Chu JJH, 2003, J MED VIROL, V71, P463, DOI 10.1002/jmv.10495
   Chu JJH, 2002, J MED VIROL, V67, P127, DOI 10.1002/jmv.2201
   Chuang CK, 2015, J GEN VIROL, V96, P793, DOI 10.1099/jgv.0.000015
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Cudmore S, 1997, TRENDS MICROBIOL, V5, P142, DOI 10.1016/S0966-842X(97)01011-1
   Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394
   Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Foo KY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/427814
   Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100
   Fraisier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068318
   Ganapathiraju Madhavi K, 2016, F1000Res, V5, P1919, DOI 10.12688/f1000research.9364.2
   Gerold G, 2017, MOL CELL PROTEOMICS, V16, pS75, DOI 10.1074/mcp.R116.065649
   Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Hackett BA, 2018, P NATL ACAD SCI USA, V115, P4246, DOI 10.1073/pnas.1720032115
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Jhan MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00182-z
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kanlaya R, 2010, J PROTEOME RES, V9, P4960, DOI 10.1021/pr100219y
   Kanlaya R, 2010, MOL BIOSYST, V6, P795, DOI 10.1039/b923864f
   Kanlaya R, 2009, J PROTEOME RES, V8, P2551, DOI 10.1021/pr900060g
   Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Lee J.W., 2004, J NANOBIOTECHNOL, V2, P6, DOI DOI 10.1186/1477-3155-2-6
   Lei S, 2013, CELL BIOCHEM BIOPHYS, V67, P1333, DOI 10.1007/s12013-013-9665-x
   Liu CC, 2017, J VIROL, V91, DOI [10.1128/JVI.01113-17, 10.1128/jvi.01113-17]
   Makino Y, 2014, J VIROL METHODS, V195, P250, DOI 10.1016/j.jviromet.2013.10.002
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Merino-Gracia J, 2011, FEBS J, V278, P2997, DOI 10.1111/j.1742-4658.2011.08252.x
   Cuartas-Lopez AM, 2018, VIRUS RES, V256, P153, DOI 10.1016/j.virusres.2018.08.013
   Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416
   Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0
   NG ML, 1987, J GEN VIROL, V68, P577
   NG ML, 1983, ARCH VIROL, V78, P177
   NG ML, 1994, ARCH VIROL, V137, P303, DOI 10.1007/BF01309477
   NG ML, 1989, ARCH VIROL, V106, P103, DOI 10.1007/BF01311042
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0
   Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Shrivastava N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025229
   Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109
   Soe HJ, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000009713, 10.1097/md.0000000000009713]
   Sum MSH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/695283
   Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574
   Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   Wang JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000809
   Wang XJ, 2017, AM J TROP MED HYG, V97, P1904, DOI 10.4269/ajtmh.17-0307
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Wu N, 2014, MICROBES INFECT, V16, P911, DOI 10.1016/j.micinf.2014.08.011
   Xu QQ, 2016, FUTURE MICROBIOL, V11, P1227, DOI 10.2217/fmb-2016-0002
   Xu XF, 2009, INTERVIROLOGY, V52, P258, DOI 10.1159/000230669
   Xu ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037886
   Yang J, 2013, MICROBES INFECT, V15, P310, DOI 10.1016/j.micinf.2013.01.004
   Zamudio-Meza H, 2009, J GEN VIROL, V90, P2902, DOI 10.1099/vir.0.014159-0
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
   Zhang J, 2016, SCI CHINA LIFE SCI, V59, P487, DOI 10.1007/s11427-016-5042-5
   Zhang MC, 2013, VIROLOGY, V444, P109, DOI 10.1016/j.virol.2013.06.001
NR 78
TC 3
Z9 3
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD FEB
PY 2019
VL 34
IS 1
BP 30
EP 41
DI 10.1007/s12250-019-00086-4
PG 12
WC Virology
SC Virology
GA HP0NF
UT WOS:000461362100004
PM 30725318
OA Green Published
DA 2020-07-08
ER

PT J
AU Shi, XD
   Hu, JP
   Guo, J
   Wu, CJ
   Xiong, SD
   Dong, CS
AF Shi, Xiaodan
   Hu, Jingping
   Guo, Jing
   Wu, Chuanjian
   Xiong, Sidong
   Dong, Chunsheng
TI A Vesicular Stomatitis Virus-Based Vaccine Carrying Zika Virus Capsid
   Protein Protects Mice from Viral Infection
SO VIROLOGICA SINICA
LA English
DT Letter
ID PROVIDES COMPLETE PROTECTION; NONHUMAN-PRIMATES; DENGUE; CHALLENGE;
   EBOLA
C1 [Shi, Xiaodan; Hu, Jingping; Guo, Jing; Wu, Chuanjian; Xiong, Sidong; Dong, Chunsheng] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China.
   [Shi, Xiaodan; Hu, Jingping; Guo, Jing; Wu, Chuanjian; Xiong, Sidong; Dong, Chunsheng] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China.
RP Xiong, SD; Dong, CS (corresponding author), Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China.; Xiong, SD; Dong, CS (corresponding author), Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China.
EM sdxiong@suda.edu.cn; chunshengdong@suda.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470848, 31470880, 31670898, 31870867]; Open
   Research Fund Program of the State Key Laboratory of Virology of China
   [2017IOV003]; Jiangsu Provincial Innovative Research Team
FX We gratefully thank Dr. Feifei Yin in Hainan Medical University for
   providing ZIKV PRVABC59 and also like to thank Prof. Yi Shi in Institute
   of Microbiology, Chinese Academy of Sciences for providing the Zika E
   monoantibody. This work was supported by the National Natural Science
   Foundation of China (31470848, 31470880, 31670898, and 31870867), Open
   Research Fund Program of the State Key Laboratory of Virology of China
   (2017IOV003) and Jiangsu Provincial Innovative Research Team.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cobleigh MA, 2013, J VIROL, V87, P2969, DOI 10.1128/JVI.02111-12
   Gagnon SJ, 1996, J VIROL, V70, P141, DOI 10.1128/JVI.70.1.141-147.1996
   Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082
   Gil L, 2014, VIROLOGY, V456, P70, DOI 10.1016/j.virol.2014.03.011
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258
   Kahn JS, 2001, J VIROL, V75, P11079, DOI 10.1128/JVI.75.22.11079-11087.2001
   Kapadia SU, 2005, VIROLOGY, V340, P174, DOI 10.1016/j.virol.2005.06.016
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazo L, 2007, VACCINE, V25, P1064, DOI 10.1016/j.vaccine.2006.09.068
   Liu XL, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0072-6
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Reuter JD, 2002, J VIROL, V76, P8900, DOI 10.1128/JVI.76.17.8900-8909.2002
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998
   Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999
   Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 30
TC 1
Z9 1
U1 3
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD FEB
PY 2019
VL 34
IS 1
BP 106
EP 110
DI 10.1007/s12250-019-00083-7
PG 5
WC Virology
SC Virology
GA HP0NF
UT WOS:000461362100013
PM 30820837
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Zimova, S
   Resnerova, K
   Vanicka, H
   Horak, J
   Trombik, J
   Kacprzyk, M
   Lindelow, A
   Duduman, ML
   Holusa, J
AF Zimova, Sona
   Resnerova, Karolina
   Vanicka, Hana
   Horak, Jakub
   Trombik, Jiri
   Kacprzyk, Magdalena
   Lindeloew, Ake
   Duduman, Mihai-Leonard
   Holusa, Jaroslav
TI Infection Levels of the Microsporidium Larssoniella duplicati in
   Populations of the Invasive Bark Beetle Ips duplicatus: From Native to
   New Outbreak Areas
SO FORESTS
LA English
DT Article
DE Ips duplicatus; pathogen; vector; infection level; invasion; latitude
ID COLEOPTERA-CURCULIONIDAE SCOLYTINAE; TYPOGRAPHUS COLEOPTERA;
   CLIMATE-CHANGE; PATHOGENS; PHEROMONE; DENSITIES
AB The microsporidium Larssoniella duplicati (Weiser, Holua, Zika, 2006) is a specific pathogen of the bark beetle Ips duplicatus (C.R. Sahlberg, 1836), which is a serious pest of Norway spruce (Picea abies (L.) H. Karst) in Europe. From 2011 to 2016, infection levels of L. duplicati and other pathogens in I. duplicatus populations were assessed along a gradient, ranging from areas in the north, where the beetle is native, to areas in the south, where the beetle has only recently invaded. The 21 study sites ranged in altitude from 229 to 1009 m a.s.l. We found that pathogen infection levels in I. duplicatus populations decreased from the native areas in the north to the new areas of beetle expansion in the south. We also found that pathogen level increased with altitude. The L. duplicati infection levels were not associated with the infection levels of other beetle natural enemies. The infection level decreased with the length of time of beetle establishment in an area. The infection level increased with the number of beetles trapped and dissected at a site.
C1 [Zimova, Sona; Resnerova, Karolina; Vanicka, Hana; Horak, Jakub; Trombik, Jiri; Holusa, Jaroslav] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Forest Protect & Entomol, Kamycka 129, CZ-16500 Prague 6, Czech Republic.
   [Kacprzyk, Magdalena] Agr Univ Krakow, Inst Forest Ecosyst Protect, Dept Forest Protect Entomol & Forest Climatol, Aleja Adama Mickiewicza 21, PL-31120 Krakow, Poland.
   [Lindeloew, Ake] Swedish Univ Agr Sci, SLU Dept Ecol, Forest Entomol Unit, Dept Ecol, Box 7044, SE-75007 Uppsala, Sweden.
   [Duduman, Mihai-Leonard] Stefan cel Mare Univ Suceava, Fac Forestry, Appl Ecol Lab, Str Univ 13, RO-720229 Suceava, Romania.
RP Zimova, S (corresponding author), Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Forest Protect & Entomol, Kamycka 129, CZ-16500 Prague 6, Czech Republic.
EM zimovas@fld.czu.cz; resnerovak@fld.czu.cz; vanicka@fld.czu.cz;
   jakub.sruby@gmail.com; trombik@fld.czu.cz;
   magdalena.kacprzyk@urk.edu.pl; ake.lindelow@slu.se; mduduman@usv.ro;
   holusa@fld.czu.cz
RI Horak, Jakub/C-1050-2011; Kacprzyk, Magdalena/AAF-8880-2019
OI Horak, Jakub/0000-0003-2049-0599; Kacprzyk,
   Magdalena/0000-0001-9679-5423
FU Czech University of Life Sciences Prague [IGA C_01_18]; grant "Advanced
   research supporting the forestry and wood-processing sector's adaptation
   to global change and the 4th industrial revolution" - OP RDE
   [CZ.02.1.01/0.0/0.0/16_019/0000803]; Ministry of Agriculture of the
   Czech RepublicMinistry of Agriculture, Czech Republic [QK1920433]
FX This work was supported by the Czech University of Life Sciences Prague
   project No. IGA C_01_18, by grant "Advanced research supporting the
   forestry and wood-processing sector's adaptation to global change and
   the 4th industrial revolution", No. CZ.02.1.01/0.0/0.0/16_019/0000803
   financed by OP RDE and by grant No. QK1920433 of the Ministry of
   Agriculture of the Czech Republic.
CR Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6
   Boratyski A., 1998, DYSJUNKCJACH ZASIEGU, P80
   Brus DJ, 2012, EUR J FOREST RES, V131, P145, DOI 10.1007/s10342-011-0513-5
   BYERS JA, 1990, EXPERIENTIA, V46, P1209, DOI 10.1007/BF01936939
   Cudmore TJ, 2010, J APPL ECOL, V47, P1036, DOI 10.1111/j.1365-2664.2010.01848.x
   Duduman M. L., 2011, Bulletin of the Transilvania University of Brasov, Series II - Forestry, Wood Industry, Agricultural Food Engineering, V4, P19
   Duduman ML, 2014, AGR FOREST ENTOMOL, V16, P102, DOI 10.1111/afe.12039
   Fiala T, 2019, FORESTS, V10, DOI 10.3390/f10010012
   Goertz D, 2017, PERIOD BIOL, V119, P285, DOI 10.18054/pb.v119i4.4998
   Grodzki W., 1997, Sylwan, V141, P25
   Grodzki W., 2002, Sylwan, V146, P45
   Grodzki W, 2003, SYLWAN, V8, P29
   Grucmanova S, 2014, J APPL ENTOMOL, V138, P723, DOI 10.1111/jen.12142
   Hilszczanski J, 2016, AGR FOREST ENTOMOL, V18, P340, DOI 10.1111/afe.12165
   Holusa J, 2017, J APPL ENTOMOL, V141, P768, DOI 10.1111/jen.12392
   Holusa J., 2013, Scientia Agriculturae Bohemica, V44, P97, DOI 10.7160/sab.2013.440205
   Holusa J, 2003, BIOLOGIA, V58, P935
   HOLUSA J, 2002, ZPRAVY LESNICKEHO VY, V47, P9
   HOLUSA J., 2006, ZPRAVODAJ OCHRANY LE, V13, P1
   Holusa J, 2007, ACTA PROTOZOOL, V46, P157
   Holusa J, 2018, FOREST ECOL MANAG, V427, P434, DOI 10.1016/j.foreco.2018.01.031
   Holusa J, 2010, PHYTOPARASITICA, V38, P435, DOI 10.1007/s12600-010-0121-9
   Holusa J, 2009, CENT EUR J BIOL, V4, P567, DOI 10.2478/s11535-009-0044-y
   Horak J, 2019, FOREST ECOL MANAG, V433, P343, DOI 10.1016/j.foreco.2018.11.019
   Horak J, 2013, NATURWISSENSCHAFTEN, V100, P327, DOI 10.1007/s00114-013-1029-2
   Jonsson AM, 2012, AGR FOREST METEOROL, V166, P188, DOI 10.1016/j.agrformet.2012.07.012
   Jurc M., 2004, ZBORNIK GOZDARSTVA L, V74, P97
   Kniek M., 1996, 20 INT C ENT AUG 25, P527
   Lukaova K., 2015, INVAZNI DRUHY HMYZU
   Lukasova K, 2013, J APPL ENTOMOL, V137, P188, DOI 10.1111/jen.12000
   Lukasova K, 2013, PERIOD BIOL, V115, P455
   Lukasova K, 2012, REP FOR RES, V57, P230
   Lukasova K, 2011, ACTA PROTOZOOL, V50, P311, DOI 10.4467/16890027AP.11.028.0065
   Novakova P, 2016, PEERJ, V4, DOI 10.7717/peerj.1592
   Peltanova A, 2012, BIOL INVASIONS, V14, P759, DOI 10.1007/s10530-011-0121-9
   Pernek M, 2009, J PEST SCI, V82, P343, DOI 10.1007/s10340-009-0259-8
   Pfeffer A., 1955, KUROVCI SCOLYTIDAE R
   Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x
   Schelhaas MJ, 2010, MITIG ADAPT STRAT GL, V15, P681, DOI 10.1007/s11027-010-9243-0
   Schnaider Z., 1955, ROCZNIKI NAUK LESNYC, V13, P437
   Schroeder LM, 2007, AGR FOREST ENTOMOL, V9, P85, DOI 10.1111/j.1461-9563.2007.00323.x
   Seidl R, 2009, REG ENVIRON CHANGE, V9, P101, DOI 10.1007/s10113-008-0068-2
   Takov D, 2010, ACTA ZOOL BULGAR, V62, P201
   TENKACOVA I, 1987, Helminthologia (Bratislava), V24, P281
   Tenkacova I., 1986, Lesnicky Casopis, V32, P381
   TENKACOVA I., 1991, NEMATODES BARK BEETL, V31, P173
   Vakula J., 2011, NEW METHODS PROTECTI
   Wegensteiner R, 2004, J PEST SCI, V77, P221, DOI 10.1007/s10340-004-0056-3
   Wegensteiner R, 1996, J APPL ENTOMOL, V120, P199, DOI 10.1111/j.1439-0418.1996.tb01591.x
   Weiser J, 2006, J PEST SCI, V79, P127, DOI 10.1007/s10340-006-0124-y
NR 50
TC 0
Z9 0
U1 1
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4907
J9 FORESTS
JI Forests
PD FEB
PY 2019
VL 10
IS 2
AR 131
DI 10.3390/f10020131
PG 10
WC Forestry
SC Forestry
GA HO2KP
UT WOS:000460744000055
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Cartaxo, MFS
   Silva, SMD
   Silva, JGM
   Beltrao, EIC
   Brayner, FA
   de Lima, JL
   Mattos, SS
   Ceballos, AGC
   Schettini, JAC
   Alves, LC
AF Cartaxo, Marina F. S.
   Silva, Sophia Maria D.
   Silva, Jaiurte G. M.
   Beltrao, Eduardo I. C.
   Brayner, Fabio Andre
   de Lima Filho, Jose Luiz
   Mattos, Sandra S.
   Ceballos, Albanita G. C.
   Schettini, Juliana A. C.
   Alves, Luiz Carlos
TI Social determinants of health associated with topical repellent use in
   pregnancy: a cross-sectional study during a Zika outbreak in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE arboviruses; insect repellents; mosquitoes; pregnant women; social
   determinants of health; Zika virus
ID VIRUS OUTBREAK; VIRGIN-ISLANDS; UNITED-STATES; INTERVENTIONS;
   TRANSMISSION; HOUSEHOLD; COVERAGE; DISEASES
AB Background Repellent use during pregnancy was strongly recommended after uncovering Zika virus (ZIKV) involvement with congenital malformations. In this context, Pernambuco, Brazil played a key role since it was the epicentre for the main studies suggesting ZIKV teratogenicity and one of Brazil's most affected states during the 2014-2016 epidemics. Thus we aimed to identify possible associations between social determinants of health and repellent use in pregnancy during the ZIKV outbreak in Pernambuco.
   Methods We conducted a cross-sectional study (July-December 2016) with 539 pregnant women residing in Pernambuco and estimated the associations by prevalence ratio and multivariable logistic regression.
   Results Repellents were associated with pregnant women 30 y; graduates, employed, health professionals, private health system users and with a monthly income per person greater than two minimum wages. Women whose domiciles favour mosquitoes (ground-floor houses, intermittent water supply from general distribution or water trucks and for 6 d/week, cesspools/open wastewater, indoor household water storage) were less likely to use repellents. There was no association for peridomiciles.
   Conclusions Repellents were not associated with ZIKV in most vulnerable pregnant women, despite all the general recommendations made during the Pernambuco epidemic. This study observed a demand for public policies focused on health, education and sanitation problems related to deprived social groups along with their co-responsibility rather than focusing on individual attitudes against mosquitoes.
C1 [Cartaxo, Marina F. S.; Silva, Sophia Maria D.; Silva, Jaiurte G. M.; Beltrao, Eduardo I. C.; Brayner, Fabio Andre; de Lima Filho, Jose Luiz; Mattos, Sandra S.; Alves, Luiz Carlos] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, BR-50670901 Recife, PE, Brazil.
   [Beltrao, Eduardo I. C.] Univ Fed Pernambuco, Dept Bioquim, BR-50670901 Recife, PE, Brazil.
   [Brayner, Fabio Andre; Alves, Luiz Carlos] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, BR-50670901 Recife, PE, Brazil.
   [Ceballos, Albanita G. C.] Univ Fed Pernambuco, Dept Med Social, BR-50670901 Recife, PE, Brazil.
   [Schettini, Juliana A. C.] Univ Catolica Pernambuco, Ctr Ciencias Biol & Saude, BR-50050900 Recife, PE, Brazil.
RP Cartaxo, MFS (corresponding author), Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, BR-50670901 Recife, PE, Brazil.
EM marina.cartaxo@ufpe.br
RI Filho, Jose Luiz Lima/M-8076-2019; Alves, Luiz/V-5314-2019; Martins,
   Jaiurte/T-4992-2019
OI Martins, Jaiurte/0000-0002-6310-1023; Cartaxo, Marina Falcao de
   Souza/0000-0002-8772-9181
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Bardosh KL, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0375-2
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Bermudez-Tamayo C, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0198-6
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, VIR ZIK BRAS RESP SU
   Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Feldstein LR, 2018, AM J TROP MED HYG, V98, P845, DOI 10.4269/ajtmh.17-0799
   Grazziotin V., 2016, 54612016 PL
   Gryseels C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16847
   McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285
   Ministerio da Saude Brasil, 2016, PROT AT SAUD RESP OC
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Patel RV, 2016, PHARMACOTHERAPY, V36, P1272, DOI 10.1002/phar.1854
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pietrobon Louise, 2008, Physis, V18, P767, DOI 10.1590/S0103-73312008000400009
   Prue CE, 2017, MMWR-MORBID MORTAL W, V66, P909, DOI 10.15585/mmwr.mm6634a4
   Quintana-Domeque C, 2018, ECON HUM BIOL, V30, P14, DOI 10.1016/j.ehb.2018.04.003
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   Secretaria de Saude do Estado de Pernambuco, 2018, 32018 SEVSSESPE SEC
   Secretaria de Saude do Estado de Pernambuco, 2016, 482016 SEVSSESPE SEC
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, RISK COMM COMM ENG Z
   Zellweger RM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006051
NR 37
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD FEB
PY 2019
VL 113
IS 2
BP 65
EP 73
DI 10.1093/trstmh/try114
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HO1CY
UT WOS:000460644100003
PM 30412231
OA Bronze
DA 2020-07-08
ER

PT J
AU Amaro, F
   Sanchez-Seco, MP
   Vazquez, A
   Alves, MJ
   Ze-Ze, L
   Luz, MT
   Minguito, T
   De la Fuente, J
   De Ory, F
AF Amaro, Fatima
   Sanchez-Seco, Maria P.
   Vazquez, Ana
   Alves, Maria J.
   Ze-Ze, Libia
   Luz, Maria T.
   Minguito, Teodora
   De la Fuente, Jesus
   De Ory, Fernando
TI The Application and Interpretation of IgG Avidity and IgA ELISA Tests to
   Characterize Zika Virus Infections
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; dengue virus; secondary infections; cross-reactions; IgA;
   IgG avidity tests
ID IMMUNOGLOBULIN-G AVIDITY; LINKED-IMMUNOSORBENT-ASSAY; DENGUE; DIAGNOSIS;
   DIFFERENTIATION; SPECIFICITY; SENSITIVITY; ANTIBODIES; PORTUGAL; SERUM
AB In the absence of viremia, the diagnostics of Zika virus (ZIKV) infections must rely on serological techniques. In order to improve the serological diagnosis of ZIKV, ZIKV-IgA and ZIKV-IgG avidity assays were evaluated. Forty patients returning from ZIKV endemic areas, with confirmed or suspected ZIKV infections were studied. Samples were classified as early acute, acute and late acute according to the number of days post illness onset. Low avidity IgG was only detected at acute and late acute stages and IgA mostly at the early acute and acute stages. The date of sampling provides useful information and can help to choose the best technique to use at a determined moment in time and to interpret low avidity IgG and IgA results, improving the serological diagnosis of ZIKV.
C1 [Amaro, Fatima] European Ctr Dis Prevent & Control ECDC, European Programme Publ Hlth Microbiol Training E, S-17165 Solna, Sweden.
   [Amaro, Fatima; Sanchez-Seco, Maria P.; Vazquez, Ana; Minguito, Teodora; De la Fuente, Jesus; De Ory, Fernando] Inst Hlth Carlos III, Natl Ctr Microbiol, Majadahonda 28220, Spain.
   [Sanchez-Seco, Maria P.; Vazquez, Ana; Alves, Maria J.; De Ory, Fernando] Virored Network Emerging Viruses, Hamburg, Germany.
   [Vazquez, Ana; De Ory, Fernando] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid 28029, Spain.
   [Alves, Maria J.; Ze-Ze, Libia; Luz, Maria T.] Ctr Vectors & Infect Dis Res, Natl Inst Hlth Doutor Ricardo Jorge, P-2965575 Aguas De Moura, Portugal.
RP De Ory, F (corresponding author), Inst Hlth Carlos III, Natl Ctr Microbiol, Majadahonda 28220, Spain.; De Ory, F (corresponding author), Virored Network Emerging Viruses, Hamburg, Germany.; De Ory, F (corresponding author), Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid 28029, Spain.
EM fatima.f.amaro@gmail.com; paz.sanchez@isciii.es; a.vazquez@isciii.es;
   m.joao.alves@insa.min-saude.pt; libia.zeze@insa.min-saude.pt;
   teresa.luz@insa.min-saude.pt; teoml@isciii.es; jfuentel@isciii.es;
   fory@isciii.es
RI Vazquez, Ana/H-4911-2013
OI Vazquez, Ana/0000-0002-9872-3316; SANCHEZ-SECO, MARIA
   PAZ/0000-0001-9033-7704; Amaro, Fatima/0000-0002-5445-4142; Ze-Ze,
   Libia/0000-0001-7258-1439; Alves, Maria Joao/0000-0003-0065-9000
FU ISCIII Project [PI16CIII/00037]
FX This work has been partially funded by the ISCIII Project
   "PI16CIII/00037".
CR Alves MJ, 2013, EUROSURVEILLANCE, V18, P2
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Centers for Disease Control and Prevention, 2016, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004
   Domingo C, 2009, DIAGN MICR INFEC DIS, V65, P42, DOI 10.1016/j.diagmicrobio.2009.05.004
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fox JL, 2006, CLIN VACCINE IMMUNOL, V13, P33, DOI 10.1128/CVI.13.1.33-36.2006
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Levett PN, 2005, J CLIN MICROBIOL, V43, P5873, DOI 10.1128/JCM.43.12.5873-5875.2005
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Pan American Health Organization, 2015, ZIK VIR ZIKV SURV AM
   Pan American Health Organization Regional Office of the WHO (PAHO/WHO), AL EP INF VIR ZIK
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Prince HE, 2005, CLIN DIAGN LAB IMMUN, V12, P231, DOI 10.1128/CDLI.12.1.231-233.2005
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Talarmin A, 1998, J CLIN MICROBIOL, V36, P1189, DOI 10.1128/JCM.36.5.1189-1192.1998
   Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461
   Ze-Ze L, 2016, IDCases, V4, P46, DOI 10.1016/j.idcr.2016.03.004
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 31
TC 4
Z9 4
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2019
VL 11
IS 2
AR 179
DI 10.3390/v11020179
PG 11
WC Virology
SC Virology
GA HO3EW
UT WOS:000460803200089
PM 30791664
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Azouz, F
   Arora, K
   Krause, K
   Nerurkar, VR
   Kumar, M
AF Azouz, Francine
   Arora, Komal
   Krause, Keeton
   Nerurkar, Vivek R.
   Kumar, Mukesh
TI Integrated MicroRNA and mRNA Profiling in Zika Virus-Infected Neurons
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; flavivirus; microRNAs; neurons; neuroinflammation;
   anti-viral immunity
ID WEST NILE VIRUS; CELLULAR MICRORNAS; RIG-I; REPLICATION; BRAIN;
   INTERFERENCE; ENCEPHALITIS; EXPRESSION; CELLS; MODEL
AB Zika virus (ZIKV) infections have caused a wide spectrum of neurological diseases, such as Guillain-Barre syndrome, myelitis, meningoencephalitis, and congenital microcephaly. No effective therapies currently exist for treating patients infected with ZIKV. MicroRNAs (miRNAs) are a group of small RNAs involved in the regulation of a wide variety of cellular and physiological processes. In this study, we analyzed digital miRNA and mRNA profiles in ZIKV-infected primary mouse neurons using the nCounter technology. A total of 599 miRNAs and 770 mRNAs were examined. We demonstrate that ZIKV infection causes global downregulation of miRNAs with only few upregulated miRNAs. ZIKV-modulated miRNAs including miR-155, miR-203, miR-29a, and miR-124-3p are known to play critical role in flavivirus infection, anti-viral immunity and brain injury. ZIKV infection also results in downregulation of miRNA processing enzymes. In contrast, ZIKV infection induces dramatic upregulation of anti-viral, inflammatory and apoptotic genes. Furthermore, our data demonstrate an inverse correlation between ZIKV-modulated miRNAs and target host mRNAs induced by ZIKV. Biofunctional analysis revealed that ZIKV-modulated miRNAs and mRNAs regulate the pathways related to neurological development and neuroinflammatory responses. Functional studies targeting specific miRNA are warranted to develop therapeutics for the management of ZIKV neurological disease.
C1 [Azouz, Francine; Krause, Keeton; Nerurkar, Vivek R.] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96813 USA.
   [Arora, Komal; Kumar, Mukesh] Georgia State Univ, Dept Biol, Coll Arts & Sci, POB 4010, Atlanta, GA 30303 USA.
RP Kumar, M (corresponding author), Georgia State Univ, Dept Biol, Coll Arts & Sci, POB 4010, Atlanta, GA 30303 USA.
EM azouzf@hawaii.edu; karora@gsu.edu; krausek@hawaii.edu;
   nerurkar@hawaii.edu; mkumar8@gsu.edu
RI Kumar, Mukesh/N-8814-2015
OI Kumar, Mukesh/0000-0003-0970-4875; Nerurkar, Vivek/0000-0002-2044-2784
FU Centers of Biomedical Research Excellence, National Institute of General
   Medical Sciences [P30GM114737]; National Institute of Neurological
   Disorders and StrokeUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [R21NS099838]; Office of the
   Director, National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R21OD024896]; Hawaii Community Foundation [18CON-90812]
FX This work was supported by a grant (P30GM114737) from the Centers of
   Biomedical Research Excellence, National Institute of General Medical
   Sciences, grant (R21NS099838) from National Institute of Neurological
   Disorders and Stroke, grant (R21OD024896) from the Office of the
   Director, National Institutes of Health, and grant (18CON-90812) from
   Hawaii Community Foundation.
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Bavia L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0541-3
   Bolisetty MT, 2009, J VIROL, V83, P12009, DOI 10.1128/JVI.01182-09
   Buggele WA, 2013, J VIROL, V87, P9260, DOI 10.1128/JVI.01064-13
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Diamond MS, 2012, TRENDS IMMUNOL, V33, P522, DOI 10.1016/j.it.2012.05.008
   Dickey LL, 2017, J NEUROIMMUNOL, V308, P17, DOI 10.1016/j.jneuroim.2017.01.016
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Escalera-Cueto M, 2015, VIRUS RES, V196, P105, DOI 10.1016/j.virusres.2014.11.010
   Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Ferreira RN, 2018, VIRAL IMMUNOL, V31, P583, DOI 10.1089/vim.2017.0186
   Forest KH, 2018, J NEUROCHEM, V144, P201, DOI 10.1111/jnc.14257
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Fredericksen BL, 2014, J NEUROVIROL, V20, P113, DOI 10.1007/s13365-013-0180-z
   Gaburro J, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0989-4
   Garofalo M, 2008, CURR OPIN PHARMACOL, V8, P661, DOI 10.1016/j.coph.2008.06.005
   Ge Q, 2012, ENDOCRINOLOGY, V153, P5285, DOI 10.1210/en.2012-1623
   Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385
   Heiss BL, 2011, J VIROL, V85, P1464, DOI 10.1128/JVI.02091-10
   Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Jiang M, 2014, J VIRAL HEPATITIS, V21, P99, DOI 10.1111/jvh.12126
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Kumar M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26350
   Kumar M, 2014, VIROLOGY, V452, P143, DOI 10.1016/j.virol.2014.01.004
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Kumar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044682
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013
   Papagiannakopoulos T, 2009, CELL STEM CELL, V4, P375, DOI 10.1016/j.stem.2009.04.007
   Pareek S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-97
   Pauley KM, 2008, ANN NY ACAD SCI, V1143, P226, DOI 10.1196/annals.1443.009
   Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205
   Pijlman GP, 2014, CURR OPIN VIROL, V7, P55, DOI 10.1016/j.coviro.2014.04.002
   Qin Z, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00406
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roy B, 2017, NEUROPSYCHOPHARMACOL, V42, P864, DOI 10.1038/npp.2016.175
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Shin OS, 2013, VIROLOGY, V446, P217, DOI 10.1016/j.virol.2013.07.036
   Slonchak A, 2016, J VIROL, V90, P2388, DOI 10.1128/JVI.02608-15
   Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11
   Song MS, 2017, BIOCHEM J, V474, P1603, DOI 10.1042/BCJ20160759
   Sun Y, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00193
   Swaminathan G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002937
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thounaojam MC, 2014, J VIROL, V88, P4798, DOI 10.1128/JVI.02979-13
   Thounaojam MC, 2014, J NEUROCHEM, V129, P143, DOI 10.1111/jnc.12609
   Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Wakayama I, 1997, BRAIN RES, V748, P237, DOI 10.1016/S0006-8993(96)01314-5
   Zhai AX, 2013, ANTIVIR RES, V98, P66, DOI 10.1016/j.antiviral.2013.02.009
   Zhang S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25073-9
   Zhu X, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003088
NR 72
TC 6
Z9 6
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2019
VL 11
IS 2
AR 162
DI 10.3390/v11020162
PG 22
WC Virology
SC Virology
GA HO3EW
UT WOS:000460803200072
PM 30781519
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ketkar, H
   Herman, D
   Wang, PH
AF Ketkar, Harshada
   Herman, Daniella
   Wang, Penghua
TI Genetic Determinants of the Re-Emergence of Arboviral Diseases
SO VIRUSES-BASEL
LA English
DT Review
DE Arbovirus; host; genetic; evolution; vector; re-emergence
ID WEST-NILE-VIRUS; DENGUE HEMORRHAGIC-FEVER; NECROSIS-FACTOR-ALPHA;
   FC-GAMMA-RIIA; SINGLE NUCLEOTIDE POLYMORPHISMS; NONSTRUCTURAL PROTEIN
   NS1; CHIKUNGUNYA VIRUS; EVOLUTIONARY EPIDEMIOLOGY; CUBAN POPULATION;
   PROTECTIVE ROLE
AB Mosquito-borne diseases constitute a large portion of infectious diseases, causing more than 700,000 deaths annually. Mosquito-transmitted viruses, such as yellow fever, dengue, West Nile, chikungunya, and Zika viruses, have re-emerged recently and remain a public health threat worldwide. Global climate change, rapid urbanization, burgeoning international travel, expansion of mosquito populations, vector competence, and host and viral genetics may all together contribute to the re-emergence of arboviruses. In this brief review, we summarize the host and viral genetic determinants that may enhance infectivity in the host, viral fitness in mosquitoes and viral transmission by mosquitoes.
C1 [Ketkar, Harshada; Herman, Daniella] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.
   [Wang, Penghua] Univ Connecticut, Ctr Hlth, Sch Med, Dept Immunol, Farmington, CT 06030 USA.
RP Wang, PH (corresponding author), Univ Connecticut, Ctr Hlth, Sch Med, Dept Immunol, Farmington, CT 06030 USA.
EM Harshada_Ketkar@nymc.edu; dherman@nymc.edu; Pewang@uchc.edu
RI wang, Penghua/AAL-4011-2020
OI WANG, PENGHUA/0000-0002-7332-1871
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI132526]
FX This work was supported by a National Institutes of Health grant
   R01AI132526 to P.W. We apologize for not including all related
   publications due to space limitation.
CR Falcon-Lezama JA, 2009, ACTA TROP, V112, P193, DOI 10.1016/j.actatropica.2009.07.025
   Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Brent SE, 2018, B WORLD HEALTH ORGAN, V96, P343, DOI 10.2471/BLT.17.205658
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Chen HL, 2008, AM J TROP MED HYG, V79, P495, DOI 10.4269/ajtmh.2008.79.495
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011
   CROOKS AJ, 1994, J GEN VIROL, V75, P3453, DOI 10.1099/0022-1317-75-12-3453
   Dolan PT, 2018, ANNU REV VIROL, V5, P69, DOI 10.1146/annurev-virology-101416-041718
   Dutta SK, 2017, VIROLOGY, V511, P207, DOI 10.1016/j.virol.2017.08.009
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493
   FAN W, 1990, VIROLOGY, V177, P470, DOI 10.1016/0042-6822(90)90511-O
   Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x
   Fernando AN, 2015, J GLOB INFECT DIS, V7, P157, DOI 10.4103/0974-777X.170501
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Garcia G, 2010, AM J TROP MED HYG, V82, P1153, DOI 10.4269/ajtmh.2010.09-0353
   Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530
   GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094
   Gubler DJ, 2000, VIRAL IMMUNOL, V13, P469, DOI 10.1089/vim.2000.13.469
   GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581
   GUBLER DJ, 1993, INFECT AGENT DIS, V2, P383
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304
   Lanteri MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022948
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320
   Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399
   McArthur MA, 2013, EXPERT REV VACCINES, V12, P933, DOI 10.1586/14760584.2013.815412
   dos Santos ACM, 2017, IMMUNOL INVEST, V46, P201, DOI 10.1080/08820139.2016.1248560
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Messer WB, 2002, AM J TROP MED HYG, V66, P765, DOI 10.4269/ajtmh.2002.66.765
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mohsin SN, 2015, AM J TROP MED HYG, V93, P691, DOI 10.4269/ajtmh.15-0199
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863
   Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189
   Noecker CA, 2014, ACTA TROP, V138, P15, DOI 10.1016/j.actatropica.2014.05.021
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Ooi EE, 2001, LANCET, V357, P685, DOI 10.1016/S0140-6736(00)04137-4
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011
   Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799
   Perez AB, 2010, HUM IMMUNOL, V71, P1135, DOI 10.1016/j.humimm.2010.08.004
   Pinheiro TM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006525
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   POST PR, 1991, VIRUS RES, V18, P291, DOI 10.1016/0168-1702(91)90025-Q
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Sam SS, 2015, INT J MED SCI, V12, P177, DOI 10.7150/ijms.8988
   Sarri CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165952
   Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001
   Simon-Loriere E, 2015, J INFECT DIS, V212, P2011, DOI 10.1093/infdis/jiv321
   Souza Thiara Manuele Alves, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x
   Sumathy K, 2012, J MED VIROL, V84, P462, DOI 10.1002/jmv.23187
   Dang TN, 2014, BMC MED GENET, V15, DOI [10.1186/1471-2350-15-59, 10.1186/1471-2350-15-58]
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0
   Velasquez CV, 2015, HUM IMMUNOL, V76, P318, DOI 10.1016/j.humimm.2015.03.009
   Wang L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000934
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Williams M, 2014, AM J TROP MED HYG, V91, P611, DOI 10.4269/ajtmh.13-0600
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   Xavier-Carvalho C, 2017, HUM IMMUNOL, V78, P649, DOI 10.1016/j.humimm.2017.07.013
   Xavier-Carvalho C, 2013, INFECT GENET EVOL, V20, P197, DOI 10.1016/j.meegid.2013.08.017
   Yakub I, 2005, J INFECT DIS, V192, P1741, DOI 10.1086/497340
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 89
TC 2
Z9 2
U1 3
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2019
VL 11
IS 2
AR 150
DI 10.3390/v11020150
PG 14
WC Virology
SC Virology
GA HO3EW
UT WOS:000460803200060
PM 30759739
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, J
   Koo, BK
   Yoon, KJ
AF Kim, Jihoon
   Koo, Bon-Kyoung
   Yoon, Ki-Jun
TI Modeling Host-Virus Interactions in Viral Infectious Diseases Using
   Stem-Cell-Derived Systems and CRISPR/Cas9 Technology
SO VIRUSES-BASEL
LA English
DT Review
DE organoid; host-virus interactions; CRISPR; Cas9 genome editing; induced
   pluripotent stem cell; adult stem cell; modeling of viral pathogenesis
ID LONG-TERM CULTURE; ZIKA-VIRUS; CEREBRAL ORGANOIDS; ROTAVIRUS INFECTION;
   NEURAL PROGENITORS; HUMAN NOROVIRUSES; DRUG-RESISTANCE; CRISPR-CAS9;
   IDENTIFICATION; NEUROGENESIS
AB Pathologies induced by viral infections have undergone extensive study, with traditional model systems such as two-dimensional (2D) cell cultures and in vivo mouse models contributing greatly to our understanding of host-virus interactions. However, the technical limitations inherent in these systems have constrained efforts to more fully understand such interactions, leading to a search for alternative in vitro systems that accurately recreate in vivo physiology in order to advance the study of viral pathogenesis. Over the last decade, there have been significant technological advances that have allowed researchers to more accurately model the host environment when modeling viral pathogenesis in vitro, including induced pluripotent stem cells (iPSCs), adult stem-cell-derived organoid culture systems and CRISPR/Cas9-mediated genome editing. Such technological breakthroughs have ushered in a new era in the field of viral pathogenesis, where previously challenging questions have begun to be tackled. These include genome-wide analysis of host-virus crosstalk, identification of host factors critical for viral pathogenesis, and the study of viral pathogens that previously lacked a suitable platform, e.g., noroviruses, rotaviruses, enteroviruses, adenoviruses, and Zika virus. In this review, we will discuss recent advances in the study of viral pathogenesis and host-virus crosstalk arising from the use of iPSC, organoid, and CRISPR/Cas9 technologies.
C1 [Kim, Jihoon; Koo, Bon-Kyoung] Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.
   [Yoon, Ki-Jun] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea.
RP Koo, BK (corresponding author), Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.; Yoon, KJ (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea.
EM jihoon.kim@imba.oeaw.ac.at; bonkyoung.koo@imba.oeaw.ac.at;
   kijunyoon@kaist.ac.kr
OI Yoon, Ki-Jun/0000-0003-2985-2541
FU National Research Foundation of Korea (NRF) - Korean Ministry of
   Science, ICT, and Future Planning (MSIP) [2018R1A5A1024261]; ERCEuropean
   Research Council (ERC) [639050]; IMBA, the Austrian Academy of Sciences
FX This work was supported by a National Research Foundation of Korea (NRF)
   grant (2018R1A5A1024261 to K.-J.Y.) funded by the Korean Ministry of
   Science, ICT, and Future Planning (MSIP). B.-K.K. is supported by an ERC
   starting grant (Troy Stem Cells, 639050) and IMBA, the Austrian Academy
   of Sciences.
CR Andersson-Rolf A, 2017, NAT METHODS, V14, P287, DOI [10.1038/nmeth.4156, 10.1038/NMETH.4156]
   Andersson-Rolf A, 2016, DEV BIOL, V420, P271, DOI 10.1016/j.ydbio.2016.10.016
   Artegiani B, 2018, HUM MOL GENET, V27, pR99, DOI 10.1093/hmg/ddy187
   Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Barrangou R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0816-9
   Bayat H, 2018, ADV PHARM BULL, V8, P591, DOI 10.15171/apb.2018.067
   Belliot G, 2014, CLIN MICROBIOL INFEC, V20, P724, DOI 10.1111/1469-0691.12722
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carlin AF, 2019, CURR OPIN VIROL, V34, P29, DOI 10.1016/j.coviro.2018.11.010
   Chakrabarti J, 2018, METHODS MOL BIOL, V1817, P157, DOI 10.1007/978-1-4939-8600-2_16
   Chen H, 2017, NATURE, V550, P92, DOI 10.1038/nature23877
   Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Aiuto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049700
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davila S, 2009, GENOME MED, V1, DOI 10.1186/gm19
   Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886
   Dijkstra KK, 2018, CELL, V174, P1586, DOI 10.1016/j.cell.2018.07.009
   Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415
   Drummond CG, 2017, P NATL ACAD SCI USA, V114, P1672, DOI 10.1073/pnas.1617363114
   Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Fessler E, 2016, EMBO MOL MED, V8, P745, DOI 10.15252/emmm.201606184
   Freiermuth JL, 2018, J CELL BIOCHEM, V119, P62, DOI 10.1002/jcb.26162
   Fujii M, 2015, NAT PROTOC, V10, P1474, DOI 10.1038/nprot.2015.088
   Fumagalli M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000849
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gao X, 2015, J CELL BIOL, V211, P669, DOI 10.1083/jcb.201506014
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Glass Z, 2018, TRENDS BIOTECHNOL, V36, P173, DOI 10.1016/j.tibtech.2017.11.006
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013
   Holly MK, 2018, J VIROL, V92, DOI 10.1128/JVI.00250-18
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Janssens Sylvie, 2018, mSystems, V3, DOI [10.1128/msystems.00219-17, 10.1128/mSystems.00219-17]
   Jiang DJ, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120575
   Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42
   Kim DS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00109
   Klenk HD, 2014, CELL HOST MICROBE, V15, P653, DOI 10.1016/j.chom.2014.05.019
   Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011
   Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/nmeth.1802, 10.1038/NMETH.1802]
   Kretzschmar K, 2016, DEV CELL, V38, P590, DOI 10.1016/j.devcel.2016.08.014
   Langhans SA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00006
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Macartney KK, 2000, J VIROL, V74, P5597, DOI 10.1128/JVI.74.12.5597-5603.2000
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08
   Nelson CT, 1997, CLIN PERINATOL, V24, P151
   Newport MJ, 2011, BRIEF FUNCT GENOMICS, V10, P98, DOI 10.1093/bfgp/elq037
   Nie J, 2017, EMBO REP, V18, P367, DOI 10.15252/embr.201643732
   Nie YZ, 2018, EBIOMEDICINE, V35, P114, DOI 10.1016/j.ebiom.2018.08.014
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Palakkan AA, 2017, BIOMED REP, V6, P367, DOI 10.3892/br.2017.867
   Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200
   Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741
   Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032
   Passier R, 2016, CELL STEM CELL, V18, P309, DOI [10.1016/j.stem.2016.02.011, 10.1016/j.stem.2016.02.013]
   Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramage H, 2015, ANNU REV VIROL, V2, P497, DOI 10.1146/annurev-virology-100114-055238
   Ramani S, 2018, CURR OPIN VIROL, V29, P79, DOI 10.1016/j.coviro.2018.04.001
   Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022
   Rotavirus vaccines, 2013, WKLY EPIDEMIOL REC, V88, P49
   Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300
   Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shaw T, 2006, J HEPATOL, V44, P593, DOI 10.1016/j.jhep.2006.01.001
   Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taylor G, 2017, VACCINE, V35, P469, DOI 10.1016/j.vaccine.2016.11.054
   To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1
   Trevisan M, 2015, VIRUSES-BASEL, V7, P3835, DOI 10.3390/v7072800
   van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279
   van der Sanden SMG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0077-2
   Warren HS, 2015, P NATL ACAD SCI USA, V112, pE345, DOI 10.1073/pnas.1414857111
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wilson SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006446
   Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111
   Yin H, 2018, NAT CHEM BIOL, V14, P311, DOI [10.1038/NCHEMBIO.2559, 10.1038/nchembio.2559]
   Yin YB, 2015, ANTIVIR RES, V123, P120, DOI 10.1016/j.antiviral.2015.09.010
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhou J, 2018, P NATL ACAD SCI USA, V115, P6822, DOI 10.1073/pnas.1806308115
   zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4
NR 108
TC 5
Z9 5
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2019
VL 11
IS 2
AR 124
DI 10.3390/v11020124
PG 17
WC Virology
SC Virology
GA HO3EW
UT WOS:000460803200034
PM 30704043
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, G
   Bos, S
   Tsetsarkin, KA
   Pletnev, AG
   Despres, P
   Gadea, G
   Zhao, RY
AF Li, Ge
   Bos, Sandra
   Tsetsarkin, Konstantin A.
   Pletnev, Alexander G.
   Despres, Philippe
   Gadea, Gilles
   Zhao, Richard Y.
TI The Roles of prM-E Proteins in Historical and Epidemic Zika
   Virus-mediated Infection and Neurocytotoxicity
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; prM-E proteins; viral pathogenicity; virus attachment; viral
   replication; viral permissiveness; viral survival; apoptosis; cytopathic
   effects; mutagenesis; chimeric viruses; human brain glial cells
ID GENOME; STRAINS; REGION; CELLS
AB The Zika virus (ZIKV) was first isolated in Africa in 1947. It was shown to be a mild virus that had limited threat to humans. However, the resurgence of the ZIKV in the most recent Brazil outbreak surprised us because it causes severe human congenital and neurologic disorders including microcephaly in newborns and Guillain-Barre syndrome in adults. Studies showed that the epidemic ZIKV strains are phenotypically different from the historic strains, suggesting that the epidemic ZIKV has acquired mutations associated with the altered viral pathogenicity. However, what genetic changes are responsible for the changed viral pathogenicity remains largely unknown. One of our early studies suggested that the ZIKV structural proteins contribute in part to the observed virologic differences. The objectives of this study were to compare the historic African MR766 ZIKV strain with two epidemic Brazilian strains (BR15 and ICD) for their abilities to initiate viral infection and to confer neurocytopathic effects in the human brain's SNB-19 glial cells, and further to determine which part of the ZIKV structural proteins are responsible for the observed differences. Our results show that the historic African (MR766) and epidemic Brazilian (BR15 and ICD) ZIKV strains are different in viral attachment to host neuronal cells, viral permissiveness and replication, as well as in the induction of cytopathic effects. The analysis of chimeric viruses, generated between the MR766 and BR15 molecular clones, suggests that the ZIKV E protein correlates with the viral attachment, and the C-prM region contributes to the permissiveness and ZIKV-induced cytopathic effects. The expression of adenoviruses, expressing prM and its processed protein products, shows that the prM protein and its cleaved Pr product, but not the mature M protein, induces apoptotic cell death in the SNB-19 cells. We found that the Pr region, which resides on the N-terminal side of prM protein, is responsible for prM-induced apoptotic cell death. Mutational analysis further identified four amino-acid residues that have an impact on the ability of prM to induce apoptosis. Together, the results of this study show that the difference of ZIKV-mediated viral pathogenicity, between the historic and epidemic strains, contributed in part the functions of the structural prM-E proteins.
C1 [Li, Ge; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.
   [Bos, Sandra; Despres, Philippe; Gadea, Gilles] Univ La Reunion, INSERM U1187, Unite Mixte Proc Infect Milieu Insulaire Trop, Plateforme Technol CYROI,CNRS UMR 9192,IRD UMR 24, F-97400 St Clotilde, Reunion, France.
   [Tsetsarkin, Konstantin A.; Pletnev, Alexander G.] NIAID, Lab Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Microbiol Immunol, Baltimore, MD 21201 USA.
   [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Global Hlth, Baltimore, MD 21201 USA.
   [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
RP Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Gadea, G (corresponding author), Univ La Reunion, INSERM U1187, Unite Mixte Proc Infect Milieu Insulaire Trop, Plateforme Technol CYROI,CNRS UMR 9192,IRD UMR 24, F-97400 St Clotilde, Reunion, France.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Microbiol Immunol, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Inst Global Hlth, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
EM lige_cn@hotmail.com; SandraBos.Lab@gmail.com;
   konstantin.tsetsarkin@nih.gov; apletnev@niaid.nih.gov;
   philippe.despres@univ-reunion.fr; gilles.gadea@inserm.fr;
   rzhao@som.umaryland.edu
OI Gilles, Gadea/0000-0001-6325-4866; BOS, Sandra/0000-0001-5036-0336
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH R21 AI129369];
   University of Maryland Medical Center; National Institute of Allergy and
   Infectious Diseases (NIAID) Intramural Program; ZIKAlert project
   (European Union-Region Reunion program) [SYNERGY: RE0001902]; La Reunion
   Island University (Ecole Doctorale STS) - French ministry MEESR
   (Ministere de l'Education, de l'Enseignement Superieur et de la
   Recherche)
FX This study was funded in part by National Institute of Health (NIH R21
   AI129369) and the University of Maryland Medical Center (to R.Y.Z.).
   A.P. and K.T. were supported by National Institute of Allergy and
   Infectious Diseases (NIAID) Intramural Program. This work was also
   supported by the ZIKAlert project (European Union-Region Reunion program
   under grant agreement n SYNERGY: RE0001902). S.B. is the recipient of a
   PhD degree scholarship from La Reunion Island University (Ecole
   Doctorale STS), funded by the French ministry MEESR (Ministere de
   l'Education, de l'Enseignement Superieur et de la Recherche).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Harris E, 2006, NOVART FDN SYMP, V277, P251
   Harris E, 2006, NOVART FDN SYMP, V277, P40
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Rodriguez RA, 2009, APPL ENVIRON MICROB, V75, P297, DOI 10.1128/AEM.01150-08
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Talero-Gutierrez C, 2018, EPIDEMIOL INFECT, V146, P673, DOI 10.1017/S0950268818000419
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157
NR 48
TC 4
Z9 4
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2019
VL 11
IS 2
AR 157
DI 10.3390/v11020157
PG 21
WC Virology
SC Virology
GA HO3EW
UT WOS:000460803200067
PM 30769824
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maucourant, C
   Petitdemange, C
   Yssel, H
   Vieillard, V
AF Maucourant, Christopher
   Petitdemange, Caroline
   Yssel, Hans
   Vieillard, Vincent
TI Control of Acute Arboviral Infection by Natural Killer Cells
SO VIRUSES-BASEL
LA English
DT Review
DE natural killer cells; arboviruses; interferon-; cytotoxicity
ID ANTIBODY-DEPENDENT ENHANCEMENT; HUMAN YELLOW-FEVER; WEST-NILE-VIRUS; NK
   CELLS; EMERGING INSIGHTS; HUMAN HEALTH; DENGUE; RECEPTOR; RESPONSES;
   CYTOTOXICITY
AB The recent explosive pandemic of chikungunya virus (CHIKV) followed by Zika (ZIKV) virus infections occurring throughout many countries represents the most unexpected arrival of arthropod-borne viral diseases in the past 20 years. Transmitted through the bite of Aedes mosquitoes, the clinical picture associated with these acute arbovirus infections, including Dengue (DENV), CHIKV and ZIKV, ranges from classical febrile illness to life-threatening disease. Whereas ZIKV and CHIKV-mediated infections have previously been recognized as relatively benign diseases, in contrast to Dengue fever, recent epidemic events have brought waves of increased morbidity and mortality leading to a serious public health problem. Although the host immune response plays a crucial role in controlling infections, it may also promote viral spread and immunopathology. Here, we review recent developments in our understanding of the immune response, with an emphasis on the early antiviral immune response mediated by natural killer cells and emphasize their Janus-faced effects in the control of arbovirus infection and pathogenesis. Improving our understanding knowledge on of the mechanisms that control viral infection is crucial in the current race against the globalization of arbovirus epidemics.
C1 [Maucourant, Christopher; Yssel, Hans; Vieillard, Vincent] UPMC Univ Paris 06, Sorbonne Univ, Ctr Immunol & Malad Infect CIMI Paris, CNRS,INSERM,U1135,ERL8255, F-75013 Paris, France.
   [Petitdemange, Caroline] CNRS, UMR9196, Unite Physiol & Pathol Mol Retrovirus Endogenes &, Inst Gustave Roussy, F-94800 Villejuif, France.
RP Vieillard, V (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Ctr Immunol & Malad Infect CIMI Paris, CNRS,INSERM,U1135,ERL8255, F-75013 Paris, France.
EM maucourantchristopher@hotmail.fr; caroline.petitdemange@gmail.com;
   hans.yssel@inserm.fr; vincent.vieillard@sorbonne-universite.fr
FU EU Horizon 2020 ZIKAlliance Program [734548]
FX This work was supported by the EU Horizon 2020 ZIKAlliance Program
   (grant agreement No. 734548).
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Adams NM, 2016, J IMMUNOL, V197, P2963, DOI 10.4049/jimmunol.1600973
   Alagarasu K, 2015, INT J IMMUNOGENET, V42, P432, DOI 10.1111/iji.12231
   Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237
   Auerswald H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0010-0
   Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x
   Baychelier F, 2013, BLOOD, V122, P2935, DOI 10.1182/blood-2013-03-489054
   Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356
   Beltrame LM, 2013, TISSUE ANTIGENS, V82, P397, DOI 10.1111/tan.12256
   Beziat V, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00507
   Beziat V, 2012, EUR J IMMUNOL, V42, P447, DOI 10.1002/eji.201141826
   Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189
   Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34
   Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762
   Blom K, 2016, J IMMUNOL, V197, P2762, DOI 10.4049/jimmunol.1600950
   Boudreau JE, 2018, CURR OPIN IMMUNOL, V50, P102, DOI 10.1016/j.coi.2017.11.003
   Braun M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004521
   Castanha PMS, 2017, J INFECT DIS, V216, P614, DOI 10.1093/infdis/jix346
   Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9
   Cheng Y, 2004, J INFECT DIS, V189, P658, DOI 10.1086/381501
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mbio.00741-17, 10.1128/mBio.00741-17]
   Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028
   Della Chiesa M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00573
   Della Chiesa M, 2014, SEMIN IMMUNOL, V26, P152, DOI 10.1016/j.smim.2014.02.001
   Drews E, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1039
   Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567
   Fox JM, 2016, J IMMUNOL, V197, P4210, DOI 10.4049/jimmunol.1601426
   Glasner A, 2017, J VIROL, V91, DOI [10.1128/JVI.00785-17, 10.1128/jvi.00785-17]
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072
   Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Hammer Q, 2018, NAT IMMUNOL, V19, P800, DOI 10.1038/s41590-018-0163-6
   Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537
   Hershkovitz O, 2009, J IMMUNOL, V183, P2610, DOI 10.4049/jimmunol.0802806
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855
   Huss RS, 2010, ARTHRITIS RHEUM-US, V62, P3799, DOI 10.1002/art.27751
   Jaime P, 2017, OSTEOARTHR CARTILAGE, V25, P1708, DOI 10.1016/j.joca.2017.06.007
   Jia XY, 1999, LANCET, V354, P1971, DOI 10.1016/S0140-6736(99)05384-2
   Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Keawvichit R, 2018, IMMUNOLOGY, V153, P455, DOI 10.1111/imm.12858
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354
   Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003
   KURANE I, 1984, J VIROL, V52, P223, DOI 10.1128/JVI.52.1.223-230.1984
   Lam VC, 2017, CURR OPIN IMMUNOL, V44, P43, DOI 10.1016/j.coi.2016.11.003
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Laoprasopwattana K, 2007, J INFECT DIS, V195, P1108, DOI 10.1086/512860
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x
   Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005
   Lopez-Botet M, 2014, SEMIN IMMUNOL, V26, P145, DOI 10.1016/j.smim.2014.03.002
   Mace EM, 2019, IMMUNOL REV, V287, P202, DOI 10.1111/imr.12725
   Malmberg KJ, 2012, EUR J IMMUNOL, V42, P3141, DOI 10.1002/eji.201243050
   Marquardt N, 2015, J IMMUNOL, V195, P3262, DOI 10.4049/jimmunol.1401811
   Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Naiyer MM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5296
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047
   Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020
   Palha N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003619
   Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953
   Petitdemange C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004499
   Petitdemange C, 2015, J ALLERGY CLIN IMMUN, V135, P846, DOI 10.1016/j.jaci.2015.01.039
   Petitdemange C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108798
   Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268
   Petitdemangew C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00209
   Pingen M, 2017, TRENDS PARASITOL, V33, P645, DOI 10.1016/j.pt.2017.04.003
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Rolle A, 2018, CELL REP, V24, P1967, DOI 10.1016/j.celrep.2018.07.069
   Rolle A, 2016, TRENDS IMMUNOL, V37, P233, DOI 10.1016/j.it.2016.01.005
   Rolle A, 2014, J CLIN INVEST, V124, P5305, DOI 10.1172/JCI77440
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722
   Strode G.K., 1951, YELLOW FEVER
   Sun JC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029538
   Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665
   Sun P, 2017, J IMMUNOL, V198
   Sun PF, 2017, J IMMUNOL METHODS, V441, P24, DOI 10.1016/j.jim.2016.11.005
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15
   Thanapati S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00895
   Townsley E, 2016, CLIN EXP IMMUNOL, V183, P419, DOI 10.1111/cei.12722
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
   Wagner JA, 2016, TRENDS IMMUNOL, V37, P351, DOI 10.1016/j.it.2016.05.001
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yao Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172625
   Zhang MJ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-3
   Zhang Y, 2007, IMMUNOLOGY, V121, P258, DOI 10.1111/j.1365-2567.2007.02573.x
NR 101
TC 8
Z9 8
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2019
VL 11
IS 2
AR 131
DI 10.3390/v11020131
PG 15
WC Virology
SC Virology
GA HO3EW
UT WOS:000460803200041
PM 30709036
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mazzon, M
   Ortega-Prieto, AM
   Imrie, D
   Luft, C
   Hess, L
   Czieso, S
   Grove, J
   Skelton, JK
   Farleigh, L
   Bugert, JJ
   Wright, E
   Temperton, N
   Angell, R
   Oxenford, S
   Jacobs, M
   Ketteler, R
   Dorner, M
   Marsh, M
AF Mazzon, Michela
   Ortega-Prieto, Ana Maria
   Imrie, Douglas
   Luft, Christin
   Hess, Lena
   Czieso, Stephanie
   Grove, Joe
   Skelton, Jessica Katy
   Farleigh, Laura
   Bugert, Joachim J.
   Wright, Edward
   Temperton, Nigel
   Angell, Richard
   Oxenford, Sally
   Jacobs, Michael
   Ketteler, Robin
   Dorner, Marcus
   Marsh, Mark
TI Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral
   Entry
SO VIRUSES-BASEL
LA English
DT Article
DE broad-spectrum antivirals; host-targeted antivirals; alphaviruses;
   flaviviruses; endocytosis; virus entry; Zika; dengue; Semliki Forest
   virus; phenotypic screening
ID SEMLIKI-FOREST-VIRUS; ZIKA VIRUS; INFECTION; CELLS; INHIBITORS; ASSAY;
   NICLOSAMIDE; RNA
AB Viruses are a major threat to human health and economic well-being. In recent years Ebola, Zika, influenza, and chikungunya virus epidemics have raised awareness that infections can spread rapidly before vaccines or specific antagonists can be made available. Broad-spectrum antivirals are drugs with the potential to inhibit infection by viruses from different groups or families, which may be deployed during outbreaks when specific diagnostics, vaccines or directly acting antivirals are not available. While pathogen-directed approaches are generally effective against a few closely related viruses, targeting cellular pathways used by multiple viral agents can have broad-spectrum efficacy. Virus entry, particularly clathrin-mediated endocytosis, constitutes an attractive target as it is used by many viruses. Using a phenotypic screening strategy where the inhibitory activity of small molecules was sequentially tested against different viruses, we identified 12 compounds with broad-spectrum activity, and found a subset blocking viral internalisation and/or fusion. Importantly, we show that compounds identified with this approach can reduce viral replication in a mouse model of Zika infection. This work provides proof of concept that it is possible to identify broad-spectrum inhibitors by iterative phenotypic screenings, and that inhibition of host-pathways critical for viral life cycles can be an effective antiviral strategy.
C1 [Mazzon, Michela; Imrie, Douglas; Luft, Christin; Hess, Lena; Czieso, Stephanie; Ketteler, Robin; Marsh, Mark] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England.
   [Ortega-Prieto, Ana Maria; Skelton, Jessica Katy; Dorner, Marcus] Imperial Coll London, Virol Sect, Dept Med, Sch Med, London W2 1PG, England.
   [Grove, Joe] UCL, Inst Immun & Transplantat, Royal Free Hosp, London NW3 2QG, England.
   [Farleigh, Laura; Bugert, Joachim J.] Cardiff Univ, Med Microbiol, Sch Med, Cardiff CF14 4XN, S Glam, Wales.
   [Bugert, Joachim J.] Bundeswehr Inst Microbiol, D-80937 Munich, Germany.
   [Wright, Edward] Univ Sussex, Brighton BN1 9RH, E Sussex, England.
   [Temperton, Nigel] Univ Kent, Medway Sch Pharm, Chatham ME4 4TB, Kent, England.
   [Angell, Richard; Oxenford, Sally] UCL, Sch Pharm, London WC1N 1AX, England.
   [Jacobs, Michael] UCL Med Sch, Fac Med Sci, London NW3 2QG, England.
RP Mazzon, M; Marsh, M (corresponding author), UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England.
EM m.mazzon@ucl.ac.uk; a.ortega-prieto@imperial.ac.uk;
   douglas_imrie@hotmail.co.uk; c.luft@ucl.ac.uk;
   lena.hess@meduniwien.ac.at; s.czieso@imperial.ac.uk; j.grove@ucl.ac.uk;
   j.skelton15@imperial.ac.uk; laurafarleigh@hotmail.com;
   Joachim1Bugert@bundeswehr.org; ew323@sussex.ac.uk;
   N.Temperton@kent.ac.uk; r.angell@ucl.ac.uk; s.oxenford@ucl.ac.uk;
   michael.jacobs@ucl.ac.uk; r.ketteler@ucl.ac.uk; m.dorner@imperial.ac.uk;
   m.marsh@ucl.ac.uk
RI Marsh, Mark/B-4105-2009; Temperton, Nigel J/K-5158-2013; Temperton,
   Nigel/M-1164-2019; Ortega-Prieto, Ana Maria/M-6431-2019
OI Marsh, Mark/0000-0002-0213-3259; Temperton, Nigel J/0000-0002-7978-3815;
   Temperton, Nigel/0000-0002-7978-3815; Ortega-Prieto, Ana
   Maria/0000-0002-9023-0103; Grove, Joe/0000-0001-5390-7579; Wright,
   Edward/0000-0001-7041-5138
FU UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12018/1]; UCL Confidence in Concept and Therapeutic Innovation
   Fund awards; Wellcome Trust New Investigator awardWellcome Trust
   [104771/Z/14/Z]; European Research CouncilEuropean Research Council
   (ERC) [ERC-StG-2015-637304]; Imperial NIHR Biomedical Research
   CentreNational Institute for Health Research (NIHR)
FX M.M. (Michela Mazzon) and M.M. (Mark Marsh) are supported by UK Medical
   Research Council funding to the MRC-UCL LMCB University Unit
   (MC_UU_12018/1), and from UCL Confidence in Concept and Therapeutic
   Innovation Fund awards. M.D. was supported by a Wellcome Trust New
   Investigator award (104771/Z/14/Z), a starting grant from the European
   Research Council (ERC-StG-2015-637304), and funding through the Imperial
   NIHR Biomedical Research Centre.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Albertini AAV, 2012, VIRUSES-BASEL, V4, P117, DOI 10.3390/v4010117
   Ayala-Nunez NV, 2011, METHODS, V55, P137, DOI 10.1016/j.ymeth.2011.07.009
   Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007
   Banbury AN, 2003, J BIOL CHEM, V278, P12022, DOI 10.1074/jbc.M211966200
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297
   Cross RW, 2018, NAT REV DRUG DISCOV, V17, P413, DOI 10.1038/nrd.2017.251
   de La Vega MA, 2015, J CLIN INVEST, V125, P4421, DOI 10.1172/JCI83162
   Dedkova E N, 2000, Membr Cell Biol, V13, P357
   Dejonghe W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11710
   Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0
   EMEA, COMM MED PROD VET US
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Giese S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004189
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Hayes W.J., 1991, HDB PESTICIDE TOXICO, V3, P1497
   HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404
   Hunt SR, 2011, J VIROL, V85, P1257, DOI 10.1128/JVI.01864-10
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kao JC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006715
   Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162
   KIELIAN M, 1985, J CELL BIOL, V101, P2284, DOI 10.1083/jcb.101.6.2284
   Kirby BJ, 2015, CLIN PHARMACOKINET, V54, P677, DOI 10.1007/s40262-015-0261-7
   KOYAMA AH, 1987, MICROBIOL IMMUNOL, V31, P123, DOI 10.1111/j.1348-0421.1987.tb03075.x
   Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Luo M, 2012, ADV EXP MED BIOL, V726, P201, DOI 10.1007/978-1-4614-0980-9_9
   Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111
   Markosyan RM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005373
   Marsh M, 1997, J CELL SCI, V110, P95
   Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007
   MARSH M, 1982, P NATL ACAD SCI-BIOL, V79, P5297, DOI 10.1073/pnas.79.17.5297
   Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002
   Mazzon M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006835
   MCCLURE MO, 1988, EMBO J, V7, P513, DOI 10.1002/j.1460-2075.1988.tb02839.x
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D
   Parker BS, 2004, J BIOL CHEM, V279, P18814, DOI 10.1074/jbc.M400931200
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110
   Salata C, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv032
   STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3
   Thi EP, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.142, 10.1038/NMICROBIOL.2016.142]
   Tscherne DM, 2010, J VIROL METHODS, V163, P336, DOI 10.1016/j.jviromet.2009.10.020
   TURONE F, 2014, BMJ-BRIT MED J, V349, DOI DOI 10.1136/bmj.g7198
   Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   Wright E, 2009, VACCINE, V27, P7178, DOI 10.1016/j.vaccine.2009.09.024
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye YH, 2015, DRUG DEV IND PHARM, V41, P1416, DOI 10.3109/03639045.2014.954585
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zhou YC, 2012, EXPERT REV ANTI-INFE, V10, P1129, DOI [10.1586/ERI.12.104, 10.1586/eri.12.104]
   Zhu JD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00517
   Ziegler T, 2018, INFLUENZA OTHER RESP, V12, P558, DOI 10.1111/irv.12570
   Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871
NR 63
TC 7
Z9 7
U1 2
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2019
VL 11
IS 2
AR 176
DI 10.3390/v11020176
PG 26
WC Virology
SC Virology
GA HO3EW
UT WOS:000460803200086
PM 30791609
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Siddharthan, V
   Miao, JX
   Van Wettere, AJ
   Li, R
   Wu, H
   Sullivan, E
   Jiao, JA
   Hooper, JW
   Safronetz, D
   Morrey, JD
   Julander, JG
   Wang, ZD
AF Siddharthan, Venkatraman
   Miao, Jinxin
   Van Wettere, Arnaud J.
   Li, Rong
   Wu, Hua
   Sullivan, Eddie
   Jiao, Jinan
   Hooper, Jay W.
   Safronetz, David
   Morrey, John D.
   Julander, Justin G.
   Wang, Zhongde
TI Human Polyclonal Antibodies Produced from Transchromosomal Bovine
   Provides Prophylactic and Therapeutic Protections Against Zika Virus
   Infection in STAT2 KO Syrian Hamsters
SO VIRUSES-BASEL
LA English
DT Article
DE STAT2 KO hamster; transchromosomal bovine antibody; Zika virus;
   therapeutic; testis
ID CATTLE; HEALTH
AB Zika virus (ZIKV) infection can cause severe congenital diseases, such as microcephaly, ocular defects and arthrogryposis in fetuses, and Guillain-Barre syndrome in adults. Efficacious therapeutic treatments for infected patients, as well as prophylactic treatments to prevent new infections are needed for combating ZIKV infection. Here, we report that ZIKV-specific human polyclonal antibodies (SAB-155), elicited in transchromosomal bovine (TcB), provide significant protection from infection by ZIKV in STAT2 knockout (KO) golden Syrian hamsters both prophylactically and therapeutically. These antibodies also prevent testicular lesions in this hamster model. Our data indicate that antibody-mediated immunotherapy is effective in treating ZIKV infection. Because suitable quantities of highly potent human polyclonal antibodies can be quickly produced from the TcB system against ZIKV and have demonstrated therapeutic efficacy in a small animal model, they have the potential as an effective countermeasure against ZIKV infection.
C1 [Siddharthan, Venkatraman; Miao, Jinxin; Li, Rong; Morrey, John D.; Julander, Justin G.; Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, 5600 Old Main Hill, Logan, UT 84322 USA.
   [Siddharthan, Venkatraman; Morrey, John D.; Julander, Justin G.] Inst Antiviral Res, 5600 Old Main Hill, Logan, UT 84322 USA.
   [Siddharthan, Venkatraman; Morrey, John D.; Julander, Justin G.] Utah State Univ, 5600 Old Main Hill, Logan, UT 84322 USA.
   [Miao, Jinxin] Zhengzhou Univ, Sch Basic Med Sci, Dept Pathol, Zhengzhou 450066, Henan, Peoples R China.
   [Van Wettere, Arnaud J.] Utah State Univ, Dept Anim Dairy & Vet Sci, Utah Vet Diagnost Lab, 5600 Old Main Hill, Logan, UT 84322 USA.
   [Wu, Hua; Sullivan, Eddie; Jiao, Jinan] SAB Biotherapeut, Sioux Falls, SD 57104 USA.
   [Hooper, Jay W.] US Army Med Res Inst Infect Dis, Virol Div, Ft Detrick, MD 21702 USA.
   [Safronetz, David] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB R3E, Canada.
RP Siddharthan, V; Wang, ZD (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, 5600 Old Main Hill, Logan, UT 84322 USA.; Siddharthan, V (corresponding author), Inst Antiviral Res, 5600 Old Main Hill, Logan, UT 84322 USA.; Siddharthan, V (corresponding author), Utah State Univ, 5600 Old Main Hill, Logan, UT 84322 USA.
EM Venkat.siddharthan@usu.edu; jinxin.miao@yahoo.com;
   arnaud.vanwettere@aggiemail.usu.edu; lirong14@gmail.com;
   hwu@sabbiotherapeutics.com; esullivan@sabbiotherapeutics.com;
   jjiao@sabbiotherapeutics.com; jay.w.hooper.civ@mail.mil;
   david.safronetz@canada.ca; john.morrey@usu.edu; justin.julander@usu.edu;
   zonda.wang@usu.edu
RI Hooper, Jay/K-2362-2017
OI Hooper, Jay/0000-0002-4475-0415; Ditton, Thomas/0000-0003-4622-2613
FU Public Health Service (PHS) research grants from the National Institute
   of Neurological Disorders and Stroke (NINDS), National Institutes of
   Health (NIH) [1R21NS09013301A1, 5R21NS08840002]; PHS grant from the
   Virology Branch, National Institute of Allergy and Infectious Diseases
   (NIAID) [5R33AI101483, HHSN272201000039I/HHSN27200018/A103]; Utah
   Agriculture Research Station research grant [UTA01176]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [1R41OD021979-01]
FX This research was partially funded by Public Health Service (PHS)
   research grants 1R21NS09013301A1 and 5R21NS08840002 from the National
   Institute of Neurological Disorders and Stroke (NINDS), National
   Institutes of Health (NIH), and PHS grant 5R33AI101483, contract
   HHSN272201000039I/HHSN27200018/A103 from the Virology Branch, National
   Institute of Allergy and Infectious Diseases (NIAID), and Utah
   Agriculture Research Station research grant UTA01176 (to J.D.M). The
   work was also partially supported by research grant 1R41OD021979-01 from
   the NIH (to Z.W). The funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. Opinions, interpretations, conclusions, and recommendations
   are ours and are not necessarily endorsed by the U.S. Army or the
   Department of Defense.
CR Beigel JH, 2018, LANCET INFECT DIS, V18, P410, DOI 10.1016/S1473-3099(18)30002-1
   Bounds CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137786
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Dye JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24897
   Fan ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109755
   Gardner CL, 2017, J VIROL, V91, DOI 10.1128/JVI.00226-17
   Hooper JW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010082
   Julander JG, 2017, J INFECT DIS, V216, pS919, DOI 10.1093/infdis/jix465
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Luke T, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1061
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Sano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078119
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siddharthan V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106535
   Silver JN, 2018, CLIN INFECT DIS, V66, P1116, DOI 10.1093/cid/cix977
   Stein DR, 2017, ANTIVIR RES, V146, P164, DOI 10.1016/j.antiviral.2017.09.005
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Valderrama A, 2017, BIOCHEM BIOPH RES CO, V492, P541, DOI 10.1016/j.bbrc.2017.05.050
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 32
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2019
VL 11
IS 2
AR 92
DI 10.3390/v11020092
PG 15
WC Virology
SC Virology
GA HO3EW
UT WOS:000460803200002
PM 30678320
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kahn, R
   Hitchings, M
   Wang, R
   Bellan, SE
   Lipsitch, M
AF Kahn, Rebecca
   Hitchings, Matt
   Wang, Rui
   Bellan, Steven E.
   Lipsitch, Marc
TI Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic
   Infection
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE asymptomatic infection; epidemics; infectious diseases; interval
   censoring; modeling; vaccine trials
ID PROTECTIVE EFFICACY; NIPAH VIRUS; OUTBREAKS
AB Vaccine efficacy against susceptibility to infection (VES), regardless of symptoms, is an important endpoint of vaccine trials for pathogens with a high proportion of asymptomatic infection, because such infections may contribute to onward transmission and long-term sequelae, such as congenital Zika syndrome. However, estimating VES is resource-intensive. We aimed to identify approaches for accurately estimating VES when limited information is available and resources are constrained. We modeled an individually randomized vaccine trial by generating a network of individuals and simulating an epidemic. The disease natural history followed a susceptible-exposed-infectious/symptomatic (or infectious/asymptomatic)-recovered model. We then used 7 approaches to estimate VES, and we also estimated vaccine efficacy against progression to symptoms (VEP). A corrected relative risk and an interval-censored Cox model accurately estimate VES and only require serological testing of participants once, while a Cox model using only symptomatic infections returns biased estimates. Only acquiring serological endpoints in a 10% sample and imputing the remaining infection statuses yields unbiased VES estimates across values of the basic reproduction number (R-0) and accurate estimates of VEP for higher R-0 values. Identifying resource-preserving methods for accurately estimating VES and VEP is important in designing trials for diseases with a high proportion of asymptomatic infection.
C1 [Kahn, Rebecca; Hitchings, Matt; Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.
   [Wang, Rui] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [Wang, Rui] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA.
   [Wang, Rui] Harvard Med Sch, Boston, MA 02115 USA.
   [Bellan, Steven E.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Bellan, Steven E.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
RP Kahn, R (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave,Suite 506, Boston, MA 02115 USA.
EM rek160@mail.harvard.edu
RI Wang, Rui/X-1699-2019
OI Kahn, Rebecca/0000-0001-9511-6142
FU National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [U54GM088558];
   National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [K01AI125830, R37 AI051164]
FX This work was supported by the National Institute of General Medical
   Sciences (grant U54GM088558) and the National Institute of Allergy and
   Infectious Diseases (grants K01AI125830 to S.E.B. and R37 AI051164 to
   R.W.).
CR Butler D, 2017, NATURE, V541, P444, DOI 10.1038/nature.2017.21329
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centers for Disease Control and Prevention [CDC], 2015, LASS FEV
   Chan KP, 2002, EPIDEMIOL INFECT, V128, P93, DOI 10.1017/S0950268801006422
   Clayton BA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004775
   Clayton BA, 2012, EMERG INFECT DIS, V18, P1983, DOI 10.3201/eid1812.120875
   Dudas G, 2018, ELIFE, V7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   HABER M, 1991, STAT MED, V10, P1573, DOI 10.1002/sim.4780101009
   Halloran ME, 2010, STAT BIOL HLTH
   Kahn R, 2018, ASYMPTOMATIC INFECT
   Kahn R, 2018, CLIN TRIALS, V15, P207, DOI 10.1177/1740774517752671
   Lessler J, 2012, EXPERT REV VACCINES, V11, P747, DOI [10.1586/ERV.12.47, 10.1586/erv.12.47]
   Lewnard JA, 2018, AM J EPIDEMIOL, V187, P2686, DOI 10.1093/aje/kwy163
   Longini IM, 1999, STAT MED, V18, P53, DOI 10.1002/(SICI)1097-0258(19990115)18:1<53::AID-SIM996>3.3.CO;2-S
   Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57
   Mulangu S, 2018, J INFECT DIS, V217, P529, DOI 10.1093/infdis/jix619
   Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819
   OGRA PL, 1971, NEW ENGL J MED, V285, P1333, DOI 10.1056/NEJM197112092852401
   Omrani AS, 2013, INT J INFECT DIS, V17, pE668, DOI 10.1016/j.ijid.2013.07.001
   Rodriguez-Barraquer I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002126
   Siegrist C.-A., 2012, VACCINES, P14
   SMITH PG, 1984, INT J EPIDEMIOL, V13, P87, DOI 10.1093/ije/13.1.87
   WHO, 2013, PLOS CURR, V5
   World Health Organization, 2017, LIST BLUEPR PRIOR DI
   World Health Organization; National Institute of Allergy and Infectious Diseases National Institutes of Health, 2017, SCI CONS ZIK VIR VAC
   Wu Y, 2018, VACCINE, V36, P2946, DOI 10.1016/j.vaccine.2018.04.046
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 29
TC 4
Z9 3
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD FEB
PY 2019
VL 188
IS 2
BP 467
EP 474
DI 10.1093/aje/kwy239
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HO0UI
UT WOS:000460620100024
PM 30329134
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Amraoui, F
   Ben Ayed, W
   Madec, Y
   Faraj, C
   Himmi, O
   Btissam, A
   Sarih, M
   Failloux, AB
AF Amraoui, Fadila
   Ben Ayed, Wiem
   Madec, Yoann
   Faraj, Chafika
   Himmi, Oumnia
   Btissam, Ameur
   Sarih, Mhammed
   Failloux, Anna-Bella
TI Potential of Aedes albopictus to cause the emergence of arboviruses in
   Morocco
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; 1ST RECORD; RIFT-VALLEY; SKUSE 1894; VECTOR;
   CHIKUNGUNYA; AFRICA; FEVER; MOSQUITOS; OUTBREAK
AB In 2015, the mosquito Aedes albopictus was detected in Rabat, Morocco. This invasive species can be involved in the transmission of more than 25 arboviruses. It is known that each combination of mosquito population and virus genotype leads to a specific interaction that can shape the outcome of infection. Testing the vector competence of local mosquitoes is therefore a prerequisite to assess the risks of emergence. A field-collected strain of Ae. albopictus from Morocco was experimentally infected with dengue (DENV), chikungunya (CHIKV), zika (ZIKV) and yellow fever (YFV) viruses. We found that this species can highly transmit CHIKV and to a lesser extent, DENV, ZIKV and YFV. Viruses can be detected in mosquito saliva at day 3 (CHIKV), day 14 (DENV and YFV), and day 21 (ZIKV) post-infection. These results suggest that the local transmission of these four arboviruses by Ae. albopictus newly introduced in Morocco is a likely scenario. Trial registration: ClinicalTrials.gov APAFIS#6573-201606l412077987v2.
   Author summary The Asian tiger mosquito Aedes albopictus is responsible for the transmission of several arboviruses such as dengue and chikungunya viruses. In 30 to 40 years, it has extended its geographical distribution in both tropical and temperate regions of all continents. The species was first detected in September 2015, in Rabat, Morocco. Using experimental infections, we demonstrated that Ae. albopictus Morocco are competent to transmit zika and yellow fever viruses in addition to the transmission of dengue and chikungunya viruses. Our results are central to suggest developing the most effective national surveillance program and to designing the most suitable control strategy to avoid the mosquito spreading beyond its point of entry in Morocco.
C1 [Amraoui, Fadila; Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
   [Ben Ayed, Wiem] Lab Epidemiol & Vet Microbiol, Med Entomol, Tunis, Tunisia.
   [Madec, Yoann] Inst Pasteur, Dept Infect & Epidemiol, Epidemiol Emerging Dis, Paris, France.
   [Faraj, Chafika] Inst Natl Hyg, Lab Entomol Med, Rabat, Morocco.
   [Himmi, Oumnia] Mohammed V Agdal Univ, Sci Inst, Geobiodivers & Nat Patrimony Lab, Geophys Nat Patrimony & Green Chem Res Ctr, Rabat, Morocco.
   [Btissam, Ameur] Direct Epidemiol & Lutte Malad, Serv Lutte Antivectorielle, Rabat, Morocco.
   [Sarih, Mhammed] Inst Pasteur Maroc, Serv Parasitol & Malad Vectorielles, Casablanca, Morocco.
RP Failloux, AB (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
EM anna-bella.failloux@pasteur.fr
RI Faraj, Chafika/AAF-3592-2020
OI FAILLOUX, Anna-Bella/0000-0001-6890-0820
FU WHO "Vector competence to Zika virus of mosquitoes in the Mediterranean
   region" (VEC-ZIKA-MED) [WCCPRD5294814 2017/700731]; European Union's
   Horizon 2020 Research and Innovation Programme under ZIKAlliance
   [734548]
FX This project was funded by the WHO "Vector competence to Zika virus of
   mosquitoes in the Mediterranean region" (VEC-ZIKA-MED), grant number
   WCCPRD5294814 2017/700731. This work was also partially supported by the
   European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance Grant Agreement no. 734548. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ayari-Fakhfakh E, 2011, VET J, V187, P402, DOI 10.1016/j.tvjl.2010.01.007
   Behnassi M, 2016, INFECT DIS CLIMATE V, P138
   Bennouna A, 2017, MED VET ENTOMOL, V31, P102, DOI 10.1111/mve.12194
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Coffinet T, 2007, J AM MOSQUITO CONTR, V23, P471, DOI 10.2987/5636.1
   CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Diallo M, 2010, TROP MED INT HEALTH, V15, P1185, DOI 10.1111/j.1365-3156.2010.02594.x
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   El-Harrak M, 2011, EMERG INFECT DIS, V17, P2372, DOI 10.3201/eid1712.110587
   Failloux Anna-Bella, 2017, Curr Trop Med Rep, V4, P27, DOI 10.1007/s40475-017-0101-y
   Figuerola J, 2009, EMERG INFECT DIS, V15, P1651, DOI 10.3201/eid1510.090340
   Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Harrack M El, 1997, VIROLOGIE, V1, P248
   Izri A, 2011, CLIN MICROBIOL INFEC, V17, P1116, DOI 10.1111/j.1469-0691.2010.03443.x
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kampango A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1361-4
   Kelvin AA, 2011, J INFECT DEV COUNTR, V5, P441, DOI 10.3855/jidc.2171
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Muller GC, 2016, ACTA TROP, V162, P245, DOI 10.1016/j.actatropica.2016.07.008
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Reis S, 2017, ACTA TROP, V171, P86, DOI 10.1016/j.actatropica.2017.03.035
   RODHAIN F, 1979, B SOC PATHOL EXOT, V72, P411
   ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153
   Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101
   Schuffenecker I, 2005, EMERG INFECT DIS, V11, P306, DOI 10.3201/eid1102.040817
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Toto JC, 2003, MED VET ENTOMOL, V17, P343, DOI 10.1046/j.1365-2915.2003.00447.x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsuda Y, 2016, JPN J INFECT DIS, V69, P1, DOI 10.7883/yoken.JJID.2014.576
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Zouache K, 2015, CURR OPIN INSECT SCI, V10, P14, DOI 10.1016/j.cois.2015.04.010
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 45
TC 7
Z9 7
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2019
VL 13
IS 2
AR e0006997
DI 10.1371/journal.pntd.0006997
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HN1TU
UT WOS:000459970700011
PM 30763312
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Beck, C
   Leparc-Goffart, I
   Desoutter, D
   Deberge, E
   Bichet, H
   Lowenski, S
   Dumarest, M
   Gonzalez, G
   Migne, C
   Vanhomwegen, J
   Zientara, S
   Durand, B
   Lecollinet, S
AF Beck, Cecile
   Leparc-Goffart, Isabelle
   Desoutter, Denise
   Deberge, Estelle
   Bichet, Herve
   Lowenski, Steeve
   Dumarest, Marine
   Gonzalez, Gaelle
   Migne, Camille
   Vanhomwegen, Jessica
   Zientara, Stephan
   Durand, Benoit
   Lecollinet, Sylvie
TI Serological evidence of infection with dengue and Zika viruses in horses
   on French Pacific Islands
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE; AEDES-AEGYPTI; JAPANESE ENCEPHALITIS; DIPTERA-CULICIDAE;
   FLAVIVIRUSES; ARBOVIRUSES; ANTIBODIES; POLYNESIA; SEROPREVALENCE;
   TRANSMISSION
AB New Caledonia and French Polynesia are areas in which arboviruses circulate extensively. A large serological survey among horses from New Caledonia and French Polynesia was carried out to investigate the seroprevalence of flaviviruses in the horse population. Here, 293 equine sera samples were screened for flaviviruses using a competitive enzyme-linked immunosorbent assay (cELISA). The positive sera were then confirmed using a flavivirus-specific microsphere immunoassay (MIA) and seroneutralization tests. This serosurvey showed that 16.6% (27/163) and 30.8% (40/130) of horses were positive for cELISA tests in New Caledonia and French Polynesia, respectively, but the MIA technique, targeting only flaviviruses causing neuro-invasive infections in humans and horses (i.e. West Nile virus [WNV], Japanese encephalitis virus [JEV] and tick-borne encephalitis virus [TBEV]), showed negative results for more than 85% (57/67) of the cELISA-positive animals. Seroneutralization tests with the main flaviviruses circulating in the South Pacific revealed that 6.1% (10/163; confidence interval [95% CI] 3.0%-11.0%) of sera in New Caledonia and 7.7% (10/130; 95% CI 3.8%-13.7%) in French Polynesia were positive for dengue virus serotype 1 (DENV1) and 4.3% (7/163; 95% CI 1.7%-8.6%) in New Caledonia and 15.4% (20/130, 95% CI 9.7%-22.8%) in French Polynesia were found positive for Zika virus (ZIKV). Seroprevalence of the JEV and WNV flaviviruses on the 293 samples from both island groups were comparatively much lower (less than 2%). This seroprevalence study in the horse population shows that horses can be infected with dengue and Zika viruses and that these infections lead to seroconversions in horses. The consequences of these infections in horses and their role in ZIKV and DENV epidemiological cycles are two issues that deserve further investigation.
   Author summary New Caledonia and French Polynesia, located in the South Pacific, are facing circulation of dengue virus (DENV) for a long time and emergence of Zika virus (ZIKV) since 2013. A large serosurvey among horses' population from these two islands was carried out to investigate the seroprevalence of the main flaviviruses circulating in the South Pacific. We find out that 6 to 7% of equine sera tested were positive for DENV serotype 1 in the two islands and 4% and 15% were positive for ZIKV in New Caledonia and French Polynesia respectively. Our study highlighted serological evidence of DENV serotype 1 and ZIKV infections of horses leading to meaningful seroconversion. Seroprevalence of other mosquito-borne flaviviruses (i.e. Japanese encephalitis and West-Nile viruses) were comparatively much lower (less than 2%) in New Caledonia and French Polynesia groups suggesting the absence of past active circulation of these viruses in both islands. This finding emphasized the need to investigate the consequences of such infections in the horse population and to determine the role of domestic animals in ZIKV and DENV epidemiological cycles.
C1 [Beck, Cecile; Lowenski, Steeve; Dumarest, Marine; Gonzalez, Gaelle; Migne, Camille; Zientara, Stephan; Lecollinet, Sylvie] EURL Equine Dis, ANSES Anim Hlth Lab, UMR 1161 Virol, ANSES,INRA,ENVA, Maisons Alfort, France.
   [Leparc-Goffart, Isabelle] CNR Arbovirus, Inst Rech Biomed Armees, Unite Virol, Marseille, France.
   [Leparc-Goffart, Isabelle] Aix Marseille Univ, UMR UVE Unite Virus Emergents, IHU Mediterranee Infect, IRD 190,Inserm 1207, Marseille, France.
   [Desoutter, Denise] Direct Affaires Vet Alimentaires & Rurales Nouvel, Serv Lab Officiels Vet Agroalimentaires & Phytosa, Paita, New Caledonia.
   [Deberge, Estelle; Bichet, Herve] Presidence Polynesie Francaise, Serv Dev Rural, Tahiti, French Polynesi, France.
   [Vanhomwegen, Jessica] Inst Pasteur, Dept Infect & Epidemiol, Environm & Infect Risks Res & Expertise Unit, Paris, France.
   [Durand, Benoit] Paris Est Univ, ANSES Anim Hlth Lab, Epidemiol Unit, Maisons Alfort, France.
RP Beck, C (corresponding author), EURL Equine Dis, ANSES Anim Hlth Lab, UMR 1161 Virol, ANSES,INRA,ENVA, Maisons Alfort, France.
EM cecile.beck@anses.fr
CR A-Nuegoonpipat A, 2004, VIROLOGY, V329, P505, DOI 10.1016/j.virol.2004.08.029
   Aubry M, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.14.30505
   Aubry M, 2018, EMERG INFECT DIS, V24, P558, DOI 10.3201/eid2403.171149
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barbic L, 2013, VECTOR-BORNE ZOONOT, V13, P772, DOI 10.1089/vbz.2012.1236
   Baronti C, 2014, GENOME ANNOUNC, V2
   Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046
   Beck C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005936
   Beck C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/678084
   Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049
   Ben Hassine T, 2014, TRANSBOUND EMERG DIS, V61, P385, DOI 10.1111/tbed.12259
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvez E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006637
   Calvez E, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2319-x
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Descloux E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000493
   Di Gennaro A, 2014, CLIN VACCINE IMMUNOL, V21, P1460, DOI 10.1128/CVI.00426-14
   Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-61
   Durand B., 2016, EPIDEMIOL INFECT, P1
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansen CA, 2017, EMERG INFECT DIS, V23, P1289, DOI 10.3201/eid2308.161440
   La direction des affaires sanitaires et sociales de Nouvelle-Caledonie (DASS), 2016, SIT SAN NOUV CAL MEM
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Macdonald J, 2010, EVOL BIOINFORM, V6, P91
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   May FJ, 2013, J GEN VIROL, V94, P1462, DOI 10.1099/vir.0.049940-0
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   OIE, 2018, MANUAL DIAGNOSTIC TE
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Prow NA, 2013, INT J ENV RES PUB HE, V10, P4432, DOI 10.3390/ijerph10094432
   Pyke AT, 2001, AM J TROP MED HYG, V65, P747
   R Development Core Team R, 2016, LANG ENV STAT COMP
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rushton JO, 2013, EMERG INFECT DIS, V19, P635, DOI 10.3201/eid1904.121450
   Singh Narendra, 2005, Pac Health Dialog, V12, P111
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Vanhomwegen J, 2017, VECTOR-BORNE ZOONOT, V17, P340, DOI 10.1089/vbz.2016.2042
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   World Health Organization, 2007, WHOIVB07
   Ziegler U, 2013, INT J ENV RES PUB HE, V10, P3112, DOI 10.3390/ijerph10083112
NR 52
TC 2
Z9 2
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2019
VL 13
IS 2
AR e0007162
DI 10.1371/journal.pntd.0007162
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HN1TU
UT WOS:000459970700050
PM 30730887
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Choi, H
   Kudchodkar, SB
   Reuschel, EL
   Asija, K
   Borole, P
   Ho, M
   Wojtak, K
   Reed, C
   Ramos, S
   Bopp, NE
   Aguilar, PV
   Weaver, SC
   Kim, JJ
   Humeau, L
   Tebas, P
   Weiner, DB
   Muthumani, K
AF Choi, Hyeree
   Kudchodkar, Sagar B.
   Reuschel, Emma L.
   Asija, Kanika
   Borole, Piyush
   Ho, Michelle
   Wojtak, Krzysztof
   Reed, Charles
   Ramos, Stephanie
   Bopp, Nathen E.
   Aguilar, Patricia V.
   Weaver, Scott C.
   Kim, J. Joseph
   Humeau, Laurent
   Tebas, Pablo
   Weiner, David B.
   Muthumani, Kar
TI Protective immunity by an engineered DNA vaccine for Mayaro virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID INFECTION; OROPOUCHE; ARTHRITIS; VECTOR; STRAIN; E2
AB Mayaro virus (MAYV) of the genus alphavirus is a mosquito-transmitted emerging infectious disease that causes an acute febrile illness, rash, headaches, and nausea that may turn into incapacitating, persistent arthralgias in some victims. Since its discovery in Trinidad in 1954, cases of MAYV infection have largely been confined there and to the northern countries of South America, but recently, MAYV cases have been reported in some island nations in the Caribbean Sea. Accompanying these reports is evidence that new vectors, including Aedes spp. mosquitos, recently implicated in the global spread of Zika and chikungunya viruses, are competent for MAYV transmission, which, if true, could facilitate the spread of MAYV beyond its current range. Despite its status as an emerging virus, there are no licensed vaccines to prevent MAYV infection nor therapeutics to treat it. Here, we describe the development and testing of a novel DNA vaccine, scMAYV-E, that encodes a synthetically-designed consensus MAYV envelope sequence. In vivo electroporation-enhanced immunization of mice with this vaccine induced potent humoral responses including neutralizing antibodies as well as robust T-cell responses to multiple epitopes in the MAYV envelope. Importantly, these scMAYV-E-induced immune responses protected susceptible mice from morbidity and mortality following a MAYV challenge.
   Author summary Mayaro virus (MAYV) is a mosquito-transmitted virus that causes fever, headache, chills, nausea and joint pain that can last for months after infection. The rising number of cases, due to increased mosquito circulation, and the threat of an epidemic emphasize its importance as an emerging virus, but there are no licensed vaccines to prevent Mayaro infection nor therapeutics to treat it. In this study, we gathered fundamental knowledge on how the immune system responds to MAYV infection, and we evaluated the efficacy of a novel, synthetic DNA envelope vaccine (scMAYV-E) in mice. Analysis of immune responses in mice demonstrated that this vaccine induces potent T cell immunity and antibodies. Mice who receive the vaccine and then are challenged with live MAYV are protected against Mayaro disease. This data provides evidence that the DNA-based MAYV vaccine may be able to prevent Mayaro disease. Thus, the scMAYV-E vaccine is a promising step forward for MAYV vaccine development. Future testing will evaluate whether this vaccine is a viable means to halt the spread of MAYV and protect individuals from Mayaro disease.
C1 [Choi, Hyeree; Kudchodkar, Sagar B.; Reuschel, Emma L.; Asija, Kanika; Borole, Piyush; Ho, Michelle; Wojtak, Krzysztof; Weiner, David B.; Muthumani, Kar] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Reed, Charles; Ramos, Stephanie; Kim, J. Joseph; Humeau, Laurent] Inovio Pharmaceut, Plymouth Meeting, PA USA.
   [Bopp, Nathen E.; Aguilar, Patricia V.; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Bopp, Nathen E.; Aguilar, Patricia V.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Aguilar, Patricia V.; Weaver, Scott C.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Tebas, Pablo] Univ Penn, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA.
RP Muthumani, K (corresponding author), Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
EM kmuthumani@wistar.org
RI Muthumani, Kar/AAQ-4939-2020
OI Muthumani, Kar/0000-0002-6807-2065; Borole, Piyush/0000-0003-3327-5847;
   WOJTAK, KRZYSZTOF/0000-0002-7834-2946; Asija,
   Kanika/0000-0002-8656-2834; Kudchodkar, Sagar/0000-0003-1754-6803
FU Inovio Pharmaceuticals, PA, USA
FX KM and DBW note funding by Inovio Pharmaceuticals, PA, USA. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846
   AITKEN THG, 1960, SCIENCE, V131, P986, DOI 10.1126/science.131.3405.986
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Duperret EK, 2018, MOL THER, V26, P435, DOI 10.1016/j.ymthe.2017.11.010
   El-Bacha T, 2004, MOL CELL BIOCHEM, V266, P191, DOI 10.1023/B:MCBI.0000049154.17866.00
   Fisher PD, 2017, GENE THER, V24, P757, DOI 10.1038/gt.2017.96
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Fox JM, 2016, J IMMUNOL, V197, P4210, DOI 10.4049/jimmunol.1601426
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11
   Haist KC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006748
   Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009
   Herrero LJ, 2013, ARTHRITIS RHEUM-US, V65, P2724, DOI 10.1002/art.38090
   Herrero LJ, 2011, P NATL ACAD SCI USA, V108, P12048, DOI 10.1073/pnas.1101089108
   Lavergne A, 2006, VIRUS RES, V117, P283, DOI 10.1016/j.virusres.2005.11.006
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lin F, 2012, HUM GENE THER METHOD, V23, P157, DOI 10.1089/hgtb.2011.209
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Muthumani K, 2016, J INFECT DIS, V214, P369, DOI 10.1093/infdis/jiw111
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   ROBINSON DM, 1976, MIL MED, V141, P163
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Rulli NE, 2007, ANN NY ACAD SCI, V1102, P96, DOI 10.1196/annals.1408.007
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Snyder JE, 2013, J VIROL, V87, P8511, DOI 10.1128/JVI.00449-13
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Tebas P, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa170812028976850, DOI 10.1056/NEJM0A170812028976850]
   Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Wang EY, 2011, J VIROL, V85, P9249, DOI 10.1128/JVI.00844-11
   Weise WJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002969
NR 37
TC 8
Z9 8
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2019
VL 13
IS 2
AR e0007042
DI 10.1371/journal.pntd.0007042
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HN1TU
UT WOS:000459970700016
PM 30730897
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Malmlov, A
   Bantle, C
   Aboellail, T
   Wagner, K
   Campbell, CL
   Eckley, M
   Chotiwan, N
   Gullberg, RC
   Perera, R
   Tjalkens, R
   Schountz, T
AF Malmlov, Ashley
   Bantle, Collin
   Aboellail, Tawfik
   Wagner, Kaitlyn
   Campbell, Corey L.
   Eckley, Miles
   Chotiwan, Nunya
   Gullberg, Rebekah C.
   Perera, Rushika
   Tjalkens, Ronald
   Schountz, Tony
TI Experimental Zika virus infection of Jamaican fruit bats (Artibeus
   jamaicensis) and possible entry of virus into brain via activated
   microglial cells
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUS; TRANSMISSION; ARBOVIRUSES; OUTBREAK; BIOLOGY; BRAZIL;
   HOSTS
AB The emergence of Zika virus (ZIKV) in the New World has led to more than 200,000 human infections. Perinatal infection can cause severe neurological complications, including fetal and neonatal microcephaly, and in adults there is an association with Guillain-Barre syndrome (GBS). ZIKV is transmitted to humans by Aedes sp. mosquitoes, yet little is known about its enzootic cycle in which transmission is thought to occur between arboreal Aedes sp. mosquitos and non-human primates. In the 1950s and 60s, several bat species were shown to be naturally and experimentally susceptible to ZIKV with acute viremia and seroconversion, and some developed neurological disease with viral antigen detected in the brain. Because of ZIKV emergence in the Americas, we sought to determine susceptibility of Jamaican fruit bats (Artibeus jamaicensis), one of the most common bats in the New World. Bats were inoculated with ZIKV PRVABC59 but did not show signs of disease. Bats held to 28 days post-inoculation (PI) had detectable antibody by ELISA and viral RNA was detected by qRT-PCR in the brain, saliva and urine in some of the bats. Immunoreactivity using polyclonal anti-ZIKV antibody was detected in testes, brain, lung and salivary glands plus scrotal skin. Tropism for mononuclear cells, including macrophages/microglia and fibroblasts, was seen in the aforementioned organs in addition to testicular Leydig cells. The virus likely localized to the brain via infection of Iba1(+) macrophage/microglial cells. Jamaican fruit bats, therefore, may be a useful animal model for the study of ZIKV infection. This work also raises the possibility that bats may have a role in Zika virus ecology in endemic regions, and that ZIKV may pose a wildlife disease threat to bat populations.
   Author summary The rapid spread of Zika virus through a naive population in the Americas resulted in novel and severe disease manifestations, including fetal and neonatal microcephaly, and GBS. These disease complications make understanding the pathology and ecology of ZIKV a priority. Captive Jamaican fruit bats were challenged with ZIKV to determine their susceptibility, to assess whether bats may play a role in virus ecology, and if they might serve as an animal model to better understand ZIKV pathophysiology. The bats became acutely infected and mounted an antibody response. Three terminally euthanized inoculated bats had antibody titers of 3200, 28 days PI. Evidence of virus replication and associated pathologies were found in the brain, testes, lungs and salivary glands of some of the inoculated bats. The virus showed predilection for mononuclear cells, including resident Iba1(+) macrophage/microglial cells, and Leydig cells. With no discernible disruption to the blood brain barrier nor distribution of viral antigen indicative of circumeventricular neuroinvasion, microglia cells may be a possible route of entry of ZIKV into brains of bats. Further investigations are needed to determine the mechanisms of neuroinvasion of ZIKV in bats, further determine feasibility of bats as an alternative animal-model for congenital Zika syndrome, and what role bats might play in ZIKV viral ecology.
C1 [Malmlov, Ashley; Wagner, Kaitlyn; Campbell, Corey L.; Eckley, Miles; Chotiwan, Nunya; Gullberg, Rebekah C.; Perera, Rushika; Schountz, Tony] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Bantle, Collin; Tjalkens, Ronald] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.
   [Aboellail, Tawfik] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Vet Diagnost Labs, Ft Collins, CO 80523 USA.
RP Schountz, T (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
EM tony.schountz@colostate.edu
RI Aboellail, Tawfik/AAB-8990-2019; Perera, Rushika/E-7183-2017
OI Perera, Rushika/0000-0001-6798-2537; Campbell, Corey
   L./0000-0002-6384-1259; Bantle, Collin/0000-0003-4567-4079; Aboellail,
   Tawfik/0000-0003-0989-5333; Chotiwan, Nunya/0000-0003-3214-6605
FU Department of Microbiology, Immunology and Pathology at Colorado State
   University; College of Veterinary Medicine and Biomedical Sciences at
   Colorado State University; Colorado State University
FX This work was supported by startup funds from the Department of
   Microbiology, Immunology and Pathology and the College of Veterinary
   Medicine and Biomedical Sciences, and the Vice President for Research at
   Colorado State University. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aguilar-Setien A, 2008, EPIDEMIOL INFECT, V136, P1678, DOI 10.1017/S0950268808000460
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   [Anonymous], 2017, ZIK CAS CONG SYNDR A
   Bratsch S, 2011, DEV COMP IMMUNOL, V35, P421, DOI 10.1016/j.dci.2010.06.004
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CHAKRABORTY AK, 1984, DEV COMP IMMUNOL, V8, P415, DOI 10.1016/0145-305X(84)90048-X
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Chung ES, 2010, BRAIN RES, V1363, P143, DOI 10.1016/j.brainres.2010.09.049
   Cogswell-Hawkinson A, 2012, J VIROL, V86, P5791, DOI 10.1128/JVI.00201-12
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ELIASSON M, 1988, J BIOL CHEM, V263, P4323
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gerrard DL, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00245-17, 10.1128/msphere.00245-17]
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Munster VJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21878
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Noronha L, 2016, MEM I O CRUZ, V11
   Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x
   ORTEGA J, 2001, AM SOC MAMMALOGISTS, V662, P1, DOI DOI 10.1644/1545-1410(2001)662%3C0001:AJ%3E2.0.C0;2
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pawitwar SS, 2017, J NEUROIMMUNE PHARM
   Paz-Bailey G, 2017, N ENGL J MED
   Phillips AT, 2016, J VIROL, V90, P5785, DOI 10.1128/JVI.03219-15
   Platt KB, 2000, J MED ENTOMOL, V37, P965, DOI 10.1603/0022-2585-37.6.965
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   REAGAN REGINALD L., 1955, TRANS AMER MICROSC SOC, V74, P77, DOI 10.2307/3223847
   Schmitt K, 2018, VIROLOGY, V515, P235, DOI 10.1016/j.virol.2017.12.026
   SHEPHERD R. C, 1964, ZOONOSES RES, V3, P125
   SIMPSON DIH, 1968, ANN TROP MED PARASIT, V62, P432, DOI 10.1080/00034983.1968.11686580
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Vicente-Santos A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005537
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wellehan JFX, 2009, COMP IMMUNOL MICROB, V32, P379, DOI 10.1016/j.cimid.2007.11.002
   Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 57
TC 2
Z9 2
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2019
VL 13
IS 2
AR e0007071
DI 10.1371/journal.pntd.0007071
PG 23
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HN1TU
UT WOS:000459970700024
PM 30716104
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Regla-Nava, JA
   Viramontes, KM
   Vozdolska, T
   Huynh, AT
   Villani, T
   Gardner, G
   Johnson, M
   Ferro, PJ
   Shresta, S
   Kim, K
AF Regla-Nava, Jose Angel
   Viramontes, Karla M.
   Vozdolska, Teodora
   Anh-Thy Huynh
   Villani, Tom
   Gardner, Graeme
   Johnson, Michael
   Ferro, Pamela J.
   Shresta, Sujan
   Kim, Kenneth
TI Detection of Zika virus in mouse mammary gland and breast milk
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUS; TRANSMISSION; INACTIVATION; INFECTION; PROTEASE; DISEASE
AB Clinical reports of Zika Virus (ZIKV) RNA detection in breast milk have been described, but evidence conflicts as to whether this RNA represents infectious virus. We infected post-parturient AG129 murine dams deficient in type I and II interferon receptors with ZIKV. ZIKV RNA was detected in pup stomach milk clots (SMC) as early as 1 day post maternal infection (dpi) and persisted as late as 7 dpi. In mammary tissues, ZIKV replication was demonstrated by immunohistochemistry in multiple cell types including cells morphologically consistent with myoepithelial cells. No mastitis was seen histopathologically. In the SMC and tissues of the nursing pups, no infectious virus was detected via focus forming assay. However, serial passages of fresh milk supernatant yielded infectious virus, and immunohistochemistry showed ZIKV replication protein associated with degraded cells in SMC. These results suggest that breast milk may contain infectious ZIKV. However, breast milk transmission (BMT) does not occur in this mouse strain that is highly sensitive to ZIKV infection. These results suggest a low risk for breast milk transmission of ZIKV, and provide a platform for investigating ZIKV entry into milk and mechanisms which may prevent or permit BMT.
   Author summary Can Zika virus be transmitted from nursing mothers to their children via breast milk? Only 4 years have passed since the Zika virus outbreak in Brazil, and much remains to be understood about the transmission and health consequences of Zika infection. To date, some case reports have detected Zika virus RNA in the breast milk of infected mothers, but the presence of a virus' RNA does not mean that intact virus is present. Milk also contains many natural defense components against infection, so even intact virus carried in breast milk may not be infectious to a child. Here we used a mouse that is genetically engineered to be highly susceptible to Zika infection, and tested whether 1) we could find intact virus in mouse breast milk and 2) infection was passed from mother to pups. We found very low levels of intact Zika virus in mouse breast milk, and found none of the nursing pups to be infected. The model of Zika virus breast milk infection developed in this study establishes a system by which we may learn whether Zika RNA in human breast milk is truly infectious to children, and how Zika virus may enter the milk.
C1 [Regla-Nava, Jose Angel; Viramontes, Karla M.; Vozdolska, Teodora; Anh-Thy Huynh; Shresta, Sujan; Kim, Kenneth] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Villani, Tom; Gardner, Graeme; Johnson, Michael] Visikol, Whitehouse Stn, NJ USA.
   [Ferro, Pamela J.] Texas Vet Med Diagnost Labs, College Stn, TX USA.
   [Shresta, Sujan] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
RP Shresta, S; Kim, K (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.; Shresta, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
EM sujan@lji.org; kenneth@lji.org
OI Shresta, Sujan/0000-0003-2906-8474; Regla-Nava, Jose
   Angel/0000-0002-5438-1369; Kim, Kenneth/0000-0002-5993-4575
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI116813, R21 NS100477];
   Chiba-UCSD Center for Mucosal Immunology, Allergy and Vaccine
   Development
FX The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. This research was
   funded by NIH grants (R01 AI116813 and R21 NS100477 to S.S.) and the
   Chiba-UCSD Center for Mucosal Immunology, Allergy and Vaccine
   Development. And the La Jolla Institute for Allergy and Immunology
   institutional support.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Arragain L, 2016, J PEDIAT INFECT DIS
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blohm G.M., 2017, GENOME ANNOUNC, V5
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   FALKLER WA, 1975, ARCH VIROL, V47, P3, DOI 10.1007/BF01315587
   FIELDSTEEL AH, 1974, CANCER RES, V34, P712
   Fouda GG, 2013, P NATL ACAD SCI USA, V110, P18220, DOI 10.1073/pnas.1307336110
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Groot F, 2005, J VIROL, V79, P3009, DOI 10.1128/JVI.79.5.3009-3015.2005
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Lanzieri TM, 2013, PEDIATRICS, V131, pE1937, DOI 10.1542/peds.2013-0076
   Lazear H. M., 2016, J VIROL
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Milligan C, 2014, J INFECT DIS, V210, pS631, DOI 10.1093/infdis/jiu344
   Moussa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063408
   Muranishi Y, 2016, BIOTECHNIQUES, V60, P47, DOI 10.2144/000114373
   Nakazawa H, 2004, VIROLOGY, V321, P154, DOI 10.1016/j.virol.2003.12.011
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pfaender S, 2017, VIRUS RES, V228, P58, DOI 10.1016/j.virusres.2016.11.025
   Pfaender S, 2013, J INFECT DIS, V208, P1943, DOI 10.1093/infdis/jit519
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   SALO RJ, 1976, ARCH VIROL, V52, P269, DOI 10.1007/BF01315616
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Stiehm ER, 2001, ADV NUTR RES, V10, P105
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Van de Perre P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003327
   Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732
   WEISS C, 1985, J GEN VIROL, V66, P2725, DOI 10.1099/0022-1317-66-12-2725
   World Health Organisation Guideline, 2016, GUID INF FEED AR ZIK
NR 35
TC 4
Z9 4
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2019
VL 13
IS 2
AR e0007080
DI 10.1371/journal.pntd.0007080
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HN1TU
UT WOS:000459970700025
PM 30742628
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, MC
   Zhang, DJ
   Li, YJ
   Sun, Q
   Li, Q
   Fan, YL
   Wu, Y
   Xi, ZY
   Zheng, XY
AF Zhang, Meichun
   Zhang, Dongjing
   Li, Yongjun
   Sun, Qiang
   Li, Qin
   Fan, Yali
   Wu, Yu
   Xi, Zhiyong
   Zheng, Xiaoying
TI Water-induced strong protection against acute exposure to low subzero
   temperature of adult Aedes albopictus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ASIAN TIGER MOSQUITO; COLD-ACCLIMATION; DIPTERA-CULICIDAE; INTERNATIONAL
   AIRPORT; GENE-EXPRESSION; DIAPAUSE; SHOCK; TOLERANCE; HARDINESS; EGGS
AB As an important vector of dengue and Zika, Aedes albopictus has been the fastest spreading invasive mosquitoes in the world over the last 3-4 decades. Cold tolerance is important for survival and expansion of insects. Ae. albopictus adults are generally considered to be cold-intolerant that cannot survive at subzero temperature. However, we found that Ae. albopictus could survive for several hours' exposure to -9 to -19 C-o so long as it was exposed with water. Median lethal time (LT50) of Ae. albopictus exposed to -15 and -19 C-o with water increased by more than 100 times compared to those exposed to the same subzero temperature without water. This phenomenon also existed in adult Aedes aegypti and Culex quinquefasciatus. Ae. albopictus female adults which exposed to low subzero temperature at -9 C-o with water had similar longevity and reproductive capacity to those of females without cold exposure. Cold exposure after a blood meal also have no detrimental impact on survival capacity of female adult Ae. albopictus compared with those cold exposed without a blood meal. Moreover, our results showed that rapid cold hardening (RCH) was induced in Ae. albopictus during exposing to low subzero temperature with water. Both the RCH and the relative high subzero temperature of water immediate after cold exposure might provide this strong protection against low subzero temperature. The molecular basis of water-induced protection for Ae. albopictus might refer to the increased glycerol during cold exposure, as well as the increased glucose and hsp70 during recovery from cold exposure. Our results suggested that the water-induced strong protection against acute decrease of air temperature for adult mosquitoes might be important for the survival and rapid expansion of Ae. albopictus.
   Author summary Aedes albopictus is one of two most important vectors for dengue and zika. During the last 3-4 decades, this mosquito has spread from native Asian area to all continents except Antarctica, becoming the most invasive mosquitoes which imposed extensive public health threat to human beings throughout the world. Cold tolerance is important for distribution and survival of insects. During the expansion of Ae. albopictus, especially a spatial expansion to cooler climate areas, it needs to cope with cold temperatures. Moreover, because of such widespread distribution adult Ae. albopictus will certainly often encounter sudden drops in air temperature even below subzero that often happens in early spring and winter, and late autumn. Thus far, adult Ae. albopictus are generally considered to be cold-intolerant that can not survive at subzero temperature. In this study, we found that water can provide strong protection against low subzero temperature even below -10 C-o. Cold exposure of adult female Ae. albopictus to low subzero temperature with water either before or after a blood meal have no detrimental impact on fitness costs of these adult mosquitoes. Considering water is common in nature, our results indicated that during the expansion of Ae. albopictus especially when adult mosquitoes encounter a sudden drop in air temperature water could be a good shelter for cope with such cold temperature below subzero.
C1 [Zhang, Meichun; Zhang, Dongjing; Li, Yongjun; Sun, Qiang; Fan, Yali; Wu, Yu; Xi, Zhiyong; Zheng, Xiaoying] Sun Yat Sen Univ, Zhongshan Sch Med, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou, Guangdong, Peoples R China.
   [Zhang, Meichun; Zhang, Dongjing; Li, Yongjun; Fan, Yali; Wu, Yu; Zheng, Xiaoying] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Guangdong, Peoples R China.
   [Zhang, Meichun; Zhang, Dongjing; Li, Yongjun; Fan, Yali; Wu, Yu; Zheng, Xiaoying] Sun Yat Sen Univ, Guangdong Prov Engn Technol Res Ctr Dis Vectors C, Guangzhou, Guangdong, Peoples R China.
   [Li, Qin] Yale Sch Med, Dept Internal Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA.
   [Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.
RP Xi, ZY; Zheng, XY (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou, Guangdong, Peoples R China.; Zheng, XY (corresponding author), Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Guangdong, Peoples R China.; Zheng, XY (corresponding author), Sun Yat Sen Univ, Guangdong Prov Engn Technol Res Ctr Dis Vectors C, Guangzhou, Guangdong, Peoples R China.; Xi, ZY (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.
EM xizy@msu.edu; zhengxy@mail.sysu.edu.cn
OI Zhang, Meichun/0000-0002-3134-8099
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81702033]; Natural Science Foundation of Guangdong
   ProvinceNational Natural Science Foundation of Guangdong Province
   [2017A030313523]
FX This work was supported by funds from the National Natural Science
   Foundation of China (No. 81702033 to MZ) at http://www.nsfc.gov.cn/ and
   the Natural Science Foundation of Guangdong Province (NO. 2017A030313523
   to MZ) at http://www.gdstc.gov.cn/.The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bataille A, 2009, P ROY SOC B-BIOL SCI, V276, P3769, DOI 10.1098/rspb.2009.0998
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boychuk EC, 2015, J INSECT PHYSIOL, V81, P157, DOI 10.1016/j.jinsphys.2015.07.015
   Brown EBE, 2012, VECTOR-BORNE ZOONOT, V12, P310, DOI 10.1089/vbz.2010.0176
   Chang LH, 2007, J MED ENTOMOL, V44, P205, DOI 10.1603/0022-2585(2007)44[205:DSOAAA]2.0.CO;2
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chowanski S, 2015, COMP BIOCHEM PHYS A, V183, P57, DOI 10.1016/j.cbpa.2015.01.007
   Coleman PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131301
   Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x
   DUMAN JG, 1991, Q REV BIOL, V66, P387, DOI 10.1086/417337
   Dutto M, 2017, ANN IG MED PREV COMU, V29, P86, DOI 10.7416/ai.2017.2135
   Erguler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149282
   Eritja R, 2000, J AM MOSQUITO CONTR, V16, P339
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   HANSON SM, 1995, J MED ENTOMOL, V32, P599, DOI 10.1093/jmedent/32.5.599
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   HAWLEY WA, 1989, J MED ENTOMOL, V26, P122, DOI 10.1093/jmedent/26.2.122
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Hofhuis A, 2009, VECTOR-BORNE ZOONOT, V9, P217, DOI 10.1089/vbz.2008.0071
   Huang LH, 2007, J INSECT PHYSIOL, V53, P1199, DOI 10.1016/j.jinsphys.2007.06.011
   Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004
   Izumi Y, 2007, J INSECT PHYSIOL, V53, P685, DOI 10.1016/j.jinsphys.2007.04.005
   Joshi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-336
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Ju RT, 2011, J INSECT PHYSIOL, V57, P1577, DOI 10.1016/j.jinsphys.2011.08.012
   Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546
   Kotsakiozi P, 2017, ECOL EVOL, V7, P10143, DOI 10.1002/ece3.3514
   Kress A, 2017, J INSECT PHYSIOL, V99, P113, DOI 10.1016/j.jinsphys.2017.04.003
   Kress A, 2016, J VECTOR ECOL, V41, P142, DOI 10.1111/jvec.12206
   LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5
   Mier-y-Teran-Romero L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005683
   Mogi M, 2011, J MED ENTOMOL, V48, P212, DOI 10.1603/ME10196
   Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012
   Overgaard J, 2014, J INSECT PHYSIOL, V62, P46, DOI 10.1016/j.jinsphys.2014.01.009
   Park Y, 2014, ENVIRON ENTOMOL, V43, P1076, DOI 10.1603/EN13291
   Park Y, 2014, J INSECT PHYSIOL, V67, P56, DOI 10.1016/j.jinsphys.2014.06.010
   Park Y, 2013, J EXP BIOL, V216, P4196, DOI 10.1242/jeb.092031
   Pluskota B, 2016, PARASITOL RES, V115, P3245, DOI 10.1007/s00436-016-5078-2
   Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104
   Rinehart JP, 2006, J MED ENTOMOL, V43, P713, DOI 10.1603/0022-2585(2006)43[713:ECADTI]2.0.CO;2
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2
   Rudolf I, 2018, ACTA TROP, V185, P239, DOI 10.1016/j.actatropica.2018.05.020
   Saeidi F, 2017, ENVIRON ENTOMOL, V46, P954, DOI 10.1093/ee/nvx087
   Saeidi M, 2017, ENVIRON ENTOMOL, V46, P960, DOI 10.1093/ee/nvx089
   Scholte Ernst-Jan, 2014, Journal of the European Mosquito Control Association, V32, P17
   Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x
   Stetina T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128976
   Sukehiro N, 2013, JPN J INFECT DIS, V66, P189, DOI 10.7883/yoken.66.189
   Swanson J, 2000, J MED ENTOMOL, V37, P454, DOI 10.1603/0022-2585(2000)037[0454:OAEOAA]2.0.CO;2
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Trudeau M, 2010, ENVIRON ENTOMOL, V39, P498, DOI 10.1603/EN09139
   Tsunoda T, 2015, J MED ENTOMOL, V52, P1203, DOI 10.1093/jme/tjv122
   Yang GP, 2018, INSECTS, V9, DOI 10.3390/insects9020053
   Yang S, 2018, GENE, V642, P9, DOI 10.1016/j.gene.2017.11.002
   Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6
NR 59
TC 2
Z9 2
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2019
VL 13
IS 2
AR e0007139
DI 10.1371/journal.pntd.0007139
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HN1TU
UT WOS:000459970700039
PM 30716071
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rathore, APS
   Saron, WAA
   Lim, T
   Johan, N
   St John, AL
AF Rathore, Abhay P. S.
   Saron, Wilfried A. A.
   Lim, Ting
   Johan, Nusrat
   St John, Ashley L.
TI Maternal immunity and antibodies to dengue virus promote infection and
   Zika virus-induced microcephaly in fetuses
SO SCIENCE ADVANCES
LA English
DT Article
ID FC-RECEPTOR; IMMUNOGLOBULIN-G; CEREBRAL-CORTEX; IGG; TRANSPORT;
   ENHANCEMENT; FETAL; SYNCYTIOTROPHOBLAST; ROLES; CELLS
AB Zika virus (ZIKV), an emergent flaviviral pathogen, has been linked to microcephaly in neonates. Although the risk is greatest during the first trimester of pregnancy in humans, timing alone cannot explain why maternal ZIKV infection leads to severe microcephaly in some fetuses, but not others. The antigenic similarities between ZIKV and dengue virus (DENV), combined with high levels of DENV immunity among ZIKV target populations in recent outbreaks, suggest that anti-DENV maternal antibodies could promote ZIKV-induced microcephaly. We demonstrated maternal-to-fetal ZIKV transmission, fetal infection, and disproportionate microcephaly in immunocompetent mice. We show that DENV-specific antibodies in ZIKV-infected pregnant mice enhance vertical ZIKV transmission and result in a severe microcephaly-like syndrome, which was dependent on the neonatal Fc receptor, FcRN. This novel immune-mediated mechanism of vertical transmission of viral infection is of special concern because ZIKV epidemic regions are also endemic to DENV.
C1 [Rathore, Abhay P. S.; Saron, Wilfried A. A.; Lim, Ting; Johan, Nusrat; St John, Ashley L.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore, Singapore.
   [Rathore, Abhay P. S.; St John, Ashley L.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.
   [St John, Ashley L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.
RP St John, AL (corresponding author), Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore, Singapore.; St John, AL (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.; St John, AL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.
EM ashley.st.john@duke-nus.edu.sg
RI amsalu, ribka/G-8780-2019
OI St. John, Ashley/0000-0001-5098-1044; /0000-0003-2039-2964
FU National Research Foundation of SingaporeSingapore National Research
   Foundation [NRF2016NRF-CRP001-063]; Duke-National University of
   Singapore (NUS) Medical SchoolNational University of Singapore
FX This study was funded by the National Research Foundation of Singapore
   (NRF2016NRF-CRP001-063) and Duke-National University of Singapore (NUS)
   Medical School.
CR Barba-Spaeth G, 2016, NATURE, V539, DOI 10.1038/nature19780
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Ben Suleiman Y, 2012, MUCOSAL IMMUNOL, V5, P87, DOI 10.1038/mi.2011.53
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   FRANTZ GD, 1994, J NEUROSCI, V14, P5725
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gomez JMM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004536
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286
   IGUCHI T, 1993, BIOL REPROD, V48, P188, DOI 10.1095/biolreprod48.1.188
   ISRAEL EJ, 1995, J IMMUNOL, V154, P6246
   Jauniaux E, 1995, HUM REPROD, V10, P3297, DOI 10.1093/oxfordjournals.humrep.a135906
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leach JL, 1996, J IMMUNOL, V157, P3317
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Mathiesen L, 2013, BLOOD, V122, P1174, DOI 10.1182/blood-2012-12-473843
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison J, 2017, J VIROL, V91, DOI 10.1128/JVI.00617-17
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Muzio L, 2002, NAT NEUROSCI, V5, P737, DOI 10.1038/nn892
   Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   OSBORN JJ, 1952, PEDIATRICS, V10, P450
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528
   Saron WAA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4297
   Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718
   Sones JL, 2016, PHYSIOL GENOMICS, V48, P565, DOI 10.1152/physiolgenomics.00125.2015
   Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002
   Taguchi T, 2013, J BIOCHEM, V153, P505, DOI 10.1093/jb/mvt034
   Valiant WG, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy151
   Valiant WG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0132-z
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Walters BT, 2016, J BIOL CHEM, V291, P1817, DOI 10.1074/jbc.M115.691568
   Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 55
TC 12
Z9 12
U1 1
U2 6
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD FEB
PY 2019
VL 5
IS 2
AR eaav3208
DI 10.1126/sciadv.aav3208
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HN4HT
UT WOS:000460145700063
PM 30820456
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hristov, DR
   Rodriguez-Quijada, C
   Gomez-Marquez, J
   Hamad-Schifferli, K
AF Hristov, Delyan R.
   Rodriguez-Quijada, Cristina
   Gomez-Marquez, Jose
   Hamad-Schifferli, Kimberly
TI Designing Paper-Based Immunoassays for Biomedical Applications
SO SENSORS
LA English
DT Review
DE paper-based immunoassays; lateral flow assay; biological sensors;
   dipstick assay; rapid diagnostics
ID LATERAL FLOW IMMUNOASSAY; HIGHLY SENSITIVE DETECTION; DEVICES MU-PADS;
   PROTEIN CORONA; IMMUNOCHROMATOGRAPHIC ASSAY; NITROCELLULOSE MEMBRANES;
   QUANTUM DOTS; SURFACE; ZIKA; IMMUNOSENSORS
AB Paper-based sensors and assays have been highly attractive for numerous biological applications, including rapid diagnostics and assays for disease detection, food safety, and clinical care. In particular, the paper immunoassay has helped drive many applications in global health due to its low cost and simplicity of operation. This review is aimed at examining the fundamentals of the technology, as well as different implementations of paper-based assays and discuss novel strategies for improving their sensitivity, performance, or enabling new capabilities. These innovations can be categorized into using unique nanoparticle materials and structures for detection via different techniques, novel biological species for recognizing biomarkers, or innovative device design and/or architecture.
C1 [Hristov, Delyan R.; Rodriguez-Quijada, Cristina; Hamad-Schifferli, Kimberly] Univ Massachusetts, Dept Engn, Boston, MA 02125 USA.
   [Gomez-Marquez, Jose] MIT, Little Devices Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
RP Hamad-Schifferli, K (corresponding author), Univ Massachusetts, Dept Engn, Boston, MA 02125 USA.
EM Delyan.Hristov@umb.edu; Cristina.Rodrigue002@umb.edu; jfgm@mit.edu;
   kim.hamad@umb.edu
RI Hristov, Delyan/AAE-9587-2020
OI Hristov, Delyan/0000-0002-1010-7966
FU Rafael del Pino Fellowship
FX C.R.-Q. was supported by a Rafael del Pino Fellowship.
CR Ahmad AL, 2008, J APPL POLYM SCI, V108, P2550, DOI 10.1002/app.27592
   Almeida MIGS, 2018, TALANTA, V177, P176, DOI 10.1016/j.talanta.2017.08.072
   Anovitz LM, 2015, REV MINERAL GEOCHEM, V80, P61, DOI 10.2138/rmg.2015.80.04
   Aragay G, 2012, CHEM REV, V112, P5317, DOI 10.1021/cr300020c
   Badu-Tawiah AK, 2015, LAB CHIP, V15, P655, DOI 10.1039/c4lc01239a
   Bahadir EB, 2016, TRAC-TREND ANAL CHEM, V82, P286, DOI 10.1016/j.trac.2016.06.006
   Bamrungsap S, 2014, MICROCHIM ACTA, V181, P223, DOI 10.1007/s00604-013-1106-4
   Ben Rejeb S, 1998, ANAL CHIM ACTA, V376, P133, DOI 10.1016/S0003-2670(98)00452-8
   Bergese P, 2007, J COLLOID INTERF SCI, V316, P1017, DOI 10.1016/j.jcis.2007.08.048
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bora U, 2006, J BIOTECHNOL, V126, P220, DOI 10.1016/j.jbiotec.2006.04.013
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Cheng N, 2017, FOOD CHEM, V214, P169, DOI [10.1016/j.foodchem.2016.07.058, 10.1016/j.foodchem.201]
   Chiao DJ, 2004, J CHROMATOGR B, V809, P37, DOI 10.1016/j.jchromb.2004.05.033
   Chin CD, 2013, CLIN CHEM, V59, P629, DOI 10.1373/clinchem.2012.199596
   Ching KH, 2012, J IMMUNOL METHODS, V380, P23, DOI 10.1016/j.jim.2012.03.008
   Cho IH, 2010, J CHROMATOGR B, V878, P271, DOI 10.1016/j.jchromb.2009.07.016
   Choi DH, 2010, BIOSENS BIOELECTRON, V25, P1999, DOI 10.1016/j.bios.2010.01.019
   Choi JR, 2017, TRAC-TREND ANAL CHEM, V93, P37, DOI 10.1016/j.trac.2017.05.007
   Costa MN, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/9/094006
   Coty JB, 2018, J CONTROL RELEASE, V275, P254, DOI 10.1016/j.jconrel.2018.02.013
   Coty JB, 2017, INT J PHARMACEUT, V532, P769, DOI 10.1016/j.ijpharm.2017.04.048
   Credou J, 2015, RSC ADV, V5, P29786, DOI 10.1039/c5ra03442f
   Dai Q, 2014, ANGEW CHEM INT EDIT, V53, P5093, DOI 10.1002/anie.201309464
   Data Bridge Market Research, 2018, GLOB BIOS MARK TREND
   de Puig H, 2017, TRENDS BIOTECHNOL, V35, P1169, DOI 10.1016/j.tibtech.2017.09.001
   de Puig H, 2017, BIOCONJUGATE CHEM, V28, P230, DOI 10.1021/acs.bioconjchem.6b00523
   de Taeye SW, 2013, TRENDS PARASITOL, V29, P119, DOI 10.1016/j.pt.2012.12.001
   DeBiasi RL, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0450-9
   Dong ML, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040684
   Du YQ, 2018, J MATER CHEM B, V6, P6217, DOI 10.1039/c8tb01526k
   Dungchai W, 2011, ANALYST, V136, P77, DOI 10.1039/c0an00406e
   Farka Z, 2017, CHEM REV, V117, P9973, DOI 10.1021/acs.chemrev.7b00037
   Fu EL, 2011, MICROFLUID NANOFLUID, V10, P29, DOI 10.1007/s10404-010-0643-y
   Fu E, 2010, LAB CHIP, V10, P918, DOI 10.1039/b919614e
   Fu X, 2016, BIOSENS BIOELECTRON, V78, P530, DOI 10.1016/j.bios.2015.11.099
   Garcia BL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005404
   Garcia-Alvarez R, 2018, NANOSCALE, V10, P1256, DOI 10.1039/c7nr08322j
   Ge SG, 2012, CHEM COMMUN, V48, P9397, DOI 10.1039/c2cc34887j
   Gebauer JS, 2012, LANGMUIR, V28, P9673, DOI 10.1021/la301104a
   Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605
   Gong MM, 2017, CHEM REV, V117, P8447, DOI 10.1021/acs.chemrev.7b00024
   Grand View Research, 2017, BIOS MARK SIZ SHAR T
   Gref R, 2003, BIOMATERIALS, V24, P4529, DOI 10.1016/S0142-9612(03)00348-X
   Guler E, 2017, ANAL CHEM, V89, P9629, DOI 10.1021/acs.analchem.7b03017
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   He YQ, 2011, BIOSENS BIOELECTRON, V26, P2018, DOI 10.1016/j.bios.2010.08.079
   Herda LM, 2017, J AM CHEM SOC, V139, P111, DOI 10.1021/jacs.6b12297
   Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397
   Hong S, 2015, MICROFLUID NANOFLUID, V19, P845, DOI 10.1007/s10404-015-1611-3
   Hristov DR, 2017, NANOSCALE, V9, P4524, DOI 10.1039/c6nr09331k
   Hristov DR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17040
   Hu J, 2013, LAB CHIP, V13, P4352, DOI 10.1039/c3lc50672j
   Huang XL, 2016, BIOSENS BIOELECTRON, V75, P166, DOI 10.1016/j.bios.2015.08.032
   Hwang J, 2016, NANOSCALE, V8, P11418, DOI 10.1039/c5nr07243c
   Jang I, 2018, INT J HEAT MASS TRAN, V120, P830, DOI 10.1016/j.ijheatmasstransfer.2017.12.078
   Johnson BJB, 2011, ADV M C M, P73, DOI 10.1079/9781845938048.0073
   Juntunen E, 2017, J MED VIROL, V89, P598, DOI 10.1002/jmv.24689
   Katz E, 2003, ELECTROANAL, V15, P913, DOI 10.1002/elan.200390114
   Klostranec JM, 2007, NANO LETT, V7, P2812, DOI 10.1021/nl071415m
   Kuang H, 2013, SENSORS-BASEL, V13, P4214, DOI 10.3390/s130404214
   Kumar R, 2010, FOOD CHEM, V122, P1298, DOI 10.1016/j.foodchem.2010.03.086
   Lager M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185434
   Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041
   Lan LY, 2017, BIOSENS BIOELECTRON, V91, P504, DOI 10.1016/j.bios.2017.01.007
   Lawrence M., 2017, BIOAGGREGATES BASED, P39, DOI DOI 10.1007/978-94-024-1031-0_2
   Lee S, 2013, SENSORS-BASEL, V13, P5109, DOI 10.3390/s130405109
   Lee S, 2016, ANAL CHEM, V88, P8359, DOI 10.1021/acs.analchem.6b01828
   Lee S, 2014, LAB CHIP, V14, P1437, DOI 10.1039/c3lc51375k
   Li JF, 2013, ANAL CHIM ACTA, V782, P54, DOI 10.1016/j.aca.2013.04.022
   Li ZH, 2010, ANAL CHEM, V82, P7008, DOI 10.1021/ac101405a
   Lou S, 2012, ANALYST, V137, P1174, DOI 10.1039/c2an15844b
   Lu Y, 2010, ANAL CHEM, V82, P329, DOI 10.1021/ac9020193
   Lu ZD, 2018, LAB CHIP, V18, P3865, DOI 10.1039/c8lc00717a
   Lutz B, 2013, LAB CHIP, V13, P2840, DOI 10.1039/c3lc50178g
   Magni R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0701-z
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Mahato K, 2017, BIOSENS BIOELECTRON, V96, P246, DOI 10.1016/j.bios.2017.05.001
   Marketsandmarkets, 2017, BIOS MARK APPL POC H
   Marques AR, 2015, INFECT DIS CLIN N AM, V29, P295, DOI 10.1016/j.idc.2015.02.005
   Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817
   Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989
   Martinez AW, 2008, LAB CHIP, V8, P2146, DOI 10.1039/b811135a
   Millipore E.M.D., 2013, RAPID LATERAL FLOW T
   Miocevic O, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00133
   Moghadam BY, 2015, ANAL CHEM, V87, P1009, DOI 10.1021/ac504552r
   Morbioli GG, 2017, ANAL CHIM ACTA, V970, P1, DOI 10.1016/j.aca.2017.03.037
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Noh N, 2010, ANAL CHEM, V82, P4181, DOI 10.1021/ac100431y
   Oncescu V, 2014, LAB CHIP, V14, P759, DOI 10.1039/c3lc51194d
   Papi M, 2017, NANOSCALE, V9, P10327, DOI 10.1039/c7nr03042h
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pelton R, 2009, TRAC-TREND ANAL CHEM, V28, P925, DOI 10.1016/j.trac.2009.05.005
   Phillips EA, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800104
   Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2
   Pratt GW, 2018, ANAL CHIM ACTA, V1017, P34, DOI 10.1016/j.aca.2018.02.039
   Prencipe G, 2009, J AM CHEM SOC, V131, P4783, DOI 10.1021/ja809086q
   Qie YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26269
   Qin ZP, 2012, ANGEW CHEM INT EDIT, V51, P4358, DOI 10.1002/anie.201200997
   Quesada-Gonzalez D, 2017, BIOSENS BIOELECTRON, V92, P549, DOI 10.1016/j.bios.2016.10.062
   Quesada-Gonzalez D, 2015, BIOSENS BIOELECTRON, V73, P47, DOI 10.1016/j.bios.2015.05.050
   Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714
   Ramanathan M, 2016, BIOSENS BIOELECTRON, V77, P580, DOI 10.1016/j.bios.2015.10.014
   Raoufi M, 2018, NANOSCALE, V10, P1228, DOI 10.1039/c7nr06970g
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Sajid M, 2015, J SAUDI CHEM SOC, V19, P689, DOI 10.1016/j.jscs.2014.09.001
   Sanchez-Purra M, 2018, ACS OMEGA, V3, P10733, DOI 10.1021/acsomega.8b01499
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Schneidman M, 2014, LAB PROFESSIONALS AF
   Shafiee H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08719
   Sher M, 2017, EXPERT REV MOL DIAGN, V17, P351, DOI 10.1080/14737159.2017.1285228
   Shyu RH, 2002, TOXICON, V40, P255, DOI 10.1016/S0041-0101(01)00193-3
   Spinhirne J, 2006, J CLIN MICROBIOL, V44, P1616, DOI 10.1128/JCM.44.4.1616-1617.2006
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tan EM, 1999, ARTHRITIS RHEUM, V42, P455, DOI 10.1002/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3
   Taranova NA, 2015, BIOSENS BIOELECTRON, V63, P255, DOI 10.1016/j.bios.2014.07.049
   Tonigold M, 2018, NAT NANOTECHNOL, V13, P862, DOI 10.1038/s41565-018-0171-6
   Tracy KE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00116
   Ulep TH, 2018, NANO CONVERG, V5, DOI 10.1186/s40580-018-0146-1
   Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448
   Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v
   Walji N, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7050073
   Wang JY, 2014, LAB CHIP, V14, P691, DOI 10.1039/c3lc51313k
   Wang R, 2018, SENSOR ACTUAT B-CHEM, V270, P72, DOI 10.1016/j.snb.2018.04.162
   Wang RG, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-018-2730-9
   Wang Y, 2015, ACS NANO, V9, P6354, DOI 10.1021/acsnano.5b01929
   Wang YL, 2013, ANALYST, V138, P1764, DOI 10.1039/c3an36610c
   Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273
   Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064
   Yang W, 2011, BIOSENS BIOELECTRON, V26, P3710, DOI 10.1016/j.bios.2011.02.016
   Yang XX, 2012, LAB CHIP, V12, P274, DOI 10.1039/c1lc20803a
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h
   You DJ, 2013, BIOSENS BIOELECTRON, V40, P180, DOI 10.1016/j.bios.2012.07.014
   Zarei M, 2017, TRAC-TREND ANAL CHEM, V91, P26, DOI 10.1016/j.trac.2017.04.001
   Zhan L, 2017, NANO LETT, V17, P7207, DOI 10.1021/acs.nanolett.7b02302
   Zhu GY, 2019, TRAC-TREND ANAL CHEM, V111, P100, DOI 10.1016/j.trac.2018.09.027
   Zhu JM, 2011, CLIN CHEM, V57, P1732, DOI 10.1373/clinchem.2011.171694
NR 141
TC 8
Z9 8
U1 10
U2 29
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD FEB 1
PY 2019
VL 19
IS 3
AR 554
DI 10.3390/s19030554
PG 24
WC Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments
   & Instrumentation
SC Chemistry; Engineering; Instruments & Instrumentation
GA HN1IR
UT WOS:000459941200117
PM 30699964
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kakooza-Mwesige, A
   Tshala-Katumbay, D
   Juliano, SL
AF Kakooza-Mwesige, Angelina
   Tshala-Katumbay, Desire
   Juliano, Sharon L.
TI Viral infections of the central nervous system in Africa
SO BRAIN RESEARCH BULLETIN
LA English
DT Review
DE CNS viral infections; Ebola; Herpes; HIV; Rabies; Zika
ID HERPES-SIMPLEX-VIRUS; WEST-NILE-VIRUS; RIFT-VALLEY FEVER; ZIKA VIRUS;
   EBOLA-VIRUS; RABIES VIRUS; ANTIRETROVIRAL THERAPY; TYPE-1 INFECTION;
   HIV-INFECTION; SOUTH-AFRICA
AB Viral infections are a major cause of human central nervous system infection, and may be associated with significant mortality, and long-term sequelae. In Africa, the lack of effective therapies, limited diagnostic and human resource facilities are especially in dire need. Most viruses that affect the central nervous system are opportunistic or accidental pathogens. Some of these viruses were initially considered harmless, however they have now evolved to penetrate the nervous system efficiently and exploit neuronal cell biology thus resulting in severe illness. A number of potentially lethal neurotropic viruses have been discovered in Africa and over the course of time shown their ability to spread wider afield involving other continents leaving a devastating impact in their trail. In this review we discuss key viruses involved in central nervous system disease and of major public health concern with respect to Africa. These arise from the families of Flaviviridae, Filoviridae, Retroviridae, Bunyaviridae, Rhabdoviridae and Herpesviridae. In terms of the number of cases affected by these viruses, HIV (Retroviridae) tops the list for morbidity, mortality and long term disability, while the Rift Valley Fever virus (Bunyaviridae) is at the bottom of the list. The most deadly are the Ebola and Marburg viruses (Filoviridae). This review describes their epidemiology and key neurological manifestations as regards the central nervous system such as meningoencephalitis and Guillain-Barre syndrome. The potential pathogenic mechanisms adopted by these viruses are debated and research perspectives suggested.
C1 [Kakooza-Mwesige, Angelina] Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda.
   [Kakooza-Mwesige, Angelina] Mulago Hosp, Kampala, Uganda.
   [Kakooza-Mwesige, Angelina] Karolinska Inst, Astrid Lindgren Childrens Hosp, Neuropediat Res Unit, Stockholm, Sweden.
   [Tshala-Katumbay, Desire] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.
   [Tshala-Katumbay, Desire] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA.
   [Tshala-Katumbay, Desire] Univ Kinshasa, Dept Neurol, Kinshasa, DEM REP CONGO.
   [Tshala-Katumbay, Desire] Univ Kinshasa, Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.
   [Juliano, Sharon L.] USUHS, Neurosci, Bethesda, MD 20814 USA.
RP Kakooza-Mwesige, A (corresponding author), POB 7072, Kampala, Uganda.
EM akakooza246@gmail.com; tshalad@ohsu.edu; sharon.juliano@usuhs.edu
RI Juliano, Sharon/AAO-1030-2020
FU DELTAS Africa Initiative grant [DEL-15-011]; New Partnership for
   Africa's Development Planning and Coordinating Agency (NEPAD Agency);
   Wellcome TrustWellcome Trust [107742/Z/15/Z]; UK government
FX AKM is supported by DELTAS Africa Initiative grant #DEL-15-011 to
   THRiVE-2. The DELTAS Africa Initiative is an independent funding scheme
   of the African Academy of Sciences (AAS)'s Alliance for Accelerating
   Excellence in Science in Africa (AESA) and supported by the New
   Partnership for Africa's Development Planning and Coordinating Agency
   (NEPAD Agency) with funding from the Wellcome Trust grant #107742/Z/15/Z
   and the UK government. The views expressed in this publication are those
   of the author(s) and not necessarily those of AAS, NEPAD Agency,
   Wellcome Trust or the UK government.
CR Abel L, 2010, J PEDIATR-US, V157, P623, DOI 10.1016/j.jpeds.2010.04.020
   Agosto LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003982
   Anand R., 2017, NEUROLOGY S, V88
   [Anonymous], 2016, WHO DIRECTOR GEN SUM
   Atuman YJ, 2014, INT J VET SCI MED, V2, P41, DOI 10.1016/j.ijvsm.2014.04.001
   Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298
   Avdoshina V, 2016, NEUROTOX RES, V29, P583, DOI 10.1007/s12640-016-9608-6
   Billioux BJ, 2017, JAMA NEUROL, V74, P1141, DOI 10.1001/jamaneurol.2017.1460
   Billioux BJ, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0573-x
   Billioux BJ, 2016, NEUROTHERAPEUTICS, V13, P461, DOI 10.1007/s13311-016-0457-z
   Bingham J, 1999, ONDERSTEPOORT J VET, V66, P11
   Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883
   Bixler SL, 2015, VIRUSES-BASEL, V7, P5489, DOI 10.3390/v7102892
   Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391
   Buchanan R, 2012, SEMIN PEDIATR NEUROL, V19, P107, DOI 10.1016/j.spen.2012.02.003
   Burk R, 2016, FEMS MICROBIOL REV, V40, P494, DOI 10.1093/femsre/fuw010
   Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chayavichitsilp P, 2009, PEDIATR REV, V30, P119, DOI 10.1542/pir.30-4-119
   Chippaux JP, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-44
   Chomel BB, 2011, EMERG INFECT DIS, V17, P167, DOI 10.3201/eid1702.101070
   Churchill M, 2013, CURR OPIN HIV AIDS, V8, P165, DOI 10.1097/COH.0b013e32835fc601
   Clay CC, 2007, J VIROL, V81, P12040, DOI 10.1128/JVI.00133-07
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   De Benedictis P, 2010, ZOONOSES PUBLIC HLTH, V57, pE42, DOI 10.1111/j.1863-2378.2009.01291.x
   de Greslan T, 2016, CLIN INFECT DIS, V63, P1076, DOI 10.1093/cid/ciw469
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Digafe Reta T, 2015, BMC Res Notes, V8, P400, DOI 10.1186/s13104-015-1357-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Egan KP, 2013, J NEUROVIROL, V19, P328, DOI 10.1007/s13365-013-0189-3
   Eisfeld C, 2013, CNS DRUGS, V27, P31, DOI 10.1007/s40263-012-0018-x
   Eugenin EA, 2013, J NEUROCHEM, V127, P644, DOI 10.1111/jnc.12443
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fearon Margaret, 2005, Can J Infect Dis Med Microbiol, V16, P26
   Feinberg Mark B., 1992, CURR OPIN IMMUNOL, P466
   Feldmann H, 1996, ADV VIRUS RES, V47, P1, DOI 10.1016/S0065-3527(08)60733-2
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   FISHBEIN DB, 1993, NEW ENGL J MED, V329, P1632, DOI 10.1056/NEJM199311253292208
   Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218
   Fooks AR, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.91
   Fraser R. T., 1989, VOCATIONAL PSYCHOSOC
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gelman BB, 2015, CURR HIV-AIDS REP, V12, P272, DOI 10.1007/s11904-015-0266-8
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Goldstein T, 2018, NAT MICROBIOL, V3, P1084, DOI 10.1038/s41564-018-0227-2
   GONZALESDUARTE A, 2006, PRN NOTEBOOK, V11, P24
   Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527
   Goto A, 2003, VACCINE, V21, P4043, DOI 10.1016/S0264-410X(03)00269-X
   Granwehr BP, 2004, LANCET INFECT DIS, V4, P547, DOI 10.1016/S1473-3099(04)01128-4
   Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544
   Greene C. E., 2006, RABIES OTHER LYSSAVI
   Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766
   Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8
   Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc
   Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hjalmarsson A, 2007, CLIN INFECT DIS, V45, P875, DOI 10.1086/521262
   Howlett P, 2016, EMERG INFECT DIS, V22, P150, DOI 10.3201/eid2201.151212
   Howlett PJ, 2018, EMERG INFECT DIS, V24, P1412, DOI 10.3201/eid2408.171367
   Huang HI, 2015, VIRUSES-BASEL, V7, P6051, DOI 10.3390/v7112920
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684
   Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493
   Jennische E, 2015, J NEUROVIROL, V21, P129, DOI 10.1007/s13365-014-0312-0
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kammouni W, 2015, J NEUROVIROL, V21, P370, DOI 10.1007/s13365-015-0320-8
   Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557
   KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5
   Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623
   Kayali U, 2006, TROP MED INT HEALTH, V11, P1058, DOI 10.1111/j.1365-3156.2006.01663.x
   Khan MY, 2017, CURR TOP MED CHEM, V17, P1320, DOI 10.2174/1568026616666161222141318
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   King JE, 2010, AM J PATHOL, V176, P2819, DOI 10.2353/ajpath.2010.090642
   Klein C, 2002, J NEUROL SCI, V200, P63, DOI 10.1016/S0022-510X(02)00135-1
   Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794
   Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360
   Koelle DM, 2000, J ANTIMICROB CHEMOTH, V45, P1, DOI 10.1093/jac/45.suppl_4.1
   Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x
   LaBeaud AD, 2008, EMERG INFECT DIS, V14, P1240, DOI 10.3201/eid1408.080082
   Lane H Clifford, 2010, Top HIV Med, V18, P2
   LANL, 2010, HIV SEQ DAT
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lefebvre A, 2014, MED MALADIES INFECT, V44, P412, DOI 10.1016/j.medmal.2014.08.005
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Leung AKC, 2007, ADV THER, V24, P1340, DOI 10.1007/BF02877781
   Lever RA, 2016, BRIT MED BULL, V117, P95, DOI 10.1093/bmb/ldw005
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Lotsch F, 2017, TRAVEL MED INFECT DI, V18, P18, DOI 10.1016/j.tmaid.2017.05.001
   Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08
   Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1
   Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109
   McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053
   Mehedi M, 2011, FUTURE VIROL, V6, P1091, DOI 10.2217/FVL.11.79
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MELTZER MS, 1990, ANNU REV IMMUNOL, V8, P169, DOI 10.1146/annurev.immunol.8.1.169
   Michos AG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000674
   Minami N, 1997, NEUROPATHOLOGY, V17, P121, DOI 10.1111/j.1440-1789.1997.tb00025.x
   MONATH TP, 1983, LAB INVEST, V48, P399
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009
   MURPHY FA, 1995, ARCH VIROL, P1
   Muyembe-Tamfum JJ, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.451
   Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca
   National Institutes of Health, 2016, TEST INV IN ZIK VACC
   Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012
   Nguku P., 2007, Morbidity and Mortality Weekly Report, V56, P73
   Nguyen AKT, 2011, JPN J INFECT DIS, V64, P391
   Nigg AJ, 2009, PHARMACOTHERAPY, V29, P1182, DOI 10.1592/phco.29.10.1182
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nyakarahuka L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2045-6
   Ohuabunwo C, 2014, INT J INFECT DIS, V2016, P23
   Pena KC, 2010, J CLIN MICROBIOL, V48, P150, DOI 10.1128/JCM.01336-09
   Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004
   Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rajagopal S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu043
   Reed DS, 2007, J INFECT DIS, V196, P441, DOI 10.1086/519391
   Rhodes CJ, 1998, PHILOS T R SOC B, V353, P999, DOI 10.1098/rstb.1998.0263
   Riancho J, 2013, NEUROL SCI, V34, P1879, DOI 10.1007/s10072-013-1475-9
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   ROCK DL, 1983, NATURE, V302, P523, DOI 10.1038/302523a0
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284
   Sagui E, 2015, CLIN INFECT DIS, V61, P1627, DOI 10.1093/cid/civ606
   Saijo M, 2006, CLIN VACCINE IMMUNOL, V13, P444, DOI 10.1128/CVI.13.4.444-451.2006
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sauerbrei A, 2007, MED MICROBIOL IMMUN, V196, P89, DOI 10.1007/s00430-006-0031-0
   Saylor D, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2016.53
   Schiff D, 1998, HUM PATHOL, V29, P215, DOI 10.1016/S0046-8177(98)90038-7
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SHIEH MT, 1994, J VIROL, V68, P1224, DOI 10.1128/JVI.68.2.1224-1228.1994
   Shukla ND, 2012, MOL VIS, V18, P2711
   Siegert R, 1968, Ger Med Mon, V13, P1
   Sili U, 2014, J CLIN VIROL, V60, P112, DOI 10.1016/j.jcv.2014.03.010
   Singh RK, 2017, VET QUART, V37, P98, DOI 10.1080/01652176.2017.1309474
   Sirbu A., 2010, EUROSURVEILLANCE, V2011, P16
   SMITH CEG, 1967, LANCET, V2, P1119
   Smith G, 2012, ANNU REV MICROBIOL, V66, P153, DOI 10.1146/annurev-micro-092611-150051
   Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739
   Smith JR, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.4.12
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Solomon T, 2002, CURR TOP MICROBIOL, V267, P171
   Steiner I, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0414-8
   Steiner I, 2011, CURR OPIN NEUROL, V24, P268, DOI 10.1097/WCO.0b013e328346be6f
   Steptoe PJ, 2017, EMERG INFECT DIS, V23, P1102, DOI 10.3201/eid2307.161608
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   SWANEPOEL R, 1993, ONDERSTEPOORT J VET, V60, P325
   Swanson PA, 2015, CURR OPIN VIROL, V11, P44, DOI 10.1016/j.coviro.2014.12.009
   Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134
   Talbi C, 2009, J GEN VIROL, V90, P783, DOI 10.1099/vir.0.007765-0
   Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737
   TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579
   TSIANG H, 1986, J NEUROPATH EXP NEUR, V45, P28, DOI 10.1097/00005072-198601000-00003
   UNAIDS, 2016, UNAIDS FACT SHEET
   van Paassen J, 2012, LANCET INFECT DIS, V12, P635, DOI 10.1016/S1473-3099(12)70018-X
   VANVELDEN DJJ, 1977, S AFR MED J, V51, P867
   Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952
   Vernet MA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88864
   Wang H, 2013, J INFECT DIS, V208, P573, DOI 10.1093/infdis/jit186
   Wang H, 2009, J NEUROVIROL, V15, P293, DOI 10.1080/13550280902973978
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   WHO, 2018, RAB KEY FACTS
   Wilde H, 2011, ADV VIRUS RES, V79, P449, DOI 10.1016/B978-0-12-387040-7.00021-4
   Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394
   WILSON ML, 1994, AM J TROP MED HYG, V50, P663, DOI 10.4269/ajtmh.1994.50.663
   Wong G, 2014, EXPERT REV CLIN IMMU, V10, P781, DOI 10.1586/1744666X.2014.908705
   World Health Organisation, 2018, EB SIT REP DEM REP C
   World Health Organization, 2018, RABIES
   World Health Organization (WHO), 2018, HIV AIDS
   World Health Organization (WHO), 2018, NEW EB OUTBR DECL DE
   Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390
   Younan P, 2017, MBIO, V8
   Zaayman D, 2012, EMERG INFECT DIS, V18, P2051, DOI 10.3201/eid1812.111208
   Zhang SY, 2015, J EXP MED, V212, P1342, DOI 10.1084/jem.2129insight4
NR 186
TC 2
Z9 2
U1 4
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD FEB
PY 2019
VL 145
SI SI
BP 2
EP 17
DI 10.1016/j.brainresbull.2018.12.019
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA HM9ZG
UT WOS:000459842900002
PM 30658129
DA 2020-07-08
ER

PT J
AU Tesoriero, C
   Del Gallo, F
   Bentivoglio, M
AF Tesoriero, Chiara
   Del Gallo, Federico
   Bentivoglio, Marina
TI Sleep and brain infections
SO BRAIN RESEARCH BULLETIN
LA English
DT Review
DE Sickness behavior; Neuroinflammation; African trypanosomiasis;
   NeuroAlDS; HIV/AIDS; Rabies; Zika virus
ID TRYPANOSOMA-BRUCEI-BRUCEI; CENTRAL-NERVOUS-SYSTEM; CONCENTRATING HORMONE
   NEURONS; HISTAMINERGIC TUBEROMAMMILLARY NEURONS; HUMAN AFRICAN
   TRYPANOSOMIASIS; MEDIAN PREOPTIC NUCLEUS; CYTOKINE MESSENGER-RNA;
   ADULT-RAT BRAIN; ANTIRETROVIRAL THERAPY; HIV-INFECTION
AB Sleep is frequently altered in systemic infections as a component of sickness behavior in response to inflammation. Sleepiness in sickness behavior has been extensively investigated. Much less attention has instead been devoted to sleep and wake alterations in brain infections. Most of these, as other neuroinfections, are prevalent in sub-Saharan Africa. The present overview highlights the importance of this topic from both the clinical and pathogenetic points of view. Vigilance states and their regulation are first summarized, emphasizing that key nodes in this distributed brain system can be targeted by neuroinflammatory signaling. Sleep-wake changes in the parasitic disease human African trypanosomiasis (HAT) and its animal models are then reviewed and discussed. Experimental data have revealed that the suprachiasmatic nucleus, the master circadian pacemaker, and peptidergic cell populations of the lateral hypothalamus (the wake-promoting orexin neurons and the sleep-promoting melanin-concentrating hormone neurons) are targeted by African trypanosome infection. It is then discussed how prominent and disturbing are sleep changes in HIV/AIDS, also when the infection is cured with antiretroviral therapy. This recalls attention on the bidirectional interactions between sleep and immune system, including the specialized brain immune response of which microglial cells are protagonists. Sleep changes in an ancient viral disease, rabies, and in the emerging infection due to Zika virus which causes a congenital syndrome, are also dealt with. Altogether the findings indicate that sleep-wake regulation is targeted by brain infections caused by different pathogens and, although the relevant pathogenetic mechanisms largely remain to be clarified, these alterations differ from hypersomnia occurring in sickness behavior. Thus, brain infections point to the vulnerability of the neural network of sleep-wake regulation as a highly relevant clinical and basic science challenge.
C1 [Tesoriero, Chiara; Del Gallo, Federico; Bentivoglio, Marina] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.
RP Bentivoglio, M (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Med Sch, Str Le Grazie 8, I-37134 Verona, Italy.
EM marina.bentivoglio@univr.it
OI Tesoriero, Chiara/0000-0001-9915-6424; Del Gallo,
   Federico/0000-0003-0248-2456
CR Amin DN, 2009, J INFECT DIS, V200, P1556, DOI 10.1086/644597
   Amin DN, 2010, AM J TROP MED HYG, V82, P983, DOI 10.4269/ajtmh.2010.09-0770
   Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006
   Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b
   ASERINSK.E, 1965, SCIENCE, V150, P763, DOI 10.1126/science.150.3697.763-a
   ASTONJONES G, 1981, J NEUROSCI, V1, P876
   Babiloni C, 2016, CLIN NEUROPHYSIOL, V127, P3455, DOI 10.1016/j.clinph.2016.09.001
   Banisadr G, 2005, J COMP NEUROL, V492, P178, DOI 10.1002/cne.20729
   Banisadr G, 2003, EUR J NEUROSCI, V18, P1593, DOI 10.1046/j.1460-9568.2003.02893.x
   Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x
   Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x
   Banyard AC, 2013, ANTIVIR RES, V98, P357, DOI 10.1016/j.antiviral.2013.04.004
   Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002
   Bentivoglio M, 2011, BRAIN RES REV, V66, P152, DOI 10.1016/j.brainresrev.2010.09.008
   Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193
   Beynon AL, 2010, CHRONOBIOL INT, V27, P1546, DOI 10.3109/07420528.2010.501927
   Santos MSB, 2010, BRAZ J MED BIOL RES, V43, P316, DOI 10.1590/S0100-879X2010007500002
   Bing EG, 2000, QUAL LIFE RES, V9, P55, DOI 10.1023/A:1008919227665
   Bishop C, 1996, SLEEP, V19, P727, DOI 10.1093/sleep/19.9.727
   Bittencourt JC, 2011, GEN COMP ENDOCR, V172, P185, DOI 10.1016/j.ygcen.2011.03.028
   Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001
   Borbely A A, 1982, Hum Neurobiol, V1, P195
   Borbely AA, 2016, J SLEEP RES, V25, P131, DOI 10.1111/jsr.12371
   BOURIN P, 1993, CHRONOBIOL INT, V10, P298, DOI 10.3109/07420529309059712
   Buguet A, 2005, ACTA TROP, V93, P107, DOI 10.1016/j.actatropica.2004.10.001
   Buguet A, 1999, J SLEEP RES, V8, P225, DOI 10.1046/j.1365-2869.1999.00160.x
   Buguet A, 2001, SLEEP MED REV, V5, P139, DOI 10.1053/smrv.2000.0130
   Buguet A., 2014, NEGLECTED TROPICAL D, P165, DOI DOI 10.1007/978-1-4614-8100-3_9
   Buscher P, 2005, TROP MED INT HEALTH, V10, P850, DOI 10.1111/j.1365-3156.2005.01468.x
   Buscher P, 2017, LANCET, V390, P2397, DOI 10.1016/S0140-6736(17)31510-6
   Carskadon M. A., 2017, NORMAL HUMAN SLEEP P, DOI [10.1016/13978-0-323-24288-2.00002-7, DOI 10.1016/B978-0-323-24288-2.00002-7]
   Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X
   Chen NC, 2017, GLIA, V65, P431, DOI 10.1002/glia.23081
   Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a
   Chianella S, 1999, BRAIN RES, V832, P54, DOI 10.1016/S0006-8993(99)01449-3
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002
   Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725
   Cirelli C, 2015, BIOL PSYCHIAT, V77, P1071, DOI 10.1016/j.biopsych.2014.12.017
   Clark JP, 2005, AM J PHYSIOL-REG I, V289, pR656, DOI 10.1152/ajpregu.00179.2005
   Clifford DB, 2013, LANCET INFECT DIS, V13, P976, DOI 10.1016/S1473-3099(13)70269-X
   Cliquet F, 2014, EXPERT REV ANTI-INFE, V12, P905, DOI 10.1586/14787210.2014.921570
   Collins B, 2006, NEURON, V50, P348, DOI 10.1016/j.neuron.2006.04.022
   Coogan AN, 2008, BRAIN RES, V1232, P104, DOI 10.1016/j.brainres.2008.07.087
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Crum-Cianflone NF, 2012, CLIN INFECT DIS, V54, P1485, DOI 10.1093/cid/cis192
   Dalwadi DA, 2018, PHARMACOL REV, V70, P684, DOI 10.1124/pr.117.013706
   DANTZ B, 1994, ELECTROEN CLIN NEURO, V90, P24, DOI 10.1016/0013-4694(94)90110-4
   Dao CN, 2011, AIDS RES HUM RETROV, V27, P1149, DOI [10.1089/aid.2010.0345, 10.1089/AID.2010.0345]
   DARKO DF, 1992, AM J PSYCHIAT, V149, P514
   Darko DF, 1998, NEUROENDOCRINOLOGY, V67, P317, DOI 10.1159/000054329
   Darsaud A, 2004, SLEEP, V27, P42, DOI 10.1093/sleep/27.1.42
   Dauvilliers Y, 2008, SLEEP, V31, P348, DOI 10.1093/sleep/31.3.348
   de Lecea L, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00016
   De Weerd A, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00155
   Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001
   Del Gallo F, 2014, ARCH ITAL BIOL, V152, P93, DOI 10.12871/000298292014234
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762
   Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010
   Duncan MJ, 2008, AM J PHYSIOL-REG I, V295, pR1680, DOI 10.1152/ajpregu.90496.2008
   Economo CV, 1930, J NERV MENT DIS, V71, P249, DOI 10.1097/00005053-193003000-00001
   ELMANSARI M, 1989, EXP BRAIN RES, V76, P519, DOI 10.1007/BF00248908
   Etet PFS, 2012, CHRONOBIOL INT, V29, P469, DOI 10.3109/07420528.2012.660713
   Faraut B, 2018, AIDS BEHAV, V22, P2877, DOI 10.1007/s10461-018-2179-1
   FERINISTRAMBI L, 1995, SLEEP, V18, P446
   Fernandez-Cruz AL, 2017, CLIN NEUROPHYSIOL, V128, P965, DOI 10.1016/j.clinph.2017.03.035
   Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2
   Fooks AR, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.91
   Fooks AR, 2014, LANCET, V384, P1389, DOI 10.1016/S0140-6736(13)62707-5
   Foster SB, 2012, CLIN IMMUNOL, V144, P13, DOI 10.1016/j.clim.2012.04.004
   Gallego L, 2004, CLIN INFECT DIS, V38, P430, DOI 10.1086/380791
   Gay CL, 2015, BRAIN BEHAV IMMUN, V47, P58, DOI 10.1016/j.bbi.2014.11.018
   Gelman BB, 2015, CURR HIV-AIDS REP, V12, P272, DOI 10.1007/s11904-015-0266-8
   Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283
   Gillette MU, 1996, BEHAV BRAIN RES, V73, P135
   Giroud C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000509
   Golombek DA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0465
   Gong H, 2004, J PHYSIOL-LONDON, V556, P935, DOI 10.1113/jphysiol.2003.056622
   GOURMELON P, 1991, BRAIN RES, V554, P159, DOI 10.1016/0006-8993(91)90184-W
   GOURMELON P, 1986, BRAIN RES, V398, P128, DOI 10.1016/0006-8993(86)91258-8
   GRASSIZUCCONI G, 1995, BRAIN RES BULL, V37, P123, DOI 10.1016/0361-9230(94)00265-3
   Grossberg AJ, 2011, J NEUROSCI, V31, P11376, DOI 10.1523/JNEUROSCI.2311-11.2011
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Guyon A, 2005, EUR J NEUROSCI, V21, P701, DOI 10.1111/j.1460-9568.2005.03890.x
   Gvilia I, 2006, J NEUROSCI, V26, P9426, DOI 10.1523/JNEUROSCI.2012-06.2006
   HANTSON P, 1993, EUR NEUROL, V33, P212, DOI 10.1159/000116939
   Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106
   Hogan D, 2003, J NEUROIMMUNOL, V137, P59, DOI 10.1016/S0165-5728(03)00038-9
   Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7
   Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037
   HUNTER CA, 1991, INFECT IMMUN, V59, P4636, DOI 10.1128/IAI.59.12.4636-4640.1991
   HUNTER CA, 1992, LAB INVEST, V67, P635
   Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576
   JACOBS BL, 1991, PHARMACOL REV, V43, P563
   Jafari B, 2010, CLIN CHEST MED, V31, P287, DOI 10.1016/j.ccm.2010.02.005
   Jean-Louis G, 2012, SLEEP, V35, P131, DOI 10.5665/sleep.1602
   Johnson N, 2014, VIRUSES-BASEL, V6, P1911, DOI 10.3390/v6051911
   Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009
   JOUVET M, 1959, Rev Neurol (Paris), V101, P255
   Kapas L, 2008, J APPL PHYSIOL, V105, P1187, DOI 10.1152/japplphysiol.90388.2008
   Keita M, 2000, EXP PARASITOL, V95, P19, DOI 10.1006/expr.2000.4505
   Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X
   Kent ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148920
   KOMSUOGLU SS, 1981, J NEUROL NEUROSUR PS, V44, P264, DOI 10.1136/jnnp.44.3.264
   Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716
   Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009
   Kristensson K, 2011, NAT REV NEUROSCI, V12, P345, DOI 10.1038/nrn3029
   Krueger JM, 2016, INT REV NEUROBIOL, V131, P207, DOI 10.1016/bs.irn.2016.07.003
   Krueger JM, 2011, PROG BRAIN RES, V193, P39, DOI 10.1016/B978-0-444-53839-0.00003-X
   KUBICIKI S, 1989, EEG-EMG, V20, P288
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   LANCEL M, 1995, AM J PHYSIOL-REG I, V268, pR1310
   Laperchia C, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00013
   Laperchia C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005854
   Laperchia C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005242
   Le Thuc O, 2016, EMBO REP, V17, P1738, DOI 10.15252/embr.201541499
   Leak RK, 2001, J COMP NEUROL, V433, P312, DOI 10.1002/cne.1142
   Lee KA, 2015, CHRONOBIOL INT, V32, P1278, DOI 10.3109/07420528.2015.1087021
   Lee KA, 2014, SLEEP, V37, P453, DOI 10.5665/sleep.3474
   Lee KA, 2012, J CLIN SLEEP MED, V8, P67, DOI 10.5664/jcsm.1666
   Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005
   Lhermitte J, 1910, MALADIE SOMMEIL NARC
   Li SB, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-015-0639-0
   Liu YJ, 1999, TROP MED INT HEALTH, V4, P85
   Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006
   Lundkvist GB, 1998, NEUROREPORT, V9, P1059, DOI 10.1097/00001756-199804200-00018
   Mackenzie S, 1890, LANCET, V136, P1100
   Manber R, 2009, CURR PSYCHIAT REP, V11, P437, DOI 10.1007/s11920-009-0066-1
   Manzar MD, 2017, SLEEP SCI, V10, P64, DOI 10.5935/1984-0063.20170011
   Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MARTINI E, 1988, AIDS, V2, P133, DOI 10.1097/00002030-198804000-00011
   Masocha W, 2008, SCAND J IMMUNOL, V68, P484, DOI 10.1111/j.1365-3083.2008.02170.x
   Masocha W, 2004, J CLIN INVEST, V114, P689, DOI 10.1172/JCI22104
   Masocha W, 2019, BRAIN RES BULL, V145, P18, DOI 10.1016/j.brainresbull.2018.05.022
   MATSUMURA H, 1994, P NATL ACAD SCI USA, V91, P11998, DOI 10.1073/pnas.91.25.11998
   MCCARLEY RW, 2008, SCHOLARPEDIA J, V3, P3313, DOI DOI 10.4249/SCHOLARPEDIA.3313
   MEHLITZ D, 1978, TROPENMED PARASITOL, V29, P101
   Mistlberger RE, 2005, J BIOL RHYTHM, V20, P339, DOI 10.1177/0748730405277982
   MONTMAYEUR A, 1994, NEUROSCI LETT, V168, P172, DOI 10.1016/0304-3940(94)90443-X
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morner A, 2003, AIDS, V17, P1451, DOI [10.1097/00002030-200307040-00005, 10.1097/01.aids.0000076269.76134.c7]
   Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P40, DOI 10.1016/j.bbi.2004.04.001
   MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8
   Mpandzou G, 2011, J NEUROL SCI, V305, P112, DOI 10.1016/j.jns.2011.03.002
   Mullington J, 2000, AM J PHYSIOL-REG I, V278, pR947
   Nadjar A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00250
   Netravathi M, 2015, J CLIN VIROL, V70, P83, DOI 10.1016/j.jcv.2015.07.003
   Njamnshi AK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001525
   NORMAN SE, 1988, JAMA-J AM MED ASSOC, V260, P922, DOI 10.1001/jama.1988.03410070046015
   Nunez M, 2001, J ACQ IMMUN DEF SYND, V28, P399
   Obukuro K, 2013, J NEUROSCI, V33, P12557, DOI 10.1523/JNEUROSCI.0595-13.2013
   Olivera GC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005442
   Omonuwa TS, 2009, J CLIN SLEEP MED, V5, P251
   Opp MR, 1996, AM J PHYSIOL-REG I, V270, pR963
   Oshinaike O, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298703
   Ferreira JGP, 2017, PHYSIOL BEHAV, V181, P75, DOI 10.1016/j.physbeh.2017.08.028
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Palomba M, 2015, NEUROSCIENCE, V290, P185, DOI 10.1016/j.neuroscience.2014.12.066
   PARMEGGIANI PL, 1987, SLEEP, V10, P426
   Patil SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099258
   Peirano PD, 2007, BIOL RES, V40, P471, DOI [/S0716-97602007000500008, 10.4067/S0716-97602007000500008]
   PERKINS DO, 1995, AM J PSYCHIAT, V152, P1776
   Peyron C, 1998, J NEUROSCI, V18, P9996
   Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690
   Peyron C, 2017, J NEUROSCI, V37, P2268, DOI 10.1523/JNEUROSCI.1708-16.2016
   Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Porkka-Heiskanen T, 2013, ACTA PHYSIOL, V208, P311, DOI 10.1111/apha.12134
   PROSPEROGARCIA O, 1994, P NATL ACAD SCI USA, V91, P12947, DOI 10.1073/pnas.91.26.12947
   Quan N, 1999, J COMP NEUROL, V414, P114, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;114::AID-CNE9&gt;3.0.CO;2-G
   RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266
   Rao VR, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-13
   Re VL, 2006, INT J STD AIDS, V17, P614, DOI 10.1258/095646206778113078
   Redman KN, 2018, BRAIN BEHAV IMMUN, V69, P548, DOI 10.1016/j.bbi.2018.02.002
   Reid S, 2005, PSYCHOSOM MED, V67, P260, DOI 10.1097/01.psy.0000151771.46127.df
   Ren JJ, 2018, J ASSOC NURSE AIDS C, V29, P924, DOI 10.1016/j.jana.2018.04.006
   Reust CE, 2011, AM FAM PHYSICIAN, V83, P1443
   Rijo-Ferreira F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02484-2
   Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496
   Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001
   Sadki A, 2007, NEUROBIOL AGING, V28, P296, DOI 10.1016/j.neurobiolaging.2005.12.007
   Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010
   Sakurai T, 2014, BRIT J PHARMACOL, V171, P1287, DOI 10.1111/bph.12529
   Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355
   Sanner BM, 2000, J NEUROL, V247, P878, DOI 10.1007/s004150070077
   Katz ISS, 2017, ARCH VIROL, V162, P3251, DOI 10.1007/s00705-017-3484-0
   Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009
   Saper CB, 2013, CURR OPIN NEUROBIOL, V23, P747, DOI 10.1016/j.conb.2013.04.004
   Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159
   Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032
   SASTRE JP, 1979, CR ACAD SCI D NAT, V289, P959
   Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970
   Scammell TE, 2015, NEW ENGL J MED, V373, P2654, DOI 10.1056/NEJMra1500587
   Scammell TE, 2009, SLEEP, V32, P111
   Schwartz MD, 2015, PSYCHIAT CLIN N AM, V38, P615, DOI 10.1016/j.psc.2015.07.002
   Seay JS, 2013, PSYCHONEUROENDOCRINO, V38, P2647, DOI 10.1016/j.psyneuen.2013.06.022
   Sherin JE, 1998, J NEUROSCI, V18, P4705
   Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216
   Shokeir A A, 1969, Zentralbl Veterinarmed B, V16, P213
   Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197
   Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0
   SNYDER F, 1964, J APPL PHYSIOL, V19, P417
   Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120
   Stenberg D, 2007, CELL MOL LIFE SCI, V64, P1187, DOI 10.1007/s00018-007-6530-3
   STERIADE M, 1990, J NEUROSCI, V10, P2541
   Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043
   Sternberg JM, 2005, J NEUROIMMUNOL, V167, P81, DOI 10.1016/j.jneuroim.2005.06.017
   Sternberg JM, 1998, PARASITE IMMUNOL, V20, P395, DOI 10.1046/j.1365-3024.1998.00164.x
   Suntsova N, 2002, J PHYSIOL-LONDON, V543, P665, DOI 10.1113/jphysiol.2002.023085
   SWOYER J, 1990, PROG CLIN BIOL RES, V341, P437
   Takahashi K, 2009, NEUROSCIENCE, V161, P269, DOI 10.1016/j.neuroscience.2009.02.075
   Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006
   Tesoriero C, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00006
   Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1
   Thannickal TC, 2009, SLEEP, V32, P993, DOI 10.1093/sleep/32.8.993
   TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O
   Torterolo P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00475
   TOTH LA, 1992, AM J PHYSIOL, V263, pR1339
   TOTH LA, 1995, PHARMACOL BIOCHEM BE, V51, P877, DOI 10.1016/0091-3057(95)00064-4
   TOTH LA, 1988, INFECT IMMUN, V56, P1785, DOI 10.1128/IAI.56.7.1785-1791.1988
   Trosman I, 2017, MED SCI, V5, P30, DOI [10.3390/medsci5040030, DOI 10.3390/MEDSCI5040030]
   UENO R, 1982, P NATL ACAD SCI-BIOL, V79, P6093, DOI 10.1073/pnas.79.19.6093
   Urade Y, 2011, SLEEP MED REV, V15, P411, DOI 10.1016/j.smrv.2011.08.003
   Uschakov A, 2007, NEUROSCIENCE, V150, P104, DOI 10.1016/j.neuroscience.2007.05.055
   VAGNUCCI AH, 1993, J ACQ IMMUN DEF SYND, V6, P1238
   VANTWYVER H, 1969, PHYSIOL BEHAV, V4, P901, DOI 10.1016/0031-9384(69)90038-9
   Venner A, 2016, CURR BIOL, V26, P2137, DOI 10.1016/j.cub.2016.05.078
   Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19
   Volk C, 2015, ARCH ITAL BIOL, V153
   VONECONOMO C, 1929, ENCEPHALITIS LETHARG
   Vosvick M, 2004, J PSYCHOSOM RES, V57, P459, DOI 10.1016/j.jpsychores.2004.03.003
   Wang T, 2014, HIV MED, V15, P565, DOI 10.1111/hiv.12154
   WEISS T, 1964, EXPERIENTIA, V20, P280, DOI 10.1007/BF02151809
   WHITE JL, 1995, AIDS, V9, P1043, DOI 10.1097/00002030-199509000-00009
   WIEGAND M, 1991, EUR ARCH PSY CLIN N, V240, P153, DOI 10.1007/BF02190756
   Wigren HK, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.13017
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu J, 2015, SLEEP MED, V16, P901, DOI 10.1016/j.sleep.2015.03.027
   Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859
   Zielinski Mark R, 2011, Front Biosci (Schol Ed), V3, P632, DOI 10.2741/s176
NR 243
TC 1
Z9 1
U1 1
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD FEB
PY 2019
VL 145
SI SI
BP 59
EP 74
DI 10.1016/j.brainresbull.2018.07.002
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA HM9ZG
UT WOS:000459842900008
PM 30016726
DA 2020-07-08
ER

PT J
AU Olivon, F
   Remy, S
   Grelier, G
   Apel, C
   Eydoux, C
   Guillemott, JC
   Neyts, J
   Delang, L
   Touboul, D
   Roussi, F
   Litaudon, M
AF Olivon, Florent
   Remy, Simon
   Grelier, Gwendal
   Apel, Cecile
   Eydoux, Cecilia
   Guillemott, Jean-Claude
   Neyts, Johan
   Delang, Leen
   Touboul, David
   Roussi, Fanny
   Litaudon, Marc
TI Antiviral Compounds from Codiaeum peltatum Targeted by a
   Multi-informative Molecular Networks Approach
SO JOURNAL OF NATURAL PRODUCTS
LA English
DT Article
ID CHIKUNGUNYA VIRUS; TIGLIANE DITERPENOIDS; MASS-SPECTROMETRY;
   NATURAL-PRODUCTS; ZIKA VIRUS; INHIBITORS; ESTERS; POTENT; EUPHORBIACEAE;
   CONSTITUENTS
AB From a set of 292 Euphorbiaceae extracts, the use of a molecular networking (MN)-based prioritization approach highlighted three clusters (MN1-3) depicting ions from the bark extract of Codiaeum peltatum. Based on their putative antiviral potential and structural novelty, the MS-guided purification of compounds present in MN1 and MN2 afforded two new daphnane-type diterpenoid orthoesters (DDO), codiapeltines A (1) and B (2), the new actephilols B (3) and C (4), and four known 1,4-dioxane-fused phenanthrene dimers (5-8). The structures of the new compounds were elucidated by NMR spectroscopic data analysis, and the absolute configurations of compounds 1 and 2 were deduced by comparison of experimental and calculated ECD spectra. Codiapeltine B (2) is the first daphnane bearing a 9,11,13-orthoester moiety, establishing a new major structural class of DDO. Compounds 1-8 and four recently reported monoterpenyl quinolones (9-12) detected in MN3 were investigated for their selective activities against chikungunya virus replication and their antipolymerase activities against the NSS proteins of dengue and zika viruses. Compounds 3-8 exhibited strong inhibitory activities on both dengue and zika NSS in primary assays, but extensive biological analyses indicated that only actephilol B (3) displayed a specific interaction with the NSS targets.
C1 [Olivon, Florent; Remy, Simon; Grelier, Gwendal; Apel, Cecile; Touboul, David; Roussi, Fanny; Litaudon, Marc] Univ Paris Saclay, UPR 2301, CNRS ICSN, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France.
   [Eydoux, Cecilia; Guillemott, Jean-Claude] Aix Marseille Univ, CNRS, AFMB, AD2P, 163 Ave Luminy, F-13288 Marseille 09, France.
   [Neyts, Johan; Delang, Leen] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Expt Chemotherapy, B-3000 Leuven, Belgium.
RP Litaudon, M (corresponding author), Univ Paris Saclay, UPR 2301, CNRS ICSN, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France.
EM marc.litaudon@cnrs.fr
RI Delang, Leen/D-9548-2018; Neyts, Johan/U-8267-2017
OI Delang, Leen/0000-0002-8874-675X; Neyts, Johan/0000-0002-0033-7514;
   REMY, Simon/0000-0003-2247-6862; Touboul, David/0000-0003-2751-774X
FU "Investissement d'Avenir" grantFrench National Research Agency (ANR)
   [ANR-10-LABX-25-01]
FX The authors are grateful to the North Province of New Caledonia, which
   has facilitated our field investigation, and V. Dumontet for his
   contribution to plant material identification and species collection. We
   thank C. Collard and C. Vanderheydt for their excellent technical
   assistance in the acquisition of the antiviral data. This work has
   benefited from an "Investissement d'Avenir" grant managed by Agence
   Nationale de la Recherche (CEBA, ref ANR-10-LABX-25-01). The tree and
   leaves icons in the graphical abstract were created by Sayan Mukerjhee,
   Alice Noir, Iejank, Lance Hancock, and LSE Designs from the Noun
   Project.
CR Allard PM, 2012, PHYTOCHEMISTRY, V84, P160, DOI 10.1016/j.phytochem.2012.07.023
   Allard PM, 2012, ORG LETT, V14, P342, DOI 10.1021/ol2030907
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bourjot M, 2014, MOLECULES, V19, P3617, DOI 10.3390/molecules19033617
   Bourjot M, 2012, J NAT PROD, V75, P2183, DOI 10.1021/np300637t
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377
   Corlay N, 2014, FITOTERAPIA, V97, P87, DOI 10.1016/j.fitote.2014.05.015
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Esposito M, 2017, J NAT PROD, V80, P2051, DOI 10.1021/acs.jnatprod.7b00233
   Esposito M, 2017, J NAT PROD, V80, P479, DOI 10.1021/acs.jnatprod.6b00990
   Frisch M. J., 2016, GAUSSIAN09 REVISION
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Lanzotti V, 2013, NATURAL PRODUCTS, P3173
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Li LZ, 2015, RSC ADV, V5, P4143, DOI 10.1039/c4ra13167c
   Li SF, 2015, NAT PROD RES, V29, P1845, DOI 10.1080/14786419.2015.1009066
   Li SF, 2011, J NAT PROD, V74, P464, DOI 10.1021/np1006444
   Liao SG, 2009, CHEM REV, V109, P1092, DOI 10.1021/cr0782832
   Lin BD, 2010, J NAT PROD, V73, P1301, DOI 10.1021/np100320h
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mwine JT, 2011, J MED PLANTS RES, V5, P652
   Myers OD, 2017, ANAL CHEM, V89, P8696, DOI 10.1021/acs.analchem.7b00947
   Nothias-Scaglia LF, 2015, J NAT PROD, V78, P2423, DOI 10.1021/acs.jnatprod.5b00511
   Nothias-Scaglia LF, 2015, J NAT PROD, V78, P1277, DOI 10.1021/acs.jnatprod.5b00073
   Nothias-Scaglia LF, 2014, J NAT PROD, V77, P1505, DOI 10.1021/np500271u
   Olivon F, 2018, ORG CHEM FRONT, V5, P2171, DOI 10.1039/c8qo00429c
   Olivon F, 2017, ACS CHEM BIOL, V12, P2644, DOI 10.1021/acschembio.7b00413
   Olivon F, 2017, ANAL BIOANAL CHEM, V409, P5767, DOI 10.1007/s00216-017-0523-3
   Olivon F, 2017, ANAL CHEM, V89, P7836, DOI 10.1021/acs.analchem.7b01563
   Olivon F, 2015, J NAT PROD, V78, P1119, DOI 10.1021/acs.jnatprod.5b00116
   Ovenden SPB, 2001, TETRAHEDRON LETT, V42, P7695, DOI 10.1016/S0040-4039(01)01628-8
   Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Seephonkai P, 2013, J NAT PROD, V76, P1358, DOI 10.1021/np400268d
   Shi QW, 2008, CHEM REV, V108, P4295, DOI 10.1021/cr078350s
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Tritsch D, 2015, BIOORG CHEM, V59, P140, DOI 10.1016/j.bioorg.2015.02.008
   Vasas A, 2014, CHEM REV, V114, P8579, DOI 10.1021/cr400541j
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang HB, 2015, CHEM REV, V115, P2975, DOI 10.1021/cr200397n
   Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597
   Weidong H., 2002, MINI-REV MED CHEM, V2, P185
   Xu JB, 2014, ORG CHEM FRONT, V1, P1225, DOI 10.1039/c4qo00161c
NR 48
TC 6
Z9 6
U1 8
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0163-3864
EI 1520-6025
J9 J NAT PROD
JI J. Nat. Prod.
PD FEB
PY 2019
VL 82
IS 2
BP 330
EP 340
DI 10.1021/acs.jnatprod.8b00800
PG 11
WC Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy
GA HM9WS
UT WOS:000459836300020
PM 30681849
DA 2020-07-08
ER

PT J
AU Kim, KH
   Kim, J
   Ko, M
   Chun, JY
   Kim, H
   Kim, S
   Min, JY
   Park, WB
   Oh, MD
   Chung, J
AF Kim, Ki Hyun
   Kim, Jinhee
   Ko, Meehyun
   Chun, June Young
   Kim, Hyori
   Kim, Seungtaek
   Min, Ji-Young
   Park, Wan Beom
   Oh, Myoung-don
   Chung, Junho
TI An anti-Gn glycoprotein antibody from a convalescent patient potently
   inhibits the infection of severe fever with thrombocytopenia syndrome
   virus
SO PLOS PATHOGENS
LA English
DT Article
ID HUMAN MONOCLONAL-ANTIBODY; TO-PERSON TRANSMISSION; NEUTRALIZING
   ANTIBODIES; POSTEXPOSURE EFFICACY; SOUTH-KOREA; MOUSE MODEL; ZIKA VIRUS;
   HEMAGGLUTININ; BUNYAVIRUS; EPITOPE
AB Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease localized to China, Japan, and Korea that is characterized by severe hemorrhage and a high fatality rate. Currently, no specific vaccine or treatment has been approved for this disease. To develop a therapeutic agent for SFTS, we isolated antibodies from a phage-displayed antibody library that was constructed from a patient who recovered from SFTS virus (SFTSV) infection. One antibody, designated as Ab10, was reactive to the Gn envelope glycoprotein of SFTSV and protected host cells and A129 mice from infection in both in vitro and in vivo experiments. Notably, Ab10 protected 80% of mice, even when injected 5 days after inoculation with a lethal dose of SFTSV. Using cross-linker assisted mass spectrometry and alanine scanning, we located the non-linear epitope of Ab10 on the Gn glycoprotein domain II and an unstructured stem region, suggesting that Ab10 may inhibit a conformational alteration that is critical for cell membrane fusion between the virus and host cell. Ab10 reacted to recombinant Gn glycoprotein in Gangwon/Korea/2012, HB28, and SD4 strains. Additionally, based on its epitope, we predict that Ab10 binds the Gn glycoprotein in 247 of 272 SFTSV isolates previously reported. Together, these data suggest that Ab10 has potential to be developed into a therapeutic agent that could protect against more than 90% of reported SFTSV isolates.
   Author summary Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease localized to China, Japan, and Korea. The tick-borne virus that causes SFTS has infected more than 5,000 humans, with a 6.4% to 20.9% fatality rate. Currently, there are no prophylactic or therapeutic measures against this virus. Historically, antibodies from patients who recovered from viral infection have been used to treat new patients, and commercially available antiviral monoclonal antibodies have been developed. Palivizumab was approved for the prophylaxis of respiratory syncytial virus (RSV) infection, and ibalizumab-uiyk was recently approved for the treatment of human immunodeficiency virus (HIV)-infected patients. To develop an antiviral monoclonal antibody for SFTS patients, we selected 10 antibodies from a patient who recovered from SFTS and found that one antibody potently inhibited SFTS viral infection both in vitro and in animal studies. We mapped the binding site of this antibody on the SFTS virus, which allowed us to predict that this antibody could bind 247 out of the 272 SFTS virus isolates reported to date. We anticipate that this antibody could be developed into a therapeutic treatment against SFTS.
C1 [Kim, Ki Hyun; Chung, Junho] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.
   [Kim, Ki Hyun; Kim, Hyori; Chung, Junho] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.
   [Kim, Jinhee; Ko, Meehyun; Min, Ji-Young] Inst Pasteur Korea, Resp Virus Lab, Seongnam, Gyeonggi Do, South Korea.
   [Chun, June Young; Park, Wan Beom; Oh, Myoung-don] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Kim, Seungtaek] Inst Pasteur Korea, Zoonot Virus Lab, Seongnam, Gyeonggi Do, South Korea.
   [Chung, Junho] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea.
   [Kim, Hyori] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea.
   [Min, Ji-Young] GlaxoSmithKline, Rockville, MD USA.
RP Chung, J (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.; Chung, J (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.; Chung, J (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea.
EM jjhchung@snu.ac.kr
RI Chun, June/AAS-2464-2020; Kim, Ki Hyun/F-2031-2019
OI Kim, Ki Hyun/0000-0001-8835-7511; Chun, June Young/0000-0001-9345-6645
FU Commercialization Promotion Agency for Research and Development outcomes
   (COMPA); National Research Foundation of Korea (NRF) - Ministry of
   Science, ICT (MSIT), Republic of Korea [2017K000459, 2017M3A9G6068245]
FX This research was supported by the Commercialization Promotion Agency
   for Research and Development outcomes (COMPA), the National Research
   Foundation of Korea (NRF), funded by the Ministry of Science, ICT
   (MSIT), Republic of Korea (grant number: 2017K000459, 2017M3A9G6068245).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Andris-Widhopf Jennifer, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot065573
   Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243
   BARBAS CF, 2001, PHAGE DISPLAY LAB MA, DOI [10. 1086/420571, DOI 10.1086/420571]
   Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268
   Chai N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14234
   Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224
   Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112
   Cyranoski D, 2018, NATURE, V556, P282, DOI 10.1038/d41586-018-04486-6
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110
   Ding YP, 2014, CLIN MICROBIOL INFEC, V20, pO870, DOI 10.1111/1469-0691.12636
   DULBECCO R, 1953, COLD SPRING HARB SYM, V18, P273, DOI 10.1101/SQB.1953.018.01.039
   Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472
   Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776
   Gowen BB, 2017, J VIROL, V91, DOI 10.1128/JVI.01942-16
   Gunn BM, 2018, CELL HOST MICROBE, V24, P221, DOI 10.1016/j.chom.2018.07.009
   Guo XL, 2013, CLIN VACCINE IMMUNOL, V20, P1426, DOI 10.1128/CVI.00222-13
   Halldorsson S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02789-2
   Hofmann H, 2013, J VIROL, V87, P4384, DOI 10.1128/JVI.02628-12
   Ikegami T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189250
   Jin J, 2018, BIOCHEM BIOPH RES CO, V496, P846, DOI 10.1016/j.bbrc.2018.01.141
   Kang CK, 2018, TICKS TICK-BORNE DIS, V9, P972, DOI 10.1016/j.ttbdis.2018.03.030
   Kato H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165207
   Kim H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019867, 10.1371/journal.pone.0024749]
   Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792
   [Korea Centers for Disease Control and Prevention cdc. go. kr], 2018, DIS INF SEV FEV THRO
   Lee S, 2012, J IMMUNOL, V189, P4592, DOI 10.4049/jimmunol.1103803
   Lee Y, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.57
   Li H, 2018, LANCET INFECT DIS, V18, P1127, DOI 10.1016/S1473-3099(18)30293-7
   Liu LC, 2016, INFECT GENET EVOL, V39, P55, DOI 10.1016/j.meegid.2015.12.022
   Liu Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep45552
   Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2
   Liu SL, 2014, REV MED VIROL, V24, P90, DOI 10.1002/rmv.1776
   Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758
   Marston HD, 2018, NEW ENGL J MED, V378, P1469, DOI 10.1056/NEJMp1802256
   [National Institute of Infectious Diseases Japan niid. go. jp], 2018, SEV FEV THROMB SYNDR
   Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245
   Park S, 2010, CLIN CHIM ACTA, V411, P1238, DOI 10.1016/j.cca.2010.04.027
   Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112
   Paules CI, 2017, J INFECT DIS, V216, P356, DOI 10.1093/infdis/jix292
   Pimenova T, 2008, J MASS SPECTROM, V43, P185, DOI 10.1002/jms.1280
   Plegge T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166013
   Rainey T, 2018, J MED ENTOMOL, V55, P757, DOI 10.1093/jme/tjy006
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929
   Shimada S, 2015, VIROLOGY, V482, P19, DOI 10.1016/j.virol.2015.03.010
   Shin J, 2015, EMERG INFECT DIS, V21, P1704, DOI 10.3201/eid2110.141928
   Sun JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08042-6
   Sun YY, 2014, J VIROL, V88, P237, DOI 10.1128/JVI.02141-13
   Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603
   Tani H, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00061-15
   Tharakaraman K, 2014, CELL HOST MICROBE, V15, P644, DOI 10.1016/j.chom.2014.04.009
   VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15
   Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0
   Wu Y, 2017, P NATL ACAD SCI USA, V114, pE7564, DOI 10.1073/pnas.1705176114
   Wu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8708
   Ying TL, 2014, J VIROL, V88, P7796, DOI 10.1128/JVI.00912-14
   Yoon A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141312
   Yu F, 2017, CELL HOST MICROBE, V22, P471, DOI 10.1016/j.chom.2017.08.011
   Yu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038291
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
   Zhan JB, 2017, VIROL SIN, V32, P51, DOI 10.1007/s12250-016-3931-1
   Zhang YZ, 2016, CURR OPIN VIROL, V16, P126, DOI 10.1016/j.coviro.2016.02.006
   Zhang YZ, 2012, J VIROL, V86, P2864, DOI 10.1128/JVI.06192-11
   Zhu Q, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj1928
NR 69
TC 4
Z9 4
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2019
VL 15
IS 2
AR e1007375
DI 10.1371/journal.ppat.1007375
PG 21
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HN1UI
UT WOS:000459972100003
PM 30707748
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roder, AE
   Vazquez, C
   Horner, SM
AF Roder, Allison E.
   Vazquez, Christine
   Horner, Stacy M.
TI The acidic domain of the hepatitis C virus NS4A protein is required for
   viral assembly and envelopment through interactions with the viral E1
   glycoprotein
SO PLOS PATHOGENS
LA English
DT Article
ID CORE PROTEIN; COMPENSATORY MUTATIONS; RNA REPLICATION; NS3 PROTEASE;
   NS5A; P7; MULTIMERIZATION; DETERMINANTS; LOCALIZATION; CONTRIBUTES
AB Hepatitis C virus (HCV) assembly and envelopment are coordinated by a complex protein interaction network that includes most of the viral structural and nonstructural proteins. While the nonstructural protein 4A (NS4A) is known to be important for viral particle production, the specific function of NS4A in this process is not well understood. We performed mutagenesis of the C-terminal acidic domain of NS4A and found that mutation of several of these amino acids prevented the formation of the viral envelope, and therefore the production of infectious virions, without affecting viral RNA replication. In an overexpression system, we found that NS4A interacted with several viral proteins known to coordinate envelopment, including the viral E1 glycoprotein. One of the NS4A C-terminal mutations, Y45F, disrupted the interaction of NS4A with E1. Specifically, NS4A interacted with the first hydrophobic region of E1, a region previously described as regulating viral particle production. Indeed, we found that an E1 mutation in this region, D72A, also disrupted the interaction of NS4A with E1. Supernatants from HCV NS4A Y45F transfected cells had significantly reduced levels of HCV RNA, however they contained equivalent levels of Core protein. Interestingly, the Core protein secreted from these cells formed high order oligomers with a density matching the infectious virus secreted from wild-type cells. These results suggest that this Y45F mutation in NS4A causes secretion of low-density Core particles lacking genomic HCV RNA. These results corroborate previous findings showing that the E1 D72A mutation also causes secretion of Core complexes lacking genomic HCV RNA, and therefore suggest that the interaction between NS4A and E1 is involved in the incorporation of viral RNA into infectious HCV particles. Our findings define a new role for NS4A in the HCV lifecycle and help elucidate the protein interactions necessary for production of infectious virus.
   Author summary RNA viruses, which encompass both established and emerging pathogens, pose significant public health challenges. Viruses in the family Flaviviridae, including Dengue virus, Zika virus, and hepatitis C virus (HCV), continue to cause morbidity and mortality worldwide. One HCV protein, NS4A, acts in several steps of the viral lifecycle; however, how it contributes to viral particle production is not understood. Here, we investigated the role of one region of NS4A, the C-terminal acidic domain, in regulating the viral lifecycle. We found that amino acids within this domain are important for viral envelopment and the production infectious particles, specifically through interaction with the E1 glycoprotein. NS4A interacts with the first hydrophobic domain of E1. Disruption of this interaction, by either mutation of E1 or NS4A, prevents the production of infectious virus particles and instead results in release of low-density Core protein complexes that lack HCV RNA into the cellular supernatant. Overall, our results reveal that NS4A is important for late stages of the HCV lifecycle and suggest that the interaction between NS4A and E1 may regulate the incorporation of viral RNA into the virion for the formation of infectious HCV particles.
C1 [Roder, Allison E.; Vazquez, Christine; Horner, Stacy M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.
   [Horner, Stacy M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27708 USA.
RP Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.; Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27708 USA.
EM stacy.horner@duke.edu
OI Horner, Stacy/0000-0002-9351-7409
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T32-CA009111, 1F31AI131477-01A1,
   R01AI25416]; Duke Whitehead Scholarship; Duke CFAR (NIH) [5P30AI064518];
   Burroughs Wellcome FundBurroughs Wellcome Fund
FX This work was supported by funds from the NIH: T32-CA009111 and
   1F31AI131477-01A1 (AER), and R01AI25416 (SMH). Additional funds were
   provided by the Duke Whitehead Scholarship, Duke CFAR (an NIH funded
   program (5P30AI064518)), and the Burroughs Wellcome Fund (SMH). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ai LS, 2009, J VIROL, V83, P9923, DOI 10.1128/JVI.00066-09
   Aligeti M, 2015, J VIROL, V89, P11523, DOI 10.1128/JVI.01185-15
   [Anonymous], 2017, GLOBAL HEPATITIS REP
   Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035
   Asabe SI, 1997, J VIROL, V71, P790, DOI 10.1128/JVI.71.1.790-796.1997
   Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005
   Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756
   Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144
   Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105
   Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07
   Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466
   De Beeck AO, 2003, REV MED VIROL, V13, P233, DOI 10.1002/rmv.391
   DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994
   FAILLA C, 1995, J VIROL, V69, P1769, DOI 10.1128/JVI.69.3.1769-1777.1995
   Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07
   Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06
   Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355
   Haddad JG, 2017, J VIROL, V91, DOI 10.1128/JVI.00048-17
   Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005
   Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141
   Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108
   Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104
   Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09
   Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233
   Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07
   Jones DM, 2011, J VIROL, V85, P12351, DOI 10.1128/JVI.05313-11
   Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023
   Kato T, 2001, J MED VIROL, V64, P334, DOI 10.1002/jmv.1055
   Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3
   Klein KC, 2005, J VIROL, V79, P6814, DOI 10.1128/JVI.79.11.6814-6826.2005
   Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485
   Kunkel M, 2001, J VIROL, V75, P2119, DOI 10.1128/JVI.75.5.2119-2129.2001
   Li D, 2015, NATL SCI REV, V2, P10
   Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651
   Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07
   Lo SY, 1996, J VIROL, V70, P5177, DOI 10.1128/JVI.70.8.5177-5182.1996
   Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111
   Ma HC, 2002, J GEN VIROL, V83, P3085, DOI 10.1099/0022-1317-83-12-3085
   Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08
   Ma YH, 2011, J VIROL, V85, P86, DOI 10.1128/JVI.01070-10
   Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001
   Matsumoto M, 1996, VIROLOGY, V218, P43, DOI 10.1006/viro.1996.0164
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x
   Nakai K, 2006, J VIROL, V80, P11265, DOI 10.1128/JVI.01203-06
   Nielsen SU, 2004, J GEN VIROL, V85, P1497, DOI 10.1099/vir.0.79967-0
   Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com
   Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09
   Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002
   Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278
   Prentoe J, 2011, VIROLOGY, V409, P148, DOI 10.1016/j.virol.2010.10.034
   Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104
   Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248
   Stapleford KA, 2011, J VIROL, V85, P1706, DOI 10.1128/JVI.02268-10
   Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005
   TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995
   Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032
   Tong YM, 2017, J VIROL, V91, DOI 10.1128/JVI.02468-16
   Tung P, 2011, J VIROL, V85, P1193, DOI 10.1128/JVI.01889-10
   Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000
   Yan Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02399-16
   Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06
   Yin CH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006834
NR 63
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2019
VL 15
IS 2
AR e1007163
DI 10.1371/journal.ppat.1007163
PG 24
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA HN1UI
UT WOS:000459972100001
PM 30730994
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chimelli, L
AF Chimelli, Leila
TI Neuropathology and neuropathogenesis of congenital Zika syndrome
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 19th International Congress of Neuropathology
CY SEP 23-27, 2018
CL Tokyo, JAPAN
C1 [Chimelli, Leila] State Inst Brain Paulo Niemeyer, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD FEB
PY 2019
VL 29
SU 1
SI SI
MA S7-3
BP 51
EP 51
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA HM9OP
UT WOS:000459814800154
DA 2020-07-08
ER

PT J
AU Beaufrere, A
   Bessieres, B
   Bonniere, M
   Therese, C
   Lecuit, M
   Nguyen, L
   Ville, Y
   Leruez-Ville, M
   Encha-Razavi, F
AF Beaufrere, Aurelie
   Bessieres, Bettina
   Bonniere, Maryse
   Therese, Couderc
   Lecuit, Marc
   Nguyen, Laurent
   Ville, Yves
   Leruez-Ville, Marianne
   Encha-Razavi, Ferechte
TI A neuropathological and neurobiological study of brain malformations
   observed in fetuses infected by the Zika virus
SO BRAIN PATHOLOGY
LA English
DT Meeting Abstract
CT 19th International Congress of Neuropathology
CY SEP 23-27, 2018
CL Tokyo, JAPAN
C1 [Beaufrere, Aurelie; Bessieres, Bettina; Bonniere, Maryse; Encha-Razavi, Ferechte] Hop Univ Necker Enfants Malad, AP HP, Embryofetopathol Unit, Paris, France.
   [Therese, Couderc; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France.
   [Therese, Couderc; Lecuit, Marc] INSERM, U1117, Paris, France.
   [Therese, Couderc; Lecuit, Marc] Ctr Infectiol Necker Pasteur, Paris, France.
   [Nguyen, Laurent] Univ Liege, GIGA Neurosci, Liege, Belgium.
   [Ville, Yves] Hop Univ Necker Enfants Malad, AP HP, Serv Gynecol Obstet, Paris, France.
   [Leruez-Ville, Marianne] Hop Univ Necker Enfants Malad, AP HP, Lab Virol, Paris, France.
RI Lecuit, Marc/J-4073-2013; Lecuit, Marc/M-4126-2019
OI Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD FEB
PY 2019
VL 29
SU 1
SI SI
MA P2-97
BP 101
EP 101
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA HM9OP
UT WOS:000459814800310
DA 2020-07-08
ER

PT J
AU Devnarain, N
   Soliman, MES
AF Devnarain, Nikita
   Soliman, Mahmoud E. S.
TI Molecular mechanism of resveratrol inhibition of Zika virus NS3
   helicase: behind the scenes
SO FUTURE VIROLOGY
LA English
DT Article
DE antiviral therapy; flavivirus; molecular dynamics; NS3 helicase;
   resveratrol; Zika virus
ID STRUCTURAL FEATURES; NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; SIMULATIONS;
   DOCKING; AMBER; BINDING
AB Aim: Zika virus (ZIKV) still poses a health risk to women and their babies without US FDA-approved vaccines or treatments. Experimentation has proved resveratrol inhibition of ZIKV NS3 helicase without specifying the molecular events during inhibition. Materials & methods: Herein, we leaped forward to study the molecular dynamics of the bound and unbound enzyme, identifying precise binding residues and interactions, and the enzyme's adaptation to support binding, since loop dynamics affect viral RNA replication. Results: Resveratrol stabilizes the P-loop and causes the RNA-binding loop to block the RNA-binding pocket for 200ns, which is concurrent with experimental evidence that resveratrol binding significantly reduces ATP hydrolysis activity. Conclusion: This study illuminates the structural dynamics of ZIKV helicase and druglikeness of resveratrol, which will advance anti-ZIKV drug development.
C1 [Devnarain, Nikita; Soliman, Mahmoud E. S.] Univ KwaZulu Natal, Sch Hlth Sci, Mol Biocomputat & Drug Design Lab, ZA-4001 Durban, South Africa.
RP Soliman, MES (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Mol Biocomputat & Drug Design Lab, ZA-4001 Durban, South Africa.
EM soliman@ukzn.ac.za
OI Devnarain, Nikita/0000-0002-9538-4611
FU German Academic Exchange Service (DAAD)Deutscher Akademischer Austausch
   Dienst (DAAD); National Research Foundation (NRF)
FX This work was financially supported by the German Academic Exchange
   Service (DAAD) and the National Research Foundation (NRF). Computational
   support was provided by the Centre for High Performance Computing (CHPC,
   http://www.chpc.ac.za).The authors have no other relevant affiliations
   or financial involvement with any organization or entity with a
   financial interest in or financial conflict with the subject matter or
   materials discussed in the manuscript apart from those disclosed.
CR Abba Y, 2015, ADV VIROL, V2015, DOI 10.1155/2015/184241
   Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067
   Bastianetto S, 2015, BBA-MOL BASIS DIS, V1852, P1195, DOI 10.1016/j.bbadis.2014.09.011
   Borriello A., 2017, RESVERATROL CANC PRE, V1, P97, DOI [10.3390/proceedings1100976, DOI 10.3390/PR0CEEDINGS1100976]
   Campagna M, 2010, BIOCHEM SOC T, V38, P50, DOI 10.1042/BST0380050
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Cele FN, 2016, DRUG DES DEV THER, V10, P1365, DOI 10.2147/DDDT.S95533
   Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717
   de Ruyck Jerome, 2016, Adv Appl Bioinform Chem, V9, P1, DOI 10.2147/AABC.S105289
   Devnarain N, 2018, CHEM BIOL DRUG DES, V92, P1838, DOI 10.1111/cbdd.13353
   Devnarain N, 2017, RSC ADV, V7, P47416, DOI 10.1039/c7ra05918c
   Dhama K, 2018, J EXP BIOL AGRIC SCI, V6, P1, DOI 10.18006/2018.6(1).1.31
   Fatima K, 2014, PLOS ONE, V9, P1
   Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936
   Ghosh D, 2018, CURR SCI INDIA, V114, P725
   Hausenblas HA, 2015, MOL NUTR FOOD RES, V59, P147, DOI 10.1002/mnfr.201400173
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lee JH, 2017, J BIOL CHEM, V292, P21011, DOI 10.1074/jbc.M117.810580
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Munir A, 2016, DRUG DES OPEN ACCESS, V5, P1
   Nandy A, 2017, EXPLOR RES HYPOTHESI, V2, P43
   Pan A, 2017, ACTA CRYSTALLOGR D, V73, P402, DOI 10.1107/S2059798317003849
   Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000
   Ryan S. J., 2019, BIORXIV, V13, P1, DOI DOI 10.1101/172221
   Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Sprenger KG, 2015, J PHYS CHEM B, V119, P5882, DOI 10.1021/acs.jpcb.5b00689
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Vanommeslaeghe K, 2014, CURR PHARM DESIGN, V20, P3281, DOI 10.2174/13816128113199990600
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang HQ, 2015, ANTIVIR RES, V113, P79, DOI 10.1016/j.antiviral.2014.11.005
   WANG JM, 2001, ABSTR PAP AM CHEM 1, V222
   Woods RJ, 2000, J MOL STRUC-THEOCHEM, V527, P149, DOI 10.1016/S0166-1280(00)00487-5
   Xia N, 2017, BRIT J PHARMACOL, V174, P1633, DOI 10.1111/bph.13492
   Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006
NR 44
TC 0
Z9 0
U1 1
U2 4
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD FEB
PY 2019
VL 14
IS 2
BP 73
EP 84
DI 10.2217/fvl-2018-0170
PG 12
WC Virology
SC Virology
GA HM8AM
UT WOS:000459700800004
DA 2020-07-08
ER

PT J
AU Watson-Brown, P
   Viennet, E
   Mincham, G
   Williams, CR
   Jansen, CC
   Montgomery, BL
   Flower, RLP
   Faddy, HM
AF Watson-Brown, Peter
   Viennet, Elvina
   Mincham, Gina
   Williams, Craig R.
   Jansen, Cassie C.
   Montgomery, Brian L.
   Flower, Robert L. P.
   Faddy, Helen M.
TI Epidemic potential of Zika virus in Australia: implications for blood
   transfusion safety
SO TRANSFUSION
LA English
DT Article
ID ROSS RIVER VIRUS; REPRODUCTION NUMBER; DENGUE; TRANSMISSION; INFECTION;
   OUTBREAK; DONORS; UNCERTAINTY; SENSITIVITY; ULTRAVIOLET
AB BACKGROUND: Zika virus (ZIKV) is transfusion-transmissible. In Australia the primary vector, Aedes aegypti, is established in the north-east, such that local transmission is possible following importation of an index case, which has the potential to impact on blood transfusion safety and public health. We estimated the basic reproduction number (R-0) to model the epidemic potential of ZIKV in Australian locations, compared this with the ecologically similar dengue viruses (DENV), and examined possible implications for blood transfusion safety.
   STUDY DESIGN AND METHODS: Varying estimates of vector control efficiency and extrinsic incubation period, "best-case" and "worst-case" scenarios of monthly R-0 for ZIKV and DENV were modeled from 1996 to 2015 in 11 areas. We visualized the geographical distribution of blood donors in relation to areas with epidemic potential for ZIKV.
   RESULTS: Epidemic potential (R-0 > 1) existed for ZIKV and DENV throughout the study period in a number of locations in northern Australia (Cairns, Darwin, Rockhampton, Thursday Island, Townsville, and Brisbane) during the warmer months of the year. R-0 for DENV was greater than ZIKV and was broadly consistent with annual estimates in Cairns. Increased vector control efficiency markedly reduced the epidemic potential and shortened the season of local transmission. Australian locations that provide the greatest number of blood donors did not have epidemic potential for ZIKV.
   CONCLUSION: We estimate that areas of northeastern Australia could sustain local transmission of ZIKV. This early contribution to understanding the epidemic potential of ZIKV may assist in the assessment and management of threats to blood transfusion safety.
C1 [Watson-Brown, Peter; Viennet, Elvina; Flower, Robert L. P.; Faddy, Helen M.] Australian Red Cross Blood Serv, Res & Dev, Kelvin Grove, Qld, Australia.
   [Watson-Brown, Peter; Faddy, Helen M.] Univ Queensland, Sch Med, Herston, Qld, Australia.
   [Mincham, Gina; Williams, Craig R.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia.
   [Jansen, Cassie C.] Queensland Hlth, Communicable Dis Branch, Dept Hlth, Herston, Qld, Australia.
   [Montgomery, Brian L.] Queensland Hlth, Metro South Publ Hlth Unit, Coopers Plains, Qld, Australia.
RP Viennet, E (corresponding author), 44 Musk Ave, Kelvin Grove, Qld 4059, Australia.
EM eviennet@redcrossblood.org.au
RI Viennet, Elvina/D-9032-2017; Viennet, Elvina/M-5818-2019; Jansen, Cassie
   C/C-1465-2009; Williams, Craig/A-1617-2011
OI Viennet, Elvina/0000-0002-1418-1426; Viennet,
   Elvina/0000-0002-1418-1426; Jansen, Cassie C/0000-0002-0655-2725; Faddy,
   Helen/0000-0002-3446-8248; Williams, Craig/0000-0002-4758-1506
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Australian Bureau of Statistics, 2012, CENS COMM PROF LOC
   Australian Government BoM, 2016, CLIM DAT ONL
   Australian Government Department of Health, SUMM INF OV ACQ VECT
   Australian Red Cross Blood Service, 2016, TRANSFUSION NEW 1212
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Crosetto M, 2000, AGR ECOSYST ENVIRON, V81, P71, DOI 10.1016/S0167-8809(00)00169-9
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faddy HM, 2018, TRANSFUSION, V58, P485, DOI 10.1111/trf.14472
   Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664
   Fitzsimmons GJ, 2010, COMMUN DIS INTELL, V34, P225
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   Fryk JJ, 2017, TRANSFUSION, V57, P2677, DOI 10.1111/trf.14256
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hanna JN, 2001, MED J AUSTRALIA, V174, P178, DOI 10.5694/j.1326-5377.2001.tb143213.x
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Jimenez A, 2017, TRANSFUSION, V57, P2077, DOI 10.1111/trf.14252
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Magnus Mariana Munari, 2018, Hematol., Transfus. Cell Ther., V40, P250, DOI 10.1016/j.htct.2018.01.011
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Marini G, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.37.30612
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Muzari MO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005286
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Queensland Health, 2015, QUEENSL DENG MAN PLA, P61
   R Core Team, 2017, R LANG ENV STAT COMP
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Rooks K, 2016, J BLOOD TRANSFUS, V2016, P6
   Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Trewin BJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005848
   U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 2018, REV REC RED RISK ZIK, P16
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Viennet E, 2016, PLOS CURR, V8
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Watson-Brown P, 2018, AUST NZ J PUBL HEAL, V42, P104, DOI 10.1111/1753-6405.12697
   Williams CR, 2008, J MED ENTOMOL, V45, P1173, DOI 10.1603/0022-2585(2008)45[1173:REOAAP]2.0.CO;2
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 73
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD FEB
PY 2019
VL 59
IS 2
BP 648
EP 658
DI 10.1111/trf.15095
PG 11
WC Hematology
SC Hematology
GA HM6UY
UT WOS:000459614500028
PM 30618208
OA Bronze
DA 2020-07-08
ER

PT J
AU Cardoso, TF
   dos Santos, RS
   Correa, RM
   Campos, JV
   Silva, RD
   Tobias, CC
   Prata-Barbosa, A
   da Cunha, AJLA
   Ferreira, HC
AF Cardoso, Taissa Ferreira
   dos Santos, Rosana Silva
   Correa, Raquel Miranda
   Campos, Juliana Vieira
   Silva, Ricardo de Bastos
   Tobias, Christine Castinheiras
   Prata-Barbosa, Arnaldo
   Ledo Alves da Cunha, Antonio Jose
   Ferreira, Halina Cidrini
TI Congenital Zika infection: neurology can occur without microcephaly
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Letter
C1 [Cardoso, Taissa Ferreira; Campos, Juliana Vieira] Univ Fed Rio de Janeiro, Maternidade Escola, Postgrad Program Perinatal Hlth Care, Rio de Janeiro, Brazil.
   [dos Santos, Rosana Silva; Ferreira, Halina Cidrini] Univ Fed Rio de Janeiro, Sch Med, Dept Phys Therapy, BR-21941913 Rio de Janeiro, RJ, Brazil.
   [dos Santos, Rosana Silva; Ferreira, Halina Cidrini] Univ Fed Rio de Janeiro, Maternidade Escola, Program Perinatal Hlth Care, Rio de Janeiro, Brazil.
   [Correa, Raquel Miranda; Tobias, Christine Castinheiras] Univ Fed Rio de Janeiro, Maternidade Escola, Rio de Janeiro, Brazil.
   [Silva, Ricardo de Bastos] Univ Fed Rio de Janeiro, Sch Med, Phys Therapy Course, Rio de Janeiro, Brazil.
   [Prata-Barbosa, Arnaldo; Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Sch Med, Dept Pediat, Rio de Janeiro, Brazil.
   [Prata-Barbosa, Arnaldo; Ledo Alves da Cunha, Antonio Jose] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
RP Ferreira, HC (corresponding author), Univ Fed Rio de Janeiro, Sch Med, Dept Phys Therapy, BR-21941913 Rio de Janeiro, RJ, Brazil.
EM halinacidrini@me.ufrj.br
RI da Cunha, Antonio Jose Ledo Alves/O-5914-2019; Prata-Barbosa,
   Arnaldo/B-2212-2009
OI da Cunha, Antonio Jose Ledo Alves/0000-0003-3592-1849; Prata-Barbosa,
   Arnaldo/0000-0002-4726-9782; Ferreira, Halina
   Cidrini/0000-0002-0111-5649
CR [Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182
   Marinho Penelope Saldanha, 2017, Matern Health Neonatol Perinatol, V3, P17, DOI 10.1186/s40748-017-0054-0
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   World Health Organization, CHILD GROWTH STAND H
   Yang H, 2012, EARLY HUM DEV, V88, P837, DOI 10.1016/j.earlhumdev.2012.06.004
NR 5
TC 5
Z9 5
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 1468-2044
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD FEB
PY 2019
VL 104
IS 2
BP 199
EP +
DI 10.1136/archdischild-2018-314782
PG 2
WC Pediatrics
SC Pediatrics
GA HM7DY
UT WOS:000459638700028
PM 29858269
DA 2020-07-08
ER

PT J
AU Lage, MLC
   de Carvalho, AL
   Ventura, PA
   Taguchi, TB
   Fernandes, AS
   Pinho, SF
   Santos, OT
   Ramos, CL
   Nascimento-Carvalho, CM
AF Lage, Maria-Lucia C.
   de Carvalho, Alessandra L.
   Ventura, Paloma A.
   Taguchi, Tania B.
   Fernandes, Adriana S.
   Pinho, Suely F.
   Santos-Junior, Onildo T.
   Ramos, Clara L.
   Nascimento-Carvalho, Cristiana M.
TI Clinical, Neuroimaging, and Neurophysiological Findings in Children with
   Microcephaly Related to Congenital Zika Virus Infection
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Zika virus; microcephaly; neuroimaging; neurologic examination
ID INFANTS; BRAZIL; STANDARDS; OUTBREAK; GROWTH; STATES; HEAD
AB Zika virus (ZIKV) infection appeared in Brazil in 2015, causing an epidemic outbreak with increased rates of microcephaly and other serious birth disorders. We reviewed 102 cases of children who were diagnosed with microcephaly at birth and who had gestational exposure to ZIKV during the outbreak. We describe the clinical, neuroimaging, and neurophysiological findings. Most mothers (81%) reported symptoms of ZIKV infection, especially cutaneous rash, during the first trimester of pregnancy. The microcephaly was severe in 54.9% of the cases. All infants presented with brain malformations. The most frequent neuroimaging findings were cerebral atrophy (92.1%), ventriculomegaly (92.1%), malformation of cortical development (85.1%), and cortical-subcortical calcifications (80.2%). Abnormalities in neurological exams were found in 97.0% of the cases, epileptogenic activity in 56.3%, and arthrogryposis in 10.8% of the infants. The sensorineural screening suggested hearing loss in 17.3% and visual impairment in 14.1% of the infants. This group of infants who presented with microcephaly and whose mothers were exposed to ZIKV early during pregnancy showed clinical and radiological criteria for congenital ZIKV infection. A high frequency of brain abnormalities and signs of early neurological disorders were found, and epileptogenic activity and signs of sensorineural alterations were common. This suggests that microcephaly can be associated with a worst spectrum of neurological manifestations.
C1 [Lage, Maria-Lucia C.; Nascimento-Carvalho, Cristiana M.] Univ Fed Bahia, Sch Med, Postgrad Programme Hlth Sci, Praca 15 Novembro Largo Terreiro de Jesus, BR-40025010 Salvador, BA, Brazil.
   [de Carvalho, Alessandra L.; Ventura, Paloma A.; Taguchi, Tania B.; Fernandes, Adriana S.; Pinho, Suely F.] SARAH Network Rehabil Hosp, Salvador Hosp, Pediat Rehabil Ctr, Ave Tancredo Neves, BR-41820900 Salvador, BA, Brazil.
   [Santos-Junior, Onildo T.] SARAH Network Rehabil Hosp, Salvador Hosp, Dept Diagnost Imaging, Ave Tancredo Neves, BR-41820900 Salvador, BA, Brazil.
   [Ramos, Clara L.] Bahiana Fdn Sci Dev, Bahiana Sch Med, Dom Joao 6, BR-40290000 Salvador, BA, Brazil.
   [Nascimento-Carvalho, Cristiana M.] Univ Fed Bahia, Sch Med, Dept Paediat, Praca 15 Novembro Largo Terreiro de Jesus, BR-40025010 Salvador, BA, Brazil.
RP Lage, MLC (corresponding author), Univ Fed Bahia, Sch Med, Postgrad Programme Hlth Sci, Praca 15 Novembro Largo Terreiro de Jesus, BR-40025010 Salvador, BA, Brazil.
EM marylulage@hotmail.com; 13110@sarah.br; 701064@sarah.br; 11786@sarah.br;
   400868@sarah.br; 701053@sarah.br; 700991@sarah.br; ccclr1@gmail.com;
   nascimentocarvalho@hotmail.com
OI Lage, Maria-Lucia Costa/0000-0001-5571-8640
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   de Franca TLB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091990
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Heath, MIN SAUD MIN SAUD DI
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC Zika and Pregnancy, CONG ZIK SYNDR OTH B
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dosman CF, 2012, PAED CHILD HEALT-CAN, V17, P561, DOI 10.1093/pch/17.10.561
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frenkel LD, 2018, EUR J CLIN MICROBIOL, V37, P209, DOI 10.1007/s10096-017-3111-8
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Oliveira J, 2018, AM J TROP MED HYG, V98, P1860, DOI 10.4269/ajtmh.17-1020
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Wood AM, 2018, CLIN PERINATOL, V45, P307, DOI 10.1016/j.clp.2018.01.005
NR 32
TC 3
Z9 3
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB 1
PY 2019
VL 16
IS 3
AR 309
DI 10.3390/ijerph16030309
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA HM0CQ
UT WOS:000459113600015
PM 30678125
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rossi, AD
   Faucz, FR
   Melo, A
   Pezzuto, P
   de Azevedo, GS
   Schamber-Reis, BLF
   Tavares, JS
   Mattapallil, JJ
   Tanuri, A
   Aguiar, RS
   Cardoso, CC
   Stratakis, CA
AF Rossi, A. D.
   Faucz, F. R.
   Melo, A.
   Pezzuto, P.
   de Azevedo, G. S.
   Schamber-Reis, B. L. F.
   Tavares, J. S.
   Mattapallil, J. J.
   Tanuri, A.
   Aguiar, R. S.
   Cardoso, C. C.
   Stratakis, C. A.
TI Variations in maternal adenylate cyclase genes are associated with
   congenital Zika syndrome in a cohort from Northeast, Brazil
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Article
DE congenital malformations; gene polymorphism; infectious disease;
   virology; zika
ID VIRUS; PATHOGENICITY; ROUTES
AB Background. Vertical transmission of Zika virus (ZIKV) is associated with congenital malformations but the mechanism of pathogenesis remains unclear. Although host genetics appear to play a role, no genetic association study has yet been performed to evaluate this question. In order to investigate if maternal genetic variation is associated with Congenital Zika Syndrome (CZS), we conducted a case-control study in a cohort of Brazilian women infected with ZIKV during pregnancy.
   Methods. A total of 100 women who reported symptoms of zika during pregnancy were enrolled and tested for ZIKV. Among 52 women positive for ZIKV infection, 28 were classified as cases and 24 as controls based on the presence or absence of CZS in their infants. Variations in the coding region of 205 candidate genes involved in cAMP signaling or immune response were assessed by high throughput sequencing and tested for association with development of CZS.
   Results. From the 817 single nucleotide variations (SNVs) included in association analyses, 22 SNVs in 17 genes were associated with CZS under an additive model (alpha=0.05). Variations c.319T>C (rs11676272) and c.1297G>A, located at ADCY3 and ADCY7 genes showed the most prominent effect. The association of ADCY3 and ADCY7 genes was confirmed using a Sequence Kernel Association Test to assess the joint effect of common and rare variations, and results were statistically significant after adjustment for multiple comparisons (P<0.002).
   Conclusion. These results suggest that maternal ADCY genes contribute to ZIKV pathogenicity and influence the outcome of CZS, being promising candidates for further replication studies and functional analysis.
C1 [Rossi, A. D.; Pezzuto, P.; Tanuri, A.; Aguiar, R. S.; Cardoso, C. C.] Univ Fed Rio de Janeiro, Inst Biol, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Faucz, F. R.; Stratakis, C. A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.
   [Melo, A.; de Azevedo, G. S.; Tavares, J. S.] Ctr Univ UniFacisa, Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Brazil.
   [Schamber-Reis, B. L. F.] Ctr Univ UniFacisa, Fac Ciencias Med Campina Grande, Nucleo Genet Med, Campina Grande, Brazil.
   [Mattapallil, J. J.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, F Edward Hebert Sch Med, Bethesda, MD USA.
RP Stratakis, CA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.; Cardoso, CC (corresponding author), Univ Fed Rio de Janeiro, Lab Virol Mol, Inst Biol, CCS, Av Carlos Chagas Filho 373,Bloco A,Sala 121, BR-21941902 Rio de Janeiro, RJ, Brazil.
EM stratakc@cc1.nichd.nih.gov; stratake@ccl.nichd.nih.gov
RI Faucz, Fabio R/C-1607-2009; Cardoso, Cynthia/K-5824-2012; Melo, Adriana
   S O/H-5650-2016; Stratakis, Constantine A./AAP-4745-2020; Aguiar, Renato
   S/G-3542-2015
OI Cardoso, Cynthia/0000-0003-0565-7047; Aguiar, Renato
   S/0000-0001-5180-3717
FU Intramural Research Program (IRP) of the Eunice Kennedy Shriver National
   Institute of Child Health and Human Development (NICHD) [Z1A HD008920];
   Uniformed Services University (USU) [R0739273]; National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [440900/2016-6];
   National Council for the Improvement of Higher Education (CAPES)CAPES
   [88881.130757/2016-01]
FX This work was supported by the following funds: Intramural Research
   Program (IRP) of the Eunice Kennedy Shriver National Institute of Child
   Health and Human Development (NICHD) to CAS (Project# Z1A HD008920),
   Uniformed Services University (USU) to JJM (grant# R0739273), National
   Council for Scientific and Technological Development (CNPq -grant #
   440900/2016-6) and National Council for the Improvement of Higher
   Education (CAPES -grant # 88881.130757/2016-01). The authors are
   indebted to the NICHD's IRP Molecular Genomics Core (Dr. Steven Coon,
   Dr. James Iben, and Dr. Li Tianwei). We also thank Biometrix Diagnostica
   for donating kits for serology tests.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08
   FREIREMAIA N, 1957, AM J HUM GENET, V9, P284
   Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045
   Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Klein M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00315
   Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007
   Lima-Costa MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09812
   McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688
   Moreno-Fernandez ME, 2011, BLOOD, V117, P5372, DOI 10.1182/blood-2010-12-323162
   Moretti C, 2002, TRENDS ENDOCRIN MET, V13, P428, DOI 10.1016/S1043-2760(02)00632-X
   Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nicol X, 2014, EUR J NEUROSCI, V39, P1742, DOI 10.1111/ejn.12543
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Olmos-Ortiz A, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12841
   Price AL, 2012, NATURE REV GENETICS, V11, P1
   Pulliainen AT, 2012, P NATL ACAD SCI USA, V109, P9581, DOI 10.1073/pnas.1117651109
   Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703
   Riva L, 2018, J VIROL, V92, DOI 10.1128/JVI.01982-17
   Santos S, 2014, J COMMUN GENET, V5, P199, DOI 10.1007/s12687-013-0174-9
   Schanton M, 2018, REPRODUCTION, V155, pR1, DOI 10.1530/REP-17-0512
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Truttmann MC, 2017, TRENDS CELL BIOL, V27, P608, DOI 10.1016/j.tcb.2017.03.004
   Vaser R, 2009, NAT PROTOC, V4, P1073
   Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weedon-Fekjraer MS, 2012, PLACENTA, V33, pS87, DOI 10.1016/j.placenta.2011.11.003
   Weller M, 2012, AM J HUM BIOL, V24, P835, DOI 10.1002/ajhb.22328
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhang XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19361
NR 47
TC 4
Z9 4
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD FEB
PY 2019
VL 285
IS 2
BP 215
EP 222
DI 10.1111/joim.12829
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA HM6IK
UT WOS:000459577200006
PM 30222212
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Bradshaw, MJ
   Venkatesan, A
AF Bradshaw, Michael J.
   Venkatesan, Arun
TI Emergency Evaluation and Management of Encephalitis and Myelitis in
   Adults
SO SEMINARS IN NEUROLOGY
LA English
DT Article
DE meningitis; encephalitis; myelitis; infectious; emergency
ID HERPES-SIMPLEX ENCEPHALITIS; MOUNTAIN-SPOTTED-FEVER; CLINICAL-PRACTICE
   GUIDELINES; INFECTIOUS-DISEASES-SOCIETY; POLYMERASE-CHAIN-REACTION;
   SPINAL EPIDURAL ABSCESS; NILE-VIRUS-INFECTION; D-ASPARTATE RECEPTOR;
   ZIKA VIRUS; NEUROLOGIC COMPLICATIONS
AB Infection of the central nervous system is often a life-threatening emergency. In many cases, the clinician faces an unknown pathogen and must rely upon clinical acumen and a thorough, systematic diagnostic investigation to establish a diagnosis and initiate appropriate treatment. Because patients typically present with a syndrome, such as temporal lobe encephalitis, rather than a known pathogen (e.g., herpes simplex virus 1 encephalitis), we describe diagnostic considerations in the context of their neuroanatomic tropisms and patterns of disease. This paradigm reflects the challenges clinicians face; however, tropisms are not absolute, patterns of disease are not specific, and this approach does not obviate the need for empirical treatment while a systematic diagnostic investigation is underway. Specific treatment is available for many infectious agents, including bacterial, fungal, and parasitic pathogens, as well as the herpesviruses. In cases with no specific treatment, clinicians must strive to establish the diagnosis (and thereby spare unneeded treatment), anticipate and recognize complications and pitfalls, and initiate appropriate supportive care, all of which are best achieved with a well-prepared multidisciplinary team.
C1 [Bradshaw, Michael J.] Rosalind Franklin Univ Med & Sci, Billings Clin, Dept Neurol, Chicago Med Sch, Billings, MT USA.
   [Venkatesan, Arun] Johns Hopkins Univ, Sch Med, Dept Neurol, Div Neuroimmunol & Neuroinfectious Dis, Baltimore, MD 21205 USA.
RP Bradshaw, MJ (corresponding author), Billings Clin, 801 N 29th St, Billings, MT 59101 USA.
EM bradshaw.michaelj@gmail.com
CR Aguilar J, 2010, MEDICINE, V89, P117, DOI 10.1097/MD.0b013e3181d5453d
   Ali M, 2005, AM J NEURORADIOL, V26, P289
   Andrade P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-149
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Armangue T, 2018, LANCET NEUROL, V17, P760, DOI 10.1016/S1474-4422(18)30244-8
   Armangue T, 2015, NEUROLOGY, V85, P1736, DOI 10.1212/WNL.0000000000002125
   ARMSTRONG RW, 1993, CLIN INFECT DIS, V16, P689, DOI 10.1093/clind/16.5.689
   Asztely F, 2012, ACTA NEUROL SCAND, V126, P365, DOI 10.1111/j.1600-0404.2012.01691.x
   BAGANZ MD, 1995, AM J NEURORADIOL, V16, P919
   Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499
   BARTHEZCARPENTIER MA, 1995, J CHILD NEUROL, V10, P363, DOI 10.1177/088307389501000504
   Beattie GC, 2013, CLIN INFECT DIS, V56, P825, DOI 10.1093/cid/cis990
   Birnbaum J, 2009, ARTHRITIS RHEUM-US, V60, P3378, DOI 10.1002/art.24937
   Bradshaw M, 2016, NEUROLOGY, V86
   Bradshaw MJ, 2018, SEMIN NEUROL, V38, P330, DOI 10.1055/s-0038-1660821
   Bradshaw MJ, 2017, RHEUM DIS CLIN N AM, V43, P607, DOI 10.1016/j.rdc.2017.06.009
   Bradshaw MJ, 2017, NEUROLOGY, V88, pE92, DOI 10.1212/WNL.0000000000003722
   Bradshaw MJ, 2016, NEUROLOGY, V87, pE61, DOI 10.1212/WNL.0000000000002981
   Bradshaw MJ, 2016, NEUROTHERAPEUTICS, V13, P493, DOI 10.1007/s13311-016-0433-7
   Bradshaw MJ, 2015, NEUROLOGY, V85, P2176, DOI 10.1212/WNL.0000000000002218
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297
   CESARIO TC, 1969, AM J EPIDEMIOL, V90, P416, DOI 10.1093/oxfordjournals.aje.a121087
   Chilver-Stainer L, 2009, NEUROLOGY, V72, P673, DOI 10.1212/01.wnl.0000342460.07764.5c
   Cho Tracey A, 2018, Continuum (Minneap Minn), V24, P386, DOI 10.1212/CON.0000000000000583
   Chow FC, 2015, CLIN INFECT DIS, V60, P1377, DOI 10.1093/cid/civ051
   Curry WT, 2005, SURG NEUROL, V63, P364, DOI 10.1016/j.surneu.2004.08.081
   Dahlgren FS, 2012, AM J TROP MED HYG, V86, P713, DOI 10.4269/ajtmh.2012.11-0453
   de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334
   De Tiege X, 2003, NEUROLOGY, V61, P241, DOI 10.1212/01.WNL.0000073985.71759.7C
   DeFroda SF, 2016, J HOSP MED, V11, P130, DOI 10.1002/jhm.2506
   Demel SL, 2015, NEUROHOSPITALIST, V5, P142, DOI 10.1177/1941874415583847
   Dubey D, 2018, ANN NEUROL, V83, P166, DOI 10.1002/ana.25131
   Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446
   Eberhardt O, 2004, NEUROLOGY, V63, P758, DOI 10.1212/01.WNL.0000134652.51657.10
   FARRELL VJ, 1990, SURG NEUROL, V34, P383, DOI 10.1016/0090-3019(90)90241-G
   Ferrari TCA, 2008, ACTA TROP, V108, P89, DOI 10.1016/j.actatropica.2008.04.007
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Flanagan EP, 2016, ANN NEUROL, V79, P437, DOI 10.1002/ana.24582
   Gable MS, 2012, CLIN INFECT DIS, V54, P899, DOI 10.1093/cid/cir1038
   Garg RK, 2015, SPINAL CORD, V53, P649, DOI 10.1038/sc.2015.58
   Garg RK, 2010, ACTA NEUROL SCAND, V122, P75, DOI 10.1111/j.1600-0404.2009.01316.x
   George BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104169
   Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330
   Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48
   Gnann JW, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0568-7
   Granerod J, 2016, CLIN RADIOL, V71, P1050, DOI 10.1016/j.crad.2016.03.015
   Granerod J, 2010, NEUROLOGY, V75, P924, DOI 10.1212/WNL.0b013e3181f11d65
   Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X
   Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9
   Grill Marie F, 2018, Continuum (Minneap Minn), V24, P441, DOI 10.1212/CON.0000000000000597
   Halperin JJ, 2007, NEUROLOGY, V69, P91, DOI 10.1212/01.wnl.0000265517.66976.28
   Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248
   Hawkes MA, 2018, CRIT CARE MED, V46, pE955, DOI 10.1097/CCM.0000000000003257
   He DM, 2014, NEUROL INDIA, V62, P89, DOI 10.4103/0028-3886.128347
   HELMICK CG, 1984, J INFECT DIS, V150, P480, DOI 10.1093/infdis/150.4.480
   Hernandez Rosa Delia Delgado, 2014, Top Magn Reson Imaging, V23, P191, DOI 10.1097/RMR.0000000000000026
   Hjalmarsson A, 2007, CLIN INFECT DIS, V45, P875, DOI 10.1086/521262
   Houten JK, 2008, J NEUROSURG-SPINE, V9, P237, DOI 10.3171/SPI/2008/9/9/237
   Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302
   ILLIS LS, 1972, LANCET, V1, P718
   Ito Y, 2000, CLIN INFECT DIS, V30, P185, DOI 10.1086/313618
   Jackson AC, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0540-y
   Kayaaslan Bircan Unal, 2009, Int J Infect Dis, V13, pe65, DOI 10.1016/j.ijid.2008.06.026
   Kempthorne JT, 2009, J CLIN NEUROSCI, V16, P1038, DOI 10.1016/j.jocn.2008.10.019
   KIRK JL, 1990, MEDICINE, V69, P35, DOI 10.1097/00005792-199001000-00003
   KIRKLAND KB, 1993, CLIN INFECT DIS, V16, P629, DOI 10.1093/clind/16.5.629
   Kirshner HS, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0572-y
   KOCEN RS, 1970, Q J MED, V39, P17
   Krupa K, 2015, POL J RADIOL, V80, P93, DOI 10.12659/PJR.892628
   LAKEMAN FD, 1995, J INFECT DIS, V171, P857, DOI 10.1093/infdis/171.4.857
   Lillie RD, 1931, PUBLIC HEALTH REP, V46, P2840, DOI 10.2307/4580261
   Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419
   Majed M, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000231
   Majid A, 2002, BRAIN, V125, P159, DOI 10.1093/brain/awf010
   Marques Adriana R, 2015, Continuum (Minneap Minn), V21, P1729, DOI 10.1212/CON.0000000000000252
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0
   Miller S, 2013, J NEUROVIROL, V19, P166, DOI 10.1007/s13365-013-0158-x
   Misra UK, 2010, ACTA TROP, V116, P206, DOI 10.1016/j.actatropica.2010.08.007
   Mohammad SS, 2014, MOVEMENT DISORD, V29, P117, DOI 10.1002/mds.25623
   Moragas M, 2011, MEDICINE, V90, P256, DOI 10.1097/MD.0b013e318224b5af
   Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Neves FS, 2013, CLIN EXP RHEUMATOL, V31, pS133
   Novy J, 2006, ARCH NEUROL-CHICAGO, V63, P1113, DOI 10.1001/archneur.63.8.1113
   Onder H, 2015, SPINE J, V15, P1689, DOI 10.1016/j.spinee.2015.03.002
   Oyanguren B, 2013, EUR J NEUROL, V20, P1566, DOI 10.1111/ene.12249
   Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2
   Patel AR, 2014, SPINE J, V14, P326, DOI 10.1016/j.spinee.2013.10.046
   Paules CI, 2018, NEW ENGL J MED, V379, P701, DOI 10.1056/NEJMp1807870
   Pearce JMS, 2005, EUR NEUROL, V53, P208, DOI 10.1159/000086731
   Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858
   Piantadosi A, 2016, CLIN INFECT DIS, V62, P707, DOI 10.1093/cid/civ1005
   Pons-Salort M, 2018, P NATL ACAD SCI USA, V115, P3078, DOI 10.1073/pnas.1721159115
   Prasad K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub3
   Reihsaus E, 2000, NEUROSURG REV, V23, P175, DOI 10.1007/PL00011954
   Renard D, 2015, J NEUROL, V262, P2101, DOI 10.1007/s00415-015-7818-0
   Roos KL., 2015, NEUROINFECT DIS, V21, P1679
   Salgado P, 1997, ARCH INTERN MED, V157, P1991, DOI 10.1001/archinte.157.17.1991
   Savoldi F, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000355
   Sawlani V, 2009, J NEUROL SCI, V287, P221, DOI 10.1016/j.jns.2009.07.010
   Scheld WM, 2002, J INFECT DIS, V186, pS225, DOI 10.1086/344939
   Schleede L, 2013, J CHILD NEUROL, V28, P321, DOI 10.1177/0883073812471428
   Schmitt SE, 2012, NEUROLOGY, V79, P1094, DOI 10.1212/WNL.0b013e3182698cd8
   SCHROTH G, 1987, NEUROLOGY, V37, P179, DOI 10.1212/WNL.37.2.179
   Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991
   Sili U, 2014, J CLIN VIROL, V60, P112, DOI 10.1016/j.jcv.2014.03.010
   Singh TD, 2015, NEUROLOGY, V84, P359, DOI 10.1212/WNL.0000000000001190
   SKOLDENBERG B, 1984, LANCET, V2, P707
   Stahl JP, 2012, EPIDEMIOL INFECT, V140, P372, DOI 10.1017/S0950268811000483
   Steiner I, 2012, EUR J NEUROL, V19, P1278, DOI 10.1111/j.1468-1331.2012.03808.x
   Sutter R, 2015, CLIN NEUROPHYSIOL, V126, P1524, DOI 10.1016/j.clinph.2014.11.006
   Taber KH, 1998, RADIOGRAPHICS, V18, P1499, DOI 10.1148/radiographics.18.6.9821197
   Takahashi Teruyuki, 2012, Tuberc Res Treat, V2012, P831292, DOI 10.1155/2012/831292
   Talbott JF, 2016, SEMIN ULTRASOUND CT, V37, P411, DOI 10.1053/j.sult.2016.05.006
   Tali ET, 2015, NEUROIMAG CLIN N AM, V25, P193, DOI 10.1016/j.nic.2015.01.003
   Tan IL, 2013, J NEUROL, V260, P2312, DOI 10.1007/s00415-013-6986-z
   Thakur KT, 2013, NEUROLOGY, V81, P793, DOI 10.1212/WNL.0b013e3182a2cc6d
   Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6
   Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1
   Tselis AC, 2014, HAND CLINIC, V123, P307, DOI 10.1016/B978-0-444-53488-0.00014-6
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368
   Tuzun E, 2007, NEUROLOGIST, V13, P261, DOI 10.1097/NRL.0b013e31813e34a5
   Vaish A K, 2011, BMJ CASE REP, V2011
   van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Venkatesan A, 2014, NEUROL CLIN PRACT, V4, P206, DOI DOI 10.1212/CPJ.0000000000000036
   Venkatesan A, 2015, CURR OPIN NEUROL, V28, P277, DOI 10.1097/WCO.0000000000000199
   Wasay M, 2008, CLIN NEUROL NEUROSUR, V110, P635, DOI 10.1016/j.clineuro.2008.03.011
   Weil AA, 2002, CLIN INFECT DIS, V34, P1154, DOI 10.1086/339550
   Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X
   WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303
   Wildemann B, 1997, NEUROLOGY, V48, P1341, DOI 10.1212/WNL.48.5.1341
   WILSON LB, 1979, REV INFECT DIS, V1, P540
   Yoon SH, 2010, EUR SPINE J, V19, P575, DOI 10.1007/s00586-009-1216-1
   Zalewski NL, 2016, NEUROLOGY, V87, P743, DOI 10.1212/WNL.0000000000002992
   Zou SMA, 2010, J INFECT DIS, V202, P1354, DOI 10.1086/656602
NR 139
TC 2
Z9 2
U1 0
U2 3
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0271-8235
EI 1098-9021
J9 SEMIN NEUROL
JI Semin. Neurol.
PD FEB
PY 2019
VL 39
IS 1
BP 82
EP 101
DI 10.1055/s-0038-1676845
PG 20
WC Clinical Neurology
SC Neurosciences & Neurology
GA HL9CY
UT WOS:000459041400010
PM 30743295
DA 2020-07-08
ER

PT J
AU Parry, R
   Bishop, C
   De Hayr, L
   Asgari, S
AF Parry, Rhys
   Bishop, Cameron
   De Hayr, Lachlan
   Asgari, Sassan
TI Density-dependent enhanced replication of a densovirus in
   Wolbachia-infected Aedes cells is associated with production of piRNAs
   and higher virus-derived siRNAs
SO VIROLOGY
LA English
DT Article
DE Wolbachia; Densovirus; Aedes aegypti; Aedes albopictus; piRNA; RNAi;
   Short interfering RNA; Mosquito
ID COMPLETE NUCLEOTIDE-SEQUENCE; ALBOPICTUS PARVOVIRUS AAPV;
   DOUBLE-STRANDED-RNA; ANTIVIRAL PROTECTION; GENOMIC ORGANIZATION;
   IRIDOVIRUS DISEASE; AEGYPTI MOSQUITOS; BLOCKS DENGUE; ZIKA VIRUS; DNA
AB The endosymbiotic bacterium Wolbachia pipientis has been shown to restrict a range of RNA viruses in Drosophila melanogaster and transinfected dengue mosquito, Aedes aegypti. Here, we show that Wolbachia infection enhances replication of Aedes albopictus densovirus (AalDNV-1), a single stranded DNA virus, in Aedes cell lines in a density-dependent manner. Analysis of previously produced small RNAs of Aag2 cells showed that Wolbachia-infected cells produced greater absolute abundance of virus-derived short interfering RNAs compared to uninfected cells. Additionally, we found production of virus-derived PIWI-like RNAs (vpiRNA) produced in response to AalDNV-1 infection. Nuclear fractions of Aag2 cells produced a primary vpiRNA signature U-1 bias whereas the typical "ping-pong" signature (U-1 - A(10) ) was evident in vpiRNAs from the cytoplasmic fractions. This is the first report of the density-dependent enhancement of DNA viruses by Wolbachia. Further, we report the generation of vpiRNAs in a DNA virus-host interaction for the first time.
C1 [Parry, Rhys; Bishop, Cameron; De Hayr, Lachlan; Asgari, Sassan] Univ Queensland, Sch Biol Sci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.
RP Asgari, S (corresponding author), Univ Queensland, Sch Biol Sci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.
EM s.asgari@uq.edu.au
RI Parry, Rhys/L-5804-2019; Asgari, Sassan/G-2678-2011
OI Parry, Rhys/0000-0001-9238-1952; Asgari, Sassan/0000-0001-7885-6544; De
   Hayr, Lachlan/0000-0001-7852-2800
FU Australian Research CouncilAustralian Research Council [DP150101782];
   University of Queensland scholarship
FX The authors would like to acknowledge Dr. Karyn Johnson and Hugo Perdomo
   Contreras for their valuable insight and discussions. Erica Ward for
   proofreading and suggestions for improving the structure of the
   document. We thank Dr. Gareth Price and Dr. Igor Makunin from the
   University of Queensland for interpretation of the PacBIO sequencing
   analysis. Additionally, we want to thank the two anonymous reviewers for
   suggestions on improving the manuscript. Funding: This project was
   funded by the Australian Research Council (grant number DP150101782) to
   SA and a University of Queensland scholarship to RP.
CR Afanasiev BN, 1999, VIROLOGY, V257, P62, DOI 10.1006/viro.1999.9621
   AFANASIEV BN, 1991, VIROLOGY, V185, P323, DOI 10.1016/0042-6822(91)90780-F
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Asad S, 2018, INSECT BIOCHEM MOLEC, V92, P45, DOI 10.1016/j.ibmb.2017.11.008
   Barreau C, 1996, J INVERTEBR PATHOL, V68, P299, DOI 10.1006/jipa.1996.0100
   Barreau C, 1997, AM J TROP MED HYG, V57, P126, DOI 10.4269/ajtmh.1997.57.126
   Becnel JJ, 2011, J INVERTEBR PATHOL, V108, P40, DOI 10.1016/j.jip.2011.06.008
   Bergoin M, 2010, INSECT VIROLOGY, P59
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   BOUBLIK Y, 1994, VIROLOGY, V200, P752, DOI 10.1006/viro.1994.1239
   Bouyer J, 2016, LANCET GLOB HEALTH, V4, pE364, DOI 10.1016/S2214-109X(16)00082-6
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brennan LJ, 2012, INSECT MOL BIOL, V21, P510, DOI 10.1111/j.1365-2583.2012.01155.x
   Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109
   BUCHATSKY LP, 1997, DENSONUCLEOSIS BLOOD
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chen SX, 2004, VIROLOGY, V318, P123, DOI 10.1016/j.virol.2003.09.013
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   de Valdez MRW, 2010, J MED ENTOMOL, V47, P392, DOI 10.1603/ME09157
   Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986
   FAUST EA, 1979, J VIROL, V32, P276, DOI 10.1128/JVI.32.1.276-292.1979
   Barletta ABF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-148
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Gloria-Soria A, 2018, J MED ENTOMOL, V55, P1354, DOI 10.1093/jme/tjy084
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Graham RI, 2012, ECOL LETT, V15, P993, DOI 10.1111/j.1461-0248.2012.01820.x
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hristov G, 2010, J VIROL, V84, P5909, DOI 10.1128/JVI.01797-09
   Hussain M, 2016, ADV INSECT PHYSIOL, V51, P189, DOI 10.1016/bs.aiip.2016.04.001
   Hussain M, 2008, J VIROL, V82, P9164, DOI 10.1128/JVI.01109-08
   Hussain M, 2013, RNA BIOL, V10, P1868, DOI 10.4161/rna.27392
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Hussain M, 2010, J VIROL, V84, P612, DOI 10.1128/JVI.01794-09
   Ishizu H, 2015, CELL REP, V12, P429, DOI 10.1016/j.celrep.2015.06.035
   Iturbe-Ormaetxe I, 2011, J MICROBIOL METH, V84, P134, DOI 10.1016/j.mimet.2010.10.019
   Jayachandran B, 2012, J VIROL, V86, P13729, DOI 10.1128/JVI.02041-12
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x
   Johnson RM, 2018, CURR OPIN INSECT SCI, V28, P90, DOI 10.1016/j.cois.2018.05.009
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   JOUSSET FX, 1993, VIRUS RES, V29, P99, DOI 10.1016/0168-1702(93)90052-O
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Karamipour N, 2018, INSECT BIOCHEM MOLEC, V101, P24, DOI 10.1016/j.ibmb.2018.07.004
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kittayapong P, 1999, AM J TROP MED HYG, V61, P612, DOI 10.4269/ajtmh.1999.61.612
   Ledermann JP, 2004, J ECON ENTOMOL, V97, P1828, DOI 10.1603/0022-0493-97.6.1828
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Marina CF, 2003, MED VET ENTOMOL, V17, P187, DOI 10.1046/j.1365-2915.2003.00422.x
   Marina CF, 1999, OECOLOGIA, V119, P383, DOI 10.1007/s004420050799
   Maringer K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3432-5
   Martinez J, 2017, MOL ECOL, V26, P4072, DOI 10.1111/mec.14164
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Mayoral JG, 2014, P NATL ACAD SCI USA, V111, P18721, DOI 10.1073/pnas.1420131112
   Mayoral JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096107
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067
   ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Mosimann ALP, 2011, MEM I OSWALDO CRUZ, V106, P285, DOI 10.1590/S0074-02762011000300006
   Parry R, 2018, J VIROL, V92, DOI [10.1128/JVI.00224-18, 10.1128/jvi.00224-18]
   Paterson A, 2005, VIROLOGY, V337, P253, DOI 10.1016/j.virol.2005.04.037
   PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6
   Poirier EZ, 2018, CELL HOST MICROBE, V23, P353, DOI 10.1016/j.chom.2018.02.001
   Pudney M., 1979, TCA (TISSUE CULTURE ASSOCIATION) MANUAL, V5, P997, DOI 10.1007/BF00919719
   Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135
   Ridley AW, 2016, J ECON ENTOMOL, V109, P2561, DOI 10.1093/jee/tow226
   Roekring S, 2006, DEV COMP IMMUNOL, V30, P878, DOI 10.1016/j.dci.2005.12.006
   Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102
   SINGH KRP, 1967, CURR SCI INDIA, V36, P506
   SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154
   Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Varjak M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00144-17, 10.1128/msphere.00144-17]
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang Y., 2018, VIRUSES, V10, pE213
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Wong ZS, 2015, APPL ENVIRON MICROB, V81, P3001, DOI 10.1128/AEM.03847-14
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
NR 107
TC 4
Z9 4
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD FEB
PY 2019
VL 528
BP 89
EP 100
DI 10.1016/j.virol.2018.12.006
PG 12
WC Virology
SC Virology
GA HM5PA
UT WOS:000459526400011
PM 30583288
OA Bronze
DA 2020-07-08
ER

PT J
AU Fang, JN
   Jing, XP
   Lu, GL
   Xu, Y
   Gong, P
AF Fang, Junnan
   Jing, Xuping
   Lu, Guoliang
   Xu, Yi
   Gong, Peng
TI Crystallographic Snapshots of the Zika Virus NS3 Helicase Help Visualize
   the Reactant Water Replenishment
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE flavivirus; Zika virus; NS3 helicase; ATP hydrolysis; reactant water
ID STRUCTURAL BASIS; RNA; MECHANISM; TRANSLOCATION; SOFTWARE; INSIGHTS
AB Zika virus (ZIKV), a positive-strand RNA virus belonging to the Flavivirus genus, has become an urgent public health concern since recent outbreaks worldwide. Its genome replication is facilitated by the viral NS3 protein bearing helicase function. The NS3 helicase uses energy derived from adenosine triphosphate (ATP) hydrolysis to unwind RNA duplexed regions. Structural studies of the flavivirus NS3 helicases have suggested a conserved mechanism of ATP hydrolysis. However, the process of the reactant water replenishment, a key part of the hydrolysis cycle, remains elusive. Here, we report two high-resolution crystal structures of ZIKV NS3 helicase in complex with adenosine diphosphate (ADP) and Mn2+, one with the reactant water already loaded as previously observed and the other with the water molecule still in a loading state. These data suggest that the reactant water replenishment can occur between the release of phosphate and the release of ADP and improves the structural basis of the NS3 ATP hydrolysis cycle.
C1 [Fang, Junnan; Xu, Yi; Gong, Peng] Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, Joint Ctr Translat Precis Med, 318 Renminzhonglu, Guangzhou 510623, Guangdong, Peoples R China.
   [Fang, Junnan; Xu, Yi; Gong, Peng] Chinese Acad Sci, Wuhan Inst Virol, Joint Ctr Translat Precis Med, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.
   [Jing, Xuping; Lu, Guoliang; Gong, Peng] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.
   [Jing, Xuping; Lu, Guoliang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Xu, Y; Gong, P (corresponding author), Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, Joint Ctr Translat Precis Med, 318 Renminzhonglu, Guangzhou 510623, Guangdong, Peoples R China.; Xu, Y; Gong, P (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Joint Ctr Translat Precis Med, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.; Gong, P (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.
EM xuyi70@163.com; gongpeng@wh.iov.cn
OI Jing, Xuping/0000-0003-4193-2210; ?, ?/0000-0002-8264-7523
FU National Key Research and Development Program of China [2016YFC1200400,
   2018YFA0507200]; Science and Technology Program of Guangzhou, China
   [2014Y2-00197]; Natural Science Foundation of Guangdong Province,
   ChinaNational Natural Science Foundation of Guangdong Province
   [2016A030310249]; Natural Science Foundation of Hubei Province,
   ChinaNatural Science Foundation of Hubei Province [ZRMS2017001469];
   "One-Three-Five" Strategic Programs, Wuhan Institute of Virology,
   Chinese Academy of Sciences, China [Y605191SA1]; Advanced Customer
   Cultivation Project of Wuhan National Biosafety Laboratory, Chinese
   Academy of Sciences, China [2018ACCP-MS06]
FX We thank Dr. Bo Zhang for providing the DNA clone of the ZIKV Strain
   MR766 as the cloning material for generating the ZIKV NS3_Hel expression
   plasmid and the Shanghai Synchrotron Radiation Facility (SSRF, beamline
   BL17U1) for access to the beamline. This work was supported by the
   National Key Research and Development Program of China (2016YFC1200400,
   2018YFA0507200), the Science and Technology Program of Guangzhou, China
   (2014Y2-00197), the Natural Science Foundation of Guangdong Province,
   China (2016A030310249), the Natural Science Foundation of Hubei
   Province, China (ZRMS2017001469), the "One-Three-Five" Strategic
   Programs, Wuhan Institute of Virology, Chinese Academy of Sciences,
   China (Y605191SA1), and the Advanced Customer Cultivation Project of
   Wuhan National Biosafety Laboratory, Chinese Academy of Sciences, China
   (2018ACCP-MS06).
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Basu RS, 2013, J BIOL CHEM, V288, P3305, DOI 10.1074/jbc.M112.387712
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Bukrejewska M, 2017, ACTA CRYSTALLOGR D, V73, P767, DOI 10.1107/S2059798317010737
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645
   Davidson RB, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006103
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   KOONIN EV, 1991, NATURE, V352, P290, DOI 10.1038/352290c0
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li L, 2018, ACTA CRYSTALLOGR F, V74, P205, DOI 10.1107/S2053230X18003813
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mancini EJ, 2007, PROTEIN SCI, V16, P2294, DOI 10.1110/ps.072843107
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334
   Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908
   Shu B, 2016, P NATL ACAD SCI USA, V113, pE4005, DOI 10.1073/pnas.1602591113
   Sitzmann M, 2012, J CHEM INF MODEL, V52, P739, DOI 10.1021/ci200595n
   Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018
   Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 33
TC 2
Z9 3
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD FEB
PY 2019
VL 5
IS 2
BP 177
EP 183
DI 10.1021/acsinfecdis.8b00214
PG 13
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA HL7QW
UT WOS:000458937100003
PM 30672289
DA 2020-07-08
ER

PT J
AU Nitsche, C
   Passioura, T
   Varava, P
   Mahawaththa, MC
   Leuthold, MM
   Klein, CD
   Suga, H
   Otting, G
AF Nitsche, Christoph
   Passioura, Toby
   Varava, Paul
   Mahawaththa, Mithun C.
   Leuthold, Mila M.
   Klein, Christian D.
   Suga, Hiroaki
   Otting, Gottfried
TI De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive
   Inhibitors of the Zika Virus NS2B-NS3 Protease
SO ACS MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Flavivirus; macrocyclic peptides; protease inhibitors; noncanonical
   amino acids; display screening
ID ALLOSTERIC INHIBITION; MEDICINAL CHEMISTRY; CRYSTAL-STRUCTURE; HYBRIDS;
   POTENT
AB The Zika virus presents a major public health concern due to severe fetal neurological disorders associated with infections in pregnant women. In addition to vaccine development, the discovery of selective antiviral drugs is essential to combat future epidemic Zika virus outbreaks. The Zika virus NS2B-NS3 protease, which performs replication-critical cleavages of the viral polyprotein, is a promising drug target. We report the first macrocyclic peptide-based inhibitors of the NS2B-NS3 protease, discovered de novo through in vitro display screening of a genetically reprogrammed library including noncanonical residues. Six compounds were selected, resynthesized, and isolated, all of which displayed affinities in the low nanomolar concentration range. Five compounds showed significant protease inhibition. Two of these were validated as hits with submicromolar inhibition constants and selectivity toward Zika over the related proteases from dengue and West Nile viruses. The compounds were characterized as noncompetitive inhibitors, suggesting allosteric inhibition.
C1 [Nitsche, Christoph; Mahawaththa, Mithun C.; Otting, Gottfried] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
   [Passioura, Toby; Varava, Paul; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo 1130033, Japan.
   [Leuthold, Mila M.; Klein, Christian D.] Heidelberg Univ, IPMB, Med Chem, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
RP Nitsche, C (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.; Suga, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Chem, Tokyo 1130033, Japan.
EM christoph.nitsche@anu.edu.au; hsuga@chem.s.u-tolcyo.ac.jp
RI Don, Mithun Mahawaththage/N-9503-2019; Klein, Christian/G-1336-2010;
   amsalu, ribka/G-8780-2019; Otting, Gottfried/H-8413-2014
OI Passioura, Toby/0000-0002-6089-5067; Otting,
   Gottfried/0000-0002-0563-0146; Klein, Christian/0000-0003-3522-9182;
   Suga, Hiroaki/0000-0002-5298-9186
FU Alexander von Humboldt FoundationAlexander von Humboldt Foundation;
   Australian Research CouncilAustralian Research Council; Laureate
   Fellowship; CREST for Molecular Technologies, JST; JSPS KAKENHIMinistry
   of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [16H06444, 26220204]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [KL-1356/3-2]
FX C.N. thanks the Alexander von Humboldt Foundation for a Feodor Lynen
   Research Fellowship. Financial support by the Australian Research
   Council, including a Laureate Fellowship for G.O. is gratefully
   acknowledged. This work was also partially supported by CREST for
   Molecular Technologies, JST, and JSPS KAKENHI (16H06444 and 26220204) to
   H.S. C.K. acknowledges support by the Deutsche Forschungsgemeinschaft
   (KL-1356/3-2). We thank Mrs. Natascha Stefan for technical support.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143
   De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424
   Goto Y, 2008, ACS CHEM BIOL, V3, P120, DOI 10.1021/cb700233t
   Hacker DE, 2017, ACS CHEM BIOL, V12, P795, DOI 10.1021/acschembio.6b01006
   Jongkees SAK, 2017, CELL CHEM BIOL, V24, P381, DOI 10.1016/j.chembiol.2017.02.001
   Kale SS, 2018, NAT CHEM, V10, P715, DOI 10.1038/s41557-018-0042-7
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Matsunaga Y, 2016, CELL CHEM BIOL, V23, P1341, DOI 10.1016/j.chembiol.2016.09.015
   Nitsche C, 2018, ADV EXP MED BIOL, V1062, P175, DOI 10.1007/978-981-10-8727-1_13
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u
   Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008
   Passioura T, 2018, CELL CHEM BIOL, V25, P906, DOI 10.1016/j.chembiol.2018.04.011
   Passioura T, 2014, ANNU REV BIOCHEM, V83, P727, DOI 10.1146/annurev-biochem-060713-035456
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Rebollo IR, 2016, ACS MED CHEM LETT, V7, P606, DOI 10.1021/acsmedchemlett.6b00045
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Song X, 2017, ORG BIOMOL CHEM, V15, P5155, DOI [10.1039/c7ob00012j, 10.1039/C7OB00012J]
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 30
TC 13
Z9 13
U1 3
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-5875
J9 ACS MED CHEM LETT
JI ACS Med. Chem. Lett.
PD FEB
PY 2019
VL 10
IS 2
BP 168
EP 174
DI 10.1021/acsmedchemlett.8b00535
PG 13
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA HM1PJ
UT WOS:000459224200003
PM 30783498
OA Green Published
DA 2020-07-08
ER

PT J
AU Glover, KKM
   Gao, A
   Zahedi-Amiri, A
   Coombs, KM
AF Glover, Kathleen K. M.
   Gao, Ang
   Zahedi-Amiri, Ali
   Coombs, Kevin M.
TI Vero Cell Proteomic Changes Induced by Zika Virus Infection
SO PROTEOMICS
LA English
DT Article
DE aptamers; proteomics; RNA virus infection; SOMAScan
ID DENGUE-VIRUS; QUANTITATIVE PROTEOMICS; ENVELOPE PROTEIN; UNITED-STATES;
   INFLUENZA; TRANSMISSION; MONOCYTES; MOLECULE; BIOLOGY; COMPLEX
AB The re-emergence and the recent spread of the Zika virus (ZIKV) has raised significant global concerns due to lack of information in patient diagnosis and management. Thus, in addition to gaining more basic information about ZIKV biology, appropriate interventions and management strategies are being sought to control ZIKV-associated diseases and its spread. This study's objective is to identify host cell proteins that are significantly dysregulated during ZIKV infection. SOMAScan, a novel aptamer-based assay, is used to simultaneously screen >1300 host proteins to detect ZIKV-induced host protein dysregulation at multiple time points during infection. A total of 125 Vero cell host proteins, including cytokines such as CXCL11 and CCL5, interferon stimulated gene 15, and translation initiation factors EIF5A and EIF4G2, are significantly dysregulated after ZIKV infection. Bioinformatic analyses of 77 host proteins, that are significantly dysregulated >= 1.25-fold, identify several activated biological processes, including the JAK/STAT, Tec kinase, and complement cascade pathways.
C1 [Glover, Kathleen K. M.; Zahedi-Amiri, Ali; Coombs, Kevin M.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3E OJ9, Canada.
   [Glover, Kathleen K. M.; Gao, Ang; Zahedi-Amiri, Ali; Coombs, Kevin M.] Manitoba Ctr Prote & Syst Biol, Winnipeg, MB R3E 3P4, Canada.
   [Coombs, Kevin M.] Childrens Hosp, Res Inst Manitoba, Buhler Res Ctr, Winnipeg, MB R3E 3P4, Canada.
RP Coombs, KM (corresponding author), Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3E OJ9, Canada.; Coombs, KM (corresponding author), Manitoba Ctr Prote & Syst Biol, Winnipeg, MB R3E 3P4, Canada.; Coombs, KM (corresponding author), Childrens Hosp, Res Inst Manitoba, Buhler Res Ctr, Winnipeg, MB R3E 3P4, Canada.
EM kevin.coombs@umanitoba.ca
FU Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR); Children's Hospital Research Institute of
   Manitoba (CHRIM); Canadian Foundation for Innovation (CFI)Canada
   Foundation for Innovation
FX K.K.M.G. and K.M.C. designed experiments. A.G. performed the SOMAScan
   analyses. K.K.M.G. performed all other experimental work. All authors
   analyzed the data and contributed to writing the manuscript. Funding for
   this study was provided by the Canadian Institutes of Health Research
   (CIHR) and the Children's Hospital Research Institute of Manitoba
   (CHRIM). The authors also acknowledge the Canadian Foundation for
   Innovation (CFI) for providing infrastructure funds for the SOMAScan
   equipment. Special thanks also to David Safronetz (Public Health Agency
   of Canada) for providing original Zika virus stocks used in this study.
   The authors thank Protiti Khan for stock cell maintenance and members of
   their lab group for critical evaluation of the manuscript.
CR Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   [Anonymous], 2015, SSM002
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Berard AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051939
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chau CH, 2002, ONCOGENE, V21, P8817, DOI 10.1038/sj.onc.1206032
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   Coombs KM, 2011, EXPERT REV PROTEOMIC, V8, P659, DOI [10.1586/EPR.11.55, 10.1586/epr.11.55]
   Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Ezzati P, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00030
   Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gold L, 2013, FEBS J, V280, P632
   Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Iranpour M, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2015.19
   Jiang X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01067
   Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936
   Koh WL, 2005, EMERG INFECT DIS, V11, P629, DOI 10.3201/eid1104.041076
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Kroeker AL, 2012, J PROTEOME RES, V11, P4132, DOI 10.1021/pr300239r
   Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109
   Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104
   Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200
   Lindenbach B.D., 2013, FIELDS VIROLOGY, P712
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nakashima H, 2015, J BIOL CHEM, V290, P1485, DOI 10.1074/jbc.M114.593871
   Nilsson SC, 2011, MOL IMMUNOL, V48, P1611, DOI 10.1016/j.molimm.2011.04.004
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Shih YT, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-214
   Shresta S, 2012, MBIO, V3, DOI 10.1128/mBio.00003-12
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035
   Zhang LK, 2013, J PROTEOME RES, V12, P2666, DOI 10.1021/pr400011k
NR 63
TC 3
Z9 3
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD FEB
PY 2019
VL 19
IS 4
AR 1800309
DI 10.1002/pmic.201800309
PG 16
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HL7VL
UT WOS:000458949000002
PM 30578658
OA Bronze
DA 2020-07-08
ER

PT J
AU Oo, A
   Teoh, BT
   Sam, SS
   Abu Bakar, S
   Zandi, K
AF Oo, Adrian
   Teoh, Boon Teong
   Sam, Sing Sin
   Abu Bakar, Sazaly
   Zandi, Keivan
TI Baicalein and baicalin as Zika virus inhibitors
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID ANTIVIRAL ACTIVITY; INFECTION; OUTBREAK; AXL
AB At present, there is no effective antiviral agent for Zika virus (ZIKV), an arbovirus that is known for its teratogenic effects on newborns. Baicalein and baicalin were found to be capable of downregulating ZIKV replication up to 10 hours postinfection, while prophylactic effects were evident in pre-treated cells. Baicalein exhibited its highest potency during intracellular ZIKV replication, whereas baicalin was most effective against virus entry. Our in silico interaction assays predicted that both compounds exhibited the strongest binding affinities towards ZIKV NS5, while the virus envelope glycoprotein was the least likely target protein. These findings serve as a crucial platform for further in-depth studies to decipher the underlying anti-ZIKV mechanism(s) of each compound.
C1 [Oo, Adrian; Teoh, Boon Teong; Sam, Sing Sin; Abu Bakar, Sazaly; Zandi, Keivan] Univ Malaya, Trop Infect Dis Res & Educ Ctr, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.
   [Zandi, Keivan] Emory Univ, Sch Med, Dept Pediat, Biochem Pharmacol Lab, Atlanta, GA 30322 USA.
RP Zandi, K (corresponding author), Univ Malaya, Trop Infect Dis Res & Educ Ctr, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.; Zandi, K (corresponding author), Emory Univ, Sch Med, Dept Pediat, Biochem Pharmacol Lab, Atlanta, GA 30322 USA.
EM keivan.zandi@emory.edu
FU University of Malaya via a Postgraduate Research Grant (PPP)
   [PG151-2016A]
FX This work was funded by the University of Malaya via a Postgraduate
   Research Grant (PPP) (PG151-2016A).
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Chu M, 2015, BIOMED RES INT, DOI 10.1155/2015/263630
   de Souza AS, 2018, CHILD NERV SYST, V34, P85, DOI 10.1007/s00381-017-3637-1
   Fangueiro JF, 2016, INT J PHARMACEUT, V502, P161, DOI 10.1016/j.ijpharm.2016.02.039
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Hassandarvish P, 2016, RSC ADV, V6, P31235, DOI 10.1039/c6ra00817h
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Holtzman M, 2018, CLIN OBSTET GYNECOL, V61, P177, DOI 10.1097/GRF.0000000000000343
   Jin J, 2018, ARCH PHARM RES, V41, P664, DOI 10.1007/s12272-018-1022-6
   Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785
   Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485
   Li M, 2014, J ETHNOPHARMACOL, V156, P210, DOI 10.1016/j.jep.2014.08.031
   Liu J, 2018, MED SCI MONITOR, V24, P2983, DOI 10.12659/MSM.909722
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Moghaddam E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05452
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Oo A, 2018, ANTIVIR RES, V150, P101, DOI 10.1016/j.antiviral.2017.12.012
   Oo A, 2016, PEERJ, V4, DOI 10.7717/peerj.2602
   Pechenov S, 2017, ADV DRUG DELIVER REV, V112, P106, DOI 10.1016/j.addr.2017.01.006
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang G, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0318-2
   Zandi K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-214
NR 32
TC 4
Z9 6
U1 3
U2 12
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD FEB
PY 2019
VL 164
IS 2
BP 585
EP 593
DI 10.1007/s00705-018-4083-4
PG 9
WC Virology
SC Virology
GA HK9BP
UT WOS:000458284300024
PM 30392049
DA 2020-07-08
ER

PT J
AU Badolo, A
   Burt, F
   Daniel, S
   Fearns, R
   Gudo, ES
   Kielian, M
   Lescar, J
   Shi, Y
   von Brunn, A
   Weiss, SR
   Hilgenfeld, R
AF Badolo, Athanase
   Burt, Felicity
   Daniel, Susan
   Fearns, Rachel
   Gudo, Eduardo Samo
   Kielian, Margaret
   Lescar, Julien
   Shi, Yi
   von Brunn, Albrecht
   Weiss, Susan R.
   Hilgenfeld, Rolf
TI Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID SARS-CORONAVIRUS REPLICATION; 1ST SEROLOGICAL EVIDENCE; CONGO
   HEMORRHAGIC-FEVER; ZIKA VIRUS; EBOLA-VIRUS; CRYSTAL-STRUCTURE; FEBRILE
   PATIENTS; UNIQUE DOMAIN; RNASE L; ANTIBODY
AB The Third Tofo Advanced Study Week on Emerging and Re-Emerging Viruses (3rd TASW) was held in Praia do Tofo, Mozambique, from September 02 to 06, 2018. It brought together 55 participants from 10 African countries as well as from Belgium, China, Germany, Singapore, and the USA. Meeting sessions covered aspects of the epidemiology, diagnosis, molecular and structural biology, vaccine development, and antiviral drug discovery for emerging RNA viruses that are current threats in Africa and included flaviviruses (dengue and Zika), alphaviruses (chikungunya), coronaviruses, filoviruses (Ebola), influenza viruses, Crimean Congo hemorrhagic fever virus, Rift Valley fever Virus, Lassa virus, and others. Data were presented on recent flavivirus and/or chikungunyavirus outbreaks in Angola, Burkina Faso, and Mozambique. In addition, these viruses are endemic in many sub-Saharan countries. The TASW series on emerging viruses is unique in Africa and successful in promoting collaborations between researchers in Africa and other parts of the world, as well as among African scientists. This report summarizes the lectures held at the meeting and highlights advances in the field.
C1 [Badolo, Athanase] Univ Ouaga, Lab Fundamental & Appl Entomol, Ouagadougou, Burkina Faso.
   [Burt, Felicity] Univ Free State, Natl Hlth Lab Serv, Div Virol, Bloemfontein, South Africa.
   [Burt, Felicity] Univ Free State, Fac Hlth Sci, Bloemfontein, South Africa.
   [Daniel, Susan] Cornell Univ, Chem & Biomol Engn, Ithaca, NY USA.
   [Fearns, Rachel] Boston Univ, Sch Med, Boston, MA 02118 USA.
   [Gudo, Eduardo Samo] Inst Nacl Saude, Maputo, Mozambique.
   [Kielian, Margaret] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA.
   [Lescar, Julien] Nanyang Technol Univ, Struct Biol & Biochem, Singapore, Singapore.
   [Shi, Yi] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.
   [von Brunn, Albrecht] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst, Munich, Germany.
   [von Brunn, Albrecht] German Ctr Infect Res DZIF, Munich Site, Munich, Germany.
   [Weiss, Susan R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Hilgenfeld, Rolf] Univ Lubeck, Inst Biochem, Lubeck, Germany.
   [Hilgenfeld, Rolf] German Ctr Infect Res DZIF, Riems Site, Lubeck, Germany.
RP Hilgenfeld, R (corresponding author), Univ Lubeck, Inst Biochem Ratzeburger, Allee 160, D-23562 Lubeck, Germany.
EM a.badolo@gmail.com; BurtFJ@ufs.ac.za; sd386@cornell.edu; rfearns@bu.edu;
   esamogudojr@gmail.com; margaret.kielian@einstein.yu.edu;
   julien@ntu.edu.sg; shiyi@im.ac.cn; vonbrunn@mvp.lmu.de;
   weisssr@pennmedicine.upenn.edu; hilgenfeld@biochem.uni-luebeck.de
RI Burt, Felicity/AAB-6993-2020
OI Badolo, Athanase/0000-0002-6652-4240
FU Euroimmun AG (Lubeck, Germany); Gilead Sciences (Foster City, CA,
   USA)Gilead Sciences; Terra Agua Ceu (Tofo, Mozambique)
FX We thank all speakers for their contributions and for sharing
   unpublished information. We are grateful to Nina Eichler, Maria Eskes,
   and Linda Ngoromani for helping organize the meeting, and to Euroimmun
   AG (Lubeck, Germany), Gilead Sciences (Foster City, CA, USA), and Terra
   Agua Ceu (Tofo, Mozambique) for financial support of this meeting. We
   gratefully acknowledge Linlin Zhang for help with this manuscript.
CR Abdelnabi R, 2018, ANTIVIR RES, V149, P113, DOI 10.1016/j.antiviral.2017.09.016
   Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   Antonio VS, 2018, VECTOR-BORNE ZOONOT, V18, P311, DOI 10.1089/vbz.2017.2227
   Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Borena W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178175
   Brown RS, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020089
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P585, DOI 10.1002/art.40383
   Chau R, 2017, INT J INFECT DIS, V61, P51, DOI 10.1016/j.ijid.2017.06.001
   Chu DK, 2015, EUROSURVEILLANCE, V20, P11, DOI 10.2807/1560-7917.ES.2015.20.49.30086
   Chu DKW, 2018, P NATL ACAD SCI USA, V115, P3144, DOI 10.1073/pnas.1718769115
   Cressey TN, 2018, NUCLEIC ACIDS RES, V46, P6785, DOI 10.1093/nar/gky480
   Dai LP, 2018, SUBCELL BIOCHEM, V88, P147, DOI 10.1007/978-981-10-8456-0_7
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Delang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31819
   Dornemann J, 2017, J INFECT DIS, V215, P171, DOI 10.1093/infdis/jiw493
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   Ferir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064010
   Fleta-Soriano E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00739-17, 10.1128/aac.00739-17]
   Gikonyo S, 2018, ECOHEALTH, V15, P372, DOI 10.1007/s10393-018-1317-6
   Goedhals D, 2015, EPIDEMIOL INFECT, V143, P1451, DOI 10.1017/S0950268814002271
   Goldstein SA, 2017, J VIROL, V91, DOI 10.1128/JVI.02201-16
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Gudo ES, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005001
   Gudo ES, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005052
   Hilgenfeld R, PROCEEDINGS OF THE 2
   Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   KOLAWOLE O, 2017, BMC RES NOTES, V10, DOI DOI 10.1186/813104-017-3063-1
   Koutsoudakis G, 2015, J HEPATOL, V63, P813, DOI 10.1016/j.jhep.2015.06.002
   Kusov Y, 2015, VIROLOGY, V484, P313, DOI 10.1016/j.virol.2015.06.016
   Lei J, 2018, ANTIVIR RES, V149, P58, DOI 10.1016/j.antiviral.2017.11.001
   Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8
   Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lindner HA, 2007, ARCH BIOCHEM BIOPHYS, V466, P8, DOI 10.1016/j.abb.2007.07.006
   Ma-Lauer Y, 2016, P NATL ACAD SCI USA, V113, pE5192, DOI 10.1073/pnas.1603435113
   Malathi K, 2014, MBIO, V5, DOI 10.1128/mBio.02012-14
   Martinez MG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006061
   Massangaie M, 2016, AM J TROP MED HYG, V94, P413, DOI 10.4269/ajtmh.15-0543
   Moiane Belisario, 2017, Infection Ecology & Epidemiology, V7, P1416248, DOI 10.1080/20008686.2017.1416248
   Mugabe VA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192110
   Muianga AF, 2017, INT J INFECT DIS, V62, P119, DOI 10.1016/j.ijid.2017.07.024
   Noton SL, 2015, VIROLOGY, V479, P545, DOI 10.1016/j.virol.2015.01.014
   Oludele J, 2017, AM J TROP MED HYG, V97, P1418, DOI 10.4269/ajtmh.17-0317
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Smith TM, 2015, J BIOMOL SCREEN, V20, P153, DOI 10.1177/1087057114551141
   Song H, 2017, CELL REP, V20, P1201, DOI 10.1016/j.celrep.2017.07.028
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tan JZ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000428
   Tharakaraman K, 2018, CELL HOST MICROBE, V23, P618, DOI 10.1016/j.chom.2018.04.004
   Thornbrough JM, 2016, MBIO, V7, DOI 10.1128/mBio.00258-16
   Tivane A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201248
   Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yuan YC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14657
   Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011
NR 66
TC 0
Z9 0
U1 3
U2 18
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD FEB
PY 2019
VL 162
BP 142
EP 150
DI 10.1016/j.antiviral.2018.12.015
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA HK8ET
UT WOS:000458222900018
PM 30597184
OA Green Published
DA 2020-07-08
ER

PT J
AU van der Linden, V
   Petribu, NCD
   Pessoa, A
   Faquini, I
   Paciorkowski, AR
   van der Linden, H
   Silveira-Moriyama, L
   Cordeiro, MT
   Hazin, AN
   Barkovich, AJ
   Raybaud, C
   Abath, MD
   Ribeiro, E
   Juca, CEB
   Aragao, MDVV
   Travassos, PTC
   Jungmann, P
AF van der Linden, Vanessa
   de Lima Petribu, Natacha Calheiros
   Pessoa, Andre
   Faquini, Igor
   Paciorkowski, Alex R.
   van der Linden, Helio, Jr.
   Silveira-Moriyama, Laura
   Cordeiro, Marli Tenorio
   Hazin, Adriano Nassri
   Barkovich, A. James
   Raybaud, Charles
   Abath, Marilia de Brito
   Ribeiro, Erlane
   Barros Juca, Carlos Eduardo
   Viana Vasco Aragao, Maria de Fatima
   Coelho Travassos, Patricia Teresa
   Jungmann, Patricia
TI Association of Severe Hydrocephalus With Congenital Zika Syndrome
SO JAMA NEUROLOGY
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; VIRUS-INFECTION; CEREBROSPINAL-FLUID; VESSELS
   DRAIN; DENGUE VIRUS; APOPTOSIS; EPIDEMIC; STRAIN; CELLS; BIRTH
AB IMPORTANCE Hydrocephalus is a treatable but potentially fatal complication that has not been previously described in congenital Zika syndrome (CZS).
   OBJECTIVE To describe the clinical features and imaging findings in 24 patients with congenital Zika syndrome (CZS) who developed hydrocephalus.
   DESIGN, SETTING, AND PARTICIPANTS This case series included patients with hydrocephalus who were born in October and November 2015 and followed up until mid-2017 in the 2 largest national referral centers for CZS in Brazil. The participants included consecutively enrolled children with a clinical and laboratorial diagnosis of CZS who developed clinical and/or image findings suggestive of hydrocephalus and who were confirmed to experience increased intracranial hypertension during ventriculoperitoneal shunt procedures.
   MAIN OUTCOMES AND MEASURES To retrospectively describe clinical and image findings in these 24 patients.
   RESULTS This multicenter cohort included 308 patients with CZS; 24 consecutive children were enrolled in this study. These children were aged between 3 to 18 months, and 13 of 24 (54%) were female. All patients presented with at least 1 positive test result for anti-Zika antibodies in cerebrospinal fluid or serum and had classic signs of CZS. At the time of hydrocephalus diagnosis, only 14 of 24 patients (58%) had symptoms and signs suggestive of hydrocephalus (mainly worsening seizures, vomiting, irritability, and/or sudden increase of head circumference percentile). Two of 24 patients (8%) had no symptoms suggestive of hydrocephalus but were found to have reduced brain volume on repeated imaging. Cerebellar or brainstem hypoplasia on baseline imaging were found in 18 of 23 patients (78%). At the second computed tomographic scan, all patients showed a marked increase of ventricular volume, compatible with communicating hydrocephalus, and reduction of brain tissue that was visibly worse than on baseline imaging for the 23 patients with repeated scans.
   CONCLUSIONS AND RELEVANCE We present evidence that hydrocephalus is a complication of CZS in at least a proportion of patients. The clinical spectrum of this condition continues to evolve, but given that presenting signs and symptoms of hydrocephalus can be challenging to recognize in CZS, we provisionally recommend that high suspicion and appropriate monitoring for hydrocephalus should be part of the standard care of patients with CZS.
C1 [van der Linden, Vanessa] Assoc Assistance Disabled Children, Ave Advogado Jose Paulo Cavalcante, BR-50080810 Recife, PE, Brazil.
   [van der Linden, Vanessa; de Lima Petribu, Natacha Calheiros; Abath, Marilia de Brito] Barao Lucena Hosp, Recife, PE, Brazil.
   [Pessoa, Andre; Ribeiro, Erlane] Albert Sabin Children Hosp, Fortaleza, Ceara, Brazil.
   [Pessoa, Andre] Christus Univ, Fortaleza, Ceara, Brazil.
   [Faquini, Igor; Hazin, Adriano Nassri] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Neurosci, Rochester, NY 14642 USA.
   [van der Linden, Helio, Jr.] Dr Henr Santillo Rehabil Ctr, Goiania, Go, Brazil.
   [Silveira-Moriyama, Laura] Univ Nove Julho, Uninove, Postgrad Program Med, Sao Paulo, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Barkovich, A. James] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Raybaud, Charles] Univ Toronto, Toronto, AB, Canada.
   [Barros Juca, Carlos Eduardo] Univ Fortaleza, Fortaleza, Ceara, Brazil.
   [Viana Vasco Aragao, Maria de Fatima] Multimagem Diagnost Ctr, Recife, PE, Brazil.
   [Coelho Travassos, Patricia Teresa; Jungmann, Patricia] Univ Pernambuco, Recife, PE, Brazil.
RP van der Linden, V (corresponding author), Assoc Assistance Disabled Children, Ave Advogado Jose Paulo Cavalcante, BR-50080810 Recife, PE, Brazil.
EM vanessavdlinden@hotmail.com
RI Faquini, Igor/S-4936-2019; Moriyama, Laura Silveira/G-4592-2014; Juca,
   Eduardo/AAF-7029-2019
OI Faquini, Igor/0000-0002-1538-396X; Moriyama, Laura
   Silveira/0000-0003-2184-626X; Juca, Eduardo/0000-0003-3269-2577; VAN DER
   LINDEN JUNIOR, HELIO/0000-0002-3123-2264
FU Association for Assistance of Disabled Children, Barao de Lucena
   Hospital
FX We thank the Association for Assistance of Disabled Children, Barao de
   Lucena Hospital, Professor Fernando Figueira Integral Medicine
   Institute, and Health Secretaries of Pernambuco for their support. We
   thank our patients and their families for participating in this study,
   particularly the family of the patient depicted in Figure 3 for granting
   permission to publish these images.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Barkovich AJ, 2012, PEDIAT NEUROIMAGING
   Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dissing-Olesen L, 2015, EBIOMEDICINE, V2, P776, DOI 10.1016/j.ebiom.2015.08.019
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ford ML, 2016, AM J TRANSPLANT, V16, P735, DOI 10.1111/ajt.13742
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Greitz D, 2007, CHILD NERV SYST, V23, P487, DOI 10.1007/s00381-007-0303-z
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013
   Jungmann P, 2017, ACTA OBSTET GYN SCAN, V96, P1039, DOI 10.1111/aogs.13184
   Krishnamurthy S, 2014, TRANSL PEDIATR, V3, P185, DOI 10.3978/j.issn.2224-4336.2014.07.02
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Raper D, 2016, TRENDS NEUROSCI, V39, P581, DOI 10.1016/j.tins.2016.07.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rekate HL, 2011, CHILD NERV SYST, V27, P1535, DOI 10.1007/s00381-011-1558-y
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Simeone RM, 2013, BIRTH DEFECTS RES A, V97, P431, DOI 10.1002/bdra.23138
   Sivagnanam M, 2012, HYDROCEPHALUS, P1, DOI [10.5772/32502, DOI 10.5772/32502]
   Svatonova J, 2006, FOLIA MICROBIOL, V51, P485, DOI 10.1007/BF02931596
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   VANDVIK B, 1982, J NEUROL, V228, P25, DOI 10.1007/BF00313407
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 40
TC 5
Z9 5
U1 1
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD FEB
PY 2019
VL 76
IS 2
BP 203
EP 210
DI 10.1001/jamaneurol.2018.3553
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA HL0AX
UT WOS:000458357400013
PM 30452526
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Wiech, A
   Rowinska-Zyrek, M
   Watly, J
   Czarnota, A
   Holubowicz, R
   Szewczuk, Z
   Ozyhar, A
   Orlowski, M
AF Wiech, Anna
   Rowinska-Zyrek, Magdalena
   Watly, Joanna
   Czarnota, Aleksandra
   Holubowicz, Rafal
   Szewczuk, Zbigniew
   Ozyhar, Andrzej
   Orlowski, Marek
TI The intrinsically disordered C-terminal F domain of the ecdysteroid
   receptor from Aedes aegypti exhibits metal ion-binding ability
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Aedes aegypti; Ecdysteroid receptor; Zika and dengue vector; nuclear
   receptors; Intrinsically disordered proteins
ID HISTIDINE-RICH GLYCOPROTEIN; NATIVELY UNFOLDED PROTEINS; NUCLEAR
   RECEPTORS; SUPEROXIDE-DISMUTASE; HORMONE RECEPTORS; ECDYSONE RECEPTOR;
   ZINC; SEQUENCE; REGIONS; GENE
AB The dominant vector of dengue and Zika diseases is a female Aedes aegypti mosquito. Its reproduction is controlled by the formation of an active heterodimer complex of the 20-hydroxyecdysone receptor (EcR) and Ultraspiracle protein (Usp). Although EcR exhibits a structural and functional organization typical of nuclear receptors (NRs), the EcR C-terminus has an additional F domain (AaFEcR) that is rarely present in the NRs superfamily. The presence of F domains is evolutionarily not well conserved in the NRs. The structure-function relationship of EcR F domains in arthropods is unclear and enigmatic. To date, there have been no data concerning the structure and function of AaFEcR.
   Our results showed that AaFEcR belongs to a family of intrinsically disordered proteins (IDPs) and possesses putative pre-molten globule (PMG) characteristics. Unexpectedly, additional amino acid composition in silico analyses revealed the presence of short unique repeated Pro-His clusters forming an HGPHPHPHG motif, which is similar to those responsible for Zn2+ and Cu2+ binding in histidine-proline-rich glycoproteins (HPRGs). Using SEC, SV-AUC and ESI-TOF MS, we showed that the intrinsically disordered AaFEcR is able to bind metal ions and form complexes with these ions. Our studies provide new insight into the structural organization and activities of the F domains of NRs. This unique for the F domains of NRs ion-binding propensity demonstrated by the AaFEcR domain may be a part of the ecdysteroid receptor's mechanism for regulating the expression of genes encoding oxidative stress-protecting proteins.
C1 [Wiech, Anna; Czarnota, Aleksandra; Holubowicz, Rafal; Ozyhar, Andrzej; Orlowski, Marek] Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.
   [Rowinska-Zyrek, Magdalena; Watly, Joanna; Szewczuk, Zbigniew] Univ Wroclaw, Fac Chem, PL-50383 Wroclaw, Poland.
RP Orlowski, M (corresponding author), Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.
EM marek.orlowski@pwr.edu.pl
RI Szewczuk, Zbigniew/A-2243-2013; Holubowicz, Rafal/AAB-7552-2020
OI Holubowicz, Rafal/0000-0002-2555-2069; Rowinska-Zyrek,
   Magdalena/0000-0002-0425-1128; OZYHAR, Andrzej/0000-0002-5874-784X;
   Orlowski, Marek/0000-0003-1282-2282
FU Polish Ministry of Science and Higher EducationMinistry of Science and
   Higher Education, Poland; National Science Centre
   [UMO-2014/13/D/ST5/02868]
FX This study was supported by a statutory activity subsidy from the Polish
   Ministry of Science and Higher Education for the Faculty of Chemistry of
   Wroclaw University of Science and Technology and from the National
   Science Centre (no. UMO-2014/13/D/ST5/02868). The publication costs were
   provided by the Wroclaw Centre of Biotechnology Programme: Leading
   National Research Centre (KNOW) from 2014-2018. We are grateful to
   Miroslawa Ostrowska, Eng. (Wroclaw University of Science and Technology)
   for her excellent technical assistance and to Natalia Baginska, M.Sc.
   Eng. (Wroclaw University of Science and Technology) for her assistance
   during initial protein purification. In addition, we are grateful to
   Professor Henryk Kozlowski (Faculty of Chemistry, University of Wroclaw,
   Poland) for giving us the opportunity to perform protein-metal ESI-TOF
   MS experiments.
CR Aagaard MM, 2011, BBA-MOL BASIS DIS, V1812, P824, DOI 10.1016/j.bbadis.2010.12.018
   Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1
   Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010
   Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101
   Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1
   Aranda A, 2001, PHYSIOL REV, V81, P1269
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Bala T, 2007, J PHYS CHEM A, V111, P6183, DOI 10.1021/jp067906x
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Belorusova AY, 2016, BIOCHEMISTRY-US, V55, P1741, DOI 10.1021/acs.biochem.5b01122
   Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310
   Byrne C, 2013, J MAMMARY GLAND BIOL, V18, P63, DOI 10.1007/s10911-013-9273-9
   Chaitanya RK, 2014, ASIAN PAC J TROP MED, V7, P680, DOI 10.1016/S1995-7645(14)60116-4
   Chen TH, 2011, VIROLOGY, V410, P410, DOI 10.1016/j.virol.2010.12.013
   CHO WL, 1995, INSECT BIOCHEM MOLEC, V25, P19, DOI 10.1016/0965-1748(94)00045-J
   Darbre PD, 2005, J INORG BIOCHEM, V99, P1912, DOI 10.1016/j.jinorgbio.2005.06.001
   Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541
   Dunker AK, 2015, SEMIN CELL DEV BIOL, V37, P44, DOI 10.1016/j.semcdb.2014.09.025
   Dunker K., 2002, PROTEINS, V41
   Dziedzic-Letka A, 2011, PROTEINS, V79, P376, DOI 10.1002/prot.22887
   FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030
   Faller P, 2014, ACCOUNTS CHEM RES, V47, P2252, DOI 10.1021/ar400293h
   FEINBERG H, 1993, J CHEM INF COMP SCI, V33, P501, DOI 10.1021/ci00013a030
   Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999
   Gkikas D, 2017, CELL MOL LIFE SCI, V74, P4097, DOI 10.1007/s00018-017-2571-4
   GUTHANS SL, 1982, ARCH BIOCHEM BIOPHYS, V218, P320, DOI 10.1016/0003-9861(82)90350-2
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Haas KL, 2009, CHEM REV, V109, P4921, DOI 10.1021/cr900134a
   Hansen IA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00103
   Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730
   Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5
   Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528
   Kapitskaya M, 1996, MOL CELL ENDOCRINOL, V121, P119, DOI 10.1016/0303-7207(96)03847-6
   Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G
   Krasowski MD, 2008, J PROTEOME RES, V7, P4359, DOI 10.1021/pr8003024
   Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161
   Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6
   Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279
   Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44
   Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718
   Manon F, 2010, ANONYMOUS INSTRUMENT, P431, DOI [DOI 10.1002/9780470602614CH15, 10.1002/9780470602614.ch15.]
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marquardt W. C., 2004, BIOLOGY OD DISEASE V
   MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286
   Martin D, 2001, MOL CELL ENDOCRINOL, V173, P75, DOI 10.1016/S0303-7207(00)00413-5
   McEwan I. J, 2015, NUCL RECEPTORS STRUC, P1, DOI [10.1007/978-3-319-18729-7, DOI 10.1007/978-3-319-18729-7]
   Mongkolsuk S, 2002, MOL MICROBIOL, V45, P9, DOI 10.1046/j.1365-2958.2002.03015.x
   MORGAN WT, 1981, BIOCHEMISTRY-US, V20, P1054, DOI 10.1021/bi00508a002
   Nocula-Lugowska M, 2009, PROTEINS, V76, P291, DOI 10.1002/prot.22342
   Patel SR, 2015, MOL CELL ENDOCRINOL, V418, P298, DOI 10.1016/j.mce.2015.07.009
   Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208
   Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886
   PETERSON CB, 1987, J BIOL CHEM, V262, P7567
   Pieprzyk J, 2014, BBA-PROTEINS PROTEOM, V1844, P1153, DOI 10.1016/j.bbapap.2014.03.010
   Poznar M, 2017, BBA-PROTEINS PROTEOM, V1865, P1358, DOI 10.1016/j.bbapap.2017.08.019
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   Raikhel AS, 1999, AM ZOOL, V39, P722
   Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5
   RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245
   Rajkovic S, 2008, DALTON T, P5059, DOI 10.1039/b808323a
   Ranieri-Raggi M, 2014, BIOMOLECULES, V4, P474, DOI 10.3390/biom4020474
   Rao AK, 2008, MOL ENDOCRINOL, V22, P1113, DOI 10.1210/me.2007-0381
   Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200
   Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656
   RIDDIFORD LM, 1993, AM ZOOL, V33, P340
   Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3
   Rowinska-Zyrek M, 2013, NEW J CHEM, V37, P58, DOI 10.1039/c2nj40558j
   SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103
   Sigalov AB, 2016, BIOCHIMIE, V125, P112, DOI 10.1016/j.biochi.2016.03.006
   Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   TIFFANY ML, 1973, BIOPOLYMERS, V12, P575, DOI 10.1002/bip.1973.360120310
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008
   Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x
   UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042
   Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7
   Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102
   Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211
   Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647
   van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m
   Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wojtas M, 2015, BIOCHEMISTRY-US, V54, P6525, DOI 10.1021/acs.biochem.5b00933
   Woody RW, 2010, INSTRUMENTAL ANAL IN, P303
   Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920
   Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011
   YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F
   Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011
NR 95
TC 1
Z9 1
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD FEB
PY 2019
VL 186
BP 42
EP 55
DI 10.1016/j.jsbmb.2018.09.008
PG 14
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA HK8EW
UT WOS:000458223200005
PM 30243841
OA Other Gold
DA 2020-07-08
ER

PT J
AU Zhao, JT
   Feng, R
AF Zhao, Jiangtao
   Feng, Ruo
TI Sensitive and rapid detection of Zika virus by loop-mediated isothermal
   amplification
SO VIRUS GENES
LA English
DT Article
DE Zika virus; LAMP; Sensitivity; Specificity; Rapid detection
ID MUMPS-VIRUS; GENOME
AB Zika virus (ZIKV) is a mosquito-borne flavivirus, which is a pathogen affecting humans in Africa, Asia, and America. It is necessary to detect ZIKV with a rapid and sensitive molecular method to guide timely treatment. In this study, a loop-mediated isothermal amplification (LAMP) assay was described, which is an attractive option as a fast, sensitive, and specific method for ZIKV detection using the NS5 protein coding region and the envelope protein (EP) coding region as target sequences. Two different techniques, a calcein/Mn2+ complex chromogenic method and real-time turbidity monitoring, were employed. The specificity and sensitivity of the LAMP assay were determined. The assay's detection limit was 0.5x10(-9)pmol/mu l DNA for NS5 protein coding region and 1.12x10(-11)pmol/mu l DNA for E coding region, respectively, which is a 100-fold increase in sensitivity compared with real-time reverse transcription-polymerase chain reaction (RT-PCR) and conventional PCR. All 12 non-ZIKA respiratory pathogens tested were negative for LAMP detection, indicating the high specificity of the primers for ZIKV. In conclusion, a visual detection LAMP assay was developed, which could be a useful tool for primary quarantine purposes and clinical screening, especially in situations where resources are poor and in point-of-care tests.
C1 [Zhao, Jiangtao; Feng, Ruo] Zhengzhou Univ, Dept Histol & Embryol, Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China.
RP Zhao, JT; Feng, R (corresponding author), Zhengzhou Univ, Dept Histol & Embryol, Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China.
EM jtaozhao@163.com; fr@zzu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81401995]
FX This work received support from National Natural Science Foundation of
   China Grant (81401995).
CR Brewster CD, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.03.01
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Castro T, 2018, J ORAL MICROBIOL, V10, DOI 10.1080/20002297.2018.1510712
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Eppes C, 2017, AM J OBSTET GYNECOL, V213
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Guo XG, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0591-6
   Kaarj K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30797-9
   Kashiwagi Y, 1997, J MED VIROL, V52, P195, DOI 10.1002/(SICI)1096-9071(199706)52:2<195::AID-JMV13>3.3.CO;2-Q
   Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042954
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lamb LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22102-5
   Lustig Y, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.11.25
   Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Okafuji T, 2005, J CLIN MICROBIOL, V43, P1625, DOI 10.1128/JCM.43.4.1625-1631.2005
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Smith Orla M, 2017, Science, V356, P497, DOI 10.1126/science.356.6337.497-g
   Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
   Zhao XN, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv148
NR 24
TC 5
Z9 5
U1 3
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD FEB
PY 2019
VL 55
IS 1
BP 43
EP 50
DI 10.1007/s11262-018-1612-x
PG 8
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA HK8WV
UT WOS:000458271300005
PM 30426316
OA Green Published
DA 2020-07-08
ER

PT J
AU Ladner, JT
   Grubaugh, ND
   Pybus, OG
   Andersen, KG
AF Ladner, Jason T.
   Grubaugh, Nathan D.
   Pybus, Oliver G.
   Andersen, Kristian G.
TI Precision epidemiology for infectious disease control
SO NATURE MEDICINE
LA English
DT Article
ID EBOLA-VIRUS; REAL-TIME; GENOMIC EPIDEMIOLOGY; SEXUAL TRANSMISSION; ZIKA
   VIRUS; OUTBREAK; EVOLUTION; IMPACT; IMPLEMENTATION; CORONAVIRUS
AB Advances in genomics and computing are transforming the capacity for the characterization of biological systems, and researchers are now poised for a precision-focused transformation in the way they prepare for, and respond to, infectious diseases. This includes the use of genome-based approaches to inform molecular diagnosis and individual-level treatment regimens. In addition, advances in the speed and granularity of pathogen genome generation have improved the capability to track and understand pathogen transmission, leading to potential improvements in the design and implementation of population-level public health interventions. In this Perspective, we outline several trends that are driving the development of precision epidemiology of infectious disease and their implications for scientists' ability to respond to outbreaks.
C1 [Ladner, Jason T.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA.
   [Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Andersen, Kristian G.] Scripps Res Translat Inst, La Jolla, CA 92037 USA.
RP Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.
EM andersen@scripps.edu
RI Pybus, Oliver g/B-2640-2012
OI Pybus, Oliver g/0000-0002-8797-2667; Grubaugh,
   Nathan/0000-0003-2031-1933
FU Oxford Martin School; NIH NCATSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS) [CTSA UL1TR001114];
   NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [HHSN272201400048C, R21AI137690,
   U19AI135995]; Ray Thomas Foundation; State of Arizona Technology and
   Research Initiative Fund (TRIF)
FX O.G.P. is supported by the Oxford Martin School. K.G.A. is a Pew
   Biomedical Scholar and is supported by NIH NCATS CTSA UL1TR001114, NIAID
   HHSN272201400048C, NIAID R21AI137690, NIAID U19AI135995, and The Ray
   Thomas Foundation. J.T.L. is supported by the State of Arizona
   Technology and Research Initiative Fund (TRIF), administered by the
   Arizona Board of Regents, through Northern Arizona University.
CR Alexandrov V, 2016, NAT BIOTECHNOL, V34, P838, DOI 10.1038/nbt.3587
   Allard MW, 2018, CURR OPIN BIOTECH, V49, P224, DOI 10.1016/j.copbio.2017.11.002
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   Ampofo WK, 2015, VACCINE, V33, P4368, DOI 10.1016/j.vaccine.2015.06.090
   Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P237
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Biek R, 2015, TRENDS ECOL EVOL, V30, P306, DOI 10.1016/j.tree.2015.03.009
   Bissonnette L, 2012, J PERS MED, V2, P50, DOI 10.3390/jpm2020050
   Bogue MA, 2018, NUCLEIC ACIDS RES, V46, pD843, DOI 10.1093/nar/gkx1082
   Both L, 2013, VACCINE, V31, P1553, DOI 10.1016/j.vaccine.2013.01.025
   Boulding H, 2012, HUM MUTAT, V33, P874, DOI 10.1002/humu.22069
   Bourgeois FT, 2007, J AM MED INFORM ASSN, V14, P765, DOI 10.1197/jamia.M2134
   Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Brownstein JS, 2007, EUROSURVEILLANCE, V12
   Butler D, 2015, NATURE NEWS, DOI [10.1038/nature.2015.18584, DOI 10.1038/NATURE.2015.18584]
   CANN AJ, 1984, NUCLEIC ACIDS RES, V12, P7787, DOI 10.1093/nar/12.20.7787
   Center for Food Safety & Nutrition A, 2018, WHOL GEN SEQ PROGR G
   Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701
   Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006
   Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   Doud MB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006271
   du Plessis L, 2015, TRENDS MICROBIOL, V23, P383, DOI 10.1016/j.tim.2015.04.007
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Eyre DW, 2018, NEW ENGL J MED, V379, P1322, DOI 10.1056/NEJMoa1714373
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Grabowski MK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001610
   Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Harrington J, 2013, SLEEP BREATH, V17, P1071, DOI 10.1007/s11325-013-0804-9
   Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2
   Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790
   Jackson BR, 2016, CLIN INFECT DIS, V63, P380, DOI 10.1093/cid/ciw242
   Johansson MA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002549
   Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1
   Kozel TR, 2017, J CLIN MICROBIOL, V55, P2313, DOI 10.1128/JCM.00476-17
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038
   Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14
   Kuhnert D, 2016, MOL BIOL EVOL, V33, P2102, DOI 10.1093/molbev/msw064
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Little SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098443
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   Milinovich GJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0690-1
   Miller S., 2019, LAB VALIDATION CLIN, DOI [10.1101/330381, DOI 10.1101/330381]
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Neher RA, 2016, P NATL ACAD SCI USA, V113, pE1701, DOI 10.1073/pnas.1525578113
   Neher RA, 2015, BIOINFORMATICS, V31, P3546, DOI 10.1093/bioinformatics/btv381
   Nsoesie E. O., 2016, PLOS CURR, V8
   Pan HQ, 2012, HUM MUTAT, V33, P849, DOI 10.1002/humu.22074
   Perrin L, 1998, SCIENCE, V280, P1871, DOI 10.1126/science.280.5371.1871
   Poon AFY, 2016, LANCET HIV, V3, pE231, DOI 10.1016/S2352-3018(16)00046-1
   Popovich KJ, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0570-0
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017
   Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080
   Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546
   Schon T, 2017, CLIN MICROBIOL INFEC, V23, P154, DOI 10.1016/j.cmi.2016.10.022
   Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486
   Siddle KJ, 2018, NEW ENGL J MED, V379, P1745, DOI 10.1056/NEJMoa1804498
   Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736
   Sozhamannan S, 2015, VIRUSES-BASEL, V7, P3130, DOI 10.3390/v7062763
   Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f
   Stern A, 2017, CELL, V169, P35, DOI 10.1016/j.cell.2017.03.013
   Stevens EL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00808
   Timme RE, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000185
   Torkamani A, 2017, CELL, V170, P828, DOI 10.1016/j.cell.2017.08.007
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   WHO, 2017, R D BLUEPR M PATH GE
   World Health Organization, 2016, GUID MAN ETH ISS INF
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Yozwiak NL, 2016, CELL, V166, P5, DOI 10.1016/j.cell.2016.06.029
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zola SM, 2013, AM J ALZHEIMERS DIS, V28, P179, DOI 10.1177/1533317512470484
NR 87
TC 14
Z9 13
U1 5
U2 18
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD FEB
PY 2019
VL 25
IS 2
BP 206
EP 211
DI 10.1038/s41591-019-0345-2
PG 6
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA HK3TW
UT WOS:000457842100014
PM 30728537
OA Green Published
DA 2020-07-08
ER

PT J
AU Tabari, D
   Scholl, C
   Hildt, E
   Stingl, J
AF Tabari, D.
   Scholl, C.
   Hildt, E.
   Stingl, J.
TI Changes of microRNA and mRNA expression induced by Zika virus infection
   in early human neural development
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
CT 21st Annual Meeting of the
   German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology
   (DGPT) / 21st Annual Meeting of the
   Association-of-the-Clinical-Pharmacology-Germany (VKliPha)
CY FEB 25-28, 2019
CL Stuttgart, GERMANY
SP German Soc Expt & Clin Pharmacol & Toxicol, Assoc Clin Pharmacol Germany
C1 [Tabari, D.; Scholl, C.; Stingl, J.] Fed Inst Drugs & Med Devices, Bonn, Germany.
   [Hildt, E.] Paul Ehrlich Inst, Langen, Germany.
RI Hildt, Eberhard/A-1040-2015
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD FEB
PY 2019
VL 392
SU 1
MA P111
BP S52
EP S52
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HK8VD
UT WOS:000458266900180
DA 2020-07-08
ER

PT J
AU Tangsongcharoen, C
   Roytrakul, S
   Smith, DR
AF Tangsongcharoen, Chontida
   Roytrakul, Sittiruk
   Smith, Duncan R.
TI Analysis of cellular proteome changes in response to ZIKV NS2B-NS3
   protease expression
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE Zika virus; Protease; Stress response; Glycolysis; NS3; NS2B
ID CRYSTAL-STRUCTURE; VIRUS; IDENTIFICATION; INFECTION; HELICASE; DOMAIN;
   PDIA3; ATP
AB The recent emergence of Zika virus (ZIKV) has caused global concern as a result of the association with neurological disorders, and brain development dysfunction in fetuses of mothers who become infected with ZIKV during pregnancy. The NS2B-NS3 protease is important for viral replication and offers an attractive drug target. In addition to processing the viral polypeptide, evidence has shown that the NS2B-NS3 protease also targets cellular proteins as part of the viral replication process. This study sought to determine new host cell protein targets of ZIKV NS2B-NS3 (zNS2B-NS3). Plasmids encoding the protease domains of zNS2B-NS3pro and an inactive zNS2B-NS3(S135A) were transfected into HEK293T/17 cells and differentially expressed proteins were detected by 2D gel electrophoresis. A total of 18 protein spots were observed as differentially expressed between zNS2B-NS3pro and zNS2B-NS3(S135A), of which 7 were selected for identification by mass spectrometry. Four proteins (protein disulfide-isomerase A3 (PDIA3), heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/ B1), voltage-dependent anion-selective channel (VDAC) and aldolase A (ALDOA)) were selected for validation by independent transient expression and western blot analysis. Three proteins (PDIA3, hnRNP A2/B1 and ALDOA) were successfully validated, but only two proteins (PDIA3 and ALDOA) were shown to be regulated in ZIKV infection in agreement with the results of the transfection experiments. This study has identified two proteins, PDIA3 an ALDOA whose expression is modulated by the ZIKV NS2B-NS3 protease, and these proteins are involved in the ER stress response and glycolysis respectively, two critical cellular processes in ZIKV infection.
C1 [Tangsongcharoen, Chontida; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamonton Sai 4, Salaya 73170, Nakhon Pathom, Thailand.
   [Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamonton Sai 4, Salaya 73170, Nakhon Pathom, Thailand.
EM duncan.smi@mahidol.ac.th
RI Smith, Duncan R/C-6891-2011
OI Smith, Duncan R/0000-0002-6592-9852
FU Mahidol University [BRG6080006]; Thailand Research FundThailand Research
   Fund (TRF)
FX The authors would like to thank Atchara Paemanee and Sucheewin Krobthong
   for technical assistance with the mass spectrometry experiment. This
   research work was supported by the Mahidol University, and the Thailand
   Research Fund and Mahidol University (BRG6080006). CT is supported by a
   Mahidol University postdoctoral fellowship.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Boya P, 2003, BIOCHEM BIOPH RES CO, V304, P575, DOI 10.1016/S0006-291X(03)00630-2
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chambers TJ, 2005, J GEN VIROL, V86, P1403, DOI 10.1099/vir.0.80427-0
   Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009
   FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Jitobaom K., 2016, SCI REP, V6, P12
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Luo D., 2012, FLAVIVIRUS NS3 PROTE
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Marshall NC, 2017, MOL CELL PROTEOMICS, V16, pS161, DOI 10.1074/mcp.O116.066456
   Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005
   Mishra KP, 2012, VIRUS RES, V163, P573, DOI 10.1016/j.virusres.2011.12.010
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabilloud T, 2011, J PROTEOMICS, V74, P1829, DOI 10.1016/j.jprot.2011.05.040
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279
   Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002
   Silva GS, 2018, J CRIT CARE, V46, P106, DOI 10.1016/j.jcrc.2018.03.030
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Smith DJ, 2016, CHURCH FAITH CULT M, P1
   Tien CF, 2014, BIOCHEM BIOPH RES CO, V443, P464, DOI 10.1016/j.bbrc.2013.11.128
   Tongluan N, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0685-9
   Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yu CY, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005350
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zhang LR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00293
   Zhao GP, 2015, J BIOL CHEM, V290, P8949, DOI 10.1074/jbc.M114.619353
NR 42
TC 2
Z9 2
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 1878-1454
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD FEB
PY 2019
VL 1867
IS 2
BP 89
EP 97
DI 10.1016/j.bbapap.2018.10.016
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA HK3IY
UT WOS:000457810900001
PM 30391636
DA 2020-07-08
ER

PT J
AU Tyson, J
   Tsai, WY
   Tsai, JJ
   Brites, C
   Massgard, L
   Youn, HH
   Pedroso, C
   Drexler, JF
   Stramer, SL
   Balmaseda, A
   Harris, E
   Wang, WK
AF Tyson, Jasmine
   Tsai, Wen-Yang
   Tsai, Jih-Jin
   Brites, Carlos
   Massgard, Ludvig
   Youn, Han Ha
   Pedroso, Celia
   Drexler, Jan Felix
   Stramer, Susan L.
   Balmaseda, Angel
   Harris, Eva
   Wang, Wei-Kung
TI Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent
   Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus
   Infections
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE Zika virus; dengue virus; nonstructural protein 1; serodiagnosis
ID WEST-NILE-VIRUS; CROSS-REACTIVITY; NEUTRALIZING ANTIBODIES;
   TRANSMISSION; ENHANCEMENT; DIAGNOSIS; TRAVELERS; KINETICS; INFANTS;
   SAFETY
AB The recent outbreaks of Zika virus (ZIKV) and associated birth defects in regions of dengue virus (DENV) endemicity emphasize the need for sensitive and specific serodiagnostic tests. We reported previously that enzyme-linked immunosor- bent assays (ELISAs) based on the nonstructural protein 1 (NS1) of DENV serotype 1 (DENV1) and ZIKV can distinguish primary DENV1, secondary DENV, and ZIKV infections. Whether ELISAs based on NS1 proteins of other DENV serotypes can discriminate various DENV and ZIKV infections remains unknown. We herein developed DENV2, DENV3, and DENV4 NS1 IgG ELISAs to test convalescent- and postconvalescent-phase samples from reverse transcription-PCR-confirmed cases, including 25 primary DENV1, 24 primary DENV2, 10 primary DENV3, 67 secondary DENV, 36 primary West Nile virus, 38 primary ZIKV, and 35 ZIKV with previous DENV infections as well as 55 flavivirus-naive samples. Each ELISA detected primary DENV infection with a sensitivity of 100% for the same serotype and 23.8% to 100% for different serotypes. IgG ELISA using a mixture of DENV1-4 NS1 proteins detected different primary and secondary DENV infections with a sensitivity of 95.6% and specificity of 89.5%. The ZIKV NS1 IgG ELISA detected ZIKV infection with a sensitivity of 100% and specificity of 82.9%. On the basis of the relative optical density ratio, the combination of DENV1-4 and ZIKV NS1 IgG ELISAs distinguished ZIKV with previous DENV and secondary DENV infections with a sensitivity of 91.7% to 94.1% and specificity of 87.0% to 95.0%. These findings have important applications to serodiagnosis, serosurveillance, and monitoring of both DENV and ZIKV infections in regions of endemicity.
C1 [Tyson, Jasmine; Tsai, Wen-Yang; Youn, Han Ha; Wang, Wei-Kung] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.
   [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Trop Med Ctr, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Kaohsiung, Taiwan.
   [Tsai, Jih-Jin] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan.
   [Brites, Carlos; Pedroso, Celia] Univ Fed Bahia, Sch Med, LAPI Lab Pesquisa Infectol, Salvador, BA, Brazil.
   [Massgard, Ludvig] Linkoping Univ, Fac Med & Hlth Sci, Linkoping, Sweden.
   [Drexler, Jan Felix] Charite Univ Med Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Humboldt Univ, Berlin, Germany.
   [Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [Drexler, Jan Felix] German Ctr Infect Res, Munich, Germany.
   [Stramer, Susan L.] Amer Red Cross Sci Support Off, Gaithersburg, MD USA.
   [Balmaseda, Angel] Minist Hlth, Natl Virol Lab, Natl Ctr Diag & Reference, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Wang, WK (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.
EM wangwk@hawaii.edu
OI TSAI, JIH-JIN/0000-0003-2226-8916; Drexler, Jan
   Felix/0000-0002-3509-0232
FU National Institute of Allergy and Infectious Diseases, NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI110769-01, R21AI135292-01A1, R01 AI099631, U54 AI065359, P01
   AI106695, U19 AI118610]; National Institute of General Medical Sciences,
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P30GM114737]; Ministry of Health and Welfare,
   Taiwan [MOHW107-TDU-B-212-123006]; National Health Research Institute,
   TaiwanNational Health Research Institutes - Taiwan [NHRI-MR-107-PP-38]
FX This work was supported by grants R01AI110769-01 (W.-K.W.),
   R21AI135292-01A1 (W.-K.W.), R01 AI099631 (A.B.), U54 AI065359 (A.B.),
   P01 AI106695 (E.H.), and U19 AI118610 (E.H.) from the National Institute
   of Allergy and Infectious Diseases, NIH, P30GM114737 from the National
   Institute of General Medical Sciences, NIH, MOHW107-TDU-B-212-123006
   (J.-J.-T.) from the Ministry of Health and Welfare, Taiwan,
   NHRI-MR-107-PP-38 (J.-J.-T.) from the National Health Research
   Institute, Taiwan, and in part by a gift from the Outpatient Parenteral
   Antimicrobial Therapy Outcomes Registry in honor of the late Alan Tice.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   CDC, 2017, GUID US LAB TEST ZIK
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Iacobucci G, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1765
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Nascimento EJM, 2018, J VIROL METHODS, V257, P48, DOI 10.1016/j.jviromet.2018.03.007
   Normile D, 2017, SCIENCE, V358, P1514, DOI 10.1126/science.358.6370.1514
   Paldanius M, 2003, CLIN DIAGN LAB IMMUN, V10, P8, DOI 10.1128/CDLI.10.1.8-12.2003
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Simmons G, 2018, CLIN INFECT DIS, V66, P1181, DOI 10.1093/cid/cix972
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Tsai JJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006879
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635
NR 51
TC 2
Z9 2
U1 1
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD FEB
PY 2019
VL 57
IS 2
AR UNSP e01464-18
DI 10.1128/JCM.01464-18
PG 13
WC Microbiology
SC Microbiology
GA HK0MA
UT WOS:000457592200019
PM 30429254
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ramirez, RR
   Ludert, JE
AF Rosales Ramirez, Romel
   Ludert, Juan E.
TI The Dengue Virus Nonstructural Protein 1 (NS1) Is Secreted from Mosquito
   Cells in Association with the Intracellular Cholesterol Transporter
   Chaperone Caveolin Complex
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE dengue virus; NS1; caveolin-1; chaperone caveolin complex; flavivirus;
   mosquito cells; unconventional secretion; viral protein trafficking;
   yellow fever virus; Zika virus
ID ENDOPLASMIC-RETICULUM; CYCLOPHILIN-D; REPLICATION; EXPRESSION;
   INTERACTS; BIOLOGY
AB Dengue virus (DENV) is a mosquito-borne virus of the family Flaviviridae. The RNA viral genome encodes three structural and seven nonstructural proteins. Nonstructural protein 1 (NS1) is a multifunctional protein actively secreted in vertebrate and mosquito cells during infection. In mosquito cells, NS1 is secreted in a caveolin-1-dependent manner by an unconventional route. The caveolin chaperone complex (CCC) is a cytoplasmic complex formed by caveolin-1 and the chaperones FKBP52, Cy40, and CyA and is responsible for the cholesterol traffic inside the cell. In this work, we demonstrate that in mosquito cells, but not in vertebrate cells, NS1 associates with and relies on the CCC for secretion. Treatment of mosquito cells with classic secretion inhibitors, such as brefeldin A, Golgicide A, and Fli-06, showed no effect on NS1 secretion but significant reductions in recombinant luciferase secretion and virion release. Silencing the expression of CAV-1 or FKBP52 with short interfering RNAs or the inhibition of CyA by cyclosporine resulted in significant decrease in NS1 secretion, again without affecting virion release. Colocalization, coimmunoprecipitation, and proximity ligation assays indicated that NS1 colocalizes and interacts with all proteins of the CCC. In addition, CAV-1 and FKBP52 expression was found augmented in DENV-infected cells. Results obtained with Zika virus-infected cells suggest that in mosquito cells, ZIKV NS1 follows the same secretory pathway as that observed for DENV NS1. These results uncover important differences in the dengue virus-cell interactions between the vertebrate host and the mosquito vector as well as novel functions for the chaperone caveolin complex.
   IMPORTANCE The dengue virus protein NS1 is secreted efficiently from both infected vertebrate and mosquito cells. Previously, our group reported that NS1 secretion in mosquito cells follows an unconventional secretion pathway dependent on caveolin-1. In this work, we demonstrate that in mosquito cells, but not in vertebrate cells, NS1 secretion takes place in association with the chaperone caveolin complex, a complex formed by caveolin-1 and the chaperones FKBP52, CyA, and Cy40, which are in charge of cholesterol transport inside the cell. Results obtained with ZIKV-infected mosquito cells suggest that ZIKV NS1 is released following an unconventional secretory route in association with the chaperone caveolin complex. These results uncover important differences in the virus-cell interactions between the vertebrate host and the mosquito vector, as well as novel functions for the chaperone caveolin complex. Moreover, manipulation of the NS1 secretory route may prove a valuable strategy to combat these two mosquito-borne diseases.
C1 [Rosales Ramirez, Romel; Ludert, Juan E.] IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Mexico City, DF, Mexico.
RP Ludert, JE (corresponding author), IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Mexico City, DF, Mexico.
EM jludert@cinvestav.mx
RI Ramirez, Romel Rosales/N-8306-2019
OI Ramirez, Romel Rosales/0000-0001-5326-4753
FU CONACYT (Mexico)Consejo Nacional de Ciencia y Tecnologia (CONACyT)
   [CB-254461]
FX This work was partially funded by CONACYT (Mexico) grant CB-254461 to
   J.E.L. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Akey ADL, 2014, SCIENCE, V343, P1, DOI DOI 10.1126/SCIENCE.1247749.FLAVIVIRUS
   Alcala AC, 2017, J GEN VIROL, V98, P2088, DOI 10.1099/jgv.0.000881
   Alcala AC, 2016, VIROLOGY, V488, P278, DOI 10.1016/j.virol.2015.11.020
   Ball JM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-336
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Byrne DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044879
   Chen XM, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-101
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Das I, 2014, PLOS ONE, V99
   Dawar FU, 2017, J LEUKOCYTE BIOL, V102, P989, DOI 10.1189/jlb.3RU0317-090RR
   Dawar FU, 2017, CURR ISSUES MOL BIOL, V21, P1, DOI 10.21775/cimb.021.001
   de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]
   Favreau DJ, 2012, J VIROL, V86, P81, DOI 10.1128/JVI.06062-11
   Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gonzalez M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00075
   GOULD EA, 1991, VIROLOGY PRACTICAL A, P43
   Gullberg M., 2010, NAT METHODS, V7, pv, DOI DOI 10.1038/NMETH.F.306
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Guy NC, 2016, CURR MOL PHARMACOL, V9, P109, DOI 10.2174/1874467208666150519114115
   Guy Naihsuan C, 2015, Subcell Biochem, V78, P35, DOI 10.1007/978-3-319-11731-7_2
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Henderson J, 1996, CELL BIOL INT, V20, P413, DOI 10.1006/cbir.1996.0052
   Ignatenko N, 2008, NEOPLASIA, V10, P140, DOI 10.1593/neo.07817
   Imai S, 2015, MOL CELL BIOCHEM, V409, P255, DOI 10.1007/s11010-015-2529-5
   Jin Y, 2009, FASEB J, V23, P341, DOI 10.1096/fj.08-108423
   Khachatoorian R, 2016, WORLD J HEPATOL, V8, P9, DOI 10.4254/wjh.v8.i1.9
   Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169
   Kramer A, 2013, NAT CHEM BIOL, V9, P731, DOI [10.1038/NCHEMBIO.1356, 10.1038/nchembio.1356]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leier HC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006952
   Li PY, 2003, ACTA CRYSTALLOGR D, V59, P16, DOI 10.1107/S0907444902017523
   Ludert JE, 2018, BIORXIV, DOI [10.1101/370932, DOI 10.1101/370932]
   Ma JZ, 2013, BIOINFORMATICS, V29, P257, DOI 10.1093/bioinformatics/btt210
   Mir KD, 2007, VIRUS RES, V126, P106, DOI 10.1016/j.virusres.2007.02.004
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3
   Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514
   Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431
   Ricciardi-Jorge T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16231-6
   Rolls MM, 1997, MOL BIOL CELL, V8, P2111, DOI 10.1091/mbc.8.11.2111
   ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z
   Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Soto-Acosta R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006257
   Srisutthisamphan K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22639-5
   Stepanyuk GA, 2008, PROTEIN EXPRES PURIF, V61, P142, DOI 10.1016/j.pep.2008.05.013
   Tanaka Y, 2013, VIRUSES-BASEL, V5, P1250, DOI 10.3390/v5051250
   Teng CY, 2013, MOL BIOTECHNOL, V54, P68, DOI 10.1007/s12033-012-9545-4
   Thiemmeca S, 2016, J IMMUNOL, V197, P4053, DOI 10.4049/jimmunol.1600323
   van der Linden L, 2010, J VIROL, V84, P7535, DOI 10.1128/JVI.02684-09
   Vinci G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002883
   Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160
   Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226
   Wang ZY, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/btt211
   Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07
   Yonemura Y, 2016, J CELL SCI, V129, P3868, DOI 10.1242/jcs.186163
   Youn S, 2010, J VIROL, V84, P9516, DOI 10.1128/JVI.00775-10
NR 61
TC 2
Z9 2
U1 2
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2019
VL 93
IS 4
AR e01985-18
DI 10.1128/JVI.01985-18
PG 25
WC Virology
SC Virology
GA HK2MB
UT WOS:000457744600045
PM 30463973
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wang, Y
   Chen, XY
   Xie, J
   Zhou, SL
   Huang, YX
   Li, YP
   Li, XB
   Liu, C
   He, JF
   Zhang, P
AF Wang, Yi
   Chen, Xiaoyan
   Xie, Jiong
   Zhou, Shili
   Huang, Yanxia
   Li, Yi-Ping
   Li, Xiaobo
   Liu, Chao
   He, Junfang
   Zhang, Ping
TI RNA Helicase A Is an Important Host Factor Involved in Dengue Virus
   Replication
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE dengue virus; flavivirus; host factor; viral replication
ID PROTEIN; TRANSLATION; ASSOCIATION; MEMBERS; HIV-1; IPS-1; NS4B
AB Dengue virus (DENV) utilizes host factors throughout its life cycle. In this study, we identified RNA helicase A (RHA), a member of the DEAD/H helicase family, as an important host factor of DENV. In response to DENV2 infection, nuclear RHA protein was partially redistributed into the cytoplasm. The short interfering RNA-mediated knockdown of RHA significantly reduced the amounts of infectious viral particles in various cells. The RHA knockdown reduced the multistep viral growth of DENV2 and Japanese encephalitis virus but not Zika virus. Further study showed that the absence of RHA resulted in a reduction of both viral RNA and protein levels, and the data obtained from the reporter replicon assay indicated that RHA does not directly promote viral protein synthesis. RHA bound to the DENV RNA and associated with three nonstructural proteins, including NS1, NS2B3, and NS4B. Further study showed that different domains of RHA mediated its interaction with these viral proteins. The expression of RHA or RHA-K417R mutant protein lacking ATPase/helicase activity in RHA-knockdown cells successfully restored DENV2 replication levels, suggesting that the helicase activity of RHA is dispensable for its proviral effect. Overall, our work reveals that RHA is an important factor of DENV and might serve as a target for antiviral agents.
   IMPORTANCE Dengue, caused by dengue virus, is a rapidly spreading disease, and currently there are no treatments available. Host factors involved in the viral replication of dengue virus are potential antiviral therapeutic targets. Although RHA has been shown to promote the multiplication of several viruses, such as HIV and adenovirus, its role in the flavivirus family, including dengue virus, Japanese encephalitis virus, and emerging Zika virus, remains elusive. The current study revealed that RHA relocalized into the cytoplasm upon DENV infection and associated with viral RNA and nonstructural proteins, implying that RHA was actively engaged in the viral life cycle. We further provide evidence that RHA promoted the viral yields of DENV2 independent of its helicase activity. These findings demonstrated that RHA is a new host factor required for DENV replication and might serve as a target for antiviral drugs.
C1 [Wang, Yi; Chen, Xiaoyan; Xie, Jiong; Zhou, Shili; Huang, Yanxia; Li, Yi-Ping; Li, Xiaobo; Liu, Chao; He, Junfang; Zhang, Ping] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou, Guangdong, Peoples R China.
   [Wang, Yi; Chen, Xiaoyan; Xie, Jiong; Zhou, Shili; Huang, Yanxia; Li, Yi-Ping; Li, Xiaobo; Liu, Chao; He, Junfang; Zhang, Ping] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Guangdong, Peoples R China.
RP He, JF; Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou, Guangdong, Peoples R China.; He, JF; Zhang, P (corresponding author), Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Guangdong, Peoples R China.
EM hejf@mail.sysu.edu.cn; zhangp36@mail.sysu.edu.cn
RI Li, Yi-Ping/A-4832-2011
OI Li, Yi-Ping/0000-0003-2360-9516
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81371794]; Guangdong Science and Technology Program
   [2017A050501012, 2016A020219003]; Natural Science Foundation of
   Guangdong ProvinceNational Natural Science Foundation of Guangdong
   Province [2017A030313504, 2014A030311007]; Fundamental Research Funds
   for the Central UniversitiesFundamental Research Funds for the Central
   Universities [17ykjc01]
FX This work was supported by the National Natural Science Foundation of
   China (81371794), the Guangdong Science and Technology Program
   (2017A050501012 and 2016A020219003), the Natural Science Foundation of
   Guangdong Province (2017A030313504 and 2014A030311007), and Fundamental
   Research Funds for the Central Universities (17ykjc01).
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075
   Brai A, 2016, P NATL ACAD SCI USA, V113, P5388, DOI 10.1073/pnas.1522987113
   Brand C, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1437
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Chuang YC, 2016, J IMMUNOL, V196, P1218, DOI 10.4049/jimmunol.1500057
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Dong YC, 2016, BIOCHEM BIOPH RES CO, V473, P648, DOI 10.1016/j.bbrc.2016.03.120
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   Fujii R, 2001, J BIOL CHEM, V276, P5445, DOI 10.1074/jbc.M006892200
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687
   Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092
   He QSC, 2008, J VIROL METHODS, V154, P216, DOI 10.1016/j.jviromet.2008.08.005
   Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034
   Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562
   Lee CG, 1998, P NATL ACAD SCI USA, V95, P13709, DOI 10.1073/pnas.95.23.13709
   Lee T, 2016, ONCOTARGET, V7, P42716, DOI 10.18632/oncotarget.8446
   Lescar J, 2018, ADV EXP MED BIOL, V1062, P115, DOI 10.1007/978-981-10-8727-1_9
   Li GH, 2015, BIOCHEM BIOPH RES CO, V456, P327, DOI 10.1016/j.bbrc.2014.11.080
   Li YY, 2015, IMMUNOLOGY, V144, P127, DOI 10.1111/imm.12357
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Lin L, 2012, J VIROL, V86, P1942, DOI 10.1128/JVI.06362-11
   Liu L, 2016, J VIROL, V90, P5384, DOI 10.1128/JVI.03216-15
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Rahman MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003465
   Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249
   Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Viktorovskaya OV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004921
   Ward AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34379
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Xia JK, 2015, ARCH VIROL, V160, P2791, DOI 10.1007/s00705-015-2574-0
   Xing L, 2012, J VIROL, V86, P13272, DOI 10.1128/JVI.01993-12
   Zhang PF, 2014, J CELL SCI, V127, P2471, DOI 10.1242/jcs.139626
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang ZQ, 2011, J IMMUNOL, V187, P4501, DOI 10.4049/jimmunol.1101307
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 45
TC 2
Z9 3
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2019
VL 93
IS 4
AR e01306-18
DI 10.1128/JVI.01306-18
PG 15
WC Virology
SC Virology
GA HK2MB
UT WOS:000457744600004
PM 30463971
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Marques, VD
   Santos, CS
   Santiago, IG
   Marques, SM
   Brasil, MDN
   Lima, TT
   Costa, PS
AF Marques, Vinicius de Melo
   Santos, Camilla Sousa
   Santiago, Isabella Godinho
   Marques, Solomar Martins
   Nunes Brasil, Maria das Gracas
   Lima, Talita Toledo
   Costa, Paulo Sucasas
TI Neurological Complications of Congenital Zika Virus Infection
SO PEDIATRIC NEUROLOGY
LA English
DT Review
DE Zika virus infection; Infant; Newborn; Microcephaly; Congenital;
   Calcification; Retinal abnormalities; Hydrocephalus
ID PREGNANT-WOMEN; BIRTH-DEFECTS; CASE SERIES; INFANTS; TERRITORIES;
   ULTRASOUND; STANDARDS; AMERICA; FETUSES; BRAZIL
AB BACKGROUND: In utero Zika virus infection resulted in many newborns with congenital defects; this public health issue was followed by unprecedented scientific productivity in this field. Many questions remain about congenital Zika virus infection and its maternal transmission, pathogenesis, clinical events, and the resulting neurological damage. There are few review articles that synthesize the current knowledge of congenital neurological complications as well as the gaps in the pediatric literature.
   OBJECTIVE: We review the full range of data on neurological complications in the newborns and infants born to Zika virus-infected women.
   METHODS: A research question (PCC: Population, newborns and infants of infected mothers; Concept, neurological outcomes at birth; Context, congenital Zika virus infection) was created to guide our review in searching several databases: PubMed, Lilacs, CINAHL, Cochrane Library, and OpenGrey literature. A total of 34 articles were included in the final review.
   RESULTS: Central nervous system calcifications, mainly at the cortical-subcortical junction, were the most prevalent neurological birth defects related to Zika infection (104/112, 92.9% from seven studies). Also, microcephaly occurred in 39.7% of all infected infants (1561/3931 patients in all the studies) and ventriculomegaly and/or hydrocephalus occurred in 63.1% (157/249 patients analyzed in 12 studies). A total of 10 articles detailed ocular findings, including macular lesions, focal pigment mottling of the retina, chorioretinal atrophy, optic nerve abnormalities, cataract, microphthalmia, and strabismus, among others.
   CONCLUSIONS: Neurological and related malformations are common lesions in individuals with congenital Zika syndrome. Long-term follow-up studies in this field are lacking. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Marques, Vinicius de Melo; Marques, Solomar Martins; Costa, Paulo Sucasas] Univ Fed Goias, Sch Med, Dept Pediat, Goiania, Go, Brazil.
   [Santos, Camilla Sousa] Univ Fed Sao Paulo UNIFESP, Dept Pediat Neurol, Sao Paulo, SP, Brazil.
   [Santiago, Isabella Godinho; Nunes Brasil, Maria das Gracas] Univ Fed Goias, Hosp Clin, Dept Pediat Neurol, Goiania, Go, Brazil.
   [Lima, Talita Toledo] Univ Fed Goias, Hosp Clin, Dept Ophtalmol, Goiania, Go, Brazil.
RP Costa, PS (corresponding author), Univ Fed Goias, Dept Pediat, Hosp Clin, Primeira Ave,S-N, BR-74605020 Goiania, Go, Brazil.
EM paulosucasas@ufg.br
RI Costa, Paulo S/L-5460-2016
OI Costa, Paulo S/0000-0001-9370-9139
CR Adamski A, 2018, J INFECTION, V76, P529, DOI 10.1016/j.jinf.2018.02.010
   Alves LV, 2018, J CHILD NEUROL, V33, P664, DOI 10.1177/0883073818780105
   [Anonymous], 2016, N Engl J Med, V375, P498, DOI 10.1056/NEJMx160025
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   ARAGAO MDV, 2016, BMJ, V353
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2016, EURO SURVEILL B, V21
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cardoso TF, 2019, ARCH DIS CHILD, V104, P199, DOI 10.1136/archdischild-2018-314782
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   ESTROFF JA, 1992, J ULTRAS MED, V11, P686
   Etienne C, 2017, AM J TROP MED HYG, V97, P16, DOI 10.4269/ajtmh.17-0207
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gharbaran R, 2019, PEDIATR DEVEL PATHOL, V22, P5, DOI 10.1177/1093526618790742
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Leal MC, 2016, BRAZ J OTORHINOLAR, DOI [10.1016/j.bjor1.2016.06.001, DOI 10.1016/J.BJOR1.2016.06.001]
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira-Soto A, 2018, MSPHERE, V3
   Moron AF, 2016, BJOG-INT J OBSTET GY, V123, P1265, DOI 10.1111/1471-0528.14072
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   Pan American Health Organization/World Health Organization, 2017, SIT REP ZIK VIR
   Pan American Health Organization/World Health Organization, 2017, ZIK EP REP COL SEP 2
   Pan American Health Organization/World Health Organization, 2015, EP AL NEUR SYNDR CON
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Perez S, 2016, EURO SURVEILL, V21
   Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050
   PETRIBU NCD, 2017, BMJ, V359
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009
   Pires P, 2018, CHILD NERV SYST, V34, P957, DOI 10.1007/s00381-017-3682-9
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2016, FETAL BRAIN DAMAGE Z
   SEFEROVIC M, 2018, SCI REP, V8
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   United States Center for Disease Control and Prevention, 2017, HEALTHC PROV
   van der Linden H, 2018, NEW ENGL J MED, V379, P891, DOI 10.1056/NEJMc1716070
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   VANDERLINDEN V, 2016, BMJ, V354
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   World Health Organization, 2016, HEAD CIRC FOR AG
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 71
TC 7
Z9 7
U1 1
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD FEB
PY 2019
VL 91
BP 3
EP 10
DI 10.1016/j.pediatrneurol.2018.11.003
PG 8
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA HK1HS
UT WOS:000457656400002
PM 30591235
DA 2020-07-08
ER

PT J
AU Freeman, MC
   Coyne, CB
   Green, M
   Williams, JV
   Silva, LA
AF Freeman, Megan Culler
   Coyne, Carolyn B.
   Green, Michael
   Williams, John V.
   Silva, Laurie A.
TI Emerging arboviruses and implications for pediatric transplantation: A
   review
SO PEDIATRIC TRANSPLANTATION
LA English
DT Review
DE arboviruses; chikungunya virus; dengue virus; pediatric transplantation;
   transplantation; Zika virus
ID DENGUE VIRUS TRANSMISSION; ZIKA VIRUS; CHIKUNGUNYA VIRUS;
   VIRAL-INFECTIONS; DOUBLE-BLIND; KIDNEY-TRANSPLANTATION; CLINICAL
   PRESENTATION; LIVING DONOR; RECIPIENTS; FEVER
AB Recent years have brought a rise in newly emergent viral infections, primarily in the form of previously known arthropod-transmitted viruses that have increased significantly in both incidence and geographical range. Of particular note are DENV, CHIKV, and ZIKV, which are transmitted mostly by Aedes species of mosquitoes that exhibit a wide and increasing global distribution. Being important pathogens for the general population, these viruses have the potential to be devastating in the international transplant community, with graft rejection and death as possible outcomes of infection. In this review, we discuss the current state of knowledge for these viruses as well as repercussions of infection in the solid organ and HSCT population, with a focus, when possible, on pediatric patients.
C1 [Freeman, Megan Culler; Coyne, Carolyn B.; Green, Michael; Williams, John V.; Silva, Laurie A.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Pediat Infect Dis,Dept Pediat,UPMC, Pittsburgh, PA USA.
RP Silva, LA (corresponding author), Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA.
EM laurie.silva@chp.edu
RI freeman, megan culler/AAF-3626-2020
OI Freeman, Megan/0000-0003-3389-6731
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Arien KK, 2018, LANCET GLOB HEALTH, V6, pE830, DOI 10.1016/S2214-109X(18)30295-X
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barroso KSN, 2017, BONE MARROW TRANSPL, V52, P1455, DOI 10.1038/bmt.2017.152
   Benamu E, 2017, CURR OPIN INFECT DIS, V30, P329, DOI 10.1097/QCO.0000000000000377
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blohm GM, 2017, GENOME ANNOUNC, V5
   Blumberg EA, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14083
   Branche E, 2018, ANTIVIR RES, V158, P1, DOI 10.1016/j.antiviral.2018.07.022
   Budigi Y, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006209
   Burke DS, 2006, J INFECT DIS, V193, P601, DOI 10.1086/499282
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   CDC, 2018, WORLD MAP AR RISK ZI
   Center for Disease Control, DENGUEMAP
   Center for Disease Control, 2018, COUNTR TERR CHIK CAS
   Charrel RN, 2014, CLIN MICROBIOL INFEC, V20, P662, DOI 10.1111/1469-0691.12694
   Chattopadhyay A, 2018, VACCINE, V36, P3894, DOI 10.1016/j.vaccine.2018.05.095
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Costa SD, 2015, AM J TROP MED HYG, V93, P394, DOI 10.4269/ajtmh.15-0038
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   Culshaw Abigail, 2018, F1000Res, V7, P203, DOI 10.12688/f1000research.12271.1
   Darrigo LG, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0612-2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Pereira BBSD, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12721
   Dubrocq G, 2017, J PEDIATR INFECT DIS, V6, pE158, DOI 10.1093/jpids/pix048
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Maia SHF, 2015, REV SOC BRAS MED TRO, V48, P783, DOI 10.1590/0037-8682-0205-2015
   Fernandes Paula Frassinetti Castelo Branco Camurca, 2017, World J Transplant, V7, P57, DOI 10.5500/wjt.v7.i1.57
   Food and Drug Administration, EM US AUTH
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gallagher LM, 2013, TRANSFUSION, V53, P455, DOI 10.1111/j.1537-2995.2012.03808.x
   Garcia JHP, 2006, TRANSPLANTATION, V82, P850, DOI 10.1097/01.tp.0000235151.60237.fe
   Gasperina DD, 2015, TRANSPL INFECT DIS, V17, P876, DOI 10.1111/tid.12453
   Girao ES, 2017, TRANSPL P, V49, P2076, DOI 10.1016/j.transproceed.2017.07.004
   Global Observatory on Donation and Transplantation, 2018, GLOB OBS DON TRANSPL
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Goodnough LT, 2017, ANESTH ANALG, V124, P282, DOI [10.1213/ANE.0000000000001770, 10.1213/ane.0000000000001770]
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Gupta RK, 2016, J CLIN EXP HEPATOL, V6, P59, DOI 10.1016/j.jceh.2016.01.005
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hagmann SHF, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0584-7
   Haidar G, 2017, CURR OPIN INFECT DIS, V30, P579, DOI [10.1097/QCO.0000000000000409, 10.1097/qco.0000000000000409]
   Heck E, 2017, AM J TRANSPLANT, V17, P2227, DOI 10.1111/ajt.14334
   Jhan M-K, 2018, J LEUKOCYTE BIOL, V6, P297
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Kee ACL, 2010, EMERG INFECT DIS, V16, P1038, DOI 10.3201/eid1606.091115
   Kerdpanich Angkool, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P488
   Kitagawa MG, 2018, J PEDIAT INF DIS SOC, V7, pE52, DOI 10.1093/jpids/pix100
   Kotton CN, 2016, TRANSPLANTATION, V100, P970, DOI 10.1097/TP.0000000000001179
   Lee PJ, 2016, PEDIAT REV, V37, P1
   Levi ME, 2013, CURR INFECT DIS REP, V15, P478, DOI 10.1007/s11908-013-0367-8
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Malakar S, 2018, VIRUS RES, V255, P171, DOI 10.1016/j.virusres.2018.07.018
   Nunez RM, 2017, REV CHIL PEDIATR-CHI, V88, P765, DOI 10.4067/S0370-41062017000600765
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moura-Neto JA, 2017, KIDNEY INT REP, V2, P1250, DOI 10.1016/j.ekir.2017.06.003
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nasim A, 2013, TRANSPL INFECT DIS, V15, P516, DOI 10.1111/tid.12114
   Neumayr A, 2017, EUROSURVEILLANCE, V22, P903
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Nogueira ML, 2016, AM J TRANSPLANT, V17, P791
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Paixao ES, 2018, T ROY SOC TROP MED H, V112, P301, DOI 10.1093/trstmh/try063
   Park SB, 2008, TRANSPL P, V40, P2431, DOI 10.1016/j.transproceed.2008.07.037
   Pierrotti LC, 2017, INT J INFECT DIS, V64, P96, DOI 10.1016/j.ijid.2017.09.009
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Potts JA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000769
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Punzel M, 2014, EMERG INFECT DIS, V20, P1366, DOI 10.3201/eid2008.140508
   Ramabhatta S, 2017, INDIAN J PEDIATR, V84, P897, DOI 10.1007/s12098-017-2423-0
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Rauf Abdul, 2017, J Ayub Med Coll Abbottabad, V29, P432
   Razonable RR, 2011, EXPERT REV ANTI-INFE, V9, P685, DOI [10.1586/eri.11.43, 10.1586/ERI.11.43]
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Ritz N, 2015, PEDIATR INFECT DIS J, V34, P789, DOI 10.1097/INF.0000000000000716
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Roques P, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050268
   Saigal S, 2013, LIVER TRANSPLANT, V19, P1413, DOI 10.1002/lt.23755
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shingde R, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12851
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Silveira FP, 2016, J HEART LUNG TRANSPL, V35, P560, DOI 10.1016/j.healun.2016.03.010
   Simarmata D, 2016, SCI REP, V6, P1
   Subbiah A, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12875
   Tangnararatchakit K, 2012, TRANSPL P, V44, P303, DOI 10.1016/j.transproceed.2011.11.025
   Tharmarajah Kothila, 2017, F1000Res, V6, P2114, DOI 10.12688/f1000research.12461.1
   Thomas S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006879
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Verhagen LM, 2014, J INFECTION, V69, pS77, DOI 10.1016/j.jinf.2014.07.020
   Viennet E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004943
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Visuthranukul J, 2009, INFECT DIS REP, V1, DOI 10.4081/idr.2009.e3
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2013, CLIN INFECT DIS, V57, P1182, DOI 10.1093/cid/cit456
   Weerakkody RM, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-016-0428-y
   Weerakkody Ranga Migara, 2014, J Med Case Rep, V8, P378, DOI 10.1186/1752-1947-8-378
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Winston DJ, 2014, TRANSPLANTATION, V97, P881, DOI 10.1097/TP.0000000000000024
   World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Yango AF, 2014, TRANSPLANTATION, V97, P953, DOI 10.1097/01.TP.0000438621.81686.ab
NR 118
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1397-3142
EI 1399-3046
J9 PEDIATR TRANSPLANT
JI Pediatr. Transplant.
PD FEB
PY 2019
VL 23
IS 1
DI 10.1111/petr.13303
PG 12
WC Pediatrics; Transplantation
SC Pediatrics; Transplantation
GA HK0HK
UT WOS:000457579500013
PM 30338634
OA Bronze
DA 2020-07-08
ER

PT J
AU Wachira, VK
   Peixoto, HM
   de Oliveira, MRF
AF Wachira, Virginia Kagure
   Peixoto, Henry Maia
   Fernandes de Oliveira, Maria Regina
TI Systematic review of factors associated with the development of
   Guillain-Barre syndrome 2007-2017: what has changed?
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Review
DE Guillain-Barre syndrome; acute inflammatory demyelinating
   polyneuropathy; acute inflammatory demyelinating polyradiculoneuropathy;
   acute inflammatory polyneuropathy; demyelinating polyradiculoneuropathy;
   systematic review
ID HUMAN-PAPILLOMAVIRUS VACCINE; ZIKA VIRUS OUTBREAK; CAMPYLOBACTER
   INFECTION; ADVERSE EVENTS; RISK; MONOVALENT; ANTIBODIES; COHORT; BRAZIL;
   USA
AB Objective The objective of this study was to describe the factors associated with the development of Guillain-Barre syndrome, both infectious and non-infectious, during and after the A(H1N1) influenza pandemic in 2009 and the recent Zika virus epidemic in the Americas. Method Systematic review of literature on factors associated with the development of the Guillain-Barre syndrome published between 2007 and 2017 listed in EBSCO, MEDLINE and LILACS databases. The quality of the studies was evaluated using the Newcastle Ottawa Scale. Results Thirty-four articles met inclusion criteria and were selected for analysis. Their quality was considered good in relation to most of the items evaluated. Many aetiological agents had the results of association with Guillain-Barre syndrome, among them Campylobacter jejuni, influenza vaccine - both pandemic and seasonal vaccines, respiratory infection, gastrointestinal infection among others. The aetiological agents found are, in most part, the same reported prior to the study period. The association with surgeries, chikungunya virus (CHIKV), Zika virus and quadrivalent human papillomavirus vaccine stand out as new aetiological agents in the list of the various possible agents that trigger Guillain-Barre syndrome reported in the study period. There were no Brazilian studies identified during this period. Conclusions The results of the review reaffirmed C. jejuni as the major trigger of GBS, whereas the association of influenza vaccines and GBS is less clear; Zika virus infection in association with GBS was found in only one study.
C1 [Wachira, Virginia Kagure; Peixoto, Henry Maia; Fernandes de Oliveira, Maria Regina] Univ Brasilia, Ctr Trop Med, Campus Univ Darcy Ribeiro S-N,Asa Norte, BR-70904970 Brasilia, DF, Brazil.
   [Peixoto, Henry Maia; Fernandes de Oliveira, Maria Regina] Natl Inst Sci & Technol Hlth Technol Assessment, Porto Alegre, RS, Brazil.
RP Wachira, VK (corresponding author), Univ Brasilia, Ctr Trop Med, Campus Univ Darcy Ribeiro S-N,Asa Norte, BR-70904970 Brasilia, DF, Brazil.
EM vgkagure@yahoo.com
RI Peixoto, Henry Maia/B-7997-2013
OI Peixoto, Henry Maia/0000-0001-5982-8855; WACHIRA,
   VIRGINIA/0000-0001-8018-9939
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Brazilian Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Apoio a Pesquisa do DF (FAP-DF)National
   Council for Scientific and Technological Development (CNPq); National
   Institute for Science and Technology for Health Technology Assessment
   (IATS)
FX This study was supported by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), the Brazilian Council for Scientific and
   Technological Development (CNPq); Fundacao de Apoio a Pesquisa do DF
   (FAP-DF) (Edital 04/2016 - Demanda Induzida - Aedes Aegypti e as
   arboviroses Zika, Chikungunya e Dengue) and the National Institute for
   Science and Technology for Health Technology Assessment (IATS).
CR Alcalde-Cabero E, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0598-z
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004
   Aparecida M, 2011, REV PAUL PEDIATR, V29, P685
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bae JS, 2014, J NEUROL NEUROSUR PS, V85, P905, DOI 10.1136/jnnp-2013-306212
   Baker MA, 2015, AM J EPIDEMIOL, V181, P608, DOI 10.1093/aje/kwu322
   Benamer HTS, 2014, J NEUROL SCI, V343, P221, DOI 10.1016/j.jns.2014.05.065
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Burwen DR, 2012, AM J PUBLIC HEALTH, V102, P1921, DOI 10.2105/AJPH.2011.300510
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0
   de Freitas MRG, 2017, ARQ NEURO-PSIQUIAT, V75, P600, DOI [10.1590/0004-282X20170093, 10.1590/0004-282x20170093]
   Dieleman J, 2011, BMJ-BRIT MED J, V343, P3908
   Esan OB, 2017, EBIOMEDICINE, V15, P100, DOI 10.1016/j.ebiom.2016.12.006
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Galeotti F, 2013, EUR J EPIDEMIOL, V28, P433, DOI 10.1007/s10654-013-9797-8
   Geier DA, 2017, IMMUNOL RES, V65, P46, DOI 10.1007/s12026-016-8815-9
   Geier DA, 2015, CLIN RHEUMATOL, V34, P1225, DOI 10.1007/s10067-014-2846-1
   Ghaderi S, 2016, EUR J EPIDEMIOL, V31, P67, DOI 10.1007/s10654-015-0047-0
   Grimaldi-Bensouda L, 2014, J INTERN MED, V275, P398, DOI 10.1111/joim.12155
   Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1
   Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005
   Hardy TA, 2011, CURR ALLERGY ASTHM R, V11, P197, DOI 10.1007/s11882-011-0190-y
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735
   Jackson BR, 2014, EPIDEMIOL INFECT, V142, P1089, DOI 10.1017/S0950268813001908
   Jasti AK, 2016, EXPERT REV CLIN IMMU, V12, P1175, DOI 10.1080/1744666X.2016.1193006
   Kang JH, 2010, CLIN INFECT DIS, V51, P525, DOI 10.1086/655136
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Arias LHM, 2015, VACCINE, V33, P3773, DOI 10.1016/j.vaccine.2015.05.013
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Orbach H, 2010, DISCOV MED, V9, P90
   Petersen I, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4515
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Pithadia AB, 2010, PHARMACOL REP, V62, P220, DOI 10.1016/S1734-1140(10)70261-9
   Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602
   Prestel J, 2014, PHARMACOEPIDEM DR S, V23, P1192, DOI 10.1002/pds.3638
   Romio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082222
   Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8
   Schonberger LB, 1979, AM J EPIDEMIOL, V95, P65
   Schulz KF, 2002, LANCET, V359, P431, DOI 10.1016/S0140-6736(02)07605-5
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sharma A, 2011, Neurol India, V59, P717, DOI 10.4103/0028-3886.86547
   Sinha S, 2007, CLIN MICROBIOL INFEC, V13, P334, DOI 10.1111/j.1469-0691.2006.01636.x
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc
   Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Taylor BV, 2007, J CLIN NEUROSCI, V14, P116, DOI 10.1016/j.jocn.2006.01.040
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   van den Berg B, 2014, NEUROLOGY, V82, P491, DOI 10.1212/WNL.0000000000000111
   Wells GA, 2014, NEWCASTLE OTTAWA SCA
   Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302
   Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342
   Williams SE, 2011, VACCINE, V29, P8302, DOI 10.1016/j.vaccine.2011.08.093
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 59
TC 7
Z9 7
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD FEB
PY 2019
VL 24
IS 2
BP 132
EP 142
DI 10.1111/tmi.13181
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HK0MN
UT WOS:000457593700001
PM 30444562
OA Bronze
DA 2020-07-08
ER

PT J
AU Marklewitz, M
   Junglen, S
AF Marklewitz, Marco
   Junglen, Sandra
TI Evolutionary and ecological insights into the emergence of
   arthropod-borne viruses
SO ACTA TROPICA
LA English
DT Article; Proceedings Paper
CT Conference on Impact of Environmental Change on Infectious Diseases
   (IECID)
CY MAY 17-19, 2017
CL Trieste, ITALY
DE Arbovirus; Mosquito; Virus evolution; Pathogen emergence; Virus ecology
ID WEST-NILE-VIRUS; INTERMEDIATE DISTURBANCE HYPOTHESIS; 6TH MASS
   EXTINCTION; AEDES-AEGYPTI; ARBOVIRUS INFECTION; CLIMATE-CHANGE;
   THROMBOCYTOPENIA SYNDROME; ENVELOPE GLYCOPROTEIN; CHIKUNGUNYA VIRUS;
   BIODIVERSITY LOSS
AB The emergence of arthropod-borne viruses (arboviruses) is of global concern as they can rapidly spread across countries and to new continents as the recent examples of chikungunya virus and Zika virus have demonstrated. Whereas the global movement patterns of emerging arboviruses are comparatively well studied, there is little knowledge on initial emergence processes that enable sylvatic (enzootic) viruses to leave their natural amplification cycle and infect humans or livestock, often also involving infection of anthropophilic vector species. Emerging arboviruses almost exclusively originate in highly biodiverse ecosystems of tropical countries. Changes in host population diversity and density can affect pathogen transmission patterns and are likely to influence arbovirus emergence processes. This review focuses on concepts from disease ecology, explaining the interplay between biodiversity and pathogen emergence.
C1 [Marklewitz, Marco; Junglen, Sandra] Charite Univ Med Berlin, Berlin, Germany.
   [Marklewitz, Marco; Junglen, Sandra] Free Univ Berlin, Berlin, Germany.
   [Marklewitz, Marco; Junglen, Sandra] Humboldt Univ, Berlin, Germany.
   [Marklewitz, Marco; Junglen, Sandra] Berlin Inst Hlth, Berlin, Germany.
   [Marklewitz, Marco; Junglen, Sandra] German Ctr Infect Res DZIF, Braunschweig, Germany.
RP Junglen, S (corresponding author), Charite Univ Med Berlin, Inst Virol, Charitepl 1, D-10117 Berlin, Germany.
EM sandra.junglen@charite.de
RI Marklewitz, Marco/AAD-1354-2019
OI Marklewitz, Marco/0000-0003-1828-8770; Junglen,
   Sandra/0000-0002-3799-6011
FU Federal Ministry of Education and Research (BMBF) as part of the
   Research Network Zoonotic Infectious DiseasesFederal Ministry of
   Education & Research (BMBF) [01KI1716]
FX This work was funded by the Federal Ministry of Education and Research
   (BMBF) under project number 01KI1716 as part of the Research Network
   Zoonotic Infectious Diseases.
CR Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9
   Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103
   Apte-Deshpande AD, 2014, INDIAN J MED RES, V139, P762
   Baak A. C., 2002, J VIROL, V76, P6387, DOI [10.1128/JVI.76.12.6387-6392.2002, DOI 10.1128/JVI.76.12.6387-6392.2002]
   Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678
   Begon M, 2009, EPIDEMICS-NETH, V1, P35, DOI 10.1016/j.epidem.2008.10.001
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Bongers F, 2009, ECOL LETT, V12, P798, DOI 10.1111/j.1461-0248.2009.01329.x
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brault AC, 2002, J VIROL, V76, P1718, DOI 10.1128/JVI.76.4.1718-1730.2002
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Charlier N, 2010, J GEN VIROL, V91, P1693, DOI 10.1099/vir.0.019851-0
   CHEN RB, 2013, PLOS PATHOG, V9, DOI DOI 10.1371/JOUMALPPAT.0030201.E201
   Chen RB, 2016, J VIROL, V90, P10600, DOI 10.1128/JVI.01166-16
   Civitello DJ, 2015, P NATL ACAD SCI USA, V112, P8667, DOI 10.1073/pnas.1506279112
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108
   Cohen JM, 2016, P NATL ACAD SCI USA, V113, pE3359, DOI 10.1073/pnas.1521657113
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   Dudas G., 2015, ELIFE, V2015, P1, DOI [10.7554/eLife.05378, DOI 10.7554/ELIFE.05378]
   Elizondo-Quiroga D, 2013, J GLOB INFECT DIS, V5, P168, DOI 10.4103/0974-777X.122014
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284
   Faust CL, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0173
   Forks D.A., 2000, AM J TROP MED HYG, V62, P11, DOI DOI 10.4269/AJTMH.2000.62.11
   Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   Fortuna C., 2018, B EUR MAL TRANSM EUR, V23, DOI [10.2807/1560-7917.E5.2018.23.22.1800246, DOI 10.2807/1560-7917.E5.2018.23.22.1800246]
   Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Greene IP, 2005, J VIROL, V79, P9128, DOI 10.1128/JVI.79.14.9128-9133.2005
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Guterres A, 2017, INFECT GENET EVOL, V49, P164, DOI 10.1016/j.meegid.2017.01.019
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   HENDRICKS DA, 1983, AM J TROP MED HYG, V32, P602, DOI 10.4269/ajtmh.1983.32.602
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   IUCN (International Union for Conservation of Nature), 2018, IUCN RED LIST THREAT
   Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032
   Jia YQ, 2007, VIROLOGY, V367, P339, DOI 10.1016/j.virol.2007.06.008
   Johnson PTJ, 2010, J EXP BIOL, V213, P961, DOI 10.1242/jeb.037721
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x
   Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575
   Khalil H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31314
   Kunkel KE, 2006, AM J TROP MED HYG, V74, P168, DOI 10.4269/ajtmh.2006.74.168
   Lacroix C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0947
   Lafferty K. D., 2016, RISE FALL INFECT DIS, DOI [10.12688/f1000research.8766.1, DOI 10.12688/F1000RESEARCH.8766.1]
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Lawrie CH, 2004, MED VET ENTOMOL, V18, P268, DOI 10.1111/j.0269-283X.2004.00505.x
   Levine RS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1999-6
   Leyssen P, 2002, VIROLOGY, V293, P125, DOI 10.1006/viro.2001.1241
   Li CX, 2015, ELIFE, V4, DOI 10.7554/eLife.05378
   Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2
   LOAIZA JR, 2017, SCI REP, V7, DOI DOI 10.1038/541598-017-07476-2
   Loss SR, 2009, OECOLOGIA, V159, P415, DOI 10.1007/s00442-008-1224-6
   Lucas KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/j.pt.2013.04.003
   Madon MB, 2002, J VECTOR ECOL, V27, P149
   Marklewitz M, 2011, J VIROL, V85, P9227, DOI 10.1128/JVI.00230-11
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   Marklewitz M, 2013, J VIROL, V87, P12850, DOI 10.1128/JVI.01862-13
   Milholland MT, 2017, ILAR J, V58, P401, DOI 10.1093/ilar/ily001
   Molino JF, 2001, SCIENCE, V294, P1702, DOI 10.1126/science.1060284
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Nasar F, 2012, P NATL ACAD SCI USA, V109, P14622, DOI 10.1073/pnas.1204787109
   NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2
   Ogden N. H., 2009, EPIDEMICS, DOI [10.10I6/j.epidem.2009.06.002, DOI 10.10I6/J.EPIDEM.2009.06.002]
   Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061
   Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022
   Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125
   Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x
   Pagan L, 2012, PLOS PATHOG, V8, P47, DOI [10.1371/journaLppat.1002796, DOI 10.1371/JOURNALPPAT.1002796]
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Palmer WH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030118
   PATTERSON EI, 2018, VIRUS EVOL, V4, DOI DOI 10.1093/VE/VEY00I
   Paz S., 2015, PHILOS T R SOC LON B, V370, DOI DOI 10.1098/RSTB.2013.0561.20130561
   Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021
   Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12
   Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200
   Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rohr JR, 2011, TRENDS ECOL EVOL, V26, P270, DOI 10.1016/j.tree.2011.03.002
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004
   Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2
   Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5
   Shaman J, 2002, EMERG INFECT DIS, V8, P6
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008
   Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vazeille M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29564
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105
   Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wernike K, 2014, PREV VET MED, V116, P423, DOI 10.1016/j.prevetmed.2014.03.021
   Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1
   Wuerth JD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060174
NR 125
TC 3
Z9 4
U1 3
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2019
VL 190
BP 52
EP 58
DI 10.1016/j.actatropica.2018.10.006
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HJ9HV
UT WOS:000457510400009
PM 30339799
DA 2020-07-08
ER

PT J
AU Higuera, A
   Ramirez, JD
AF Higuera, Adriana
   David Ramirez, Juan
TI Molecular epidemiology of dengue, yellow fever, Zika and Chikungunya
   arboviruses: An update
SO ACTA TROPICA
LA English
DT Review
DE Dengue virus; Yellow fever virus; Zika virus; Chikungunya virus;
   Molecular epidemiology
ID 3 NONCODING REGION; VIRUS SEROTYPE 4; HEMORRHAGIC-FEVER;
   PHYLOGENETIC-RELATIONSHIPS; VERTICAL TRANSMISSION; NUCLEOTIDE-SEQUENCE;
   GENE-EXPRESSION; GENOME ANALYSIS; AEDES-AEGYPTI; EVOLUTION
AB Arboviruses are a group of viruses transmitted by arthropods. They are characterized by a wide geographic distribution, which is associated with the presence of the vector, and cause asymptomatic infections or febrile diseases in humans in both enzootic and urban cycles. Recent reports of human infections caused by viruses such as dengue, Zika, and chikungunya have raised concern regarding public health, and have led to the re-evaluation of surveillance mechanisms and measures to control the transmission of these arboviruses. Viruses such as Mayaro and Usutu are not currently responsible for a high number of symptomatic infections in humans, but should remain under epidemiological surveillance to avoid the emergence of new epidemics, as happened with Zika virus, that are associated with new or more severe symptoms. Additionally, significant variation has been observed in these viruses, giving rise to different lineages. Until recently, the emergence of new lineages has primarily been related to geographical distribution and dispersion, allowing us to ascertain the possible origins and direction of expansion of each virus type, and to make predictions regarding regions where active infections in humans are likely to occur. Therefore, this review is focused on untangling the molecular epidemiology of Dengue, Yellow fever, Zika and Chikungunya due to their recent epidemics in Latinamerica but provides an update on the geographical distribution globally of these viral variants, and outlines the need for further understanding of the genotypes/lineages assignment.
C1 [Higuera, Adriana; David Ramirez, Juan] Univ Rosario, Fac Ciencias Nat & Matemat, Programa Biol, Grp Invest Microbiol UR GIMUR, Bogota, Colombia.
RP Ramirez, JD (corresponding author), Univ Rosario, Fac Ciencias Nat & Matemat, Programa Biol, Grp Invest Microbiol UR GIMUR, Bogota, Colombia.
EM juand.ramirez@urosario.edu.co
CR AbuBakar S, 2002, J GEN VIROL, V83, P2437, DOI 10.1099/0022-1317-83-10-2437
   ACOSTAAMPUDIA Y, EMERG MICROBES INFEC, P3
   Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Andral L., 1968, B WORLD HEALTH ORGAN, V38
   Anez G, 2012, ISBT SCI SERIES, V7, P274, DOI DOI 10.1111/J.1751-2824.2012.01602.X
   Aquino VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007299
   Auguste AJ, 2010, J VIROL, V84, P9967, DOI 10.1128/JVI.00588-10
   Awadh A., 2017, PLOS CURRENTS OUTBRE
   Azhar EI, 2015, COMPLETE, V12, P1
   BADII M, 2007, ECOLOGIA A HISTORIA
   Badii M., 2007, VIROL J
   BEATY BJ, 1980, AM J TROP MED HYG, V29, P125, DOI 10.4269/ajtmh.1980.29.125
   Beck A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001910
   BESNARD M, 2014, EVIDENCE, P2013
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blohm GM, 2018, CLIN INFECT DIS, V67, P619, DOI 10.1093/cid/ciy224
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bryant JE, 2005, J VIROL, V79, P3807, DOI 10.1128/JVI.79.6.3807-3821.2005
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Calzolari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063978
   Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CARNACHO D, 2017, ACTA TROP, V174, P88
   Carrington CVF, 2013, INFECT GENET EVOL, V13, P198, DOI 10.1016/j.meegid.2012.08.015
   CDC, 2017, ARBOVIRUS CATALOG VI
   *CDC, 2017, INFECTIOUS DISEASES, V3, P2016
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Chao DY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-72
   Chen KC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-169
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Clark BM, 2012, J CLIN VIROL, V54, P376, DOI 10.1016/j.jcv.2012.04.012
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108
   Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DERODANICHE E, 1957, AM J TROP MED HYG, V1956, P6
   DEUBEL V, 1986, J GEN VIROL, V67, P209, DOI 10.1099/0022-1317-67-1-209
   DEUBEL V, 1985, AM J TROP MED HYG, V34, P976, DOI 10.4269/ajtmh.1985.34.976
   DIALLO D, 2014, PLOS ONE, V9
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dutary B. E., 1981, THE ORIGIN AND EVOLU
   DUTARY BE, 1981, TRANSOVARIAL TRANSMI
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   EYROLLEGUIGNOT D, 2016, LANCET, V387, P2125, DOI DOI 10.1016/50140-6736(16)00651-6.PUBMED
   FAMON E, 2007, UPDATE, V56, P276
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   FAYE O, 2014, PLOS NEGLECT TROP D, V8, P5624
   Foster JE, 2003, VIROLOGY, V306, P126, DOI 10.1016/S0042-6822(02)00033-8
   FOURIE ED, 1979, S AFR MED J, V56, P130
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   de Araujo JMG, 2009, MEM I OSWALDO CRUZ, V104, P526, DOI 10.1590/S0074-02762009000300021
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Goenaga S, 2012, VECTOR-BORNE ZOONOT, V12, P986, DOI 10.1089/vbz.2011.0730
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   GOULD EA, 1985, J GEN VIROL, V66, P1369, DOI 10.1099/0022-1317-66-7-1369
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler DJ, 1996, T ROY SOC TROP MED H, V90, P449, DOI 10.1016/S0035-9203(96)90286-2
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gutierrez-Bugallo G, 2017, ACTA TROP, V174, P146, DOI 10.1016/j.actatropica.2017.07.012
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102
   Harwood PF, 2015, INFECT GENET EVOL, V34, P479
   HAYES EB, 2009, ZIKA VIRUS OUTSIDE A, V9, P2009
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Huang JH, 2009, EMERG INFECT DIS, V15, P1854, DOI 10.3201/eid1511.090398
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Idrees Sobia, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P232, DOI 10.1016/S2221-1691(13)60057-X
   KARBAAT J, 1964, TROP GEOGR MED, V16, P370
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   Kim JH, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0388-y
   KING CC, 2008, VIRAL J, V3, P5
   Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   KOCHAKATN T, 2016, MED, V9, P1048
   KRAEMER MUG, 2015, C M, V4
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   LANCIOTTI RS, 2008, EMERG INFECT DIS, P2007
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lourenco-de-Oliveira R, 2017, PLOS NEGL TROP DIS, V11
   Luciani K, 2015, AM J TROP MED HYG, V92, P1130, DOI 10.4269/ajtmh.14-0845
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Manakkadan A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-37
   Marc G., 2011, EMERG INFECT DIS J, V17, P910
   Masri Sembiring M., 2015, AM J TROP MED HYG, V21, P379, DOI 10.3201/eid2102.141121
   May M., 2016, EMERG INFECT DIS J, V11, DOI 10.1371/journal.pone
   Mctsky H. C., 2017, PLOS ONE, V546, P411, DOI 10.1038/nature22402
   Mohan A, 2010, NATURE, V55, P54
   Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355
   Monath T P, 2006, Bull Soc Pathol Exot, V99, P341
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   MOSSO D, 2016, ZIKA VIRUS CLIN MICR, V29, P487
   Mowatt L, 2014, INFECT DIS THER, V3, P63, DOI 10.1007/s40121-014-0043-9
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307
   Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012
   Norwood PF, 2015, REV SCI TECH OIE, V34, P479, DOI 10.20506/rst.34.2.2373
   Nyari N, 2016, ACTA TROP, V158, P117, DOI 10.1016/j.actatropica.2016.02.019
   [PAHO Pan American Health Organization], 2016, MMWR-MORBID MORTAL W
   Pecorari M., 2008, GUIDELINES FOR SURVE, V14, P298
   PIET MK, 2018, VIRUS RES
   Pietila M. K., 2018, EUR COMMUN DIS B, DOI 10.1016/j.virusres.2017.01.007
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Pulmanausahakul R, 2011, INT J INFECT DIS, V15, pE671, DOI 10.1016/j.ijid.2011.06.002
   RAMAIAH A, 2016, BIORXIV 050278
   Ramos-Castaneda J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005224
   Reiter P, 1998, AM J TROP MED HYG, V59, P650, DOI 10.4269/ajtmh.1998.59.650
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RICO H, 1997, VIROLOGY, V230, P244
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   ROMERO A, 2018, MICROBES INFECT, V20, P135
   ROMERO GAS, 2017, PLOS NEGLECT TROP D, V11
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rubach JK, 2009, VIROLOGY, V384, P201, DOI 10.1016/j.virol.2008.10.030
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Savini G, 2011, VET MICROBIOL, V151, P264, DOI 10.1016/j.vetmic.2011.03.036
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   SHRINET J, 2016, BULL WORLD HEALTH OR, P2015
   Shrinet J., 2016, MMWR-MORBID MORTAL W, V22
   Simon F, 2011, BIOL, V13, P218
   Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Singh S, 2017, INFECT GENET EVOL, V52, P34, DOI 10.1016/j.meegid.2017.04.022
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sittivicharpinyo T, 2017, MEM I OSWALDO CRUZ, V112, P580, DOI 10.1590/0074-02760170022
   SOUZA TM, 2017, PLOS CURR, V9, DOI DOI 10.1371/CURRENTS.OUTBREAKS.4200119978D62CCAA454599ED2735727
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   STRAUSS EG, 1986, STRUCTURE REPLICATIO, P35
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Sudeep AB, 2008, J BIOSCIENCES, V33, P443, DOI 10.1007/s12038-008-0063-2
   Suleman M, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0258-6
   Talarmin A, 1998, AM J TROP MED HYG, V59, P452, DOI 10.4269/ajtmh.1998.59.452
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tang YX, 2010, AM J TROP MED HYG, V83, P1156, DOI 10.4269/ajtmh.2010.10-0052
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tittarelli E, 2017, EMERG INFECT DIS, V23, P1684, DOI 10.3201/eid2310.161718
   Tomashek KM, 2011, TRANSFUSION, V51, P1654, DOI 10.1111/j.1537-2995.2011.03269.x
   Tsetsarkin K.A., 2007, EPIDEMIOLOGY AND CON, V3, pe201, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   TUN MMN, 2014, CHIKUNGUNYA
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   Vaddadi K, 2017, EPIDEMIOL INFECT, V145, P2563, DOI 10.1017/S0950268817001479
   Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91
   Vasilakis N, 2008, EMERG INFECT DIS, V14, P502, DOI 10.3201/eid1403.070843
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   VIRUS I, VIROL J, V20, P1378
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   Wagner D, 2004, EMERG INFECT DIS, V10, P1872, DOI 10.3201/eid1010.031037
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Waman VP, 2017, INFECT GENET EVOL, V49, P234, DOI 10.1016/j.meegid.2017.01.022
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
   Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   WEINBREN M P, 1958, Trans R Soc Trop Med Hyg, V52, P258
   *WHO, 2016, DENGUE CONTROL EPIDE
   Williams LE, 2013, GENOME BIOL EVOL, V5, P599, DOI 10.1093/gbe/evt033
   Woodall J., 1964, ORGANIZATION, V2, P141
   WOODALL JP, 1964, P E AFR ACAD, V2, P141
   Worobey M, 2017, NATURE, V546, P355, DOI 10.1038/nature22495
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   YUN SI, 2016, GENUINE ANNOUNC, V4
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 194
TC 6
Z9 6
U1 3
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2019
VL 190
BP 99
EP 111
DI 10.1016/j.actatropica.2018.11.010
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HJ9HV
UT WOS:000457510400016
PM 30444971
DA 2020-07-08
ER

PT J
AU Costa, MCD
   Maia, LMS
   de Souza, VC
   Gonzaga, AM
   de Azevedo, VC
   Martins, LR
   Pavoni, JHC
   Naveca, FG
   Slhessarenko, RD
AF de Souza Costa, M. C.
   Siqueira Maia, L. M.
   Costa de Souza, V.
   Gonzaga, A. M.
   Correa de Azevedo, V.
   Ramos Martins, L.
   Chavez Pavoni, J. H.
   Games Naveca, F.
   Dezengrini Slhessarenko, R.
TI Arbovirus investigation in patients from Mato Grosso during Zika and
   Chikungunya virus introdution in Brazil, 2015-2016
SO ACTA TROPICA
LA English
DT Article
DE Zika virus; Dengue virus; Chikungunya virus; Mayaro virus; Public
   health; Epidemiology
ID YELLOW-FEVER-VIRUS; INFECTION; STATE
AB Arboviruses have become a major public health concern in Brazil, especially after Zika virus (ZIKV) and Chikungunya virus (CHIKV) introduction, leading to massive epidemics. We conducted an investigation of arboviruses in patients with acute febrile illness for less than five days in Mato Grosso state (MT) during the period of ZIKV and CHIKV dissemination in Brazil. To achieve that, 453 human serum samples of patients suspected of Dengue (DENY), Yellow Fever (YFV), ZIKV or CHIKV collected in health units of 31 cities of MT were subjected to RT-PCR protocols for 10 flaviviruses, 5 alphaviruses and orthobunyaviruses from Simbu serogroup, nucleotide sequencing and viral isolation. Regarding flaviviruses, five (1.1%) patients were infected with DENV-1 genotype V, 22 (4.4%) with DENV-4 genotype II, 3 (0.7%) with YFV South American genotype It and five (1.1%) with ZIKV Asian genotype. The first human case of ZIKV in MT was detected in this study during August, 2015 in Tapurah. Alphaviruses were detected in 2 (0.4%) patients infected with CHIKV genotype ECSA, 1 (0.2%) with Madariaga (EEEV) lineage III and 34 (7.5%) with Mayaro (MAYV) genotype L. Four (11.4%) patients presented dual infections with DENV-1/ZIKV, DENV-1/DENV4, DENV-4/MAYV and ZIKV/MAYV. The majority- 13/34 positive for MAYV, one for Madariaga virus - are residents in Varzea Grande (VG), metropolitan region of Cuiaba, capital of MT. The first CH1KV infection in MT was detected in this study in Mirassol D'Oeste, during July, 2015. In addition, 20 (4.4%) patients were positive for OROV Segment S genotype IA. These results reinforce the variation in arboviruses frequency and distribution during outbreaks, highlinghing the importance of differential diagnosis to identify agents silently co-circulating with major health problem arboviruses.
C1 [de Souza Costa, M. C.; Siqueira Maia, L. M.; Dezengrini Slhessarenko, R.] Univ Fed Moro Grosso, Fac Med, Dept Ciencias Basicas Saude, Programa Posgrad Ciencias Saude, Ave Fernando Correa da Costa,2367,CCBS 1,Solo 82, BR-78060900 Cuiaba, Mato Grosso, Brazil.
   [Costa de Souza, V.; Games Naveca, F.] Fiocruz MS, Inst Leonidas & Maria Deane, Rua Terezina 476, BR-69057070 Manaus, Amazonas, Brazil.
   [Gonzaga, A. M.; Correa de Azevedo, V.] LACEN MT, Seeretaria Estadual Saude, Travessa Thogo da Silva Pereira 63, BR-78020500 Cuiaba, Mato Grosso, Brazil.
   [Ramos Martins, L.] Univ Fed Mato Grosso, Fac Med Vet, Grad Med Vet, Cuiaba, Mato Grosso, Brazil.
   [Chavez Pavoni, J. H.] Univ Fed Mato Grosso, Fac Med, Ave Estudantes 5005,Vila Aurora 1, BR-78735901 Rondonopolis, Mato Grosso, Brazil.
RP Slhessarenko, RD (corresponding author), Univ Fed Moro Grosso, Fac Med, Dept Ciencias Basicas Saude, Programa Posgrad Ciencias Saude, Ave Fernando Correa da Costa,2367,CCBS 1,Solo 82, BR-78060900 Cuiaba, Mato Grosso, Brazil.
EM renatadezengrini@yahoo.com.br
RI Naveca, Felipe/H-1130-2012; Slhessarenko, Renata Dezengrini/R-2390-2019
OI Naveca, Felipe/0000-0002-2888-1060; 
FU FAPEMAT grant [FAPEMAT.0132298/2017]
FX We are very thankful for Michellen S. Carvalho, Otacilia P. Serra and
   Andressa Z. Pinto for their assistance in RT-PCR testing, and to Ana
   Elisa Viniski for her fundamental assistance on sampling. This study was
   supported by a FAPEMAT grant (FAPEMAT.0132298/2017). MCSC and LMSM are
   CAPES (001) fellows, LRM is a FAPEMAT fellow. We are very thankfull. for
   PDTIS-FIOCRUZ for nucleotide sequencing facilities at ILMD-Fiocruz
   Amazonia.
CR Aguiar D. M., 2008, Brazilian Journal of Veterinary Research and Animal Science, V45, P269
   Alice F., 1956, B I BIOL BAHIA, V3, P3
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Costa A.C., 2017, EMERGENCE PERSISTENC
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O., 2009, J CLIN MICROBIOL, V43, P96
   Figueiredo L. T.M., 2015, SOC BRASILEIRA MED T, V48, P1
   Fiocruz Fundacao Oswaldo Cruz, 2017, ARB DES DIAGN DIF PR
   HEINEN LBS, 2015, REV INST MED TROP SP, V57, P1
   IBGE Institute Brasileiro de Geografia e estatistica, MAT GROSS
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Maia L.M.S., 2018, MED VET ENTOMOL
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Ministerio da Saude, 2015, SIT EP FEBR AM REC I
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   Pimentel IRS, 2011, REV BRASILEIRA MED F, V6, P175
   Secretaria Municipal de Satide dc MT - SES-MT, 2016, B EP DENG CHIK ZIK, V18
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva MLCR, 2017, TRANSBOUND EMERG DIS, V64, P990, DOI 10.1111/tbed.12441
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Travassos da Rosa JFS, 1998, OVERVIEW ARBOVIROLOG, P19
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P72
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 35
TC 4
Z9 4
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2019
VL 190
BP 395
EP 402
DI 10.1016/j.actatropica.2018.12.019
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HJ9HV
UT WOS:000457510400059
PM 30552880
DA 2020-07-08
ER

PT J
AU Ferreira, AC
   Reis, PA
   de Freitas, CS
   Sacramento, CQ
   Hoelz, LVB
   Bastos, MM
   Mattos, M
   Rocha, N
   Quintanilha, IGD
   Pedrosa, CDG
   Souza, LRQ
   Loiola, EC
   Trindade, P
   Vieira, YR
   Barbosa-Lima, G
   Faria, HCD
   Boechat, N
   Rehen, SK
   Bruning, K
   Bozza, FA
   Bozza, PT
   Souza, TML
AF Ferreira, Andre C.
   Reis, Patricia A.
   de Freitas, Caroline S.
   Sacramento, Carolina Q.
   Boas Hoelz, Lucas Villas
   Bastos, Monica M.
   Mattos, Mayara
   Rocha, Natasha
   de Azevedo Quintanilha, Isaclaudia Gomes
   Gouveia Pedrosa, Carolina da Silva
   Quintino Souza, Leticia Rocha
   Loiola, Erick Correia
   Trindade, Pablo
   Vieira, Yasmine Rangel
   Barbosa-Lima, Giselle
   de Castro Faria Neto, Hugo C.
   Boechat, Nubia
   Rehen, Stevens K.
   Bruning, Karin
   Bozza, Fernando A.
   Bozza, Patricia T.
   Souza, Thiago Moreno L.
TI Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits
   Chikungunya Virus Replication
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE chikungunya; chikungunya virus; arthralgia; antiviral; sofosbuvir; drug
ID INTERFERON-ALPHA; STEM-CELLS; ZIKA; INFECTION; ANTIVIRALS; IVERMECTIN;
   DISCOVERY; RIBAVIRIN; BINDING; GROWTH
AB Chikungunya virus (CHIKV) causes a febrile disease associated with chronic arthralgia, which may progress to neurological impairment. Chikungunya fever (CF) is an ongoing public health problem in tropical and subtropical regions of the world, where control of the CHIKV vector, Aedes mosquitos, has failed. As there is no vaccine or specific treatment for CHIKV, patients receive only palliative care to alleviate pain and arthralgia. Thus, drug repurposing is necessary to identify antivirals against CHIKV. CHIKV RNA polymerase is similar to the orthologue enzyme of other positive-sense RNA viruses, such as members of the Flaviviridae family. Among the Flaviviridae, not only is hepatitis C virus RNA polymerase susceptible to sofosbuvir, a clinically approved nucleotide analogue, but so is dengue, Zika, and yellow fever virus replication. Here, we found that sofosbuvir was three times more selective in inhibiting CHIKV production in human hepatoma cells than ribavirin, a panantiviral drug. Although CHIKV replication in human induced pluripotent stem cellderived astrocytes was less susceptible to sofosbuvir than were hepatoma cells, sofosbuvir nevertheless impaired virus production and cell death in a multiplicity of infection-dependent manner. Sofosbuvir also exhibited antiviral activity in vivo by preventing CHIKV-induced paw edema in adult mice at a dose of 20 mg/kg of body weight/day and prevented mortality in a neonate mouse model at 40-and 80-mg/kg/day doses. Our data demonstrate that a prototypic alphavirus, CHIKV, is also susceptible to sofosbuvir. As sofosbuvir is a clinically approved drug, our findings could pave the way to it becoming a therapeutic option against CF.
C1 [Ferreira, Andre C.; Reis, Patricia A.; de Freitas, Caroline S.; Sacramento, Carolina Q.; Mattos, Mayara; Rocha, Natasha; de Azevedo Quintanilha, Isaclaudia Gomes; de Castro Faria Neto, Hugo C.; Bozza, Fernando A.; Bozza, Patricia T.; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz Fiocruz, IOC, Lab Imunofarmacol, Rio De Janeiro, Brazil.
   [Ferreira, Andre C.; Vieira, Yasmine Rangel; Barbosa-Lima, Giselle; Bozza, Fernando A.; Souza, Thiago Moreno L.] Fiocruz MS, INI, Rio De Janeiro, Brazil.
   [Boas Hoelz, Lucas Villas; Bastos, Monica M.; Boechat, Nubia] Fiocruz MS, Inst Tecnol Farmacos Farmanguinhos, Rio De Janeiro, Brazil.
   [Gouveia Pedrosa, Carolina da Silva; Quintino Souza, Leticia Rocha; Loiola, Erick Correia; Trindade, Pablo; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Rehen, Stevens K.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Rio De Janeiro, Brazil.
   [Bruning, Karin] BMK Consortium, Rio De Janeiro, Brazil.
   [Ferreira, Andre C.; de Freitas, Caroline S.; Sacramento, Carolina Q.; Mattos, Mayara; Rocha, Natasha; Vieira, Yasmine Rangel; Souza, Thiago Moreno L.] Fiocruz MS, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Rio De Janeiro, Brazil.
RP Souza, TML (corresponding author), Fundacao Oswaldo Cruz Fiocruz, IOC, Lab Imunofarmacol, Rio De Janeiro, Brazil.; Souza, TML (corresponding author), Fiocruz MS, INI, Rio De Janeiro, Brazil.; Souza, TML (corresponding author), Fiocruz MS, Ctr Technol Dev Hlth CDTS, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Rio De Janeiro, Brazil.
EM tmoreno@cdts.fiocruz.br
RI Trindade, Pablo/D-8913-2016; Rehen, Stevens K/J-5874-2012; Souza, Thiago
   Moreno L./G-2900-2012; Boechat, Nubia/K-2520-2019; Boechat,
   Nubia/N-1406-2014
OI Trindade, Pablo/0000-0001-5953-7054; Rehen, Stevens
   K/0000-0003-4216-9501; Souza, Thiago Moreno L./0000-0003-2212-3899;
   Boechat, Nubia/0000-0003-0146-2218; Boechat, Nubia/0000-0003-0146-2218;
   Bozza, Fernando Augusto/0000-0003-4878-0256; Bozza,
   Patricia/0000-0001-8349-9529
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Ministry of Science, Technology, Information and Communications
   [465313/2014-0]; Ministry of Education/CAPESCAPES [465313/2014-0];
   Research Foundation of the State of Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [465313/2014-0]; Oswaldo Cruz Foundation (Fiocruz)
FX Funding was provided by the National Council for Scientific and
   Technological Development (CNPq), Ministry of Science, Technology,
   Information and Communications (grants including, but not limited to,
   465313/2014-0), Ministry of Education/CAPES (465313/2014-0), Research
   Foundation of the State of Rio de Janeiro (FAPERJ) (grants including,
   but not limited to, 465313/2014-0), and the Oswaldo Cruz Foundation
   (Fiocruz). A competing financial interest exists for K.B., who is
   partner in a consortium able to produce generic sofosbuvir. The
   consortium and her participation were limited to providing sofosbuvir
   for this study. The BMK Consortium is comprised of Blanver Farmoquimica
   Ltd., Microbiologica Quimica e Farmaceutica Ltd., and Karin Bruning &
   Cia Ltd. A.C.F., P.A.R., C.S.D.F., C.Q.S., L.V.B.H., M.M.B., M.M., N.R.,
   I.G.A.Q., C.S.G.P., L.R.Q.S., E.C.L., P.T., Y.R.V., and G.B.-L.
   performed the experiments. H.C.C.F.N., N.B., S.K.R., K.B., F.A.B.,
   P.T.B., and T.M.L.S. conceptualized the experiments and raised funds.
   K.B. provided critical material. T.M.L.S. organized the study. All
   authors revised and approved the manuscript. Funders had no role in the
   experiment design or interpretation.
CR Abdelnabi R, 2015, ANTIVIR RES, V121, P59, DOI 10.1016/j.antiviral.2015.06.017
   Bhatia HK, 2014, J PHARMACOL PHARMACO, V5, P278, DOI 10.4103/0976-500X.142464
   Briolant S, 2004, ANTIVIR RES, V61, P111, DOI 10.1016/j.antiviral.2003.09.005
   Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chen MW, 2017, ANTIVIR RES, V143, P38, DOI 10.1016/j.antiviral.2017.04.001
   CRUZ DJM, 2013, PLOS NEGLECT TROP D, V7
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   da Silva-Junior EF, 2017, BIOORGAN MED CHEM, V25, P4219, DOI 10.1016/j.bmc.2017.06.049
   Das PK, 2014, J BIOL CHEM, V289, P5635, DOI 10.1074/jbc.M113.503433
   Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP), 2013, COMM MED PROD HUM US
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Freitas CD, 2018, YELLOW FEVER VIRUS I, DOI [10.1101/266361, DOI 10.1101/266361]
   Gallegos KM, 2016, J INFECT DIS, V214, P1192, DOI 10.1093/infdis/jiw358
   Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gasque P, 2016, J INFECT DIS, V214, pS446, DOI 10.1093/infdis/jiw362
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Gazos-Lopes F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003077
   Gilead Sciences, 2015, PROD MON PR SOV SOF
   Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200
   Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Inglis FM, 2016, J NEUROVIROL, V22, P140, DOI 10.1007/s13365-015-0378-3
   Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12
   Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009
   Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010
   Krishnamoorthy K, 2009, J VECTOR DIS, V46, P26
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Li GY, 2006, ORG LETT, V8, P3613, DOI 10.1021/ol061525k
   MASON P. J., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P238
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   National Research Council, 2011, GUIDE CARE USE LAB A
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Rothan HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126360
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sangeetha K, 2017, BIOMED PHARMACOTHER, V87, P302, DOI 10.1016/j.biopha.2016.12.069
   SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013
   SCUDIERO DA, 1988, CANCER RES, V48, P4827
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Souza TMA, 2017, PLOS CURR, V9
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   SVS-MS, 2018, MON CAS DENG FEBR CH
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e
   TONG XL, 2017, SCI REP UK, V7
   Varghese FS, 2016, J VIROL, V90, P9743, DOI 10.1128/JVI.01382-16
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   World Health Organisation, 2008, GUID CLIN MAN CHIK F
   Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Zhang HM, 2013, J MED CHEM, V56, P1074, DOI 10.1021/jm301519z
NR 63
TC 10
Z9 10
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD FEB
PY 2019
VL 63
IS 2
AR e01389-18
DI 10.1128/AAC.01389-18
PG 15
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA HJ3YN
UT WOS:000457110200025
PM 30455237
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Peters, R
   Stevenson, M
AF Peters, R.
   Stevenson, M.
TI Zika virus diagnosis: challenges and solutions
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Review
DE Diagnosis; Diagnostics; Emerging infectious disease; Global health;
   Infectious disease; Nucleic acid amplification testing; Point-of-care
   testing; Public health; Re-emerging; Serology; Zika virus
ID MOLECULAR-DETECTION; VIRAL DYNAMICS; INFECTION; DENGUE; RNA;
   TRANSMISSION; BLOOD; BRAZIL; FEVER; SEMEN
AB Background: Since its sudden appearance and link to microcephaly in 2015, the number of PubMed references for Zika virus (ZIKV) has risen from 181 to 5163, at time of writing, with a vast proportion focused on the consequences of ZIKV infection during pregnancy. This level of attention underlies increased demand for sensitive and specific diagnostic tools able to assess risk to an unborn child, as well as to understand the dynamics and consequences of viral persistence.
   Aim: Review the expanding knowledge on ZIKV persistence and diagnostic challenges and summarize current advancements in detection. Sources: Peer-reviewed articles based on the search terms 'Zika' and 'ZIKV' combined with the terms 'diagnostics' 'point-of-care diagnostics' 'viral load' 'persistence' 'detection' 'treatment' 'nucleic acid amplification testing' 'microsphere' 'PVRT' 'RVNT' 'RT-LAMP' 'NASBA' SIBA' 'RPA' 'SHERLOCK' 'ELISA', and 'TMA' as well as laboratory experience of the authors.
   Content: Topics covered include the emergence of the ZIKV epidemic, pathogenesis of ZIKV infection, the nature of ZIKV persistence, complications in serological diagnosis, tried and novel diagnostic laboratory techniques, and a recent accounting of point-of-care testing (POCT) methods. (C) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Peters, R.] Univ Miami, Miller Sch Med, Grad Program Microbiol & Immunol, Miami, FL 33136 USA.
   [Stevenson, M.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.
RP Peters, R (corresponding author), Univ Miami, Miller Sch Med, Grad Program Microbiol & Immunol, Miami, FL 33136 USA.
EM rjp137@miami.edu
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   [Anonymous], 2018, DPP ZIK IGM IGG SYST
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Arsuaga M, 2016, LANCET INFECT DIS, P16
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bedin F, 2017, J MED VIROL, V89, P1520, DOI 10.1002/jmv.24806
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2017, UPD INT GUID HLTH CA, V66, P781
   Chan K, 2018, ANAL BIOCHEM, V545, P4, DOI 10.1016/j.ab.2018.01.008
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chen LH, 2005, DENGUE B, P29
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Draz MS, 2018, NANOSCALE
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   [ICTV Genus ICTV online], 2017, FLAV FLAV POS SENS R
   Jiang QS, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201700096
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lee D, 2017, SIMPLE FAST HIGHLY S, P20
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Lustig Y, 2016, EURO SURVEILL, V21
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mata VE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2679-z
   Mauk Michael G, 2017, Clin Lab Int, V41, P25
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   PAHO W, 2017, ZIKA EPIDEMIOLOGICAL
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Puren A, 2010, J INFECT DIS, V201, pS27, DOI 10.1086/650390
   Purpura LJ, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30330-9
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8
   Sanabani SS, 2017, PLOS CURR, V9
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Song JZ, 2017, CLIN CHEM, V63, P714, DOI 10.1373/clinchem.2016.263665
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   St George K, 2017, REV MED MICROBIOL
   Sudiro TM, 2001, J MED VIROL, V63, P29, DOI 10.1002/1096-9071(200101)63:1&lt;29::AID-JMV1004&gt;3.0.CO;2-S
   Taylor CT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050253
   Tran A, 2017, REV MED MICROBIOL
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   WHO, 2016, ZIK PROD LANDSC
   WHO T, 2009, WHO HLTH ORG RES TRA
   Wong KHK, 2016, SCI REP-UK, V6, DOI 10.1038/srep21023
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization. WHO statement on the first meeting of the International Health Regulations, 2005, EM COMM ZIK VIR OBS
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 77
TC 2
Z9 2
U1 5
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD FEB
PY 2019
VL 25
IS 2
BP 142
EP 146
DI 10.1016/j.cmi.2018.12.002
PG 5
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HI9AP
UT WOS:000456747400006
PM 30553031
OA Bronze
DA 2020-07-08
ER

PT J
AU Kempster, S
   Ham, C
   Hall, J
   Ferguson, D
   Berry, N
   Mattiuzzo, G
   Page, M
   Almond, N
AF Kempster, S.
   Ham, C.
   Hall, J.
   Ferguson, D.
   Berry, N.
   Mattiuzzo, G.
   Page, M.
   Almond, N.
TI Evaluation of a candidate WHO international standard for Zika antibody
   as a vaccine reference reagent
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Kempster, S.; Ham, C.; Hall, J.; Ferguson, D.; Berry, N.; Almond, N.] NIBSC, Virol, Potters Bar, Herts, England.
   [Mattiuzzo, G.; Page, M.] NIBSC, Potters Bar, Herts, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2019
VL 79
SU 1
MA 10.003
BP 13
EP 13
DI 10.1016/j.ijid.2018.11.049
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA HJ4NO
UT WOS:000457150900028
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Sasmono, RT
   Dhenni, R
   Yohan, B
   Pronyk, P
   Hadinegoro, SR
   Soepardi, EJ
   Ma'roef, C
   Satari, H
   Menzies, H
   Hawley, W
   Powers, A
   Rosenberg, R
   Myint, KS
   Soebandrio, A
AF Sasmono, R. T.
   Dhenni, R.
   Yohan, B.
   Pronyk, P.
   Hadinegoro, S. R.
   Soepardi, E. J.
   Ma'roef, C.
   Satari, H.
   Menzies, H.
   Hawley, W.
   Powers, A.
   Rosenberg, R.
   Myint, K. S.
   Soebandrio, A.
TI Endemicity of Zika virus in Indonesia: serological evidence in pediatric
   population
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Sasmono, R. T.; Dhenni, R.; Yohan, B.; Ma'roef, C.; Myint, K. S.; Soebandrio, A.] Eijkman Inst Mol Biol, Jakarta, Indonesia.
   [Pronyk, P.] UNICEF Indonesia, Jakarta, Indonesia.
   [Hadinegoro, S. R.; Satari, H.] Univ Indonesia, Fac Med, Jakarta, Indonesia.
   [Soepardi, E. J.] Minist Hlth, Jakarta, Indonesia.
   [Menzies, H.; Hawley, W.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Powers, A.; Rosenberg, R.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2019
VL 79
SU 1
MA 10.004
BP 13
EP 14
DI 10.1016/j.ijid.2018.11.050
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA HJ4NO
UT WOS:000457150900029
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hansen, S
   Hotop, SK
   Faye, O
   Ndiaye, O
   Bohlken-Fascher, S
   Pessoa, R
   Hufert, F
   Stahl-Hennig, C
   Frank, R
   Cherny, CP
   Schmidt-Chanasit, J
   Sanabani, SS
   Sall, A
   Niedrig, M
   Bronstrup, M
   Fritz, HJ
   Abd El Wahed, A
AF Hansen, S.
   Hotop, S. -K.
   Faye, O.
   Ndiaye, O.
   Boehlken-Fascher, S.
   Pessoa, R.
   Hufert, F.
   Stahl-Hennig, C.
   Frank, R.
   Cherny, C. -P.
   Schmidt-Chanasit, J.
   Sanabani, S. S.
   Sall, A.
   Niedrig, M.
   Broenstrup, M.
   Fritz, H. -J.
   Abd El Wahed, A.
TI Elucidation of specific and cross reactive Zika virus antibody target
   regions
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Hansen, S.; Boehlken-Fascher, S.; Cherny, C. -P.; Abd El Wahed, A.] Univ Goettingen, Gottingen, Germany.
   [Hotop, S. -K.] Helmholtz Zentrum Infekt Forsch, Braunschweig, Germany.
   [Faye, O.; Ndiaye, O.; Sall, A.] Inst Pasteur, Dakar, Senegal.
   [Pessoa, R.; Sanabani, S. S.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Hufert, F.] Brandenburg Med Sch Fontane, Senftenberg, Germany.
   [Stahl-Hennig, C.] Deutsch Primatenzentrum GmbH, Gottingen, Germany.
   [Frank, R.] AIMS Sci Prod GmbH, Berlin, Germany.
   [Schmidt-Chanasit, J.] Natl Reference Ctr Trop Infect Dis, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Niedrig, M.] Robert Koch Inst, Berlin, Germany.
   [Fritz, H. -J.] Akad Wissensch Gottingen, Gottingen, Germany.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2019
VL 79
SU 1
MA 19.017
BP 33
EP 33
DI 10.1016/j.ijid.2018.11.094
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA HJ4NO
UT WOS:000457150900073
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Escalante-Maldonado, O
   Garcia, P
   Cabezas, C
   Cabezas, C
   Gavilan, R
   Yamazaki, W
AF Escalante-Maldonado, O.
   Garcia, P.
   Cabezas, C.
   Cabezas, C.
   Gavilan, R.
   Yamazaki, W.
TI Development of a loop-mediated isothermal amplification method to detect
   Zika virus
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Escalante-Maldonado, O.; Cabezas, C.; Cabezas, C.; Gavilan, R.] Inst Nacl Salud, Lima, Peru.
   [Garcia, P.] ViroRed CYTED, Inst Nacl Salud, Lima, Peru.
   [Yamazaki, W.] Univ Myazaki, Miyazaki, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2019
VL 79
SU 1
MA 19.019
BP 34
EP 34
DI 10.1016/j.ijid.2018.11.096
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA HJ4NO
UT WOS:000457150900075
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kayem, ND
   Longuere, KS
   Martelli, CMT
   Marsh, K
   Horby, P
   Carson, G
AF Kayem, N. D.
   Longuere, K. -S.
   Martelli, C. M. T.
   Marsh, K.
   Horby, P.
   Carson, G.
TI Harmonisation of research data for congenital Zika syndrome: need for
   core data sets for epidemic-prone infectious diseases
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Kayem, N. D.; Marsh, K.] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Longuere, K. -S.] Univ Oxford, ISARIC, Oxford, England.
   [Martelli, C. M. T.] Fiocruz Pernambuco, Ctr Pesquisa Aggeu Magalhaes, Saude Colet, Recife, PE, Brazil.
   [Horby, P.] Univ Oxford, Trop Med ERGO, Oxford, England.
   [Carson, G.] Univ Oxford, ISARIC, Nuffield Dept Med, Trop Med, Oxford, England.
OI Kayem, Nzelle Delphine/0000-0001-8308-3312
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2019
VL 79
SU 1
MA 19.025
BP 37
EP 37
DI 10.1016/j.ijid.2018.11.102
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA HJ4NO
UT WOS:000457150900081
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hunsawong, T
   Suthangkornkul, R
   Ong-Ajchaowlerd, P
   Thaisomboonsuk, B
   Klungtong, C
   Poolpanichupatam, Y
   Phonpakobsin, T
   Macareo, LR
   Srikiatkhachorn, A
   Fernandez, S
   Ellison, DW
AF Hunsawong, T.
   Suthangkornkul, R.
   Ong-Ajchaowlerd, P.
   Thaisomboonsuk, B.
   Klungtong, C.
   Poolpanichupatam, Y.
   Phonpakobsin, T.
   Macareo, L. R.
   Srikiatkhachorn, A.
   Fernandez, S.
   Ellison, D. W.
TI Potential immune-mediated genes expression induced by dengue antibodies
   enhance zika virus infection in THP-1 cell line
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Hunsawong, T.; Suthangkornkul, R.; Ong-Ajchaowlerd, P.; Thaisomboonsuk, B.; Klungtong, C.; Poolpanichupatam, Y.; Phonpakobsin, T.; Macareo, L. R.; Fernandez, S.] USAMD, AFRIMS, Virol, Bangkok, Thailand.
   [Srikiatkhachorn, A.] Univ Rhode Isl, Kingston, RI 02881 USA.
   [Ellison, D. W.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2019
VL 79
SU 1
MA 19.029
BP 38
EP 38
DI 10.1016/j.ijid.2018.11.105
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA HJ4NO
UT WOS:000457150900084
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rana, J
   Campos, JLS
   Poggianella, M
   Bestagno, M
   Sunil, S
   Cesco-Gaspere, M
   Burrone, OR
AF Rana, J.
   Campos, J. L. Slon
   Poggianella, M.
   Bestagno, M.
   Sunil, S.
   Cesco-Gaspere, M.
   Burrone, O. R.
TI Degradation of ZIKV and DENV envelope protein through selective
   targeting to ERAD pathway
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Rana, J.; Campos, J. L. Slon; Poggianella, M.; Bestagno, M.; Cesco-Gaspere, M.; Burrone, O. R.] ICGEB, Mol Immunol, Trieste, Italy.
   [Sunil, S.] ICGEB, Vector Borne Dis, New Delhi, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2019
VL 79
SU 1
MA 19.033
BP 39
EP 40
DI 10.1016/j.ijid.2018.11.109
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA HJ4NO
UT WOS:000457150900088
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Favoretto, S
   Araujo, DB
   Duarte, N
   Oliveira, D
   Da Crus, NG
   Mesquita, F
   Leal, F
   Machado, R
   Gaio, F
   Oliveira, W
   Zanotto, P
   Durigon, EL
AF Favoretto, S.
   Araujo, D. B.
   Duarte, N.
   Oliveira, D.
   Da Crus, N. G.
   Mesquita, F.
   Leal, F.
   Machado, R.
   Gaio, F.
   Oliveira, W.
   Zanotto, P.
   Durigon, E. L.
TI Detection of Zika virus RNA and neutralizing antibodies in neotropical
   primates during the epidemic period for the disease in Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Favoretto, S.; Oliveira, D.; Da Crus, N. G.; Mesquita, F.; Leal, F.; Machado, R.; Zanotto, P.; Durigon, E. L.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Araujo, D. B.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Duarte, N.] Hlth Dept Ceara State SESA, Ctr Vector Borne Dis NUVET, Fortaleza, Ceara, Brazil.
   [Gaio, F.; Oliveira, W.] Brazilian Inst Environm & Renewable Nat Resources, Wild Animals Screening Ctr CETAS, Fortaleza, Ceara, Brazil.
RI Araujo, Danielle B/M-9540-2013; de A. Zanotto, Paolo M./B-9286-2019
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Rahal Guaragna Machado,
   Rafael/0000-0001-6974-5092
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2019
VL 79
SU 1
MA 20.063
BP 59
EP 59
DI 10.1016/j.ijid.2018.11.154
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA HJ4NO
UT WOS:000457150900133
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cimini, E
   de Minicis, S
   Sacchi, A
   Bordoni, V
   Casetti, R
   Colavita, F
   Capobianchi, MR
   Castilletti, C
   Agrati, C
AF Cimini, E.
   de Minicis, S.
   Sacchi, A.
   Bordoni, V.
   Casetti, R.
   Colavita, F.
   Capobianchi, M. R.
   Castilletti, C.
   Agrati, C.
TI V delta 2 T cells inhibit ZIKA replication by cytolitic and non
   cytolitic mechanisms
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Cimini, E.; de Minicis, S.; Sacchi, A.; Bordoni, V.; Casetti, R.; Agrati, C.] Natl Inst Infect Dis Lazzaro Spallanzani, Lab Cellular Immunol & Pharmacol, Rome, Italy.
   [Colavita, F.; Capobianchi, M. R.; Castilletti, C.] Natl Inst Infect Dis L Spallanzani, Lab Virol, Rome, Italy.
RI Castilletti, Concetta/B-6545-2016; Castilletti, Concetta/AAA-8408-2019;
   Colavita, Francesca/I-8848-2018
OI Castilletti, Concetta/0000-0001-9819-236X; Castilletti,
   Concetta/0000-0001-9819-236X; Colavita, Francesca/0000-0003-0640-8667
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD FEB
PY 2019
VL 79
SU 1
MA 21.091
BP 122
EP 122
DI 10.1016/j.ijid.2018.11.299
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA HJ4NO
UT WOS:000457150900278
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cumming, HE
   Bourke, NM
AF Cumming, Helen E.
   Bourke, Nollaig M.
TI Type I IFNs in the female reproductive tract: The first line of defense
   in an ever-changing battleground
SO JOURNAL OF LEUKOCYTE BIOLOGY
LA English
DT Review
DE Chlamydia; female reproductive tract; HIV; hormonal regulation; mucosal
   immunity; Type I IFNs; Zika
ID UTERINE NK CELLS; GMP-AMP SYNTHASE; ZIKA VIRUS; SEXUAL TRANSMISSION;
   INTERFERON-EPSILON; EPITHELIAL-CELLS; MENSTRUAL-CYCLE; HIV-INFECTION;
   INNATE IMMUNITY; RNA
AB The primary function of the female reproductive tract (FRT) is to enable successful reproduction, yet the biologic mechanisms required to accomplish this, which include fluctuating sex hormones and tolerance of semen and a semi-allogeneic fetus, can leave this unique mucosal environment susceptible to pathogenic challenge. Consequently, the FRT has evolved specialized innate and adaptive immune responses tailored to protecting itself from infection without compromising reproductive success. A family of innate immune cytokines that has emerged as important regulators of these immune responses is the type I IFNs. Type I IFNs are typically rapidly produced in response to pathogenic stimulation and are capable of sculpting pleotropic biologic effects, including immunomodulation, antiproliferative effects, and inducing antiviral and bactericidal molecules. Here, we review what is currently known about type I IFN-mediated immunity in the FRT in human, primate, and murine models and explore their importance with respect to three highly relevant FRT infections: HIV, Zika, and Chlamydia.
C1 [Cumming, Helen E.] Monash Univ, Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia.
   [Bourke, Nollaig M.] Trinity Coll Dublin, Trinity Translat Med Inst, Dept Med Gerontol, Dublin, Ireland.
RP Cumming, HE (corresponding author), Monash Univ, Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia.
EM helen.cumming@hudson.org.au
RI Bourke, Nollaig/AAE-7279-2019
OI Bourke, Nollaig/0000-0003-4313-6859
FU Victorian State Government's Operational Infrastructure Support fund
FX The Hudson Institute of Medical Research is supported by the Victorian
   State Government's Operational Infrastructure Support fund.
CR Abdulhaqq SA, 2016, MUCOSAL IMMUNOL, V9, P1027, DOI 10.1038/mi.2015.116
   Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005
   Andrew A, 2011, J INTERF CYTOK RES, V31, P137, DOI 10.1089/jir.2010.0108
   Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13
   Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032
   Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012
   Bourke NM, 2018, CELL MOL LIFE SCI, V75, P775, DOI 10.1007/s00018-017-2652-4
   Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1
   Bulmer JN, 2015, ADV EXP MED BIOL, V868, P95, DOI 10.1007/978-3-319-18881-2_5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200
   de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9
   Demers A, 2014, J LEUKOCYTE BIOL, V96, P1101, DOI 10.1189/jlb.3A0214-088RRR
   Domanski P, 1997, J BIOL CHEM, V272, P26388, DOI 10.1074/jbc.272.42.26388
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200
   Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101
   Ferreira VH, 2014, AM J REPROD IMMUNOL, V71, P543, DOI 10.1111/aji.12221
   Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321
   Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933
   Garcia-Minambres A, 2017, IMMUNOL CELL BIOL, V95, P478, DOI 10.1038/icb.2016.123
   Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665
   Hertzog PJ, 2013, CYTOKINE GROWTH F R, V24, P217, DOI 10.1016/j.cytogfr.2013.04.002
   Hirbod T, 2006, JAIDS-J ACQ IMM DEF, V43, P137, DOI 10.1097/01.qai.0000229016.85192.60
   Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1
   Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302
   Hu SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119235
   ISAACS A, 1987, J INTERFERON RES, V7, P429, DOI 10.1089/jir.1987.7.429
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Kaushic C, 2011, J REPROD IMMUNOL, V88, P204, DOI 10.1016/j.jri.2010.12.004
   Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004
   Kersh EN, 2014, J MED PRIMATOL, V43, P310, DOI 10.1111/jmp.12124
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee SK, 2015, IMMUNE NETW, V15, P16, DOI 10.4110/in.2015.15.1.16
   Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284
   Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831
   Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monzani M V, 1997, Boll Chim Farm, V136, P272
   Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08
   Nazli A, 2018, CELL MOL IMMUNOL
   O'Leary S, 2004, REPRODUCTION, V128, P237, DOI 10.1530/rep.1.00160
   Perelman SS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006102
   Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039
   Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x
   Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Prantner D, 2011, INFECT IMMUN, V79, P3922, DOI 10.1128/IAI.00140-11
   Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704
   Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092
   Lenicov FR, 2012, J IMMUNOL, V189, P4777, DOI 10.4049/jimmunol.1202089
   RIVERO J, 1994, BIOTHERAPY, V8, P23, DOI 10.1007/BF01878118
   ROBERTSON SA, 1992, BIOL REPROD, V46, P1069, DOI 10.1095/biolreprod46.6.1069
   Robertson SA, 2013, AM J REPROD IMMUNOL, V69, P315, DOI 10.1111/aji.12107
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215
   Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sentman CL, 2004, J IMMUNOL, V173, P6760, DOI 10.4049/jimmunol.173.11.6760
   Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081
   SILVERMAN RH, 1994, J INTERFERON RES, V14, P101, DOI 10.1089/jir.1994.14.101
   Slade J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146186
   Snyder DT, 2017, J IMMUNOL RES, DOI 10.1155/2017/9361802
   Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08
   Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400
   Tasker C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88255
   Veazey RS, 2016, MUCOSAL IMMUNOL, V9, P1528, DOI 10.1038/mi.2015.146
   Vishwanathan SA, 2015, J VIROL, V89, P9167, DOI 10.1128/JVI.00263-15
   Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3
   Webster SJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006383
   Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10
   Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4
   Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
   Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x
   Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x
   Yan H, 1996, MOL CELL BIOL, V16, P2074
   Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang YG, 2014, J IMMUNOL, V193, P2394, DOI 10.4049/jimmunol.1302718
   Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353
   Zhou Z, 2011, VIROLOGY, V409, P175, DOI 10.1016/j.virol.2010.10.008
NR 88
TC 3
Z9 3
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0741-5400
EI 1938-3673
J9 J LEUKOCYTE BIOL
JI J. Leukoc. Biol.
PD FEB
PY 2019
VL 105
IS 2
BP 353
EP 361
DI 10.1002/JLB.MR0318-122RR
PG 9
WC Cell Biology; Hematology; Immunology
SC Cell Biology; Hematology; Immunology
GA HJ8EH
UT WOS:000457429100015
PM 30549324
OA Bronze
DA 2020-07-08
ER

PT J
AU Koopmans, M
   de Lamballerie, X
   Jaenisch, T
   Rosenberger, KD
   Morales, I
   Marques, ETA
   Viana, IFT
   Brasil, P
   Rabello, R
   Avelino-Silva, VI
   Segurado, A
   Alexander, N
   Mayaud, P
   Netto, EM
   Tami, A
   Bethencourt, S
   Miranda, MC
   Lozano, A
   Soria, C
   Cisneros, SPS
   Gotuzzo, E
   Guzman, MG
   Rodriguez, PAM
   Lopez-Gatell, H
   Hegewisch-Taylor, J
   Borja-Aburto, VH
   Bonilla, CRG
   Hoen, B
   van Roode, M
   Rockx, B
AF Koopmans, Marion
   de lamballerie, Xavier
   Jaenisch, Thomas
   Rosenberger, Kerstin D.
   Morales, Ivonne
   Marques, Ernesto T. A.
   Viana, Isabelle F. T.
   Brasil, Patricia
   Rabello, Renata
   Avelino-Silva, Vivian I.
   Segurado, Aluisio
   Alexander, Neal
   Mayaud, Philippe
   Netto, Eduardo Martins
   Tami, Adriana
   Bethencourt, Sarah
   Consuelo Miranda, Maria
   Lozano, Anyela
   Soria, Carmen
   Salgado Cisneros, Silvia P.
   Gotuzzo, Eduardo
   Guzman, Maria G.
   Rodriguez, Pedro A. M.
   Lopez-Gatell, Hugo
   Hegewisch-Taylor, Jennifer
   Hugo Borja-Aburto, Victor
   Gonzalez Bonilla, Cesar R.
   Hoen, Bruno
   van Roode, Martine
   Rockx, Barry
CA ZIKAlliance Consortium
TI Familiar barriers still unresolved-a perspective on the Zika virus
   outbreak research response
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
AB Research is an important component of an effective response to the increasing frequency of widespread infectious disease outbreaks. In turn, the ability to do such studies relies on willingness of partners in different regions to collaborate and the capacity to mount a rapid research response. The EU-funded ZIKAlliance Consortium has initiated a multicountry epidemiological, clinical, and laboratory research agenda to determine the incidence, risk factors, and outcomes of Zika virus infection in pregnant women and their children. We reviewed the timeline of patient cohort initiation in relation to the Zika virus epidemic and mapped key events regarding funding, regulatory approvals, and site preparation during this timeline. We then assessed barriers and delays that the international research team experienced through a systematic telephone interview. We have identified three major bottlenecks in the implementation of a swift response: the absence of a timeline for the funding process, delays in regulatory and ethical approval, and the challenging logistics of laboratory support, including diagnostics. These bottlenecks illustrate the clear and urgent need for implementing a strong and permanent global emerging infectious diseases research capacity that has structured funding, enables long-term partnerships, and develops basic clinical and laboratorial research and a response infrastructure that is ready to deploy.
C1 [Koopmans, Marion; van Roode, Martine; Rockx, Barry] Erasmus MC, Rotterdam, Netherlands.
   [de lamballerie, Xavier] Aix Marseille Univ, Unite Virus Emergents, Marseille, France.
   [Jaenisch, Thomas] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Rosenberger, Kerstin D.; Morales, Ivonne] Heidelberg Univ Hosp, Dept Infect Dis, Heidelberg, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Viana, Isabelle F. T.; Brasil, Patricia; Rabello, Renata] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Avelino-Silva, Vivian I.; Segurado, Aluisio] Univ Sao Paulo, Sao Paulo, Brazil.
   [Alexander, Neal; Mayaud, Philippe] London Sch Hyg & Trop Med, London, England.
   [Netto, Eduardo Martins] Univ Fed Bahia, Salvador, BA, Brazil.
   [Tami, Adriana; Bethencourt, Sarah] Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.
   [Tami, Adriana; Bethencourt, Sarah] Univ Carabobo, Fac Ciencias Salud, Valencia, Venezuela.
   [Consuelo Miranda, Maria; Lozano, Anyela] Univ Ind Santander, Bucaramanga, Colombia.
   [Soria, Carmen] Univ Catolica, Santiago De Guayaquil, Guayaqil, Ecuador.
   [Salgado Cisneros, Silvia P.] Inst Nacl Invest Salud Publ Dr Leopoldo Izquieta, Guayaquil, Ecuador.
   [Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, San Martin De Porres, Peru.
   [Guzman, Maria G.; Rodriguez, Pedro A. M.] Inst Trop Med Pedro Kouri, Havana, Cuba.
   [Lopez-Gatell, Hugo; Hegewisch-Taylor, Jennifer] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   [Hugo Borja-Aburto, Victor; Gonzalez Bonilla, Cesar R.] Mexican Inst Social Secur, Mexico City, DF, Mexico.
   [Hoen, Bruno] INSERM, Paris, France.
RP Koopmans, M (corresponding author), Erasmus MC, Virosci, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.
EM m.koopmans@erasmusmc.nl
RI Avelino-Silva, Vivian I/L-2640-2013; Koopmans, Marion/Y-9170-2019;
   Segurado, Aluisio C/K-2229-2012; Marques, Ernesto T. A/L-4967-2013;
   Netto, Eduardo/D-1432-2013; Viana, Isabelle/M-4435-2017
OI Avelino-Silva, Vivian I/0000-0002-6660-3088; Koopmans,
   Marion/0000-0002-5204-2312; Segurado, Aluisio C/0000-0002-6311-8036;
   Marques, Ernesto T. A/0000-0003-3826-9358; Netto,
   Eduardo/0000-0003-1691-6761; Viana, Isabelle/0000-0003-4648-6635;
   Hegewisch Taylor, Jennifer/0000-0002-1057-2921
FU EU Directorate General for Research [734548]
FX The work described in the manuscript was funded by the EU Directorate
   General for Research grant number 734548 (ZIKAlliance). The sponsor of
   the study had no role in study design, data collection, data analysis,
   data interpretation, or writing of the report. We thank Sandra Kamga for
   her support in collecting information from the questionnaires. We also
   thank Martine van Roode and Barry Rockx that assisted MK in drafting an
   interview with a list of questions for the cohort initiation part of the
   study and, with the help of Sandra Kamga, created interviews to assess
   the list of possible barriers encountered.
CR Alirol E, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0201-1
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Lee WT, 2017, J CLIN MICROBIOL, V22, P56
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Paules CI, 2017, ANN INTERN MED, V167, P805, DOI 10.7326/M17-2496
   Perkins MD, 2017, LANCET, V390, P2111, DOI 10.1016/S0140-6736(17)31224-2
   Reusken CB, 2018, CLIN MICROBIOL INFEC, V24, P221, DOI 10.1016/j.cmi.2017.12.010
   Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220
   Ribeiro CD, 2018, SCIENCE, V362, P404, DOI 10.1126/science.aau5229
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 3
Z9 3
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD FEB
PY 2019
VL 19
IS 2
BP E59
EP E62
DI 10.1016/S1473-3099(18)30497-3
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA HJ6LD
UT WOS:000457299500006
PM 30420230
DA 2020-07-08
ER

PT J
AU Rubio, A
   Cardo, MV
   Carbajo, AE
   Vezzani, D
AF Rubio, Alejandra
   Cardo, Maria V.
   Carbajo, Anibal E.
   Vezzani, Dario
TI Assessment of combined tools and strategies for Aedes aegypti control
   with low environmental impact
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Dengue; Mosquito control; Triflumuron; Container management; Non-target
   species; Chironomus
ID CULEX-QUINQUEFASCIATUS DIPTERA; CHITIN SYNTHESIS INHIBITOR; INSECT
   GROWTH-REGULATORS; MIDGES DIPTERA; TRIFLUMURON; MOSQUITOS; CULICIDAE;
   CHIRONOMIDAE; EFFICACY; DENGUE
AB The control of the mosquito vector Aedes aegypti L. (Diptera: Culicidae) is the main action against dengue, chikungunya, and Zika. The excessive use of conventional insecticides has promoted the development of other control methods and strategies with lower environmental impact. We evaluated the effectiveness of applying triflumuron 1ppm and emptying water-filled containers in a field trial in temperate Argentina. Both control methods were implemented either individually or combined and regularly from the beginning of the mosquito reproductive season or once it reached peak abundance. The impact on a non-target midge of the genus Chironomus was also tested. The highest reductions of Ae. aegypti were achieved in treatments which included triflumuron. This effect was stronger when applied from the beginning of the reproductive season, with <1.3% of positive containers throughout the entire season. No enhancing effects were obtained when combining both control methods. Treatments with triflumuron were not completely innocuous for the non-target species, with Chironomus sp. more susceptible to treatments including triflumuron applied from the beginning of the reproductive season than all others. Sharp reductions of mosquito populations in urban environments with high density of water-filled containers are possible with minimum container management efforts, by applying triflumuron 1ppm every 6weeks. In temperate urban settings, better results can be obtained when applications begin early in the reproductive season of the mosquito vector Aedes aegypti.
C1 [Rubio, Alejandra; Cardo, Maria V.; Carbajo, Anibal E.] Univ Nacl San Martin UNSAM, Inst Invest & Ingn Ambiental, Ecol Enfermedades Transmitidas Vectores, Av 25 Mayo 1400, RA-1650 Gen San Martin, Buenos Aires, Argentina.
   [Rubio, Alejandra; Cardo, Maria V.; Carbajo, Anibal E.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
   [Vezzani, Dario] UNCPBA CIC, Inst Multidisciplinario Ecosistemas & Desarrollo, Tandil, Buenos Aires, Argentina.
RP Rubio, A (corresponding author), Univ Nacl San Martin UNSAM, Inst Invest & Ingn Ambiental, Ecol Enfermedades Transmitidas Vectores, Av 25 Mayo 1400, RA-1650 Gen San Martin, Buenos Aires, Argentina.; Rubio, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.
EM arubio@unsam.edu.ar
RI Carbajo, Anibal Eduardo/AAF-3405-2020
OI Cardo, Maria/0000-0001-9779-2208; Rubio, Alejandra/0000-0002-8980-3410
FU Agencia Nacional de Promocion Cientifica y TecnologicaANPCyT [PICT
   2014-3217]; Consejo Nacional de Investigaciones Cientificas y
   TecnicasConsejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET) [PIP 112-201301-00038]
FX This work was financially supported by the Agencia Nacional de Promocion
   Cientifica y Tecnologica (PICT 2014-3217) and the Consejo Nacional de
   Investigaciones Cientificas y Tecnicas (PIP 112-201301-00038).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   ALI A, 1991, J AM MOSQUITO CONTR, V7, P260
   ALI A, 1980, J ECON ENTOMOL, V73, P243, DOI 10.1093/jee/73.2.243
   Amarasekare KG, 2004, J ECON ENTOMOL, V97, P1595, DOI 10.1603/0022-0493-97.5.1595
   BANG YH, 1972, B WORLD HEALTH ORGAN, V46, P416
   Barton K, 2013, R PACKAGE VERSION, V1, P6
   Batra C. P., 2005, Journal of Vector Borne Diseases, V42, P109
   Belinato TA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-83
   Belinato TA, 2009, MEM I OSWALDO CRUZ, V104, P43, DOI 10.1590/S0074-02762009000100007
   Braga I, 2005, MEM I OSWALDO CRUZ, V100, P435, DOI 10.1590/S0074-02762005000400016
   Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043
   Chang MS, 2011, WEST PAC SURVEILL RE, V2, P9, DOI [10.5365/WPSAR.2010.1.1.012, 10.5365/wpsar.2010.1.1.012]
   Epler J.H., 2001, SPECIAL PUBLICATION, VSJ2001-SP13
   Fernandez EA, 1998, ACTA TROP, V70, P171, DOI 10.1016/S0001-706X(98)00033-3
   Giraldo-Calderon GI, 2008, BIOMEDICA, V28, P224
   Guzzetta G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005918
   Hu JY, 2009, B ENVIRON CONTAM TOX, V82, P610, DOI 10.1007/s00128-009-9654-3
   Jacups SP, 2014, PEST MANAG SCI, V70, P572, DOI 10.1002/ps.3576
   JOHNSON GD, 1982, J ECON ENTOMOL, V75, P297, DOI 10.1093/jee/75.2.297
   Kantor IN, 2018, MEDICINA-BUENOS AIRE, V78, P23
   Luz PM, 2009, EPIDEMIOL INFECT, V137, P1203, DOI 10.1017/S0950268808001799
   Oki M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001367
   Phuanukoonnon S, 2005, TROP MED INT HEALTH, V10, P755, DOI 10.1111/j.1365-3156.2005.01452.x
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rafikov  M., 2015, J APPL MATH, V9, P1, DOI [10.1155/2015/918194, DOI 10.1155/2015/918194]
   Rossi G.C., 2002, DIPTEROS VECTORES CU
   Rubio A, 2018, J ASIA-PAC ENTOMOL, V21, P150, DOI 10.1016/j.aspen.2017.11.010
   Rubio A, 2013, ECOL ENTOMOL, V38, P303, DOI 10.1111/een.12016
   Rubio A, 2012, LANDSCAPE URBAN PLAN, V105, P288, DOI 10.1016/j.landurbplan.2012.01.009
   Soltani N, 1999, ANN SOC ENTOMOL FR, V35, P502
   Sulaiman S., 2004, TROP BIOMED, V21, P97
   Suman D. S., 2010, Journal of Entomology, V7, P33, DOI 10.3923/je.2010.33.43
   Tassou KT, 2011, ECOTOX ENVIRON SAFE, V74, P1203, DOI 10.1016/j.ecoenv.2011.02.013
   Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x
   Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]
   Wiederholm T, 1983, SCANDINAVIAN ENTOMOL
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2012, HDB INT VECT MAN
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
   Zuur Alain F., 2009, P1
NR 41
TC 0
Z9 0
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD FEB
PY 2019
VL 118
IS 2
BP 411
EP 420
DI 10.1007/s00436-018-6178-y
PG 10
WC Parasitology
SC Parasitology
GA HJ2DJ
UT WOS:000456975700004
PM 30607607
DA 2020-07-08
ER

PT J
AU Pena, F
   Pimentel, R
   Khosla, S
   Mehta, SD
   Brito, MO
AF Pena, Farah
   Pimentel, Raquel
   Khosla, Shaveta
   Mehta, Supriya D.
   Brito, Maximo O.
TI Zika Virus Epidemic in Pregnant Women, Dominican Republic, 2016-2017
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID SEXUAL TRANSMISSION; OUTBREAK; INFECTION; STATES; ISLAND
AB Zika virus infection during pregnancy may result in birth defects and pregnancy complications. We describe the Zika virus outbreak in pregnant women in the Dominican Republic during 2016-2017. We conducted multinomial logistic regression to identify factors associated with fetal losses and preterm birth. The Ministry of Health identified 1,282 pregnant women with suspected Zika virus infection, a substantial proportion during their first trimester. Fetal loss was reported for approximate to 10% of the reported pregnancies, and 3 cases of fetal microcephaly were reported. Women infected during the first trimester were more likely to have early fetal loss (adjusted odds ratio 5.9, 95% CI 3.5-10.0). Experiencing fever during infection was associated with increased odds of premature birth (adjusted odds ratio 1.65, 95% CI 1.03-2.65). There was widespread morbidity during the epidemic. Our findings strengthen the evidence for a broad range of adverse pregnancy outcomes resulting from Zika virus infection.
C1 [Pena, Farah] Minist Hlth, Epidemiol Directorate, Continuous Improvement Unit, Santo Domingo, Dominican Rep.
   [Pimentel, Raquel] Minist Hlth, Santo Domingo, Dominican Rep.
   [Khosla, Shaveta; Mehta, Supriya D.; Brito, Maximo O.] Univ Illinois, Chicago, IL USA.
RP Brito, MO (corresponding author), Univ Illinois, Div Infect Dis, 808 S Wood St,MC735, Chicago, IL 60612 USA.
EM mbrito@uic.edu
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Center for Demographic Studies, 2007, HLTH DEM SURV DOM RE
   Centers for Disease Control and Prevention, 2016, MEAS HEAD CIRC
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   Fernandes RCDC, 2016, LANCET INFECT DIS, V16, P772, DOI 10.1016/S1473-3099(16)30079-2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Ministerio de Salud Publica, 2018, PRACTICAL CLINICAL G
   Ministry of Health, 2017, EP B EP WEEK
   Ministry of Health, 2016, EP B EP WEEK
   National Bureau of Statistics, 2012, 9 CENS POP HOUS
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organization, 2016, ZIK RES CAS DEF
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   SEFEROVIC M, 2018, SCI REP UK, V8
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   World Health Organization, 2011, COUNTR STILLB RAT PE
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 2
Z9 2
U1 1
U2 6
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2019
VL 25
IS 2
BP 247
EP 255
DI 10.3201/eid2502.181054
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HI0LV
UT WOS:000456134000007
PM 30666928
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Griffin, I
   Martin, SW
   Fischer, M
   Chambers, TV
   Kosoy, O
   Falise, A
   Ponomareva, O
   Gillis, LD
   Blackmore, C
   Jean, R
AF Griffin, Isabel
   Martin, Stacey W.
   Fischer, Marcs
   Chambers, Trudy V.
   Kosoy, Olga
   Falise, Alyssa
   Ponomareva, Olga
   Gillis, Leah D.
   Blackmore, Carina
   Jean, Reynald
TI Zika Virus IgM Detection and Neutralizing Antibody Profiles 12-19 Months
   after Illness Onset
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INTERIM GUIDANCE; PERSISTENCE; YELLOW; FLORIDA; SERUM
AB Data on the duration of detectable Zika virus-specific IgM in infected persons are limited. Neutralizing antibody cross-reactivity occurs between Zika virus and related flaviviruses, but the degree to which this confounds diagnosis is uncertain. We tested serum specimens collected 12-19 months after illness onset from patients with confirmed Zika virus disease for Zika virus IgM and Zika virus and dengue virus neutralizing antibodies. Among 62 participants, 45 (73%) had detectable Zika virus IgM and 12 (19%) had an equivocal result. Although all patients tested had Zika virus neutralizing antibodies, 39 (63%) also had neutralizing antibodies against dengue virus; of those, 12 (19%) had <4-fold difference between Zika virus and dengue virus titers, and 5 (8%) had dengue virus titer >= 4-fold higher than Zika virus titer. Prolonged detection of IgM and neutralizing antibody cross-reactivity make it difficult to determine the timing of Zika virus infection and differentiate between related flaviviruses.
C1 [Griffin, Isabel; Falise, Alyssa; Ponomareva, Olga; Jean, Reynald] Florida Dept Hlth Miami Dade Cty, Miami, FL USA.
   [Martin, Stacey W.; Fischer, Marcs; Chambers, Trudy V.; Kosoy, Olga] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Gillis, Leah D.] Bur Publ Hlth Labs, Miami, FL USA.
   [Blackmore, Carina] Florida Dept Hlth, Tallahassee, FL USA.
RP Griffin, I (corresponding author), Florida Dept Hlth Miami Dade Cty, Epidemiol Dis Control & Immunizat Serv, 8600 NW 17th St,Ste 200, Miami, FL 33126 USA.
EM isabel.griffin@flhealth.gov
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Centers for Disease Control and Prevention, 2017, PROLONGED IGM ANT RE
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Florida Department of Health, 2018, 2016 ZIK MAP
   Gibney KB, 2012, AM J TROP MED HYG, V87, P1112, DOI 10.4269/ajtmh.2012.12-0182
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
NR 23
TC 9
Z9 9
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2019
VL 25
IS 2
BP 299
EP 303
DI 10.3201/eid2502.181286
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HI0LV
UT WOS:000456134000013
PM 30666931
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bozza, FA
   Moreira-Soto, A
   Rockstroh, A
   Fischer, C
   Nascimento, AD
   Calheiros, AS
   Drosten, C
   Bozza, PT
   Souza, TML
   Ulbert, S
   Drexler, JF
AF Bozza, Fernando A.
   Moreira-Soto, Andres
   Rockstroh, Alexandra
   Fischer, Carlo
   Nascimento, Alessandra D.
   Calheiros, Andrea S.
   Drosten, Christian
   Bozza, Patricia T.
   Souza, Thiago Moreno L.
   Ulbert, Sebastian
   Drexler, Jan Felix
TI Differential Shedding and Antibody Kinetics of Zika and Chikungunya
   Viruses, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID CROSS-REACTIVITY; SPREAD
AB In seroconversion panels obtained from patients from Brazil, diagnostic testing for Zika virus infection was improved by combining multiple antibody isotypes, techniques, and antigens, but sensitivity remained suboptimal. In contrast, chikungunya virus diagnostic testing was unambiguous. Recurrent recent arbovirus infections suggested by serologic data and unspecific symptoms highlight the need for exhaustive virologic testing.
C1 [Bozza, Fernando A.; Nascimento, Alessandra D.] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil.
   [Bozza, Fernando A.; Nascimento, Alessandra D.] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Moreira-Soto, Andres; Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Charite Univ Med Berlin, Berlin, Germany.
   [Moreira-Soto, Andres; Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Moreira-Soto, Andres; Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Humboldt Univ, Berlin, Germany.
   [Moreira-Soto, Andres; Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [Rockstroh, Alexandra; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany.
   [Calheiros, Andrea S.; Bozza, Patricia T.] Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Drosten, Christian; Drexler, Jan Felix] German Ctr Infect Res, Berlin, Germany.
   [Souza, Thiago Moreno L.] Ctr Technol Dev Hlth, Rio De Janeiro, Brazil.
   [Drexler, Jan Felix] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia.
RP Drexler, JF (corresponding author), Campus Charite Mitte, Inst Virol, Helmut Ruska Haus,Charitepl 1, D-10098 Berlin, Germany.
EM felix.drexler@charite.de
OI Bozza, Fernando Augusto/0000-0003-4878-0256; Fischer,
   Carlo/0000-0001-9163-2406; Bozza, Patricia/0000-0001-8349-9529;
   Moreira-Soto, Andres/0000-0002-9224-5157; Souza,
   Thiago/0000-0003-2212-3899; Drexler, Jan Felix/0000-0002-3509-0232
FU European Union's Horizon 2020 Research and Innovation Programme through
   the ZIKAlliance project [734548]; German Centre for Infection Research
   through the ZIKApath project; Conselho Nacional de Desenvolvimento e
   Pesquisa (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ)
FX This work was supported by the European Union's Horizon 2020 Research
   and Innovation Programme through the ZIKAlliance project (grant
   agreement no. 734548), the German Centre for Infection Research through
   the ZIKApath project, by the Conselho Nacional de Desenvolvimento e
   Pesquisa (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ).
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Hassing RJ, 2010, EUROSURVEILLANCE, V15, P22
   Jain J, 2017, CLIN INFECT DIS, V65, P133, DOI 10.1093/cid/cix283
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organization (WHO), UPD QUEST ANSW REL D
NR 15
TC 8
Z9 9
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2019
VL 25
IS 2
BP 311
EP 315
DI 10.3201/eid2502.180166
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HI0LV
UT WOS:000456134000015
PM 30666934
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gutierrez-Lopez, R
   Bialosuknia, SM
   Ciota, AT
   Montalvo, T
   Martinez-de la Puente, J
   Gangoso, L
   Figuerola, J
   Kramer, LD
AF Gutierrez-Lopez, Rafael
   Bialosuknia, Sean M.
   Ciota, Alexander T.
   Montalvo, Tomas
   Martinez-de la Puente, Josue
   Gangoso, Laura
   Figuerola, Jordi
   Kramer, Laura D.
TI Vector Competence of Aedes caspius and Ae. albopictus Mosquitoes for
   Zika Virus, Spain
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We assessed the vector competence of Aedes caspius and Aedes albopictus mosquitoes in Spain for the transmission of Zika virus. Whereas Ae. albopictus mosquitoes were a competent vector, Ae. caspius mosquitoes were unable to transmit Zika virus. We also identified high levels of vertical transmission of Zika virus in Ae. albopictus mosquitoes.
C1 [Gutierrez-Lopez, Rafael; Martinez-de la Puente, Josue; Gangoso, Laura; Figuerola, Jordi] Estn Biol Donana, Seville, Spain.
   [Bialosuknia, Sean M.; Ciota, Alexander T.; Kramer, Laura D.] New York State Dept Hlth, Slingerlands, NY USA.
   [Montalvo, Tomas] Agencia Salut Publ Barcelona, Barcelona, Spain.
   [Montalvo, Tomas; Martinez-de la Puente, Josue; Figuerola, Jordi] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain.
RP Gutierrez-Lopez, R (corresponding author), CSIC Wetland Ecol, Estn Biol Donana, Ave Americo Vespucio 26, Seville 41092, Spain.
EM rgutierrez@ebd.csic.es
RI Gutierrez-Lopez, Rafael/N-1348-2017; Gangoso, Laura/C-6575-2015; la
   Puente, Josue Martinez-de/E-8597-2011; Figuerola, Jordi/B-7917-2008;
   Ciota, Alexander/E-1634-2017
OI Gutierrez-Lopez, Rafael/0000-0003-0107-5357; Gangoso,
   Laura/0000-0002-6205-6769; la Puente, Josue
   Martinez-de/0000-0001-8055-4115; Figuerola, Jordi/0000-0002-4664-9011;
   Ciota, Alexander/0000-0001-6589-4728
FU MINECO [CGL2012-30759 (BES-2013-065274), CGL2015-65055P]
FX Projects CGL2012-30759 (BES-2013-065274) and CGL2015-65055P from MINECO
   supported this study.
CR Balenghien T, 2006, J MED ENTOMOL, V43, P936, DOI 10.1603/0022-2585(2006)43[936:HBAHBA]2.0.CO;2
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   European Centre for Disease Prevention and Control and European Food Safety Authority, 2018, MOSQ MAPS
   Fontenille D, 2007, ECOL CONT VECTOR-BOR, V1, P169
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Millet JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01319
   Ministerio de sanidad servicios sociales e igualdad del gobierno de Espana, 2017, RAP ASS RISK TRANSM
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Turell MJ, 1996, AM J TROP MED HYG, V54, P136, DOI 10.4269/ajtmh.1996.54.136
   Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 15
TC 8
Z9 8
U1 1
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2019
VL 25
IS 2
BP 346
EP 348
DI 10.3201/eid2502.171123
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HI0LV
UT WOS:000456134000023
PM 30666939
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chua, CL
   Chan, YF
   Andu, ESGS
   Rovie-Ryan, JJ
   Sitam, FT
   Verasahib, K
   Sam, IC
AF Chua, Chong Long
   Chan, Yoke Fun
   Andu, Eva S. G. Soh
   Rovie-Ryan, Jeffrine J.
   Sitam, Frankie Thomas
   Verasahib, Khebir
   Sam, I-Ching
TI Little Evidence of Zika Virus Infection in Wild Long-Tailed Macaques,
   Peninsular Malaysia
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB We tested a sample of 234 wild long-tailed macaques (Macaca fascicularis) trapped in Peninsular Malaysia in 2009, 2010, and 2016 for Zika virus RNA and antibodies. None were positive for RNA, and only 1.3% were seropositive for neutralizing antibodies. Long-tailed macaques are unlikely to be reservoirs for Zika virus in Malaysia.
C1 [Chua, Chong Long; Chan, Yoke Fun; Andu, Eva S. G. Soh; Sam, I-Ching] Univ Malaya, Kuala Lumpur, Malaysia.
   [Rovie-Ryan, Jeffrine J.; Sitam, Frankie Thomas] Dept Wildlife & Natl Pk Peninsular Malaysia, Kuala Lumpur, Malaysia.
   [Verasahib, Khebir] Natl Publ Hlth Lab, Sungai Buloh, Malaysia.
RP Sam, IC (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia.
EM jicsam@ummc.edu.my
RI Chan, Yoke Fun/B-5351-2010; Chua, Chong Long/J-3028-2016; Rovie-Ryan,
   Jeffrine Japning/M-8860-2019; Sam, Jamal I-Ching/B-8688-2010
OI Chan, Yoke Fun/0000-0001-7089-0510; Chua, Chong
   Long/0000-0002-8854-4955; Rovie-Ryan, Jeffrine
   Japning/0000-0003-2910-5431; Sam, Jamal I-Ching/0000-0002-1296-7898
FU Malaysia One Health University Network research grant; US Agency for
   International DevelopmentUnited States Agency for International
   Development (USAID)
FX This study was supported by a Malaysia One Health University Network
   research grant and the US Agency for International Development.
CR Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Sam IC, 2015, EMERG INFECT DIS, V21, P1683, DOI 10.3201/eid2109.150439
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
NR 10
TC 2
Z9 2
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2019
VL 25
IS 2
BP 374
EP 376
DI 10.3201/eid2502.180258
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HI0LV
UT WOS:000456134000033
PM 30666941
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hetman, M
   Slomnicki, LP
AF Hetman, Michal
   Slomnicki, Lukasz P.
TI Ribosomal biogenesis as an emerging target of neurodevelopmental
   pathologies
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Review
DE apoptosis; neurodevelopment; nucleolus; protein; ribosome; rRNA;
   microcephaly
ID RNA-POLYMERASE-I; ZIKA VIRUS-INFECTION; UPSTREAM BINDING-FACTOR;
   CENTRAL-NERVOUS-SYSTEM; DOUBLE-STRAND BREAKS; MESSENGER-RNA; NUCLEOLAR
   DISRUPTION; TRANSCRIPTION FACTOR; RETT-SYNDROME; CELL-CYCLE
AB Development of the nervous system is carried out by complex gene expression programs that are regulated at both transcriptional and translational level. In addition, quality control mechanisms such as the TP53-mediated apoptosis or neuronal activity-stimulated survival ensure successful neurogenesis and formation of functional circuitries. In the nucleolus, production of ribosomes is essential for protein synthesis. In addition, it participates in chromatin organization and regulates the TP53 pathway via the ribosomal stress response. Its tight regulation is required for maintenance of genomic integrity. Mutations in several ribosomal components and trans-acting ribosomal biogenesis factors result in neurodevelopmental syndromes that present with microcephaly, autism, intellectual deficits and/or progressive neurodegeneration. Furthermore, ribosomal biogenesis is perturbed by exogenous factors that disrupt neurodevelopment including alcohol or Zika virus. In this review, we present recent literature that argues for a role of dysregulated ribosomal biogenesis in pathogenesis of various neurodevelopmental syndromes. We also discuss potential mechanisms through which such dysregulation may lead to cellular pathologies of the developing nervous system including insufficient proliferation and/or loss of neuroprogenitors cells, apoptosis of immature neurons, altered neuronal morphogenesis, and neurodegeneration.
C1 [Hetman, Michal; Slomnicki, Lukasz P.] Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY USA.
   [Hetman, Michal] Univ Louisville, Pharmacol & Toxicol, Louisville, KY 40292 USA.
RP Hetman, M; Slomnicki, LP (corresponding author), Univ Louisville, KY Spinal Cord Injury Res Ctr, 511 S Floyd St,MDR616, Louisville, KY 40292 USA.
EM michal.hetman@louisville.edu; lukasz.slomnicki@louisville.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R21NS103433-01A1, 1R01NS108529-01];
   intramural research grant-II from UofL Executive Vice-President for
   Research office; Leona and Harry Helmsley Charitable Trust; Blackfan
   Diamond Anemia Foundation Pilot Grant; Commonwealth of Kentucky
   Challenge for Excellence Fund
FX This work was supported by NIH (1R21NS103433-01A1 and 1R01NS108529-01),
   intramural research grant-II from UofL Executive Vice-President for
   Research office, Leona and Harry Helmsley Charitable Trust, Blackfan
   Diamond Anemia Foundation Pilot Grant, and, the Commonwealth of Kentucky
   Challenge for Excellence Fund. The authors thank Mr. Michael Forston and
   dr. Donghoon Chung for critical reading of this manuscript. Finally, one
   should note that there are many excellent articles that are related to
   the subject of this review but that are not cited here owing to space
   limitations. The authors declare no conflict of interest.
CR Allen KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104364
   Alupei MC, 2018, CELL REP, V23, P1612, DOI 10.1016/j.celrep.2018.04.041
   Amineva SP, 2004, J GEN VIROL, V85, P2969, DOI 10.1099/vir.0.80164-0
   Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13
   Banerjee R, 2005, J GEN VIROL, V86, P2315, DOI 10.1099/vir.0.80817-0
   Barna M, 2013, P NATL ACAD SCI USA, V110, P9, DOI 10.1073/pnas.1218764110
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642
   Bernabo P, 2017, CELL REP, V21, P953, DOI 10.1016/j.celrep.2017.10.010
   Berres ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169351
   Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383
   Bose T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002749
   Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0
   Brooks SS, 2014, GENETICS, V198, P723, DOI 10.1534/genetics.114.168211
   Butterfield RJ, 2014, NEUROLOGY, V82, P1322, DOI 10.1212/WNL.0000000000000305
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582
   Chau KF, 2018, ELIFE, V7, DOI 10.7554/eLife.36998
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Chiocchetti AG, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-10
   Chu J, 2016, TRENDS CELL BIOL, V26, P918, DOI 10.1016/j.tcb.2016.06.005
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Danilova N, 2015, DIS MODEL MECH, V8, P1013, DOI 10.1242/dmm.020529
   Deisenroth C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026138
   Despres P, 1998, J VIROL, V72, P823
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844
   Duan ZQ, 2014, VIROLOGY, V452, P212, DOI 10.1016/j.virol.2014.01.011
   Edvardson S, 2017, AM J HUM GENET, V101, P267, DOI 10.1016/j.ajhg.2017.07.002
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Ellis SR, 2014, BBA-MOL BASIS DIS, V1842, P765, DOI 10.1016/j.bbadis.2013.12.013
   Ernst C, 2016, TRENDS NEUROSCI, V39, P290, DOI 10.1016/j.tins.2016.03.001
   Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194
   Fraser JE, 2016, J VIROL, V90, P5797, DOI 10.1128/JVI.02727-15
   Fujii K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14443
   Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858
   Gard S, 2009, J CELL BIOL, V187, P455, DOI 10.1083/jcb.200906075
   Garic A, 2014, ALCOHOL CLIN EXP RES, V38, P1874, DOI 10.1111/acer.12457
   Gillespie A, 2017, RNA, V23, P466, DOI 10.1261/rna.060004.116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Gomes C, 2011, J BIOL CHEM, V286, P4357, DOI 10.1074/jbc.M110.170134
   Gouzil J, 2017, J VIROL, V91, DOI [10.1128/JVI.01263-16, 10.1128/jvi.01263-16]
   Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224
   Greene NDE, 2014, ANNU REV NEUROSCI, V37, P221, DOI 10.1146/annurev-neuro-062012-170354
   Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124
   Hamdane N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004505
   Harris B, 2014, MOL BIOL CELL, V25, P337, DOI 10.1091/mbc.E13-07-0377
   Heiman M, 2014, NAT PROTOC, V9, P1282, DOI 10.1038/nprot.2014.085
   Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269
   Herrmann D, 2018, CELL TISSUE RES, V373, P351, DOI 10.1007/s00441-018-2806-1
   Hetman M, 2012, TRENDS NEUROSCI, V35, P305, DOI 10.1016/j.tins.2012.01.002
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193
   Hyland K, 2010, J INHERIT METAB DIS, V33, P563, DOI 10.1007/s10545-010-9159-6
   Iadevaia V, 2014, SEMIN CELL DEV BIOL, V36, P113, DOI 10.1016/j.semcdb.2014.08.004
   Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044
   Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056
   Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963
   James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235
   Ji BH, 2014, HUM MOL GENET, V23, P5683, DOI 10.1093/hmg/ddu285
   Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x
   Kara B, 2017, EUR J HUM GENET, V25, P315, DOI 10.1038/ejhg.2016.183
   Karikkineth AC, 2017, AGEING RES REV, V33, P3, DOI 10.1016/j.arr.2016.08.002
   Katagiri N, 2015, SCI REP-UK, V5, DOI 10.1038/srep08903
   Kiryk A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00207
   Klauck SM, 2006, MOL PSYCHIATR, V11, P1073, DOI 10.1038/sj.mp.4001883
   Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204
   Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202
   Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102
   Kobayashi T, 2011, GENES CELLS, V16, P617, DOI 10.1111/j.1365-2443.2011.01519.x
   Koch S, 2014, CELL CYCLE, V13, P2029, DOI 10.4161/cc.29018
   Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028
   Kreiner G, 2013, CELL DEATH DIFFER, V20, P1455, DOI 10.1038/cdd.2013.66
   Kressler D, 2017, TRENDS BIOCHEM SCI, V42, P640, DOI 10.1016/j.tibs.2017.05.005
   Kumazawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10854
   Kusnadi EP, 2015, GENE, V556, P27, DOI 10.1016/j.gene.2014.11.010
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Langhendries JL, 2016, ONCOTARGET, V7, P59519, DOI 10.18632/oncotarget.11148
   Lee J, 2014, BBA-MOL BASIS DIS, V1842, P785, DOI 10.1016/j.bbadis.2013.09.017
   Lee Kyung Yeon, 2016, Korean J Pediatr, V59, P395
   Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002
   Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103
   Leung KN, 2009, HUM MOL GENET, V18, P4227, DOI 10.1093/hmg/ddp373
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273
   Lindstrom MS, 2018, ONCOGENE, V37, P2351, DOI 10.1038/s41388-017-0121-z
   Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557
   Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6
   Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007
   Mao HQ, 2015, J NEUROSCI, V35, P7003, DOI 10.1523/JNEUROSCI.0018-15.2015
   Martin LJ, 2009, CEREB CORTEX, V19, P1273, DOI 10.1093/cercor/bhn167
   Mills EW, 2017, SCIENCE, V358, DOI 10.1126/science.aan2755
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mitrea DM, 2016, ELIFE, V5, DOI 10.7554/eLife.13571
   Murawski NJ, 2015, ALCOHOL RES-CURR REV, V37, P97
   Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390
   O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Paolini NA, 2017, AM J HUM GENET, V100, P506, DOI 10.1016/j.ajhg.2017.01.034
   Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376
   Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106
   Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008
   Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014
   Pelava A, 2016, BIOCHEM SOC T, V44, P1086, DOI 10.1042/BST20160106
   Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104
   Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009
   Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001
   Pietrzak M, 2011, J NEUROCHEM, V117, P1033, DOI 10.1111/j.1471-4159.2011.07279.x
   Poortinga G, 2011, NUCLEIC ACIDS RES, V39, P3267, DOI 10.1093/nar/gkq1205
   Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107
   Puccioni-Sohler M, 2015, ARQ NEURO-PSIQUIAT, V73, P698, DOI 10.1590/0004-282X20150074
   Quin J, 2016, ONCOTARGET, V7, P49800, DOI 10.18632/oncotarget.10452
   Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015
   Rieker C, 2011, J NEUROSCI, V31, P453, DOI 10.1523/JNEUROSCI.0590-10.2011
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579
   Sahin M, 2015, SCIENCE, V350, DOI 10.1126/science.aab3897
   Salvetti A, 2014, BBA-MOL BASIS DIS, V1842, P840, DOI 10.1016/j.bbadis.2013.12.010
   Sanij E, 2015, GENOME RES, V25, P201, DOI 10.1101/gr.176115.114
   Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106
   Sartor F, 2015, BIOCHEM SOC T, V43, P1259, DOI 10.1042/BST20150168
   Scheibye-Knudsen M, 2016, P NATL ACAD SCI USA, V113, P12502, DOI 10.1073/pnas.1610198113
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Seah C, 2008, J NEUROSCI, V28, P12570, DOI 10.1523/JNEUROSCI.4048-08.2008
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sharifi S, 2018, ANNU REV BIOCHEM, V87, P51, DOI 10.1146/annurev-biochem-062917-012612
   Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003
   Singleton MK, 2011, NEUROBIOL DIS, V43, P190, DOI 10.1016/j.nbd.2011.03.011
   Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6
   Slomnicki LP, 2018, MOL NEUROBIOL, V55, P538, DOI 10.1007/s12035-016-0336-y
   Slomnicki LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16952-8
   Slomnicki LP, 2016, MOL CELL PROTEOMICS, V15, P2055, DOI 10.1074/mcp.M115.051920
   Slomnicki LP, 2016, J BIOL CHEM, V291, P5721, DOI 10.1074/jbc.M115.682161
   Smith SM, 2014, BIRTH DEFECTS RES C, V102, P210, DOI 10.1002/bdrc.21078
   Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859
   STOYKOVA AS, 1983, J NEUROCHEM, V41, P942, DOI 10.1111/j.1471-4159.1983.tb09038.x
   Subbaiah KCV, 2015, INT J BIOCHEM CELL B, V64, P97, DOI 10.1016/j.biocel.2015.03.019
   Switon K, 2017, NEUROSCIENCE, V341, P112, DOI 10.1016/j.neuroscience.2016.11.017
   Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tapia O, 2017, NEUROBIOL DIS, V108, P83, DOI 10.1016/j.nbd.2017.08.004
   Tchurikov NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25866
   Tebbenkamp ATN, 2014, CURR OPIN NEUROL, V27, P149, DOI 10.1097/WCO.0000000000000069
   Thapar A, 2017, LANCET PSYCHIAT, V4, P339, DOI 10.1016/S2215-0366(16)30376-5
   Thevenon J, 2015, AM J MED GENET A, V167, P1908, DOI 10.1002/ajmg.a.37094
   Thiffault I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8623
   Toro C, 2018, HUM MOL GENET, V27, P691, DOI 10.1093/hmg/ddx435
   Trainor PA, 2014, BBA-MOL BASIS DIS, V1842, P769, DOI 10.1016/j.bbadis.2013.11.010
   Tsai RYL, 2014, FASEB J, V28, P3290, DOI 10.1096/fj.14-254680
   Tsoi H, 2012, P NATL ACAD SCI USA, V109, P13428, DOI 10.1073/pnas.1204089109
   Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x
   Urbanowski MD, 2008, CELL SIGNAL, V20, P1227, DOI 10.1016/j.cellsig.2007.12.018
   Valnegri P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01333-6
   van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8
   Vashishta A, 2018, MOL NEUROBIOL, V55, P8374, DOI 10.1007/s12035-018-0989-9
   Waggoner S, 1998, J VIROL, V72, P6699, DOI 10.1128/JVI.72.8.6699-6709.1998
   Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254
   Wehner KA, 2002, BRAIN RES, V945, P160, DOI 10.1016/S0006-8993(02)02750-6
   Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006
   Wright KM, 2007, J CELL BIOL, V179, P825, DOI 10.1083/jcb.200708086
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xie Q, 2017, NUCLEIC ACIDS RES, V45, P2472, DOI 10.1093/nar/gkw1208
   Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103
   Xu BS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2354-y
   Xu BS, 2015, HUM MOL GENET, V24, P1540, DOI 10.1093/hmg/ddu565
   Xu BS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003857
   Xu ZK, 2012, VIROLOGY, V433, P226, DOI 10.1016/j.virol.2012.08.011
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023
   Zakari M, 2015, WIRES DEV BIOL, V4, P489, DOI 10.1002/wdev.190
   Zanni G, 2015, HUM MUTAT, V36, P1155, DOI 10.1002/humu.22860
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003
NR 185
TC 13
Z9 13
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD FEB
PY 2019
VL 148
IS 3
BP 325
EP 347
DI 10.1111/jnc.14576
PG 23
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA HI6VK
UT WOS:000456593300001
PM 30144322
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Eddowes, L
   Al-Hourani, K
   Ramamurthy, N
   Frankish, J
   Baddock, HT
   Sandor, C
   Ryan, JD
   Fusco, DN
   Arezes, J
   Giannoulatou, E
   Boninsegna, S
   Chevaliez, S
   Owens, BMJ
   Sun, CC
   Fabris, P
   Giordani, MT
   Martines, D
   Vukicevic, S
   Crowe, J
   Lin, HY
   Rehwinkel, J
   McHugh, PJ
   Binder, M
   Babitt, JL
   Chung, RT
   Lawless, MW
   Armitage, AE
   Webber, C
   Klenerman, P
   Drakesmith, H
AF Eddowes, Lucya
   Al-Hourani, Kinda
   Ramamurthy, Narayan
   Frankish, Jamie
   Baddock, Hannah T.
   Sandor, Cynthia
   Ryan, John D.
   Fusco, Dahlene N.
   Arezes, Joao
   Giannoulatou, Eleni
   Boninsegna, Sara
   Chevaliez, Stephane
   Owens, Benjamin M. J.
   Sun, Chia Chi
   Fabris, Paolo
   Giordani, Maria Teresa
   Martines, Diego
   Vukicevic, Slobodan
   Crowe, John
   Lin, Herbert Y.
   Rehwinkel, Jan
   McHugh, Peter J.
   Binder, Marco
   Babitt, Jodie L.
   Chung, Raymond T.
   Lawless, Matthew W.
   Armitage, Andrew E.
   Webber, Caleb
   Klenerman, Paul
   Drakesmith, Hal
TI Antiviral activity of bone morphogenetic proteins and activins
SO NATURE MICROBIOLOGY
LA English
DT Article
ID B-VIRUS REPLICATION; HEPATITIS-B; HEPCIDIN EXPRESSION; INTERFERON;
   INFECTION; IDENTIFICATION; TRANSCRIPTION; BMP; INHIBITION; INDUCTION
AB Understanding the control of viral infections is of broad importance. Chronic hepatitis C virus (HCV) infection causes decreased expression of the iron hormone hepcidin, which is regulated by hepatic bone morphogenetic protein (BMP)/SMAD signalling. We found that HCV infection and the BMP/SMAD pathway are mutually antagonistic. HCV blunted induction of hepcidin expression by BMP6, probably via tumour necrosis factor (TNF)-mediated downregulation of the BMP co-receptor haemojuvelin. In HCV-infected patients, disruption of the BMP6/hepcidin axis and genetic variation associated with the BMP/SMAD pathway predicted the outcome of infection, suggesting that BMP/SMAD activity influences antiviral immunity. Correspondingly, BMP6 regulated a gene repertoire reminiscent of type I interferon (IFN) signalling, including upregulating interferon regulatory factors (IRFs) and downregulating an inhibitor of IFN signalling, USP18. Moreover, in BMP-stimulated cells, SMAD1 occupied loci across the genome, similar to those bound by IRF1 in IFN-stimulated cells. Functionally, BMP6 enhanced the transcriptional and antiviral response to IFN, but BMP6 and related activin proteins also potently blocked HCV replication independently of IFN. Furthermore, BMP6 and activin A suppressed growth of HBV in cell culture, and activin A inhibited Zika virus replication alone and in combination with IFN. The data establish an unappreciated important role for BMPs and activins in cellular antiviral immunity, which acts independently of, and modulates, IFN.
C1 [Eddowes, Lucya; Al-Hourani, Kinda; Arezes, Joao; Rehwinkel, Jan; Armitage, Andrew E.; Drakesmith, Hal] Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.
   [Ramamurthy, Narayan; Boninsegna, Sara; Klenerman, Paul] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England.
   [Frankish, Jamie; Binder, Marco] German Canc Res Ctr, Div Virus Associated Carcinogenesis F170, Res Grp Dynam Early Viral Infect & Innate Antivir, Heidelberg, Germany.
   [Baddock, Hannah T.; McHugh, Peter J.] Univ Oxford, MRC Weatherall Inst Mol Med, Dept Oncol, Oxford, England.
   [Sandor, Cynthia; Webber, Caleb] Cardiff Univ, Dementia Res Inst, Cardiff, S Glam, Wales.
   [Ryan, John D.; Crowe, John] Mater Misericordiae Univ Hosp, Ctr Liver Dis, Dublin, Ireland.
   [Ryan, John D.; Owens, Benjamin M. J.; Klenerman, Paul] John Radcliffe Hosp, Nuffield Dept Med, Expt Med Div, Translat Gastroenterol Unit, Oxford, England.
   [Fusco, Dahlene N.; Chevaliez, Stephane; Chung, Raymond T.] Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Unit, Liver Ctr,Dept Med, Boston, MA USA.
   [Giannoulatou, Eleni] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England.
   [Boninsegna, Sara; Martines, Diego] Univ Padua, Dept Surg Gastroenterol Sci, Padua, Italy.
   [Sun, Chia Chi; Lin, Herbert Y.; Babitt, Jodie L.] Harvard Med Sch, Massachusetts Gen Hosp, Nephrol Div, Program Anemia Signaling Res,Program Membrane Bio, Boston, MA USA.
   [Sun, Chia Chi; Lin, Herbert Y.; Babitt, Jodie L.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA USA.
   [Fabris, Paolo; Giordani, Maria Teresa] San Bortolo Hosp, Dept Infect Dis & Trop Med, Vicenza, Italy.
   [Vukicevic, Slobodan] Univ Zagreb, Ctr Translat & Clin Res, Sch Med, Zagreb, Croatia.
   [Lawless, Matthew W.] Mater Misericordiae Univ Hosp, UCD Sch Med & Med Sci, Expt Med, Dublin, Ireland.
   [Webber, Caleb] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.
   [Klenerman, Paul] John Radcliffe Hosp, NIHR Biomed Res Ctr, Oxford, England.
   [Drakesmith, Hal] Oxford Biomed Res Ctr, Haematol Theme, Oxford, England.
RP Drakesmith, H (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.; Drakesmith, H (corresponding author), Oxford Biomed Res Ctr, Haematol Theme, Oxford, England.
EM alexander.drakesmith@imm.ox.ac.uk
RI Binder, Marco/E-9717-2011
OI Binder, Marco/0000-0002-5805-6109; Rehwinkel, Jan/0000-0003-3841-835X;
   Arezes, Joao/0000-0003-4214-7337; Webber, Caleb/0000-0001-8063-7674;
   Drakesmith, Alexander/0000-0002-8503-6103
FU MRC UKMedical Research Council UK (MRC) [92044]; Wellcome TrustWellcome
   Trust [WT091663MA, 109965MA]; NIHR Biomedical Research Centre,
   OxfordNational Institute for Health Research (NIHR); Oxford Martin
   School; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NIAID U19AI082630, NIDDK R01DK087727,
   RO1DK-069533, RO1DK-071837]; Beit Memorial Trust for Medical Research;
   CORELuxembourg National Research Fund; Rosetrees TrustRosetrees Trust;
   EU Fund [KK01.1.1.01.0008]; GI Research Fund of Dublin, Ireland
FX The authors thank MRC UK (grant no. 92044), the Wellcome Trust
   (WT091663MA and 109965MA), NIHR Biomedical Research Centre, Oxford, the
   Oxford Martin School, the NIH (NIAID U19AI082630, NIDDK R01DK087727,
   RO1DK-069533 and RO1DK-071837), the Beit Memorial Trust for Medical
   Research, CORE, The Rosetrees Trust, EU Fund to the University of Zagreb
   School of Medicine (grant no. KK01.1.1.01.0008) and the GI Research Fund
   of Dublin, Ireland for funding. The authors also thank A. Townsend and
   L. Swift for useful discussions and technical guidance.
CR Alliston T, 2005, J BIOL CHEM, V280, P24227, DOI 10.1074/jbc.M414305200
   Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777
   Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470
   Caldwell RL, 2006, J LEUKOCYTE BIOL, V79, P192, DOI 10.1189/jlb.0405194
   Cao XZ, 2015, J HEPATOL, V62, P771, DOI 10.1016/j.jhep.2014.11.007
   Carlin AF, 2017, CELL REP, V21, P1600, DOI 10.1016/j.celrep.2017.10.054
   Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059
   Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414
   Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052
   Denard B, 2011, CELL HOST MICROBE, V10, P65, DOI 10.1016/j.chom.2011.06.006
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Durrington HJ, 2010, J BIOL CHEM, V285, P37641, DOI 10.1074/jbc.M110.132415
   Eroshkin A, 1999, J MOL MED-JMM, V77, P403, DOI 10.1007/s001090050369
   Fillebeen C, 2005, J BIOL CHEM, V280, P9049, DOI 10.1074/jbc.M412687200
   Fletcher SP, 2013, HEPATOLOGY, V57, P13, DOI 10.1002/hep.25954
   Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541
   Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita
   Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013
   Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309
   Girelli D, 2009, J HEPATOL, V51, P845, DOI 10.1016/j.jhep.2009.06.027
   GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198
   Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138
   Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415
   Kim JH, 2008, J IMMUNOL, V181, P6467, DOI 10.4049/jimmunol.181.9.6467
   Lin QY, 2009, ORG LETT, V11, P1999, DOI 10.1021/ol900350k
   Liu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046631
   Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109
   MacParland SA, 2016, J VIROL, V90, P5549, DOI 10.1128/JVI.02557-15
   Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149
   Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494
   Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908
   Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034
   Olsayszky V, 2017, GENE, V627, P491, DOI 10.1016/j.gene.2017.06.051
   Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043
   Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172
   Ryan JD, 2010, HEPATOLOGY, V52, P1266, DOI 10.1002/hep.23814
   Sakamoto N, 2007, BIOCHEM BIOPH RES CO, V357, P467, DOI 10.1016/j.bbrc.2007.03.167
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Spottiswoode N, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00191-17, 10.1128/iai.00191-17]
   Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08
   Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952
   Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001
   Theurl I, 2004, J INFECT DIS, V190, P819, DOI 10.1086/422261
   Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044
   Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733
   Wu QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046307
   Xu PL, 2014, MOL CELL, V56, P723, DOI 10.1016/j.molcel.2014.11.027
   Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801
NR 48
TC 3
Z9 3
U1 6
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD FEB
PY 2019
VL 4
IS 2
BP 339
EP 351
DI 10.1038/s41564-018-0301-9
PG 13
WC Microbiology
SC Microbiology
GA HI5ZA
UT WOS:000456531600017
PM 30510168
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Pandey, RK
   Dahiya, S
   Mahita, J
   Sowdhamini, R
   Prajapati, VK
AF Pandey, Rajan Kumar
   Dahiya, Surbhi
   Mahita, Jarjapu
   Sowdhamini, Ramanathan
   Prajapati, Vijay Kumar
TI Vaccination and immunization strategies to design Aedes aegypti salivary
   protein based subunit vaccine tackling Flavivirus infection
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Flavivirus; Subunit vaccine; Epitopes; Adjuvant; Salivary protein; Aedes
   mosquito
ID IMMUNE-RESPONSE; POTENTIAL INHIBITOR; MOLECULAR DOCKING;
   LEISHMANIA-MAJOR; CELL EPITOPES; MOSQUITO; VIRUS; ANALOGS; PREDICTION;
   EXPOSURE
AB Flavivirus causes arthropod-borne severe diseases that sometimes lead to the death. The Flavivirus species including Dengue virus, Zika virus and yellow fever virus are transmitted by the bite of Aedes mosquitoes. All these viral species target the people living in their respective endemic zone causing a high mortality rate. Recent studies show that immune factors present in the Ae. aegypd saliva is the hidden culprit promoting blood meal collection, suppressing host immune molecules and promoting disease establishment. This study was designed to develop a subunit vaccine using Aedes mosquito salivary proteins targeting the aforementioned Flaviviruses. Subunit vaccine was designed very precisely by combining the immunogenic B-cell epitope with CTL and HTL epitopes and also suitable adjuvant and linkers. Immunogenicity, allergenicity and physiochemical characterization were also performed for scientific validation. Molecular docking and molecular dynamics simulations studies were carried out to confirm the stable affinity between the vaccine protein (3D) and TLR3 receptor. At last, in silico cloning was executed to get the subunit vaccine restriction clone into pET28a vectro to express it in microbial expression system. Additionally, this study warrants the experimental evaluation for the validation purposes. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Pandey, Rajan Kumar; Dahiya, Surbhi; Prajapati, Vijay Kumar] Cent Univ Rajasthan, Sch Life Sci, Dept Biochem, Ajmer 305817, Rajasthan, India.
   [Mahita, Jarjapu; Sowdhamini, Ramanathan] TIFR, NCBS, Bangalore, Karnataka, India.
RP Prajapati, VK (corresponding author), Cent Univ Rajasthan, Sch Life Sci, Dept Biochem, Ajmer 305817, Rajasthan, India.
EM vkprajapati@curaj.ac.in
RI Pandey, Rajan Kumar/AAP-1788-2020; Prajapati, Vijay K/M-8539-2013
OI Prajapati, Vijay K/0000-0001-6510-0596; Pandey, Dr Rajan
   Kumar/0000-0002-2135-5287
FU Department of Science and TechnologyDepartment of Science & Technology
   (India); JC Bose fellowship [SB/S2/JCB-071/2015]
FX RKP is thankful to Department of Science and Technology for providing
   INSPIRE fellowship. VKP is thankful to the Central University of
   Rajasthan for providing the computational facility. The project was
   partially supported by RS's JC Bose fellowship (SB/S2/JCB-071/2015). MJ
   and RS would also like to thank NCBS (TIFR) for infrastructural
   facilities.
CR Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w
   Andrade BB, 2007, SCAND J IMMUNOL, V66, P122, DOI 10.1111/j.1365-3083.2007.01964.x
   Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529
   Bassi MR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004464
   Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266
   Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200
   Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039
   Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dimitrov I, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S4
   Doucoure S, 2012, AM J TROP MED HYG, V87, P504, DOI 10.4269/ajtmh.2012.11-0477
   Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376
   Han YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004319
   Hayes E. B., 2012, PRINCIPLES PRACTICE
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Khatoon N, 2019, J BIOMOL STRUCT DYN, V37, P2381, DOI 10.1080/07391102.2018.1484815
   Khatoon N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08842-w
   Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493
   Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08
   Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024
   Liang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021696
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   McCracken MK, 2014, VIROLOGY, V468, P133, DOI 10.1016/j.virol.2014.07.019
   Mohan T, 2013, VACCINE, V31, P1707, DOI 10.1016/j.vaccine.2013.01.041
   Morris RV, 2001, J IMMUNOL, V167, P5226, DOI 10.4049/jimmunol.167.9.5226
   Narula A, 2018, INFECT GENET EVOL, V61, P4, DOI 10.1016/j.meegid.2018.03.007
   Oktarianti R, 2015, J INFECT PUBLIC HEAL, V8, P575, DOI 10.1016/j.jiph.2015.04.022
   Pandey RK, 2018, J CELL BIOCHEM, V119, P7631, DOI 10.1002/jcb.27110
   Pandey RK, 2018, VACCINE, V36, P4555, DOI 10.1016/j.vaccine.2018.05.082
   Pandey RK, 2018, INFECT GENET EVOL, V63, P5, DOI 10.1016/j.meegid.2018.05.005
   Pandey RK, 2019, J CELL BIOCHEM, V120, P1141, DOI 10.1002/jcb.26719
   Pandey RK, 2018, VACCINE, V36, P2262, DOI 10.1016/j.vaccine.2018.03.042
   Pandey RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19456-1
   Pandey RK, 2017, J BIOMOL STRUCT DYN, V35, P791, DOI 10.1080/07391102.2016.1161560
   Pandey RK, 2017, J RECEPT SIG TRANSD, V37, P60, DOI 10.3109/10799893.2016.1171344
   Pandey RK, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00206
   Pandey RK, 2015, J BIOMOL STRUCT DYN, V33, P2541, DOI 10.1080/07391102.2015.1085904
   Peng J, 2011, PROTEINS, V79, P161, DOI 10.1002/prot.23175
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Prates D. B., 2012, J PARASITOL RES, V2012, P11
   Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Vinhas V, 2007, EUR J IMMUNOL, V37, P3111, DOI 10.1002/eji.200737431
   Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568
   Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626
   Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x
   Wheat WH, 2017, VACCINE, V35, P6611, DOI 10.1016/j.vaccine.2017.10.039
   Wichit S, 2016, CURR OPIN VIROL, V21, P139, DOI 10.1016/j.coviro.2016.10.001
   Wilkins MR, 1999, METH MOL B, V112, P531
   Yano A, 2013, VACCINE, V31, P1510, DOI 10.1016/j.vaccine.2012.12.083
NR 58
TC 0
Z9 0
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD FEB 1
PY 2019
VL 122
BP 1203
EP 1211
DI 10.1016/j.ijbiomac.2018.09.071
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA HI1TA
UT WOS:000456226700130
PM 30219509
DA 2020-07-08
ER

PT J
AU Dupin, N
   Piguet, V
AF Dupin, Nicolas
   Piguet, Vincent
TI Zika Virus Infection RIG-ged by Keratinocytes and Fibroblasts
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Editorial Material
AB Zika virus is an emergent virus targeting the skin. Ji-Ae et al. (2018) explore the interactions between Zika virus and skin cells. They showed that human keratinocytes play an important role in control of initial infection via the interaction with retinoic acideinducible gene receptors.
C1 [Dupin, Nicolas] Cochin Hosp, AP HP, Dept Dermatol, 89 Rue Assas, F-75006 Paris, France.
   [Dupin, Nicolas] Univ Paris 05, Paris, France.
   [Piguet, Vincent] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada.
   [Piguet, Vincent] Womens Coll Hosp, Div Dermatol, Toronto, ON, Canada.
RP Dupin, N (corresponding author), Cochin Hosp, AP HP, Dept Dermatol, 89 Rue Assas, F-75006 Paris, France.; Piguet, V (corresponding author), Univ Toronto, Womens Coll Hosp, Dept Med, Dermatol, 76 Grenville St,Off 6425, Toronto, ON M5S 1B2, Canada.
EM nicolas.dupin@aphp.fr; vincent.piguet@utoronto.ca
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bradley MP, 2017, COMPARATIVE MED, V67, P242
   Cordel N, 2018, BRIT J DERMATOL, V178, pE108, DOI 10.1111/bjd.16096
   Cordel N, 2017, JAMA DERMATOL, V153, P326, DOI 10.1001/jamadermatol.2016.5442
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Fellner Chris, 2016, P T, V41, P242
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Dias IKR, 2018, REV SOC BRAS MED TRO, V51, P261, DOI 10.1590/0037-8682-0130-2018
NR 9
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-202X
EI 1523-1747
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD FEB
PY 2019
VL 139
IS 2
BP 281
EP 282
DI 10.1016/j.jid.2018.09.003
PG 2
WC Dermatology
SC Dermatology
GA HI0VI
UT WOS:000456162000016
PM 30665581
OA Bronze
DA 2020-07-08
ER

PT J
AU Kim, JA
   Seong, RK
   Son, SW
   Shin, OS
AF Kim, Ji-Ae
   Seong, Rak-Kyun
   Son, Sang Wook
   Shin, Ok Sarah
TI Insights into ZIKV-Mediated Innate Immune Responses in Human Dermal
   Fibroblasts and Epidermal Keratinocytes
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Article
ID RIG-I; MEMBRANE ASSOCIATION; VIRUS; RNA; MDA5; RECOGNITION; INFECTION;
   HELICASES; BIOLOGY
AB Zika virus (ZIKV) has emerged as a global pathogen causing significant public health concern. ZIKV infections in humans principally occur via mosquito bites. Thus, host skin cells are permissive to ZIKV infection and are the first line of defense against the virus. Here, we examined the role and mechanisms of antiviral skin immunity against ZIKV infection. ZIKV infection (African lineage MR766) in human dermal fibroblasts, human epidermal keratinocytes, and HaCaT keratinocytes resulted in distinct expression changes in RIG-Ielike receptors, such as RIG-I and MDA5. Inhibition of RIG-I using small interfering RNA resulted in increased viral gene expression and reduced induction of IFNs and IFN-stimulated genes. Furthermore, ZIKV NS1 directly interacted with RIG-I or MDA5 and down-regulated RIG-Ielike receptoremediated antiviral signaling pathways. Asian lineage ZIKV (PRVABC59) infection also showed a distinct pattern of antiviral immunity in human skin cells, compared with other ZIKV strains. Additionally, ZIKV infections in human neural progenitor cells induced the robust activation of RIG-Ielike receptoremediated signaling, followed by highly enhanced IFN-stimulated gene expression. Our findings provide important insights into ZIKV tropism and subsequent antiviral signaling pathways that regulate ZIKV replication in human dermal fibroblasts and human epidermal keratinocytes.
C1 [Kim, Ji-Ae; Seong, Rak-Kyun; Shin, Ok Sarah] Korea Univ, Guro Hosp, Coll Med, Dept Biomed Sci, Seoul, South Korea.
   [Son, Sang Wook] Korea Univ, Coll Med, Dept Dermatol, Seoul, South Korea.
   [Son, Sang Wook] Korea Univ, Coll Med, Div BK21 Project Biomed Sci, Seoul, South Korea.
RP Shin, OS (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.
EM oshin@korea.ac.kr
FU National Research Foundation of Korea (NRF) - Korea government
   [NRF-2016R1C1B2006493]; Korea University Grant
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (NRF-2016R1C1B2006493), and
   Korea University Grant.
CR Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Deen GF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005723
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Duangkhae P, 2018, J INVEST DERMATOL, V138, P618, DOI 10.1016/j.jid.2017.10.018
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia M, 2017, EUR CYTOKINE NETW, V28, P41, DOI 10.1684/ecn.2017.0394
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Handfield C, 2018, TRENDS IMMUNOL, V39, P328, DOI 10.1016/j.it.2018.02.003
   Higgins Sarah C, 2010, Curr Infect Dis Rep, V12, P4, DOI 10.1007/s11908-009-0080-9
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Oh SJ, 2018, YONSEI MED J, V59, P176, DOI 10.3349/ymj.2018.59.2.176
   Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
NR 41
TC 11
Z9 11
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-202X
EI 1523-1747
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD FEB
PY 2019
VL 139
IS 2
BP 391
EP 399
DI 10.1016/j.jid.2018.07.038
PG 9
WC Dermatology
SC Dermatology
GA HI0VI
UT WOS:000456162000030
PM 30218650
OA Bronze
DA 2020-07-08
ER

PT J
AU Nurnberger, C
   Bodmer, BS
   Fiedler, AH
   Gabriel, G
   Muhlebach, MD
AF Nuernberger, Cindy
   Bodmer, Bianca S.
   Fiedler, Anna H.
   Gabriel, Guelsah
   Muehlebach, Michael D.
TI A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika
   Virus in an Allogeneic Mouse Pregnancy Model
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE measles virus; ZIKV pathology; Zika virus; allogeneic pregnancy model;
   immunization; teratogenic infection; vaccines
ID YELLOW-FEVER; IMMUNE-RESPONSES; SCHWARZ STRAIN; PLASMID DNA; IN-VITRO;
   LIVE; IMMUNIZATION; PATHOGENESIS; LYMPHOCYTES; CULTIVATION
AB The impact of the Zika virus (ZIKV) epidemic highlights the need for vaccines that reduce or prevent infection and reliably prevent teratogenic complications. The live-attenuated measles virus (MV) vaccine strains are a promising vaccine platform, since they induce robust humoral and cellular immune responses against additional antigens and have an excellent safety record. To explore its potential to protect against ZIKV, we compared a recombinant Schwarz strain MV that encodes ZIKV prM and soluble E proteins (MV-Zika-sE) with a prototypic alum-adjuvanted whole inactivated ZIKV particle vaccine. Analysis of MV-Zika-sE-infected cells confirmed antigen expression, and the virus replicated with vaccine strain characteristics. Immunized IFNAR(-/-) -CD46Ge mice developed E protein-specific and neutralizing antibodies, and ZIKV E-specific cellular immune responses were observed by gamma interferon (IFN-gamma) enzyme-linked immunospot (ELISpot) and in vitro T cell proliferation assays. To analyze protective efficacy, vaccinated female mice were challenged with ZIKV after allogeneic mating. In MV-Zika-sE-vaccinated mice, weight gain was similar to that in uninfected mice, while no plasma viremia was detectable in the majority of the animals. In contrast, infected control animals gained less weight and experienced about 100-fold higher viremia over at least 3 days. Moreover, vaccination with MV-Zika-sE reduced the ZIKV load in different organs and the placentas and prevented infection of the fetus. Consequently, no fetal growth retardation, anemia, or death due to ZIKV infection was seen in MV-Zika-sE-vaccinated dams. In contrast, the inactivated ZIKV vaccine had little to no effect in our studies. Therefore, the MV-derived ZIKV vaccine is a promising candidate for further preclinical and clinical development.
   IMPORTANCE Zika virus (ZIKV) is a mosquito-borne flavivirus that causes a variety of neurological complications, including congenital birth defects. Despite the urgent need, no ZIKV vaccine has yet been licensed. Recombinant vaccine strain-derived measles viruses (MV) constitute a promising vector platform to induce immunity against foreign pathogens by expressing antigens from additional transcription units while at the same time possessing a remarkable safety profile. This concept has already been validated against different pathogens, including at least 3 other flaviviruses, and our data show that vaccination with MV expressing soluble ZIKV E protein significantly diminishes infection and prevents fetal loss or damage in an allogeneic mouse pregnancy model. It can thus be regarded as a promising emergency vaccine candidate with the potential for inclusion in routine vaccination settings in areas of endemicity to prevent teratogenic effects of circulating ZIKV during pregnancy, comparable to standard rubella virus vaccination.
C1 [Nuernberger, Cindy; Bodmer, Bianca S.; Fiedler, Anna H.; Muehlebach, Michael D.] Paul Ehrlich Inst, Vet Med Div, Langen, Germany.
   [Nuernberger, Cindy; Fiedler, Anna H.; Muehlebach, Michael D.] German Ctr Infect Res, Giessen, Germany.
   [Gabriel, Guelsah] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.
   [Gabriel, Guelsah] Univ Vet Med, Inst Virol, Hannover, Germany.
RP Muhlebach, MD (corresponding author), Paul Ehrlich Inst, Vet Med Div, Langen, Germany.; Muhlebach, MD (corresponding author), German Ctr Infect Res, Giessen, Germany.
EM Michael.Muehlebach@pei.de
OI Muehlebach, Michael/0000-0002-7069-5018; Horner,
   Cindy/0000-0002-9653-1249
FU BMG grant [1-2516-FSB-416]; German Center for Infection Research (DZIF)
   [TTU 01.802, TTU 01.916]
FX This work was supported by BMG grant 1-2516-FSB-416 (M.D.M. and G.G.)
   and by the German Center for Infection Research (DZIF) (TTU 01.802
   [M.D.M.] and TTU 01.916 [G.G.]).
CR Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Bodmer BS, 2018, VIROLOGY, V521, P99, DOI 10.1016/j.virol.2018.05.028
   Brandler S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000096
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cheng X, 2013, J INFECT DIS, V208, P594, DOI 10.1093/infdis/jit207
   Combredet C, 2003, J VIROL, V77, P11546, DOI 10.1128/JVI.77.21.11546-11554.2003
   Corr M, 1996, J EXP MED, V184, P1555, DOI 10.1084/jem.184.4.1555
   DARWISH MA, 1966, P SOC EXP BIOL MED, V122, P813
   del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07
   Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Doe B, 1996, P NATL ACAD SCI USA, V93, P8578, DOI 10.1073/pnas.93.16.8578
   Engels G, 2017, CELL HOST MICROBE, V21, P321, DOI 10.1016/j.chom.2017.02.020
   Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128
   Gilbert SC, 2012, IMMUNOLOGY, V135, P19, DOI 10.1111/j.1365-2567.2011.03517.x
   Higuchi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150213
   Hubert JJ, 1984, BIOASSAY, P65
   Hutzler S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16928-8
   Iankov ID, 2011, VACCINE, V29, P1710, DOI 10.1016/j.vaccine.2010.12.020
   James KT, 2016, SCI REP-UK, V6, DOI 10.1038/srep36826
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Kochel T, 1997, VACCINE, V15, P547, DOI 10.1016/S0264-410X(97)00215-6
   KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993
   Laksono BM, 2018, J VIROL, V92, DOI 10.1128/JVI.00131-18
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4
   Malczyk AH, 2015, J VIROL, V89, P11654, DOI 10.1128/JVI.01815-15
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998
   Muhlebach MD, 2017, VIRUS GENES, V53, P733, DOI 10.1007/s11262-017-1486-3
   Mura M, 2018, VIROLOGY, V524, P151, DOI 10.1016/j.virol.2018.08.014
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pan American Health Organization, 2017, ZIK EP REP BRAZ
   Phillpotts RJ, 1996, ARCH VIROL, V141, P743, DOI 10.1007/BF01718332
   PRICE WH, 1969, NATURE, V222, P1294, DOI 10.1038/2221294a0
   RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schlender J, 1996, P NATL ACAD SCI USA, V93, P13194, DOI 10.1073/pnas.93.23.13194
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stanelle-Bertram S, 2018, NAT MICROBIOL, V3, P1161, DOI 10.1038/s41564-018-0236-1
   Suder E, 2018, HUM VACC IMMUNOTHER, V14, P2107, DOI 10.1080/21645515.2018.1473698
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Thomssen R, 1975, Monogr Allergy, V9, P155
   Tlaxca JL, 2015, ADV DRUG DELIVER REV, V93, P56, DOI 10.1016/j.addr.2014.10.002
   Trosemeier JH, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00917-16
   World Health Organization, 2018, LIST BLUEPR PRIOR DI
   World Health Organization/UNICEF, 2017, WHO UNICEF ZIK VACC
NR 54
TC 6
Z9 6
U1 2
U2 17
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2019
VL 93
IS 3
AR e01485-18
DI 10.1128/JVI.01485-18
PG 15
WC Virology
SC Virology
GA HH8RY
UT WOS:000456001300012
PM 30429338
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wong, R
   Bhattacharya, D
AF Wong, Rachel
   Bhattacharya, Deepta
TI Basics of memory B-cell responses: lessons from and for the real world
SO IMMUNOLOGY
LA English
DT Review
DE antibodies; B cell; memory; viral
ID DENGUE VIRUS-INFECTION; ORIGINAL ANTIGENIC SIN; ZIKA VIRUS;
   PLASMODIUM-FALCIPARUM; PLASMA-CELL; HUMORAL IMMUNITY; STRUCTURAL BASIS;
   NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; REACTIVE ANTIBODIES
AB The production of pathogen-specific B cells and antibodies underlies protective immunity elicited by most vaccines and many infections. Humoral immunity follows a regulated process by which high-affinity antibody-secreting plasma cells and memory B cells are generated. Yet for certain pathogens, protective immunity is inefficiently generated and/or maintained. For example, Dengue virus infections lead to lasting immunity against re-infection by the same serotype. However, if infected with a different Dengue serotype, the individual is predisposed to more severe disease than if he/she was completely naive. As another example, both natural infections with or vaccination against malaria do not necessarily lead to lasting immunity, as the same individual can be re-infected many times over the course of a lifetime. In this review, we discuss how these real-world problems can both instruct and be informed by recent basic studies using model organisms and antigens. An emphasis is placed on protective epitopes and functional distinctions between memory B-cell subsets in both mice and humans. Using flavivirus and Plasmodium infections as examples, we also speculate on the differences between ineffective B-cell responses that actually occur in the real world, and perfect-world responses that would generate lasting immunity.
C1 [Wong, Rachel] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA.
   [Wong, Rachel; Bhattacharya, Deepta] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA.
RP Bhattacharya, D (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA.
EM deeptab@email.arizona.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI099108, R01AI129945,
   R21AI132910]; NSF fellowshipNational Science Foundation (NSF)
   [DGE1143954]
FX This work was supported by NIH grants R01AI099108, R01AI129945, and
   R21AI132910, and by NSF fellowship DGE1143954.
CR Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023
   Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736
   Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092
   Appanna R, 2016, EBIOMEDICINE, V12, P178, DOI 10.1016/j.ebiom.2016.09.003
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bemark M, 2011, J IMMUNOL, V186, P1399, DOI 10.4049/jimmunol.1002881
   Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4
   Centers for Disease Control and Prevention, 2018, MAL MAL IMP WORLDW
   Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690
   COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0
   Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596
   Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814
   Doyle-Cooper C, 2013, J IMMUNOL, V191, P3186, DOI 10.4049/jimmunol.1301285
   Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879
   Fernandez E, 2018, MBIO, V9, DOI [10.1128/mBio.00008-18, 10.1128/mbio.00008-18]
   Francis T, P AM PHILOS SOC, V104, P572
   FRUH K, 1991, INFECT IMMUN, V59, P1319
   Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004
   Guthmiller JJ, 2017, J IMMUNOL, V198, P617, DOI 10.4049/jimmunol.1601762
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Inoue T, 2018, IMMUNOL REV, V283, P138, DOI 10.1111/imr.12640
   JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0
   Jash A, 2016, J IMMUNOL, V197, P1159, DOI 10.4049/jimmunol.1600882
   Keitany GJ, 2016, CELL REP, V17, P3193, DOI 10.1016/j.celrep.2016.11.060
   Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82
   Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679
   Knode LMR, 2017, J IMMUNOL, V198, P1921, DOI 10.4049/jimmunol.1601106
   Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lam WY, 2018, CELL REP, V24, P2479, DOI 10.1016/j.celrep.2018.07.084
   Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011
   Lavinder JJ, 2014, P NATL ACAD SCI USA, V111, P2259, DOI 10.1073/pnas.1317793111
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li HF, 2016, J IMMUNOL, V196, P4064, DOI 10.4049/jimmunol.1501027
   Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540
   Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752
   Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600
   Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970
   Murugan R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aap8029
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Obeng-Adjei N, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006576
   Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564
   Pape KA, 2018, IMMUNITY, V48, P1135, DOI 10.1016/j.immuni.2018.04.019
   Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087
   Perez-Mazliah D, 2018, BIORXIV
   Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254
   Piovesan D, 2017, CELL REP, V19, P461, DOI 10.1016/j.celrep.2017.03.060
   Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740
   Reed JH, 2016, J EXP MED, V213, P1255, DOI 10.1084/jem.20151978
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111
   SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0
   Seifert M, 2001, P NATL ACAD SCI USA, V98, P1166
   Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202
   Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657
   Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813
   Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450
   Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691
   Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023
   Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294
   Wang YN, 2014, J EXP MED, V211, P841, DOI 10.1084/jem.20131821
   Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531
   Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004
   Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983
   Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912
   Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297
   White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914
NR 108
TC 2
Z9 2
U1 2
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD FEB
PY 2019
VL 156
IS 2
BP 120
EP 129
DI 10.1111/imm.13019
PG 10
WC Immunology
SC Immunology
GA HH3HB
UT WOS:000455609300003
PM 30488482
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Galvao, JG
   Cerpe, P
   Santos, DA
   Gonsalves, JKMC
   Santos, AJ
   Nunes, RKV
   Lira, AAM
   Alves, PB
   La Corte, R
   Blank, AF
   Silva, GF
   Cavalcanti, SCH
   Nunes, RS
AF Galvao, Juliana G.
   Cerpe, Patricia
   Santos, Darlisson A.
   Gonsalves, Joyce K. M. C.
   Santos, Adriana J.
   Nunes, Rafaela K. V.
   Lira, Ana A. M.
   Alves, Pericles B.
   La Corte, Roseli
   Blank, Arie F.
   Silva, Gabriel F.
   Cavalcanti, Socrates C. H.
   Nunes, Rogeria S.
TI Lippia gracilis essential oil in -cyclodextrin inclusion complexes: an
   environmentally safe formulation to control Aedes aegypti larvae
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE Aedes aegypti; inclusion complexes; larvicidal activity; arboviruses;
   Artemia sp
ID ENCAPSULATION; AGENT
AB BACKGROUNDOne of the most efficient ways to prevent arboviruses, such as dengue fever, yellow fever, chikungunya and Zika, is by controlling their vector, the Aedes aegypti. Because this vector is becoming resistant to most larvicides used, the development of new larvicides should be considered. -Cyclodextrin (-CD) complexes have been investigated as an interesting way of enabling the use of essential oils in water as larvicides. This study comprised the development of Lippia gracilis essential oil (LGEO) and -CD inclusion complexes for control of Ae. aegypti.
   RESULTSThermal analysis clearly showed the formation of complexes using kneading and co-evaporation methods. Gas chromatography analysis showed that kneading without co-solvent (KW) gave the highest content (approximate to 15%) of the LGEO major component. Moreover, KW showed that the complex had a 50% lethal concentration (LC50; 33ppm) lower than that of pure LGEO (39ppm); in other words, complexing LGEO with -CD improved the larvicidal activity. In addition, LGEO complexed with -CD (KW) was not harmful to non-target organisms at the concentrations needed to control Ae. aegypti larvae.
   CONCLUSIONThe inclusion complex with LGEO was a feasible formulation, being economically viable, easy-to-apply and without impact on non-target organisms and, therefore, is a potential alternative larvicide for Ae. aegypti control. (c) 2018 Society of Chemical Industry
C1 [Galvao, Juliana G.; Cerpe, Patricia; Gonsalves, Joyce K. M. C.; Santos, Adriana J.; Nunes, Rafaela K. V.; Lira, Ana A. M.; Cavalcanti, Socrates C. H.; Nunes, Rogeria S.] Univ Fed Sergipe, Pharm Dept, Av Marechal Rondon S-N, BR-49000100 Sao Cristovao, Sergipe, Brazil.
   [Santos, Darlisson A.; Alves, Pericles B.] Univ Fed Sergipe, Chem Dept, Sao Cristovao, Brazil.
   [La Corte, Roseli] Univ Fed Sergipe, Morphol Dept, Sao Cristovao, Brazil.
   [Blank, Arie F.] Univ Fed Sergipe, Agron Dept, Sao Cristovao, Brazil.
   [Silva, Gabriel F.] Univ Fed Sergipe, Chem Engn Dept, Sao Cristovao, Brazil.
RP Nunes, RS (corresponding author), Univ Fed Sergipe, Pharm Dept, Av Marechal Rondon S-N, BR-49000100 Sao Cristovao, Sergipe, Brazil.
EM rogeria.ufs@hotmail.com
RI Galvao, Juliana Gouveia/AAI-9737-2020; Cavalcanti,
   Socrates/AAQ-7004-2020; Alves, Pericles/S-8768-2019; Nunes, Rogeria
   RSN/R-5248-2018; Santos, Roseli LC/F-1735-2015; da Cunha Gonsalves,
   Joyce Kelly Marinheiro/S-2297-2018; Santos, Darlisson A/E-2970-2016;
   Lira, Ana/Y-8196-2019
OI Galvao, Juliana Gouveia/0000-0002-5471-4530; Alves,
   Pericles/0000-0002-8955-9614; Nunes, Rogeria RSN/0000-0001-6681-2042;
   Santos, Darlisson A/0000-0001-5817-5792; Lira, Ana/0000-0003-3451-9049
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/Brazil)CAPES; Fundacao de Amparo a Pesquisa do Estado de
   Sergipe (FAPITEC/SE)
FX The authors acknowledge the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq/Brazil), the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil) and the
   Fundacao de Amparo a Pesquisa do Estado de Sergipe (FAPITEC/SE) for
   supporting funds, Herbarium of the Federal University of Sergipe (ASE)
   and CMNano for SEM analysis.
CR Adams RP, 2007, IDENTIFICATION ESSEN, V804
   Anjali CH, 2012, PEST MANAG SCI, V68, P158, DOI 10.1002/ps.2233
   Boonyarattanakalin KS, 2011, J INCL PHENOM MACRO, V70, P279, DOI 10.1007/s10847-010-9913-2
   Marques HMC, 2010, FLAVOUR FRAG J, V25, P313, DOI 10.1002/ffj.2019
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cruz EMD, 2013, VET PARASITOL, V195, P198, DOI 10.1016/j.vetpar.2012.12.046
   Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9
   Dias CN, 2015, EVID-BASED COMPL ALT, DOI 10.1155/2015/490765
   Ezeonu FC, 2001, BIORESOURCE TECHNOL, V76, P273, DOI 10.1016/S0960-8524(00)00120-6
   Ferreira SG, 2015, J COLLOID INTERF SCI, V456, P190, DOI 10.1016/j.jcis.2015.06.012
   Finney D.J, 1971, PROBIT ANAL, P31
   Galvao JG, 2015, THERMOCHIM ACTA, V608, P14, DOI 10.1016/j.tca.2015.04.001
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Hadaruga NG, 2012, FOOD CHEM, V132, P1741, DOI 10.1016/j.foodchem.2011.11.003
   Higuchi T, 1965, ADV ANAL CHEM INSTRU, V4, P117
   Jun SW, 2007, EUR J PHARM BIOPHARM, V66, P413, DOI 10.1016/j.ejpb.2006.11.013
   Li N, 2005, J PHARMACEUT BIOMED, V39, P824, DOI 10.1016/j.jpba.2005.05.011
   Macedo OFL, 2012, SPECTROCHIM ACTA A, V86, P101, DOI 10.1016/j.saa.2011.10.010
   Marreto RN, 2008, THERMOCHIM ACTA, V475, P53, DOI 10.1016/j.tca.2008.06.015
   Menezes PP, 2012, THERMOCHIM ACTA, V548, P45, DOI 10.1016/j.tca.2012.08.023
   MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236
   Moretti M. D. L., 2002, AAPS PHARMSCITECH, V3, P13, DOI DOI 10.1208/PT030213
   Scalia S, 2002, J PHARMACEUT BIOMED, V30, P1181, DOI 10.1016/S0731-7085(02)00433-8
   Scalia S, 2006, INT J PHARMACEUT, V320, P79, DOI 10.1016/j.ijpharm.2006.04.008
   Serafini MR, 2012, J THERM ANAL CALORIM, V109, P951, DOI 10.1007/s10973-011-1736-x
   Shrestha M, 2017, FOOD CHEM, V221, P1474, DOI 10.1016/j.foodchem.2016.11.003
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Songkro S, 2012, J INCL PHENOM MACRO, V72, P339, DOI 10.1007/s10847-011-9985-7
   Teles TV, 2010, AFR J BIOTECHNOL, V9, P8800
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   Venturini CDG, 2008, QUIM NOVA, V31, P360, DOI 10.1590/S0100-40422008000200032
   Wang J, 2011, FOOD CHEM, V127, P1680, DOI 10.1016/j.foodchem.2011.02.036
NR 32
TC 3
Z9 3
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD FEB
PY 2019
VL 75
IS 2
BP 452
EP 459
DI 10.1002/ps.5138
PG 8
WC Agronomy; Entomology
SC Agriculture; Entomology
GA HH0KM
UT WOS:000455405500017
PM 29998608
OA Bronze
DA 2020-07-08
ER

PT J
AU Piltch-Loeb, R
   Merdjanoff, AA
   Bhanja, A
   Abramson, DM
AF Piltch-Loeb, Rachael
   Merdjanoff, Alexis A.
   Bhanja, Aditi
   Abramson, David M.
TI Support for vector control strategies in the United States during the
   Zika outbreak in 2016: The role of risk perception, knowledge, and
   confidence in government
SO PREVENTIVE MEDICINE
LA English
DT Article
ID WEST-NILE-VIRUS; HEALTH; AMERICA; CHALLENGES; DISEASE; SPREAD; DENGUE;
   MODEL
AB Limiting the spread and impact of Zika was a major global priority in 2016, which required a variety of vector control measures. The success of vector control campaigns is varied and often dependent on public or political will. This paper examines the change over time in the United States population's support for vector control and the factors that predicted support for three vector control strategies (i.e., indoor spraying, outdoor spraying, and use of larvacide tablets) during the 2016 Zika outbreak in the United States. Data is from a nationally representative random digit dial sample conducted at three time points in 2016. Bivariate and multivariate regression analyses were used, treating data as a pooled cross-sectional sample. Results show public support for vector control strategies depends on both perceived risk for disease and knowledge of disease characteristics, as well is confidence in government to prevent the threat. Support varied based on vector control method: indoor spraying, aerial spraying, and use of larvacide tables. Results can aide public health officials in implementing effective vector control campaigns depending on the vector control strategy of choice. Results have implications for ways to design effective prevention campaigns in future emerging infectious disease threats.
C1 [Piltch-Loeb, Rachael; Merdjanoff, Alexis A.; Bhanja, Aditi; Abramson, David M.] NYU, Coll Global Publ Hlth, New York, NY 10012 USA.
RP Piltch-Loeb, R (corresponding author), NYU, Coll Global Publ Hlth, New York, NY 10012 USA.
EM rp15@nyu.edu
FU National Science FoundationNational Science Foundation (NSF) [1638545]
FX This research was funded by the National Science Foundation grant number
   1638545.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Adalja A., 2016, PLOS CURR, V8
   Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Al-Muhandis N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001278
   Barry JA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002803
   Becker MH, 1974, HLTH BELIEF MODEL PE
   Blind P. K, 2007, 7 GLOB FOR REINV GOV, P26
   Bouzid M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005176
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Buldeo P, 2015, AJAR-AFR J AIDS RES, V14, P209, DOI 10.2989/16085906.2015.1052527
   Bults M., 2010, DUTCH J MED, V154
   Caceres M., 2016, THE VACCINE REACTION
   Chandler J., 2016, ORANGE COUNTY REGIST
   Covello VT, 2001, J URBAN HEALTH, V78, P382, DOI 10.1093/jurban/78.2.382
   Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756
   Dutwin D., 2016, SURV PRACT, V9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gubler D. J., 2006, NOVARTIS FDN S, V277
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Holmes BJ, 2008, HEALTH RISK SOC, V10, P349, DOI 10.1080/13698570802166431
   Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296
   Kinkela D., 2016, BANNED HIST PESTICID
   Kohut A., 2012, ASSESSING REPRESENTA
   Kramer ADI, 2014, P NATL ACAD SCI USA, V111, P8788, DOI 10.1073/pnas.1320040111
   Likos A., 2016, MMWR MORB MORTAL WKL, V65
   Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x
   Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108
   McCarthy M., 2016, BMJ BR MED J, V354
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Oussayef N. L., 2017, MORB MORTAL WKLY REP, V65
   Paek HJ, 2008, HEALTH PROMOT PRACT, V9, p60S, DOI 10.1177/1524839908322114
   Piltch-Loeb R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188666
   Piltch-Loeb RN, 2014, PUBLIC HEALTH REP, V129, P28, DOI 10.1177/00333549141296S405
   RATHER IA, 2017, FRONT MICROBIOL, V8
   Rudisill C, 2013, J RISK RES, V16, P959, DOI 10.1080/13669877.2012.761271
   Sommerfeld J, 2015, T ROY SOC TROP MED H, V109, P85, DOI 10.1093/trstmh/tru176
   Spiegel Jerry, 2005, EcoHealth, V2, P273, DOI 10.1007/s10393-005-8388-x
   Tedesco C, 2010, HEALTH PLACE, V16, P1188, DOI 10.1016/j.healthplace.2010.08.003
   van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575
   WEINSTEIN ND, 1993, HEALTH PSYCHOL, V12, P324, DOI 10.1037/0278-6133.12.4.324
   WHO, 2016, ZIK SIT REP NEUR SYN
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 45
TC 0
Z9 0
U1 8
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-7435
EI 1096-0260
J9 PREV MED
JI Prev. Med.
PD FEB
PY 2019
VL 119
BP 52
EP 57
DI 10.1016/j.ypmed.2018.12.019
PG 6
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA HH4XM
UT WOS:000455729700010
PM 30594531
DA 2020-07-08
ER

PT J
AU Marques, FJP
   Teixeira, MCS
   Barra, RR
   de Lima, FM
   Dias, BLS
   Pupe, C
   Nascimento, OJM
   Leyser, M
AF Marques, Fernanda J. P.
   Teixeira, Marta C. S.
   Barra, Rafael R.
   de Lima, Fernanda M.
   Scofano Dias, Bruno L.
   Pupe, Camila
   Nascimento, Osvaldo J. M.
   Leyser, Marcio
TI Children Born With Congenital Zika Syndrome Display Atypical Gross Motor
   Development and a Higher Risk for Cerebral Palsy
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE congenital Zika syndrome; cerebral palsy; gross motor development
ID VIRUS-INFECTION; CHILDHOOD; SPECTRUM
AB Importance: Congenital Zika syndrome virus infection is said to interfere in children's development. Objective: evaluate gross motor trajectories and the frequency of cerebral palsy in children with congenital Zika syndrome. Design: Cohort study applying the Alberta Infant Motor Scale (AIMS) and the Bayley III Scales in infants from 6 to 18 months of age. Setting: The SARAH network, Rio de Janeiro. Participants: Thirty-nine infants whose diagnoses were established through clinical history, serology tests, and neuroimaging findings. Main outcomes and measures: Congenital Zika syndrome is associated with severe motor delays and is a risk factor to the diagnosis of cerebral palsy. Results: The Alberta Infant Motor Scale mean raw score at 6 months was 9.74 (SD 4.80) or equivalent to 2 to 3 months of motor developmental age. At the age of 12 months, 14.13 (SD 11.90), corresponding to 3 to 4 months of motor development age; the Bayley III Scales results correlated to the Alberta Infant Motor Scale (P < .001) at this age. At 18 months, 15.77 (SD 13.80) or a motor development equivalent to 4 to 5 months of age. Thirty-five of 39 children (89.7%) met criteria for the diagnosis of cerebral palsy. Conclusions and relevance: Gross motor development marginally progresses from 6 to 18 months of age. These individuals also displayed a high frequency of cerebral palsy.
C1 [Marques, Fernanda J. P.; Teixeira, Marta C. S.; Barra, Rafael R.; de Lima, Fernanda M.; Scofano Dias, Bruno L.] SARAH Network Rehabil Hosp, Av Canal Arroio Pavuna S-N, BR-22261001 Rio De Janeiro, Brazil.
   [Marques, Fernanda J. P.; Pupe, Camila; Nascimento, Osvaldo J. M.] Fed Fluminense Univ, Niteroi, RJ, Brazil.
   [Leyser, Marcio] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA USA.
RP Marques, FJP (corresponding author), SARAH Network Rehabil Hosp, Av Canal Arroio Pavuna S-N, BR-22261001 Rio De Janeiro, Brazil.
EM fernandajpmarques@gmail.com
RI Leyser, Marcio/Z-4422-2019
OI Leyser, Marcio/0000-0002-2929-8416
CR Braga LW, 2005, CHILD TRAUMATIC BRAI
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jacobsson B, 2004, BEST PRACT RES CL OB, V18, P425, DOI 10.1016/j.bpobgyn.2004.02.011
   Leyser M, 2017, JAMA NEUROL, V74, P610, DOI 10.1001/jamaneurol.2017.0048
   Leyser M, 2017, J NEUROL SCI, V372, P73, DOI 10.1016/j.jns.2016.11.030
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689
   PIPER MC, 1992, CAN J PUBLIC HEALTH, V83, pS46
   Ribeiro BG, 2017, RADIOGRAPHICS, V37, P1840, DOI 10.1148/rg.2017170023
   Rintala P, 2013, PERCEPT MOTOR SKILL, V116, P294, DOI 10.2466/25.10.PMS.116.1.294-303
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   SILVA N. D. S. H., 2011, REV BRAS CRESC DESEN, V21, P85, DOI DOI 10.7322/JHGD.19998
   UNICEF, EARL CHILDH DEV KEY
   Valentini Nadia Cristina, 2011, Rev. paul. pediatr., V29, P231, DOI 10.1590/S0103-05822011000200015
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 24
TC 4
Z9 4
U1 0
U2 16
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD FEB
PY 2019
VL 34
IS 2
BP 81
EP 85
DI 10.1177/0883073818811234
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA HG4JF
UT WOS:000454940800004
PM 30421639
DA 2020-07-08
ER

PT J
AU Hernandez, HW
   Soeung, M
   Zorn, KM
   Ashoura, N
   Mottin, M
   Andrade, CH
   Caffrey, CR
   de Siqueira-Neto, JL
   Ekins, S
AF Hernandez, Helen W.
   Soeung, Melinda
   Zorn, Kimberley M.
   Ashoura, Norah
   Mottin, Melina
   Andrade, Carolina Horta
   Caffrey, Conor R.
   de Siqueira-Neto, Jair Lage
   Ekins, Sean
TI High Throughput and Computational Repurposing for Neglected Diseases
SO PHARMACEUTICAL RESEARCH
LA English
DT Review
DE dengue; ebola; echinococcosis; elephantiasis; high throughput screening;
   kinetoplastids; lymphatic filariasis; neglected tropical diseases;
   onchocerciasis; repurposing; schistosoma; zika
ID SMALL-MOLECULE INHIBITORS; THIOREDOXIN GLUTATHIONE-REDUCTASE; FEMALE
   GENITAL SCHISTOSOMIASIS; CYSTEINE PROTEASE INHIBITORS; MARBURG VIRUS
   ENTRY; ACCESS MALARIA BOX; DRUG DISCOVERY; TRYPANOSOMA-BRUCEI; ZIKA
   VIRUS; CHAGAS-DISEASE
AB PurposeNeglected tropical diseases (NTDs) represent are a heterogeneous group of communicable diseases that are found within the poorest populations of the world. There are 23 NTDs that have been prioritized by the World Health Organization, which are endemic in 149 countries and affect more than 1.4 billion people, costing these developing economies billions of dollars annually. The NTDs result from four different causative pathogens: protozoa, bacteria, helminth and virus. The majority of the diseases lack effective treatments. Therefore, new therapeutics for NTDs are desperately needed.MethodsWe describe various high throughput screening and computational approaches that have been performed in recent years. We have collated the molecules identified in these studies and calculated molecular properties.ResultsNumerous global repurposing efforts have yielded some promising compounds for various neglected tropical diseases. These compounds when analyzed as one would expect appear drug-like. Several large datasets are also now in the public domain and this enables machine learning models to be constructed that then facilitate the discovery of new molecules for these pathogens.ConclusionsIn the space of a few years many groups have either performed experimental or computational repurposing high throughput screens against neglected diseases. These have identified compounds which in many cases are already approved drugs. Such approaches perhaps offer a more efficient way to develop treatments which are generally not a focus for global pharmaceutical companies because of the economics or the lack of a viable market. Other diseases could perhaps benefit from these repurposing approaches.
C1 [Hernandez, Helen W.] KAL Res Initiat LLC, Houston, TX 77042 USA.
   [Soeung, Melinda] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
   [Zorn, Kimberley M.; Ekins, Sean] Collaborat Pharmaceut Inc, 840 Main Campus Dr,Lab 3510, Raleigh, NC 27606 USA.
   [Ashoura, Norah] Univ Texas Austin, Austin, TX 78712 USA.
   [Mottin, Melina; Andrade, Carolina Horta] Univ Fed Goias UFG, Fac Farm, LabMol Lab Mol Modeling & Drug Design, BR-74605170 Goiania, Go, Brazil.
   [Caffrey, Conor R.; de Siqueira-Neto, Jair Lage] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Ctr Discovery & Innovat Parasit Dis, San Diego, CA 92093 USA.
RP Hernandez, HW (corresponding author), KAL Res Initiat LLC, Houston, TX 77042 USA.; Ekins, S (corresponding author), Collaborat Pharmaceut Inc, 840 Main Campus Dr,Lab 3510, Raleigh, NC 27606 USA.
EM helenwhernandez@kalresearchinitiatives.com;
   sean@collaborationspharma.com
RI Mottin, Melina/D-8700-2016; Andrade, Carolina/C-3960-2014
OI Mottin, Melina/0000-0003-0878-9029; Andrade,
   Carolina/0000-0003-0101-1492
FU NIH/NIGMSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [1R43GM122196-01, R44GM122196-02A1];
   NIH/NCATSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [1R21TR001718-0]; Brazilian CNPq/FAPEG
   DCR [300508/2017-4]
FX This work was supported by Award Numbers 1R43GM122196-01 and
   R44GM122196-02A1 "Centralized assay datasets for modelling support of
   small drug discovery organizations" from NIH/NIGMS. 1UH2TR002084-01
   "Repurposing pyronaridine as a treatment for Chagas disease" from
   NIH/NCATS 1R21TR001718-01 "Repurposing pyronaridine as a treatment for
   the Ebola virus" from NIH/NCATS. MM thanks the support of the Brazilian
   CNPq/FAPEG DCR (grant 300508/2017-4). We are very grateful for our many
   collaborators and colleagues who contributed to the various efforts
   referenced herein. HWH is a Managing Member of KAL Research Initiatives,
   LLC. KMZ is an employee and SE is an employee and owner of
   Collaborations Pharmaceuticals, Inc.
CR Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478
   Alonso-Padilla J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003493
   Anantpadma M, 2016, ANTIMICROB AGENTS CH, V60, P4471, DOI 10.1128/AAC.00543-16
   ANDREWS P, 1983, MED RES REV, V3, P147, DOI 10.1002/med.2610030204
   Asarnow D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S2-S1
   Bahia MT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001870
   Baker NC, 2018, DRUG DISCOV TODAY, V23, P661, DOI 10.1016/j.drudis.2018.01.018
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Ben Khalaf N, 2012, PARASITOL RES, V110, P1911, DOI 10.1007/s00436-011-2717-5
   Berman J, 2017, AM J TROP MED HYG, V96, P11, DOI 10.4269/ajtmh.16-0099
   Bettiol E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000384
   Bilsland E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004401
   Blaazer AR, 2015, J BIOMOL SCREEN, V20, P131, DOI 10.1177/1087057114549735
   Bland ND, 2011, J MED CHEM, V54, P8188, DOI 10.1021/jm201148s
   Blatt J, 2014, DRUG DISCOV TODAY, V19, P1696, DOI 10.1016/j.drudis.2014.08.003
   Boguski MS, 2009, SCIENCE, V324, P1394, DOI 10.1126/science.1169920
   Uliana SRB, 2009, SCIENCE, V326, P935, DOI 10.1126/science.326.5955.935-a
   Boyom FF, 2014, ANTIMICROB AGENTS CH, V58, P5848, DOI 10.1128/AAC.02541-14
   Bulman CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003534
   Burns AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8485
   Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031
   Caffrey CR, 2015, FUTURE MED CHEM, V7, P675, DOI [10.4155/FMC.15.27, 10.4155/fmc.15.27]
   Caffrey CR, 2011, CURR OPIN INFECT DIS, V24, P410, DOI 10.1097/QCO.0b013e328349156f
   Caffrey CR, 2002, INT J ANTIMICROB AG, V19, P227, DOI 10.1016/S0924-8579(01)00488-5
   Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1
   Caffrey CR, 2012, PARASITIC HELMINTHS
   Calvo-Alvarez E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003666
   CAMPBELL NRC, 1987, MOL PHARMACOL, V32, P813
   Chatelain E, 2015, J BIOMOL SCREEN, V20, P22, DOI 10.1177/1087057114550585
   Chen CK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000651
   Cheng H, 2015, J VIROL
   Cheng H, 2015, J VIROL, V89, P9932, DOI 10.1128/JVI.01337-15
   Cheung YY, 2014, ANTIVIR RES, V111, P93, DOI 10.1016/j.antiviral.2014.09.007
   Chopra G, 2016, MOLECULES, V21, DOI 10.3390/molecules21121537
   Christinet V, 2016, INT J PARASITOL, V46, P395, DOI 10.1016/j.ijpara.2016.02.006
   Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104
   Coffee M, UNDERSTANDING ZIKA O
   Cole ST, 2017, DRUG DISCOV TODAY, V22, P477, DOI 10.1016/j.drudis.2016.09.026
   Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2
   Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221
   Crowther GJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002628
   Cruz DJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002471
   Cruz DJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002073
   De Muylder G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001253
   De Rycker M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004584
   De Rycker M, 2013, ANTIMICROB AGENTS CH, V57, P2913, DOI 10.1128/AAC.02398-12
   Diaz R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003253
   Diaz-Gonzalez R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001297
   DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P286, DOI 10.1067/mcp.2001.115132
   Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Edwards MR, 2015, ACS INFECT DIS, V1, P380, DOI 10.1021/acsinfecdis.5b00053
   Ekins S., 2016, F1000RES, V4, P1091, DOI DOI 10.12688/f1000research.7217.2
   Ekins S, 2017, ANTIMICROB AGENTS CH
   Ekins S, 2017, DRUG DISCOV TODAY, V22, P479, DOI 10.1016/j.drudis.2017.03.002
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Ekins Sean, 2015, F1000Res, V4, P1091, DOI 10.12688/f1000research.7217.1
   Ekins S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003878
   Ekins Sean, 2015, F1000Res, V4, P58, DOI 10.12688/f1000research.6181.1
   Ekpo UF, 2012, PARASITOLOGY, V139, P835, DOI 10.1017/S0031182012000029
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FDA, TROP DIS PRIOR REW V
   FELDMEIER H, 1994, INT J STD AIDS, V5, P368, DOI 10.1177/095646249400500517
   Fonseca NC, 2015, ANTIMICROB AGENTS CH
   Frevert U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043913
   Fricker SP, 2008, J INORG BIOCHEM, V102, P1839, DOI 10.1016/j.jinorgbio.2008.05.010
   Gabrielli AF, 2011, T ROY SOC TROP MED H, V105, P683, DOI 10.1016/j.trstmh.2011.08.013
   Gaffney Alexander, REGULATORY EXPLAINER
   Greenbaum DC, 2004, J MED CHEM, V47, P3212, DOI 10.1021/jm030549j
   Guiguemde WA, 2012, CHEM BIOL, V19, P116, DOI 10.1016/j.chembiol.2012.01.004
   Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099
   Gunatilleke SS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001736
   Guyett PJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01865-16
   Hart CJS, 2017, INT J PARASITOL-DRUG, V7, P83, DOI 10.1016/j.ijpddr.2017.01.005
   Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786
   Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005896
   Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498
   Hotez PJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000718
   Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862
   Ingram-Sieber K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002610
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   Johnston KL, 2014, INT J PARASITOL-DRUG, V4, P278, DOI 10.1016/j.ijpddr.2014.09.001
   Kaiser M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135556
   Kaiser M, 2015, J BIOMOL SCREEN, V20, P634, DOI 10.1177/1087057115569155
   Kannan S, 2014, J CHEM INF MODEL, V54, P3005, DOI 10.1021/ci5004653
   Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320
   Keenan M, 2013, FUTURE MED CHEM, V5, P1733, DOI [10.4155/FMC.13.139, 10.4155/fmc.13.139]
   Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6
   Khare S, 2016, NATURE, V537, P229, DOI 10.1038/nature19339
   Kinnings SL, 2011, J CHEM INF MODEL, V51, P408, DOI 10.1021/ci100369f
   Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a
   Kobylinski KC, 2014, AM J TROP MED HYG
   Kotz J., 2012, SCIBX, V5, P15
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206
   Lane T, 2018, MOL PHARM
   Lee H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S4
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Li T, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0071-z
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064984
   Long T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005680
   Love MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005373
   Mackey ZB, 2011, CHEM BIOL DRUG DES, V78, P454, DOI 10.1111/j.1747-0285.2011.01156.x
   Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Mahmoudzadeh-Niknam H, 2004, EXP PARASITOL, V106, P158, DOI 10.1016/j.exppara.2004.03.005
   Mallari JP, 2008, J MED CHEM, V51, P545, DOI 10.1021/jm070760l
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansour NR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004659
   Manzano M, 2014, METHODS MOL BIOL, V1138, P331, DOI 10.1007/978-1-4939-0348-1_20
   Martorana A, 2016, CURR TOP MED CHEM, V16, P2088, DOI 10.2174/1568026616666160216153457
   Mashiyama ST, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001942
   Mathew MD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005058
   McCall LI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003588
   McCall LI, 2014, TRENDS PARASITOL, V30, P342, DOI 10.1016/j.pt.2014.05.001
   McCarthy SDS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004364
   McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151
   McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9
   MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133
   Mhashilkar AS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004772
   Mirza MU, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111748
   Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122
   Mottin M, 2018, DRUG DISCOV TODAY
   Mottin M, 2018, BRAZ J PHARM SCI, V54, DOI 10.1590/s2175-97902018000001002
   Mudhasani R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003095
   Naing C, 2013, T ROY SOC TROP MED H, V107, P672, DOI 10.1093/trstmh/trt086
   Navarro G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046172
   Neves BJ, 2016, J MED CHEM, V59, P7075, DOI 10.1021/acs.jmedchem.5b02038
   Neves BJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003435
   Neves B, 2016, MEDCHEMCOMM, V7, P1176, DOI 10.1039/c5md00596e
   Njogu PM, 2016, ACS INFECT DIS, V2, P8, DOI 10.1021/acsinfecdis.5b00093
   Nuhs A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004094
   Nwaka S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000440
   Ochiana SO, 2013, EUR J MED CHEM, V62, P777, DOI 10.1016/j.ejmech.2012.07.038
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oprea TI, 2012, AAPS J, V14, P759, DOI 10.1208/s12248-012-9390-1
   Oprea TI, 2007, J COMPUT AID MOL DES, V21, P113, DOI 10.1007/s10822-007-9105-3
   Organization WH, UNPR PROGR AG NEGL T
   Paape D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003363
   Panic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1233-3
   Panic G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003962
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Patel G, 2013, J MED CHEM, V56, P3820, DOI 10.1021/jm400349k
   Paveley RA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001762
   Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201
   Pena I, 2015, SCI REP-UK, V5, DOI 10.1038/srep08771
   Planer JD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002977
   Ponder EL, 2014, PHARM RES-DORDR, V31, P271, DOI 10.1007/s11095-013-1170-9
   Pothineni VR, 2016, DRUG DES DEV THER, V10, P1307, DOI 10.2147/DDDT.S101486
   RAETHER W, 1983, ANN TROP MED PARASIT, V77, P13, DOI 10.1080/00034983.1983.11811668
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ribeiro I, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000484
   Ridley DB, 2017, AM J TROP MED HYG, V96, P14, DOI 10.4269/ajtmh.16-0600
   Riley J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004014
   Rojo-Arreola L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087594
   Russo DP, 2018, MOL PHARM
   SABAH AA, 1986, EXP PARASITOL, V61, P294, DOI 10.1016/0014-4894(86)90184-0
   Sanchez LM, 2013, J NAT PROD, V76, P630, DOI 10.1021/np300834q
   Sanderson L, 2014, J ANTIMICROB CHEMOTH, V69, P1888, DOI 10.1093/jac/dku069
   Sandoval PJ, 2018, MOL PHARM
   Scheidt KA, 1998, BIOORGAN MED CHEM, V6, P2477, DOI 10.1016/S0968-0896(98)80022-9
   Selzer PM, 1999, P NATL ACAD SCI USA, V96, P11015, DOI 10.1073/pnas.96.20.11015
   Shahinas D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00368
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Singh R, 2009, IEEE S COMP BAS MED, P1, DOI 10.1109/CBMS.2009.5255338
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Stadelmann B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004535
   Sutherland CS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003397
   Swenerton RK, 2011, J BIOL CHEM, V286, P429, DOI 10.1074/jbc.M110.138313
   Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480
   Tarral A, 2014, CLIN PHARMACOKINET, V53, P565, DOI 10.1007/s40262-014-0136-3
   Torrico F, 2018, LANCET INFECT DIS, V18, P419, DOI 10.1016/S1473-3099(17)30538-8
   Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048
   Troeberg L, 1999, EXP PARASITOL, V91, P349, DOI 10.1006/expr.1998.4386
   Troeberg L, 2000, MOL MED, V6, P660, DOI 10.1007/BF03402046
   Uebelhoer LS, 2014, ANTIVIR RES, V106, P86, DOI 10.1016/j.antiviral.2014.03.018
   van den Enden E, 2009, EXPERT OPIN PHARMACO, V10, P435, DOI [10.1517/14656560902722463 , 10.1517/14656560902722463]
   Van der Hart O, 2012, THE PROSECUTOR IN TR, pXI, DOI DOI 10.1017/CBO9781139095174.001
   Van Voorhis WC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005763
   Vicik R, 2006, BIOORG MED CHEM LETT, V16, P2753, DOI 10.1016/j.bmcl.2006.02.026
   Wang YZ, 2016, ANTIVIR RES, V125, P1, DOI 10.1016/j.antiviral.2015.11.003
   Watts KR, 2010, BIOORGAN MED CHEM, V18, P2566, DOI 10.1016/j.bmc.2010.02.034
   Wiggers HJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002370
   Witola WH, 2011, INFECT IMMUN, V79, P756, DOI 10.1128/IAI.00898-10
   World Health Organization, DENG SEV DENG
   World Health Organization, NEGLECTED TROPICAL D
   XIAO SH, 1987, CHINESE MED J-PEKING, V100, P759
   Xu M., 2016, NAT MED
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
   Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648
   Zhao Z, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0941-9
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 200
TC 7
Z9 7
U1 5
U2 31
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD FEB
PY 2019
VL 36
IS 2
AR UNSP 27
DI 10.1007/s11095-018-2558-3
PG 20
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA HE7QC
UT WOS:000453632900001
PM 30560386
OA Green Published
DA 2020-07-08
ER

PT J
AU Ximenes, ASFC
   Pires, P
   Werner, H
   Jungmann, PM
   Rolim, EL
   Andrade, EP
   Lemos, RS
   Peixoto, AB
   Mehrjardi, MZ
   Tonni, G
   Araujo, E
AF Franca Cruz Ximenes, Ana Sofia
   Pires, Pedro
   Werner, Heron
   Jungmann, Patricia Mello
   Rolim Filho, Epitacio Leite
   Andrade, Etiene Pedrosa
   Lemos, Roberto Souza
   Peixoto, Alberto Borges
   Mehrjardi, Mohammad Zare
   Tonni, Gabriele
   Araujo Junior, Edward
TI Neuroimaging findings using transfontanellar ultrasound in newborns with
   microcephaly: a possible association with congenital Zika virus
   infection
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Congenital Zika virus infection; microcephaly; newborns; transfontanelle
   cranial ultrasound
ID PATHOLOGY; INFANTS; BIRTH; BORN; AGE
AB Objective: The objective of this study is to determine the main neuroimaging findings of microcephalic newborns with possible Zika virus (ZIKV) intrauterine infection using transfontanellar cranial ultrasound. Methods: We performed a retrospective study to describe the main neuroimaging findings in newborns with microcephaly and possible association with congenital ZIKV infection. Microcephaly was defined in the postnatal period using transfontanellar cranial examination which was performed using both two- (2D) and three-dimensional (3D) ultrasound. Results: One hundred and fifty newborns with microcephaly were identified during the study period. The mean +/- (standard deviation - SD) of cephalic perimeter was 28.5 +/- 4.2 cm (range, 25-38 cm). Transfontanellar neuroimaging patterns detected cerebral calcifications, neuronal migrational abnormalities, dysgenesis of the corpus callosum, and cerebellar atrophy in 34.9%, 31.1%, 26%, and 16.2%, respectively. Hydrocephalus was seen in 28% of overall newborns. A history of maculopapular rash was present in almost half of the mothers (46.1%). Conclusion: Neuroimaging patterns by means of transfontanellar ultrasound are accurate and diagnostic investigations of brain pathology in newborns affected by microcephaly and possible intrauterine ZIKV infection.
C1 [Franca Cruz Ximenes, Ana Sofia] Pernambuco Univ UPE, Dept Radiol, Recife, PE, Brazil.
   [Pires, Pedro] Pernambuco Univ UPE, Dept Maternal & Child, Recife, PE, Brazil.
   [Werner, Heron] Clin Diagnost Imagem CDPI, Dept Radiol, Rio De Janeiro, Brazil.
   [Jungmann, Patricia Mello] Pernambuco Univ UPE, Dept Pathol, Recife, PE, Brazil.
   [Rolim Filho, Epitacio Leite] Fed Univ Pernambuco UFPE, Dept Surg, Recife, PE, Brazil.
   [Andrade, Etiene Pedrosa; Lemos, Roberto Souza] Getulio Vargas Hosp, Radiol Unit, Recife, PE, Brazil.
   [Peixoto, Alberto Borges] Univ Uberaba UNIUBE, Mario Palmerio Univ Hosp, Uberaba, Brazil.
   [Mehrjardi, Mohammad Zare] Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Sch Med, Dept Radiol, Tehran, Iran.
   [Mehrjardi, Mohammad Zare] Climax Radiol Educ Fdn, Div Clin Res, Sect Pediat Imaging, Tehran, Iran.
   [Tonni, Gabriele] AUSL Reggio Emilia, Guastalla Civil Hosp, Dept Obstet & Gynecol, Reggio Emilia, Italy.
   [Araujo Junior, Edward] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Obstet, Rua Belchior de Azevedo,156 Apto,111 Torre Vitori, Sao Paulo, SP, Brazil.
RP Araujo, E (corresponding author), Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Obstet, Rua Belchior de Azevedo,156 Apto,111 Torre Vitori, Sao Paulo, SP, Brazil.
EM araujojred@terra.com.br
RI Tonni, Gabriele/AAM-9842-2020; Junior, Edward Araujo/E-1228-2012;
   Werner, Heron/W-1578-2019; Zare Mehrjardi, Mohammad/G-8980-2017
OI Junior, Edward Araujo/0000-0002-6145-2532; Zare Mehrjardi,
   Mohammad/0000-0001-5793-5323
CR Araujo E, 2017, CURR OPIN OBSTET GYN, V29, P95, DOI 10.1097/GCO.0000000000000345
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Mehrjardi MZ., 2017, VIROLOGY AUCKL, V8
   Rademaker KJ, 2005, ARCH DIS CHILD-FETAL, V90, pF489, DOI 10.1136/adc.2005.073908
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Wiley CA, 2017, NEUROPATHOLOGY, V37, P393, DOI 10.1111/neup.12385
NR 17
TC 8
Z9 8
U1 1
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD FEB 1
PY 2019
VL 32
IS 3
BP 493
EP 501
DI 10.1080/14767058.2017.1384459
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HB0GI
UT WOS:000450690600021
PM 28942698
DA 2020-07-08
ER

PT J
AU da Silva, SR
   Cheng, F
   Huang, IC
   Jung, JU
   Gao, SJ
AF da Silva, Suzane Ramos
   Cheng, Fan
   Huang, I-Chueh
   Jung, Jae U.
   Gao, Shou-Jiang
TI Efficiencies and kinetics of infection in different cell types/lines by
   African and Asian strains of Zika virus
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE cell type tropism; Guillain-Barre syndrome; infection kinetics;
   microcephaly; Zika virus
ID FETAL-BRAIN; AXL; TRANSMISSION; OUTBREAK; ASSOCIATION
AB After recent outbreaks, Zika virus (ZIKV) was linked to severe neurological diseases including Guillain-Barre syndrome in adults and microcephaly in newborns. The severities of pathological manifestations have been associated with different ZIKV strains. To better understand the tropism of ZIKV, we infected 10 human and four nonhuman cell lines (types) with two African (IbH30656 and MR766) and two Asian (PRVABC59 and H/FP/2013) ZIKV strains. Cell susceptibility to ZIKV infection was determined by examining viral titers, synthesis of viral proteins, and replication of positive and negative strands of viral genome. Among nonhuman cell lines, only Vero cells were efficiently infected by ZIKV. Among human cell lines, all were permissive to ZIKV infection. However, 293T and HeLa cells showed differential susceptibility towards African strains. In 293T cells, the NS1 protein was expressed at the high level by African strains but was almost not expressed by Asian strains though there was no obvious difference in viral genome replication, suggesting that the differential susceptibility might be controlled at the stage of viral protein translation. This study provides comprehensive results of the permissiveness of different cell types to both African and Asian ZIKV strains, which might help clarify their different pathogenesis.
C1 [da Silva, Suzane Ramos; Cheng, Fan; Huang, I-Chueh; Jung, Jae U.; Gao, Shou-Jiang] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
   [da Silva, Suzane Ramos; Gao, Shou-Jiang] Univ Pittsburgh, UPMC, Hillman Canc Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA USA.
   [Gao, Shou-Jiang] Shantou Univ, Med Coll, Lab Human Virol & Oncol, Shantou, Guangdong, Peoples R China.
RP Gao, SJ (corresponding author), UPMC, Hillman Canc Ctr, Canc Virol Program, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.
EM gaos8@upmc.edu
OI Gao, Shou-Jiang/0000-0001-6194-1742
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [CA197153, CA124332, DE025465,
   CA132637, CA213275, CA096512, CA177377]
FX NIH, Grant/Award Numbers: CA197153, CA124332, DE025465, CA132637,
   CA213275, CA096512, CA177377
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Journel I, 2017, MMWR-MORBID MORTAL W, V66, P172, DOI 10.15585/mmwr.mm6606a4
   Kato F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16475-2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Piorkowski G., 2016, New Microbes and New Infections, V11, P52, DOI 10.1016/j.nmni.2016.02.013
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Sohan K, 2017, INT J GYNECOL OBSTET, V139, P278, DOI 10.1002/ijgo.12313
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, 2017, ZIK SIT REP ZIK VIR
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 59
TC 4
Z9 4
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD FEB
PY 2019
VL 91
IS 2
BP 179
EP 189
DI 10.1002/jmv.25306
PG 11
WC Virology
SC Virology
GA HE1KF
UT WOS:000453029000003
PM 30192399
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Ng, EY
   Loh, YR
   Li, Y
   Li, QX
   Kang, CB
AF Ng, Elizabeth Yihui
   Loh, Ying Ru
   Li, Yan
   Li, Qingxin
   Kang, CongBao
TI Expression, purification of Zika virus membrane protein-NS2B in
   detergent micelles for NMR studies
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE Zika virus; Membrane protein; Protease; Detergent; NMR spectroscopy
ID PROTEASE INHIBITORS; SECONDARY STRUCTURE; NS4B; TOPOLOGY; NS2B;
   REPLICATION; DOMAIN
AB The Zika virus (ZIKV) genome encodes a polyprotein that can be post-translationally processed into functional viral proteins. The viral protease is indispensable in the maturation of viral proteins. The Zika protease comprises of two components crucial for catalysis. The N-terminal region of NS3 contains the catalytic triad and approximately 40 amino acids of NS2B are essential for folding and protease activity. NS2B is a membrane protein with transmembrane domains that are critical for the localization of NS3 to the membrane. In this study, we expressed and purified full-length NS2B from ZIKV in E. coli. Purified NS2B was then reconstituted into lysomyristoyl phosphatidylglycerol (LMPG) micelles. It was found that compared to wild type NS2B, NS2B C11S mutation in LMPG exhibited dispersed cross peaks in the H-1- N-15-HSQC spectrum, thereby suggesting the feasibility for structural characterization using solution NMR spectroscopy.
C1 [Ng, Elizabeth Yihui; Loh, Ying Ru; Li, Yan; Kang, CongBao] ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.
   [Li, Qingxin] ASTAR, Inst Chem & Engn Sci, 1 Pesek Rd, Singapore 627833, Singapore.
   [Li, Yan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathogen Biol, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.
RP Kang, CB (corresponding author), ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.
EM cbkang@etc.a-star.edu.sg
RI cai, yuanyuan/C-6301-2014; Kang, Congbao/AAP-7572-2020; Li,
   Yan/G-4642-2013
OI Kang, Congbao/0000-0002-9886-9374; Li, Yan/0000-0003-1963-839X
FU Agency for Science, Technology and Research (A*STAR) JCO grant
   [1431AFG102/1331A028]; Science and Engineering Research Council (SERC)
   of A*STAR of Singapore (SERC) [1526004161]
FX CK appreciates the support from the Agency for Science, Technology and
   Research (A*STAR) JCO grant (1431AFG102/1331A028). QL thanks the support
   from the Science and Engineering Research Council (SERC) of A*STAR of
   Singapore (SERC grant number: 1526004161).
CR Bakulin I, 2014, WORLD J HEPATOL, V6, P326, DOI 10.4254/wjh.v6.i5.326
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Huang QW, 2013, PROTEIN EXPRES PURIF, V92, P156, DOI 10.1016/j.pep.2013.09.015
   Huang QW, 2011, PROTEIN EXPRES PURIF, V80, P169, DOI 10.1016/j.pep.2011.08.008
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kang CB, 2011, CURR OPIN CHEM BIOL, V15, P560, DOI 10.1016/j.cbpa.2011.05.025
   Kang CB, 2010, BIOCHEMISTRY-US, V49, P653, DOI 10.1021/bi902155t
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kimple ME, 2013, CURR PROTOC PROTEIN, V73, P9, DOI DOI 10.1002/0471140864.PS0909S73
   Kroncke BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501228
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Li QX, 2014, BIOPHYS J, V107, P2325, DOI 10.1016/j.bpj.2014.10.013
   Li XD, 2016, J VIROL, V90, P5735, DOI 10.1128/JVI.00340-16
   Li XD, 2014, J GEN VIROL, V95, P806, DOI 10.1099/vir.0.061838-0
   Li Y, 2018, BIOCHEM BIOPH RES CO, V503, P691, DOI 10.1016/j.bbrc.2018.06.062
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2016, ANGEW CHEM INT EDIT, V55, P12068, DOI 10.1002/anie.201606609
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P3150, DOI 10.1016/j.bbamem.2015.09.016
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   Liew LSY, 2016, PROTEIN EXPRES PURIF, V121, P141, DOI 10.1016/j.pep.2016.02.001
   Lv ZT, 2015, HIV AIDS-RES PALLIAT, V7, P95, DOI 10.2147/HIV.S79956
   Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200
   Vinogradova O, 1997, BIOPHYS J, V72, P2688, DOI 10.1016/S0006-3495(97)78912-4
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
NR 32
TC 2
Z9 3
U1 1
U2 29
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD FEB
PY 2019
VL 154
BP 1
EP 6
DI 10.1016/j.pep.2018.09.013
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA HC2TE
UT WOS:000451654000001
PM 30248452
DA 2020-07-08
ER

PT J
AU Kasai, S
   Caputo, B
   Tsunoda, T
   Cuong, TC
   Maekawa, Y
   Lam-Phua, SG
   Pichler, V
   Itokawa, K
   Murota, K
   Komagata, O
   Yoshida, C
   Chung, HH
   Bellini, R
   Tsuda, Y
   Teng, HJ
   de Lima, JL
   Alves, LC
   Ng, LC
   Minakawa, N
   Yen, NT
   Phong, TV
   Sawabe, K
   Tomita, T
AF Kasai, Shinji
   Caputo, Beniamino
   Tsunoda, Takashi
   Tran Chi Cuong
   Maekawa, Yoshihide
   Lam-Phua, Sai Gek
   Pichler, Verena
   Itokawa, Kentaro
   Murota, Katsunori
   Komagata, Osamu
   Yoshida, Chigusa
   Chung, Han-Hsuan
   Bellini, Romeo
   Tsuda, Yoshio
   Teng, Hwa-Jen
   de Lima Filho, Jose Luiz
   Alves, Luiz Carlos
   Ng, Lee Ching
   Minakawa, Noboru
   Nguyen Thi Yen
   Tran Vu Phong
   Sawabe, Kyoko
   Tomita, Takashi
TI First detection of a Vssc allele V1016G conferring a high level of
   insecticide resistance in Aedes albopictus collected from Europe (Italy)
   and Asia (Vietnam), 2016: a new emerging threat to controlling arboviral
   diseases
SO EUROSURVEILLANCE
LA English
DT Article
ID AUTOCHTHONOUS DENGUE-FEVER; PYRETHROID RESISTANCE; CHIKUNGUNYA VIRUS;
   MUTATIONS; GENE; KDR; IDENTIFICATION; DIVERSITY; OUTBREAK; VECTOR
AB Introduction: Aedes albopictus (Skuse) is an important vector of arboviral diseases, including dengue, chikungunya and Zika virus disease. Monitoring insecticide resistance and mechanisms by which the mosquito develops resistance is crucial to minimise disease transmission. Aim: To determine insecticide resistance status and mechanisms in Ae. albopictus from different geographical regions. Methods: We sampled 33 populations of Ae. albopictus from Asia, Europe and South America, and tested these for susceptibility to permethrin, a pyrethroid insecticide. In resistant populations, the target site for pyrethroids, a voltage-sensitive sodium channel (Vssc) was genotyped. Three resistant sub-strains, each harbouring a resistance allele homozygously, were established and susceptibilities to three different pyrethroids (with and without a cytochrome P450 inhibitor) were assayed. Results: Most populations of Ae. albopictus tested were highly susceptible to permethrin but a few from Italy and Vietnam (4/33), exhibited high-level resistance. Genotyping studies detected a knockdown resistance (kdr) allele V1016G in Vssc for the first time in Ae. albopictus. Two previously reported kdr alleles, F1534C and F1534S, were also detected. The bioassays indicated that the strain homozygous for the V1016G allele showed much greater levels of pyrethroid resistance than other strains harbouring F1534C or F1534S.
   Conclusion: The V1016G allele was detected in both-Asian and Italian Ae. albopictus populations, thus a spread of this allele beyond Italy in Europe cannot be ruled out. This study emphasises the necessity to frequently and regularly monitor the V1016G allele in Ae. albopictus, particularly where this mosquito species is the main vector of arboviruses.
C1 [Kasai, Shinji; Maekawa, Yoshihide; Itokawa, Kentaro; Murota, Katsunori; Komagata, Osamu; Yoshida, Chigusa; Tsuda, Yoshio; Sawabe, Kyoko; Tomita, Takashi] Natl Inst Infect Dis, Dept Med Entomol, Tokyo, Japan.
   [Caputo, Beniamino; Pichler, Verena] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Parasitol Unit, Rome, Italy.
   [Tsunoda, Takashi; Minakawa, Noboru] Nagasaki Univ, Dept Vector Ecol & Environm, Nagasaki, Japan.
   [Tran Chi Cuong; Nguyen Thi Yen; Tran Vu Phong] Natl Inst Hyg & Epidemiol, Med Entomol & Zool Dept, Hanoi, Vietnam.
   [Lam-Phua, Sai Gek] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
   [Itokawa, Kentaro; Murota, Katsunori; Ng, Lee Ching] Japan Agcy Med Res & Dev, Dept Res Promot, Tokyo, Japan.
   [Chung, Han-Hsuan; Teng, Hwa-Jen] Minist Hlth & Welf, Ctr Dis Control, Ctr Diagnost & Vaccine Dev, Taipei, Taiwan.
   [Bellini, Romeo] Agr & Environm Ctr G Nicoli, Crevalcore, Italy.
   [de Lima Filho, Jose Luiz; Alves, Luiz Carlos] Univ Fed Pernambuco, Lab Imunopatol Keizo Asami, Recife, PE, Brazil.
   [Alves, Luiz Carlos] Fiocruz MS, Aggeu Magalhaes Inst, Recife, PE, Brazil.
RP Kasai, S (corresponding author), Natl Inst Infect Dis, Dept Med Entomol, Tokyo, Japan.
EM kasacin@nih.go.jp
RI Alves, Luiz/V-5314-2019
OI Itokawa, Kentaro/0000-0003-1300-9883
FU Research Program on Emerging and Re-emerging Infectious Diseases from
   Japan Agency for Medical Research and development (AMED)Japan Agency for
   Medical Research and Development (AMED); Japan Initiative for Global
   Research Network on Infectious Diseases (J-GRID) from Ministry of
   Education, Culture, Sports, Science and Technology in Japan; AMEDJapan
   Agency for Medical Research and Development (AMED)
FX This research was partially supported by the Research Program on
   Emerging and Re-emerging Infectious Diseases from Japan Agency for
   Medical Research and development (AMED) and by Japan Initiative for
   Global Research Network on Infectious Diseases (J-GRID) from Ministry of
   Education, Culture, Sports, Science and Technology in Japan and AMED.
   The authors would like to thank Enago (www.enago.jp) for the English
   language review.
CR Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Chen HY, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0125-x
   Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Finney D.T., 1971, PROBIT ANAL
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Georghiou G.P., 1983, PEST RESISTANCE PEST
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gubler D.J., 1997, DENGUE DENGUE HEMORR
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Hu ZN, 2011, INSECT BIOCHEM MOLEC, V41, P9, DOI 10.1016/j.ibmb.2010.09.005
   Kasai S, 2017, INSECT MOL BIOL, V26, P13, DOI 10.1111/imb.12267
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Liu ZQ, 2004, P NATL ACAD SCI USA, V101, P11862, DOI 10.1073/pnas.0307695101
   Lok C, 1985, SINGAPORES DENGUE HA
   Manica M, 2017, PEST MANAG SCI, V73, P138, DOI 10.1002/ps.4315
   MILANI R., 1954, Rivista di Parassitologia, V15, P513
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Pichler V, 2018, PEST MANAG SCI, V74, P1319, DOI 10.1002/ps.4840
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007
   Rudbeck L, 1998, BIOTECHNIQUES, V25, P588, DOI 10.2144/98254bm09
   Sang SW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003808
   SHONO T, 1985, J PESTIC SCI, V10, P141
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Sun HN, 2017, PESTIC BIOCHEM PHYS, V143, P116, DOI 10.1016/j.pestbp.2017.08.013
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204
   World Health Organization, 2016, TEST PROC INREMO
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
NR 35
TC 7
Z9 8
U1 0
U2 7
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 31
PY 2019
VL 24
IS 5
BP 48
EP 59
AR 1700847
DI 10.2807/1560-7917.ES.2019.24.5.1700847
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA HJ7MM
UT WOS:000457381800006
PM 30722810
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Takemura, K
   Adegoke, O
   Suzuki, T
   Park, EY
AF Takemura, Kenshin
   Adegoke, Oluwasesan
   Suzuki, Tetsuro
   Park, Enoch Y.
TI A localized surface plasmon resonance-amplified immunofluorescence
   biosensor for ultrasensitive and rapid detection of nonstructural
   protein 1 of Zika virus
SO PLOS ONE
LA English
DT Article
ID GOLD NANOPARTICLES; EMERGENCE; HYBRIDS; RNA
AB Among the members of flaviviruses, the Zika virus (ZIKV) remains a potent infectious disease agent, with its associated pandemic prompting the World Health Organization (WHO) to declare it a global public health concern. Thus, rapid and accurate diagnosis of the ZIKV is needed. In this study, we report a new immunofluorescence biosensor for the detection of nonstructural protein 1 (NS1) of the ZIKV, which operates using the localized surface plasmon resonance (LSPR) signal from plasmonic gold nanoparticles (AuNPs) to amplify the fluorescence intensity signal of quantum dots (QDs) within an antigen-antibody detection process. The LSPR signal from the AuNPs was used to amplify the fluorescence intensity of the QDs. For ultrasensitive, rapid, and quantitative detection of NS1 of the ZIKV, four different thiol-capped AuNPs were investigated. Our biosensor could detect the ZIKV in a wide concentration range from 10-10(7) RNA copies/mL, and we found that the limit of detection (LOD) for the ZIKV followed the order Ab-(L)-cysteine-AuNPs (LOD = 8.2 copies/mL) > Ab-3-mercaptopropionic acid-AuNPs (LOD = 35.0 copies/mL). Immunofluorescence biosensor for NS1 exhibited excellent specificity against other negative control targets and could also detect the ZIKV in human serum.
C1 [Takemura, Kenshin; Park, Enoch Y.] Shizuoka Univ, Biotechnol Lab, Dept Biosci, Grad Sch Sci & Technol,Suruga Ku, Shizuoka, Japan.
   [Adegoke, Oluwasesan; Park, Enoch Y.] Shizuoka Univ, Biotechnol Lab, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka, Japan.
   [Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka, Japan.
   [Adegoke, Oluwasesan] Univ Dundee, Leverhulme Res Ctr Forens Sci, Dundee, Scotland.
RP Park, EY (corresponding author), Shizuoka Univ, Biotechnol Lab, Dept Biosci, Grad Sch Sci & Technol,Suruga Ku, Shizuoka, Japan.; Park, EY (corresponding author), Shizuoka Univ, Biotechnol Lab, Res Inst Green Sci & Technol, Suruga Ku, Shizuoka, Japan.
EM park.enoch@shizuoka.ac.jp
OI Adegoke, Oluwasesan/0000-0002-8087-460X; Park, Enoch
   Y./0000-0002-7840-1424
FU Japan Society for the Promotion of Science (JSPS)Ministry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [P13454]; Bilateral Joint Research Project of
   the JSPS, Japan
FX OA thanks the Japan Society for the Promotion of Science (JSPS) for a
   postdoctoral fellowship for overseas researchers (P13454). This work was
   supported partly by the Bilateral Joint Research Project of the JSPS,
   Japan. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adegoke O, 2017, J MATER CHEM B, V5, P3047, DOI 10.1039/c7tb00388a
   Adegoke O, 2017, BIOSENS BIOELECTRON, V94, P513, DOI 10.1016/j.bios.2017.03.046
   Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Ahmed SR, 2017, BIOSENS BIOELECTRON, V87, P558, DOI 10.1016/j.bios.2016.08.101
   Barzon L., 2016, EUROSURVEILLANCE, V21
   Bollweg BC, 2018, J PATHOL CLIN RES, V4, P19, DOI 10.1002/cjp2.84
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen R, 2010, RARE METALS, V29, P180, DOI 10.1007/s12598-010-0031-5
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Draz MS, 2018, NANOSCALE
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gebre Y, ASIAN PAC J BIOMED, V6, P815
   Ghosh SK, 2007, CHEM REV, V107, P4797, DOI 10.1021/cr0680282
   Kaarj K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30797-9
   Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lee J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102332
   Lee J, 2015, BIOSENS BIOELECTRON, V64, P311, DOI 10.1016/j.bios.2014.09.021
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Takemura K, 2017, BIOSENS BIOELECTRON, V89, P998, DOI 10.1016/j.bios.2016.10.045
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 30
TC 2
Z9 2
U1 4
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 31
PY 2019
VL 14
IS 1
AR e0211517
DI 10.1371/journal.pone.0211517
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HJ6LR
UT WOS:000457301600053
PM 30703161
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rao, VB
   Maneesha, K
   Sravya, P
   Franchito, SH
   Dasari, H
   Gan, MA
AF Rao, V. Brahmananda
   Maneesha, K.
   Sravya, Panangipalli
   Franchito, Sergio H.
   Dasari, Hariprasad
   Gan, Manoel A.
TI Future increase in extreme El Nino events under greenhouse warming
   increases Zika virus incidence in South America
SO NPJ CLIMATE AND ATMOSPHERIC SCIENCE
LA English
DT Article
ID CLIMATE-CHANGE; AEDES-AEGYPTI; VECTOR; MALARIA; DENGUE; TEMPERATURE;
   TRANSMISSION; FREQUENCY; EPIDEMICS
AB The Zika virus (ZIKV) was first found in Zika forest, Uganda in 1947. The disease appeared in the Americas, Northeast Brazil in May 2015. ZIKV propagated rapidly across the Americas and the World Health Organization (WHO) in February 2016 declared this as a public health emergency of international concern. The temperature conditions related to extreme El Nino of 2015-16 were exceptionally favorable for ZIKV spreading in South America. For the recent spreading of ZIKV, in Americas, Northeast Brazil was the starting point and it was associated with the extreme El Nino 2015-16. Paz and Semenza found that there is a striking overlap when the regions with extreme climatic conditions in 1 month are juxtaposed with the geographic distribution of ZIKV in subsequent months. They found that the unique climatic conditions generated by extreme El Nino of 2015-16 are congenial for the dispersal of ZIKV in the Americas. This is not a just coincidence and many authors noted that ZIKV vector Aedes aegypti is strongly dependent on surface climate conditions that occur during extreme El Nino events. Recently a study found that extreme El Nino events will double in future in response to greenhouse warming. Also it was discovered that the increase of extreme El Nino frequency will continue long after 1.5 degrees C warming stabilization. We analyze future extreme El Nino events along with associated surface temperatures and calculated the ZIKV quantitatively in future extreme El Nino events and found that large parts of South America are highly favorable for the spread of the disease.
C1 [Rao, V. Brahmananda; Franchito, Sergio H.; Gan, Manoel A.] INPE, CP 515, BR-12245970 Sao Jose Dos Campos, SP, Brazil.
   [Maneesha, K.] CSIR Natl Inst Oceanog, Reg Ctr Visakhapatnam, Visakhapatnam, Andhra Pradesh, India.
   [Sravya, Panangipalli] CSIR Ctr Cellular Mol Biol, Hyderabad, Telangana, India.
   [Dasari, Hariprasad] King Abdulla Univ Sci & Technol, Div Phys Sci & Engn, Tuwal, Saudi Arabia.
RP Maneesha, K (corresponding author), CSIR Natl Inst Oceanog, Reg Ctr Visakhapatnam, Visakhapatnam, Andhra Pradesh, India.
EM kkpalli_manisha@yahoo.com
RI DASARI, HARI PRASAD/AAD-5446-2019; Gan, Manoel A/O-6634-2018
OI DASARI, HARI PRASAD/0000-0003-0628-4481; Gan, Manoel
   A/0000-0003-1322-1374
CR Alexandre S., 2002, INT J BIOMETEOROL, V46, P81
   Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772
   Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x
   Buizer JL, 2000, B AM METEOROL SOC, V81, P2121, DOI 10.1175/1520-0477(2000)081<2121:GIARAP>2.3.CO;2
   Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Collins JM, 2009, J CLIMATE, V22, P5854, DOI 10.1175/2009JCLI2551.1
   Ferreira DAD, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2025-8
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Espinoza JC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047862
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   Gagnon AS, 2001, CLIM RES, V19, P35, DOI 10.3354/cr019035
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Jimenez-Munoz JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33130
   Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kogan F, 2017, INT J REMOTE SENS, V38, P161, DOI 10.1080/01431161.2016.1259679
   Kovats RS, 2000, B WORLD HEALTH ORGAN, V78, P1127
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   MARTENS WJM, 1995, GLOBAL ENVIRON CHANG, V5, P195, DOI 10.1016/0959-3780(95)00051-O
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Poveda G, 2001, ENVIRON HEALTH PERSP, V109, P489, DOI 10.2307/3454707
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Ramesh C. D., 2017, MALARIA J, V16, P122
   Sponberg K., 1999, NAVIGATING NUMBERS C, V1, P13
   Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1
   Wang GJ, 2017, NAT CLIM CHANGE, V7, P568, DOI 10.1038/NCLIMATE3351
   Weare BC, 2013, CLIM DYNAM, V41, P2165, DOI 10.1007/s00382-012-1537-3
   Weller E, 2013, J CLIMATE, V26, P5139, DOI 10.1175/JCLI-D-12-00789.1
   World Health Organization, 2015, ZIK VIR INF BRAZ COL
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
NR 37
TC 5
Z9 5
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2397-3722
J9 NPJ CLIM ATMOS SCI
JI npj Clim. Atmos. Sci.
PD JAN 29
PY 2019
VL 2
AR 4
DI 10.1038/s41612-019-0061-0
PG 7
WC Meteorology & Atmospheric Sciences
SC Meteorology & Atmospheric Sciences
GA HY3FJ
UT WOS:000468008400001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Robinson, M
   Sweeney, TE
   Barouch-Bentov, R
   Sahoo, MK
   Kalesinskas, L
   Vallania, F
   Sanz, AM
   Ortiz-Lasso, E
   Albornoz, LL
   Rosso, F
   Montoya, JG
   Pinsky, BA
   Khatri, P
   Einav, S
AF Robinson, Makeda
   Sweeney, Timothy E.
   Barouch-Bentov, Rina
   Sahoo, Malaya Kumar
   Kalesinskas, Larry
   Vallania, Francesco
   Maria Sanz, Ana
   Ortiz-Lasso, Eliana
   Luis Albornoz, Ludwig
   Rosso, Fernando
   Montoya, Jose G.
   Pinsky, Benjamin A.
   Khatri, Purvesh
   Einav, Shirit
TI A 20-Gene Set Predictive of Progression to Severe Dengue
SO CELL REPORTS
LA English
DT Article
ID GENE TRANSCRIPT ABUNDANCE; HEMORRHAGIC-FEVER; VIRUS-INFECTION;
   DIAGNOSIS; BLOOD; EXPRESSION; CORRELATE; PATTERNS; CHILDREN; ZIKA
AB There is a need to identify biomarkers predictive of severe dengue. Single-cohort transcriptomics has not yielded generalizable results or parsimonious, predictive gene sets. We analyzed blood samples of dengue patients from seven gene expression datasets (446 samples, five countries) using an integrated multi-cohort analysis framework and identified a 20-gene set that predicts progression to severe dengue. We validated the predictive power of this 20-gene set in three retrospective dengue datasets (84 samples, three countries) and a prospective Colombia cohort (34 patients), with an area under the receiver operating characteristic curve of 0.89, 100% sensitivity, and 76% specificity. The 20-gene dengue severity scores declined during the disease course, suggesting an infection-triggered host response. This 20-gene set is strongly associated with the progression to severe dengue and represents a predictive signature, generalizable across ages, host genetic factors, and virus strains, with potential implications for the development of a host response-based dengue prognostic assay.
C1 [Robinson, Makeda; Barouch-Bentov, Rina; Montoya, Jose G.; Pinsky, Benjamin A.; Einav, Shirit] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Robinson, Makeda; Einav, Shirit] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.
   [Sweeney, Timothy E.; Kalesinskas, Larry; Vallania, Francesco; Khatri, Purvesh] Stanford Univ, Dept Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.
   [Sweeney, Timothy E.; Kalesinskas, Larry; Vallania, Francesco; Khatri, Purvesh] Stanford Univ, Dept Med, Div Biomed Informat Res, Stanford, CA 94305 USA.
   [Sahoo, Malaya Kumar; Pinsky, Benjamin A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.
   [Maria Sanz, Ana; Rosso, Fernando] Fdn Valle Lili, Clin Res Ctr, Cali, Colombia.
   [Ortiz-Lasso, Eliana; Luis Albornoz, Ludwig] Fdn Valle Lili, Pathol & Lab Dept, Cali, Colombia.
   [Rosso, Fernando] Fdn Valle Lili, Div Infect Dis, Dept Internal Med, Cali, Colombia.
   [Sweeney, Timothy E.] Inflammatix Inc, Burlingame, CA USA.
RP Einav, S (corresponding author), Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.; Einav, S (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.; Khatri, P (corresponding author), Stanford Univ, Dept Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Khatri, P (corresponding author), Stanford Univ, Dept Med, Div Biomed Informat Res, Stanford, CA 94305 USA.
EM pkhatri@stanford.edu; seinav@stanford.edu
OI Robinson, Makeda/0000-0002-5919-4159; Pinsky,
   Benjamin/0000-0001-8751-4810; Sahoo, Malaya/0000-0001-9837-4032
FU Stanford Bio-X Interdisciplinary Initiatives Seed Grants program;
   Stanford Translational Research and Applied Medicine (TRAM) program;
   Stanford SPARK program; Stanford Child Health Research Institute;
   Stanford Institute for Immunity, Transplantation, and Infection; Bill &
   Melinda Gates FoundationGates Foundation [OPT1113682]; National
   Institute for Allergy and Infectious Diseases grants [R01 AI125197-01,
   U19AI109662, U19AI057229]; Stanford Advanced Residency Training at
   Stanford (ARTS) fellowship program
FX This work was supported by seed grants from the Stanford Bio-X
   Interdisciplinary Initiatives Seed Grants program, Stanford
   Translational Research and Applied Medicine (TRAM) program, Stanford
   SPARK program, Stanford Child Health Research Institute, and Stanford
   Institute for Immunity, Transplantation, and Infection (to S.E., P.K.,
   and B.A.P.). P.K. is supported in part by the Bill & Melinda Gates
   Foundation (OPT1113682) and National Institute for Allergy and
   Infectious Diseases grants R01 AI125197-01, U19AI109662, and
   U19AI057229. M.R. was supported by the Stanford Advanced Residency
   Training at Stanford (ARTS) fellowship program. We are thankful for the
   patients who participated in this study and for their families.
CR Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x
   Andres-Terre M, 2015, IMMUNITY, V43, P1199, DOI 10.1016/j.immuni.2015.11.003
   Baril M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003416
   Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bianchi C, 1999, EXP CELL RES, V248, P329, DOI 10.1006/excr.1999.4428
   Bongen E, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0554-1
   Cheow LF, 2015, NAT PROTOC, V10, P619, DOI 10.1038/nprot.2015.041
   Chowdhury RR, 2018, NATURE, V560, P644, DOI 10.1038/s41586-018-0439-x
   Devignot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011671
   Fong AM, 2002, J BIOL CHEM, V277, P19418, DOI 10.1074/jbc.M201396200
   Hassibi A, 2018, NAT BIOTECHNOL, V36, P738, DOI 10.1038/nbt.4179
   Haynes WA, 2017, BIOCOMPUTING, P144, DOI 10.1142/9789813207813_0015
   He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021
   Kalayanarooj S, 2017, J INFECT DIS, V215, pS79, DOI 10.1093/infdis/jiw609
   Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709
   Khursheed M, 2013, J PAK MED ASSOC, V63, P670
   Knudsen BS, 2008, J MOL DIAGN, V10, P169, DOI 10.2353/jmoldx.2008.070127
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Leo YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-498
   Lin TY, 2013, CURR OPIN VIROL, V3, P531, DOI 10.1016/j.coviro.2013.07.005
   Liu J, 2011, J CLIN VIROL, V50, P308, DOI 10.1016/j.jcv.2010.12.009
   Lofgren S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89073
   Loke P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000710
   Long HT, 2009, J INFECT DIS, V199, P537, DOI 10.1086/596507
   Long TH, 2010, J VIROL, V84, P12982, DOI 10.1128/JVI.01224-10
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892
   Nujum ZT, 2014, PATHOG GLOB HEALTH, V108, P103, DOI 10.1179/2047773214Y.0000000131
   Lam PK, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005498
   Popper SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001966
   Saito T, 2004, BIOCHEM BIOPH RES CO, V317, P335, DOI 10.1016/j.bbrc.2004.03.056
   Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162
   Srikiatkhachorn A, 2011, CLIN INFECT DIS, V53, P563, DOI 10.1093/cid/cir451
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Sweeney TE, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw797
   Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165
   Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5
   Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993
   Thein TL, 2011, AM J TROP MED HYG, V85, P942, DOI 10.4269/ajtmh.2011.11-0149
   Tissera H, 2017, J INFECT DIS, V216, P1112, DOI 10.1093/infdis/jix447
   Vallania F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07242-6
   van de Weg CAMV, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003522
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   World Health Organization, 2012, HDB CLIN MAN DENG
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959
NR 54
TC 8
Z9 8
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JAN 29
PY 2019
VL 26
IS 5
BP 1104
EP +
DI 10.1016/j.celrep.2019.01.033
PG 12
WC Cell Biology
SC Cell Biology
GA HJ1VJ
UT WOS:000456952400005
PM 30699342
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Long, F
   Doyle, M
   Fernandez, E
   Miller, AS
   Klose, T
   Sevvana, M
   Bryan, A
   Davidson, E
   Doranz, BJ
   Kuhn, RJ
   Diamond, MS
   Crowe, JE
   Rossmann, MG
AF Long, Feng
   Doyle, Michael
   Fernandez, Estefania
   Miller, Andrew S.
   Klose, Thomas
   Sevvana, Madhumati
   Bryan, Aubrey
   Davidson, Edgar
   Doranz, Benjamin J.
   Kuhn, Richard J.
   Diamond, Michael S.
   Crowe, James E., Jr.
   Rossmann, Michael G.
TI Structural basis of a potent human monoclonal antibody against Zika
   virus targeting a quaternary epitope
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; monoclonal antibody; membrane-fusion inhibition;
   neutralization mechanism; cryo-EM structure
ID DENGUE VIRUS; DEPENDENT ENHANCEMENT; CROSS-REACTIVITY; RECONSTRUCTION;
   NEUTRALIZATION; GLYCOSYLATION; MATURATION; MICROSCOPY; INFECTION;
   COMPLEX
AB Zika virus (ZIKV) is a major human pathogen and member of the Flavivirus genus in the Flaviviridae family. In contrast to most other insect-transmitted flaviviruses, ZIKV also can be transmitted sexually and from mother to fetus in humans. During recent outbreaks, ZIKV infections have been linked to microcephaly, congenital disease, and Guillain-Barre syndrome. Neutralizing antibodies have potential as therapeutic agents. We report here a 4-angstrom-resolution cryo-electron microscopy structure of the ZIKV virion in complex with Fab fragments of the potently neutralizing human monoclonal antibody ZIKV-195. The footprint of the ZIKV-195 Fab fragment expands across two adjacent envelope (E) protein protomers. ZIKV neutralization by this antibody is presumably accomplished by cross-linking the E proteins, which likely prevents formation of E protein trimers required for fusion of the viral and cellular membranes. A single dose of ZIKV-195 administered 5 days after virus inoculation showed marked protection against lethality in a stringent mouse model of infection.
C1 [Long, Feng; Miller, Andrew S.; Klose, Thomas; Sevvana, Madhumati; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Doyle, Michael; Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.
   [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Bryan, Aubrey; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA 19104 USA.
   [Kuhn, Richard J.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.
RP Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
EM mr@purdue.edu
RI Sevvana, Madhumati/S-3297-2019; Diamond, Michael/AAH-1733-2019; Crowe,
   James E./B-5549-2009
OI Sevvana, Madhumati/0000-0003-4992-6296; Diamond,
   Michael/0000-0002-8791-3165; Crowe, James E./0000-0002-0049-1079
FU US National Institutes of Health (NIH)United States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R01 AI076331,
   NIH R01 AI127828, NIH R01 AI073755, NIH R01 AI104972, HHSN272201400024C,
   HHSN272201400058C]
FX We thank Sheryl Kelly for help in preparing the manuscript. We thank
   Geeta Buda for help with cell culture as well as Yingyuan Sun and Yue
   Liu for their help with cryo-EM data collection and for further
   discussion. We thank members of the J.E.C. research laboratory
   (Vanderbilt University Medical Center) for their technical support,
   including Robin Bombardi (antibody sequence analysis, Fab synthesis, and
   cloning), Nurgun Kose (ELISA verification of mAb binding), Rachel Nargi
   (production of recombinant IgG and Fab molecules), Dina Yousif (IgG
   purification), and Robert Carnahan and Merissa Mayo (antibody project
   oversight). Cryo-EM data were collected at the Purdue University Cryo-EM
   Facility. The computation was supported, in part, through computational
   resources provided by Information Technology Research Computing at
   Purdue University, West Lafayette, Indiana. This work was supported by
   US National Institutes of Health (NIH) Grants R01 AI076331 (to M.G.R.
   and R.J.K.), NIH R01 AI127828 (to J.E.C. and M.S.D.), NIH R01 AI073755
   (to M.S.D.; subawards to M.G.R., J.E.C., and R.J.K.), NIH R01 AI104972
   (to M.S.D.), HHSN272201400024C (to J.E.C.), and HHSN272201400058C (to
   B.J.D.).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Fuzik T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02882-0
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Guo F, 2014, METHODS MOL BIOL, V1117, P401, DOI 10.1007/978-1-62703-776-1_19
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   National Research Council, 2011, GUIDE CARE USE LAB A
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008
   Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013
   ROSSMANN MG, 1976, J MOL BIOL, V105, P75, DOI 10.1016/0022-2836(76)90195-9
   Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Xiao CA, 2007, J STRUCT BIOL, V158, P182, DOI 10.1016/j.jsb.2006.10.013
   Yu GM, 2016, J STRUCT BIOL, V195, P207, DOI 10.1016/j.jsb.2016.06.003
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193
NR 64
TC 11
Z9 11
U1 0
U2 6
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 29
PY 2019
VL 116
IS 5
BP 1591
EP 1596
DI 10.1073/pnas.1815432116
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HJ1SN
UT WOS:000456944600025
PM 30642974
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Murcia, O
   Henriquez, B
   Castro, A
   Koo, S
   Young, J
   Marquez, R
   Perez, D
   Caceres, L
   Valderrama, A
AF Murcia, Osiris
   Henriquez, Brigitte
   Castro, Angelica
   Koo, Susana
   Young, Josue
   Marquez, Ricardo
   Perez, Debora
   Caceres, Lorenzo
   Valderrama, Anayansi
TI Presence of the point mutations Val1016Gly in the voltage-gated sodium
   channel detected in a single mosquito from Panama
SO PARASITES & VECTORS
LA English
DT Article
DE kdr mutations; Pyrethroid resistance; Voltage-gated sodium channel;
   Aedes aegypti; Aedes albopictus; Panama
ID AEDES-AEGYPTI; INSECTICIDE RESISTANCE; DIPTERA-CULICIDAE; POPULATIONS;
   GENE; KDR
AB BackgroundIn Panama, arboviroses such as dengue fever, and more recently chikungunya fever and Zika disease, are transmitted by Aedes aegypti and Aedes albopictus. Their control is based on the elimination of breeding sites and fogging with pyrethroid insecticides. However, one of the significant issues derived from the prolonged use of pyrethroid insecticide is the development of resistance mechanisms, such as knockdown resistance or kdr. The objective of this study was to evaluate the presence of kdr mutations in a partial region of the VGSC gene in samples of wild-caught Aedes mosquitoes from different locations of the Metropolitan Region of Panama.ResultsBased on the analysis of 194 sequences of the VGSC gene, two kdr mutations (Ile1011Met and Val1016Gly) were detected in a specimen of Ae. aegypti. The frequency of kdr mutations in the evaluated samples of Ae. aegypti was 0.01.ConclusionsThis study provides evidence for a low frequency of kdr mutations in Ae. aegypti populations in Panama. It is possible that these changes have no impact on vector control interventions. To our knowledge, we report, for the first time in America the Val1016Gly mutation documented in Asia. In general terms, this result is highly relevant to the Aedes Control Programme in Panama since it constitutes a feasible approach for the timely detection of resistance as well as for the development of strategies.
C1 [Murcia, Osiris] Univ Panama, Vicerrectoria Invest & Postgrad, Ciencias Biol, Panama City, Panama.
   [Murcia, Osiris] Univ Autonoma Chiriqui, Chiriqui, Panama.
   [Henriquez, Brigitte; Castro, Angelica; Koo, Susana; Young, Josue; Marquez, Ricardo; Perez, Debora; Caceres, Lorenzo; Valderrama, Anayansi] Gorgas Mem Inst Hlth Studies, Dept Res Med Entomol, Panama City, Panama.
RP Valderrama, A (corresponding author), Gorgas Mem Inst Hlth Studies, Dept Res Med Entomol, Panama City, Panama.
EM avalderrama@gorgas.gob.pa
OI Marquez, Ricardo/0000-0002-5169-3551
FU project "The Panama Dengue Fever Research"; Secretaria Nacional de
   Ciencia y Tecnologia e Innovacion (SENACYT) through the Sistema Nacional
   de Investigacion (SNI); Panama Science and Innovation Fund 2015 grant
FX Financial support was provided by the project "The Panama Dengue Fever
   Research" to Sandra Lopez Verges (PI). Secretaria Nacional de Ciencia y
   Tecnologia e Innovacion (SENACYT), through the Sistema Nacional de
   Investigacion (SNI), supported research activities by AV and LC.
   Financial Support was also provided by the Panama Science and Innovation
   Fund 2015 grant (UK).
CR Aguirre-Obando OA, 2015, ZOOLOGIA-CURITIBA, V32, P14, DOI 10.1590/S1984-46702015000100003
   Aguirre-Obando OA, 2016, REV BRAS ENTOMOL, V60, P94, DOI 10.1016/j.rbe.2015.11.009
   Gonzalez LA, 2014, B MALARIOL SALUD AMB, V54, P58
   Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Bisset JA, 2014, J AM MOSQUITO CONTR, V30, P298, DOI 10.2987/14-6431.1
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bisset Juan A., 2003, Rev Cubana Med Trop, V55, P191
   CACERES L, 1999, LUCHA ANTIMALARICA D
   Caceres L, 2013, THESIS
   Caceres L, 2013, BIOMEDICA, V33, P70, DOI 10.7705/biomedica.v33i0.703
   Carrera JP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005338
   CLARK-GIL S, 1983, Mosquito Systematics, V15, P151
   David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Chaves LF, 2015, B INSECTOL, V68, P61
   Figueroa DP, 2015, PARASITOL LATINOAM, V64, P30
   Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Labbe P, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P363, DOI 10.1016/B978-0-12-384890-1.00014-5
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Ministerio de Salud, 2015, B EP, V34
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Organizacion Panamericana de la Salud, 2014, GUIAS AB INT DENG PA
   Pang SC, 2015, TROP BIOMED, V32, P140
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rey JR, 2015, BIOMEDICA, V35, P177, DOI [10.1590/S0120-41572015000200005, 10.7705/biomedica.v35i2.2514]
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Valderrama A, 2016, REV MED PANAMA, V36, P30
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
NR 44
TC 2
Z9 2
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 28
PY 2019
VL 12
AR 62
DI 10.1186/s13071-019-3309-y
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HK7OS
UT WOS:000458179300001
PM 30691518
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ramacciotti, E
   Agati, LB
   Aguiar, VCR
   Wolosker, N
   Guerra, JC
   de Almeida, RP
   Alves, JC
   Lopes, RD
   Wakefield, TW
   Comerota, AJ
   Walenga, J
   Fareed, J
AF Ramacciotti, Eduardo
   Agati, Leandro B.
   Aguiar, Valeria C. R.
   Wolosker, Nelson
   Guerra, Joao C.
   de Almeida, Roque P.
   Alves, Juliana Cardoso
   Lopes, Renato D.
   Wakefield, Thomas W.
   Comerota, Anthony J.
   Walenga, Jeanine
   Fareed, Jawed
TI Zika and Chikungunya Virus and Risk for Venous Thromboembolism
SO CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
LA English
DT Article
DE Zika virus; Chikungunya virus; deep venous thrombosis
AB A variety of viral infections are associated with hypercoagulable states and may be linked to the development of deep venous thrombosis and pulmonary embolism. The Zika and Chikungunya viral infections spread through the South and Central American continents, moving to North America in 2016, with severe cases of polyarthralgia, fever, and Guillain-Barre syndrome leading eventually to death. A decreased trend for both infections was reported in the first quarter of 2017. In this article, we report the possible association of venous thromboembolic events associated with Zika infection. After 2 cases of deep venous thrombosis in patients with acute Zika infections, D-dimer levels were measured in 172 consecutive patients who presented to the emergency department of a university hospital in an endemic region of Brazil with either Zika or Chikungunya infections confirmed by polymerase chain reaction tests. D-dimer levels were increased in 19.4% of 31 patients with Zika and in 63.8% of 141 patients with Chikungunya infections. The mechanisms behind this association are yet to be elucidated as well as the potential for venous thromboembolism prevention strategies for in-hospital patients affected by Zika and Chikungunya infections.
C1 [Ramacciotti, Eduardo; Agati, Leandro B.; Aguiar, Valeria C. R.] Hosp & Maternidade Dr Christovao da Gama, Santo Andre, SP, Brazil.
   [Wolosker, Nelson; Guerra, Joao C.] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.
   [de Almeida, Roque P.; Alves, Juliana Cardoso] Univ Fed Sergipe, Aracaju, SE, Brazil.
   [Lopes, Renato D.] Duke Univ Hosp, Duke Clin, Durham, NC USA.
   [Wakefield, Thomas W.] Univ Michigan, Michigan Med, Cardiovasc Ctr, Ann Arbor, MI 48109 USA.
   [Comerota, Anthony J.] Mercy St Vincent Med Ctr, Toledo, OH USA.
   [Walenga, Jeanine; Fareed, Jawed] Loyola Univ, Med Ctr, Maywood, IL 60153 USA.
RP Ramacciotti, E (corresponding author), Hosp & Maternidade Dr Christovao da Gama, Santo Andre, SP, Brazil.
EM eduardoramacciotti@gmail.com
RI WOLOSKER, NELSON/E-2591-2013
OI Cardoso Alves, Juliana/0000-0001-9294-3257
FU Hospital e Maternidade Dr. Christovao da Gama, SP, Brazil; Albert
   Einstein Israeli Hospital, SP, Brazil; FINEP grant (Financiadora de
   Estudos e Projetos) [0116005600]; "Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior"-Brazil (CAPES)CAPES [001]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was self-funded by Hospital e Maternidade Dr. Christovao da Gama, SP,
   Brazil and Albert Einstein Israeli Hospital, SP, Brazil. Roque Almeida
   reports a FINEP grant (Financiadora de Estudos e Projetos) number
   0116005600. Juliana Alves reports that this study was financed in part
   by the "Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior"-Brazil (CAPES)-Finance Code 001. Laboratory kits were provided
   by Loyola University Medical Center, Maywood, Illinois.
CR Avnon LS, 2015, EUR J INTERN MED, V26, P596, DOI 10.1016/j.ejim.2015.08.017
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Goeijenbier M, 2012, J MED VIROL, V84, P1680, DOI 10.1002/jmv.23354
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Li H., 2016, BMJ-BRIT MED J, V19, P593
   Marques Marcos Arêas, 2017, J. vasc. bras., V16, P60, DOI 10.1590/1677-5449.009616
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Wang CC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001585
NR 11
TC 4
Z9 4
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1076-0296
EI 1938-2723
J9 CLIN APPL THROMB-HEM
JI Clin. Appl. Thromb.-Hemost.
PD JAN 28
PY 2019
VL 25
AR UNSP 1076029618821184
DI 10.1177/1076029618821184
PG 5
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA HJ4AH
UT WOS:000457115300001
PM 30808213
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garcia-Nicolas, O
   Lewandowska, M
   Ricklin, ME
   Summerfield, A
AF Garcia-Nicolas, Obdulio
   Lewandowska, Marta
   Ricklin, Meret E.
   Summerfield, Artur
TI Monocyte-Derived Dendritic Cells as Model to Evaluate Species Tropism of
   Mosquito-Borne Flaviviruses
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Flavivirus; monocyte-derived dendritic cells; in vitro model; infection;
   tropism; innate immune response
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS; WESSELSBRON-DISEASE; FEVER
   VIRUSES; DC-SIGN; INFECTION; DENGUE; INTERFERON; USUTU; PIGS
AB Several mosquito-borne Flaviviruses such as Japanese encephalitis virus (JEV), West Nile virus (WNV), Dengue Virus (DENV), and Zika virus (ZIKV) can cause severe clinical disease. Being zoonotic, Flaviviruses infect a wide variety of terrestrial vertebrates, which dependent of the virus-host interactions, can enhance ongoing epidemics and maintain the virus in the environment for prolonged periods. Targeted species can vary from amphibians, birds to various mammals, dependent on the virus. For many mosquito-borne flaviviruses the spectrum of targeted species is incompletely understood, in particular with respect to their contribution to the maintenance of virus in certain geographical regions. Furthermore, little is known about virus and host factors contributing to species tropism. The present study utilized human and porcine monocyte-derived dendritic cells (MoDC) as a cell culture model to better understand Flavivirus species tropism and innate immune responses. MoDC were selected based on their presence in the skin and their role as an early target cell for several Flaviviruses and their role as immune sentinels. While differences in viral infectivity and replication were minor when comparing porcine with human MoDC for some of the tested Flaviviruses, a particularly strong replication in human MoDC was found with USUV, while JEV appeared to have a stronger tropism for porcine MoDC. With respect to innate immune responses we found high induction of TNF and IFN-beta in both human and porcine MoDC after infection with JEV, WNV, and USUV, but not with DENV, ZIKV, and Wesselsbron virus. Spondweni virus induced these cytokine responses only in porcine MoDC. Overall, innate immune responses correlated with early infectivity and cytokine production. In conclusion, we demonstrate Flavivirus-dependent differences in the interaction with MoDC. These may play a role in pathogenesis but appear to only partially reflect the expected species tropism.
C1 [Garcia-Nicolas, Obdulio; Lewandowska, Marta; Summerfield, Artur] IVI, Bern, Switzerland.
   [Garcia-Nicolas, Obdulio; Lewandowska, Marta; Summerfield, Artur] Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
   [Lewandowska, Marta] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland.
   [Ricklin, Meret E.] Univ Hosp Bern, Dept Emergency Med, Inselspital, Bern, Switzerland.
RP Summerfield, A (corresponding author), IVI, Bern, Switzerland.; Summerfield, A (corresponding author), Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
EM Artur.Summerfield@ivi.admin.ch
RI Summerfield, Artur/H-6025-2019
OI Summerfield, Artur/0000-0001-8292-4634
FU European Union's Seventh Framework Program for research, technological
   development, and demonstrationEuropean Union (EU) [278433-PREDEMICS];
   European Union's Horizon 2020 research and innovation program
   [734548-ZIKAlliance]
FX This work was partially supported by the European Union's Seventh
   Framework Program for research, technological development, and
   demonstration under Grant No. 278433-PREDEMICS. Also, partially
   supported by the European Union's Horizon 2020 research and innovation
   program under Grant No. 734548-ZIKAlliance.
CR Barnard BJH, 1997, ONDERSTEPOORT J VET, V64, P95
   Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cacciotti G, 2015, VIROLOGY, V485, P189, DOI 10.1016/j.virol.2015.07.015
   Cao SB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-39
   Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x
   Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   COETZER JAW, 1977, ONDERSTEPOORT J VET, V44, P205
   COETZER JAW, 1982, ONDERSTEPOORT J VET, V49, P19
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Thoisy B, 2004, T ROY SOC TROP MED H, V98, P409, DOI 10.1016/j.trstmh.2003.12.003
   Diagne MM, 2017, ONE HEALTH-AMSTERDAM, V3, P23, DOI 10.1016/j.onehlt.2017.02.001
   Escribano-Romero E, 2015, VET MICROBIOL, V176, P365, DOI 10.1016/j.vetmic.2015.02.005
   Espada-Murao LA, 2011, J VIROL, V85, P6736, DOI 10.1128/JVI.00233-11
   Garcia-Nicolas O, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050124
   Garcia-Nicolas O, 2014, VIRUS RES, V179, P204, DOI 10.1016/j.virusres.2013.08.009
   Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P261, DOI 10.1089/vbz.2006.6.261
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Gupta N, 2014, EUR J IMMUNOL, V44, P1363, DOI 10.1002/eji.201343701
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hubalek Z, 2014, TRANSBOUND EMERG DIS, V61, P273, DOI 10.1111/tbed.12025
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   ILKAL MA, 1994, ACTA VIROL, V38, P157
   Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185
   Lannes N, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0931-5
   Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mansfield KL, 2017, VET MICROBIOL, V201, P85, DOI 10.1016/j.vetmic.2017.01.014
   McCullough KC, 2009, VET IMMUNOL IMMUNOP, V128, P7, DOI 10.1016/j.vetimm.2008.10.290
   Michel F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010171
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Rawle DJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0279-3
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Shimojima M, 2014, ARCH VIROL, V159, P2023, DOI 10.1007/s00705-014-2042-2
   Silveira GF, 2011, J VIROL, V85, P5374, DOI 10.1128/JVI.01915-10
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   SIMPSON VR, 1979, VET REC, V105, P329, DOI 10.1136/vr.105.14.329
   Sooryanarain H, 2012, ARCH VIROL, V157, P1905, DOI 10.1007/s00705-012-1386-8
   Su CM, 2001, VIROLOGY, V286, P206, DOI 10.1006/viro.2001.0986
   Summerfield A, 2003, J IMMUNOL METHODS, V280, P113, DOI 10.1016/S0022-1759(03)00273-4
   Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004
   Teehee ML, 2005, ARCH VIROL, V150, P1249, DOI 10.1007/s00705-004-0478-5
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
NR 62
TC 4
Z9 4
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JAN 28
PY 2019
VL 9
AR 5
DI 10.3389/fcimb.2019.00005
PG 13
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HJ1PC
UT WOS:000456934800001
PM 30746342
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ramos, RD
   Costa, JD
   Silva, RC
   da Costa, GV
   Rodrigues, ABL
   Rabelo, EDM
   Souto, RNP
   Taft, CA
   da Silva, CHTD
   Rosa, JMC
   dos Santos, CBR
   Macedo, WJD
AF Ramos, Ryan da Silva
   Costa, Josivan da Silva
   Silva, Rai Campos
   da Costa, Glauber Vilhena
   Lobato Rodrigues, Alex Bruno
   Rabelo, Erica de Menezes
   Picanco Souto, Raimundo Nonato
   Taft, Carlton Anthony
   Tomich de Paula da Silva, Carlos Henrique
   Campos Rosa, Joaquin Maria
   Rodrigues dos Santos, Cleydson Breno
   da Cruz Macedo, Williams Jorge
TI Identification of Potential Inhibitors from Pyriproxyfen with
   Insecticidal Activity by Virtual Screening
SO PHARMACEUTICALS
LA English
DT Article
DE acetylcholinesterase; juvenile hormone; PASS; molecular docking
ID PREDICTING DRUG-METABOLISM; AEDES-AEGYPTI DIPTERA; EXPERIMENTAL
   INTERSEXUALITY; SEXUAL DEVELOPMENT; DENGUE VECTOR; ACETYLCHOLINESTERASE;
   DERIVATIVES; SKIN; MUTAGENICITY; PERMEABILITY
AB Aedes aegypti is the main vector of dengue fever transmission, yellow fever, Zika, and chikungunya in tropical and subtropical regions and it is considered to cause health risks to millions of people in the world. In this study, we search to obtain new molecules with insecticidal potential against Ae. aegypti via virtual screening. Pyriproxyfen was chosen as a template compound to search molecules in the database Zinc_Natural_Stock (ZNSt) with structural similarity using ROCS (rapid overlay of chemical structures) and EON (electrostatic similarity) software, and in the final search, the top 100 were selected. Subsequently, in silico pharmacokinetic and toxicological properties were determined resulting in a total of 14 molecules, and these were submitted to the PASS online server for the prediction of biological insecticide and acetylcholinesterase activities, and only two selected molecules followed for the molecular docking study to evaluate the binding free energy and interaction mode. After these procedures were performed, toxicity risk assessment such as LD50 values in mg/kg and toxicity class using the PROTOX online server, were undertaken. Molecule ZINC00001624 presented potential for inhibition for the acetylcholinesterase enzyme (insect and human) with a binding affinity value of -10.5 and -10.3 kcal/mol, respectively. The interaction with the juvenile hormone was -11.4 kcal/mol for the molecule ZINC00001021. Molecules ZINC00001021 and ZINC00001624 had excellent predictions in all the steps of the study and may be indicated as the most promising molecules resulting from the virtual screening of new insecticidal agents.
C1 [Ramos, Ryan da Silva; Lobato Rodrigues, Alex Bruno; Rabelo, Erica de Menezes; Rodrigues dos Santos, Cleydson Breno; da Cruz Macedo, Williams Jorge] Univ Fed Amapa, Postgrad Program Biotechnol & Biodivers Network B, BR-68903419 Macapa, Amapa, Brazil.
   [Ramos, Ryan da Silva; Costa, Josivan da Silva; Silva, Rai Campos; da Costa, Glauber Vilhena; Lobato Rodrigues, Alex Bruno; Rodrigues dos Santos, Cleydson Breno; da Cruz Macedo, Williams Jorge] Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol & Hlth Sci, BR-68902280 Macapa, AP, Brazil.
   [Ramos, Ryan da Silva; Costa, Josivan da Silva; Tomich de Paula da Silva, Carlos Henrique; da Cruz Macedo, Williams Jorge] Fed Rural Univ Amazonia, Lab Mol Modeling & Simulat Syst, BR-68700030 Capanema, Para, Brazil.
   [Silva, Rai Campos; Tomich de Paula da Silva, Carlos Henrique; Rodrigues dos Santos, Cleydson Breno] Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
   [Picanco Souto, Raimundo Nonato] Univ Fed Amapa, Lab Arthropoda, BR-68902280 Macapa, AP, Brazil.
   [Taft, Carlton Anthony] Brazilian Ctr Phys Res, BR-22290180 Urca, RJ, Brazil.
   [Campos Rosa, Joaquin Maria] Univ Granada, Dept Organ Pharmaceut Chem, E-18071 Granada, Spain.
RP dos Santos, CBR (corresponding author), Univ Fed Amapa, Postgrad Program Biotechnol & Biodivers Network B, BR-68903419 Macapa, Amapa, Brazil.; dos Santos, CBR (corresponding author), Univ Fed Amapa, Lab Modeling & Computat Chem, Dept Biol & Hlth Sci, BR-68902280 Macapa, AP, Brazil.; dos Santos, CBR (corresponding author), Fac Pharmaceut Sci Ribeirao Preto, Computat Lab Pharmaceut Chem, BR-14040903 Sao Paulo, Brazil.
EM ryanquimico@hotmail.com; josivan.chemistry@gmail.com;
   camposchemistry@gmail.com; vilhenac@hotmail.com;
   alexrodrigues.quim@gmail.com; ericamrabelo@gmail.com;
   nonatoiepa@hotmail.com; catff@terra.com.br; tomich@fcfrp.usp.br;
   jmcampos@ugr.es; breno@unifap.br; williamsmacedo@yahoo.com.br
RI Rodrigues, Alex/AAM-3606-2020; da Silva Costa, Josivan/AAA-9565-2020;
   Rosa, Joaquin/L-8436-2014; Ramos, Ryan/X-5824-2019
OI Rodrigues, Alex/0000-0003-2170-1773; da Silva Costa,
   Josivan/0000-0001-5069-5283; Rosa, Joaquin/0000-0002-9035-8123; Ramos,
   Ryan/0000-0003-1802-1320; Rodrigues dos Santos, Cleydson
   Breno/0000-0002-0271-335X; Souto, Raimundo/0000-0002-8795-1217
FU Federal University of Amapa; Program in Biotechnology and
   Biodiversity-Network BIONORTE; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX Federal University of Amapa, Program in Biotechnology and
   Biodiversity-Network BIONORTE, Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for funding in the publication of this
   article.
CR Ahmadi F, 2012, DNA CELL BIOL, V31, P259, DOI 10.1089/dna.2011.1303
   Anderson JA, 2012, PESTIC BIOCHEM PHYS, V102, P124, DOI 10.1016/j.pestbp.2011.12.002
   [Anonymous], 2009, STUD DISC INS
   Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5
   Atanasova M, 2015, BIOORGAN MED CHEM, V23, P5382, DOI 10.1016/j.bmc.2015.07.058
   Banerjee P, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00362
   Banerjee P, 2018, NUCLEIC ACIDS RES, V46, pW257, DOI 10.1093/nar/gky318
   BARBER ED, 1981, MUTAT RES, V90, P31, DOI 10.1016/0165-1218(81)90048-3
   BARRATT MD, 1994, TOXICOL IN VITRO, V8, P823, DOI 10.1016/0887-2333(94)90077-9
   Berankova M, 2017, FOOD CHEM TOXICOL, V108, P224, DOI 10.1016/j.fct.2017.07.060
   Blenau W, 2012, APIDOLOGIE, V43, P334, DOI 10.1007/s13592-011-0108-7
   Botas GD, 2017, MOLECULES, V22, DOI 10.3390/molecules22111990
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Burkert U, 1982, ACS MONOGRAPH, V177
   Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x
   Chigurupati S, 2016, BIOORG CHEM, V67, P9, DOI 10.1016/j.bioorg.2016.05.002
   Coscolla C, 2008, J CHROMATOGR A, V1200, P100, DOI 10.1016/j.chroma.2008.05.075
   Costa JD, 2018, CURR PHARM DESIGN, V24, P576, DOI 10.2174/1381612823666170711112510
   Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901
   Cruz JV, 2018, MOLECULES, V23, DOI 10.3390/molecules23020453
   da Silva Ramos Ryan, 2017, ScientificWorldJournal, V2017, P4927214, DOI 10.1155/2017/4927214
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Drwal MN, 2014, NUCLEIC ACIDS RES, V42, pW53, DOI 10.1093/nar/gku401
   Engdahl C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138598
   ERIKSSON L, 1991, ACTA CHEM SCAND, V45, P935, DOI 10.3891/acta.chem.scand.45-0935
   Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y
   Ferreira JV, 2017, CHEMMEDCHEM, V12, P1408, DOI 10.1002/cmdc.201700129
   FOURNIER D, 1993, CHEM-BIOL INTERACT, V87, P233, DOI 10.1016/0009-2797(93)90047-3
   Gaddaguti V, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-015-0346-x
   GNAGEY AL, 1987, J BIOL CHEM, V262, P13290
   Goel RK, 2011, MED CHEM RES, V20, P1509, DOI 10.1007/s00044-010-9398-y
   Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14
   Greene RR, 1939, ANAT REC, V74, P429, DOI 10.1002/ar.1090740405
   Greene RR, 1940, AM J ANAT, V67, P305, DOI 10.1002/aja.1000670206
   Harburguer LV, 2009, PEST MANAG SCI, V65, P1208, DOI 10.1002/ps.1811
   Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063
   Harriott ND, 2018, PROGR MED CHEM, V57, P87, DOI 10.1016/bs.pmch.2017.12.002
   Harwood JF, 2016, J AM MOSQUITO CONTR, V32, P217, DOI 10.2987/16-6553.1
   Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k
   Hevener KE, 2009, J CHEM INF MODEL, V49, P444, DOI 10.1021/ci800293n
   Hostettmann K, 2006, CURR ORG CHEM, V10, P825, DOI 10.2174/138527206776894410
   International Agency for Research on Cancer (IARC), 2007, IARC MONOGRAPHS EVAL, V91, P543
   Itoh T., 1994, TROP MED, V35, P259
   Jorgensen WL, 2002, ADV DRUG DELIVER REV, V54, P355, DOI 10.1016/S0169-409X(02)00008-X
   Kang G, 2015, ACTA CRYSTALLOGR E, V71, pO588, DOI 10.1107/S2056989015013481
   Kim IH, 2017, J BIOL CHEM, V292, P15329, DOI [10.1074/jbc.M117.802009, 10.1074/jbc.m117.802009]
   Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581
   Kroupova A, 2019, NUCLEIC ACIDS RES, V47, P1030, DOI 10.1093/nar/gky1164
   Lagunin A, 2010, CURR PHARM DESIGN, V16, P1703, DOI 10.2174/138161210791164063
   Lekweiry KM, 2015, J MED ENTOMOL, V52, P730, DOI 10.1093/jme/tjv051
   Lhasa Limited, 2007, DER NEX VERSAO 10 0
   Li B, 2010, PESTIC BIOCHEM PHYS, V98, P19, DOI 10.1016/j.pestbp.2010.04.004
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Macoris M., 2008, DENGUE B, V32, P186
   MARCHAND B, 1982, ARCH DERMATOL RES, V272, P61
   Meric A, 2017, BULG CHEM COMMUN, V49, P5
   Ministerio da Saude, 2015, B EPIDEMIOL, V46, P7
   Miyazawa M, 2001, NAT PROD LETT, V15, P205, DOI 10.1080/10575630108041281
   Mossa A. T. H., 2016, Journal of Environmental Science and Technology, V9, P354
   Mostafiz MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208552
   Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150
   Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013
   Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982
   Opdyke D.L.J., 1974, FOOD COSMETICS TOXIC, V12, P521, DOI 10.1016/0015-6264(74)90068-6
   Padilha EC, 2016, J BRAZIL CHEM SOC, V27, P1636, DOI 10.5935/0103-5053.20160043
   Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2
   PAYNE MP, 1994, J CHEM INF COMP SCI, V34, P154, DOI 10.1021/ci00017a019
   Pereira ALE, 2018, J BIOMOL STRUCT DYN, V36, P318, DOI 10.1080/07391102.2016.1277163
   Perry MD, 2015, J PHYSIOL-LONDON, V593, P2575, DOI 10.1113/JP270095
   Costa IMP, 2016, EPIDEMIOL SERV SAUDE, V25, P735, DOI [10.5123/S1679-49742016000400007, 10.5123/s1679-49742016000400007]
   Pizova H, 2017, MOLECULES, V22, DOI 10.3390/molecules22111969
   Ponlawat A, 2013, SE ASIAN J TROP MED, V44, P167
   Rindings J.E, 1996, TOXICOLOGY, V106, P267, DOI DOI 10.1016/0300-483X(95)03190-Q
   dos Santos CBR, 2018, J ETHNOPHARMACOL, V222, P107, DOI 10.1016/j.jep.2018.04.041
   SANDERSON DM, 1991, HUM EXP TOXICOL, V10, P261, DOI 10.1177/096032719101000405
   Savelev S, 2003, PHARMACOL BIOCHEM BE, V75, P661, DOI 10.1016/S0091-3057(03)00125-4
   Schmidt RJ, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/ehp604, 10.1289/EHP604]
   Schrodinger, 2011, QIKPROP RAP ADME PRE
   Silva RC, 2019, J SERB CHEM SOC, V84, P153, DOI 10.2298/JSC180129047S
   Simoes M.O., 2003, FARMACOGNOSIA PLANTA
   Sullivan JJ, 2008, J PESTIC SCI, V33, P339, DOI 10.1584/jpestics.R08-02
   TAN EL, 1983, J TOXICOL ENV HEALTH, V11, P373, DOI 10.1080/15287398309530351
   Tan L., 2015, IEEE T POWER ELECTR, VPP, P1, DOI DOI 10.1155/2015/896314
   Testa B, 2005, CHEM BIODIVERS, V2, P872, DOI 10.1002/cbdv.200590064
   Timms BG, 2005, P NATL ACAD SCI USA, V102, P7014, DOI 10.1073/pnas.0502544102
   Vale Allister, 2015, Handb Clin Neurol, V131, P149, DOI 10.1016/B978-0-444-62627-1.00010-X
   Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019
   World Health Organization (WHO), 2009, WHO REC CLASS PEST H
   World Health Organizations, 2012, GLOB STRAT DENG PREV, V43
   Yamamoto J.E.C., 1999, NICOTINOID INSECTICI, P1
   Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2
   Yang YJ, 2014, RICE SCI, V21, P181, DOI 10.1016/S1672-6308(13)60181-X
   YASUDA Y, 1985, TERATOLOGY, V32, P219, DOI 10.1002/tera.1420320210
   Zimmerman H. J., 1999, HEPATOTOXICITY ADVER
NR 94
TC 6
Z9 6
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JAN 25
PY 2019
VL 12
IS 1
AR UNSP 20
DI 10.3390/ph12010020
PG 22
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HS8ZR
UT WOS:000464158100001
PM 30691028
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tai, WB
   Voronin, D
   Chen, JW
   Bao, WL
   Kessler, DA
   Shaz, B
   Jiang, SB
   Yazdanbakhsh, K
   Du, LY
AF Tai, Wanbo
   Voronin, Denis
   Chen, Jiawei
   Bao, Weili
   Kessler, Debra A.
   Shaz, Beth
   Jiang, Shibo
   Yazdanbakhsh, Karina
   Du, Lanying
TI Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to
   Broad Tissue Tropism With Severe Placental Damage and Fetal Demise
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; blood transmissibility; broad tissue tropism; placental
   infection; fetal demise
ID GUILLAIN-BARRE-SYNDROME; WEST-NILE-VIRUS; BLOOD-DONORS; VACCINE;
   REPLICATION; DISEASE; TRANSMISSION; PERSISTENCE; OUTBREAK; VIREMIA
AB Zika virus (ZIKV) infection during pregnancy can cause significant problems, particularly congenital Zika syndrome. Nevertheless, the potential deleterious consequences and associated mechanisms of transfusion-transmitted ZIKV infection on pregnant individuals and their fetuses and babies have not been investigated. Here we examined transmissibility of ZIKV through blood transfusion in ZIKV-susceptible pregnant A129 mice. Our data showed that transfused-transmitted ZIKV at the early infection stage led to significant viremia and broad tissue tropism in the pregnant recipient mice, which were not seen in those transfused with ZIKV-positive (ZIKV(+)) plasma at later infection stages. Importantly, pregnant mice transfused with early-stage, but not later stages, ZIKV(+) plasma also exhibited severe placental infection with vascular damage and apoptosis, fetal infection and fetal damage, accompanied by fetal and pup death. Overall, this study suggests that transfusion-related transmission of ZIKV during initial stage of infection, which harbors high plasma viral titers, can cause serious adverse complications in the pregnant recipients and their fetuses and babies.
C1 [Tai, Wanbo; Voronin, Denis; Chen, Jiawei; Bao, Weili; Kessler, Debra A.; Shaz, Beth; Jiang, Shibo; Yazdanbakhsh, Karina; Du, Lanying] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
   [Jiang, Shibo] Fudan Univ, MOE, MOH, Key Lab Med Mol Virol, Shanghai, Peoples R China.
RP Du, LY (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
EM ldu@nybc.org
RI Jiang, Shibo/L-4500-2014; Tai, Wanbo/G-3838-2018
OI Tai, Wanbo/0000-0002-9864-8993
FU New York Blood Center [NYB000552, NYB000475, NYB000486]
FX The ZIKV strain R103451 used in this study was obtained from BEI
   Resources. This work was supported by intramural funds of the New York
   Blood Center (NYB000552, NYB000475, and NYB000486).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Angelidou A, 2018, NEONATOLOGY, V113, P177, DOI 10.1159/000484656
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Benjamin RJ, 2017, BLOOD, V129, P144, DOI 10.1182/blood-2016-12-751925
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Bloch EM, 2018, NEW ENGL J MED, V378, P1837, DOI 10.1056/NEJMsb1704752
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Du LY, 2017, EXPERT REV VACCINES, V16, P951, DOI 10.1080/14760584.2017.1363648
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   Harrington T, 2003, TRANSFUSION, V43, P1018, DOI 10.1046/j.1537-2995.2003.00481.x
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   da Cruz LCH, 2018, AM J NEURORADIOL, V39, P1967, DOI 10.3174/ajnr.A5649
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Jiang SB, 2019, CELL MOL IMMUNOL, V16, P96, DOI 10.1038/s41423-018-0043-x
   Julander JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27611-x
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Magnus Mariana Munari, 2018, Hematol., Transfus. Cell Ther., V40, P250, DOI 10.1016/j.htct.2018.01.011
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savino W, 2017, GERONTOLOGY, V63, P210, DOI 10.1159/000453579
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Soncin F, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156273
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Turner LH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006684
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilder-Smith A, 2009, EMERG INFECT DIS, V15, P8, DOI 10.3201/eid1501.071097
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Willyard C, 2017, NATURE, V549, pS19, DOI 10.1038/549S19a
   Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159
   Wu SS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00227
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhou K, 2017, J NEUROVIROL, V23, P341, DOI 10.1007/s13365-017-0514-3
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 64
TC 8
Z9 8
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 23
PY 2019
VL 10
AR 29
DI 10.3389/fmicb.2019.00029
PG 14
WC Microbiology
SC Microbiology
GA HI5OC
UT WOS:000456502200001
PM 30728813
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Taguwa, S
   Yeh, MT
   Rainbolt, TK
   Nayak, A
   Shao, H
   Gestwicki, JE
   Andino, R
   Frydman, J
AF Taguwa, Shuhei
   Yeh, Ming-Te
   Rainbolt, T. Kelly
   Nayak, Arabinda
   Shao, Hao
   Gestwicki, Jason E.
   Andino, Raul
   Frydman, Judith
TI Zika Virus Dependence on Host Hsp70 Provides a Protective Strategy
   against Infection and Disease
SO CELL REPORTS
LA English
DT Article
ID DENGUE VIRUS; REPLICATION; PROTEIN; HSP90; IDENTIFICATION; INHIBITORS;
   BIOLOGY; GENOME
AB The spread of mosquito-borne Zika virus (ZIKV), which causes neurological disorders and microcephaly, highlights the need for countermeasures against sudden viral epidemics. Here, we tested the concept that drugs targeting host proteostasis provide effective antivirals. We show that different cytosolic Hsp70 isoforms are recruited to ZIKV-induced compartments and are required for virus replication at pre- and post-entry steps. Drugs targeting Hsp70 significantly reduce replication of different ZIKV strains in human and mosquito cells, including human neural stem cells and a placental trophoblast cell line, at doses without appreciable toxicity to the host cell. By targeting several ZIKV functions, including entry, establishment of active replication complexes, and capsid assembly, Hsp70 inhibitors are refractory to the emergence of drug-resistant virus. Importantly, these drugs protected mouse models from ZIKV infection, reducing viremia, mortality, and disease symptoms. Hsp70 inhibitors are thus attractive candidates for ZIKV therapeutics with the added benefit of a broad spectrum of action.
C1 [Taguwa, Shuhei; Rainbolt, T. Kelly; Frydman, Judith] Stanford Univ, Dept Biol & Genet, Stanford, CA 94305 USA.
   [Yeh, Ming-Te; Nayak, Arabinda; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.
   [Shao, Hao; Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.
RP Frydman, J (corresponding author), Stanford Univ, Dept Biol & Genet, Stanford, CA 94305 USA.
EM jfrydman@stanford.edu
OI Rainbolt, Thomas/0000-0002-5205-0523
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI127447, NS059690]; Naito
   FoundationNaito Memorial Foundation; Uehara Memorial FoundationUehara
   Memorial Foundation
FX We thank Drs. Yoshi Matsuura and Jan Carrette for generously sharing
   valuable plasmids and reagents, Drs. Satoshi Koike and Julie Pfeiffer
   for respectively generating and providing the Tg21/IFNR-KO mice, Drs.
   Scott Weaver and Robert Tesh for ZIKV strains, Dr. Len Neckers for
   advice on the animal drug treatments, and Yoko Nishimura and Gloria
   Presley for technical support. We thank the NIH (grant AI127447 to J.F.
   and grant NS059690 to J.E.G.) and the Naito Foundation and Uehara
   Memorial Foundation (fellowships to S.T.) for support.
CR Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Chavez-Salinas S, 2008, VIRUS RES, V138, P111, DOI 10.1016/j.virusres.2008.08.012
   De Clercq E, 1996, MED MICROBIOLOGY
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307
   Geller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056762
   Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007
   Gilfoy F, 2009, VIROLOGY, V385, P74, DOI 10.1016/j.virol.2008.11.034
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Goodwin EC, 2011, MBIO, V2, DOI 10.1128/mBio.00101-11
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Hafirassou ML, 2018, CELL REP, V22, P1364, DOI 10.1016/j.celrep.2018.01.038
   Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060
   Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005
   Inoue Y, 2011, VIROLOGY, V410, P38, DOI 10.1016/j.virol.2010.10.026
   Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li XK, 2016, CURR TOP MED CHEM, V16, P2729, DOI 10.2174/1568026616666160413140911
   Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n
   Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020
   Lindenbach B. D. R., 2007, FIELDS VIROLOGY, P712
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Maggioni C, 2005, CURR TOP MICROBIOL, V285, P175
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Moses MA, 2018, CANCER RES, V78, P4022, DOI 10.1158/0008-5472.CAN-17-3728
   Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692
   Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shao H, 2018, J MED CHEM, V61, P6163, DOI 10.1021/acs.jmedchem.8b00583
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Teoh PG, 2014, J VIROL, V88, P7998, DOI 10.1128/JVI.00940-14
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wright CM, 2009, VIRUS RES, V141, P71, DOI 10.1016/j.virusres.2008.12.018
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075188
   Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4
NR 64
TC 10
Z9 10
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JAN 22
PY 2019
VL 26
IS 4
BP 906
EP +
DI 10.1016/j.celrep.2018.12.095
PG 18
WC Cell Biology
SC Cell Biology
GA HI3GF
UT WOS:000456335100010
PM 30673613
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Zhuang, XD
   Magri, A
   Hill, M
   Lai, AG
   Kumar, A
   Rambhatla, SB
   Donald, CL
   Lopez-Clavijo, AF
   Rudge, S
   Pinnick, K
   Chang, WH
   Wing, PAC
   Brown, R
   Qin, XM
   Simmonds, P
   Baumert, TF
   Ray, D
   Loudon, A
   Balfe, P
   Wakelam, M
   Butterworth, S
   Kohl, A
   Jopling, CL
   Zitzmann, N
   McKeating, JA
AF Zhuang, Xiaodong
   Magri, Andrea
   Hill, Michelle
   Lai, Alvina G.
   Kumar, Abhinav
   Rambhatla, Srinivasa Bhargav
   Donald, Claire L.
   Lopez-Clavijo, Andrea F.
   Rudge, Simon
   Pinnick, Katherine
   Chang, Wai Hoong
   Wing, Peter A. C.
   Brown, Ryan
   Qin, Ximing
   Simmonds, Peter
   Baumert, Thomas F.
   Ray, David
   Loudon, Andrew
   Balfe, Peter
   Wakelam, Michael
   Butterworth, Sam
   Kohl, Alain
   Jopling, Catherine L.
   Zitzmann, Nicole
   McKeating, Jane A.
TI The circadian clock components BMAL1 and REV-ERB alpha regulate
   flavivirus replication
SO NATURE COMMUNICATIONS
LA English
DT Article
ID VIRUS-RNA REPLICATION; CELL-LINES; METABOLISM; INFECTION; ENTRY;
   INHIBITORS; REPLICONS; IMMUNITY; BEHAVIOR; MIR-122
AB The circadian clock regulates immune responses to microbes and affects pathogen replication, but the underlying molecular mechanisms are not well understood. Here we demonstrate that the circadian components BMAL1 and REV-ERB alpha influence several steps in the hepatitis C virus (HCV) life cycle, including particle entry into hepatocytes and RNA genome replication. Genetic knock out of Bmal1 and over-expression or activation of REV-ERB with synthetic agonists inhibits the replication of HCV and the related flaviruses dengue and Zika via perturbation of lipid signaling pathways. This study highlights a role for the circadian clock component REV-ERB alpha in regulating flavivirus replication.
C1 [Zhuang, Xiaodong; Magri, Andrea; Lai, Alvina G.; Chang, Wai Hoong; Wing, Peter A. C.; Simmonds, Peter; McKeating, Jane A.] Univ Oxford, Nuffield Dept Med, Oxford OX3 7FZ, England.
   [Hill, Michelle; Kumar, Abhinav; Zitzmann, Nicole] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England.
   [Rambhatla, Srinivasa Bhargav; Balfe, Peter] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England.
   [Donald, Claire L.; Kohl, Alain] Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Lopez-Clavijo, Andrea F.; Rudge, Simon; Wakelam, Michael] Babraham Inst, Cambridge CB22 3AT, England.
   [Pinnick, Katherine] Univ Oxford, Oxford Ctr Diabet Endocrinol Metab, Oxford OX3 9DU, England.
   [Brown, Ryan] Univ Birmingham, Dept Chem, Birmingham B15 2TT, W Midlands, England.
   [Qin, Ximing] Anhui Univ, Inst Phys Sci, Hefei 230601, Anhui, Peoples R China.
   [Qin, Ximing] Anhui Univ, Inst Informat Technol, Hefei 230601, Anhui, Peoples R China.
   [Baumert, Thomas F.] INSERM, U1110, Inst Rech Malad Virales & Hepat, F-67000 Strasbourg, France.
   [Ray, David; Loudon, Andrew] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England.
   [Butterworth, Sam] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Hlth Sci, Div Pharm & Optometry, Manchester M13 9NT, Lancs, England.
   [Jopling, Catherine L.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
RP McKeating, JA (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford OX3 7FZ, England.
EM jane.mckeating@ndm.ox.ac.uk
RI Donald, Claire/AAC-7556-2019; Pinnick, Katherine/B-7209-2012; Lai,
   Alvina/T-6851-2019
OI Donald, Claire/0000-0002-4370-0707; Pinnick,
   Katherine/0000-0002-2422-248X; Loudon, Andrew/0000-0003-3648-445X; Lai,
   Alvina/0000-0001-8960-8095; Simmonds, Peter/0000-0002-7964-4700;
   Butterworth, Sam/0000-0002-6549-3753; Zhuang,
   Xiaodong/0000-0002-6870-9003; McKeating, Jane/0000-0002-7229-5886;
   Wakelam, Michael/0000-0003-4059-9276; Wing, Peter A
   C/0000-0002-2354-3281; Ray, David/0000-0002-4739-6773
FU EU 2020 Research and Innovation Programme Consortia HEP-CAR [667273];
   Wellcome TrustWellcome Trust [IA 200838/Z/16/Z]; UK MRCMedical Research
   Council UK (MRC) [MC-UU-12014, MR/N017552/1]; Oxford Glyco-biology
   Endowment; BBSRCBiotechnology and Biological Sciences Research Council
   (BBSRC) [BB/PO13384/1]; EU2020 HEP-CAR grant
FX We would like to thank Koichi Watashi (National Institute of Infectious
   Diseases, Tokyo, Japan) for sharing their SCD promoter construct;
   Charles Rice (Rockefeller University, US) for HCV WT and m15 viruses and
   miR122 KO Huh-7 cells; Andrew Davidson (University of Bristol, UK) for
   DENV reporter replicon; Stuart Ray (Johns Hopkins University, US) for
   HCV E1E2 expression vectors; E. Gould (Centre for Ecology and Hydrology,
   Oxford, UK) for DENV2 strain 1668; Rick Randall (University of St
   Andrews, UK) for the A549/BVDV-Npro cell line and Benedetto Grimaldi for
   lenti-shRev-erba construct (Department of Drug Discovery and
   Development, Genoa, Italy). We acknowledge technical assistance of Jiaqi
   Chen, Greg West, Aimee L. Parsons and Claudia Orbegozo Rubio. Work in
   the J.A.M. laboratory is funded by: EU 2020 Research and Innovation
   Programme Consortia HEP-CAR under grant agreement No. 667273 and
   Wellcome Trust IA 200838/Z/16/Z. A.K. was funded by the UK MRC
   (MC-UU-12014, MR/N017552/1). Work by M.H., A.K. and N.Z. are supported
   by the Oxford Glyco-biology Endowment. D.R. and A. L. are Wellcome Trust
   investigators 107849/Z/15/Z. M.W. lab is supported by the EU2020 HEP-CAR
   grant and by the BBSRC (BB/PO13384/1).
CR Bartenschlager R, 2018, VIRUS RES, V248, P53, DOI 10.1016/j.virusres.2018.02.016
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10
   Burdge GC, 2000, BRIT J NUTR, V84, P781
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048
   Collins JM, 2010, J BIOL CHEM, V285, P6044, DOI 10.1074/jbc.M109.053280
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Douam Florian, 2016, F1000Res, V5, DOI 10.12688/f1000research.7354.1
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011
   Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035
   Edgar RS, 2016, P NATL ACAD SCI USA, V113, P10085, DOI 10.1073/pnas.1601895113
   Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005
   Everett LJ, 2014, TRENDS ENDOCRIN MET, V25, P586, DOI 10.1016/j.tem.2014.06.011
   Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009
   Grove Joe, 2017, Wellcome Open Res, V2, P82, DOI 10.12688/wellcomeopenres.12058.1
   Gullberg RC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007261
   Hartler J, 2017, NAT METHODS, V14, P1171, DOI [10.1038/NMETH.4470, 10.1038/nmeth.4470]
   He J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003701
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100
   Janich P, 2015, GENOME RES, V25, P1848, DOI 10.1101/gr.195404.115
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339
   Kulkarni MM, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0368-z
   Laue T, 1999, J CLIN MICROBIOL, V37, P2543, DOI 10.1128/JCM.37.8.2543-2547.1999
   Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181
   Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003
   Long JE, 2016, VACCINE, V34, P2679, DOI 10.1016/j.vaccine.2016.04.032
   Luna JM, 2015, CELL, V160, P1099, DOI 10.1016/j.cell.2015.02.025
   Lyn RK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04549
   Magri A, 2017, LIVER INT, V37, P669, DOI 10.1111/liv.13303
   Magri A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29487
   Majumdar T, 2017, INNATE IMMUN-LONDON, V23, P147, DOI 10.1177/1753425916681075
   Man K, 2016, SCIENCE, V354, P999, DOI 10.1126/science.aah4966
   Masse N, 2010, ANTIVIR RES, V86, P296, DOI 10.1016/j.antiviral.2010.03.010
   Meredith LW, 2013, J HEPATOL, V58, P1074, DOI 10.1016/j.jhep.2013.01.019
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Du NH, 2014, ELIFE, V3, DOI 10.7554/eLife.02510
   Nio Y, 2016, ANTIVIR RES, V132, P262, DOI 10.1016/j.antiviral.2016.07.003
   Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165
   Ohol YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144648
   Pariollaud M, 2018, J CLIN INVEST, V128, P2281, DOI 10.1172/JCI93910
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008
   Ramakrishnan Sathiya N, 2006, Nucl Recept Signal, V4, pe009
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Ringehan M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0274
   Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386
   Shi YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21894-w
   Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017
   Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   Timpe JM, 2008, GUT, V57, P1728, DOI 10.1136/gut.2007.141630
   Trump RP, 2013, J MED CHEM, V56, P4729, DOI 10.1021/jm400458q
   Witteveldt J, 2016, ANTIMICROB AGENTS CH, V60, P2981, DOI 10.1128/AAC.02932-15
   Wu YL, 2017, CELL METAB, V25, P73, DOI 10.1016/j.cmet.2016.09.009
   Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179
   Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021
   Zhuang Xiaodong, 2018, Wellcome Open Res, V3, P96, DOI [10.12688/wellcomeopenres.14696.1, 10.12688/wellcomeopenres.14696.2]
   Zhuang XD, 2017, J MOL MED, V95, P1283, DOI 10.1007/s00109-017-1592-7
NR 65
TC 8
Z9 8
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 22
PY 2019
VL 10
AR 377
DI 10.1038/s41467-019-08299-7
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HI2PE
UT WOS:000456286400005
PM 30670689
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Nurtop, E
   Villarroel, PMS
   Pastorino, B
   Ninove, L
   Drexler, JF
   Roca, Y
   Gake, B
   Dubot-Peres, A
   Grard, G
   Peyrefitte, C
   Priet, S
   de Lamballerie, X
   Gallian, P
AF Nurtop, Elif
   Villarroel, Paola Mariela Saba
   Pastorino, Boris
   Ninove, Laetitia
   Drexler, Jan Felix
   Roca, Yelin
   Gake, Bouba
   Dubot-Peres, Audrey
   Grard, Gilda
   Peyrefitte, Christophe
   Priet, Stephane
   de Lamballerie, Xavier
   Gallian, Pierre
TI Combination of ELISA screening and seroneutralisation tests to expedite
   Zika virus seroprevalence studies (vol 15, 192, 2018)
SO VIROLOGY JOURNAL
LA English
DT Correction
AB In the original publication of this article [1], Table 1 has some errors.
C1 [Nurtop, Elif; Villarroel, Paola Mariela Saba; Pastorino, Boris; Ninove, Laetitia; Gake, Bouba; Dubot-Peres, Audrey; Grard, Gilda; Peyrefitte, Christophe; Priet, Stephane; de Lamballerie, Xavier; Gallian, Pierre] Aix Marseille Univ, Unite Virus Emergents, IRD 190, IHU Mediterranee Infect,Inserm 1207, Marseille, France.
   [Villarroel, Paola Mariela Saba; Roca, Yelin] Ctr Nacl Enfermedades Trop CENETROP, Virol 2, Santa Cruz, Bolivia.
   [Drexler, Jan Felix] Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
   [Gake, Bouba] Ctr Pasteur Cameroun, Yaounde, Cameroon.
   [Grard, Gilda; Peyrefitte, Christophe] French Armed Forces Biomed Res Inst, Natl Reference Ctr Arboviruses, Marseille, France.
   [Gallian, Pierre] Etab Francais Sang Alpes Mediterranee EFS, Lab Virol, Marseille, France.
RP Nurtop, E (corresponding author), Aix Marseille Univ, Unite Virus Emergents, IRD 190, IHU Mediterranee Infect,Inserm 1207, Marseille, France.
EM enurtop@gmail.com
OI pastorino, boris/0000-0001-5233-5193
CR Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5
NR 1
TC 1
Z9 1
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JAN 18
PY 2019
VL 16
DI 10.1186/s12985-019-1118-8
PG 1
WC Virology
SC Virology
GA HH9XG
UT WOS:000456094100001
PM 30654811
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Caine, EA
   Scheaffer, SM
   Arora, N
   Zaitsev, K
   Artyomov, MN
   Coyne, CB
   Moley, KH
   Diamond, MS
AF Caine, Elizabeth A.
   Scheaffer, Suzanne M.
   Arora, Nitin
   Zaitsev, Konstantin
   Artyomov, Maxim N.
   Coyne, Carolyn B.
   Moley, Kelle H.
   Diamond, Michael S.
TI Interferon lambda protects the female reproductive tract against Zika
   virus infection
SO NATURE COMMUNICATIONS
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; IFN-LAMBDA; MOUSE MODEL; PLACENTAL PATHOLOGY;
   ANTIVIRAL ACTIVITY; VIRAL-INFECTION; SUSCEPTIBILITY; PROLIFERATION;
   PROGESTERONE; INOCULATION
AB Although Zika virus (ZIKV) can be transmitted sexually and cause congenital birth defects, immune control mechanisms in the female reproductive tract (FRT) are not well characterized. Here we show that treatment of primary human vaginal and cervical epithelial cells with interferon (IFN)-alpha/beta or IFN-lambda induces host defense transcriptional signatures and inhibits ZIKV infection. We also assess the effects of IFNs on intravaginal infection of the FRT using ovariectomized mice treated with reproductive hormones. We find that mice receiving estradiol are protected against intravaginal ZIKV infection, independently of IFN-alpha/beta or IFN-lambda signaling. In contrast, mice lacking IFN-lambda signaling sustain greater FRT infection when pro-gesterone is administered. Exogenous IFN-lambda treatment confers an antiviral effect when mice receive both estradiol and progesterone, but not progesterone alone. Our results identify a hormonal stage-dependent role for IFN-lambda in controlling ZIKV infection in the FRT and suggest a path for minimizing sexual transmission of ZIKV in women.
C1 [Caine, Elizabeth A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Scheaffer, Suzanne M.; Moley, Kelle H.] Washington Univ, Sch Med, Obstet & Gynecol, St Louis, MO 63110 USA.
   [Arora, Nitin; Coyne, Carolyn B.] Univ Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA 15224 USA.
   [Arora, Nitin; Coyne, Carolyn B.] Univ Pittsburgh, Childrens Hosp, Sch Med, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
   [Zaitsev, Konstantin; Artyomov, Maxim N.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Zaitsev, Konstantin] ITMO Univ, Comp Technol Dept, St Petersburg 197101, Russia.
   [Artyomov, Maxim N.; Diamond, Michael S.] Washington Univ, Andrew M & Jane M Bursky Ctr Human Immunol Progra, Sch Med, St Louis, MO 63110 USA.
   [Artyomov, Maxim N.; Diamond, Michael S.] Washington Univ, Andrew M & Jane M Bursky Ctr Immunotherapy Progra, Sch Med, St Louis, MO 63110 USA.
   [Moley, Kelle H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Arora, Nitin] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35233 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Moley, KH (corresponding author), Washington Univ, Sch Med, Obstet & Gynecol, St Louis, MO 63110 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA 15224 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Childrens Hosp, Sch Med, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Andrew M & Jane M Bursky Ctr Human Immunol Progra, Sch Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Andrew M & Jane M Bursky Ctr Immunotherapy Progra, Sch Med, St Louis, MO 63110 USA.; Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
EM coynec2@pitt.edu; moleyk@wustl.edu; diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Arora, Nitin/0000-0001-6840-4333;
   Zaitsev, Konstantin/0000-0003-3749-0886
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI127828, R01
   HD091218, T32AI055397, R01 AI081759, HD075665, R01 HD083895]; Burroughs
   Wellcome Investigators in the Pathogenesis of Infectious Disease
   AwardBurroughs Wellcome Fund; Children's Hospital of Pittsburgh of the
   UPMC Health System; Government of the Russian Federation [08-08]
FX This work was supported by grants from the NIH (R01 AI073755, R01
   AI127828, and R01 HD091218 to M.S.D; T32AI055397 to E.C.; R01 AI081759
   and HD075665 to C.B.C.; and R01 HD083895 to K.H.M.). In addition, work
   was supported by a Burroughs Wellcome Investigators in the Pathogenesis
   of Infectious Disease Award (C.B.C) and the Children's Hospital of
   Pittsburgh of the UPMC Health System (C.B.C. and N.A.) K.Z. was
   supported by the Government of the Russian Federation (Grant 08-08). We
   thank Haina Shin for experimental advice and Sean Doyle (Zymogenetics, a
   Bristol-Myers Squibb company) for providing the Ifnlr1<SUP>-/-</SUP>
   mice and pegylated IFN-lambda 2.
CR Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006
   Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474
   Baldridge MT, 2017, J VIROL, V91, DOI 10.1128/JVI.02079-16
   Banos-Lara MD, 2015, J VIROL, V89, P730, DOI 10.1128/JVI.02897-14
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321
   Gillgrass AE, 2005, J VIROL, V79, P3107, DOI 10.1128/JVI.79.5.3107-3116.2005
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hemann EA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01707
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382
   Katz HI, 1999, J AM ACAD DERMATOL, V41, pS7, DOI 10.1016/S0190-9622(99)70359-2
   Kaushic C, 2000, INFECT IMMUN, V68, P4207, DOI 10.1128/IAI.68.7.4207-4216.2000
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Patton DL, 2000, AM J OBSTET GYNECOL, V183, P967, DOI 10.1067/mob.2000.108857
   Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Schaefer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114824
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Smith SM, 2000, J INFECT DIS, V182, P708, DOI 10.1086/315776
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
   Stifter SA, 2018, J BIOL CHEM, V293, P3168, DOI 10.1074/jbc.M117.800755
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   TEEPE AG, 1990, ANTIVIR RES, V14, P227, DOI 10.1016/0166-3542(90)90004-Q
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang YZ, 2015, J INTERF CYTOK RES, V35, P213, DOI 10.1089/jir.2014.0064
   Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 60
TC 18
Z9 18
U1 1
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 17
PY 2019
VL 10
AR 280
DI 10.1038/s41467-018-07993-2
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH8AP
UT WOS:000455953900006
PM 30655513
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pujhari, S
   Brustolin, M
   Macias, VM
   Nissly, RH
   Nomura, M
   Kuchipudi, SV
   Rasgon, JL
AF Pujhari, Sujit
   Brustolin, Marco
   Macias, Vanessa M.
   Nissly, Ruth H.
   Nomura, Masashi
   Kuchipudi, Suresh V.
   Rasgon, Jason L.
TI Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication,
   and egress from host cells
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Arbovirus; receptor; mosquito-borne; heat shock
ID DENGUE-VIRUS; STRESS; PROTEINS; RECEPTOR; MEMBRANE; EPIDEMIC; COMPLEX;
   ROUTES; FORM
AB Zika virus (ZIKV) is a historically neglected mosquito-borne flavivirus that has caused recent epidemics in the western hemisphere. ZIKV has been associated with severe symptoms including infant microcephaly and Guillain-Barre syndrome, stimulating interest in understanding factors governing ZIKV infection. Heat shock protein 70 (Hsp70) has been shown to be an infection factor for multiple viruses, leading us to investigate the role of Hsp70 in the ZIKV infection process. ZIKV infection induced Hsp70 expression in host cells 48-h post-infection. Inducing Hsp70 expression in mammalian cells increased ZIKV production, whereas inhibiting Hsp70 activity reduced ZIKV viral RNA production and virion release from the cell. Hsp70 was localized both on the cell surface where it could interact with ZIKV during the initial stages of the infection process, and intracellularly where it localized with viral RNA. Blocking cell surface-localized Hsp70 using antibodies decreased ZIKV cell infection rates and production of infectious virus particles, as did competition with recombinant Hsp70 protein. Overall, Hsp70 was found to play a functional role in both the pre- and post-ZIKV infection processes affecting viral entry, replication, and egress. Understanding the interactions between Hsp70 and ZIKV may lead to novel therapeutics for ZIKV infection.
C1 [Pujhari, Sujit; Brustolin, Marco; Macias, Vanessa M.; Nomura, Masashi; Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.
   [Pujhari, Sujit; Brustolin, Marco; Macias, Vanessa M.; Nomura, Masashi; Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.
   [Nissly, Ruth H.; Kuchipudi, Suresh V.] Penn State Univ, Dept Vet & Biomed Sci, Anim Diagnost Lab, University Pk, PA 16802 USA.
   [Nomura, Masashi] Chiba Univ, Grad Sch Hort, Chiba, Japan.
RP Rasgon, JL (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.; Rasgon, JL (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.
EM jlr54@psu.edu
OI Brustolin, Marco/0000-0002-3594-4488; Macias,
   Vanessa/0000-0002-8008-7403
FU Penn State Huck Institutes of the Life Sciences; NIH/National Institute
   of Allergy and Infectious Diseases (NIAID)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI128918, R01AI116636, R01AI128201]
FX This study was supported by funds from the Penn State Huck Institutes of
   the Life Sciences and NIH/National Institute of Allergy and Infectious
   Diseases (NIAID) grants R21AI128918, R01AI116636, and R01AI128201 to
   JLR.
CR Baquero-Perez B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005274
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broquet AH, 2007, J VIROL, V81, P1297, DOI 10.1128/JVI.01336-06
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323
   Chong KY, 1998, J MOL CELL CARDIOL, V30, P599, DOI 10.1006/jmcc.1997.0623
   Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679
   Crunkhorn S., 2016, NAT REV DRUG DISCOV, V15, P18
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heldens L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023512
   Hinners I, 1999, ANAL BIOCHEM, V276, P1, DOI 10.1006/abio.1999.4325
   Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Howe MK, 2016, ANTIVIR RES, V130, P81, DOI 10.1016/j.antiviral.2016.03.017
   Iordanskiy S, 2004, J VIROL, V78, P9697, DOI 10.1128/JVI.78.18.9697-9704.2004
   Kurucz I, 1999, CELL STRESS CHAPERON, V4, P139
   Lahaye X, 2012, J VIROL, V86, P4743, DOI 10.1128/JVI.06501-11
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546
   Li YH, 2004, ANTIMICROB AGENTS CH, V48, P867, DOI 10.1128/AAC.48.3.867-872.2004
   Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Padwad YS, 2010, VIRAL IMMUNOL, V23, P557, DOI 10.1089/vim.2010.0052
   Paiva CN, 2014, ANTIOXID REDOX SIGN, V20, P1000, DOI 10.1089/ars.2013.5447
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413
   Surtees R, 2016, J VIROL, V90, P9305, DOI 10.1128/JVI.00661-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Takashima K, 2018, J INNATE IMMUN, V10, P44, DOI 10.1159/000480740
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299
   Walters RW, 2015, TRENDS BIOCHEM SCI, V40, P552, DOI 10.1016/j.tibs.2015.08.004
   Walters RW, 2015, RNA, V21, P1660, DOI 10.1261/rna.053116.115
   Watanabe Y, 2017, AUTOPHAGY, V13, P133, DOI 10.1080/15548627.2016.1248018
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
NR 49
TC 3
Z9 3
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 16
PY 2019
VL 8
IS 1
BP 8
EP 16
DI 10.1080/22221751.2018.1557988
PG 9
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HH5ZK
UT WOS:000455807500002
PM 30866755
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Watanabe, S
   Tan, NWW
   Chan, KWK
   Vasudevan, SG
AF Watanabe, Satoru
   Tan, Nicole Wei Wen
   Chan, Kitti Wing Ki
   Vasudevan, Subhash G.
TI Dengue Virus and Zika Virus Serological Cross-reactivity and Their
   Impact on Pathogenesis in Mice
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Dengue virus; Zika virus; antibody-dependent enhancement; serological
   cross-reactivity; vaccine design
ID ANTIBODY-DEPENDENT ENHANCEMENT; CD8(+) T-CELLS; INFECTION; PROTECTION;
   MODELS
AB Preexisting immunity to Zika virus (ZIKV) or dengue virus (DENV) may alter the course of their infection, and here we use robust mouse models to examine pathological outcomes following passive immunization, sequential cross-infection, or vaccination with inactivated virus. DENV infection was enhanced (through antibody-dependent enhancement [ADE]) or was suppressed by both DENV and ZIKV immunity. Notably, inactivated ZIKV vaccination enhanced dengue disease severity, although it was highly protective against ZIKV infection. On the other hand, ADE was not observed upon ZIKV infection in mice that were passively immunized or preinfected with DENV. Surprisingly, however, we found that vaccination with inactivated DENV enhanced ZIKV infection, mainly in the mesenteric lymph node, indicating the potential for DENV immunity to cause ADE in vivo. Collectively, our data call for greater attention to detail in the design of ZIKV or DENV vaccines.
C1 [Watanabe, Satoru; Tan, Nicole Wei Wen; Chan, Kitti Wing Ki; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
RP Watanabe, S (corresponding author), DUKE NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
EM satoru.watanabe@duke-nus.edu.sg
OI Vasudevan, Subhash/0000-0002-5083-3831
FU National Medical Research CouncilMedical Research Council UK (MRC)
   [0003/2016, 0103/2016]
FX This work was supported by the National Medical Research Council (Open
   Fund Young Individual Research Grant 0003/2016 to S. W. and Cooperative
   Basic Research Grant/0103/2016 to S. G. V.).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Chacko AM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93474
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diaz C, 2018, AM J TROP MED HYG, V98, P1435, DOI 10.4269/ajtmh.17-0627
   Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gubler DJ, 2006, NOVART FDN SYMP, V277, P22
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783
   Marzi A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00117
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Schmidt AC, 2017, AM J TROP MED HYG, V96, P1325, DOI 10.4269/ajtmh.16-0634
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Watanabe S, 2015, J VIROL, V89, P5847, DOI 10.1128/JVI.00216-15
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 42
TC 8
Z9 8
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JAN 15
PY 2019
VL 219
IS 2
BP 223
EP 233
DI 10.1093/infdis/jiy482
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HN8WB
UT WOS:000460476700008
PM 30085051
DA 2020-07-08
ER

PT J
AU Hengphasatporn, K
   Kungwan, N
   Rungrotmongkol, T
AF Hengphasatporn, Kowit
   Kungwan, Nawee
   Rungrotmongkol, Thanyada
TI Binding pattern and susceptibility of epigallocatechin gallate against
   envelope protein homodimer of Zika virus: A molecular dynamics study
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE EGCG; Zika E protein; Molecular docking; Molecular dynamics simulation;
   Principal component analysis
ID INHIBITS ZIKA; DOCKING; DENGUE; TRANSMISSION; POLYMERASE; PREDICTION;
   STABILITY; INFECTION; DOMAIN; GBSA
AB Zika virus (ZIKV) has caused an infant neurologic disorder, microcephaly, leading to a global health problem. Until now, no antiviral drug against ZIKV is commercially available. The recent studies reported that epigallocatechin gallate (EGCG) was found as a potential agent inhibiting the ZIKV entry process in Vero E6 cell. A pH-induced conformational change of the viral envelope (E) protein is a key step in such process. Herein, we focused on how EGCG could inhibit the dimeric E protein at the three possible binding sites at acidic pH condition by all-atom molecular dynamics (MD) simulations for 500 ns. The three EGCG binding sites on dimeric E protein are (i) the hinge region between domains I and III; (ii) the conserved region among flaviviruses; and (iii) the dimer interface. As a result, the binding pattern of EGCG in each pocket was presented in the mode of action of inhibition. The ligand-protein binding interactions, protein motions and binding free energies indicated that EGCG favorably interacted with the conserved region greater than the hinge region and the dimer interface, respectively. The obtained results via 4 different end-point free energy calculation methods suggested how this compound binds and prevents the rearrangement in the E protein at low pH. (C) 2018 Published by Elsevier B.V.
C1 [Hengphasatporn, Kowit; Rungrotmongkol, Thanyada] Chulalongkorn Univ, Grad Sch, PhD Program Bioinformat & Computat Biol, Bangkok 10330, Thailand.
   [Kungwan, Nawee] Chiang Mai Univ, Dept Chem, Fac Sci, Chiang Mai 50200, Thailand.
   [Kungwan, Nawee] Chiang Mai Univ, Res Ctr Chem Dev Hlth Promoting Prod Northern Res, Chiang Mai 50200, Thailand.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Dept Biochem, Struct & Computat Biol Res Grp, Fac Sci, Bangkok 10330, Thailand.
RP Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Grad Sch, PhD Program Bioinformat & Computat Biol, Bangkok 10330, Thailand.; Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Dept Biochem, Struct & Computat Biol Res Grp, Fac Sci, Bangkok 10330, Thailand.
EM thanyada.r@chula.ac.th
FU Asia Research Center fund, Chulalongkorn University (CU); 90th
   Anniversary of CU (Rachadaphiseksomphot Endowment Fund); Overseas
   Presentations of Graduate Level Academic Thesis from Graduate School of
   CU; Research Center on Chemistry for Development of Health Promoting
   Products from Northern Resources, Chiang Mai University
FX This research was supported by Asia Research Center fund, Chulalongkorn
   University (CU). K.H. received the Scholarship from the 90th Anniversary
   of CU (Rachadaphiseksomphot Endowment Fund), and the Overseas
   Presentations of Graduate Level Academic Thesis from Graduate School of
   CU. N.K. thanks Research Center on Chemistry for Development of Health
   Promoting Products from Northern Resources, Chiang Mai University for
   financial support. We also thank the Structural and Computational
   Biology Research Group, Special Task Force for Activating Research
   (STAR), Faculty of Science, CU, and the Research Chair Grant, the
   National Science and Technology Development Agency (NSTDA), Thailand,
   The Center of Excellence Computational Chemistry is acknowledged for
   facility and computing resources.
CR [Anonymous], 2017, MARVINSKETCH VERS 17
   Azar AT, 2013, COMPUT METH PROG BIO, V111, P1, DOI 10.1016/j.cmpb.2013.01.002
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Csizmadia F, 1997, J PHARM SCI-US, V86, P865, DOI 10.1021/js960177k
   Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dassault Systemes BIOVIA, 2016, DISC STUD MOD ENV RE
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIXON SL, 1993, J COMPUT CHEM, V14, P1460, DOI 10.1002/jcc.540141208
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fuzo CA, 2013, J MOL MODEL, V19, P1369, DOI 10.1007/s00894-012-1687-6
   Fuzo CA, 2014, J BIOMOL STRUCT DYN, V32, P1563, DOI 10.1080/07391102.2013.827132
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830
   Ismail N.A., 2016, INTERDISCIP SCI, P1
   Kaiyawet N, 2013, J CHEM INF MODEL, V53, P1315, DOI 10.1021/ci400131y
   Khuntawee W, 2012, J CHEM INF MODEL, V52, P76, DOI 10.1021/ci200304v
   Kongkaew S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135575
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahalapbutr P, 2017, J MOL LIQ, V247, P374, DOI 10.1016/j.molliq.2017.10.021
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marchette N.J., 1969, AM J TROP MED HYG, V18, P5
   Meeprasert A, 2014, J CHEM INF MODEL, V54, P1208, DOI 10.1021/ci400605a
   Meeprasert A, 2012, J MOL GRAPH MODEL, V38, P148, DOI 10.1016/j.jmgm.2012.06.007
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mishra SK, 2018, J PHYS CHEM B, V122, P8113, DOI 10.1021/acs.jpcb.8b03655
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nutho B, 2017, J BIOMOL STRUCT DYN, V35, P1743, DOI 10.1080/07391102.2016.1193444
   Nutho B, 2014, BEILSTEIN J ORG CHEM, V10, P2789, DOI 10.3762/bjoc.10.296
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sangpheak W, 2014, J MOL GRAPH MODEL, V50, P10, DOI 10.1016/j.jmgm.2014.03.001
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875
   Soares ROS, 2013, BBA-PROTEINS PROTEOM, V1834, P221, DOI 10.1016/j.bbapap.2012.09.007
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun JX, 2017, J MOL GRAPH MODEL, V74, P203, DOI 10.1016/j.jmgm.2017.04.009
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Tripathi S., 2018, APPROACHES CLUSTERIN, V7, P802
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Virtanen SI, 2015, J MOL GRAPH MODEL, V62, P303, DOI 10.1016/j.jmgm.2015.10.012
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wichapong K, 2014, J CHEM INF MODEL, V54, P881, DOI 10.1021/ci4007326
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306
   Yennamalli R, 2009, J COMPUT AID MOL DES, V23, P333, DOI 10.1007/s10822-009-9263-6
NR 61
TC 3
Z9 3
U1 3
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
EI 1873-3166
J9 J MOL LIQ
JI J. Mol. Liq.
PD JAN 15
PY 2019
VL 274
BP 140
EP 147
DI 10.1016/j.molliq.2018.10.111
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA HK1JB
UT WOS:000457660000015
DA 2020-07-08
ER

PT J
AU Roman, GC
   Anaya, JM
   Mancera-Paez, O
   Pardo-Turriago, R
   Rodriguez, Y
AF Roman, Gustavo C.
   Anaya, Juan-Manuel
   Mancera-Paez, Oscar
   Pardo-Turriago, Rodrigo
   Rodriguez, Yohan
TI Concurrent Guillain-Barre syndrome, transverse myelitis and encephalitis
   post-Zika: A case report and review of the pathogenic role of multiple
   arboviral immunity
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
C1 [Roman, Gustavo C.] Houston Methodist Hosp, Houston Neurol Inst, Dept Neurol, Houston, TX 77030 USA.
   [Roman, Gustavo C.] Cornell Univ, Weill Cornell Coll Med, New York, NY 10021 USA.
   [Anaya, Juan-Manuel; Rodriguez, Yohan] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.
   [Mancera-Paez, Oscar; Pardo-Turriago, Rodrigo] Univ Nacl Colombia, Hosp Univ Nacl, Dept Neurol, Fac Med, Bogota, Colombia.
RP Roman, GC (corresponding author), Houston Methodist Hosp, Houston Neurol Inst, Dept Neurol, Houston, TX 77030 USA.; Roman, GC (corresponding author), Cornell Univ, Weill Cornell Coll Med, New York, NY 10021 USA.
EM gcroman@houstonmethodist.org; juan.anaya@urosario.edu.co;
   ogmancerap@unal.edu.co; rpardot@unal.edu.co
RI Anaya, Juan-Manuel/J-1960-2016
OI Anaya, Juan-Manuel/0000-0002-6444-1249; Pardo Turriago,
   Rodrigo/0000-0001-7411-5853
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Joob B, 2018, ARQ NEURO-PSIQUIAT, V76, P63, DOI 10.1590/0004-282X20170173
   Mancera-Paez O, 2018, J NEUROL SCI, V395, P47, DOI 10.1016/j.jns.2018.09.028
   Suwanmanee S, 2018, ACTA TROP, V188, P244, DOI 10.1016/j.actatropica.2018.09.012
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Thahir-Silva Shehana, 2018, Infez Med, V26, P178
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
NR 8
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD JAN 15
PY 2019
VL 396
BP 84
EP 85
DI 10.1016/j.jns.2018.10.032
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HI7MA
UT WOS:000456639100016
PM 30423542
OA Green Published
DA 2020-07-08
ER

PT J
AU McLean, BJ
   Dainty, KR
   Flores, HA
   O'Neill, SL
AF McLean, Breeanna J.
   Dainty, Kimberley R.
   Flores, Heather A.
   O'Neill, Scott L.
TI Differential suppression of persistent insect specific viruses in
   trans-infected wMel and wMelPop-CLA Aedes-derived mosquito lines
SO VIROLOGY
LA English
DT Article
DE Wolbachia; Flavivirus; Bunyavirus; Insect specific viruses; Mosquito
   cell lines
ID WEST NILE VIRUS; FUSING AGENT VIRUS; FLAVIVIRUS INFECTION; CELL-LINE;
   WOLBACHIA; AEGYPTI; TRANSMISSION; STRAIN; DENGUE; ESTABLISHMENT
AB Wolbachia suppresses the replication of + ssRNA viruses such as dengue and Zika viruses in Aedes aegypti mosquitoes. However, the range of viruses affected by this endosymbiont is yet to be explored. Recently, novel insect-specific viruses (ISVs) have been described from numerous mosquito species and mosquito-derived cell lines. Cell-fusing agent virus (Flaviviridae) and Phasi Charoen-like virus (Bunyaviridae) persistently infect the Ae. aegypti cell line Aag2 which has been used for experimental studies with both the wMel and wMelPop-CLA strains. Wolbachia was found to restrict the replication of CFAV but not the PCLV infection in these lines. Furthermore, an additional Ae. albopictus cell line (RML-12) which contained either wMel or wMelPop-CLA was assessed. While no infectious + ssRNA or dsRNA viruses were detected, a PCLV infection was identified. These observations provide additional evidence to support that insect-specific, + ssRNA viruses can be suppressed in cell culture by Wolbachia but -ssRNA viruses may not.
C1 [McLean, Breeanna J.; Dainty, Kimberley R.; Flores, Heather A.; O'Neill, Scott L.] Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
RP O'Neill, SL (corresponding author), Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
EM Scott.Oneill@monash.edu
RI O'Neill, Scott/R-9560-2019; O'Neill, Scott L/B-3568-2009; Flores,
   Heather/A-7403-2019
OI O'Neill, Scott/0000-0002-4131-3615; O'Neill, Scott
   L/0000-0002-4131-3615; Flores, Heather/0000-0001-5003-7547
FU Bill and Melinda Gates Foundation through Vector-Based Transmission of
   Control: Discovery Research (VCTR) program of the Grand Challenges in
   Global Health initiative [ONEILL11VCTR]; Wellcome TrustWellcome Trust
   [102591]
FX The authors would like to extend their gratitude to Daniela Goncalves
   for the maintenance and tetracycline treatment of the Aag2, wMel and
   wMelPop-CLA cell lines. This work was supported by the Bill and Melinda
   Gates Foundation through a grant as part the Vector-Based Transmission
   of Control: Discovery Research (VCTR) program of the Grand Challenges in
   Global Health initiative managed by the Foundation for the National
   Institutes of Health (ONEILL11VCTR). This work was also supported by the
   Wellcome Trust (102591).
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Amuzu HE, 2018, ECOL EVOL, V8, P5441, DOI 10.1002/ece3.4066
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Chandler JA, 2014, VIROLOGY, V464, P312, DOI 10.1016/j.virol.2014.06.036
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Dodson B. J, 2017, WOLBACHIA EFFECTS RI
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Maringer K. Y. A., 2015, P INT M ARB THEIR VE
   Maringer K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3432-5
   Marklewitz M, 2011, J VIROL, V85, P9227, DOI 10.1128/JVI.00230-11
   McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Parry R, 2018, J VIROL, V92, DOI [10.1128/JVI.00224-18, 10.1128/jvi.00224-18]
   PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Schultz MJ, 2018, MBIO, V9, DOI [10.1128/mBio.00738-18, 10.1128/mbio.00738-18]
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Shaw AE, 2012, J VIROL, V86, P9015, DOI 10.1128/JVI.00131-12
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yamao T, 2009, ARCH VIROL, V154, P153, DOI 10.1007/s00705-008-0285-5
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
NR 41
TC 0
Z9 0
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JAN 15
PY 2019
VL 527
BP 141
EP 145
DI 10.1016/j.virol.2018.11.012
PG 5
WC Virology
SC Virology
GA HI7LE
UT WOS:000456636900016
PM 30503908
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Lin, SL
   Yang, SX
   He, J
   Guest, JD
   Ma, ZX
   Yang, LP
   Pierce, BG
   Tang, QY
   Zhang, YJ
AF Lin, Shaoli
   Yang, Shixing
   He, Jia
   Guest, Johnathan D.
   Ma, Zexu
   Yang, Liping
   Pierce, Brian G.
   Tang, Qiyi
   Zhang, Yan-Jin
TI Zika virus NS5 protein antagonizes type I interferon production via
   blocking TBK1 activation
SO VIROLOGY
LA English
DT Article
DE Zika virus; ZIKV; Interferon; NS5; TBK1; IRF3
ID BINDING KINASE 1; RNA; INITIATION; INDUCTION; UBIQUITIN
AB Zika virus (ZIKV) is a mosquito-borne positive-sense single-stranded RNA virus in the family of Flaviviridae. Unlike other flaviviruses, ZIKV infection of pregnant women may result in birth defects in their newborns, such as microcephaly or vision problem. ZIKV is known to antagonize the interferon (IFN) production in infected cells. However, the exact mechanism of this interference is not fully understood. Here, we demonstrate that NS5 protein of ZIKV MR766 strain antagonizes IFN production through inhibiting the activation of TANK-binding kinase 1 (TBK1), which phosphorylates the transcription activator IFN regulatory factor 3 (IRF3). Mechanistically, NS5 interacts with the ubiquitin-like domain of TBK1 and results in less complex of TBK1 and TNF (tumor necrosis factor) receptor-associated factor 6 (TRAF6), leading to dampened TBK1 activation and IRF3 phosphorylation. Our study provides insights into the mechanism of ZIKV evasion of IFN-mediated innate immunity.
C1 [Lin, Shaoli; Yang, Shixing; He, Jia; Ma, Zexu; Yang, Liping; Zhang, Yan-Jin] Univ Maryland, VA MD Coll Vet Med, Mol Virol Lab, College Pk, MD 20742 USA.
   [Lin, Shaoli; Yang, Shixing; He, Jia; Ma, Zexu; Yang, Liping; Zhang, Yan-Jin] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA.
   [Yang, Shixing] Jiangsu Univ, Sch Med, Zhenjiang, Jiangsu, Peoples R China.
   [Guest, Johnathan D.; Pierce, Brian G.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA.
   [Guest, Johnathan D.; Pierce, Brian G.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.
   [Tang, Qiyi] Howard Univ, Coll Med, Dept Microbiol, Washington, DC USA.
RP Zhang, YJ (corresponding author), Univ Maryland, VA MD Coll Vet Med, Mol Virol Lab, College Pk, MD 20742 USA.; Zhang, YJ (corresponding author), Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA.
EM zhangyj@umd.edu
RI Yang, Liping/AAA-9183-2019; ma, zexu/AAG-1431-2019
OI Guest, Johnathan/0000-0003-1521-5242; Pierce, Brian/0000-0003-4821-0368;
   Yang, Liping/0000-0001-9527-6015
FU Chinese Scholarship CouncilChina Scholarship Council; University of
   Maryland, College Park, MD; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [T32 AI125186]
FX S. Lin was partially sponsored by Chinese Scholarship Council. This
   study was partially funded by a seed grant from the University of
   Maryland, College Park, MD. J. Guest was supported by NIH T32 AI125186
   (Virology Training Grant).
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Britt W. J., 2018, SEMIN PERINATOL
   CDC, 2018, ZIK CAS US
   Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004
   Cruz VH, 2018, J CELL COMMUN SIGNAL, V12, P83, DOI 10.1007/s12079-017-0438-y
   Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109
   Ding Q, 2018, P NATL ACAD SCI US
   Elliott R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006486
   Fang R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006720
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hertzog J, 2018, EUR J IMMUNOL
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034
   Li J, 2012, PROTEIN CELL, V3, P383, DOI 10.1007/s13238-012-2929-1
   Ma J, 2018, FRONT MICROBIOL, V9
   May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200
   Nan YC, 2014, J VIROL, V88, P11924, DOI 10.1128/JVI.01935-14
   Nan YC, 2012, VIROLOGY, V432, P261, DOI 10.1016/j.virol.2012.05.015
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920
   Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Tu D, 2013, CELL REP, V3, DOI [10.1016/j.celrep.2013.1001.1033, DOI 10.1016/J.CELREP.2013.1001.1033]
   van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xiang WW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501889
   Yang S, 2018, J VIROL, V92, DOI 10.1128/JVI.00254-18
   Yin X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006417
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 39
TC 13
Z9 13
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JAN 15
PY 2019
VL 527
BP 180
EP 187
DI 10.1016/j.virol.2018.11.009
PG 8
WC Virology
SC Virology
GA HI7LE
UT WOS:000456636900020
PM 30530224
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Kerr, SM
   Van Bennekom, CM
   Mitchell, AA
AF Kerr, Stephen M.
   Van Bennekom, Carla M.
   Mitchell, Allen A.
TI Risk factors for congenital microcephaly in the pre-Zika era
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE epidemiology; infections; medications; microcephaly; pregnancy risk
   factors
ID INFECTION
AB Background The Zika epidemic has brought increased attention to congenital microcephaly as a birth outcome. However, little is known about risks for microcephaly unrelated to Zika. Methods Using data from the Slone Epidemiology Center Birth Defects Study from 1993 to 2015, we identified 57 cases of microcephaly alone ("isolated") and 109 cases of microcephaly that included other major birth defects ("non-isolated"), and considered a large number of potential risk factors including demographic characteristics, illnesses, and medications used during pregnancy. Where numbers permitted, we used logistic regression models to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Results Substantial differences in risk factors were observed for isolated versus non-isolated microcephaly. For isolated microcephaly, risk estimates were elevated for mothers of non-Hispanic, non-White race/ethnicity, and underweight pre-pregnancy body mass index (BMI). The risk for exposure anytime in pregnancy to acetaminophen was null; in contrast, the aOR for NSAIDs was 2.4 (95% CI: 1.3-4.2). This association was weakened (but not eliminated) after excluding those exposed to opioids or illicit drugs, and risk was not present among those reporting less frequent exposures. For non-isolated microcephaly, elevated risk estimates were found for urinary tract infection. Conclusions Risk factors differed for isolated and non-isolated microcephaly. While some findings support previously reported associations, (e.g., smoking, alcohol, underweight BMI), we also identified risk factors not previously described, notably NSAID use for isolated microcephaly and urinary tract infection for non-isolated microcephaly; however, these results should be viewed as hypothesis generating.
C1 [Kerr, Stephen M.; Van Bennekom, Carla M.; Mitchell, Allen A.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA.
RP Kerr, SM (corresponding author), Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA.
EM skerr1@bu.edu
OI Kerr, Stephen/0000-0001-9442-9737
FU National Vaccine Program Office (NVPO); Biomedical Advanced Research and
   Development Authority (BARDA); Food and Drug Administration (FDA) [HHSP
   233201600064C]
FX National Vaccine Program Office (NVPO) in collaboration with the
   Biomedical Advanced Research and Development Authority (BARDA) and the
   Food and Drug Administration (FDA), Grant/Award Number: HHSP
   233201600064C
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Almgren M, 2009, SEIZURE-EUR J EPILEP, V18, P672, DOI 10.1016/j.seizure.2009.09.002
   [Anonymous], 2016, MED GUID NONST ANT D
   [Anonymous], 2015, FDA HAS REV POSS RIS
   [Anonymous], 2015, ZIKA VIRUS INFECTION
   Auger N, 2018, ARCH DIS CHILD-FETAL, V103, pF167, DOI 10.1136/archdischild-2016-311199
   BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007
   Congenital Zika Syndrome & Other Birth Defects, 2018, ZIKA AND PREGNANCY
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hoyt AT, 2018, BIRTH DEFECTS RES, V110, P395, DOI 10.1002/bdr2.1164
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Leroy Jules G, 2005, Adv Pediatr, V52, P261, DOI 10.1016/j.yapd.2005.04.003
   Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Pan American Health Organization/World Health Organization, 2015, NEUR SYNDR CONG MALF
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Webster WS, 1998, TERATOLOGY, V58, P13
   Wemakor A, 2015, EUR J EPIDEMIOL, V30, P1187, DOI 10.1007/s10654-015-0065-y
NR 22
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD JAN 15
PY 2019
VL 111
IS 2
BP 96
EP 118
DI 10.1002/bdr2.1443
PG 23
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA HH9BW
UT WOS:000456029900007
PM 30584689
OA Bronze
DA 2020-07-08
ER

PT J
AU Goncalves, DD
   Iturbe-Ormaetxe, I
   Martins-da-Silva, A
   Telleria, EL
   Rocha, MN
   Traub-Cseko, YM
   O'Neill, SL
   Sant'Anna, MRV
   Moreira, LA
AF Goncalves, Daniela da Silva
   Iturbe-Ormaetxe, Inaki
   Martins-da-Silva, Andrea
   Telleria, Erich Loza
   Rocha, Marcele Neves
   Traub-Cseko, Yara M.
   O'Neill, Scott L.
   Viana Sant'Anna, Mauricio Roberto
   Moreira, Luciano Andrade
TI Wolbachia introduction into Lutzomyia longipalpis (Diptera: Psychodidae)
   cell lines and its effects on immune-related gene expression and
   interaction with Leishmania infantum
SO PARASITES & VECTORS
LA English
DT Article
DE Wolbachia; Lutzomyia longipalpis; Lulo cell; LL-5 cell; Leishmania
   infantum
ID PHLEBOTOMINE SAND FLIES; MAJOR SURFACE PROTEIN; VISCERAL LEISHMANIASIS;
   INNATE IMMUNITY; INFECTION; DENGUE; ESTABLISHMENT; TRANSMISSION;
   DISEASE; VECTOR
AB BackgroundThe leishmaniases are important neglected diseases caused by Leishmania spp. which are transmitted by sand flies, Lutzomyia longipalpis being the main vector of visceral leishmaniasis in the Americas. The methodologies for leishmaniasis control are not efficient, causing 1.5 million reported cases annually worldwide, therefore showing the need for development of novel strategies and interventions to control transmission of the disease. The bacterium Wolbachia pipientis is being used to control viruses transmitted by mosquitoes, such as dengue and Zika, and its introduction in disease vectors has been effective against parasites such as Plasmodium. Here we show the first successful establishment of Wolbachia into two different embryonic cell lines from L. longipalpis, LL-5 and Lulo, and analysed its effects on the sand fly innate immune system, followed by in vitro Leishmania infantum interaction.ResultsOur results show that LL-5 cells respond to wMel and wMelPop-CLA strains within the first 72 h post-infection, through the expression of antimicrobial peptides and inducible nitric oxide synthase resulting in a decrease of Wolbachia detection in the early stages of infection. In subsequent passages, the wMel strain was not able to infect any of the sand fly cell lines while the wMelPop-CLA strain was able to stably infect Lulo cells and LL-5 at lower levels. In Wolbachia stably infected cells, the expression of immune-related genes involved with downregulation of the IMD, Toll and Jak-Stat innate immune pathways was significantly decreased, in comparison with the uninfected control, suggesting immune activation upon Wolbachia transinfection. Furthermore, Wolbachia transinfection did not promote a negative effect on parasite load in those cells.ConclusionsInitial strong immune responses of LL5 cells might explain the inefficiency of stable infections in these cells while we found that Lulo cells are more permissive to infection with Wolbachia causing an effect on the cell immune system, but not against in vitro L. infantum interaction. This establishes Lulo cells as a good system for the adaptation of Wolbachia in L. longipalpis.
C1 [Goncalves, Daniela da Silva; Rocha, Marcele Neves; Moreira, Luciano Andrade] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Grp Mosquitos Vetores Endossimbiontes & Interacao, Av Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
   [Iturbe-Ormaetxe, Inaki; O'Neill, Scott L.] Monash Univ, Inst Vector Borne Dis, World Mosquito Program, 12 Innovat Walk, Clayton, Vic 3800, Australia.
   [Martins-da-Silva, Andrea; Telleria, Erich Loza; Traub-Cseko, Yara M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Parasitos & Vetores, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Viana Sant'Anna, Mauricio Roberto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Insetos Hematofagos, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
RP Moreira, LA (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Grp Mosquitos Vetores Endossimbiontes & Interacao, Av Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM luciano@minas.fiocruz.br
RI O'Neill, Scott L/B-3568-2009; Telleria, Erich L/F-1580-2015; O'Neill,
   Scott/R-9560-2019; Martins da Silva, Andrea/F-6580-2018
OI O'Neill, Scott L/0000-0002-4131-3615; Telleria, Erich
   L/0000-0003-0006-0057; O'Neill, Scott/0000-0002-4131-3615; Moreira,
   Luciano/0000-0002-9240-3506; da Silva Goncalves,
   Daniela/0000-0002-3191-9509; Martins da Silva,
   Andrea/0000-0002-1477-4360
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; Bill and Melinda Gates FoundationGates Foundation;
   Instituto Oswaldo Cruz, Fiocruz, Brazil
FX DSG, MRVS and LAM were funded by CNPq and CAPES grants. Also, the
   Brazilian Ministry of Health and a grant to Monash University from the
   Bill and Melinda Gates Foundation. YMTC was funded by the Instituto
   Oswaldo Cruz, Fiocruz, Brazil.
CR Akuffo H, 1998, INT J MOL MED, V1, P77
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003
   Bello FJ, 2005, MEM I OSWALDO CRUZ, V100, P619, DOI 10.1590/S0074-02762005000600004
   Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004
   Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x
   Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cortes LMC, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-216
   Da Rocha NO, 2018, MED VET ENTOMOL, V32, P111, DOI 10.1111/mve.12255
   Salomon OD, 2015, MEM I OSWALDO CRUZ, V110, P831, DOI 10.1590/0074-02760150207
   Cortes LMD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-142
   de Oliveira CD, 2015, B ENTOMOL RES, V105, P305, DOI 10.1017/S0007485315000085
   Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0
   Dostalova A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-276
   Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335
   Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5
   Gomes B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005504
   Gossage SA, 2003, INT J PARASITOL, V33, P1027, DOI 10.1016/S0020-7519(03)00142-5
   Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Iturbe-Ormaetxe I, 2011, J MICROBIOL METH, V84, P134, DOI 10.1016/j.mimet.2010.10.019
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936
   McCall LI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003053
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Ono M, 2001, J MED ENTOMOL, V38, P237, DOI 10.1603/0022-2585-38.2.237
   Pan XL, 2018, ISME J, V12, P277, DOI 10.1038/ismej.2017.174
   Parvizi P, 2013, J ARTHROPOD-BORNE DI, V7, P46
   Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]
   Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400
   Rafiqi AM, 2012, DEVELOPMENT, V139, P3373, DOI 10.1242/dev.083873
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557
   Rey GJ, 2000, MEM I OSWALDO CRUZ, V95, P103, DOI 10.1590/S0074-02762000000100017
   Rogers ME, 2002, PARASITOLOGY, V124, P495, DOI 10.1017/S0031182002001439
   Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453
   Sant'Anna MRV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042531
   Soaresa RP, 2017, PROTIST, V168, P326, DOI 10.1016/j.protis.2017.03.004
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Telleria EL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-12
   Telleria EL, 2012, J BIOL CHEM, V287, P12985, DOI 10.1074/jbc.M111.331561
   TESH RB, 1983, J MED ENTOMOL, V20, P199, DOI 10.1093/jmedent/20.2.199
   Tinoco-Nunes B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1507-4
   Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x
   Walker T, 2011, MEM I OSWALDO CRUZ, V106, P212, DOI 10.1590/S0074-02762011000900026
   Warburg A, 2011, J VECTOR ECOL, V36, pS10, DOI 10.1111/j.1948-7134.2011.00107.x
   Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430
   World Health Organization, 2016, LEISHMANIASIS
   Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Zug R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01201
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 69
TC 4
Z9 4
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 15
PY 2019
VL 12
AR 33
DI 10.1186/s13071-018-3227-4
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HH6AE
UT WOS:000455809900004
PM 30646951
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Haqshenas, G
   Terradas, G
   Paradkar, PN
   Duchemin, JB
   McGraw, EA
   Doerig, C
AF Haqshenas, Gholamreza
   Terradas, Gerard
   Paradkar, Prasad N.
   Duchemin, Jean-Bernard
   McGraw, Elizabeth A.
   Doerig, Christian
TI A Role for the Insulin Receptor in the Suppression of Dengue Virus and
   Zika Virus in Wolbachia-Infected Mosquito Cells
SO CELL REPORTS
LA English
DT Article
ID LIFE-SHORTENING WOLBACHIA; AEDES-AEGYPTI; POPULATIONS; STRAIN; WMEL;
   TRANSMISSION; AUSTRALIA; CAVEOLAE; KINASE; GROWTH
AB Wolbachia-infected mosquitoes are refractory to super-infection with arthropod-borne pathogens, but the role of host cell signaling proteins in pathogen blocking mechanisms remains to be elucidated. Here, we use an antibody microarray approach to provide a comprehensive picture of the signaling response of Aedes aegypti-derived cells to Wolbachia. This approach identifies the host cell insulin receptor as being downregulated by the bacterium. Furthermore, siRNA-mediated knockdown and treatment with a small-molecule inhibitor of the insulin receptor kinase concur to assign a crucial role for this enzyme in the replication of dengue and Zika viruses in cultured mosquito cells. Finally, we show that the production of Zika virus in Wolbachia-free live mosquitoes is impaired by treatment with the selective inhibitor mimicking Wolbachia infection. This study identifies Wolbachia-mediated downregulation of insulin receptor kinase activity as a mechanism contributing to the blocking of super-infection by arboviruses.
C1 [Haqshenas, Gholamreza; Doerig, Christian] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.
   [Haqshenas, Gholamreza; Doerig, Christian] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.
   [Terradas, Gerard; McGraw, Elizabeth A.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.
   [Paradkar, Prasad N.; Duchemin, Jean-Bernard] Australian Anim Hlth Lab, CSIRO Hlth & Biosecur, Geelong, Vic, Australia.
   [McGraw, Elizabeth A.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.
   [Doerig, Christian] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic 3083, Australia.
RP Haqshenas, G; Doerig, C (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Haqshenas, G; Doerig, C (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.; McGraw, EA (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.; McGraw, EA (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.; Doerig, C (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic 3083, Australia.
EM gholamreza.haqshenas@monash.edu; eam7@psu.edu;
   christian.doerig@rmit.edu.au
RI Doerig, Christian/Q-9900-2019; Duchemin, Jean-Bernard/AAE-8077-2020
OI Duchemin, Jean-Bernard/0000-0001-5044-4855; Terradas,
   Gerard/0000-0003-4285-4007
FU C.D. group and NHMRC [APP1103804]
FX The research was supported by the C.D. group and NHMRC project grant
   APP1103804 (to E.M.). The Higgs and Brisbane mosquito lines were gifts
   from Dr. Akbari (University of California, Riverside) and Dr. Ary
   Hoffmann (University of Melbourne, Australia), respectively. The authors
   would like to thank Emily Kerton (Monash University, Australia) for her
   technical assistance.
CR Adachi M, 2002, J BIOL CHEM, V277, P38998, DOI 10.1074/jbc.M203262200
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Asad S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006405
   Asad S, 2018, INSECT BIOCHEM MOLEC, V92, P45, DOI 10.1016/j.ibmb.2017.11.008
   Asad S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36850
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Buchman A, 2018, ENG RESISTANCE ZIKA, DOI [10.1101/344697, DOI 10.1101/344697]
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6
   Fan BS, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00079
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Gustavsson J, 1999, FASEB J, V13, P1961
   Haqshenas G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15158
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   KASUGA M, 1982, J BIOL CHEM, V257, P392
   Kumar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30490
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   O'Neill SL, 2018, ADV EXP MED BIOL, V1062, P355, DOI 10.1007/978-981-10-8727-1_24
   Paradkar PN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005143
   Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200
   PELEG J, 1968, VIROLOGY, V35, P617, DOI 10.1016/0042-6822(68)90293-6
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Schultz MJ, 2018, MBIO, V9, DOI [10.1128/mBio.00738-18, 10.1128/mbio.00738-18]
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Terradas G, 2017, CURR OPIN INSECT SCI, V22, P37, DOI 10.1016/j.cois.2017.05.005
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Thomas S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006879
   Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wen ZM, 2010, MOL CELL ENDOCRINOL, V328, P47, DOI 10.1016/j.mce.2010.07.003
   Wilson HL, 2017, J CLIN MICROBIOL, V55, P3104, DOI [10.1128/JCM.00673-17, 10.1128/jcm.00673-17]
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Ye YXH, 2014, AM J TROP MED HYG, V90, P422, DOI 10.4269/ajtmh.13-0186
   Ye YXH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002362
   Zhang GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07279-5
NR 49
TC 4
Z9 4
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JAN 15
PY 2019
VL 26
IS 3
BP 529
EP +
DI 10.1016/j.celrep.2018.12.068
PG 10
WC Cell Biology
SC Cell Biology
GA HH3NX
UT WOS:000455627400003
PM 30650347
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Evans, AS
   Coyne, CB
AF Evans, Azia S.
   Coyne, Carolyn B.
TI RIPK3: Beyond Necroptosis
SO IMMUNITY
LA English
DT Editorial Material
ID PATHOGENESIS
AB In this issue of Immunity, Daniels et al. (2019) demonstrate that RIPK3 signaling limits Zika virus (ZIKV) infection in the central nervous system independently of its function in necroptosis by promoting itaconate production in infected neurons, thereby revealing a neuron-specific mechanism of metabolite-mediated ZIKV control.
C1 [Evans, Azia S.; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.
   [Evans, Azia S.; Coyne, Carolyn B.] UPMC Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA USA.
   [Coyne, Carolyn B.] UPMC Childrens Hosp Pittsburgh, RK Mellon Inst Pediat Res, Pittsburgh, PA 15219 USA.
RP Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Coyne, CB (corresponding author), UPMC Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA USA.; Coyne, CB (corresponding author), UPMC Childrens Hosp Pittsburgh, RK Mellon Inst Pediat Res, Pittsburgh, PA 15219 USA.
EM coynec2@pitt.edu
CR Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792
   Daniels BP, 2019, IMMUNITY, V50, P64, DOI 10.1016/j.immuni.2018.11.017
   Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015
   Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012
   Maximova OA, 2018, ANNU REV VIROL, V5, P255, DOI 10.1146/annurev-virology-092917-043439
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Nair S, 2015, CURR OPIN IMMUNOL, V36, P47, DOI 10.1016/j.coi.2015.06.011
   Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1
NR 8
TC 0
Z9 0
U1 1
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD JAN 15
PY 2019
VL 50
IS 1
BP 1
EP 3
DI 10.1016/j.immuni.2018.12.031
PG 3
WC Immunology
SC Immunology
GA HH4AF
UT WOS:000455661600001
PM 30650369
OA Bronze
DA 2020-07-08
ER

PT J
AU Daniels, BP
   Kofman, SB
   Smith, JR
   Norris, GT
   Snyder, AG
   Kolb, JP
   Gao, X
   Locasale, JW
   Martinez, J
   Gale, M
   Loo, YM
   Oberst, A
AF Daniels, Brian P.
   Kofman, Sigal B.
   Smith, Julian R.
   Norris, Geoffrey T.
   Snyder, Annelise G.
   Kolb, Joseph P.
   Gao, Xia
   Locasale, Jason W.
   Martinez, Jennifer
   Gale, Michael, Jr.
   Loo, Yueh-Ming
   Oberst, Andrew
TI The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to
   Promote an Antiviral Metabolic State in Neurons
SO IMMUNITY
LA English
DT Article
ID NILE-VIRUS-REPLICATION; INNATE IMMUNE-RESPONSE; ZIKA VIRUS;
   SUCCINATE-DEHYDROGENASE; PROGRAMMED NECROSIS; CELL-DEATH; ITACONATE;
   PATHOGENESIS; INFLAMMATION; NECROPTOSIS
AB As long-lived post-mitotic cells, neurons employ unique strategies to resist pathogen infection while preserving cellular function. Here, using a murine model of Zika virus (ZIKV) infection, we identified an innate immune pathway that restricts ZIKV replication in neurons and is required for survival upon ZIKV infection of the central nervous system (CNS). We found that neuronal ZIKV infection activated the nucleotide sensor ZBP1 and the kinases RIPK1 and RIPK3, core components of virus-induced necroptotic cell death signaling. However, activation of this pathway in ZIKV-infected neurons did not induce cell death. Rather, RIPK signaling restricted viral replication by altering cellular metabolism via upregulation of the enzyme IRG1 and production of the metabolite itaconate. Itaconate inhibited the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes. These findings demonstrate an immuno-metabolic mechanism of viral restriction during neuroinvasive infection.
C1 [Daniels, Brian P.; Kofman, Sigal B.; Smith, Julian R.; Norris, Geoffrey T.; Snyder, Annelise G.; Gale, Michael, Jr.; Loo, Yueh-Ming; Oberst, Andrew] Univ Washington, Dept Immunol, Seattle, WA 98109 USA.
   [Kolb, Joseph P.; Martinez, Jennifer] NIEHS, Immun Inflammat & Dis Lab, NIH, Res Triangle Pk, NC 27703 USA.
   [Gao, Xia; Locasale, Jason W.] Duke Univ, Dept Pharmacol & Canc Biol, Sch Med, Durham, NC 27710 USA.
   [Gale, Michael, Jr.; Loo, Yueh-Ming; Oberst, Andrew] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98109 USA.
RP Oberst, A (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98109 USA.; Oberst, A (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98109 USA.
EM oberst@uw.edu
RI Martinez, Jennifer/C-3740-2019
OI Martinez, Jennifer/0000-0002-3060-2518; Daniels,
   Brian/0000-0002-8473-0654
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI132595, R21 NS101542, U19
   AI083019, F32 AI129254, T32 GM007270]; NIH Intramural Research
   ProgramUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [ZIA ES10328601]; National Science
   Foundation Graduate Research FellowshipNational Science Foundation (NSF)
   [DGE-1256082]; Canadian Institutes of Health ResearchCanadian Institutes
   of Health Research (CIHR) [146818]
FX The authors thank Pooja Ralli-Jain and Tayla Olsen for technical
   assistance. We thank Kevin Gerrish and Rick Fannin in the Molecular
   Genomics Core at the National Institute of Environmental Health Sciences
   for microarray support, John Bertin (GlaxoSmithKline) for providing
   RIPK1 and RIPK3 inhibitors and Ripk1<SUP>KD/KD</SUP> mice used in this
   study, and Luke O'Neill (Trinity College, Dublin) for providing 4-octyl
   itaconate. This work was supported by NIH grants R01 AI132595 (AO), R21
   NS101542 (AO), U19 AI083019 (MG), F32 AI129254 (BPD), T32 GM007270 (SBK
   and AGS), and the NIH Intramural Research Program ZIA ES10328601 (JM).
   A.G.S. was also supported by a National Science Foundation Graduate
   Research Fellowship (DGE-1256082). X.G. was supported by a fellowship
   from the Canadian Institutes of Health Research (reference number
   146818).
CR Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z
   Brien J. D, 2013, CURRENT PROTOCOLS MI, V31, P1
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037
   Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792
   Costa F, 2018, LANCET INFECT DIS, V18, P236, DOI 10.1016/S1473-3099(17)30697-7
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011
   Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V
   Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018
   Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002
   da Cruz LCH, 2018, AM J NEURORADIOL, V39, P1967, DOI 10.3174/ajnr.A5649
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012
   Kole AJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.220
   Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u
   Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110
   Mills EL, 2018, NATURE, V556, P113, DOI [10.1038/nature25986, 10.1038/s41586-018-0353-2]
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Nair S, 2018, J EXP MED, V215, P1035, DOI 10.1084/jem.20180118
   Naujoks J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005408
   Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46
   Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011
   Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76
   Orozco S, 2017, IMMUNOL REV, V277, P102, DOI 10.1111/imr.12536
   Piret J, 2018, J GEN VIROL, V99, P209, DOI 10.1099/jgv.0.000992
   Shen HY, 2017, CELL, V171, P771, DOI 10.1016/j.cell.2017.09.051
   Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10
   Tallam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149050
   Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012
   Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI 10.1016/j.chom.2012.01.016
   Williams JL, 2014, J EXP MED, V211, P791, DOI 10.1084/jem.20131224
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 37
TC 23
Z9 22
U1 2
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD JAN 15
PY 2019
VL 50
IS 1
BP 64
EP +
DI 10.1016/j.immuni.2018.11.017
PG 17
WC Immunology
SC Immunology
GA HH4AF
UT WOS:000455661600011
PM 30635240
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Cai, YL
   Ding, ZQ
   Yang, B
   Peng, ZH
   Wang, WM
AF Cai, Yongli
   Ding, Zuqin
   Yang, Bin
   Peng, Zhihang
   Wang, Weiming
TI Transmission dynamics of Zika virus with spatial structure-A case study
   in Rio de Janeiro, Brazil
SO PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS
LA English
DT Article
DE Zika virus (ZIKV); Spatial heterogeneity; Basic reproduction number;
   Infection-free equilibrium; Uniformly persistent
ID EPIDEMIC MODEL; STEADY-STATES; ASYMPTOTIC PROFILES; REPRODUCTION
   NUMBERS; GLOBAL STABILITY; SPREAD
AB In this paper, we investigate the effect of the spatial heterogeneity on the extinction and persistence of the Zika virus (ZIKV) further. We define the basic reproduction number R-0 and prove that no can be used to govern the threshold dynamics of the ZIKV: if R-0 < 1, the unique disease-free equilibrium is globally asymptotic stable and the ZIKV will die out, while if R-0 > 1, there is at least one endemic equilibrium and the ZIKV will persist uniformly. Via numerical simulations, we show the evolution of the spatial distribution of infected people and find that the final size of the infected people is 25,717, which agrees nearly with the real weekly reported case data 25,400 from November 1, 2015 to April 10, 2016 in Rio de Janeiro, Brazil. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Cai, Yongli; Ding, Zuqin; Yang, Bin; Wang, Weiming] Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
   [Peng, Zhihang] Nanjing Med Univ, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China.
RP Wang, WM (corresponding author), Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
EM yonglicai@hytc.edu.cn; dingding@hytc.edu.cn; yangbin@hytc.edu.cn;
   zihangpeng@njmu.edu.cn; wangwm_math@hytc.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11601179, 61672013, 61772017, 81673275, U1503123];
   Huaian Key Laboratory for Infectious Diseases Control and Prevention of
   Huaian, Jiangsu Province, PR China [HAP201704]; Priority Academic
   Program Development of Jiangsu Higher Education Institution (PAPD);
   Science and Technology Demonstration Project for Emerging Infectious
   Diseases Control and Prevention of Jiangsu Province, PR China
   [BE2015714]
FX The authors would like to thank Prof. G. Webb in Vanderbilt University,
   USA for providing us their new papers and Mathematica code. This
   research was supported by the National Natural Science Foundation of
   China (Grant No. 11601179, 61672013 and 61772017) and Huaian Key
   Laboratory for Infectious Diseases Control and Prevention of Huaian,
   Jiangsu Province, PR China (HAP201704). And this research of Zhihang
   Peng was supported by the National Natural Science Foundation of China
   (Grant No. 81673275 and U1503123), Priority Academic Program Development
   of Jiangsu Higher Education Institution (PAPD), and Science and
   Technology Demonstration Project for Emerging Infectious Diseases
   Control and Prevention of Jiangsu Province, PR China (No. BE2015714).
CR Allen LJS, 2007, SIAM J APPL MATH, V67, P1283, DOI 10.1137/060672522
   Allen LJS, 2008, DISCRETE CONT DYN-A, V21, P1
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Auger P, 2008, LECT NOTES MATH, V1936, P209
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Britton T, 2009, MATH BIOSCI, V222, P109, DOI 10.1016/j.mbs.2009.10.001
   Cai YL, 2018, APPL MATH COMPUT, V329, P210, DOI 10.1016/j.amc.2018.02.009
   Cai YL, 2018, NONLINEAR ANAL-REAL, V40, P444, DOI 10.1016/j.nonrwa.2017.10.001
   Cai YL, 2017, APPL MATH COMPUT, V305, P221, DOI 10.1016/j.amc.2017.02.003
   Cai YL, 2016, NONLINEAR ANAL-REAL, V30, P99, DOI 10.1016/j.nonrwa.2015.12.002
   Caraco T, 2001, THEOR POPUL BIOL, V59, P185, DOI 10.1006/tpbi.2000.1517
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN, V14
   Fitzgibbon WE, 2018, NONLINEAR ANAL-REAL, V41, P692, DOI 10.1016/j.nonrwa.2017.11.005
   Fitzgibbon WE, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0051-z
   Fitzgibbon WE, 2004, DISCRETE CONT DYN-B, V4, P893, DOI 10.3934/dcdsb.2004.4.893
   Fitzgibbon WE, 2001, SIAM J MATH ANAL, V33, P570, DOI 10.1137/S0036141000371757
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Ge J, 2015, J DIFFER EQUATIONS, V259, P5486, DOI 10.1016/j.jde.2015.06.035
   Henry D., 1981, GEOMETRIC THEORY SEM, V840
   Huang WZ, 2010, MATH BIOSCI ENG, V7, P51, DOI 10.3934/mbe.2010.7.51
   Kibona I. E., 2017, Health, V9, P1190, DOI 10.4236/health.2017.98086
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kuniya T, 2017, APPL ANAL, V96, P1935, DOI 10.1080/00036811.2016.1199796
   Ma Z, 2009, MODELING DYNAMICS IN
   Magal P, 2005, SIAM J MATH ANAL, V37, P251, DOI 10.1137/S0036141003439173
   Magal P., 2018, VECTOR HOST EPIDEMIC, DOI [10.13140/RG.2.2.34596.37766, DOI 10.13140/RG.2.2.34596.37766]
   MARTIN RH, 1990, T AM MATH SOC, V321, P1, DOI 10.2307/2001590
   Neuhauser C., 2001, NOT AM MATH SOC, V48, P1304
   Peng R, 2009, J DIFFER EQUATIONS, V247, P1096, DOI 10.1016/j.jde.2009.05.002
   Peng R, 2009, NONLINEAR ANAL-THEOR, V71, P239, DOI 10.1016/j.na.2008.10.043
   Protter M.H., 1984, MAXIMUM PRINCIPLES D
   Rao F, 2014, NONLINEAR DYNAM, V76, P1661, DOI 10.1007/s11071-014-1237-0
   Rojas D.P., 2016, EURO SURVEIL, V21
   Smith HL, 2001, NONLINEAR ANAL-THEOR, V47, P6169, DOI 10.1016/S0362-546X(01)00678-2
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   THIEME HR, 1992, J MATH BIOL, V30, P755
   Tuncer N, 2012, J BIOL DYNAM, V6, P406, DOI 10.1080/17513758.2011.614697
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wang JL, 2016, IMA J APPL MATH, V81, P321, DOI 10.1093/imamat/hxv039
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Wang WM, 2018, J FRANKLIN I, V355, P7226, DOI 10.1016/j.jfranklin.2018.07.014
   Wang WM, 2018, PHYSICA A, V509, P921, DOI 10.1016/j.physa.2018.06.099
   Wang WM, 2017, J FRANKLIN I, V354, P7410, DOI 10.1016/j.jfranklin.2017.08.034
   Wang WD, 2012, SIAM J APPL DYN SYST, V11, P1652, DOI 10.1137/120872942
   WEBB GF, 1981, J MATH ANAL APPL, V84, P150, DOI 10.1016/0022-247X(81)90156-6
   World Health Organization, 2016, ZIK VIR
NR 49
TC 14
Z9 14
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4371
EI 1873-2119
J9 PHYSICA A
JI Physica A
PD JAN 15
PY 2019
VL 514
BP 729
EP 740
DI 10.1016/j.physa.2018.09.100
PG 12
WC Physics, Multidisciplinary
SC Physics
GA HA3GB
UT WOS:000450137000066
DA 2020-07-08
ER

PT J
AU Yoshida, F
   Yoshinaka, H
   Tanaka, H
   Hanashima, S
   Yamaguchi, Y
   Ishihara, M
   Saburomaru, M
   Kato, Y
   Saito, R
   Ando, H
   Kiso, M
   Imamura, A
   Ishida, H
AF Yoshida, Fumi
   Yoshinaka, Hiroki
   Tanaka, Hidenori
   Hanashima, Shinya
   Yamaguchi, Yoshiki
   Ishihara, Mikio
   Saburomaru, Miyuki
   Kato, Yuki
   Saito, Risa
   Ando, Hiromune
   Kiso, Makoto .
   Imamura, Akihiro
   Ishida, Hideharu
TI Synthesis of the Core Oligosaccharides of Lipooligosaccharides from
   Campylobacter jejuni: A Putative Cause of Guillain-Barre Syndrome
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE carbohydrates; gangliosides; glycosylation; Guillain-Barre syndrome;
   lipooligosaccharides
ID 3-DEOXY-D-MANNO-OCT-2-ULOSONIC ACID KDO; RING-CLOSING METATHESIS;
   3-DEOXY-D-MANNO-2-OCTULOSONIC ACID; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR;
   CARBOHYDRATE-CHEMISTRY; ALLYL ETHERS; ZIKA VIRUS; LIPOPOLYSACCHARIDES;
   TETRASACCHARIDE; GLYCOSYL
AB The chemical synthesis of the highly branched core oligosaccharides of lipooligosaccharides (LOSs) found in Campylobacter jejuni, which causes Guillain-Barre syndrome by a preceding infection, is described. The target LOS mimics, consisting of eight or nine monosaccharides, were classified into three groups as key building blocks: ganglioside-core tetra-/pentasaccharides (GM1-/GD1a-like), l-glycero-d-manno-heptose-containing trisaccharides, and 3-deoxy-d-manno-2-octulosonic acid (KDO) residues. These synthetic fragments were obtained from commercially available monosaccharides. Less obtainable l-glycero-d-manno-heptose and KDO residues, as key components of the LOSs, were synthesized from p-methoxyphenyl d-mannoside and di-O-isopropylidene-protected d-mannose, respectively. The synthesis of alpha-KDO glycoside, as one of the most difficult stereocontrolled glycosidic constructions, was achieved by treating a 2,3-ene derivative of KDO with phenylselenyl trifluoromethanesulfonate as a suitable alpha-directing reagent. All synthetic blocks were constructed through a convergent synthetic route, which resulted in the first synthesis of structurally challenging LOS core glycans containing ganglioside GM1 and GD1a-core sequences.
C1 [Yoshida, Fumi; Yoshinaka, Hiroki; Ishihara, Mikio; Saburomaru, Miyuki; Kato, Yuki; Saito, Risa; Kiso, Makoto .; Imamura, Akihiro; Ishida, Hideharu] Gifu Univ, Dept Appl Bioorgan Chem, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.
   [Tanaka, Hidenori; Ando, Hiromune; Ishida, Hideharu] Gifu Univ, Ctr Highly Adv Integrat & Nano & Life Sci G CHAIN, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.
   [Hanashima, Shinya; Yamaguchi, Yoshiki] RIKEN Global Res Cluster, Syst Glycobiol Res Grp, Struct Glycobiol Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
RP Imamura, A; Ishida, H (corresponding author), Gifu Univ, Dept Appl Bioorgan Chem, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.; Ishida, H (corresponding author), Gifu Univ, Ctr Highly Adv Integrat & Nano & Life Sci G CHAIN, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.
EM aimamura@gifu-u.ac.jp; ishida@gifu-u.ac.jp
RI Hanashima, Shinya/AAE-2816-2019; Yamaguchi, Yoshiki/N-5246-2015; Ando,
   Hiromune/J-8294-2017
OI Hanashima, Shinya/0000-0003-3102-7890; Yamaguchi,
   Yoshiki/0000-0003-0100-5439; Ando, Hiromune/0000-0002-0551-0830
FU Japan Society for the Promotion of Science (JSPS)Ministry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of Science [10660107]
FX This work was financially supported in part by Japan Society for the
   Promotion of Science (JSPS), Grants-in-Aid for Scientific Research
   [KAKENHI, grant No. 10660107]. We thank Dr. Y.O. Kamatari for helpful
   assistance with the NMR spectroscopy measurements (Bruker AVANCE III 800
   in Life Science Research Center, Gifu University). This article is
   reported as synthetic studies on sialoglycoconjugates 167. Part 166:
   Ref. [44].
CR ABEN RWM, 1988, TETRAHEDRON LETT, V29, P3597, DOI 10.1016/0040-4039(88)85303-6
   ALTER M, 1990, ANN NEUROL, V27, pS7, DOI 10.1002/ana.410270704
   Ando H, 2003, TETRAHEDRON LETT, V44, P6883, DOI 10.1016/S0040-4039(03)01707-6
   Ang CW, 2002, INFECT IMMUN, V70, P5081, DOI 10.1128/IAI.70.9.5081-5085.2002
   AUZANNEAU FI, 1988, CARBOHYD RES, V179, P125, DOI 10.1016/0008-6215(88)84114-4
   Baeschlin D. K., 1998, ANGEW CHEM, V110, P3609
   Baeschlin DK, 2000, CHEM-EUR J, V6, P172, DOI 10.1002/(SICI)1521-3765(20000103)6:1<172::AID-CHEM172>3.0.CO;2-5
   Baeschlin DK, 1998, ANGEW CHEM INT EDIT, V37, P3423, DOI [10.1002/(SICI)1521-3773(19981231)37:24<3423::AID-ANIE3423>3.0.CO;2-I, 10.1002/(SICI)1521-3773(19981231)37:24&lt;3423::AID-]
   Bernlind C, 1998, J ORG CHEM, V63, P7780, DOI 10.1021/jo9808573
   BOULLANGER P, 1986, J CARBOHYD CHEM, V5, P541, DOI 10.1080/07328308608062974
   Burke SD, 1999, ORG LETT, V1, P71, DOI 10.1021/ol9905506
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chandrasekhar S, 2001, TETRAHEDRON, V57, P3435, DOI 10.1016/S0040-4020(01)00187-9
   Corey EJ, 1996, J AM CHEM SOC, V118, P9202, DOI 10.1021/ja962480t
   Crich D, 2000, J ORG CHEM, V65, P1291, DOI 10.1021/jo9910482
   Crich D, 2008, J ORG CHEM, V73, P7003, DOI 10.1021/jo801414c
   DASSER M, 1990, J CHEM SOC PERK T 1, P3091, DOI 10.1039/p19900003091
   Dixon DJ, 2002, CHEM-EUR J, V8, P1621, DOI 10.1002/1521-3765(20020402)8:7<1621::AID-CHEM1621>3.0.CO;2-8
   Fujikawa K, 2011, CHEM-EUR J, V17, P5641, DOI 10.1002/chem.201003357
   FUKUYAMA T, 1985, TETRAHEDRON LETT, V26, P6291, DOI 10.1016/S0040-4039(01)84580-9
   Fuse T, 2006, GLYCOCONJUGATE J, V23, P329, DOI 10.1007/s10719-006-5704-9
   Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268
   Hanashima S, 2011, TRENDS GLYCOSCI GLYC, V23, P111, DOI 10.4052/tigg.23.111
   Hasegawa A, 1996, J CARBOHYD CHEM, V15, P623, DOI 10.1080/07328309608005679
   Hekking KFW, 2003, TETRAHEDRON, V59, P6751, DOI 10.1016/S0040-4020(03)00819-6
   Hekking KFW, 2006, J ORG CHEM, V71, P6444, DOI 10.1021/jo060913x
   Hense A, 1997, J CHEM SOC PERK T 1, P2023, DOI 10.1039/a702497e
   Hori K, 2003, EUR J ORG CHEM, V2003, P3752, DOI 10.1002/ejoc.200300309
   Houliston RS, 2007, BIOCHEMISTRY-US, V46, P36, DOI 10.1021/bi062001v
   Hughes RAC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub6
   Ichiyanagi T, 2018, TRENDS GLYCOSCI GLYC, V30, pE25, DOI 10.4052/tigg.1709.1E
   Ichiyanagi T, 2009, J CARBOHYD CHEM, V28, P53, DOI 10.1080/07328300802650303
   IKEDA K, 1989, CARBOHYD RES, V189, pC1, DOI 10.1016/0008-6215(89)84116-3
   Imamura A, 2005, ORG LETT, V7, P4415, DOI 10.1021/ol051592z
   Imamura A, 2009, J ORG CHEM, V74, P3009, DOI 10.1021/jo8027888
   Ishii K, 2002, CARBOHYD RES, V337, P11, DOI 10.1016/S0008-6215(01)00282-8
   Ishiwata A, 2008, TETRAHEDRON, V64, P92, DOI 10.1016/j.tet.2007.10.087
   Kikelj V, 2006, SYNTHESIS-STUTTGART, P1200, DOI 10.1055/s-2006-926375
   Kim BG, 2005, SYNTHESIS-STUTTGART, P1507, DOI 10.1055/s-2005-865325
   Kiso M., 2008, GLYCOSCIENCE, V2, P1313
   Kong LB, 2016, NAT CHEM, V8, P242, DOI [10.1038/NCHEM.2432, 10.1038/nchem.2432]
   Kosma P, 2016, TETRAHEDRON LETT, V57, P2133, DOI 10.1016/j.tetlet.2016.04.005
   Kuboki A, 2004, TETRAHEDRON LETT, V45, P4545, DOI 10.1016/j.tetlet.2004.04.016
   Kuwabara S, 2004, DRUGS, V64, P597, DOI 10.2165/00003495-200464060-00003
   Ley SV, 1998, J CHEM SOC PERK T 1, P3907, DOI 10.1039/a807957i
   Li LS, 2003, CURR ORG CHEM, V7, P447, DOI 10.2174/1385272033372789
   MANCUSO AJ, 1979, J ORG CHEM, V44, P4148, DOI 10.1021/jo01337a028
   Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935
   MATSUMOTO T, 1988, TETRAHEDRON LETT, V29, P3567, DOI 10.1016/0040-4039(88)85294-8
   MATSUZAKI Y, 1993, TETRAHEDRON LETT, V34, P1061, DOI 10.1016/S0040-4039(00)77492-2
   NAKAYAMA K, 1992, CHEM PHARM BULL, V40, P1718
   NICOLAOU KC, 1990, J AM CHEM SOC, V112, P3693, DOI 10.1021/ja00165a084
   OLTVOORT JJ, 1981, SYNTHESIS-STUTTGART, P305
   PAPPO R, 1956, J ORG CHEM, V21, P478, DOI 10.1021/jo01110a606
   Peng YL, 2015, ORG LETT, V17, P2388, DOI 10.1021/acs.orglett.5b00901
   PETITOU M, 1988, TETRAHEDRON LETT, V29, P1389, DOI 10.1016/S0040-4039(00)80304-4
   Pradhan TK, 2013, SYNLETT, V24, P219, DOI 10.1055/s-0032-1317932
   Rajput VK, 2006, TETRAHEDRON LETT, V47, P6987, DOI 10.1016/j.tetlet.2006.07.125
   SCHMIDT RR, 1980, ANGEW CHEM INT EDIT, V19, P731, DOI 10.1002/anie.198007311
   SCHMIDT RR, 1986, ANGEW CHEM INT EDIT, V25, P212, DOI 10.1002/anie.198602121
   SCHMIDT RR, 1986, ANGEW CHEM, V98, P213
   SCHMIDT RR, 1980, ANGEW CHEM, V92, P763
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Shahrizaila N, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/829129
   Stephenson HN, 2013, J BIOL CHEM, V288, P19661, DOI 10.1074/jbc.M113.468298
   Tanase M, 2017, BIOSCI BIOTECH BIOCH, V81, P2268, DOI 10.1080/09168451.2017.1395682
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Sorge NM, 2004, AUTOIMMUN REV, V3, P151, DOI 10.1016/S1568-9972(03)00089-2
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Yamasaki R, 2001, J CARBOHYD CHEM, V20, P171, DOI 10.1081/CAR-100103956
   Yoshikawa T, 2008, GLYCOCONJUGATE J, V25, P545, DOI 10.1007/s10719-008-9111-2
   Yoshizaki H, 2001, ANGEW CHEM INT EDIT, V40, P1475, DOI 10.1002/1521-3773(20010417)40:8<1475::AID-ANIE1475>3.0.CO;2-V
   Yoshizaki H., 2001, ANGEW CHEM, V113, P1523
   Yuki N, 2005, CURR OPIN IMMUNOL, V17, P577, DOI 10.1016/j.coi.2005.09.004
   Yuki N, 1997, J INFECT DIS, V176, pS150, DOI 10.1086/513800
NR 76
TC 1
Z9 1
U1 2
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD JAN 14
PY 2019
VL 25
IS 3
BP 796
EP 805
DI 10.1002/chem.201804862
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA HI2NB
UT WOS:000456280800019
PM 30351481
DA 2020-07-08
ER

PT J
AU Ferreira, JE
   Ferreira, SC
   Almeida-Neto, C
   Nishiya, AS
   Alencar, CS
   Gouveia, GR
   Caiaffa, H
   Gomes, H
   Santosid, RTD
   Witkin, SS
   Mendrone, A
   Sabino, EC
AF Ferreira, Jerenice E.
   Ferreira, Suzete C.
   Almeida-Neto, Cesar
   Nishiya, Anna S.
   Alencar, Cecilia S.
   Gouveia, Gisele R.
   Caiaffa-Filho, Helio
   Gomes, Helio
   de Macedo Santosid, Raimunda Telma
   Witkin, Steven S.
   Mendrone-Junior, Alfredo
   Sabino, Ester C.
TI Molecular characterization of viruses associated with encephalitis in
   Sao Paulo, Brazil
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS; PCR ASSAYS; DENGUE; INFECTIONS; EPIDEMIOLOGY; ENTEROVIRUS;
   DISEASES
AB The objective of this study was to characterize the prevalence of viral encephalitis due to arbovirus infection of the Togaviridae and Flaviviridae families in Sao Paulo, Brazil. A total of 500 cerebrospinal fluid (CSF) samples collected between August 2012 and January 2013, from patients with symptoms of acute encephalitis were analyzed. Findings suggestive of viral encephalitis-elevations in cell concentration, glucose and total protein-were observed in 234 (46.8%) samples, designated as Group 1. The remaining 266 samples comprised Group 2. All samples were tested for Flaviviruses (dengue virus 1, 2, 3 and 4, yellow fever virus and West Nile virus), Alphavirus (NS5 region) and enterovirus by RT-PCR and for herpesviruses and enteroviruses using CLART(-)Entherpex. A presumptive viral etiological agent was detected in 26 samples (5.2%), 18 (8.0%) in Group 1 and 8 (3.0%) in Group 2. In Group 1 human herpesviruses were detected in 9 cases, enteroviruses in 7 cases, dengue viruses (DENV) in 2 CSFs and St. Louis encephalitis virus (SLEV) in one case. In Group 2 there were 3 CSFs positive for human herpesviruses, 2 for enteroviruses, 2 for DENV and 1 for SLEV. Detection of arboviruses, even though present in a minority of infected patients, identifies these viruses as a probable etiological agent of encephalitis. This is of special concern in regions where this class of viruses is endemic and has been linked to other recent epidemics.
C1 [Ferreira, Jerenice E.; Sabino, Ester C.] Univ Sao Paulo, Med Sch, Inst Trop Med IMT, LIM 46 Lab Med Parasitol, Sao Paulo, Brazil.
   [Ferreira, Jerenice E.; Caiaffa-Filho, Helio; de Macedo Santosid, Raimunda Telma] Adolf Lutz Inst IAL, Pathol Ctr, Sao Paulo, Brazil.
   [Ferreira, Suzete C.; Almeida-Neto, Cesar; Nishiya, Anna S.; Mendrone-Junior, Alfredo] FPS HSP, Sao Paulo, Brazil.
   [Almeida-Neto, Cesar] Univ Sao Paulo, Fac Med, Disciplina Ciencias Med, Sao Paulo, Brazil.
   [Alencar, Cecilia S.; Caiaffa-Filho, Helio; Gomes, Helio] HCSP, DLC, Cent Lab Div, Sao Paulo, Brazil.
   [Alencar, Cecilia S.; Gomes, Helio] Univ Sao Paulo, Med Sch, Dept Clin Hosp, Clin Lab, Sao Paulo, Brazil.
   [Alencar, Cecilia S.; Gomes, Helio] Univ Sao Paulo, Med Sch, Dept Clin Hosp, LIM 03, Sao Paulo, Brazil.
   [Gouveia, Gisele R.] Univ Sao Paulo, Fac Med, FMUSP, Sao Paulo, Brazil.
   [Witkin, Steven S.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA.
RP Ferreira, JE (corresponding author), Univ Sao Paulo, Med Sch, Inst Trop Med IMT, LIM 46 Lab Med Parasitol, Sao Paulo, Brazil.; Ferreira, JE (corresponding author), Adolf Lutz Inst IAL, Pathol Ctr, Sao Paulo, Brazil.
EM jerenice.ferreira@gmail.com
RI Gouveia, Gisele/T-6376-2019; Sabino, Ester Cerdeira/F-7750-2010; Witkin,
   Steven/AAF-3812-2019; DE ALMEIDA-NETO, CESAR/O-9224-2014
OI Gouveia, Gisele/0000-0002-1627-4490; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Ferreira, Jerenice/0000-0002-9729-9154; DE
   ALMEIDA-NETO, CESAR/0000-0002-8490-4634
FU Foundation for Research Support of the State of Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2011/52094-3]
FX This work was supported by Foundation for Research Support of the State
   of Sao Paulo for the Financial Assistance (FAPESP) (Process Number:
   2011/52094-3). Principal Investigator: Ester C. Sabino.; We thank the
   Foundation for Research Support of the State of Sao Paulo for financial
   assistance (Process 2011/52094-3). The funders had no role in the study
   design, data collection, and analyses, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2012, DIR ASS PROT ENC
   Bale JF, 2015, PEDIATR NEUROL, V53, P3, DOI 10.1016/j.pediatrneurol.2015.03.013
   Barcellos C, 2009, EPIDEMIOL SERV SAUDE, V18, P285
   Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   Briese T, 2000, LANCET, V355, P1614, DOI 10.1016/S0140-6736(00)02220-0
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cerri GG., 2014, HOSP CLIN FACULDADE
   Collucci C, 2016, HC FAZ ANIVERSARIO M
   Vieira MACES, 2015, REV INST MED TROP SP, V57, P276, DOI 10.1590/S0036-46652015000300017
   da Silva ANM, 2006, MEM I OSWALDO CRUZ, V101, P547, DOI 10.1590/S0074-02762006000500011
   Heinen LBD, 2015, REV INST MED TROP SP, V57, P215, DOI 10.1590/S0036-46652015000300006
   Faria JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep44949
   Ferreira MLB, 2005, ARQ NEURO-PSIQUIAT, V63, P488, DOI 10.1590/S0004-282X2005000300023
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Fujita DM, 2018, J TRAVEL MED, V25
   Gendelman HE, 2005, LANCET NEUROL, V4, P12, DOI 10.1016/S1474-4422(04)00951-2
   Gilden DH, 2008, ACP MED, P1, DOI [10.1016/S1474-4422(04)00951-2, DOI 10.1016/S1474-4422(04)00951-2]
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Huppatz C, 2009, EMERG INFECT DIS, V15, P1359, DOI 10.3201/eid1509.081540
   Jaijakul S, 2017, INT J INFECT DIS, V59, P77, DOI 10.1016/j.ijid.2017.04.010
   Johnson BW, 2004, AM J TROP MED HYG, V70, P89, DOI 10.4269/ajtmh.2004.70.89
   Kaewpoowat Q, 2016, INFECTION, V44, P337, DOI 10.1007/s15010-015-0867-6
   Kennedy PGE, 2005, J NEUROL, V252, P268, DOI 10.1007/s00415-005-0770-7
   Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   LOPES ODS, 1979, AM J TROP MED HYG, V28, P583
   Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Pinheiro FP, 1997, DOENCAS INFECCIOSAS, P208
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008
   Rodrigues SG, 2010, PAN AMAZ SAUDE, V1, P81
   Rosa R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002537
   Silva MTT, 2013, ARQ NEURO-PSIQUIAT, V71, P703, DOI 10.1590/0004-282X20130155
   TEIXEIRA MG, 1999, INF EPIDEMIOL SUS, V8, P5, DOI DOI 10.5123/S0104-16731999000400002
   Vasconcelos P. F. C., 2015, REV PANAMAZ SAUDE, V2, P9
   Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P72
   VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Volle R, 2012, J VIROL METHODS, V185, P142, DOI 10.1016/j.jviromet.2012.06.019
   Whitley RJ, 2002, LANCET, V359, P507, DOI 10.1016/S0140-6736(02)07681-X
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 47
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 14
PY 2019
VL 14
IS 1
AR e0209993
DI 10.1371/journal.pone.0209993
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH5ZP
UT WOS:000455808000017
PM 30640927
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Motta, D
   Santos, AAB
   Winkler, I
   Machado, BAS
   Pereira, DADI
   Cavalcanti, AM
   Fonseca, EOL
   Kirchner, F
   Badaro, R
AF Motta, Daniel
   Bandeira Santos, Alex Alisson
   Winkler, Ingrid
   Souza Machado, Bruna Aparecida
   Dias Imperial Pereira, Daniel Andre
   Cavalcanti, Alexandre Morais
   Lins Fonseca, Eduardo Oyama
   Kirchner, Frank
   Badaro, Roberto
TI Application of convolutional neural networks for classification of adult
   mosquitoes in the field
SO PLOS ONE
LA English
DT Article
ID AEDES-AEGYPTI; SPATIAL-DISTRIBUTION; CHIKUNGUNYA VIRUS; ZIKA; DIPTERA;
   SYSTEM
AB Dengue, chikungunya and Zika are arboviruses transmitted by mosquitos of the genus Aedes and have caused several outbreaks in world over the past ten years. Morphological identification of mosquitos is currently restricted due to the small number of adequately trained professionals. We implemented a computational model based on a convolutional neural network (CNN) to extract features from mosquito images to identify adult mosquitoes from the species Aedes aegypti, Aedes albopictus and Culex quinquefasciatus. To train the CNN to perform automatic morphological classification of mosquitoes, we used a dataset that included 4,056 mosquito images. Three neural networks, including LeNet, AlexNet and GoogleNet, were used. During the validation phase, the accuracy of the mosquito classification was 57.5% using LeNet, 74.7% using AlexNet and 83.9% using GoogleNet. During the testing phase, the best result (76.2%) was obtained using GoogleNet; results of 52.4% and 51.2% were obtained using LeNet and AlexNet, respectively. Significantly, accuracies of 100% and 90% were achieved for the classification of Aedes and Culex, respectively. A classification accuracy of 82% was achieved for Aedes females. Our results provide information that is fundamental for the automatic morphological classification of adult mosquito species in field. The use of CNN's is an important method for autonomous identification and is a valuable and accessible resource for health workers and taxonomists for the identification of some insects that can transmit infectious agents to humans.
C1 [Motta, Daniel; Bandeira Santos, Alex Alisson; Winkler, Ingrid; Souza Machado, Bruna Aparecida; Dias Imperial Pereira, Daniel Andre; Cavalcanti, Alexandre Morais; Badaro, Roberto] Univ Ctr SENAI CIMATEC, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil.
   [Souza Machado, Bruna Aparecida; Lins Fonseca, Eduardo Oyama; Badaro, Roberto] Hlth Inst Technol CIMATEC ITS, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil.
   [Kirchner, Frank] DFKI, Res Ctr Artificial Intelligence, Bremen, Germany.
RP Machado, BAS (corresponding author), Univ Ctr SENAI CIMATEC, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil.; Machado, BAS (corresponding author), Hlth Inst Technol CIMATEC ITS, Natl Serv Ind Learning SENAI, Salvador, BA, Brazil.
EM brunam@fieb.org.br
RI Santos, Alex A.B./J-4829-2012; Machado, Bruna Aparecida
   Souza/C-3130-2016; Kirchner, Frank/P-6503-2016
OI Machado, Bruna Aparecida Souza/0000-0003-1655-0325; Kirchner,
   Frank/0000-0002-1713-9784
CR Arthur BJ, 2014, J ACOUST SOC AM, V135, P933, DOI 10.1121/1.4861233
   Batista G. E. A. P. A., 2011, Proceedings of the 2011 Tenth International Conference on Machine Learning and Applications (ICMLA 2011), P364, DOI 10.1109/ICMLA.2011.145
   Bova J, 2016, J AM MOSQUITO CONTR, V32, P244, DOI 10.2987/15-6535.1
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC C for DC and P, 2016, SURV CONTR AED AEG A, P1, DOI [10.1371/journal.pntd.0004043, DOI 10.1371/JOURNAL.PNTD.0004043]
   Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029
   de Souza VMA, 2013, 2013 BRAZILIAN CONFERENCE ON INTELLIGENT SYSTEMS (BRACIS), P76, DOI 10.1109/BRACIS.2013.21
   del Carpio-Orantes L, 2018, J ASIA-PAC BIODIVERS, V11, P317, DOI 10.1016/j.japb.2018.01.002
   Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Gaburro J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1870-1
   Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Henry A, 2010, INFECT GENET EVOL, V10, P207, DOI 10.1016/j.meegid.2009.12.001
   Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x
   Karthika P, 2018, ACTA TROP, V183, P84, DOI 10.1016/j.actatropica.2018.04.006
   Kesavaraju B, 2012, J AM MOSQUITO CONTR, V28, P330, DOI 10.2987/12-6254R.1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386
   Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2
   Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Lorenz C, 2015, ACTA TROP, V152, P165, DOI 10.1016/j.actatropica.2015.09.011
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Mewara A, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2854-0
   Mundada R., 2013, IOSR J ELECT COMMUN, V5, P57
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Ouyang TH, 2015, COMPUT ELECTRON AGR, V118, P47, DOI 10.1016/j.compag.2015.08.021
   PAHO, 2017, TOOL DIAGN CAR PAT S
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Sanchez AH, 2017, P REL MAINT S
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Schaper S, 2006, REV BIOL TROP, V54, P847
   Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003
   Schneider J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162493
   Shin JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161015
   Sifferlin A, 2018, TIME
   Silva DF, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P99, DOI 10.1109/ICMLA.2013.24
   Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   van de Vossenberg BTLH, 2015, J MED ENTOMOL, V52, P336, DOI 10.1093/jme/tjv020
   Wang JN, 2012, KNOWL-BASED SYST, V33, P102, DOI 10.1016/j.knosys.2012.03.014
   WHO, 2017, GLOBAL VECTOR CONTRO, V2030, P47
   Yang H., 2015, SCI REP, V5, P1, DOI DOI 10.1038/SREP12786
   Yao Q, 2012, J INTEGR AGR, V11, P978, DOI 10.1016/S2095-3119(12)60089-6
   Zhong YH, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051489
NR 48
TC 5
Z9 5
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 14
PY 2019
VL 14
IS 1
AR e0210829
DI 10.1371/journal.pone.0210829
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH5ZP
UT WOS:000455808000050
PM 30640961
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Amerson-Brown, MH
   Miller, AL
   Maxwell, CA
   White, MM
   Vincent, KL
   Bourne, N
   Pyles, RB
AF Amerson-Brown, Megan H.
   Miller, Aaron L.
   Maxwell, Carrie A.
   White, Mellodee M.
   Vincent, Kathleen L.
   Bourne, Nigel
   Pyles, Richard B.
TI Cultivated Human Vaginal Microbiome Communities Impact Zika and Herpes
   Simplex Virus Replication in ex vivo Vaginal Mucosal Cultures
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE vaginal microbiome; Zika virus; herpes simplex virus type 2; women's
   health; vaginal mucosa
ID SEXUAL TRANSMISSION; IMMUNE ACTIVATION; HIV ACQUISITION; WOMEN;
   INFECTION; INFLAMMATION; RESPONSES; BACTERIA; HEALTH; TRACT
AB The human vaginal microbiome (VMB) is a complex bacterial community that interacts closely with vaginal epithelial cells (VECs) impacting the mucosal phenotype and its responses to pathogenic insults. The VMB and VEC relationship includes nutrient exchange and regulation of signaling molecules that controls numerous host functions and defends against invading pathogens. To better understand infection and replication of sexually transmitted viral pathogens in the human vaginal mucosa we used our ex vivo VEC multilayer culture system. We tested the hypothesis that selected VMB communities could be identified that alter the replication of sexually transmitted viruses consistent with reported clinical associations. Sterile VEC multilayer cultures or those colonized with VMB dominated by specific Lactobacillus spp., or VMB lacking lactobacilli, were infected with Zika virus, (ZIKV) a single stranded RNA virus, or Herpes Simplex Virus type 2 (HSV-2), a double stranded DNA virus. The virus was added to the apical surface of the cultured VEC multilayer to model transmission during vaginal intercourse. Viral replication was measured 48 h later by qPCR. The results indicated that VEC cultures colonized by VMB containing Staphylococcus spp., previously reported as inflammatory, significantly reduced the quantity of viral genomes produced by ZIKV. HSV-2 titers were decreased by nearly every VMB tested relative to the sterile control, although Lactobacillus spp.-dominated VMBs caused the greatest reduction in HSV-2 titer consistent with clinical observations. To explore the mechanism for reduced ZIKV titers, we investigated inflammation created by ZIKV infection, VMB colonization or pre-exposure to selected TLR agonists. Finally, expression levels of human beta defensins 1-3 were quantified in cultures infected by ZIKV and those colonized by VMBs that impacted ZIKV titers. Human beta defensins 1-3 produced by the VEC showed no association with ZIKV titers. The data presented expands the utility of this ex vivo model system providing controlled and reproducible methods to study the VMB impact on STIs and indicated an association between viral replication and specific bacterial species within the VMB.
C1 [Amerson-Brown, Megan H.] Univ Texas Med Branch, Grad Sch Biomed Sci, Galveston, TX 77555 USA.
   [Miller, Aaron L.; White, Mellodee M.; Bourne, Nigel; Pyles, Richard B.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.
   [Maxwell, Carrie A.; Bourne, Nigel; Pyles, Richard B.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Vincent, Kathleen L.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA.
RP Pyles, RB (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.; Pyles, RB (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM rbpyles@utmb.edu
OI Vincent, Kathleen/0000-0003-3051-9551
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1 TR001439]; NIAID NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01 AI100744, U19 AI113048]
CR Alcaide ML, 2017, AIDS RES HUM RETROV, V33, P309, DOI [10.1089/aid.2016.0187, 10.1089/AID.2016.0187]
   Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Borgdorff H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181135
   Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chen HW, 2016, SCI REP-UK, V6, DOI 10.1038/srep27870
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Barros JBD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00821
   DiGiulio DB, 2017, CLIN INFECT DIS, V64, P32, DOI 10.1093/cid/ciw638
   Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Ghartey J, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.03.052
   Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Herbst MM, 2003, J ANTIMICROB CHEMOTH, V52, P887, DOI 10.1093/jac/dkg481
   Herbst-Kralovetz MM, 2006, J VIROL, V80, P9988, DOI 10.1128/JVI.01099-06
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157
   Malki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166757
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Marrazzo JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011139
   Martin DH, 2016, J INFECT DIS, V214, pS36, DOI 10.1093/infdis/jiw184
   Medina-Colorado AA, 2017, ANAEROBE, V45, P10, DOI 10.1016/j.anaerobe.2017.04.014
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Namvar L, 2005, J CLIN MICROBIOL, V43, P2058, DOI 10.1128/JCM.43.5.2058-2064.2005
   Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465
   Noyes N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191625
   Passmore JAS, 2016, CURR OPIN HIV AIDS, V11, P156, DOI 10.1097/COH.0000000000000232
   Perry CL, 2016, J IMMUNOL METHODS, V439, P1, DOI 10.1016/j.jim.2016.09.004
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Pyles RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093419
   Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]
   Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107
   Rose WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032728
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942
   Srinivasan S, 2015, MBIO, V6, DOI 10.1128/mBio.00204-15
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thurman AR, 2015, AIDS RES HUM RETROV, V31, P1139, DOI 10.1089/aid.2015.0006
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Valeri M, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw111
   van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998
   Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038
   Zhang JK, 2017, J BIOMED MATER RES A, V105, P1949, DOI 10.1002/jbm.a.36066
   Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017
   Zhu YQ, 2017, ONCOTARGET, V8, P15267, DOI 10.18632/oncotarget.14840
NR 57
TC 3
Z9 3
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 14
PY 2019
VL 9
AR 3340
DI 10.3389/fmicb.2018.03340
PG 12
WC Microbiology
SC Microbiology
GA HH3OC
UT WOS:000455627900001
PM 30692980
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roosa, K
   Chowell, G
AF Roosa, Kimberlyn
   Chowell, Gerardo
TI Assessing parameter identifiability in compartmental dynamic models
   using a computational approach: application to infectious disease
   transmission models
SO THEORETICAL BIOLOGY AND MEDICAL MODELLING
LA English
DT Article
DE Compartmental models; Parameter identifiability; Uncertainty
   quantification; Epidemic models; Structural parameter identifiability;
   Practical parameter identifiability
ID EPIDEMIC; INFERENCE; INFLUENZA; NUMBER
AB BackgroundMathematical modeling is now frequently used in outbreak investigations to understand underlying mechanisms of infectious disease dynamics, assess patterns in epidemiological data, and forecast the trajectory of epidemics. However, the successful application of mathematical models to guide public health interventions lies in the ability to reliably estimate model parameters and their corresponding uncertainty. Here, we present and illustrate a simple computational method for assessing parameter identifiability in compartmental epidemic models.MethodsWe describe a parametric bootstrap approach to generate simulated data from dynamical systems to quantify parameter uncertainty and identifiability. We calculate confidence intervals and mean squared error of estimated parameter distributions to assess parameter identifiability. To demonstrate this approach, we begin with a low-complexity SEIR model and work through examples of increasingly more complex compartmental models that correspond with applications to pandemic influenza, Ebola, and Zika.ResultsOverall, parameter identifiability issues are more likely to arise with more complex models (based on number of equations/states and parameters). As the number of parameters being jointly estimated increases, the uncertainty surrounding estimated parameters tends to increase, on average, as well. We found that, in most cases, R-0 is often robust to parameter identifiability issues affecting individual parameters in the model. Despite large confidence intervals and higher mean squared error of other individual model parameters, R-0 can still be estimated with precision and accuracy.ConclusionsBecause public health policies can be influenced by results of mathematical modeling studies, it is important to conduct parameter identifiability analyses prior to fitting the models to available data and to report parameter estimates with quantified uncertainty. The method described is helpful in these regards and enhances the essential toolkit for conducting model-based inferences using compartmental dynamic models.
C1 [Roosa, Kimberlyn; Chowell, Gerardo] Georgia State Univ, Dept Populat Hlth Sci, Sch Publ Hlth, Atlanta, GA 30303 USA.
   [Chowell, Gerardo] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
RP Roosa, K (corresponding author), Georgia State Univ, Dept Populat Hlth Sci, Sch Publ Hlth, Atlanta, GA 30303 USA.
EM kroosa1@student.gsu.edu
RI Roosa, Kimberlyn/X-5779-2019
OI Roosa, Kimberlyn/0000-0003-1169-7125
FU NSF, joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases
   programNational Science Foundation (NSF) [1414374]; UK Biotechnology and
   Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [BB/M008894/1]
FX GC acknowledges financial support from the NSF grant 1414374 as part of
   the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases
   program; UK Biotechnology and Biological Sciences Research Council grant
   BB/M008894/1.
CR ANDERSON R M, 1991
   Banks HT, 2010, MATH COMPUT MODEL, V52, P1610, DOI 10.1016/j.mcm.2010.06.026
   Banks H. T., 2009, MATH STAT ESTIMATION, P249, DOI DOI 10.1007/978-90-481-2313-1_11
   Ben Abdessalem A, 2018, MECH SYST SIGNAL PR, V99, P306, DOI 10.1016/j.ymssp.2017.06.017
   BRAUER F, 2008, MATH EPIDEMIOLOGY
   Breto C, 2018, STAT SCI, V33, P57, DOI 10.1214/17-STS636
   Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755
   Chowell G, 2006, VACCINE, V24, P6747, DOI 10.1016/j.vaccine.2006.05.055
   Chowell G, 2005, BASIC REPROD NUMBER
   Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161
   Chowell Gerardo, 2017, Infect Dis Model, V2, P379, DOI 10.1016/j.idm.2017.08.001
   Chowell G, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0811-y
   COBELLI C, 1976, IEEE T BIO-MED ENG, V23, P93, DOI 10.1109/TBME.1976.324568
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Efron B., 1993, INTRO BOOTSTRAP
   Eisenberg MC, 2013, J THEOR BIOL, V324, P84, DOI 10.1016/j.jtbi.2012.12.021
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gibson GJ, 2018, STAT SCI, V33, P19, DOI 10.1214/17-STS615
   Goeyvaerts N, 2015, EPIDEMICS-NETH, V13, P1, DOI 10.1016/j.epidem.2015.04.002
   He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151
   JACQUEZ JA, 1985, COMPARTMENTAL ANAL B
   Kao YH, 2018, EPIDEMICS-NETH, V25, P89, DOI 10.1016/j.epidem.2018.05.010
   Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217
   Ljung L, 1991, IFAC P VOLUMES, V24, P1085, DOI [10.1016/S1474-6670(17)52494-5, DOI 10.1016/S1474-6670(17)52494-5]
   Lloyd A, 2007, INTRO EPIDEMIOLOGICA
   Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009
   POHJANPALO H, 1978, MATH BIOSCI, V41, P21, DOI 10.1016/0025-5564(78)90063-9
   Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358
   Scranton K, 2014, ECOLOGY, V95, P1418, DOI 10.1890/13-1065.1
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Nguyen VK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00257
   Wu KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148061
NR 32
TC 7
Z9 7
U1 5
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4682
J9 THEOR BIOL MED MODEL
JI Theor. Biol. Med. Model.
PD JAN 14
PY 2019
VL 16
AR 1
DI 10.1186/s12976-018-0097-6
PG 15
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA HH4EH
UT WOS:000455673300001
PM 30642334
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baraniuk, C
AF Baraniuk, Chris
TI Zika outbreak was 'hidden' in Cuba
SO NEW SCIENTIST
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU REED BUSINESS INFORMATION LTD
PI SUTTON
PA QUADRANT HOUSE THE QUADRANT, SUTTON SM2 5AS, SURREY, ENGLAND
SN 0262-4079
J9 NEW SCI
JI New Sci.
PD JAN 12
PY 2019
VL 241
IS 3212
BP 8
EP 8
DI 10.1016/S0262-4079(19)30041-7
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH2OR
UT WOS:000455558500008
DA 2020-07-08
ER

PT J
AU dos Santos, SFM
   Soares, FVM
   de Abranches, AD
   da Costa, ACC
   Moreira, MEL
   Fonseca, VD
AF Morais dos Santos, Samira Fernandes
   Mendes Soares, Fernanda Valente
   de Abranches, Andrea Dunshee
   Carioca da Costa, Ana Carolina
   Lopes Moreira, Maria Elisabeth
   Fonseca, Vania de Matos
TI Infants with microcephaly due to ZIKA virus exposure: nutritional status
   and food practices
SO NUTRITION JOURNAL
LA English
DT Article
DE Zika virus; Microcephaly; Nutritional status; Infant nutrition
ID FEEDING PRACTICES; CHILDREN; BRAZIL; AGE
AB BackgroundChildren with microcephaly due to vertical exposure to Zika virus are an interesting population for investigation. Highlighted among their unique aspects are those related to nutrition due to its impact on child growth and development. Knowledge about the nutrition of microcephalic infants can help mothers and caregivers provide better care. Thus, this study aimed to describe the nutritional status and feeding practices of infants with microcephaly due to Zika virus exposure at birth and 12-23months of age.MethodsThis is a descriptive study developed from a cohort of patients attending a public institution of reference. A total of 65 infants attended outpatient nutrition clinics. The food practices were described using the 24-h food recall and food consumption indicators. Anthropometric measurements and consultations were made using the Child Health Handbook to obtain information on the nutritional status (weight, height and head circumference) at the time of consultation and birth.ResultsThere was a significant decrease in z-scores for weight, height and head circumference (HC) from birth to the time of the consultation. However, most infants did not show weight-for-height deficits. Additionally, HC was correlated with the anthropometric indices weight-for-age, height-for-age, body mass index-for-age and weight-for-height.ConclusionInfants exhibited a worsening of their nutritional status between birth and the time of their consultation, notably when we evaluated the indices of height and head circumference for age. The main inadequacies regarding dietary practices were low food diversity, use of ultra-processed products and low lipid intake.
C1 [Morais dos Santos, Samira Fernandes; Mendes Soares, Fernanda Valente; de Abranches, Andrea Dunshee; Carioca da Costa, Ana Carolina; Lopes Moreira, Maria Elisabeth; Fonseca, Vania de Matos] Fiocruz MS, Fundacao Oswaldo Cruz, IFF, Inst Inst Nacl Saude Mulher Crianca & Adolescente, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
RP dos Santos, SFM (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, IFF, Inst Inst Nacl Saude Mulher Crianca & Adolescente, Av Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM samira_fernandes13@hotmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Santos,
   Samira/0000-0002-1745-7678
FU Wellcome TrustWellcome Trust [205377/Z/16/Z]; United Kingdom's
   Department for International Development; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [441098/2016-9];
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E_18/2015TXB]; European Union's Horizon 2020 research
   and innovation programme under Zika-PLAN grant [734584]
FX This study was supported by the Wellcome Trust (205377/Z/16/Z) and the
   United Kingdom's Department for International Development; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   (441098/2016-9); Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)(E_18/2015TXB) and European Union's Horizon 2020
   research and innovation programme under Zika-PLAN grant agreement no.
   734584.
CR [Anonymous], 2015, DEZ PASS AL SAUD GUI
   [Anonymous], 2017, OR INT VIG AT SAUD A
   [Anonymous], 2011, OR COL AN DAD ANTR S
   Claro RM, 2015, EPIDEMIOL SERV SAUDE, V24, P257, DOI 10.5123/S1679-49742015000200008
   Cozzolino SMF, 2013, BASES BIOQUIMICAS FI, P1257
   CULLEY WJ, 1969, J PEDIATR-US, V75, P380, DOI 10.1016/S0022-3476(69)80262-3
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Marinho LMF, 2016, CIENC SAUDE COLETIVA, V21, P977, DOI 10.1590/1413-81232015213.06532015
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leandro CG, 2016, DEV MED CHILD NEUROL, V58, P893, DOI 10.1111/dmcn.13134
   da Cunha AJLA, 2015, J PEDIAT-BRAZIL, V91, pS44, DOI 10.1016/j.jped.2015.07.002
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Ministerio da Saude, 2015, OR AV MARC CONS AL A
   Ministerio da Saude (BR), 2015, MIN SAUD CONF REL EN
   Ministerio da Saude. Sistema de Vigilancia Alimentar e Nutricional, 2006, SIST VIG AL NUTR
   Monteiro C, 2010, WORLD NUTR, V1, P237
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mozetic RM, 2016, REAS REV ELETRONICA, V8
   National Academy Press, 2002, DIET REF INT EN CARB
   Oliveira JM, 2015, CAD SAUDE PUBLICA, V31, P377, DOI 10.1590/0102-311X00209513
   Penagini F, 2015, NUTRIENTS, V7, P9400, DOI 10.3390/nu7115469
   Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102
   Saldan PC, 2015, REV NUTR, V28, P409, DOI 10.1590/1415-52732015000400007
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   White JM, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12505
   WHO, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2011, WHO ANTHR VERS 3 2 2
   World Health Organization, 2016, ASS INF MICR CONT ZI
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 30
TC 1
Z9 1
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2891
J9 NUTR J
JI Nutr. J.
PD JAN 11
PY 2019
VL 18
AR 4
DI 10.1186/s12937-019-0429-3
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA HH2LR
UT WOS:000455550600002
PM 30634976
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hao, HJ
   Hao, SJ
   Chen, HH
   Chen, Z
   Zhang, YF
   Wang, J
   Wang, HZ
   Zhang, B
   Qiu, JM
   Deng, F
   Guan, WX
AF Hao, Haojie
   Hao, Sujuan
   Chen, Honghe
   Chen, Zhen
   Zhang, Yanfang
   Wang, Jun
   Wang, Hanzhong
   Zhang, Bo
   Qiu, Jianming
   Deng, Fei
   Guan, Wuxiang
TI N-6-methyladenosine modification and METTL3 modulate enterovirus 71
   replication
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID MESSENGER-RNA METHYLATION; M(6)A RNA; GENE-EXPRESSION; NUCLEAR-RNA;
   VIRUS; N6-METHYLADENOSINE; TRANSLATION; M6A; IDENTIFICATION; METHYLOMES
AB N-6-methyladenosine (m(6)A) constitutes one of the most abundant internal RNA modifications and is critical for RNA metabolism and function. It has been previously reported that viral RNA contains internal m(6)A modifications; however, only recently the function of m(6)A modification in viral RNAs has been elucidated during infections of HIV, hepatitis C virus and Zika virus. In the present study, we found that enterovirus 71 (EV71) RNA undergoes m(6)A modification during viral infection, which alters the expression and localization of the methyltransferase and demethylase of m(6)A, and its binding proteins. Moreover, knockdown of m(6)A methyltransferase resulted in decreased EV71 replication, whereas knockdown of the demethylase had the opposite effect. Further study showed that the m(6)A binding proteins also participate in the regulation of viral replication. In particular, two m(6)A modification sites were identified in the viral genome, of which mutations resulted in decreased virus replication, suggesting that m(6)A modification plays an important role in EV71 replication. Notably, we found that METTL3 interacted with viral RNA-dependent RNA polymerase 3D and induced enhanced sumoylation and ubiquitination of the 3D polymerase that boosted viral replication. Taken together, our findings demonstrated that the host m(6)A modification complex interacts with viral proteins to modulate EV71 replication.
C1 [Hao, Haojie; Hao, Sujuan; Chen, Honghe; Chen, Zhen; Zhang, Yanfang; Wang, Jun; Wang, Hanzhong; Zhang, Bo; Deng, Fei; Guan, Wuxiang] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Wuhan 430071, Hubei, Peoples R China.
   [Hao, Haojie; Hao, Sujuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Qiu, Jianming] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA.
RP Deng, F; Guan, WX (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Wuhan 430071, Hubei, Peoples R China.
EM df@wh.iov.cn; guanwx@wh.iov.cn
OI Zhang, Bo/0000-0002-8895-3679
FU Ministry of Science and Technology of ChinaMinistry of Science and
   Technology, China [2016YFC1200400]; Chinese Academy of SciencesChinese
   Academy of Sciences [ZDRW-ZS-2016-4]; Open Research Fund Program of CAS
   Key Laboratory of Special Pathogens and Biosafety, Chinese Academy of
   Sciences [ZDRW-ZS-2016-4, 2015SPCAS002]
FX Ministry of Science and Technology of China [2016YFC1200400]; Chinese
   Academy of Sciences [ZDRW-ZS-2016-4]; Open Research Fund Program of CAS
   Key Laboratory of Special Pathogens and Biosafety, Chinese Academy of
   Sciences [2015SPCAS002 to W.G.]. The funders had no role in the design,
   interpretation, or submission of this work for publication. Funding for
   open access charge: Chinese Academy of Sciences [ZDRW-ZS-2016-4].
CR Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732
   BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980
   Basanta-Sanchez M, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv971
   Bokar JA, 1997, RNA, V3, P1233
   BOONE RF, 1977, VIROLOGY, V79, P67, DOI 10.1016/0042-6822(77)90335-X
   BOTH GW, 1975, P NATL ACAD SCI USA, V72, P1189, DOI 10.1073/pnas.72.3.1189
   Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9
   Chen HH, 2014, J IMMUNOL, V192, P1162, DOI 10.4049/jimmunol.1300798
   Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004
   Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1
   Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417
   Gokhale NS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006188
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Hao SJ, 2017, J VIROL, V91, DOI 10.1128/JVI.02026-16
   Harcourt EM, 2013, J AM CHEM SOC, V135, P19079, DOI 10.1021/ja4105792
   Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995
   Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397
   Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]
   KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298
   Kennedy EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02263-16
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   Lewis CJT, 2017, NAT REV MOL CELL BIO, V18, P202, DOI 10.1038/nrm.2016.163
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432
   Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234
   Liu Y, 2016, J VIROL, V90, P10472, DOI 10.1128/JVI.01756-16
   Mallette FA, 2012, CELL RES, V22, P1221, DOI 10.1038/cr.2012.58
   McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1016/S0168-6445(02)00070-0
   Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012
   Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   MOYER SA, 1976, VIROLOGY, V70, P339, DOI 10.1016/0042-6822(76)90276-2
   NARAYAN P, 1987, MOL CELL BIOL, V7, P1572, DOI 10.1128/MCB.7.4.1572
   Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342
   PEREIRAMONTECINOS, 2017, BIOCHIM BIOPHYS ACTA, V1860, P460, DOI DOI 10.1016/J.BBAGRM.2017.02.002
   Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3
   PIZZI M, 1950, Hum Biol, V22, P151
   Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048
   Shang BD, 2013, ANTIVIR RES, V97, P198, DOI 10.1016/j.antiviral.2012.12.010
   Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8
   Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8
   Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   Tsai K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006919
   Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014
   Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730
   Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]
   Ye FC, 2017, J VIROL, V91, DOI 10.1128/JVI.00466-17
   Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
   Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883
   Zhou J, 2018, MOL CELL, V69, P636, DOI 10.1016/j.molcel.2018.01.019
   Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377
NR 57
TC 14
Z9 15
U1 6
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 10
PY 2019
VL 47
IS 1
BP 362
EP 374
DI 10.1093/nar/gky1007
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HQ7GA
UT WOS:000462586700033
PM 30364964
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zorec, R
   Zupanc, TA
   Verkhratsky, A
AF Zorec, Robert
   Zupanc, Tatjana Avsic
   Verkhratsky, Alexei
TI Astrogliopathology in the infectious insults of the brain
SO NEUROSCIENCE LETTERS
LA English
DT Review
DE Astroglia; Neuroinfection; CNS homeostasis; Zika virus; Tick-borne
   encephalitis virus
ID BORNE ENCEPHALITIS-VIRUS; DORSOLATERAL PREFRONTAL CORTEX; AEROBIC
   GLYCOLYSIS; VESICLE MOBILITY; CORTICAL ASTROCYTES; HEPARAN-SULFATE;
   DENGUE-VIRUS; GLIAL-CELLS; WEST-NILE; LACTATE
AB Astroglia, a heterogeneous type of neuroglia, play key homeostatic functions in the central nervous system (CNS) and represent an important defence system. Impaired homeostatic capacity of astrocytes manifests in diseases and this is mirrored in various astrocyte-based pathological features including reactive astrogliosis, astro-degeneration with astroglial atrophy and pathological remodelling of astrocytes. All of these manifestations are most prominently associated with infectious insults, mediated by bacteria, protozoa and viruses. Here we focus onto neurotropic viruses such as tick-borne encephalitis (TBEV) and Zika virus (ZIKV), both belonging to Flaviviridae and both causing severe neurological impairments. We argue that astrocytes provide a route through which neurotropic infectious agents attack the CNS, since they are anatomically associated with the blood-brain barrier and exhibit aerobic glycolysis, a metabolic specialisation of highly morphologically dynamic cells, which may provide a suitable metabolic milieu for proliferation of infectious agents, including viral bodies.
C1 [Zorec, Robert; Verkhratsky, Alexei] Univ Ljubljana, Inst Pathophysiol, Lab Neuroendocrinol & Mol Cell Physiol, Zaloska Cesta 4, SI-1000 Ljubljana, Slovenia.
   [Zorec, Robert; Verkhratsky, Alexei] Celica, BIOMEDICAL, Technol Pk 24, Ljubljana 1000, Slovenia.
   [Verkhratsky, Alexei] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, DK-2200 Copenhagen, Denmark.
   [Zupanc, Tatjana Avsic] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Zaloska 4, Ljubljana 1000, Slovenia.
   [Verkhratsky, Alexei] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England.
   [Verkhratsky, Alexei] Basque Fdn Sci, Ikerbasque, Achucarro Ctr Neurosci, Bilbao 48011, Spain.
RP Zorec, R (corresponding author), Univ Ljubljana, Inst Pathophysiol, Lab Neuroendocrinol & Mol Cell Physiol, Zaloska Cesta 4, SI-1000 Ljubljana, Slovenia.
EM robert.zorec@mf.uni-lj.si
RI li, jian/AAD-5811-2019; Verkhratsky, Alexei/J-4527-2013
OI Verkhratsky, Alexei/0000-0003-2592-9898; AVSIC ZUPANC,
   TATJANA/0000-0001-6243-0688
FU Slovenian Research Agency (ARRS)Slovenian Research Agency - Slovenia [P3
   310, J3 6790, J3 6789, J3 7605]; CipKeBip; COST ActionEuropean
   Cooperation in Science and Technology (COST) [BM1002]; EU COST
   ActionEuropean Union (EU)European Cooperation in Science and Technology
   (COST) [CM1207 - GLISTEN]
FX This work was supported by grantsP3 310, J3 6790, J3 6789 and J3 7605
   from the Slovenian Research Agency (ARRS), CipKeBip, COST Action BM1002,
   EU COST Action CM1207 - GLISTEN (to RZ).
CR Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004
   Achucarro N., 1915, TRAB LAB INVEST BIOL, V13, P169
   Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059
   Alzheimer A., 1910, HISTOLOGISCHE HISTOP, V3
   Andriezen W L, 1893, Br Med J, V2, P227
   Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613
   Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040
   Bernacki J, 2008, PHARMACOL REP, V60, P600
   Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06
   Brissette CA, 2013, ASN NEURO, V5, DOI 10.1042/AN20130010
   Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034
   Cabral CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005447
   Carmignoto G, 2010, BRAIN RES REV, V63, P138, DOI 10.1016/j.brainresrev.2009.11.007
   Castillo X, 2015, J CEREBR BLOOD F MET, V35, P1561, DOI 10.1038/jcbfm.2015.115
   Chauhan A, 2014, NEUROSCI RES, V88, P16, DOI 10.1016/j.neures.2014.08.013
   Chauhan VS, 2008, J IMMUNOL, V180, P8241, DOI 10.4049/jimmunol.180.12.8241
   Chu JJH, 2006, VIROLOGY, V349, P463, DOI 10.1016/j.virol.2006.01.022
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Ciofi P, 2011, NEUROSCI LETT, V487, P187, DOI 10.1016/j.neulet.2010.10.019
   Combes V, 2012, TRENDS PARASITOL, V28, P311, DOI 10.1016/j.pt.2012.05.008
   Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386
   Czeh B, 2013, EUR NEUROPSYCHOPHARM, V23, P171, DOI 10.1016/j.euroneuro.2012.04.017
   Dienel GA, 2016, J NEUROCHEM, V138, P14, DOI 10.1111/jnc.13630
   Ding FF, 2013, CELL CALCIUM, V54, P387, DOI 10.1016/j.ceca.2013.09.001
   Dotevall L, 1996, INFECTION, V24, P125, DOI 10.1007/BF01713316
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Esen N, 2007, GLIA, V55, P104, DOI 10.1002/glia.20438
   Ferrer I., 2018, NEUROGLIA, V1, P10
   Ferrer I, 2017, BRAIN PATHOL, V27, P645, DOI 10.1111/bpa.12538
   FOOTE SL, 1983, PHYSIOL REV, V63, P844
   Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020
   Greene W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000512
   Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1
   GROSS PM, 1987, J CEREBR BLOOD F MET, V7, P663, DOI 10.1038/jcbfm.1987.120
   Grummer B, 2004, J VET MED B, V51, P427, DOI 10.1111/j.1439-0450.2004.00798.x
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Helsel AR, 2017, STEM CELL REP, V8, P1430, DOI 10.1016/j.stemcr.2017.03.004
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Hertz Leif, 2013, Front Endocrinol (Lausanne), V4, P59, DOI 10.3389/fendo.2013.00059
   Hidano S, 2016, MBIO, V7, DOI 10.1128/mBio.01881-16
   Horvat A, 2017, CURR PHARM DESIGN, V23, P4969, DOI 10.2174/1381612823666170622112734
   Jastrowitz M, 1870, ARCH PSYCHIAT, V2, P389, DOI [10.1007/BF02046645, DOI 10.1007/BF02046645]
   Jones VC, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.89
   KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123
   Kirischuk S, 1996, EUR J NEUROSCI, V8, P1198, DOI 10.1111/j.1460-9568.1996.tb01288.x
   Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012
   Kozlovskaya LI, 2010, VIROLOGY, V398, P262, DOI 10.1016/j.virol.2009.12.012
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Lanciotti A, 2013, TRANSL NEUROSCI, V4, P144, DOI 10.2478/s13380-013-0118-1
   Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006
   lovino F., 2013, PLOS ONE, V8
   Magistretti PJ, 2018, NAT REV NEUROSCI, V19, P235, DOI 10.1038/nrn.2018.19
   Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007
   Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001
   MASON WT, 1988, J EXP BIOL, V139, P287
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7
   Medana IM, 1997, GLIA, V19, P91, DOI 10.1002/(SICI)1098-1136(199702)19:2<91::AID-GLIA1>3.0.CO;2-C
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012
   Miguel-Hidalgo Jose Javier, 2009, Curr Drug Abuse Rev, V2, P76
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morland C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15557
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nissl F, 1899, ARCH PSYCH, V32, P1
   Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3
   Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967
   Pankratov Y, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00230
   Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038
   Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1
   Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013
   Potokar M, 2005, BIOCHEM BIOPH RES CO, V329, P678, DOI 10.1016/j.bbrc.2005.02.030
   Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x
   Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219
   Potokar M, 2013, GLIA, V61, P917, DOI 10.1002/glia.22485
   Prebil M, 2011, GLIA, V59, P903, DOI 10.1002/glia.21161
   Rajkowska G, 2002, SCHIZOPHR RES, V57, P127, DOI 10.1016/S0920-9964(02)00339-0
   Ramesh G, 2003, EUR J IMMUNOL, V33, P2539, DOI 10.1002/eji.200323872
   Rodriguez JJ, 2016, CURR ALZHEIMER RES, V13, P343, DOI 10.2174/1567205013666160229112911
   Roland CL, 2014, CANCER RES, V74, P5301, DOI 10.1158/0008-5472.CAN-14-0319
   Rose CR, 2016, GLIA, V64, P1611, DOI 10.1002/glia.22964
   Ruzek D, 2008, VIRUS RES, V137, P142, DOI 10.1016/j.virusres.2008.05.013
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032
   Schmitt A, 2009, ACTA NEUROPATHOL, V117, P395, DOI 10.1007/s00401-008-0430-y
   Schulz Martina, 2005, Cerebrospinal Fluid Res, V2, P8, DOI 10.1186/1743-8454-2-8
   Schwarcz R, 2007, SCHIZOPHRENIA BULL, V33, P652, DOI 10.1093/schbul/sbm030
   Scofield MD, 2016, BIOL PSYCHIAT, V80, P207, DOI 10.1016/j.biopsych.2015.12.022
   SIKDAR SK, 1990, FEBS LETT, V273, P150, DOI 10.1016/0014-5793(90)81072-V
   Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420
   Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466
   Stenovec M, 2018, MOL NEUROBIOL
   Stenzel W, 2004, J NEUROPATH EXP NEUR, V63, P631, DOI 10.1093/jnen/63.6.631
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Suzuki Y, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002018
   Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284
   Tech K, 2015, TRANSL PEDIATR, V4, P12, DOI 10.3978/j.issn.2224-4336.2015.01.03
   Vardjan N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00148
   Vardjan N, 2015, NEUROCHEM RES, V40, P2414, DOI 10.1007/s11064-015-1545-x
   Vardjan N, 2015, CELL TRANSPLANT, V24, P599, DOI 10.3727/096368915X687750
   Verkhratsky A, 2018, NEUROGLIA, V1, P4
   Verkhratsky A., 2016, PHILOS T R SOC LON B, V371
   Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016
   Verkhratsky A, 2017, BRAIN PATHOL, V27, P629, DOI 10.1111/bpa.12537
   Verkhratsky A, 2016, EMBO J, V35, P239, DOI 10.15252/embj.201592705
   Verkhratsky A, 2016, PROG NEUROBIOL, V144, P188, DOI 10.1016/j.pneurobio.2015.09.003
   Verkhratsky A, 2016, CURR OPIN PHARMACOL, V26, P74, DOI 10.1016/j.coph.2015.09.011
   Verkhratsky A, 2016, NEUROBIOL DIS, V85, P254, DOI 10.1016/j.nbd.2015.03.025
   Verkhratsky A, 2015, NEUROSCIENTIST, V21, P552, DOI 10.1177/1073858414547132
   Verkhratsky A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0595
   Verkhratsky A, 2014, NEUROSCIENTIST, V20, P576, DOI 10.1177/1073858413510208
   Verkhratsky A, 2013, FUTUR NEUROL, V8, P149, DOI 10.2217/fnl.12.90
   Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017
   Wilson EH, 2004, INT J PARASITOL, V34, P543, DOI 10.1016/j.ijpara.2003.12.010
   Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012
   Zorec R, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12915
NR 123
TC 8
Z9 8
U1 1
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD JAN 10
PY 2019
VL 689
SI SI
BP 56
EP 62
DI 10.1016/j.neulet.2018.08.003
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA HI9DO
UT WOS:000456755700009
PM 30096375
DA 2020-07-08
ER

PT J
AU Paz-Bailey, G
   Rosenberg, ES
   Sharp, TM
AF Paz-Bailey, Gabriela
   Rosenberg, Eli S.
   Sharp, Tyler M.
TI Persistence of Zika Virus in Body Fluids - Final Report Reply
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Paz-Bailey, Gabriela; Sharp, Tyler M.] Ctr Dis Control & Prevent, San Juan, PR 00920 USA.
   [Rosenberg, Eli S.] SUNY Albany, Sch Publ Hlth, Albany, NY USA.
RP Paz-Bailey, G (corresponding author), Ctr Dis Control & Prevent, San Juan, PR 00920 USA.
EM gmb5@cdc.gov
FU NCEZID CDC HHS [U01 CK000437]
CR Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Turner LH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006684
NR 5
TC 1
Z9 1
U1 1
U2 5
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JAN 10
PY 2019
VL 380
IS 2
BP 198
EP 199
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA HG9EV
UT WOS:000455310300026
PM 30625068
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Sanchez-Montalva, A
   Salvador, F
   Molina, I
AF Sanchez-Montalva, Adrian
   Salvador, Fernando
   Molina, Israel
TI Persistence of Zika Virus in Body Fluids - Final Report
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID DENGUE
C1 [Sanchez-Montalva, Adrian; Salvador, Fernando; Molina, Israel] Hosp Univ Vall dHebron, Barcelona, Spain.
RP Sanchez-Montalva, A (corresponding author), Hosp Univ Vall dHebron, Barcelona, Spain.
EM adsanche@vhebron.net
OI Salvador, Fernando/0000-0002-0546-1354; Molina Romero,
   Israel/0000-0001-6642-7515
CR Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Thomas L, 2012, ANN EMERG MED, V59, P42, DOI 10.1016/j.annemergmed.2011.08.010
NR 5
TC 1
Z9 1
U1 0
U2 3
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JAN 10
PY 2019
VL 380
IS 2
BP 198
EP 198
DI 10.1056/NEJMc1814416
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA HG9EV
UT WOS:000455310300025
PM 30628425
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Fang, Y
   Zhang, Y
   Zhou, ZB
   Xia, S
   Shi, WQ
   Xue, JB
   Li, YY
   Wu, JT
AF Fang, Yuan
   Zhang, Yi
   Zhou, Zheng-Bin
   Xia, Shang
   Shi, Wen-Qi
   Xue, Jing-Bo
   Li, Yuan-Yuan
   Wu, Jia-Tong
TI New strains of Japanese encephalitis virus circulating in Shanghai,
   China after a ten-year hiatus in local mosquito surveillance
SO PARASITES & VECTORS
LA English
DT Article
DE Japanese encephalitis; Mosquito-borne diseases; Culex tritaeniorhynchus;
   Culex pipiens; SA14-14-2
ID WEST-NILE-VIRUS; CLINICAL-FEATURES; DOMINANT GENOTYPE; VACCINE;
   INFECTION; OUTBREAK; SA14-14-2; EMERGENCE; DYNAMICS; PROVINCE
AB BackgroundContinuous vector pathogen surveillance is essential for preventing outbreaks of mosquito-borne diseases. Several mosquito species acting as vectors of Japanese encephalitis virus (JEV), dengue virus, Zika virus, malaria parasites and other pathogens are primary mosquito species in Shanghai, China. However, few surveys of human pathogenic arboviruses in mosquitoes in Shanghai have been reported in the last ten years. Therefore, in this study, we evaluated mosquito activity in Shanghai, China during 2016 and tested for the presence of alphaviruses, flaviviruses, orthobunyaviruses and several parasitic pathogens.ResultsFive pooled samples were JEV-positive [4/255 pools of Culex tritaeniorhynchus and 1/256 pools of Cx. pipiens (s.l.)] based on analysis of the NS5 gene. Alphaviruses, orthobunyaviruses, Plasmodium and filariasis were not found in this study. Phylogenetic and molecular analyses revealed that the JEV strains belonged to genotype I. Moreover, newly detected Shanghai JEV strains were genetically close to previously isolated Shandong strains responsible for transmission during the 2013 Japanese encephalitis (JE) outbreak in Shandong Province, China but were more distantly related to other Shanghai strains detected in the early 2000s. The E proteins of the newly detected Shanghai JEV strains differed from that in the live attenuated vaccine SA14-14-2-derived strain at six amino residues: E130 (IleVal), E222 (AlaSer), E327 (SerThr), E366 (ArgSer/Pro), E393 (AsnSer) and E433 (ValIle). However, no differences were observed in key amino acid sites related to antigenicity. Minimum JEV infection rates were 1.01 and 0.65 per 1000 Cx. tritaeniorhynchus and Cx. pipiens (s.l.), respectively.ConclusionsFive new Shanghai JEV genotype I strains, detected after a ten-year hiatus in local mosquito surveillance, were genetically close to strains involved in the 2013 Shandong JE outbreak. Because JEV is still circulating, vaccination in children should be extensively and continuously promoted. Moreover, JEV mosquito surveillance programmes should document the genotype variation, intensity and distribution of circulating viruses for use in the development and implementation of disease prevention and control strategies.
C1 [Zhang, Yi] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 20025, Peoples R China.
   WHO Collaborating Ctr Trop Dis, Shanghai 20025, Peoples R China.
   Natl Ctr Int Res Trop Dis, Minist Sci & Technol, Shanghai 20025, Peoples R China.
   Minist Hlth, Key Lab Parasite & Vector Biol, Shanghai 20025, Peoples R China.
RP Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 20025, Peoples R China.
EM zhang1972003@163.com
FU National Key Research and Development Programme of China
   [2016YFC1202000, 2016YFC1202002, 2016YFC1202003]
FX This work was supported by the National Key Research and Development
   Programme of China (grant nos. 2016YFC1202000, 2016YFC1202002,
   2016YFC1202003).
CR Baig S, 2013, MMWR-MORBID MORTAL W, V62, P658
   Batchelor Patricia, 2015, Trop Dis Travel Med Vaccines, V1, P11, DOI 10.1186/s40794-015-0013-6
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Biggerstaff BJ, 2006, POOLEDINFRATE VERSIO
   Bista MB, 2001, LANCET, V358, P791, DOI 10.1016/S0140-6736(01)05967-0
   Bryant JE, 2005, AM J TROP MED HYG, V73, P470, DOI 10.4269/ajtmh.2005.73.470
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004686
   Chen HL, 2015, J CHIN MED ASSOC, V78, P271, DOI 10.1016/j.jcma.2014.12.009
   Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0
   Ding D, 2003, B WORLD HEALTH ORGAN, V81, P334
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Fang Y, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0457-9
   Fang Y, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2351-x
   Feng J, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3018-8
   Gao Q, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111150
   Gao Xiaoyan, 2015, Bing Du Xue Bao, V31, P264
   Gao XY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002459
   [龚道方 GONG Dao-fang], 2010, [中国病原生物学杂志, Journal of Pathogen Biology], V5, P57
   HALE JH, 1952, ANN TROP MED PARASIT, V46, P220, DOI 10.1080/00034983.1952.11685526
   Han N, 2014, J VIROL, V88, P11469, DOI 10.1128/JVI.02050-14
   Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2
   Hoffmann PR, 2004, J MED ENTOMOL, V41, P731, DOI 10.1603/0022-2585-41.4.731
   Hu J, 2017, J PUBLIC HLTH EMERG, V1, P77, DOI [10.21037/jphe.2017.09.01, DOI 10.21037/JPHE.2017.09.01]
   Hu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052687
   [王环宇 Wang Huanyu], 2004, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V24, P843
   Johansen CA, 2001, J MED ENTOMOL, V38, P581, DOI 10.1603/0022-2585-38.4.581
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Konishi E, 2010, VACCINE, V28, P2664, DOI 10.1016/j.vaccine.2010.01.008
   Kumar R, 2006, CLIN INFECT DIS, V43, P123, DOI 10.1086/505121
   Kumar R, 2014, PEDIATR HEALTH MED T, V5, P99, DOI 10.2147/PHMT.S49049
   Kumar R, 2009, NEW ENGL J MED, V360, P1465, DOI 10.1056/NEJMc0808664
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuno G, 1996, J CLIN MICROBIOL, V34, P1184, DOI 10.1128/JCM.34.5.1184-1188.1996
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lee DW, 2012, INT J INFECT DIS, V16, pE448, DOI 10.1016/j.ijid.2012.02.006
   LEWIS L, 1947, ARCH NEURO PSYCHIATR, V57, P430, DOI 10.1001/archneurpsyc.1947.02300270048004
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231
   Li XL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004611
   Liang G, 2018, REV MED VIROL, V28
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu Hong-xia, 2017, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V28, P305
   Liu HX, 2008, SHANGHAI J PREV MED, V20, P209
   Liu W, 2010, HDB DIS BURDENS QUAL, P1391
   Liu XY, 2011, VACCINE, V29, P2127, DOI 10.1016/j.vaccine.2010.12.108
   Do LP, 2016, ASIAN PAC J TROP MED, V9, P325, DOI 10.1016/j.apjtm.2016.03.007
   Do LP, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0278-4
   Lu BL, 1997, FAUNA SINICA INSECTA
   Lu GY, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-269
   Lu Z, 2014, EMERG INFECT DIS, V20, P1421, DOI 10.3201/eid2008.131433
   McArthur Monica A, 2011, J Bioterror Biodef, VS1, P2
   Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0
   Pan JR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004936
   Pan XL, 2011, J VIROL, V85, P9847, DOI 10.1128/JVI.00825-11
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Schuh AJ, 2014, J VIROL, V88, P4522, DOI 10.1128/JVI.02686-13
   Schuh AJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002411
   Schuh AJ, 2013, VECTOR-BORNE ZOONOT, V13, P479, DOI 10.1089/vbz.2011.0870
   Schuh AJ, 2010, J GEN VIROL, V91, P95, DOI 10.1099/vir.0.013631-0
   Seo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055165
   Shen B, 2001, CHIN J VACCINES IMMU, V8, P215
   Sheng-Qiang Wang, 2017, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V30, P9, DOI 10.16250/j.32.1374.2017208
   Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003
   Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263
   Song LG, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0454-z
   Sun DJ, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-30
   Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396
   Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449
   Tao ZX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04908
   Vasuki V, 2003, ACTA TROP, V86, P109, DOI 10.1016/S0001-706X(02)00267-X
   Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0
   Wang Jun-wen, 2006, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V20, P61
   Wang LH, 2007, EMERG INFECT DIS, V13, P1123, DOI 10.3201/eid1307.070010
   Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00
   Williams DT, 2000, J GEN VIROL, V81, P2471, DOI 10.1099/0022-1317-81-10-2471
   Wu D, 2015, CHIN J VACCINE IMMUN, V21, P486
   Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034
   Wu Y, 2017, CHIN PREV MED, V29, P113
   XIE H, 1994, PARASITE, V1, P255, DOI 10.1051/parasite/1994013255
   Yan J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-73
   Yin ZD, 2010, AM J TROP MED HYG, V83, P766, DOI 10.4269/ajtmh.2010.09-0748
   Yu YX, 2010, VACCINE, V28, P3635, DOI 10.1016/j.vaccine.2010.02.105
   [张丽 Zhang Li], 2017, [中国寄生虫学与寄生虫病杂志, Chinese Journal of Parasitology & Parasitic Diseases], V35, P515
   Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710
   Zhou Zheng-bin, 2015, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V26, P28
   Zhu Min, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P817
NR 89
TC 4
Z9 4
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 9
PY 2019
VL 12
AR 22
DI 10.1186/s13071-018-3267-9
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HG9ZA
UT WOS:000455370000001
PM 30626442
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chiang, HS
   Liu, HM
AF Chiang, Hao-Sen
   Liu, Helene Minyi
TI The Molecular Basis of Viral Inhibition of IRF- and STAT-Dependent
   Immune Responses
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE interferon; interferon-regulatory factor; signal transducer and
   activator of transcription signaling; interferon-stimulated gene;
   antiviral response; viral attenuation; viral antagonism
ID INTERFERON SIGNAL-TRANSDUCTION; REGULATORY FACTOR FAMILY; NUCLEAR EXPORT
   SIGNAL; CREB-BINDING PROTEIN; TOLL-LIKE RECEPTORS; I-INTERFERON;
   TRANSCRIPTION FACTORS; NEGATIVE REGULATION; ALPHA-INTERFERON; V-PROTEIN
AB The antiviral innate immunity is the first line of host defense against virus infections. In mammalian cells, viral infections initiate the expression of interferons (IFNs) in the host that in turn activate an antiviral defense program to restrict viral replications by induction of IFN stimulated genes (ISGs), which are largely regulated by the IFN-regulatory factor (IRF) family and signal transducer and activator of transcription (STAT) family transcription factors. The mechanisms of action of IRFs and STATs involve several post-translational modifications, complex formation, and nuclear translocation of these transcription factors. However, many viruses, including human immunodeficiency virus (HIV), Zika virus (ZIKV), and herpes simplex virus (HSV), have evolved strategies to evade host defense, including alteration in IRF and STAT post-translational modifications, disturbing the formation and nuclear translocation of the transcription complexes as well as proteolysis/degradation of IRFs and STATs. In this review, we discuss and summarize the molecular mechanisms by which how viral components may target IRFs and STATs to antagonize the establishment of antiviral host defense. The underlying host-viral interactions determine the outcome of viral infection. Gaining mechanistic insight into these processes will be crucial in understanding how viral replication can be more effectively controlled and in developing approaches to improve virus infection outcomes.
C1 [Chiang, Hao-Sen] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan.
   [Chiang, Hao-Sen] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei, Taiwan.
   [Liu, Helene Minyi] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei, Taiwan.
RP Chiang, HS (corresponding author), Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan.; Chiang, HS (corresponding author), Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei, Taiwan.; Liu, HM (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei, Taiwan.
EM hschiang@ntu.edu.tw; mliu@ntu.edu.tw
RI Chiang, Hao-Sen/K-7658-2019; Liu, Helene/Y-1834-2019
OI Chiang, Hao-Sen/0000-0001-5041-9705; Liu, Helene/0000-0003-4837-5373
FU Ministry of Science and Technology of TaiwanMinistry of Science and
   Technology, Taiwan [105-2628-B-002-013-MY3, 105-2628-B-002-014-MY3];
   National Taiwan UniversityNational Taiwan University [107L7717];
   National Health Research Institutes of TaiwanNational Health Research
   Institutes - Taiwan [NHRI-EX107-10417S]
FX This work was supported by grants from the Ministry of Science and
   Technology of Taiwan (grant #105-2628-B-002-013-MY3 to H-SC, grant
   #105-2628-B-002-014-MY3 to HL), a grant from the National Taiwan
   University to H-SC (grant #107L7717), and a grant from the National
   Health Research Institutes of Taiwan to HL (grant #NHRI-EX107-10417S).
CR Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002
   Arnold MM, 2013, J VIROL, V87, P9813, DOI 10.1128/JVI.01146-13
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06
   Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003
   Bentz GL, 2010, VIROLOGY, V402, P121, DOI 10.1016/j.virol.2010.03.014
   Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0
   Bi XH, 2011, J INTERF CYTOK RES, V31, P373, DOI 10.1089/jir.2010.0084
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bradfute SB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-300
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Cao Jie, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P894
   Carty M, 2010, CLIN EXP IMMUNOL, V161, P397, DOI 10.1111/j.1365-2249.2010.04196.x
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chee AV, 2004, J VIROL, V78, P4185, DOI 10.1128/JVI.78.8.4185-4196.2004
   Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042
   Chen WG, 2004, J ALLERGY CLIN IMMUN, V114, P476, DOI 10.1016/j.jaci.2004.06.042
   Christensen MH, 2016, EMBO J, V35, P1385, DOI 10.15252/embj.201593458
   Collins AS, 2014, J LEUKOCYTE BIOL, V96, P255, DOI 10.1189/jlb.2A1211-608RRRR
   Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010
   Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08
   Dar HA, 2017, INFECT GENET EVOL, V51, P143, DOI 10.1016/j.meegid.2017.03.027
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200
   Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018
   Doehle BP, 2012, J VIROL, V86, P8367, DOI 10.1128/JVI.00423-12
   Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   Goertz GP, 2018, J VIROL, V92, DOI 10.1128/JVI.01008-18
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gupta SP, 2017, VIRAL PROTEASES THEI, Vxv
   Han MY, 2013, VIRUS RES, V172, P54, DOI 10.1016/j.virusres.2012.12.012
   Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07
   Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9
   Holloway G, 2009, J VIROL, V83, P4942, DOI 10.1128/JVI.01450-08
   Honda K, 2004, P NATL ACAD SCI USA, V101, P2416, DOI 10.1073/pnas.0307336101
   Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641
   HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301
   Hung HC, 2011, J INFECT DIS, V203, P1784, DOI 10.1093/infdis/jir174
   Ikushima Hiroaki, 2013, Cold Spring Harb Symp Quant Biol, V78, P105, DOI 10.1101/sqb.2013.78.020321
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Ivashkiv LB, 2018, NAT REV IMMUNOL, V18, P545, DOI 10.1038/s41577-018-0029-z
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07
   Kim K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008649
   Koeberlein B, 2010, VIRUS RES, V148, P51, DOI 10.1016/j.virusres.2009.12.003
   Koksal AC, 2011, J BIOL CHEM, V286, P14373, DOI 10.1074/jbc.M111.226357
   Kumthip K, 2012, J VIROL, V86, P8581, DOI 10.1128/JVI.00533-12
   Kuo YP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006417
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12
   Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909
   LINDENMANN J, 1957, BRIT J EXP PATHOL, V38, P551
   LIU K, 1995, J VIROL, V69, P7823, DOI 10.1128/JVI.69.12.7823-7834.1995
   Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111
   Ma Z, 2016, CELL HOST MICROBE, V19, P150, DOI 10.1016/j.chom.2016.01.010
   Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002
   Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782
   Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149
   McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196
   McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754
   Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004
   Meraro D, 1999, J IMMUNOL, V163, P6468
   Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X
   Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041
   Morin G, 2015, J VIROL, V89, P7707, DOI 10.1128/JVI.01175-15
   Mukherjee A, 2015, J VIROL, V89, P3356, DOI 10.1128/JVI.03085-14
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001
   Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102
   Oda K, 2017, J BIOL CHEM, V292, P19752, DOI 10.1074/jbc.M117.786285
   Oda K, 2015, J VIROL, V89, P11487, DOI 10.1128/JVI.01887-15
   Odendall C, 2015, CURR OPIN VIROL, V12, P47, DOI 10.1016/j.coviro.2015.02.003
   Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428
   Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003
   Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856
   Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7
   Park SY, 2014, J BIOL CHEM, V289, P35102, DOI 10.1074/jbc.M114.597062
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521
   Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002
   READ GS, 1993, J VIROL, V67, P7149, DOI 10.1128/JVI.67.12.7149-7160.1993
   Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342
   Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111
   Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004
   Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002
   SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836
   Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200
   Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schomacker H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028382
   Sen A, 2014, J VIROL, V88, P41, DOI 10.1128/JVI.01501-13
   Seo T, 2000, BIOCHEM BIOPH RES CO, V270, P23, DOI 10.1006/bbrc.2000.2393
   Shabman RS, 2011, J INFECT DIS, V204, pS904, DOI 10.1093/infdis/jir323
   Sugai A, 2017, J VIROL, V91, DOI 10.1128/JVI.01136-17
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Taddeo B, 2013, J VIROL, V87, P4516, DOI 10.1128/JVI.00005-13
   Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x
   Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400
   Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920
   Tsai MH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01886
   Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247
   Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721
   Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212
   Wan SW, 2017, J IMMUNOL, V199, P2834, DOI 10.4049/jimmunol.1601523
   Wang CY, 2017, J BIOL CHEM, V292, P10262, DOI 10.1074/jbc.M116.745729
   Wang WB, 2011, J IMMUNOL, V187, P2578, DOI 10.4049/jimmunol.1004128
   Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9
   Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156
   Xiang ZC, 2016, J VIROL, V90, P1613, DOI 10.1128/JVI.02395-15
   Xing JJ, 2013, J VIROL, V87, P9788, DOI 10.1128/JVI.01440-13
   Xu W, 2014, CELL HOST MICROBE, V16, P187, DOI 10.1016/j.chom.2014.07.008
   Yanai H, 2012, ONCOIMMUNOLOGY, V1, P1376, DOI 10.4161/onci.22475
   Yang HM, 2004, EUR J BIOCHEM, V271, P3693, DOI 10.1111/j.1432-1033.2004.04310.x
   Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087
   Zanoni I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01661
   Zhang DD, 2016, J VIROL, V90, P5824, DOI 10.1128/JVI.00186-16
   Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092
   Zhang QZ, 2016, VIROLOGY, V489, P252, DOI 10.1016/j.virol.2015.12.010
   Zhang RX, 2016, VIRUS GENES, V52, P797, DOI 10.1007/s11262-016-1377-z
   Zhang RX, 2015, VIROLOGY, V485, P414, DOI 10.1016/j.virol.2015.08.005
   Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052
NR 131
TC 3
Z9 3
U1 2
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JAN 8
PY 2019
VL 9
AR 3086
DI 10.3389/fimmu.2018.03086
PG 11
WC Immunology
SC Immunology
GA HG6YL
UT WOS:000455134300001
PM 30671058
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Grubaugh, ND
   Gangavarapu, K
   Quick, J
   Matteson, NL
   De Jesus, JG
   Main, BJ
   Tan, AL
   Paul, LM
   Brackney, DE
   Grewal, S
   Gurfield, N
   Van Rompay, KKA
   Isern, S
   Michael, SF
   Coffey, LL
   Loman, NJ
   Andersen, KG
AF Grubaugh, Nathan D.
   Gangavarapu, Karthik
   Quick, Joshua
   Matteson, Nathaniel L.
   De Jesus, Jaqueline Goes
   Main, Bradley J.
   Tan, Amanda L.
   Paul, Lauren M.
   Brackney, Doug E.
   Grewal, Saran
   Gurfield, Nikos
   Van Rompay, Koen K. A.
   Isern, Sharon
   Michael, Scott F.
   Coffey, Lark L.
   Loman, Nicholas J.
   Andersen, Kristian G.
TI An amplicon-based sequencing framework for accurately measuring
   intrahost virus diversity using PrimalSeq and iVar
SO GENOME BIOLOGY
LA English
DT Article
DE Viral sequencing; Amplicon sequencing; Intrahost evolution; Zika; West
   Nile; SNP calling
ID WEST-NILE-VIRUS; NATURALLY INFECTED MOSQUITOS; ZIKA VIRUS; REAL-TIME;
   TRANSMISSION; GENOME; POPULATIONS; EVOLUTION; SELECTION; FITNESS
AB How viruses evolve within hosts can dictate infection outcomes; however, reconstructing this process is challenging. We evaluate our multiplexed amplicon approach, PrimalSeq, to demonstrate how virus concentration, sequencing coverage, primer mismatches, and replicates influence the accuracy of measuring intrahost virus diversity. We develop an experimental protocol and computational tool, iVar, for using PrimalSeq to measure virus diversity using Illumina and compare the results to Oxford Nanopore sequencing. We demonstrate the utility of PrimalSeq by measuring Zika and West Nile virus diversity from varied sample types and show that the accumulation of genetic diversity is influenced by experimental and biological systems.
C1 [Grubaugh, Nathan D.; Gangavarapu, Karthik; Matteson, Nathaniel L.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Quick, Joshua; De Jesus, Jaqueline Goes; Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
   [De Jesus, Jaqueline Goes] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Lab Expt Pathol, Salvador, BA, Brazil.
   [Main, Bradley J.; Coffey, Lark L.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Tan, Amanda L.; Paul, Lauren M.; Isern, Sharon; Michael, Scott F.] Florida Gulf Coast Univ, Coll Arts & Sci, Dept Biol Sci, Ft Myers, FL 33965 USA.
   [Brackney, Doug E.] Connecticut Agr Expt Stn, Dept Environm Sci, New Haven, CT 06504 USA.
   [Grewal, Saran; Gurfield, Nikos] San Diego Cty Vector Control Program, Dept Environm Hlth, San Diego, CA 92123 USA.
   [Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Van Rompay, Koen K. A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Andersen, Kristian G.] Scripps Res Translat Inst, La Jolla, CA 92037 USA.
RP Grubaugh, ND; Gangavarapu, K (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
EM nathan.grubaugh@yale.edu; gkarthik@scripps.edu
RI Loman, Nicholas/Z-1573-2019
OI Grubaugh, Nathan/0000-0003-2031-1933; Paul, Lauren/0000-0001-5503-7570
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5T32AI007244-33, R21AI129479,
   1R21AI129479-01]; NIHR Surgical Reconstruction and Microbiology Research
   Centre (SRMRC); Office of Research Infrastructure Programs/OD
   [P51OD011107]; NIH NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI099210]; UC Davis
   Department of Pathology, Microbiology and Immunology; Pacific Southwest
   Regional Center of Excellence for Vector-Borne Diseases - U.S. Centers
   for Disease Control and Prevention [1U01CK000516]; Abt Associates;
   consortium of vector control district in California: Coachella Valley;
   consortium of vector control district in California: Orange County;
   consortium of vector control district in California: Greater Los Angeles
   County; consortium of vector control district in California: San Gabriel
   Valley; consortium of vector control district in California: West
   Valley; consortium of vector control district in California: Kern;
   consortium of vector control district in California: Butte County;
   consortium of vector control district in California: Tulare; consortium
   of vector control district in California: Sacramento-Yolo; consortium of
   vector control district in California: Placer; consortium of vector
   control district in California: Turlock; Supplement, California National
   Primate Research Center pilot research grant [P51OD011107]; FDAUnited
   States Department of Health & Human Services [HHS HHSF223201610542P];
   Medical Research Council Bioinformatics Fellowship as part of the Cloud
   Infrastructure for Microbial Bioinformatics (CLIMB) project; NIH NCATS
   CTSAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR001114]; NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [HHSN272201400048C, R21AI137690, U19AI135995]; Ray Thomas Foundation
FX NDG was supported by NIH training grant 5T32AI007244-33. JQ is supported
   by a grant from the NIHR Surgical Reconstruction and Microbiology
   Research Centre (SRMRC). KKAVR is supported by the Office of Research
   Infrastructure Programs/OD (P51OD011107) to CNPRC and NIH R21AI129479.
   SI and SFM are supported by NIH NIAID R01AI099210. LLC was supported by
   startup funds from the UC Davis Department of Pathology, Microbiology
   and Immunology and the Pacific Southwest Regional Center of Excellence
   for Vector-Borne Diseases funded by the U.S. Centers for Disease Control
   and Prevention (Cooperative Agreement 1U01CK000516). BJM was supported
   by Abt Associates and a consortium of vector control districts in
   California: Coachella Valley, Orange County, Greater Los Angeles County,
   San Gabriel Valley, West Valley, Kern, Butte County, Tulare,
   Sacramento-Yolo, Placer, and Turlock. The rhesus macaque studies were
   supported by NIH 1R21AI129479-01 & Supplement, California National
   Primate Research Center pilot research grant P51OD011107 and FDA HHS
   HHSF223201610542P. NJL is supported by a Medical Research Council
   Bioinformatics Fellowship as part of the Cloud Infrastructure for
   Microbial Bioinformatics (CLIMB) project. KGA is a Pew Biomedical
   Scholar, and is supported by NIH NCATS CTSA UL1TR001114, NIAID contract
   HHSN272201400048C, NIAID R21AI137690, NIAID U19AI135995, and The Ray
   Thomas Foundation.
CR Acevedo A, 2014, NAT PROTOC, V9, P1760, DOI 10.1038/nprot.2014.118
   Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861
   Andersen KG, PROTOCOLS ANDERSEN L
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Black A, 2017, GENETIC CHARACTERIZA
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Ciota AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007876
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10
   Dolan PT, 2018, CELL HOST MICROBE, V23, P435, DOI 10.1016/j.chom.2018.03.012
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Ebler J, 2018, HAPLOTYPE AWARE GENO
   Ekblom R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-467
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   Gangavarapu K, 2018, ADDITIONAL FILES DAT
   Gangavarapu K, IVAR GITHUB
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Grubaugh N. D., 2017, NATURE, V90, P4864
   Grubaugh ND, 2017, CELL REP, V19, P709, DOI 10.1016/j.celrep.2017.03.076
   Grubaugh ND, 2017, CELL, V169, P1, DOI 10.1016/j.cell.2017.03.018
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Grubaugh ND, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004874
   Grubaugh ND, AMPLICON SEQUENCING
   Grubaugh ND, 2018, PRJNA4385NCBI
   Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529
   Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258
   Hepp CM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205801
   HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255
   Illingworth CJR, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex030
   Iyer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135903
   Jain M, 2018, NAT BIOTECHNOL, V36, P338, DOI 10.1038/nbt.4060
   Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0
   Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032
   Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111
   Krehenwinkel H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17333-x
   LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669
   Lee S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv834
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Li CH, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0140-7
   Li H, 2013, ALIGNING SEQUENCE RE
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lin SR, 2004, J VIROL, V78, P12717, DOI 10.1128/JVI.78.22.12717-12721.2004
   Loman NJ, ADDITIONAL FILES DAT
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   McCrone JT, 2016, J VIROL, V90, P6884, DOI 10.1128/JVI.00667-16
   Metsky H. C., 2017, NATURE, V66, P366
   Moncla LH, 2016, CELL HOST MICROBE, V19, P169, DOI 10.1016/j.chom.2016.01.011
   Nelson CW, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey013
   Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986
   Parameswaran P, 2017, CELL HOST MICROBE, V22, P400, DOI 10.1016/j.chom.2017.08.003
   Poirier EZ, 2017, CURR OPIN VIROL, V23, P82, DOI 10.1016/j.coviro.2017.03.013
   Potapov V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181128
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rang FJ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1462-9
   Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655
   Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341
   Sim S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004052
   Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x
   Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008
   Stern A, 2017, CELL, V169, P35, DOI 10.1016/j.cell.2017.03.013
   Tardif KD, 2013, J CLIN MICROBIOL, V51, P1278, DOI 10.1128/JCM.00091-13
   Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Worby CJ, 2017, AM J EPIDEMIOL, V186, P1209, DOI 10.1093/aje/kwx182
   Worobey M, 2016, NATURE, V539, P98, DOI 10.1038/nature19827
   Zanini F, 2017, VIRUS RES, V239, P106, DOI 10.1016/j.virusres.2016.12.009
   Zanini F, 2015, ELIFE, V4, DOI 10.7554/eLife.11282
NR 79
TC 15
Z9 15
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PD JAN 8
PY 2019
VL 20
AR 8
DI 10.1186/s13059-018-1618-7
PG 19
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA HG8HP
UT WOS:000455241300002
PM 30621750
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Petit, MJ
   Shah, PS
AF Petit, Marine J.
   Shah, Priya S.
TI Mapping Arbovirus-Vector Interactions Using Systems Biology Techniques
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE arbovirus; virus; arthropod; vector; interactions; systems biology
ID NILE VIRUS TRANSMISSION; ZIKA VIRUS; FLAVIVIRUS; INFECTION; DENGUE; RNA;
   REPLICATION; DIVERSITY; REVEALS; VIROME
AB Studying how arthropod-borne viruses interact with their arthropod vectors is critical to understanding how these viruses replicate and are transmitted. Until recently, these types of studies were limited in scale because of the lack of classical tools available to study virus-host interaction for non-model viruses and non-model organisms. Advances in systems biology "-omics"-based techniques such as next-generation sequencing (NGS) and mass spectrometry can rapidly provide an unbiased view of arbovirus-vector interaction landscapes. In this mini-review, we discuss how arbovirus-vector interaction studies have been advanced by systems biology. We review studies of arbovirus-vector interactions that occur at multiple time and length scales, including intracellular interactions, interactions at the level of the organism, viral and vector populations, and how new techniques can integrate systems-level data across these different scales.
C1 [Petit, Marine J.; Shah, Priya S.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.
   [Petit, Marine J.; Shah, Priya S.] Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.
RP Shah, PS (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.; Shah, PS (corresponding author), Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.
EM prsshah@ucdavis.edu
OI Shah, Priya/0000-0001-7518-2839; PETIT, marine/0000-0001-7427-7203
FU W. M. Keck FoundationW.M. Keck Foundation
FX PS was supported in part by funding from the W. M. Keck Foundation.
CR Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Brackney DE, 2015, J VIROL, V89, P4035, DOI 10.1128/JVI.02612-14
   Chaverra-Rodriguez D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05425-9
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Cross ST, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070388
   Munoz MD, 2013, BIOMED RES INT, DOI 10.1155/2013/875958
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Depledge DP, 2018, BIORXIV, DOI [10.1101/373522, DOI 10.1101/373522]
   Dong SZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3775-6
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Frey KG, 2016, EVOL BIOINFORM, V12, P1, DOI 10.4137/EBO.S38518
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Grabowski JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1944-0
   Grabowski JM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004180
   Grubaugh ND, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew033
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Harvey E, 2019, J VIROL, V93, DOI 10.1128/JVI.01358-18
   Jaworski E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006365
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Maringer K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3432-5
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Paradkar PN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005143
   Patterson EI, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey001
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Poelchau MF, 2018, METHODS MOL BIOL, V1757, P557, DOI 10.1007/978-1-4939-7737-6_18
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Russell JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23641-7
   Sadeghi M, 2018, VIROLOGY, V523, P74, DOI 10.1016/j.virol.2018.07.029
   Saucereau Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3985-y
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Severo MS, 2018, P NATL ACAD SCI USA, V115, pE7568, DOI 10.1073/pnas.1803062115
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shrinet J, 2018, J PROTEOME RES, V17, P3348, DOI 10.1021/acs.jproteome.8b00211
   Sim S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004052
   Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011
   Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]
   ter Horst A. M, 2018, BIORXIV, DOI [10.1101/396382, DOI 10.1101/396382]
   Tham HW, 2015, J INFECT DEV COUNTR, V9, P1338, DOI 10.3855/jidc.6422
   Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14
   Wang YH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040213
   Weger-Lucarelli J, 2018, VIROLOGY, V521, P138, DOI 10.1016/j.virol.2018.06.004
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
NR 58
TC 1
Z9 1
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JAN 7
PY 2019
VL 8
AR 440
DI 10.3389/fcimb.2018.00440
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HG5NR
UT WOS:000455024500002
PM 30666300
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gorshkov, K
   Shiryaev, SA
   Fertel, S
   Lin, YW
   Huang, CT
   Pinto, A
   Farhy, C
   Strongin, AY
   Zheng, W
   Terskikh, AV
AF Gorshkov, Kirill
   Shiryaev, Sergey A.
   Fertel, Sophie
   Lin, Yi-Wen
   Huang, Chun-Teng
   Pinto, Antonella
   Farhy, Chen
   Strongin, Alex Y.
   Zheng, Wei
   Terskikh, Alexey V.
TI Zika Virus: Origins, Pathological Action, and Treatment Strategies
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE ZIKV; re-purposing; in vivo; drugs; maternal transmission
ID ANTIBODY-DEPENDENT ENHANCEMENT; HUMAN PLACENTAL TROPHOBLASTS; INFECTION
   IN-VITRO; NEURAL STEM-CELLS; FDA-APPROVED DRUG; SEXUAL TRANSMISSION;
   NS2B-NS3 PROTEASE; BROAD-SPECTRUM; INHIBITS ZIKA; DENGUE VIRUS
AB The Zika virus (ZIKV) global epidemic prompted the World Health Organization to declare it a 2016 Public Health Emergency of International Concern. The overwhelming experience over the past several years teaches us that ZIKV and the associated neurological complications represent a long-term world-wide challenge to public health. Although the number of ZIKV cases in the Western Hemisphere has dropped since 2016, the need for basic research and anti-ZIKV drug development remains strong. Re-emerging viruses like ZIKV are an ever-present threat in the 21st century where fast transcontinental travel lends itself to viral epidemics. Here, we first present the origin story for ZIKV and review the rapid progress researchers have made toward understanding of the ZIKV pathology and in the design, re-purposing, and testing-particularly in vivo-drug candidates for ZIKV prophylaxis and therapy ZIKV. Quite remarkably, a short, but intensive, drug-repurposing effort has already resulted in several readily available FDA-approved drugs that are capable of effectively combating the virus in infected adult mouse models and, most importantly, in both preventing maternal-fetal transmission and severe microcephaly in newborns in pregnant mouse models.
C1 [Gorshkov, Kirill; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.
   [Shiryaev, Sergey A.; Fertel, Sophie; Lin, Yi-Wen; Huang, Chun-Teng; Pinto, Antonella; Farhy, Chen; Strongin, Alex Y.; Terskikh, Alexey V.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.
RP Gorshkov, K (corresponding author), NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.; Terskikh, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.
EM kirill.gorshkov@nih.gov; terskikh@sbp.edu
RI amsalu, ribka/G-8780-2019; Strongin, Alex/R-6609-2019; Terskikh,
   Alexey/U-8407-2019; Gorshkov, Kirill/AAQ-7272-2020; Gorshkov,
   Kirill/W-2188-2019
OI Strongin, Alex/0000-0003-3765-3016; Gorshkov,
   Kirill/0000-0002-4652-8818; Huang, Chun-Teng/0000-0003-3737-7875
FU National Institute of Neurological Disorders and StrokeUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R21NS100477, R01NS106387]; Intramural Research Program of the
   Therapeutics for Rare and Neglected Diseases, National Center for
   Advancing Translational Sciences, National Institutes of Health
FX We would like to thank Dr. Emily Lee for her critical review and edits
   of this manuscript. This work was supported by the R21NS100477 and
   R01NS106387 grants from National Institute of Neurological Disorders and
   Stroke and the Intramural Research Program of the Therapeutics for Rare
   and Neglected Diseases, National Center for Advancing Translational
   Sciences, National Institutes of Health.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   ABBASI J, 2016, JAMA-J AM MED ASSOC, V316, P1249, DOI DOI 10.1001/JAMA.2016.19328
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Arbuckle JH, 2017, MBIO, V8, DOI [10.1128/mBio.01141-17, 10.1128/mbio.01141-17]
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Behrendt P, 2017, ANTIVIR RES, V147, P19, DOI 10.1016/j.antiviral.2017.09.006
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Centers for Disease Control, 2017, CDC ZIK VIR HOM REP
   Centers for Disease Control and Prevention, 2018, CDC ZIK VIR HOM REP
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Carvalho OV, 2017, INT J ANTIMICROB AG, V50, P718, DOI 10.1016/j.ijantimicag.2017.08.016
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Koppolu V, 2018, J NEUROVIROL, V24, P255, DOI 10.1007/s13365-018-0614-8
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kumar A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00403
   Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Mao HQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006282
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Medina FA, 2019, J INFECT DIS, V219, P31, DOI 10.1093/infdis/jiy462
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Organization PAH, 2018, ZIK CUM CAS
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petreanu L, 2002, J NEUROSCI, V22, P6106
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rocker AE, 2018, ANTIVIR RES, V152, P26, DOI 10.1016/j.antiviral.2018.02.003
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   SACRAMENTO CQ, 2017, SCI REP UK, V7
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Sherley M, 2018, SEX HEALTH, V15, P183, DOI 10.1071/SH17046
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zea-Vera AF, 2017, LUPUS, V26, P890, DOI 10.1177/0961203316671816
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 169
TC 5
Z9 5
U1 1
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 7
PY 2019
VL 9
AR 3252
DI 10.3389/fmicb.2018.03252
PG 17
WC Microbiology
SC Microbiology
GA HG5GP
UT WOS:000455004800001
PM 30666246
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shavit-Stein, E
   Aronovich, R
   Sylantiev, C
   Gera, O
   Gofrit, SG
   Chapman, J
   Dori, A
AF Shavit-Stein, Efrat
   Aronovich, Ramona
   Sylantiev, Constantin
   Gera, Orna
   Gofrit, Shany G.
   Chapman, Joab
   Dori, Amir
TI Blocking Thrombin Significantly Ameliorates Experimental Autoimmune
   Neuritis
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE thrombin; experimental autoimmune neuritis; node of Ranvier; PAR1;
   Guillain-Barre syndrome
ID GUILLAIN-BARRE-SYNDROME; EXPERIMENTAL ALLERGIC NEURITIS;
   PROTEASE-ACTIVATED RECEPTOR-1; ZIKA VIRUS; RAT; INHIBITION; MYELIN;
   PATHOGENESIS; NEUROPATHY; CONDUCTION
AB Thrombin and its protease-activated receptor 1 (PAR1) are potentially important in peripheral nerve inflammatory diseases. We studied the role of thrombin and PAR1 in rat experimental autoimmune neuritis (EAN), a model of the human Guillain-Barre syndrome (GBS). EAN was induced by bovine peripheral myelin with complete Freund's adjuvant (CFA). Thrombin activity in the sciatic nerves, clinical scores and rotarod performance were measured. Thrombin activity in the sciatic nerve was elevated in EAN compared to CFA control rats (sham rats) (p <= 0.004). The effect of blocking the thrombin-PAR1 pathway was studied using the non-selective thrombin inhibitor N-Tosyl-Lys-chloromethylketone (TLCK), and the highly specific thrombin inhibitor N-alpha 2 naphtalenesulfonylglycyl 4 amidino-phenylalaninepiperidide (NAPAP). in-vitro TLCK and NAPAP significantly inhibited specific thrombin activity in EAN rats sciatics (p <0.0001 for both inhibitors). Treatment with TLCK 4.4 mg/kg and NAPAP 69.8 mg/kg significantly improved clinical and rotarod scores starting at day 12 and 13 post immunization (DPI12, DPI13) respectively (p < 0.0001) compared to the untreated EAN rats. In nerve conduction studies, distal amplitude was significantly lower in EAN compared to sham rats (0.76 +/- 0.34 vs. 9.8 +/- 1.2, mV, p < 0.0001). Nerve conduction velocity was impaired in EAN rats (23.6 +/- 2.6 vs. sham 43 +/- 4.5, m/s p = 0.01) and was normalized by TLCK (41.2 +/- 7.6 m/s, p < 0.05). PAR1 histology of the sciatic node of Ranvier indicated significant structural damage in the EAN rats which was prevented by TLCK treatment. These results suggest the thrombin-PAR1 pathway as a possible target for future intervention in GBS.
C1 [Shavit-Stein, Efrat; Gera, Orna; Gofrit, Shany G.; Chapman, Joab; Dori, Amir] Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel.
   [Aronovich, Ramona; Sylantiev, Constantin; Gera, Orna; Chapman, Joab; Dori, Amir] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel.
   [Chapman, Joab; Dori, Amir] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel.
   [Chapman, Joab; Dori, Amir] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, Tel Aviv, Israel.
   [Chapman, Joab] Sackler Fac Med, Robert & Martha Harden Chair Mental & Neurol Dis, Tel Aviv, Israel.
RP Shavit-Stein, E (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel.
EM efrat.shavit.stein@gmail.com
FU Wolfson Foundation, Israel
FX Partly supported by a grant from the Wolfson Foundation, Israel.
CR Beilin O, 2005, J NEUROSCI RES, V79, P351, DOI 10.1002/jnr.20270
   Beilin O, 2001, NEUROREPORT, V12, P2347, DOI 10.1097/00001756-200108080-00013
   Beilin O, 2007, NEUROREPORT, V18, P581, DOI 10.1097/WNR.0b013e328091c1e6
   Bushi D, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00138
   Chevret S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub3
   Davalos D, 2014, ANN NEUROL, V75, P303, DOI 10.1002/ana.24078
   Dugina TN, 2004, B EXP BIOL MED+, V138, P463, DOI 10.1007/s10517-005-0071-2
   Ebrahimi S, 2017, J CELL PHYSIOL, V232, P482, DOI 10.1002/jcp.25501
   Feldman EL, 2015, NAT REV NEUROL, V11, P646, DOI 10.1038/nrneurol.2015.192
   Festoff BW, 1996, J NEUROBIOL, V30, P255, DOI 10.1002/(SICI)1097-4695(199606)30:2<255::AID-NEU7>3.0.CO;2-4
   Garcia PS, 2010, THROMB HAEMOSTASIS, V103, P1145, DOI 10.1160/TH09-12-0848
   Gera O, 2016, NEUROSCIENCE, V339, P587, DOI 10.1016/j.neuroscience.2016.10.034
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Hadden RDM, 1999, CURR OPIN NEUROL, V12, P573, DOI 10.1097/00019052-199910000-00011
   HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414
   HOFFMAN PM, 1980, BRAIN RES, V195, P355, DOI 10.1016/0006-8993(80)90071-2
   Hughes RA, 2014, COCHRANE DB SYST REV, P6
   Hughes RAC, 2016, COCHRANE DB SYST REV, V2016, DOI 10.1002/14651858.CD001445
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146
   KADLUBOWSKI M, 1980, BRAIN RES, V184, P439, DOI 10.1016/0006-8993(80)90811-2
   Kafri M, 2005, J NEUROIMMUNOL, V168, P46, DOI 10.1016/j.jneuroim.2005.07.008
   Kafri M, 2002, MUSCLE NERVE, V25, P51, DOI 10.1002/mus.10011
   Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084
   Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A
   Lunn MPT, 2009, POSTGRAD MED J, V85, P437, DOI 10.1136/jnnp.2008.158303
   Ramkalawan H, 2012, INFLAMMATION, V35, P1338, DOI 10.1007/s10753-012-9447-4
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Shavit E, 2008, BRAIN, V131, P1113, DOI 10.1093/brain/awn005
   Shavit E, 2011, J NEUROCHEM, V119, P460, DOI 10.1111/j.1471-4159.2011.07436.x
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Soliven B, 2014, ILAR J, V54, P282, DOI 10.1093/ilar/ilt054
   Stein ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep07912
   Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Wijdicks EFM, 2017, MAYO CLIN PROC, V92, P467, DOI 10.1016/j.mayocp.2016.12.002
   Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Xia RH, 2010, MUSCLE NERVE, V41, P850, DOI 10.1002/mus.21588
   Yanagita M, 2007, BIOCHEM BIOPH RES CO, V364, P318, DOI 10.1016/j.bbrc.2007.10.002
   Yuki N, 2006, CURR OPIN NEUROL, V19, P451, DOI 10.1097/01.wco.0000245367.36576.e9
   Zhang JL, 2001, J SURG RES, V96, P296, DOI 10.1006/jsre.2000.6065
NR 43
TC 3
Z9 3
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD JAN 4
PY 2019
VL 9
AR 1139
DI 10.3389/fneur.2018.01139
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HG4DE
UT WOS:000454923700002
PM 30662428
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, FF
   Lang, YE
   Ji, ZL
   Xia, ZQ
   Han, YW
   Cheng, YT
   Liu, GM
   Sun, F
   Zhao, YH
   Gao, MJ
   Chen, ZY
   Wu, YL
   Li, WX
   Cao, ZJ
AF Li, Fangfang
   Lang, Yange
   Ji, Zhenglin
   Xia, Zhiqiang
   Han, Yuewen
   Cheng, Yuting
   Liu, Gaomin
   Sun, Fang
   Zhao, Yonghui
   Gao, Minjun
   Chen, Zongyun
   Wu, Yingliang
   Li, Wenxin
   Cao, Zhijian
TI A scorpion venom peptide Ev37 restricts viral late entry by alkalizing
   acidic organelles
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE peptides; infection; dengue virus (DENV); hepatitis C virus (HCV); virus
   entry; antiviral agent; antiviral mechanism; antiviral peptide; dengue
   virus; scorpion venom peptide; Zika virus; herpes simplex virus;
   membrane fusion; endosome
ID INHIBITORY-ACTIVITY; VIRUS-INFECTION; HOST-CELLS; BIOAVAILABILITY;
   ACIDIFICATION; REPLICATION; EXPRESSION; TARGETS
AB Viral infections still threaten human health all over the world, and many people die from viral diseases every year. However, there are no effective vaccines or drugs for preventing or managing most viral diseases. Thus, the discovery and development of broad-spectrum antiviral agents remain urgent. Here, we expressed and purified a venom peptide, Ev37, from the scorpion Euscorpiops validus in a prokaryotic system. We found that rEv37 can inhibit dengue virus type 2 (DENV-2), hepatitis C virus (HCV), Zika virus (ZIKV), and herpes simplex virus type 1 (HSV-1) infections in a dose-dependent manner at noncytotoxic concentrations, but that it has no effect on Sendai virus (SeV) and adenovirus (AdV) infections in vitro. Furthermore, rEv37 alkalized acidic organelles to prevent low pH-dependent fusion of the viral membrane-endosomal membrane, which mainly blocks the release of the viral genome from the endosome to the cytoplasm and then restricts viral late entry. Taken together, our results indicate that the scorpion venom peptide Ev37 is a broad-spectrum antiviral agent with a specific molecular mechanism against viruses undergoing low pH-dependent fusion activation during entry into host cells. We conclude that Ev37 is a potential candidate for development as an antiviral drug.
C1 [Li, Fangfang; Lang, Yange; Ji, Zhenglin; Xia, Zhiqiang; Han, Yuewen; Cheng, Yuting; Liu, Gaomin; Sun, Fang; Zhao, Yonghui; Gao, Minjun; Chen, Zongyun; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, State Key Lab Virol, Modern Virol Res Ctr, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.
   [Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Biodrug Res Ctr, Wuhan 430072, Hubei, Peoples R China.
   [Cao, Zhijian] Wuhan Univ, Hubei Prov Engn & Technol Res, Ctr Fluorinated Pharmaceut, Wuhan 430072, Hubei, Peoples R China.
RP Cao, ZJ (corresponding author), Wuhan Univ, State Key Lab Virol, Modern Virol Res Ctr, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.
EM zjcao@whu.edu.cn
CR Bagh MB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14612
   Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8
   Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105
   Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3
   El-Bitar AMH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0276-6
   FAN DP, 1978, CELL, V15, P985, DOI 10.1016/0092-8674(78)90282-9
   Feng J, 2013, PROTEIN EXPRES PURIF, V88, P127, DOI 10.1016/j.pep.2012.12.004
   Goh KCM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26100
   da Mata ECG, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-016-0089-0
   Hong W, 2013, BIOMATERIALS, V34, P3511, DOI 10.1016/j.biomaterials.2013.01.075
   Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845
   Huang S, 1999, J VIROL, V73, P2798, DOI 10.1128/JVI.73.4.2798-2802.1999
   Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002
   Li ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097539
   Lin LT, 2015, J HEPATOL, V62, P541, DOI 10.1016/j.jhep.2014.10.040
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Marvin SA, 2012, BIOL CELL, V104, P188, DOI 10.1111/boc.201100096
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346
   Nicola AV, 2016, TRAFFIC, V17, P965, DOI 10.1111/tra.12408
   Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008
   Rattanaburee T, 2015, ANTIVIR RES, V124, P83, DOI 10.1016/j.antiviral.2015.10.005
   Ravindran MS, 2016, NAT REV MICROBIOL, V14, P407, DOI 10.1038/nrmicro.2016.60
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758
   Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108
   Shan C, 2018, J VIROL, V92, DOI 10.1128/JVI.01002-18
   Sinha S, 2003, ANTIMICROB AGENTS CH, V47, P494, DOI 10.1128/AAC.47.2.494-500.2003
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005
   Yacoub Sophie, 2016, F1000Res, V5, DOI 10.12688/f1000research.6233.1
   Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623
   Zeng XC, 2012, PEPTIDES, V33, P44, DOI 10.1016/j.peptides.2011.11.012
   Zeng ZY, 2018, THERANOSTICS, V8, P199, DOI 10.7150/thno.21425
   Zeng ZY, 2016, TOXINS, V8, DOI 10.3390/toxins8050124
   Zhao ZH, 2012, J BIOL CHEM, V287, P30181, DOI 10.1074/jbc.M112.370312
NR 39
TC 5
Z9 5
U1 1
U2 8
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 4
PY 2019
VL 294
IS 1
BP 182
EP 194
DI 10.1074/jbc.RA118.005015
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA HG6PT
UT WOS:000455105500022
PM 30404919
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kafetzopoulou, LE
   Pullan, ST
   Lemey, P
   Suchard, MA
   Ehichioya, DU
   Pahlmann, M
   Thielebein, A
   Hinzmann, J
   Oestereich, L
   Wozniak, DM
   Efthymiadis, K
   Schachten, D
   Koenig, F
   Matjeschk, J
   Lorenzen, S
   Lumley, S
   Ighodalo, Y
   Adomeh, DI
   Olokor, T
   Omomoh, E
   Omiunu, R
   Agbukor, J
   Ebo, B
   Aiyepada, J
   Ebhodaghe, P
   Osiemi, B
   Ehikhametalor, S
   Akhilomen, P
   Airende, M
   Esumeh, R
   Muoebonam, E
   Giwa, R
   Ekanem, A
   Igenegbale, G
   Odigie, G
   Okonofua, G
   Enigbe, R
   Oyakhilome, J
   Yerumoh, EO
   Odia, I
   Aire, C
   Okonofua, M
   Atafo, R
   Tobin, E
   Asogun, D
   Akpede, N
   Okokhere, PO
   Rafiu, MO
   Iraoyah, KO
   Iruolagbe, CO
   Akhideno, P
   Erameh, C
   Akpede, G
   Isibor, E
   Naidoo, D
   Hewson, R
   Hiscox, JA
   Vipond, R
   Carroll, MW
   Ihekweazu, C
   Formenty, P
   Okogbenin, S
   Ogbaini-Emovon, E
   Gunther, S
   Duraffour, S
AF Kafetzopoulou, L. E.
   Pullan, S. T.
   Lemey, P.
   Suchard, M. A.
   Ehichioya, D. U.
   Pahlmann, M.
   Thielebein, A.
   Hinzmann, J.
   Oestereich, L.
   Wozniak, D. M.
   Efthymiadis, K.
   Schachten, D.
   Koenig, F.
   Matjeschk, J.
   Lorenzen, S.
   Lumley, S.
   Ighodalo, Y.
   Adomeh, D. I.
   Olokor, T.
   Omomoh, E.
   Omiunu, R.
   Agbukor, J.
   Ebo, B.
   Aiyepada, J.
   Ebhodaghe, P.
   Osiemi, B.
   Ehikhametalor, S.
   Akhilomen, P.
   Airende, M.
   Esumeh, R.
   Muoebonam, E.
   Giwa, R.
   Ekanem, A.
   Igenegbale, G.
   Odigie, G.
   Okonofua, G.
   Enigbe, R.
   Oyakhilome, J.
   Yerumoh, E. O.
   Odia, I.
   Aire, C.
   Okonofua, M.
   Atafo, R.
   Tobin, E.
   Asogun, D.
   Akpede, N.
   Okokhere, P. O.
   Rafiu, M. O.
   Iraoyah, K. O.
   Iruolagbe, C. O.
   Akhideno, P.
   Erameh, C.
   Akpede, G.
   Isibor, E.
   Naidoo, D.
   Hewson, R.
   Hiscox, J. A.
   Vipond, R.
   Carroll, M. W.
   Ihekweazu, C.
   Formenty, P.
   Okogbenin, S.
   Ogbaini-Emovon, E.
   Gunther, S.
   Duraffour, S.
TI Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever
   outbreak
SO SCIENCE
LA English
DT Article
ID REAL-TIME; VIRUS; ZIKA
AB The 2018 Nigerian Lassa fever season saw the largest ever recorded upsurge of cases, raising concerns over the emergence of a strain with increased transmission rate. To understand the molecular epidemiology of this upsurge, we performed, for the first time at the epicenter of an unfolding outbreak, metagenomic nanopore sequencing directly from patient samples, an approach dictated by the highly variable genome of the target pathogen. Genomic data and phylogenetic reconstructions were communicated immediately to Nigerian authorities and the World Health Organization to inform the public health response. Real-time analysis of 36 genomes and subsequent confirmation using all 120 samples sequenced in the country of origin revealed extensive diversity and phylogenetic intermingling with strains from previous years, suggesting independent zoonotic transmission events and thus allaying concerns of an emergent strain or extensive human-to-human transmission.
C1 [Kafetzopoulou, L. E.; Pullan, S. T.; Lumley, S.; Hewson, R.; Vipond, R.; Carroll, M. W.] Publ Hlth England, Natl Infect Serv, Porton Down, England.
   [Kafetzopoulou, L. E.; Pullan, S. T.; Hewson, R.; Hiscox, J. A.; Vipond, R.; Carroll, M. W.] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, NIHR, Liverpool, Merseyside, England.
   [Kafetzopoulou, L. E.; Ehichioya, D. U.; Pahlmann, M.; Thielebein, A.; Hinzmann, J.; Oestereich, L.; Wozniak, D. M.; Schachten, D.; Koenig, F.; Matjeschk, J.; Lorenzen, S.; Gunther, S.; Duraffour, S.] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Lemey, P.] Univ Leuven, KU Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.
   [Suchard, M. A.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA.
   [Suchard, M. A.] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA.
   [Suchard, M. A.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA.
   [Ehichioya, D. U.; Pahlmann, M.; Thielebein, A.; Hinzmann, J.; Oestereich, L.; Wozniak, D. M.; Gunther, S.; Duraffour, S.] German Ctr Infect Res DZIF, Partner Site Hamburg, Braunschweig, Germany.
   [Efthymiadis, K.] Vrije Univ Brussel, Artificial Intelligence Lab, Brussels, Belgium.
   [Ighodalo, Y.; Adomeh, D. I.; Olokor, T.; Omomoh, E.; Omiunu, R.; Agbukor, J.; Ebo, B.; Aiyepada, J.; Ebhodaghe, P.; Osiemi, B.; Ehikhametalor, S.; Akhilomen, P.; Airende, M.; Esumeh, R.; Muoebonam, E.; Giwa, R.; Ekanem, A.; Igenegbale, G.; Odigie, G.; Okonofua, G.; Enigbe, R.; Oyakhilome, J.; Yerumoh, E. O.; Odia, I.; Aire, C.; Okonofua, M.; Atafo, R.; Tobin, E.; Asogun, D.; Akpede, N.; Okokhere, P. O.; Rafiu, M. O.; Iraoyah, K. O.; Iruolagbe, C. O.; Akhideno, P.; Erameh, C.; Akpede, G.; Isibor, E.; Okogbenin, S.; Ogbaini-Emovon, E.] Irrua Specialist Teaching Hosp, Irrua, Nigeria.
   [Asogun, D.; Okokhere, P. O.; Akpede, G.; Okogbenin, S.] Ambrose Alli Univ, Coll Med, Fac Clin Sci, Ekpoma, Nigeria.
   [Naidoo, D.; Formenty, P.] WHO, Geneva, Switzerland.
   [Hewson, R.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Fac Infect & Trop Dis, London, England.
   [Hewson, R.] Univ Liverpool Liverpool Sch Trop Med, Fac Clin Sci & Int Publ Hlth, Liverpool, Merseyside, England.
   [Hiscox, J. A.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Hiscox, J. A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Ihekweazu, C.] Nigeria Ctr Dis Control, Abuja, Nigeria.
RP Gunther, S (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.; Gunther, S (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg, Braunschweig, Germany.
EM guenther@bni.uni-hamburg.de
RI Lemey, Philippe/C-3755-2018
OI Lemey, Philippe/0000-0003-2826-5353; Pullan, Steven/0000-0002-8983-599X;
   Ehichioya, Deborah/0000-0002-5777-685X; Hiscox,
   Julian/0000-0002-6582-0275; Wozniak, David/0000-0001-6719-6931; Gunther,
   Stephan/0000-0002-6562-0230; Kafetzopoulou, Liana
   Eleni/0000-0003-4531-1374
FU National Institute for Health Research Health Protection Research Unit
   (NIHR HPRU) in Emerging and Zoonotic Infections at the University of
   Liverpool; Public Health England (PHE); Liverpool School of Tropical
   Medicine; European Research Council under the European Union's Horizon
   2020 research and innovation program [725422-ReservoirDOCS]; Wellcome
   Trust Collaborative AwardWellcome Trust [206298/Z/17/Z]; Special
   Research Fund, KU Leuven ("Bijzonder Onderzoeksfonds," KU Leuven)
   [OT/14/115]; Research Foundation-Flanders ("Fonds voor Wetenschappelijk
   Onderzoek - Vlaanderen")FWO [G066215N, G0D5117N, G0B9317N]; National
   Science FoundationNational Science Foundation (NSF) [DMS 1264153];
   German Federal Ministry of Health through WHO Collaborating Centre for
   Arboviruses and Hemorrhagic Fever Viruses at the Bernhard Nocht
   Institute for Tropical Medicine [ZMV I 1-2517WHO005, ZMV I
   1-2517WHO010]; German Federal Ministry of Health through Global Health
   Protection Program [ZMVI1-2517-GHP-704]; German Federal Ministry for
   Economic Cooperation and Development through the Rapid Deployment Expert
   Group to Combat Threats (SEEG); European Union's Horizon 2020 research
   and innovation program [653316-EVAg]; German Research Foundation
   (DFG)German Research Foundation (DFG) [GU 883/4-1]; Alexander von
   Humboldt FoundationAlexander von Humboldt Foundation; Kirmser
   Foundation; Oxford Nanopore
FX L.E.K., S.T.P., R.H., R.V., M.W.C., and J.A.H. acknowledge funding by
   the National Institute for Health Research Health Protection Research
   Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the University
   of Liverpool in partnership with Public Health England (PHE), in
   collaboration with Liverpool School of Tropical Medicine. The views
   expressed are those of the author(s) and not necessarily those of the
   NHS, the NIHR, the Department of Health, or Public Health England.
   L.E.K. has received travel expenses and accommodation from Oxford
   Nanopore to speak at conferences regarding this work. L.E.K. has
   received some reagents free of charge from Oxford Nanopore in support of
   her Ph.D. project. M.W.C. has received reagents free of charge from
   Oxford Nanopore in support of previous projects not related to the work
   presented in this manuscript. L.E.K. and M.W.C. have not received other
   financial compensation nor hold shares. P.L. and M.A.S. acknowledge
   funding from the European Research Council under the European Union's
   Horizon 2020 research and innovation program (grant
   725422-ReservoirDOCS) and from the Wellcome Trust Collaborative Award,
   206298/Z/17/Z. P.L. acknowledges support by the Special Research Fund,
   KU Leuven ("Bijzonder Onderzoeksfonds," KU Leuven, OT/14/115), and the
   Research Foundation-Flanders (" Fonds voor Wetenschappelijk Onderzoek -
   Vlaanderen," G066215N, G0D5117N, and G0B9317N). M.A.S. acknowledges
   support under National Science Foundation grant DMS 1264153. This study
   was supported by the German Federal Ministry of Health through support
   of the WHO Collaborating Centre for Arboviruses and Hemorrhagic Fever
   Viruses at the Bernhard Nocht Institute for Tropical Medicine
   (agreements ZMV I 1-2517WHO005 and ZMV I 1-2517WHO010) and through the
   Global Health Protection Program (agreement ZMVI1-2517-GHP-704), the
   German Federal Ministry for Economic Cooperation and Development through
   the Rapid Deployment Expert Group to Combat Threats (SEEG), the European
   Union's Horizon 2020 research and innovation program to S.G. (grant
   653316-EVAg), and the German Research Foundation (DFG) to S.G. and
   D.U.E. (GU 883/4-1). D.U.E. acknowledges fellowships from Alexander von
   Humboldt Foundation and Kirmser Foundation. The funders had no role in
   the design and interpretation of the data and preparation of the
   manuscript.
CR Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020
   Asogun DA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001839
   Baele G, 2017, BIOINFORMATICS, V33, P1798, DOI 10.1093/bioinformatics/btx088
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0
   Kafetzopoulou LE, 2018, EUROSURVEILLANCE, V23, P18, DOI 10.2807/1560-7917.ES.2018.23.50.1800228
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116
   LI H, 2013, 13033997 ARXIV, V1303, P3997, DOI DOI 10.1093/BI0INF0RMATICS/BTP352
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Nikisins S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003793
   Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Trovao NS, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev016
   Whitmer SLM, 2018, EMERG INFECT DIS, V24, P599, DOI 10.3201/eid2403.171905
   World Health Organisation, 2018, LASS FEV NIG
NR 28
TC 48
Z9 50
U1 3
U2 26
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JAN 4
PY 2019
VL 363
IS 6422
BP 74
EP +
DI 10.1126/science.aau9343
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HG9GQ
UT WOS:000455315800063
PM 30606844
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Rosa-Ribeiro, R
   Weinlich, R
AF Rosa-Ribeiro, Rafaela
   Weinlich, Ricardo
TI Necroptosis may be triggered in human neuroprogenitor cells after
   zika(br) infection
SO CELL DEATH DISCOVERY
LA English
DT Meeting Abstract
C1 [Rosa-Ribeiro, Rafaela; Weinlich, Ricardo] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PD JAN 3
PY 2019
VL 5
MA ECDO 91
PG 2
WC Cell Biology
SC Cell Biology
GA HR4BB
UT WOS:000463087500102
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Miranda, J
   Mattar, S
   Gonzalez, M
   Hoyos-Lopez, R
   Aleman, A
   Aponte, J
AF Miranda, Jorge
   Mattar, Salim
   Gonzalez, Marco
   Hoyos-Lopez, Richard
   Aleman, Ader
   Aponte, Jose
TI First report of Culex flavivirus infection from Culex coronator
   (Diptera: Culicidae), Colombia
SO VIROLOGY JOURNAL
LA English
DT Article
DE Arboviruses; Culicidae; Environment and public health; Insect vector;
   Flaviviruses; Tropical climate
ID WEST-NILE-VIRUS; INSECT-SPECIFIC FLAVIVIRUS; GENETIC-CHARACTERIZATION;
   MOSQUITOS; IDENTIFICATION; TRANSMISSION; ALPHAVIRUSES; RNA
AB BackgroundFlaviviruses are important pathogens for humans and animals (Dengue viruses, Yellow fever virus, Zika virus and West Nile virus). Culex flavivirus (CxFV) is an insect-specific virus of the genus Flavivirus, detected in a wide variety of mosquito species.ObjectiveTo detect Flavivirus in mosquitoes of a tropical region of the Colombian Caribbean.MethodsIn 2014, an entomological surveillance of arboviruses was conducted in the department of Cordoba area of the Caribbean, Colombia. A total of 8270 mosquitoes were captured as follow: Mansonia (n=3271/39.5%), Culex (n=2668/32.26%), Anopheles (n=840/10.15%), Aedeomyia (n=411/4.9%), Psorophora (n=397/4.8%), Coquilletidia (n=369/4.46%), Uranotaenia (n=261/3.15%) and Aedes (n=53/0.6%). All mosquito species were collected in dry tropical forest of the Caribbean area. Universal primers for NS5 gene (958 pb), RT-PCR for flavivirus and sequencing were used for molecular identification of viruses detected.ResultsTwo pools belonging to Culex coronator were positive for flavivirus RNA sequence by RT-PCR. The sequences of the PCR amplicons, matched that of the Culex flaviviruses, CxFv COL PM_149 (GenBank: KR014201) and CxFv COL PM_212 (GenBank: KT307717). Phylogenetic analysis of the NS5 protein sequences of the Culex flaviviruses sequences with those of reference sequences available in GenBank indicated viruses of Genotype II, closely related to the Brazilian strain, BR_SJRP_01_ (GenBank: KT726939), from Culex sp. The alignment of Culex flavivirus sequences CxFv COL_ PM 212 and CxFv COL_ PM 149 with sequences of strains detected in different geographical regions grouped the strains in a Latin American clade reported in Brazil, Argentina and Mexico.ConclusionsThe present work illustrated that CxFV was circulating among vectors of human pathogenic arboviruses in Colombia, but the impact of CxFV on other flaviviruses which are endemic in the study area still remains to be explored.
C1 [Miranda, Jorge; Mattar, Salim; Gonzalez, Marco; Aleman, Ader; Aponte, Jose] Univ Cordoba, Fac Med Vet & Zootecnia, Inst Invest Biol Trop, Monteria, Colombia.
   [Hoyos-Lopez, Richard] Univ Sinu, Grp Invest Enfermedades Trop & Resistencia Bacter, Monteria, Colombia.
RP Mattar, S (corresponding author), Univ Cordoba, Fac Med Vet & Zootecnia, Inst Invest Biol Trop, Monteria, Colombia.
EM mattarsalim@hotmail.com
RI Miranda, Jorge L/K-8943-2013
OI Miranda, Jorge L/0000-0002-7110-7791; Hoyos, Richard/0000-0003-1195-681X
FU University of Cordoba [FMV-01-17]
FX This study was supported by the University of Cordoba, Research Project
   number FMV-01-17.
CR Alvarez J, 2010, REV MVZ CORDOBA, V15, P2021, DOI 10.21897/rmvz.337
   Bittar C, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0614-3
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Bryant JE, 2005, AM J TROP MED HYG, V73, P470, DOI 10.4269/ajtmh.2005.73.470
   Burivong P, 2004, VIROLOGY, V329, P261, DOI 10.1016/j.virol.2004.08.032
   Calzolari M, 2016, INFECT GENET EVOL, V40, P381, DOI 10.1016/j.meegid.2015.07.032
   Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0
   CLARK-GIL S, 1983, Mosquito Systematics, V15, P151
   Cova PSZ, 1966, MOSQUITOS CULICINOS
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114
   Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85
   FORATTINI O.P., 2002, CULICIDOLOGIA MED, V2
   Goenaga S, 2014, J MED ENTOMOL, V51, P900, DOI 10.1603/ME13172
   Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039
   Lopez RH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0310-8
   Hoyos-Lopez R, 2016, MEM I OSWALDO CRUZ, V111, P625, DOI 10.1590/0074-02760160096
   Hoyos-Lopez R, 2015, MEM I OSWALDO CRUZ, V110, P719, DOI 10.1590/0074-02760280040
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LANE J., 1953, NEOTROPICAL CULICIDA
   Laurito M, 2018, ZOOL J LINN SOC-LOND, V182, P735, DOI 10.1093/zoolinnean/zlx053
   Liang WK, 2015, ARCH VIROL, V160, P2259, DOI 10.1007/s00705-015-2492-1
   Loftin KC, 2006, J ENVIRON HEALTH, V68, P33
   Mattar S, 2005, EMERG INFECT DIS, V11, P1497, DOI 10.3201/eid1109.050426
   Mattar S, 2017, J INFECT PUBLIC HEAL, V10, P507, DOI 10.1016/j.jiph.2016.09.014
   Newman CM, 2017, VECTOR-BORNE ZOONOT, V17, P567, DOI 10.1089/vbz.2017.2124
   Newman CM, 2016, J MED ENTOMOL, V53, P233, DOI 10.1093/jme/tjv161
   Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140
   Pacca C, 2009, VIRUS GENES, V38, P224, DOI 10.1007/s11262-009-0328-3
   Talavera S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2887-4
NR 34
TC 2
Z9 2
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JAN 3
PY 2019
VL 16
AR 1
DI 10.1186/s12985-018-1108-2
PG 6
WC Virology
SC Virology
GA HG3XD
UT WOS:000454907400001
PM 30606229
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Willis, A
AF Willis, Amy
TI Confidence Sets for Phylogenetic Trees
SO JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
LA English
DT Article
DE Non-Euclidean; Phylogenies; Simultaneous testing; Statistical inference
ID ALGORITHM; INFERENCE; EVOLUTION; GEOMETRY; SPACE
AB Inferring evolutionary histories (phylogenetic trees) has important applications in biology, criminology, and public health. However, phylogenetic trees are complex mathematical objects that reside in a non-Euclidean space, which complicates their analysis. While our mathematical, algorithmic, and probabilistic understanding of phylogenies in their metric space is mature, rigorous inferential infrastructure is as yet undeveloped. In this manuscript, we unify recent computational and probabilistic advances to construct tree-valued confidence sets. The procedure accounts for both center and multiple directions of tree-valued variability. We draw on block replicates to improve testing, identifying the best supported most recent ancestor of the Zika virus, and formally testing the hypothesis that a Floridian dentist with AIDS infected two of his patients with HIV. The method illustrates connections between variability in Euclidean and tree space, opening phylogenetic tree analysis to techniques available in the multivariate Euclidean setting. Supplementary materials for this article are available online.
C1 [Willis, Amy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
RP Willis, A (corresponding author), Penn State Univ, Dept Stat, Seattle, WA 98195 USA.
EM adwillis@uw.edu
OI Willis, Amy/0000-0002-2802-4317
CR Amenta N, 2015, ASSN WOMEN MATH, V1, P57, DOI 10.1007/978-3-319-16348-2_5
   [Anonymous], 2016, BBC MUNDO
   Bacak M, 2014, SIAM J OPTIMIZ, V24, P1542, DOI 10.1137/140953393
   Barden D., 2016, ANN I STAT MATH
   Barden D., 2017, ARXIV170307081
   Bendich P, 2016, ANN APPL STAT, V10, P198, DOI 10.1214/15-AOAS886
   Benner P., 2014, ARXIV13053692
   Benner P, 2014, BIOINFORMATICS, V30, pI534, DOI 10.1093/bioinformatics/btu461
   Bhattacharya R., 2016, P AM MATH SOC
   Billera LJ, 2001, ADV APPL MATH, V27, P733, DOI 10.1006/aama.2001.0759
   BRIDSON MR, 1999, GRUND MATH WISS, V319, P2
   Brown D. G., 2017, ARXIV170800294
   CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616
   FELSENSTEIN J, 1983, J ROY STAT SOC A STA, V146, P246, DOI 10.2307/2981654
   Feragen A, 2012, LECT NOTES COMPUT SC, V7512, P147, DOI 10.1007/978-3-642-33454-2_19
   Gerard D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-291
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274
   HILLIS DM, 1994, NATURE, V369, P24, DOI 10.1038/369024a0
   Holmes S, 2003, STAT SCI, V18, P241, DOI 10.1214/ss/1063994979
   Holmes S, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P91
   Holmes S, 2003, THEOR POPUL BIOL, V63, P17, DOI 10.1016/S0040-5809(02)00005-9
   Holmes S, 2015, ARXIV150802906
   Hotz T, 2013, ANN APPL PROBAB, V23, P2238, DOI 10.1214/12-AAP899
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lubiw A., 2016, ARXIV160300847
   Miller E, 2015, ADV APPL MATH, V68, P51, DOI 10.1016/j.aam.2015.04.002
   Notimerica, 2016, DOND PROC VIR ZIK
   Nye TMW, 2014, IEEE ACM T COMPUT BI, V11, P304, DOI 10.1109/TCBB.2014.2309599
   Nye TMW, 2011, ANN STAT, V39, P2716, DOI 10.1214/11-AOS915
   OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165
   Owen M, 2011, IEEE ACM T COMPUT BI, V8, P2, DOI 10.1109/TCBB.2010.3
   Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235
   Rasmussen MD, 2012, GENOME RES, V22, P755, DOI 10.1101/gr.123901.111
   Reid N. M., 2013, SYSTEMATIC BIOL
   RoyChoudhury A, 2015, J STAT PLAN INFER, V161, P73, DOI 10.1016/j.jspi.2015.01.001
   Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Skwerer S, 2014, J MATH IMAGING VIS, V50, P126, DOI 10.1007/s10851-013-0473-0
   Spinks PQ, 2013, MOL PHYLOGENET EVOL, V68, P269, DOI 10.1016/j.ympev.2013.03.031
   Sturm K. T., 2003, CONT MATH, V338, P357, DOI DOI 10.1090/CONM/338/06080
   SUTRADHAR BC, 1989, J MULTIVARIATE ANAL, V29, P155, DOI 10.1016/0047-259X(89)90082-1
   Tang X., 2016, ARXIV160903045
   Timm N. H., 2002, APPL MULTIVARIATE AN, P79
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weyenberg G., 2016, IEEE ACM T COMPUTATI
   Weyenberg G., 2016, THESIS
   Weyenberg G, 2014, BIOINFORMATICS, V30, P2280, DOI 10.1093/bioinformatics/btu258
   Willis A., J ROYAL STAT SOC C
   Ziezold H, 1977, T 7 PRAG C INF THEOR, P591
NR 51
TC 3
Z9 3
U1 1
U2 3
PU AMER STATISTICAL ASSOC
PI ALEXANDRIA
PA 732 N WASHINGTON ST, ALEXANDRIA, VA 22314-1943 USA
SN 0162-1459
EI 1537-274X
J9 J AM STAT ASSOC
JI J. Am. Stat. Assoc.
PD JAN 2
PY 2019
VL 114
IS 525
BP 235
EP 244
DI 10.1080/01621459.2017.1395342
PG 10
WC Statistics & Probability
SC Mathematics
GA IC9SY
UT WOS:000471325500023
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Zhu, Z
   Chu, H
   Wen, L
   Yuan, SF
   Chik, KKH
   Yuen, TTT
   Yip, CCY
   Wang, D
   Zhou, J
   Yin, FF
   Jin, DY
   Kok, KH
   Yuen, KY
   Chan, JFW
AF Zhu, Zheng
   Chu, Hin
   Wen, Lei
   Yuan, Shuofeng
   Chik, Kenn Ka-Heng
   Yuen, Terrence Tsz-Tai
   Yip, Cyril Chik-Yan
   Wang, Dong
   Zhou, Jie
   Yin, Feifei
   Jin, Dong-Yan
   Kok, Kin-Hang
   Yuen, Kwok-Yung
   Chan, Jasper Fuk-Woo
TI Targeting SUMO Modification of the Non-Structural Protein 5 of Zika
   Virus as a Host-Targeting Antiviral Strategy
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE antiviral; flavivirus; inhibitor; interferon; NS5; post-translational
   modification; SUMO; Zika
ID PCR ASSAY; SUMOYLATION; INSIGHTS; RECOGNITION; INHIBITOR; INFECTION;
   DENGUE; FEVER; MICE
AB Post-translational modifications of host or viral proteins are key strategies exploited by viruses to support virus replication and counteract host immune response. SUMOylation is a post-translational modification process mediated by a family of ubiquitin-like proteins called small ubiquitin-like modifier (SUMO) proteins. Multiple sequence alignment of 78 representative flaviviruses showed that most (72/78, 92.3%) have a putative SUMO-interacting motif (SIM) at their non-structural 5 (NS5) protein's N-terminal domain. The putative SIM was highly conserved among 414 pre-epidemic and epidemic Zika virus (ZIKV) strains, with all of them having a putative SIM core amino acid sequence of VIDL (327/414, 79.0%) or VVDL (87/414, 21.0%). Molecular docking predicted that the hydrophobic SIM core residues bind to the 2 strand of the SUMO-1 protein, and the acidic residues flanking the core strengthen the binding through interactions with the basic surface of the SUMO protein. The SUMO inhibitor 2-D08 significantly reduced replication of flaviviruses and protected cells against ZIKV-induced cytopathic effects in vitro. A SIM-mutated ZIKV NS5 failed to efficiently suppress type I interferon signaling. Overall, these findings may suggest SUMO modification of the viral NS5 protein to be an evolutionarily conserved post-translational modification process among flaviviruses to enhance virus replication and suppress host antiviral response.
C1 [Zhu, Zheng; Chu, Hin; Yuan, Shuofeng; Zhou, Jie; Kok, Kin-Hang; Yuen, Kwok-Yung; Chan, Jasper Fuk-Woo] Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Zhu, Zheng; Chu, Hin; Wen, Lei; Yuan, Shuofeng; Chik, Kenn Ka-Heng; Yuen, Terrence Tsz-Tai; Yip, Cyril Chik-Yan; Wang, Dong; Zhou, Jie; Kok, Kin-Hang; Yuen, Kwok-Yung; Chan, Jasper Fuk-Woo] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
   [Yin, Feifei; Yuen, Kwok-Yung; Chan, Jasper Fuk-Woo] Hainan Med Univ, Hainan Med Univ Univ Hong Kong Joint Lab Trop Inf, Haikou, Hainan, Peoples R China.
   [Yin, Feifei; Yuen, Kwok-Yung; Chan, Jasper Fuk-Woo] Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Dept Pathogen Biol, Haikou 571101, Hainan, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Key Lab Translat Trop Med, Haikou 571101, Hainan, Peoples R China.
   [Jin, Dong-Yan] Univ Hong Kong, Sch Biomed Sci, Pokfulam, Hong Kong, Peoples R China.
   [Yuen, Kwok-Yung; Chan, Jasper Fuk-Woo] Univ Hong Kong, Carol Yu Ctr Infect, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
RP Yuen, KY; Chan, JFW (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY; Chan, JFW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY; Chan, JFW (corresponding author), Hainan Med Univ, Hainan Med Univ Univ Hong Kong Joint Lab Trop Inf, Haikou, Hainan, Peoples R China.; Yuen, KY; Chan, JFW (corresponding author), Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY; Chan, JFW (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
EM zhengzhu@hku.hk; hinchu@hku.hk; wenlei07@hku.hk; yuansf@hku.hk;
   kchik929@connect.hku.hk; ttyuenii@connect.hku.hk; yipcyril@hku.hk;
   u3004628@connect.hku.hk; jiezhou@hku.hk; yinfeifeiff@163.com;
   dyjin@hku.hk; khkok@hku.hk; kyyuen@hku.hk; jfwchan@hku.hk
RI Chan, Jasper F. W./D-8007-2013; ZHU, ZHENG/P-2173-2016
OI Chan, Jasper F. W./0000-0001-6336-6657; ZHU, ZHENG/0000-0002-2035-0804;
   ZHOU, Jie/0000-0002-2948-3873; Yuen, Kwok-yung/0000-0002-2083-1552;
   /0000-0003-3426-332X; CHU, HIN/0000-0003-2855-9837; Yuan,
   Shuofeng/0000-0001-7996-1119
FU High Level Hospital-Summit Program in Guangdong, The University of Hong
   Kong-Shenzhen Hospital; Collaborative Innovation Center for Diagnosis
   and Treatment of Infectious Diseases, the Ministry of Education of
   ChinaMinistry of Education, China; Consultancy Service for Enhancing
   Laboratory Surveillance of Emerging Infectious Diseases and Research
   Capability on Antimicrobial Resistance for Department of Health of the
   Hong Kong Special Administrative Region Government; Hong Kong Hainan
   Commercial Association South China Microbiology Research Fund
FX This work was partly supported by the donations of Michael Seak-Kan
   Tong, Hui Ming, Hui Hoy and Chow Sin Lan Charity Fund Limited, Chan Yin
   Chuen Memorial Charitable Foundation, and the Hong Kong Hainan
   Commercial Association South China Microbiology Research Fund; and
   funding from the High Level Hospital-Summit Program in Guangdong, The
   University of Hong Kong-Shenzhen Hospital; the Collaborative Innovation
   Center for Diagnosis and Treatment of Infectious Diseases, the Ministry
   of Education of China; and the Consultancy Service for Enhancing
   Laboratory Surveillance of Emerging Infectious Diseases and Research
   Capability on Antimicrobial Resistance for Department of Health of the
   Hong Kong Special Administrative Region Government. The sponsors had no
   role in the design and conduct of the study, in the collection, analysis
   and interpretation of data, or in the preparation, review or approval of
   the manuscript.
CR Alm E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003416
   Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2018, ANTIVIR RES, V160, P38, DOI 10.1016/j.antiviral.2018.10.007
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chaudhary V, 2015, J GEN VIROL, V96, P3204, DOI 10.1099/jgv.0.000280
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759
   FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840
   Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293
   Guo Q, 2018, J INFECT DIS, V218, P365, DOI 10.1093/infdis/jiy187
   Hannoun Z, 2016, CYTOKINE GROWTH F R, V29, P3, DOI 10.1016/j.cytogfr.2016.04.003
   Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478
   Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118
   Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980
   Kim YS, 2013, CHEM BIOL, V20, P604, DOI 10.1016/j.chembiol.2013.04.001
   Lee HS, 2014, J VIRAL HEPATITIS, V21, pE108, DOI 10.1111/jvh.12241
   Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118
   Rengachari S, 2018, P NATL ACAD SCI USA, V115, pE601, DOI 10.1073/pnas.1718426115
   Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200
   Saisawang C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193133
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   Su CI, 2016, J VIROL, V90, P4308, DOI 10.1128/JVI.00223-16
   Tang HMV, 2015, J VIROL, V89, P8623, DOI 10.1128/JVI.01229-15
   Tseng CH, 2010, J VIROL, V84, P918, DOI 10.1128/JVI.01034-09
   Urena E, 2016, MOL BIOL EVOL, V33, P568, DOI 10.1093/molbev/msv242
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
   Vazquez A, 2016, J VIROL METHODS, V236, P266, DOI 10.1016/j.jviromet.2016.07.026
   WHO, 2017, ZIK SIT REP
   Wu CY, 2011, J VIROL, V85, P6618, DOI 10.1128/JVI.02401-10
   Wu YC, 2007, BIOCHEM SOC T, V35, P1433, DOI 10.1042/BST0351433
   Yuan SF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08015-x
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 45
TC 4
Z9 5
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN 2
PY 2019
VL 20
IS 2
AR 392
DI 10.3390/ijms20020392
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HM8QS
UT WOS:000459746500160
PM 30658479
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Soares-Marangoni, DD
   Tedesco, NM
   Nascimento, AL
   De Almeida, PR
   Pereira, CND
AF Soares-Marangoni, Daniele de Almeida
   Tedesco, Natalia Matos
   Nascimento, Andressa Lagoa
   De Almeida, Priscila Rimoli
   dos Santos Pereira, Caroline Neder
TI General movements and motor outcomes in two infants exposed to Zika
   virus: brief report
SO DEVELOPMENTAL NEUROREHABILITATION
LA English
DT Article
DE Child development; general movements; maternal fetal infection
   transmission; movement disorders; Zika virus
ID EARLY MARKER; INFECTION
AB Objective: We described the general movements (GMs) in the fidgety period and the motor performance of two infants who were exposed to Zika virus (ZIKV) during distinct trimesters of gestation. Methods: Infants were assessed at 4 and 12 months of age. Prechtl's GM assessment and the Alberta Infant Motor Scale were used. Results: In Case 1, the mother presented confirmed ZIKV infection in the 10th week of gestation and the infant was born full-term with brain abnormalities and microcephaly. Fidgety movements were absent at 16 weeks after term and motor development was severely impaired at 12 months of age. In Case 2, the mother presented confirmed ZIKV infection in the 34th week of gestation and the infant was born full-term with no signs of brain changes or microcephaly. Fidgety movements at 13 weeks were normal in presentation and motor outcome was typical at 12 months. Conclusion: GM assessment can be useful for ZIKV-exposed infants. These findings represent the first information on GMs and long-term motor outcomes in ZIKV-exposed infants.
C1 [Soares-Marangoni, Daniele de Almeida] Univ Fed Mato Grosso do Sul, UFMS, Inst Hlth, Sch Phys Therapy, Campo Grande, Brazil.
   [Tedesco, Natalia Matos; Nascimento, Andressa Lagoa] Univ Fed Mato Grosso do Sul, Fac Med, Program Postgrad Hlth & Dev, Campo Grande, Brazil.
   [De Almeida, Priscila Rimoli] Mato Grosso Reg Hosp, Phys Therapy Ambulatory, Campo Grande, Brazil.
   [dos Santos Pereira, Caroline Neder] Maria Aparecida Pedrossian Univ Hosp, Pediat Ambulatory, UFMS, Campo Grande, Brazil.
RP Soares-Marangoni, DD (corresponding author), Univ Fed Mato Grosso do Sul, Curso Fisioterapia, Unidade 12, BR-79070900 Campo Grande, MS, Brazil.
EM daniele.soares@ufms.br
RI de Almeida Soares-Marangoni, Daniele/B-5938-2011
OI de Almeida Soares-Marangoni, Daniele/0000-0002-5354-5456
FU Coordination for the Improvement of Higher Education Personnel (CAPES),
   BrazilCAPES [1711415]
FX This work was supported by the Coordination for the Improvement of
   Higher Education Personnel (CAPES), Brazil, under grant number 1711415.
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Botelho Ana Carla Gomes, 2016, Rev. Bras. Saude Mater. Infant., V16, P39, DOI 10.1590/1806-9304201600s100004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Einspieler C, 2005, MENT RETARD DEV D R, V11, P61, DOI 10.1002/mrdd.20051
   Einspieler C, 2016, J PEDIAT-BRAZIL, V92, pS64, DOI 10.1016/j.jped.2015.12.003
   Ferrari F, 2002, ARCH PEDIAT ADOL MED, V156, P460, DOI 10.1001/archpedi.156.5.460
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Ministerio da Saude do Brasil [Brazilian Ministry of Health], 2015, PROT AT SAUD RESP O
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Palchik AB, 2013, EARLY HUM DEV, V89, P229, DOI 10.1016/j.earlhumdev.2013.02.004
   Piper M.C., 1994, MOTOR ASSESSMENT DEV
   Prechtl HFR, 2001, DEV MED CHILD NEUROL, V43, P198, DOI 10.1017/S0012162201000378
   Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   World Health Organization, ZIK VIR MICR GUILL B
NR 19
TC 2
Z9 2
U1 1
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1751-8423
EI 1751-8431
J9 DEV NEUROREHABIL
JI Dev. Neurorehabil.
PD JAN 2
PY 2019
VL 22
IS 1
BP 71
EP 74
DI 10.1080/17518423.2018.1437843
PG 4
WC Clinical Neurology; Pediatrics; Rehabilitation
SC Neurosciences & Neurology; Pediatrics; Rehabilitation
GA HJ0WY
UT WOS:000456885100011
PM 29452026
DA 2020-07-08
ER

PT J
AU Delorme-Axford, E
   Klionsky, DJ
AF Delorme-Axford, Elizabeth
   Klionsky, Daniel J.
TI Inflammatory-dependent Sting activation induces antiviral autophagy to
   limit zika virus in the Drosophila brain
SO AUTOPHAGY
LA English
DT Editorial Material
DE flavivirus; pregnancy; virophagy; xenophagy; ZIKV
ID INTERFERONS; RECOGNITION; INFECTION; CELLS
AB Incidences of congenital syndrome associated with maternal zika virus (ZIKV) infection during pregnancy are well documented; however, the cellular and molecular mechanisms by which ZIKV infection causes these devastating fetal pathologies are still under active investigation. ZIKV is a member of the flavivirus family and is mainly transmitted to human hosts through Aedes mosquito vectors. However, in vivo models for the neurological tropism of the virus and the arthropod vector have been lacking. A recent study published in Cell Host & Microbe from Dr. Sara Cherry's lab investigates both of these key aspects of the ZIKV infectious life cycle. Liu et al. demonstrate how inflammatory activated Sting/dSTING-dependent antiviral macroautophagy/autophagy is sufficient to restrict ZIKV infection in the Drosophila melanogaster brain. Additionally, this study provides further evidence for the ancestral function of autophagy in protecting host cells from viral invaders. Abbreviations: AGO2: Argonaute 2; ATG: autophagy-related; Dcr-2: Dicer-2; DptA/Dipt: Diptericin A; Drs: Drosomycin; DCV: Drosophila C virus; IMD: immune-deficiency; qRT-PCR: quantitative real-time PCR; Rel/NF-kappa B: Relish; RNAi: RNA interference; ZIKV: zika virus
C1 [Delorme-Axford, Elizabeth; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Rm 6036,210 Washtenaw Ave, Ann Arbor, MI 48109 USA.
RP Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Rm 6036,210 Washtenaw Ave, Ann Arbor, MI 48109 USA.
EM klionsky@umich.edu
RI Delorme-Axford, Elizabeth/AAL-4641-2020
OI Klionsky, Daniel/0000-0002-7828-8118
FU National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [GM053396]
FX This work was supported by the National Institute of General Medical
   Sciences [GM053396].
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Diamond MS, 2018, NAT REV IMMUNOL, V18, P89, DOI 10.1038/nri.2017.132
   Gammon DB, 2015, CURR OPIN INSECT SCI, V8, P111, DOI 10.1016/j.cois.2015.01.006
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Levine B, 2017, P NATL ACAD SCI USA, V114, P201, DOI 10.1073/pnas.1619876114
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004
   Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176
   Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
NR 27
TC 1
Z9 1
U1 0
U2 20
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD JAN 2
PY 2019
VL 15
IS 1
BP 1
EP 3
DI 10.1080/15548627.2018.1539585
PG 3
WC Cell Biology
SC Cell Biology
GA HC1PX
UT WOS:000451574800001
PM 30354937
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Liu, Y
   Cherry, S
AF Liu, Yuan
   Cherry, Sara
TI Zika virus infection activates sting-dependent antiviral autophagy in
   the Drosophila brain
SO AUTOPHAGY
LA English
DT Editorial Material
DE Arbovirus; encephalitis; flavivirus; inflammatory; NFKB
AB Viral infection of neurons is pathogenic, yet the factors that govern innate control of neurons remain incompletely understood. Using a Drosophila model we have defined the essential role that inflammatory-dependent Sting activation plays in inducing antiviral macroautophagy/autophagy to restrict Zika infection in the fly brain. Our discovery that Sting is an essential mediator of innate defenses in Drosophila provides further support for an ancient and conserved pathway that likely evolved to target intracellular pathogens for autophagic destruction.
C1 [Liu, Yuan; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
RP Cherry, S (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
EM cherrys@mail.med.upenn.edu
FU Burroughs Wellcome FundBurroughs Wellcome Fund; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5R01AI074951, 5R01AI122749]
FX This work was supported by the Burroughs Wellcome Fund [Investigator in
   the Pathogenesis of Infectious Disease]; National Institutes of Health
   [5R01AI122749]; National Institutes of Health [5R01AI074951].
CR Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
NR 1
TC 7
Z9 7
U1 1
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD JAN 2
PY 2019
VL 15
IS 1
BP 174
EP 175
DI 10.1080/15548627.2018.1528813
PG 2
WC Cell Biology
SC Cell Biology
GA HC1PX
UT WOS:000451574800013
PM 30260713
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Bos, S
   Viranaicken, W
   Turpin, J
   El-Kalamouni, C
   Roche, M
   Krejbich-Trotot, P
   Despres, P
   Gadea, G
AF Bos, Sandra
   Viranaicken, Wildriss
   Turpin, Jonathan
   El-Kalamouni, Chaker
   Roche, Marjolaine
   Krejbich-Trotot, Pascale
   Despres, Philippe
   Gadea, Gilles
TI The structural proteins of epidemic and historical strains of Zika virus
   differ in their ability to initiate viral infection in human host cells
   (vol 516, pg 265, 2018)
SO VIROLOGY
LA English
DT Correction
C1 [Bos, Sandra; Viranaicken, Wildriss; Turpin, Jonathan; El-Kalamouni, Chaker; Roche, Marjolaine; Krejbich-Trotot, Pascale; Despres, Philippe; Gadea, Gilles] Univ Reunion, INSERM, CNRS,U1187,UMR 9192,IRD,UMR 249,CYROI, Unite Mixte Proc Infect Milieu Insulaire Trop, F-94791 St Clotilde, Reunion, France.
RP Despres, P; Gadea, G (corresponding author), Univ Reunion, INSERM, CNRS,U1187,UMR 9192,IRD,UMR 249,CYROI, Unite Mixte Proc Infect Milieu Insulaire Trop, F-94791 St Clotilde, Reunion, France.
EM philippe.despres@univ-reunion.fr; gilles.gadea@inserm.fr
RI Gilles, Gadea/M-9966-2015
OI Gilles, Gadea/0000-0001-6325-4866; El Kalamouni,
   Chaker/0000-0003-4673-6614
CR Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
NR 1
TC 0
Z9 0
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JAN 2
PY 2019
VL 526
BP 233
EP 233
DI 10.1016/j.virol.2018.11.006
PG 1
WC Virology
SC Virology
GA HE0CL
UT WOS:000452934300027
PM 30502856
OA Bronze
DA 2020-07-08
ER

PT J
AU Poehlman, JA
   Sidibe, T
   Jimenez-Magdaleno, KV
   Vazquez, N
   Ray, SE
   Mitchell, EW
   Squiers, L
AF Poehlman, Jon A.
   Sidibe, Turquoise
   Jimenez-Magdaleno, Karla, V
   Vazquez, Natasha
   Ray, Sarah E.
   Mitchell, Elizabeth W.
   Squiers, Linda
TI Developing and Testing the Deten El Zika Campaign in Puerto Rico
SO JOURNAL OF HEALTH COMMUNICATION
LA English
DT Article
ID HEALTH; EFFICACY; DENGUE
AB Responding to an emerging health threat often requires rapid deployment of behavior change communication. Health communication best practices include developing and testing draft messages and materials to ensure that they resonate with and inspire priority groups to act. However, when faced with an emergency health threat, the timeline for these activities can be compressed from months to weeks. This article discusses the rapid development and implementation of a Zika virus prevention campaign for pregnant women in Puerto Rico. The goal of the campaign was to increase knowledge among and motivate pregnant women, their partners and family members, and the community to follow Zika virus prevention recommendations. The steps in campaign development include environmental scanning, concept development and testing, and message testing to ensure development of campaign materials that resonated with and were well-received by key audience groups. The materials adhere to principles of behavior change communication, and offer our insights for development of future campaigns when under time constraints.
C1 [Poehlman, Jon A.; Jimenez-Magdaleno, Karla, V; Vazquez, Natasha] RTI Int, Ctr Commun Sci, Res Triangle Pk, NC 27709 USA.
   [Sidibe, Turquoise] CDC Fdn, Internal Operat, Atlanta, GA USA.
   [Ray, Sarah E.] RTI Int, Ctr Commun Sci, Atlanta, GA USA.
   [Mitchell, Elizabeth W.] Natl Ctr Birth Defects & Dev Disabil, Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Squiers, Linda] RTI Int, Ctr Commun Sci, Rockville, MD USA.
RP Poehlman, JA (corresponding author), RTI Int, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.
EM jpoehlman@rti.org
FU Bill & Melinda Gates FoundationGates Foundation; Annie E. Casey
   Foundation; Walgreens Company; RTI International under the CDC
   Foundation (MOA) [197-16 SC]
FX This research was funded by the Bill & Melinda Gates Foundation, the
   Annie E. Casey Foundation, and Walgreens Company and conducted by RTI
   International under the guidance of the CDC Foundation (MOA #:197-16
   SC); Annie E. Casey Foundation; Bill and Melinda Gates Foundation;
   Walgreens Company.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x
   Ajzen I, 1985, ACTION CONTROL COGNI, DOI DOI 10.1007/978-3-642-69746-3_2
   Andreasen AR, 2002, J PUBLIC POLICY MARK, V21, P3, DOI 10.1509/jppm.21.1.3.17602
   Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422
   BECK KH, 1981, J APPL SOC PSYCHOL, V11, P401, DOI 10.1111/j.1559-1816.1981.tb00832.x
   Becker M. H., 1974, HLTH ED MONOGRAPHS, V2, P324, DOI DOI 10.1177/109019817400200407
   BLOCK CD, 2017, WASH U J L POLY, V53, P215
   CDC, 2017, ZIK VIR DIS US 2015
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kaplan B H, 1977, Med Care, V15, P47, DOI 10.1097/00005650-197705001-00006
   Lefebvre R. C., 2013, SOCIAL MARKETING SOC
   Maibach E., 1991, HEALTH COMMUN, V3, P1, DOI [10. 1207/s15327027hc0301_1, DOI 10.1207/S15327027HC0301_1]
   Miles M.B., 1994, QUALITATIVE DATA ANA
   Nickel R, 2016, REUTERS HLTH NEWS
   Oster A. M, 2016, MMWR MORBIDITY MORTA
   PAHO & WHO, 2015, EP AL ZIK VIR INF PA
   Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005
   Perez-Guerra CL, 2005, REV PANAM SALUD PUBL, V17, P243, DOI 10.1590/S1020-49892005000400005
   Porterfield Deborah S, 2012, Am J Public Health, V102 Suppl 3, pS375, DOI 10.2105/AJPH.2012.300692
   Prue C, 2016, EVALUATION ZIKA PREV
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rowel R, 2005, J NATL MED ASSOC, V97, P527
   Snyder LB, 2007, J NUTR EDUC BEHAV, V39, pS32, DOI 10.1016/j.jneb.2006.09.004
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355
   WHO, 2016, HIST ZIK VIR
NR 27
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1081-0730
EI 1087-0415
J9 J HEALTH COMMUN
JI J. Health Commun.
PY 2019
VL 24
IS 12
BP 900
EP 911
DI 10.1080/10810730.2019.1683655
PG 12
WC Communication; Information Science & Library Science
SC Communication; Information Science & Library Science
GA LY3WT
UT WOS:000540460200004
PM 31665987
DA 2020-07-08
ER

PT J
AU Tokash-Peters, AG
   Tokash, IW
   Campos, AJ
   Woodhams, DC
AF Tokash-Peters, Amanda G.
   Tokash, Ivan W.
   Campos, Alberto J.
   Woodhams, Douglas C.
TI Developing Effective Mosquito Control Strategies by Utilizing Vector
   Mosquito Life Histories and Ecology
SO CASE STUDIES IN THE ENVIRONMENT
LA English
DT Article
ID AEDES-ALBOPICTUS; ANOPHELES; COMPETITION; DIPTERA; WOLBACHIA; CULICIDAE;
   AEGYPTI; GENE; BATS; REFRACTORINESS
AB Globally, mosquitoes have the propensity to severely impact public health by transmitting infectious agents that can lead to diseases, such as malaria, dengue fever, chikungunya, Zika fever, and West Nile fever. To develop appropriate control and mitigation measures for controlling the spread of mosquito-borne disease, we need to better understand ecological influences on mosquitoes, including competition, predation, and interactions with the environment. Building novel and environmentally conscious strategies has become increasingly important under the threat of potential range expansion with climate change and increased global connectivity. As a result of this case study and answering the corresponding questions, readers will be able to identify modern approaches to mosquito control based on an ecological understanding of these disease vectors. Readers will actively engage in scenarios where they will balance trade-offs between public health and environmental health, while considering the breadth of factors involved in global mosquito control efforts.
C1 [Tokash-Peters, Amanda G.; Tokash, Ivan W.; Campos, Alberto J.; Woodhams, Douglas C.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.
   [Tokash-Peters, Amanda G.] Univ Rwanda, Ctr Excellence Biodivers & Nat Resource Managemen, Huye, Rwanda.
RP Tokash-Peters, AG (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.; Tokash-Peters, AG (corresponding author), Univ Rwanda, Ctr Excellence Biodivers & Nat Resource Managemen, Huye, Rwanda.
EM amanda.peters001@umb.edu
FU National Science FoundationNational Science Foundation (NSF) [DGE
   1249946]; Craig R. Bollinger Memorial Research Grant; Nancy Goranson
   Endowment Fund; University of Massachusetts Global Programs Office Seed
   Grant Fund; UMass Boston Proposal Development Grant Program; University
   of Massachusetts Sanofi-Genzyme Doctoral Fellowship
FX AT-P was supported by National Science Foundation grant DGE 1249946,
   Integrative Graduate Education and Research Traineeship (IGERT): Coasts
   and Communities - Natural and Human Systems in Urbanizing Environments,
   the University of Massachusetts Sanofi-Genzyme Doctoral Fellowship, the
   Craig R. Bollinger Memorial Research Grant, the Nancy Goranson Endowment
   Fund, and the University of Massachusetts Global Programs Office Seed
   Grant Fund. DW was supported by the UMass Boston Proposal Development
   Grant Program.
CR Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Almeida RM, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0526
   Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Alto BW, 2013, ECOL CONT VECTOR-BOR, V3, P81
   Alto BW, 2005, ECOLOGY, V86, P3279
   Baldacchino F, 2017, PEST MANAG SCI, V73, P87, DOI 10.1002/ps.4417
   Barnard DR, 2004, J MED ENTOMOL, V41, P726, DOI 10.1603/0022-2585-41.4.726
   BAUMANN P, 1991, MICROBIOL REV, V55, P425, DOI 10.1128/MMBR.55.3.425-436.1991
   Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x
   Becker N, 1998, ISRAEL J ENTOMOL, VXXXH, P63
   Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Brady OJ, 2015, INT HEALTH, V7, P121, DOI 10.1093/inthealth/ihv010
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Braks MAH, 2009, INTERSPECIFIC COMPET, DOI [10.1603/0013-8746%282004%29097%, DOI 10.1603/0013-8746%282004%29097%]
   BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839
   Briegel H, 2003, J VECTOR ECOL, V28, P1
   CAMARGO S, 1967, B WORLD HEALTH ORGAN, V36, P602
   Carlson J, 2004, J VECTOR ECOL, V29, P331
   Carson R., 2002, SILENT SPRING
   Cassidy RA, 2005, BREAST CANCER RES TR, V90, P55, DOI 10.1007/s10549-004-2755-0
   CDC, 2017, EST RANG AED AEG AED
   Chase JM, 2009, ECOL ENTOMOL, V34, P741, DOI 10.1111/j.1365-2311.2009.01128.x
   Cole DC, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-54
   Crans WJ, 2004, CLASSIFICATION SYSTE
   DAntonio M, 2001, MOSQUITO NATURAL HIS
   DENNISON NJ, 2014, NIH PUBLIC ACCESS, V3, P6, DOI DOI 10.1016/J.COIS.2014.07.004
   EDGERLY JS, 1993, ECOL ENTOMOL, V18, P123, DOI 10.1111/j.1365-2311.1993.tb01193.x
   Emami SN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40520
   Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2
   Ernst KC, 2015, EMERG INFECT DIS, V21, P320, DOI 10.3201/eid2102.141035
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Floore TG, 2006, J AM MOSQUITO CONTR, V22, P527, DOI 10.2987/8756-971X(2006)22[527:MLCPPA]2.0.CO;2
   Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Gachelin G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2244-2
   Garry VF, 2004, CANCER EPIDEM BIOMAR, V1, P287
   Gildenhard M, 2019, NAT MICROBIOL, P1
   Gjullin CM, 1941, J CELL COMPAR PHYSL, V17, P193, DOI 10.1002/jcp.1030170205
   GOLDBERG LJ, 1977, MOSQ NEWS, V37, P355
   Goodsell JA, 1999, CONSERV BIOL, V13, P921, DOI 10.1046/j.1523-1739.1999.98237.x
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guidi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055658
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Hillyer JF, 2016, DEV COMP IMMUNOL, V58, P102, DOI 10.1016/j.dci.2015.12.006
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2011, SUCCESSFUL ESTABLISH
   Ingabire CM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2046-y
   JUDSON CHARLES L., 1960, ANN ENT SOC AMER, V53, P688, DOI 10.1093/aesa/53.5.688
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Kamel F, 2005, ENVIRON HEALTH PERSP, V113, P877, DOI 10.1289/ehp.7645
   Kim M, 2017, ADV SCI, V4
   KRUGMAN P, 1995, Q J ECON, V110, P857, DOI 10.2307/2946642
   Lacey LA, MICROBIAL CONTROL BL, DOI [10.1146/annurev.en.31.010186.001405., DOI 10.1146/ANNUREV.EN.31.010186.001405]
   League GP, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0305-y
   Leendertz SAJ, 2016, ECOHEALTH, V13, P18, DOI 10.1007/s10393-015-1053-0
   Li C., 2017, SCI TOTAL ENVIRON, V493, P622
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   LIVDAHL TP, 1982, ECOLOGY, V63, P1751, DOI 10.2307/1940117
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Meghani Z, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006501
   MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025
   Milam CD, 2000, ARCH ENVIRON CON TOX, V39, P324, DOI 10.1007/s002440010111
   Moller-Jacobs LL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0593-4
   Montibeler EE, 2018, ACTA TROP, V178, P318, DOI 10.1016/j.actatropica.2017.11.016
   MOUCHES C, 1986, SCIENCE, V233, P778, DOI 10.1126/science.3755546
   MURRAY JV, 2016, FRONTIERS MEDIA SA, V4, DOI DOI 10.3389/FPUBH.2016.00043
   Ng'habi K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31805-8
   Novakova E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00526
   Oteera, CUL MOSQ BIT SUCK HU
   Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196
   Pike A, 2017, SCIENCE, V357, P1396, DOI 10.1126/science.aak9691
   PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994
   Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409
   Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159
   Purdue MP, 2007, INT J CANCER, V120, P642, DOI 10.1002/ijc.22258
   Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4
   Reiskind MH, 2009, J MED ENTOMOL, V46, P1037, DOI 10.1603/033.046.0510
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Saha N, 2010, AQUAT ECOL, V44, P167, DOI 10.1007/s10452-009-9250-y
   Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Steelman CD, 1972, J ECON ENTOMOL, V65, P462
   STORER TRACY I., 1926, JOUR MAMMALOGY, V7, P85, DOI 10.2307/1373673
   TOOHEY MK, 1985, J MED ENTOMOL, V22, P102, DOI 10.1093/jmedent/22.1.102
   US Centers for Disease Control and Prevention, 2015, CDC MAL AN MOSQ
   US Centers for Disease Control and Prevention, 2016, AV BUG BIT TRAV HLTH
   US Centers for Disease Control and Prevention, 2018, CDC MAL IMP WORLDW
   van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785
   Verhulst NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028991
   Wang S, 2012, PNAS, V109, P1734
   Wang SB, 2017, SCIENCE, V357, P1399, DOI 10.1126/science.aan5478
   Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767
   Wetzler GC, 2018, CAN J ZOOL, V96, P373, DOI 10.1139/cjz-2017-0162
   Williamson S, 2008, CROP PROT, V27, P1327, DOI 10.1016/j.cropro.2008.04.006
   Wilson C, 2001, ECOL ECON, V39, P449, DOI 10.1016/S0921-8009(01)00238-5
   Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520
   World Health Organization, 2017, VECT BORN DIS
   World Health Organization, 2016, MOSQ BORN DIS
   World Health Organization, 2017, WORLD MAL REP 2016 E
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 106
TC 0
Z9 0
U1 0
U2 0
PU UNIV CALIFORNIA PRESS
PI OAKLAND
PA 155 GRAND AVE, SUITE 400, OAKLAND, CA 94612-3758 USA
SN 2473-9510
J9 CASE STUD ENVIRON
JI Case Stud. Environ.
PY 2019
VL 3
IS 1
DI 10.1525/cse.2018.001743
PG 12
WC Education & Educational Research; Environmental Studies
SC Education & Educational Research; Environmental Sciences & Ecology
GA LE7VX
UT WOS:000526932900018
DA 2020-07-08
ER

PT B
AU Ziwei, BY
   Chua, HN
AF Ziwei, Bernice Yeow
   Chua, Hui Na
GP ACM
TI An Application for Classifying Depression in Tweets
SO 2019 2ND INTERNATIONAL CONFERENCE ON COMPUTING AND BIG DATA (ICCBD 2019)
LA English
DT Proceedings Paper
CT 2nd International Conference on Computing and Big Data (ICCBD)
CY OCT 18-20, 2019
CL Taichung, TAIWAN
DE Data mining; Social media analytics; Sentiment analysis; Depression
   classification
ID PRIME-MD; UTILITY
AB A depressed person feels sad, hopeless on a regular basis, lose interest in activities and experiences physical symptoms such as chronic pain or digestive issues [1]. Each day, millions of people suffered from depression and only a small fraction of them undergo proper treatment. In the past, doctors analyzed depressed people via a face to face session and apply the diagnostic criteria written by a professional psychologist to determine depression. However, past research revealed that most patients would not seek help from doctors at the early stage of depression which results in a declination of their mental health condition. On the other hand, many people are using the social media platform to share their feelings daily. Since then, there have been many studies on using social media to predict mental and physical diseases such as cardiac arrest, zika virus, Muppalla, and prescription drug abuse. However, currently there is a lack of work on an application that leverages social media data for detecting depressive thoughts to determine the depression state of a Twitter user. To achieve this aim, we developed a web application that performs sentiment analysis through a classification function that discerns the proportion of depressive and non-depressive thoughts of an individual. This application further provides individuals to visualize their depression state via a web interface.
C1 [Ziwei, Bernice Yeow; Chua, Hui Na] Sunway Univ, Dept Comp & Informat Syst, Bandar Sunway, Selangor, Malaysia.
RP Ziwei, BY (corresponding author), Sunway Univ, Dept Comp & Informat Syst, Bandar Sunway, Selangor, Malaysia.
EM 15096241@imail.sunway.edu.my; huinac@sunway.edu.my
CR Agarwal A., 2011, P WORKSH LANG SOC ME, P30
   Akhtar N, 2017, PROCEDIA COMPUT SCI, V115, P563, DOI 10.1016/j.procs.2017.09.115
   American Psychiatric Association, 2014, THESIS
   [Anonymous], 2019, TWITTER LIMITS
   Bermingham A., 2010, P 19 ACM INT C INF K, P1833, DOI DOI 10.1145/1871437.1871741
   Cavazos-Rehg PA, 2016, COMPUT HUM BEHAV, V54, P351, DOI 10.1016/j.chb.2015.08.023
   Collomb A., 2014, RRLIRIS2014002
   De Choudhury M., 2013, SOCIAL MEDIA MEASURE, DOI [10.1145/2464464.2464480, DOI 10.1145/2464464.2464480, 10.1145/2464464.2464480.]
   De Choudhury Munmun, 2013, 7 INT AAAI C WEBL SO
   Detels R., 2015, OXFORD TXB GLOBAL PU, DOI [10.1093/med/9780199661756.003.0001., DOI 10.1093/MED/9780199661756.003.0001]
   Fottrell Q., 2018, PEOPLE SPEND MOST TH
   Go A, 2009, ENTROPY, V2009, P1
   Haque M., 2014, ARXIV14033185
   Karmen C, 2015, COMPUT METH PROG BIO, V120, P27, DOI 10.1016/j.cmpb.2015.03.008
   Liu B, 2011, DATA CENTRIC SYST AP, P459, DOI 10.1007/978-3-642-19460-3_11
   Malmasi S, 2016, P 3 WORKSH COMP LING, P133, DOI DOI 10.18653/V1/W16-0314
   Nations D, 2018, WHAT IS EX IS TWEET
   Park M., 2012, P ACM SIGKDD WORKSH
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Ritchie H., 2018, MENTAL HLTH EMPIRICA
   Rude SS, 2004, COGNITION EMOTION, V18, P1121, DOI 10.1080/02699930441000030
   Sadilek A, 2012, P 6 INT AAAI C WEBL
   Saxena A., 2018, SEMANTICALLY ENHANCE
   Shelton J., 2019, DEPRESSION DEFINITIO
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580
   Statista, 2018, TWITT NUMB MONTHL AC
   Taboada M, 2011, COMPUT LINGUIST, V37, P267, DOI 10.1162/COLI_a_00049
   Vryniotis V., 2013, MACHINE LEARNING BLO
   Witten I.H., 2016, DATA MINING PRACTICA
   Yazdavar Amir Hossein, 2017, Proc IEEE ACM Int Conf Adv Soc Netw Anal Min, V2017, P1191, DOI 10.1145/3110025.3123028
NR 31
TC 0
Z9 0
U1 0
U2 0
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-7290-9
PY 2019
BP 37
EP 41
DI 10.1145/3366650.3366653
PG 5
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Computer Science, Theory & Methods
SC Computer Science
GA BO7ZK
UT WOS:000526359700008
DA 2020-07-08
ER

PT B
AU Musah, A
   Rubio-Solis, A
   Birjovanu, G
   dos Santos, WP
   Massoni, T
   Kostkova, P
AF Musah, Anwar
   Rubio-Solis, Adrian
   Birjovanu, Georgiana
   dos Santos, Wellington P.
   Massoni, Tiago
   Kostkova, Patty
GP ACM
TI Assessing the Relationship between various Climatic Risk Factors &
   Mosquito Abundance in Recife, Brazil
SO PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON DIGITAL PUBLIC HEALTH
   (DPH '19)
LA English
DT Proceedings Paper
CT 9th International Conference on Digital Public Health (DPH)
CY NOV 20-23, 2019
CL Marseille, FRANCE
SP Assoc Comp Machinery, KDD, ICPS, ACM In Cooperat
DE Vector control; surveillance; Zika virus; climate conditions;
   spatial-temporal models
AB Recife is one of many regions in the North Eastern section of Brazil to be hit hard by the Zika virus outbreak in 2015. Zika infection is caused by the arboviruses transmitted by the Aedes mosquitoes which are abundant in Brazil. It is a known fact that increased abundance of the Aedes mosquito is typically associated with standing (or stagnant) water which serves as a reservoir or hotspot for breeding. Apart from the presence of standing (or stagnated) water in human dwellings, it is important to consider other intermediate factors that drive the mosquitoes to increase in population size. We consider the example of a set of climate conditions such as land surface temperature, humidity, precipitation, seasonality etc. These are typical risk factors that must be taken into consideration especially for the spatial and early warning prediction of breeding hotspots for the Aedes mosquito species responsible for transmitting Zika viruses in Brazil. In this work-in-progress study, we bring together historical records from a mosquito surveillance and control programme conducted by the Centre for Environmental Surveillance Agency in Recife and open source climate information. We use a population-based ecological study design to explore the regional-level spatial-temporal relationship between the prevalence of households detected to have increased mosquito larvae density and environmental risk factors such as temperature and precipitation.
C1 [Musah, Anwar; Birjovanu, Georgiana; Kostkova, Patty] UCL, Ctr Digital Publ Hlth & Emergencies, London, England.
   [Rubio-Solis, Adrian] Ctr Engn & Ind Dev CIDESI, Mexico City, DF, Mexico.
   [dos Santos, Wellington P.] Univ Fed Pernambuco, Dept Biomed Engn, Recife, PE, Brazil.
   [Massoni, Tiago] Univ Fed Campina Grande, Dept Syst & Comp, Campina Grande, Paraiba, Brazil.
RP Musah, A (corresponding author), UCL, Ctr Digital Publ Hlth & Emergencies, London, England.
EM a.musah@ucl.ac.uk; adrian.rubio@cidesi.edu.mx;
   georgiana.birjovanu.15@ucl.ac.uk; wellington.santos@ufpe.br;
   massoni@dsc.ufcg.edu.br; p.kostkova@ucl.ac.uk
OI Musah, Anwar/0000-0001-7978-1871
CR Beltran JD, 2018, DH '18: PROCEEDINGS OF THE 2018 INTERNATIONAL CONFERENCE ON DIGITAL HEALTH, P90, DOI 10.1145/3194658.3194683
   de Quincey E, 2009, ELECT HEALTHCARE, P21, DOI [10.1007/978-3-642-11745-9_4, DOI 10.1007/978-3-642-11745-9_4]
   Dile Y.T., 2014, J AM WATER RESOUR AS, P1, DOI DOI 10.1111/jawr.12182
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fuka DR, 2014, HYDROL PROCESS, V28, P5613, DOI 10.1002/hyp.10073
   Javed F, 2018, J BASIC MICROB, V58, P3, DOI 10.1002/jobm.201700398
   Kostkova Patty, 2013, P 22 INT C WORLD WID, P687
   Lee D, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i09
   Martines Roosecelis Brasil, 2016, MMWR MORBIDITY MORTA
   McHale TC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101759
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Romero-Vivas CME, 2005, J AM MOSQUITO CONTR, V21, P15, DOI 10.2987/8756-971X(2005)21[15:IORBAA]2.0.CO;2
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-7208-4
PY 2019
BP 97
EP 100
DI 10.1145/3357729.3357744
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Public, Environmental & Occupational Health
SC Computer Science; Engineering; Public, Environmental & Occupational
   Health
GA BO7GL
UT WOS:000524252200017
DA 2020-07-08
ER

PT B
AU Rubio-Solis, A
   Musah, A
   Dos Santos, WP
   Massoni, T
   Birjovanu, G
   Kostkova, P
AF Rubio-Solis, Adrian
   Musah, Anwar
   Dos Santos, Wellington P.
   Massoni, Tiago
   Birjovanu, Georgiana
   Kostkova, Patty
GP ACM
TI ZIKA Virus: Prediction of Aedes Mosquito Larvae Occurrence in Recife
   (Brazil) using Online Extreme Learning Machine and Neural Networks
SO PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON DIGITAL PUBLIC HEALTH
   (DPH '19)
LA English
DT Proceedings Paper
CT 9th International Conference on Digital Public Health (DPH)
CY NOV 20-23, 2019
CL Marseille, FRANCE
SP Assoc Comp Machinery, KDD, ICPS, ACM In Cooperat
DE ZIKA virus (ZIKV); Neural Networks; Online Learning; Extreme Learning
   Machines; Fuzzy Logic; Classification; Regression
ID AMERICA
AB Geographical maps showing the abundance of the Aedes species (A. Aegypti and A. Albopictus) in Latin America plays a crucial role in the fight against the Zika Virus (ZIKV). They aid in the identification of sites that promotes mosquito breeding and transmission of ZIKV. In the case of Brazil, one of the greatest factors that favours rapid mosquito reproduction is the presence of stagnated water in the environment. This could be in the form of non-flowing water filled in tanks, barrels, discarded tires, and many other containers situated in human dwellings. After the ZIKV outbreak from 2015, the environmental agency in Brazil have intensively been engaged with routine surveillance of water bodies present in households and the environment to destroy mosquito breeding hotspots as public health measure to prevent vector-to-human transmission of ZIKV. The objective of this study is to use data from their routine surveillance to showcase how our predictive framework based on Neural Networks and Online Extreme Learning Machine (OELM) can predict for Recife (Brazil) at a health district-level the following: firstly, the spatial distribution of the number of properties with water containers contaminated with the Aedes mosquito larvae responsible for ZIKV; and secondly, the spatial distribution of properties with the Aedes mosquito larvae stratified by type of water container. The ultimate goal for this research is to subsequently implement these models to their real-time surveillance data so as an early warning system is present to identify spatially the mosquito hotspots and provide an early warning. This system will be built to guide policy makers for directing resources for controlling the mosquito populations thereby limiting transmission to humans.
C1 [Rubio-Solis, Adrian] Ctr Engn & Ind Dev CIDESI Mexico, Santiago De Queretaro, Qro, Mexico.
   [Musah, Anwar; Birjovanu, Georgiana; Kostkova, Patty] UCL, IRDR Ctr Digital Publ Hlth Emergencies dPHE, London, England.
   [Dos Santos, Wellington P.] Feb Univ Pernambuco, Dept Biomed Engn, Recife, PE, Brazil.
   [Massoni, Tiago] Feb Univ Pernambuco, Dept Syst & Comp, Recife, PE, Brazil.
RP Rubio-Solis, A (corresponding author), Ctr Engn & Ind Dev CIDESI Mexico, Santiago De Queretaro, Qro, Mexico.
EM adrian.rubio@cidesi.edu.mx; a.musah@ucl.ac.uk;
   wellington.santos@ufpe.br; massoni@computacao.ufcg.edu.br;
   georgiana.birjovanu.15@ucl.ac.uk; p.kostkova@ucl.ac.uk
CR Basso C, 2012, AM J TROP MED HYG, V87, P1083, DOI 10.4269/ajtmh.2012.12-0328
   Beltran JD, 2018, DH '18: PROCEEDINGS OF THE 2018 INTERNATIONAL CONFERENCE ON DIGITAL HEALTH, P90, DOI 10.1145/3194658.3194683
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   CALHEIROS RV, 1987, J CLIM APPL METEOROL, V26, P118, DOI 10.1175/1520-0450(1987)026<0118:RRRRFR>2.0.CO;2
   de Lima-Camara TN, 2017, CABI CLIM CHANGE SER, P127, DOI 10.1079/9781780645377.0127
   de Quincey E, 2009, ELECT HEALTHCARE, P21, DOI [10.1007/978-3-642-11745-9_4, DOI 10.1007/978-3-642-11745-9_4]
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fuller TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188002
   Gulland Anne, 2016, WHO URGES COUNTRIES
   Heukelbach J, 2016, INFECT DEV CTRIES, V2, P116
   Huang GB, 2004, IEEE IJCNN, P985
   Javed F, 2018, J BASIC MICROB, V58, P3, DOI 10.1002/jobm.201700398
   Jun W, 2011, INT J MACH LEARN CYB, V2, P261, DOI 10.1007/s13042-011-0024-1
   Kamal M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210122
   Kostkova P, 2018, LIFE SCI SOC POLICY, V14, DOI 10.1186/s40504-018-0078-x
   Kostkova P, 2014, ACM TRANS MANAG INF, V5, DOI 10.1145/2597892
   Kostkova P, 2013, J MED INTERNET RES, V15, P167, DOI 10.2196/jmir.2146
   Kostkova Patty, 2013, P 22 INT C WORLD WID, P687
   Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583
   Martines Roosecelis Brasil, 2016, MMWR MORBIDITY MORTA
   MARTINEZHERNANDEZ, 2016, IEEE IJCNN, P4927, DOI DOI 10.1109/IJCNN.2016.7727848
   Mendel JM, 2014, IEEE T FUZZY SYST, V22, P1162, DOI 10.1109/TFUZZ.2013.2286414
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Rong HJ, 2009, IEEE T SYST MAN CY B, V39, P1067, DOI 10.1109/TSMCB.2008.2010506
   Rubio-Solis A., 2017, FUZZY SYSTEMS FUZZ I, P1
   Rubio-Solis A., 2018, 2018 IEEE INT C FUZZ, P1
   Rubio-Solis A, 2019, IEEE T FUZZY SYST, V27, P333, DOI 10.1109/TFUZZ.2018.2858740
   Rubio-Solis A, 2015, IEEE T FUZZY SYST, V23, P457, DOI 10.1109/TFUZZ.2014.2315656
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Soria-Olivas E, 2011, IEEE T NEURAL NETWOR, V22, P505, DOI 10.1109/TNN.2010.2103956
   Wu DR, 2009, IEEE T FUZZY SYST, V17, P923, DOI 10.1109/TFUZZ.2008.924329
NR 33
TC 0
Z9 0
U1 1
U2 1
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-7208-4
PY 2019
BP 101
EP 110
DI 10.1145/3357729.3357738
PG 10
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Public, Environmental & Occupational Health
SC Computer Science; Engineering; Public, Environmental & Occupational
   Health
GA BO7GL
UT WOS:000524252200018
DA 2020-07-08
ER

PT S
AU Spatafora, LR
   El Khayati, M
   Vall-Llossera, M
   Gurgel, H
   Camps, A
   Angelis, CF
   Portal, G
   Chaparro, D
AF Spatafora, L. Rossato
   El Khayati, M.
   Vall-Llossera, M.
   Gurgel, H.
   Camps, A.
   Angelis, C. F.
   Portal, G.
   Chaparro, D.
GP IEEE
TI EVALUATION OF DENGUE DISEASE IN BRAZIL: MULTIVARIABLE ANALYSIS
SO 2019 IEEE INTERNATIONAL GEOSCIENCE AND REMOTE SENSING SYMPOSIUM (IGARSS
   2019)
SE IEEE International Symposium on Geoscience and Remote Sensing IGARSS
LA English
DT Proceedings Paper
CT IEEE International Geoscience and Remote Sensing Symposium (IGARSS)
CY JUL 28-AUG 02, 2019
CL Yokohama, JAPAN
SP Inst Elect & Elect Engineers, Inst Elect & Elect Engineers, Geoscience & Remote Sensing Soc
DE Dengue; Aedes aegypti; Soil Moisture; SMOS; GeoHealth studies; Brazil
AB Mosquitoes are the most important vectors of some human diseases in tropical countries. In particular, Aedes aegypti is the main vector for Chikungunya, Dengue, and Zika viruses in Brazil (Scavuzzo, 2018). The infection causes flu-like symptoms, and sometimes evolves into a life-threatening condition called severe dengue or hemorrhagic dengue. It is a widespread infection that occurs in all regions of the planet's tropical climate, and now because of the climate change, it may expand to some other regions. In recent years, transmission has increased predominantly in urban areas and has become a major public health problem.
   Recently, there has been an increasing trend on GeoHealth studies by use of remotely sensed data for mapping health risk and monitoring vector-borne diseases. Thus, the aim of this work is to generate risk maps integrating those environmental and climate indicators with adaptive capacity factors to define regions with high risk of vector-borne diseases in Brazil. Consequently, we present a multi-indicator study, similar to the one already developed in Vietnam by Nguyen and Liou (Nguyen and Liou, 2018) for the Aedes Albopictus, but the present study is in Brazil for the Aedes aegypti and adding the information of the Soil Moisture (SM) from the Barcelona Expert Center (BEC). Then, the study combines climatological data (e.g. soil moisture, temperature and precipitation), and demographic and socioeconomic data over the Brazilian territory for the 2013-2018 period. Dengue episodes distribution data for this period have been obtained from the Notifiable Diseases Information System (SINAN), developed by Ministry of Health.
C1 [Spatafora, L. Rossato; El Khayati, M.; Vall-Llossera, M.; Camps, A.; Portal, G.; Chaparro, D.] UPC, IEEC, Jordi Girona 1-3,UPC Campus Nord,Bldg D3, Barcelona 08034, Spain.
   [Spatafora, L. Rossato; El Khayati, M.; Vall-Llossera, M.; Camps, A.; Portal, G.; Chaparro, D.] SMOS Barcelona Expert Ctr, Jordi Girona 1-3,UPC Campus Nord,Bldg D3, Barcelona 08034, Spain.
   [Gurgel, H.] Univ Brasilia UnB, Dept Geog GEA, Brasilia, DF, Brazil.
   [Angelis, C. F.] Natl Ctr Monitoring & Early Warning Nat Disasters, Sao Jose Dos Campos, SP, Brazil.
RP Spatafora, LR (corresponding author), UPC, IEEC, Jordi Girona 1-3,UPC Campus Nord,Bldg D3, Barcelona 08034, Spain.; Spatafora, LR (corresponding author), SMOS Barcelona Expert Ctr, Jordi Girona 1-3,UPC Campus Nord,Bldg D3, Barcelona 08034, Spain.
RI Gurgel, Helen/K-2266-2016
OI Gurgel, Helen/0000-0002-4250-6742
FU Spanish Ministry of Economy and Competitiveness [ESP2017-89463-C3-2-R];
   ERDF (European Regional Development Fund)European Union (EU); Unidad de
   Excelencia Maria de Maeztu [MDM-2016-0600]; Agencia estatal de
   Investigacion, Spain
FX This work was supported by the Spanish Ministry of Economy and
   Competitiveness, through the project ESP2017-89463-C3-2-R the ERDF
   (European Regional Development Fund) and the "Unidad de Excelencia Maria
   de Maeztu MDM-2016-0600", financed by the "Agencia estatal de
   Investigacion, Spain".
CR Eakin H, 2008, GLOBAL ENVIRON CHANG, V18, P112, DOI 10.1016/j.gloenvcha.2007.09.001
   Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Kesetyaningsih Tri Wulandari, 2018, Afr J Infect Dis, V12, P13, DOI [10.21010/ajid.v12i1s.3, 10.2101/Ajid.12v1S.3]
   Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9
   Nguyen, 2018, IGARSS 2018 2018 IEE, DOI [10.1109/IGARSS.2018.851919, DOI 10.1109/IGARSS.2018.851919]
   Sanna M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19168-6
   Scavuzzo J. M., 2018, ACTA TROPICA, V8
NR 9
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2153-6996
BN 978-1-5386-9154-0
J9 INT GEOSCI REMOTE SE
PY 2019
BP 7112
EP 7115
PG 4
WC Geosciences, Multidisciplinary; Remote Sensing
SC Geology; Remote Sensing
GA BO5ZH
UT WOS:000519270606164
DA 2020-07-08
ER

PT B
AU Maia, LFMP
   Lenzi, M
   Rabello, ET
   Oliveira, J
AF Monsores Passos Maia, Luis Fernando
   Lenzi, Marcia
   Rabello, Elaine Teixeira
   Oliveira, Jonice
BE Barnaghi, P
   Gottlob, G
   Manolopoulos, Y
   Tzouramanis, T
   Vakali, A
TI REALM: An Altmetrics-based Framework to Map Science Impacts on Society.
   A Case Study on Zika Research
SO 2019 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE (WI 2019)
LA English
DT Proceedings Paper
CT 19th IEEE/WIC/ACM International Conference on Web Intelligence (WI)
CY OCT 13-17, 2019
CL Thessaloniki, GREECE
SP IEEE, WIC, Assoc Comp Machinery, Aristotle Univ Thessaloniki, Open Univ Cyprus
DE Altmetrics; Bibliometrics; Social network analysis; Zika; RDF
ID VIRUS-INFECTION; INFANTS; NETWORK; BIRTH; WOMEN
AB Nowadays, a lot of universities and research institutes are concerned with measuring their scientists' productivity and the public awareness of its scientific discoveries, that is, how citizens interpret the efficiency of scientists and their efforts to find solutions. This scenario demands mechanisms to identify the experts' reputation in specific domains or topics of interest, such as the Zika epidemic. In this paper we describe an altmetrics-based framework which allows the identification of specialists and important research in specific research scenarios. Besides, we did an implementation of the framework and applied it in the Zika scenario where the most important names and disease-related studies were identified and their public awareness was analysed via altmetrics.
C1 [Monsores Passos Maia, Luis Fernando; Oliveira, Jonice] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Lenzi, Marcia; Rabello, Elaine Teixeira] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Maia, LFMP (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
EM luisfmpm@ufrj.br; marcia@cdts.fiocruz.br; elaine@cdts.fiocruz.br;
   jonice@dcc.ufrj.br
FU European UnionEuropean Union (EU); CNPqNational Council for Scientific
   and Technological Development (CNPq); ZIKAlliance [734548]
FX The authors wish to thank the Brazilian Coordination for the Improvement
   of Higher Education Personnel (CAPES), Brazilian National Council of
   Scientific and Technological Development (CNPq), Rio de Janeiro State
   Research Foundation (FAPERJ), the Zika Social Sciences Network
   (Fiocruz), and ZIKAlliance. The study was partially financed by the
   European Union's Horizon 2020 Research and Innovation Programme,
   ZIKAlliance Grant Agreement no. 734548, and CNPq.
CR Adie E, 2013, LEARN PUBL, V26, P11, DOI 10.1087/20130103
   Barabasi A.-L., 2016, NETWORK SCI
   Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7
   Barrat A, 2008, DYNAMICAL PROCESSES
   Bell BP, 2016, AM J PUBLIC HEALTH, V106, P589, DOI 10.2105/AJPH.2016.303124
   Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280
   Bornmann L, 2015, SCIENTOMETRICS, V103, P1123, DOI 10.1007/s11192-015-1565-y
   Bornmann L, 2014, J INFORMETR, V8, P935, DOI 10.1016/j.joi.2014.09.007
   Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Harmon Amy, 2016, NY TIMES
   Hassan Saeed-Ul, 2016, ARXIV160307992CS
   Hoffmann CP, 2014, P ANN HICSS, P1576, DOI 10.1109/HICSS.2014.202
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Honein MA, 2016, NEW ENGL J MED, V375, P2393, DOI 10.1056/NEJMe1613368
   Kong XJ, 2019, J NETW COMPUT APPL, V132, P86, DOI 10.1016/j.jnca.2019.01.029
   Kwak H, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P563, DOI 10.1145/2567948.2576956
   Maia Luis Fernando Monsores Passos, 2017, WEBMEDIA 17, P413, DOI [10.1145/3126858.3131593, DOI 10.1145/3126858.3131593]
   Maia Luis Fernando Monsores Passos, 2018, P INT S ZIK VIR RES, P101
   McNeil Jr Donald G., 2016, NY TIMES
   Mohammadi E, 2015, J ASSOC INF SCI TECH, V66, P1832, DOI 10.1002/asi.23286
   Maia LFMP, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00220217, 10.1590/0102-311x00220217]
   Petersen LR, 2019, AM J TROP MED HYG, V100, P242, DOI 10.4269/ajtmh.18-0841
   Priem J., 2010, ALTMETRICS MANIFESTO
   Priem J., 2010, 1 MONDAY, DOI [10.5210/fm.v15i7.2874, DOI 10.5210/FM.V15I7.2874]
   Priem J, 2013, NATURE, V495, P437, DOI 10.1038/495437a
   Priem J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048753
   Priem Jason, 2012, LAUNCH IMPACTSTORY U
   Rumsey D. J., 2016, INTERPRET CORRELATIO
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Tattersall Andy, 2016, ALTMETRICS PRACTICAL
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wasserman S., 1994, SOCIAL NETWORK ANAL, V8
   Yan EJ, 2009, J AM SOC INF SCI TEC, V60, P2107, DOI 10.1002/asi.21128
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 38
TC 0
Z9 0
U1 1
U2 1
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-6934-3
PY 2019
BP 233
EP 241
DI 10.1145/3350546.3352523
PG 9
WC Computer Science, Artificial Intelligence
SC Computer Science
GA BO5YE
UT WOS:000519076200030
DA 2020-07-08
ER

PT J
AU Guagliardo, SAJ
   Roldan, SCA
   Santacoloma, L
   Luna, C
   Alvarez, JMC
   Gacha, JDR
   Mansur, M
   Levine, RS
   Lenhart, A
   Oviedo, PF
AF Guagliardo, Sarah Anne J.
   Ardila Roldan, Susana Carolina
   Santacoloma, Liliana
   Luna, Cesar
   Cordovez Alvarez, Juan Manuel
   Rojas Gacha, Juan David
   Mansur, Mariana
   Levine, Rebecca S.
   Lenhart, Audrey
   Fuya Oviedo, Patricia
TI Enhanced vector surveillance to control arbovirus epidemics in Colombia
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Mosquito vectors; epidemiological monitoring; vector control; Colombia
AB In the wake of the Zika epidemic, there has been intensified interest in the surveillance and control of the arbovirus vectors Aedes aegypti and Aedes albopictus, yet many existing surveillance systems could benefit from improvements. Vector control programs are often directed by national governments, but are carried out at the local level, resulting in the discounting of spatial heterogeneities in ecology and epidemiology. Furthermore, entomological and epidemiological data are often collected by separate governmental entities, which can slow vector control responses to outbreaks. Colombia has adopted several approaches to address these issues. First, a web-based, georeferenced Aedes surveillance system called SIVIEN AEDES was developed to allow field entomologists to record vector abundance and insecticide resistance data. Second, autocidal gravid oviposition (AGO) traps are deployed as an alternative way to measure vector abundance. Third, data collected by SIVIEN AEDES are used to develop mathematical models predicting Ae. aegypti abundance down to a city block, thus allowing public health authorities to target interventions to specific neighborhoods within cities. Finally, insecticide resistance is monitored through bioassays and molecular testing in 15 high-priority cities, providing a comprehensive basis to inform decisions about insecticide use in different regions. The next step will be to synchronize SIVIEN AEDES data together with epidemiological and climatic data to improve the understanding of the drivers of local variations in arbovirus transmission dynamics. By integrating these surveillance data, health authorities will be better equipped to develop tailored and timely solutions to control and prevent Aedes-borne arbovirus outbreaks.
C1 [Guagliardo, Sarah Anne J.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30329 USA.
   [Ardila Roldan, Susana Carolina; Santacoloma, Liliana; Luna, Cesar; Fuya Oviedo, Patricia] Inst Nacl Salud, Lab Nacl Referencia, Grp Entomol, Bogota, Colombia.
   [Cordovez Alvarez, Juan Manuel] Univ Los Andes, Dept Ingn Biomed, Bogota, Colombia.
   [Rojas Gacha, Juan David] Univ Nacl Colombia, Dept Matemat, Bogota, Colombia.
   [Mansur, Mariana] Task Force Global Hlth, Decatur, GA USA.
   [Levine, Rebecca S.; Lenhart, Audrey] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA.
RP Guagliardo, SAJ (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30329 USA.
EM sguagliardo@cdc.gov
FU Office of Infectious Disease, Bureau for Global Health, U.S. Agency for
   International DevelopmentUnited States Agency for International
   Development (USAID); CDCUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
FX This publication was made possible through support provided by the
   Office of Infectious Disease, Bureau for Global Health, U.S. Agency for
   International Development, under the terms of an Interagency Agreement
   with CDC. The opinions expressed herein are those of the authors and do
   not necessarily reflect the views of the U.S. Agency for International
   Development.
CR Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Maestre-Serrano R, 2014, PESTIC BIOCHEM PHYS, V116, P63, DOI 10.1016/j.pestbp.2014.09.014
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 6
TC 0
Z9 0
U1 0
U2 0
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2019
VL 43
AR e50
DI 10.26633/RPSP.2019.50
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KO2IL
UT WOS:000515373400004
PM 31171922
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rico-Mendoza, A
   Porras-Ramirez, A
   Chang, A
   Encinales, L
   Lynch, R
AF Rico-Mendoza, Alejandro
   Porras-Ramirez, Alexandra
   Chang, Aileen
   Encinales, Liliana
   Lynch, Rebecca
TI Co-circulation of dengue, chikungunya, and Zika viruses in Colombia from
   2008 to 2018
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Zika virus; dengue virus; chikungunya virus; coinfection; Colombia
ID COINFECTION; OUTBREAK
AB Objective. This study aimed to identify the co-circulation patterns of three viruses (dengue, Zika, and chikungunya) in Colombia from 2008 to 2018 by using notification reports provided to the national surveillance system.
   Methods. This cross-sectional study was conducted through a review of data for 2008 through 2018 from Colombia's Public Health Surveillance System (SIVIGILA).
   Results. In 2015, when chikungunya was first detected, it had a higher incidence (1 359.0 cases per 100 000 persons) than did the two other diseases. In 2016, when the circulation of Zika virus was first found, the incidence was 296.4 cases per 100 000 persons; that incidence declined dramatically in the next two years. Between 2015 and 2018, there was a substantial decrease in the frequency of dengue circulation, with it going from 334.1 cases per 100 000 persons in 2015 to 90.7 cases per 100 000 in 2017 and 173.1 cases per 100 000 in 2018.
   Conclusions. The decrease in the number of dengue cases after co-circulation of the three viruses could indicate possible cross-protection. This finding should be further analyzed.
C1 [Rico-Mendoza, Alejandro; Porras-Ramirez, Alexandra] Univ El Bosque, Grp Med Comunitaria & Salud Colect, Bogota, Colombia.
   [Chang, Aileen] George Washington Univ, Dept Med, Washington, DC USA.
   [Encinales, Liliana] Allied Res Soc, Barranquilla, Atlantico, Colombia.
   [Lynch, Rebecca] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
RP Porras-Ramirez, A (corresponding author), Univ El Bosque, Grp Med Comunitaria & Salud Colect, Bogota, Colombia.
EM porras.alexandra@gmail.com
FU Universidad El Bosque
FX The study was supported with resources from the Universidad El Bosque.
CR Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Costa SDB, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860062, 10.1590/s1678-9946201860062]
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Estofolete CF, 2019, J INFECT PUBLIC HEAL, V12, P178, DOI 10.1016/j.jiph.2018.09.007
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Mercado-Reyes M, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s095026881800359x, 10.1017/S095026881800359X]
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Raut CG, 2015, EMERG INFECT DIS, V21, P908, DOI 10.3201/eid2105.141804
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Suwanmanee S, 2018, ACTA TROP, V188, P244, DOI 10.1016/j.actatropica.2018.09.012
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
NR 18
TC 4
Z9 4
U1 1
U2 1
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2019
VL 43
AR e49
DI 10.26633/RPSP.2019.49
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KO2IL
UT WOS:000515373400003
PM 31171921
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Co-circulation of dengue, chikungunya, and Zika viruses and
   cross-protection
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Dept Community Med, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
CR Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rico-Mendoza A, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.49
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
NR 3
TC 0
Z9 0
U1 0
U2 0
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2019
VL 43
AR e75
DI 10.26633/RPSP.2019.75
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KO2IZ
UT WOS:000515374800001
PM 31507637
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rico-Mendoza, A
   Porras-Ramirez, A
   Chang, A
   Encinales, L
   Lynch, R
AF Rico-Mendoza, Alejandro
   Porras-Ramirez, Alexandra
   Chang, Aileen
   Encinales, Liliana
   Lynch, Rebecca
TI Authors' response to the letter to the editor entitled: Co-circulation
   of dengue, chikungunya, and Zika viruses and cross-protection
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Letter
ID ANTIBODY-DEPENDENT ENHANCEMENT; INFECTION; DISEASE
C1 [Rico-Mendoza, Alejandro; Porras-Ramirez, Alexandra] Univ El Bosque, Grp Med Comunitaria & Salud Colect, Bogota, Colombia.
   [Chang, Aileen] George Washington Univ, Dept Med, Washington, DC USA.
   [Encinales, Liliana] Allied Res Soc, Barranquilla, Colombia.
   [Lynch, Rebecca] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
RP Porras-Ramirez, A (corresponding author), Univ El Bosque, Grp Med Comunitaria & Salud Colect, Bogota, Colombia.
EM porras.alexandra@gmail.com
CR Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Rico-Mendoza A, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.49
NR 5
TC 0
Z9 0
U1 0
U2 0
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2019
VL 43
AR e77
DI 10.26633/RPSP.2019.77
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KO2JC
UT WOS:000515375100001
PM 31507639
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Adams, LE
   Sanchez-Gonzalez, L
   Gonzalez, RR
   Ryff, K
   Rodriguez, DM
   Major, C
   Little, EM
   Lorenzi, O
   Delorey, M
   Medina, FA
   Beltran, M
   Munoz-Jordan, JL
   Waterman, SH
   Ortiz, M
   Rivera-Amill, V
   Paz-Bailey, G
AF Adams, Laura E.
   Sanchez-Gonzalez, Liliana
   Gonzalez, Robert Rodriguez
   Ryff, Kyle
   Rodriguez, Dania M.
   Major, Chelsea
   Little, Emma M.
   Lorenzi, Olga
   Delorey, Mark
   Medina, Freddy A.
   Beltran, Manuela
   Munoz-Jordan, Jorge L.
   Waterman, Stephen H.
   Ortiz, Marianyoly
   Rivera-Amill, Vanessa
   Paz-Bailey, Gabriela
TI RISK FACTORS FOR INFECTION WITH CHIKUNGUNYA AND ZIKA VIRUSES IN A
   COMMUNITY-BASED COHORT STUDY IN SOUTHERN PUERTO RICO
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Adams, Laura E.; Sanchez-Gonzalez, Liliana; Ryff, Kyle; Rodriguez, Dania M.; Major, Chelsea; Little, Emma M.; Lorenzi, Olga; Delorey, Mark; Medina, Freddy A.; Beltran, Manuela; Munoz-Jordan, Jorge L.; Waterman, Stephen H.; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [Gonzalez, Robert Rodriguez; Rivera-Amill, Vanessa] Ponce Hlth Sci Univ, Ponce, PR USA.
   [Ortiz, Marianyoly] Puerto Rico Vector Control Unit, San Juan, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 58
BP 18
EP 19
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502058
DA 2020-07-08
ER

PT J
AU Gurman, T
   Ballard, A
   Hunter, G
AF Gurman, Tilly
   Ballard, Anne
   Hunter, Gabrielle
TI THE VALUE-ADD OF PARTICIPATORY RESEARCH TECHNIQUES TO INFORM ZIKA
   PREVENTION PROGRAMS: A QUALITATIVE STUDY IN THE DOMINICAN REPUBLIC
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Gurman, Tilly; Ballard, Anne; Hunter, Gabrielle] Johns Hopkins Univ, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 105
BP 33
EP 33
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502105
DA 2020-07-08
ER

PT J
AU Brustolin, M
   Pujhari, S
   Henderson, C
   Rasgon, J
AF Brustolin, Marco
   Pujhari, Sujit
   Henderson, Cory
   Rasgon, Jason
TI EMERGENT VIRUSES AND THEIR INTERACTIONS IN AEDES AEGYPTI: MAYARO AND
   ZIKA VIRUS COINFECTED MOSQUITOES CAN SUCCESSFULLY TRANSMIT BOTH
   PATHOGENS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Brustolin, Marco; Pujhari, Sujit; Henderson, Cory; Rasgon, Jason] Penn State Univ, University Pk, PA 16802 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 164
BP 50
EP 50
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502164
DA 2020-07-08
ER

PT J
AU Almeida, RP
   Almeida, PNG
   Alves, JC
   Santos, CN
   Macedo, PJ
   de Jesus, AR
AF Almeida, Roque P.
   Almeida, Phillip Nicolau G.
   Alves, Juliana C.
   Santos, Camilla N.
   Macedo, Philippe J.
   de Jesus, Amelia R.
TI MOTOR NEURON DISEASE, PARKINSONISM AND OTHER NEUROLOGIC DISORDERS
   ASSOCIATED TO CHIKUNGUNYA AND ZIKA VIRUS INFECTION: A CASE SERIES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Almeida, Roque P.; Almeida, Phillip Nicolau G.; Alves, Juliana C.; Santos, Camilla N.; Macedo, Philippe J.; de Jesus, Amelia R.] Univ Fed Sergipe, Aracaju, Sergipe, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 176
BP 53
EP 53
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502176
DA 2020-07-08
ER

PT J
AU Serrano-Collazo, C
   Pantoja, P
   Cruz, LA
   Perez, EX
   Rodriguez, IV
   Arana, T
   Martinez, M
   Hassert, M
   White, LJ
   Brien, JD
   Hodara, V
   Giavedoni, L
   de Silva, A
   Pinto, A
   Sariol, CA
AF Serrano-Collazo, Crisanta
   Pantoja, Petraleigh
   Cruz, Lorna A.
   Perez, Erick X.
   Rodriguez, Idia V.
   Arana, Teresa
   Martinez, Melween
   Hassert, Mariah
   White, Laura J.
   Brien, James D.
   Hodara, Vida
   Giavedoni, Luis
   de Silva, Aravinda
   Pinto, Amelia
   Sariol, Carlos A.
TI PRIMARY DENGUE INFECTION MODULATES ZIKA PATHOGENESIS IN A TIME-DEPENDENT
   MANNER
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Serrano-Collazo, Crisanta; Pantoja, Petraleigh; Cruz, Lorna A.; Perez, Erick X.; Arana, Teresa; Sariol, Carlos A.] UPR Med Sci Campus, San Juan, PR USA.
   [Rodriguez, Idia V.; Martinez, Melween] UPR Med Sci Campus, Unit Comparat Med, Caribbean Primate Res Ctr, San Juan, PR USA.
   [Hassert, Mariah; Brien, James D.; Pinto, Amelia] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA.
   [White, Laura J.; de Silva, Aravinda] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Hodara, Vida; Giavedoni, Luis] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 197
BP 59
EP 59
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502197
DA 2020-07-08
ER

PT J
AU de Almeida, BL
   Giovanetti, M
   Oliveira, JV
   Xavier, TC
   Figueiredo, EM
   Goes, JJ
   Alcantara, LC
   de Siqueira, IC
AF de Almeida, Breno L.
   Giovanetti, Marta
   Oliveira, Joao V.
   Xavier, Tereza C.
   Figueiredo, Eduardo M.
   Goes, Jaqueline J.
   Alcantara, Luiz C.
   de Siqueira, Isadora C.
TI DETECTION AND SEQUENCING OF ZIKA VIRUS IN NORMOCEPHALIC NEWBORNS WITH
   CONGENITAL ZIKA IN FECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [de Almeida, Breno L.; Giovanetti, Marta; Oliveira, Joao V.; Goes, Jaqueline J.; Alcantara, Luiz C.; de Siqueira, Isadora C.] Fundacao Oswaldo Cruz Fiocruz, Salvador, BA, Brazil.
   [Xavier, Tereza C.] Maternidade Referencia Prof Jose Maria de Maglhae, Salvador, BA, Brazil.
   [Figueiredo, Eduardo M.] Maternidade Referencia Prof Jose Maria de Magalha, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 209
BP 63
EP 63
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502209
DA 2020-07-08
ER

PT J
AU Glaessner, AG
   Barrera, P
   Morrison, AC
   Scott, TW
   Leguia, M
AF Garcia Glaessner, Alejandra
   Barrera, Patricia
   Morrison, Amy C.
   Scott, Thomas W.
   Leguia, Mariana
TI ZIKA VIRUS DETECTION IN PREVIOUSLY UNDIAGNOSABLE SAMPLES: OPTIMIZATION
   OF A QUANTITATIVE RT-PCR ASSAY FOR SAMPLES OF LOW VIRAL CONCENTRATION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Garcia Glaessner, Alejandra; Leguia, Mariana] Pontificia Univ Catolica Peru, Genom Lab, Lima, Peru.
   [Barrera, Patricia] Asociac Benef Prisma, Lima, Peru.
   [Morrison, Amy C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 210
BP 63
EP 63
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502210
DA 2020-07-08
ER

PT J
AU Adams, CR
   Jadi, R
   Ylade, M
   Daag, J
   Agrupis, KA
   Deen, J
   de Silva, A
   Lakshmanane, P
   Lopez, AL
AF Adams, Cameron R.
   Jadi, Ramesh
   Ylade, Michelle
   Daag, Jedas
   An Agrupis, Kristal
   Deen, Jacqueline
   de Silva, Aravinda
   Lakshmanane, Premkumar
   Lena Lopez, Anna
TI SEROPREVALENCEOF ZIKA VIRUS (ZIKV) IN CEBU PROVINCE, PHILIPPINES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Adams, Cameron R.; Jadi, Ramesh; de Silva, Aravinda; Lakshmanane, Premkumar] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Ylade, Michelle; Daag, Jedas; An Agrupis, Kristal; Deen, Jacqueline; Lena Lopez, Anna] Univ Philippines Manila, Inst Child Hlth & Human Dev, Manila, Philippines.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 211
BP 64
EP 64
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502211
DA 2020-07-08
ER

PT J
AU Carrillo, FAB
   Burger-Calderon, R
   Gresh, L
   Ojeda, S
   Sanchez, N
   Plazaola, M
   Katzelnick, L
   Mercado, BL
   Monterrey, JC
   Elizondo, D
   Arguello, S
   Nunez, A
   Gordon, A
   Balmaseda, A
   Kuan, G
   Harris, E
AF Carrillo, Fausto A. Bustos
   Burger-Calderon, Raquel
   Gresh, Lionel
   Ojeda, Sergio
   Sanchez, Nery
   Plazaola, Miguel
   Katzelnick, Leah
   Mercado, Brenda L.
   Monterrey, Jairo C.
   Elizondo, Douglas
   Arguello, Sonia
   Nunez, Andrea
   Gordon, Aubree
   Balmaseda, Angel
   Kuan, Guillermina
   Harris, Eva
TI PEDIATRIC ZIKA VARIES BY AGE AND IS OFTEN MISSED UNDER CURRENT CASE
   DEFINITIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Carrillo, Fausto A. Bustos; Burger-Calderon, Raquel; Katzelnick, Leah; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Gresh, Lionel; Ojeda, Sergio; Sanchez, Nery; Plazaola, Miguel; Mercado, Brenda L.; Monterrey, Jairo C.; Elizondo, Douglas; Arguello, Sonia] Sustainable Sci Inst, Managua, Nicaragua.
   [Nunez, Andrea; Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Gordon, Aubree] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Kuan, Guillermina] Minist Salud, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 213
BP 64
EP 64
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502213
DA 2020-07-08
ER

PT J
AU Tong, V
   Mercado, M
   Gilboa, S
   Valencia, D
   Daza, M
   Galang, R
   Winfield, C
   Godfred-Cato, S
   Benavides, M
   Villanueva, J
   Daniels, J
   Bhatnaga, J
   Schiffer, J
   Corchuelo, S
   Tinker, S
   Anderson, K
   Osorio, J
   Burkel, V
   Hojnacki, J
   Gonzalez, M
   Moore, C
   Honein, M
   Ospina, M
AF Van Tong
   Mercado, Marcela
   Gilboa, Suzanne
   Valencia, Diana
   Daza, Marcela
   Galang, Romeo
   Winfield, Christina
   Godfred-Cato, Shana
   Benavides, Monica
   Villanueva, Julie
   Daniels, Jonathan
   Bhatnaga, Julu
   Schiffer, Jarad
   Corchuelo, Sheryll
   Tinker, Sarah
   Anderson, Kayla
   Osorio, Johana
   Burkel, Veronica
   Hojnacki, Jacob
   Gonzalez, Maritza
   Moore, Cynthia
   Honein, Margaret
   Ospina, Martha
TI PREGNANCY AND BIRTH OUTCOMES AMONG COLOMBIAN WOMEN WITH ZIKA VIRUS
   DISEASE IN THREE SURVEILLANCE SITES, PROYECTO VIGILANCIA DE EMBARAZADAS
   CON ZIKA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Van Tong; Gilboa, Suzanne; Valencia, Diana; Galang, Romeo; Winfield, Christina; Godfred-Cato, Shana; Villanueva, Julie; Daniels, Jonathan; Bhatnaga, Julu; Schiffer, Jarad; Tinker, Sarah; Anderson, Kayla; Moore, Cynthia; Honein, Margaret] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Mercado, Marcela; Gonzalez, Maritza; Ospina, Martha] Natl Inst Hlth, Bogota, Colombia.
   [Daza, Marcela; Benavides, Monica; Corchuelo, Sheryll; Osorio, Johana] Vysnova Partners, Bethesda, MD USA.
   [Burkel, Veronica] Eagle Med Serv LLC, San Antonio, TX USA.
   [Hojnacki, Jacob] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 212
BP 64
EP 64
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502212
DA 2020-07-08
ER

PT J
AU Bowman, NM
   Bucardo, F
   Collins, MH
   Reyes, Y
   Centeno, E
   Guerra, QP
   Rubinstein, RJ
   Liou, GJA
   de Silva, A
   Sylvia, BD
AF Bowman, Natalie M.
   Bucardo, Filemon
   Collins, Matthew H.
   Reyes, Yaoska
   Centeno, Edwing
   Guerra, Quique P.
   Rubinstein, Rebecca J.
   Liou, Guei-Jiun Alice
   de Silva, Aravinda
   Sylvia, Becker-Dreps
TI CLINICAL AND EPIDEMIOLOGICAL FEATURES OF THE ZIKA OUTBREAK IN NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Bowman, Natalie M.; Guerra, Quique P.; Rubinstein, Rebecca J.; Liou, Guei-Jiun Alice; de Silva, Aravinda; Sylvia, Becker-Dreps] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Bucardo, Filemon; Reyes, Yaoska; Centeno, Edwing] Univ Nacl Autonoma Nicaragua Leon, Leon, Nicaragua.
   [Collins, Matthew H.] Emory Univ, Atlanta, GA 30322 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 214
BP 65
EP 65
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502214
DA 2020-07-08
ER

PT J
AU Fonseca, BA
   Agostinho, MR
   Esposito, DL
   Floriano, VG
   Siconelli, MJ
AF Fonseca, Benedito A.
   Agostinho, Mayara R.
   Esposito, Danillo L.
   Floriano, Vitor G.
   Siconelli, Marcio J.
TI TGF-B AND TNF-A CYTOKINE GENE POLYMORPHISMS MAY INFLUENCE PREGNANCY
   OUTCOMES OF ZIKA VIRUS INFECTED WOMEN
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Fonseca, Benedito A.; Agostinho, Mayara R.; Esposito, Danillo L.; Floriano, Vitor G.; Siconelli, Marcio J.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 216
BP 65
EP 65
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502216
DA 2020-07-08
ER

PT J
AU Han, HH
AF Han, Htay Htay
CA ZKV-101 Study Grp
TI DOSE SELECTION OF A PURIFIED IN ACTIVATED ZIKA VIRUS VACCINE (PIZV)
   CANDIDATE FOR FURTHER CLINICAL DEVELOPMENT
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Han, Htay Htay] Takeda Vaccines Inc, Cambridge, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 215
BP 65
EP 65
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502215
DA 2020-07-08
ER

PT J
AU Hernandez-Donoso, LA
   Meroc, E
   De Moerlooze, L
AF Hernandez-Donoso, Leyla A.
   Meroc, Estelle
   De Moerlooze, Laurence
TI ZIKA VIRUS COMPLICATIONS BEYOND CONGENITAL ZIKA SYNDROME: A SYSTEMATIC
   REVIEW
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Hernandez-Donoso, Leyla A.; De Moerlooze, Laurence] Takeda Pharmaceut, Zurich, Switzerland.
   [Meroc, Estelle] P95 Pharmacovigilance & Epidemiol, Leuven, Belgium.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 219
BP 66
EP 66
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502219
DA 2020-07-08
ER

PT J
AU Young, G
   Sonnberg, S
   Chen, HL
   Sanisetty, S
   Zahralban-Steele, M
   Powell, T
   Lee, J
   Johnson, M
   Hather, G
   Karwal, L
   Bohning, K
   Andserson, L
   Patel, H
   Dean, H
AF Young, Ginger
   Sonnberg, Stephanie
   Chen, Hui-Ling
   Sanisetty, Srisowmya
   Zahralban-Steele, Melissa
   Powell, Tim
   Lee, Joseph
   Johnson, Michael
   Hather, Greg
   Karwal, Lovkesh
   Bohning, Kelly
   Andserson, Lydia
   Patel, Hetal
   Dean, Hansi
TI CHARACTERIZATION OF A POTENTIAL CORRELATE OF PROTECTION PROVIDED BY
   TAKEDA'S PURIFIED INACTIVATED ZIKA VACCINE IN INDIAN RHESUS MACAQUES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Young, Ginger; Sonnberg, Stephanie; Chen, Hui-Ling; Sanisetty, Srisowmya; Zahralban-Steele, Melissa; Powell, Tim; Lee, Joseph; Johnson, Michael; Karwal, Lovkesh; Bohning, Kelly; Andserson, Lydia; Patel, Hetal; Dean, Hansi] Takeda Vaccines Inc, Cambridge, MA USA.
   [Hather, Greg] Takeda Pharmaceut Inc, Cambridge, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 217
BP 66
EP 66
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502217
DA 2020-07-08
ER

PT J
AU Pavan, MG
   Garcia, GA
   Santos, LM
   David, MR
   Sikulu-Lord, MT
   Martins, AJ
   Powell, JR
   Mason, CE
   Maciel-de-Freitas, R
AF Pavan, Marcio G.
   Garcia, Gabriela A.
   Santos, Lilha M.
   David, Mariana R.
   Sikulu-Lord, Maggy T.
   Martins, Ademir J.
   Powell, Jeffrey R.
   Mason, Cristopher E.
   Maciel-de-Freitas, Rafael
TI DEVELOPING ALTERNATIVE SURVEILLANCE METHODS, FROM THE NEAR INFRARED
   SPECTROSCOPY TO PREDICT ZIKA INFECTION ON AEDES AEGYPTI, TO METAGENOMICS
   TO DETECT THE INVASION OF NEW ARBOVIRUSES AND HAPLOTYPES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Pavan, Marcio G.; Garcia, Gabriela A.; Santos, Lilha M.; David, Mariana R.; Martins, Ademir J.; Maciel-de-Freitas, Rafael] Fiocruz MS, Rio De Janeiro, Brazil.
   [Sikulu-Lord, Maggy T.] Univ Queensland, St Lucia, Qld, Australia.
   [Powell, Jeffrey R.] Yale Univ, New Haven, CT USA.
   [Mason, Cristopher E.] Weill Cornell Med, New York, NY USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 228
BP 69
EP 69
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502228
DA 2020-07-08
ER

PT J
AU Muirhead, A
   Zhu, KJ
   Brown, J
   Brinton, MA
   Costa, F
   Hayat, MJ
   Stauber, CE
AF Muirhead, Aaron
   Zhu, Kevin J.
   Brown, Joe
   Brinton, Margo A.
   Costa, Federico
   Hayat, Matthew J.
   Stauber, Christine E.
TI ZIKA VIRUS RNA PERSISTENCE IN SEWAGE: A NOVEL SURVEILLANCE TOOL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Muirhead, Aaron; Brinton, Margo A.; Hayat, Matthew J.; Stauber, Christine E.] Georgia State Univ, Atlanta, GA 30303 USA.
   [Zhu, Kevin J.; Brown, Joe] Georgia Inst Technol, Atlanta, GA 30332 USA.
   [Costa, Federico] Univ Fed Bahia, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 608
BP 186
EP 186
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364502607
DA 2020-07-08
ER

PT J
AU Levine, R
   Padilla, N
   Ragoo, R
   Impoinvil, D
   Dadzie, S
   Coulibaly, M
   Lenhart, A
AF Levine, Rebecca
   Padilla, Norma
   Ragoo, Rajesh
   Impoinvil, Daniel
   Dadzie, Samuel
   Coulibaly, Mamadou
   Lenhart, Audrey
TI CDC'S INTERNATIONAL RESPONSE TO THE ZIKA VIRUS OUTBREAK: STRENGTHENING
   REGIONAL PUBLIC HEALTH ENTOMOLOGY NETWORKS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Levine, Rebecca; Impoinvil, Daniel; Lenhart, Audrey] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Padilla, Norma] Univ Valle Guatemala, Guatemala City, Guatemala.
   [Ragoo, Rajesh] Caribbean Publ Hlth Agcy, Port Of Spain, Trinidad Tobago.
   [Dadzie, Samuel] Noguchi Mem Inst Med Res, Legon, Ghana.
   [Coulibaly, Mamadou] Univ Sci Tech & Technol Bamako, Bamako, Mali.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 748
BP 229
EP 230
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503101
DA 2020-07-08
ER

PT J
AU Russell, T
   Bobogare, A
   MacLaren, D
   McBryde, E
   Horwood, P
   Burkot, T
AF Russell, Tanya
   Bobogare, Albino
   MacLaren, David
   McBryde, Emma
   Horwood, Paul
   Burkot, Tom
TI ENHANCED SURVEILLANCE FOR DENGUE, ZIKA AND CHIKUNGUNYA IN THE SOLOMON
   ISLANDS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Russell, Tanya; MacLaren, David; McBryde, Emma; Horwood, Paul; Burkot, Tom] James Cook Univ, Cairns, Qld, Australia.
   [Bobogare, Albino] Natl Vector Borne Dis Control Program, Honiara, Solomon Islands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 781
BP 239
EP 239
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503134
DA 2020-07-08
ER

PT J
AU Louie, W
   Coffey, LL
AF Louie, William
   Coffey, Lark L.
TI IMPACTS OF LARVA-ACQUIRED AEDES AEGYPTI MICROBIOTA ON VECTOR COMPETENCE
   FOR ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Louie, William; Coffey, Lark L.] Univ Calif Davis, Davis, CA 95616 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 785
BP 240
EP 240
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503138
DA 2020-07-08
ER

PT J
AU Henderson, A
   Aubry, M
   Kama, M
   Vanhomwegen, J
   Teissier, A
   Mariteragi-Helle, T
   Paoaafaite, T
   Manuguerra, JC
   Edmunds, J
   Whitworth, J
   Watson, C
   Lau, C
   Cao-Lormeau, VM
   Kucharski, A
AF Henderson, Alasdair
   Aubry, Maite
   Kama, Mike
   Vanhomwegen, Jessica
   Teissier, Anita
   Mariteragi-Helle, Teheipuauara
   Paoaafaite, Tuterarii
   Manuguerra, Jean-Claude
   Edmunds, John
   Whitworth, Jimmy
   Watson, Conall
   Lau, Colleen
   Cao-Lormeau, Van-Mai
   Kucharski, Adam
TI ZIKA VIRUS SEROPREVALENCE DECLINES AND NEUTRALIZATION ANTIBODIES WANE IN
   ADULTS FOLLOWING OUTBREAKS IN FRENCH POLYNESIA AND FIJI
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Henderson, Alasdair; Edmunds, John; Whitworth, Jimmy; Watson, Conall; Kucharski, Adam] London Sch Hyg & Trop Med, London, England.
   [Aubry, Maite; Teissier, Anita; Mariteragi-Helle, Teheipuauara; Paoaafaite, Tuterarii; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete, French Polynesi, France.
   [Kama, Mike] Fiji Ctr Communicable Dis Control, Suva, Fiji.
   [Vanhomwegen, Jessica; Manuguerra, Jean-Claude] Inst Pasteur, Paris, France.
   [Lau, Colleen] Australian Natl Univ, Canberra, ACT, Australia.
RI Lau, Colleen L/F-5974-2012
OI Lau, Colleen L/0000-0001-8288-4169
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 788
BP 241
EP 241
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503141
DA 2020-07-08
ER

PT J
AU Kikuti, M
   Tauro, LB
   Moreira, PS
   Nascimento, LCJ
   Portilho, MM
   Soares, GC
   Weaver, SC
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Kikuti, Mariana
   Tauro, Laura B.
   Moreira, Patricia S.
   Nascimento, Leile Camila J.
   Portilho, Moyra M.
   Soares, Gubio C.
   Weaver, Scott C.
   Reis, Mitermayer G.
   Kitron, Uriel
   Ribeiro, Guilherme S.
TI EVALUATION OF TWO COMMERCIALLY AVAILABLE CHIKUNGUNYA VIRUS IGM
   ENZYME-LINKED IMMUNOASSAY (ELISA) IN AN ENDEMIC REGION FOR CHIKUNGUNYA,
   DENGUE AND ZIKA VIRUSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Kikuti, Mariana] Univ Minnesota, St Paul, MN 55108 USA.
   [Tauro, Laura B.] UNAM, Conicet, Puerto Iguazu, Argentina.
   [Moreira, Patricia S.; Nascimento, Leile Camila J.; Portilho, Moyra M.; Reis, Mitermayer G.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Soares, Gubio C.; Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RI Reis, Mitermayer/AAO-9742-2020; Ribeiro, Guilherme/B-6624-2008
OI Reis, Mitermayer/0000-0002-3051-9060; Ribeiro,
   Guilherme/0000-0002-6798-2059
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 802
BP 245
EP 245
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503155
DA 2020-07-08
ER

PT J
AU Falconi-Agapito, F
   Merino, X
   Kerkhof, K
   Arien, KK
   Talledo, M
AF Falconi-Agapito, Francesca
   Merino, Xiomara
   Kerkhof, Karen
   Arien, Kevin K.
   Talledo, Michael
TI CO-CIRCULATION OF DENGUE, ZIKA AND CHIKUNGUNYA IN THE PERUVIAN AMAZON
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Falconi-Agapito, Francesca; Kerkhof, Karen; Arien, Kevin K.] Inst Trop Med, Antwerp, Belgium.
   [Merino, Xiomara; Talledo, Michael] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
RI Falconi, Francesca/F-4347-2016
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 807
BP 247
EP 247
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503160
DA 2020-07-08
ER

PT J
AU Andrade, P
   Coloma, J
   Balmaseda, A
   Harris, E
AF Andrade, Paulina
   Coloma, Josefina
   Balmaseda, Angel
   Harris, Eva
TI PRIMARY AND SECONDARY DENGUE VIRUS INFECTIONS ELICIT SIMILAR MEMORY B
   CELL PROFILES BUT CROSS-REACTIVITY TO ZIKA VIRUS IS HIGHER IN SECONDARY
   DENGUE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Andrade, Paulina; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 816
BP 249
EP 250
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503169
DA 2020-07-08
ER

PT J
AU Montoya, M
   Bustos, F
   Collado, D
   Miranda, T
   Kuan, G
   Balmaseda, A
   Harris, E
AF Montoya, Magelda
   Bustos, Fausto
   Collado, Damaris
   Miranda, Tatiana
   Kuan, Guillermina
   Balmaseda, Angel
   Harris, Eva
TI PERSISTENCE OF ANTI-ZIKA VIRUS ANTIBODIES OVER TIME IN PEDIATRIC AND
   ADULT COHORT STUDIES IN NICARAGUA USING DIFFERENT SEROLOGICAL ASSAYS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Montoya, Magelda; Bustos, Fausto; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Collado, Damaris; Miranda, Tatiana] Sustainable Sci Inst, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Salud, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost Referencia, Lab Nacl Virol, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 819
BP 250
EP 251
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503172
DA 2020-07-08
ER

PT J
AU Parham, L
   Garcia, K
   Figueroa, I
   Lorenzana, I
AF Parham, Leda
   Garcia, Kimberly
   Figueroa, Isis
   Lorenzana, Ivette
TI LABORATORY DIAGNOSIS ZIKA IN NEUROLOGICAL CASES DURING ZIKA OUTBREAK
   2016 AND 2018
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Parham, Leda; Garcia, Kimberly; Figueroa, Isis; Lorenzana, Ivette] Univ Nacl Autonoma Honduras, Ctr Invest Genet, Tegucigalpa, Honduras.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 829
BP 253
EP 254
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503182
DA 2020-07-08
ER

PT J
AU Fontes-Garfias, CR
   Nunes, B
   Shan, C
   Muruato, A
   Weaver, SC
   Vasconcelos, PF
   Medeiros, DB
   Shi, PY
AF Fontes-Garfias, Camila R.
   Nunes, Bruno
   Shan, Chao
   Muruato, Antonio
   Weaver, Scott C.
   Vasconcelos, Pedro F.
   Medeiros, Daniele B.
   Shi, Pei-Yong
TI CHARACTERIZATION OF GENETIC VARIATION BETWEEN ZIKV ASIAN AND AFRICAN
   STRAINS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Fontes-Garfias, Camila R.; Shan, Chao; Muruato, Antonio; Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Nunes, Bruno; Vasconcelos, Pedro F.; Medeiros, Daniele B.] Minist Hlth, Evandro Chagas Inst, Ananindeua, Para, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 835
BP 255
EP 255
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503188
DA 2020-07-08
ER

PT J
AU Olson, D
   Lamb, MM
   Huleatt, JW
   Bonaparte, M
   Paniagua-Avila, MA
   Zacarias, A
   Rojop, N
   Chacon-Juarez, A
   Natrajan, M
   Waggoner, J
   Lopez, MR
   Cordon-Rosales, C
   Asturias, EJ
AF Olson, Daniel
   Lamb, Molly M.
   Huleatt, James W.
   Bonaparte, Matthew
   Alejandra Paniagua-Avila, Maria
   Zacarias, Alma
   Rojop, Neudy
   Chacon-Juarez, Andrea
   Natrajan, Muktha
   Waggoner, Jesse
   Renee Lopez, Maria
   Cordon-Rosales, Celia
   Asturias, Edwin J.
TI PERFORMANCE OF TWO ZIKA VIRUS NEUTRALIZING ANTIBODY TITER CLASSIFICATION
   SCHEMES AGAINST ZIKA NS1 BLOCKADE-OF-BINDING ASSAY DURING THE 2015-2016
   EPIDEMIC IN GUATEMALA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Olson, Daniel; Asturias, Edwin J.] Univ Colorado, Sch Med, Aurora, CO USA.
   [Lamb, Molly M.] Colorado Sch Publ Hlth, Aurora, CO USA.
   [Huleatt, James W.; Bonaparte, Matthew] Sanofi Pasteur, Swiftwater, PA USA.
   [Alejandra Paniagua-Avila, Maria; Zacarias, Alma; Rojop, Neudy; Chacon-Juarez, Andrea] Fdn Salud Integral Guatemaltecos, Los Encuentros, Guatemala.
   [Natrajan, Muktha] Emory Vaccine Ctr, Atlanta, GA USA.
   [Waggoner, Jesse] Emory Univ, Sch Med, Atlanta, GA USA.
   [Renee Lopez, Maria; Cordon-Rosales, Celia] Univ Valle Guatemala, Ciudad De Guatemala, Guatemala.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 836
BP 255
EP 255
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503189
DA 2020-07-08
ER

PT J
AU Bohning, K
   Zahralban-Steele, M
   Chen, HL
   Hather, G
   Powell, T
   Patel, H
   Sonnberg, S
   Dean, H
AF Bohning, Kelly
   Zahralban-Steele, Melissa
   Chen, Hui-Ling
   Hather, Greg
   Powell, Tim
   Patel, Hetal
   Sonnberg, Stephanie
   Dean, Hansi
TI CHARACTERISTICS OF A HIGH THROUGHPUT, SPECIES-INDEPENDENT PLATE-BASED
   ZIKA REPORTER VIRUS PARTICLE (Z-RVP) NEUTRALIZATION ASSAY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Bohning, Kelly; Zahralban-Steele, Melissa; Chen, Hui-Ling; Powell, Tim; Patel, Hetal; Sonnberg, Stephanie; Dean, Hansi] Takeda Vaccines Inc, Cambridge, MA USA.
   [Hather, Greg] Takeda Pharmaceut Inc, Cambridge, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 838
BP 256
EP 256
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503191
DA 2020-07-08
ER

PT J
AU Byers, NM
   Fitzgerald, BL
   Petersen, LR
   Fleshman, AC
   Graham, B
   Gullberg, RC
   Perera, R
   Busch, MP
   Stone, M
   Molins, CR
AF Byers, Nathaniel M.
   Fitzgerald, Bryna L.
   Petersen, Lyle R.
   Fleshman, Amy C.
   Graham, Barbara
   Gullberg, Rebekah C.
   Perera, Rushika
   Busch, Michael P.
   Stone, Mars
   Molins, Claudia R.
TI ZIKA VIRUS INFECTION INDUCES DETECTABLE METABOLIC ALTERATIONS IN HUMANS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Byers, Nathaniel M.; Fitzgerald, Bryna L.; Petersen, Lyle R.; Fleshman, Amy C.; Molins, Claudia R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Graham, Barbara; Perera, Rushika] Colorado State Univ, Ft Collins, CO 80523 USA.
   [Gullberg, Rebekah C.] Stanford Univ, Stanford, CA 94305 USA.
   [Busch, Michael P.; Stone, Mars] Vitalant Res Inst, San Francisco, CA USA.
   [Busch, Michael P.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 837
BP 256
EP 256
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503190
DA 2020-07-08
ER

PT J
AU Moore, SM
   Oidtman, RJ
   Soda, KJ
   Siraj, AS
   Reiner, RC
   Barker, CM
   Perkins, TA
AF Moore, Sean M.
   Oidtman, Rachel J.
   Soda, K. James
   Siraj, Amir S.
   Reiner, Robert C., Jr.
   Barker, Chris M.
   Perkins, T. Alex
TI LEVERAGING MULTIPLE DATA TYPES TO ESTIMATE THE TRUE SIZE OF THE ZIKA
   EPIDEMIC IN THE AMERICAS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Moore, Sean M.; Oidtman, Rachel J.; Soda, K. James; Siraj, Amir S.; Perkins, T. Alex] Univ Notre Dame, Notre Dame, IN 46556 USA.
   [Reiner, Robert C., Jr.] Univ Washington, Seattle, WA 98195 USA.
   [Barker, Chris M.] Univ Calif Davis, Davis, CA 95616 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 840
BP 256
EP 257
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503193
DA 2020-07-08
ER

PT J
AU Loyola, S
   Popuche, D
   Huaman, A
   Rios, Z
   Silva, M
   Guevara, C
AF Loyola, Steev
   Popuche, Dina
   Huaman, Alfredo
   Rios, Zonia
   Silva, Maria
   Guevara, Carolina
TI STATISTICAL MODELS TO ESTIMATE THE NUMBER OF INFECTIOUS DENGUE AND ZIKA
   VIRUSES USING A REAL-TIME PCR
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Loyola, Steev; Popuche, Dina; Huaman, Alfredo; Rios, Zonia; Silva, Maria; Guevara, Carolina] US Naval Med Res Unit 6, Lima, Peru.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 841
BP 257
EP 257
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503194
DA 2020-07-08
ER

PT J
AU Popuche, D
   Loyola, S
   Rios, Z
   Ampuero, JS
   Guevara, C
AF Popuche, Dina
   Loyola, Steev
   Rios, Zonia
   Ampuero, Julia S.
   Guevara, Carolina
TI DETECTION OF ZIKA VIRUS IN PATIENTS WITH ACUTE FEBRILE RESPIRATORY
   SYMPTOMS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Popuche, Dina; Rios, Zonia; Ampuero, Julia S.; Guevara, Carolina] US Naval Med Res Unit 6, Lima, Peru.
   [Loyola, Steev] Asociac Benef PRISMA, Lima, Peru.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 842
BP 257
EP 257
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503195
DA 2020-07-08
ER

PT J
AU Lamb, MM
   Paniagua-Avila, MA
   Zacharias, A
   Rojop, N
   Chacon, A
   Huleatt, JW
   Bonaparte, MI
   Lopez, MR
   Cordon-Rosales, C
   Asturias, EJ
   Olson, D
AF Lamb, Molly M.
   Alejandra Paniagua-Avila, Maria
   Zacharias, Alma
   Rojop, Neudy
   Chacon, Andrea
   Huleatt, James W.
   Bonaparte, Matthew I.
   Renee Lopez, Maria
   Cordon-Rosales, Celia
   Asturias, Edwin J.
   Olson, Daniel
TI PREDICTORS OF ZIKA VIRUS SEROPOSITIVITY AMONG RURAL GUATEMALAN CHILDREN
   EARLY IN THE 2015-16 EPIDEMIC, USING RAPID ACTIVE SAMPLING SURVEYS AND
   THE ZIKV NS1 IGG BLOCKADE-OF-BINDING ASSAY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Lamb, Molly M.] Univ Colorado, Sch Publ Hlth, Aurora, CO USA.
   [Alejandra Paniagua-Avila, Maria; Zacharias, Alma; Rojop, Neudy; Chacon, Andrea] Fdn Salud Integral Guatemaltecos, Los Encuentros, Guatemala.
   [Huleatt, James W.; Bonaparte, Matthew I.] Sanofi Pasteur, Swiftwater, PA USA.
   [Renee Lopez, Maria; Cordon-Rosales, Celia] Univ Valle Guatemala, Guatemala City, Guatemala.
   [Asturias, Edwin J.; Olson, Daniel] Univ Colorado, Sch Med, Aurora, CO USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 845
BP 258
EP 258
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503198
DA 2020-07-08
ER

PT J
AU Rao, CY
   Sagastume, MD
   Martinez, C
   Palmieri, M
   Jefferds, MED
   Henao, OL
AF Rao, Carol Y.
   Sagastume, Manuel de Jesus
   Martinez, Carolina
   Palmieri, Mireya
   Jefferds, Maria Elena D.
   Henao, Olga L.
TI RECENT ZIKA INFECTION AMONG WOMEN OF REPRODUCTIVE AGE IN GUATEMALA,
   2017-2018
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Rao, Carol Y.; Jefferds, Maria Elena D.; Henao, Olga L.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Sagastume, Manuel de Jesus] Minist Hlth, Guatemala City, Guatemala.
   [Martinez, Carolina; Palmieri, Mireya] INCAP, Guatemala City, Guatemala.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 846
BP 258
EP 259
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503199
DA 2020-07-08
ER

PT J
AU Thompson, D
   Vang, L
   Uranga, C
   Espinosa, D
   Guenther, B
   Mendy, J
   Manayani, D
   Beaty, S
   Smith, J
   Harris, E
   Alexander, J
AF Thompson, Danielle
   Lo Vang
   Uranga, Carla
   Espinosa, Diego
   Guenther, Ben
   Mendy, Jason
   Manayani, Darly
   Beaty, Shannon
   Smith, Jon
   Harris, Eva
   Alexander, Jeff
TI ZIKA VIRUS-LIKE-PARTICLE VACCINE DEVELOPMENT BASED ON IMMATURE AND
   MATURE PARTICLES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Thompson, Danielle; Lo Vang; Guenther, Ben; Mendy, Jason; Beaty, Shannon] Emergent BioSolut, San Diego, CA USA.
   [Uranga, Carla] J Craig Venter Inst, San Diego, CA USA.
   [Espinosa, Diego; Harris, Eva] Univ Calif Berkeley, San Diego, CA USA.
   [Smith, Jon] ClearPath Vaccines RRD Int, Rockville, MD USA.
   [Alexander, Jeff] JL Alexander Res & Dev Consulting LLC, Greater San Diego Area, San Diego, CA USA.
RI Uranga, Carla/AAL-4748-2020
OI Uranga, Carla/0000-0003-1437-3521
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 844
BP 258
EP 258
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503197
DA 2020-07-08
ER

PT J
AU MacMillan, LM
   Meyer, CB
   Finnegan, MA
   Venugopalan, G
   Sun, LT
   Torres-Mendoza, Y
   Giraldo, D
   Billings, E
   Jackson, SS
   da Veiga, ABG
   Chowell, G
   Mistry, N
   Rush, MA
AF MacMillan, Laurel M.
   Meyer, Corey B.
   Finnegan, Mikaela A.
   Venugopalan, Gautham
   Sun, Landy T.
   Torres-Mendoza, Yaritbel
   Giraldo, Dianet
   Billings, Emily
   Jackson, Shawn S.
   da Veiga, Ana B. Gorini
   Chowell, Gerardo
   Mistry, Neeraj
   Rush, Margaret A.
TI A NOVEL METHOD FOR ASSESSING THE CASE DEFINITION SENSITIVITY,
   SPECIFICITY AND OVERLAP BETWEEN CO-CIRCULATING INFECTIOUS DISEASES
   APPLIED TO DENGUE, CHIKUNGUNYA AND ZIKA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [MacMillan, Laurel M.; Meyer, Corey B.; Finnegan, Mikaela A.; Venugopalan, Gautham; Sun, Landy T.; Giraldo, Dianet; Billings, Emily; Jackson, Shawn S.; Rush, Margaret A.] Gryphon Sci, Takoma Pk, MD USA.
   [Torres-Mendoza, Yaritbel] Univ Georgia, Coll Vet Med, Athens, GA USA.
   [da Veiga, Ana B. Gorini] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil.
   [Chowell, Gerardo] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA.
   [Mistry, Neeraj] Georgetown Univ, Dept Int Hlth, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1117
BP 342
EP 343
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503470
DA 2020-07-08
ER

PT J
AU Walteros, DM
   Daza, M
   Suarez, AC
   Mercado, M
   Prieto, F
   Rico, A
   Gonzalez, M
   Opsina, M
AF Marcela Walteros, Diana
   Daza, Marcela
   Cristina Suarez, Ana
   Mercado, Marcela
   Prieto, Franklyn
   Rico, Angelica
   Gonzalez, Maritza
   Opsina, Martha
TI NEUROLOGICAL SYNDROMES IN THE PEDIATRIC POPULATION DURING THE ZIKA VIRUS
   EPIDEMIC IN COLOMBIA 2015 TO 2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Marcela Walteros, Diana; Cristina Suarez, Ana; Mercado, Marcela; Prieto, Franklyn; Rico, Angelica; Gonzalez, Maritza; Opsina, Martha] Inst Nacl Salud, Bogota, Colombia.
   [Daza, Marcela] Vysnova Partners, Zika Res Div, Bogota, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1133
BP 348
EP 348
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503486
DA 2020-07-08
ER

PT J
AU Dong, YM
   Dong, SZ
   Dizaji, NB
   Rutkowski, N
   Gebhardt, M
   Dimopoulos, G
AF Dong, Yuemei
   Dong, Shengzhang
   Dizaji, Nahid Borhani
   Rutkowski, Natalie
   Gebhardt, Mary
   Dimopoulos, George
TI ENGINEERED RESISTANCE TO DENGUE AND ZIKA VIRUSES IN TRANSGENIC AEDES
   OVER-EXPRESSING RNAI PATHWAY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Dong, Yuemei; Dong, Shengzhang; Dizaji, Nahid Borhani; Rutkowski, Natalie; Gebhardt, Mary; Dimopoulos, George] Johns Hopkins Univ, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1257
BP 385
EP 385
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364503610
DA 2020-07-08
ER

PT J
AU Sharp, TM
   Santiago, G
   Rosenberg, E
   Cardona, IIS
   Alvarado, L
   Paz-Bailey, G
   Munoz-Jordan, JL
AF Sharp, Tyler M.
   Santiago, Gilberto
   Rosenberg, Eli
   Cardona, Iris I. Sosa
   Alvarado, Luisa
   Paz-Bailey, Gabriela
   Munoz-Jordan, Jorge L.
TI PRIOR DENGUE VIRUS INFECTION IS ASSOCIATED WITH INCREASED VIRAL LOAD IN
   PATIENTS INFECTED WITH DENGUE BUT NOT ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Sharp, Tyler M.; Santiago, Gilberto; Cardona, Iris I. Sosa; Paz-Bailey, Gabriela; Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, San Juan, PR USA.
   [Rosenberg, Eli] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Rensselaer, NY USA.
   [Alvarado, Luisa] San Lucas Episcopal Hosp, Ponce, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1319
BP 404
EP 405
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504029
DA 2020-07-08
ER

PT J
AU Katzelnick, L
   Collado, D
   Elizondo, D
   Mercado, JC
   Gresh, L
   Zambrana, JV
   Schiller, A
   Arguello, S
   Burger-Calderon, R
   Miranda, T
   Ojeda, S
   Sanchez, N
   Lopez, B
   Halloran, ME
   Coloma, J
   Gordon, A
   Kuan, G
   Balmaseda, A
   Harris, E
AF Katzelnick, Leah
   Collado, Damaris
   Elizondo, Douglas
   Carlos Mercado, Juan
   Gresh, Lionel
   Victor Zambrana, Jose
   Schiller, Amy
   Arguello, Sonia
   Burger-Calderon, Raquel
   Miranda, Tatiana
   Ojeda, Sergio
   Sanchez, Nery
   Lopez, Brenda
   Halloran, M. Elizabeth
   Coloma, Josefina
   Gordon, Aubree
   Kuan, Guillermina
   Balmaseda, Angel
   Harris, Eva
TI ANTI-FLAVIVIRUS ANTIBODY DYNAMICS BEFORE, DURING, AND AFTER THE ARRIVAL
   OF ZIKA IN THE AMERICAS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Katzelnick, Leah; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Collado, Damaris; Elizondo, Douglas; Gresh, Lionel; Victor Zambrana, Jose; Arguello, Sonia; Burger-Calderon, Raquel; Miranda, Tatiana; Ojeda, Sergio; Sanchez, Nery; Lopez, Brenda] Sustainable Sci Inst, Managua, Nicaragua.
   [Carlos Mercado, Juan; Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Schiller, Amy; Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1325
BP 406
EP 407
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504035
DA 2020-07-08
ER

PT J
AU Castanha, PMD
   Duangkhae, P
   Erdos, G
   Watkins, SC
   Falo, LD
   Marques, ET
   Barratt-Boyes, SM
AF Castanha, Priscila Mayrelle da Silva
   Duangkhae, Parichat
   Erdos, Geza
   Watkins, Simon C.
   Falo, Louis D., Jr.
   Marques, Ernesto T., Jr.
   Barratt-Boyes, Simon M.
TI PREEXISTING IMMUNITY ENHANCES RECRUITMENT AND INFECTION OF MYELOID CELLS
   WITH DENGUE AND ZIKA VIRUSES IN HUMAN SKIN
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Castanha, Priscila Mayrelle da Silva; Duangkhae, Parichat; Erdos, Geza; Watkins, Simon C.; Falo, Louis D., Jr.; Marques, Ernesto T., Jr.; Barratt-Boyes, Simon M.] Univ Pittsburgh, Pittsburgh, PA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1363
BP 419
EP 419
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504073
DA 2020-07-08
ER

PT J
AU Perez-Guzman, EX
   Pantoja, P
   Serrano-Collazo, C
   Hassert, MA
   Ortiz, A
   Rodriguez, IV
   Giavedoni, L
   Hodara, V
   Parodi, L
   Cruz, L
   Arana, T
   White, L
   Martinez, MI
   Weiskopf, D
   Brien, JD
   de Silva, A
   Pinto, A
   Sariol, CA
AF Perez-Guzman, Erick X.
   Pantoja, Petraleigh
   Serrano-Collazo, Crisanta
   Hassert, Mariah A.
   Ortiz, Alexandra
   Rodriguez, Idia V.
   Giavedoni, Luis
   Hodara, Vida
   Parodi, Laura
   Cruz, Lorna
   Arana, Teresa
   White, Laura
   Martinez, Melween I.
   Weiskopf, Daniela
   Brien, James D.
   de Silva, Aravinda
   Pinto, Amelia
   Sariol, Carlos A.
TI PREVIOUS ZIKA EXPOSURE IMPROVES IMMUNE RESPONSE AGAINST DENGUE WITHOUT
   PATHOGENESIS ENHANCEMENT IN RHESUS MACAQUES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Perez-Guzman, Erick X.; Pantoja, Petraleigh; Serrano-Collazo, Crisanta; Rodriguez, Idia V.; Cruz, Lorna; Arana, Teresa; Martinez, Melween I.; Sariol, Carlos A.] Univ Puerto Rico, Med Sci Campus, San Juan, PR 00936 USA.
   [Hassert, Mariah A.; Brien, James D.; Pinto, Amelia] St Louis Univ, Sch Med, St Louis, MO USA.
   [Ortiz, Alexandra] Univ Puerto Rico, Rio Piedras Campus, San Juan, PR 00936 USA.
   [Giavedoni, Luis; Hodara, Vida; Parodi, Laura] Texas Biomed Res Inst, San Antonio, TX USA.
   [White, Laura; de Silva, Aravinda] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Weiskopf, Daniela] La Jolla Inst Immunol, La Jolla, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1364
BP 419
EP 419
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504074
DA 2020-07-08
ER

PT J
AU Zambrano, B
   Rivera, DM
   Arredondo, JL
   Reynales, H
   Luz, K
   Deseda, C
   Bonaparte, M
   Langevin, E
   Wu, YK
   Cortes, M
   Dayan, GH
   Granados, CD
   Savarino, S
   Noriega, F
AF Zambrano, Betzana
   Maribel Rivera, Doris
   Luis Arredondo, Jose
   Reynales, Humberto
   Luz, Kleber
   Deseda, Carmen
   Bonaparte, Matthew
   Langevin, Edith
   Wu, Yukun
   Cortes, Margarita
   Dayan, Gustavo H.
   Granados, Carlos Diaz
   Savarino, Stephen
   Noriega, Fernando
TI PRIOR VACCINATION WITH CYD-TDV DID NOT POTENTIATE SYMPTOMATIC ZIKA IN
   DENGUE ENDEMIC AREAS OF LATIN AMERICA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Zambrano, Betzana] Sanofi Pasteur, Montevideo, Uruguay.
   [Maribel Rivera, Doris] Invers Invest Med, Tegucigalpa, Honduras.
   [Luis Arredondo, Jose] Inst Nacl Pediat, Mexico City, DF, Mexico.
   [Reynales, Humberto] Ctr Atenc & Invest Med, Bogota, Colombia.
   [Luz, Kleber] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
   [Deseda, Carmen] Caribbean Travel Med Clin, San Juan, PR USA.
   [Bonaparte, Matthew; Wu, Yukun; Dayan, Gustavo H.; Granados, Carlos Diaz; Savarino, Stephen; Noriega, Fernando] Sanofi Pasteur, Swiftwater, PA USA.
   [Langevin, Edith] Sanofi Pasteur, Marcy Letoile, France.
   [Cortes, Margarita] Sanofi Pasteur, Bogota, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1367
BP 420
EP 420
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504077
DA 2020-07-08
ER

PT J
AU Onyango, MG
   Bialosuknia, S
   Payne, A
   Nicholas, M
   Kuo, L
   Ciota, A
   Kramer, LD
AF Onyango, Maria G.
   Bialosuknia, Sean
   Payne, Anne
   Nicholas, Mathias
   Kuo, Lilli
   Ciota, Alexander
   Kramer, Laura D.
TI INVESTIGATING THE MOLECULAR PLASTICITY OF AEDES ALBOPICTUS IN RESPONSE
   TO ZIKA VIRUS INFECTION UNDER INCREASED TEMPERATURES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Onyango, Maria G.; Bialosuknia, Sean; Payne, Anne; Nicholas, Mathias; Kuo, Lilli; Ciota, Alexander; Kramer, Laura D.] New York State Dept Hlth, Wadsworth Ctr, Slingerlands, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1369
BP 421
EP 421
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504079
DA 2020-07-08
ER

PT J
AU Joannides, J
   Dzodzomenyo, M
   Azerigyik, F
   Agbosu, EE
   Pratt, D
   Osei, JH
   Pwalia, R
   Amlalo, GK
   Appawu, MA
   Takashi, H
   Buchwald, A
   Rochford, R
   Boakye, DA
   Koram, KA
   Bonney, K
   Dadzie, SK
AF Joannides, Joannitta
   Dzodzomenyo, Mawuli
   Azerigyik, Faustus
   Agbosu, Esinam E.
   Pratt, Deborah
   Osei, Joseph H.
   Pwalia, Rebecca
   Amlalo, Godwin K.
   Appawu, Maxwell A.
   Takashi, Hayashi
   Buchwald, Andrea
   Rochford, Rosemary
   Boakye, Daniel A.
   Koram, Kwadwo A.
   Bonney, Kofi
   Dadzie, Samuel K.
TI RISK OF TRANSMISSION OF DENGUE, CHIKUNGUNYA AND ZIKA IN SOME YELLOW
   FEVER HOTSPOT AREAS IN NORTHERN GHANA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Joannides, Joannitta; Azerigyik, Faustus; Osei, Joseph H.; Pwalia, Rebecca; Amlalo, Godwin K.; Appawu, Maxwell A.; Takashi, Hayashi; Boakye, Daniel A.; Dadzie, Samuel K.] Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana.
   [Dzodzomenyo, Mawuli] Univ Ghana, Sch Publ Hlth, Dept Biol Environm & Occupat Hlth, Accra, Ghana.
   [Agbosu, Esinam E.; Pratt, Deborah; Bonney, Kofi] Noguchi Mem Inst Med Res, Dept Virol, Accra, Ghana.
   [Buchwald, Andrea] Univ Colorado, Sch Publ Hlth, Dept Environm & Occupat Hlth, Denver, CO 80202 USA.
   [Rochford, Rosemary] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Denver, CO 80202 USA.
   [Koram, Kwadwo A.] Univ Ghana, Sch Publ Hlth, Dept Epidemiol, Legon, Accra, Ghana.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1414
BP 435
EP 435
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504124
DA 2020-07-08
ER

PT J
AU Ryan, SJ
   Carlson, CJ
   Tesla, B
   Bonds, MH
   Ngonghala, CN
   Mordecai, EA
   Johnson, LR
   Murdock, CC
AF Ryan, Sadie Jane
   Carlson, Colin J.
   Tesla, Blanka
   Bonds, Matthew H.
   Ngonghala, Calistus N.
   Mordecai, Erin A.
   Johnson, Leah R.
   Murdock, Courtney C.
TI CLIMATE CHANGE COULD EXPOSE 1.3 BILLION NEW PEOPLE TO ZIKA VIRUS
   TRANSMISSION RISK BY 2050
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Ryan, Sadie Jane; Ngonghala, Calistus N.] Univ Florida, Gainesville, FL USA.
   [Carlson, Colin J.] Georgetown Univ, Washington, DC USA.
   [Tesla, Blanka; Murdock, Courtney C.] Univ Georgia, Athens, GA 30602 USA.
   [Bonds, Matthew H.] Harvard Med Sch, Boston, MA 02115 USA.
   [Mordecai, Erin A.] Stanford Univ, Stanford, CA 94305 USA.
   [Johnson, Leah R.] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1428
BP 439
EP 439
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504138
DA 2020-07-08
ER

PT J
AU Katzelnick, L
   Marquez, S
   Vivero, S
   Cevallos, W
   Balmaseda, A
   Harris, E
   Messer, W
   Eisenberg, J
   Trueba, G
   Coloma, J
AF Katzelnick, Leah
   Marquez, Sully
   Vivero, Sandra
   Cevallos, William
   Balmaseda, Angel
   Harris, Eva
   Messer, William
   Eisenberg, Joseph
   Trueba, Gabriel
   Coloma, Josefina
TI USE OF DENGUE RAPID DIAGNOSTIC TESTS TO DETECT HISTORICAL DENGUE VIRUS
   INFECTIONS IN POPULATIONS WHERE DENGUE AND ZIKA VIRUSES CO-CIRCULATE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Katzelnick, Leah; Harris, Eva; Coloma, Josefina] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Marquez, Sully; Trueba, Gabriel] Univ San Francisco Quito, Inst Microbiol, Quito, Ecuador.
   [Vivero, Sandra; Cevallos, William] Univ Cent, Quito, Ecuador.
   [Balmaseda, Angel] Minist Hlth, Labo Nacl Virol, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Messer, William] Oregon Hlth & Sci Univ, Sch Med, Div Infect Dis, Portland, OR 97201 USA.
   [Eisenberg, Joseph] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1464
BP 449
EP 449
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504174
DA 2020-07-08
ER

PT J
AU Kim, E
   Che, Y
   Michlmayr, D
   Wolinksy, S
   Harris, E
AF Kim, Eunyoung
   Che, Yan
   Michlmayr, Daniela
   Wolinksy, Steven
   Harris, Eva
TI IDENTIFICATION OF GENES THAT ARE DIFFERENTIALLY EXPRESSED IN RESPONSE TO
   DENGUE, ZIKA OR CHIKUNGUNYA VIRUS INFECTION IN NICARAGUAN PATIENTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Kim, Eunyoung; Che, Yan; Wolinksy, Steven] Northwestern Univ, Div Infect Dis, Chicago, IL 60611 USA.
   [Michlmayr, Daniela; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1469
BP 450
EP 451
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504179
DA 2020-07-08
ER

PT J
AU Stadler, V
   Loeffler, F
   Sekul, R
   Heiss, K
   Cruz, MM
   Coloma, J
   Harris, E
AF Stadler, Volker
   Loeffler, Felix
   Sekul, Renate
   Heiss, Kirsten
   Cruz, Magelda Montoya
   Coloma, Josefina
   Harris, Eva
TI DISCOVERY OF EPITOPE BIOMARKERS FOR THE DIAGNOSIS OF DENGUE AND ZIKA
   VIRUS INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Stadler, Volker; Sekul, Renate; Heiss, Kirsten] PEPperPRINT GmbH, Heidelberg, Germany.
   [Loeffler, Felix] Max Planck Inst Colloids & Interfaces, Potsdam, Germany.
   [Cruz, Magelda Montoya; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
FU U.S. Department of Homeland Security Science & Technology
   DirectorateUnited States Department of Homeland Security (DHS)
   [HSHQDC-15-C-B0010]
FX This work was supported by the U.S. Department of Homeland Security
   Science & Technology Directorate (Contract HSHQDC-15-C-B0010).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1473
BP 452
EP 452
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504183
DA 2020-07-08
ER

PT J
AU Parham, L
   Garcia, M
   Pickett, B
   Tan, GS
   Fedorova, N
   Amedeo, P
   Garcia, K
   Viedma, P
   Durbin, A
   Williams, T
   Lorenzana, I
AF Parham, Leda
   Garcia, Monica
   Pickett, Brett
   Tan, Gene S.
   Fedorova, Nadia
   Amedeo, Paolo
   Garcia, Kimberly
   Viedma, Pilar
   Durbin, Alan
   Williams, Torrey
   Lorenzana, Ivette
TI SEQUENCING OF ZIKA VIRUS ISOLATE FROM THE AMNIOTIC FLUID OF A FETUS WITH
   MICROCEPHALY DURING AN OUTBREAK IN HONDURAS-2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Parham, Leda; Garcia, Kimberly; Lorenzana, Ivette] Univ Nacl Autonoma Honduras, Ctr Invest Genet, Tegucigalpa, Honduras.
   [Garcia, Monica] Ctr Hondureno Med Fetal, San Pedro Sula, Honduras.
   [Pickett, Brett; Tan, Gene S.; Fedorova, Nadia; Amedeo, Paolo; Viedma, Pilar; Durbin, Alan; Williams, Torrey] J Craig Venter Inst, La Jolla, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1476
BP 453
EP 453
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504186
DA 2020-07-08
ER

PT J
AU Edgerton, SV
   Wang, CL
   Thongsripong, P
   Saborio, SI
   Montoya, M
   Coloma, J
   Balmaseda, A
   Harris, E
   Bennett, SN
AF Edgerton, Sean V.
   Wang, Chunling
   Thongsripong, Panpim
   Saborio, Saira I.
   Montoya, Magelda
   Coloma, Josefina
   Balmaseda, Angel
   Harris, Eva
   Bennett, Shannon N.
TI EVOLUTION AND EPIDEMIOLOGIC DYNAMICS OF DENGUE VIRUS SEROTYPES IN
   NICARAGUA DURING THE EMERGENCE OF CHIKUNGUNYA AND ZIKA VIRUSES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Edgerton, Sean V.; Thongsripong, Panpim; Bennett, Shannon N.] Calif Acad Sci, San Francisco, CA 94118 USA.
   [Wang, Chunling; Montoya, Magelda; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Saborio, Saira I.; Balmaseda, Angel] Minist Hlth, Lab Nacl Virol, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1482
BP 455
EP 455
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504192
DA 2020-07-08
ER

PT J
AU Greig, H
AF Greig, Hannah
TI DECLINE IN MAGNITUDE OF ZIKA VIRUS-SPECIFIC LONG TERM MEMORY T-CELLS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Greig, Hannah] Univ Western Australia, Nedlands, WA, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1493
BP 458
EP 459
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504203
DA 2020-07-08
ER

PT J
AU De Lorenzo, G
   Doig, J
   Tandavanitj, R
   Poggianella, M
   Sanchez-Velazquez, R
   Setthapramote, C
   Scales, H
   Campos, JLS
   Kohl, A
   Brewer, J
   Burrone, OR
   Patel, A
AF De Lorenzo, Giuditta
   Doig, Jennifer
   Tandavanitj, Rapeepat
   Poggianella, Monica
   Sanchez-Velazquez, Ricardo
   Setthapramote, Chayanee
   Scales, Hannah
   Campos, Jose Luis Slon
   Kohl, Alain
   Brewer, James
   Burrone, Oscar R.
   Patel, Arvind
TI PRECLINICAL EVALUATION OF ZIKA VIRUS VACCINE CANDIDATES BASED ON
   COVALENTLY STABLE E DIMERS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [De Lorenzo, Giuditta; Doig, Jennifer; Tandavanitj, Rapeepat; Sanchez-Velazquez, Ricardo; Setthapramote, Chayanee; Kohl, Alain; Patel, Arvind] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland.
   [Poggianella, Monica; Campos, Jose Luis Slon; Burrone, Oscar R.] Int Ctr Genet Ingeneering & Biotechnol, Trieste, Italy.
   [Scales, Hannah; Brewer, James] Univ Glasgow, Glasgow, Lanark, Scotland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1495
BP 459
EP 459
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504205
DA 2020-07-08
ER

PT J
AU Gajewski, A
   Ortega, O
   Llufrio, L
   Elizondo, D
   Montoya, M
   Collado, D
   Urbina, A
   Rivas, W
   Kuan, G
   Balmaseda, A
   Harris, E
AF Gajewski, Anna
   Ortega, Oscar
   Llufrio, Liliam
   Elizondo, Douglas
   Montoya, Magelda
   Collado, Damaris
   Urbina, Anna
   Rivas, William
   Kuan, Guillermina
   Balmaseda, Angel
   Harris, Eva
TI PREGNANCY AND INFANT OUTCOMES POST-ZIKA VIRUS INFECTION IN NICARAGUA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Gajewski, Anna; Ortega, Oscar; Llufrio, Liliam; Elizondo, Douglas; Collado, Damaris; Urbina, Anna; Rivas, William] Sustainable Sci Inst, Managua, Nicaragua.
   [Montoya, Magelda; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Kuan, Guillermina] Minist Salud, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Salud, Lab Nacl Virol, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1496
BP 459
EP 459
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504206
DA 2020-07-08
ER

PT J
AU Driesse, K
   Tsai, WY
   Brites, C
   Pedroso, C
   Wang, WK
AF Driesse, Kaitlin
   Tsai, Wen-Yang
   Brites, Carlos
   Pedroso, Celia
   Wang, Wei-Kung
TI DENGUE VIRUS IMMUNE STATUS AND ANTIBODY TITERS AMONG ASYMPTOMATIC
   PREGNANT WOMEN DURING THE ZIKA OUTBREAK IN SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Driesse, Kaitlin; Tsai, Wen-Yang; Wang, Wei-Kung] Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI 96822 USA.
   [Brites, Carlos; Pedroso, Celia] Univ Fed Bahia, LAPI Lab Pesquisa Infectol, Sch Med, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1497
BP 460
EP 460
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504207
DA 2020-07-08
ER

PT J
AU Haun, BK
   To, A
   Wong, T
   Ndhlovu, L
   Lehrer, A
AF Haun, Brien K.
   To, Albert
   Wong, Teri
   Ndhlovu, Lishomwa
   Lehrer, Axel
TI PRETREATMENT WITH PUTATIVE NOVEL ADJUVANTS MODULATE T FOLLICULAR HELPER
   AND B CELL RESPONSES TO ZIKV-E ANTIGEN
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Haun, Brien K.; To, Albert; Wong, Teri; Ndhlovu, Lishomwa; Lehrer, Axel] Univ Hawaii, Honolulu, HI 96822 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1500
BP 460
EP 461
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504210
DA 2020-07-08
ER

PT J
AU Kuklis, CH
   Pollett, SD
   Barvir, DA
   Jarman, RG
   Forshey, BM
   Gromowski, GD
AF Kuklis, Caitlin H.
   Pollett, Simon D.
   Barvir, David A.
   Jarman, Richard G.
   Forshey, Brett M.
   Gromowski, Gregory D.
TI ZIKA VIRUS SEROPREVALENCE ESTIMATES IN A US MILITARY POPULATION INDICATE
   POSSIBLE CRYPTIC ZIKV TRANSMISSION IN PUERTO RICO BY EARLY 2015
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Kuklis, Caitlin H.; Pollett, Simon D.; Barvir, David A.; Jarman, Richard G.; Gromowski, Gregory D.] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Forshey, Brett M.] Armed Forces Hlth Surveillance Branch, Silver Spring, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1499
BP 460
EP 460
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504209
DA 2020-07-08
ER

PT J
AU Martin, E
   Garcia-Luna, S
   Juarez, J
   de Valdez, MW
   Badillo-Vargas, I
   Hamer, G
AF Martin, Estelle
   Garcia-Luna, Selene
   Juarez, Jose
   de Valdez, Megan Wise
   Badillo-Vargas, Ismael
   Hamer, Gabriel
TI SURVEY FOR CELL FUSING AGENT VIRUS (FLAVIVIRUS) IN AEDES AEGYPTI
   MOSQUITOES FROM TEXAS, USA AND THE INFLUENCE ON ZIKA VIRUS VECTOR
   COMPETENCE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Martin, Estelle; Garcia-Luna, Selene; Juarez, Jose; de Valdez, Megan Wise; Badillo-Vargas, Ismael; Hamer, Gabriel] Texas A&M, College Stn, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1498
BP 460
EP 460
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504208
DA 2020-07-08
ER

PT J
AU Graham, S
   Janda, A
   Tu, H
   Diehl, S
   de Silva, A
AF Graham, Stephen
   Janda, Alena
   Tu, Huy
   Diehl, Sean
   de Silva, Aravinda
TI DETERMINING THE BINDING SITES OF NEUTRALIZING ANTIBODIES ISOLATED FROM A
   ZIKA VIRUS INFECTED INDIVIDUAL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Graham, Stephen; de Silva, Aravinda] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27515 USA.
   [Janda, Alena; Tu, Huy] Univ N Carolina, Dept Med, Div Infect Dis, Sch Med, Chapel Hill, NC 27515 USA.
   [Diehl, Sean] Univ Vermont, Cellular Mol & Biomed Sci Program, Burlington, VT USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1503
BP 461
EP 461
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504213
DA 2020-07-08
ER

PT J
AU Markmann, AJ
   Tu, H
   Graham, S
   Collins, M
   Diehl, S
   de Silva, A
AF Markmann, Alena Janda
   Tu, Huy
   Graham, Stephen
   Collins, Matthew
   Diehl, Sean
   de Silva, Aravinda
TI ZIKA VIRUS MEMORY B CELL RESPONSES DIFFER IN DENGUE IMMUNE AND DENGUE
   NAIVE INDIVIDUALS WITHIN A US-BASED TRAVELER STUDY COHORT
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Markmann, Alena Janda; Graham, Stephen; de Silva, Aravinda] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Tu, Huy; Diehl, Sean] Univ Vermont, Burlington, VT USA.
   [Collins, Matthew] Emory Univ, Atlanta, GA 30322 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1502
BP 461
EP 461
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504212
DA 2020-07-08
ER

PT J
AU Orbegozo, J
   Palermo, PM
   Joshi, A
   Garg, H
   Watts, DM
AF Orbegozo, Jeanette
   Palermo, Pedro M.
   Joshi, Anjali
   Garg, Himanshu
   Watts, Douglas M.
TI ZIKV ANTIBODY DEPENDENT ENHANCEMENT OF INFECTION MEDIATED BY WNV AND
   DENV SEROPOSITIVE CORD-BLOOD SAMPLES FROM MOTHERS IN EL PASO-TEXAS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Orbegozo, Jeanette; Palermo, Pedro M.; Watts, Douglas M.] Univ Texas El Paso, El Paso, TX 79968 USA.
   [Joshi, Anjali; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1504
BP 461
EP 462
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504214
DA 2020-07-08
ER

PT J
AU Valiant, WG
   Mattapallil, JJ
AF Valiant, William G.
   Mattapallil, Joseph John
TI INTERFERON LAMBDA (IFN Lambda 1, IFN Lambda 2, AND IFN Lambda 3)
   ENHANCES ZIKA VIRUS REPLICATION IN GLIAL CELLS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Valiant, William G.; Mattapallil, Joseph John] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1501
BP 461
EP 461
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364504211
DA 2020-07-08
ER

PT J
AU Clinton, JLS
   Tran, LL
   Vogt, MB
   Rowley, DR
   Kimata, JT
   Rico-Hesse, RR
AF Clinton, Jennifer L. S.
   Tran, Linda L.
   Vogt, Megan B.
   Rowley, David R.
   Kimata, Jason T.
   Rico-Hesse, Rebecca R.
TI THE ROLE OF IP-10 AND CXCR3 SIGNALING IN ZIKA VIRUS PROSTATE CELL
   INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Clinton, Jennifer L. S.; Tran, Linda L.; Vogt, Megan B.; Rowley, David R.; Kimata, Jason T.; Rico-Hesse, Rebecca R.] Baylor Coll Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1898
BP 584
EP 584
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505018
DA 2020-07-08
ER

PT J
AU Gallichotte, E
   Murrieta, R
   Bellis, E
   Friedrich, T
   Aliota, M
   Ebel, G
AF Gallichotte, Emily
   Murrieta, Reyes
   Bellis, Eric
   Friedrich, Thomas
   Aliota, Matthew
   Ebel, Gregory
TI A POINT MUTATION BETWEEN ASIAN AND AFRICAN LINEAGE ZIKA VIRUSES AUGMENTS
   MOSQUITO INFECTIVITY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Gallichotte, Emily; Murrieta, Reyes; Bellis, Eric; Ebel, Gregory] Colorado State Univ, Ft Collins, CO 80523 USA.
   [Friedrich, Thomas] Univ Wisconsin, Madison, WI USA.
   [Aliota, Matthew] Univ Minnesota, St Paul, MN 55108 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1899
BP 584
EP 585
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505019
DA 2020-07-08
ER

PT J
AU Crooks, CM
   Jaeger, AS
   Weiler, AM
   Rybarczyk, SL
   Bliss, MI
   Brown, EA
   Simmons, HA
   Hayes, JM
   Mejia, A
   Yamamoto, K
   Shepherd, P
   Murphy, ME
   Golos, TG
   Possell, A
   Weaver, K
   Morgan, TK
   Dudley, DM
   Schultz-Darken, N
   Peterson, E
   O'Connor, DH
   Aliota, MT
   Friedrich, TC
AF Crooks, Chelsea M.
   Jaeger, Anna S.
   Weiler, Andrea M.
   Rybarczyk, Sierra L.
   Bliss, Mason I.
   Brown, Elizabeth A.
   Simmons, Heather A.
   Hayes, Jennifer M.
   Mejia, Andres
   Yamamoto, Keisuke
   Shepherd, Phoenix
   Murphy, Megan E.
   Golos, Thaddeus G.
   Possell, Amber
   Weaver, Kara
   Morgan, Terry K.
   Dudley, Dawn M.
   Schultz-Darken, Nancy
   Peterson, Eric
   O'Connor, David H.
   Aliota, Matthew T.
   Friedrich, Thomas C.
TI AFRICAN-LINEAGE ZIKA VIRUS CAUSES PLACENTAL PATHOLOGY IN PREGNANT RHESUS
   MACAQUES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Crooks, Chelsea M.; Brown, Elizabeth A.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Jaeger, Anna S.; Aliota, Matthew T.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
   [Weiler, Andrea M.; Rybarczyk, Sierra L.; Bliss, Mason I.; Simmons, Heather A.; Hayes, Jennifer M.; Mejia, Andres; Possell, Amber; Weaver, Kara; Schultz-Darken, Nancy; Peterson, Eric] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Yamamoto, Keisuke; Shepherd, Phoenix; Dudley, Dawn M.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.
   [Murphy, Megan E.; Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI USA.
   [Morgan, Terry K.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA.
   [Morgan, Terry K.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1901
BP 585
EP 585
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505021
DA 2020-07-08
ER

PT J
AU McDonald, EM
   Brault, AC
AF McDonald, Erin M.
   Brault, Aaron C.
TI STRUCTURAL PROTEINS (PRME) DICTATE SEXUAL TRANSMISSION POTENTIAL OF ZIKV
   AND SPONV IN AN IN VITRO EPIDIDYMAL EPITHELIAL CELL MODEL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [McDonald, Erin M.; Brault, Aaron C.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1900
BP 585
EP 585
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505020
DA 2020-07-08
ER

PT J
AU Vogels, CB
   Oliveira, G
   Saraf, S
   Ontiveros, C
   Agarwal, R
   Klitting, R
   Fauver, JR
   Brito, AF
   Allen, E
   Weger-Lucarelli, J
   Ebel, GD
   Andersen, KG
   Grubaugh, ND
AF Vogels, Chantal B.
   Oliveira, Glenn
   Saraf, Sharada
   Ontiveros, Carlos
   Agarwal, Rimjhim
   Klitting, Raphaelle
   Fauver, Joseph R.
   Brito, Anderson F.
   Allen, Emma
   Weger-Lucarelli, James
   Ebel, Gregory D.
   Andersen, Kristian G.
   Grubaugh, Nathan D.
TI IMPACT OF ZIKA VIRUS EVOLUTION ON MOSQUITO TRANSMISSION DURING THE
   EPIDEMIC IN THE AMERICAS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Vogels, Chantal B.; Fauver, Joseph R.; Brito, Anderson F.; Allen, Emma; Grubaugh, Nathan D.] Yale Sch Publ Hlth, New Haven, CT USA.
   [Oliveira, Glenn; Saraf, Sharada; Ontiveros, Carlos; Agarwal, Rimjhim; Klitting, Raphaelle; Andersen, Kristian G.] Scripps Res Inst, La Jolla, CA 92037 USA.
   [Weger-Lucarelli, James] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.
   [Ebel, Gregory D.] Colorado State Univ, Ft Collins, CO 80523 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1902
BP 585
EP 585
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505022
DA 2020-07-08
ER

PT J
AU Davidson, E
   Whitbeck, C
   Thomas, A
   Bryan, AL
   Sullivan, T
   Stafford, LJ
   Chambers, R
   Rossmann, MG
   Crowe, JE
   Doranz, BJ
AF Davidson, Edgar
   Whitbeck, Chuck
   Thomas, Anu
   Bryan, Aubrey L.
   Sullivan, Tabb
   Stafford, Lewis J.
   Chambers, Ross
   Rossmann, Michael G.
   Crowe, James E., Jr.
   Doranz, Benjamin J.
TI CHARACTERIZING THE IMMUNE RESPONSE TO ZIKA VIRUS USING EPITOPE MAPPING:
   REPORTER VIRUS PARTICLES AND ANTI-ZIKV ANTIBODIES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Davidson, Edgar; Whitbeck, Chuck; Thomas, Anu; Bryan, Aubrey L.; Sullivan, Tabb; Stafford, Lewis J.; Chambers, Ross; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA.
   [Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.
RI Crowe, James E./B-5549-2009
OI Crowe, James E./0000-0002-0049-1079
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1903
BP 586
EP 586
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505023
DA 2020-07-08
ER

PT J
AU Schouest, B
   Fahlberg, M
   Scheef, EA
   Ward, MJ
   Headrick, K
   Szeltner, DM
   Blair, RV
   Gilbert, MH
   Doyle-Meyers, LA
   Danner, VW
   Wesson, DM
   Panganiban, AT
   Maness, NJ
AF Schouest, Blake
   Fahlberg, Marissa
   Scheef, Elizabeth A.
   Ward, Matthew J.
   Headrick, Kyra
   Szeltner, Dawn M.
   Blair, Robert V.
   Gilbert, Margaret H.
   Doyle-Meyers, Lara A.
   Danner, Victoria W.
   Wesson, Dawn M.
   Panganiban, Antonito T.
   Maness, Nicholas J.
TI CD8+LYMPHOCYTES MODULATE ZIKA VIRUS DYNAMICS AND TISSUE DISSEMINATION
   AND ORCHESTRATE ANTIVIRAL IMMUNITY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Schouest, Blake; Fahlberg, Marissa; Scheef, Elizabeth A.; Szeltner, Dawn M.; Blair, Robert V.; Gilbert, Margaret H.; Doyle-Meyers, Lara A.; Danner, Victoria W.; Panganiban, Antonito T.; Maness, Nicholas J.] Tulane Natl Primate Res Ctr, Covington, LA USA.
   [Ward, Matthew J.; Headrick, Kyra; Wesson, Dawn M.] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1904
BP 586
EP 586
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505024
DA 2020-07-08
ER

PT J
AU Durbin, AP
   Pierce, KK
   Kirkpatrick, BD
   Blankenheim, R
   Han, J
   Lutton, P
   Fang, X
   Pavlovic, R
   Carmolli, M
   Klopfer, C
   Whitehead, SS
AF Durbin, Anna P.
   Pierce, Kristen K.
   Kirkpatrick, Beth D.
   Blankenheim, Rachel
   Han, Jennifer
   Lutton, Patricia
   Fang, Xi
   Pavlovic, Radmila
   Carmolli, Marya
   Klopfer, Connor
   Whitehead, Stephen S.
TI PHASE 1 EVALUATION OF A LIVE ATTENUATED VACCINE FOR THE PREVENTION OF
   ZIKA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Durbin, Anna P.; Blankenheim, Rachel; Han, Jennifer; Fang, Xi; Pavlovic, Radmila] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Pierce, Kristen K.; Kirkpatrick, Beth D.; Lutton, Patricia; Carmolli, Marya; Klopfer, Connor] Univ Vermont, Burlington, VT USA.
   [Whitehead, Stephen S.] NIH, Bldg 10, Bethesda, MD 20892 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1947
BP 600
EP 600
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505067
DA 2020-07-08
ER

PT J
AU Han, HH
AF Han, Htay Htay
CA Zik-101 Study Grp
TI SAFETY OF A PURIFIED INACTIVATED ZIKA VIRUS VACCINE (PIZV) CANDIDATE IN
   FLAVIVIRUS PRIMED HEALTHY ADULTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Han, Htay Htay; Zik-101 Study Grp] Takeda Vaccines Inc, Cambridge, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1948
BP 600
EP 600
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505068
DA 2020-07-08
ER

PT J
AU Ribeiro, AR
   Santos, CN
   Ribeiro, DR
   Cardoso, JA
   Cazzaniga, RA
   Magalhaes, LS
   de Souza, MS
   Fonseca, AB
   Bispo, AJ
   Porto, RL
   dos Santos, CA
   da Silva, AM
   Teixeira, MM
   de Almeida, RP
AF Ribeiro, Amelia R.
   Santos, Camilla N.
   Ribeiro, Danielle R.
   Cardoso, Juliana A.
   Cazzaniga, Rodrigo A.
   Magalhaes, Lucas S.
   de Souza, Mercia S.
   Fonseca, Adriana B.
   Bispo, Ana J.
   Porto, Roseane L.
   dos Santos, Cliomar A.
   da Silva, Angela M.
   Teixeira, Mauro M.
   de Almeida, Roque P.
TI ASSOCIATION BETWEEN ZIKA VIRUS MICROCEPHALY IN THE NEWBORN WITH THE
   RS3775291 VARIANT AT TOLL-LIKE RECEPTOR 3 AND RS1799964 VARIANT AT TNFA
   GENES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Ribeiro, Amelia R.; Santos, Camilla N.; Ribeiro, Danielle R.; Cardoso, Juliana A.; Cazzaniga, Rodrigo A.; Magalhaes, Lucas S.; de Souza, Mercia S.; Fonseca, Adriana B.; Bispo, Ana J.; Porto, Roseane L.; dos Santos, Cliomar A.; da Silva, Angela M.; de Almeida, Roque P.] Univ Fed Sergipe, Aracaju, Sergipe State, Brazil.
   [Teixeira, Mauro M.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1949
BP 600
EP 601
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505069
DA 2020-07-08
ER

PT J
AU Alvarado-Domenech, LI
   Rosario-Villafane, V
   Perez-Rodriguez, NM
   Repollet-Carrer, IC
   Vargas-Lassalle, L
   Rivera-Amill, V
   Rodriguez-Rabassa, M
AF Alvarado-Domenech, Luisa I.
   Rosario-Villafane, Viviana
   Perez-Rodriguez, Nicole M.
   Repollet-Carrer, Irelis C.
   Vargas-Lassalle, Luzeida
   Rivera-Amill, Vanessa
   Rodriguez-Rabassa, Mary
TI MOTOR FUNCTION AT 18 MONTHS AMONG INFANTS FROM THE PEDIATRIC OUTCOMES OF
   PRENATAL ZIKA EXPOSURE (POPZE) STUDY IN SOUTHERN PUERTO RICO
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Alvarado-Domenech, Luisa I.; Rosario-Villafane, Viviana; Repollet-Carrer, Irelis C.; Vargas-Lassalle, Luzeida] Ponce Hlth Sci Univ, St Lukes Episcopal Hosp, Ponce, PR USA.
   [Perez-Rodriguez, Nicole M.; Rivera-Amill, Vanessa; Rodriguez-Rabassa, Mary] Ponce Hlth Sci Univ, Ponce, PR USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1951
BP 601
EP 601
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505071
DA 2020-07-08
ER

PT J
AU Brady, OJ
   Hay, SI
   Reiner, RC
   Marinho, F
AF Brady, Oliver J.
   Hay, Simon I.
   Reiner, Robert C.
   Marinho, Fatima
TI MAPPING THE ASSOCIATION BETWEEN ZIKA VIRUS INFECTION AND MICROCEPHALY IN
   BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Brady, Oliver J.] London Sch Hyg & Trop Med, London, England.
   [Hay, Simon I.; Reiner, Robert C.; Marinho, Fatima] Univ Washington, IHME, Seattle, WA 98195 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1950
BP 601
EP 601
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505070
DA 2020-07-08
ER

PT J
AU Simmons, G
   Stone, M
   Cruz, MM
   Larrick, J
   Cheng, C
   Singh, I
   Dave, H
   Williamson, P
   Harris, E
   Busch, M
AF Simmons, Graham
   Stone, Mars
   Cruz, Magelda Montoya
   Larrick, Jasmine
   Cheng, Celine
   Singh, Inder
   Dave, Honey
   Williamson, Phillip
   Harris, Eva
   Busch, Michael
TI ESTIMATION OF ZIKA VIRUS INFECTION RATES IN BLOOD DONORS FOLLOWING THE
   2016 EPIDEMIC IN PUERTO RICO USING TWO SEROLOGICAL ASSAYS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Simmons, Graham; Stone, Mars; Cheng, Celine; Singh, Inder; Dave, Honey; Busch, Michael] Vitalant Res Inst, San Francisco, CA USA.
   [Cruz, Magelda Montoya; Larrick, Jasmine; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Williamson, Phillip] Creat Testing Solut, Tempe, AZ USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1952
BP 601
EP 601
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505072
DA 2020-07-08
ER

PT J
AU Olson, D
   Lamb, M
   Paniagua-Avila, MA
   Zacarias, A
   Rojop, NC
   Chacon-Juarez, A
   Hodge, S
   Bonaparte, M
   Lopez, MR
   Cordon-Rosales, C
   Asturias, EJ
AF Olson, Daniel
   Lamb, Molly
   Paniagua-Avila, Maria Alejandra
   Zacarias, Alma
   Rojop, Neudy C.
   Chacon-Juarez, Andrea
   Hodge, Shekema
   Bonaparte, Matthew
   Lopez, Maria Renee
   Cordon-Rosales, Celia
   Asturias, Edwin J.
TI RAPID ACTIVE SEROPREVALENCE (RAS) SURVEYS PERFORMED IN RURAL GUATEMALA
   DEMONSTRATED A RAPIDLY CHANGING ZIKA DISEASE BURDEN IN 2015-16 AND
   PROVIDE A USEFUL TOOL TO MEASURE ARBOVIRUS DISEASE BURDEN IN
   RESOURCE-LIMITED SETTINGS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the
   American-Society-for-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 20-24, 2019
CL National Harbor, MD
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Bavarian Nord, GSK, Takeda, Integrum Sci, Celgene, Vulcan, Plos Neglected Trop Dis, Elsevier
C1 [Olson, Daniel; Asturias, Edwin J.] Univ Colorado, Sch Med, Aurora, CO USA.
   [Lamb, Molly] Colorado Sch Publ Hlth, Aurora, CO USA.
   [Paniagua-Avila, Maria Alejandra; Zacarias, Alma; Rojop, Neudy C.; Chacon-Juarez, Andrea] Fdn Salud Integral Guatemaltecos, Encuentros, Guatemala.
   [Hodge, Shekema; Bonaparte, Matthew] Sanofi Pasteur, Swiftwater, PA USA.
   [Lopez, Maria Renee; Cordon-Rosales, Celia] Univ Valle Guatemala, Guatemala City, Guatemala.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
SU 5
MA 1953
BP 602
EP 602
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA KC7PF
UT WOS:000507364505073
DA 2020-07-08
ER

PT S
AU Andayani, P
AF Andayani, Puji
BE Cakalli, H
   Kocinac, LDR
   Harte, R
   Cavalcanti, VND
   Ashyralyev, A
   Sakalli, I
   Canak, I
   Gurtug, O
   Cavalcanti, MM
   Turkoglu, D
   Tez, M
   Kandemir, HS
   Uyaver, S
   Akay, KU
   Gul, I
   Yilmazturk, TE
   Akyel, T
   Ucgun, FC
   Sahin, H
TI The Effect of Social Media for a Zika Virus Transmission with Beddington
   DeAngelis Incidence Rate: Modeling and Analysis
SO THIRD INTERNATIONAL CONFERENCE OF MATHEMATICAL SCIENCES (ICMS 2019)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 3rd International Conference of Mathematical Sciences (ICMS)
CY SEP 04-08, 2019
CL Maltepe Univ, Istanbul, TURKEY
HO Maltepe Univ
DE Zika Virus; dynamics; social media; reproduction number; Next Generation
   Matrix; Beddington-De Angelis; saturated incidence rate
AB This paper discuss a modified mathematical model of Zika virus transmission and analyzes the impact of the awareness programs on social media the modification of of Zika Virus model with saturated incidence rate. The Beddington-De Angelis functional responses used to describe the interaction between a suspected human and an infected human. The dynamics of the model were analyzed by identifying the disease-free (DFE) and endemic equilibrium (END). Next Generation Matrix (NGM) was used to determine the Basic Reproduction Number. The stability of DFE and END were analyzed locally by computing the determinant of Jacobian. The DFE was identified as locally stable when the basic reproduction number was less than unity; and was identified as unstable otherwise. Meanwhile, the END was identified as existents when the basic reproduction number was greater than unity. The Routh-Hurwitz Criterion showed that the END was locally stable under a specific condition. A sensitivity analysis was also computed to determine the most influential parameter value of the model. In the end, the stability of DFE and END were also identified numerically depending on certain parameter values.
C1 [Andayani, Puji] Univ Int Semen Indonesia, Gresik, Indonesia.
RP Andayani, P (corresponding author), Univ Int Semen Indonesia, Gresik, Indonesia.
EM puji.andayani@uisi.ac.id
FU Direktorat Riset dan Pengabdian Masyarakat (DRPM), Direktorat Jenderal
   Penguatan Riset dan Pengembangan, the Ministry of Research, Technology,
   and Higher Education, Indonesia
FX The authors give deep gratitude to Direktorat Riset dan Pengabdian
   Masyarakat (DRPM), Direktorat Jenderal Penguatan Riset dan Pengembangan,
   the Ministry of Research, Technology, and Higher Education, Indonesia
   for the funding support. The author also expresses big thanks to
   Research and Human Responsibility Institute of Universitas International
   Semen Indonesia and the crew of the Informatics department, for the
   greatest support.
CR Andayani A. P., 2019, FAR E J MATH SCI FJM, V11, P145
   Andayani R. P., 2019, J EXP LIFE SCI, V8, P161
   Collinson S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-376
   Ishaku A. A., 2018, IOSR J MATH, V4, P72
   Misra AK, 2018, MATH BIOSCI ENG, V15, P1315, DOI 10.3934/mbe.2018061
   Padmanabhan P., 2017, LETT BIOMATHEMATICS, V4, P148, DOI DOI 10.1080/23737867.2017.1319746
   U. D. of Health and H. Services, ZIK TRANSM
NR 7
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1930-8
J9 AIP CONF PROC
PY 2019
VL 2183
AR UNSP 090003
DI 10.1063/1.5136203
PG 4
WC Mathematics; Physics, Applied
SC Mathematics; Physics
GA BO2DT
UT WOS:000505225800097
OA Bronze
DA 2020-07-08
ER

PT S
AU da Silva, OAP
   Miranda, DCD
   Cabral, FD
   Morya, E
   Freitas, RAD
   Nascimento, MSL
AF Pereira da Silva, Ozair Argentille
   da Silva Miranda, Danielly Carla
   Cabral Junior, Francisco das Chagas
   Morya, Edgard
   de Oliveira Freitas-Junior, Reginaldo Antonio
   Lima Nascimento, Manuela Sales
BE CostaFelix, R
   Machado, JC
   Alvarenga, AV
TI Brainstem Evoked Response Audiometry Reveals Integrity of the
   Retrocochlear Pathway in Children with Microcephaly
SO XXVI BRAZILIAN CONGRESS ON BIOMEDICAL ENGINEERING, CBEB 2018, VOL. 2
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 26th Brazilian Congress on Biomedical Engineering (CBEB)
CY OCT 21-25, 2018
CL Armacao de Buzios, BRAZIL
SP Equipacare, Senfio, Brazilian Soc Biomed Engn
DE Zika virus infection; Microcephaly; Brainstem evoked response
   audiometry; Retrocochlear auditory pathway
ID ZIKA VIRUS-INFECTION; NEUROIMAGING FINDINGS; CMV INFECTION;
   HEARING-LOSS; PREMATURE; BRAZIL
AB Congenital Zika virus (ZIKV) infection can cause abnormalities in the central nervous system with several levels of deficiency. The pathophysiology of this disorder has not yet been fully clarified, but neuroimaging studies have shown significant brainstem hypoplasia. Therefore, an unknown and possible increased risk of late-onset hearing loss need to be analyzed in these patients. We aimed to evaluate the brainstem evoked potential responses in children with microcephaly due to ZIKV congenital syndrome. Four children at ages 1-2.5 years underwent synchronous repeated stimulation of 80 dBNA to analyze the absolute latencies of waves I, III and V and the interpeak latencies I-III, III-V and I-V. The mean absolute wave latencies of children with microcephaly were similar to expected for healthy children of the same age. These wave latencies suggest integrity of the retrocochlear pathway, despite the brainstem hypoplasia. However, a regular follow-up is indicated since there is a risk of late-onset of hearing loss.
C1 [Pereira da Silva, Ozair Argentille; da Silva Miranda, Danielly Carla; Morya, Edgard; de Oliveira Freitas-Junior, Reginaldo Antonio; Lima Nascimento, Manuela Sales] Santos Dumont Inst, ELS IIN, BR-59280000 Macaiba, RN, Brazil.
   [da Silva Miranda, Danielly Carla; Cabral Junior, Francisco das Chagas; de Oliveira Freitas-Junior, Reginaldo Antonio] Santos Dumont Inst RN, Anita Garibaldi Ctr Educ & Hlth Res CEPS, BR-59280970 Macaiba, RN, Brazil.
   [de Oliveira Freitas-Junior, Reginaldo Antonio] Fed Univ Rio Grande Norte UFRN, Dept Tocoginecol, BR-5907897 Natal, RN, Brazil.
RP da Silva, OAP (corresponding author), Santos Dumont Inst, ELS IIN, BR-59280000 Macaiba, RN, Brazil.
EM argentille.ozair@gmail.com; manuela.nascimento@isd.org.br
RI MORYA, EDGARD/R-1251-2019
OI MORYA, EDGARD/0000-0003-0954-5317
FU Santos Dumont Institute; Brazil Ministry of Education (MEC)National
   Health and Medical Research Council of Australia
FX We thank Rogeria Dias, Raquel Justino and Antonelia de Carvalho for
   technical assistance. This work was supported by the Santos Dumont
   Institute and Brazil Ministry of Education (MEC).
CR Abramov DM, 2018, NEUROLOGY, V90, pE606, DOI 10.1212/WNL.0000000000004974
   Angrisani Rosanna Mariangela Giaffredo, 2012, J. Soc. Bras. Fonoaudiol., V24, P162, DOI 10.1590/S2179-64912012000200013
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Costa S.M.B., 1988, PRO-FONO REV ATUAL C, V10, P21
   Costa S.M.B., 1998, REV BRAS OTORRINOLAR, V64, P231
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Esteves Maria Carolina Braga Norte, 2009, Braz. j. otorhinolaryngol., V75, P420, DOI 10.1590/S1808-86942009000300018
   Fernandes L.C.B.C., 2011, REV CEFAC
   Fichino Silvia Nápole, 2007, Rev. Bras. Otorrinolaringol., V73, P251, DOI 10.1590/S0034-72992007000200017
   Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016
   Angrisani RMG, 2013, CODAS, V25, P22, DOI 10.1590/S2317-17822013000100005
   Goderis J, 2014, PEDIATRICS, V134, P972, DOI 10.1542/peds.2014-1173
   Guilhoto LMFF, 2003, ARQ NEURO-PSIQUIAT, V61, P906, DOI 10.1590/S0004-282X2003000600003
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Legatt A.D., 2012, BRAINSTEM AUDITORY E
   Matas Carla Gentile, 2006, Braz J Infect Dis, V10, P264, DOI 10.1590/S1413-86702006000400010
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Ministerio da Saude, 2015, MICR MIN SAUD DIV B
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atencao a Saude, 2017, OR INT VIG AT SAUD A
   Munhoz M.S.L., 2003, AUDIOLOGIA CLIN, P191
   Nance WE, 2006, J CLIN VIROL, V35, P221, DOI 10.1016/j.jcv.2005.09.017
   Pan American Health Organization-WHO, 2015, NEUR SYNDR CONG MALF
   Pass Robert F, 2005, Herpes, V12, P50
   Pialarissi P.R., 1997, INT ARCH OTORHINOLAR, V1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silva Daniela Polo C., 2013, Rev. paul. pediatr., V31, P550, DOI 10.1590/S0103-05822013000400020
   Sleifer P, 2007, INT J PEDIATR OTORHI, V71, P1449, DOI 10.1016/j.ijporl.2007.05.029
   Smiechura Malgorzata, 2014, Otolaryngol Pol, V68, P303, DOI 10.1016/j.otpol.2014.04.003
   Souza L.C.A., 2016, ELETROFISIOLOGIA AUD
   WHO World Health Organization, 2016, MICR
   Yinon Y, 2010, OBSTET GYNECOL SURV, V65, P736, DOI 10.1097/OGX.0b013e31821102b4
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 33
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-981-13-2517-5; 978-981-13-2516-8
J9 IFMBE PROC
PY 2019
VL 70
IS 2
BP 545
EP 549
DI 10.1007/978-981-13-2517-5_82
PG 5
WC Engineering, Biomedical
SC Engineering
GA BO2BH
UT WOS:000505041400082
DA 2020-07-08
ER

PT J
AU Caplivski, D
AF Caplivski, Daniel
TI Zika Virus Infection and Its Devastating Consequences
SO ANNALS OF GLOBAL HEALTH
LA English
DT Editorial Material
C1 [Caplivski, Daniel] Icahn Sch Med Mt Sinai, Div Infect Dis, Travel Med Program, New York, NY 10029 USA.
RP Caplivski, D (corresponding author), Icahn Sch Med Mt Sinai, Div Infect Dis, Travel Med Program, New York, NY 10029 USA.
EM daniel.caplivski@mountsinai.org
NR 0
TC 0
Z9 0
U1 0
U2 0
PU UBIQUITY PRESS LTD
PI LONDON
PA 2N, 6 OSBORNE ST, LONDON, E1 6TD, ENGLAND
SN 2214-9996
J9 ANN GLOB HEALTH
JI Ann. Glob. Health
PY 2019
VL 85
IS 1
DI 10.5334/aogh.2601
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JZ6LP
UT WOS:000505214400002
PM 31468956
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rocha, SGMO
   Correia, LL
   da Cunha, AJLA
   Rocha, HAL
   Leite, AJM
   Campos, JS
   Bandeira, TDPG
   do Nascimento, LS
   Silva, ACE
AF Maia Oliveira Rocha, Sabrina Gabriele
   Correia, Luciano Lima
   Ledo Alves da Cunha, Antonio Jose
   Lima Rocha, Hermano Alexandre
   Madeiro Leite, Alvaro Jorge
   Campos, Jocileide Sales
   Pinheiro Gomes Bandeira, Tereza de Jesus
   do Nascimento, Lucas Silveira
   Cavalcante e Silva, Anamaria
TI Zika Virus Infection and Microcephaly: A Case-Control Study in Brazil
SO ANNALS OF GLOBAL HEALTH
LA English
DT Article
ID RUBELLA; SIZE; RISK
AB Background: Brazil presented an alarming number of newborns with microcephaly in the years 2015 and 2016. The investigation of the cases raised the suspicion of the association of these cases with maternal infections by the zika virus. Also, in 2015, there was an epidemic of zika virus infection in Brazil, reinforcing this hypothesis.
   Objective: The objective of this study was to identify factors associated with the diagnosis of microcephaly in newborns, including zika virus infection.
   Methods: We conducted a case-control study. The cases were defined as children who received clinical and imaging diagnosis of microcephaly, born after October 2015 in Ceara, Brazil, which recorded the highest number of microcephaly cases in Brazil during the outbreak. The cases were identified in medical records of public and private maternity hospitals and in child development stimulation clinics tracked until June 2017. Epidemiological, clinical, and socioeconomic variables were collected, visiting their homes and confirming data from their medical records. Controls were children without microcephaly identified in the vicinity of the residence of each case. Logistic regression models were used to control confounding.
   Findings: We evaluated 58 cases and 116 controls. The odds of having a baby with microcephaly was 14 times higher among mothers who had zika virus infection (p < 0.001), after multivariate analysis. Arboviruses infections symptoms, as fever (p = 0.220), skin change (p < 0.001), and joint pain (p = 0.002) also demonstrated an association with microcephaly.
   Conclusions: Maternal infection zika virus was associated with a diagnosis of microcephaly. Our study contributes to the investigation of the epidemiological factors associated with the diagnosis of microcephaly.
C1 [Maia Oliveira Rocha, Sabrina Gabriele; Correia, Luciano Lima; Lima Rocha, Hermano Alexandre; Madeiro Leite, Alvaro Jorge; do Nascimento, Lucas Silveira] Univ Fed Ceara, Community Hlth Dept, Fortaleza, Ceara, Brazil.
   [Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Lima Rocha, Hermano Alexandre; Campos, Jocileide Sales; Pinheiro Gomes Bandeira, Tereza de Jesus; Cavalcante e Silva, Anamaria] Christus Univ Ctr Unichristus, Fortaleza, Ceara, Brazil.
RP Rocha, HAL (corresponding author), Univ Fed Ceara, Community Hlth Dept, Fortaleza, Ceara, Brazil.; Rocha, HAL (corresponding author), Christus Univ Ctr Unichristus, Fortaleza, Ceara, Brazil.
EM hermano@ufc.br
RI Rocha, Hermano Alexandre Lima/D-4827-2014; Rocha, Hermano/AAL-8574-2020
OI Rocha, Hermano Alexandre Lima/0000-0001-9096-0969; Rocha,
   Hermano/0000-0001-9096-0969
CR Abdel-Salam G, 2000, EPIDEMIOLOGY, V11, P571, DOI 10.1097/00001648-200009000-00013
   [Anonymous], 2016, INF EP N 43 SEM EP S
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Fenig E, 2001, CANCER TREAT REV, V27, P1, DOI 10.1053/ctrv.2000.0193
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   IBGE, 2010, CENS DEM BRAS 2010, P2013
   Ipea P, 2013, ATLAS DESENVOLVIMENT
   IPECE, 2011, CEAR NUM 2011
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   LEONE B N, 1961, Rass Neuropsichiatr, V15, P430
   Leviton A, 2010, EARLY HUM DEV, V86, P515, DOI 10.1016/j.earlhumdev.2010.07.001
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   MACFARLANE DW, 1975, PEDIATRICS, V55, P797
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Ozeki Y, 2010, JPN J OPHTHALMOL, V54, P626, DOI 10.1007/s10384-010-0885-y
   Rocha HAL, 2016, B WORLD HLTH O UNPUB, DOI [10.2471/BLT.16.171215, DOI 10.2471/BLT.16.171215]
   Rodrigues LC, 2016, LANCET INFECT DIS
   Saude MD, 2016, INF EP N 28 SEM EP S
   SEVER LE, 1988, AM J EPIDEMIOL, V127, P226, DOI 10.1093/oxfordjournals.aje.a114799
   TAYLOR JMG, 1986, STAT MED, V5, P29, DOI 10.1002/sim.4780050106
   TOKUGAWA K, 1986, REV INFECT DIS, V8, P874
   Transmissiveis MdSSdVeSDdVdD, 2015, PROT VIG RESP OC MIC
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Wentzel M., 2016, BBC
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Yamamoto A Y, 1999, J Pediatr (Rio J), V75, P23
   Yazigi A, 2016, J MATERN-FETAL NEO M, P1, DOI [10.3109/14767058.2016.1169526, DOI 10.3109/14767058.2016.1169526]
NR 33
TC 0
Z9 0
U1 1
U2 1
PU UBIQUITY PRESS LTD
PI LONDON
PA 2N, 6 OSBORNE ST, LONDON, E1 6TD, ENGLAND
SN 2214-9996
J9 ANN GLOB HEALTH
JI Ann. Glob. Health
PY 2019
VL 85
IS 1
AR UNSP 116
DI 10.5334/aogh.2394
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JZ6LP
UT WOS:000505214400001
PM 31468955
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bonaparte, M
   Zheng, LY
   Garg, S
   Guy, B
   Lustig, Y
   Schwartz, E
   DiazGranados, CA
   Savarino, S
   Ataman-Onal, Y
AF Bonaparte, Matthew
   Zheng, Lingyi
   Garg, Sanjay
   Guy, Bruno
   Lustig, Yaniv
   Schwartz, Eli
   DiazGranados, Carlos A.
   Savarino, Stephen
   Ataman-Onal, Yasemin
TI Evaluation of rapid diagnostic tests and conventional enzyme-linked
   immunosorbent assays to determine prior dengue infection
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Dengue vaccine; CYD-TDV; Dengvaxia; prevaccination screening; serostatus
   testing; cross-reactivity; flavivirus
ID VACCINE; ANTIBODY; SAFETY; TRIAL; IMMUNOGENICITY; CHILDREN; EFFICACY;
   ADULTS
AB Background: In September 2018, the World Health Organization recommended that prevaccination screening be used with the tetravalent dengue vaccine (CYD-TDV), to ensure that only individuals with evidence of prior dengue infection (PDI) are vaccinated. Dengue rapid diagnostic tests (RDTs) would offer a potential solution for prevaccination screening at the point-of-care, but data on performance of available RDTs for identifying PDI are limited. We determined the suitability of four dengue RDTs and two conventional enzyme-linked immunosorbent assays (ELISAs) to identify PDI and evaluated cross-reactivity with co-circulating flaviviruses.
   Methods: Specificity was assessed using 534 dengue-negative [determined by 50% plaque reduction neutralization test (PRNT50)] serum samples from USA (n = 229) and dengue-endemic regions (n = 305). Sensitivity was assessed using 270 samples from recent (n = 90) or remote (n = 90) virologically confirmed prior dengue cases, and dengue PRNT50-positive samples (n = 90). Cross-reactivity was assessed in dengue-seronegative samples that were seropositive for yellow fever (n = 57), Japanese encephalitis (n = 37), West Nile (n = 59) or Zika (n = 41).
   Results: Dengue IgG RDTs and the Panbio ELISA exhibited favourable specificities (99-100%), higher than the Focus ELISA (95%). The RDTs had variable sensitivities (40-70%) that were lower than those of the ELISAs (>= 90%). Cross-reactivity to other flaviviruses was low with RDTs (<= 7%), but more significant with ELISAs (up to 51% for West Nile and 34% for Zika). No cross-reactivity to any of the four closely related flaviviruses was observed with the CTK Biotech RDT. For each SeroTest, sensitivity appeared similar in samples from individuals with recent (<13 months) vs remote (3-4 years) virologically confirmed PDI.
   Conclusions: In general, dengue IgG RDTs were found to be more specific and less cross-reactive than the ELISAs, but the latter were more sensitive for identifying PDI cases. Currently available RDTs could be temporizing tools for rapid and safe prevaccination screening until improved RDTs with increased sensitivity become available.
C1 [Bonaparte, Matthew; Garg, Sanjay] Sanofi Pasteur, Global Clin Immunol, 1 Discovery Dr, Swiftwater, PA 18370 USA.
   [Zheng, Lingyi] Sanofi Pasteur, Global Biostat, 1 Discovery Dr, Swiftwater, PA 18370 USA.
   [Guy, Bruno] Sanofi Pasteur, Global Res, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.
   [Lustig, Yaniv] Israel Minist Hlth, Cha Sheba Med Ctr, Cent Virol Lab, Publ Hlth Serv, IL-52621 Ramat Gan, Israel.
   [Schwartz, Eli] Sheba Med Ctr, Inst Geog Med & Trop Dis, Ramat Gan, Israel.
   [Schwartz, Eli] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   [DiazGranados, Carlos A.] Sanofi Pasteur, Global Clin Sci, 1 Discovery Dr, Swiftwater, PA 18370 USA.
   [Savarino, Stephen] Sanofi Pasteur, Translat Sci & Biomarkers, 1 Discovery Dr, Swiftwater, PA 18370 USA.
   [Ataman-Onal, Yasemin] Sanofi Pasteur, Translat Sci & Biomarkers, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.
RP Ataman-Onal, Y (corresponding author), Sanofi Pasteur, Translat Sci & Biomarkers, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.
EM yasemin.ataman-onal@sanofi.com
FU Sanofi Pasteur
FX This study was funded by Sanofi Pasteur.
CR [Anonymous], 2019, VACCINE, V37, P4848, DOI 10.1016/j.vaccine.2018.09.063
   Arien KK, 2018, LANCET GLOB HEALTH, V6, pE830, DOI 10.1016/S2214-109X(18)30295-X
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057
   Dubey AP, 2016, HUM VACC IMMUNOTHER, V12, P512, DOI 10.1080/21645515.2015.1076598
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Imrie A, 2007, VIRAL IMMUNOL, V20, P672, DOI 10.1089/vim.2007.0050
   Kosack CS, 2017, B WORLD HEALTH ORGAN, V95, P639, DOI 10.2471/BLT.16.187468
   Krishnananthasivam S, 2015, SE ASIAN J TROP MED, V46, P602
   Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18077
   Luo R, 2019, CLIN MICROBIOL INFEC, V25, P659, DOI 10.1016/j.cmi.2019.01.002
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Meersman K, 2016, EURO SURVEILL, V21
   Nascimento EJM, 2018, J VIROL METHODS, V257, P48, DOI 10.1016/j.jviromet.2018.03.007
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   Pal S, 2015, J CLIN MICROBIOL, V53, P1092, DOI 10.1128/JCM.03042-14
   Piedrahita LD, 2016, AM J TROP MED HYG, V95, P315, DOI 10.4269/ajtmh.15-0492
   Plennevaux E, 2018, CLIN INFECT DIS, V66, P1164, DOI 10.1093/cid/cix966
   Plennevaux E, 2016, VACCINE, V34, P2707, DOI 10.1016/j.vaccine.2016.04.028
   Sanchez-Vargas LA, 2014, DIAGN MICR INFEC DIS, V78, P368, DOI 10.1016/j.diagmicrobio.2013.12.019
   Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002
   Schwartz E, 2000, J CLIN VIROL, V19, P169, DOI 10.1016/S1386-6532(00)00114-1
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Tun MMN, 2016, BIORESEARCH OPEN ACC, V5, P188, DOI 10.1089/biores.2016.0016
   Vickers IE, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0164-9
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villar LA, 2013, PEDIATR INFECT DIS J, V32, P1102, DOI 10.1097/INF.0b013e31829b8022
   Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2
   WHO, 2017, INF VACC PROGR GUID
   Wilder-Smith A, 2019, VACCINE, V37, P5137, DOI 10.1016/j.vaccine.2019.07.016
   Wilder-Smith A, 2019, LANCET INFECT DIS, V19, pE31, DOI 10.1016/S1473-3099(18)30494-8
   World Health Organisation, GUID PLAQ RED NEUTR
   World Health Organization, 2018, WKLY EPIDEMIOL REC, V93, P457
NR 34
TC 3
Z9 3
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PY 2019
VL 26
IS 8
AR taz078
DI 10.1093/jtm/taz078
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA JY2RT
UT WOS:000504268600011
PM 31616949
DA 2020-07-08
ER

PT J
AU Vouga, M
   Chiu, YC
   Pomar, L
   de Meyer, SV
   Masmejan, S
   Genton, B
   Musso, D
   Baud, D
   Stojanov, M
AF Vouga, Manon
   Chiu, Yen-Chi
   Pomar, Leo
   de Meyer, Sara V.
   Masmejan, Sophie
   Genton, Blaise
   Musso, Didier
   Baud, David
   Stojanov, Milos
TI Dengue, Zika and chikungunya during pregnancy: pre- and post-travel
   advice and clinical management
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Review
DE Dengue; Chikungunya; Zika; Pregnancy
ID VIRUS-INFECTION; LABORATORY DIAGNOSIS; SEXUAL TRANSMISSION; SYMPTOMATIC
   DENGUE; US TERRITORIES; UNITED-STATES; WOMEN; OUTCOMES; CYTOMEGALOVIRUS;
   FETAL
AB Rationale for review: Young adults of childbearing age and pregnant women are travelling more frequently to tropical areas, exposing them to specific arboviral infections such as dengue, zika and chikungunya viruses, which may impact ongoing and future pregnancies. In this narrative review, we analyse their potential consequences on pregnancy outcomes and discuss current travel recommendations.
   Main findings: Dengue virus may be associated with severe maternal complications, particularly post-partum haemorrhage. Its association with adverse fetal outcomes remains unclear, but prematurity, growth retardation and stillbirths may occur, particularly in cases of severe maternal infection. Zika virus is a teratogenic infectious agent associated with severe brain lesions, with similar risks to other well-known TORCH pathogens. Implications of chikungunya virus in pregnancy are mostly related to intrapartum transmission that may be associated with severe neonatal infections and long-term morbidity.
   Travel recommendations: Few agencies provide specific travel recommendations for travelling pregnant patients or couples trying to conceive and discrepancies exist, particularly regarding Zika virus prevention. The risks significantly depend on epidemiological factors that may be difficult to predict. Prevention relies principally on mosquito control measures. Couples trying to conceive and pregnant women should receive adequate information about the potential risks. It seems reasonable to advise pregnant women to avoid unnecessary travel to Aedes spp. endemic regions. The current rationale to avoid travel and delay conception is debatable in the absence of any epidemic. Post-travel laboratory testing should be reserved for symptomatic patients.
C1 [Vouga, Manon; Chiu, Yen-Chi; Pomar, Leo; de Meyer, Sara V.; Masmejan, Sophie; Baud, David; Stojanov, Milos] Lausanne Univ Hosp CHUV, Dept Woman Mother Child, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Genton, Blaise] Lausanne Univ Hosp CHUV, Travel Med, Lausanne, Switzerland.
   [Musso, Didier] Aix Marseille Univ, AP HM, IHU Mediterranee Infect, IRD,SSA,VITROME, Marseille, France.
RP Stojanov, M (corresponding author), CHU Vaudois, Dept Woman Mother Child, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
EM milos.stojanov@chuv.ch
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Baud, David/0000-0001-9914-6496
FU Department of Obstetrics and Gynecology, Lausanne University Hospital,
   Switzerland; SNSFSwiss National Science Foundation (SNSF)
   [310030-156169/1, 320030-169853/1, 320030-169853/2]; Lausanne
   University; 'Fondation Leenaards' through the 'Bourse pour la releve
   academique'; Fondation Divesa; Loterie Romande
FX This work was supported by the Department of Obstetrics and Gynecology,
   Lausanne University Hospital, Switzerland, and by the SNSF grant numbers
   310030-156169/1, 320030-169853/1 and 320030-169853/2 attributed to David
   Baud. David Baud is also supported by the Lausanne University
   (Interdisciplinary Grant), by the 'Fondation Leenaards' through the
   'Bourse pour la releve academique', by the 'Fondation Divesa' and by the
   'Loterie Romande'.
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   American College of Obstetricians and Gynecologists, 2015, Obstet Gynecol, V125, P1510, DOI 10.1097/01.AOG.0000466430.19823.53
   [Anonymous], 2019, WHO GUID PREV SEX TR
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Basurko C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202005
   Basurko C, 2018, AM J TROP MED HYG, V98, P1826, DOI 10.4269/ajtmh.16-0794
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Bopeththa BVKM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3352-x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRIGHTON SW, 1984, CLIN RHEUMATOL, V3, P253, DOI 10.1007/BF02030766
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Callaghan WM, 2015, OBSTET GYNECOL, V126, P486, DOI 10.1097/AOG.0000000000000996
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CATMAT, 2019, ZIK VIR HLTH PROF
   CATMAT, 2010, ADV COMM STAT ACS CO
   CATMAT, 2019, ZIK VIR PREV TREATM
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2018, CENT DIS CONTROL PRE
   Centers for Disease Control and Prevention, 2018, CHIK VIR PREV, V17
   Centers for Disease Control and Prevention, 2019, SEX TRANSM PREV, V21
   Centers for Disease Control and Prevention, 2019, DENG VIR, V15
   Centers for Disease Control and Prevention, PREGN WOM PREN CAR
   Centers for Disease Control and Prevention, 2019, ZIK VIR HLTH CAR PRO
   Centers for Disease Control and Prevention, ZIK TRAV INF
   Centers for Disease Control and Prevention, 2019, PREGN WOM TEST DIAGN
   Centre de Reference sur les Agents Teratogenes, 2018, REP GROSS ALL
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Chen LH, 2018, J TRAVEL MED, V25, DOI [10.1093/jtm/-tay095, DOI 10.1093/JTM/-TAY095]
   Chen Lin H, 2016, Trop Dis Travel Med Vaccines, V2, P15, DOI 10.1186/s40794-016-0032-y
   Contopoulos-Ioannidis D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006510
   Dalugama Chamara, 2018, J Med Case Rep, V12, P137, DOI 10.1186/s13256-018-1626-y
   de Jong EP, 2011, PRENATAL DIAG, V31, P419, DOI 10.1002/pd.2714
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Desclaux A, 2018, NEW ENGL J MED, V378, P1458, DOI 10.1056/NEJMc1710453
   DeSilva M, 2017, VACCINE, V35, P6472, DOI 10.1016/j.vaccine.2017.01.044
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Duarte Maria do Carmo Menezes Bezerra, 2016, Rev. Bras. Saude Mater. Infant., V16, pS63, DOI 10.1590/1806-9304201600s100006
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eperon Gilles, 2019, Rev Med Suisse, V15, P911
   Escobar M, 2017, EMERG INFECT DIS, V23, P1777, DOI 10.3201/eid2311.170480
   European Centre for Disease Prevention and Control, 2019, ZIK VIR TRANSM WORLD, DOI 10.1002/jts.22439
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Escobar MF, 2020, J MATERN-FETAL NEO M, V33, P2445, DOI 10.1080/14767058.2018.1554044
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226
   Hamer DH, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz012
   Hariyanto Hori, 2016, J Med Case Rep, V10, P357, DOI 10.1186/s13256-016-1129-7
   Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Lalle E, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.18.18-00197
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   LANG DJ, 1974, NEW ENGL J MED, V291, P121, DOI 10.1056/NEJM197407182910303
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lee C, 2019, INFECT DIS-NOR, V51, P150, DOI 10.1080/23744235.2018.1521004
   Leruez-Ville M, 2017, BEST PRACT RES CL OB, V38, P97, DOI 10.1016/j.bpobgyn.2016.10.005
   Levi LI, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7050133
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Luna E, 2018, INT J INFECT DIS, V73, P17, DOI 10.1016/j.ijid.2018.04.3464
   Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Masyeni S, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay061
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molton JS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay023
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Muller DA, 2017, J INFECT DIS, V215, pS89, DOI 10.1093/infdis/jiw649
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nascimento LB, 2017, LANCET INFECT DIS, V17, P949, DOI 10.1016/S1473-3099(17)30169-X
   NaTHNaC, 2016, TRAV HLTH PROPR
   NaTHNaC, 2019, ZIK RISK ASS
   Natrajan MS, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00350-19
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Paixao ES, 2018, EMERG INFECT DIS, V24, P1748, DOI 10.3201/eid2409.170361
   Paixao ES, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28387-w
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Paul BJ, 2018, RHEUMATOL THER, V5, P317, DOI 10.1007/s40744-018-0121-7
   Pomar L, 2018, BMJ K, V4431, P363
   Pomar L, 2019, PRENATAL DIAG, V39, P420, DOI 10.1002/pd.5446
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Public Health England, 2019, ZIK VIR PREV INF SEX
   Public Health England, 2019, ZIK VIR TRAV ADV
   Public Health England, 2019, REV ALG 1 ASS PREGN
   Rajagopala Lavanya, 2017, BMC Res Notes, V10, P79, DOI 10.1186/s13104-017-2391-5
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040
   RIVM, 2018, ZIK VIR
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Sakkas H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030066
   Schaub B, 2017, LANCET CHILD ADOLESC
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Secretaria de Vigilancia em Saude. Ministerio da Saude, 2015, SIT EP OC MICR BRAS, V46, P1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Staples JE, 2017, CDC YELLOW BOOK 2017
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
   Swiss Tropical and Public Health Institue, 2019, ZIK VIR INF REC SWIS
   The royal college of obstetricians and gynecologists, 2018, BJOG INT J OBSTET GY
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uno N, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0168-0
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   Voermans JJC, 2019, EMERG INFECT DIS, V25, P1394, DOI 10.3201/eid2507.182000
   Vouga M, 2018, LANCET, V392, P818, DOI 10.1016/S0140-6736(18)31827-0
   Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   Wilder-Smith A, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay157
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   World Health Organization, 2012, HDB CLIN MAN DENG
   World Health Organization, 2019, ZIK EP UPD
   Yang J, 2017, INFECT DIS-NOR, V49, P315, DOI 10.1080/23744235.2016.1237039
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 149
TC 2
Z9 2
U1 2
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PY 2019
VL 26
IS 8
AR taz077
DI 10.1093/jtm/taz077
PG 13
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA JY2RT
UT WOS:000504268600008
PM 31616923
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Simiao, AR
   Barreto, FKD
   Oliveira, RDAB
   Cavalcante, JW
   Neto, ASL
   Barbosa, RB
   Lins, CD
   Meira, AG
   Araujo, FMD
   Lemos, DRQ
   Alencar, CH
   Cavalcanti, LPD
AF Simiao, Adriana Rocha
   de Almeida Barreto, Francisca Kalline
   Barbosa Oliveira, Rhaquel de Morais Alves
   Cavalcante, John Washington
   Lima Neto, Antonio Silva
   Barbosa, Rebeca Bandeira
   Lins, Camila de Sousa
   Meira, Anna Giulia
   de Carvalho Araujo, Fernanda Montenegro
   Queiroz Lemos, Daniele Rocha
   Alencar, Carlos Henrique
   de Goes Cavalcanti, Luciano Pamplona
TI A major chikungunya epidemic with high mortality in northeastern Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Chikungunya; Outbreak; Arbovirus; Dengue; Zika
ID VIRUS; OUTBREAK; ZIKA
AB Introduction: Chikungunya causes fever and severe and persistent joint pain. Methods: We reported a chikungunya outbreak that occurred in Ceara State, Brazil between 2016 and 2017 with emphasis on epidemiological characterization of cases, high number of deaths, mortality-associated factors, and spatial and temporal spread of the epidemic among municipalities. Results: In November 2015, the first autochthonous cases of chikungunya were confirmed in Ceara, Brazil. In 2016-2017, 195,993 cases were reported, with an incidence of 2,186.5/100,000 inhabitants and 244 confirmed deaths. Conclusions: Rapid transmission and high mortality rate are serious problems, especially in regions with co-circulating arboviruses.
C1 [Simiao, Adriana Rocha; de Almeida Barreto, Francisca Kalline; Barbosa Oliveira, Rhaquel de Morais Alves; Barbosa, Rebeca Bandeira; Lins, Camila de Sousa; Alencar, Carlos Henrique; de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Programa Posgrad Saude Colet, Fortaleza, Ceara, Brazil.
   [Cavalcante, John Washington; Alencar, Carlos Henrique; de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Programa Posgrad Patol, Fortaleza, Ceara, Brazil.
   [Cavalcante, John Washington] Serv Verificacao Obitos Dr Rocha Furtado, Secretaria Saude Estado Ceara, Fortaleza, Ceara, Brazil.
   [Simiao, Adriana Rocha; Queiroz Lemos, Daniele Rocha] Secretaria Saude Estado Ceara, Fortaleza, Ceara, Brazil.
   [Meira, Anna Giulia; de Carvalho Araujo, Fernanda Montenegro; Queiroz Lemos, Daniele Rocha] Ctr Univ Christus, Fac Med, Fortaleza, Ceara, Brazil.
   [de Carvalho Araujo, Fernanda Montenegro] Lab Cent Saude Publ Ceara, Fortaleza, Ceara, Brazil.
   [Lima Neto, Antonio Silva; Lins, Camila de Sousa] Secretaria Saude Municipio Fortaleza, Fortaleza, Ceara, Brazil.
   [Lima Neto, Antonio Silva] Chan Sch Publ Hlth, Boston, MA USA.
RP Cavalcanti, LPD (corresponding author), Univ Fed Ceara, Programa Posgrad Saude Colet, Fortaleza, Ceara, Brazil.; Cavalcanti, LPD (corresponding author), Univ Fed Ceara, Programa Posgrad Patol, Fortaleza, Ceara, Brazil.
EM pamplona.luciano@gmail.com
FU Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico
   (FUNCAP) through the call 01/2017-SUS/PPSUS-CE
   FUNCAPSESA-Decit/SCTIE/MS-CNPq; National Council for Scientific and
   Technological Development (CNPQ) through the call MCTIC/CNPq
   28/2018National Council for Scientific and Technological Development
   (CNPq)
FX LPGC is a class 2 research fellow at the National Council for Scientific
   and Technological Development (CNPq/Brazil). Fundacao Cearense de Apoio
   ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) financially
   supported this study through the call 01/2017-SUS/PPSUS-CE
   FUNCAPSESA-Decit/SCTIE/MS-CNPq and National Council for Scientific and
   Technological Development (CNPQ) through the call MCTIC/CNPq 28/2018.
CR Brasil. Ministerio da Saude, 2019, GUIA VIG SAUD VOL UN
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cavalcanti LPG, 2018, J HLTH BIOL SCI, V6, P65, DOI DOI 10.12662/2317-3076JHBS.V6I1.1415.P65-82.2018
   de la Hoz JM, 2015, J CLIN VIROL, V69, P27, DOI 10.1016/j.jcv.2015.05.021
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Freitas F, 2017, SYM REL DIST SYST, P1, DOI 10.1109/SRDS.2017.9
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   PAHO, 2017, NUMB REP CAS CHIK FE
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   World Health Organization, 2017, CHIK FACT SHEET
NR 15
TC 1
Z9 1
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2019
VL 52
AR e20190266
DI 10.1590/0037-8682-0266-2019
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA JX8ZJ
UT WOS:000504016700001
PM 31596354
OA DOAJ Gold
DA 2020-07-08
ER

PT S
AU Silva, HD
   Braga, RTV
AF Silva, Henrique de Araujo
   Vaccare Braga, Rosana Teresinha
GP IEEE
TI IoT applications to combat Aedes aegypti: a Systematic Literature
   Mapping
SO 2019 IEEE 32ND INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS
   (CBMS)
SE IEEE International Symposium on Computer-Based Medical Systems
LA English
DT Proceedings Paper
CT 32nd IEEE International Symposium on Computer-Based Medical Systems
   (IEEE CBMS)
CY JUN 05-07, 2019
CL Inst Maimonides Investigac Biomedica Cordoba, Cordoba, SPAIN
SP IEEE, IEEE Comp Soc, Univ Campus Bio Medico Roma, Hosp Univ Reina Sofia, Grupo Solutia, Grupo FIBRATEL, Tech Comm Computat Life Sci, IMIBIC
HO Inst Maimonides Investigac Biomedica Cordoba
DE Internet of Things; IoT Applications; Development; Support; Health;
   Disease; Mosquito; Aedes aegypti; Outbreak
ID TECHNOLOGY; DENGUE
AB Dengue, zika and chikungunya are examples of serious diseases affecting mainly developing countries, such as Brazil. Data from the World Health Organization (WHO) about these diseases transmitted by Aedes aegypti mosquito are worrisome, especially in relation to their possible effects. Considering this scenario severity, Internet of Things based applications (IoT applications) are being used to support it. So, this paper aims to select and organize, through information collection, difficulties that can be found in the medical use of IoT applications to combat this mosquito. The objective was to find possible gaps for future research. A Systematic Literature Mapping was performed to find possible deficiencies in the methodologies addressed by the authors of the returned studies. This systematic mapping intends to list these difficulties, as well methods proposed to improve the use of IoT in Health (especially combat to Aedes aegypti). In total, 570 studies were found. When applying the inclusion and exclusion criteria, 22 studies were selected for a full reading, which led to rejection of 15, therefore 07 studies were finally accepted. By analyzing these selected studies, it was possible to observe monitoring of information is essential in dengue combat systems. It was also possible to notice the lack of software reuse initiatives that could make it easier to develop new applications in this domain.
C1 [Silva, Henrique de Araujo; Vaccare Braga, Rosana Teresinha] Univ Sao Paulo, Inst Ciencias Matemat & Comp ICMC, Sao Carlos, SP, Brazil.
RP Silva, HD (corresponding author), Univ Sao Paulo, Inst Ciencias Matemat & Comp ICMC, Sao Carlos, SP, Brazil.
EM henriarasilva@usp.br; rtvb@icmc.usp.br
OI Braga, Rosana/0000-0003-4259-0785
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX We would like to thank CNPq and CAPES for the financial support
CR Amarasinghe A, 2017, PROCEEDINGS OF THE 15TH ACM CONFERENCE ON EMBEDDED NETWORKED SENSOR SYSTEMS (SENSYS'17), DOI 10.1145/3131672.3136986
   Andrade L. H., 2016, P 12 BRAZ S INF SYST, V1, P50
   Botelho A., 2015, ORG HLTH DEV INNNOVA, P279
   Pinochet LHC, 2011, MUNDO SAUDE, V35, P382
   Matthews J, 2012, MOBILE NETW APPL, V17, P178, DOI 10.1007/s11036-011-0295-5
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Petersen K., 2008, P 12 INT C EV ASS SO, P68, DOI DOI 10.1142/S0218194007003112
   Rani S., 2018, IEEE INTERNET THINGS
   Salim ZT, 2017, MICROELECTRON ENG, V179, P83, DOI 10.1016/j.mee.2017.04.016
   Sareen S, 2017, INT J TECHNOL ASSESS, V33, P11, DOI 10.1017/S0266462317000113
   Silva J. S., 2008, HYGEIA REV BRASILEIR, V4
   Souza V. M., 2016, IB C PATT REC, P10
NR 12
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2372-9198
BN 978-1-7281-2286-1
J9 COMP MED SY
PY 2019
BP 696
EP 701
DI 10.1109/CBMS.2019.00141
PG 6
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Engineering, Biomedical
SC Computer Science; Engineering
GA BO1SY
UT WOS:000502356600132
DA 2020-07-08
ER

PT S
AU Stass, R
   Ng, WM
   Kim, YC
   Huiskonen, JT
AF Stass, Robert
   Ng, Weng M.
   Kim, Young Chan
   Huiskonen, Juha T.
BE Rey, FA
TI Structures of enveloped virions determined by cryogenic electron
   microscopy and tomography
SO COMPLEMENTARY STRATEGIES TO UNDERSTAND VIRUS STRUCTURE AND FUNCTION
SE Advances in Virus Research
LA English
DT Review; Book Chapter
ID BORNE ENCEPHALITIS-VIRUS; CRYO-EM STRUCTURES; DENGUE VIRUS;
   INFLUENZA-VIRUS; CRYOELECTRON MICROSCOPY; 3-DIMENSIONAL STRUCTURE;
   LOW-PH; MONOCLONAL-ANTIBODIES; ZIKA VIRUS; EBOLA-VIRUS
AB Enveloped viruses enclose their genomes inside a lipid bilayer which is decorated by membrane proteins that mediate virus entry. These viruses display a wide range of sizes, morphologies and symmetries. Spherical viruses are often isometric and their envelope proteins follow icosahedral symmetry. Filamentous and pleomorphic viruses lack such global symmetry but their surface proteins may display locally ordered assemblies. Determining the structures of enveloped viruses, including the envelope proteins and their protein-protein interactions on the viral surface, is of paramount importance. These structures can reveal how the virions are assembled and released by budding from the infected host cell, how the progeny virions infect new cells by membrane fusion, and how antibodies bind surface epitopes to block infection. In this chapter, we discuss the uses of cryogenic electron microscopy (cryo-EM) in elucidating structures of enveloped virions. Starting from a detailed outline of data collection and processing strategies, we highlight how cryo-EM has been successfully utilized to provide unique insights into enveloped virus entry, assembly, and neutralization.
C1 [Stass, Robert; Ng, Weng M.; Kim, Young Chan; Huiskonen, Juha T.] Univ Oxford, Div Struct Biol, Wellcome Ctr Human Genet, Oxford, England.
   [Huiskonen, Juha T.] Univ Helsinki, Fac Biol & Environm Sci, Helsinki Inst Life Sci HiLIFE, Helsinki, Finland.
   [Huiskonen, Juha T.] Univ Helsinki, Fac Biol & Environm Sci, Res Programme Mol & Integrat Biosci, Helsinki, Finland.
RP Huiskonen, JT (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Ctr Human Genet, Oxford, England.; Huiskonen, JT (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Helsinki Inst Life Sci HiLIFE, Helsinki, Finland.; Huiskonen, JT (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Res Programme Mol & Integrat Biosci, Helsinki, Finland.
EM juha.huiskonen@helsinki.fi
OI Huiskonen, Juha/0000-0002-0348-7323; Ng, Weng Ming/0000-0001-8218-5544;
   Stass, Robert/0000-0002-5224-0036; Kim, Young Chan/0000-0003-2847-9407
CR Abrescia NGA, 2004, NATURE, V432, P68, DOI 10.1038/nature03056
   Abrescia NGA, 2008, MOL CELL, V31, P749, DOI 10.1016/j.molcel.2008.06.026
   ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182
   Battisti AJ, 2012, P NATL ACAD SCI USA, V109, P13996, DOI 10.1073/pnas.1210275109
   Battisti AJ, 2011, J VIROL, V85, P835, DOI 10.1128/JVI.01847-10
   Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500
   Bederka LH, 2014, MBIO, V5, DOI 10.1128/mBio.02063-14
   Beniac D, 2017, SCI REP-UK, V7, DOI 10.1038/srep46374
   Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109
   Bharat TAM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001196
   Bowden TA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003374
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010
   Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143
   BROWN HR, 1987, ARCH VIROL, V94, P163, DOI 10.1007/BF01313735
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   Calder LJ, 2016, NAT STRUCT MOL BIOL, V23, P853, DOI 10.1038/nsmb.3271
   Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107
   Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173
   Castano-Diez D, 2017, J STRUCT BIOL, V197, P135, DOI 10.1016/j.jsb.2016.06.005
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008
   Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967
   Chen LH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07704-x
   Chlanda P, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.50, 10.1038/nmicrobiol.2016.50]
   Cohen-Dvashi H, 2015, J VIROL, V89, P7584, DOI 10.1128/JVI.00651-15
   Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102
   De Colibus L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09451-z
   Dryden KA, 2006, MOL CELL, V22, P843, DOI 10.1016/j.molcel.2006.04.025
   Effantin G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005721
   El Omari K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08728-7
   Fan YX, 2016, INT CONF MANIP MANU, P15, DOI 10.1109/3M-NANO.2016.7824986
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Fontana J, 2013, J VIROL, V87, P5621, DOI 10.1128/JVI.00276-13
   Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2
   Fuzik T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02882-0
   Ge P, 2010, SCIENCE, V327, P689, DOI 10.1126/science.1181766
   Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284
   Gui L, 2015, MBIO, V6, DOI 10.1128/mBio.02393-14
   Guichard P, 2011, J STRUCT BIOL, V176, P32, DOI 10.1016/j.jsb.2011.07.003
   Halldorsson S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02789-2
   Happonen LJ, 2010, J VIROL, V84, P4747, DOI 10.1128/JVI.02156-09
   Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Hasan SS, 2018, CELL REP, V25, P3136, DOI 10.1016/j.celrep.2018.11.067
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hastie KM, 2017, SCIENCE, V356, P923, DOI 10.1126/science.aam7260
   Hetzel U, 2013, J VIROL, V87, P10918, DOI 10.1128/JVI.01123-13
   Huiskonen JT, 2004, NAT STRUCT MOL BIOL, V11, P850, DOI 10.1038/nsmb807
   Huiskonen JT, 2007, J STRUCT BIOL, V158, P156, DOI 10.1016/j.jsb.2006.08.021
   Huiskonen JT, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20170203
   Huiskonen JT, 2014, JOVE-J VIS EXP, DOI 10.3791/51714
   Huiskonen JT, 2010, J VIROL, V84, P4889, DOI 10.1128/JVI.00057-10
   Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08
   HYATT AD, 1993, VIROLOGY, V193, P592, DOI 10.1006/viro.1993.1167
   Ilca SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9843
   Jaalinoja HT, 2007, STRUCTURE, V15, P157, DOI 10.1016/j.str.2006.12.004
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Ke ZL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080446
   Ke ZL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04058-2
   Khayat R, 2010, J VIROL, V84, P9575, DOI 10.1128/JVI.00708-10
   Kielian M, 2014, ANNU REV VIROL, V1, P171, DOI 10.1146/annurev-virology-031413-085521
   Kiss G, 2014, MICROSC MICROANAL, V20, P164, DOI 10.1017/S1431927613013937
   Klose T, 2010, INTERVIROLOGY, V53, P268, DOI 10.1159/000312911
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Laanto E, 2017, P NATL ACAD SCI USA, V114, P8378, DOI 10.1073/pnas.1703834114
   Laurinmaki PA, 2005, STRUCTURE, V13, P1819, DOI 10.1016/j.str.2005.08.020
   Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049
   Li S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005418
   Liljeroos L, 2013, P NATL ACAD SCI USA, V110, P11133, DOI 10.1073/pnas.1309070110
   Liljeroos L, 2011, P NATL ACAD SCI USA, V108, P18085, DOI 10.1073/pnas.1105770108
   Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Loney C, 2009, J VIROL, V83, P8191, DOI 10.1128/JVI.00693-09
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   Long F, 2015, P NATL ACAD SCI USA, V112, P13898, DOI 10.1073/pnas.1515558112
   Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9
   Mattei S, 2016, SCIENCE, V354, P1434, DOI 10.1126/science.aah4972
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Neuman BW, 2006, J VIROL, V80, P7918, DOI 10.1128/JVI.00645-06
   Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298
   Overby AK, 2008, P NATL ACAD SCI USA, V105, P2375, DOI 10.1073/pnas.0708738105
   Park GW, 2011, LETT APPL MICROBIOL, V52, P162, DOI 10.1111/j.1472-765X.2010.02982.x
   Porta J, 2016, J VIROL, V90, P1169, DOI 10.1128/JVI.02364-15
   Porta J, 2014, J VIROL, V88, P9616, DOI 10.1128/JVI.01286-14
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Pryce R, 2019, J VIROL, V93, DOI 10.1128/JVI.01048-18
   Punch EK, 2018, J BIOL CHEM, V293, P9937, DOI 10.1074/jbc.RA118.002494
   Renner M, 2018, NAT IMMUNOL, V19, P1248, DOI 10.1038/s41590-018-0227-7
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rissanen I, 2017, J VIROL, V91, DOI 10.1128/JVI.00378-17
   RUIGROK RWH, 1986, EMBO J, V5, P41, DOI 10.1002/j.1460-2075.1986.tb04175.x
   San Martin C, 2002, NAT STRUCT BIOL, V9, P756, DOI 10.1038/nsb837
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Shankar S, 2016, J VIROL, V90, P6799, DOI 10.1128/JVI.00597-16
   Sherman MB, 2013, J STRUCT BIOL, V181, P223, DOI 10.1016/j.jsb.2012.12.007
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968
   Strauss JD, 2016, J VIROL, V90, P1507, DOI 10.1128/JVI.01880-15
   Subramaniam S, 2007, CURR OPIN STRUC BIOL, V17, P596, DOI 10.1016/j.sbi.2007.09.009
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435
   Sun ZY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14814
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Thompson RF, 2016, METHODS, V100, P3, DOI 10.1016/j.ymeth.2016.02.017
   Tran EEH, 2016, J VIROL, V90, P7618, DOI 10.1128/JVI.00406-16
   Tran EEH, 2014, J VIROL, V88, P10958, DOI 10.1128/JVI.00870-14
   Veesler D, 2013, P NATL ACAD SCI USA, V110, P5504, DOI 10.1073/pnas.1300601110
   Wang JM, 2017, PROTEIN SCI, V26, P122, DOI 10.1002/pro.3060
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang QS, 2016, J INVERTEBR PATHOL, V134, P15, DOI 10.1016/j.jip.2015.12.001
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Wei H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006850
   Welsch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000875
   WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0
   Wirawan M, 2019, STRUCTURE, V27, P253, DOI 10.1016/j.str.2018.10.009
   Wolf M, 2006, ULTRAMICROSCOPY, V106, P376, DOI 10.1016/j.ultramic.2005.11.001
   Xiao C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05824-w
   Xiao C, 2011, CURR OPIN VIROL, V1, P101, DOI 10.1016/j.coviro.2011.06.005
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Xu K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005322
   Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685
   Yan XD, 2005, J VIROL, V79, P9236, DOI 10.1128/JVI.79.14.9236-9243.2005
   Ye YY, 2018, ENVIRON SCI TECHNOL, V52, P7698, DOI 10.1021/acs.est.8b00824
   Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang XZ, 2011, P NATL ACAD SCI USA, V108, P14837, DOI 10.1073/pnas.1107847108
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhong QX, 2016, ENVIRON SCI TECHNOL, V50, P13520, DOI 10.1021/acs.est.6b04170
   Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100
   Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817
NR 148
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0065-3527
BN 978-0-12-818456-1
J9 ADV VIRUS RES
JI Adv.Virus Res.
PY 2019
VL 105
BP 35
EP 71
DI 10.1016/bs.aivir.2019.07.009
PG 37
WC Virology
SC Virology
GA BO1NU
UT WOS:000501594500003
PM 31522708
OA Green Published
DA 2020-07-08
ER

PT B
AU Dietz, L
AF Dietz, Laura
GP ACM
TI ENT Rank: Retrieving Entities for Topical Information Needs through
   Entity-Neighbor-Text Relations
SO PROCEEDINGS OF THE 42ND INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH
   AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR '19)
LA English
DT Proceedings Paper
CT 42nd Annual International ACM SIGIR Conference on Research and
   Development in Information Retrieval (SIGIR)
CY JUL 21-25, 2019
CL Paris, FRANCE
SP Assoc Comp Machinery, ACM Special Interest Grp Informat Retrieval
AB Related work has demonstrated the helpfulness of utilizing information about entities in text retrieval; here we explore the converse: Utilizing information about text in entity retrieval. We model the relevance of Entity-Neighbor-Text (ENT) relations to derive a learning-to-rank-entities model.
   We focus on the task of retrieving (multiple) relevant entities in response to a topical information need such as "Zika fever". The ENT Rank model is designed to exploit semi-structured knowledge resources such as Wikipedia for entity retrieval. The ENT Rank model combines (1) established features of entity-relevance, with (2) information from neighboring entities (co-mentioned or mentioned-on-page) through (3) relevance scores of textual contexts through traditional retrieval models such as BM25 and RM3.
C1 [Dietz, Laura] Univ New Hampshire, Durham, NH 03824 USA.
RP Dietz, L (corresponding author), Univ New Hampshire, Durham, NH 03824 USA.
EM dietz@cs.unh.edu
FU National Science FoundationNational Science Foundation (NSF) [1846017]
FX This material is based upon work supported by the National Science
   Foundation under Grant No. 1846017. Any opinions, findings, and
   conclusions or recommendations expressed in this material are those of
   the author(s) and do not necessarily reflect the views of the National
   Science Foundation.
CR Allan J., 2012, SIGIR FORUM, V46, P2, DOI DOI 10.1145/2215676.2215678
   Balog K, 2011, ACM T INFORM SYST, V29, DOI 10.1145/2037661.2037667
   Balog Krisztian, 2009, TREC
   Balog Krisztian, 2010, SEMSEARCH WORKSH ACM, P9
   Balog Krisztian, 2011, TREC
   Bast Holger, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P671, DOI 10.1145/1277741.1277856
   Bast H., 2015, P 24 ACM INT C INF K, P1431, DOI [DOI 10.1145/2806416.2806472, 10.1145/2806416.2806472]
   Bendersky M., 2010, P 3 ACM INT C WEB SE, P31, DOI DOI 10.1145/1718487.1718492
   Chen J, 2016, SIGIR'16: PROCEEDINGS OF THE 39TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P737, DOI 10.1145/2911451.2914725
   Dalton J., 2014, SIGIR
   Dalton Jeffrey, 2013, P 10 C OP RES AR INF, P149
   Demartini G, 2010, LECT NOTES COMPUT SC, V6203, P254, DOI 10.1007/978-3-642-14556-8_26
   Dietz Laura, 2018, TREC COMPLEX ANSWER
   Dietz Laura, 2018, TREC CAR 2 0 DATA SE
   Ferragina P., 2010, P 19 ACM INT C INF K, DOI [10.1145/1871437.1871689, DOI 10.1145/1871437.1871689]
   Garigliotti D, 2017, ICTIR'17: PROCEEDINGS OF THE 2017 ACM SIGIR INTERNATIONAL CONFERENCE THEORY OF INFORMATION RETRIEVAL, P27, DOI 10.1145/3121050.3121054
   Hasibi F, 2016, P 2016 ACM INT C THE, P209, DOI DOI 10.1145/2970398.2970406
   Hasibi F, 2017, SIGIR'17: PROCEEDINGS OF THE 40TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P1289, DOI 10.1145/3077136.3084149
   Hasibi F, 2017, SIGIR'17: PROCEEDINGS OF THE 40TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P1265, DOI 10.1145/3077136.3080751
   Hasibi Faegheh, 2015, P 2015 INT C THEOR I, P171, DOI DOI 10.1145/2808194.2809473
   Kotov A., 2012, P 5 ACM INT C WEB SE, P403, DOI DOI 10.1145/2124295.2124344
   Lavrenko V., 2001, SIGIR Forum, P120
   Liu XT, 2015, INFORM RETRIEVAL J, V18, P473, DOI 10.1007/s10791-015-9267-x
   Meij E., 2012, P 5 ACM INT C WEB SE, P563, DOI DOI 10.1145/2124295.2124364
   Meij E, 2011, J WEB SEMANT, V9, P418, DOI 10.1016/j.websem.2011.04.001
   Metzler D., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P472
   Nikolaev Fedor, 2016, SIGIR
   Pound J., 2010, P 19 INT C WORLD WID, P771, DOI DOI 10.1145/1772690.1772769
   Raviv H., 2016, SIGIR
   Raviv Hadas, 2012, N AM POW S NAPS, P1
   Schuhmacher M., 2015, P 24 ACM INT C INF K, P1461
   Tong HH, 2006, IEEE DATA MINING, P613
   Tonon Alberto, 2012, SIGIR
   Wang F, 2008, IEEE T KNOWL DATA EN, V20, P55, DOI 10.1109/TKDE.2007.190672
   Xiong CY, 2017, SIGIR'17: PROCEEDINGS OF THE 40TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P763, DOI 10.1145/3077136.3080768
   Zhiltsov N, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P253, DOI 10.1145/2766462.2767756
   Zhou D, 2007, 2007 IEEE NORTH-EAST WORKSHOP ON CIRCUITS AND SYSTEMS, P167, DOI 10.1109/CADCG.2007.4407875
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ASSOC COMPUTING MACHINERY
PI NEW YORK
PA 1515 BROADWAY, NEW YORK, NY 10036-9998 USA
BN 978-1-4503-6172-9
PY 2019
BP 215
EP 224
DI 10.1145/3331184.3331257
PG 10
WC Computer Science, Information Systems; Information Science & Library
   Science
SC Computer Science; Information Science & Library Science
GA BO1LU
UT WOS:000501488900024
DA 2020-07-08
ER

PT J
AU Blohm, GM
   Marquez-Colmenarez, MC
   Lednicky, JA
   Bonny, TS
   Mavian, C
   Salemi, M
   Delgado-Noguera, L
   Morris, JG
   Paniz-Mondolfi, AE
AF Blohm, Gabriela M.
   Marquez-Colmenarez, Marilianna C.
   Lednicky, John A.
   Bonny, Tania S.
   Mavian, Carla
   Salemi, Marco
   Delgado-Noguera, Lourdes
   Morris, John Glenn, Jr.
   Paniz-Mondolfi, Alberto E.
TI Isolation of Mayaro Virus from a Venezuelan Patient with Febrile
   Illness, Arthralgias, and Rash: Further Evidence of Regional Strain
   Circulation and Possible Long-Term Endemicity
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PITYRIASIS ROSEA; ZIKA VIRUS; IQ-TREE; TRANSMISSION; DISEASE; CHILD
AB Fifty-two febrile patients living in Barquisimeto, Venezuela, were screened for arbovirus infection by virus culture during an outbreak of what was thought to be Zika virus infection. We report identification of Mayaro virus (MAYV) on culture of plasma from one patient, an 18-year-old woman with acute febrile illness, arthralgias, and psoriasiform rash. The strain was sequenced and was found to be most closely related to a 1999 strain from French Guiana, which, in turn, was related to two 2014 strains from Haiti. By contrast, previously reported outbreak-related MAYV strains from a sylvatic area approximately 80 miles from where the case patient lived were most closely related to Peruvian isolates. The two strain groups show evidence of having diverged genetically approximately 100 years ago.
C1 [Blohm, Gabriela M.; Lednicky, John A.] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.
   [Blohm, Gabriela M.; Lednicky, John A.; Mavian, Carla; Salemi, Marco; Morris, John Glenn, Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Blohm, Gabriela M.; Marquez-Colmenarez, Marilianna C.; Delgado-Noguera, Lourdes; Paniz-Mondolfi, Alberto E.] Zoonoses & Emerging Pathogens Collaborat Network, Venezuelan Sci Res Incubator, Barquisimeto, Venezuela.
   [Marquez-Colmenarez, Marilianna C.] Univ Centroccidental Lisandro Alvarado, Dept Med, Barquisimeto, Venezuela.
   [Bonny, Tania S.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Mavian, Carla; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA.
   [Morris, John Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA.
   [Paniz-Mondolfi, Alberto E.] Inst Diagnost Barquisimeto IDB, Barquisimeto, Venezuela.
   [Paniz-Mondolfi, Alberto E.] Inst Estudios Avanzados IDEA, Lab Cellular Signaling & Parasite Biochem, Caracas, Venezuela.
RP Morris, JG (corresponding author), Univ Florida, POB 100009, Gainesville, FL 32611 USA.
EM gblohm@ufl.edu; mariliannamarquez@gmail.com; jlednicky@phhp.ufl.edu;
   bonny4190@gmail.com; cmavian@ufl.edu; salemi@pathology.ufl.edu;
   lourdesadelgado01@gmail.com; jgmorris@epi.ufl.edu;
   albertopaniz@yahoo.com
RI Lednicky, John A/C-5678-2012
OI Delgado - Noguera, Lourdes/0000-0003-0910-5434
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI126357]
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Blohm G, 2019, INT J INFECT DIS, V87, P151, DOI 10.1016/j.ijid.2019.07.031
   Blohm GM, 2018, MICROBIOL RESOUR ANN, V6, DOI [10.1128/genomeA.00529-18, 10.1128/genomea.00529-18]
   Blohm GM, 2018, CLIN INFECT DIS, V67, P619, DOI 10.1093/cid/ciy224
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024
   Drago F, 2016, DERMATOLOGY, V232, P431, DOI 10.1159/000445375
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Fry L, 2007, CLIN DERMATOL, V25, P606, DOI 10.1016/j.clindermatol.2007.08.015
   Hall MD, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew003
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Katoh K, 2016, BIOINFORMATICS, V32, P1933, DOI 10.1093/bioinformatics/btw108
   Kumar Ramesh, 2017, Indian Dermatol Online J, V8, P336, DOI 10.4103/idoj.IDOJ_429_16
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li A, 2018, HUM VACC IMMUNOTHER, V14, P1024, DOI 10.1080/21645515.2017.1409928
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   Paniz-Mondolfi AE, 2017, CLIN EXP DERMATOL, V43, P171
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Pinheiro F, 1998, ARBOVIRUSES EPIDEMIO, V3, P137
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Seetharam KA, 2011, J DERMATOL, V38, P1033, DOI 10.1111/j.1346-8138.2011.01200.x
   Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256
   Wiggins K, 2018, MED VET ENTOMOL, V32, P436, DOI 10.1111/mve.12322
   Xia XH, 2018, MOL BIOL EVOL, V35, P1550, DOI 10.1093/molbev/msy073
NR 37
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
IS 6
BP 1219
EP 1225
DI 10.4269/ajtmh.19-0357
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JT4CJ
UT WOS:000500938900010
PM 31595869
DA 2020-07-08
ER

PT J
AU Rana, J
   Campos, JLS
   Poggianella, M
   Burrone, OR
AF Rana, Jyoti
   Campos, Jose Luis Slon
   Poggianella, Monica
   Burrone, Oscar R.
TI Dengue virus capsid anchor modulates the efficiency of polyprotein
   processing and assembly of viral particles
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE dengue virus; capsid anchor; polyprotein processing; viral protease;
   host protease; domain swapping; positive strand RNA virus; Flaviviridae;
   DENV2; pseudovirus production
ID BORNE ENCEPHALITIS-VIRUS; PR-M CLEAVAGE; SIGNAL PEPTIDASE; IN-VITRO;
   LINKED GLYCANS; FLAVIVIRUS; PROTEIN; DETERMINANTS; CONSTRUCTION;
   GLYCOPROTEIN
AB The assembly and secretion of flaviviruses are part of an elegantly regulated process. During maturation, the viral polyprotein undergoes several co- and post-translational cleavages mediated by both viral and host proteases. Among these, sequential cleavage at the N and C termini of the hydrophobic capsid anchor (Ca) is crucial in deciding the fate of viral infection. Here, using a refined dengue pseudovirus production system, along with cleavage and furin inhibition assays, immunoblotting and secondary structure prediction analysis, we show that Ca plays a key role in the processing efficiency of dengue virus type 2 (DENV2) structural proteins and viral particle assembly. Replacement of the DENV2 Ca with the homologous regions from West nile or Zika viruses or, alternatively, increasing its length, improved cleavage and hence particle assembly. Further, we showed that substitution of the Ca conserved proline residue (P110) to alanine abolishes pseudovirus production, regardless of the Ca sequence length. Besides providing the results of a biochemical analysis of DENV2 structural polyprotein processing, this study also presents a system for efficient production of dengue pseudoviruses.
C1 [Rana, Jyoti; Campos, Jose Luis Slon; Poggianella, Monica; Burrone, Oscar R.] ICGEB, Padriciano 99, I-34149 Trieste, Italy.
   [Rana, Jyoti] IUPUI, IU Sch Med, Wells Ctr Pediat Res, Gene & Cell Therapy Grp, Indianapolis, IN 46202 USA.
   [Campos, Jose Luis Slon] Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Med, Roosevelt Dr, Oxford OX3 7BN, England.
RP Rana, J; Burrone, OR (corresponding author), ICGEB, Padriciano 99, I-34149 Trieste, Italy.; Rana, J (corresponding author), IUPUI, IU Sch Med, Wells Ctr Pediat Res, Gene & Cell Therapy Grp, Indianapolis, IN 46202 USA.
EM Jrana@iu.edu; burrone@icgeb.org
RI Rana, Jyoti/AAP-3614-2020
OI Rana, Jyoti/0000-0001-9683-4592
FU ICGEB post-doctoral fellowships
FX J. R. and J. L. S. C. were supported by ICGEB post-doctoral fellowships.
CR AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Bennett KM, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0194-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332
   Goto A, 2005, VACCINE, V23, P3043, DOI 10.1016/j.vaccine.2004.11.068
   Heinz FX, 2003, ADV VIRUS RES, V59, P63, DOI 10.1016/S0065-3527(03)59003-0
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09
   Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10
   Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415
   Paetzel M, 1998, NATURE, V396, P186
   Petris G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096700
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Rana J, 2018, J VIROL, V92, DOI 10.1128/JVI.01174-18
   RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D
   Sambrook J., 1989, MOL CLONING LAB MANU, P1546
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004
   SHAPIRO D, 1972, VIROLOGY, V50, P906, DOI 10.1016/0042-6822(72)90445-X
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   VanBlargan LA, 2015, J VIROL, V89, P8632, DOI 10.1128/JVI.01253-15
   von Heijne G, 1998, NATURE, V396, P111, DOI 10.1038/24036
   Wang CG, 2015, ASIA-PAC J PUBLIC HE, V27, pNP844, DOI 10.1177/1010539513477681
   WENGLER G, 1989, J VIROL, V63, P2521, DOI 10.1128/JVI.63.6.2521-2526.1989
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   Yoshii K, 2008, J GEN VIROL, V89, P200, DOI 10.1099/vir.0.82824-0
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
NR 45
TC 1
Z9 1
U1 2
U2 2
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PY 2019
VL 100
IS 12
BP 1663
EP 1673
DI 10.1099/jgv.0.001346
PG 11
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA JT1RJ
UT WOS:000500774800006
PM 31682219
OA Bronze
DA 2020-07-08
ER

PT J
AU Lum, FM
   Narang, V
   Hue, S
   Chen, J
   McGovern, N
   Rajarethinam, R
   Tan, JJL
   Amrun, SN
   Chan, YH
   Lee, CYP
   Chua, TK
   Yee, WX
   Yeo, NKW
   Tan, TC
   Liu, X
   Haldenby, S
   Leo, YS
   Ginhoux, F
   Chan, JKY
   Hiscox, J
   Chong, CY
   Ng, LFP
AF Lum, Fok-Moon
   Narang, Vipin
   Hue, Susan
   Chen, Jie
   McGovern, Naomi
   Rajarethinam, Ravisankar
   Tan, Jeslin J. L.
   Amrun, Siti Naqiah
   Chan, Yi-Hao
   Lee, Cheryl Y. P.
   Chua, Tze-Kwang
   Yee, Wearn-Xin
   Yeo, Nicholas K. W.
   Tan, Thiam-Chye
   Liu, Xuan
   Haldenby, Sam
   Leo, Yee-sin
   Ginhoux, Florent
   Chan, Jerry K. Y.
   Hiscox, Julian
   Chong, Chia-Yin
   Ng, Lisa F. P.
TI Immunological observations and transcriptomic analysis of
   trimester-specific full-term placentas from three Zika virus-infected
   women
SO CLINICAL & TRANSLATIONAL IMMUNOLOGY
LA English
DT Article
DE histology; infection; placenta; RNA-seq; transcriptomics; Zika virus
ID EXPRESSION; MECHANISMS; PREGNANCY; MARKERS; INDUCE
AB Objectives Effects of Zika virus (ZIKV) infection on placental development during pregnancy are unclear. Methods Full-term placentas from three women, each infected with ZIKV during specific pregnancy trimesters, were harvested for anatomic, immunologic and transcriptomic analysis. Results In this study, each woman exhibited a unique immune response with raised IL-1RA, IP-10, EGF and RANTES expression and neutrophil numbers during the acute infection phase. Although ZIKV NS3 antigens co-localised to placental Hofbauer cells, the placentas showed no anatomic defects. Transcriptomic analysis of samples from the placentas revealed that infection during trimester 1 caused a disparate cellular response centred on differential eIF2 signalling, mitochondrial dysfunction and oxidative phosphorylation. Despite these, the babies were delivered without any congenital anomalies. Conclusion These findings should translate to improve clinical prenatal screening procedures for virus-infected pregnant patients.
C1 [Lum, Fok-Moon; Narang, Vipin; Tan, Jeslin J. L.; Amrun, Siti Naqiah; Chan, Yi-Hao; Lee, Cheryl Y. P.; Chua, Tze-Kwang; Yee, Wearn-Xin; Yeo, Nicholas K. W.; Ginhoux, Florent; Chan, Jerry K. Y.; Hiscox, Julian; Ng, Lisa F. P.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore.
   [Hue, Susan; Rajarethinam, Ravisankar] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.
   [Hue, Susan] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore.
   [Chen, Jie] KK Womens & Childrens Hosp, Singapore, Singapore.
   [McGovern, Naomi] Univ Cambridge, Dept Pathol, Cambridge, England.
   [Chan, Yi-Hao; Lee, Cheryl Y. P.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.
   [Tan, Thiam-Chye] KK Womens & Childrens Hosp, Dept O&G, Singapore, Singapore.
   [Liu, Xuan; Haldenby, Sam] Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Liverpool, Merseyside, England.
   [Liu, Xuan; Hiscox, Julian; Ng, Lisa F. P.] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England.
   [Leo, Yee-sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore.
   [Leo, Yee-sin] Natl Ctr Infect Dis, Singapore, Singapore.
   [Leo, Yee-sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Leo, Yee-sin; Chong, Chia-Yin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore.
   [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore.
   [Chan, Jerry K. Y.] DukeNUS Med Sch, Canc & Stem Cell Program, Singapore, Singapore.
   [Hiscox, Julian; Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Chong, Chia-Yin] KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore.
   [Chong, Chia-Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Chong, Chia-Yin] Duke NUS Med Sch, Grad Med Sch, Singapore, Singapore.
   [Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.
RP Ng, LFP (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
FU Singapore Biomedical Research Council [BMRC]Agency for Science
   Technology & Research (ASTAR); BMRCAgency for Science Technology &
   Research (ASTAR) [15/1/82/27/001, H16/99/b0/011]; Singapore Agency for
   Science, Technology, and Research-led Zika Virus Consortium Fund
   [15/1/82/27/001]; Immunomonitoring Service Platform (ISP) grant
   [NRF2017_SISFP09]; National Institute for Health Research Health
   Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections
   at University of Liverpool; Public Health England (PHE); Liverpool
   School of Tropical Medicine
FX We thank Ivy Low, Seri Mustafah and Anis Larbi (SIgN flow cytometry
   team) and the SIgN Immunomonitoring Group for their assistance. We are
   also grateful to Fatima Yturriaga and Emmerie Wong Phaik Yen of KKH for
   the patient recruitment, Kai-Er Eng and Guillaume Carissimo of SIgN and
   Jessica Tamanini of Insight Editing London for editing the manuscript
   prior to submission. We also thank all study participants for their
   participation in this study. This work was supported by the Singapore
   Biomedical Research Council [BMRC; core research grants to the Singapore
   Immunology Network (SIgN)] and the BMRC and Singapore Agency for
   Science, Technology, and Research-led Zika Virus Consortium Fund
   (project 15/1/82/27/001). SIgN immunomonitoring and flow cytometry
   platforms are supported by the Immunomonitoring Service Platform (ISP)
   grant, NRF2017_SISFP09, and BMRC transition funds #H16/99/b0/011. This
   work was also partly funded by the National Institute for Health
   Research Health Protection Research Unit (NIHR HPRU) in Emerging and
   Zoonotic Infections at University of Liverpool in partnership with
   Public Health England (PHE), in collaboration with Liverpool School of
   Tropical Medicine.
CR Abdallah MW, 2013, WORLD J BIOL PSYCHIA, V14, P528, DOI 10.3109/15622975.2011.639803
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Borjesson DL, 2005, J IMMUNOL, V174, P6364, DOI 10.4049/jimmunol.174.10.6364
   Brasil P, 2016, NEW ENGL J MED, V6, P95
   Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   ESCOFIER B, 1994, COMPUT STAT DATA AN, V18, P121, DOI 10.1016/0167-9473(94)90135-X
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Gaccioli F, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109702
   Giaglis S, 2016, CELL ADHES MIGR, V10, P208, DOI 10.1080/19336918.2016.1148866
   Guerra S, 2004, J VIROL, V78, P5820, DOI 10.1128/JVI.78.11.5820-5834.2004
   Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111
   Hayat M, 2015, CLIN CASE REP, V3, P345, DOI 10.1002/ccr3.105
   Holland O, 2017, PLACENTA, V54, P2, DOI 10.1016/j.placenta.2016.12.012
   Hoover SE, 2006, J VIROL, V80, P3459, DOI 10.1128/JVI.80.7.3459-3468.2006
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kacerovsky M, 2015, J MATERN-FETAL NEO M, V28, P1250, DOI 10.3109/14767058.2014.951628
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kang JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132955
   Kawai Y, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007387
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   Li J, 2019, ISCIENCE, V16, P468, DOI 10.1016/j.isci.2019.06.008
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Park Chan-Wook, 2013, Obstet Gynecol Sci, V56, P167, DOI 10.5468/ogs.2013.56.3.167
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P821, DOI 10.1016/0002-9378(91)90423-O
   Sappenfield Elisabeth, 2013, Infect Dis Obstet Gynecol, V2013, P752852, DOI 10.1155/2013/752852
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Shaily S, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2050
   Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.2
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130
   Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360
   Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870
   Xu Y, 2020, AUTOPHAGY, V16, P3, DOI 10.1080/15548627.2019.1603547
   Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193
   Zhang LL, 2018, AUTOPHAGY, V14, P1665, DOI 10.1080/15548627.2018.1466014
NR 50
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2050-0068
J9 CLIN TRANSL IMMUNOL
JI Clin. Transl. Immunol.
PY 2019
VL 8
IS 11
AR e01082
DI 10.1002/cti2.1082
PG 15
WC Immunology
SC Immunology
GA JS0IM
UT WOS:000499997800009
PM 31709049
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lundie, RJ
   Helbig, KJ
   Pearson, JS
   Fairfax, KA
AF Lundie, Rachel J.
   Helbig, Karla J.
   Pearson, Jaclyn S.
   Fairfax, Kirsten A.
TI Fluorescent antibiotics, vomocytosis, vaccine candidates and the
   inflammasome
SO CLINICAL & TRANSLATIONAL IMMUNOLOGY
LA English
DT Editorial Material
ID LISTERIA-MONOCYTOGENES; PROTECTION; MALARIA
AB This article summarises recent advances reported at the 9th Lorne Infection and Immunity Conference. This exciting conference hosted speakers in the fields of innate and adaptive responses to infection including host-pathogen interactions as well as novel strategies for the detection, control and treatment of infectious diseases such as fluorescent antibiotics and vaccine development. Host-pathogen studies focused on a broad range of pathogens including malaria, CMV, influenza, dengue and Zika viruses, listeria and tuberculosis.
C1 [Lundie, Rachel J.; Fairfax, Kirsten A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.
   [Helbig, Karla J.] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia.
   [Pearson, Jaclyn S.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia.
   [Fairfax, Kirsten A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.
   [Fairfax, Kirsten A.] Univ Tasmania, Menzies Res Inst Tasmania, Sch Med, Hobart, Tas 7000, Australia.
RP Fairfax, KA (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Sch Med, Hobart, Tas 7000, Australia.
EM kirsten.fairfax@utas.edu.au
OI Pearson, Jaclyn/0000-0002-7358-4479; Fairfax,
   Kirsten/0000-0002-8394-137X
FU Independent Research Institute Infrastructure Support Scheme grant from
   the NHMRCNational Health and Medical Research Council of Australia
   [361646]; NHMRCNational Health and Medical Research Council of Australia
   [1048087, 1113577]; ACRF; Victorian State Government Operational
   Infrastructure Support; CSL; National Health and Medical Research
   Council (NHMRC) of Australia Career Development FellowshipNational
   Health and Medical Research Council of Australia; Maddie Riewoldt's
   Vision - Alex Gadomski Fellowship
FX Many thanks go to Rebecca Smith and Gabrielle Belz for proofreading and
   comment on the article. This work was supported by the Independent
   Research Institute Infrastructure Support Scheme grant (361646) from the
   NHMRC; attendance at the conference was supported by NHMRC project grant
   (1048087) and NHMRC programme grant (1113577); funding from the ACRF;
   funding from the Victorian State Government Operational Infrastructure
   Support; and funding from CSL. JSP is supported by the National Health
   and Medical Research Council (NHMRC) of Australia Career Development
   Fellowship. KAF is supported by the Maddie Riewoldt's Vision - Alex
   Gadomski Fellowship.
CR BARCLAY W R, 1970, Infection and Immunity, V2, P574
   Buchman A, 2019, P NATL ACAD SCI USA, V116, P3656, DOI 10.1073/pnas.1810771116
   COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989
   Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548
   Gilbert AS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700898
   Gruszczyk J, 2018, NATURE, V559, P135, DOI 10.1038/s41586-018-0249-1
   Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006
   Malet JK, 2018, MOL CELL PROTEOMICS, V17, P1627, DOI 10.1074/mcp.RA118.000767
   Pawliw R, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2435-x
   Quereda JJ, 2017, GUT MICROBES, V8, P384, DOI 10.1080/19490976.2017.1290759
   Radoshevich L, 2018, NAT REV MICROBIOL, V16, P32, DOI 10.1038/nrmicro.2017.126
   Rey FA, 2018, CELL, V172, P1319, DOI 10.1016/j.cell.2018.02.054
   Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800
   Seoane P. I., 2019, VIRAL INFECT ENHANCE, DOI [10.1101/512293, DOI 10.1101/512293]
   Sharpe S, 2016, TUBERCULOSIS, V101, P174, DOI 10.1016/j.tube.2016.09.004
   Stern L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01672
   Stone MRL, 2018, TRENDS BIOTECHNOL, V36, P523, DOI 10.1016/j.tibtech.2018.01.004
   Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053
   Vince JE, 2018, CELL REP, V25, P2339, DOI 10.1016/j.celrep.2018.10.103
   WHO, 2019, 10 THREATS GLOB HLTH
   Wong W, 2019, NATURE, V565, P118, DOI 10.1038/s41586-018-0779-6
NR 21
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2050-0068
J9 CLIN TRANSL IMMUNOL
JI Clin. Transl. Immunol.
PY 2019
VL 8
IS 11
AR e01083
DI 10.1002/cti2.1083
PG 5
WC Immunology
SC Immunology
GA JS0IM
UT WOS:000499997800007
PM 31700626
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maniero, VC
   Rangel, PSC
   Coelho, LMC
   Silva, CSB
   Aguiar, RS
   Lamas, CC
   Cardozo, SV
AF Maniero, V. C.
   Rangel, P. S. C.
   Coelho, L. M. C.
   Silva, C. S. B.
   Aguiar, R. S.
   Lamas, C. C.
   Cardozo, S., V
TI Identification of Zika virus in immature phases of Aedes aegypti and
   Aedes albopictus: a surveillance strategy for outbreak anticipation
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Zika virus; Aedes aegypti; Aedes albopictus; Arbovirus; Georeferencing;
   Xenomonitoring
ID DENGUE VIRUSES; VERTICAL TRANSMISSION; MOSQUITOS; CHIKUNGUNYA;
   INFECTION; BRAZIL
AB A progressive increase in the circulation of arboviruses in tropical countries has been observed, accounting for 700,000 yearly deaths in the world. The main objective of this article was to identify the presence of Zika (ZIKV), dengue (DENV), and Chikungunya (CHIKV) viruses in immature stages of Aedes aegypti and Ae. albopictus. Household collections of immature phases of the vectors were carried out in the years 2015 and 2016. A total of 2902 dwellings were visited and the rate of infestation with larvae and pupae of Aedes mosquitoes was 283/1462 (19.4%) in March 2015 and 55/1440 (3.8%) in June 2015. In March 2015, 907 larvae/pupae were collected (583 or 64.3% of Ae. aegypti and 324 or 35.7% of Ae. albopictus) while in June 2015 there was a reduction in the number of immature forms found: 197 larvae/pupae (121 or 61.4% of Ae. aegypti and 76 or 38.6% of Ae. albopictus). This reduction was accompanied by a decrease in suspected human ZIKV cases from March to June 2015. The RT-qPCR performed in 18 pools identified that three (two of Ae. aegypti and one of Ae. albopictus) were positive for ZIKV, and none were positive for DENV or CHIKV. Our findings demonstrated that ZIKV was present in immature stages of insect vectors in the study region at least five months prior to the peak of ZIKV associated cases. Xenomonitoring of immature phases of the vectors may prove useful for predicting outbreaks.
C1 [Maniero, V. C.; Lamas, C. C.; Cardozo, S., V] Univ Grande Rio, Dept Saude, Programa Posgrad Biomed Translac, Duque De Caxias, RJ, Brazil.
   [Rangel, P. S. C.] Univ Grande Rio, Fac Med Vet, Dept Saude, Duque De Caxias, RJ, Brazil.
   [Coelho, L. M. C.] Univ Grande Rio, Fac Med, Dept Saude, Duque De Caxias, RJ, Brazil.
   [Silva, C. S. B.; Aguiar, R. S.] Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Mol, Rio De Janeiro, RJ, Brazil.
   [Lamas, C. C.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.
   [Lamas, C. C.] Inst Nacl Cardiol, Rio De Janeiro, RJ, Brazil.
RP Cardozo, SV (corresponding author), Univ Grande Rio, Dept Saude, Programa Posgrad Biomed Translac, Duque De Caxias, RJ, Brazil.
EM sergianvc@unigranrio.edu.br
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717; Lamas,
   Cristiane/0000-0002-5561-999X; Cardozo, Sergian/0000-0003-2990-7936;
   Salgado Benvindo da Silva, Clarisse/0000-0002-2244-7992
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [114133/2016-6, 124429/2017-3]; Fundacao de Amparo a Pesquisa no
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E26/201.772/2015]
FX We thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq, Grant Nos. 114133/2016-6 and 124429/2017-3) and Fundacao de
   Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ, Grant No.
   E26/201.772/2015). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BRASIL, 2018, B EPIDEMIOLOGICO, V49, P1, DOI DOI 10.1111/are.13485
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2013, LEV RAP IND AED AEG
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chompoosri J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1505-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   CRUZ LCT, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   da Costa CA, 2009, REV SOC BRAS MED TRO, V42, P677, DOI 10.1590/S0037-86822009000600013
   da Silva NM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300003, 10.5123/s1679-49742018000300003]
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Joyce AL, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3226-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Miagostovich MP, 1997, MEM I OSWALDO CRUZ, V92, P595, DOI 10.1590/S0074-02761997000500006
   MULLA MS, 1982, APPL ENVIRON MICROB, V43, P1288, DOI 10.1128/AEM.43.6.1288-1293.1982
   PAHO/WHO (Pan American Health Organization/World Health Organization), 2016, ZIK VIR DET AED ALB
   Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Romero-Vivas CME, 1998, MED VET ENTOMOL, V12, P284, DOI 10.1046/j.1365-2915.1998.00117.x
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   World Health Organization, 2017, INT NEGL TROP DIS GL
   Zeidler Julianna Dias, 2008, Rev. Saúde Pública, V42, P986, DOI 10.1590/s0034-89102008000600002
NR 37
TC 1
Z9 1
U1 1
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2019
VL 52
IS 11
AR e8339
DI 10.1590/1414-431X20198339
PG 8
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA JO0ZR
UT WOS:000497315700001
PM 31721902
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vazeille, M
   Madec, Y
   Mousson, L
   Bellone, R
   Barre-Cardi, H
   Sousa, CA
   Jiolle, D
   Yebakima, A
   de Lamballerie, X
   Failloux, AB
AF Vazeille, Marie
   Madec, Yoann
   Mousson, Laurence
   Bellone, Rachel
   Barre-Cardi, Helene
   Sousa, Carla Alexandra
   Jiolle, Davy
   Yebakima, Andre
   de Lamballerie, Xavier
   Failloux, Anna-Bella
TI Zika virus threshold determines transmission by European Aedes
   albopictus mosquitoes
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Zika; epidemic potential; arbovirus; Aedes albopictus; Europe
ID OUTBREAK; SUSCEPTIBILITY
AB Since its emergence in Yap Island in 2007, Zika virus (ZIKV) has affected all continents except Europe. Despite the hundreds of cases imported to European countries from ZIKV-infested regions, no local cases have been reported in localities where the ZIKV-competent mosquito Aedes albopictus is well established. Here we analysed the vector competence of European Aedes (aegypti and albopictus) mosquitoes to different genotypes of ZIKV. We demonstrate that Ae. albopictus from France was less susceptible to the Asian ZIKV than to the African ZIKV. Critically we show that effective crossing of anatomical barriers (midgut and salivary glands) after an infectious blood meal depends on a viral load threshold to trigger: (i) viral dissemination from the midgut to infect mosquito internal organs and (ii) viral transmission from the saliva to infect a vertebrate host. A viral load in body >= 4800 viral copies triggered dissemination and >= 12,000 viral copies set out transmission. Only 27.3% and 18.2% of Ae. albopictus Montpellier mosquitoes meet respectively these two criteria. Collectively, these compelling results stress the poor ability of Ae. albopictus to sustain a local transmission of ZIKV in Europe and provide a promising tool to evaluate the risk of ZIKV transmission in future outbreaks.
C1 [Vazeille, Marie; Mousson, Laurence; Bellone, Rachel; Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
   [Madec, Yoann] Inst Pasteur, Dept Infect & Epidemiol, Emerging Dis Epidemiol, Paris, France.
   [Barre-Cardi, Helene] Observ Conservatoire Insectes Corse, Off Environm Corse, Corte, France.
   [Sousa, Carla Alexandra] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal.
   [Jiolle, Davy] IRD, UMR MIVEGEC IRD CNRS UM 224 5290, Malad Infect & Vecteurs Ecol Genet Evolut & Contr, Montpellier, France.
   [Yebakima, Andre] VECCOTRA, Riviere Salee, Martinique, France.
   [de Lamballerie, Xavier] Aix Marseille Univ, UVE, IHU Mediterranee Infect, Marseille, France.
RP Failloux, AB (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
EM anna-bella.failloux@pasteur.fr
OI FAILLOUX, Anna-Bella/0000-0001-6890-0820
FU European Union's Horizon 2020 research and innovation program under
   ZIKAlliance [734548]; French Government's Investissement d'Avenir
   program, Laboratoire d'Excellence "Integrative Biology of Emerging
   Infectious Diseases"French National Research Agency (ANR)
   [ANR-10-LABX-62-IBEID]; European UnionEuropean Union (EU) [731060,
   653316]
FX This study was supported by the European Union's Horizon 2020 research
   and innovation program (10.13039/501100007601/) under ZIKAlliance grant
   agreement no. 734548. It was partly funded by the French Government's
   Investissement d'Avenir program, Laboratoire d'Excellence "Integrative
   Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID,
   10.13039/501100001665 to A-BF), the European Union's Horizon 2020
   research and innovation program under grant agreement no. 731060
   (Infravec2, Research Infrastructures for the control of vector-borne
   diseases; http://infravec2.eu/), and the European Union's Horizon 2020
   research and innovation program under EVAg grant agreement no. 653316
   (https://www.european-virus-archive.com/).
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   BRES P., 1963, BULL SOC PATHOL EXOTIQUE, V56, P384
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dalla Pozza G., 1992, Journal of the American Mosquito Control Association, V8, P318
   Delaunay P, 2009, ARCH PEDIATRIE, V16, pS66, DOI 10.1016/S0929-693X(09)75304-7
   DELISLE E, 2015, EUROSURVEILLANCE, V20, P17
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gonzalez MA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3359-1
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lord CC, 2006, J MED ENTOMOL, V43, P623, DOI 10.1603/0022-2585(2006)43[623:RBHVAV]2.0.CO;2
   Margarita Y, 2006, ACTA PARASITOL, V1, P59
   Mogling R, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.36.30609
   Ogunrinade A, 1980, Afr J Med Med Sci, V9, P69
   Piorkowski G., 2016, New Microbes and New Infections, V11, P52, DOI 10.1016/j.nmni.2016.02.013
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Seixas G, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3081-4
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sousa CA, 2012, EUROSURVEILLANCE, V17, DOI DOI 10.2807/ESE.17.49.20333-EN
   Spiteri G, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.41.17-00254
   Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008
   Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 37
TC 2
Z9 2
U1 1
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JAN 1
PY 2019
VL 8
IS 1
BP 1668
EP 1678
DI 10.1080/22221751.2019.1689797
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA JN5QL
UT WOS:000496952700001
PM 31735122
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Del Carpio-Orantes, L
   Sanchez-Diaz, JS
AF Del Carpio-Orantes, Luis
   Sanchez-Diaz, Jesus Salvador
TI Guillain-Barre Syndrome, Before and After Zika
SO JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE
LA English
DT Letter
C1 [Del Carpio-Orantes, Luis; Sanchez-Diaz, Jesus Salvador] Mexican Inst Social Secur, Delegat Veracruz North, Dept Internal Med & Crit Med, Xalapa, Veracruz, Mexico.
RP Del Carpio-Orantes, L (corresponding author), Inst Mexicano Seguro Social, Alley 12 Octubre 603, Xalapa 91900, Veracruz, Mexico.
EM neurona23@hotmail.com
RI Del Carpio-Orantes, Luis/H-6745-2017
OI Del Carpio-Orantes, Luis/0000-0003-2436-5744
CR Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Del Carpio-Orantes Luis, 2016, Rev Med Inst Mex Seguro Soc, V54, P540
   del Carpio-Orantes Luis, 2016, Rev Med Inst Mex Seguro Soc, V54, P278
   Dias IKR, 2018, REV SOC BRAS MED TRO, V51, P261, DOI 10.1590/0037-8682-0130-2018
   Secretaria de Salud, 2016, DIAGNOSTICO TRATAMIE
NR 5
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0976-3147
EI 0976-3155
J9 J NEUROSCI RURAL PRA
JI J. Neurosci. Rural Pract.
PY 2019
VL 10
IS 3
BP 567
EP 568
DI 10.1055/s-0039-1697564
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA JL7UD
UT WOS:000495733700042
PM 31602158
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodriguez, AK
   Munoz, AL
   Segura, NA
   Rangel, HR
   Bello, F
AF Karely Rodriguez, Anny
   Luisa Munoz, Ana
   Alexandra Segura, Nidya
   Rafael Rangel, Hector
   Bello, Felio
TI MOLECULAR CHARACTERISTICS AND REPLICATION MECHANISM OF DENGUE, ZIKA AND
   CHIKUNGUNYA ARBOVIRUSES, AND THEIR TREATMENTS WITH NATURAL EXTRACTS FROM
   PLANTS: AN UPDATED REVIEW
SO EXCLI JOURNAL
LA English
DT Review
DE Dengue virus; Zika virus; Chikungunya virus; viral replication; viruses
   biology; natural extracts
ID VIRUS-REPLICATION; RNA-SYNTHESIS; ALPHAVIRUS REPLICATION; VIRAL
   REPLICATION; ENVELOPE PROTEINS; INHIBITS ZIKA; NS4B PROTEINS;
   AEDES-AEGYPTI; FLAVIVIRUS; PATHOGENESIS
AB Viruses transmitted by arthropods (arboviruses) are the etiological agents of several human diseases with worldwide distribution; including dengue (DENV), zika (ZIKV), yellow fever (YFV), and chikungunya (CHIKV) viruses. These viruses are especially important in tropical and subtropical regions; where, ZIKV and CHIKV are involved in epidemics worldwide, while the DENV remains as the biggest problem in public health. Factors, such as, environmental conditions promote the distribution of vectors, deficiencies in health services, and lack of effective vaccines, guarantee the presence of these vector-borne diseases. Treatment against these viral diseases is only palliative since available therapies formulated lack to demonstrate specific antiviral activity and vaccine candidates fail to demonstrate enough effectiveness. The use of natural products, as therapeutic tools, is an ancestral practice in different cultures. According to WHO 80 % of the population of some countries from Africa and Asia depend on the use of traditional medicines to deal with some diseases. Molecular characteristics of these viruses are important in determining its cellular pathogenesis, emergence, and dispersion mechanisms, as well as for the development of new antivirals and vaccines to control strategies. In this review, we summarize the current knowledge of the molecular structure and replication mechanisms of selected arboviruses, as well as their mechanism of entry into host cells, and a brief overview about the potential targets accessed to inhibit these viruses in vitro and a summary about their treatment with natural extracts from plants.
C1 [Karely Rodriguez, Anny; Luisa Munoz, Ana] UAN, Fac Sci, Bogota 110231, Colombia.
   [Alexandra Segura, Nidya] Univ Pedag & Tecnol Colombia, Fac Sci, Tunja 150003, Colombia.
   [Rafael Rangel, Hector] Inst Venezolano Invest Cient, Lab Mol Virol, Caracas 1204, Venezuela.
   [Bello, Felio] Univ La Salle, Program Vet Med, Fac Agr & Livestock Sci, Bogota 110131, Colombia.
RP Rodriguez, AK (corresponding author), UAN, Fac Sci, Bogota 110231, Colombia.; Bello, F (corresponding author), Univ La Salle, Program Vet Med, Fac Agr & Livestock Sci, Bogota 110131, Colombia.
EM akrodrig@uan.edu.co; felbello@unisalle.edu.co
RI segura, alexandra/J-2783-2016; Rangel, Hector/E-5575-2010
OI segura, alexandra/0000-0001-5810-4847; Rangel,
   Hector/0000-0001-5937-9690
FU Vice-rectory of Science Technology and Research (VCTI) of the
   Universidad Antonio Narino [2017230]; ColcienciasDepartamento
   Administrativo de Ciencia, Tecnologia e Innovacion Colciencias
   [124380664546, 325672553402]
FX The authors would like to thank Vice-rectory of Science Technology and
   Research (VCTI) of the Universidad Antonio Narino (research grant
   #2017230) and Colciencias (research grant cod. 124380664546 and research
   grant cod. 325672553402).
CR Abd Kadir SL, 2013, J NAT MED-TOKYO, V67, P677, DOI 10.1007/s11418-013-0767-y
   Abu Bakar F, 2018, VIRUSES, V10, pE71
   Alayli F, 2016, VIROLOGY, V496, P227, DOI 10.1016/j.virol.2016.06.008
   Allard PM, 2011, J NAT PROD, V74, P2446, DOI 10.1021/np200715v
   ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Baronti C, 2010, VIROLOGY, V404, P319, DOI 10.1016/j.virol.2010.05.020
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   BARTON DJ, 1991, J VIROL, V65, P1496, DOI 10.1128/JVI.65.3.1496-1506.1991
   Bautista-Reyes E, 2017, REV INVEST CLIN, V69, P299, DOI 10.24875/RIC.17002029
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blitvich BJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060154
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brand C, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1437
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Chen HR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0462-0
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Oliveira AFCD, 2017, MOLECULES, V22, DOI 10.3390/molecules22030505
   Douam F, 2018, TRENDS MICROBIOL, V26, P913, DOI 10.1016/j.tim.2018.05.012
   DYER O, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5759
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   Ganesan VK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120368
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gotte B, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030105
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Higuera A, 2019, ACTA TROP, V190, P99, DOI 10.1016/j.actatropica.2018.11.010
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]
   Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12
   Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004
   Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009
   Khan M, 2010, J MED VIROL, V82, P817, DOI 10.1002/jmv.21663
   Kiat TS, 2006, BIOORG MED CHEM LETT, V16, P3337, DOI 10.1016/j.bmcl.2005.12.075
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Litvoc MN, 2018, REV ASSOC MED BRAS, V64, P106, DOI 10.1590/1806-9282.64.02.106
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Malisheni M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00863
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Figueiredo LTM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00259
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Mutso M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050226
   Natarajan S, 2010, GENET MOL BIOL, V33, P214, DOI 10.1590/S1415-47572010000200002
   Nemesio H, 2012, BBA-BIOMEMBRANES, V1818, P2818, DOI 10.1016/j.bbamem.2012.06.022
   PAHO-CHA-IR, 2016, VECT BORN DIS VBD RE
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pietla MK, 2017, VIRUS RES, V234, P44, DOI 10.1016/j.virusres.2017.01.007
   Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Prompetchara E, 2019, ASIAN PACIFIC J ALLE
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Rana J, 2017, ACTA VIROL, V61, P39, DOI 10.4149/av_2017_01_39
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Sharma R, 2018, VIROLOGY, V515, P223, DOI 10.1016/j.virol.2017.12.020
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shin G, 2012, P NATL ACAD SCI USA, V109, P16534, DOI 10.1073/pnas.1210418109
   SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Silva LA, 2014, J VIROL, V88, P2385, DOI 10.1128/JVI.03116-13
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Sjoberg M, 2011, J VIROL, V85, P5644, DOI 10.1128/JVI.00130-11
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tambonis T, 2017, BIORXIV
   Taylor A, 2017, MBIO, V8, DOI 10.1128/mBio.01970-16
   Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tomar S, 2006, J VIROL, V80, P9962, DOI 10.1128/JVI.01067-06
   Torres JR, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8045435
   Uno N, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0168-0
   Volk DE, 2007, VIROLOGY, V364, P147, DOI 10.1016/j.virol.2007.02.023
   Volk DE, 2009, VIROLOGY, V394, P12, DOI 10.1016/j.virol.2009.09.001
   Vu DM, 2017, CLIN LAB MED, V37, P371, DOI 10.1016/j.cll.2017.01.008
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   Wang HY, 2017, SCI CHINA LIFE SCI, V60, P1403, DOI 10.1007/s11427-017-9238-8
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weger-Lucarelli J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002970
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Yap ML, 2017, P NATL ACAD SCI USA, V114, P13703, DOI 10.1073/pnas.1713166114
   Yap SSL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01415
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 104
TC 1
Z9 1
U1 1
U2 1
PU EXCLI JOURNAL MANAGING OFFICE
PI DORTMUND
PA LEIBNIZ RESEARCH CENTRE WORKING ENVIRONMENT & HUMAN FACTORS EXCLI
   JOURNAL, ARDEYSTR 67, DORTMUND, D-44139, GERMANY
SN 1611-2156
J9 EXCLI J
JI EXCLI J.
PY 2019
VL 18
BP 988
EP 1006
DI 10.17179/excli2019-1825
PG 19
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA JJ7LA
UT WOS:000494333600001
PM 31762724
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dibo, M
   Battocchio, EC
   Souza, LMD
   da Silva, MDV
   Banin-Hirata, BK
   Sapla, MMM
   Marinello, P
   Rocha, SPD
   Faccin-Galhardi, LC
AF Dibo, Miriam
   Battocchio, Eduardo C.
   dos Santos Souza, Lucas M.
   Veloso da Silva, Matheus D.
   Banin-Hirata, Bruna K.
   Sapla, Milena M. M.
   Marinello, Poliana
   Rocha, Sergio P. D.
   Faccin-Galhardi, Ligia C.
TI Antibody Therapy for the Control of Viral Diseases: An Update
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Review
DE Immunotherapy; monoclonal antibodies; viral diseases; treatment;
   emerging viruses; immunotherapeutics
ID HUMAN MONOCLONAL-ANTIBODIES; DENGUE VIRUS; LIVER-TRANSPLANTATION;
   BISPECIFIC ANTIBODIES; ZIKA VIRUS; BINDING; SAFETY; CELLS; GLYCOPROTEIN;
   COMBINATION
AB The epidemiological impact of viral diseases, combined with the emergence and re-emergence of some viruses, and the difficulties in identifying effective therapies, have encouraged several studies to develop new therapeutic strategies for viral infections. In this context, the use of immunotherapy for the treatment of viral diseases is increasing. One of the strategies of immunotherapy is the use of antibodies, particularly the monoclonal antibodies (mAbs) and multi-specific antibodies, which bind directly to the viral antigen and bring about activation of the immune system. With current advancements in science and technology, several such antibodies are being tested, and some are already approved and are undergoing clinical trials. The present work aims to review the status of mAb development for the treatment of viral diseases.
C1 [Dibo, Miriam; Battocchio, Eduardo C.; dos Santos Souza, Lucas M.; Veloso da Silva, Matheus D.; Rocha, Sergio P. D.; Faccin-Galhardi, Ligia C.] Univ Estadual Londrina, Biol Sci Ctr, Dept Microbiol, POB 10-011, Londrina, Parana, Brazil.
   [Banin-Hirata, Bruna K.; Sapla, Milena M. M.; Marinello, Poliana] Univ Estadual Londrina, Biol Sci Ctr, Dept Pathol Sci, Londrina, Parana, Brazil.
RP Faccin-Galhardi, LC (corresponding author), Univ Estadual Londrina, Biol Sci Ctr, Dept Microbiol, POB 10-011, Londrina, Parana, Brazil.
EM ligiagalhardi@gmail.com
RI Miranda-Sapla, Milena M/D-1231-2017
OI Miranda-Sapla, Milena M/0000-0001-8324-9642; Galhardi,
   Ligia/0000-0002-7522-9710
CR Akamatsu Y, 2007, J IMMUNOL METHODS, V327, P40, DOI 10.1016/j.jim.2007.07.007
   Asokan M, 2015, J VIROL, V89, P12501, DOI 10.1128/JVI.02097-15
   Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05
   Bakker ABH, 2008, VACCINE, V26, P5922, DOI 10.1016/j.vaccine.2008.08.050
   Baranovich T, 2016, ANTIMICROB AGENTS CH, V60, P2118, DOI 10.1128/AAC.02457-15
   Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747
   Beigel JH, 2018, CURR OPIN INFECT DIS, V31, P527, DOI 10.1097/QCO.0000000000000499
   Berger M, 2002, AM J MED SCI, V324, P14, DOI 10.1097/00000441-200207000-00004
   Borucki MJ, 2004, ANTIVIR RES, V64, P103, DOI [10.1016/S0166-3542(04)00131-7, 10.1016/j.antivirial.2004.06.012]
   Boutz DR, 2014, ANAL CHEM, V86, P4758, DOI 10.1021/ac4037679
   Caidi H, 2018, ANTIVIR RES, V154, P149, DOI 10.1016/j.antiviral.2018.04.014
   Caidi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051485
   Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411
   Chao TY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006133
   Chaudhuri S, 2018, ANTIVIR RES, V155, P76, DOI 10.1016/j.antiviral.2018.05.005
   Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039
   Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167
   Chung RT, 2013, AM J TRANSPLANT, V13, P1047, DOI 10.1111/ajt.12083
   Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224
   Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669
   Costa W.A., 2000, MANUAL TECNICO I PAS
   Cox KS, 2016, MABS-AUSTIN, V8, P129, DOI 10.1080/19420862.2015.1109757
   da Silva Cordeiro M.L., 2014, REV SAUDE CIENCIA ON, V3, P253
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15
   Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675
   Dole K, 2016, ANTIMICROB AGENTS CH, V60, P2881, DOI 10.1128/AAC.02698-15
   Domachowske JB, 2018, PEDIATR INFECT DIS J, V37, P886, DOI [10.1097/INF.0000000000001916, 10.1097/inf.0000000000001916]
   dos Santos R.V., 2006, REV BRAS ALERG IMUNO, V29, P77
   Emu B, 2018, NEW ENGL J MED, V379, P645, DOI 10.1056/NEJMoa1711460
   FENNER M, 1986, SCAND J IMMUNOL, V24, P341
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Food and Drug Administration (U.S.), PAL PROD APPR INF
   Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106
   Galun E, 2002, HEPATOLOGY, V35, P673, DOI 10.1053/jhep.2002.31867
   Gaudinski MR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002493
   Gerlich W., 1993, VIRAL HEPATITIS, P83
   Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879
   Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107
   Hahn CS, 2001, J IMMUNOL, V166, P1057, DOI 10.4049/jimmunol.166.2.1057
   Han JY, 2014, AM J RESP CELL MOL, V51, P143, DOI 10.1165/rcmb.2013-0360OC
   Hershberger E, 2019, EBIOMEDICINE, V40, P574, DOI 10.1016/j.ebiom.2018.12.051
   Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117
   Huang K, 2010, J VIROL, V84, P8132, DOI 10.1128/JVI.02699-09
   Iacob SA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02323
   Ishida JH, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01794-16
   Kallewaard NL, 2016, CELL, V166, P596, DOI 10.1016/j.cell.2016.05.073
   Kaplon H., 2018, MABS
   Kaplon H, 2018, MABS-AUSTIN, V10, P183, DOI 10.1080/19420862.2018.1415671
   Kauvar LM, 2015, ANTIMICROB AGENTS CH, V59, P1563, DOI 10.1128/AAC.04295-14
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Koszalka P, 2017, INFLUENZA OTHER RESP, V11, P240, DOI 10.1111/irv.12446
   Kugler M, 2010, BRIT J HAEMATOL, V150, P574, DOI 10.1111/j.1365-2141.2010.08300.x
   Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110
   Levstik M, 2011, ANN HEPATOL, V10, P441, DOI 10.1016/S1665-2681(19)31510-8
   Lim JJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00279-17, 10.1128/aac.00279-17]
   Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221
   Lu XS, 2019, CELL REP, V26, P438, DOI 10.1016/j.celrep.2018.12.065
   Luna M.S., 2018, PAEDIATR RESPIR REV
   Mabry R, 2010, PROTEIN ENG DES SEL, V23, P115, DOI 10.1093/protein/gzp073
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Mao SL, 1999, P NATL ACAD SCI USA, V96, P6953, DOI 10.1073/pnas.96.12.6953
   McVoy MM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123982
   Mehlhorn H., 2015, ENCY PARASITOLOGY, DOI [10.1007/978-3-642-27769-6_3730-1, DOI 10.1007/978-3-642-27769-6_3730-1]
   Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393
   Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102
   Moekotte AL, 2016, EXPERT OPIN INV DRUG, V25, P1325, DOI 10.1080/13543784.2016.1240785
   Nardin A, 1998, J IMMUNOL METHODS, V211, P21, DOI 10.1016/S0022-1759(97)00168-3
   Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9
   Nogales A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22307-8
   Nyakatura EK, 2018, J BIOL CHEM, V293, P6201, DOI [10.1074/jbc.RA117.001627, 10.1074/jbc.ra117.001627]
   Nyakatura EK, 2017, HUM VACC IMMUNOTHER, V13, P836, DOI 10.1080/21645515.2016.1251536
   Ohlin M, 2015, MOL IMMUNOL, V67, P153, DOI 10.1016/j.molimm.2015.02.026
   Ozawa T, 2018, ANTIVIR RES, V154, P58, DOI 10.1016/j.antiviral.2018.04.011
   Pan XY, 2018, ANTIVIR RES, V156, P21, DOI 10.1016/j.antiviral.2018.06.002
   Pelegrin M, 2015, TRENDS MICROBIOL, V23, P653, DOI 10.1016/j.tim.2015.07.005
   Peregrine Pharmaceuticals, PER IN RAND PHAS 2 T
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Qiu XG, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9875
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Qiu XG, 2011, CLIN IMMUNOL, V141, P218, DOI 10.1016/j.clim.2011.08.008
   Ramos EL, 2015, J INFECT DIS, V211, P1038, DOI 10.1093/infdis/jiu539
   Reichert JM, 2015, MABS-AUSTIN, V7, P1, DOI 10.4161/19420862.2015.988944
   Resch B, 2017, HUM VACC IMMUNOTHER, V13, P2138, DOI 10.1080/21645515.2017.1337614
   Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13
   Roque ACA, 2004, BIOTECHNOL PROGR, V20, P639, DOI 10.1021/bp030070k
   Roskopf CC, 2016, ONCOTARGET, V7, P22579, DOI 10.18632/oncotarget.8022
   Salazar G, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0019-3
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sato S, 2012, NAT BIOTECHNOL, V30, P1039, DOI 10.1038/nbt.2406
   Scherer EM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004461
   Schiano TD, 2006, LIVER TRANSPLANT, V12, P1381, DOI 10.1002/lt.20876
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shi X, 2016, MABS-AUSTIN, V8, P574, DOI 10.1080/19420862.2016.1148850
   Shivalingaiah AH, 2018, INDAN J COMMUNITY HE, V30, P196
   Sparrow E, 2019, VACCINE, V37, pA132, DOI 10.1016/j.vaccine.2018.11.004
   Tan WL, 2013, MABS-AUSTIN, V5, P946, DOI 10.4161/mabs.26390
   Taylor RP, 1997, J IMMUNOL, V159, P4035
   Tharakaraman K, 2014, CELL HOST MICROBE, V15, P644, DOI 10.1016/j.chom.2014.04.009
   Theraclone Sciences Inc, 2013, THER SCI ANN POS TOP
   Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942
   Turner JA, 2016, CLIN J ONCOL NURS, V20, P165, DOI 10.1188/16.CJON.165-168
   Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22789
   van Nunen AB, 2001, LIVER, V21, P207, DOI 10.1034/j.1600-0676.2001.021003207.x
   Wagner K, 2014, P NATL ACAD SCI USA, V111, P16820, DOI 10.1073/pnas.1408605111
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664
   Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110
   Wu XF, 2019, METHODS, V154, P3, DOI 10.1016/j.ymeth.2018.08.010
   Young J, 2002, RESP MED, V96, pS31, DOI 10.1053/rmed.2002.1298
   Zhou B, 2019, ANTIVIR RES, V161, P28, DOI 10.1016/j.antiviral.2018.11.001
   Zydek M, 2014, VIRUSES-BASEL, V6, P1346, DOI 10.3390/v6031346
NR 116
TC 1
Z9 1
U1 0
U2 0
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
EI 1873-4316
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PY 2019
VL 20
IS 13
BP 1108
EP 1121
DI 10.2174/1389201020666190809112704
PG 14
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA JI3VH
UT WOS:000493396500003
PM 31400263
DA 2020-07-08
ER

PT J
AU Qu, ZL
   Hyman, JM
AF Qu, Zhuolin
   Hyman, James M.
TI GENERATING A HIERARCHY OF REDUCED MODELS FOR A SYSTEM OF DIFFERENTIAL
   EQUATIONS MODELING THE SPREAD OF WOLBACHIA IN MOSQUITOES
SO SIAM JOURNAL ON APPLIED MATHEMATICS
LA English
DT Article
DE mosquito-borne diseases; model reduction; backward bifurcation;
   mathematical modeling; sensitivity analysis
ID AEDES-AEGYPTI DIPTERA; ZIKA VIRUS; DENGUE; TRANSMISSION; INFECTION;
   CULICIDAE; STRAIN
AB We create and analyze a hierarchy of reduced order models for the spread of a Wolbachia bacteria infection in mosquitoes. Mosquitoes that are infected with some strains of the Wolbachia bacteria are much less effective at transmitting zoonotic diseases, including Zika, chikungunya, dengue fever, and other mosquito-borne diseases. The infection will persist in a wild mosquito population only if the fraction of infected mosquitoes exceeds a minimum threshold. Mathematical models can be used to understand the complex maternal transmission of Wolbachia infection and to guide efforts for keeping the infection above the threshold. This threshold can be characterized as a backward bifurcation for a system of nine ordinary differential equations modeling the Wolbachia infection in a heterosexual mosquito population. Although this system captures the detailed transmission dynamics, they are difficult to analyze. We describe the mathematical approach used in each model reduction to create a system of seven, four, or two ordinary differential equations that capture the important properties of the original system. We evaluate the quality of the approximation at each step by comparing the associated important dimensionless numbers, analyzing the critical threshold condition for each reduced model, and using phase plane analysis to demonstrate that all the reduced models accurately reproduce the dynamics of the full system.
C1 [Qu, Zhuolin; Hyman, James M.] Tulane Univ, Dept Math, New Orleans, LA 70118 USA.
RP Qu, ZL (corresponding author), Tulane Univ, Dept Math, New Orleans, LA 70118 USA.
EM zqu1@tulane.edu; mhyman@tulane.edu
RI Hyman, James M/AAF-7389-2020
OI Hyman, James M/0000-0001-5247-5794
FU NSFNational Science Foundation (NSF) [1563531]; NIH-NIGMS Models of
   Infectious Disease Agent Study (MIDAS) [U01GM097661]
FX This work was partially supported by the NSF award 1563531 and the
   NIH-NIGMS Models of Infectious Disease Agent Study (MIDAS) award
   U01GM097661.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hyman JM, 2003, MATH BIOSCI, V181, P17, DOI 10.1016/S0025-5564(02)00128-1
   Koiller J., 2014, THESIS
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Qu ZL, 2018, SIAM J APPL MATH, V78, P826, DOI 10.1137/17M1130800
   SCHOOF HF, 1967, B WORLD HEALTH ORGAN, V36, P600
   Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Xue L., 2016, J BIOL DYNAM, P1
   Xue L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006666
   Zheng B, 2018, J MATH BIOL, V76, P235, DOI 10.1007/s00285-017-1142-5
NR 20
TC 0
Z9 0
U1 3
U2 3
PU SIAM PUBLICATIONS
PI PHILADELPHIA
PA 3600 UNIV CITY SCIENCE CENTER, PHILADELPHIA, PA 19104-2688 USA
SN 0036-1399
EI 1095-712X
J9 SIAM J APPL MATH
JI SIAM J. Appl. Math.
PY 2019
VL 79
IS 5
BP 1675
EP 1699
DI 10.1137/19M1250054
PG 25
WC Mathematics, Applied
SC Mathematics
GA JJ1DK
UT WOS:000493900600003
DA 2020-07-08
ER

PT J
AU Halstead, S
   Wilder-Smith, A
AF Halstead, Scott
   Wilder-Smith, Annelies
TI Severe dengue in travellers: pathogenesis, risk and clinical management
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Review
DE Antibody-dependent enhancement; capillary leakage; dengue haemorrhagic
   fever; dengue vaccines; CYD-TDV; Aedes; risk assessment
ID ANTIBODY-DEPENDENT ENHANCEMENT; VIRUS-INFECTION; HEMORRHAGIC-FEVER;
   SYMPTOMATIC DENGUE; HOSPITALIZED-PATIENTS; RETURNED TRAVELERS;
   CHIKUNGUNYA VIRUS; SHOCK SYNDROME; ZIKA VIRUS; CHILDREN
AB Rationale for review: Dengue is a frequent cause of febrile illness among travellers and has overtaken malaria as the leading cause of febrile illness for those traveling to Southeast Asia. The purpose is to review the risk of dengue and severe dengue in travellers with a particular focus on the pathogenesis and clinical management of severe dengue.
   Risk, pathogenesis and clinical management: The risk of travel-acquired dengue depends on destination, season and duration of travel and activities during travel. Seroconversion rates reported in travellers, therefore, vary between <1% and >20%. The most common life-threatening clinical response to dengue infection is the dengue vascular permeability syndrome, epidemiologically linked to secondary infection, but can also occur in primary infection. Tertiary and quaternary infections are usually associated with mild or no disease. Antibody-dependent enhancement, viral factors, age, host factors and clinical experience of the managing physician modulate the risk of progressing to severe dengue. The relative risk of severe dengue in secondary versus primary infection ranges from 2 to 7. The absolute risk of severe dengue in children in highly endemic areas is similar to 0.1% per year for primary infections and 0.4% for secondary infections. About 2-4% of secondary infections lead to severe dengue. Severe dengue and death are both relatively rare in general travellers but more frequently in those visiting friends and relatives. Clinical management of severe dengue depends on judicious use of fluid rehydration.
   Conclusions: Although dengue is a frequent cause of travel illness, severe dengue and deaths are rare. Nevertheless, dengue infections can interrupt travel and lead to evacuation and major out-of-pocket costs. Dengue is more frequent than many other travel-related vaccine preventable diseases, such as hepatitis A, hepatitis B, rabies, Japanese encephalitis and yellow fever, indicating a need for a dengue vaccine for travellers.
C1 [Halstead, Scott] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Wilder-Smith, Annelies] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.
RP Wilder-Smith, A (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.; Wilder-Smith, A (corresponding author), Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.
EM annelies.wilder-smith@lshtm.ac.uk
CR Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0
   Ang LW, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007389
   Arien KK, 2018, LANCET GLOB HLTH
   Arragain L, 2017, J PEDIAT INF DIS SOC, V6, P324, DOI 10.1093/jpids/piw058
   Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022
   Basurko C, 2018, AM J TROP MED HYG
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Caci Jennifer B, 2014, J Spec Oper Med, V14, P111
   Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316
   Clapham HE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005926
   Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x
   Dalugama Chamara, 2018, J Med Case Rep, V12, P137, DOI 10.1186/s13256-018-1626-y
   Durbin AP, 2019, J TRAVEL MED
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   Ferguson RW, 2016, J TRAVEL MED, V23
   Gamble J, 2000, CLIN SCI, V98, P211, DOI 10.1042/CS19990296
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Goodyer L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay005
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412
   Greenaway C, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay060
   Griffiths KM, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay007
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2019, P NATL ACAD SCI USA, V116, P17, DOI 10.1073/pnas.1819607116
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Halstead SB, 2013, CLIN INFECT DIS, V56, P900, DOI 10.1093/cid/cis1047
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hariyanto Hori, 2016, J Med Case Rep, V10, P357, DOI 10.1186/s13256-016-1129-7
   Horstick O, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003632
   Janssen HLA, 1998, J INFECTION, V36, P344, DOI 10.1016/S0163-4453(98)94783-1
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jelinek T, 2009, EURO SURVEILL, V14
   Jensenius M, 2007, SCAND J INFECT DIS, V39, P272, DOI 10.1080/00365540600891307
   Jensenius M, 2013, AM J TROP MED HYG, V88, P397, DOI 10.4269/ajtmh.12-0551
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   Kirawittaya T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003943
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kobayashi K, 2015, J TRAVEL MED, V22, P64, DOI 10.1111/jtm.12158
   KOURI GP, 1987, T ROY SOC TROP MED H, V81, P821, DOI 10.1016/0035-9203(87)90042-3
   Kumar J, 2009, BMJ CASE REP, V2009
   L'Azou M, 2016, NEW ENGL J MED, V374, P1155, DOI 10.1056/NEJMoa1503877
   Lagi F, 2014, J TRAVEL MED, V21, P340, DOI 10.1111/jtm.12144
   Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043
   Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Lim M., 2005, SMJ Singapore Medical Journal, V46, P645
   Ling LM, 2007, J CLIN VIROL, V38, P265, DOI 10.1016/j.jcv.2006.12.011
   Loconsole D, 2018, VECTOR-BORNE ZOONOT, V18, P331, DOI 10.1089/vbz.2017.2260
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Lye DC, 2017, LANCET, V389, P1611, DOI 10.1016/S0140-6736(17)30269-6
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Masyeni S, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay061
   McCarthy AE, 2013, CLIN INFECT DIS, V56, P925, DOI 10.1093/cid/cis1016
   Meltzer E, 2012, AM J TROP MED HYG, V86, P536, DOI 10.4269/ajtmh.2012.10-0670
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Mohammed HP, 2010, J TRAVEL MED, V17, P8, DOI 10.1111/j.1708-8305.2009.00374.x
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Nascimento LB, 2017, LANCET INFECT DIS, V17, P949, DOI 10.1016/S1473-3099(17)30169-X
   Neuberger A, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw003
   Neumayr A, EURO SURVEILL, V22
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Olivero RM, 2016, AM J TROP MED HYG, V95, P1130, DOI 10.4269/ajtmh.16-0159
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Paixao ES, 2018, EMERG INFECT DIS, V24, P1748, DOI 10.3201/eid2409.170361
   Paixao ES, 2017, LANCET INFECT DIS, V17, P957, DOI 10.1016/S1473-3099(17)30366-3
   Pang JX, 2017, SCI REP-UK, V7, DOI 10.1038/srep39872
   Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594
   Poddighe D, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav013
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Ramos JM, 2015, J TRAVEL MED, V22, P133, DOI 10.1111/jtm.12157
   Ratnam I, 2012, EUR J CLIN MICROBIOL, V31, P1203, DOI 10.1007/s10096-011-1429-1
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Riddell A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax015
   Rocklov J, 2014, SCAND J INFECT DIS, V46, P412, DOI 10.3109/00365548.2014.887222
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rodriguez-Morales AJ, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay162
   Rodriguez-Roche R, 2011, VECTOR-BORNE ZOONOT, V11, P675, DOI 10.1089/vbz.2010.0177
   Rothman Alan L, 2014, Curr Trop Med Rep, V1, P13
   Sadarangani SP, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax014
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Sanchez-Vegas C, 2013, J TRAVEL MED, V20, P352, DOI 10.1111/jtm.12057
   Schmidt-Chanasit J, 2012, INFECTION, V40, P441, DOI 10.1007/s15010-011-0208-3
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Seet RCS, 2007, J CLIN VIROL, V38, P1, DOI 10.1016/j.jcv.2006.10.011
   Sessions OM, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21822
   Shivanthan MC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-156
   Sierra B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006220
   Sridhar S, 2018, N ENGL J MED
   Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Statler J, 2008, J CLIN ULTRASOUND, V36, P413, DOI 10.1002/jcu.20476
   Streit JA, 2011, EMERG INFECT DIS, V17, P914, DOI 10.3201/eid1705.101023
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Tang KF, 2012, EXPERT REV ANTI-INFE, V10, P895, DOI [10.1586/eri.12.76, 10.1586/ERI.12.76]
   Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566
   'Thein TL, 2014, AM J TROP MED HYG, V90, P984, DOI 10.4269/ajtmh.14-0004
   Bich TD, 2015, LANCET, V385, P1260, DOI 10.1016/S0140-6736(15)60239-2
   Tozan Y, 2019, AM J TROP MED HYG, V100, P1525, DOI 10.4269/ajtmh.18-0780
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2018, J TRAVEL MED, V25
   Wilder-Smith A, 2019, J TRAVEL MED, V26
   Wilder-Smith A, 2019, VACCINE
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2016, LANCET INFECT DIS, V16, P629, DOI 10.1016/S1473-3099(16)00076-1
   Wilder-Smith A, 2015, J TRAVEL MED, V22, P200, DOI 10.1111/jtm.12198
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2018, WKLY EPIDEMIOL REC, V93, P457
   Yacoub S, 2014, NAT REV CARDIOL, V11, P335, DOI 10.1038/nrcardio.2014.40
   Zea D, 2014, AM J TROP MED HYG, V91, P156, DOI 10.4269/ajtmh.13-0637
NR 132
TC 9
Z9 8
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PY 2019
VL 26
IS 7
AR taz062
DI 10.1093/jtm/taz062
PG 15
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA JI3UD
UT WOS:000493393300010
PM 31423536
DA 2020-07-08
ER

PT J
AU Hamer, DH
   Chen, LH
AF Hamer, Davidson H.
   Chen, Lin H.
TI Zika in Angola and India
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Editorial Material
ID VIRUS
C1 [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.
   [Hamer, Davidson H.; Chen, Lin H.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.
   [Chen, Lin H.] Mt Auburn Hosp, Div Infect Dis & Travel Med, Cambridge, MA USA.
   [Chen, Lin H.] Harvard Med Sch, Fac Med, Boston, MA 02115 USA.
RP Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.; Hamer, DH (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.
EM dhamer@bu.edu
RI Hamer, Davidson/J-2020-2019
OI Hamer, Davidson/0000-0002-4700-1495; Chen, Lin/0000-0002-5684-8436
FU NCEZID CDC HHS [U50 CK000189]
CR Baskar D, 2018, NEUROL INDIA, V66, P1324, DOI 10.4103/0028-3886.241402
   Chen LH, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay095
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Grubaugh ND, INT TRAVELERS GENOMI
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hill SC, 2019, EMERGENCE ZIKA VIRUS
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Sornjai W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35643-6
   Watts Alexander G, 2018, J Travel Med, V25, DOI 10.1093/jtm/tay132
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
NR 12
TC 4
Z9 4
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PY 2019
VL 26
IS 5
AR taz012
DI 10.1093/jtm/taz012
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA JI3TQ
UT WOS:000493392000006
PM 30753689
DA 2020-07-08
ER

PT J
AU Leshem, E
   Lustig, Y
   Brosh-Nissimov, T
   Paran, Y
   Schwartz, E
AF Leshem, Eyal
   Lustig, Yaniv
   Brosh-Nissimov, Tal
   Paran, Yael
   Schwartz, Eli
TI Incidence of laboratory-confirmed Zika in Israeli travelers to Thailand:
   2016-2019
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Editorial Material
C1 [Leshem, Eyal; Paran, Yael; Schwartz, Eli] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.
   [Leshem, Eyal; Schwartz, Eli] Sheba Med Ctr, Ctr Travel & Trop Med, IL-52621 Tel Hashomer, Israel.
   [Lustig, Yaniv] Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, IL-52621 Tel Hashomer, Israel.
   [Brosh-Nissimov, Tal] Assuta Ashdod Univ Hosp, Infect Dis Unit, 7 Ha Refua St, IL-7747629 Ashdod, Israel.
   [Paran, Yael] Tel Aviv Sourasky Med Ctr, 6 Weitzman St, IL-6423906 Tel Aviv, Israel.
RP Leshem, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.; Leshem, E (corresponding author), Sheba Med Ctr, Ctr Travel & Trop Med, IL-52621 Tel Hashomer, Israel.
EM Eyal.Leshem@sheba.health.gov.il
CR Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Meltzer E, 2019, AM J TROP MED HYG, V100, P178, DOI 10.4269/ajtmh.18-0379
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
NR 4
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PY 2019
VL 26
IS 7
AR taz057
DI 10.1093/jtm/taz057
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA JI3UD
UT WOS:000493393300007
PM 31407788
DA 2020-07-08
ER

PT J
AU Nasserie, T
   Brent, SE
   Tuite, AR
   Moineddin, R
   Yong, JHE
   Miniota, J
   Bogoch, II
   Watts, AG
   Khan, K
AF Nasserie, Tahmina
   Brent, Shannon E.
   Tuite, Ashleigh R.
   Moineddin, Rahim
   Yong, Jean H. E.
   Miniota, Jennifer
   Bogoch, Isaac I.
   Watts, Alexander G.
   Khan, Kamran
TI Association between air travel and importation of chikungunya into the
   USA
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Chikungunya; travel medicine; infectious disease epidemiology
ID ZIKA VIRUS; SPREAD
AB Background: During infectious disease outbreaks with pandemic potential, the number of air passengers travelling from the outbreak source to international destinations has been used as a proxy for disease importation risk to new locations. However, evaluations of the validity of this approach are limited. We sought to quantify the association between international air travel and disease importation using the 2014-2016 chikungunya outbreak in the Americas as a case study.
   Methods: We used country-level chikungunya case data to define a time period of epidemic activity for each of the 45 countries and territories in the Americas reporting outbreaks between 2014 and 2016. For each country, we identified airports within or proximate to areas considered suitable for chikungunya transmission and summed the number of commercial air passengers departing from these airports during the epidemic period to each US state. We used negative binomial models to quantify the association between the number of incoming air passengers from countries experiencing chikungunya epidemics and the annual rate of chikungunya importation into the USA at the state level.
   Results: We found a statistically significant positive association between passenger flows via airline travel from countries experiencing chikungunya epidemics and the number of imported cases in the USA at the state level (P < 0.0001). Additionally, we found that as the number of arriving airline passengers increased by 10%, the estimated number of imported cases increased by 5.2% (95% CI: 3.0-7.6).
   Conclusion: This validation study demonstrated that air travel was strongly associated with observed importation of chikungunya cases in the USA and can be a useful proxy for identifying areas at increased risk for disease importation. This approach may be useful for understanding exportation risk of other arboviruses.
C1 [Nasserie, Tahmina; Brent, Shannon E.; Tuite, Ashleigh R.; Yong, Jean H. E.; Miniota, Jennifer; Watts, Alexander G.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Nasserie, Tahmina; Brent, Shannon E.; Tuite, Ashleigh R.; Moineddin, Rahim; Yong, Jean H. E.; Miniota, Jennifer; Watts, Alexander G.; Khan, Kamran] BlueDot, Toronto, ON, Canada.
   [Nasserie, Tahmina] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA.
   [Brent, Shannon E.] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada.
   [Tuite, Ashleigh R.; Moineddin, Rahim] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.; Khan, Kamran] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.
RP Khan, K (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.; Khan, K (corresponding author), BlueDot, Toronto, ON, Canada.; Khan, K (corresponding author), Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.
EM khank@smh.ca
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [USG CK000433-01]
FX This work was supported by the Centers for Disease Control and
   Prevention [grant number USG CK000433-01].
CR Blohm GM, 2018, CLIN INFECT DIS, V67, P619, DOI 10.1093/cid/ciy224
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Cassadou S., 2014, EUROSURVEILLANCE, V19, P1
   Centers for Disease Control and Prevention, CHIK VIR 2015 FIN DA
   Centers for Disease Control and Prevention, CHIK VIR 2014 FIN DA
   Centers for Disease Control and Prevention, CHIK VIR 2016 FIN DA
   Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases Division of Vec- tor-Borne Diseases, CHIK VIR US
   Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005
   Evans A. S, 1997, VIRAL INFECT HUMANS
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   International Air Transport Association, 2017, AIRP INT SERV AIRPOR
   Jacobsen KH, 2016, ECOHEALTH, V13, P200, DOI 10.1007/s10393-016-1100-5
   Khan K, 2014, PLOS CURR, V6, P2
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Lednicky JA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006972
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Morse SS, 2007, HEALTH AFFAIR, V26, P1069, DOI 10.1377/hlthaff.26.4.1069
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Nsoesie EO, 2016, EURO SURVEILL, V21
   Pan American Health Organization/World Health Organization, GEOGR SPREAD CHIK AM
   Pan American Health Organization/World Health Organization, CHIK DAT MAPS STAT
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Woolhouse MEJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0191
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
NR 32
TC 2
Z9 2
U1 3
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PY 2019
VL 26
IS 5
AR taz028
DI 10.1093/jtm/taz028
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA JI3TQ
UT WOS:000493392000009
PM 31011752
DA 2020-07-08
ER

PT J
AU Semenza, JC
   Ebi, KL
AF Semenza, Jan C.
   Ebi, Kristie L.
TI Climate change impact on migration, travel, travel destinations and the
   tourism industry
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Review
DE Climate change; travel; migration
ID POSTTRAUMATIC-STRESS-DISORDER; EMERGING INFECTIOUS-DISEASES;
   HEALTH-CARE; ZIKA VIRUS; POPULATION; MIGRANTS; DRIVERS; VARIABILITY;
   PERCEPTIONS; INCREASES
AB Background: Climate change is not only increasing ambient temperature but also accelerating the frequency, duration and intensity of extreme weather and climate events, such as heavy precipitation and droughts, and causing sea level rise, which can lead to population displacement. Climate change-related reductions in land productivity and habitability and in food and water security can also interact with demographic, economic and social factors to increase migration. In addition to migration, climate change has also implications for travel and the risk of disease. This article discusses the impact of climate change on migration and travel with implications for public health practice.
   Methods: Literature review.
   Results: Migrants may be at increased risk of communicable and non-communicable diseases, due to factors in their country of origin and their country of destination or conditions that they experience during migration. Although migration has not been a significant driver of communicable disease outbreaks to date, public health authorities need to ensure that effective screening and vaccination programmes for priority communicable diseases are in place.
   Population growth coupled with socio-economic development is increasing travel and tourism, and advances in technology have increased global connectivity and reduced the time required to cover long distances. At the same time, as a result of climate change, many temperate regions, including high-income countries, are now suitable for vector-borne disease transmission. This is providing opportunities for importation of vectors and pathogens from endemic areas that can lead to cases or outbreaks of communicable diseases with which health professionals may be unfamiliar.
   Conclusion: Health systems need to be prepared for the potential population health consequences of migration, travel and tourism and the impact of climate change on these. Integrated surveillance, early detection of cases and other public health interventions are critical to protect population health and prevent and control communicable disease outbreaks.
C1 [Semenza, Jan C.] European Ctr Dis Prevent & Control ECDC, Sci Assessment Sect, Gustav III S Blvd 40, S-16973 Solna, Sweden.
   [Ebi, Kristie L.] Univ Washington, Dept Global Hlth, POB 354695,Suite 2330, Seattle, WA 98105 USA.
RP Semenza, JC (corresponding author), European Ctr Dis Prevent & Control ECDC, Sci Assessment Sect, Gustav III S Blvd 40, S-16973 Solna, Sweden.
EM Jan.Semenza@ecdc.europa.eu
CR Abbott A, 2016, NATURE, V538, P158, DOI 10.1038/538158a
   Adger WNP, 2015, HUMAN SECURITY
   Aitsi-Selmi A, 2016, PREHOSP DISASTER MED, V31, P74, DOI 10.1017/S1049023X15005531
   Albert MA, 2017, AM HEART J, V192, P1, DOI 10.1016/j.ahj.2017.06.012
   Alla A, 2006, J MED VIROL, V78, P1465, DOI 10.1002/jmv.20720
   Alter HJ, 2007, SEMIN HEMATOL, V44, P32, DOI 10.1053/j.seminhematol.2006.09.016
   Alvarez-del Arco D, 2017, AIDS, V31, P1979, DOI 10.1097/QAD.0000000000001571
   Backhaus A, 2015, IZA J MIGR, V4, DOI 10.1186/s40176-014-0026-3
   Banerjee L, 2007, WORLD DEV, V35, P1989, DOI 10.1016/j.worlddev.2006.11.010
   Black R, 2011, NATURE, V478, P447, DOI 10.1038/478477a
   Black R, 2011, ENVIRON PLANN A, V43, P431, DOI 10.1068/a43154
   Brzoska M., 2015, MIGRATION DEV, V5, P190
   Burrows K, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040443
   Cai RH, 2016, J ENVIRON ECON MANAG, V79, P135, DOI 10.1016/j.jeem.2016.06.005
   Coniglio ND, 2015, ENVIRON DEV ECON, V20, P434, DOI 10.1017/S1355770X14000722
   de Sherbinin A, 2011, SCIENCE, V334, P456, DOI 10.1126/science.1208821
   deMenocal PB, 2016, NATURE, V538, P49, DOI 10.1038/nature19471
   Desgrees-du-Lou A, 2015, EUROSURVEILLANCE, V20, P31, DOI 10.2807/1560-7917.ES.2015.20.46.30065
   Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548
   Dodd RY, 2004, ANNU REV MED, V55, P191, DOI 10.1146/annurev.med.55.091902.103831
   Ebi KL, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1509
   Edmondson D, 2013, AM J PUBLIC HEALTH, V103, pE130, DOI 10.2105/AJPH.2012.301146
   Ejebe IH, 2015, PREV MED, V71, P57, DOI 10.1016/j.ypmed.2014.12.004
   EUROPEAN CENTER FOR DISEASE CONTROL (ECDC), 2015, INF DIS SPEC REL NEW
   European Centre for Disease Prevention and Control, 2018, ECDC ISS MIGR SCREEN
   European Centre for Disease Prevention and Control, 2018, AED ALB CURR KNOWN D
   Fakoya I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1852-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fussell E, 2015, AM BEHAV SCI, V59, P1231, DOI 10.1177/0002764215591181
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Greenaway C, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay060
   Growth Analysis, 2018, EFF IMM EC GROWTH LI
   Heaney AK, 2016, INT J PUBLIC HEALTH, V61, P641, DOI 10.1007/s00038-015-0759-7
   Heywood AE, 2018, J TRAVEL MED, V25
   Hsiang SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep25697
   Hussain Mumtaz, 2014, Reviews on Environmental Health, V29, P71, DOI 10.1515/reveh-2014-0020
   Internal Displacement Monitoring Center (IDMC), 2018, GLOBAL REPORT INTERN
   International Organization for Migration (IOM), 2018, WORLD MIGR REP
   IPCC, 2018, IPCC 2018 SUMM POL
   Jajou R, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01100-17
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kay S, 2015, ENVIRON SCI-PROC IMP, V17, P1311, DOI 10.1039/c4em00683f
   Keim SM, 2006, ARIZONA J IMMIGR MIN, V8, P185, DOI DOI 10.1007/s10903-006-8527-z
   Kelley CP, 2015, P NATL ACAD SCI USA, V112, P3241, DOI 10.1073/pnas.1421533112
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820
   Lemelin RH, 2012, CONTEMP GEOGR LEIS T, P1
   Lillepold K, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz017
   Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436
   MacFadden DR, 2018, NAT CLIM CHANGE, V8, P510, DOI 10.1038/s41558-018-0161-6
   Massey D, 2015, THEORY MIGRATION
   McMichael C, 2015, VIRULENCE, V6, P544, DOI 10.1080/21505594.2015.1021539
   McMichael C, 2012, ENVIRON HEALTH PERSP, V120, P646, DOI 10.1289/ehp.1104375
   Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020
   Monaghan AJ, 2018, CLIMATIC CHANGE, V146, P487, DOI 10.1007/s10584-016-1679-0
   Mueller V, 2014, NAT CLIM CHANGE, V4, P182, DOI [10.1038/nclimate2103, 10.1038/NCLIMATE2103]
   Munoz AG, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0146-1
   Myers N., 2005, 13 EC FOR P 13 M ORG
   Nellums LB, 2018, LANCET INFECT DIS, V18, P796, DOI 10.1016/S1473-3099(18)30219-6
   Ng C, 2018, SCI TOTAL ENVIRON, V610, P651, DOI 10.1016/j.scitotenv.2017.08.099
   OECD, 2014, IS MIGR GOOD EC MIGR
   Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349
   Organization for Economic Cooperation and Development (OECD), 2014, IS MIGR GOOD EC
   Pavli A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax016
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Phan VTM, 2011, AM J TROP MED HYG, V85, P768, DOI 10.4269/ajtmh.2011.11-0364
   Piggott-McKellar AE, 2017, J SUSTAIN TOUR, V25, P397, DOI 10.1080/09669582.2016.1213849
   Radke J, 2018, ASSESSING EXTREME WE
   Reuveny R, 2007, POLIT GEOGR, V26, P656, DOI 10.1016/j.polgeo.2007.05.001
   Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80
   Rigaud K.K., 2018, GROUNDSWELL PREPARIN
   Rito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080031
   Sagud M, 2017, PSYCHIAT DANUB, V29, P421, DOI 10.24869/psyd.2017.421
   Sastry N, 2014, DEMOGRAPHY, V51, P753, DOI 10.1007/s13524-014-0284-y
   Schutte S, 2018, LANCET PLANET HEALTH, V2, pE58, DOI 10.1016/S2542-5196(18)30004-4
   Schwerdtle P, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0981-7
   Schwerdtle PN, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay160
   Semenza JC, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.13.20757
   Semenza JC, 2016, ANN NY ACAD SCI, V1382, P73, DOI 10.1111/nyas.13132
   Semenza JC, 2016, EUR J PUBLIC HEALTH, V26, P372, DOI 10.1093/eurpub/ckw023
   Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204.151073, 10.3201/eid2204]
   Semenza JC, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0105-4
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Semenza JC, 2013, NAT CLIM CHANGE, V3, P432, DOI 10.1038/nclimate1867
   Semenza JC, 2018, FEMS MICROBIOL LETT, V1, P365
   Simatele D, 2015, DISASTERS, V39, P762, DOI 10.1111/disa.12124
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Smith SK, 1996, DEMOGRAPHY, V33, P265, DOI 10.2307/2061876
   Stephenson J, 2010, J PUBLIC HEALTH-UK, V32, P150, DOI 10.1093/pubmed/fdq038
   Stewart EJ, 2016, TOURISM GEOGR, V18, P377, DOI 10.1080/14616688.2016.1198416
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Stringer C, 2003, NATURE, V423, P692, DOI 10.1038/423692a
   Swaddiwudhipong Witaya, 2008, Journal of the Medical Association of Thailand, V91, P1433
   Tacoli C, 2009, ENVIRON URBAN, V21, P513, DOI 10.1177/0956247809342182
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tervo-Kankare K, 2013, TOURISM GEOGR, V15, P292, DOI 10.1080/14616688.2012.726265
   The Government Office for Science, 2018, FOR MIGR GLOB ENV CH
   Thomas Fuller KJ, 2018, NY TIMES, V15, P2018
   Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Tuggle AC, 2018, J PHYSIOL ANTHROPOL, V37, DOI 10.1186/s40101-018-0188-4
   Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P627, DOI 10.1080/13548506.2012.749355
   United Nations High Commissioner for Refugees (UNHCR), 2018, OP PORT REF SIT MED
   Walker JT, 2018, PERSPECT PUBLIC HEAL, V138, P282, DOI 10.1177/1757913918791198
   Weir T, 2017, REG ENVIRON CHANGE, V17, P1017, DOI 10.1007/s10113-016-1012-5
   Windsor-Essex County Health Unit, 2018, AED AEG MOSQ
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 109
TC 4
Z9 4
U1 2
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PY 2019
VL 26
IS 5
AR taz026
DI 10.1093/jtm/taz026
PG 13
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA JI3TQ
UT WOS:000493392000008
PM 30976790
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Shanks, GD
AF Shanks, G. Dennis
TI Could Ross River Virus be the next Zika?
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Editorial Material
ID DISEASE; QUEENSLAND; INFECTION; AUSTRALIA; EPIDEMIC; VACCINE
C1 [Shanks, G. Dennis] Australian Def Force Malaria & Infect Dis Inst, Enoggera, Australia.
   [Shanks, G. Dennis] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.
RP Shanks, GD (corresponding author), Australian Def Force Malaria & Infect Dis Inst, Enoggera, Australia.; Shanks, GD (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.
EM dennis.shanks@defence.gov.au
CR AASKOV JG, 1981, MED J AUSTRALIA, V2, P17, DOI 10.5694/j.1326-5377.1981.tb132047.x
   AASKOV JG, 1981, AM J TROP MED HYG, V30, P1053, DOI 10.4269/ajtmh.1981.30.1053
   Aichinger G, 2011, VACCINE, V29, P9376, DOI 10.1016/j.vaccine.2011.09.125
   Gatton ML, 2005, AM J TROP MED HYG, V72, P792, DOI 10.4269/ajtmh.2005.72.792
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Lau C, 2017, INT J INFECT DIS, V57, P73, DOI 10.1016/j.ijid.2017.01.041
   Olivia Lwande Wesula, 2015, Infection Ecology & Epidemiology, V5, P29853, DOI 10.3402/iee.v5.29853
   Wressnigg N, 2015, CLIN VACCINE IMMUNOL, V22, P267, DOI 10.1128/CVI.00546-14
   Yu WW, 2014, AM J TROP MED HYG, V91, P109, DOI 10.4269/ajtmh.13-0455
   YUND J, 1997, MED SURV MTHLY RPT U, V3, P13
NR 10
TC 3
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PY 2019
VL 26
IS 5
AR taz003
DI 10.1093/jtm/taz003
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA JI3TQ
UT WOS:000493392000004
PM 30657934
DA 2020-07-08
ER

PT J
AU dos Santos, SFM
   Soares, FVM
   de Abranches, AD
   da Costa, ACC
   Gomes, SD
   Fonseca, VD
   Moreira, MEL
AF Morais dos Santos, Samira Fernandes
   Mendes Soares, Fernanda Valente
   de Abranches, Andrea Dunshee
   Carioca da Costa, Ana Carolina
   Dos Santos Gomes-Junior, Saint Clair
   Fonseca, Vania de Matos
   Lopes Moreira, Maria Elisabeth
TI Nutritional profile of newborns with microcephaly and factors associated
   with worse outcomes
SO CLINICS
LA English
DT Article
DE Zika Virus; Microcephaly; Nutritional Status; Newborn
ID ZIKA VIRUS-INFECTION; CHILDREN; INFANTS; BRAZIL
AB OBJECTIVE: To describe the nutritional profile of newborns with microcephaly and factors associated with worse outcomes during the first 14 days of life.
   METHODS: This investigation is a longitudinal, descriptive study carried out in 21 full-term neonates exposed vertically to the Zika virus and hospitalized in a neonatal intensive care unit from February to September 2016. Patients receiving parenteral nutrition were excluded. Data analysis was performed using a generalized estimating equation model and Student's t-test to evaluate the association between worsening weight-for-age z-scores and independent clinical, sociodemographic and nutritional variables during hospitalization, with p < 0.05 indicating significance.
   RESULTS: During hospitalization, there was a decrease in the mean values of the weight-for-age z-scores. The factors associated with worse nutritional outcomes were symptomatic exposure to the Zika virus, low maternal schooling, absence of maternal income and consumption of infant formula (p <0.05). Calcification and severe microcephaly were also associated with poor nutritional outcomes. Energy and macronutrient consumption remained below the recommendations and had an upward trend during hospitalization.
   CONCLUSION: The presence of cerebral calcification, the severity of microcephaly and symptomatic maternal exposure to Zika virus affected the nutritional status of newborns. In terms of nutritional factors, human milk intake had a positive impact, reducing weight loss in the first days of life. Other known factors, such as income and maternal schooling, were still associated with a poor nutritional status.
C1 [Morais dos Santos, Samira Fernandes; Mendes Soares, Fernanda Valente; de Abranches, Andrea Dunshee; Carioca da Costa, Ana Carolina; Dos Santos Gomes-Junior, Saint Clair; Fonseca, Vania de Matos; Lopes Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz IFF Fiocruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
RP Moreira, MEL (corresponding author), Fundacao Oswaldo Cruz IFF Fiocruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.
EM bebethiff@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   441098/2016-9]; Fundacao de Amparo a Pesquisa do Estado do Rio de
   JaneiroCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [FAPERJ -E_18/2015TXB]; Wellcome
   TrustWellcome Trust [205377/Z/16/Z]; United Kingdom's Department for
   International Development; European Union's Horizon 2020 research and
   innovation programme under Zika-PLAN grant [734584]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq
   441098/2016-9. Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   - FAPERJ -E_18/2015TXB. Wellcome Trust (205377/Z/16/Z) and the United
   Kingdom's Department for International Development. European Union's
   Horizon 2020 research and innovation programme under Zika-PLAN grant
   agreement no. 734584.
CR Caram ALA, 2010, REV NUTR, V23, P211, DOI 10.1590/S1415-52732010000200004
   Bell KL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-179
   Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7
   Botelho AC, 2016, REV BRAS SAUDE MA S1, V16, pS45
   Brasil. Ministerio da Saude, 2012, SAUDE CRIANCA CRESCI
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   Davanzo R, 2013, J HUM LACT, V29, P45, DOI 10.1177/0890334412444005
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Institute of Medicine, 2002, DIET REF INT EN CARB
   Kehinde O, 2013, NIGER J PAEDIAT, V40, P299
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leandro CG, 2016, DEV MED CHILD NEUROL, V58, P893, DOI 10.1111/dmcn.13134
   da Cunha AJLA, 2015, J PEDIAT-BRAZIL, V91, pS44, DOI 10.1016/j.jped.2015.07.002
   Lopes Patrícia Ayrosa C., 2013, Rev. paul. pediatr., V31, P344, DOI 10.1590/S0103-05822013000300011
   Ministerio da Saude (BR), 2015, SAUD CRIANC AL MAT A
   Ministerio da Saude (BR), 2015, MIN SAUD CONF REL EN
   Ministerio da Saude Brazil, 2009, ALEITAMENTO MATERNO, V123
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atencao a Saude, 2017, OR INT VIG AT SAUD A
   National Institute of Neurological Disorders and Stroke, HYDR FACT SHEET
   Oliveira FLC, 2013, MANUAL TERAPIA NUTR
   Penagini F, 2015, NUTRIENTS, V7, P9400, DOI 10.3390/nu7115469
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soares FVM, 2017, PED AC SOC M SAN FRA
   Souza Alex Sandro Rolland, 2016, Rev. Bras. Saude Mater. Infant., V16, P467, DOI 10.1590/1806-93042016000400007
   Vieira AA, 2011, EARLY HUM DEV, V87, P577, DOI 10.1016/j.earlhumdev.2011.04.016
   WHO, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2011, CHILD GROWTH STAND W
   World Health Organization (WHO), 2016, WHO CHILD GROWTH STA
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 36
TC 0
Z9 0
U1 1
U2 1
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2019
VL 74
AR e798
DI 10.6061/clinics/2019/e798
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA JH5QK
UT WOS:000492823100001
PM 31644665
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT S
AU Jiang, CY
   Scholle, F
   Ghiladi, RA
AF Jiang, Chenyu
   Scholle, Frank
   Ghiladi, Reza A.
BE Dai, T
   Popp, J
   Wu, MX
TI Mn-doped Zn/S quantum dots as photosensitizers for antimicrobial
   photodynamic inactivation
SO PHOTONIC DIAGNOSIS AND TREATMENT OF INFECTIONS AND INFLAMMATORY DISEASES
   II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Photonic Diagnosis and Treatment of Infections and
   Inflammatory Diseases II
CY FEB 04-05, 2019
CL San Francisco, CA
SP SPIE, Photon Diagnosis & Treatment Infect & Inflammatory Dis II, GAMA Therapeut LLC, Kernel Med Equipment Co
DE antimicrobial photodynamic inactivation; quantum dots; photosensitizer;
   antibacterial; Enterococcus faecium; Staphylococcus aureus;
   Acinetobacter baumannii; Klebsiella pneumoniae; antiviral; Zika virus
ID PORPHYRIN-CELLULOSE NANOCRYSTALS; IN-VITRO; PHOTOLUMINESCENCE
   PROPERTIES; RESISTANCE; THERAPY; BLUE; ZNS; ANTIFUNGAL
AB The survival of pathogens on surfaces is a major contributor to infection transmission, and drives the development of self-sterilizing surfaces. Here, we have investigated if manganese-doped zinc sulfide quantum dots (Mn:ZnS QDs) can be used as photosensitizers for their potential application in surface disinfection via antimicrobial photodynamic inactivation (aPDI). A small library of Mn: ZnS QDs capped with 3-mercaptopropionic acid was synthesized using a hydrothermal approach in which both the amount of manganese (0-30 at.%) and heating period (9 - 20 h) were varied. The resultant Mn:ZnS QDs were shown by transmission electron microscopy to vary in size from 2.6-3.9 angstrom as a function of heating time, and exhibited a strong emission band at similar to 598 nm (lambda(ex) = 325 nm). Upon excitation of 5%-Mn: ZnS QDs at 514 nm, a near-IR emission band attributable to singlet oxygen phosphorescence was observed at 1278 nm, confirming that these QDs may function as photosensitizers via a Type II mechanism. The aPDI efficacy of the Mn:ZnS QDs was evaluated against both Gram-positive [methicillin-resistant S. aureus (MRSA; ATCC-44), vancomycin-resistant E. faecium (VRE; ATCC-2320)], and Gram-negative [multidrug-resistant A. baumannii (MDRAB; ATCC-1605), NDM-1 positive K. pneumoniae (KP; ATCC-2146)] bacteria. Our best results demonstrated detection limit photodynamic inactivation (6 log units reduction) of KP, MDRAB, and MRSA upon illumination (30 min; 65 +/- 5 mW/cm(2); 400-700 nm), but only a similar to 1 log unit reduction against VRE. Together with antiviral studies of Zika virus that showed similar to 3 log units of inactivation, these findings demonstrate the utility of Mn:ZnS QDs as photosensitizers for aPDI.
C1 [Jiang, Chenyu; Ghiladi, Reza A.] North Carolina State Univ, Dept Chem, Box 8204, Raleigh, NC 27695 USA.
   [Scholle, Frank] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.
RP Ghiladi, RA (corresponding author), North Carolina State Univ, Dept Chem, Box 8204, Raleigh, NC 27695 USA.; Scholle, F (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.
EM Frank_Scholle@NCSU.edu; Reza_Ghiladi@NCSU.edu
FU Biotechnology Innovation Grant from the North Carolina Biotechnology
   Center [2016-BIG-6537]; 2016 NC State University Chancellor's Innovation
   Funds award; State of North Carolina; National Science
   FoundationNational Science Foundation (NSF) [ECCS-1542015]
FX This research was supported by a Biotechnology Innovation Grant
   (2016-BIG-6537) from the North Carolina Biotechnology Center and a 2016
   NC State University Chancellor's Innovation Funds award. The materials
   characterization work was performed in part at the Analytical
   Instrumentation Facility (AIF) at North Carolina State University, which
   is supported by the State of North Carolina and the National Science
   Foundation (award number ECCS-1542015). The AIF is a member of the North
   Carolina Research Triangle Nanotechnology Network (RTNN), a site in the
   National Nanotechnology Coordinated Infrastructure (NNCI).
CR Abrahamse H, 2016, BIOCHEM J, V473, P347, DOI 10.1042/BJ20150942
   Vera DMA, 2012, PHOTOCHEM PHOTOBIOL, V88, P499, DOI 10.1111/j.1751-1097.2012.01087.x
   Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009
   Banfi S, 2012, J PHOTOCH PHOTOBIO B, V114, P52, DOI 10.1016/j.jphotobiol.2012.05.010
   Beltran-Huarac J, 2013, J APPL PHYS, V114, DOI 10.1063/1.4817371
   BEZMAN SA, 1978, PHOTOCHEM PHOTOBIOL, V28, P325, DOI 10.1111/j.1751-1097.1978.tb07714.x
   BHARGAVA RN, 1994, J LUMIN, V60-1, P275, DOI 10.1016/0022-2313(94)90146-5
   BHARGAVA RN, 1994, PHYS REV LETT, V72, P416, DOI 10.1103/PhysRevLett.72.416
   Carpenter BL, 2015, BIOMACROMOLECULES, V16, P2482, DOI 10.1021/acs.biomac.5b00758
   Carpenter BL, 2015, MOLECULES, V20, P10604, DOI 10.3390/molecules200610604
   Carpenter BL, 2012, PHOTOCHEM PHOTOBIOL, V88, P527, DOI 10.1111/j.1751-1097.2012.01117.x
   Caruso E, 2012, J PHOTOCH PHOTOBIO B, V114, P44, DOI 10.1016/j.jphotobiol.2012.05.007
   Chen T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23289
   Chen WBF, 2018, FIBER POLYM, V19, P1687, DOI 10.1007/s12221-018-8068-4
   Dai T, 2009, PHOTODIAGN PHOTODYN, V6, P170, DOI 10.1016/j.pdpdt.2009.10.008
   Dei D, 2006, J PORPHYR PHTHALOCYA, V10, P147, DOI 10.1142/S1088424606000181
   Demidova TN, 2005, APPL ENVIRON MICROB, V71, P6918, DOI 10.1128/AEM.71.11.6918-6925.2005
   Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304
   Diaz-Diestra D, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3269-x
   Dong JC, 2018, NANOTECHNOLOGY, V29, DOI 10.1088/1361-6528/aabb3c
   Dong JC, 2018, CELLULOSE, V25, P1673, DOI 10.1007/s10570-018-1697-3
   Donnelly RF, 2008, MICROBIOL RES, V163, P1, DOI 10.1016/j.micres.2007.08.001
   Feese E, 2011, BIOMACROMOLECULES, V12, P3528, DOI 10.1021/bm200718s
   Feese E, 2009, J ANTIMICROB CHEMOTH, V64, P782, DOI 10.1093/jac/dkp278
   Giuliani F, 2010, ANTIMICROB AGENTS CH, V54, P637, DOI 10.1128/AAC.00603-09
   Hamblin MR, 2016, CURR OPIN MICROBIOL, V33, P67, DOI 10.1016/j.mib.2016.06.008
   Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a
   Huang LY, 2018, PHOTOCH PHOTOBIO SCI, V17, P638, DOI 10.1039/c7pp00389g
   Huang LY, 2012, LASER SURG MED, V44, P490, DOI 10.1002/lsm.22045
   Huang YY, 2012, CHEMMEDCHEM, V7, P2155, DOI 10.1002/cmdc.201200351
   Ke MR, 2014, EUR J MED CHEM, V84, P278, DOI 10.1016/j.ejmech.2014.07.022
   KHOSRAVI AA, 1995, APPL PHYS LETT, V67, P2506, DOI 10.1063/1.114440
   Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9
   Le Guern F, 2017, J MATER CHEM B, V5, P6953, DOI 10.1039/c7tb01274h
   Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x
   Maisch T, 2009, MINI-REV MED CHEM, V9, P974, DOI 10.2174/138955709788681582
   Mathai S, 2007, PHOTOCH PHOTOBIO SCI, V6, P995, DOI 10.1039/b705853e
   Muli DK, 2015, TETRAHEDRON LETT, V56, P3541, DOI 10.1016/j.tetlet.2015.01.076
   Paschoal MA, 2013, PHOTODIAGN PHOTODYN, V10, P313, DOI 10.1016/j.pdpdt.2013.02.002
   Peddinti BST, 2018, ACS APPL MATER INTER, V10, P25955, DOI 10.1021/acsami.8b09139
   Peng WQ, 2005, J CRYST GROWTH, V279, P454, DOI 10.1016/j.jcrysgro.2005.02.066
   Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007
   Rossolini GM, 2014, CURR OPIN PHARMACOL, V18, P56, DOI 10.1016/j.coph.2014.09.006
   Soltani N, 2012, INT J MOL SCI, V13, P12242, DOI 10.3390/ijms131012242
   Sooklal K, 1996, J PHYS CHEM-US, V100, P4551, DOI 10.1021/jp952377a
   Soukos NS, 1998, ANTIMICROB AGENTS CH, V42, P2595, DOI 10.1128/AAC.42.10.2595
   Sperandio Felipe F, 2013, Recent Pat Antiinfect Drug Discov, V8, P108
   Stanley SL, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6040077
   Stojiljkovic I, 2001, EXPERT OPIN INV DRUG, V10, P309, DOI 10.1517/13543784.10.2.309
   Su YJ, 2011, J PHOTOCH PHOTOBIO B, V103, P29, DOI 10.1016/j.jphotobiol.2011.01.008
   Tanaka M, 2002, J LUMIN, V100, P163, DOI 10.1016/S0022-2313(02)00448-9
   Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091
   Tran TQH, 2011, OPT MATER, V33, P308, DOI 10.1016/j.optmat.2010.09.008
   Tseng SP, 2009, LASER SURG MED, V41, P391, DOI 10.1002/lsm.20765
   Vatankhah C, 2015, ORIENT J CHEM, V31, P907, DOI 10.13005/ojc/310234
   Wainwright M., 2015, J PHOTOCH PHOTOBIO B, V150, P28
   Wainwright M, 2014, INT J ANTIMICROB AG, V44, P26, DOI 10.1016/j.ijantimicag.2014.02.013
   Wainwright M, 2010, INT J ANTIMICROB AG, V36, P14, DOI 10.1016/j.ijantimicag.2010.03.002
   Wang WN, 2007, CHEM MATER, V19, P1723, DOI 10.1021/cm062887p
   WHO, 2017, WHO PRIOR PATH LIST
NR 60
TC 0
Z9 0
U1 3
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-1-5106-2368-2; 978-1-5106-2369-9
J9 PROC SPIE
PY 2019
VL 10863
AR UNSP 108630Q
PG 14
WC Infectious Diseases; Optics; Physics, Applied; Radiology, Nuclear
   Medicine & Medical Imaging
SC Infectious Diseases; Optics; Physics; Radiology, Nuclear Medicine &
   Medical Imaging
GA BO0NH
UT WOS:000492322800010
DA 2020-07-08
ER

PT J
AU Wilder-Smith, A
   Preet, R
   Brickley, EB
   Ximenes, RAD
   Miranda, DD
   Martelli, CMT
   de Araujo, TVB
   Montarroyos, UR
   Moreira, ME
   Turchi, MD
   Solomon, T
   Jacobs, BC
   Villamizar, CP
   Osorio, L
   de Filipps, AMB
   Neyts, J
   Kaptein, S
   Huits, R
   Arien, KK
   Willison, HJ
   Edgar, JM
   Barnett, SC
   Peeling, R
   Boeras, D
   Guzman, MG
   de Silva, AM
   Falconar, AK
   Romero-Vivas, C
   Gaunt, MW
   Sette, A
   Weiskopf, D
   Lambrechts, L
   Dolk, H
   Morris, JK
   Orioli, IM
   O'Reilly, KM
   Yakob, L
   Rocklov, J
   Soares, C
   Ferreira, MLB
   Franca, RFD
   Precioso, AR
   Logan, J
   Lang, T
   Jamieson, N
   Massad, E
AF Wilder-Smith, Annelies
   Preet, Raman
   Brickley, Elizabeth B.
   de Alencar Ximenes, Ricardo Arraes
   Miranda-Filho, Democrito de Barros
   Turchi Martelli, Celina Maria
   Barreto de Araujo, Thalia Velho
   Montarroyos, Ulisses Ramos
   Moreira, Maria Elisabeth
   Turchi, Marilia Dalva
   Solomon, Tom
   Jacobs, Bart C.
   Pardo Villamizar, Carlos
   Osorio, Lyda
   de Filipps, Ana Maria Bispo
   Neyts, Johan
   Kaptein, Suzanne
   Huits, Ralph
   Arien, Kevin K.
   Willison, Hugh J.
   Edgar, Julia M.
   Barnett, Susan C.
   Peeling, Rosanna
   Boeras, Debi
   Guzman, Maria G.
   de Silva, Aravinda M.
   Falconar, Andrew K.
   Romero-Vivas, Claudia
   Gaunt, Michael W.
   Sette, Alessandro
   Weiskopf, Daniela
   Lambrechts, Louis
   Dolk, Helen
   Morris, Joan K.
   Orioli, Ieda M.
   O'Reilly, Kathleen M.
   Yakob, Laith
   Rocklov, Joacim
   Soares, Cristiane
   Ferreira, Maria Lucia Brito
   Franca, Rafael Freitas de Oliveira
   Precioso, Alexander R.
   Logan, James
   Lang, Trudie
   Jamieson, Nina
   Massad, Eduardo
TI ZikaPLAN: addressing the knowledge gaps and working towards a research
   preparedness network in the Americas
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE Zika; congenital Zika syndrome; birth defect; epidemic preparedness;
   research capacity building; European Commission; microcephaly;
   Guillain-Barr? syndrome; encephalitis; sustainability
ID GUILLAIN-BARRE-SYNDROME; VIRUS-INFECTION; TRAVELERS; BRAZIL;
   EPIDEMIOLOGY; SURVEILLANCE; TRANSMISSION; DIAGNOSIS; OUTBREAK; HISTORY
AB Zika Preparedness Latin American Network (ZikaPLAN) is a research consortium funded by the European Commission to address the research gaps in combating Zika and to establish a sustainable network with research capacity building in the Americas. Here we present a report on ZikaPLAN`s mid-term achievements since its initiation in October 2016 to June 2019, illustrating the research objectives of the 15 work packages ranging from virology, diagnostics, entomology and vector control, modelling to clinical cohort studies in pregnant women and neonates, as well as studies on the neurological complications of Zika infections in adolescents and adults. For example, the Neuroviruses Emerging in the Americas Study (NEAS) has set up more than 10 clinical sites in Colombia. Through the Butantan Phase 3 dengue vaccine trial, we have access to samples of 17,000 subjects in 14 different geographic locations in Brazil. To address the lack of access to clinical samples for diagnostic evaluation, ZikaPLAN set up a network of quality sites with access to well-characterized clinical specimens and capacity for independent evaluations. The International Committee for Congenital Anomaly Surveillance Tools was formed with global representation from regional networks conducting birth defects surveillance. We have collated a comprehensive inventory of resources and tools for birth defects surveillance, and developed an App for low resource regions facilitating the coding and description of all major externally visible congenital anomalies including congenital Zika syndrome. Research Capacity Network (REDe) is a shared and open resource centre where researchers and health workers can access tools, resources and support, enabling better and more research in the region. Addressing the gap in research capacity in LMICs is pivotal in ensuring broad-based systems to be prepared for the next outbreak. Our shared and open research space through REDe will be used to maximize the transfer of research into practice by summarizing the research output and by hosting the tools, resources, guidance and recommendations generated by these studies. Leveraging on the research from this consortium, we are working towards a research preparedness network.
C1 [Wilder-Smith, Annelies; Preet, Raman; Rocklov, Joacim] Umea Univ, Dept Epidemiol & Global Hlth, S-90185 Umea, Sweden.
   [Brickley, Elizabeth B.; Peeling, Rosanna; Boeras, Debi; Falconar, Andrew K.; Gaunt, Michael W.; O'Reilly, Kathleen M.; Yakob, Laith; Logan, James] London Sch Hyg & Trop Med, London, England.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Miranda-Filho, Democrito de Barros] Univ Pernambuco, Dept Med Interna, Recife, PE, Brazil.
   [Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil.
   [Montarroyos, Ulisses Ramos] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Turchi, Marilia Dalva] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
   [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
   [Pardo Villamizar, Carlos] Johns Hopkins Univ, Baltimore, MD USA.
   [Pardo Villamizar, Carlos; Osorio, Lyda] Univ Valle, Cali, Colombia.
   [de Filipps, Ana Maria Bispo] Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Neyts, Johan; Kaptein, Suzanne] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol Immunol & Transplantat, Leuven, Belgium.
   [Huits, Ralph; Arien, Kevin K.] Inst Trop Med, Antwerp, Belgium.
   [Willison, Hugh J.; Edgar, Julia M.; Barnett, Susan C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Guzman, Maria G.] Inst Med Trop, Pedro Kouri, Cuba.
   [de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
   [Falconar, Andrew K.; Romero-Vivas, Claudia] Fdn Univ Norte, Dept Med, Barranquilla, Colombia.
   [Sette, Alessandro; Weiskopf, Daniela] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.
   [Sette, Alessandro] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Lambrechts, Louis] Inst Pasteur, CNRS, Insect Virus Interact Unit, UMR2000, Paris, France.
   [Dolk, Helen] Ulster Univ, Inst Nursing & Hlth Res, Maternal Fetal & Infant Res Ctr, Newtownabbey, North Ireland.
   [Morris, Joan K.] St Georges Univ London, Populat Hlth Res Inst, London, England.
   [Orioli, Ieda M.] Univ Fed Rio de Janeiro, Inst Biol, Assoc Tecn Cient Estudo Colaborat Latino Amer Mal, Dept Genet, Rio De Janeiro, Brazil.
   [Soares, Cristiane] Hosp Fed Serv Estado, Rio De Janeiro, Brazil.
   [Ferreira, Maria Lucia Brito] Hosp Restauracao, Recife, PE, Brazil.
   [Franca, Rafael Freitas de Oliveira] Fundacao Oswaldo Cruz, Recife, PE, Brazil.
   [Precioso, Alexander R.] Inst Butantan, Sao Paulo, Brazil.
   [Precioso, Alexander R.] Univ Sao Paulo, Sch Med, Pediat Dept, Sao Paulo, Brazil.
   [Lang, Trudie; Jamieson, Nina] Univ Oxford, Global Hlth Network Masters & Scholars, Oxford, England.
RP Wilder-Smith, A (corresponding author), Umea Univ, Dept Epidemiol & Global Hlth, S-90185 Umea, Sweden.
EM anneliesws@gmail.com
RI Kaptein, Suzanne JF/O-4714-2019; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; O'Reilly, Kathleen/H-9170-2019; Huits,
   Ralph/I-8361-2019; Montarroyos, Ulisses/AAJ-7527-2020; Precioso,
   Alexander Roberto/A-9712-2013; NEYTS, Johan/U-8267-2017; Brickley,
   Elizabeth/U-3625-2017
OI Kaptein, Suzanne JF/0000-0002-7935-0219; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; O'Reilly, Kathleen/0000-0002-4892-8022;
   Huits, Ralph/0000-0001-8803-9468; Precioso, Alexander
   Roberto/0000-0001-8657-9292; Preet, Raman Kaur/0000-0002-4371-5941;
   Solomon, Tom/0000-0001-7266-6547; NEYTS, Johan/0000-0002-0033-7514;
   Rocklov, Joacim/0000-0003-4030-0449; Brickley,
   Elizabeth/0000-0003-0280-2288; Wilder-Smith,
   Annelies/0000-0003-0362-5375
FU European UnionEuropean Union (EU) [734584]; National Institute for
   Health Research (NIHR), Health Protection Research Unit in Emerging and
   Zoonotic Infections [IS-HPU-1112-10117]; NIHR Global Health Research
   Group on Brain Infections [17/63/110]; Wellcome Trust UKWellcome Trust;
   Department for International Development UK; Medical Research Council
   UKMedical Research Council UK (MRC); CNPqNational Council for Scientific
   and Technological Development (CNPq); Secretaria de Vigilancia de Saude
   (SVS); Fundacao do Amparo a Ciencia e Tecnologia (FACEPE)
FX This project, ZikaPLAN is funded by the European Union's Horizon 2020
   research and innovation programme under Grant Agreement No. 734584. Some
   authors have received additional research funding. For example, TS is
   supported by the National Institute for Health Research (NIHR), Health
   Protection Research Unit in Emerging and Zoonotic Infections (Grant No.
   IS-HPU-1112-10117), and NIHR Global Health Research Group on Brain
   Infections (No. 17/63/110). MERG as a group has received funding from
   Wellcome Trust UK, Department for International Development UK, Medical
   Research Council UK, the Brazilian funding through CNPq, Secretaria de
   Vigilancia de Saude (SVS), and Fundacao do Amparo a Ciencia e Tecnologia
   (FACEPE).
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Albuquerque MSV, 2019, HLTH POLICY PLAN
   Angelo KM, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay074
   Awadh A, 2017, PLOS CURR, V9
   Barbosa F, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw094
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Beran D, 2017, LANCET GLOB HEALTH, V5, pE567, DOI 10.1016/S2214-109X(17)30180-8
   Black WC, 2011, TRENDS PARASITOL, V27, P362, DOI 10.1016/j.pt.2011.04.004
   Boggild AK, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay117
   Boggild AK, 2015, ANN INTERN MED, V162, P757, DOI 10.7326/M15-0074
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LH, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay095
   Chen LH, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tax097
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Duttine Antony, 2019, Wellcome Open Res, V4, P80, DOI 10.12688/wellcomeopenres.15085.1
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Falconar AKI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021024
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fischer C, 2019, LANCET INFECT DIS, V19, P240, DOI 10.1016/S1473-3099(19)30049-0
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Goodyer L, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay005
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Gubler DJ, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay097
   Hamer DH, 2019, J TRAVEL MED, V26
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huits R, 2019, INT J INFECT DIS, V78, P39, DOI 10.1016/j.ijid.2018.10.010
   Huits R, 2019, TRAVEL MED INFECT DI, V27, P107, DOI 10.1016/j.tmaid.2018.08.007
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Leonhard Sonja Emily, 2018, Pract Neurol, V18, P271, DOI 10.1136/practneurol-2017-001789
   Massad E, 2017, EPIDEMIOL INFECT, P1
   Massad E, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000712, 10.1017/s0950268819000712]
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Michal Stevens A, 2017, J TRAVEL MED, V24
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Molton JS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay023
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   dos Santos SFM, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0429-3
   Msall ME, 2010, ARCH PEDIAT ADOL MED, V164, P391, DOI 10.1001/archpediatrics.2010.25
   Neumayr A, 2017, EURO SURVEILL, V22
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Orioli IM, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5018
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Rezza G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay004
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Ritchie SA, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay084
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P582, DOI 10.2105/AJPH.2016.303114
   Salzer HJF, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay055
   SCHRECK CE, 1984, AM J TROP MED HYG, V33, P725, DOI 10.4269/ajtmh.1984.33.725
   Shanks GD, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz003
   Sheldrick RC, 2013, ACAD PEDIATR, V13, P577, DOI 10.1016/j.acap.2013.07.001
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sinkins SP, 2013, FUTURE MICROBIOL, V8, P1249, DOI 10.2217/fmb.13.95
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Torresi J, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax064
   Tuite AR, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay077
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Wang G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay022
   Watts AG, 2018, J TRAVEL MED, V25
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilder-Smith Annelies, 2019, BMJ Open, V9, pe026092, DOI 10.1136/bmjopen-2018-026092
   Wilder-Smith A, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay157
   Wilder-Smith A, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1549930
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay139
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Xu X, 2016, PLOS CURR, V8
   Yakob L, 2017, PLOS CURR, V9
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
NR 96
TC 0
Z9 0
U1 2
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PD JAN 1
PY 2019
VL 12
IS 1
AR 1666566
DI 10.1080/16549716.2019.1666566
PG 16
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JF7EZ
UT WOS:000491550400001
PM 31640505
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT B
AU Bliman, PA
AF Bliman, Pierre-Alexandre
GP IEEE
TI Feedback Control Principles for Biological Control of Dengue Vectors
SO 2019 18TH EUROPEAN CONTROL CONFERENCE (ECC)
LA English
DT Proceedings Paper
CT 18th European Control Conference (ECC)
CY JUN 25-28, 2019
CL Naples, ITALY
SP Unvi Naples Federico II, Univ Sannio Benevento
ID AEDES-AEGYPTI; WOLBACHIA INFECTION; POPULATIONS; MODEL
AB Controlling diseases such as dengue fever, chikungunya and zika fever by introduction of the intracellular parasitic bacterium Wolbachia in mosquito populations which are their vectors, is presently quite a promising tool to reduce their spread. While description of the conditions of such experiments has received ample attention from biologists, entomologists and applied mathematicians, the issue of effective scheduling of the releases remains an interesting problem for Control theory. Having in mind the important uncertainties present in the dynamics of the two populations in interaction, we attempt here to identify general ideas for building release strategies, which should apply to several models and situations. These principles are exemplified by two interval observer-based feedback control laws whose stabilizing properties are demonstrated when applied to a model retrieved from [1]. Crucial use is made of the theory of monotone dynamical systems.
C1 [Bliman, Pierre-Alexandre] Univ Paris Diderot SPC, Sorbonne Univ, Lab Jacques Louis Lions, Inria,CNRS,Equipe Mamba, F-75005 Paris, France.
RP Bliman, PA (corresponding author), Univ Paris Diderot SPC, Sorbonne Univ, Lab Jacques Louis Lions, Inria,CNRS,Equipe Mamba, F-75005 Paris, France.
EM pierre-alexandre.bliman@inria.fr
FU Franco-Columbian program ECOS-Nord [C17M01]; Regional Council of La
   Reunion; European Regional Development Fund (ERDF) under the 2014-2020
   Operational ProgramEuropean Union (EU)
FX The author acknowledges the financial support of the Franco-Columbian
   program ECOS-Nord, through the project C17M01. This work benefited from
   fruitful discussions with Y. Dumont (CIRAD, University of Pretoria)
   within the framework of the Phase 2 SIT feasibility project against
   Aedes albopictus in Reunion Island, jointly funded by the Regional
   Council of La Reunion and the European Regional Development Fund (ERDF)
   under the 2014-2020 Operational Program.
CR Almeida L., 2018, OPTIMAL RELEASES POP
   Almeida L., 2019, ARXIV190105688
   Alphey L., 2014, ANN REV ENTOMOLOGY, V59
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Bliman P.-A., 2018, ARXIV181201277
   Bliman P.-A., 2019, ARXIV190300730
   Bliman PA, 2018, J MATH BIOL, V76, P1269, DOI 10.1007/s00285-017-1174-x
   Campo-Duarte DE, 2017, APPL MATH INFORM SCI, V11, P1011, DOI [10.18576/amis/110408, DOI 10.18576/AMIS/110408]
   Campo-Duarte DE, 2018, J MATH BIOL, V76, P1907, DOI 10.1007/s00285-018-1213-2
   Efimov D, 2016, AUTOMAT REM CONTR+, V77, P191, DOI 10.1134/S0005117916020016
   Efimov D, 2013, AUTOMATICA, V49, P200, DOI 10.1016/j.automatica.2012.07.004
   Farkas JZ, 2010, B MATH BIOL, V72, P2067, DOI 10.1007/s11538-010-9528-1
   Ferreira CP, 2014, ECOLOGICAL MODELLING
   Focks D. A., 2004, TECH REP
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes H, 2013, B MATH BIOL, V75, P796, DOI 10.1007/s11538-013-9835-4
   Keeling MJ, 2003, HEREDITY, V91, P382, DOI 10.1038/sj.hdy.6800343
   Koiller J., 2014, RR8462 INR
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Moisan M, 2009, AUTOMATICA, V45, P291, DOI 10.1016/j.automatica.2008.07.006
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Ndii MZ, 2015, MATH BIOSCI, V262, P157, DOI 10.1016/j.mbs.2014.12.011
   ONEILL S, 1998, INFLUENTIAL PASSENGE
   Ruang-areerate T, 2006, P NATL ACAD SCI USA, V103, P12534, DOI 10.1073/pnas.0508879103
   Silver JB., 2007, MOSQUITO ECOLOGY FIE
   Smith H. L., 1995, MATH SURVEYS MONOGRA, V41
   SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Xue L, 2017, J BIOL DYNAM, V11, P216, DOI 10.1080/17513758.2016.1229051
   Yakob L., 2017, PLOS CURRENTS, V9
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zheng B., 2017, NONLINEAR ANAL DIFFE, V5, P197
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
NR 36
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-3-907144-00-8
PY 2019
BP 1659
EP 1664
PG 6
WC Automation & Control Systems
SC Automation & Control Systems
GA BO0FE
UT WOS:000490488301111
DA 2020-07-08
ER

EF